Citrus Sinensis ID: 004672
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 738 | 2.2.26 [Sep-21-2011] | |||||||
| Q9CAV6 | 700 | Serine/threonine-protein | yes | no | 0.758 | 0.8 | 0.586 | 0.0 | |
| Q0D598 | 704 | Probable serine/threonine | yes | no | 0.876 | 0.919 | 0.515 | 0.0 | |
| A2YMV6 | 704 | Probable serine/threonine | N/A | no | 0.612 | 0.642 | 0.685 | 0.0 | |
| Q8S8Y9 | 568 | Serine/threonine-protein | no | no | 0.649 | 0.843 | 0.601 | 1e-173 | |
| Q2V338 | 492 | Probable serine/threonine | no | no | 0.584 | 0.876 | 0.658 | 1e-170 | |
| Q65X23 | 621 | Probable serine/threonine | no | no | 0.535 | 0.636 | 0.566 | 1e-132 | |
| Q9STK6 | 516 | Probable serine/threonine | no | no | 0.478 | 0.684 | 0.578 | 1e-127 | |
| Q0D847 | 601 | Probable serine/threonine | no | no | 0.626 | 0.768 | 0.491 | 1e-124 | |
| Q8S8Y8 | 567 | Probable serine/threonine | no | no | 0.548 | 0.714 | 0.516 | 1e-120 | |
| Q8LST2 | 557 | Probable serine/threonine | no | no | 0.543 | 0.719 | 0.513 | 1e-118 |
| >sp|Q9CAV6|WNK1_ARATH Serine/threonine-protein kinase WNK1 OS=Arabidopsis thaliana GN=WNK1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 691 bits (1782), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/643 (58%), Positives = 448/643 (69%), Gaps = 83/643 (12%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
YRAFDEYEGIEVAWNQVKLYDFLQSPE+LERLYCEIHLLKTLKH+NIMKFYTSWVDTANR
Sbjct: 39 YRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
NINFVTE+FTSGTLRQYRL+H+RVNIRA+KHWCRQIL GL YLHS DPPVIHRDLKCDNI
Sbjct: 99 NINFVTELFTSGTLRQYRLRHKRVNIRAMKHWCRQILRGLHYLHSHDPPVIHRDLKCDNI 158
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEM 217
FVNGNQGEVKIGDLGLAAILRKSHAA CVGTPEFMAPEVYEE YNELVDIYSFGMCILEM
Sbjct: 159 FVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEM 218
Query: 218 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTD 277
VTFDYPYSECTHPAQIYKKV+SGKKP+AL+KV+DPEV+ FIEKCLATVS R+SARELL D
Sbjct: 219 VTFDYPYSECTHPAQIYKKVMSGKKPDALYKVKDPEVKCFIEKCLATVSLRVSARELLDD 278
Query: 278 PFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLY--------------------GIYHSNS 317
PFL+IDD + DLR + + D + PL RQ + G Y SNS
Sbjct: 279 PFLRIDDGEFDLRSVDME---DSVGPLYRQPHHLPDYYNYPSNSSSLNRQYSNGNYPSNS 335
Query: 318 SSNN---GCGHYIGYDTENGLDYHPHEFQESE-IDLFTC------QEDEHLTNFDISIKG 367
SS N G+ ++ +NG Y+P E +E+ I+LF +E++ N DI+IKG
Sbjct: 336 SSLNRQYSNGYNSHHEYQNGWAYNPAETEETHGIELFESRNNDDQEEEKKSGNVDITIKG 395
Query: 368 KRREDDGIFLRLRIADKEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEII 427
KRR+D G+FLRLRIADKEGR+RNIYFPFDI+TDTALSVATEMV+ELD+ D VTKIA +I
Sbjct: 396 KRRDDGGLFLRLRIADKEGRVRNIYFPFDIETDTALSVATEMVAELDMDDHGVTKIANMI 455
Query: 428 DSEIASLVPEWKRGMAMEE------SPHRSSFCHNCASN----GCLPDYILSDGSGAKNL 477
D EI+SLVP W+ G EE + + +S C+NC SN G + D++ ++ GA
Sbjct: 456 DGEISSLVPSWRPGPEFEECLAAAAAANAASICNNCVSNRTSMGSVMDFLRTN-PGA--- 511
Query: 478 QVLQCSKDGCAAIHGRFEEITYQVDGAEQCAPEGADQAASPQSAVVHYADIWA---QHEG 534
V+QC ++GC HGRFEEIT + V ++W Q E
Sbjct: 512 NVIQCCRNGCGETHGRFEEITI-------------------RETEVRLRELWKLQQQQES 552
Query: 535 QVLSSQGSRDIHCDEEHKTLNQSSYGAEEKIINMDSQSKCHERNCFSMNSAMDYGLLDDY 594
+ LSS I H + E NM S +E N S + + + + Y
Sbjct: 553 RELSS-----IDSGHNHSEEEEEEEVLYEDPENMFSCEAGNEINHISGSGSFSF-MPSKY 606
Query: 595 --------ENEIRQELRWLKAKYQIQLRELRDQQLGVKYKSSS 629
EN+++QELRWLKAK QI+LR+++D+QL ++ S
Sbjct: 607 CDEPSEKTENQVQQELRWLKAKCQIELRDIQDEQLKTRWPESG 649
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates APRR3. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q0D598|WNK1_ORYSJ Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. japonica GN=WNK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 660 bits (1702), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/714 (51%), Positives = 461/714 (64%), Gaps = 67/714 (9%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
YRAFDEY+G+EVAWNQVKL+DFLQSPE+LERLYCEIHLLKTLKHRNIMKFYTSWVD + R
Sbjct: 42 YRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLYCEIHLLKTLKHRNIMKFYTSWVDVSRR 101
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
NINF+TEMFTSGTLRQYR KH RVNI AVKHWCRQILSGLLYLHS DPP+IHRDLKCDNI
Sbjct: 102 NINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCRQILSGLLYLHSHDPPIIHRDLKCDNI 161
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEM 217
FVNGNQGEVKIGDLGLAAILRKSHA CVGTPEFMAPEVYEEEYNELVDIYSFGMC+LEM
Sbjct: 162 FVNGNQGEVKIGDLGLAAILRKSHAVHCVGTPEFMAPEVYEEEYNELVDIYSFGMCVLEM 221
Query: 218 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTD 277
VTF+YPYSECTHP QIYKKVISG KPEAL+KV+DP VRQF+EKCLAT S RLSARELL D
Sbjct: 222 VTFEYPYSECTHPVQIYKKVISGTKPEALYKVKDPMVRQFVEKCLATASRRLSARELLKD 281
Query: 278 PFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCGHYIGYD--TENGL 335
PFLQ+D DL DY ++ L + L Y + S +NG I D TE+
Sbjct: 282 PFLQVD----DLVFCPGDGDYSLMNYLRQPYLEHAYSNVSMMSNGLSESIDEDTPTEDRW 337
Query: 336 DYHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPF 395
D + + IDLF EDE L N DI+IKG++ ED IFLRLRIAD +G +RNIYFPF
Sbjct: 338 DCEDDDIKADGIDLFNGHEDEPLGNVDITIKGRKSEDGSIFLRLRIADNDGHVRNIYFPF 397
Query: 396 DIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAMEESPHRSSFCH 455
DI+ DTALSVATEMV+ELDITD +VT+IAE+ID E+++LVP+W+ G +EES +++CH
Sbjct: 398 DIEADTALSVATEMVAELDITDHEVTRIAEMIDGEVSALVPDWRPGPGIEES-QDTTYCH 456
Query: 456 NCASN----GCLPDYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEITYQVDGAEQCAPEG 511
NC SN G L Y+ S G + CA +HGRFEEIT+Q +G + +
Sbjct: 457 NCGSNVSSCGSLYAYMSSAARGCQ-----------CAELHGRFEEITFQANGEQTDLQDS 505
Query: 512 ADQAASPQSAVVHYADIWAQHEGQV--LSSQGSRDIHCDEEHKTLNQSSYGAEEKIINMD 569
+ H D A H + +G RD C SS+
Sbjct: 506 GGSSDDGGGQTQHVKDQEAVHSNGFVQMGRRGPRDQFC--------FSSF---------- 547
Query: 570 SQSKCHERNCFSMNSAMDYGLLDDYENEIRQELRWLKAKYQIQLRELRDQQLGVKYKSSS 629
+ C R+ YE + + + K+++++ + + +++ ++
Sbjct: 548 QEQSCSPRH---------------YEYDTSLQAKGFDMKHEVKMAKYKARKMAHLRRAIH 592
Query: 630 LTLITDD-----KTRASDDKVSPSSVLPEPESNRPP--QRTIAHRPTKHLTSCLPIGDEK 682
+L D+ + ++S +K+ S + + + R P +R+ R + +
Sbjct: 593 PSLDFDNLNGERRMKSSLNKLQ-SFHIGKNHNFRIPTCERSPGARDAEEDPDIFNLAYHS 651
Query: 683 KCGNVANQRVHSFEQMNWPCSPEQMVTAKSYYTPL-LPHSLHRATSLPVDSVDV 735
+ + QR E ++ SP+ M TA+SYYT LP +L R S+ +++VD
Sbjct: 652 RHPDPGAQRARHCE-VDAQSSPDLMFTARSYYTGAQLPTNLPRTKSVTLNAVDA 704
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YMV6|WNK1_ORYSI Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. indica GN=WNK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 655 bits (1690), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 325/474 (68%), Positives = 371/474 (78%), Gaps = 22/474 (4%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
YRAFDEY+G+EVAWNQVKL+DFLQSPE+LERLYCEIHLLKTLKHRNIMKFYTSWVD + R
Sbjct: 42 YRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLYCEIHLLKTLKHRNIMKFYTSWVDVSRR 101
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
NINF+TEMFTSGTLRQYR KH RVNI AVKHWCRQILSGLLYLHS DPP+IHRDLKCDNI
Sbjct: 102 NINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCRQILSGLLYLHSHDPPIIHRDLKCDNI 161
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEM 217
FVNGNQGEVKIGDLGLAAILRKSHA CVGTPEFMAPEVYEEEYNELVDIYSFGMC+LEM
Sbjct: 162 FVNGNQGEVKIGDLGLAAILRKSHAVHCVGTPEFMAPEVYEEEYNELVDIYSFGMCVLEM 221
Query: 218 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTD 277
VTF+YPYSECTHP QIYKKVISG KPEAL+KV+DP VRQF+EKCLAT S RLSARELL D
Sbjct: 222 VTFEYPYSECTHPVQIYKKVISGTKPEALYKVKDPMVRQFVEKCLATASRRLSARELLKD 281
Query: 278 PFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCGHYIGYD--TENGL 335
PFLQ+D DL DY ++ L + L Y + S +NG I D TE+
Sbjct: 282 PFLQVD----DLVFCPGDGDYSLMNYLRQPYLEHAYSNVSMMSNGLSESIDEDTPTEDRW 337
Query: 336 DYHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPF 395
D + + IDLF EDE L N DI+IKG++ ED IFLRLRIAD +G +RNIYFPF
Sbjct: 338 DCEDDDIKADGIDLFNGHEDEPLGNVDITIKGRKSEDGSIFLRLRIADNDGHVRNIYFPF 397
Query: 396 DIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAMEESPHRSSFCH 455
DI+ DTALSVATEMV+ELDITD +VT+IAE+ID E+++LVP+W+ G +EES +++CH
Sbjct: 398 DIEADTALSVATEMVAELDITDHEVTRIAEMIDGEVSALVPDWRPGPGIEES-QDTTYCH 456
Query: 456 NCASN----GCLPDYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEITYQVDGAE 505
NC SN G L Y+ S G + CA +HGRFEEIT+Q +G +
Sbjct: 457 NCGSNVSSCGSLYAYMSSAARGCQ-----------CAELHGRFEEITFQANGEQ 499
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8S8Y9|WNK2_ARATH Serine/threonine-protein kinase WNK2 OS=Arabidopsis thaliana GN=WNK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 609 bits (1570), Expect = e-173, Method: Compositional matrix adjust.
Identities = 312/519 (60%), Positives = 372/519 (71%), Gaps = 40/519 (7%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
YRAFDEYEGIEVAWNQVKL +F ++PEELE+ + EIHLLKTL H+NIMKFYTSWVDT N
Sbjct: 39 YRAFDEYEGIEVAWNQVKLRNFTRNPEELEKFFREIHLLKTLNHQNIMKFYTSWVDTNNL 98
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
+INFVTE+FTSGTLRQYRL+HRRVNIRAVK WC+QIL GLLYLHSR PP+IHRDLKCDNI
Sbjct: 99 SINFVTELFTSGTLRQYRLRHRRVNIRAVKQWCKQILKGLLYLHSRSPPIIHRDLKCDNI 158
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEM 217
F+NGNQGEVKIGDLGLAAILRKSHA RCVGTPEFMAPEVY+EEYNELVD+Y+FGMC+LEM
Sbjct: 159 FINGNQGEVKIGDLGLAAILRKSHAVRCVGTPEFMAPEVYDEEYNELVDVYAFGMCVLEM 218
Query: 218 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTD 277
VTFDYPYSECTHPAQIYKKV SGKKPEA + V+DPEVR+F+EKCLA V+ RL+A ELL D
Sbjct: 219 VTFDYPYSECTHPAQIYKKVTSGKKPEAFYLVKDPEVREFVEKCLANVTCRLTALELLQD 278
Query: 278 PFLQIDDYDS-DLRMIQYQTDYDEISPLLRQSLYG--IYHSNSSSNNGCGHYIGYDTENG 334
PFLQ D+ D +R I Y YDE LR L +YH S+ C
Sbjct: 279 PFLQDDNMDGFVMRPIDYYNGYDETGVFLRHPLIDDPLYHDQFESSQIC----------- 327
Query: 335 LDYHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFP 394
EIDLF +++H+ DISIKGKR DDGIFLRLRI+D EGRIRNIYFP
Sbjct: 328 -----------EIDLFANDDEDHV---DISIKGKRNGDDGIFLRLRISDAEGRIRNIYFP 373
Query: 395 FDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAMEESPHR---- 450
F+ DTA SVA EMVSELDIT+QDV KIAE+ID+EIA+LVP+WK ++ +
Sbjct: 374 FETAIDTAWSVAVEMVSELDITNQDVAKIAEMIDAEIAALVPDWKNDTESSQNVNNNKNN 433
Query: 451 --SSFCHNCASNGCLPDYILSDGSGAKNLQVLQCSKD-GCAAIHGRFEEI-----TYQVD 502
+ FC CASNG + + + S N S+D C+++HGRF ++ +Y D
Sbjct: 434 NTAGFCGECASNGYIQETVSSGEKSHHNHHEFDSSEDKSCSSVHGRFADMWGLRESYSDD 493
Query: 503 GAEQCAPEGADQAASPQSAVVHYADIWAQHEGQVLSSQG 541
G +Q + + S + A+H+ Q++ +G
Sbjct: 494 GEKQSSRKVRSGRWSENEMRRELRWLKARHKIQLMKMRG 532
|
Regulates flowering time by modulating the photoperiod pathway. Possesses kinase activity in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2V338|WNK9_ARATH Probable serine/threonine-protein kinase WNK9 OS=Arabidopsis thaliana GN=WNK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 599 bits (1544), Expect = e-170, Method: Compositional matrix adjust.
Identities = 314/477 (65%), Positives = 364/477 (76%), Gaps = 46/477 (9%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
YR FDEY+GIEVAWNQVKLYDFLQSP+ELERLYCEIHLLKTLKH++IMKFY SWVDT NR
Sbjct: 40 YRGFDEYQGIEVAWNQVKLYDFLQSPQELERLYCEIHLLKTLKHKSIMKFYASWVDTDNR 99
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
NINFVTEMFTSGTLRQYRLKH+RVNIRAVK+WCRQIL GL YLH+ DPPVIHRDLKCDNI
Sbjct: 100 NINFVTEMFTSGTLRQYRLKHKRVNIRAVKNWCRQILRGLNYLHTHDPPVIHRDLKCDNI 159
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEM 217
F+NGNQGEVKIGDLGLAA L+ SHAA CVGTPEFMAPEVY+EEYN+LVDIYSFGMC+LEM
Sbjct: 160 FINGNQGEVKIGDLGLAACLQHSHAAHCVGTPEFMAPEVYKEEYNQLVDIYSFGMCVLEM 219
Query: 218 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTD 277
VTFDYPYSEC+HPAQIYK+VISGKKP+ L KV+DPEVR FIEKCLATVS RLSA ELL D
Sbjct: 220 VTFDYPYSECSHPAQIYKRVISGKKPDGLDKVKDPEVRGFIEKCLATVSLRLSACELLDD 279
Query: 278 PFLQIDDYDSDLRMIQYQTDY-DEISPLLRQSLYGIYHSNSSSNNGCGHYIGYDTENGLD 336
FL ID +SD+R ++ + DE LR S + ++SN G+Y Y+ +N D
Sbjct: 280 HFLCID--ESDMRRVESEKGLIDEAGTPLRHSYHIPHYSN-------GYYSLYN-QNQWD 329
Query: 337 YHPHEFQES-EIDLFTCQE-------DEHLTNFDISIKGKRRED-DGIFLRLRIADKEGR 387
Y+ E ES EIDL Q D+ + DISIKGKRR++ DG+FLRL+ +KEG
Sbjct: 330 YNGDETVESHEIDLLEFQNDDDEEEEDKRFGSVDISIKGKRRDNGDGLFLRLKTVNKEGC 389
Query: 388 IRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAMEES 447
+RNIYFPFDI+TDTA+SVA EMV EL++ D+DVTKIA +ID EIASLVP W
Sbjct: 390 VRNIYFPFDIETDTAISVAREMVEELEMDDRDVTKIANMIDGEIASLVPNW--------- 440
Query: 448 PHRSSFC---HNCASNGCLPDYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEITYQV 501
S FC N +S G + D+ +QC +DGC HGRFEEIT+++
Sbjct: 441 ---SIFCSSESNRSSVGSVMDF-----------NEMQCGRDGCEEKHGRFEEITFEI 483
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q65X23|WNK2_ORYSJ Probable serine/threonine-protein kinase WNK2 OS=Oryza sativa subsp. japonica GN=WNK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 474 bits (1219), Expect = e-132, Method: Compositional matrix adjust.
Identities = 233/411 (56%), Positives = 306/411 (74%), Gaps = 16/411 (3%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y+AFD+ EG+EVAWNQ+K+ D L++ ++LERL E+ LLKTLKH+NI+KFY SW+D N
Sbjct: 43 YKAFDQLEGLEVAWNQIKVGDILRNNDDLERLRSEVRLLKTLKHKNIIKFYNSWLDKKNN 102
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
NINF+TE+FTSGTLRQYR+KH++V++RA+K W RQILSGL+YLHS DPPVIHRDLKCDNI
Sbjct: 103 NINFITEVFTSGTLRQYRIKHKKVDVRALKKWSRQILSGLVYLHSHDPPVIHRDLKCDNI 162
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARC-VGTPEFMAPEVYEEEYNELVDIYSFGMCILE 216
FVNGNQGEVKIGDLGLA IL + +A +GTPEFMAPE+Y+EEYNELVDIY+FGMC+LE
Sbjct: 163 FVNGNQGEVKIGDLGLATILDNARSAHSIIGTPEFMAPELYDEEYNELVDIYAFGMCLLE 222
Query: 217 MVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLT 276
+VTF+YPY EC++ AQIYKKV G+KP +L K+EDPEVR FIEKC+A S RLSA+ELL
Sbjct: 223 LVTFEYPYCECSNAAQIYKKVSDGEKPSSLAKIEDPEVRFFIEKCIAKASQRLSAQELLM 282
Query: 277 DPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCGHYIGYDTENGLD 336
DPFL+ DD + +Q T + + S+ Y ++SS H + E+ D
Sbjct: 283 DPFLR-DDGEKIFYPLQSNTKASDGAGSSNSSMGYKYDRDASSMAIREHTGSFAEEHPSD 341
Query: 337 YHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPFD 396
+ H + + + I+++ + ++ + IFL+LRIAD G +NI+FPFD
Sbjct: 342 RYIH----------STMDPQAAAGRIITVESQMKDLNTIFLKLRIADSTGHAQNIHFPFD 391
Query: 397 IQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAMEES 447
I+ DT++SVATEMV +LD+TDQDVT IAE+ID+EI + +P+W A+EES
Sbjct: 392 IEADTSISVATEMVVQLDLTDQDVTAIAEMIDAEIRAHIPDW----ALEES 438
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9STK6|WNK3_ARATH Probable serine/threonine-protein kinase WNK3 OS=Arabidopsis thaliana GN=WNK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 456 bits (1174), Expect = e-127, Method: Compositional matrix adjust.
Identities = 233/403 (57%), Positives = 294/403 (72%), Gaps = 50/403 (12%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
YRAFD+ EGIEVAWNQVKL D S E+L+RLY E+HLLKTLKH++I+KFYTSW+D +
Sbjct: 37 YRAFDQLEGIEVAWNQVKLDDKFCSSEDLDRLYSEVHLLKTLKHKSIIKFYTSWIDHQHM 96
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
IN +TE+FTSG LRQYR KH+ V++RA+K W RQIL GL+YLHS DPPVIHRDLKCDNI
Sbjct: 97 TINLITEVFTSGNLRQYRKKHKCVDLRALKKWSRQILEGLVYLHSHDPPVIHRDLKCDNI 156
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCV-GTPEFMAPEVYEEEYNELVDIYSFGMCILE 216
F+NGNQGEVKIGDLGLAAIL ++ +A V GTPEFMAPE+YEE+YN LVDIY+FGMC+LE
Sbjct: 157 FINGNQGEVKIGDLGLAAILHRARSAHSVIGTPEFMAPELYEEDYNVLVDIYAFGMCLLE 216
Query: 217 MVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLT 276
+VTF+YPYSECT+ AQIY+KV SG KP AL V DP+VR FIEKC+A VS RLSA+ELL
Sbjct: 217 LVTFEYPYSECTNAAQIYRKVTSGIKPAALLNVTDPQVRAFIEKCIAKVSQRLSAKELLD 276
Query: 277 DPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCGHYIGYDTENGLD 336
DPFL+ Y+ + + +S S NG Y G NG+
Sbjct: 277 DPFLKC-----------YKENTENVS--------------SHKENG---YNG----NGI- 303
Query: 337 YHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPFD 396
+ +SE+ L T ++G+R++ + IFL+LRI D +G+IRNI+FPF+
Sbjct: 304 --VDKLSDSEVGLLT-------------VEGQRKDLNTIFLKLRITDSKGQIRNIHFPFN 348
Query: 397 IQTDTALSVATEMVSELDIT-DQDVTKIAEIIDSEIASLVPEW 438
I+TDT+ SVA EMV ELD+T DQD++ IA++ID+EI S +P+W
Sbjct: 349 IETDTSFSVAIEMVEELDLTDDQDISTIAKMIDTEIHSHIPDW 391
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D847|WNK3_ORYSJ Probable serine/threonine-protein kinase WNK3 OS=Oryza sativa subsp. japonica GN=WNK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 445 bits (1145), Expect = e-124, Method: Compositional matrix adjust.
Identities = 253/515 (49%), Positives = 321/515 (62%), Gaps = 53/515 (10%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
YR FDE+ G+EVAWNQV+L D ++ ELER Y E+HLL L+HR I++ + WVD R
Sbjct: 49 YRGFDEWRGVEVAWNQVRLRDVVRGGGELERFYGEVHLLAALRHRGIVRLHAYWVDAPRR 108
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
+NFVTE+F SGTLRQYR +HRRV+ AV+ WC QIL GL YLH+ PP+IHRDLKCDNI
Sbjct: 109 ALNFVTELFVSGTLRQYRERHRRVSAAAVRRWCAQILDGLAYLHAHSPPIIHRDLKCDNI 168
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEM 217
FVNGNQGEVKIGDLGLAA R ARCVGTPEFMAPEVY+E Y+EL D+YSFGMC+LEM
Sbjct: 169 FVNGNQGEVKIGDLGLAAFRRGGGHARCVGTPEFMAPEVYDESYDELADVYSFGMCVLEM 228
Query: 218 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTD 277
VT DYPYSEC++P QIYK+VISG KP AL++V DP VRQFIE+CLA + R +ARELL D
Sbjct: 229 VTLDYPYSECSNPIQIYKRVISGIKPAALYRVSDPVVRQFIERCLAPAARRPAARELLDD 288
Query: 278 PFLQIDDYDSDLRMIQYQTD-------YDEISPLLRQ----------SLYGIYHSNSSSN 320
PFL + D Y+ + L Q S G+ SNS +
Sbjct: 289 PFLLPLEDDGFFSGDGGDGHGGFGVGYYNLMYNYLHQPACIDDHHACSNGGLSPSNSVGD 348
Query: 321 NGCGHYIGYDTENG----LDYHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIF 376
N + ++G D H F E + D +E + DI+IKG+R +D G++
Sbjct: 349 NDVDAAVQRGDDDGDNWLRDIH-MLFDEDDDDAAAADANERVGGVDITIKGRRTDDGGVY 407
Query: 377 LRLRIADKE--GRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASL 434
L LRIADK GR R I F FD + DTA++VA EMV+ELDITD +VT+IA++ID ++A+L
Sbjct: 408 LGLRIADKNGTGRGRIICFRFDTEADTAMTVAAEMVAELDITDHEVTRIAQLIDGKVAAL 467
Query: 435 VPEWKRGMAMEESPHRSSF----------------CHNCASN-------GCLPDYILSDG 471
VP W+ G A ++ C NC G L D++ S
Sbjct: 468 VPGWRPGPATDDDDDDDLVGGGDDPDAPGGAAAACCKNCRPAASSSSSCGSLVDFMSSAA 527
Query: 472 SGAKNLQVLQCSKDGCAAIHGRFEEITYQVDGAEQ 506
+ ++ C + CA +HGRFEEIT+Q D E+
Sbjct: 528 AAERH----GCRR--CAELHGRFEEITFQADDDEE 556
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8S8Y8|WNK6_ARATH Probable serine/threonine-protein kinase WNK6 OS=Arabidopsis thaliana GN=WNK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 433 bits (1113), Expect = e-120, Method: Compositional matrix adjust.
Identities = 214/414 (51%), Positives = 286/414 (69%), Gaps = 9/414 (2%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y+AFDE +GIEVAWNQV++ D LQSP LERLY E+ LLK+LKH NI++FY SW+D N+
Sbjct: 43 YKAFDEVDGIEVAWNQVRIDDVLQSPNCLERLYSEVRLLKSLKHNNIIRFYNSWIDDKNK 102
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
+N +TE+FTSG+LR YR KHR+VN++AVK+W RQIL GL YLH ++PP+IHRDLKCDNI
Sbjct: 103 TVNIITELFTSGSLRHYRKKHRKVNMKAVKNWARQILMGLRYLHGQEPPIIHRDLKCDNI 162
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEM 217
F+NGN GEVKIGDLGLA ++ +++A +GTPEFMAPE+Y+E YNEL DIYSFGMC+LEM
Sbjct: 163 FINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 222
Query: 218 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTD 277
VTFDYPY EC + AQIYKKV SG KP +L +V+DPEV+QFIEKCL S RLSA+ELL D
Sbjct: 223 VTFDYPYCECKNSAQIYKKVSSGIKPASLSRVKDPEVKQFIEKCLLPASERLSAKELLLD 282
Query: 278 PFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYG--IYHSNSSSNNGCGHYIGYDTENGL 335
PFLQ++ L M D + P ++ +G S + D +
Sbjct: 283 PFLQLN----GLTMNNPLPLPDIVMP--KEGAFGDRCLMSEGPPTTRPSKTLSIDLDEDS 336
Query: 336 DYHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPF 395
+ F ++ NF + +KG+ ++ + L LRI D+ GR+RNI+F F
Sbjct: 337 NLPIVTFSDNSGSRCIEVRRAKRGNFFV-LKGEENDEQSVSLILRIVDENGRVRNIHFLF 395
Query: 396 DIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAMEESPH 449
+ DTA V++EMV +L++TDQ+VT IAE+ID + +++P WK + ++ H
Sbjct: 396 YQEGDTASKVSSEMVEQLELTDQNVTFIAELIDILLVNMIPTWKTDVTVDHLIH 449
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LST2|WNK7_ARATH Probable serine/threonine-protein kinase WNK7 OS=Arabidopsis thaliana GN=WNK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 427 bits (1099), Expect = e-118, Method: Compositional matrix adjust.
Identities = 214/417 (51%), Positives = 289/417 (69%), Gaps = 16/417 (3%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
++ FDE +GIEVAWNQV++ D LQSP+ LERLY E+ LLK+LKH+NI++FY SW+D N+
Sbjct: 43 FKGFDEVDGIEVAWNQVRIDDLLQSPDCLERLYSEVRLLKSLKHKNIIRFYNSWIDDKNK 102
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
+N +TE+FTSG+LRQYR KHR+VN++AVK W RQIL+GL YLHS+DPP+IHRD+KCDNI
Sbjct: 103 TVNIITELFTSGSLRQYRKKHRKVNMKAVKCWARQILTGLKYLHSQDPPIIHRDIKCDNI 162
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEM 217
F+NGN GEVKIGDLGLA ++ +++A +GTPEFMAPE+Y+E YNEL DIYSFGMC+LEM
Sbjct: 163 FINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 222
Query: 218 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTD 277
VTF+YPY EC + AQIYKKV SG KP +L KV+DPEV +FIEKCL S RLSA ELL D
Sbjct: 223 VTFEYPYCECRNSAQIYKKVSSGIKPASLSKVKDPEVMKFIEKCLLPASERLSAEELLLD 282
Query: 278 PFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYG---IYHSNSSSNNGCGHYIGYDTENG 334
FL ++ L M D + P ++ +G + + + D +N
Sbjct: 283 SFLNVN----GLVMNNPLPLPDIVMP--KEGSFGERCLMSEGPPNARNRTMSMNLDEDNN 336
Query: 335 LDYHPHEFQESEIDLFTCQEDEHLT--NFDISIKGKRREDDGIFLRLRIADKEGRIRNIY 392
L S C E NF + +KG+ +++ + L LRI D+ GR+RNI+
Sbjct: 337 LPI----VISSNNSGTNCIEVRRAKRGNFFV-LKGEENDENSVSLILRIVDENGRVRNIH 391
Query: 393 FPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAMEESPH 449
F F + DTA +V++EMV +L++TD++V IAE+ID + +L+P WK +A++ H
Sbjct: 392 FLFFQEGDTASNVSSEMVEQLELTDKNVKFIAELIDVLLVNLIPNWKTDVAVDHLIH 448
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 738 | ||||||
| 225432654 | 729 | PREDICTED: serine/threonine-protein kina | 0.929 | 0.941 | 0.721 | 0.0 | |
| 255552205 | 732 | conserved hypothetical protein [Ricinus | 0.930 | 0.938 | 0.682 | 0.0 | |
| 449444242 | 740 | PREDICTED: serine/threonine-protein kina | 0.926 | 0.924 | 0.639 | 0.0 | |
| 147815157 | 752 | hypothetical protein VITISV_035622 [Viti | 0.975 | 0.957 | 0.614 | 0.0 | |
| 359487822 | 743 | PREDICTED: serine/threonine-protein kina | 0.928 | 0.921 | 0.635 | 0.0 | |
| 356575845 | 658 | PREDICTED: serine/threonine-protein kina | 0.825 | 0.925 | 0.620 | 0.0 | |
| 255542364 | 775 | kinase, putative [Ricinus communis] gi|2 | 0.857 | 0.816 | 0.630 | 0.0 | |
| 351723121 | 652 | with no lysine kinase 2 [Glycine max] gi | 0.823 | 0.932 | 0.617 | 0.0 | |
| 224125588 | 730 | predicted protein [Populus trichocarpa] | 0.918 | 0.928 | 0.609 | 0.0 | |
| 356535149 | 708 | PREDICTED: serine/threonine-protein kina | 0.883 | 0.920 | 0.596 | 0.0 |
| >gi|225432654|ref|XP_002278361.1| PREDICTED: serine/threonine-protein kinase WNK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1016 bits (2627), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 507/703 (72%), Positives = 575/703 (81%), Gaps = 17/703 (2%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
YRAFDEYEGIEVAWNQVKL DFLQSPEELERLYCEIHLLKTLKH NIMKFYTSWVD ANR
Sbjct: 37 YRAFDEYEGIEVAWNQVKLNDFLQSPEELERLYCEIHLLKTLKHNNIMKFYTSWVDPANR 96
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQIL GLLYLH+ PPVIHRDLKCDNI
Sbjct: 97 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILRGLLYLHNHKPPVIHRDLKCDNI 156
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEM 217
FVNGNQGEVKIGDLGLAAILRKSHAA CVGTPEFMAPEVYEEEYNELVDIYSFGMCILEM
Sbjct: 157 FVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEM 216
Query: 218 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTD 277
VTF+YPYSECTHPAQIYKKVISGKKP+AL+KV+DPEVRQF+EKCLATV+ RLSARELL D
Sbjct: 217 VTFEYPYSECTHPAQIYKKVISGKKPDALYKVKDPEVRQFVEKCLATVTLRLSARELLKD 276
Query: 278 PFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCGHYIGYDTENGLDY 337
PFLQ DDY SDLR I+YQ D E+ PL R YGI+HS SS N Y ++ ENGLD
Sbjct: 277 PFLQSDDYGSDLRPIEYQRDLGEVGPLPRLPHYGIHHSYSSLRNEYSGYPDFEPENGLDC 336
Query: 338 HPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPFDI 397
HP EF+ +EIDLFT QEDEHL N DISI+G++R+D GIFLRLRI+DKEGR+RNIYFPFD+
Sbjct: 337 HPVEFERNEIDLFTYQEDEHLENVDISIEGRKRDDHGIFLRLRISDKEGRVRNIYFPFDM 396
Query: 398 QTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAMEES---PHRSSFC 454
+TDTALSVA EMVSELDITDQDVTKIA++ID EIASLVP WK G+ +EES H +SFC
Sbjct: 397 ETDTALSVAMEMVSELDITDQDVTKIADMIDDEIASLVPGWKMGLGIEESQNYGHDASFC 456
Query: 455 HNCASNGCLPDYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEITYQVDGAEQCAPEGADQ 514
H+CASNG DY+ + G KNLQVLQCS+ GCAA+HGRFEEITY+V+G+EQC EGA
Sbjct: 457 HHCASNGSPLDYVSPNNPGTKNLQVLQCSRQGCAAVHGRFEEITYRVEGSEQCVTEGA-P 515
Query: 515 AASPQSAVVHYADIWAQHEGQVLSSQGSRDIHCDEEHKTLNQSSYGAEEKIINMDSQSKC 574
S QS + YADIWAQ EG LSS+GSR+I DEEH++L++S YG +E++IN+D+QS+
Sbjct: 516 VVSSQSDGMQYADIWAQREGPELSSEGSREIQSDEEHESLDKSIYGKDERVINIDNQSES 575
Query: 575 HERNCFSMNSAMDYGLLDDYENEIRQELRWLKAKYQIQLRELRDQQLGVKYKSSSLTLIT 634
+ +N F+ LDDYENEIRQELRWLKAKYQ+QLRELRDQQLG K K SLT +
Sbjct: 576 NAKNSFAP--------LDDYENEIRQELRWLKAKYQMQLRELRDQQLGAKPKWLSLTPNS 627
Query: 635 DDKTRASDDKVSPSSVLP--EPESNRPPQRTIAHRPTKHLTSCLPIGDEKKCGNVANQRV 692
D + D+KVSPSS+ E E N PP ++ KH S P+ E+ C N+A +R
Sbjct: 628 DSMEHSRDNKVSPSSLSTPLEGEDNDPPLKSFPC--GKHFNSFFPVDTERGCANLAYRRP 685
Query: 693 HSFEQMNWPCSPEQMVTAKSYYT-PLLPHSLHRATSLPVDSVD 734
H+ E ++ CSPE MVTAKS++T LLP SLHRATSLPVD+VD
Sbjct: 686 HNREPVSESCSPEDMVTAKSFFTGTLLPQSLHRATSLPVDAVD 728
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255552205|ref|XP_002517147.1| conserved hypothetical protein [Ricinus communis] gi|223543782|gb|EEF45310.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 960 bits (2481), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 481/705 (68%), Positives = 551/705 (78%), Gaps = 18/705 (2%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y+AFDEYEGIEVAWNQVKLYDFLQ PE+LERLYCEIHLLKTLKH NIMKFYTSWVDTANR
Sbjct: 39 YKAFDEYEGIEVAWNQVKLYDFLQCPEDLERLYCEIHLLKTLKHENIMKFYTSWVDTANR 98
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQIL GLLYLHS +PPVIHRDLKCDNI
Sbjct: 99 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILKGLLYLHSHNPPVIHRDLKCDNI 158
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEM 217
FVNGNQGEVKIGDLGLAAIL+KS+AARCVGTPEFMAPEVYEEEYNELVDIY+FGMC+LEM
Sbjct: 159 FVNGNQGEVKIGDLGLAAILKKSYAARCVGTPEFMAPEVYEEEYNELVDIYAFGMCVLEM 218
Query: 218 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTD 277
VT +YPYSEC HPAQIYKKV+SGKKPEAL+KVEDPEVRQF+EKCLATVS RLSARELL D
Sbjct: 219 VTSEYPYSECNHPAQIYKKVVSGKKPEALYKVEDPEVRQFVEKCLATVSRRLSARELLDD 278
Query: 278 PFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCGHYIGYDTENGLDY 337
PFLQIDDY DLR ++YQ D +E+ L+RQ YGI H+N S + HY+GYD EN L Y
Sbjct: 279 PFLQIDDYGYDLRSLEYQGDSNEMGALVRQPFYGINHTNGSLFSSYAHYLGYDLENELPY 338
Query: 338 HPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPFDI 397
HP F+ SEIDLF+CQEDEHL N DI+I+G+R+ +D IFLRLRIAD+EG IRNIYFPFDI
Sbjct: 339 HPVGFEPSEIDLFSCQEDEHLENVDITIQGRRKGNDCIFLRLRIADEEGCIRNIYFPFDI 398
Query: 398 QTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAMEESPHRS--SFCH 455
+TDTALSVA EMVSEL +TDQDV KI ++ID EIASLVPEWKR EESPH + +FC
Sbjct: 399 ETDTALSVAAEMVSELGMTDQDVLKITDMIDGEIASLVPEWKRRHGKEESPHEANDTFCQ 458
Query: 456 NCASNGCLPDYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEITYQVDGAEQCAPEGADQA 515
NCA L D++ S+ SG KNL VL+CSK GCA IHGRFEEITYQV+G E+CA
Sbjct: 459 NCAPVDYLLDHVSSNNSGVKNLHVLECSKHGCANIHGRFEEITYQVEGPEKCATMDCVPV 518
Query: 516 ASPQSAVVHYADIWAQHEGQVLSSQGSRDIHCDEEHKTLNQSSYGAEEKIINMDSQSKCH 575
+S QS + + DIWAQ E LSSQGS+D+HCDE H +++QS EE+IINM S +
Sbjct: 519 SSSQSNGISFTDIWAQREAPDLSSQGSKDVHCDERHNSVDQSVTEKEERIINMVSVCESK 578
Query: 576 ERNCFSMNSAMDYGLLDDYENEIRQELRWLKAKYQIQLRELRDQQLGVKYKSSSLTLITD 635
RN + + DDYENEIRQELRWLKAKYQ+QLRELRDQQL TLI D
Sbjct: 579 RRNSVCSSPSTACAHWDDYENEIRQELRWLKAKYQMQLRELRDQQLQ--------TLILD 630
Query: 636 DKTR----ASDDKVSPSSVLPEPESNRPPQRTIAHRPTKHLTSCLPIGDEKKCGNVANQR 691
+ D+ VS S+LP+ + ++ + K + + +K CGN Q
Sbjct: 631 PSSNKLGYKKDNGVSLPSILPKVKRDKYKPILESLPSGKQFNTDISTDADKNCGNSEYQ- 689
Query: 692 VHSFEQMNWPCSPEQMVTAKSYYT-PLLPHSLHRATSLPVDSVDV 735
+FE +N CSPEQMVTAK++YT LLP+ LHRATSLPVD++DV
Sbjct: 690 --NFEAINKGCSPEQMVTAKNFYTGALLPYPLHRATSLPVDALDV 732
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449444242|ref|XP_004139884.1| PREDICTED: serine/threonine-protein kinase WNK1-like [Cucumis sativus] gi|449492629|ref|XP_004159053.1| PREDICTED: serine/threonine-protein kinase WNK1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 862 bits (2226), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 455/711 (63%), Positives = 539/711 (75%), Gaps = 27/711 (3%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
YRAFDEY+GIEVAWNQVKL DFLQ+PE+LERLY EIHLLKTLKH NIMKFY+SWVD ANR
Sbjct: 42 YRAFDEYDGIEVAWNQVKLSDFLQTPEDLERLYREIHLLKTLKHNNIMKFYSSWVDIANR 101
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
NINFVTEMFTSGTLRQYRLKH++VNIRAVKHWCRQIL GLLYLHS DPPVIHRDLKCDNI
Sbjct: 102 NINFVTEMFTSGTLRQYRLKHKKVNIRAVKHWCRQILKGLLYLHSHDPPVIHRDLKCDNI 161
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEM 217
FVNGNQGEVKIGDLGLAAILRKS+ ARCVGTPEFMAPE+YEEEYNELVDIYSFGMCILEM
Sbjct: 162 FVNGNQGEVKIGDLGLAAILRKSYVARCVGTPEFMAPEIYEEEYNELVDIYSFGMCILEM 221
Query: 218 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTD 277
VTF+YPYSECTHPAQIYKKVISGKKP+AL+KV+D EVR F+EKCLATVS+RLSARELL D
Sbjct: 222 VTFEYPYSECTHPAQIYKKVISGKKPDALYKVKDLEVRCFVEKCLATVSTRLSARELLND 281
Query: 278 PFLQIDDYDSDLRMIQYQTDYDEI-SPLLRQS-LYGIYHSNSSSNNGCGHYIGYDTENGL 335
PFLQID DS LR I Y ++YDE+ + L+R YG H +NG +Y ++ NGL
Sbjct: 282 PFLQIDGCDSLLRPIDYYSEYDEVNNSLIRGGPFYGTSH--GPLDNGYANYFSHEAGNGL 339
Query: 336 DYHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPF 395
DY P + + SEIDLF+CQEDEHL + DI+IKG+RR+DD IFLRLRI DKEGRIRNIYFPF
Sbjct: 340 DYCPIDNEASEIDLFSCQEDEHLEDVDITIKGRRRDDDDIFLRLRIVDKEGRIRNIYFPF 399
Query: 396 DIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAMEESPH--RSSF 453
D++ D+A SVA EMVSELDITDQDV KIA++ID EIA+LVPEWK+G ++EE+P+ S+
Sbjct: 400 DLENDSASSVANEMVSELDITDQDVKKIADMIDGEIATLVPEWKKGKSLEETPNCSDSNV 459
Query: 454 CHNCASNGCLPDYILSDGSGAKNLQVLQCSKD-GCAAIHGRFEEITYQVDGAEQCAPEGA 512
CHNC+ N L DY+ KNL +LQCS++ GCA+IHGRFEEITYQV+G+EQ +
Sbjct: 460 CHNCSLNSSLLDYVSPHNLAKKNLHILQCSEEHGCASIHGRFEEITYQVEGSEQFNGDEN 519
Query: 513 DQAASPQSAVVHYADIWAQHEGQVLSSQGSRDIHCDEEHKTLNQSSYGAEEKIINMDSQS 572
+ S+ +HYADIWAQ +G + S S + C+E + Q EE +NMD
Sbjct: 520 LHRTTGNSSDIHYADIWAQRDGPDVVSPESLEA-CNEFGAS-EQPKLEKEESNVNMDDND 577
Query: 573 KCHE-RNCFSMNSAMDYGLLDDYENEIRQELRWLKAKYQIQLRELRDQQLGVKYKSSSL- 630
E + S +S +DD+ENEIRQELRWLKAKYQ+QLRELRDQQLGVK KS SL
Sbjct: 578 HQMEFQTRNSSSSNPSESFVDDHENEIRQELRWLKAKYQMQLRELRDQQLGVKTKSLSLH 637
Query: 631 --TLITDDKTRASDDKVSPSSVLPEPESNRPPQRTIAHRPTKHLTSCLPIGDEKKCGNVA 688
+ +T+ AS +SP+ E N+ Q +++ K++TS P N+
Sbjct: 638 PISNLTETDNGASVSYLSPN--FNEAAKNKTVQTSLSF--GKNITSHSPY---VAADNIL 690
Query: 689 NQRVHSFEQMNWPC----SPEQMVTAKSYYT-PLLPHSLHRATSLPVDSVD 734
+ +F+ N SPE +VTAKS+YT L PHSL RATSLPVD++D
Sbjct: 691 ENK--TFQDNNVIVDELSSPELIVTAKSFYTGALFPHSLQRATSLPVDAID 739
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147815157|emb|CAN72330.1| hypothetical protein VITISV_035622 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 853 bits (2205), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 466/758 (61%), Positives = 544/758 (71%), Gaps = 38/758 (5%)
Query: 3 FQAQKNQ-IPPSLLKLIPLEDMEDTM------KFLVKELQRHYRAFDEYEGIEVAWNQVK 55
F Q+N IP S L PL + K + ++ YRAFDEYEGIEVAWNQVK
Sbjct: 8 FLDQENTLIPNSNFGLYPLGTRNYKIVAIPAPKVSERRKKKSYRAFDEYEGIEVAWNQVK 67
Query: 56 LYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYR 115
LYDFLQSPE+LERLYCEIHLLKT+KH NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYR
Sbjct: 68 LYDFLQSPEDLERLYCEIHLLKTMKHNNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYR 127
Query: 116 LKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175
KH+RVNIRAVKHWCRQIL GLLYLHS DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA
Sbjct: 128 QKHKRVNIRAVKHWCRQILRGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 187
Query: 176 ILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 235
ILRKSHAA CVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTF+YPYSECTHPAQIYK
Sbjct: 188 ILRKSHAAHCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFEYPYSECTHPAQIYK 247
Query: 236 KVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDYDSDLRMIQYQ 295
KVISGKKP+AL+KV+DPEVR+F+EKCLA+VS RLSARELL DPFL+IDD +SDLR I+ +
Sbjct: 248 KVISGKKPDALYKVKDPEVREFVEKCLASVSLRLSARELLQDPFLRIDDCESDLRPIECR 307
Query: 296 TDYDEISPLLRQSLYGIYHSNSSSNNGCGHYIGYDTENGLDYHPHEFQESEIDLFTCQED 355
+ D++ PLLRQ +HSN+S +NG + + +D NG Y P E + + I+LF ED
Sbjct: 308 REPDDMVPLLRQPFLEYHHSNNSFSNGYSNAVDFDAHNGWGYQPLEMEPTGIELFEYHED 367
Query: 356 EHLTNFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPFDIQTDTALSVATEMVSELDI 415
EH N DISIKGKRREDDGIFLRLRIADKE IRNIYFPFDI+ DTALSVATEMV+ELDI
Sbjct: 368 EHPANVDISIKGKRREDDGIFLRLRIADKEDHIRNIYFPFDIEMDTALSVATEMVAELDI 427
Query: 416 TDQDVTKIAEIIDSEIASLVPEWKRGMAMEESPHRSS--FCHNCA----SNGCLPDYILS 469
TDQDVTKIA++ID EIASLVPEWK G +EE+P ++ CHNC SNG L D IL+
Sbjct: 428 TDQDVTKIADMIDGEIASLVPEWKPGPGIEETPCFATLNLCHNCVSNHTSNGSLMD-ILA 486
Query: 470 DGSGAKNLQVLQCSKDGCAAIHGRFEEITYQVDGAEQCAPEGADQAASPQSAVVHYADIW 529
+ GAKNLQ+ QCS +GCAA+HGRFEEITYQVDGA+ PEG QS +H +IW
Sbjct: 487 NNPGAKNLQIFQCS-NGCAAMHGRFEEITYQVDGADHHIPEG-------QSEELHCTEIW 538
Query: 530 AQHEGQVLSSQGSRDIHCDEEHKTLNQSSYGAEE-----KIINMDSQSKCHERNCFSMNS 584
+HE + LSS S + DEE++ +N S E + + S H RN S ++
Sbjct: 539 YKHESRELSSVSSGESPSDEEYEKINHSIIKDERGSGTGNVASNVKNSISHLRNPSSSSA 598
Query: 585 AMDY--GLLDDYENEIRQELRWLKAKYQIQLRELRDQQLGVKYKSSSLTLITDDKTRASD 642
L DDYENEI+Q LRWLKAK+Q+++R LRD QLG K SSL D++ D
Sbjct: 599 IPSMSCALSDDYENEIQQVLRWLKAKHQMEMRGLRDLQLGFASKPSSL----DNRQLKPD 654
Query: 643 DKVSPSSVLPEPESNRPPQRTIAHRPTKHLTSCLPIGDEKKCGNVANQRVHSFEQMNWPC 702
++ S++ + + + KH TS K ++ + E
Sbjct: 655 NEGLFSTLSNTSQGHNNGLFLKSSAYDKHFTSNCATQVNKCSPDLVTHGARNCEANKGSR 714
Query: 703 SPEQM---VTAKSYYTP--LLPHSLHRATSLPVDSVDV 735
S E M VTAKS+YT LLP +HR SLPVD+VD+
Sbjct: 715 SAEDMVHVVTAKSFYTAGSLLPCPIHRTMSLPVDAVDI 752
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359487822|ref|XP_003633655.1| PREDICTED: serine/threonine-protein kinase WNK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 852 bits (2200), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 456/717 (63%), Positives = 529/717 (73%), Gaps = 32/717 (4%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
YRAFDEYEGIEVAWNQVKLYDFLQSPE+LERLYCEIHLLKT+KH NIMKFYTSWVDTANR
Sbjct: 40 YRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTMKHNNIMKFYTSWVDTANR 99
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
NINFVTEMFTSGTLRQYR KH+RVNIRAVKHWCRQIL GLLYLHS DPPVIHRDLKCDNI
Sbjct: 100 NINFVTEMFTSGTLRQYRQKHKRVNIRAVKHWCRQILRGLLYLHSHDPPVIHRDLKCDNI 159
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEM 217
FVNGNQGEVKIGDLGLAAILRKSHAA CVGTPEFMAPEVYEEEYNELVDIYSFGMCILEM
Sbjct: 160 FVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEM 219
Query: 218 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTD 277
VTF+YPYSECTHPAQIYKKVISGKKP+AL+KV+DPEVR+F+EKCLA+VS RLSARELL D
Sbjct: 220 VTFEYPYSECTHPAQIYKKVISGKKPDALYKVKDPEVREFVEKCLASVSLRLSARELLQD 279
Query: 278 PFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCGHYIGYDTENGLDY 337
PFL+IDD +SDLR I+ + + D++ PLLRQ +HSN+S +NG + + +D NG Y
Sbjct: 280 PFLRIDDCESDLRPIECRREPDDMVPLLRQPFLEYHHSNNSFSNGYSNAVDFDAHNGWGY 339
Query: 338 HPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPFDI 397
P E + + I+LF EDEH N DISIKGKRREDDGIFLRLRIADKE IRNIYFPFDI
Sbjct: 340 QPLEMEPTGIELFEYHEDEHPANVDISIKGKRREDDGIFLRLRIADKEDHIRNIYFPFDI 399
Query: 398 QTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAMEESPHRSS--FCH 455
+ DTALSVATEMV+ELDITDQDVTKIA++ID EIASLVPEWK G +EE+P ++ CH
Sbjct: 400 EMDTALSVATEMVAELDITDQDVTKIADMIDGEIASLVPEWKPGPGIEETPCFATLNLCH 459
Query: 456 NCA----SNGCLPDYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEITYQVDGAEQCAPEG 511
NC SNG L D IL++ GAKNLQ+ QCS +GCAA+HGRFEEITYQVDGA+ PEG
Sbjct: 460 NCVSNHTSNGSLMD-ILANNPGAKNLQIFQCS-NGCAAMHGRFEEITYQVDGADHHIPEG 517
Query: 512 ADQAASPQSAVVHYADIWAQHEGQVLSSQGSRDIHCDEEHKTLNQS------SYGAEEKI 565
QS +H +IW +HE + LSS S + DEE++ +N S G +
Sbjct: 518 -------QSEELHCTEIWDKHESRELSSVSSGESPSDEEYEKINHSIIKDERGSGTGNVV 570
Query: 566 INMDSQSKCHERNCFSMNSAMDY--GLLDDYENEIRQELRWLKAKYQIQLRELRDQQLGV 623
+ S H RN S ++ L DDYENEI+Q LRWLKAK+Q+++R LRD QLG
Sbjct: 571 ASNVKNSISHLRNPSSSSAIPSMSCALSDDYENEIQQVLRWLKAKHQMEMRGLRDLQLGF 630
Query: 624 KYKSSSLTLITDDKTRASDDKVSPSSVLPEPESNRPPQRTIAHRPTKHLTSCLPIGDEKK 683
K SSL D++ D++ S++ + + + KH TS K
Sbjct: 631 ASKPSSL----DNRQLKPDNEGLFSTLSNTSQGHNNGLFLKSSAYDKHFTSNCATQVNKC 686
Query: 684 CGNVANQRVHSFEQMNWPCSPEQM---VTAKSYYTP--LLPHSLHRATSLPVDSVDV 735
++ + E S E M VTAKS+YT LLP +HR SLPVD+VD+
Sbjct: 687 SPDLVTHGARNCEANKGSRSAEDMVHVVTAKSFYTAGSLLPCPIHRTMSLPVDAVDI 743
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575845|ref|XP_003556047.1| PREDICTED: serine/threonine-protein kinase WNK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 829 bits (2141), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 440/709 (62%), Positives = 507/709 (71%), Gaps = 100/709 (14%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
YRAFDEYEGIEVAWNQVK YDFLQ+PE+LERLY EIHLLKTLKH+NIMK YTSWVDTANR
Sbjct: 39 YRAFDEYEGIEVAWNQVKFYDFLQNPEDLERLYSEIHLLKTLKHKNIMKLYTSWVDTANR 98
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
+INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQIL GLLYLHS DPPVIHRDLKCDNI
Sbjct: 99 HINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILEGLLYLHSHDPPVIHRDLKCDNI 158
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEM 217
F+NGNQGEVKIGDLGLAAILRKS+AARCVGTPEFMAPEVYEE+YNELVDIYSFGMCILEM
Sbjct: 159 FINGNQGEVKIGDLGLAAILRKSNAARCVGTPEFMAPEVYEEDYNELVDIYSFGMCILEM 218
Query: 218 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTD 277
VTF+YPYSEC HPAQIYKKV+SGKKPEAL+KV++PEVRQF+EKCLATVS RLSARELL D
Sbjct: 219 VTFEYPYSECNHPAQIYKKVVSGKKPEALYKVDNPEVRQFVEKCLATVSLRLSARELLED 278
Query: 278 PFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCGHYI-GYDTENGLD 336
PFLQIDDY D +++QYQ D E++PL+RQ + GI N++ +G I GY + LD
Sbjct: 279 PFLQIDDYGFDSKVLQYQRDCYEVTPLIRQPVNGICIINNNLMSGDTDNIGGYGPVSELD 338
Query: 337 YHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPFD 396
YH +F+ +EI LF C+ED++L D +IKG RREDDGIFLRLRIADKEGRIRNIYFPFD
Sbjct: 339 YHQDDFEATEIGLFDCEEDDNLAEVDTTIKG-RREDDGIFLRLRIADKEGRIRNIYFPFD 397
Query: 397 IQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAMEESPHRS--SFC 454
I+TDTALSVA EMV+ELDI DQDVT +A +ID+EIA LVPEWK G +EE S S C
Sbjct: 398 IETDTALSVANEMVAELDINDQDVTNLASMIDNEIARLVPEWKTGPRIEEKSECSSASVC 457
Query: 455 HNCASNGCLPDYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEITYQVDGAEQCAPEGADQ 514
NCA+NG L DY+ S+ KNLQ L CSK GCAA+HGRFEEITYQV+G+E A E
Sbjct: 458 LNCAANGSLFDYVSSNNPCGKNLQFLHCSKTGCAAVHGRFEEITYQVEGSENSAREA--- 514
Query: 515 AASPQSAVVHYADIWAQHEGQVLSSQGSRDIHCDEEHKTLNQSSYGAEEKIINMDSQSKC 574
H+ N S+ + K +N+D QS
Sbjct: 515 ------------------------------------HEASNSSNIKEDRKTVNVDEQSDL 538
Query: 575 HERNCFSMNSAMDYGLLDDYENEIRQELRWLKAKYQIQLRELRDQQLGVKYKSSSLTL-- 632
+ + S N A + L DYENEIRQELRWLKAKYQ+QLRELRDQQLG K K +S++
Sbjct: 539 NTKKS-SSNPAPNCVFL-DYENEIRQELRWLKAKYQMQLRELRDQQLGRKPKFTSISPDP 596
Query: 633 -----ITDDKTRASDDKVSPSSVLPEPESNRPPQRTIAHRPTKHLTSCLPIGDEKKCGNV 687
+ D R SD +P+ + ++N+P RTI
Sbjct: 597 EKLEHLKDGILRLSD---TPNLKI---QNNKPLLRTI----------------------- 627
Query: 688 ANQRVHSFEQMNWPCSPEQMVTAKSYYTP-LLPHSLHRATSLPVDSVDV 735
QM+TA+ ++T LLPHSL RATSLPVD+VDV
Sbjct: 628 ------------------QMITARDFFTGVLLPHSLQRATSLPVDAVDV 658
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542364|ref|XP_002512245.1| kinase, putative [Ricinus communis] gi|223548206|gb|EEF49697.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 820 bits (2119), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 426/676 (63%), Positives = 507/676 (75%), Gaps = 43/676 (6%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
YRAFDEYEGIEVAWNQVKLYDFLQSPE+LERLYCEIHLLKTLKH+NIMKFYTSWVDTANR
Sbjct: 40 YRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 99
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
NINFVTEMFTSGTLRQYRLKH+RVNIRAVKHWCRQIL GLLYLHS DPPVIHRDLKCDNI
Sbjct: 100 NINFVTEMFTSGTLRQYRLKHKRVNIRAVKHWCRQILRGLLYLHSHDPPVIHRDLKCDNI 159
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEM 217
FVNGNQGEVKIGDLGLAAILRKSHAA CVGTPEFMAPEVYEE YNELVD+YSFGMCILEM
Sbjct: 160 FVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEAYNELVDVYSFGMCILEM 219
Query: 218 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTD 277
VTF+YPYSECTHPAQIYKKVISG+KP+AL+KV+DPEVRQF+EKCLATVS RLSARELL D
Sbjct: 220 VTFEYPYSECTHPAQIYKKVISGRKPDALYKVKDPEVRQFVEKCLATVSLRLSARELLND 279
Query: 278 PFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCGHYIGYDTENGLDY 337
PFLQ+DD +S+++ I Y ++D + PL+RQ Y + +NG + GY+ +N +Y
Sbjct: 280 PFLQMDDCESNIKSIDYGEEFDGMGPLIRQPYYEFHDDTYPYSNGYSNGYGYEAQNEFEY 339
Query: 338 HPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPFDI 397
+P EF++S I+LF +DEH N DISIKGKRR+D GIFLRLRIADK+GRIRNIYFPFDI
Sbjct: 340 YPVEFEQSGIELFEHHDDEHSPNLDISIKGKRRDDGGIFLRLRIADKDGRIRNIYFPFDI 399
Query: 398 QTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAMEESPHRS--SFCH 455
+TDTAL+VATEMV+ELDITDQDVTKIAE+ID EIASLVPEW+RG +EE+P + + CH
Sbjct: 400 ETDTALTVATEMVAELDITDQDVTKIAEMIDEEIASLVPEWRRGPGIEETPRFANLTLCH 459
Query: 456 NCA----SNGCLPDYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEITYQ-VDGAEQCAPE 510
NCA SNG L D+I ++ C ++GCA++HGRFEEIT+Q D +E E
Sbjct: 460 NCASARTSNGSLMDFISNN----------PCCRNGCASMHGRFEEITFQAADESEHHLTE 509
Query: 511 GADQAASPQSAVVHYADIWAQHEGQVLSSQGSRDIHCDEEHKTLNQSSYGAEEKIINMDS 570
A A S S V Y IWAQHE + ++ GS H DEE++ +QS +E + M++
Sbjct: 510 VAPNALS-HSDCVDYQRIWAQHESREVTPMGSGRSHSDEEYEKFDQSISTKDENDVKMEN 568
Query: 571 QSKCHERN---------CFSMNSAMDYGLLDDYENEIRQELRWLKAKYQIQLRELRDQQL 621
S+ RN F ++ L D EN+++QELRWLKAKYQI+L +LRDQQL
Sbjct: 569 GSQSGSRNSIPYLKGSGSFYRLPSVCSDLQDSNENKMQQELRWLKAKYQIELSKLRDQQL 628
Query: 622 GVKYKSSSLTLITDDKTRASDDKVSPSSVLPEPESNRPPQ--RTIAH----RPTKHLTSC 675
+SS+ ++ TD K R + VS S+++ + NR ++ AH RP H
Sbjct: 629 DFASRSST-SINTDCKIR---NGVSSSTIMNSFQENRNEDLLKSFAHEKLYRPNLHTDV- 683
Query: 676 LPIGDEKKCGNVANQR 691
K C N+ +R
Sbjct: 684 -----NKSCPNLDTRR 694
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351723121|ref|NP_001235988.1| with no lysine kinase 2 [Glycine max] gi|225348633|gb|ACN87278.1| with no lysine kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 819 bits (2116), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/704 (61%), Positives = 502/704 (71%), Gaps = 96/704 (13%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
YRAFDEYEGIEVAWNQVK YDFLQ+PE+LERLY EIHLLKTLKH+NIMKFYTSWVDT NR
Sbjct: 39 YRAFDEYEGIEVAWNQVKFYDFLQNPEDLERLYSEIHLLKTLKHKNIMKFYTSWVDTTNR 98
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
+INFVTEMFTSGTLRQYRLKH+RVNIRAVKHWCRQIL GLLYLHS DPPVIHRDLKCDNI
Sbjct: 99 HINFVTEMFTSGTLRQYRLKHKRVNIRAVKHWCRQILEGLLYLHSHDPPVIHRDLKCDNI 158
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEM 217
F+NGNQGEVKIGDLGLAAILRKS+AARCVGTPEFMAPEVYEE+YNELVDIYSFGMCILEM
Sbjct: 159 FINGNQGEVKIGDLGLAAILRKSNAARCVGTPEFMAPEVYEEDYNELVDIYSFGMCILEM 218
Query: 218 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTD 277
VTF+YPYSEC HPAQIYKKV+SGKKPEAL+KV++ EVRQF+EKCLATVS RLSARELL D
Sbjct: 219 VTFEYPYSECNHPAQIYKKVVSGKKPEALYKVDNTEVRQFVEKCLATVSLRLSARELLDD 278
Query: 278 PFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNG-CGHYIGYDTENGLD 336
PFLQI DY D +++QY D E++PL+RQ L GIY N++ +G + GY + LD
Sbjct: 279 PFLQIYDYGFDSKVVQYHRDCYEVNPLIRQPLNGIYSINNNLMSGDTDNVGGYGPVSKLD 338
Query: 337 YHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPFD 396
YH +F+ SEI LF C+ED++L D +IKG RREDDGIFLRLRIADKEGRIRNIYFPFD
Sbjct: 339 YHRDDFEASEIGLFGCEEDDNLAEVDTTIKG-RREDDGIFLRLRIADKEGRIRNIYFPFD 397
Query: 397 IQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAMEESPH--RSSFC 454
I+TDTALSVA EMV+ELDI DQDVT +A +ID+EIA+LVPEWK G +EE +S C
Sbjct: 398 IETDTALSVANEMVAELDINDQDVTNLANMIDNEIATLVPEWKTGPIIEEKSECSSASVC 457
Query: 455 HNCASNGCLPDYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEITYQVDGAEQCAPEGADQ 514
NCA+NG L DY+LS+ KNLQ L CSK GCAA+HGRFEEITYQV+G++ A E
Sbjct: 458 LNCAANGYLFDYVLSNNPCGKNLQFLHCSKTGCAAVHGRFEEITYQVEGSKNSAREA--- 514
Query: 515 AASPQSAVVHYADIWAQHEGQVLSSQGSRDIHCDEEHKTLNQSSYGAEEKIINMDSQSKC 574
H+ N S+ + K IN+D QS
Sbjct: 515 ------------------------------------HEASNSSNIKEDGKTINVDEQSDL 538
Query: 575 HERNCFSMNSAMDYGLLDDYENEIRQELRWLKAKYQIQLRELRDQQLGVKYKSSSLTLIT 634
+ R S N A + L DYENEIRQELRWLKAKYQ+QLRELRDQQLG K K +S++ T
Sbjct: 539 NTRKP-SSNPAPNCVFL-DYENEIRQELRWLKAKYQMQLRELRDQQLGGKPKFTSISPDT 596
Query: 635 DDKTRASDD--KVSPSSVLPEPESNRPPQRTIAHRPTKHLTSCLPIGDEKKCGNVANQRV 692
D D ++S +S L + ++N+P +TI
Sbjct: 597 DKLEHLKDGILRLSDASNL-KIQNNKPLLKTI---------------------------- 627
Query: 693 HSFEQMNWPCSPEQMVTAKSYYTP-LLPHSLHRATSLPVDSVDV 735
++T LLPHSL RATSLPVD+VDV
Sbjct: 628 -------------------DFFTGVLLPHSLQRATSLPVDAVDV 652
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224125588|ref|XP_002319623.1| predicted protein [Populus trichocarpa] gi|222857999|gb|EEE95546.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 813 bits (2100), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 433/711 (60%), Positives = 521/711 (73%), Gaps = 33/711 (4%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
YRAFDEYEGIEVAWNQVKLYDFLQSPE+LERLYCEIHLLKTLKH+NIMKFYTSWVDTANR
Sbjct: 40 YRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 99
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
NINFVTEMFTSGTLRQYRLKH+RVNIRAVKHWCRQIL GLLYLHS DPPVIHRDLKCDNI
Sbjct: 100 NINFVTEMFTSGTLRQYRLKHKRVNIRAVKHWCRQILRGLLYLHSHDPPVIHRDLKCDNI 159
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEM 217
FVNGNQGEVKIGDLGLAAILRKSHAA CVGTPEFMAPEVYEE YNELVDIYSFGMCILEM
Sbjct: 160 FVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEM 219
Query: 218 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTD 277
VTF+YPYSECTHP QIYKKVISGKKP+AL+KV+DPEVR F+EKCLATVS RLSARELL D
Sbjct: 220 VTFEYPYSECTHPVQIYKKVISGKKPDALYKVKDPEVRHFVEKCLATVSLRLSARELLND 279
Query: 278 PFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCGHYIGYDTENGLDY 337
PFLQID +SDLR++ ++ + D + PL+R + +N+S ++G + Y+ +N +Y
Sbjct: 280 PFLQIDGCESDLRLLDHRIEVDGLGPLMRPPYLEHHDNNNSYSSGYLNGYDYEAQNEWEY 339
Query: 338 HPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPFDI 397
H E + S I+LF DEH N DISIKGKR +D GIFLRLRIADKEGRIRNIYFPFDI
Sbjct: 340 HQVEVELSGIELFEYH-DEHPANVDISIKGKRGDDGGIFLRLRIADKEGRIRNIYFPFDI 398
Query: 398 QTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAMEESP--HRSSFCH 455
+ DTALSVATEMV+ELDITDQDVTKIA++ID EIASLVPEW+ G +EE+P + CH
Sbjct: 399 ENDTALSVATEMVAELDITDQDVTKIADMIDGEIASLVPEWRPGPGIEETPCFANQTLCH 458
Query: 456 NCASNGCLPDYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEITYQVDGAEQCAPEGADQA 515
NCAS S+GS L C GCA++HGRF EI ++VD +E EGA
Sbjct: 459 NCAST------CTSNGSFMDFLSNNPCCSHGCASMHGRFGEIIFEVDESEHHLTEGAPNI 512
Query: 516 ASPQSAVVHYADIWAQHEGQVLSSQGSRDIHCDEEHKTLNQSSYGAEEKIINMDS----- 570
+ Q +HY +IW Q E + L+ GS DEE++ +QS + K M++
Sbjct: 513 LN-QPDYLHYKEIWGQQESRQLTPIGSGKSQLDEEYENFDQSIPEKDTKDTKMENGIPGG 571
Query: 571 QSKCHERNCFSMN--SAMDYGLLDDYENEIRQELRWLKAKYQIQLRELRDQQLGVKYKSS 628
+S H S++ +++ L D ENEI+Q+LRWLKAK+Q++LR+LRD++LG+ K S
Sbjct: 572 KSFQHFTGSGSLSRLTSLYNDLADSNENEIQQDLRWLKAKHQMELRKLRDERLGLAVKPS 631
Query: 629 SLTLITDDKTRASDDKVSPSSVLP--EPESNRPPQRTIAHRPTKHL-TSCLPIGDEKKCG 685
+ + + + + VS +S+L + SN +++A + + L T + D
Sbjct: 632 T----SRNGEEKTSNVVSSTSMLNSFQEGSNGDLLKSLAKQISHSLHTHAGALSD----- 682
Query: 686 NVANQRVHSFEQMNWPCSPEQMVTAKSYYT-PLLPHSLHRATSLPVDSVDV 735
QR + + MN P + MV AK+ T P+LPHSLHR TSLPVD+VDV
Sbjct: 683 ---TQRPWNHKVMNQPPRAKDMVNAKNLCTGPMLPHSLHRTTSLPVDAVDV 730
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356535149|ref|XP_003536111.1| PREDICTED: serine/threonine-protein kinase WNK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 799 bits (2064), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/716 (59%), Positives = 515/716 (71%), Gaps = 64/716 (8%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
YRAFDEY+GIEVAWNQVKLYDFLQSPE+LERLYCEIHLLKTLKHRNIMKFYTSWVDTANR
Sbjct: 39 YRAFDEYQGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 98
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
NINFVTEMFTSGTLRQYRLKH+RVNIRAVKHWCRQILSGLLYLHS DPPVIHRDLKCDNI
Sbjct: 99 NINFVTEMFTSGTLRQYRLKHKRVNIRAVKHWCRQILSGLLYLHSHDPPVIHRDLKCDNI 158
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEM 217
FVNGNQGEVKIGDLGLAAILRKSHAA CVGTPEFMAPEVYEE YNELVDIYSFGMCILEM
Sbjct: 159 FVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEM 218
Query: 218 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTD 277
VTF+YPYSECTHPAQIYKKVISGKKP+AL++V+DPEVRQF+EKCLATVS RLSARELL D
Sbjct: 219 VTFEYPYSECTHPAQIYKKVISGKKPDALYRVKDPEVRQFVEKCLATVSLRLSARELLDD 278
Query: 278 PFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCGHYIGYDTENGLDY 337
PFLQIDDY+ DLR + + DE PL+RQ + ++ S S+ +N + GY+ + G
Sbjct: 279 PFLQIDDYEYDLRTVD-NGELDEFGPLMRQPFFDLHRSYSNFSNEYTNGFGYEGDWGP-- 335
Query: 338 HPHEFQESEIDLFTCQEDEHLT-NFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPFD 396
HP E + S I+LF ++D+ + + DISIKGKR++D GIFLRLRIADKEGRIRNIYFPFD
Sbjct: 336 HPAEIEPSGIELFEYRDDDEPSEDVDISIKGKRKDDGGIFLRLRIADKEGRIRNIYFPFD 395
Query: 397 IQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAMEESPH--RSSFC 454
I+ DTA+SVATEMV+ELD+TDQDVT+IA++ID EIASLVPEW+ G ++E+P C
Sbjct: 396 IEMDTAISVATEMVAELDMTDQDVTRIADMIDGEIASLVPEWRPGPGIDETPRFANQGLC 455
Query: 455 HNCASN----GCLPDYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEITYQVDGAEQCAPE 510
HNC SN G D+ LS+ KNLQ+L C + GCA++HGRF EIT+
Sbjct: 456 HNCVSNHTSSGSFLDF-LSNNPDNKNLQLLDCCRHGCASMHGRFGEITF----------- 503
Query: 511 GADQAASPQSAVVHYADIWAQHEGQVLSSQGSRDIHCDEEHKTLNQSSYGAEE-KIINMD 569
QS + Y ++W QHE + LS S H DE+++ L++ ++ + + D
Sbjct: 504 --------QSEDLQYQELWNQHESRELSPVESDQSHSDEQYEQLDKPILAKDKAQDVWED 555
Query: 570 SQSKCHERNCFSMNSAMDYG--------LLDDYENEIRQELRWLKAKYQIQLRELRDQQL 621
S + +++ + D+ L DDYE EI++ELRWL+AKYQ++LR+ +D+Q
Sbjct: 556 KFSPNAANSLRNLSGSHDFSTIRSTYCDLEDDYEKEIQKELRWLRAKYQMELRDHKDRQF 615
Query: 622 GVKYKSSSLTLITDDKTRASDDKVSPSSVLPEPESNRPPQRTIAHRPTKHLTSCLPIGDE 681
G S + + R + +SPS E+ + P H +S P D
Sbjct: 616 GQCSHS------CNSEHRTENGFLSPSLT----ETLKGGNNGTHSHPHVHESS--PNSDT 663
Query: 682 KKCGNVANQRVHSFEQMNWPCSP-EQMVTAKSYYT-PLLPHSLHRATSLPVDSVDV 735
++ N + SP E MVTAKS+YT LLPHSLHR SLPVD+VD+
Sbjct: 664 QRAQNCVAIK-----------SPGEGMVTAKSFYTGSLLPHSLHRTVSLPVDAVDI 708
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 738 | ||||||
| TAIR|locus:2114845 | 700 | WNK1 "with no lysine (K) kinas | 0.361 | 0.381 | 0.866 | 9.8e-187 | |
| TAIR|locus:2182039 | 492 | WNK9 [Arabidopsis thaliana (ta | 0.546 | 0.819 | 0.705 | 3.7e-151 | |
| TAIR|locus:504955638 | 516 | WNK3 "with no lysine (K) kinas | 0.330 | 0.472 | 0.722 | 1.1e-118 | |
| TAIR|locus:2093994 | 567 | WNK6 "with no lysine (K) kinas | 0.333 | 0.433 | 0.682 | 1.9e-118 | |
| TAIR|locus:2028521 | 557 | WNK7 [Arabidopsis thaliana (ta | 0.333 | 0.441 | 0.670 | 3e-112 | |
| TAIR|locus:2098242 | 549 | WNK5 "with no lysine (K) kinas | 0.340 | 0.457 | 0.660 | 5.5e-111 | |
| TAIR|locus:2161278 | 571 | WNK4 "with no lysine (K) kinas | 0.334 | 0.432 | 0.649 | 5.5e-111 | |
| TAIR|locus:2165790 | 563 | WNK8 "with no lysine (K) kinas | 0.333 | 0.436 | 0.682 | 4.5e-109 | |
| TAIR|locus:2019404 | 524 | WNK10 "with no lysine (K) kina | 0.518 | 0.730 | 0.522 | 7.4e-103 | |
| TAIR|locus:2176135 | 314 | AT5G55560 [Arabidopsis thalian | 0.345 | 0.812 | 0.608 | 9.4e-82 |
| TAIR|locus:2114845 WNK1 "with no lysine (K) kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1255 (446.8 bits), Expect = 9.8e-187, Sum P(3) = 9.8e-187
Identities = 234/270 (86%), Positives = 251/270 (92%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
YRAFDEYEGIEVAWNQVKLYDFLQSPE+LERLYCEIHLLKTLKH+NIMKFYTSWVDTANR
Sbjct: 39 YRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
NINFVTE+FTSGTLRQYRL+H+RVNIRA+KHWCRQIL GL YLHS DPPVIHRDLKCDNI
Sbjct: 99 NINFVTELFTSGTLRQYRLRHKRVNIRAMKHWCRQILRGLHYLHSHDPPVIHRDLKCDNI 158
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEM 217
FVNGNQGEVKIGDLGLAAILRKSHAA CVGTPEFMAPEVYEE YNELVDIYSFGMCILEM
Sbjct: 159 FVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEM 218
Query: 218 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTD 277
VTFDYPYSECTHPAQIYKKV+SGKKP+AL+KV+DPEV+ FIEKCLATVS R+SARELL D
Sbjct: 219 VTFDYPYSECTHPAQIYKKVMSGKKPDALYKVKDPEVKCFIEKCLATVSLRVSARELLDD 278
Query: 278 PFLQIDDYDSDLRMIQYQTDYDEISPLLRQ 307
PFL+IDD + DLR + + D + PL RQ
Sbjct: 279 PFLRIDDGEFDLRSVDME---DSVGPLYRQ 305
|
|
| TAIR|locus:2182039 WNK9 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1475 (524.3 bits), Expect = 3.7e-151, P = 3.7e-151
Identities = 300/425 (70%), Positives = 341/425 (80%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
YR FDEY+GIEVAWNQVKLYDFLQSP+ELERLYCEIHLLKTLKH++IMKFY SWVDT NR
Sbjct: 40 YRGFDEYQGIEVAWNQVKLYDFLQSPQELERLYCEIHLLKTLKHKSIMKFYASWVDTDNR 99
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
NINFVTEMFTSGTLRQYRLKH+RVNIRAVK+WCRQIL GL YLH+ DPPVIHRDLKCDNI
Sbjct: 100 NINFVTEMFTSGTLRQYRLKHKRVNIRAVKNWCRQILRGLNYLHTHDPPVIHRDLKCDNI 159
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEM 217
F+NGNQGEVKIGDLGLAA L+ SHAA CVGTPEFMAPEVY+EEYN+LVDIYSFGMC+LEM
Sbjct: 160 FINGNQGEVKIGDLGLAACLQHSHAAHCVGTPEFMAPEVYKEEYNQLVDIYSFGMCVLEM 219
Query: 218 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTD 277
VTFDYPYSEC+HPAQIYK+VISGKKP+ L KV+DPEVR FIEKCLATVS RLSA ELL D
Sbjct: 220 VTFDYPYSECSHPAQIYKRVISGKKPDGLDKVKDPEVRGFIEKCLATVSLRLSACELLDD 279
Query: 278 PFLQIDDYDSDLRMIQYQTDY-DEISPLLRQSLYGIYHXXXXXXXGCGHYIGYDTENGLD 336
FL ID+ SD+R ++ + DE LR S Y I H G+Y Y+ +N D
Sbjct: 280 HFLCIDE--SDMRRVESEKGLIDEAGTPLRHS-YHIPHYSN------GYYSLYN-QNQWD 329
Query: 337 YHPHEFQES-EIDLFTCQ-------EDEHLTNFDISIKGKRRED-DGIFLRLRIADKEGR 387
Y+ E ES EIDL Q ED+ + DISIKGKRR++ DG+FLRL+ +KEG
Sbjct: 330 YNGDETVESHEIDLLEFQNDDDEEEEDKRFGSVDISIKGKRRDNGDGLFLRLKTVNKEGC 389
Query: 388 IRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAMEES 447
+RNIYFPFDI+TDTA+SVA EMV EL++ D+DVTKIA +ID EIASLVP W + E +
Sbjct: 390 VRNIYFPFDIETDTAISVAREMVEELEMDDRDVTKIANMIDGEIASLVPNWSIFCSSESN 449
Query: 448 PHRSS 452
RSS
Sbjct: 450 --RSS 452
|
|
| TAIR|locus:504955638 WNK3 "with no lysine (K) kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 954 (340.9 bits), Expect = 1.1e-118, Sum P(2) = 1.1e-118
Identities = 177/245 (72%), Positives = 209/245 (85%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
YRAFD+ EGIEVAWNQVKL D S E+L+RLY E+HLLKTLKH++I+KFYTSW+D +
Sbjct: 37 YRAFDQLEGIEVAWNQVKLDDKFCSSEDLDRLYSEVHLLKTLKHKSIIKFYTSWIDHQHM 96
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
IN +TE+FTSG LRQYR KH+ V++RA+K W RQIL GL+YLHS DPPVIHRDLKCDNI
Sbjct: 97 TINLITEVFTSGNLRQYRKKHKCVDLRALKKWSRQILEGLVYLHSHDPPVIHRDLKCDNI 156
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCV-GTPEFMAPEVYEEEYNELVDIYSFGMCILE 216
F+NGNQGEVKIGDLGLAAIL ++ +A V GTPEFMAPE+YEE+YN LVDIY+FGMC+LE
Sbjct: 157 FINGNQGEVKIGDLGLAAILHRARSAHSVIGTPEFMAPELYEEDYNVLVDIYAFGMCLLE 216
Query: 217 MVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLT 276
+VTF+YPYSECT+ AQIY+KV SG KP AL V DP+VR FIEKC+A VS RLSA+ELL
Sbjct: 217 LVTFEYPYSECTNAAQIYRKVTSGIKPAALLNVTDPQVRAFIEKCIAKVSQRLSAKELLD 276
Query: 277 DPFLQ 281
DPFL+
Sbjct: 277 DPFLK 281
|
|
| TAIR|locus:2093994 WNK6 "with no lysine (K) kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 947 (338.4 bits), Expect = 1.9e-118, Sum P(3) = 1.9e-118
Identities = 168/246 (68%), Positives = 207/246 (84%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y+AFDE +GIEVAWNQV++ D LQSP LERLY E+ LLK+LKH NI++FY SW+D N+
Sbjct: 43 YKAFDEVDGIEVAWNQVRIDDVLQSPNCLERLYSEVRLLKSLKHNNIIRFYNSWIDDKNK 102
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
+N +TE+FTSG+LR YR KHR+VN++AVK+W RQIL GL YLH ++PP+IHRDLKCDNI
Sbjct: 103 TVNIITELFTSGSLRHYRKKHRKVNMKAVKNWARQILMGLRYLHGQEPPIIHRDLKCDNI 162
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEM 217
F+NGN GEVKIGDLGLA ++ +++A +GTPEFMAPE+Y+E YNEL DIYSFGMC+LEM
Sbjct: 163 FINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 222
Query: 218 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTD 277
VTFDYPY EC + AQIYKKV SG KP +L +V+DPEV+QFIEKCL S RLSA+ELL D
Sbjct: 223 VTFDYPYCECKNSAQIYKKVSSGIKPASLSRVKDPEVKQFIEKCLLPASERLSAKELLLD 282
Query: 278 PFLQID 283
PFLQ++
Sbjct: 283 PFLQLN 288
|
|
| TAIR|locus:2028521 WNK7 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 931 (332.8 bits), Expect = 3.0e-112, Sum P(2) = 3.0e-112
Identities = 165/246 (67%), Positives = 206/246 (83%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
++ FDE +GIEVAWNQV++ D LQSP+ LERLY E+ LLK+LKH+NI++FY SW+D N+
Sbjct: 43 FKGFDEVDGIEVAWNQVRIDDLLQSPDCLERLYSEVRLLKSLKHKNIIRFYNSWIDDKNK 102
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
+N +TE+FTSG+LRQYR KHR+VN++AVK W RQIL+GL YLHS+DPP+IHRD+KCDNI
Sbjct: 103 TVNIITELFTSGSLRQYRKKHRKVNMKAVKCWARQILTGLKYLHSQDPPIIHRDIKCDNI 162
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEM 217
F+NGN GEVKIGDLGLA ++ +++A +GTPEFMAPE+Y+E YNEL DIYSFGMC+LEM
Sbjct: 163 FINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 222
Query: 218 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTD 277
VTF+YPY EC + AQIYKKV SG KP +L KV+DPEV +FIEKCL S RLSA ELL D
Sbjct: 223 VTFEYPYCECRNSAQIYKKVSSGIKPASLSKVKDPEVMKFIEKCLLPASERLSAEELLLD 282
Query: 278 PFLQID 283
FL ++
Sbjct: 283 SFLNVN 288
|
|
| TAIR|locus:2098242 WNK5 "with no lysine (K) kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 902 (322.6 bits), Expect = 5.5e-111, Sum P(2) = 5.5e-111
Identities = 167/253 (66%), Positives = 205/253 (81%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y+AFD+ G+EVAWNQVKL + +SPE L+RLY E+HLLK L H +I+++ TSW+D R
Sbjct: 40 YKAFDQVLGMEVAWNQVKLNEVFRSPEPLQRLYSEVHLLKNLNHESIIRYCTSWIDVNRR 99
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
NF+TE+FTSGTLR+YR K+++V+IRA+K W RQIL+GL YLH DPPVIHRDLKCDNI
Sbjct: 100 TFNFITELFTSGTLREYRRKYQKVDIRAIKSWARQILNGLAYLHGHDPPVIHRDLKCDNI 159
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCV-GTPEFMAPEVYEEEYNELVDIYSFGMCILE 216
FVNG+ G+VKIGDLGLAAILR S A V GTPEFMAPE+YEE+YNELVDIYSFGMC+LE
Sbjct: 160 FVNGHLGQVKIGDLGLAAILRGSQNAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLE 219
Query: 217 MVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLT 276
M+T +YPYSECT+PAQIYKKV SGK P++ ++ E ++F+ KCL TVS RL A+ELL
Sbjct: 220 MLTGEYPYSECTNPAQIYKKVTSGKLPDSFHLIQHTEAQRFVGKCLETVSRRLPAKELLA 279
Query: 277 DPFLQIDDYDSDL 289
DPFL D + DL
Sbjct: 280 DPFLAATD-ERDL 291
|
|
| TAIR|locus:2161278 WNK4 "with no lysine (K) kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 901 (322.2 bits), Expect = 5.5e-111, Sum P(2) = 5.5e-111
Identities = 161/248 (64%), Positives = 202/248 (81%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y+A DE GIEVAW+QVKL + L+S +L+RLY E+HLL TL H++I++FYTSW+D N
Sbjct: 34 YKAIDEKLGIEVAWSQVKLKEVLRSSVDLQRLYSEVHLLSTLNHKSIIRFYTSWIDVHNH 93
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
+NF+TE+FTSGTLRQY+ K+ R++IRA+K W RQIL GL+YLH DPPVIHRDLKCDNI
Sbjct: 94 TLNFITELFTSGTLRQYKNKYLRIDIRAIKSWARQILEGLVYLHEHDPPVIHRDLKCDNI 153
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCV-GTPEFMAPEVYEEEYNELVDIYSFGMCILE 216
FVNG+ G+VKIGDLGLA +LR H+A + GTPEFMAPE+YEE YNEL+D+YSFGMC LE
Sbjct: 154 FVNGHLGQVKIGDLGLARMLRDCHSAHSIIGTPEFMAPELYEENYNELIDVYSFGMCFLE 213
Query: 217 MVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLT 276
M+T ++PYSEC HPAQIYKKV+ GK P A ++V D E ++FI KCL + S R+SA+ELL
Sbjct: 214 MITSEFPYSECNHPAQIYKKVVGGKLPGAFYRVGDIEAQRFIGKCLVSASKRVSAKELLQ 273
Query: 277 DPFLQIDD 284
DPFL D+
Sbjct: 274 DPFLASDE 281
|
|
| TAIR|locus:2165790 WNK8 "with no lysine (K) kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 907 (324.3 bits), Expect = 4.5e-109, Sum P(3) = 4.5e-109
Identities = 168/246 (68%), Positives = 201/246 (81%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y+AFDE +GIEVAWN V + D +Q P +LERLY E+HLLK LKH NI+K + SWVD N+
Sbjct: 44 YKAFDEVDGIEVAWNLVSIEDVMQMPGQLERLYSEVHLLKALKHENIIKLFYSWVDEKNK 103
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
IN +TE+FTSG+LR YR KHR+V+ +A+K+W RQIL GL YLHS++PPVIHRDLKCDNI
Sbjct: 104 TINMITELFTSGSLRVYRKKHRKVDPKAIKNWARQILKGLNYLHSQNPPVIHRDLKCDNI 163
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEM 217
FVNGN GEVKIGDLGLA +L++ A +GTPEFMAPE+YEEEYNELVDIYSFGMC+LEM
Sbjct: 164 FVNGNTGEVKIGDLGLATVLQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEM 223
Query: 218 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTD 277
VT +YPY+EC + AQIYKKV S KP++L KV+DP+VRQFIEKCL SSR +A EL D
Sbjct: 224 VTCEYPYNECRNQAQIYKKVTSNIKPQSLGKVDDPQVRQFIEKCLLPASSRPTALELSKD 283
Query: 278 PFLQID 283
PFL D
Sbjct: 284 PFLARD 289
|
|
| TAIR|locus:2019404 WNK10 "with no lysine (K) kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 993 (354.6 bits), Expect = 7.4e-103, Sum P(2) = 7.4e-103
Identities = 208/398 (52%), Positives = 263/398 (66%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y+AFDE EGIEVAWN + + D LQ P +L+RLY E+HLL +LKH NI+K + SWVD N+
Sbjct: 31 YKAFDEVEGIEVAWNLMSIEDVLQMPGQLDRLYSEVHLLNSLKHDNIIKLFYSWVDDHNK 90
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
+IN +TE+FTSG+L YR KHR+V+ +A+ +W RQIL GL YLHS+ PPVIHRDLKCDNI
Sbjct: 91 SINMITELFTSGSLTLYRKKHRKVDPKAIMNWARQILKGLHYLHSQTPPVIHRDLKCDNI 150
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEM 217
FVNGN G+VKIGDLGLAA++++ A +GTPEFMAPE+YEEEYNELVDIYSFGMC+LEM
Sbjct: 151 FVNGNTGKVKIGDLGLAAVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEM 210
Query: 218 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTD 277
VT +YPY EC + AQIYKKV SG KP++L KV+DP+V+QFIEKCL SR +A ELL D
Sbjct: 211 VTCEYPYRECRNQAQIYKKVTSGIKPQSLSKVDDPQVKQFIEKCLLPAPSRPTALELLKD 270
Query: 278 PFLQIDDY-DSDLRMIQYQTDYDEISPLLRQSLYGIYHXXXXXXXGCGHYIGYDTENGLD 336
L +D DS L T + P + + C E L
Sbjct: 271 QLLAVDGAKDSTLTASSNTTFKPAMPPQCEYRPMDVEYKKNTSVSICSSAKS-SQECAL- 328
Query: 337 YHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPFD 396
Q E+ Q T F +S G+RR+D + LRIA G+ R + F F+
Sbjct: 329 -----LQTMEV-----QRVAESTEFKLS--GERRDDVAASMALRIAGSSGQARKVDFDFN 376
Query: 397 IQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASL 434
++TDTA +V EMV ELD++ +VT IAE+ID I L
Sbjct: 377 LKTDTARAVTGEMVEELDLSSHEVTVIAEMIDELIMKL 414
|
|
| TAIR|locus:2176135 AT5G55560 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 820 (293.7 bits), Expect = 9.4e-82, P = 9.4e-82
Identities = 157/258 (60%), Positives = 191/258 (74%)
Query: 34 LQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD 93
+++ YRAFD+ EGIEVAWNQVKL F P ERLY E+ LLK LK+ NI+ Y W D
Sbjct: 42 VKKVYRAFDQEEGIEVAWNQVKLRCFSDDPAMTERLYSEVRLLKNLKNSNIITLYKVWRD 101
Query: 94 TANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 153
N +NF+TE+ TSG LR+YR KHR V++RA+K W +QIL GL YLH+ DP +IHRDL
Sbjct: 102 ERNNTLNFITEICTSGNLREYRKKHRHVSMRALKKWSKQILKGLDYLHTHDPCIIHRDLN 161
Query: 154 CDNIFVNGNQGEVKIGDLGLAAILRKSHAARCV-GTPEFMAPEVYEEEYNELVDIYSFGM 212
C NIFVNGN G+VKIGDLGLAAI+ K+H A + GTPEFMAPE+YEE Y E+VDIYS+GM
Sbjct: 162 CSNIFVNGNIGQVKIGDLGLAAIVGKNHLAHSILGTPEFMAPELYEENYTEMVDIYSYGM 221
Query: 213 CILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSAR 272
C+LE+V+ + PYSEC A+IYK+V G KPEAL KV DPE + FIEKC+A +R SA
Sbjct: 222 CVLELVSLEIPYSECDSVAKIYKRVSKGLKPEALNKVNDPEAKAFIEKCIAQPRARPSAA 281
Query: 273 ELLTDPFLQ--IDDYDSD 288
ELL DPF +DD D D
Sbjct: 282 ELLCDPFFDGILDDDDED 299
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q0D598 | WNK1_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.5154 | 0.8766 | 0.9190 | yes | no |
| Q9CAV6 | WNK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5863 | 0.7588 | 0.8 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.VIII.1962.1 | hypothetical protein (500 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 738 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-58 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-54 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-46 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-40 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-39 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-38 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-37 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-32 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-32 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-31 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-30 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-30 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-29 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-29 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-29 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-29 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-29 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-29 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-28 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-28 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-28 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-28 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-27 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-27 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-27 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-27 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-26 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-26 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-25 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-25 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-25 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-25 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-24 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-24 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-23 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-23 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-23 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-22 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-22 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-22 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-22 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-22 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-22 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-21 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-19 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-19 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-16 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-15 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-15 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-15 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-12 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-12 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-11 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-08 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-08 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-07 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-06 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-06 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-05 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-05 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-05 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-04 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-04 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 0.001 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.002 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 0.002 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 0.002 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 0.002 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 198 bits (506), Expect = 2e-58
Identities = 88/248 (35%), Positives = 124/248 (50%), Gaps = 14/248 (5%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y A D+ G VA +K + E + R EI +LK LKH NI++ Y + D
Sbjct: 16 YLARDKKTGKLVAIKVIKKKKIKKDRERILR---EIKILKKLKHPNIVRLYDVFED--ED 70
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
+ V E G L K R++ + + RQILS L YLHS+ ++HRDLK +NI
Sbjct: 71 KLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG--IVHRDLKPENI 128
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVY-EEEYNELVDIYSFGMCIL 215
++ + G VK+ D GLA L VGTPE+MAPEV + Y + VDI+S G IL
Sbjct: 129 LLDED-GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLG-VIL 186
Query: 216 -EMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE-DPEVRQFIEKCLAT-VSSRLSAR 272
E++T P+ +++KK+ K P + + PE + I K L RL+A
Sbjct: 187 YELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAE 246
Query: 273 ELLTDPFL 280
E L PF
Sbjct: 247 EALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 2e-54
Identities = 90/249 (36%), Positives = 126/249 (50%), Gaps = 11/249 (4%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y A D+ G +A V+L S EELE L EI +L +L+H NI+++Y S D
Sbjct: 17 YLALDKDTGELMAVKSVELSG--DSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKN 74
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
+N E + G+L K ++ ++ + RQIL GL YLHS ++HRD+K NI
Sbjct: 75 TLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANI 132
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARC----VGTPEFMAPEVYE-EEYNELVDIYSFGM 212
V+ + G VK+ D G A L GTP +MAPEV EEY DI+S G
Sbjct: 133 LVDSD-GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGC 191
Query: 213 CILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSA 271
++EM T P+SE +P K+ S +P + + E + F+ KCL R +A
Sbjct: 192 TVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTA 251
Query: 272 RELLTDPFL 280
ELL PFL
Sbjct: 252 DELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 2e-50
Identities = 80/252 (31%), Positives = 121/252 (48%), Gaps = 16/252 (6%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y+A + G VA +K + ++ + EI +L+ L H NI++ ++ D
Sbjct: 16 YKAKHKGTGKIVAVKILKKRS--EKSKKDQTARREIRILRRLSHPNIVRLIDAFED--KD 71
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
++ V E G L Y + ++ K QIL GL YLHS +IHRDLK +NI
Sbjct: 72 HLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG--IIHRDLKPENI 129
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPEV--YEEEYNELVDIYSFGMC 213
++ N G VKI D GLA L KS ++ VGTP +MAPEV Y VD++S G+
Sbjct: 130 LLDEN-GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVI 188
Query: 214 ILEMVTFDYPYSECTHPAQIYK--KVISGKKPEALFKV--EDPEVRQFIEKCLAT-VSSR 268
+ E++T P+S Q+ +++ K E + I+KCL S R
Sbjct: 189 LYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKR 248
Query: 269 LSARELLTDPFL 280
+A E+L P+
Sbjct: 249 PTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 4e-46
Identities = 79/247 (31%), Positives = 113/247 (45%), Gaps = 47/247 (19%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y A D+ G +VA +K D EEL R EI +LK L H NI+K Y + D
Sbjct: 10 YLARDKKTGKKVAIKIIKKEDSSSLLEELLR---EIEILKKLNHPNIVKLYGVFED--EN 64
Query: 98 NINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
++ V E G+L+ + +++ + QIL GL YLHS +IHRDLK +N
Sbjct: 65 HLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN--GIIHRDLKPEN 122
Query: 157 IFVNGNQGEVKIGDLGLAAILR--KSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGM 212
I ++ + G+VK+ D GL+ +L KS VGTP +MAPEV Y+E DI+S G+
Sbjct: 123 ILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGV 182
Query: 213 CILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSA 271
+ E+ PE++ I K L R SA
Sbjct: 183 ILYEL----------------------------------PELKDLIRKMLQKDPEKRPSA 208
Query: 272 RELLTDP 278
+E+L
Sbjct: 209 KEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 5e-41
Identities = 92/258 (35%), Positives = 130/258 (50%), Gaps = 31/258 (12%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y+A D G EVA +++L + E + EI ++K KH NI+ +Y S++
Sbjct: 36 YKATDRATGKEVAIKKMRLRK-----QNKELIINEILIMKDCKHPNIVDYYDSYLV--GD 88
Query: 98 NINFVTEMFTSGTL----RQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 153
+ V E G+L Q ++ I V CR++L GL YLHS+ VIHRD+K
Sbjct: 89 ELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV---CREVLQGLEYLHSQ--NVIHRDIK 143
Query: 154 CDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYE-EEYNELVDIYSF 210
DNI ++ G VK+ D G AA L K + R VGTP +MAPEV + ++Y VDI+S
Sbjct: 144 SDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSL 202
Query: 211 GMCILEMVTFDYPYSECTHPAQ-IYKKVISG----KKPEALFKVEDPEVRQFIEKCLAT- 264
G+ +EM + PY P + ++ G K PE PE + F+ KCL
Sbjct: 203 GIMCIEMAEGEPPYLREP-PLRALFLITTKGIPPLKNPEKW----SPEFKDFLNKCLVKD 257
Query: 265 VSSRLSARELLTDPFLQI 282
R SA ELL PFL+
Sbjct: 258 PEKRPSAEELLQHPFLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 85/250 (34%), Positives = 133/250 (53%), Gaps = 21/250 (8%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y+A + G EVA +KL +S E+ E++ EI +LK KH NI+K+Y S++
Sbjct: 17 YKARHKRTGKEVAIKVIKL----ESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK--KD 70
Query: 98 NINFVTEMFTSGTLRQ-YRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
+ V E + G+L+ + ++ + + + C+++L GL YLHS +IHRD+K N
Sbjct: 71 ELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAAN 128
Query: 157 IFVNGNQGEVKIGDLGLAAILRKSHAA-RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCI 214
I + + GEVK+ D GL+A L + A VGTP +MAPEV + Y+ DI+S G+
Sbjct: 129 ILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITA 187
Query: 215 LEMVTFDYPYSECTHPAQIYKKVISG----KKPEALFKVEDPEVRQFIEKCLA-TVSSRL 269
+E+ PYSE ++K +G + PE E + F++KCL R
Sbjct: 188 IELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKW----SDEFKDFLKKCLQKNPEKRP 243
Query: 270 SARELLTDPF 279
+A +LL PF
Sbjct: 244 TAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 1e-39
Identities = 73/251 (29%), Positives = 121/251 (48%), Gaps = 17/251 (6%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y + +G ++ L S +E E E+ +LK L H NI+K+Y S+ +
Sbjct: 17 YLVRRKSDGKLYVLKEIDL--SNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE--KG 72
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNI----RAVKHWCRQILSGLLYLHSRDPPVIHRDLK 153
+ V E G L Q K ++ + W Q+ L YLHSR ++HRD+K
Sbjct: 73 KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIK 130
Query: 154 CDNIFVNGNQGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEEE-YNELVDIYSF 210
NIF+ N G VK+GD G++ +L + A VGTP +++PE+ + + YN DI+S
Sbjct: 131 PQNIFLTSN-GLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSL 189
Query: 211 GMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATV-SSRL 269
G + E+ T +P+ E + ++ K++ G+ P + E+R + L R
Sbjct: 190 GCVLYELCTLKHPF-EGENLLELALKILKGQYP-PIPSQYSSELRNLVSSLLQKDPEERP 247
Query: 270 SARELLTDPFL 280
S ++L PF+
Sbjct: 248 SIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 5e-38
Identities = 85/251 (33%), Positives = 130/251 (51%), Gaps = 17/251 (6%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEE-LERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96
Y + +G A +V L D Q+ +E +++L EI LL L+H NI+++ + +
Sbjct: 17 YEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGT--EREE 74
Query: 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
N+ E+ G+L + K+ ++ + RQIL GL YLH R+ +HRD+K N
Sbjct: 75 DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGAN 132
Query: 157 IFVNGNQGEVKIGDLGLAA-ILRKSHAARCVGTPEFMAPEVYEEE--YNELVDIYSFGMC 213
I V+ N G VK+ D G+A ++ S A G+P +MAPEV ++ Y DI+S G
Sbjct: 133 ILVDTN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCT 191
Query: 214 ILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED---PEVRQFIEKCL-ATVSSRL 269
+LEM T P+S+ A ++K S + P + D E + FI KCL S R
Sbjct: 192 VLEMATGKPPWSQLEGVAAVFKIGRSKELPP----IPDHLSDEAKDFILKCLQRDPSLRP 247
Query: 270 SARELLTDPFL 280
+A ELL PF+
Sbjct: 248 TAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 80/247 (32%), Positives = 126/247 (51%), Gaps = 13/247 (5%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y+ + G VA Q+ L E L+ + EI LLK LKH NI+K+ S ++T++
Sbjct: 17 YKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVKYIGS-IETSD- 72
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
++ + E +G+LRQ K V + Q+L GL YLH + VIHRD+K NI
Sbjct: 73 SLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANI 130
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYEEE-YNELVDIYSFGMCI 214
+ G VK+ D G+A L VGTP +MAPEV E + DI+S G +
Sbjct: 131 LTTKD-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTV 189
Query: 215 LEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARE 273
+E++T + PY + P +++ P L + PE++ F+ +C + R +A++
Sbjct: 190 IELLTGNPPYYDLN-PMAALFRIVQDDHP-PLPEGISPELKDFLMQCFQKDPNLRPTAKQ 247
Query: 274 LLTDPFL 280
LL P++
Sbjct: 248 LLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 74/246 (30%), Positives = 120/246 (48%), Gaps = 16/246 (6%)
Query: 46 GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEM 105
G + W ++ Y + + +E ++L E+++L+ LKH NI+++Y +D +N+ + V E
Sbjct: 25 GKILVWKEID-YGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY 82
Query: 106 FTSGTL----RQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPP---VIHRDLKCDNIF 158
G L ++ + + + + + Q+L L H+R P V+HRDLK NIF
Sbjct: 83 CEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIF 142
Query: 159 VNGNQGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVY-EEEYNELVDIYSFGMCIL 215
++ N VK+GD GLA IL A VGTP +M+PE Y+E DI+S G I
Sbjct: 143 LDAN-NNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIY 201
Query: 216 EMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSAREL 274
E+ P++ Q+ K+ GK + E+ + I+ L R S EL
Sbjct: 202 ELCALSPPFTARNQ-LQLASKIKEGKFRR-IPYRYSSELNEVIKSMLNVDPDKRPSTEEL 259
Query: 275 LTDPFL 280
L P +
Sbjct: 260 LQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 75/248 (30%), Positives = 125/248 (50%), Gaps = 16/248 (6%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y+A D+ VA +K+ D ++ +E+E + EI L + I K+Y S++ +
Sbjct: 18 YKAIDKRTNQVVA---IKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKL 74
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
I + E G+ LK +++ + R++L GL YLH IHRD+K NI
Sbjct: 75 WI--IMEYCGGGSCLDL-LKPGKLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANI 129
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVY-EEEYNELVDIYSFGMCI 214
++ +G+VK+ D G++ L + + R VGTP +MAPEV + Y+E DI+S G+
Sbjct: 130 LLS-EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITA 188
Query: 215 LEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE-DPEVRQFIEKCL-ATVSSRLSAR 272
+E+ + P S+ HP ++ +I P +L + + F+ CL R SA+
Sbjct: 189 IELAKGEPPLSD-LHPMRVL-FLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAK 246
Query: 273 ELLTDPFL 280
ELL F+
Sbjct: 247 ELLKHKFI 254
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 73/251 (29%), Positives = 119/251 (47%), Gaps = 15/251 (5%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y+ + G A +K E ++L E+ L++ + ++K Y ++
Sbjct: 18 YKVRHKPTGKIYA---LKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK--EG 72
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
I+ V E G+L K ++ + + RQIL GL YLH +IHRD+K N+
Sbjct: 73 EISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH-TKRHIIHRDIKPSNL 131
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARC---VGTPEFMAPEVYE-EEYNELVDIYSFGMC 213
+N ++GEVKI D G++ +L + +C VGT +M+PE + E Y+ DI+S G+
Sbjct: 132 LIN-SKGEVKIADFGISKVLENT-LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLT 189
Query: 214 ILEMVTFDYPYS--ECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL-ATVSSRLS 270
+LE +P+ ++ + + G P + PE R FI CL R S
Sbjct: 190 LLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPS 249
Query: 271 ARELLTDPFLQ 281
A ELL PF++
Sbjct: 250 AAELLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 79/254 (31%), Positives = 124/254 (48%), Gaps = 23/254 (9%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y+A D G VA +KL ++ E + EI +LK +H NI+ ++ S++
Sbjct: 20 YKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVAYFGSYL--RRD 73
Query: 98 NINFVTEMFTSGTLRQ-YRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
+ V E G+L+ Y++ ++ + + CR+ L GL YLH IHRD+K N
Sbjct: 74 KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGAN 131
Query: 157 IFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYEEE----YNELVDIYSF 210
I + G+VK+ D G++A L + A R +GTP +MAPEV E Y+ DI++
Sbjct: 132 ILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWAL 190
Query: 211 GMCILEMVTFDYPYSECTHPAQ-IYKKVISGKKPEALFKVE--DPEVRQFIEKCLATVSS 267
G+ +E+ P + HP + ++ S P L E P FI+KCL T
Sbjct: 191 GITAIELAELQPPMFD-LHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCL-TKDP 248
Query: 268 RL--SARELLTDPF 279
+ +A +LL PF
Sbjct: 249 KKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 83/257 (32%), Positives = 136/257 (52%), Gaps = 23/257 (8%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y A + G +A ++++ D P+ ++ + E+ +L+ LKH N++K+Y V+
Sbjct: 17 YTAVNLDTGELMAVKEIRIQD--NDPKTIKEIADEMKVLELLKHPNLVKYYG--VEVHRE 72
Query: 98 NINFVTEMFTSGTLRQYRLKHRRV-NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
+ E + GTL + L+H R+ + ++ + Q+L GL YLHS ++HRD+K N
Sbjct: 73 KVYIFMEYCSGGTLEEL-LEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPAN 129
Query: 157 IFVNGNQGEVKIGDLGLAAILRKSHAARC-------VGTPEFMAPEVY----EEEYNELV 205
IF++ N G +K+GD G A L K++ GTP +MAPEV + +
Sbjct: 130 IFLDHN-GVIKLGDFGCAVKL-KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAA 187
Query: 206 DIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE-DPEVRQFIEKCLAT 264
DI+S G +LEM T P+SE + QI V +G KP ++ PE + F+++CL +
Sbjct: 188 DIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLES 247
Query: 265 V-SSRLSARELLTDPFL 280
R +A ELL PF+
Sbjct: 248 DPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 5e-30
Identities = 81/254 (31%), Positives = 124/254 (48%), Gaps = 11/254 (4%)
Query: 36 RHYRAFDEYEGIEVAWNQVKL-YDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 94
R Y +D G E+A QV+ + ++ +E+ L CEI LLK L+H I+++Y D
Sbjct: 17 RVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR 76
Query: 95 ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 154
A + + E G+++ + + + + RQIL G+ YLHS ++HRD+K
Sbjct: 77 AEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN--MIVHRDIKG 134
Query: 155 DNIFVNGNQGEVKIGDLG----LAAILRKSHAARCV-GTPEFMAPEVYE-EEYNELVDIY 208
NI + + G VK+GD G L I R V GTP +M+PEV E Y D++
Sbjct: 135 ANILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVW 193
Query: 209 SFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSR 268
S G ++EM+T P++E A I+K P+ + + R F+ R
Sbjct: 194 SLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE-HARDFLGCIFVEARHR 252
Query: 269 LSARELLTDPFLQI 282
SA ELL PF Q+
Sbjct: 253 PSAEELLRHPFAQL 266
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 64/234 (27%), Positives = 102/234 (43%), Gaps = 21/234 (8%)
Query: 37 HYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96
+ + + +EVA +K Q EE R E +++ L H NI+K V T
Sbjct: 19 TLKGKGDGKEVEVAVKTLKEDASEQQIEEFLR---EARIMRKLDHPNIVKLLG--VCTEE 73
Query: 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKC 154
+ V E G L Y K+R + + QI G+ YL S+ IHRDL
Sbjct: 74 EPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK--NFIHRDLAA 131
Query: 155 DNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPE---FMAPEVYEE-EYNELVDIYSF 210
N V N VKI D GL+ L + G +MAPE +E ++ D++SF
Sbjct: 132 RNCLVGENLV-VKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSF 190
Query: 211 GMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPEALFKVED--PEVRQFIEKC 261
G+ + E+ T + PY + A++ + + G + K + PE+ + + +C
Sbjct: 191 GVLLWEIFTLGEEPYPGMS-NAEVLEYLKKGYRLP---KPPNCPPELYKLMLQC 240
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 78/225 (34%), Positives = 117/225 (52%), Gaps = 16/225 (7%)
Query: 64 EELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQ-YRLKHRRVN 122
E+L+ + EI +LK I+K+Y S+ N ++ V E +G++ ++ ++ +
Sbjct: 40 EDLQEIIKEISILKQCDSPYIVKYYGSYF--KNTDLWIVMEYCGAGSVSDIMKITNKTLT 97
Query: 123 IRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 182
+ Q L GL YLHS IHRD+K NI +N +G+ K+ D G++ L + A
Sbjct: 98 EEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMA 154
Query: 183 AR--CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPA-QIYKKVI 238
R +GTP +MAPEV +E YN DI+S G+ +EM PYS+ HP I+ +I
Sbjct: 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD-IHPMRAIF--MI 211
Query: 239 SGKKPEALFKVED--PEVRQFIEKCLA-TVSSRLSARELLTDPFL 280
K P L E PE F++KCL R SA +LL PF+
Sbjct: 212 PNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 78/251 (31%), Positives = 120/251 (47%), Gaps = 16/251 (6%)
Query: 38 YRAFDEYEGIEVAWNQVKL-YDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96
Y +D G E+A QV D ++ +E+ L CEI LLK L+H I+++Y D +
Sbjct: 19 YLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--D 76
Query: 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
++ E G+++ + + + + RQIL G+ YLHS ++HRD+K N
Sbjct: 77 ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGAN 134
Query: 157 IFVNGNQGEVKIGDLG----LAAILRKSHAARCV-GTPEFMAPEVYE-EEYNELVDIYSF 210
I + G VK+GD G L I + V GTP +M+PEV E Y D++S
Sbjct: 135 ILRDSA-GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSV 193
Query: 211 GMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE-DPEVRQFIEKCLA-TVSSR 268
G ++EM+T P++E A I+K I+ + P+ R F+ + R
Sbjct: 194 GCTVVEMLTEKPPWAEFEAMAAIFK--IATQPTNPQLPSHVSPDARNFLRRTFVENAKKR 251
Query: 269 LSARELLTDPF 279
SA ELL F
Sbjct: 252 PSAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 81/262 (30%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y A +VA +K D + ++ L E+ + H N++K+YTS+V
Sbjct: 18 YAAICLPNNEKVA---IKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV--VGD 72
Query: 98 NINFVTEMFTSGTLRQYRLKHR-------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 150
+ V + G+L +K I V +++L GL YLHS IHR
Sbjct: 73 ELWLVMPYLSGGSLLDI-MKSSYPRGGLDEAIIATV---LKEVLKGLEYLHSNG--QIHR 126
Query: 151 DLKCDNIFVNGNQGEVKIGDLGLAAILRK----SHAAR--CVGTPEFMAPEVYEEE--YN 202
D+K NI + G G VKI D G++A L + R VGTP +MAPEV E+ Y+
Sbjct: 127 DIKAGNILL-GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185
Query: 203 ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP----EALFKVEDPEVRQFI 258
DI+SFG+ +E+ T PYS+ P ++ + P A +K R+ I
Sbjct: 186 FKADIWSFGITAIELATGAAPYSKYP-PMKVLMLTLQNDPPSLETGADYKKYSKSFRKMI 244
Query: 259 EKCLAT-VSSRLSARELLTDPF 279
CL S R +A ELL F
Sbjct: 245 SLCLQKDPSKRPTAEELLKHKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 9e-29
Identities = 82/255 (32%), Positives = 122/255 (47%), Gaps = 15/255 (5%)
Query: 36 RHYRAFDEYEGIEVAWNQVKLYDFLQSPE---ELERLYCEIHLLKTLKHRNIMKFYTSWV 92
R Y +D G E+A QV+ +SPE E+ L CEI LLK L H I+++Y
Sbjct: 17 RVYLCYDADTGRELAVKQVQFDP--ESPETSKEVNALECEIQLLKNLLHERIVQYYGCLR 74
Query: 93 DTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL 152
D R ++ E G+++ + + + + RQIL G+ YLHS ++HRD+
Sbjct: 75 DPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN--MIVHRDI 132
Query: 153 KCDNIFVNGNQGEVKIGDLGLAAILRK-----SHAARCVGTPEFMAPEVYE-EEYNELVD 206
K NI + + G VK+GD G + L+ + GTP +M+PEV E Y D
Sbjct: 133 KGANILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKAD 191
Query: 207 IYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVS 266
I+S G ++EM+T P++E A I+K P V D R F+++
Sbjct: 192 IWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD-HCRDFLKRIFVEAK 250
Query: 267 SRLSARELLTDPFLQ 281
R SA ELL F+
Sbjct: 251 LRPSADELLRHTFVH 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 66/248 (26%), Positives = 110/248 (44%), Gaps = 21/248 (8%)
Query: 37 HYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96
+ + +EVA +K Q EE R E +++ L H N++K V T
Sbjct: 19 KLKGKGGKKKVEVAVKTLKEDASEQQIEEFLR---EARIMRKLDHPNVVKLLG--VCTEE 73
Query: 97 RNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
+ V E G L Y K+R ++++ + + QI G+ YL S+ IHRDL
Sbjct: 74 EPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK--NFIHRDLAAR 131
Query: 156 NIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPE---FMAPEVYEE-EYNELVDIYSFG 211
N V N VKI D GL+ L R G +MAPE +E ++ D++SFG
Sbjct: 132 NCLVGENLV-VKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFG 190
Query: 212 MCILEMVTF-DYPYSECTHPAQIYKKVISGKKPEALFKVED--PEVRQFIEKCLAT-VSS 267
+ + E+ T + PY + ++ + + +G + + + PE+ + +C A
Sbjct: 191 VLLWEIFTLGEQPYPGMS-NEEVLEYLKNGYRLP---QPPNCPPELYDLMLQCWAEDPED 246
Query: 268 RLSARELL 275
R + EL+
Sbjct: 247 RPTFSELV 254
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 77/240 (32%), Positives = 116/240 (48%), Gaps = 31/240 (12%)
Query: 60 LQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR 119
++S EELE EI +L KH NI+ Y ++ I + E G L L+
Sbjct: 40 IESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI--LIEFCDGGALDSIMLELE 97
Query: 120 RV----NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175
R IR V CRQ+L L +LHS VIHRDLK NI + G+VK+ D G++A
Sbjct: 98 RGLTEPQIRYV---CRQMLEALNFLHSHK--VIHRDLKAGNILLT-LDGDVKLADFGVSA 151
Query: 176 ILRKSHAAR--CVGTPEFMAPEVYEEE------YNELVDIYSFGMCILEMVTFDYPYSEC 227
+ + R +GTP +MAPEV E Y+ DI+S G+ ++E+ + P+ E
Sbjct: 152 KNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE- 210
Query: 228 THPAQIYKKVISGKKPEALFKVEDP-----EVRQFIEKCLA-TVSSRLSARELLTDPFLQ 281
+P ++ K++ + P ++ P F++ CL R +A ELL PF+
Sbjct: 211 LNPMRVLLKILKSEPP----TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVS 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 65 ELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIR 124
E+E E ++L + H I+K + ++ + V E G L + K R +
Sbjct: 36 EVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVLEYAPGGELFSHLSKEGRFSEE 93
Query: 125 AVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR 184
+ + +I+ L YLHS +I+RDLK +NI ++ G +K+ D GLA L S +R
Sbjct: 94 RARFYAAEIVLALEYLHSLG--IIYRDLKPENILLD-ADGHIKLTDFGLAKEL-SSEGSR 149
Query: 185 C---VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 240
GTPE++APEV + Y + VD +S G+ + EM+T P+ +IY+K++
Sbjct: 150 TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF-YAEDRKEIYEKIL-- 206
Query: 241 KKPEALFKVEDPEVRQFIEKCLA 263
K P + PE R I L
Sbjct: 207 KDPLRFPEFLSPEARDLISGLLQ 229
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 78/257 (30%), Positives = 117/257 (45%), Gaps = 24/257 (9%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEE--LERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95
Y+A D G +A QV S +E +E L EI L+ L H +I++ + + +
Sbjct: 17 YQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS 76
Query: 96 NRNINFVTEM---FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL 152
+ N+ FV M S L +Y V I + Q+L GL YLH +IHRD+
Sbjct: 77 HFNL-FVEWMAGGSVSHLLSKYGAFKEAVIIN----YTEQLLRGLSYLHENQ--IIHRDV 129
Query: 153 KCDNIFVNGNQGEVKIGDLGLAAILRKS------HAARCVGTPEFMAPEVYE-EEYNELV 205
K N+ ++ ++I D G AA L + +GT FMAPEV E+Y
Sbjct: 130 KGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSC 189
Query: 206 DIYSFGMCILEMVTFDYPYSE---CTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 262
D++S G I+EM T P++ H A I+ K+ S ++ + P +R +CL
Sbjct: 190 DVWSVGCVIIEMATAKPPWNAEKHSNHLALIF-KIASATTAPSIPEHLSPGLRDVTLRCL 248
Query: 263 -ATVSSRLSARELLTDP 278
R +RELL P
Sbjct: 249 ELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 84/247 (34%), Positives = 128/247 (51%), Gaps = 18/247 (7%)
Query: 40 AFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99
A D+ G +VA VK D L+ + E L+ E+ +++ +H NI++ Y+S++ +
Sbjct: 38 ATDKSTGRQVA---VKKMD-LRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL--VGDEL 91
Query: 100 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 159
V E G L + H R+N + C +L L +LH++ VIHRD+K D+I +
Sbjct: 92 WVVMEFLEGGALTDI-VTHTRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILL 148
Query: 160 NGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILE 216
+ G VK+ D G A + K R VGTP +MAPEV Y VDI+S G+ ++E
Sbjct: 149 TSD-GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIE 207
Query: 217 MVTFDYPYSECTHPAQIYKKVISGKKPEA--LFKVEDPEVRQFIEKCLA-TVSSRLSARE 273
MV + PY P Q K++ P+ L KV P +R F+++ L + R +A E
Sbjct: 208 MVDGEPPYFN-EPPLQAMKRIRDNLPPKLKNLHKVS-PRLRSFLDRMLVRDPAQRATAAE 265
Query: 274 LLTDPFL 280
LL PFL
Sbjct: 266 LLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 7e-28
Identities = 76/227 (33%), Positives = 113/227 (49%), Gaps = 21/227 (9%)
Query: 66 LERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI--NFVTEMFTSGTLRQYRLKHRRVNI 123
L+ L EI LLK L+H NI+++ S +D + NI +V + L Y +
Sbjct: 50 LDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL-- 107
Query: 124 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL------ 177
V+++ RQIL GL YLH+R +IHRD+K NI V+ N+G +KI D G++ L
Sbjct: 108 --VRNFVRQILKGLNYLHNRG--IIHRDIKGANILVD-NKGGIKISDFGISKKLEANSLS 162
Query: 178 --RKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 234
G+ +MAPEV ++ Y DI+S G ++EM+T +P+ +CT I+
Sbjct: 163 TKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF 222
Query: 235 KKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFL 280
K I + E F+EK + R +A ELL PFL
Sbjct: 223 K--IGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 83/251 (33%), Positives = 126/251 (50%), Gaps = 22/251 (8%)
Query: 44 YEGIEVAWNQV---KLYDFLQSPE-ELERLYCEIHLLKTLKH---RNIMKFYTSWVDTAN 96
Y G V +V K+ + L +P+ ++ + E+ LL L+ NI K+Y S++
Sbjct: 18 YRGKHVPTGRVVALKIIN-LDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPR 76
Query: 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
I + E G++R +K + + + R++L L Y+H VIHRD+K N
Sbjct: 77 LWI--IMEYAEGGSVRTL-MKAGPIAEKYISVIIREVLVALKYIHKV--GVIHRDIKAAN 131
Query: 157 IFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPEVYEE--EYNELVDIYSFGM 212
I V N G VK+ D G+AA+L ++ + R VGTP +MAPEV E Y+ DI+S G+
Sbjct: 132 ILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGI 190
Query: 213 CILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE-DPEVRQFIEKCLATV-SSRLS 270
I EM T + PYS+ A +I KP L +R+F+ CL RLS
Sbjct: 191 TIYEMATGNPPYSD--VDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLS 248
Query: 271 ARELLTDPFLQ 281
A ELL +++
Sbjct: 249 AEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 63/250 (25%), Positives = 102/250 (40%), Gaps = 20/250 (8%)
Query: 37 HYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96
+ E +VA VK S EE E E ++K L H NI++ V T
Sbjct: 19 TLKGDGEGTETKVA---VKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLG--VCTQG 73
Query: 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKC 154
+ VTE G L + L+ + QI G+ YL S+ +HRDL
Sbjct: 74 EPLYIVTEYMPGGDLLDF-LRKHGEKLTLKDLLQMALQIAKGMEYLESK--NFVHRDLAA 130
Query: 155 DNIFVNGNQGEVKIGDLGLA-AILRKSHAARCVGTPE---FMAPEVYEE-EYNELVDIYS 209
N V VKI D GL+ I + + G +MAPE ++ ++ D++S
Sbjct: 131 RNCLV-TENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWS 189
Query: 210 FGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSS 267
FG+ + E+ T + PY + ++ + + G + E+ + + +C A
Sbjct: 190 FGVLLWEIFTLGEQPYPGMS-NEEVLELLEDGYRLPRPENC-PDELYELMLQCWAYDPED 247
Query: 268 RLSARELLTD 277
R + EL+ D
Sbjct: 248 RPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 1e-27
Identities = 90/255 (35%), Positives = 121/255 (47%), Gaps = 26/255 (10%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y A D G EVA Q+ L Q +EL + EI +++ KH NI+ + S++
Sbjct: 36 YTAIDVATGQEVAIKQMNLQQ--QPKKEL--IINEILVMRENKHPNIVNYLDSYL--VGD 89
Query: 98 NINFVTEMFTSGTLRQY--RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
+ V E G+L I AV CR+ L L +LHS VIHRD+K D
Sbjct: 90 ELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALEFLHSNQ--VIHRDIKSD 144
Query: 156 NIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPEVY-EEEYNELVDIYSFGM 212
NI + G G VK+ D G A + + R VGTP +MAPEV + Y VDI+S G+
Sbjct: 145 NILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203
Query: 213 CILEMVTFDYPYSECTHPAQIYKKVISGK----KPEALFKVEDPEVRQFIEKCLAT-VSS 267
+EMV + PY +Y +G PE L R F+ +CL V
Sbjct: 204 MAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL----SAIFRDFLNRCLEMDVEK 259
Query: 268 RLSARELLTDPFLQI 282
R SA+ELL PFL+I
Sbjct: 260 RGSAKELLQHPFLKI 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 72/234 (30%), Positives = 121/234 (51%), Gaps = 16/234 (6%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y+A +G VA +V++++ + + + EI LLK L H N++K+ S+++ N
Sbjct: 19 YKAICLLDGRVVALKKVQIFE-MMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--NN 75
Query: 98 NINFVTEMFTSGTLRQYRLKH-----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL 152
+N V E+ +G L + +KH R + R + + Q+ S L ++HS+ ++HRD+
Sbjct: 76 ELNIVLELADAGDLSRM-IKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDI 132
Query: 153 KCDNIFVNGNQGEVKIGDLGLAAIL-RKSHAARC-VGTPEFMAPE-VYEEEYNELVDIYS 209
K N+F+ G VK+GDLGL K+ AA VGTP +M+PE ++E YN DI+S
Sbjct: 133 KPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWS 191
Query: 210 FGMCILEMVTFDYP-YSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 262
G + EM P Y + + + KK+ P E+R + +C+
Sbjct: 192 LGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCI 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 81/233 (34%), Positives = 111/233 (47%), Gaps = 27/233 (11%)
Query: 64 EELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR---- 119
++ L+ EI L LKHRNI+++ S D+ N E G+L L+ +
Sbjct: 47 RYVQPLHEEIALHSYLKHRNIVQYLGS--DSENGFFKIFMEQVPGGSLSAL-LRSKWGPL 103
Query: 120 RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG----LAA 175
+ N + + + +QIL GL YLH ++HRD+K DN+ VN G VKI D G LA
Sbjct: 104 KDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161
Query: 176 ILRKSHAARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ 232
I GT ++MAPEV ++ Y DI+S G I+EM T P+ E P
Sbjct: 162 I--NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA 219
Query: 233 IYKKVISGKK----PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280
KV K PE+L E + FI +C R SA +LL DPFL
Sbjct: 220 AMFKVGMFKIHPEIPESL----SAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 1e-26
Identities = 76/292 (26%), Positives = 122/292 (41%), Gaps = 32/292 (10%)
Query: 58 DFLQSPEELERLYCEIHLLKTLKH-RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-- 114
+E+ER EI +L +L H NI+K Y + D ++ V E G+L
Sbjct: 33 KLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD--EGSLYLVMEYVDGGSLEDLLK 90
Query: 115 -RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 173
+ ++ QILS L YLHS+ +IHRD+K +NI ++ + VK+ D GL
Sbjct: 91 KIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGL 148
Query: 174 AAILRKSHAAR--------CVGTPEFMAPEVY----EEEYNELVDIYSFGMCILEMVTFD 221
A +L + VGTP +MAPEV + DI+S G+ + E++T
Sbjct: 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
Query: 222 YPY---SECTHPAQIYKKVISGKKPEALFKV-------EDPEVRQFIEKCLA-TVSSRLS 270
P+ + +Q K ++ P + ++K LA +RLS
Sbjct: 209 PPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS 268
Query: 271 ARELLTDPFL-QIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNN 321
+ L+ L + +SDL + D + L SL + S +S
Sbjct: 269 SSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAI 320
|
Length = 384 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 77/249 (30%), Positives = 120/249 (48%), Gaps = 11/249 (4%)
Query: 38 YRAFDEYEGIEVAWNQVKL-YDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96
Y +D G E+A QV D ++ +E+ L CEI LLK L+H I+++Y D
Sbjct: 19 YLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE 78
Query: 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
+ ++ E G+++ + + + + RQIL G+ YLHS ++HRD+K N
Sbjct: 79 KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN--MIVHRDIKGAN 136
Query: 157 IFVNGNQGEVKIGDLG----LAAILRKSHAARCV-GTPEFMAPEVYE-EEYNELVDIYSF 210
I + + G VK+GD G + I + V GTP +M+PEV E Y D++S
Sbjct: 137 ILRD-SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSV 195
Query: 211 GMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLS 270
++EM+T P++E A I+K KP V D R F+++ R +
Sbjct: 196 ACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD-ACRDFLKQIFVEEKRRPT 254
Query: 271 ARELLTDPF 279
A LL PF
Sbjct: 255 AEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (271), Expect = 5e-26
Identities = 79/280 (28%), Positives = 116/280 (41%), Gaps = 50/280 (17%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYC-EIHLLKTLKHRNIMKFYTSWVDTAN 96
Y+A D+ G VA +++L E + EI LLK LKH NI+K V
Sbjct: 16 YKARDKKTGEIVALKKIRLD---NEEEGIPSTALREISLLKELKHPNIVKLLD--VIHTE 70
Query: 97 RNINFVTEMFTSGTLRQYRLKHRR--VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 154
R + V E + L++Y L R ++ +K Q+L GL Y HS ++HRDLK
Sbjct: 71 RKLYLVFE-YCDMDLKKY-LDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKP 126
Query: 155 DNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFM-----APEVY--EEEYNELVDI 207
NI +N + G +K+ D GLA R T E + APE+ + Y+ VDI
Sbjct: 127 QNILINRD-GVLKLADFGLARAF--GIPLRTY-THEVVTLWYRAPEILLGSKHYSTAVDI 182
Query: 208 YSFGMCILEMVTFDYPYSECTHPAQIYK--------------------------KVISGK 241
+S G EM+T + + Q++K K
Sbjct: 183 WSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPK 242
Query: 242 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280
E + DPE + K L + R+SA+E L P+
Sbjct: 243 DLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 76/266 (28%), Positives = 118/266 (44%), Gaps = 36/266 (13%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTAN 96
Y+A + G VA +K+ D + +E E + E ++L+ H NI FY +++
Sbjct: 23 YKARHKKTGQLVA---IKIMDII--EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77
Query: 97 RN----INFVTEMFTSGTLRQYRLKHRRVNIRAVKHW----CRQILSGLLYLHSRDPPVI 148
+ V E+ G++ R+ R + W R+ L GL YLH VI
Sbjct: 78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VI 135
Query: 149 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEV------YEEE 200
HRD+K NI + N EVK+ D G++A L + R +GTP +MAPEV +
Sbjct: 136 HRDIKGQNILLTKN-AEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDAS 194
Query: 201 YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE-----VR 255
Y+ D++S G+ +E+ P + HP + K+ P ++ PE
Sbjct: 195 YDARSDVWSLGITAIELADGKPPLCD-MHPMRALFKIPRNPPP----TLKSPENWSKKFN 249
Query: 256 QFIEKCLA-TVSSRLSARELLTDPFL 280
FI +CL R ELL PF+
Sbjct: 250 DFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 53/215 (24%), Positives = 87/215 (40%), Gaps = 22/215 (10%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV 121
S EE + E ++K L H N+++ V T + V E G L Y K R V
Sbjct: 36 SEEERKDFLKEARVMKKLGHPNVVRLLG--VCTEEEPLYLVLEYMEGGDLLDYLRKSRPV 93
Query: 122 NIRAVK---------HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 172
K + QI G+ YL S+ +HRDL N V + VKI D G
Sbjct: 94 FPSPEKSTLSLKDLLSFAIQIAKGMEYLASK--KFVHRDLAARNCLVGED-LVVKISDFG 150
Query: 173 LA-AILRKSHAARCVGTPE---FMAPEVYEE-EYNELVDIYSFGMCILEMVTF-DYPYSE 226
L+ + + + G +MAPE ++ + D++SFG+ + E+ T PY
Sbjct: 151 LSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG 210
Query: 227 CTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKC 261
+ ++ + + G + E+ + + C
Sbjct: 211 LS-NEEVLEYLRKGYRLPKPEYC-PDELYELMLSC 243
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 69/239 (28%), Positives = 115/239 (48%), Gaps = 17/239 (7%)
Query: 49 VAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTS 108
V W +V L S +E EI +L L+H NI+ +Y ++D I E
Sbjct: 28 VVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM--EYANG 83
Query: 109 GTLRQYRLKHRRVNI---RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 165
GTL ++ ++ + V + QI+S + Y+H ++HRD+K NIF+ G
Sbjct: 84 GTLYD-KIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLT-KAGL 139
Query: 166 VKIGDLGLAAIL--RKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDY 222
+K+GD G++ IL S A VGTP +M+PE+ + +YN DI++ G + E++T
Sbjct: 140 IKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR 199
Query: 223 PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFL 280
+ + T+P + K++ G + V E+ + L R +A E+L P L
Sbjct: 200 TF-DATNPLNLVVKIVQGNY-TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 72/229 (31%), Positives = 116/229 (50%), Gaps = 15/229 (6%)
Query: 60 LQSPEELERLYC--EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK 117
L ER E +L L I+++Y S++D NI V E +G L +
Sbjct: 35 LSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNI--VMEYAENGDLHKLLKM 92
Query: 118 HRRVNIRAVKHW--CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175
R + + W QIL GL +LHS+ ++HRD+K N+F++ VKIGDLG+A
Sbjct: 93 QRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYD-NVKIGDLGVAK 149
Query: 176 ILRKSH--AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQ 232
+L + A VGTP +++PE+ E++ YNE D+++ G+ + E T +P+ A
Sbjct: 150 LLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL 209
Query: 233 IYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280
I K+I G P + ++ ++ Q I++CL R +LL +P L
Sbjct: 210 I-LKIIRGVFP-PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 88/255 (34%), Positives = 124/255 (48%), Gaps = 26/255 (10%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+ A D G EVA Q+ L Q + E + EI ++K LK+ NI+ F S++
Sbjct: 36 FTAIDVATGQEVAIKQINL----QKQPKKELIINEILVMKELKNPNIVNFLDSFL--VGD 89
Query: 98 NINFVTEMFTSGTLRQYRLK--HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
+ V E G+L + I AV CR+ L L +LH+ VIHRD+K D
Sbjct: 90 ELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CRECLQALEFLHANQ--VIHRDIKSD 144
Query: 156 NIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPEVYEEE-YNELVDIYSFGM 212
N+ + G G VK+ D G A + + R VGTP +MAPEV + Y VDI+S G+
Sbjct: 145 NVLL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203
Query: 213 CILEMVTFDYPYSECTHPAQIYKKVISG----KKPEALFKVEDPEVRQFIEKCLAT-VSS 267
+EMV + PY +Y +G + PE L P R F+ +CL V
Sbjct: 204 MAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL----SPIFRDFLNRCLEMDVEK 259
Query: 268 RLSARELLTDPFLQI 282
R SA+ELL PFL++
Sbjct: 260 RGSAKELLQHPFLKL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-25
Identities = 73/233 (31%), Positives = 123/233 (52%), Gaps = 14/233 (6%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
YRA +G+ VA +V+++D + + + + EI LLK L H N++K+Y S+++ +
Sbjct: 19 YRATCLLDGVPVALKKVQIFDLMDAKARADCIK-EIDLLKQLNHPNVIKYYASFIE--DN 75
Query: 98 NINFVTEMFTSGTL----RQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 153
+N V E+ +G L + ++ + R + + V + Q+ S L ++HSR V+HRD+K
Sbjct: 76 ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIK 133
Query: 154 CDNIFVNGNQGEVKIGDLGLAAIL--RKSHAARCVGTPEFMAPE-VYEEEYNELVDIYSF 210
N+F+ G VK+GDLGL + + A VGTP +M+PE ++E YN DI+S
Sbjct: 134 PANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSL 192
Query: 211 GMCILEMVTFDYP-YSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 262
G + EM P Y + + + KK+ P E+RQ + C+
Sbjct: 193 GCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCI 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 69/227 (30%), Positives = 113/227 (49%), Gaps = 13/227 (5%)
Query: 60 LQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY----R 115
S +E E EI +L ++ H NI+ + +++D + V E G L + +
Sbjct: 37 SMSQKEREDAVNEIRILASVNHPNIISYKEAFLD--GNKLCIVMEYAPFGDLSKAISKRK 94
Query: 116 LKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175
K + + + + Q+L GL LH + ++HRDLK NI + N VKIGDLG++
Sbjct: 95 KKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVAN-DLVKIGDLGISK 151
Query: 176 ILRKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 234
+L+K+ A +GTP +MAPEV++ Y+ DI+S G + EM TF P+ E +
Sbjct: 152 VLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF-EARSMQDLR 210
Query: 235 KKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFL 280
KV GK P + + +++ FI L R + ++L P +
Sbjct: 211 YKVQRGKYP-PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 63/246 (25%), Positives = 100/246 (40%), Gaps = 45/246 (18%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFT---SGTLRQYRLKHRRVNIRAVKH 128
EI LL+ L+H NI++ +I V E +G L +K +K
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK---FTESQIKC 104
Query: 129 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--- 185
+ +Q+L GL YLHS ++HRD+K NI +N N G +K+ D GLA K ++A
Sbjct: 105 YMKQLLEGLQYLHSNG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSADYTNR 161
Query: 186 VGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EMVT-------------FDYPYSECTH 229
V T + PE+ Y VD++S G CIL E+ + + C
Sbjct: 162 VITLWYRPPELLLGATRYGPEVDMWSVG-CILAELFLGKPIFQGSTELEQLEKIFELCGS 220
Query: 230 PA----------QIYKKVISGKKPEALFK-----VEDPEVRQFIEKCLA-TVSSRLSARE 273
P ++ + K + + + DP ++K L R+SA +
Sbjct: 221 PTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQ 280
Query: 274 LLTDPF 279
L +
Sbjct: 281 ALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 67/221 (30%), Positives = 102/221 (46%), Gaps = 20/221 (9%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCR 131
EI LK L H NI+++ +T ++ E G++ + R + V+ +
Sbjct: 58 EIETLKDLDHLNIVQYLG--FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE 115
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL----AAILRKSHAARCVG 187
Q+L GL YLHS+ ++HRDLK DN+ V+ G KI D G+ I G
Sbjct: 116 QVLEGLAYLHSKG--ILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQG 172
Query: 188 TPEFMAPEV---YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK-- 242
+ +MAPEV Y + Y+ VDI+S G +LEM P+S+ A ++K + K+
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK--LGNKRSA 230
Query: 243 ---PEALFKVEDPEVRQFI-EKCLATVSSRLSARELLTDPF 279
P + P F+ +R +ARELL PF
Sbjct: 231 PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-24
Identities = 80/246 (32%), Positives = 127/246 (51%), Gaps = 16/246 (6%)
Query: 40 AFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99
A +++ G +VA VK+ D L+ + E L+ E+ +++ +H+N+++ Y S++ +
Sbjct: 40 AREKHSGRQVA---VKMMD-LRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL--VGEEL 93
Query: 100 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 159
+ E G L + R+N + C +L L YLHS+ VIHRD+K D+I +
Sbjct: 94 WVLMEFLQGGALTDI-VSQTRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILL 150
Query: 160 NGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILE 216
+ G VK+ D G A + K R VGTP +MAPEV Y VDI+S G+ ++E
Sbjct: 151 TLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIE 209
Query: 217 MVTFDYPYSECTHPAQIYKKVISGKKPEAL-FKVEDPEVRQFIEKCLA-TVSSRLSAREL 274
MV + PY + P Q K++ P+ P +R F+E+ L R +A+EL
Sbjct: 210 MVDGEPPYFSDS-PVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQEL 268
Query: 275 LTDPFL 280
L PFL
Sbjct: 269 LDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 63/228 (27%), Positives = 112/228 (49%), Gaps = 11/228 (4%)
Query: 61 QSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQ-YRLKHR 119
+ +++ E+ +L I+ FY ++ + N +I+ E G+L + +
Sbjct: 38 INEAIQKQILRELDILHKCNSPYIVGFYGAFYN--NGDISICMEYMDGGSLDKILKEVQG 95
Query: 120 RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179
R+ R + +L GL YLH +IHRD+K NI VN ++G++K+ D G++ L
Sbjct: 96 RIPERILGKIAVAVLKGLTYLHE-KHKIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVN 153
Query: 180 SHAARCVGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPA----QIY 234
S A VGT +MAPE + +Y+ DI+S G+ ++E+ T +PY P ++
Sbjct: 154 SLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELL 213
Query: 235 KKVISGKKPEALFKVEDPEVRQFIEKCL-ATVSSRLSARELLTDPFLQ 281
+ +++ P P+ + F+ CL R S +ELL PF++
Sbjct: 214 QYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 85/254 (33%), Positives = 128/254 (50%), Gaps = 24/254 (9%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y A D G EVA Q+ L Q P++ E + EI +++ K+ NI+ + S++
Sbjct: 36 YTAIDIATGQEVAIKQMNLQ---QQPKK-ELIINEILVMRENKNPNIVNYLDSYL--VGD 89
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
+ V E G+L + ++ + CR+ L L +LHS VIHRD+K DNI
Sbjct: 90 ELWVVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNI 146
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPEVYEEE-YNELVDIYSFGMCI 214
+ G G VK+ D G A + + R VGTP +MAPEV + Y VDI+S G+
Sbjct: 147 LL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 205
Query: 215 LEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE-----VRQFIEKCLAT-VSSR 268
+EMV + PY +P + + + PE +++PE R F+ +CL V R
Sbjct: 206 IEMVEGEPPYLN-ENPLRALYLIATNGTPE----LQNPERLSAVFRDFLNRCLEMDVDRR 260
Query: 269 LSARELLTDPFLQI 282
SA+ELL PFL++
Sbjct: 261 GSAKELLQHPFLKL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 2e-23
Identities = 65/212 (30%), Positives = 114/212 (53%), Gaps = 11/212 (5%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR--VNIRAVKHW 129
E +LK L H NI+++Y ++++ ++ + V E GTL +Y K ++ + H+
Sbjct: 49 ECQVLKLLSHPNIIEYYENFLE--DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHF 106
Query: 130 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-RKSHAARCVGT 188
QIL L ++H++ ++HRDLK NI ++ ++ VKIGD G++ IL KS A VGT
Sbjct: 107 FVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGT 164
Query: 189 PEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF 247
P +++PE+ E + YN+ DI++ G + E+ + + PA + K++SG
Sbjct: 165 PCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA-LVLKIMSGTFAPISD 223
Query: 248 KVEDPEVRQFIEKCLAT-VSSRLSARELLTDP 278
+ P++RQ I L S R +++ P
Sbjct: 224 RYS-PDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 5e-23
Identities = 79/249 (31%), Positives = 126/249 (50%), Gaps = 18/249 (7%)
Query: 40 AFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99
A +++ G +VA VK D L+ + E L+ E+ +++ H N++ Y S++ +
Sbjct: 41 ATEKHTGKQVA---VKKMD-LRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL--VGDEL 94
Query: 100 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 159
V E G L + H R+N + C +L L YLH++ VIHRD+K D+I +
Sbjct: 95 WVVMEFLEGGALTDI-VTHTRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILL 151
Query: 160 NGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYEE-EYNELVDIYSFGMCILE 216
+ G +K+ D G A + K R VGTP +MAPEV Y VDI+S G+ ++E
Sbjct: 152 TSD-GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIE 210
Query: 217 MVTFDYPYSECTHPAQIYKKVISGKKP--EALFKVEDPEVRQFIEKCLA-TVSSRLSARE 273
M+ + PY P Q +++ P + KV +R F++ L S R +A+E
Sbjct: 211 MIDGEPPYFN-EPPLQAMRRIRDNLPPRVKDSHKVSSV-LRGFLDLMLVREPSQRATAQE 268
Query: 274 LLTDPFLQI 282
LL PFL++
Sbjct: 269 LLQHPFLKL 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 9/207 (4%)
Query: 67 ERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAV 126
E ++ E +L+ H I+K Y ++ D + I + E G L +
Sbjct: 38 EHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLGGELWTILRDRGLFDEYTA 95
Query: 127 KHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-RKSHAARC 185
+ + ++ YLH+R +I+RDLK +N+ ++ + G VK+ D G A L
Sbjct: 96 RFYIACVVLAFEYLHNRG--IIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTF 152
Query: 186 VGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSEC-THPAQIYKKVISGKKP 243
GTPE++APE+ + Y+ VD +S G+ + E++T P+ E P +IY ++ G
Sbjct: 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK 212
Query: 244 EALFKVEDPEVRQFIEK-CLATVSSRL 269
D + I++ RL
Sbjct: 213 LEFPNYIDKAAKDLIKQLLRRNPEERL 239
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 1e-22
Identities = 65/196 (33%), Positives = 105/196 (53%), Gaps = 17/196 (8%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYC--EIHLLKTLKHRNIMKFYTSWVDTA 95
YRA + VA +V++++ + + R C EI LLK L H N++K+ S++
Sbjct: 19 YRATCLLDRKPVALKKVQIFEMMDAKA---RQDCVKEIDLLKQLNHPNVIKYLDSFI--E 73
Query: 96 NRNINFVTEMFTSGTLRQ----YRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 151
+ +N V E+ +G L Q ++ + R + R V + Q+ S + ++HSR V+HRD
Sbjct: 74 DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRD 131
Query: 152 LKCDNIFVNGNQGEVKIGDLGLAAIL--RKSHAARCVGTPEFMAPE-VYEEEYNELVDIY 208
+K N+F+ G VK+GDLGL + + A VGTP +M+PE ++E YN DI+
Sbjct: 132 IKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIW 190
Query: 209 SFGMCILEMVTFDYPY 224
S G + EM P+
Sbjct: 191 SLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 60/238 (25%), Positives = 120/238 (50%), Gaps = 24/238 (10%)
Query: 63 PEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTL----RQYRLKH 118
P+ +++ E+ + K+ K I+K+Y +++D ++ +I E G+L ++ + +
Sbjct: 40 PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRG 99
Query: 119 RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178
R+ + + +L GL YLHSR +IHRD+K NI + +G+VK+ D G++ L
Sbjct: 100 GRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLT-RKGQVKLCDFGVSGELV 156
Query: 179 KSHAARCVGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDYPY----SECTHPAQI 233
S A GT +MAPE + + Y+ D++S G+ +LE+ +P+ P ++
Sbjct: 157 NSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIEL 216
Query: 234 YKKVISGKKPEALFKVEDPEV--------RQFIEKCLA-TVSSRLSARELLTDPFLQI 282
+++ PE ++P + FI++CL + R + ++L P+++
Sbjct: 217 LSYIVNMPNPEL---KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-22
Identities = 76/260 (29%), Positives = 117/260 (45%), Gaps = 36/260 (13%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKF-------YTS 90
Y A D VA ++ Y QS E+ + + E+ L+ L+H N +++ +T+
Sbjct: 32 YFARDVRTNEVVAIKKM-SYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90
Query: 91 WVDTANRNINFVTEMF---TSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPV 147
W+ V E S L ++ + V I A+ C L GL YLHS +
Sbjct: 91 WL---------VMEYCLGSASDILEVHKKPLQEVEIAAI---CHGALQGLAYLHSHE--R 136
Query: 148 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVY----EEEYNE 203
IHRD+K NI + G VK+ D G A++ S A VGTP +MAPEV E +Y+
Sbjct: 137 IHRDIKAGNILLTEP-GTVKLADFGSASL--VSPANSFVGTPYWMAPEVILAMDEGQYDG 193
Query: 204 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE-DPEVRQFIEKCL 262
VD++S G+ +E+ P + +Y I+ L + R F++ CL
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYH--IAQNDSPTLSSNDWSDYFRNFVDSCL 251
Query: 263 ATV-SSRLSARELLTDPFLQ 281
+ R S+ ELL F+
Sbjct: 252 QKIPQDRPSSEELLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 54/172 (31%), Positives = 94/172 (54%), Gaps = 10/172 (5%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCR 131
E +L++++H ++ Y S+ D + N+ V E G L + K R + +
Sbjct: 51 EKRILQSIRHPFLVNLYGSFQD--DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAA 108
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF 191
Q++ L YLHS D +++RDLK +N+ + + G +KI D G A ++ C GTPE+
Sbjct: 109 QVVLALEYLHSLD--IVYRDLKPENLLL-DSDGYIKITDFGFAKRVKGRTYTLC-GTPEY 164
Query: 192 MAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP-YSECTHPAQIYKKVISGK 241
+APE+ + Y + VD ++ G+ I EM+ P + + +P QIY+K++ GK
Sbjct: 165 LAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD--NPIQIYEKILEGK 214
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 71/227 (31%), Positives = 113/227 (49%), Gaps = 14/227 (6%)
Query: 60 LQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR 119
L+ + E L+ E+ +++ +H N+++ Y S++ + V E G L + H
Sbjct: 55 LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL--VGDELWVVMEFLEGGALTDI-VTHT 111
Query: 120 RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179
R+N + C +L L LH++ VIHRD+K D+I + + G VK+ D G A + K
Sbjct: 112 RMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSK 168
Query: 180 SHAAR--CVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 236
R VGTP +MAPE+ Y VDI+S G+ ++EMV + PY P K
Sbjct: 169 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF--NEPPLKAMK 226
Query: 237 VISGKKPEALFKVE--DPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280
+I P L + P ++ F+++ L + R +A ELL PFL
Sbjct: 227 MIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 69/234 (29%), Positives = 118/234 (50%), Gaps = 17/234 (7%)
Query: 61 QSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HR 119
+S EELE EI +L + H NI+K ++ N+ + E G + L+ R
Sbjct: 41 KSEEELEDYMVEIDILASCDHPNIVKLLDAFY--YENNLWILIEFCAGGAVDAVMLELER 98
Query: 120 RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179
+ ++ C+Q L L YLH + +IHRDLK NI + G++K+ D G++A +
Sbjct: 99 PLTEPQIRVVCKQTLEALNYLH--ENKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTR 155
Query: 180 SHAAR--CVGTPEFMAPEVY------EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPA 231
+ R +GTP +MAPEV + Y+ D++S G+ ++EM + P+ E +P
Sbjct: 156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE-LNPM 214
Query: 232 QIYKKVISGKKPE-ALFKVEDPEVRQFIEKCL-ATVSSRLSARELLTDPFLQID 283
++ K+ + P A E + F++KCL V +R + +LL PF+ ++
Sbjct: 215 RVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 65/216 (30%), Positives = 110/216 (50%), Gaps = 14/216 (6%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI---RAVKH 128
E LL LKH NI+ + SW + ++ F G ++LK ++ + V
Sbjct: 49 EAQLLSQLKHPNIVAYRESW--EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVE 106
Query: 129 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--AARCV 186
W QI L YLH + ++HRDLK N+F+ +K+GDLG+A +L A+ +
Sbjct: 107 WFVQIAMALQYLHEKH--ILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLI 163
Query: 187 GTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEA 245
GTP +M+PE++ + YN D+++ G C+ EM T + ++ + +Y ++I GK P
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY-RIIEGKLPP- 221
Query: 246 LFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFL 280
+ K PE+ + I L+ R S + +L P++
Sbjct: 222 MPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 97.9 bits (243), Expect = 2e-22
Identities = 84/254 (33%), Positives = 127/254 (50%), Gaps = 24/254 (9%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y A D G EVA Q+ L Q P++ E + EI +++ K+ NI+ + S++
Sbjct: 37 YTAMDVATGQEVAIRQMNLQ---QQPKK-ELIINEILVMRENKNPNIVNYLDSYL--VGD 90
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
+ V E G+L + ++ + CR+ L L +LHS VIHRD+K DNI
Sbjct: 91 ELWVVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNI 147
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPEVYEEE-YNELVDIYSFGMCI 214
+ G G VK+ D G A + + R VGTP +MAPEV + Y VDI+S G+
Sbjct: 148 LL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 206
Query: 215 LEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE-----VRQFIEKCL-ATVSSR 268
+EM+ + PY +P + + + PE +++PE R F+ +CL V R
Sbjct: 207 IEMIEGEPPYLN-ENPLRALYLIATNGTPE----LQNPEKLSAIFRDFLNRCLDMDVEKR 261
Query: 269 LSARELLTDPFLQI 282
SA+ELL FL+I
Sbjct: 262 GSAKELLQHQFLKI 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 5e-22
Identities = 64/236 (27%), Positives = 105/236 (44%), Gaps = 42/236 (17%)
Query: 75 LLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQIL 134
L + H I+K Y ++ D N+ FV E +G L QY K+ ++ + + + +IL
Sbjct: 55 LTRLNGHPGIIKLYYTFQD--EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEIL 112
Query: 135 SGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL----------------- 177
L YLHS+ +IHRDLK +NI ++ + +KI D G A +L
Sbjct: 113 LALEYLHSKG--IIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 178 -----RKSHAARCVGTPEFMAPEVYEEEY-NELVDIYSFGMCIL-EMVTFDYPYSECTHP 230
+ A VGT E+++PE+ E+ + D+++ G CI+ +M+T P+
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALG-CIIYQMLTGKPPFRGSNEY 228
Query: 231 AQIYKKVISG--KKPEALFKVEDPEVRQFIEKCLAT-VSSRL----SARELLTDPF 279
++K++ P P+ + IEK L RL EL PF
Sbjct: 229 -LTFQKILKLEYSFPPNFP----PDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 50/155 (32%), Positives = 78/155 (50%), Gaps = 7/155 (4%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCR 131
E +L+ L H ++ + S+ D N+ V ++ G LR + + + + VK W
Sbjct: 50 ERRILQELNHPFLVNLWYSFQD--EENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC 107
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCV-GTPE 190
+I+ L YLHS+ +IHRD+K DNI ++ QG V I D +A + GTP
Sbjct: 108 EIVLALEYLHSKG--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPG 164
Query: 191 FMAPEVY-EEEYNELVDIYSFGMCILEMVTFDYPY 224
+MAPEV + Y+ VD +S G+ E + PY
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 2e-20
Identities = 83/272 (30%), Positives = 119/272 (43%), Gaps = 40/272 (14%)
Query: 40 AFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99
A D+ G VA K+ +P +R Y E+ LLK L+H NI+ ++ + +I
Sbjct: 29 ARDQLTGQNVAIK--KIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFI-SPLEDI 85
Query: 100 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 159
FVTE+ GT L R + + ++++ QIL GL Y+HS V+HRDLK NI +
Sbjct: 86 YFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILI 141
Query: 160 NGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCILEM 217
N N ++KI D GLA I + V T + APE+ ++Y+ VDI+S G EM
Sbjct: 142 NEN-CDLKICDFGLARI-QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEM 199
Query: 218 VTFDYPYSECTHPAQIY----------KKVISG-----------------KKP-EALFKV 249
+ + H Q VI+ P FK
Sbjct: 200 LEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKN 259
Query: 250 EDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280
DP +EK L R+SA E L P+L
Sbjct: 260 ADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 3e-20
Identities = 71/231 (30%), Positives = 119/231 (51%), Gaps = 12/231 (5%)
Query: 54 VKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQ 113
+K+ D ++ +E+E + EI +L + K+Y S++ + + + E G+
Sbjct: 34 IKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWIIMEYLGGGSALD 91
Query: 114 YRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 173
L+ ++ + R+IL GL YLHS IHRD+K N+ ++ GEVK+ D G+
Sbjct: 92 L-LEPGPLDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLLS-EHGEVKLADFGV 147
Query: 174 AAILRKSHAAR--CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHP 230
A L + R VGTP +MAPEV ++ Y+ DI+S G+ +E+ + P+SE HP
Sbjct: 148 AGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE-LHP 206
Query: 231 AQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSS-RLSARELLTDPFL 280
++ +I P L +++F+E CL S R +A+ELL F+
Sbjct: 207 MKVL-FLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 5e-20
Identities = 75/244 (30%), Positives = 121/244 (49%), Gaps = 15/244 (6%)
Query: 44 YEGIEVAWNQV---KLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100
Y+GI+ +V K+ D ++ +E+E + EI +L I ++Y S++ I
Sbjct: 21 YKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI- 79
Query: 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 160
+ E G+ LK + + R+IL GL YLHS IHRD+K N+ ++
Sbjct: 80 -IMEYLGGGSALDL-LKPGPLEETYIATILREILKGLDYLHSERK--IHRDIKAANVLLS 135
Query: 161 GNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEM 217
QG+VK+ D G+A L + R VGTP +MAPEV ++ Y+ DI+S G+ +E+
Sbjct: 136 -EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIEL 194
Query: 218 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSS-RLSARELLT 276
+ P S+ HP ++ +I P L ++F+E CL R +A+ELL
Sbjct: 195 AKGEPPNSD-LHPMRVL-FLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252
Query: 277 DPFL 280
F+
Sbjct: 253 HKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 5e-20
Identities = 77/239 (32%), Positives = 116/239 (48%), Gaps = 23/239 (9%)
Query: 54 VKLYDFLQSP-EELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLR 112
+K D + P +E E E+ LL +KH NI+ F+ S+ + N + V E G L
Sbjct: 30 IKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE--NGRLFIVMEYCDGGDLM 87
Query: 113 QYRLKHRRVNIR--AVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 170
+ + R V + W QI GL ++H R ++HRD+K NIF++ N K+GD
Sbjct: 88 KRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGD 145
Query: 171 LGLAAILRKSH--AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSEC 227
G+A L S A CVGTP +++PE+ + YN DI+S G + E+ T +P+ E
Sbjct: 146 FGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF-EG 204
Query: 228 THPAQIYKKVISGKKPEALFKVEDP----EVRQFIEKCLATVS--SRLSARELLTDPFL 280
+ Q+ K+ G F P ++R I + L VS R S +L PFL
Sbjct: 205 NNLHQLVLKICQGY-----FAPISPNFSRDLRSLISQ-LFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 8e-20
Identities = 73/249 (29%), Positives = 118/249 (47%), Gaps = 19/249 (7%)
Query: 45 EGIEVAWNQVKLY--DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 102
+G +A QV+L + L + +E E+L E+ LLK+LKH NI+++ + +D + I+
Sbjct: 23 QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--DNTISIF 80
Query: 103 TEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 162
E G++ + + + +QIL G+ YLH + V+HRD+K +N+ + N
Sbjct: 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH--NNCVVHRDIKGNNVMLMPN 138
Query: 163 QGEVKIGDLGLAAIL-------RKSHAARCV-GTPEFMAPEVYEEE-YNELVDIYSFGMC 213
G +K+ D G A L S+ + + GTP +MAPEV E Y DI+S G
Sbjct: 139 -GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCT 197
Query: 214 ILEMVTFDYPYSECTHPAQIYKKVISGKKP-EALFKVEDPEVRQFIEKCLA-TVSSRLSA 271
+ EM T P + A ++ + + + L F+ CL R SA
Sbjct: 198 VFEMATGKPPLASMDRLAAMF-YIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSA 256
Query: 272 RELLTDPFL 280
+LL FL
Sbjct: 257 LQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 66/228 (28%), Positives = 113/228 (49%), Gaps = 18/228 (7%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSG-----TLRQYRL 116
+P E + E LL L H I+KF+ S+++ +TE + G L + +
Sbjct: 42 NPNETVQANQEAQLLSKLDHPAIVKFHASFLE--RDAFCIITE-YCEGRDLDCKLEELKH 98
Query: 117 KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176
+ ++ V W Q+L G+ Y+H R ++HRDLK NIF+ N +KIGD G++ +
Sbjct: 99 TGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKNNL--LKIGDFGVSRL 154
Query: 177 LRKS--HAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQI 233
L S A GTP +M+PE + + Y+ DI+S G + EM + + E + +
Sbjct: 155 LMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF-EGQNFLSV 213
Query: 234 YKKVISGKKPEALFKVEDPEVRQFIEKCLATVSS-RLSARELLTDPFL 280
+++ G P +L + ++ ++ L S R SA E+L +PF+
Sbjct: 214 VLRIVEGPTP-SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 74/241 (30%), Positives = 116/241 (48%), Gaps = 17/241 (7%)
Query: 61 QSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HR 119
+S EELE EI +L T H I+K ++ I + E G + L+ R
Sbjct: 48 KSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI--MIEFCPGGAVDAIMLELDR 105
Query: 120 RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179
+ ++ CRQ+L L YLHS +IHRDLK N+ + G++K+ D G++A K
Sbjct: 106 GLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVK 162
Query: 180 SHAAR--CVGTPEFMAPEVYEEE------YNELVDIYSFGMCILEMVTFDYPYSECTHPA 231
+ R +GTP +MAPEV E Y+ DI+S G+ ++EM + P+ E +P
Sbjct: 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE-LNPM 221
Query: 232 QIYKKVISGKKPEALFKVE-DPEVRQFIEKCL-ATVSSRLSARELLTDPFLQIDDYDSDL 289
++ K+ + P + E R F++ L +R SA +LL PF+ + L
Sbjct: 222 RVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPL 281
Query: 290 R 290
R
Sbjct: 282 R 282
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 67 ERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAV 126
+ ++ E +LK + H I++ + + D R + + E G L Y R +
Sbjct: 46 QHVHNEKRVLKEVSHPFIIRLFWTEHD--QRFLYMLMEYVPGGELFSYLRNSGRFSNSTG 103
Query: 127 KHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCV 186
+ +I+ L YLHS++ +++RDLK +NI ++ +G +K+ D G A LR C
Sbjct: 104 LFYASEIVCALEYLHSKE--IVYRDLKPENILLD-KEGHIKLTDFGFAKKLRDRTWTLC- 159
Query: 187 GTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--P 243
GTPE++APEV + + +N+ VD ++ G+ I EM+ YP +P IY+K+++GK P
Sbjct: 160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLV-GYPPFFDDNPFGIYEKILAGKLEFP 218
Query: 244 EALFKVEDPEVRQFIEKCL 262
L D + I+K L
Sbjct: 219 RHL----DLYAKDLIKKLL 233
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 2e-19
Identities = 73/234 (31%), Positives = 110/234 (47%), Gaps = 26/234 (11%)
Query: 40 AFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNI---MKFYTSWVDTAN 96
AFD G +VA KL QS +R Y E+ LLK + H N+ + +T ++
Sbjct: 34 AFDTKTGRKVAIK--KLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTP--ASSL 89
Query: 97 RNIN---FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 153
+ VT L +K ++++ ++ QIL GL Y+HS +IHRDLK
Sbjct: 90 EDFQDVYLVTH-LMGADLNNI-VKCQKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLK 145
Query: 154 CDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFG 211
NI VN + E+KI D GLA V T + APE+ YN+ VDI+S G
Sbjct: 146 PSNIAVNED-CELKILDFGLARHTDDEMTGY-VATRWYRAPEIMLNWMHYNQTVDIWSVG 203
Query: 212 MCIL-EMVTFD--YPYSECTHPAQIYK--KVISGKKPEALFKVEDPEVRQFIEK 260
CI+ E++T +P S+ H Q+ + ++ E L K+ R +I+
Sbjct: 204 -CIMAELLTGKTLFPGSD--HIDQLKRIMNLVGTPDEELLQKISSESARNYIQS 254
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 4e-19
Identities = 83/293 (28%), Positives = 118/293 (40%), Gaps = 67/293 (22%)
Query: 40 AFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99
A D+ G +VA K+ + + +R+ EI LL+ L+H NI+ +
Sbjct: 19 AVDKRTGRKVAIK--KISNVFDDLIDAKRILREIKLLRHLRHENIIGLLD--ILRPPSPE 74
Query: 100 NF-----VTEMFTSGTLRQYRLKHRRVNIRAVKHWCR---QILSGLLYLHSRDPPVIHRD 151
+F VTE+ + +++ + H QIL GL YLHS + VIHRD
Sbjct: 75 DFNDVYIVTELMETDL---HKVIKSPQPL-TDDHIQYFLYQILRGLKYLHSAN--VIHRD 128
Query: 152 LKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFM----------APEVY--EE 199
LK NI VN N ++KI D GLA + F+ APE+
Sbjct: 129 LKPSNILVNSNC-DLKICDFGLARGVDPDED-----EKGFLTEYVVTRWYRAPELLLSSS 182
Query: 200 EYNELVDIYSFGMCIL-EMVT----F---DY-------------PYSE----CTHP-AQI 233
Y + +DI+S G CI E++T F DY P E T A+
Sbjct: 183 RYTKAIDIWSVG-CIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARN 241
Query: 234 YKKVISGKKP---EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282
Y K + K LF PE +EK L R++A E L P+L
Sbjct: 242 YLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 61/177 (34%), Positives = 91/177 (51%), Gaps = 12/177 (6%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-R 120
+ E L EI +LK+L+H NI+K+ RN+ V E G+LR Y KHR R
Sbjct: 45 TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER 104
Query: 121 VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180
++ R + + QI G+ YL S+ +HRDL NI V ++ VKIGD GL +L +
Sbjct: 105 LDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVE-SENRVKIGDFGLTKVLPQD 161
Query: 181 HAARCVGTPE-----FMAPE-VYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPA 231
V P + APE + E +++ D++SFG+ + E+ F Y C+ PA
Sbjct: 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL--FTYSDKSCSPPA 216
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 64/231 (27%), Positives = 99/231 (42%), Gaps = 40/231 (17%)
Query: 79 LKHRNIM---------KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI-----R 124
L R+I+ K Y S+ +N+ V E G L L N+
Sbjct: 41 LTERDILSQAQSPYVVKLYYSF--QGKKNLYLVMEYLPGGDL--ASLLE---NVGSLDED 93
Query: 125 AVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---------- 174
+ + +I+ L YLHS +IHRDLK DNI ++ N G +K+ D GL+
Sbjct: 94 VARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQIN 150
Query: 175 AILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQI 233
+ R VGTP+++APEV + +++ VD +S G + E + P+ T P +I
Sbjct: 151 LNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-PEEI 209
Query: 234 YKKVISGKKPEALFKVEDPEVRQFIEKCL-ATVSSRL---SARELLTDPFL 280
++ +++GK E I K L RL S E+ PF
Sbjct: 210 FQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 53/156 (33%), Positives = 79/156 (50%), Gaps = 9/156 (5%)
Query: 133 ILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC-VGTPEF 191
I+ L YLHS+ VIHRD+K N+ +N G+VK+ D G++ L S A G +
Sbjct: 112 IVKALEYLHSK-LSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPY 169
Query: 192 MAPEVYEEE-----YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL 246
MAPE E Y+ D++S G+ ++E+ T +PY P Q K+V+ P+
Sbjct: 170 MAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP 229
Query: 247 FKVEDPEVRQFIEKCLATVSS-RLSARELLTDPFLQ 281
+ PE + F+ KCL R + ELL PF +
Sbjct: 230 AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 3e-18
Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 25/222 (11%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRN--INFVTEMFTSGTLRQYRLKHRRVNIRAVKHW 129
EI +L+ + H N++K + D + N I + E G+L + + +
Sbjct: 122 EIEILRDVNHPNVVKCH----DMFDHNGEIQVLLEFMDGGSLEGTHIADEQ----FLADV 173
Query: 130 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--AARCVG 187
RQILSG+ YLH R ++HRD+K N+ +N + VKI D G++ IL ++ VG
Sbjct: 174 ARQILSGIAYLHRRH--IVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSSVG 230
Query: 188 TPEFMAPEVYEEEYNELV------DIYSFGMCILE--MVTFDYPYSECTHPAQIYKKVIS 239
T +M+PE + N DI+S G+ ILE + F + A + +
Sbjct: 231 TIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM 290
Query: 240 GKKPEALFKVEDPEVRQFIEKCL-ATVSSRLSARELLTDPFL 280
+ PEA E R FI CL + R SA +LL PF+
Sbjct: 291 SQPPEAPATAS-REFRHFISCCLQREPAKRWSAMQLLQHPFI 331
|
Length = 353 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 74/244 (30%), Positives = 122/244 (50%), Gaps = 15/244 (6%)
Query: 44 YEGIEVAWNQV---KLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100
++GI+ QV K+ D ++ +E+E + EI +L + K+Y S++ I
Sbjct: 21 FKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI- 79
Query: 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 160
+ E G+ L+ + + ++IL GL YLHS IHRD+K N+ ++
Sbjct: 80 -IMEYLGGGSALDL-LRAGPFDEFQIATMLKEILKGLDYLHSEKK--IHRDIKAANVLLS 135
Query: 161 GNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEM 217
QG+VK+ D G+A L + R VGTP +MAPEV ++ Y+ DI+S G+ +E+
Sbjct: 136 -EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIEL 194
Query: 218 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSS-RLSARELLT 276
+ P S+ HP ++ +I P L ++FI+ CL S R +A+ELL
Sbjct: 195 AKGEPPNSD-MHPMRVL-FLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252
Query: 277 DPFL 280
F+
Sbjct: 253 HKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 76/256 (29%), Positives = 124/256 (48%), Gaps = 25/256 (9%)
Query: 44 YEGIEVAWNQ---VKLYDFLQSPEELERLYCEIHLLKTLKH-RNIMKFYTSWVDTA---- 95
Y+G V Q +K+ D + +E E + EI++LK H RNI +Y +++ +
Sbjct: 33 YKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90
Query: 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRA--VKHWCRQILSGLLYLHSRDPPVIHRDLK 153
+ + V E +G++ + ++ + + CR+IL GL +LH+ VIHRD+K
Sbjct: 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIK 148
Query: 154 CDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVY------EEEYNELV 205
N+ + N EVK+ D G++A L ++ R +GTP +MAPEV + Y+
Sbjct: 149 GQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRS 207
Query: 206 DIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-T 264
DI+S G+ +EM P + HP + + P+ K + FIE CL
Sbjct: 208 DIWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKN 266
Query: 265 VSSRLSARELLTDPFL 280
SR S +LL PF+
Sbjct: 267 YLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 5e-18
Identities = 59/187 (31%), Positives = 95/187 (50%), Gaps = 11/187 (5%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV 121
SP+E E E+ +L +KH NI+++ S+ + N I V + G L + R V
Sbjct: 39 SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYI--VMDYCEGGDLYKKINAQRGV 96
Query: 122 NI--RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179
+ W QI L ++H R ++HRD+K NIF+ G +K+GD G+A +L
Sbjct: 97 LFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNS 153
Query: 180 SH--AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 236
+ A C+GTP +++PE+ E YN DI++ G + EM T + + E + + K
Sbjct: 154 TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF-EAGNMKNLVLK 212
Query: 237 VISGKKP 243
+I G P
Sbjct: 213 IIRGSYP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 75/257 (29%), Positives = 124/257 (48%), Gaps = 27/257 (10%)
Query: 44 YEGIEVAWNQ---VKLYDFLQSPEELERLYCEIHLLKTLKH-RNIMKFYTSWVDT----A 95
Y+G V Q +K+ D + +E E + EI++LK H RNI +Y +++
Sbjct: 23 YKGRHVKTGQLAAIKVMDV--TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80
Query: 96 NRNINFVTEMFTSGTLRQYRLKHRRVNI---RAVKHWCRQILSGLLYLHSRDPPVIHRDL 152
+ + V E +G++ +K+ + N + + CR+IL GL +LH VIHRD+
Sbjct: 81 DDQLWLVMEFCGAGSVTDL-IKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDI 137
Query: 153 KCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVY------EEEYNEL 204
K N+ + N EVK+ D G++A L ++ R +GTP +MAPEV + Y+
Sbjct: 138 KGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFK 196
Query: 205 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA- 263
D++S G+ +EM P + HP + + P K + + FIE CL
Sbjct: 197 SDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVK 255
Query: 264 TVSSRLSARELLTDPFL 280
S R + +L+ PF+
Sbjct: 256 NHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 54/182 (29%), Positives = 94/182 (51%), Gaps = 13/182 (7%)
Query: 64 EELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVN 122
+ L EI +L+ L H NI+K+ + I + E SG+L++Y +++ ++N
Sbjct: 48 NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKIN 107
Query: 123 IRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 182
++ + QI G+ YL SR +HRDL N+ V ++ +VKIGD GL +
Sbjct: 108 LKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKE 164
Query: 183 ARCV----GTPEF-MAPE-VYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 236
V +P F APE + + ++ D++SFG+ + E++T Y SE + P ++ K
Sbjct: 165 YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT--YCDSESS-PMTLFLK 221
Query: 237 VI 238
+I
Sbjct: 222 MI 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 56/159 (35%), Positives = 87/159 (54%), Gaps = 12/159 (7%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI---RAVKH 128
E LL +KH NI+ F S+ A+ ++ V E G L Q ++K +R + +
Sbjct: 48 EAVLLAKMKHPNIVAFKESF--EADGHLYIVMEYCDGGDLMQ-KIKLQRGKLFPEDTILQ 104
Query: 129 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--V 186
W Q+ G+ ++H + V+HRD+K NIF+ N G+VK+GD G A +L A C V
Sbjct: 105 WFVQMCLGVQHIH--EKRVLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPGAYACTYV 161
Query: 187 GTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPY 224
GTP ++ PE++E YN DI+S G + E+ T +P+
Sbjct: 162 GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 56/177 (31%), Positives = 94/177 (53%), Gaps = 12/177 (6%)
Query: 60 LQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR 119
L+ ++ + EI ++K KH NI+ ++ S++ + + E G+L+
Sbjct: 44 LEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL--SREKLWICMEYCGGGSLQDIYHVTG 101
Query: 120 RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179
++ + + CR+ L GL YLHS+ +HRD+K NI + N G+VK+ D G+AA +
Sbjct: 102 PLSELQIAYVCRETLQGLAYLHSKGK--MHRDIKGANILLTDN-GDVKLADFGVAAKITA 158
Query: 180 SHAAR--CVGTPEFMAPEVYEEE----YNELVDIYSFGMCILEMVTFDYPYSECTHP 230
+ A R +GTP +MAPEV E YN+L DI++ G+ +E+ P + HP
Sbjct: 159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD-LHP 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 6e-17
Identities = 52/179 (29%), Positives = 96/179 (53%), Gaps = 8/179 (4%)
Query: 64 EELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI 123
++++ + E +L L H I+ S+ D + F+ E G L + K R
Sbjct: 60 KQVQHVAQEKSILMELSHPFIVNMMCSFQD--ENRVYFLLEFVVGGELFTHLRKAGRFPN 117
Query: 124 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 183
K + +++ YLHS+D +I+RDLK +N+ ++ N+G VK+ D G A +
Sbjct: 118 DVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPDRTFT 174
Query: 184 RCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 241
C GTPE++APEV + + + + VD ++ G+ + E + P+ + T P +IY+K+++G+
Sbjct: 175 LC-GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT-PFRIYEKILAGR 231
|
Length = 329 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 66/238 (27%), Positives = 113/238 (47%), Gaps = 20/238 (8%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV 121
+ E +++ E+ +L I+ FY ++ NR I+ TE G+L YR V
Sbjct: 39 TVELQKQIMSELEILYKCDSPYIIGFYGAFF-VENR-ISICTEFMDGGSLDVYRKIPEHV 96
Query: 122 NIR-AVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180
R AV ++ GL YL S ++HRD+K N+ VN +G+VK+ D G++ L S
Sbjct: 97 LGRIAVA-----VVKGLTYLWSLK--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNS 148
Query: 181 HAARCVGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDYPYSECTH------PAQI 233
A VGT +MAPE + E+Y D++S G+ +E+ +PY + P Q+
Sbjct: 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL 208
Query: 234 YKKVISGKKPEALFKVEDPEVRQFIEKCLATV-SSRLSARELLTDPFL-QIDDYDSDL 289
+ ++ P + FI +C+ R + L+ PF+ Q +D ++++
Sbjct: 209 LQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNAEV 266
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 55/168 (32%), Positives = 79/168 (47%), Gaps = 15/168 (8%)
Query: 60 LQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY--RL 116
S EE L E+ L+ L H NI+K + + N + FV E + G L Q
Sbjct: 36 FYSWEECMNLR-EVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFE-YMEGNLYQLMKDR 91
Query: 117 KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-A 175
K + + ++ QIL GL ++H HRDLK +N+ V+G VKI D GLA
Sbjct: 92 KGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGP-EVVKIADFGLARE 148
Query: 176 ILRKSHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EMVTF 220
I + V T + APE+ Y+ VDI++ G CI+ E+ T
Sbjct: 149 IRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALG-CIMAELYTL 195
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 57/187 (30%), Positives = 91/187 (48%), Gaps = 13/187 (6%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y+A D+ G VA ++KL +S + EI LLK L H NI+K V
Sbjct: 16 YKARDKLTGEIVAIKKIKL--RFESEGIPKTALREIKLLKELNHPNIIKLLD--VFRHKG 71
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
++ V E + + + + R + +K + Q+L GL + HS ++HRDLK +N+
Sbjct: 72 DLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENL 129
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPEVY--EEEYNELVDIYSFGMC 213
+N G +K+ D GLA V T + APE+ ++ Y+ VDI+S G C
Sbjct: 130 LINTE-GVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVG-C 187
Query: 214 IL-EMVT 219
I E+++
Sbjct: 188 IFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 59/194 (30%), Positives = 89/194 (45%), Gaps = 33/194 (17%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELER-LYCEIHLLKTLKHRNIMKFYTSWVDTAN 96
Y+A D+ G VA ++KL + ++ + + EI LL+ LKH NI+ V
Sbjct: 17 YKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLD--VFGHK 74
Query: 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRA--VKHWCRQILSGLLYLHSRDPPVIHRDLKC 154
NIN V E F L + +K + + + +K + L GL YLHS ++HRDLK
Sbjct: 75 SNINLVFE-FMETDLEKV-IKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKP 130
Query: 155 DNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP-EFMAPEV----YE--------EEY 201
+N+ + + G +K+ D GL AR G+P M +V Y Y
Sbjct: 131 NNLLIASD-GVLKLADFGL---------ARSFGSPNRKMTHQVVTRWYRAPELLFGARHY 180
Query: 202 NELVDIYSFGMCIL 215
VD++S G CI
Sbjct: 181 GVGVDMWSVG-CIF 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 46/168 (27%), Positives = 86/168 (51%), Gaps = 13/168 (7%)
Query: 126 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC 185
K + +++ G+ LH R +IHRD+K +N+ ++ G +K+ D GL+ ++ +
Sbjct: 99 AKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLENK--KF 153
Query: 186 VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK-- 242
VGTP+++APE +++ D +S G I E + F YP P ++ ++S +
Sbjct: 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFL-FGYPPFHAETPDAVFDNILSRRINW 212
Query: 243 PEALFKVEDPEVRQFIEKCLAT-VSSRLSA---RELLTDPFLQIDDYD 286
PE + + PE I + L + RL A +E+ + PF + ++D
Sbjct: 213 PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 68/230 (29%), Positives = 113/230 (49%), Gaps = 16/230 (6%)
Query: 60 LQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR 119
L+ E+ + EI ++K KH NI+ ++ S++ I E G+L+
Sbjct: 44 LEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM--EFCGGGSLQDIYHVTG 101
Query: 120 RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179
++ + + R+ L GL YLHS+ +HRD+K NI + N G VK+ D G++A +
Sbjct: 102 PLSESQIAYVSRETLQGLYYLHSKGK--MHRDIKGANILLTDN-GHVKLADFGVSAQITA 158
Query: 180 SHAAR--CVGTPEFMAPEVYEEE----YNELVDIYSFGMCILEMVTFDYPYSECTHPAQ- 232
+ A R +GTP +MAPEV E YN+L DI++ G+ +E+ P + HP +
Sbjct: 159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD-LHPMRA 217
Query: 233 IYKKVISGKKPEALF-KVE-DPEVRQFIEKCLA-TVSSRLSARELLTDPF 279
++ S +P L K++ F++ L R +A +LL PF
Sbjct: 218 LFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 58/225 (25%), Positives = 106/225 (47%), Gaps = 17/225 (7%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCR 131
E+ ++ + I+ FY +++ NI E G+L + K + + +
Sbjct: 53 ELQIMHECRSPYIVSFYGAFL--NENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAV 110
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF 191
++ GL YL++ ++HRD+K NI VN +G++K+ D G++ L S A VGT +
Sbjct: 111 AVVEGLTYLYNVHR-IMHRDIKPSNILVNS-RGQIKLCDFGVSGELINSIADTFVGTSTY 168
Query: 192 MAPE-VYEEEYNELVDIYSFGMCILEMVTFDYPYSE-------CTHPAQIYKKV--ISGK 241
M+PE + +Y D++S G+ I+E+ +P++ P I + I +
Sbjct: 169 MSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE 228
Query: 242 KPEALFKVEDPEV-RQFIEKCL-ATVSSRLSARELL-TDPFLQID 283
P L + PE R F++ CL + R + ++L PF+Q
Sbjct: 229 PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 48/174 (27%), Positives = 85/174 (48%), Gaps = 17/174 (9%)
Query: 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
++ FV E G L + R + + + +I+ GL +LH + +I+RDLK D
Sbjct: 68 KEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLD 125
Query: 156 NIFVNGNQGEVKIGDLGLAA--ILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGM 212
N+ ++ G +KI D G+ + + A+ GTP+++APE+ + ++YNE VD +SFG+
Sbjct: 126 NVLLD-KDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGV 184
Query: 213 CILEMVTFDYPYSEC---------THPAQIYKKVISGKKPEALFK--VEDPEVR 255
+ EM+ P+ + + + IS + + L K DP R
Sbjct: 185 LLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 37 HYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96
Y + G +VA + Q + ER EI +L+TL H NI+K+
Sbjct: 24 RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFER---EIEILRTLDHENIVKYKGVCEKPGG 80
Query: 97 RNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
R++ + E SG+LR Y +HR ++N++ + + QI G+ YL S+ IHRDL
Sbjct: 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAAR 138
Query: 156 NIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPE-----FMAPE-VYEEEYNELVDIYS 209
NI V ++ VKI D GLA +L + V P + APE + +++ D++S
Sbjct: 139 NILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWS 197
Query: 210 FGMCILEMVTFDYPYSECTHPAQI 233
FG+ + E+ F Y + PA+
Sbjct: 198 FGVTLYEL--FTYGDPSQSPPAEF 219
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 53/154 (34%), Positives = 86/154 (55%), Gaps = 10/154 (6%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCR 131
EI++LKTL H NI+K+ + + + + E G+LR Y KH ++N+ + + +
Sbjct: 56 EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQ 114
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG---- 187
QI G+ YLHS+ IHRDL N+ ++ N VKIGD GLA + + H V
Sbjct: 115 QICEGMAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 188 TPEF-MAPEVYEE-EYNELVDIYSFGMCILEMVT 219
+P F A E +E +++ D++SFG+ + E++T
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 55/164 (33%), Positives = 84/164 (51%), Gaps = 20/164 (12%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQ-----YRLKHRRVNIRAV 126
EI LL+ LKH N++ +++ A++++ + + + L Q + K + V
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFD-YAEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 127 KHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN---QGEVKIGDLGLAAILRK---- 179
K QIL+G+ YLHS V+HRDLK NI V G +G VKIGDLGLA +
Sbjct: 111 KSLLWQILNGVHYLHSN--WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168
Query: 180 -SHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EMVT 219
+ V T + APE+ Y + +DI++ G CI E++T
Sbjct: 169 LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG-CIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 63/236 (26%), Positives = 97/236 (41%), Gaps = 43/236 (18%)
Query: 84 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR 143
I+ FY ++ + I+ E G+L Q K R+ + +L GL YL R
Sbjct: 61 IVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYL--R 116
Query: 144 DP-PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEY 201
+ ++HRD+K NI VN GE+K+ D G++ L S A VGT +M+PE + Y
Sbjct: 117 EKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 175
Query: 202 NELVDIYSFGMCILEMVT----------------FDYPYSECTHPAQIYKKVISG---KK 242
DI+S G+ ++EM F P SE +
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235
Query: 243 PEALFKVED----------------PEVRQFIEKCLATV-SSRLSARELLTDPFLQ 281
P A+F++ D E + F++KCL R +EL PF++
Sbjct: 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (198), Expect = 2e-15
Identities = 71/241 (29%), Positives = 120/241 (49%), Gaps = 42/241 (17%)
Query: 65 ELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQ-----YRLKHR 119
E +L E+++++ LKH+NI+++ +++ AN+ + + E +G L + Y++
Sbjct: 55 EKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKM-FG 113
Query: 120 RVNIRAVKHWCRQILSGLLYLHS-RDPP----VIHRDLKCDNIFV--------------N 160
++ A+ RQ+L L Y H+ +D P V+HRDLK NIF+ N
Sbjct: 114 KIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN 173
Query: 161 GNQGE--VKIGDLGLAA-ILRKSHAARCVGTPEFMAPEVYEEE---YNELVDIYSFGMCI 214
G KIGD GL+ I +S A CVGTP + +PE+ E Y++ D+++ G I
Sbjct: 174 NLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCII 233
Query: 215 LEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLATVSSRLSAR 272
E+ + P+ H A + ++IS K P+ K + E+ I+ L LSA+
Sbjct: 234 YELCSGKTPF----HKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLN-----LSAK 284
Query: 273 E 273
E
Sbjct: 285 E 285
|
Length = 1021 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 22/178 (12%)
Query: 133 ILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFM 192
++ GL +L + +IHRD+K N+ VNGN G+VK+ D G++ L S A +G +M
Sbjct: 111 VVKGLKFL-KEEHNIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVASLAKTNIGCQSYM 168
Query: 193 APEVYEEE-------YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV------IS 239
APE + Y D++S G+ ILEM YPY P + Y + I
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY-----PPETYANIFAQLSAIV 223
Query: 240 GKKPEALFKVEDPEVRQFIEKCLATVSS-RLSARELLTDPFLQIDDYDSDLRMIQYQT 296
P L + + F+ KCL + + R + +LL P+L + ++D+ M ++ T
Sbjct: 224 DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL-VKYKNADVDMAEWVT 280
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 83/304 (27%), Positives = 131/304 (43%), Gaps = 44/304 (14%)
Query: 40 AFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99
A D G +VA KLY QS +R Y E+ LLK +KH N++ V T + ++
Sbjct: 34 ALDRRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLD--VFTPDLSL 89
Query: 100 ----NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
+F M GT +KH +++ ++ Q+L GL Y+H+ +IHRDLK
Sbjct: 90 DRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPG 147
Query: 156 NIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMC 213
N+ VN E+KI D GLA S V T + APEV Y + VDI+S G
Sbjct: 148 NLAVN-EDCELKILDFGLAR-QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCI 205
Query: 214 ILEMVTFDYPYSECTHPAQIYK--KVISGKKPEALFKVEDPEVRQFIEK----------- 260
+ EM+T + H Q+ + KV E + K++ + + +++K
Sbjct: 206 MAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRS 265
Query: 261 ----------------CLATVSSRLSARELLTDPFL-QIDDYDSDLRMIQYQTDYDEISP 303
+ SR++A E L P+ + D + + Y +DE+
Sbjct: 266 LLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPPYDDSFDEVDQ 325
Query: 304 LLRQ 307
L +
Sbjct: 326 SLEE 329
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 16/161 (9%)
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA-ILRKSHAARCVGTPE 190
QI+ GL +LH R +++RDLK +N+ ++ + G V+I DLGLA + GTP
Sbjct: 103 QIICGLEHLHQRR--IVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAGTPG 159
Query: 191 FMAPEVY-EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKV 249
+MAPEV E Y+ VD ++ G + EM+ P+ + ++ K+ + + E +
Sbjct: 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ--RKEKVEKEELKRRTLEMAVEY 217
Query: 250 ED---PEVRQFIEKCLAT-VSSRL-----SARELLTDPFLQ 281
D PE + E L RL SA E+ P +
Sbjct: 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 18/166 (10%)
Query: 133 ILSGLLYL---HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-ARCVGT 188
I+ L YL H VIHRD+K NI ++ + G VK+ D G++ L S A R G
Sbjct: 123 IVKALHYLKEKHG----VIHRDVKPSNILLDAS-GNVKLCDFGISGRLVDSKAKTRSAGC 177
Query: 189 PEFMAPEVYE-----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 243
+MAPE + +Y+ D++S G+ ++E+ T +PY C ++ K++ + P
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP 237
Query: 244 E-ALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDS 287
+ P+ F++ CL R RELL PF++ Y++
Sbjct: 238 SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR--RYET 281
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 5e-15
Identities = 70/248 (28%), Positives = 97/248 (39%), Gaps = 47/248 (18%)
Query: 72 EIHLLKTLK---HRNIMKFYTSWVDTANRN-----INFVTEMFTSGTLRQYRLKHRRVNI 123
EI LLK L+ H NI++ V R + V E L Y K + +
Sbjct: 48 EIALLKQLESFEHPNIVRLLD--VCHGPRTDRELKLTLVFE-HVDQDLATYLSKCPKPGL 104
Query: 124 --RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 181
+K RQ+L G+ +LHS ++HRDLK NI V + G+VKI D GLA I
Sbjct: 105 PPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVT-SDGQVKIADFGLARIY-SFE 160
Query: 182 AAR--CVGTPEFMAPEVY-EEEYNELVDIYSFGMCIL-EMVT----FDYPY--------- 224
A V T + APEV + Y VD++S G CI E+ F
Sbjct: 161 MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVG-CIFAELFRRRPLFRGTSEADQLDKIF 219
Query: 225 ------SECTHPAQIYKKVIS-----GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSAR 272
SE P + S + ++ E ++K L R+SA
Sbjct: 220 DVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAF 279
Query: 273 ELLTDPFL 280
E L P+
Sbjct: 280 EALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 39/127 (30%), Positives = 67/127 (52%), Gaps = 6/127 (4%)
Query: 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 160
FV E G L + + R + + + +I+ GL +LH R +I+RDLK DN+ ++
Sbjct: 73 FVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLD 130
Query: 161 GNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVY-EEEYNELVDIYSFGMCILEM 217
+G +KI D G+ IL + GTP+++APE+ + Y VD ++ G+ + EM
Sbjct: 131 S-EGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEM 189
Query: 218 VTFDYPY 224
+ P+
Sbjct: 190 LAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 6e-15
Identities = 48/179 (26%), Positives = 87/179 (48%), Gaps = 21/179 (11%)
Query: 59 FLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTL---RQYR 115
L P+ ++ EI +++ L H NI+K Y + + V + ++ ++Y
Sbjct: 39 VLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM 98
Query: 116 -------LKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 168
L+ ++ + + Q+L GL Y+HS + V+HRDLK N+F+N +KI
Sbjct: 99 ETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKI 156
Query: 169 GDLGLAAIL-----RKSHAARCVGTPEFMAPEV--YEEEYNELVDIYSFGMCIL-EMVT 219
GD GLA I+ K + + + T + +P + Y + +D+++ G CI EM+T
Sbjct: 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG-CIFAEMLT 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 86/302 (28%), Positives = 136/302 (45%), Gaps = 51/302 (16%)
Query: 12 PSLLKLIPLEDMEDTMKFLVK----ELQRHYRAFDEYEGIEVAWNQVKLYDFLQS-PEEL 66
S+L L L D DT + + + Y+ ++ +G A VK+ D + EE+
Sbjct: 9 SSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAA---VKILDPISDVDEEI 65
Query: 67 ERLYCEIHLLKTL-KHRNIMKFYTS------------WVDTANRNINFVTEMFTSGTLRQ 113
E E ++L++L H N++KFY W+ N VTE+ G L
Sbjct: 66 E---AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTEL-VKGLLI- 120
Query: 114 YRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 173
+R++ + + L GL +LH+ +IHRD+K +NI + +G VK+ D G+
Sbjct: 121 ---CGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLT-TEGGVKLVDFGV 174
Query: 174 AAILRKSHAAR--CVGTPEFMAPEV------YEEEYNELVDIYSFGMCILEMVTFDYPYS 225
+A L + R VGTP +MAPEV Y+ Y+ D++S G+ +E+ D P
Sbjct: 175 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF 234
Query: 226 ECTHPAQIYKKVISGKKPEALFKVEDPE-----VRQFIEKCL-ATVSSRLSARELLTDPF 279
+ HP + K+ P L PE FI +CL +R S LL PF
Sbjct: 235 D-MHPVKTLFKIPRNPPPTLL----HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPF 289
Query: 280 LQ 281
++
Sbjct: 290 IK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 9e-15
Identities = 42/96 (43%), Positives = 62/96 (64%), Gaps = 6/96 (6%)
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAARCVGTP 189
QI+SGL +LH R +I+RDLK +N+ ++ N G V+I DLGLA L+ +S GTP
Sbjct: 105 QIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYAGTP 161
Query: 190 EFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPY 224
FMAPE+ + EEY+ VD ++ G+ + EM+ P+
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 73/246 (29%), Positives = 112/246 (45%), Gaps = 45/246 (18%)
Query: 57 YDFLQSPEELERLYCEIHLLKTLKHRNIMKF-------YTSWVDTANRNINFVTEM---F 106
Y QS E+ + + E+ L+ L+H N +++ +T+W+ V E
Sbjct: 50 YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL---------VMEYCLGS 100
Query: 107 TSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV 166
S L ++ + V I AV H L GL YLHS + +IHRD+K NI ++ G V
Sbjct: 101 ASDLLEVHKKPLQEVEIAAVTHGA---LQGLAYLHSHN--MIHRDVKAGNILLS-EPGLV 154
Query: 167 KIGDLGLAAILRKSHAARCVGTPEFMAPEVY----EEEYNELVDIYSFGMCILEMVTFDY 222
K+GD G A+I+ + A VGTP +MAPEV E +Y+ VD++S G+ +E+
Sbjct: 155 KLGDFGSASIM--APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212
Query: 223 P------YSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATV-SSRLSARELL 275
P S H AQ + F R F++ CL + R ++ LL
Sbjct: 213 PLFNMNAMSALYHIAQNESPALQSGHWSEYF-------RNFVDSCLQKIPQDRPTSEVLL 265
Query: 276 TDPFLQ 281
F+
Sbjct: 266 KHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 53/174 (30%), Positives = 84/174 (48%), Gaps = 12/174 (6%)
Query: 58 DFLQSPEELERLYCEIHLLKTL---KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY 114
+ + +E+E L CE + +T +H ++ + + T + + FV E G L +
Sbjct: 35 GDIIARDEVESLMCEKRIFETANSERHPFLVNLF-ACFQTEDH-VCFVMEYAAGGDLMMH 92
Query: 115 RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174
RAV + +L GL YLH +++RDLK DN+ ++ +G VKI D GL
Sbjct: 93 IHTDVFSEPRAVFYAACVVL-GLQYLHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLC 148
Query: 175 --AILRKSHAARCVGTPEFMAPEVY-EEEYNELVDIYSFGMCILEMVTFDYPYS 225
+ + GTPEF+APEV E Y VD + G+ I EM+ + P+
Sbjct: 149 KEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFP 202
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 73/266 (27%), Positives = 124/266 (46%), Gaps = 37/266 (13%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQS-PEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTA 95
++ ++ G + A VK+ D + EE+E E ++LK L H N++KFY +
Sbjct: 35 FKVLNKKNGSKAA---VKILDPIHDIDEEIE---AEYNILKALSDHPNVVKFYGMYYKKD 88
Query: 96 NRN---INFVTEMFTSGTL----RQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVI 148
+N + V E+ G++ + + + R+ + + + L GL +LH I
Sbjct: 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TI 146
Query: 149 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEV------YEEE 200
HRD+K +NI + +G VK+ D G++A L + R VGTP +MAPEV +
Sbjct: 147 HRDVKGNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDST 205
Query: 201 YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEV-----R 255
Y+ D++S G+ +E+ D P ++ HP + K+ P + PE+
Sbjct: 206 YDARCDVWSLGITAIELGDGDPPLAD-LHPMRALFKIPRNPPP----TLHQPELWSNEFN 260
Query: 256 QFIEKCLAT-VSSRLSARELLTDPFL 280
FI KCL R + +LL F+
Sbjct: 261 DFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 70/242 (28%), Positives = 111/242 (45%), Gaps = 33/242 (13%)
Query: 57 YDFLQSPEELERLYCEIHLLKTLKHRNIMKF-------YTSWVDTANRNINFVTEM---F 106
Y Q+ E+ + + E+ L+ LKH N +++ +T+W+ V E
Sbjct: 56 YSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL---------VMEYCLGS 106
Query: 107 TSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV 166
S L ++ + V I A+ H L GL YLHS + +IHRD+K NI + G+V
Sbjct: 107 ASDLLEVHKKPLQEVEIAAITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQV 160
Query: 167 KIGDLGLAAILRKSHAARCVGTPEFMAPEVY----EEEYNELVDIYSFGMCILEMVTFDY 222
K+ D G A+ S A VGTP +MAPEV E +Y+ VD++S G+ +E+
Sbjct: 161 KLADFGSASKS--SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 218
Query: 223 PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATV-SSRLSARELLTDPFLQ 281
P + +Y + P R F++ CL + R ++ ELL F++
Sbjct: 219 PLFNMNAMSALY-HIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVR 277
Query: 282 ID 283
D
Sbjct: 278 RD 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 3e-14
Identities = 70/239 (29%), Positives = 111/239 (46%), Gaps = 33/239 (13%)
Query: 57 YDFLQSPEELERLYCEIHLLKTLKHRNIMKF-------YTSWVDTANRNINFVTEM---F 106
Y QS E+ + + E+ L+ +KH N +++ +T+W+ V E
Sbjct: 60 YSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL---------VMEYCLGS 110
Query: 107 TSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV 166
S L ++ + V I A+ H L GL YLHS + +IHRD+K NI + G+V
Sbjct: 111 ASDLLEVHKKPLQEVEIAAITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQV 164
Query: 167 KIGDLGLAAILRKSHAARCVGTPEFMAPEVY----EEEYNELVDIYSFGMCILEMVTFDY 222
K+ D G A+I S A VGTP +MAPEV E +Y+ VD++S G+ +E+
Sbjct: 165 KLADFGSASIA--SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 222
Query: 223 PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATV-SSRLSARELLTDPFL 280
P + +Y + + P R F++ CL + R ++ ELL F+
Sbjct: 223 PLFNMNAMSALY-HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 42/225 (18%)
Query: 58 DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY--R 115
DFL E ++K L+H +++ Y V T I VTE+ G+L +Y
Sbjct: 47 DFLA----------EAQIMKKLRHPKLIQLYA--VCTLEEPIYIVTELMKYGSLLEYLQG 94
Query: 116 LKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175
R + + + Q+ SG+ YL +++ IHRDL N+ V G K+ D GLA
Sbjct: 95 GAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLV-GENNICKVADFGLAR 151
Query: 176 ILRKS-HAARCVGTP---EFMAPEVYEEEYNELV---DIYSFGMCILEMVTF-DYPYSEC 227
++++ + AR G ++ APE YN D++SFG+ + E+VT+ PY
Sbjct: 152 VIKEDIYEAR-EGAKFPIKWTAPEA--ALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM 208
Query: 228 THPAQIYKKVISGKK-------PEALFKV------EDPEVRQFIE 259
T+ A++ ++V G + P+ L+ + EDP+ R E
Sbjct: 209 TN-AEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-14
Identities = 69/228 (30%), Positives = 107/228 (46%), Gaps = 16/228 (7%)
Query: 40 AFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN--- 96
AFD G+ VA KL QS +R Y E+ LLK +KH N++ + +
Sbjct: 36 AFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93
Query: 97 -RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
++ VT + G +K +++ V+ QIL GL Y+HS D +IHRDLK
Sbjct: 94 FNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPS 149
Query: 156 NIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMC 213
N+ VN E+KI D GLA V T + APE+ YN+ VDI+S G
Sbjct: 150 NLAVN-EDCELKILDFGLARHTDDEMTGY-VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 207
Query: 214 ILEMVTFD--YPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 259
+ E++T +P ++ ++ +++ E L K+ R +I+
Sbjct: 208 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 255
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 9e-14
Identities = 52/164 (31%), Positives = 76/164 (46%), Gaps = 32/164 (19%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY--RLKHRRVNIRAVKHW 129
EI LLK L H NI++ V + + V E F L++Y ++ +K +
Sbjct: 48 EISLLKELNHPNIVRLLD--VVHSENKLYLVFE-FLDLDLKKYMDSSPLTGLDPPLIKSY 104
Query: 130 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP 189
Q+L G+ Y HS V+HRDLK N+ ++ +G +K+ D GL AR G P
Sbjct: 105 LYQLLQGIAYCHSHR--VLHRDLKPQNLLID-REGALKLADFGL---------ARAFGVP 152
Query: 190 E-----------FMAPEVY--EEEYNELVDIYSFGMCIL-EMVT 219
+ APE+ +Y+ VDI+S G CI EMV
Sbjct: 153 VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIG-CIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 68/275 (24%), Positives = 116/275 (42%), Gaps = 54/275 (19%)
Query: 54 VKLYDF-LQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLR 112
VK + S E+L+ L EI + L+H NI+ + TS++ + + V+ + G+
Sbjct: 30 VKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYVVSPLMAYGSCE 87
Query: 113 QYRLKHRRVNIR--AVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 170
H + A+ + +L+ L Y+HS+ IHR +K +I ++G+ G+V +
Sbjct: 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGD-GKVVLSG 144
Query: 171 LGLA-AILRKSHAARCV-GTPEF-------MAPEVYEEE---YNELVDIYSFGMCILEMV 218
L + ++++ R V P+ ++PEV ++ YNE DIYS G+ E+
Sbjct: 145 LRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELA 204
Query: 219 TFDYPYSECTHPAQIYKKVISGKKPEALFK-------------------------VEDPE 253
P+ + Q+ + + G P L K V+ P
Sbjct: 205 NGHVPFKD-MPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPY 263
Query: 254 VR-------QFIEKCLA-TVSSRLSARELLTDPFL 280
R QF+E CL SR SA +LL F
Sbjct: 264 TRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 49/182 (26%), Positives = 89/182 (48%), Gaps = 23/182 (12%)
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
N+ FV E G L + + ++ + +I+ GL +LHS+ +++RDLK DNI
Sbjct: 70 NLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNI 127
Query: 158 FVNGNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVY-EEEYNELVDIYSFGMCI 214
++ G +KI D G+ +L + GTP+++APE+ ++YN VD +SFG+ +
Sbjct: 128 LLD-TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLL 186
Query: 215 LEMVTFDYPYSECTHPAQIYKKVISGKKPEALF---KVEDPEVRQFIEKCLATVSSRLSA 271
EM+ P+ G E LF ++++P +++ + + +L
Sbjct: 187 YEMLIGQSPF--------------HGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFV 232
Query: 272 RE 273
RE
Sbjct: 233 RE 234
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 60/188 (31%), Positives = 96/188 (51%), Gaps = 16/188 (8%)
Query: 101 FVTEMFTSGTLRQ--YRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 158
V + G L+ Y + R + + V H+ QI G+L+LHS D +++RD+K +N+
Sbjct: 70 LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVL 127
Query: 159 VNGNQGEVKIGDLGLAAILR--KSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCIL 215
++ +QG ++ DLGLA L+ K+ R GT +MAPE+ +EE Y+ VD ++ G I
Sbjct: 128 LD-DQGNCRLSDLGLAVELKDGKTITQR-AGTNGYMAPEILKEEPYSYPVDWFAMGCSIY 185
Query: 216 EMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE----DPEVRQFIEKCLA-TVSSRLS 270
EMV P+ + H ++ K+ + + E K E E + LA RL
Sbjct: 186 EMVAGRTPFKD--HKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLG 243
Query: 271 ARELLTDP 278
+RE DP
Sbjct: 244 SREKNDDP 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 44/165 (26%), Positives = 83/165 (50%), Gaps = 12/165 (7%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-R 120
SP+ + + E +++ ++ H ++++ + + +T++ G L Y H+
Sbjct: 49 SPKANKEILDEAYVMASVDHPHVVRLLGI---CLSSQVQLITQLMPLGCLLDYVRNHKDN 105
Query: 121 VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--- 177
+ + + +WC QI G+ YL + ++HRDL N+ V Q VKI D GLA +L
Sbjct: 106 IGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLDVD 162
Query: 178 RKSHAARCVGTP-EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF 220
K + A P ++MA E + Y D++S+G+ + E++TF
Sbjct: 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 53/213 (24%), Positives = 101/213 (47%), Gaps = 12/213 (5%)
Query: 58 DFLQSPEELERLYCEIHLLK-TLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-- 114
D + + + + E+ ++K L+H NI+++Y ++++ N + V ++ L ++
Sbjct: 44 DKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE--NDRLYIVMDLIEGAPLGEHFN 101
Query: 115 RLKHRRVNIRAVKHWCR--QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 172
LK ++ + W Q++ L YLH ++ ++HRDL +NI + G +V I D G
Sbjct: 102 SLKEKKQRFTEERIWNIFVQMVLALRYLH-KEKRIVHRDLTPNNIML-GEDDKVTITDFG 159
Query: 173 LAAIL-RKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHP 230
LA +S VGT + PE+ + E Y E D+++FG + +M T P+ T+
Sbjct: 160 LAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNM 218
Query: 231 AQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 263
+ K++ + +V I CL
Sbjct: 219 LSLATKIVEAVYEPLPEGMYSEDVTDVITSCLT 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 40/127 (31%), Positives = 70/127 (55%), Gaps = 6/127 (4%)
Query: 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 160
FV E G L + R ++ + +I+ GL +LHS+ +I+RDLK DN+ ++
Sbjct: 73 FVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLD 130
Query: 161 GNQGEVKIGDLGLAA--ILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEM 217
+ G +KI D G+ + + A+ GTP+++APE+ + +Y VD +SFG+ + EM
Sbjct: 131 RD-GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEM 189
Query: 218 VTFDYPY 224
+ P+
Sbjct: 190 LIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 6e-13
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 35/205 (17%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLY--CEIH--------LLKTLKHRNIMKF 87
+A+D G VA +VK+ + + +L C IH ++ +KH NIM
Sbjct: 26 EKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85
Query: 88 YTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPV 147
+V+ IN V ++ + L++ + R+ VK QIL+GL LH
Sbjct: 86 VDVYVEGDF--INLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--F 140
Query: 148 IHRDLKCDNIFVNGNQGEVKIGDLGLA-----------AILRKSHAARCVGTPE-----F 191
+HRDL NIF+N ++G KI D GLA ++ R T + +
Sbjct: 141 MHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWY 199
Query: 192 MAPEVY--EEEYNELVDIYSFGMCI 214
APE+ E+Y+ VD++S G CI
Sbjct: 200 RAPELLMGAEKYHFAVDMWSVG-CI 223
|
Length = 335 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 7e-13
Identities = 47/179 (26%), Positives = 73/179 (40%), Gaps = 39/179 (21%)
Query: 148 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA------------------------- 182
IHRD+K DNI + G +K+ D GL + K+
Sbjct: 123 IHRDIKPDNILI-DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181
Query: 183 ---ARC---VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 235
R VGTP+++APEV Y D +S G+ + EM+ P+ T + Y
Sbjct: 182 QRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT-LQETYN 240
Query: 236 KVISGKKPEALFKVED---PEVRQFIEKCLATVSSRL-SARELLTDPFLQIDDYDSDLR 290
K+I+ K+ F + PE I + L RL S E+ + PF + D+++
Sbjct: 241 KIINWKE-SLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDWENLRE 298
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 53/153 (34%), Positives = 85/153 (55%), Gaps = 15/153 (9%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWC 130
EI LLK LKH+NI++ Y V +++ + V E + L++Y ++ VK +
Sbjct: 49 EICLLKELKHKNIVRLYD--VLHSDKKLTLVFE-YCDQDLKKYFDSCNGDIDPEIVKSFM 105
Query: 131 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAARCVG 187
Q+L GL + HS + V+HRDLK N+ +N N GE+K+ D GLA I + ++A V
Sbjct: 106 FQLLKGLAFCHSHN--VLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCYSAEVV- 161
Query: 188 TPEFMAPEVY--EEEYNELVDIYSFGMCIL-EM 217
T + P+V + Y+ +D++S G CI E+
Sbjct: 162 TLWYRPPDVLFGAKLYSTSIDMWSAG-CIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 20/164 (12%)
Query: 68 RLYCEIHLLKTLKHRNIMKFYTSWVDTAN--RNINFVTEMFTSGTLRQYRLKHRR--VNI 123
R E+ +L+ KH NI+ +++ V ++ S + + H +
Sbjct: 50 RTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDL---HHIIHSDQPLTE 106
Query: 124 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 183
++++ Q+L GL Y+HS + VIHRDLK N+ VN + E++IGD G+A L S
Sbjct: 107 EHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNED-CELRIGDFGMARGLSSSPTE 163
Query: 184 RC------VGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EMV 218
V T + APE+ EY +D++S G CI EM+
Sbjct: 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVG-CIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 9e-13
Identities = 39/127 (30%), Positives = 68/127 (53%), Gaps = 6/127 (4%)
Query: 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 160
FV E G L + K RR + + + +I S L++LH + +I+RDLK DN+ ++
Sbjct: 73 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLD 130
Query: 161 GNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEM 217
++G K+ D G+ I + GTP+++APE+ +E Y VD ++ G+ + EM
Sbjct: 131 -HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEM 189
Query: 218 VTFDYPY 224
+ P+
Sbjct: 190 LCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 53/168 (31%), Positives = 85/168 (50%), Gaps = 33/168 (19%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNI---NFVTEMFTSGTLRQYRLKHRRVNIRAVKH 128
E LL+ + H ++++ + V A + ++ ++++T T R R + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS-----RPLPIDQALI 161
Query: 129 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--- 185
+QIL GL YLH++ +IHRD+K +NIF+N + +V IGDLG AA+
Sbjct: 162 IEKQILEGLRYLHAQR--IIHRDVKTENIFIN-DVDQVCIGDLG---------AAQFPVV 209
Query: 186 -------VGTPEFMAPEVY-EEEYNELVDIYSFGMCILEMVTFDYPYS 225
GT E APEV ++YN DI+S G+ + EM+ YP +
Sbjct: 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA--YPST 255
|
Length = 357 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 49/156 (31%), Positives = 79/156 (50%), Gaps = 17/156 (10%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDT--ANRNINFVTEMFTSGTLRQYRLKHRR-VNIRAVKH 128
E LLK LKH NI+ + D + + V E + L+QY +++ V+
Sbjct: 53 EASLLKDLKHANIVTLH----DIIHTKKTLTLVFE-YLDTDLKQYMDDCGGGLSMHNVRL 107
Query: 129 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAARC 185
+ Q+L GL Y H R V+HRDLK N+ ++ +GE+K+ D GLA ++ K+++
Sbjct: 108 FLFQLLRGLAYCHQRR--VLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEV 164
Query: 186 VGTPEFMAPEVY--EEEYNELVDIYSFGMCILEMVT 219
V T + P+V EY+ +D++ G EM T
Sbjct: 165 V-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 43/136 (31%), Positives = 70/136 (51%), Gaps = 16/136 (11%)
Query: 148 IHRDLKCDNIFVNGNQGEVKIGDLGLAA-ILRKSHAARCVGTPEFMAPEV-YEEEYNELV 205
IHRDLK +N F+ G +K+ D GL+ I+ +++ VG+P++MAPEV + Y+ V
Sbjct: 123 IHRDLKPEN-FLIDASGHIKLTDFGLSKGIVTYANSV--VGSPDYMAPEVLRGKGYDFTV 179
Query: 206 DIYSFGMCIL-EMVTFDYPYSECTHPAQIYKKVISGKK-------PEALFKVEDPEVRQF 257
D +S G C+L E + P+S T P + ++ + K+ + F + D E
Sbjct: 180 DYWSLG-CMLYEFLCGFPPFSGST-PNETWENLKYWKETLQRPVYDDPRFNLSD-EAWDL 236
Query: 258 IEKCLATVSSRLSARE 273
I K + S R + E
Sbjct: 237 ITKLINDPSRRFGSLE 252
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 53/165 (32%), Positives = 83/165 (50%), Gaps = 33/165 (20%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH---RRVNIRAVKH 128
EI L+K LKH NI++ + + T N+ + V E + L++Y H ++ VK
Sbjct: 48 EISLMKELKHENIVRLHDV-IHTENK-LMLVFE-YMDKDLKKYMDTHGVRGALDPNTVKS 104
Query: 129 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT 188
+ Q+L G+ + H + V+HRDLK N+ +N +GE+K+ D GL AR G
Sbjct: 105 FTYQLLKGIAFCH--ENRVLHRDLKPQNLLINK-RGELKLADFGL---------ARAFGI 152
Query: 189 PE-----------FMAPEVY--EEEYNELVDIYSFGMCIL-EMVT 219
P + AP+V Y+ +DI+S G CI+ EM+T
Sbjct: 153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVG-CIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 44/157 (28%), Positives = 70/157 (44%), Gaps = 22/157 (14%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR--VNIRAVKHW 129
EI L+ +H ++K V V E S L+ + VK +
Sbjct: 49 EIKALQACQHPYVVKLLD--VFPHGSGFVLVMEYMPSDLSE--VLRDEERPLPEAQVKSY 104
Query: 130 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK------SHAA 183
R +L G+ Y+H+ ++HRDLK N+ + G +KI D GLA + + SH
Sbjct: 105 MRMLLKGVAYMHANG--IMHRDLKPANLLI-SADGVLKIADFGLARLFSEEEPRLYSHQ- 160
Query: 184 RCVGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EM 217
V T + APE+ +Y+ VD+++ G CI E+
Sbjct: 161 --VATRWYRAPELLYGARKYDPGVDLWAVG-CIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 44/132 (33%), Positives = 68/132 (51%), Gaps = 6/132 (4%)
Query: 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 160
FV E G L + + R + + +I+S L YLHSRD V++RD+K +N+ ++
Sbjct: 72 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD 129
Query: 161 GNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEM 217
G +KI D GL I + GTPE++APEV E+ +Y VD + G+ + EM
Sbjct: 130 -KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 188
Query: 218 VTFDYPYSECTH 229
+ P+ H
Sbjct: 189 MCGRLPFYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 51/155 (32%), Positives = 77/155 (49%), Gaps = 14/155 (9%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYR--LKHRRVNIRAVKHW 129
EI LLK L H NI+K V + V E F L+++ + + +K +
Sbjct: 49 EISLLKELNHPNIVKLLD--VIHTENKLYLVFE-FLHQDLKKFMDASPLSGIPLPLIKSY 105
Query: 130 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAARCV 186
Q+L GL + HS V+HRDLK N+ +N +G +K+ D GLA + +++ V
Sbjct: 106 LFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVV 162
Query: 187 GTPEFMAPEVY--EEEYNELVDIYSFGMCILEMVT 219
T + APE+ + Y+ VDI+S G EMVT
Sbjct: 163 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 63/248 (25%), Positives = 104/248 (41%), Gaps = 48/248 (19%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRN--INFVTEMFTSGTLRQYRLKHRRVNIRAVKHW 129
E+ +L+ L+H NI+ + R + V E L + AV+ +
Sbjct: 50 EVKVLRQLRHENIVNL----KEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSY 105
Query: 130 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC---V 186
Q+L + Y HS + +IHRD+K +NI V+ + G +K+ D G A LR A+ V
Sbjct: 106 IWQLLQAIAYCHSHN--IIHRDIKPENILVSES-GVLKLCDFGFARALRARPASPLTDYV 162
Query: 187 GTPEFMAPE--VYEEEYNELVDIYSFGMCIL-EMVTFDYPYSECTHPAQIYK-------- 235
T + APE V + Y + VD+++ G CI+ E++ + + + Q+Y
Sbjct: 163 ATRWYRAPELLVGDTNYGKPVDVWAIG-CIMAELLDGEPLFPGDSDIDQLYLIQKCLGPL 221
Query: 236 -----------------KVISGKKPEAL-----FKVEDPEVRQFIEKCLAT-VSSRLSAR 272
+PE+L KV P + F++ CL RL+
Sbjct: 222 PPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPAL-DFLKACLRMDPKERLTCD 280
Query: 273 ELLTDPFL 280
ELL P+
Sbjct: 281 ELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 63/199 (31%), Positives = 100/199 (50%), Gaps = 36/199 (18%)
Query: 40 AFDEYEGIEVAWNQVKLYDFLQSPEELERLYC-----EIHLLKTLKHRNIMKFY----TS 90
A + G++VA ++ SP E + +C EI +L+ KH NI+
Sbjct: 24 ATHKPTGVKVAIKKI-------SPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPP 75
Query: 91 WVDTANRNINFVTE-MFTSGTLRQYRL-KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVI 148
++ N ++ V E M T Y+L K + ++ ++++ QIL GL Y+HS + V+
Sbjct: 76 SFESFN-DVYIVQELMETD----LYKLIKTQHLSNDHIQYFLYQILRGLKYIHSAN--VL 128
Query: 149 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-----ARCVGTPEFMAPEVY--EEEY 201
HRDLK N+ +N N ++KI D GLA I H V T + APE+ + Y
Sbjct: 129 HRDLKPSNLLLNTN-CDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGY 187
Query: 202 NELVDIYSFGMCIL-EMVT 219
+ +DI+S G CIL EM++
Sbjct: 188 TKAIDIWSVG-CILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 26/212 (12%)
Query: 66 LERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSG----TLRQYRLKHRRV 121
++ E ++ +L H N+++ Y + + VTE+ G LR+ L H
Sbjct: 40 MDDFLKEAAIMHSLDHENLIRLYGVVLTHP---LMMVTELAPLGSLLDRLRKDALGH--F 94
Query: 122 NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 181
I + + QI +G+ YL S+ IHRDL NI + + +VKIGD GL L ++
Sbjct: 95 LISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDD-KVKIGDFGLMRALPQNE 151
Query: 182 ------AARCVGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQI 233
V + APE + ++ D++ FG+ + EM T+ + P++ + +QI
Sbjct: 152 DHYVMEEHLKVPFA-WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS-GSQI 209
Query: 234 YKKVISGKKPEALFKVED--PEVRQFIEKCLA 263
KK+ K+ E L + E ++ + +C A
Sbjct: 210 LKKI--DKEGERLERPEACPQDIYNVMLQCWA 239
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 16/215 (7%)
Query: 75 LLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQIL 134
LLK +KH ++ + S+ TA++ + FV + G L + + R + + +I
Sbjct: 49 LLKNVKHPFLVGLHYSF-QTADK-LYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIA 106
Query: 135 SGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTPEFM 192
S L YLHS + +I+RDLK +NI ++ +QG V + D GL I + GTPE++
Sbjct: 107 SALGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYL 163
Query: 193 APEV-YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED 251
APEV ++ Y+ VD + G + EM+ + P A++Y +++ KP L
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEML-YGLPPFYSRDTAEMYDNILN--KPLRLKPNIS 220
Query: 252 PEVRQFIEKCL-ATVSSRLSARELLTDPFLQIDDY 285
R +E L + RL A+ D FL+I ++
Sbjct: 221 VSARHLLEGLLQKDRTKRLGAK----DDFLEIKNH 251
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 5e-12
Identities = 51/162 (31%), Positives = 79/162 (48%), Gaps = 27/162 (16%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK------HRRVNIRA 125
EI++L L+H NI+ V + I V E ++ LK +
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV------EHDLKSLMETMKQPFLQSE 107
Query: 126 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK-----S 180
VK Q+LSG+ +LH ++HRDLK N+ +N N+G +KI D GLA R+
Sbjct: 108 VKCLMLQLLSGVAHLHDN--WILHRDLKTSNLLLN-NRGILKICDFGLA---REYGSPLK 161
Query: 181 HAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EMVT 219
+ V T + APE+ +EY+ +D++S G CI E++T
Sbjct: 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVG-CIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 49/203 (24%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 47 IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMF 106
+EVA +K +E R E ++ L H I++ + V E+
Sbjct: 24 VEVAVKTLKQEHIAAGKKEFLR---EASVMAQLDHPCIVRLIGVCKGEP---LMLVMELA 77
Query: 107 TSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV 166
G L +Y K R + + +K Q+ G+ YL S+ +HRDL N+ + N+ +
Sbjct: 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLV-NRHQA 134
Query: 167 KIGDLGLAAILRKS---HAARCVGT-P-EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF 220
KI D G++ L + A G P ++ APE + +++ D++S+G+ + E ++
Sbjct: 135 KISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSY 194
Query: 221 -DYPYSECTHPAQIYKKVISGKK 242
PY E ++ + SG++
Sbjct: 195 GAKPYGEMKGA-EVIAMLESGER 216
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-12
Identities = 46/153 (30%), Positives = 79/153 (51%), Gaps = 5/153 (3%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCR 131
E+ +L I+ FY ++ ++ I+ E G+L Q + +R+ +
Sbjct: 53 ELQVLHECNSPYIVGFYGAFY--SDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSI 110
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF 191
+L GL YL + ++HRD+K NI VN ++GE+K+ D G++ L S A VGT +
Sbjct: 111 AVLRGLAYLREKHQ-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSY 168
Query: 192 MAPEVYE-EEYNELVDIYSFGMCILEMVTFDYP 223
M+PE + Y+ DI+S G+ ++E+ YP
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 47/150 (31%), Positives = 64/150 (42%), Gaps = 12/150 (8%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCR 131
EI LL L+H NI++ V +I V E + VK
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLML 115
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR----CVG 187
Q+L GL YLH +IHRDLK N+ + G +KI D GLA A+ V
Sbjct: 116 QLLRGLQYLHEN--FIIHRDLKVSNLLLTDK-GCLKIADFGLAR--TYGLPAKPMTPKVV 170
Query: 188 TPEFMAPEVY--EEEYNELVDIYSFGMCIL 215
T + APE+ Y +D+++ G CIL
Sbjct: 171 TLWYRAPELLLGCTTYTTAIDMWAVG-CIL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 46/152 (30%), Positives = 70/152 (46%), Gaps = 9/152 (5%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCR 131
EI +LK LKH N++ V R ++ V E L + R V +K
Sbjct: 50 EIRMLKQLKHPNLVNLIE--VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIW 107
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA--RCVGTP 189
Q L + + H + IHRD+K +NI + QG++K+ D G A IL V T
Sbjct: 108 QTLQAVNFCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTDYVATR 164
Query: 190 EFMAPE--VYEEEYNELVDIYSFGMCILEMVT 219
+ APE V + +Y VD+++ G E++T
Sbjct: 165 WYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 7e-12
Identities = 87/298 (29%), Positives = 128/298 (42%), Gaps = 51/298 (17%)
Query: 40 AFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKF---YTSWVDTAN 96
A D+ G +VA KL QS +R Y E+ LLK ++H N++ +TS V
Sbjct: 34 AIDKRTGEKVAIK--KLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91
Query: 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
++ + L++ ++ V++ Q+L GL Y+HS +IHRDLK N
Sbjct: 92 FQDFYLVMPYMQTDLQKIMGHP--LSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGN 147
Query: 157 IFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPEVYEE--EYNELVDIYSFGM 212
+ VN E+KI D GLA R + A V T + APEV YN+ VDI+S G
Sbjct: 148 LAVN-EDCELKILDFGLA---RHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGC 203
Query: 213 CILEMVTFDYPYSECTHPAQIYK--KVISGKKPEALFKVEDPEVRQFI------------ 258
+ EM+T + + Q+ + KV PE + K+ED + +I
Sbjct: 204 IMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFS 263
Query: 259 --------------EKCLA-TVSSRLSARELLTDPFL-QIDDYDSDLRMIQYQTDYDE 300
EK L V RL+A E L P+ D D + Q YD+
Sbjct: 264 TLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETE----QQPYDD 317
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 8e-12
Identities = 56/164 (34%), Positives = 78/164 (47%), Gaps = 31/164 (18%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYR---LKHRRVNIRAVKH 128
EI LLK L+H NI+ V + + E F S L++Y K + ++ VK
Sbjct: 49 EISLLKELQHPNIVCLQD--VLMQESRLYLIFE-FLSMDLKKYLDSLPKGQYMDAELVKS 105
Query: 129 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT 188
+ QIL G+L+ HSR V+HRDLK N+ ++ N+G +K+ D GL AR G
Sbjct: 106 YLYQILQGILFCHSRR--VLHRDLKPQNLLID-NKGVIKLADFGL---------ARAFGI 153
Query: 189 PE-----------FMAPEVY--EEEYNELVDIYSFGMCILEMVT 219
P + APEV Y+ VDI+S G EM T
Sbjct: 154 PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 8e-12
Identities = 53/177 (29%), Positives = 80/177 (45%), Gaps = 28/177 (15%)
Query: 58 DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK 117
FLQ E ++K L+H +++ Y V + I VTE + G+L + LK
Sbjct: 47 AFLQ----------EAQIMKKLRHDKLVQLYA--VCSEEEPIYIVTEYMSKGSLLDF-LK 93
Query: 118 H---RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174
+++ + + QI G+ YL SR+ IHRDL NI V G KI D GLA
Sbjct: 94 SGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILV-GENLVCKIADFGLA 150
Query: 175 AILRKSHAARCVGTP---EFMAPEVYEEEYNELV---DIYSFGMCILEMVTF-DYPY 224
++ G ++ APE Y D++SFG+ + E+VT+ PY
Sbjct: 151 RLIEDDEYTAREGAKFPIKWTAPEA--ANYGRFTIKSDVWSFGILLTEIVTYGRVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 52/155 (33%), Positives = 83/155 (53%), Gaps = 15/155 (9%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHW 129
E+ LLK LKH NI+ + + R + V E S L+QY L + +++ VK +
Sbjct: 53 EVSLLKNLKHANIVTLHD--IIHTERCLTLVFEYLDS-DLKQY-LDNCGNLMSMHNVKIF 108
Query: 130 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAARCV 186
Q+L GL Y H R ++HRDLK N+ +N +GE+K+ D GLA ++ K+++ V
Sbjct: 109 MFQLLRGLSYCHKRK--ILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVV 165
Query: 187 GTPEFMAPEVY--EEEYNELVDIYSFGMCILEMVT 219
T + P+V EY+ +D++ G + EM T
Sbjct: 166 -TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 9e-12
Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 14/213 (6%)
Query: 55 KLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY 114
KL QS R Y E+ LLK +KH N++ V T +I E++ L
Sbjct: 47 KLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLD--VFTPATSIENFNEVYLVTNLMGA 104
Query: 115 RL----KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 170
L K ++++ V+ Q+L GL Y+HS +IHRDLK N+ VN E++I D
Sbjct: 105 DLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVN-EDCELRILD 161
Query: 171 LGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFD--YPYSE 226
GLA V T + APE+ YN+ VDI+S G + E++ +P ++
Sbjct: 162 FGLARQADDEMTGY-VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220
Query: 227 CTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 259
+ +V+ PE L K+ R++I+
Sbjct: 221 YIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQ 253
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 56/196 (28%), Positives = 92/196 (46%), Gaps = 24/196 (12%)
Query: 104 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 163
E+FT R++ + V+ + +I+ L +LH +I+RD+K +NI ++
Sbjct: 91 ELFTHLYQREHFTESE------VRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSE- 141
Query: 164 GEVKIGDLGLAAILRKSHAARC---VGTPEFMAPEVY---EEEYNELVDIYSFGMCILEM 217
G V + D GL+ R GT E+MAPEV +++ VD +S G+ E+
Sbjct: 142 GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201
Query: 218 VTFDYPYS---ECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRL---S 270
+T P++ E ++I ++++ K P K E R FI+K L RL
Sbjct: 202 LTGASPFTVDGEQNSQSEISRRILKSKPP--FPKTMSAEARDFIQKLLEKDPKKRLGANG 259
Query: 271 ARELLTDPFLQIDDYD 286
A E+ PF Q D+D
Sbjct: 260 ADEIKNHPFFQGIDWD 275
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 63/216 (29%), Positives = 110/216 (50%), Gaps = 18/216 (8%)
Query: 75 LLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA-VKHWCRQI 133
LLK +KH ++ + S+ TA++ + FV + G L Y L+ R + + + +I
Sbjct: 49 LLKNVKHPFLVGLHFSF-QTADK-LYFVLDYINGGELF-YHLQRERCFLEPRARFYAAEI 105
Query: 134 LSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA--ILRKSHAARCVGTPEF 191
S L YLHS + +++RDLK +NI ++ +QG + + D GL I + GTPE+
Sbjct: 106 ASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEY 162
Query: 192 MAPEV-YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE 250
+APEV +++ Y+ VD + G + EM+ + P + A++Y +++ KP L
Sbjct: 163 LAPEVLHKQPYDRTVDWWCLGAVLYEML-YGLPPFYSRNTAEMYDNILN--KPLQLKPNI 219
Query: 251 DPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDY 285
R +E L + RL A D F++I ++
Sbjct: 220 TNSARHLLEGLLQKDRTKRLGA----KDDFMEIKNH 251
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 49/173 (28%), Positives = 74/173 (42%), Gaps = 32/173 (18%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFT---------SGTLRQYRLKHRRVN 122
EI +LK LKH N++ V+ +++ ++ SG L +K +
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LT 113
Query: 123 IRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR---- 178
+K + Q+L G+ YLH ++HRD+K NI ++ NQG +KI D GLA
Sbjct: 114 ESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADFGLARPYDGPPP 170
Query: 179 ---------KSHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EMVT 219
V T + PE+ E Y VDI+ G C+ EM T
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIG-CVFAEMFT 222
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 22/197 (11%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQS-PEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96
Y+A D+ G VA +V+L + + P R EI +L+ L HRNI+ D +
Sbjct: 24 YKARDKDTGELVALKKVRLDNEKEGFPITAIR---EIKILRQLNHRNIVNLKEIVTDKQD 80
Query: 97 --------RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVI 148
V E + + +K + +Q+L GL Y H ++ +
Sbjct: 81 ALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FL 138
Query: 149 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA---ARCVGTPEFMAPEVY--EEEYNE 203
HRD+KC NI +N N+G++K+ D GLA + + V T + PE+ EE Y
Sbjct: 139 HRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGP 197
Query: 204 LVDIYSFGMCIL-EMVT 219
+D++S G CIL E+ T
Sbjct: 198 AIDVWSCG-CILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 47/153 (30%), Positives = 79/153 (51%), Gaps = 5/153 (3%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCR 131
E+ +L I+ FY ++ ++ I+ E G+L Q K R+ + +
Sbjct: 53 ELQVLHECNSPYIVGFYGAFY--SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI 110
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF 191
++ GL YL + ++HRD+K NI VN ++GE+K+ D G++ L S A VGT +
Sbjct: 111 AVIKGLTYLREKHK-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSY 168
Query: 192 MAPEVYE-EEYNELVDIYSFGMCILEMVTFDYP 223
M+PE + Y+ DI+S G+ ++EM YP
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWC 130
E+ LLK LKH NI+ + + +++ V E + L+QY +N+ VK +
Sbjct: 54 EVSLLKDLKHANIVTLHD--IIHTEKSLTLVFE-YLDKDLKQYLDDCGNSINMHNVKLFL 110
Query: 131 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAARCVG 187
Q+L GL Y H R V+HRDLK N+ +N +GE+K+ D GLA +I K+++ V
Sbjct: 111 FQLLRGLNYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVV- 166
Query: 188 TPEFMAPEVY--EEEYNELVDIYSFGMCILEMVT 219
T + P++ +Y+ +D++ G EM T
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 12/177 (6%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWC 130
E ++ L H +++ Y V T R I VTE ++G L Y R +R + C
Sbjct: 49 EAKVMMKLSHEKLVQLYG--VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMC 106
Query: 131 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP- 189
+ + G+ YL S+ IHRDL N V+ +QG VK+ D GL+ + VG+
Sbjct: 107 KDVCEGMAYLESKQ--FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLDDEYTSSVGSKF 163
Query: 190 --EFMAPEVYE-EEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK 242
+ PEV +++ D+++FG+ + E+ + PY + ++ +KV G +
Sbjct: 164 PVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-SETVEKVSQGLR 219
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 13/196 (6%)
Query: 99 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 158
++F+ ++ G L + +H + ++ + +I+ GL ++H+R V++RDLK NI
Sbjct: 72 LSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANIL 129
Query: 159 VNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILE 216
++ + G V+I DLGLA K VGT +MAPEV ++ Y+ D +S G + +
Sbjct: 130 LDEH-GHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK 188
Query: 217 MVTFDYPYSE-CTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRL----- 269
++ P+ + T ++ E L PE+R +E L V+ RL
Sbjct: 189 LLRGHSPFRQHKTKDKHEIDRMTLTMAVE-LPDSFSPELRSLLEGLLQRDVNRRLGCLGR 247
Query: 270 SARELLTDPFLQIDDY 285
A+E+ PF + D+
Sbjct: 248 GAQEVKEHPFFRSLDW 263
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 48/162 (29%), Positives = 72/162 (44%), Gaps = 18/162 (11%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRN----INFVTEMFTSGTLRQYRLKHRRVNIR--- 124
EI LL+ L + +N + V E + L+++ + R R
Sbjct: 50 EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFE-YLDSDLKKFMDSNGRGPGRPLP 108
Query: 125 --AVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRK 179
+K + Q+L G+ + H V+HRDLK N+ V+ +G +KI DLGL +I K
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK 166
Query: 180 SHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCILEMVT 219
S+ V T + APEV Y+ VDI+S G EM
Sbjct: 167 SYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR 207
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 50/171 (29%), Positives = 85/171 (49%), Gaps = 8/171 (4%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV 121
+ +E+ E +LK +H + S+ T +R + FV E G L + + R
Sbjct: 35 AKDEVAHTLTESRVLKNTRHPFLTSLKYSF-QTKDR-LCFVMEYVNGGELFFHLSRERVF 92
Query: 122 NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRK 179
+ + + +I+S L YLHS +++RDLK +N+ ++ + G +KI D GL I
Sbjct: 93 SEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDA 149
Query: 180 SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTH 229
+ GTPE++APEV E+ +Y VD + G+ + EM+ P+ H
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 50/167 (29%), Positives = 85/167 (50%), Gaps = 9/167 (5%)
Query: 75 LLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQIL 134
LLK +KH ++ + S+ T + FV + G L + + R + + +I
Sbjct: 49 LLKNVKHPFLVGLHYSFQTT--EKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIA 106
Query: 135 SGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTPEFM 192
S L YLHS + +++RDLK +NI ++ +QG V + D GL I + GTPE++
Sbjct: 107 SALGYLHSIN--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYL 163
Query: 193 APEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 238
APEV ++ Y+ VD + G + EM+ + P C A++Y ++
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEML-YGLPPFYCRDVAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 50/162 (30%), Positives = 74/162 (45%), Gaps = 27/162 (16%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTE---------MFTSGTLRQYRLKHRRVN 122
EI LLK ++H NI++ V + + + V E M +S + N
Sbjct: 51 EISLLKEMQHGNIVRLQD--VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAK--------N 100
Query: 123 IRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRK 179
R +K + QIL G+ Y HS V+HRDLK N+ ++ +K+ D GLA I +
Sbjct: 101 PRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158
Query: 180 SHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCILEMVT 219
+ V T + APE+ Y+ VDI+S G EMV
Sbjct: 159 TFTHEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 23/162 (14%)
Query: 102 VTEMFTSGTLRQY----RLKHRRVNIRAVKH------WCRQILSGLLYLHSRDPPVIHRD 151
V E+ G L+ Y R + +I G+ YL ++ +HRD
Sbjct: 87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRD 144
Query: 152 LKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT---P-EFMAPE-VYEEEYNELVD 206
L N V + VKIGD G+ + ++ R G P +MAPE + + + D
Sbjct: 145 LAARNCMVAED-LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSD 203
Query: 207 IYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGK---KPE 244
++SFG+ + EM T + PY ++ ++ K VI G PE
Sbjct: 204 VWSFGVVLWEMATLAEQPYQGLSN-EEVLKFVIDGGHLDLPE 244
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 10/153 (6%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWC 130
E ++ L H N+++ Y V T R I VTE +G L Y + + ++ + C
Sbjct: 49 EAKVMMKLSHPNLVQLYG--VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMC 106
Query: 131 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP- 189
+ + YL S IHRDL N V G VK+ D GLA + GT
Sbjct: 107 SDVCEAMEYLESNG--FIHRDLAARNCLV-GEDNVVKVSDFGLARYVLDDQYTSSQGTKF 163
Query: 190 --EFMAPEVYE-EEYNELVDIYSFGMCILEMVT 219
++ PEV++ ++ D++SFG+ + E+ +
Sbjct: 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 55/171 (32%), Positives = 87/171 (50%), Gaps = 12/171 (7%)
Query: 64 EELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV-- 121
+E+ E +L+ +H + S+ T +R + FV E G L + L RV
Sbjct: 37 DEVAHTLTESRVLQNTRHPFLTALKYSF-QTHDR-LCFVMEYANGGELF-FHLSRERVFS 93
Query: 122 NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRK 179
RA + + +I+S L YLHS D V++RDLK +N+ ++ + G +KI D GL I
Sbjct: 94 EDRA-RFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDG 149
Query: 180 SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTH 229
+ GTPE++APEV E+ +Y VD + G+ + EM+ P+ H
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 50/168 (29%), Positives = 87/168 (51%), Gaps = 9/168 (5%)
Query: 75 LLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQIL 134
LLK LKH ++ + S+ TA + + FV + G L + + R + + ++
Sbjct: 49 LLKNLKHPFLVGLHYSF-QTAEK-LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVA 106
Query: 135 SGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTPEFM 192
S + YLHS + +I+RDLK +NI ++ +QG V + D GL + + + GTPE++
Sbjct: 107 SAIGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYL 163
Query: 193 APEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 239
APEV +E Y+ VD + G + EM+ + P +Q+Y ++
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEML-YGLPPFYSRDVSQMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV-NIRAVKHWC 130
E+ LLK LKH NI+ + + ++++ V E + L+QY + ++ VK +
Sbjct: 54 EVSLLKDLKHANIVTLHD--IVHTDKSLTLVFE-YLDKDLKQYMDDCGNIMSMHNVKIFL 110
Query: 131 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAARCVG 187
QIL GL Y H R V+HRDLK N+ +N +GE+K+ D GLA ++ K+++ V
Sbjct: 111 YQILRGLAYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVV- 166
Query: 188 TPEFMAPEVY--EEEYNELVDIYSFGMCILEMVT 219
T + P+V EY+ +D++ G EM +
Sbjct: 167 TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 69/302 (22%), Positives = 130/302 (43%), Gaps = 63/302 (20%)
Query: 84 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR 143
++K + S+ D N + + E G + +K + + + + + + +H
Sbjct: 63 VVKMFYSFQDKLN--LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 144 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH---------------------- 181
IHRD+K DN+ ++ ++G VK+ D GL L+K+H
Sbjct: 121 G--FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 182 ---------------AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYS 225
A VGTP+++APEV+ + YN+L D +S G+ + EM+ P+
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 226 ECTHPAQIYKKVISGKKPEALFKVEDP---EVRQFIEKCLATVSSRLSA---RELLTDPF 279
T P + YKKV++ K+ +F E P + + I + R+ A E+ T+PF
Sbjct: 238 SET-PQETYKKVMNWKE-TLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPF 295
Query: 280 LQIDDYDS----------DLRMIQYQTDYDEI--SPLLRQSLYGIYHSNSSSNNGCGHYI 327
+ D++ +++ I +++DE S +L+ ++ H + N +I
Sbjct: 296 FEGVDWEHIRERPAAIPIEIKSIDDTSNFDEFPDSDILKPTVATSNHPETDYKNKDWVFI 355
Query: 328 GY 329
Y
Sbjct: 356 NY 357
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 6e-11
Identities = 50/178 (28%), Positives = 85/178 (47%), Gaps = 17/178 (9%)
Query: 72 EIHLLKTLKHRNIMKF-----YTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAV 126
EI L L H NI+K + + +F F ++ + RA+
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAI 272
Query: 127 KHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR-- 184
+Q+L + Y+H + +IHRD+K +NIF+N + G++ +GD G A K A
Sbjct: 273 M---KQLLCAVEYIHDK--KLIHRDIKLENIFLNCD-GKIVLGDFGTAMPFEKEREAFDY 326
Query: 185 -CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDY-PYSECT-HPAQIYKKVI 238
VGT +PE+ + Y E+ DI+S G+ +L+M++ D+ P + P + K+I
Sbjct: 327 GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII 384
|
Length = 501 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 43/133 (32%), Positives = 69/133 (51%), Gaps = 10/133 (7%)
Query: 99 INFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
+ +T++ G L Y +H+ + + + +WC QI G+ YL R ++HRDL N+
Sbjct: 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNV 140
Query: 158 FVNGNQGEVKIGDLGLAAIL---RKSHAARCVGTP-EFMAPE-VYEEEYNELVDIYSFGM 212
V Q VKI D GLA +L K + A P ++MA E + Y D++S+G+
Sbjct: 141 LVKTPQ-HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 199
Query: 213 CILEMVTF-DYPY 224
+ E++TF PY
Sbjct: 200 TVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 8e-11
Identities = 58/226 (25%), Positives = 93/226 (41%), Gaps = 33/226 (14%)
Query: 64 EELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR--- 120
+E + E HL+ H NI+K + N + E+ G L Y R
Sbjct: 41 QEKKEFLKEAHLMSNFNHPNIVKLLGVCLL--NEPQYIIMELMEGGDLLSYLRDARVERF 98
Query: 121 ----VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE----VKIGDLG 172
+ ++ + C + G +YL IHRDL N V+ + VKIGD G
Sbjct: 99 GPPLLTLKELLDICLDVAKGCVYL--EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156
Query: 173 LAAILRKSHAARCVGTP----EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSE 226
LA + KS R G +MAPE + + ++ D++SFG+ + E++T PY
Sbjct: 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY-- 214
Query: 227 CTHPAQIYKKVISGKKPEALFKVEDPE-----VRQFIEKCLATVSS 267
PA ++V+ +++ PE + Q + C A S
Sbjct: 215 ---PALNNQEVLQHVTAGG--RLQKPENCPDKIYQLMTNCWAQDPS 255
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 8e-11
Identities = 46/181 (25%), Positives = 85/181 (46%), Gaps = 14/181 (7%)
Query: 45 EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTE 104
E I VA VK SP E+ E ++++ H +I+K + + V E
Sbjct: 33 EKIAVA---VKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENP---VWIVME 86
Query: 105 MFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 163
+ G LR Y ++ +++ ++ + Q+ + L YL S+ +HRD+ N+ V+
Sbjct: 87 LAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPD 144
Query: 164 GEVKIGDLGLAAILRKS---HAARCVGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVT 219
VK+GD GL+ L A++ ++MAPE + + D++ FG+C+ E++
Sbjct: 145 C-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 203
Query: 220 F 220
Sbjct: 204 L 204
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 12/150 (8%)
Query: 147 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-ARCVGTPEFMAPEVYEEE----Y 201
+IHRD+K NI ++ N G +K+ D G++ L S A R G +MAPE + Y
Sbjct: 129 IIHRDVKPSNILLDRN-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGY 187
Query: 202 NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE---ALFKVEDPEVRQFI 258
+ D++S G+ + E+ T +PY + +V+ G P + + P FI
Sbjct: 188 DVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFI 247
Query: 259 EKCL-ATVSSRLSARELLTDPFLQIDDYDS 287
CL S R +ELL PF++ DY+
Sbjct: 248 NLCLIKDESKRPKYKELLEHPFIK--DYEE 275
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 42/128 (32%), Positives = 70/128 (54%), Gaps = 9/128 (7%)
Query: 99 INFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
I VT++ G L Y +H+ + + + +WC QI G++YL R ++HRDL N+
Sbjct: 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNV 140
Query: 158 FVNGNQGEVKIGDLGLAAIL---RKSHAARCVGTP-EFMAPE-VYEEEYNELVDIYSFGM 212
V + VKI D GLA +L K + A P ++MA E ++ ++ D++S+G+
Sbjct: 141 LVK-SPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGV 199
Query: 213 CILEMVTF 220
I E++TF
Sbjct: 200 TIWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 65/263 (24%), Positives = 114/263 (43%), Gaps = 37/263 (14%)
Query: 42 DEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLK-TLKHRNIMKFYTSWVDTANRNIN 100
DE I+V V L D ++++ E +L KH + + + T +R +
Sbjct: 20 DEVYAIKVLKKDVILQD-----DDVDCTMTEKRILALAAKHPFLTALHCCF-QTKDR-LF 72
Query: 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 160
FV E G L + R+ + + + ++ L++LH VI+RDLK DNI ++
Sbjct: 73 FVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLD 130
Query: 161 GNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEM 217
+G K+ D G+ IL GTP+++APE+ +E EY VD ++ G+ + EM
Sbjct: 131 A-EGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEM 189
Query: 218 VTFDYPYS--------------ECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 263
+ P+ + +P + K+ +S K F ++P R L
Sbjct: 190 MAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKA---FMTKNPNKR------LG 240
Query: 264 TVSSRLSARELLTDPFLQIDDYD 286
V+S+ + PF + D+
Sbjct: 241 CVASQGGEDAIKQHPFFKEIDWV 263
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 20/198 (10%)
Query: 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 160
VT+ + G L + K R + K + +++ L +LH D +++RDLK +NI ++
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLD 130
Query: 161 GNQGEVKIGDLGLA-AILRKSHAARC-VGTPEFMAPEVYEEE--YNELVDIYSFGMCILE 216
G + + D GL+ A L + GT E++APEV +E Y + VD +S G+ + E
Sbjct: 131 AT-GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFE 189
Query: 217 MVTFDYP-YSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLA-----TVSSR 268
M P Y+E T Q+Y+ + GK P+ + E RQF++ L + +
Sbjct: 190 MCCGWSPFYAEDTQ--QMYRNIAFGKVRFPKNVLSDEG---RQFVKGLLNRNPQHRLGAH 244
Query: 269 LSARELLTDPFLQIDDYD 286
A EL PF D+D
Sbjct: 245 RDAVELKEHPFFADIDWD 262
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 51/189 (26%), Positives = 85/189 (44%), Gaps = 56/189 (29%)
Query: 148 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-------------------------- 181
IHRD+K DN+ ++ +G +K+ D GL L+KSH
Sbjct: 123 IHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSS 181
Query: 182 --------------AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--Y 224
A VGTP+++APEV+ + YN+ D +S G+ + EM+ YP
Sbjct: 182 KRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV-GYPPFC 240
Query: 225 SECTHPAQIYKKVISGKKPEALFKVED----PEVRQFIEKCLATVSSRL---SARELLTD 277
S+ +P + Y+K+I+ K E L ++ PE + I++ RL E+ +
Sbjct: 241 SD--NPQETYRKIINWK--ETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSH 296
Query: 278 PFLQIDDYD 286
PF + D++
Sbjct: 297 PFFKGVDWE 305
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 38/128 (29%), Positives = 69/128 (53%), Gaps = 5/128 (3%)
Query: 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 160
F+ ++ G L + +H + + ++ + +I+ GL ++H+R V++RDLK NI ++
Sbjct: 74 FILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLD 131
Query: 161 GNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMV 218
G V+I DLGLA K VGT +MAPEV ++ Y+ D +S G + +++
Sbjct: 132 -EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190
Query: 219 TFDYPYSE 226
P+ +
Sbjct: 191 RGHSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 65/248 (26%), Positives = 118/248 (47%), Gaps = 25/248 (10%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN------INFVTEMFTSGTLRQYR 115
S + R E+ L +I+K + + RN I V + +G LRQ
Sbjct: 71 SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQ-E 129
Query: 116 LKHRRVNIRA-VKHWCR----QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 170
+K R R +H Q+L + ++HS+ +IHRD+K NI + N G VK+GD
Sbjct: 130 IKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSN-GLVKLGD 186
Query: 171 LGL----AAILRKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYS 225
G AA + GTP ++APE++ + Y++ D++S G+ + E++T P+
Sbjct: 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF- 245
Query: 226 ECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDD 284
+ + ++ K ++G+ + L PE+++ + L++ R S+ +LL P ++
Sbjct: 246 DGENMEEVMHKTLAGRY-DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL-- 302
Query: 285 YDSDLRMI 292
+ S L I
Sbjct: 303 FISGLLEI 310
|
Length = 496 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 60/265 (22%), Positives = 99/265 (37%), Gaps = 63/265 (23%)
Query: 84 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR 143
++K Y S+ D N + FV + G + ++ + + ++ + +H
Sbjct: 63 VVKLYYSFQDKDN--LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM 120
Query: 144 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA-------------------- 183
IHRD+K DNI ++ G +K+ D GL R +H +
Sbjct: 121 G--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177
Query: 184 --------------------RC-----VGTPEFMAPEVYEEE-YNELVDIYSFGMCILEM 217
RC VGTP ++APEV Y +L D +S G+ + EM
Sbjct: 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237
Query: 218 VTFDYPYSECTHPAQIYKKVISGKK-----PEALFKVEDPEVRQFIEKCLATVSSRL--- 269
+ P+ T PA+ KVI+ + +A E I + RL
Sbjct: 238 LVGQPPFLADT-PAETQLKVINWETTLHIPSQAKLS---REASDLILRLCCGAEDRLGKN 293
Query: 270 SARELLTDPFLQIDDYDSDLRMIQY 294
A E+ PF + D+ S +R +
Sbjct: 294 GADEIKAHPFFKGIDFASLIRRQKA 318
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 33/96 (34%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA--ILRKSHAARCVGTP 189
+I GL +LHS+ +I+RDLK DN+ ++ +G +KI D G+ I GTP
Sbjct: 109 EIAIGLFFLHSKG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGGKTTRTFCGTP 165
Query: 190 EFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDYPY 224
+++APE + + Y + VD ++FG+ + EM+ P+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 70/270 (25%), Positives = 113/270 (41%), Gaps = 52/270 (19%)
Query: 55 KLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR-NINFVTEMFTSGTLRQ 113
K+ + Q+ +R++ E+ +L KH N++ S +D +I+ E++ L Q
Sbjct: 32 KMPNVFQNLVSCKRVFRELKMLCFFKHDNVL----SALDILQPPHIDPFEEIYVVTELMQ 87
Query: 114 YRL-----KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 168
L + ++ VK + QIL GL YLHS ++HRD+K N+ VN N +KI
Sbjct: 88 SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSN-CVLKI 144
Query: 169 GDLGLAAI--LRKS-HAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCI--------- 214
D GLA + +S H + V T + APE+ Y VDI+S G CI
Sbjct: 145 CDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVG-CIFAELLGRRI 203
Query: 215 ----------LEMVTFDY----PYSECTHPAQIYKKVI--SGKKPEA---LFKVEDP--- 252
L+++T D + + I KP + L+ +
Sbjct: 204 LFQAQSPIQQLDLIT-DLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATH 262
Query: 253 EVRQFIEKCLA-TVSSRLSARELLTDPFLQ 281
E + + L R+SA + L P+L
Sbjct: 263 EAVHLLCRMLVFDPDKRISAADALAHPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 7/169 (4%)
Query: 64 EELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI 123
+E+ E +L+ +H + S+ T +R + FV E G L + + R +
Sbjct: 37 DEVAHTLTENRVLQNSRHPFLTALKYSF-QTHDR-LCFVMEYANGGELFFHLSRERVFSE 94
Query: 124 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSH 181
+ + +I+S L YLHS + V++RDLK +N+ ++ + G +KI D GL I +
Sbjct: 95 DRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGAT 152
Query: 182 AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTH 229
GTPE++APEV E+ +Y VD + G+ + EM+ P+ H
Sbjct: 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 59/247 (23%), Positives = 109/247 (44%), Gaps = 51/247 (20%)
Query: 84 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR 143
++K + S+ D RN+ + E G + +K ++ A + + + + + +H
Sbjct: 63 VVKMFYSFQD--KRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 144 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH---------------------- 181
IHRD+K DN+ ++ +G VK+ D GL L+K+H
Sbjct: 121 G--FIHRDIKPDNLLLDA-KGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 182 ---------------AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYS 225
A VGTP+++APEV+ + YN+L D +S G+ + EM+ P+
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 226 ECTHPAQIYKKVISGKKPEALFKVEDP---EVRQFIEKCLATVSSRL---SARELLTDPF 279
T P + Y+KV++ K+ +F E P + + I + +R+ E+ + PF
Sbjct: 238 SET-PQETYRKVMNWKE-TLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPF 295
Query: 280 LQIDDYD 286
+ D+
Sbjct: 296 FEGVDWG 302
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 33/207 (15%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNIN---FVTE-MFTSGTLRQYRLKHRRVNIRAVK 127
EI LL+ L H N++ N V E M T L Q + ++ +
Sbjct: 54 EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTD--LHQIIRSSQTLSDDHCQ 111
Query: 128 HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG 187
++ Q+L GL Y+HS + V+HRDLK N+ +N N ++KI D GLA R +
Sbjct: 112 YFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNAN-CDLKICDFGLA---RTTSE----- 160
Query: 188 TPEFM----------APEVY--EEEYNELVDIYSFGMCIL-EMVTFD--YPYSECTHPAQ 232
+FM APE+ EY +D++S G CI E++ +P + H +
Sbjct: 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVG-CIFAELLGRKPLFPGKDYVHQLK 219
Query: 233 IYKKVISGKKPEALFKVEDPEVRQFIE 259
+ +++ E L + + + R++I
Sbjct: 220 LITELLGSPSEEDLGFIRNEKARRYIR 246
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 70/233 (30%), Positives = 104/233 (44%), Gaps = 27/233 (11%)
Query: 40 AFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN--- 96
AFD GI VA KL Q+ +R Y E+ LLK + H+NI+ + +
Sbjct: 40 AFDTVLGINVAVK--KLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97
Query: 97 -RNINFVTEMFTSGTLR--QYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 153
+++ V E+ + + L H R++ + Q+L G+ +LHS +IHRDLK
Sbjct: 98 FQDVYLVMELMDANLCQVIHMELDHERMS-----YLLYQMLCGIKHLHSAG--IIHRDLK 150
Query: 154 CDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP-----EFMAPEV-YEEEYNELVDI 207
NI V + +KI D GLA ++ + TP + APEV Y E VDI
Sbjct: 151 PSNIVVKSD-CTLKILDFGLA----RTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDI 205
Query: 208 YSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE-DPEVRQFIE 259
+S G + E+V + H Q K + P A F P VR ++E
Sbjct: 206 WSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVE 258
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 45/133 (33%), Positives = 67/133 (50%), Gaps = 14/133 (10%)
Query: 124 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 183
RAV + +I GL LH +++RDLK +NI ++ + G ++I DLGLA + +
Sbjct: 103 RAV-FYAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETI 158
Query: 184 RC-VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 241
R VGT +MAPEV + E Y D + G I EM+ E P + K+ + +
Sbjct: 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMI-------EGKSPFRQRKEKVKRE 211
Query: 242 KPEALFKVEDPEV 254
+ E K ED E
Sbjct: 212 EVERRVK-EDQEE 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 76/245 (31%), Positives = 110/245 (44%), Gaps = 51/245 (20%)
Query: 40 AFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99
A+D G VA KL Q+ +R Y E+ L+K + H+NI+ V T +++
Sbjct: 35 AYDTVTGQNVAIK--KLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLN--VFTPQKSL 90
Query: 100 N------FVTEMFTSGTLR--QYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 151
V E+ + + Q L H R++ + Q+L G+ +LHS +IHRD
Sbjct: 91 EEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQMLCGIKHLHSAG--IIHRD 143
Query: 152 LKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFM-----------APEV-YEE 199
LK NI V + +KI D GL AR GT FM APEV
Sbjct: 144 LKPSNIVVKSD-CTLKILDFGL---------ARTAGT-SFMMTPYVVTRYYRAPEVILGM 192
Query: 200 EYNELVDIYSFGMCIL-EMV--TFDYPYSECTHPAQIYKKVIS--GKKPEALFKVEDPEV 254
Y E VDI+S G CI+ EM+ T +P ++ H Q + K+I G + P V
Sbjct: 193 GYKENVDIWSVG-CIMGEMIRGTVLFPGTD--HIDQ-WNKIIEQLGTPSDEFMSRLQPTV 248
Query: 255 RQFIE 259
R ++E
Sbjct: 249 RNYVE 253
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 40/133 (30%), Positives = 69/133 (51%), Gaps = 10/133 (7%)
Query: 99 INFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
+ VT++ G L Y +++ R+ + + +WC QI G+ YL + ++HRDL N+
Sbjct: 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL--EEVRLVHRDLAARNV 140
Query: 158 FVNGNQGEVKIGDLGLAAIL----RKSHAARCVGTPEFMAPE-VYEEEYNELVDIYSFGM 212
V + VKI D GLA +L + HA ++MA E + + D++S+G+
Sbjct: 141 LVK-SPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGV 199
Query: 213 CILEMVTFDY-PY 224
+ E++TF PY
Sbjct: 200 TVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 43/170 (25%), Positives = 84/170 (49%), Gaps = 7/170 (4%)
Query: 58 DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK 117
+ + E+++ + E H+ + + + S T +R + FV E G L + +
Sbjct: 31 ELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQR 89
Query: 118 HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--A 175
R++ + + +I L YLH R +I+RDLK DN+ ++ ++G +K+ D G+
Sbjct: 90 QRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEG 146
Query: 176 ILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPY 224
+ + GTP ++APE+ E+Y VD ++ G+ + EM+ P+
Sbjct: 147 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 49/154 (31%), Positives = 72/154 (46%), Gaps = 14/154 (9%)
Query: 72 EIHLLKTLK-HRNIMKFY-TSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHW 129
E+ LL+ + H+NI Y V N N ++ E L Q + + + +
Sbjct: 51 ELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSF 110
Query: 130 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA------AILRKSHAA 183
QIL GL Y+HS + V+HRDLK N+ VN + E+KI D GLA
Sbjct: 111 IYQILCGLKYIHSAN--VLHRDLKPGNLLVNAD-CELKICDFGLARGFSENPGENAGFMT 167
Query: 184 RCVGTPEFMAPEVY--EEEYNELVDIYSFGMCIL 215
V T + APE+ + Y + +D++S G CIL
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVG-CIL 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 48/156 (30%), Positives = 81/156 (51%), Gaps = 19/156 (12%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----RRVNIRAVK 127
E LLK LKH NI+ + + + FV E + L QY ++H N+R
Sbjct: 53 EASLLKGLKHANIVLLHD--IIHTKETLTFVFE-YMHTDLAQYMIQHPGGLHPYNVRL-- 107
Query: 128 HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAAR 184
+ Q+L GL Y+H + ++HRDLK N+ ++ GE+K+ D GLA +I +++++
Sbjct: 108 -FMFQLLRGLAYIHGQH--ILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSE 163
Query: 185 CVGTPEFMAPEVY--EEEYNELVDIYSFGMCILEMV 218
V T + P+V +Y+ +DI+ G +EM+
Sbjct: 164 VV-TLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 9e-10
Identities = 53/170 (31%), Positives = 80/170 (47%), Gaps = 40/170 (23%)
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA--------- 182
+I + + Y+HS+ V+HRDLK DNI + G GEV I D G AAI +K
Sbjct: 121 KICATIEYVHSKG--VLHRDLKPDNILL-GLFGEVVILDWG-AAIFKKLEEEDLLDIDVD 176
Query: 183 ------------ARCVGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDYPYSECTH 229
+ VGTP++MAPE + +E DIY+ G+ + +M+T +PY
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR--- 233
Query: 230 PAQIYKKVISGKKPEALFKVEDP-EVRQFIEKCLATVSSRLSARELLTDP 278
KK G+K + P EV + E + S+++ + L DP
Sbjct: 234 -----KK---GRKISYRDVILSPIEVAPYRE--IPPFLSQIAMKALAVDP 273
|
Length = 932 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 52/229 (22%), Positives = 100/229 (43%), Gaps = 37/229 (16%)
Query: 66 LERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA 125
+ E+ LK L+H++++ + V + + +TE+ G+L + L+ +
Sbjct: 46 QQDFQKEVQALKRLRHKHLISLFA--VCSVGEPVYIITELMEKGSLLAF-LRSPEGQVLP 102
Query: 126 VKH---WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-H 181
V Q+ G+ YL ++ IHRDL NI V G K+ D GLA ++++ +
Sbjct: 103 VASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILV-GEDLVCKVADFGLARLIKEDVY 159
Query: 182 AARCVGTP-EFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPA----QIYK 235
+ P ++ APE ++ D++SFG+ + EM T Y + +P ++Y
Sbjct: 160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT----YGQVPYPGMNNHEVYD 215
Query: 236 KVISG-------KKPEALFKV------EDPEVRQFIEKCLATVSSRLSA 271
++ +G K P+ ++K+ +PE R + L
Sbjct: 216 QITAGYRMPCPAKCPQEIYKIMLECWAAEPEDR----PSFKALREELDN 260
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 53/166 (31%), Positives = 83/166 (50%), Gaps = 19/166 (11%)
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTP 189
+I L +LH + +I+RDLK +NI ++ QG VK+ D GL +I + GT
Sbjct: 108 EISLALEHLHQQG--IIYRDLKPENILLDA-QGHVKLTDFGLCKESIHEGTVTHTFCGTI 164
Query: 190 EFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEAL 246
E+MAPE+ + + VD +S G + +M+T P++ I K++ GK P L
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI-DKILKGKLNLPPYL 223
Query: 247 FKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDYD 286
PE R ++K L SSRL A E+ + PF + ++D
Sbjct: 224 ----TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWD 265
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 1e-09
Identities = 60/183 (32%), Positives = 89/183 (48%), Gaps = 31/183 (16%)
Query: 55 KLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTA--NRNINFVTE-MFT--S 108
K++D ++ + +R + EI L+ L H NI+K V A +++I V E M T
Sbjct: 39 KIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLN--VIKAENDKDIYLVFEYMETDLH 96
Query: 109 GTLRQYRLK--HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV 166
+R L+ H+R + Q+L L Y+HS + VIHRDLK NI +N + V
Sbjct: 97 AVIRANILEDVHKRYIM-------YQLLKALKYIHSGN--VIHRDLKPSNILLNSD-CRV 146
Query: 167 KIGDLGLAAILRKSHAARC-------VGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-E 216
K+ D GLA L + V T + APE+ Y + VD++S G CIL E
Sbjct: 147 KLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVG-CILGE 205
Query: 217 MVT 219
M+
Sbjct: 206 MLL 208
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 55/181 (30%), Positives = 92/181 (50%), Gaps = 19/181 (10%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY---RLK-HRRVNIRAVK 127
E+H L H I+K + + ++ + + E + G L + RLK H V
Sbjct: 115 ELHCLAACDHFGIVKHFDDF--KSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 128 HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AA 183
QI+ L +HSR ++HRDLK NIF+ G +K+GD G + S A+
Sbjct: 173 LLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPT-GIIKLGDFGFSKQYSDSVSLDVAS 229
Query: 184 RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ--IYKKVISG 240
GTP ++APE++E + Y++ D++S G+ + E++T P+ P+Q I ++V+ G
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK---GPSQREIMQQVLYG 286
Query: 241 K 241
K
Sbjct: 287 K 287
|
Length = 478 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 38/127 (29%), Positives = 65/127 (51%), Gaps = 6/127 (4%)
Query: 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 160
FV E G L + R + +I GL +LHS+ +I+RDLK DN+ ++
Sbjct: 78 FVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD 135
Query: 161 GNQGEVKIGDLGLAA--ILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEM 217
++G +KI D G+ + GTP+++APE+ + Y + VD ++FG+ + EM
Sbjct: 136 -SEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 194
Query: 218 VTFDYPY 224
+ P+
Sbjct: 195 LAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 27/208 (12%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH---RRVNIRAVKH 128
E +L+K L+H +++ Y I +TE +G+L + LK ++ I +
Sbjct: 51 EANLMKQLQHPRLVRLYAV---VTQEPIYIITEYMENGSLVDF-LKTPEGIKLTINKLID 106
Query: 129 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT 188
QI G+ ++ ++ IHRDL+ NI V+ KI D GLA ++ + G
Sbjct: 107 MAAQIAEGMAFIERKN--YIHRDLRAANILVS-ETLCCKIADFGLARLIEDNEYTAREGA 163
Query: 189 P---EFMAPEVYE-EEYNELVDIYSFGMCILEMVTFD-YPYSECTHPAQI------YKKV 237
++ APE + D++SFG+ + E+VT+ PY T+P I Y+
Sbjct: 164 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP 223
Query: 238 ISGKKPEALFKV------EDPEVRQFIE 259
PE L+++ E PE R E
Sbjct: 224 RPDNCPEELYELMRLCWKEKPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 64/224 (28%), Positives = 95/224 (42%), Gaps = 37/224 (16%)
Query: 55 KLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN----RNINFVTEMFTSGT 110
KL Q+ +R Y E+ L+K + H+NI+ + + +++ V E+ +
Sbjct: 56 KLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL 115
Query: 111 LR--QYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 168
+ Q L H R++ + Q+L G+ +LHS +IHRDLK NI V + +KI
Sbjct: 116 CQVIQMELDHERMS-----YLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKI 167
Query: 169 GDLGLAAILRKSHAARCVGTPEFMAPEVYEEE-----------YNELVDIYSFGMCILEM 217
D GL AR GT M P V Y E VDI+S G + EM
Sbjct: 168 LDFGL---------ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 218 VTFDYPYSECTHPAQIYKKVIS--GKKPEALFKVEDPEVRQFIE 259
+ + H Q + KVI G K P VR ++E
Sbjct: 219 IKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMKKLQPTVRTYVE 261
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 47/152 (30%), Positives = 73/152 (48%), Gaps = 9/152 (5%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCR 131
EI +LK L+H N++ V + + V E L ++ V+ +
Sbjct: 50 EIRMLKQLRHENLVNLIE--VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLF 107
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTP 189
QIL G+ + HS + +IHRD+K +NI V+ + G VK+ D G A L V T
Sbjct: 108 QILRGIEFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYTDYVATR 164
Query: 190 EFMAPE--VYEEEYNELVDIYSFGMCILEMVT 219
+ APE V + +Y VDI++ G + EM+T
Sbjct: 165 WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 18/154 (11%)
Query: 148 IHRDLKCDNIFVNGNQGEVKIGDLGLAAIL---RKSHAARCVGTPEFMAPEVYEE----- 199
+HRD+K +N+ ++ G +K+ D G AA L + ++ VGTP+++APEV
Sbjct: 124 VHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 200 --EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEV--- 254
Y D +S G+ EM+ P+ E T A+ Y +++ + L EDP+V
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFHEGT-SAKTYNNIMNFQ--RFLKFPEDPKVSSD 239
Query: 255 -RQFIEKCLATVSSRLSARELLTDPFLQIDDYDS 287
I+ L RL L PF D+++
Sbjct: 240 FLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNN 273
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 46/152 (30%), Positives = 76/152 (50%), Gaps = 10/152 (6%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCR 131
E H+L+ + H +I++ ++ T N+ + + + L Y R + I + R
Sbjct: 133 EAHILRAINHPSIIQLKGTF--TYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIER 189
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR---CVGT 188
+L + YLH +IHRD+K +NIF+N + G+V +GD G A +A + GT
Sbjct: 190 SVLRAIQYLHENR--IIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINANKYYGWAGT 246
Query: 189 PEFMAPEVYEEE-YNELVDIYSFGMCILEMVT 219
APE+ + Y VDI+S G+ + EM T
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-09
Identities = 35/91 (38%), Positives = 51/91 (56%), Gaps = 8/91 (8%)
Query: 131 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR----CV 186
RQ+LS + Y+H +IHRD+K +N+ VNG + ++ +GD G A R S +
Sbjct: 267 RQLLSAIDYIHGEG--IIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHYGIA 323
Query: 187 GTPEFMAPEVYE-EEYNELVDIYSFGMCILE 216
GT + APEV + Y VDI+S G+ I E
Sbjct: 324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-09
Identities = 56/185 (30%), Positives = 88/185 (47%), Gaps = 22/185 (11%)
Query: 53 QVKLYDFLQSPEELERLYCEIHLLKTLKHRNIM----KFYTSWVDTANRNI--NFVTEMF 106
+V + LQ P+ R E+ ++K L H NI+ +YT +NI N V E F
Sbjct: 93 KVAIKKVLQDPQYKNR---ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVME-F 148
Query: 107 TSGTLRQYRLKHRRVNIRA-----VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 161
T+ +Y +KH N A VK + Q+ L Y+HS+ + HRDLK N+ ++
Sbjct: 149 IPQTVHKY-MKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDP 205
Query: 162 NQGEVKIGDLGLAA-ILRKSHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCILEMV 218
N +K+ D G A +L + + + + APE+ Y +D++S G I EM+
Sbjct: 206 NTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
Query: 219 TFDYP 223
YP
Sbjct: 266 -LGYP 269
|
Length = 440 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 6/127 (4%)
Query: 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 160
FV E + G L + + R++ + + +I L +LH R +I+RDLK DN+ ++
Sbjct: 73 FVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLD 130
Query: 161 GNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEM 217
+G +K+ D G+ I + GTP ++APE+ E+Y VD ++ G+ + EM
Sbjct: 131 A-EGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 189
Query: 218 VTFDYPY 224
+ P+
Sbjct: 190 MAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 43/178 (24%), Positives = 88/178 (49%), Gaps = 8/178 (4%)
Query: 64 EELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI 123
++++ ++ E +L + H + Y S+ D + + V E G + +++R
Sbjct: 73 KQVDHVFSERKILNYINHPFCVNLYGSFKDESY--LYLVLEFVIGGEFFTFLRRNKRFPN 130
Query: 124 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 183
+ QI+ YL S + +++RDLK +N+ ++ + G +K+ D G A ++
Sbjct: 131 DVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKD-GFIKMTDFGFAKVVDTRTYT 187
Query: 184 RCVGTPEFMAPEV-YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 240
C GTPE++APE+ + + D ++ G+ I E++ P+ P IY+K++ G
Sbjct: 188 LC-GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFY-ANEPLLIYQKILEG 243
|
Length = 340 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 38/142 (26%), Positives = 72/142 (50%), Gaps = 7/142 (4%)
Query: 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 160
V G L + + R ++ + + ++L L LH + VI+RDLK +NI ++
Sbjct: 70 LVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD 127
Query: 161 GNQGEVKIGDLGLAAI-LRKSHAARC-VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEM 217
QG + + D GL + ++ GTPE++APE+ Y + VD ++ G+ + EM
Sbjct: 128 -YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEM 186
Query: 218 VTFDYPYSECTHPAQIYKKVIS 239
+T P+ + ++Y+K++
Sbjct: 187 LTGLPPFYDENVN-EMYRKILQ 207
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 7e-09
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 65 ELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIR 124
E+E E ++K +KH N+++ V T +TE T G L Y + R +
Sbjct: 45 EVEEFLKEAAVMKEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVN 102
Query: 125 AVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 182
AV + QI S + YL ++ IHRDL N V G VK+ D GL+ ++
Sbjct: 103 AVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTY 159
Query: 183 ARCVGTP---EFMAPEVYEEEYNEL---VDIYSFGMCILEMVTFD---YPYSECTHPAQI 233
G ++ APE YN+ D+++FG+ + E+ T+ YP + + ++
Sbjct: 160 TAHAGAKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 217
Query: 234 YKKVISGKKPEALFKVEDPEVRQFIEKC 261
+K ++PE P+V + + C
Sbjct: 218 LEKGYRMERPEGC----PPKVYELMRAC 241
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 62/191 (32%), Positives = 90/191 (47%), Gaps = 18/191 (9%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYC--EIHLLKTLK---HRNIMKFYTSWV 92
Y+A D + G VA V++ Q+ E+ L E+ LLK L+ H NI++
Sbjct: 17 YKARDPHSGHFVALKSVRV----QTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCA 72
Query: 93 DTANRNINFVTEMF--TSGTLRQY--RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVI 148
+ VT +F LR Y ++ + +K RQ L GL +LH+ ++
Sbjct: 73 TSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN--CIV 130
Query: 149 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-ARCVGTPEFMAPEV-YEEEYNELVD 206
HRDLK +NI V + G+VK+ D GLA I A V T + APEV + Y VD
Sbjct: 131 HRDLKPENILVT-SGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVD 189
Query: 207 IYSFGMCILEM 217
++S G EM
Sbjct: 190 MWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 36/102 (35%), Positives = 59/102 (57%), Gaps = 6/102 (5%)
Query: 126 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAA 183
VK + ++ L +LHS +I+RDLK +NI ++ +G +K+ D GL+ +I + A
Sbjct: 100 VKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAY 156
Query: 184 RCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPY 224
GT E+MAPEV + + D +SFG+ + EM+T P+
Sbjct: 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 49/189 (25%), Positives = 84/189 (44%), Gaps = 21/189 (11%)
Query: 43 EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 102
+Y G +VA +K + E ++ TL+H N+++ V + V
Sbjct: 26 DYRGQKVAVKCLK-----DDSTAAQAFLAEASVMTTLRHPNLVQLLG--VVLQGNPLYIV 78
Query: 103 TEMFTSGTLRQY-RLKHRRVNIRAVKH-WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 160
TE G+L Y R + R V A + + + G+ YL ++ +HRDL N+ V+
Sbjct: 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVS 136
Query: 161 GNQGEVKIGDLGLAAILRKSHAARCVGT-P-EFMAPEVYEE-EYNELVDIYSFGMCILEM 217
K+ D GLA + G P ++ APE E +++ D++SFG+ + E+
Sbjct: 137 -EDLVAKVSDFGLAKEASQGQD---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192
Query: 218 VTFD---YP 223
+F YP
Sbjct: 193 YSFGRVPYP 201
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 65/215 (30%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 55 KLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN----RNINFVTEMFTSGT 110
KL Q+ +R Y E+ L+K + H+NI+ + + +++ V E+ +
Sbjct: 49 KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANL 108
Query: 111 LR--QYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 168
+ Q L H R++ + Q+L G+ +LHS +IHRDLK NI V + +KI
Sbjct: 109 CQVIQMELDHERMS-----YLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKI 160
Query: 169 GDLGLAAILRKSHAAR-CVGTPEFMAPEV-YEEEYNELVDIYSFGMCILEMVTFDYPYSE 226
D GLA S V T + APEV Y E VDI+S G + EMV +
Sbjct: 161 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220
Query: 227 CTHPAQIYKKVIS--GKKPEALFKVEDPEVRQFIE 259
+ Q + KVI G K P VR ++E
Sbjct: 221 RDYIDQ-WNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 39/131 (29%), Positives = 67/131 (51%), Gaps = 14/131 (10%)
Query: 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 160
FV E G L + + + + +I GL +LH R +I+RDLK DN+ ++
Sbjct: 78 FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLD 135
Query: 161 GNQGEVKIGDLGLAAILRKSHAARCV------GTPEFMAPEVYE-EEYNELVDIYSFGMC 213
++G +KI D G+ K H V GTP+++APE+ + Y + VD +++G+
Sbjct: 136 -SEGHIKIADFGMC----KEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVL 190
Query: 214 ILEMVTFDYPY 224
+ EM+ P+
Sbjct: 191 LYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 28/214 (13%)
Query: 63 PEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRV 121
P+ + E +LK H NI+K V + I V E+ G+L + R K R+
Sbjct: 33 PDLKRKFLQEAEILKQYDHPNIVKLIG--VCVQKQPIYIVMELVPGGSLLTFLRKKKNRL 90
Query: 122 NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-----AI 176
++ + +G+ YL S++ IHRDL N V G +KI D G++ I
Sbjct: 91 TVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLV-GENNVLKISDFGMSREEEGGI 147
Query: 177 LRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIY 234
S + + ++ APE Y D++S+G+ + E + D PY ++ Q
Sbjct: 148 YTVSDGLKQIPI-KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-QQTR 205
Query: 235 KKVISGKK-------PEALFKV------EDPEVR 255
+++ SG + PE ++++ DPE R
Sbjct: 206 ERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENR 239
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 42/170 (24%), Positives = 81/170 (47%), Gaps = 7/170 (4%)
Query: 58 DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK 117
+ + E+++ + E H+ + + S T +R + V E G L + +
Sbjct: 31 ELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSR-LFLVIEYVNGGDLMFHMQR 89
Query: 118 HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--A 175
R++ + + +I L +LH R +I+RDLK DN+ ++ + G +K+ D G+
Sbjct: 90 QRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDAD-GHIKLTDYGMCKEG 146
Query: 176 ILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPY 224
+ + GTP ++APE+ EEY VD ++ G+ + EM+ P+
Sbjct: 147 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 69/310 (22%), Positives = 140/310 (45%), Gaps = 40/310 (12%)
Query: 12 PSLLKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEV----AWNQVKLYDFLQSPEELE 67
P+L K +++ + + +V+++++ ++Y+ ++V A+ +V+L S +
Sbjct: 13 PALRKNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYA 72
Query: 68 -RLYCEIHLLKT------LKHRNIMKFYTS-WVDTA------NRNINFVTEMFTSGTLRQ 113
+L + ++K + R+IM F S WV ++ + V E G L
Sbjct: 73 MKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN 132
Query: 114 YRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 173
+ + V + K + +++ L +HS +IHRD+K DN+ ++ G +K+ D G
Sbjct: 133 L-MSNYDVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLD-KHGHLKLADFGT 188
Query: 174 AAILRKSHAARC---VGTPEFMAPEVYEEE-----YNELVDIYSFGMCILEMVTFDYPYS 225
+ ++ RC VGTP++++PEV + + Y D +S G+ + EM+ D P+
Sbjct: 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248
Query: 226 ECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSAR-------ELLTDP 278
Y K++ K +L ED E+ + + + + R E+ P
Sbjct: 249 -ADSLVGTYSKIMDHKN--SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305
Query: 279 FLQIDDYDSD 288
F + D ++ D
Sbjct: 306 FFKNDQWNWD 315
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 60/232 (25%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 40 AFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR-- 97
A D + G +VA K+ D + + R+ EI LL+ L+H +I++ + + R
Sbjct: 19 AIDTHTGEKVAIK--KINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 76
Query: 98 -NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
+I V E+ S L Q + + + + Q+L L Y+H+ + V HRDLK N
Sbjct: 77 KDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKN 133
Query: 157 IFVNGNQGEVKIGDLGLAAILRKSHAARC-----VGTPEFMAPEV---YEEEYNELVDIY 208
I N + ++KI D GLA + V T + APE+ + +Y +DI+
Sbjct: 134 ILANAD-CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 192
Query: 209 SFGMCILEMVTFD--YPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 258
S G E++T +P H + ++ PE + +V + + R+++
Sbjct: 193 SIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYL 244
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 48/170 (28%), Positives = 75/170 (44%), Gaps = 26/170 (15%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH------------R 119
E LL L+H +I+KFY D + V E G L ++ H R
Sbjct: 57 EAELLTNLQHEHIVKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 114
Query: 120 RVN----IRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175
+ + + H QI SG++YL S+ +HRDL N V G VKIGD G++
Sbjct: 115 QAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLV-GANLLVKIGDFGMSR 171
Query: 176 ILRKSHAARCVGTP----EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF 220
+ + R G +M PE + ++ D++SFG+ + E+ T+
Sbjct: 172 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 39/143 (27%), Positives = 75/143 (52%), Gaps = 11/143 (7%)
Query: 98 NINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
++ VT++ G+L + +HR ++ + + +WC QI G+ YL ++HR+L N
Sbjct: 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARN 139
Query: 157 IFVNGNQGEVKIGDLGLAAIL---RKSHAARCVGTP-EFMAPE-VYEEEYNELVDIYSFG 211
I + + V+I D G+A +L K + TP ++MA E + Y D++S+G
Sbjct: 140 ILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYG 198
Query: 212 MCILEMVTFDY-PYSECTHPAQI 233
+ + EM+++ PY+ P ++
Sbjct: 199 VTVWEMMSYGAEPYAG-MRPHEV 220
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 47/161 (29%), Positives = 79/161 (49%), Gaps = 14/161 (8%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR---RVNIRAVKH 128
E +L+KTL+H +++ Y V T I +TE G+L + LK +V + +
Sbjct: 51 EANLMKTLQHDKLVRLYA--VVTKEEPIYIITEYMAKGSLLDF-LKSDEGGKVLLPKLID 107
Query: 129 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT 188
+ QI G+ Y+ ++ IHRDL+ N+ V+ KI D GLA ++ + G
Sbjct: 108 FSAQIAEGMAYIERKN--YIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREGA 164
Query: 189 P---EFMAPEVYE-EEYNELVDIYSFGMCILEMVTF-DYPY 224
++ APE + D++SFG+ + E+VT+ PY
Sbjct: 165 KFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 58/186 (31%), Positives = 91/186 (48%), Gaps = 14/186 (7%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y+ + G VA ++L + +P R E LLK LKH NI+ + +
Sbjct: 22 YKGKSKVNGKLVALKVIRLQEEEGTPFTAIR---EASLLKGLKHANIVLLHD--IIHTKE 76
Query: 98 NINFVTEMFTSGTLRQYRLKHRR-VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
+ V E + L QY KH ++ VK + Q+L GL Y+H R ++HRDLK N
Sbjct: 77 TLTLVFE-YVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR--YILHRDLKPQN 133
Query: 157 IFVNGNQGEVKIGDLGLA-AILRKSHA-ARCVGTPEFMAPEVY--EEEYNELVDIYSFGM 212
+ ++ + GE+K+ D GLA A SH + V T + P+V EY+ +D++ G
Sbjct: 134 LLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGC 192
Query: 213 CILEMV 218
+EM+
Sbjct: 193 IFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 45/160 (28%), Positives = 76/160 (47%), Gaps = 19/160 (11%)
Query: 80 KHRNIMKFYTS-WVDTA------NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQ 132
+ R+IM F S WV +R + V E G L + + V + + + +
Sbjct: 92 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNL-MSNYDVPEKWARFYTAE 150
Query: 133 ILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC---VGTP 189
++ L +HS IHRD+K DN+ ++ G +K+ D G + K RC VGTP
Sbjct: 151 VVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 207
Query: 190 EFMAPEVYEEE-----YNELVDIYSFGMCILEMVTFDYPY 224
++++PEV + + Y D +S G+ + EM+ D P+
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 46/153 (30%), Positives = 69/153 (45%), Gaps = 15/153 (9%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGT--LRQYRLKHRRVNIRAVKHW 129
EI +LKT+ HR I+ A R + V + L Y + + +
Sbjct: 136 EIDILKTISHRAIINLIH-----AYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITI 190
Query: 130 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-HAARC--- 185
R++L L YLH R +IHRD+K +NIF++ +GD G A L +C
Sbjct: 191 QRRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTPQCYGW 247
Query: 186 VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEM 217
GT E +PE+ + Y DI+S G+ + EM
Sbjct: 248 SGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 45/166 (27%), Positives = 73/166 (43%), Gaps = 25/166 (15%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFT---------SGTLRQYRLKHRRVN 122
EI +L+ LKH N++ A + + +G L +K
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE 120
Query: 123 IRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA--ILRKS 180
I+ V + +L+GL Y+H ++HRD+K NI + + G +K+ D GLA L K+
Sbjct: 121 IKKV---MKMLLNGLYYIHRNK--ILHRDMKAANILITKD-GILKLADFGLARAFSLSKN 174
Query: 181 HAARC----VGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EMVT 219
V T + PE+ E +Y +D++ G CI+ EM T
Sbjct: 175 SKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAG-CIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 22/167 (13%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRA---- 125
EI LL+ LKH N++ ++ A+R + + + + L HR + N +
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFD-YAEHDLWHIIKFHRASKANKKPVQLP 106
Query: 126 ---VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG---NQGEVKIGDLGLAAILRK 179
VK QIL G+ YLH+ V+HRDLK NI V G +G VKI D+G A +
Sbjct: 107 RGMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 180 -----SHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCILEMVT 219
+ V T + APE+ Y + +DI++ G E++T
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 8e-08
Identities = 44/157 (28%), Positives = 74/157 (47%), Gaps = 21/157 (13%)
Query: 148 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC---VGTPEFMAPEVYEE----- 199
IHRD+K DN+ ++ + G +K+ D G + + RC VGTP++++PEV +
Sbjct: 164 IHRDVKPDNMLLDKS-GHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 200 EYNELVDIYSFGMCILEMVTFDYP-YSECTHPAQIYKKVISGKKPEALFKVEDPEV---- 254
Y D +S G+ + EM+ D P Y++ Y K++ K +L +D E+
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTPFYADSL--VGTYSKIMDHKN--SLTFPDDIEISKQA 278
Query: 255 RQFIEKCLATVSSRL---SARELLTDPFLQIDDYDSD 288
+ I L RL E+ + PF + D + D
Sbjct: 279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTFD 315
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 17/157 (10%)
Query: 124 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 183
RAV + +I GL LH +++RDLK +NI ++ + G ++I DLGLA + +
Sbjct: 103 RAV-FYAAEICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTI 158
Query: 184 RC-VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 241
+ VGT +MAPEV + E Y D ++ G + EM+ P+ Q KK I +
Sbjct: 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF-------QQRKKKIKRE 211
Query: 242 KPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTDP 278
+ E L K E + ++ L L DP
Sbjct: 212 EVERLVKEVQEEYSEKFSPDARSLCKML----LCKDP 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 61/263 (23%), Positives = 101/263 (38%), Gaps = 63/263 (23%)
Query: 84 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR 143
++K Y S+ D N+ FV + G + ++ + + ++ + +H
Sbjct: 63 VVKLYYSFQD--KDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM 120
Query: 144 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA-------------------- 183
IHRD+K DNI ++ + G +K+ D GL R +H +
Sbjct: 121 G--FIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177
Query: 184 ------------------------RC-----VGTPEFMAPEV-YEEEYNELVDIYSFGMC 213
RC VGTP ++APEV + Y +L D +S G+
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 214 ILEMVTFDYPYSECTHPAQIYKKVISGKKP---EALFKVEDPEVRQFIEKCLATVSSRL- 269
+ EM+ P+ T P + KVI+ + K+ PE I K + RL
Sbjct: 238 LFEMLVGQPPFLAPT-PTETQLKVINWENTLHIPPQVKLS-PEAVDLITKLCCSAEERLG 295
Query: 270 --SARELLTDPFLQIDDYDSDLR 290
A ++ PF D+ SD+R
Sbjct: 296 RNGADDIKAHPFFSEVDFSSDIR 318
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 35/98 (35%), Positives = 54/98 (55%), Gaps = 5/98 (5%)
Query: 129 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC-VG 187
+ +IL GL LH + ++RDLK +NI ++ + G ++I DLGLA + + + R VG
Sbjct: 107 YAAEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVG 163
Query: 188 TPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPY 224
T +MAPEV + Y D + G I EM+ P+
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 50/205 (24%), Positives = 91/205 (44%), Gaps = 43/205 (20%)
Query: 54 VKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQ 113
VK+ S EL L E +LLK + H +++K Y + + + + + E G+LR
Sbjct: 35 VKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGAC--SQDGPLLLIVEYAKYGSLRS 92
Query: 114 YRLKHRRV------------------------NIRAVKHWCRQILSGLLYLHSRDPPVIH 149
+ + R+V + + + QI G+ YL + ++H
Sbjct: 93 FLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL--AEMKLVH 150
Query: 150 RDLKCDNIFVNGNQGEVKIGDLGLA-------AILRKSHAARCVGTPEFMAPE-VYEEEY 201
RDL N+ V + ++KI D GL+ + +++S V ++MA E +++ Y
Sbjct: 151 RDLAARNVLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPV---KWMAIESLFDHIY 206
Query: 202 NELVDIYSFGMCILEMVTFD---YP 223
D++SFG+ + E+VT YP
Sbjct: 207 TTQSDVWSFGVLLWEIVTLGGNPYP 231
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 16/164 (9%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWC 130
E ++ L H +++ Y V T I V E G L Y R + + + + C
Sbjct: 49 EAQVMMKLSHPKLVQLYG--VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMC 106
Query: 131 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP- 189
+ G+ YL S + VIHRDL N V NQ VK+ D G+ + GT
Sbjct: 107 LDVCEGMAYLESSN--VIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLDDQYTSSTGTKF 163
Query: 190 --EFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHP 230
++ +PEV+ +Y+ D++SFG+ + E+ +SE P
Sbjct: 164 PVKWSSPEVFSFSKYSSKSDVWSFGVLMWEV------FSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 21/192 (10%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH---RRVNIRAVKH 128
E +++KTL+H ++K + I +TE G+L + LK + + +
Sbjct: 51 EANVMKTLQHDKLVKLHAV---VTKEPIYIITEFMAKGSLLDF-LKSDEGSKQPLPKLID 106
Query: 129 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT 188
+ QI G+ ++ R+ IHRDL+ NI V+ + KI D GLA ++ + G
Sbjct: 107 FSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREGA 163
Query: 189 P---EFMAPE-VYEEEYNELVDIYSFGMCILEMVTFD-YPYSECTHPAQI------YKKV 237
++ APE + + D++SFG+ ++E+VT+ PY ++P I Y+
Sbjct: 164 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP 223
Query: 238 ISGKKPEALFKV 249
PE L+ +
Sbjct: 224 RPENCPEELYNI 235
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 47/177 (26%), Positives = 80/177 (45%), Gaps = 27/177 (15%)
Query: 137 LLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI--------LRKSHAAR---- 184
L YLH+ ++HRDLK DN+ + + G +K+ D GL+ I L + H +
Sbjct: 114 LEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 185 -----CVGTPEFMAPEV-YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 238
GTPE++APEV + Y + VD ++ G+ + E + P+ T P +++ +VI
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-PEELFGQVI 229
Query: 239 SG-----KKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDYDSDLR 290
S + EAL + + + + A E+ F D++ LR
Sbjct: 230 SDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLR 286
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 48/176 (27%), Positives = 75/176 (42%), Gaps = 27/176 (15%)
Query: 64 EELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY--------- 114
++ ER E LL +H NI+KFY V T V E G L ++
Sbjct: 53 KDFER---EAELLTNFQHENIVKFYG--VCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAA 107
Query: 115 -----RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIG 169
+ + + QI SG++YL S+ +HRDL N V G VKIG
Sbjct: 108 FLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLV-GYDLVVKIG 164
Query: 170 DLGLAAILRKSHAARCVGTP----EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF 220
D G++ + + R G +M PE + ++ D++SFG+ + E+ T+
Sbjct: 165 DFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTY 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 43/155 (27%), Positives = 74/155 (47%), Gaps = 14/155 (9%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH---RRVNIRAVKH 128
E ++K L+H +++ Y + I VTE + G+L + LK R + + +
Sbjct: 51 EAQIMKKLRHDKLVQLYAV---VSEEPIYIVTEYMSKGSLLDF-LKDGEGRALKLPNLVD 106
Query: 129 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT 188
Q+ +G+ Y+ + IHRDL+ NI V G+ KI D GLA ++ + G
Sbjct: 107 MAAQVAAGMAYIERMN--YIHRDLRSANILV-GDGLVCKIADFGLARLIEDNEYTARQGA 163
Query: 189 P---EFMAPE-VYEEEYNELVDIYSFGMCILEMVT 219
++ APE + D++SFG+ + E+VT
Sbjct: 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 34/213 (15%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTS-GTLRQY----RL 116
S ++ L E LL L H+NI+ V + FV + + G L+ + RL
Sbjct: 48 SEIQVTLLLQESCLLYGLSHQNILP--ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRL 105
Query: 117 ----KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 172
+ ++ + + H QI G+ YLH R VIH+D+ N ++ + +VKI D
Sbjct: 106 GEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVID-EELQVKITDNA 162
Query: 173 LAAILRKS--HAARCVGTPE-----FMAPEVYE-EEYNELVDIYSFGMCILEMVTF-DYP 223
L+ L H C+G E +MA E +EY+ D++SFG+ + E++T P
Sbjct: 163 LSRDLFPMDYH---CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
Query: 224 YSECTHPAQIYKKVISGKK-------PEALFKV 249
Y E P ++ + G + P+ LF V
Sbjct: 220 YVE-IDPFEMAAYLKDGYRLAQPINCPDELFAV 251
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 22/167 (13%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRA---- 125
EI LL+ LKH N++ ++ ++R + + + + L HR + N +
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFD-YAEHDLWHIIKFHRASKANKKPMQLP 106
Query: 126 ---VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG---NQGEVKIGDLGLAAILRK 179
VK QIL G+ YLH+ V+HRDLK NI V G +G VKI D+G A +
Sbjct: 107 RSMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 180 -----SHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCILEMVT 219
+ V T + APE+ Y + +DI++ G E++T
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 52/187 (27%), Positives = 79/187 (42%), Gaps = 36/187 (19%)
Query: 65 ELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI 123
+L L E+ ++K + KH+NI+ V T + V E G LR + R
Sbjct: 58 DLSDLVSEMEMMKMIGKHKNIINLLG--VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGE 115
Query: 124 RAVKHWCR----------------QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVK 167
A R Q+ G+ +L S+ IHRDL N+ V +K
Sbjct: 116 YASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLV-TEDHVMK 172
Query: 168 IGDLGLAAIL------RKSHAARCVGTP-EFMAPE-VYEEEYNELVDIYSFGMCILEMVT 219
I D GLA + RK+ R P ++MAPE +++ Y D++SFG+ + E+ T
Sbjct: 173 IADFGLARDIHHIDYYRKTTNGR---LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
Query: 220 FD---YP 223
YP
Sbjct: 230 LGGSPYP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 37/94 (39%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 126 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR-KSHAAR 184
+K Q+L GL +LHS V+HRDLK NI V + G++K+ D GLA I +
Sbjct: 112 IKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTS 168
Query: 185 CVGTPEFMAPEV-YEEEYNELVDIYSFGMCILEM 217
V T + APEV + Y VD++S G EM
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 68/293 (23%), Positives = 108/293 (36%), Gaps = 75/293 (25%)
Query: 84 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR 143
+++ Y S+ D N+ FV + G + ++ + + ++ + +H
Sbjct: 63 VVRLYYSFQD--KDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120
Query: 144 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA-------------------- 183
IHRD+K DNI ++ G +K+ D GL R +H +
Sbjct: 121 G--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177
Query: 184 ------------------------RC-----VGTPEFMAPEV-YEEEYNELVDIYSFGMC 213
RC VGTP ++APEV Y +L D +S G+
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237
Query: 214 ILEMVTFDYPYSECTHPAQIYKKVISGKK-----PEALFKVEDPEVRQFIEKCLATVSSR 268
+ EM+ P+ T P + KVI+ + P+A PE I K R
Sbjct: 238 LYEMLVGQPPFLAQT-PLETQMKVINWQTSLHIPPQAKLS---PEASDLIIKLCRGPEDR 293
Query: 269 L---SARELLTDPFLQIDDYDSDLRM--------IQYQTDYDEISPLLRQSLY 310
L A E+ PF + D+ SDLR I + TD P+ L+
Sbjct: 294 LGKNGADEIKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSNFDPVDPDKLW 346
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 25/169 (14%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH------------- 118
E LL L+H++I++FY V T R + V E G L ++ H
Sbjct: 57 EAELLTVLQHQHIVRFYG--VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDV 114
Query: 119 --RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176
++ + + QI SG++YL S +HRDL N V G VKIGD G++
Sbjct: 115 APGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLV-GQGLVVKIGDFGMSRD 171
Query: 177 LRKSHAARCVGTP----EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF 220
+ + R G +M PE + ++ DI+SFG+ + E+ T+
Sbjct: 172 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTY 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 42/149 (28%), Positives = 79/149 (53%), Gaps = 18/149 (12%)
Query: 104 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 163
E+FT + R+ R K + V I + +I+ L +LH +I+RD+K +NI ++ N
Sbjct: 91 ELFTHLSQRE-RFKEQEVQI-----YSGEIVLALEHLHKLG--IIYRDIKLENILLDSN- 141
Query: 164 GEVKIGDLGLAAILRKSHAARC---VGTPEFMAPEVY---EEEYNELVDIYSFGMCILEM 217
G V + D GL+ + R GT E+MAP++ + +++ VD +S G+ + E+
Sbjct: 142 GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYEL 201
Query: 218 VTFDYPYS---ECTHPAQIYKKVISGKKP 243
+T P++ E A+I ++++ + P
Sbjct: 202 LTGASPFTVDGEKNSQAEISRRILKSEPP 230
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 46/192 (23%), Positives = 86/192 (44%), Gaps = 25/192 (13%)
Query: 104 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 163
EMFT R + V+ + +I+ L +LH +++RD+K +NI ++ ++
Sbjct: 91 EMFTHLYQRDN------FSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLD-SE 141
Query: 164 GEVKIGDLGLAAILRKSHAARC---VGTPEFMAPEVYEEE--YNELVDIYSFGMCILEMV 218
G V + D GL+ R GT E+MAPE+ + + + VD +S G+ I E++
Sbjct: 142 GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201
Query: 219 TFDYPYS---ECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT------VSSRL 269
T P++ E +++ ++++ P PE + + K L +
Sbjct: 202 TGASPFTLEGERNTQSEVSRRILKCDPP--FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQ 259
Query: 270 SARELLTDPFLQ 281
A E+ PF +
Sbjct: 260 GASEIKEHPFFK 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 71 CEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHW 129
E ++ H NI+ V T ++ + VTE +G+L + KH + + +
Sbjct: 54 SEASIMGQFDHPNIIHL--EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGM 111
Query: 130 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK----SHAARC 185
R I SG+ YL D +HRDL NI VN N K+ D GL+ +L ++ R
Sbjct: 112 LRGIASGMKYL--SDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTRG 168
Query: 186 VGTP-EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTH 229
P + APE + ++ D++S+G+ + E++++ + PY E ++
Sbjct: 169 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 34/200 (17%)
Query: 45 EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVT 103
E + VA VK+ + ++L L E+ ++K + KH+NI+ + T + + +
Sbjct: 46 EAVTVA---VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC--TQDGPLYVIV 100
Query: 104 EMFTSGTLRQY----------------RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPV 147
E + G LR+Y R+ ++ + + Q+ G+ YL S+
Sbjct: 101 EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--C 158
Query: 148 IHRDLKCDNIFVNGNQGEVKIGDLGLAAIL------RKSHAARCVGTPEFMAPE-VYEEE 200
IHRDL N+ V N +KI D GLA + +K+ R ++MAPE +++
Sbjct: 159 IHRDLAARNVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRL--PVKWMAPEALFDRV 215
Query: 201 YNELVDIYSFGMCILEMVTF 220
Y D++SFG+ + E+ T
Sbjct: 216 YTHQSDVWSFGVLMWEIFTL 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 8e-07
Identities = 40/153 (26%), Positives = 71/153 (46%), Gaps = 10/153 (6%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWC 130
E ++ L H +++ Y V T + + VTE +G L Y R + +++ + C
Sbjct: 49 EAKVMMKLSHPKLVQLYG--VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMC 106
Query: 131 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP- 189
+ + G+ YL IHRDL N V+ + G VK+ D G+ + G
Sbjct: 107 QDVCEGMEYLERNS--FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEYTSSSGAKF 163
Query: 190 --EFMAPEVYE-EEYNELVDIYSFGMCILEMVT 219
++ PEV+ +Y+ D++SFG+ + E+ T
Sbjct: 164 PVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 9e-07
Identities = 41/190 (21%), Positives = 77/190 (40%), Gaps = 43/190 (22%)
Query: 65 ELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSG----TLRQYRLKHRR 120
+++R+ E +L TL H + Y + V + + G L Q + +
Sbjct: 44 KVKRVLTEQEILATLDHPFLPTLY--ASFQTETYLCLVMD-YCPGGELFRLLQRQ-PGKC 99
Query: 121 VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA------ 174
++ + + ++L L YLH +++RDLK +NI ++ + G + + D L+
Sbjct: 100 LSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHES-GHIMLSDFDLSKQSDVE 156
Query: 175 -----AILRKSHAAR--------------------CVGTPEFMAPEVYEEE-YNELVDIY 208
LRK VGT E++APEV + + VD +
Sbjct: 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWW 216
Query: 209 SFGMCILEMV 218
+ G+ + EM+
Sbjct: 217 TLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 43/172 (25%), Positives = 83/172 (48%), Gaps = 21/172 (12%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY---------RLKHRRVN 122
E+ + + L H+N+++ + + + E G L+Q+ +LK ++
Sbjct: 58 ELDMFRKLSHKNVVRLLGLCREAEPHYM--ILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115
Query: 123 IRAVKHWCRQILSGLLYLH-SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS- 180
+ C QI G+ +L +R +HRDL N V+ +Q EVK+ L L+ + S
Sbjct: 116 TKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVS-SQREVKVSLLSLSKDVYNSE 171
Query: 181 -HAARCVGTP-EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECT 228
+ R P ++APE V E++++ D++SFG+ + E+ T + P+ +
Sbjct: 172 YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS 223
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 40/157 (25%), Positives = 78/157 (49%), Gaps = 21/157 (13%)
Query: 148 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS---HAARCVGTPEFMAPEVYEE----- 199
+HRD+K DNI ++ N G +++ D G L + ++ VGTP++++PE+ +
Sbjct: 124 VHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182
Query: 200 -EYNELVDIYSFGMCILEMVTFDYP-YSECTHPAQIYKKVISGKK----PEALFKVEDPE 253
+Y D +S G+C+ EM+ + P Y+E + Y K+++ K+ P + V + +
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGKIMNHKERFQFPAQVTDVSE-D 239
Query: 254 VRQFIEKCLATVSSRLSA---RELLTDPFLQIDDYDS 287
+ I + + + RL + PF D+D+
Sbjct: 240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDN 276
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-06
Identities = 46/187 (24%), Positives = 72/187 (38%), Gaps = 16/187 (8%)
Query: 65 ELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIR 124
+ R E L L H NI+ S + V E TLR+ +
Sbjct: 21 QRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYVPGRTLREVLAADGALPAG 79
Query: 125 AVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE--VKIGDLGLAAILRKSHA 182
Q+L L H++ ++HRDLK NI V+ K+ D G+ +L
Sbjct: 80 ETGRLMLQVLDALACAHNQG--IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRD 137
Query: 183 A---------RCVGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ 232
A +GTP + APE + E D+Y++G+ LE +T + A+
Sbjct: 138 ADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLT-GQRVVQGASVAE 196
Query: 233 IYKKVIS 239
I + +S
Sbjct: 197 ILYQQLS 203
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 52/192 (27%), Positives = 87/192 (45%), Gaps = 33/192 (17%)
Query: 54 VKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLR 112
VK+ + ++L L E+ L+K + KH+NI+ V T + + E G LR
Sbjct: 49 VKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLG--VCTQEGPLYVIVEYAAKGNLR 106
Query: 113 QYRLKHRR-----------------VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
++ L+ RR ++ + + Q+ G+ YL SR IHRDL
Sbjct: 107 EF-LRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAAR 163
Query: 156 NIFVNGNQGEVKIGDLGLAA------ILRKSHAARCVGTPEFMAPE-VYEEEYNELVDIY 208
N+ V + +KI D GLA +K+ R ++MAPE +++ Y D++
Sbjct: 164 NVLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRL--PVKWMAPEALFDRVYTHQSDVW 220
Query: 209 SFGMCILEMVTF 220
SFG+ + E+ T
Sbjct: 221 SFGILMWEIFTL 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 30/80 (37%), Positives = 47/80 (58%), Gaps = 3/80 (3%)
Query: 147 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC-VGTPEFMAPEVYE-EEYNEL 204
+++RDLK +NI ++ ++G ++I DLGLA + + R VGT +MAPEV E+Y
Sbjct: 123 IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS 181
Query: 205 VDIYSFGMCILEMVTFDYPY 224
D + G I EM+ P+
Sbjct: 182 PDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 28/202 (13%)
Query: 65 ELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY--RLKHRRV 121
E E L E+ ++ L H NI+ + T I +TE G L + R + +
Sbjct: 81 EREALMSELKIMSHLGNHENIVNLLGAC--TIGGPILVITEYCCYGDLLNFLRRKRESFL 138
Query: 122 NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV-KIGDLGLAA-ILRK 179
+ + + Q+ G+ +L S++ IHRDL N+ + G++ KI D GLA I+
Sbjct: 139 TLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLT--HGKIVKICDFGLARDIMND 194
Query: 180 SH-----AARCVGTP-EFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDY-PYSECTHPA 231
S+ AR P ++MAPE ++ Y D++S+G+ + E+ + PY +
Sbjct: 195 SNYVVKGNAR---LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS 251
Query: 232 QIYKKVISGKKPEALFKVEDPE 253
+ YK + G +++ PE
Sbjct: 252 KFYKLIKEG------YRMAQPE 267
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 40/157 (25%), Positives = 76/157 (48%), Gaps = 23/157 (14%)
Query: 148 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR---CVGTPEFMAPEVYEE----- 199
+HRD+K DN+ ++ N G +++ D G L + VGTP++++PE+ +
Sbjct: 124 VHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182
Query: 200 -EYNELVDIYSFGMCILEMVTFDYP-YSECTHPAQIYKKVISGKKPEAL-FKVEDPEV-- 254
Y D +S G+C+ EM+ + P Y+E + Y K+++ K E F + +V
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGKIMNHK--EHFQFPPDVTDVSE 238
Query: 255 --RQFIEKCLATVSSRL---SARELLTDPFLQIDDYD 286
+ I + + + +RL ++ PF + D+D
Sbjct: 239 EAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWD 275
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 13/163 (7%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWC 130
E ++ H NI++ V T + +TE +G L +Y R + +
Sbjct: 56 EASIMGQFSHHNIIRL--EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGML 113
Query: 131 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP- 189
R I +G+ YL D +HRDL NI VN + E K+ D GL+ +L +
Sbjct: 114 RGIAAGMKYL--SDMNYVHRDLAARNILVN-SNLECKVSDFGLSRVLEDDPEGTYTTSGG 170
Query: 190 ----EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSE 226
+ APE + ++ D++SFG+ + E+++F + PY +
Sbjct: 171 KIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 48/204 (23%), Positives = 85/204 (41%), Gaps = 13/204 (6%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANR--NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHW 129
EI L+ + NI+K Y +D + ++ + E T G LR+ K + ++ +
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDM 127
Query: 130 CRQILSGLLYLHSRD--PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG 187
GL L+ P +++L + V N ++KI GL IL S + V
Sbjct: 128 AIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTEN-YKLKIICHGLEKIL-SSPPFKNVN 182
Query: 188 TPEFMAPEVYE---EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE 244
+ + ++ EY DIYS G+ + E+ T P+ T +IY +I+
Sbjct: 183 FMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-KEIYDLIINKNNSL 241
Query: 245 ALFKVEDPEVRQFIEKCLATVSSR 268
L E++ +E C + S +
Sbjct: 242 KLPLDCPLEIKCIVEACTSHDSIK 265
|
Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 38/156 (24%), Positives = 65/156 (41%), Gaps = 14/156 (8%)
Query: 72 EIHLLKTLK-HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWC 130
EI L+ L H NI++ D + V E+ + + R + + VK +
Sbjct: 47 EIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYM 106
Query: 131 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG-LAAILRKSHAARCVGTP 189
Q+L L ++H + HRD+K +NI + +K+ D G I K + T
Sbjct: 107 YQLLKSLDHMHRNG--IFHRDIKPENILI--KDDILKLADFGSCRGIYSKPPYTEYISTR 162
Query: 190 EFMAPEV-----YEEEYNELVDIYSFGMCILEMVTF 220
+ APE Y Y +DI++ G E+++
Sbjct: 163 WYRAPECLLTDGY---YGPKMDIWAVGCVFFEILSL 195
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 33/192 (17%)
Query: 54 VKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLR 112
VK+ + ++L L E+ ++K + KH+NI+ + T + + + E + G LR
Sbjct: 55 VKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC--TQDGPLYVIVEYASKGNLR 112
Query: 113 QYRLKHRR-----------------VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
+Y L+ RR ++ + + Q+ G+ YL S+ IHRDL
Sbjct: 113 EY-LRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAAR 169
Query: 156 NIFVNGNQGEVKIGDLGLAAIL------RKSHAARCVGTPEFMAPE-VYEEEYNELVDIY 208
N+ V + +KI D GLA + +K+ R ++MAPE +++ Y D++
Sbjct: 170 NVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRL--PVKWMAPEALFDRIYTHQSDVW 226
Query: 209 SFGMCILEMVTF 220
SFG+ + E+ T
Sbjct: 227 SFGVLLWEIFTL 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 70/262 (26%), Positives = 111/262 (42%), Gaps = 39/262 (14%)
Query: 44 YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 103
+ G+ A VK +P+E E+ + L H N+++ +++ V
Sbjct: 17 HRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIP--YLLVL 74
Query: 104 EMFTSGTLRQYRLKHRRVNIRA------VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
E G L+ Y L+ R + ++ ++ SGLL+LH D IH DL N
Sbjct: 75 EFCPLGDLKNY-LRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNC 131
Query: 158 FVNGNQGEVKIGDLGLAAILRKSH---AARCVGTP-EFMAPEVYEEEYNELV-------- 205
+ + VKIGD GLA C P ++APE+ E +L+
Sbjct: 132 QLTADL-SVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKS 190
Query: 206 DIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGK-----KPEALFKVEDP--EVRQF 257
+I+S G+ + E+ T D PY + + Q+ K+V+ + KP+ K D EV QF
Sbjct: 191 NIWSLGVTMWELFTAADQPYPDLSD-EQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQF 249
Query: 258 IEKCLATVSSRLSARE---LLT 276
C +R +A E LLT
Sbjct: 250 ---CWLDPETRPTAEEVHELLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 36/157 (22%), Positives = 79/157 (50%), Gaps = 21/157 (13%)
Query: 148 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS---HAARCVGTPEFMAPEVYEE----- 199
+HRD+K DN+ ++ N G +++ D G + + ++ VGTP++++PE+ +
Sbjct: 124 VHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182
Query: 200 -EYNELVDIYSFGMCILEMVTFDYP-YSECTHPAQIYKKVISGKK----PEALFKVEDPE 253
+Y D +S G+C+ EM+ + P Y+E + Y K+++ ++ P + V + E
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGKIMNHEERFQFPSHITDVSE-E 239
Query: 254 VRQFIEKCLATVSSRLSAR---ELLTDPFLQIDDYDS 287
+ I++ + + RL + F + D+++
Sbjct: 240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWEN 276
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 43/164 (26%), Positives = 73/164 (44%), Gaps = 15/164 (9%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV 121
SPE + E ++K L+H +++ Y + I VTE + G+L +
Sbjct: 44 SPEAFLQ---EAQVMKKLRHEKLVQLYAV---VSEEPIYIVTEYMSKGSLLDFLKGEMGK 97
Query: 122 NIR--AVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179
+R + QI SG+ Y+ + +HRDL+ NI V G K+ D GLA ++
Sbjct: 98 YLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIED 154
Query: 180 SHAARCVGTP---EFMAPE-VYEEEYNELVDIYSFGMCILEMVT 219
+ G ++ APE + D++SFG+ + E+ T
Sbjct: 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 45/167 (26%), Positives = 74/167 (44%), Gaps = 23/167 (13%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH------------- 118
E LL L+H +I+KFY V+ + V E G L ++ H
Sbjct: 57 EAELLTNLQHEHIVKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRP 114
Query: 119 RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178
+ + H +QI +G++YL S+ +HRDL N V G VKIGD G++ +
Sbjct: 115 AELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLV-GENLLVKIGDFGMSRDVY 171
Query: 179 KSHAARCVGTP----EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF 220
+ R G +M PE + ++ D++S G+ + E+ T+
Sbjct: 172 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTY 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 44/137 (32%), Positives = 72/137 (52%), Gaps = 12/137 (8%)
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE-VKIGDLGLAA-ILRKSHAARCVGT- 188
Q+ +G+ +L S++ +HRDL N+ + +G+ VKI D GLA I+R S+ T
Sbjct: 247 QVANGMEFLASKN--CVHRDLAARNVLIC--EGKLVKICDFGLARDIMRDSNYISKGSTF 302
Query: 189 -P-EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPE 244
P ++MAPE ++ Y L D++SFG+ + E+ T PY E Q Y + G +
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA 362
Query: 245 ALFKVEDPEVRQFIEKC 261
D E+ + ++KC
Sbjct: 363 KPAHASD-EIYEIMQKC 378
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 45/191 (23%), Positives = 78/191 (40%), Gaps = 21/191 (10%)
Query: 54 VKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQ 113
VK S ++ E ++ H+NI++ + R I + E+ G L+
Sbjct: 41 VKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFI--LLELMAGGDLKS 98
Query: 114 YRLKHRRVN--------IRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN--GNQ 163
+ L+ R ++ + R + G YL IHRD+ N + G
Sbjct: 99 F-LRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPG 155
Query: 164 GEVKIGDLGLAA-ILRKSH---AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMV 218
KI D G+A I R S+ R + ++M PE + + + D++SFG+ + E+
Sbjct: 156 RVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIF 215
Query: 219 TFDY-PYSECT 228
+ Y PY T
Sbjct: 216 SLGYMPYPGRT 226
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 8e-06
Identities = 48/183 (26%), Positives = 78/183 (42%), Gaps = 23/183 (12%)
Query: 64 EELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----- 118
E E+ +L L NI + V T + + + E +G L Q+ KH
Sbjct: 61 NAREDFLKEVKILSRLSDPNIARLLG--VCTVDPPLCMIMEYMENGDLNQFLQKHVAETS 118
Query: 119 ------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 172
+ ++ + + QI SG+ YL S + +HRDL N V N +KI D G
Sbjct: 119 GLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNY-TIKIADFG 175
Query: 173 LAAILRKSHAARCVGTP----EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF--DYPYS 225
++ L S R G +MA E V ++ D+++FG+ + E++T + PY
Sbjct: 176 MSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235
Query: 226 ECT 228
T
Sbjct: 236 HLT 238
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 8e-06
Identities = 48/198 (24%), Positives = 82/198 (41%), Gaps = 63/198 (31%)
Query: 148 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-------------------------- 181
IHRD+K DNI ++ G +K+ D GL+ K H
Sbjct: 123 IHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAV 181
Query: 182 -----------------------AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEM 217
A VGTP+++APE++ ++ Y + D +S G + E
Sbjct: 182 DSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFEC 241
Query: 218 VTFDYPY-SECTHPAQIYKKVISGKKPEALFKVED----PEVRQFIEKCLATVSSRL--- 269
+ P+ SE +H + Y+K+I+ + E L+ +D E I + + +RL
Sbjct: 242 LIGWPPFCSENSH--ETYRKIINWR--ETLYFPDDIHLSVEAEDLIRRLITNAENRLGRG 297
Query: 270 SARELLTDPFLQIDDYDS 287
A E+ + PF + D+D+
Sbjct: 298 GAHEIKSHPFFRGVDWDT 315
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 41/163 (25%), Positives = 74/163 (45%), Gaps = 15/163 (9%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWC 130
E ++ H NI+ V T +R + +TE +G L + R + + +
Sbjct: 55 EASIMGQFDHPNIIHL--EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGML 112
Query: 131 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA----ARCV 186
R I +G+ YL + +HRDL NI VN N K+ D GL+ L + +
Sbjct: 113 RGIAAGMKYL--SEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSL 169
Query: 187 GTP---EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPY 224
G + APE + ++ D++S+G+ + E++++ + PY
Sbjct: 170 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 68/287 (23%), Positives = 122/287 (42%), Gaps = 47/287 (16%)
Query: 64 EELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-------- 114
++L L E+ ++K + KH+NI+ + T + + + E + G LR+Y
Sbjct: 59 KDLSDLVSEMEMMKMIGKHKNIINLLGAC--TQDGPLYVLVEYASKGNLREYLRARRPPG 116
Query: 115 --------RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV 166
+L ++ + + Q+ G+ YL S+ IHRDL N+ V +
Sbjct: 117 MDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVT-EDNVM 173
Query: 167 KIGDLGLAAIL------RKSHAARCVGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVT 219
KI D GLA + +K+ R ++MAPE +++ Y D++SFG+ + E+ T
Sbjct: 174 KIADFGLARDVHNIDYYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
Query: 220 FD---YPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATV-SSRLSARELL 275
YP ++ K+ KP E+ + +C V S R + ++L
Sbjct: 232 LGGSPYPGIPVEELFKLLKEGHRMDKPANCTH----ELYMIMRECWHAVPSQRPTFKQL- 286
Query: 276 TDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNG 322
++D D L + +Y ++S Q G S SS ++G
Sbjct: 287 ------VEDLDRVLTVTS-TDEYLDLSVPFEQYSPGCPDSPSSCSSG 326
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 46/168 (27%), Positives = 81/168 (48%), Gaps = 15/168 (8%)
Query: 81 HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLL 138
H NI++ V T +R + +TE +G+L ++ L+ + R I SG+
Sbjct: 64 HPNIIRLEG--VVTKSRPVMIITEYMENGSLDKF-LRENDGKFTVGQLVGMLRGIASGMK 120
Query: 139 YLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA---RCVGTP-EFMAP 194
YL + +HRDL NI VN + K+ D GL+ L S A + P + AP
Sbjct: 121 YLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAP 177
Query: 195 E-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISG 240
E + ++ D++SFG+ + E++++ + PY + ++ + K V G
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDG 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 14/155 (9%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH---RRVNIRAVKH 128
E ++K L+H ++ Y + I VTE G+L + LK + + + +
Sbjct: 51 EAQIMKKLRHDKLVPLYAV---VSEEPIYIVTEFMGKGSLLDF-LKEGDGKYLKLPQLVD 106
Query: 129 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT 188
QI G+ Y+ + IHRDL+ NI V N KI D GLA ++ + G
Sbjct: 107 MAAQIADGMAYIERMN--YIHRDLRAANILVGDNL-VCKIADFGLARLIEDNEYTARQGA 163
Query: 189 P---EFMAPE-VYEEEYNELVDIYSFGMCILEMVT 219
++ APE + D++SFG+ + E+VT
Sbjct: 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 41/164 (25%), Positives = 62/164 (37%), Gaps = 31/164 (18%)
Query: 130 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCV--- 186
C Q L L LH + K NI + + GL L S A +
Sbjct: 23 CLQCLGALRELHRQA--------KSGNILLTWD---------GLLK-LDGSVAFKTPEQS 64
Query: 187 -GTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE 244
P FMAPEV + Y E DIYS G+ + E + ++ PY+E + I + +++G +
Sbjct: 65 RPDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD 124
Query: 245 A------LFKVED-PEVRQFIEKCLATVSS-RLSARELLTDPFL 280
L V F+ C + + R +A L
Sbjct: 125 DPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRA 168
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 54/233 (23%), Positives = 104/233 (44%), Gaps = 30/233 (12%)
Query: 43 EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 102
EY G +VA +K Q+ E ++ L H+N+++ + + + V
Sbjct: 26 EYTGQKVAVKNIKCDVTAQA------FLEETAVMTKLHHKNLVRLLGVIL---HNGLYIV 76
Query: 103 TEMFTSGTLRQY-RLKHRR-VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 160
E+ + G L + R + R V++ + + + G+ YL S+ ++HRDL NI V+
Sbjct: 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVS 134
Query: 161 GNQGEVKIGDLGLAAILRKSHAARCVGTP-EFMAPEVYEE-EYNELVDIYSFGMCILEMV 218
G K+ D GLA + P ++ APE + +++ D++S+G+ + E+
Sbjct: 135 -EDGVAKVSDFGLARVGSM--GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEV- 190
Query: 219 TFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSA 271
+ Y +P K+V + E +++E P E C A V +++
Sbjct: 191 ---FSYGRAPYPKMSLKEV--KECVEKGYRMEPP------EGCPADVYVLMTS 232
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 33/113 (29%), Positives = 53/113 (46%), Gaps = 15/113 (13%)
Query: 131 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPE 190
+Q+ +G+ YL R +HRDL N V N VKI D GL+ R ++A E
Sbjct: 137 KQVAAGMAYLSERK--FVHRDLATRNCLVGENM-VVKIADFGLS---RNIYSADYYKASE 190
Query: 191 -------FMAPE-VYEEEYNELVDIYSFGMCILEMVTFDY-PYSECTHPAQIY 234
+M PE ++ Y D++++G+ + E+ ++ PY H IY
Sbjct: 191 NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY 243
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 17/103 (16%)
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK------SHAARC 185
Q+ G+ +L SR IHRDL NI ++ N VKI D GLA + K AR
Sbjct: 181 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDAR- 236
Query: 186 VGTP-EFMAPE-VYEEEYNELVDIYSFGMCILEMVTFD---YP 223
P ++MAPE ++++ Y D++SFG+ + E+ + YP
Sbjct: 237 --LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 31/77 (40%), Positives = 36/77 (46%), Gaps = 19/77 (24%)
Query: 131 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT-- 188
RQIL L LHS ++HRD+K NI + G KI DLG AA LR VG
Sbjct: 262 RQILFALDGLHSTG--IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLR-------VGINY 312
Query: 189 --------PEFMAPEVY 197
P + APE Y
Sbjct: 313 IPKEFLLDPRYAAPEQY 329
|
Length = 566 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 37/123 (30%), Positives = 63/123 (51%), Gaps = 14/123 (11%)
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE-VKIGDLGLAAILRKSHAARCVGTP- 189
Q+ G+ +L S++ +HRDL N+ + QG+ VKI D GLA + G+
Sbjct: 245 QVARGMEFLASKN--CVHRDLAARNVLLA--QGKIVKICDFGLARDIMHDSNYVSKGSTF 300
Query: 190 ---EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISG---K 241
++MAPE +++ Y L D++S+G+ + E+ + PY + Y K+ SG
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA 360
Query: 242 KPE 244
KP+
Sbjct: 361 KPD 363
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 8e-05
Identities = 47/184 (25%), Positives = 77/184 (41%), Gaps = 33/184 (17%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR----------- 120
E+ +L LK NI++ VD + +TE +G L Q+ L
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVD--EDPLCMITEYMENGDLNQF-LSSHHLDDKEENGNDA 125
Query: 121 ---------VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 171
++ ++ H QI SG+ YL S + +HRDL N V N +KI D
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENL-TIKIADF 182
Query: 172 GLAAILRKSHAARCVGTP----EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF--DYPY 224
G++ L R G +MA E + ++ D+++FG+ + E++ + PY
Sbjct: 183 GMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242
Query: 225 SECT 228
E T
Sbjct: 243 GELT 246
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 49/215 (22%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 43 EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 102
+Y G +VA +K + + E ++ L+H N+++ V+ + V
Sbjct: 26 DYRGNKVAVKCIK------NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIV 78
Query: 103 TEMFTSGTLRQY-RLKHRRV-NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 160
TE G+L Y R + R V + + + + YL + + +HRDL N+ V+
Sbjct: 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVS 136
Query: 161 GNQGEVKIGDLGLAAILRKSHAARCVGTP-EFMAPE-VYEEEYNELVDIYSFGMCILEMV 218
K+ D GL S P ++ APE + E++++ D++SFG+ + E+
Sbjct: 137 -EDNVAKVSDFGLTK--EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI- 192
Query: 219 TFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 253
Y + +P K V+ + E +K++ P+
Sbjct: 193 ---YSFGRVPYPRIPLKDVVP--RVEKGYKMDAPD 222
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 40/139 (28%), Positives = 68/139 (48%), Gaps = 16/139 (11%)
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA-------ILRKSHAAR 184
Q+ G+ +L SR IHRDL NI ++ N VKI D GLA +RK A
Sbjct: 182 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 185 CVGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTFD-YPYSECTHPAQIYKKVISGKK 242
+ ++MAPE ++++ Y D++SFG+ + E+ + PY + +++ G +
Sbjct: 239 PL---KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR 295
Query: 243 PEALFKVEDPEVRQFIEKC 261
A + PE+ + + C
Sbjct: 296 MRAP-ENATPEIYRIMLAC 313
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 2e-04
Identities = 40/180 (22%), Positives = 79/180 (43%), Gaps = 28/180 (15%)
Query: 117 KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176
K +++ VK RQ++ L LH + +IH D+K +N+ + + + + D GL
Sbjct: 102 KEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGL--- 156
Query: 177 LRKSHAARCVGTP-------EFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDYPY---- 224
+ +GTP ++ +PE + Y+ D ++ G+ E++T +P+
Sbjct: 157 ------CKIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
Query: 225 SECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSA-RELLTDPFLQI 282
E + K+ +K K F++ L ++ RL+ E++ PFL+I
Sbjct: 211 DEELDLESLLKRQ---QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267
|
Length = 267 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 49/198 (24%), Positives = 87/198 (43%), Gaps = 18/198 (9%)
Query: 73 IHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK---HW 129
I+LL +HR + + N ++F+ + T + + + + + + H+
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNL-LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 130 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA----AILRKSHAARC 185
+ G+ YL + IHRDL NI V G KI D GL+ ++K+
Sbjct: 130 AADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADFGLSRGQEVYVKKTMGRLP 186
Query: 186 VGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKP 243
V +MA E Y D++S+G+ + E+V+ PY T A++Y+K+ G +
Sbjct: 187 V---RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEKLPQGYRL 242
Query: 244 EALFKVEDPEVRQFIEKC 261
E +D EV + +C
Sbjct: 243 EKPLNCDD-EVYDLMRQC 259
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 9/103 (8%)
Query: 128 HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG 187
H QI +G+ YL S +H+DL NI + G Q VKI DLGL+ + + R
Sbjct: 128 HIAIQIAAGMEYLSSHF--FVHKDLAARNILI-GEQLHVKISDLGLSREIYSADYYRVQP 184
Query: 188 TP----EFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDY-PY 224
+M PE + +++ DI+SFG+ + E+ +F PY
Sbjct: 185 KSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 29/94 (30%), Positives = 45/94 (47%), Gaps = 8/94 (8%)
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP-- 189
QI +G+ YL S +HRDL N V G VKI D GL+ + + R
Sbjct: 132 QIAAGMEYLSSHH--FVHRDLAARNCLV-GEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 190 --EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF 220
+M PE + ++ DI+SFG+ + E+ ++
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSY 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 36/129 (27%), Positives = 61/129 (47%), Gaps = 17/129 (13%)
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV-KIGDLGLAAILRKSHAARCVGTP- 189
Q+ G+ +L S++ IHRDL NI + G + KI D GLA +R G
Sbjct: 222 QVAKGMSFLASKN--CIHRDLAARNILL--THGRITKICDFGLARDIRNDSNYVVKGNAR 277
Query: 190 ---EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPE 244
++MAPE ++ Y D++S+G+ + E+ + PY ++ YK + G
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG---- 333
Query: 245 ALFKVEDPE 253
+++ PE
Sbjct: 334 --YRMLSPE 340
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 14/97 (14%)
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA-------ILRKSHAAR 184
Q+ G+ +L SR IHRDL NI ++ N VKI D GLA +RK A
Sbjct: 187 QVAKGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 185 CVGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTF 220
+ ++MAPE +++ Y D++SFG+ + E+ +
Sbjct: 244 PL---KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 44/166 (26%), Positives = 70/166 (42%), Gaps = 30/166 (18%)
Query: 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 160
V E+ G L ++ K++ V + + Q+ G+ YL + +HRDL N+ +
Sbjct: 72 LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLV 129
Query: 161 GNQGEVKIGDLGLAAILRKS---HAARCVGT-P-EFMAPEVYE-EEYNELVDIYSFGMCI 214
Q KI D GL+ L + A+ G P ++ APE +++ D++SFG+ +
Sbjct: 130 -TQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLM 188
Query: 215 LEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 260
E F Y G+KP K EV Q IE
Sbjct: 189 WE--AFSY-----------------GQKPYKGMK--GNEVTQMIES 213
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 42 DEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN--- 98
D+ ++VA +KL S E+E E +K H N+MK + ++
Sbjct: 23 DDGSQLKVAVKTMKLDIHTYS--EIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80
Query: 99 INFVTEMFTS-GTLRQYRLKHR------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 151
V F G L + L R ++ ++ + + I G+ YL +R+ IHRD
Sbjct: 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRD 138
Query: 152 LKCDNIFVNGNQGEVKIGDLGLAAIL------RKSHAARCVGTP-EFMAPEVYEEE-YNE 203
L N + + V + D GL+ + R+ A+ P +++A E + Y
Sbjct: 139 LAARNCMLREDM-TVCVADFGLSKKIYSGDYYRQGRIAK---MPVKWIAIESLADRVYTS 194
Query: 204 LVDIYSFGMCILEMVTFDY-PYSECTHPAQIYKKVISG---KKPE 244
D+++FG+ + E+ T PY + +IY + G K+PE
Sbjct: 195 KSDVWAFGVTMWEIATRGQTPYPGVEN-HEIYDYLRHGNRLKQPE 238
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 24/75 (32%), Positives = 41/75 (54%), Gaps = 12/75 (16%)
Query: 109 GTLRQYRLKHRRV---------NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 159
G L ++ + +++ +I +K RQ+L+GL LH ++HRD+K +N+ V
Sbjct: 285 GCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLV 342
Query: 160 NGNQGEVKIGDLGLA 174
+ G+VKI D G A
Sbjct: 343 TVD-GQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 28/174 (16%)
Query: 55 KLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSW---------VDTANRNINFVTEM 105
K D ++ E E E+ +L+TLK NI++ ++ + +N+ + E
Sbjct: 33 KFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEE 92
Query: 106 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 165
+G + + I+A+ HWC H D ++HRD+K +N+ ++ N
Sbjct: 93 MPNGVPPEKVRSYIYQLIKAI-HWC----------HKND--IVHRDIKPENLLISHND-V 138
Query: 166 VKIGDLGLAAILRKSHAA---RCVGTPEFMAPE-VYEEEYNELVDIYSFGMCIL 215
+K+ D G A L + A V T + +PE + Y + VD++S G CIL
Sbjct: 139 LKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVG-CIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.002
Identities = 40/133 (30%), Positives = 62/133 (46%), Gaps = 14/133 (10%)
Query: 135 SGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA----AILRKSHAARCVGTPE 190
G+ YL + IHRDL NI V N KI D GL+ ++K+ V
Sbjct: 123 RGMDYLSQKQ--FIHRDLAARNILVGENYVA-KIADFGLSRGQEVYVKKTMGRLPV---R 176
Query: 191 FMAPEVYEEE-YNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPEALFK 248
+MA E Y D++S+G+ + E+V+ PY T A++Y+K+ G + E
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEKLPQGYRLEKPLN 235
Query: 249 VEDPEVRQFIEKC 261
+D EV + +C
Sbjct: 236 CDD-EVYDLMRQC 247
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 40/133 (30%), Positives = 64/133 (48%), Gaps = 14/133 (10%)
Query: 135 SGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA----AILRKSHAARCVGTPE 190
+G+ YL + IHRDL N+ V G KI D GL+ ++K+ V
Sbjct: 130 TGMQYL--SEKQFIHRDLAARNVLV-GENLASKIADFGLSRGEEVYVKKTMGRLPV---R 183
Query: 191 FMAPEVYEEE-YNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPEALFK 248
+MA E Y D++SFG+ + E+V+ PY T A++Y+K+ G + E
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT-CAELYEKLPQGYRMEKPRN 242
Query: 249 VEDPEVRQFIEKC 261
+D EV + + +C
Sbjct: 243 CDD-EVYELMRQC 254
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 43/182 (23%), Positives = 75/182 (41%), Gaps = 25/182 (13%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV 121
S +E + E ++L+H N+++ + V E G L+ Y L+ R
Sbjct: 35 SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT--PYLLVMEFCPLGDLKGY-LRSCRK 91
Query: 122 ------NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175
+ ++ +I GLL+LH + IH DL N + + VKIGD GL+
Sbjct: 92 AELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADL-TVKIGDYGLSH 148
Query: 176 ILRKSH----AARCVGTPEFMAPEVYEEEYNELV--------DIYSFGMCILEMVTF-DY 222
K + ++APE+ +E + L+ +++S G+ I E+
Sbjct: 149 NKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQ 208
Query: 223 PY 224
PY
Sbjct: 209 PY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 738 | |||
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.64 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.62 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.52 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.49 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.44 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.39 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.17 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.16 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.16 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.11 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.08 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.92 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.91 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.85 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.83 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.61 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.57 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.55 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.35 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.29 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.27 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.27 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.18 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.07 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.06 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.84 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.83 | |
| PF12202 | 38 | OSR1_C: Oxidative-stress-responsive kinase 1 C ter | 97.77 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.66 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.64 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.57 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.55 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.32 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.3 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.28 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.24 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.16 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.13 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.12 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.1 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.06 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.92 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.65 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.61 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.47 | |
| PLN02236 | 344 | choline kinase | 96.34 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.21 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.07 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.01 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.94 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.74 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.71 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.71 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.63 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.49 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.04 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 94.6 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.46 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 92.56 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 91.51 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 90.84 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 90.79 | |
| PTZ00296 | 442 | choline kinase; Provisional | 90.7 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 84.34 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 84.24 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 83.05 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 82.97 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-86 Score=737.92 Aligned_cols=465 Identities=56% Similarity=0.852 Sum_probs=383.0
Q ss_pred eEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEE
Q 004672 24 EDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 103 (738)
Q Consensus 24 ~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~ 103 (738)
+....||+|+|+|||+|+|..+|.+|||+++++.++.++++.+++|+.|+++|+.|+|||||+||++|++..++++++|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 45678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccccc
Q 004672 104 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 183 (738)
Q Consensus 104 Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~~~ 183 (738)
|+|++|+|+.|++++++++.++++.|++||++||.|||++.||||||||||+||||+++.|.|||+|+|||+.++.++..
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ak 202 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAK 202 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCccccccccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh
Q 004672 184 RCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 263 (738)
Q Consensus 184 ~~vGTp~YmAPEvl~~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~ 263 (738)
+++|||+|||||+|.+.|++.+||||||||++||+|+++||++|.+++|||++|++|.+|..+.++.+|++++||++||.
T Consensus 203 svIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~ 282 (632)
T KOG0584|consen 203 SVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLA 282 (632)
T ss_pred eeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCHHHHhcCcccCCCCCchhhhhhhccCcccccchhhhhhhhccccCCCCCCCCCCccccccCCCCCCCCCcccc
Q 004672 264 TVSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCGHYIGYDTENGLDYHPHEFQ 343 (738)
Q Consensus 264 dP~~RpSa~ELL~Hpf~~~~~~~~~~~~~~~~~~~~~i~p~l~~~~~~~~~s~~s~~~~~~~~~~~d~~~~~~~~~~e~~ 343 (738)
..+.|+||.|||+||||+.++........+ ........+.-++....... +...+.+. .++++-.++.+
T Consensus 283 ~~~~R~sa~eLL~d~Ff~~d~g~~~~~~e~---d~~~~~~~~~~~~~~~~~~~----~~~~n~i~----~~~~~~~D~~e 351 (632)
T KOG0584|consen 283 TKSERLSAKELLKDPFFDEDGGIVELAPED---DMSDPALSLSLRDEDGKKNK----RPKANAIQ----FDYNLNTDESE 351 (632)
T ss_pred CchhccCHHHHhhChhhccccccccccchh---hcccccccccccccchhhcC----Cccccccc----ceeecCCCchh
Confidence 999999999999999999875421000000 00000000001110000000 00001110 11122221111
Q ss_pred c--ccccccc-ccc------ccccccccccccccccCCC-ceEEEEEEecCCCCccceeeeeecCCCCHHHHHHHHHhcC
Q 004672 344 E--SEIDLFT-CQE------DEHLTNFDISIKGKRREDD-GIFLRLRIADKEGRIRNIYFPFDIQTDTALSVATEMVSEL 413 (738)
Q Consensus 344 ~--~~~~~~e-~~~------~~~~~~~d~~~~G~~~~~~-~i~L~Lri~d~~g~~r~i~F~Fd~~~Dta~svA~EMV~~l 413 (738)
. ..+..++ ..+ ....+..++.++|+++++. +++|.|||+|.+|+.|||+|||++++|||.+||.|||+++
T Consensus 352 ~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~~~~~~~~l~l~i~~~~g~~r~i~fpf~~~~dta~~Va~eMv~el 431 (632)
T KOG0584|consen 352 EVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRNDRQTEISLELRIADEDGLVRNIHFPFDLEGDTAPSVAHEMVEEL 431 (632)
T ss_pred HHHHHHHHhccCCcchHHHHHHHhccceeeechhhhcccccceeEeeccCCCCCcccccCCCcCCCcchhHHHHHHHhhc
Confidence 1 0111111 111 1236678999999999877 9999999999999999999999999999999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHhhCCCccCCCCCCCCCC------CcccccccccCCChhhhhhccCCCCCcccccccccC-c
Q 004672 414 DITDQDVTKIAEIIDSEIASLVPEWKRGMAMEESPH------RSSFCHNCASNGCLPDYILSDGSGAKNLQVLQCSKD-G 486 (738)
Q Consensus 414 ~i~~~dv~~IA~~Id~~i~~l~p~w~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 486 (738)
++++++|..||+|||++|.+|+|.|+.....++++. ..+.|.+|.++.....-.+++.+++......+|+.+ .
T Consensus 432 ~~~dq~v~~ia~mid~~i~~L~p~~~~~~~~~~s~~~~~~~~~~s~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 511 (632)
T KOG0584|consen 432 EITDQPVVNIAEMIDGEISALVPNWKASTPNDESPHEQHTDNSVSIQRSSESATQSQKSFSSADPQQVAPFVQQSMEDPL 511 (632)
T ss_pred CCcccchhhHHHHHhchhhhcCCccCCCCCccccchhccCcccccccCCCcccccccccccccccccccccccccccCCC
Confidence 999999999999999999999999998876666544 278999999864444333332333344456666666 8
Q ss_pred cccccccceeeEE
Q 004672 487 CAAIHGRFEEITY 499 (738)
Q Consensus 487 ~~~~~~~~~~~~~ 499 (738)
|+..|+||...+.
T Consensus 512 ~~~~~~r~~~~~~ 524 (632)
T KOG0584|consen 512 SSDVESRFSKNEL 524 (632)
T ss_pred ccccccccccccc
Confidence 9999999987655
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-51 Score=433.01 Aligned_cols=261 Identities=29% Similarity=0.459 Sum_probs=239.0
Q ss_pred cCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC
Q 004672 16 KLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95 (738)
Q Consensus 16 ~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 95 (738)
..+..+++..+..||+|+.|+||++.|+.|++.+|+|.|.. ...+...+++.+|+++|+.++||+||++|+.|+...
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~---~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL---NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc---cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 44666789999999999999999999999999999999853 346788899999999999999999999999998854
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs-~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
. .+.|+||||.+|+|.++++..+++++..+..+++++++||.|||. ++ ||||||||+||||+.+ |.|||||||.+
T Consensus 151 ~-~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNsk-GeVKicDFGVS 226 (364)
T KOG0581|consen 151 E-EISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSK-GEVKICDFGVS 226 (364)
T ss_pred c-eEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccC-CCEEecccccc
Confidence 4 699999999999999999999999999999999999999999996 66 9999999999999965 89999999999
Q ss_pred HHhhccccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCC----CCCHHHHHHHHHcCCCCcccccC
Q 004672 175 AILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSE----CTHPAQIYKKVISGKKPEALFKV 249 (738)
Q Consensus 175 ~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~----~~~~~qi~k~i~~g~~p~~l~~~ 249 (738)
..+-.+...+++||..|||||.+.+ .|+.++||||||++++||++|++||.. .....+++..|..+..|......
T Consensus 227 ~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~ 306 (364)
T KOG0581|consen 227 GILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGE 306 (364)
T ss_pred HHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCccc
Confidence 9998888899999999999999986 699999999999999999999999976 35778889999988877665556
Q ss_pred CChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 250 EDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 250 ~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
.++++++||..||+ +|.+|+|+.|||.|||++..
T Consensus 307 fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 307 FSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred CCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 89999999999999 99999999999999999754
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-50 Score=430.53 Aligned_cols=263 Identities=24% Similarity=0.320 Sum_probs=231.2
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCH---HHHHHHHHHHHHHHhCCCCCcceeeEEEEecC
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSP---EELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~---e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 95 (738)
..+.|.+.+.||+|+||+|-+|+.+.||+.||||++......... .....+.+|+++|++|+|||||+++++|..
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~-- 247 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV-- 247 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec--
Confidence 557889999999999999999999999999999999876543322 123346899999999999999999998855
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCC--CCcEEEeccch
Q 004672 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN--QGEVKIGDLGL 173 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~--~g~VKL~DFGl 173 (738)
..+.||||||++||+|.+.+..++.+.+...+.+++||+.||.|||++| |+||||||+|||+..+ +-.+||+|||+
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccch
Confidence 6788999999999999999999999999999999999999999999999 9999999999999744 23689999999
Q ss_pred hHHhhc-cccccccCCCCCCCccccccc----cCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCc--cc
Q 004672 174 AAILRK-SHAARCVGTPEFMAPEVYEEE----YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE--AL 246 (738)
Q Consensus 174 A~~l~~-~~~~~~vGTp~YmAPEvl~~~----ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~--~l 246 (738)
|+..+. +...+.+|||.|.|||++..+ |..++||||+||+||-+++|.+||++......+++.|..|.++. ..
T Consensus 326 AK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 326 AKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred hhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 998864 456788999999999999742 55589999999999999999999998777777889999998763 34
Q ss_pred ccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCCC
Q 004672 247 FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 285 (738)
Q Consensus 247 ~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~~ 285 (738)
+...+.++++||.+||. ||++|||+.|+|+||||+..+.
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 56779999999999999 9999999999999999986543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=431.67 Aligned_cols=264 Identities=31% Similarity=0.450 Sum_probs=237.1
Q ss_pred CcccccCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEE
Q 004672 11 PPSLLKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTS 90 (738)
Q Consensus 11 p~~l~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~ 90 (738)
.++.+.......|...+.||+|+|++||.+.+..+|+.||+|+|.... ...+...+.+.+||+|.++|+|||||+||++
T Consensus 8 ip~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~-l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~ 86 (592)
T KOG0575|consen 8 IPEVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKL-LKKPKQREKVLNEIEIHRSLKHPNIVQFYHF 86 (592)
T ss_pred CCCeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHH-hcCcchHHHHHHHHHHHHhcCCCcEEeeeeE
Confidence 344444544588999999999999999999999999999999998654 4566788999999999999999999999999
Q ss_pred EEecCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEec
Q 004672 91 WVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 170 (738)
Q Consensus 91 fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~D 170 (738)
|.+ ..++|||.|+|..++|..++++.+.++|..++.+++||+.||.|||+++ |||||||..|||++.+ .+|||+|
T Consensus 87 FED--s~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~-~~VKIgD 161 (592)
T KOG0575|consen 87 FED--SNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNEN-MNVKIGD 161 (592)
T ss_pred eec--CCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCc-CcEEecc
Confidence 955 7899999999999999999999999999999999999999999999999 9999999999999966 6999999
Q ss_pred cchhHHhhc--cccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccc
Q 004672 171 LGLAAILRK--SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF 247 (738)
Q Consensus 171 FGlA~~l~~--~~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~ 247 (738)
||||+.+.. ....+.+|||.|+|||++.. .++..+||||+||+||.||+|++||.. .+..++|.+|...... .+
T Consensus 162 FGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~Ik~~~Y~--~P 238 (592)
T KOG0575|consen 162 FGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNKIKLNEYS--MP 238 (592)
T ss_pred cceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHHHHhcCcc--cc
Confidence 999998763 34567789999999999974 599999999999999999999999986 6788899999877654 34
Q ss_pred cCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 248 KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 248 ~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
...++++++||.++|. +|.+|||+.++|.|+||+..
T Consensus 239 ~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 239 SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 4779999999999999 99999999999999999543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-47 Score=406.85 Aligned_cols=257 Identities=27% Similarity=0.372 Sum_probs=223.3
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCe
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 98 (738)
-.++|.+.+.||.|+.++||+|+...+++.||||++.+.+. ...++.+.+|++.|+.++||||++++.+|+. +..
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc---~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv--~~~ 98 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC---NNDLDALRKEVQTMSLIDHPNIVTYHCSFVV--DSE 98 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh---hhhHHHHHHHHHHhhhcCCCCcceEEEEEEe--cce
Confidence 34689999999999999999999999999999999998763 3347899999999999999999999999977 689
Q ss_pred EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 99 INFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
+|+||.||.+||+.++++.. ..++|..+..+++++++||.|||.+| .||||||+.||||+.+ |.|||+|||.+..
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~d-G~VkLadFgvsa~ 175 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSD-GTVKLADFGVSAS 175 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCC-CcEEEcCceeeee
Confidence 99999999999999998875 45999999999999999999999999 9999999999999855 9999999999876
Q ss_pred hhccc-----c-ccccCCCCCCCccccc---cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC----
Q 004672 177 LRKSH-----A-ARCVGTPEFMAPEVYE---EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP---- 243 (738)
Q Consensus 177 l~~~~-----~-~~~vGTp~YmAPEvl~---~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p---- 243 (738)
+.... . .+.+|||+|||||++. ..|+.|+||||||++..||.+|..||.......-+..++ .+..|
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-qn~pp~~~t 254 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-QNDPPTLLT 254 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cCCCCCccc
Confidence 64321 1 5668999999999965 359999999999999999999999999876555555544 44444
Q ss_pred ----cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 244 ----EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 244 ----~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
..-.+.++..++.+|..||+ ||.+||||.+||+|+||+...
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 12234456789999999999 999999999999999998654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=401.23 Aligned_cols=264 Identities=26% Similarity=0.418 Sum_probs=237.1
Q ss_pred cCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC
Q 004672 16 KLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95 (738)
Q Consensus 16 ~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 95 (738)
+.+..++|.+++.||+|+||+||.++.+.||+.+|+|+++....... ........|..||..++||+||+++-.|.+
T Consensus 20 ~~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt-- 96 (357)
T KOG0598|consen 20 EMVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-KEVRHTKAERNILSKIKHPFIVKLIYSFQT-- 96 (357)
T ss_pred ccCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-hhHHHHHHHHHHHHhCCCCcEeeeEEeccc--
Confidence 47788999999999999999999999999999999999987764333 567889999999999999999999998865
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
...+|||+||+.||.|+..+++.+.|++..++.|+..|+.||.|||++| ||||||||+|||++ .+|+|+|+||||++
T Consensus 97 ~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd-~~GHi~LtDFgL~k 173 (357)
T KOG0598|consen 97 EEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLD-EQGHIKLTDFGLCK 173 (357)
T ss_pred CCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeec-CCCcEEEeccccch
Confidence 7899999999999999999999999999999999999999999999999 99999999999998 55999999999998
Q ss_pred Hhhc--cccccccCCCCCCCccccc-cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCCh
Q 004672 176 ILRK--SHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 252 (738)
Q Consensus 176 ~l~~--~~~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~sp 252 (738)
..-. ....+.+||+.|||||++. ..|+..+|.||||+++|+|+||.+||.. .+...++++|..++.+. .+...++
T Consensus 174 ~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-~~~~~~~~~I~~~k~~~-~p~~ls~ 251 (357)
T KOG0598|consen 174 EDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-EDVKKMYDKILKGKLPL-PPGYLSE 251 (357)
T ss_pred hcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-ccHHHHHHHHhcCcCCC-CCccCCH
Confidence 5433 3445678999999999886 4699999999999999999999999986 67888999999888443 3355799
Q ss_pred HHHHHHHHHHh-CcCCCC----CHHHHhcCcccCCCCCch
Q 004672 253 EVRQFIEKCLA-TVSSRL----SARELLTDPFLQIDDYDS 287 (738)
Q Consensus 253 el~~lI~kcL~-dP~~Rp----Sa~ELL~Hpf~~~~~~~~ 287 (738)
+++++|.++|+ +|.+|. .+.++-+||||+..+++.
T Consensus 252 ~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~ 291 (357)
T KOG0598|consen 252 EARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEK 291 (357)
T ss_pred HHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHH
Confidence 99999999999 999996 799999999999887764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-48 Score=396.50 Aligned_cols=252 Identities=30% Similarity=0.436 Sum_probs=226.0
Q ss_pred cCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC
Q 004672 16 KLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95 (738)
Q Consensus 16 ~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 95 (738)
...+..+|.++++||.|+||+||++.+..+|..||+|.++.. .-+....+.+..|+.+|++|+|||||++|+.-+.+.
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~--~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~ 91 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG--MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIED 91 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh--hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhcc
Confidence 566778999999999999999999999999999999999944 345677889999999999999999999999434455
Q ss_pred CCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCC--ceeccCCcccEEEeCCCCcEEEe
Q 004672 96 NRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPP--VIHRDLKCDNIFVNGNQGEVKIG 169 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~l~k----~~~lse~~i~~i~~QIl~aL~yLHs~gp~--IIHRDLKP~NILl~~~~g~VKL~ 169 (738)
+..++||||||.+|+|.+.++. ++.++++.++.++.|++.||.+||++-|. |+||||||.|||++.+ |.|||+
T Consensus 92 ~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~-gvvKLG 170 (375)
T KOG0591|consen 92 NEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN-GVVKLG 170 (375)
T ss_pred chhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC-Cceeec
Confidence 6669999999999999998765 35699999999999999999999995444 9999999999999965 899999
Q ss_pred ccchhHHhhcc--ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCccc
Q 004672 170 DLGLAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL 246 (738)
Q Consensus 170 DFGlA~~l~~~--~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l 246 (738)
||||++.+... ...+.+|||.||+||++.+ .|+.++||||+||++|||+..+.||.+ .+..++-++|..|..|.-+
T Consensus 171 DfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g-~n~~~L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 171 DFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG-DNLLSLCKKIEQGDYPPLP 249 (375)
T ss_pred cchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc-ccHHHHHHHHHcCCCCCCc
Confidence 99999998765 3467789999999998874 699999999999999999999999998 4889999999999988766
Q ss_pred ccCCChHHHHHHHHHHh-CcCCCCCH
Q 004672 247 FKVEDPEVRQFIEKCLA-TVSSRLSA 271 (738)
Q Consensus 247 ~~~~spel~~lI~kcL~-dP~~RpSa 271 (738)
...++.+++.+|..|+. +|..||+.
T Consensus 250 ~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 250 DEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHhhhHHHHHHHHHccCCcccCCCc
Confidence 68899999999999999 99999997
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=400.13 Aligned_cols=259 Identities=27% Similarity=0.448 Sum_probs=228.9
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCe
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 98 (738)
.+++|.+..+||+|+|++||+|.++.+|..||||.|..... +++..+.+..||++|+.|+|||||.++++... .+.
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~--~~~ 83 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVELLLSEIKILKELKHPNIVRLLDCIED--DDF 83 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHHHHHHHHHHHhcCCcceeeEEEEEec--CCe
Confidence 46789999999999999999999999999999999886543 67788999999999999999999999997644 779
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCC-C----CcEEEeccch
Q 004672 99 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN-Q----GEVKIGDLGL 173 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~-~----g~VKL~DFGl 173 (738)
+|||||||.||+|.+|+.+++.+++..++.++.||+.||++||+++ ||||||||+|||++.. . -.+||+|||+
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 9999999999999999999999999999999999999999999999 9999999999999854 1 3589999999
Q ss_pred hHHhhccc-cccccCCCCCCCcccc-ccccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCC-CcccccCC
Q 004672 174 AAILRKSH-AARCVGTPEFMAPEVY-EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK-PEALFKVE 250 (738)
Q Consensus 174 A~~l~~~~-~~~~vGTp~YmAPEvl-~~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~-p~~l~~~~ 250 (738)
|+.+.... ..+.+|+|.|||||++ .++|+.|+|+||+|+|+|+|++|+.||.. .++.++...+..+.. ...+....
T Consensus 162 AR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a-~t~~eL~~~~~k~~~~~~~~~~~~ 240 (429)
T KOG0595|consen 162 ARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA-ETPKELLLYIKKGNEIVPVLPAEL 240 (429)
T ss_pred hhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc-cCHHHHHHHHhccccccCchhhhc
Confidence 99987654 4567899999999999 47899999999999999999999999987 566777777776653 33344556
Q ss_pred ChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 251 DPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 251 spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
++.+.+++-..|. ++.+|.+..+-+.|+|+....
T Consensus 241 s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 241 SNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred cCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 7777899999998 899999999999999997554
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=397.76 Aligned_cols=258 Identities=31% Similarity=0.472 Sum_probs=220.8
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeE
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
..+|...+.||+|+||+||++.++.+|...|||.+.+.+ .+. .+.+.+|+.+|++|+|||||++++.........+
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~ 91 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEY 91 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeee
Confidence 467889999999999999999999999999999998652 222 7889999999999999999999996322212379
Q ss_pred EEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh
Q 004672 100 NFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~~-~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~ 178 (738)
+++|||+++|+|.+++.+.+ ++++..++.+.+||++||+|||++| ||||||||+|||++...|.+||+|||++....
T Consensus 92 ~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 92 NIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred EeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 99999999999999999987 7999999999999999999999999 99999999999999634799999999998776
Q ss_pred c-----cccccccCCCCCCCccccccccC--cccccccchhhhhhhhhcCCCCCC-CCCHHHHHHHHHcCCCCcccccCC
Q 004672 179 K-----SHAARCVGTPEFMAPEVYEEEYN--ELVDIYSFGMCILEMVTFDYPYSE-CTHPAQIYKKVISGKKPEALFKVE 250 (738)
Q Consensus 179 ~-----~~~~~~vGTp~YmAPEvl~~~ys--~~sDIWSLGviLyeLlTG~~Pf~~-~~~~~qi~k~i~~g~~p~~l~~~~ 250 (738)
. .......|||.|||||++...+. .++|||||||+++||+||+.||.+ ......++.....+..| .++...
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P-~ip~~l 248 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP-EIPDSL 248 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC-CCCccc
Confidence 3 22345679999999999984433 499999999999999999999987 34444455555555455 677788
Q ss_pred ChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 251 DPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 251 spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
++++++||.+|+. +|.+||||.+||.|||++...
T Consensus 249 s~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 249 SDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 9999999999999 999999999999999997643
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=409.07 Aligned_cols=264 Identities=25% Similarity=0.375 Sum_probs=234.6
Q ss_pred ccCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEe
Q 004672 15 LKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVD 93 (738)
Q Consensus 15 ~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~ 93 (738)
.......+|.+++.||+|+|++||+|.++.++.+||||++.... ...+...+-+..|-.+|.+| .||.|+++|-.|.+
T Consensus 67 ~~kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~-Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD 145 (604)
T KOG0592|consen 67 EEKKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRY-IIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD 145 (604)
T ss_pred hccCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHH-HHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec
Confidence 33556789999999999999999999999999999999877543 33445567888999999999 99999999999877
Q ss_pred cCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccch
Q 004672 94 TANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 173 (738)
Q Consensus 94 ~~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGl 173 (738)
...+|+|+||+++|+|.++|++.+.|++..++.++.||+.||+|||++| ||||||||+|||++.+ |++||+|||.
T Consensus 146 --~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~d-mhikITDFGs 220 (604)
T KOG0592|consen 146 --EESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKD-GHIKITDFGS 220 (604)
T ss_pred --ccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCC-CcEEEeeccc
Confidence 6789999999999999999999999999999999999999999999999 9999999999999966 8999999999
Q ss_pred hHHhhccc---------------cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHH
Q 004672 174 AAILRKSH---------------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 237 (738)
Q Consensus 174 A~~l~~~~---------------~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i 237 (738)
|+.+.... ..+++||..|.+||++.. ..++.+|||+||||||+|+.|.+||.+ .|.-.++++|
T Consensus 221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra-~NeyliFqkI 299 (604)
T KOG0592|consen 221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA-ANEYLIFQKI 299 (604)
T ss_pred cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc-ccHHHHHHHH
Confidence 98875321 145789999999999975 478899999999999999999999987 6788889998
Q ss_pred HcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCCCch
Q 004672 238 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDS 287 (738)
Q Consensus 238 ~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~~~~ 287 (738)
+.-... ++...++.+++||+++|. +|++|+|+.+|..||||...+++.
T Consensus 300 ~~l~y~--fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 300 QALDYE--FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred HHhccc--CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 865443 456678999999999999 999999999999999999888764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=402.43 Aligned_cols=260 Identities=27% Similarity=0.470 Sum_probs=228.6
Q ss_pred CcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCC-HHHHHHHHHHHHHHHhCC-CCCcceeeEEEEec
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQS-PEELERLYCEIHLLKTLK-HRNIMKFYTSWVDT 94 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s-~e~~e~l~~Ei~iLk~L~-HpNIVkl~~~fv~~ 94 (738)
....+.|.+.+.||+|+||+|++|.+..+|..||+|.+........ ....+.+.+|+.+|+.++ ||||+++++++..
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t- 91 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT- 91 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec-
Confidence 4667899999999999999999999999999999997665422111 134567889999999998 9999999998744
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 95 ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 95 ~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
...+++||||+.||+|.+++...+++.+..++.+++||+.|++|||++| |+||||||+|||++.+.+.+||+|||++
T Consensus 92 -~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 92 -PTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred -CCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 5569999999999999999999999999999999999999999999999 9999999999999976589999999999
Q ss_pred HHh--hccccccccCCCCCCCcccccc-c-cC-cccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccC
Q 004672 175 AIL--RKSHAARCVGTPEFMAPEVYEE-E-YN-ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKV 249 (738)
Q Consensus 175 ~~l--~~~~~~~~vGTp~YmAPEvl~~-~-ys-~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~ 249 (738)
... ......+.+|||.|+|||++.+ . |+ .++||||+|++||.|++|..||.. .+...++.++..|...- +..
T Consensus 169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~~~~~~--p~~ 245 (370)
T KOG0583|consen 169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRKGEFKI--PSY 245 (370)
T ss_pred cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhcCCccC--CCC
Confidence 988 3456778899999999999986 3 65 689999999999999999999997 67777888888887653 233
Q ss_pred C-ChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 250 E-DPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 250 ~-spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
. +++++.+|.+||. +|.+|+|+.+++.||||+..
T Consensus 246 ~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 246 LLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred cCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 3 9999999999999 99999999999999999873
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=381.41 Aligned_cols=259 Identities=27% Similarity=0.460 Sum_probs=236.4
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCC
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 97 (738)
..+++|.+++.||.|+||+|.+++++.+|..+|+|++++.+.. .-.+.+...+|..+|+.+.||+++++++.|.+ ..
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vV-klKQveH~~nEk~vL~~v~~PFlv~l~~t~~d--~~ 117 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVV-KLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD--NS 117 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHH-HHHHHHHHhhHHHHHhhccCceeEEEEEeecc--CC
Confidence 7789999999999999999999999999999999999877643 34567889999999999999999999998866 78
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
.++|||||++||.|+.++.+.++|++..++.++.||+.||+|||+++ |++|||||+|||++.+ |.+||+|||+|+..
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~-G~iKitDFGFAK~v 194 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQN-GHIKITDFGFAKRV 194 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccC-CcEEEEeccceEEe
Confidence 99999999999999999999999999999999999999999999999 9999999999999965 99999999999887
Q ss_pred hccccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004672 178 RKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 256 (738)
Q Consensus 178 ~~~~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~ 256 (738)
... ..+.+|||.|+|||++.. .|+.++|.||||+++|||+.|.+||.. .++.++|.+|..|+.. ++...++++++
T Consensus 195 ~~r-T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~-~~~~~iY~KI~~~~v~--fP~~fs~~~kd 270 (355)
T KOG0616|consen 195 SGR-TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD-DNPIQIYEKILEGKVK--FPSYFSSDAKD 270 (355)
T ss_pred cCc-EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC-CChHHHHHHHHhCccc--CCcccCHHHHH
Confidence 665 667789999999998875 599999999999999999999999987 6779999999999864 45667999999
Q ss_pred HHHHHHh-CcCCC-----CCHHHHhcCcccCCCCCc
Q 004672 257 FIEKCLA-TVSSR-----LSARELLTDPFLQIDDYD 286 (738)
Q Consensus 257 lI~kcL~-dP~~R-----pSa~ELL~Hpf~~~~~~~ 286 (738)
||+++|+ |-.+| ....++..||||+.-++.
T Consensus 271 Ll~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~ 306 (355)
T KOG0616|consen 271 LLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWE 306 (355)
T ss_pred HHHHHHhhhhHhhhcCcCCCccccccCcccccccHH
Confidence 9999999 88888 467899999999977765
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=409.38 Aligned_cols=257 Identities=33% Similarity=0.514 Sum_probs=228.8
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeE
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
...|....+||+|+.|.||.|....++..||||++.+.. ....+-+.+|+.+|+.++|+|||.|+++|+. .+.+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~----Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv--~deL 345 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK----QPKKELLLNEILVMRDLHHPNIVNFLDSYLV--GDEL 345 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc----CCchhhhHHHHHHHHhccchHHHHHHHHhcc--ccee
Confidence 456888999999999999999999999999999999754 2334679999999999999999999999976 4789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 100 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
|+||||++||+|-+.+.. -.++|.++..+++.++.||+|||.++ |+|||||.+|||+. .+|.|||+|||++..+..
T Consensus 346 WVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~-~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLT-MDGSVKLTDFGFCAQISE 421 (550)
T ss_pred EEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEec-cCCcEEEeeeeeeecccc
Confidence 999999999999998655 45999999999999999999999999 99999999999998 458999999999998876
Q ss_pred cc--cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004672 180 SH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 256 (738)
Q Consensus 180 ~~--~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~ 256 (738)
.. ..+.+|||.|||||++.. .|++++||||||++++||+-|++||-.-.....+|..-..|......+...++++++
T Consensus 422 ~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kd 501 (550)
T KOG0578|consen 422 EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKD 501 (550)
T ss_pred ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHH
Confidence 44 456689999999999974 699999999999999999999999987566666777667788777778889999999
Q ss_pred HHHHHHh-CcCCCCCHHHHhcCcccCCCCCc
Q 004672 257 FIEKCLA-TVSSRLSARELLTDPFLQIDDYD 286 (738)
Q Consensus 257 lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~~~ 286 (738)
|+.+||+ |+.+|++|.|||.||||+.....
T Consensus 502 FL~~cL~~dv~~RasA~eLL~HpFl~~a~p~ 532 (550)
T KOG0578|consen 502 FLDRCLVVDVEQRASAKELLEHPFLKMAKPE 532 (550)
T ss_pred HHHHHhhcchhcCCCHHHHhcChhhhhcCCH
Confidence 9999999 99999999999999999765443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=378.00 Aligned_cols=254 Identities=26% Similarity=0.377 Sum_probs=218.7
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeE
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
++.|..+.++|+|+||+||++.++.||+.||||++.-. ..++...+-..+||++|++|+|+|+|.++++| ..++.+
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es--edd~~VkKIAlREIrmLKqLkH~NLVnLiEVF--rrkrkl 76 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES--EDDPVVKKIALREIRMLKQLKHENLVNLIEVF--RRKRKL 76 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC--CccHHHHHHHHHHHHHHHhcccchHHHHHHHH--Hhccee
Confidence 36789999999999999999999999999999987633 45677788999999999999999999999987 457899
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 100 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
++|+|||...-|.++-.....++...++.+++|++.|+.|||+++ +|||||||+||||+.+ |.+||||||+|+.+..
T Consensus 77 hLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~-gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQN-GVVKLCDFGFARTLSA 153 (396)
T ss_pred EEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecC-CcEEeccchhhHhhcC
Confidence 999999977666655333456999999999999999999999999 9999999999999855 8999999999999873
Q ss_pred --cccccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc-CCCC-----------
Q 004672 180 --SHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKKP----------- 243 (738)
Q Consensus 180 --~~~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~-g~~p----------- 243 (738)
...+.++.|.+|+|||++.+ +|+..+||||+||++.||+||++.|++.++.+|+|..... |..+
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 23456689999999999876 5999999999999999999999999999999999865432 2221
Q ss_pred -------------ccc---ccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 244 -------------EAL---FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 244 -------------~~l---~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
+.+ +...+.-+.+|+++||. ||.+|++.++||.||||
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF 287 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF 287 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence 111 22345678999999999 99999999999999999
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=396.76 Aligned_cols=264 Identities=23% Similarity=0.376 Sum_probs=231.8
Q ss_pred CcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCC
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 96 (738)
-+..++|.++..||+||||.||+|.-+.||..+|+|+++..+ .....+.+.+..|-.+|...++|.||++|-+|.+ .
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~-M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD--~ 213 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSE-MLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD--K 213 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHH-HHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC--C
Confidence 457889999999999999999999999999999999999776 3456778899999999999999999999999966 7
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
.++||||||++||++..+|.+.+.|++..++.++.+++.|+..||..| +|||||||+|+||+.. |++||+||||+..
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~-GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAK-GHIKLSDFGLSTG 290 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCC-CCEeeccccccch
Confidence 899999999999999999999999999999999999999999999999 9999999999999955 9999999999953
Q ss_pred hhc-------------------------c------------------------ccccccCCCCCCCcccccc-ccCcccc
Q 004672 177 LRK-------------------------S------------------------HAARCVGTPEFMAPEVYEE-EYNELVD 206 (738)
Q Consensus 177 l~~-------------------------~------------------------~~~~~vGTp~YmAPEvl~~-~ys~~sD 206 (738)
+.. . ...+.+|||.|||||++.+ .|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 310 0 0113479999999999875 5999999
Q ss_pred cccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC--cccccCCChHHHHHHHHHHhCcCCCCC---HHHHhcCcccC
Q 004672 207 IYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP--EALFKVEDPEVRQFIEKCLATVSSRLS---ARELLTDPFLQ 281 (738)
Q Consensus 207 IWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p--~~l~~~~spel~~lI~kcL~dP~~RpS---a~ELL~Hpf~~ 281 (738)
.||||||+||||.|.+||.. .++.+.+++|.....- ..-....++++++||.+||.+|.+|+. +.||.+||||+
T Consensus 371 wWSLG~ImyEmLvGyPPF~s-~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~ 449 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCS-ETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFK 449 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccc
Confidence 99999999999999999987 7888999998875421 111234569999999999999999974 99999999999
Q ss_pred CCCCch
Q 004672 282 IDDYDS 287 (738)
Q Consensus 282 ~~~~~~ 287 (738)
..+++.
T Consensus 450 ~v~W~~ 455 (550)
T KOG0605|consen 450 GVDWDH 455 (550)
T ss_pred cCCcch
Confidence 888763
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=402.63 Aligned_cols=284 Identities=23% Similarity=0.370 Sum_probs=244.2
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCe
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 98 (738)
.++-|++++.||.|+.|.|-+|.+..||+.+|||.|.... ..+......+.+||-||+.+.||||+++|++|. .+..
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~-~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe--~~~~ 86 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS-ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE--NKQH 86 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeecccc-ccccccccchhhhhHHHHHhcCCCeeeeeeeec--cCce
Confidence 3567999999999999999999999999999999988653 334456678999999999999999999999984 4889
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh
Q 004672 99 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~ 178 (738)
+|+|.||++||.|++|+.+++++++..+..+++||+.|+.|||..+ |+||||||+|+|++.+ +.|||+|||+|..-.
T Consensus 87 lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~-~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVK-NNIKIADFGMASLEV 163 (786)
T ss_pred EEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcc-cCEeeeccceeeccc
Confidence 9999999999999999999999999999999999999999999999 9999999999999966 569999999997654
Q ss_pred c-cccccccCCCCCCCccccccc-c-CcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHH
Q 004672 179 K-SHAARCVGTPEFMAPEVYEEE-Y-NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVR 255 (738)
Q Consensus 179 ~-~~~~~~vGTp~YmAPEvl~~~-y-s~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~ 255 (738)
. ....+.||+|.|.|||++.+. | +.++||||.|||||.||||+.||.+ .|...++.+|..|..- .+...+++++
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~f~--MPs~Is~eaQ 240 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGVFE--MPSNISSEAQ 240 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCccc--CCCcCCHHHH
Confidence 4 456788999999999999864 5 4689999999999999999999985 7899999999999864 3467799999
Q ss_pred HHHHHHHh-CcCCCCCHHHHhcCcccCCCCCchhhhhhh--------ccCcccccchhhhhhhhc
Q 004672 256 QFIEKCLA-TVSSRLSARELLTDPFLQIDDYDSDLRMIQ--------YQTDYDEISPLLRQSLYG 311 (738)
Q Consensus 256 ~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~~~~~~~~~~--------~~~~~~~i~p~l~~~~~~ 311 (738)
+||.+||. ||.+|+|.+|+++|||+...........+. ......+++|.+.+.+.-
T Consensus 241 dLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~~~~~~~~i~s~ps~~~IDp~Il~~l~i 305 (786)
T KOG0588|consen 241 DLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSSKSLRPPVSVPILSIPSIQEIDPLILQHLCI 305 (786)
T ss_pred HHHHHHhccCccccccHHHHhhCchhhcCCCCChhhhcCCCcccceeecCCcccCCHHHHhhhhh
Confidence 99999999 999999999999999998765443321111 112344666766665543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=378.82 Aligned_cols=262 Identities=24% Similarity=0.377 Sum_probs=228.0
Q ss_pred cccCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEe
Q 004672 14 LLKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD 93 (738)
Q Consensus 14 l~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~ 93 (738)
......+++|.+.+.||.|+||+||+|.++.+|..||+|.++.... ......+.+.+|+.+|+.++||||++++++|..
T Consensus 11 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 89 (329)
T PTZ00263 11 DTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI-LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD 89 (329)
T ss_pred ccCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc
Confidence 4556677999999999999999999999999999999999885432 223456789999999999999999999998865
Q ss_pred cCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccch
Q 004672 94 TANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 173 (738)
Q Consensus 94 ~~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGl 173 (738)
.+.+++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+
T Consensus 90 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~-~~~kl~Dfg~ 164 (329)
T PTZ00263 90 --ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNK-GHVKVTDFGF 164 (329)
T ss_pred --CCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCC-CCEEEeeccC
Confidence 6789999999999999999998889999999999999999999999998 9999999999999854 8999999999
Q ss_pred hHHhhccccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCCh
Q 004672 174 AAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 252 (738)
Q Consensus 174 A~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~sp 252 (738)
+...... .....||+.|+|||++.+ .++.++|||||||++|+|+||..||.+ .+..+++..+..+..+ ++...++
T Consensus 165 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~--~p~~~~~ 240 (329)
T PTZ00263 165 AKKVPDR-TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAGRLK--FPNWFDG 240 (329)
T ss_pred ceEcCCC-cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCcC--CCCCCCH
Confidence 9765433 234569999999999875 488999999999999999999999986 5667778888877643 3445788
Q ss_pred HHHHHHHHHHh-CcCCCCC-----HHHHhcCcccCCCCC
Q 004672 253 EVRQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDDY 285 (738)
Q Consensus 253 el~~lI~kcL~-dP~~RpS-----a~ELL~Hpf~~~~~~ 285 (738)
.+++||.+||+ +|.+|++ +.+|+.||||+..++
T Consensus 241 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~ 279 (329)
T PTZ00263 241 RARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANW 279 (329)
T ss_pred HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCH
Confidence 99999999999 9999997 799999999986544
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=371.75 Aligned_cols=255 Identities=26% Similarity=0.407 Sum_probs=221.8
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.+++.||.|+||+||+|.++.+|..||+|++..... ......+.+.+|+.+|+.++||||+++++++.+ ...++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 77 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV-IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--QRFLY 77 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH-hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--CCeEE
Confidence 478999999999999999999999999999999875432 223456778999999999999999999987654 67899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
+||||+++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~-~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKE-GHIKLTDFGFAKKLRDR 154 (291)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCC-CCEEEEecCcchhccCC
Confidence 99999999999999998889999999999999999999999998 9999999999999854 89999999999876543
Q ss_pred ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHH
Q 004672 181 HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 259 (738)
Q Consensus 181 ~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~ 259 (738)
.....||+.|+|||++.+ .++.++|||||||++|+|+||..||.. .+...++..+..+... ++...++.++++|.
T Consensus 155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~ 230 (291)
T cd05612 155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKLE--FPRHLDLYAKDLIK 230 (291)
T ss_pred -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCcC--CCccCCHHHHHHHH
Confidence 234569999999998875 488999999999999999999999986 4567777887776543 34456899999999
Q ss_pred HHHh-CcCCCCC-----HHHHhcCcccCCCCC
Q 004672 260 KCLA-TVSSRLS-----ARELLTDPFLQIDDY 285 (738)
Q Consensus 260 kcL~-dP~~RpS-----a~ELL~Hpf~~~~~~ 285 (738)
+||. +|.+|++ +.+++.||||+.-++
T Consensus 231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 231 KLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred HHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence 9999 9999995 999999999976443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=387.26 Aligned_cols=270 Identities=26% Similarity=0.306 Sum_probs=227.5
Q ss_pred ccCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEec
Q 004672 15 LKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 94 (738)
Q Consensus 15 ~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~ 94 (738)
+.....+.|..+++||+|.||.||+|++..||+.||+|+|++.. ..+.......+||.||++|+||||+++.+..++.
T Consensus 111 w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~--~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~ 188 (560)
T KOG0600|consen 111 WGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN--EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK 188 (560)
T ss_pred ccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc--CCCcchHHHHHHHHHHHhcCCCcccceeeEEEec
Confidence 44455677999999999999999999999999999999999764 2345566789999999999999999999987776
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccch
Q 004672 95 ANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 173 (738)
Q Consensus 95 ~~~~l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGl 173 (738)
....+|||+|||+. +|.-++... -+|++.+++.+++||+.||+|||++| |+|||||+.||||+ +.|.+||+||||
T Consensus 189 ~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLid-n~G~LKiaDFGL 264 (560)
T KOG0600|consen 189 LSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILID-NNGVLKIADFGL 264 (560)
T ss_pred CCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEc-CCCCEEeccccc
Confidence 67899999999964 888776653 47999999999999999999999999 99999999999998 559999999999
Q ss_pred hHHhhccc---cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc-CCCCccc-
Q 004672 174 AAILRKSH---AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKKPEAL- 246 (738)
Q Consensus 174 A~~l~~~~---~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~-g~~p~~l- 246 (738)
|+++.... .+..+-|.+|+|||++.+ .|+.++|+||.||||.||++|++.|.+.+..+|+-+...- |...+..
T Consensus 265 Ar~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 265 ARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW 344 (560)
T ss_pred eeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence 99776543 456678999999999876 5999999999999999999999999998888877543321 2211111
Q ss_pred ------------------------ccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCCCchhhh
Q 004672 247 ------------------------FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDSDLR 290 (738)
Q Consensus 247 ------------------------~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~~~~~~~ 290 (738)
+...++...+|++++|. ||.+|.||.++|.++||..+....+..
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p~ 413 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDPS 413 (560)
T ss_pred ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCcc
Confidence 23456789999999999 999999999999999997766554433
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=384.62 Aligned_cols=256 Identities=30% Similarity=0.449 Sum_probs=216.0
Q ss_pred cccCcCCCCceEEEEEcccCCeEEEEEEEcCCCeE-EEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEE
Q 004672 14 LLKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIE-VAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWV 92 (738)
Q Consensus 14 l~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~-VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv 92 (738)
....|..+++.+.+.||.|+||+||+|. +.|.. ||+|.+...+.. ....+.|.+|+.+|.+|+|||||+|++++.
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~--~~g~~~vavK~~~~~~~~--~~~~~~f~~E~~il~~l~HpNIV~f~G~~~ 109 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGK--WRGTDVVAVKIISDPDFD--DESRKAFRREASLLSRLRHPNIVQFYGACT 109 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEE--eCCceeEEEEEecchhcC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4456667777888889999999999995 67777 999998865532 233789999999999999999999999875
Q ss_pred ecCCCeEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEec
Q 004672 93 DTANRNINFVTEMFTSGTLRQYRLK--HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 170 (738)
Q Consensus 93 ~~~~~~l~LV~Ey~~gGSL~~~l~k--~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~D 170 (738)
... ..+.+||||+++|+|.+++.+ .+.++...+..|+.+|+.||.|||+++| ||||||||+|||++.+.-++||+|
T Consensus 110 ~~~-~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~D 187 (362)
T KOG0192|consen 110 SPP-GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIAD 187 (362)
T ss_pred CCC-CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECC
Confidence 422 278999999999999999988 5789999999999999999999999986 999999999999986523999999
Q ss_pred cchhHHhhcc--ccccccCCCCCCCccccccc---cCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcc
Q 004672 171 LGLAAILRKS--HAARCVGTPEFMAPEVYEEE---YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEA 245 (738)
Q Consensus 171 FGlA~~l~~~--~~~~~vGTp~YmAPEvl~~~---ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~ 245 (738)
||+++..... ......||+.|||||++.+. |+.++||||||+++|||+||+.||.+... .++...+..+.....
T Consensus 188 FGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp~ 266 (362)
T KOG0192|consen 188 FGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRPP 266 (362)
T ss_pred CccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCCC
Confidence 9999876653 23335799999999999853 99999999999999999999999998766 666555554444334
Q ss_pred cccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 246 LFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 246 l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
++...++.+..+++.||. +|.+||+..+++.
T Consensus 267 ~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 267 IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 555588999999999999 9999999998863
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=377.00 Aligned_cols=258 Identities=24% Similarity=0.424 Sum_probs=218.8
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.+++.||.|+||+||+|.+..+|..||+|+++.... ........+.+|+.+|+.++||||++++++|.+ +..++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~ 77 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM-LEKEQVAHVRAERDILAEADNPWVVKLYYSFQD--ENYLY 77 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCeEE
Confidence 479999999999999999999999999999999985432 223455678899999999999999999998755 67899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..+...
T Consensus 78 lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKS 154 (364)
T ss_pred EEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC-CCEEEeecccceecccc
Confidence 99999999999999998888999999999999999999999999 9999999999999855 89999999998654221
Q ss_pred c----------------------------------------cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhh
Q 004672 181 H----------------------------------------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT 219 (738)
Q Consensus 181 ~----------------------------------------~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlT 219 (738)
. ....+||+.|+|||++.. .|+.++|||||||++|+|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 0 112469999999998864 58999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCccc--ccCCChHHHHHHHHHHhCcCCCCC---HHHHhcCcccCCCCC
Q 004672 220 FDYPYSECTHPAQIYKKVISGKKPEAL--FKVEDPEVRQFIEKCLATVSSRLS---ARELLTDPFLQIDDY 285 (738)
Q Consensus 220 G~~Pf~~~~~~~qi~k~i~~g~~p~~l--~~~~spel~~lI~kcL~dP~~RpS---a~ELL~Hpf~~~~~~ 285 (738)
|..||... +..+.+..+........+ ....++++++||.+||.+|.+|++ +.++|.||||+..++
T Consensus 235 G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~ 304 (364)
T cd05599 235 GYPPFCSD-NPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDW 304 (364)
T ss_pred CCCCCCCC-CHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 99999864 455666666654432222 224588999999999999999997 999999999987654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=389.08 Aligned_cols=252 Identities=26% Similarity=0.387 Sum_probs=225.1
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.+.+.||+|+||.||||+.++|+..||+|.+.+. ...+.+++.+.+|++|++.|+|||||.++++| +....+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~--gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf--Et~~~~~ 77 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKS--GRNEKELKNLRQEVRILRSLKHPNIVEMLESF--ETSAHLW 77 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhc--CCchHHHHHHHHHHHHHHhcCCcchhhHHHhh--cccceEE
Confidence 5788899999999999999999999999999987754 45677889999999999999999999999988 5578999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
+|+||+.| +|+.++...+.++++.++.++.+++.||.|||+++ |+|||+||.|||+..+ |.+|++|||+|+.+...
T Consensus 78 vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~-~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 78 VVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKG-GTLKLCDFGLARAMSTN 153 (808)
T ss_pred EEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCC-CceeechhhhhhhcccC
Confidence 99999976 99999999999999999999999999999999999 9999999999999855 89999999999987653
Q ss_pred --ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004672 181 --HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 257 (738)
Q Consensus 181 --~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~l 257 (738)
...+..|||.|||||++.+ .|+..+|.||+||++|||++|++||.. ....++.+.|.... ..++...+..++.|
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~I~~d~--v~~p~~~S~~f~nf 230 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKSILKDP--VKPPSTASSSFVNF 230 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHHHhcCC--CCCcccccHHHHHH
Confidence 3345569999999999985 599999999999999999999999975 55667777776543 33455789999999
Q ss_pred HHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 258 IEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 258 I~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
++.+|. ||.+|+|..+|+.|||.+..
T Consensus 231 l~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 231 LQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHHhhcChhhcccHHHHhcChHHhhh
Confidence 999999 99999999999999998754
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=374.59 Aligned_cols=266 Identities=22% Similarity=0.373 Sum_probs=228.6
Q ss_pred CCcccccCcCCCCceEEEEEcccCCeEEEEEEEcCCC-eEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceee
Q 004672 10 IPPSLLKLIPLEDMEDTMKFLVKELQRHYRAFDEYEG-IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY 88 (738)
Q Consensus 10 vp~~l~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG-~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~ 88 (738)
..+.....+..++|.+.+.||.|+||+||+|.+..++ ..||+|++..... ......+.+.+|+.+|+.++||||++++
T Consensus 19 ~~~~~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~ 97 (340)
T PTZ00426 19 KEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI-IKQKQVDHVFSERKILNYINHPFCVNLY 97 (340)
T ss_pred cccccCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhCCCCCCcceE
Confidence 3455667788899999999999999999999977665 7899999875432 2334567889999999999999999999
Q ss_pred EEEEecCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEE
Q 004672 89 TSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 168 (738)
Q Consensus 89 ~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL 168 (738)
++|.+ ...+++||||+.+|+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ |.+||
T Consensus 98 ~~~~~--~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~-~~ikL 172 (340)
T PTZ00426 98 GSFKD--ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKD-GFIKM 172 (340)
T ss_pred EEEEe--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCC-CCEEE
Confidence 98855 6789999999999999999999889999999999999999999999998 9999999999999854 89999
Q ss_pred eccchhHHhhccccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccc
Q 004672 169 GDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF 247 (738)
Q Consensus 169 ~DFGlA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~ 247 (738)
+|||++...... .....||+.|||||++.+ .++.++|||||||++|+|+||..||.. .+...+++.+..+... ++
T Consensus 173 ~DFG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~~~~--~p 248 (340)
T PTZ00426 173 TDFGFAKVVDTR-TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA-NEPLLIYQKILEGIIY--FP 248 (340)
T ss_pred ecCCCCeecCCC-cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCC--CC
Confidence 999999765432 234569999999999865 488999999999999999999999986 4566777888776542 34
Q ss_pred cCCChHHHHHHHHHHh-CcCCCC-----CHHHHhcCcccCCCCC
Q 004672 248 KVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDY 285 (738)
Q Consensus 248 ~~~spel~~lI~kcL~-dP~~Rp-----Sa~ELL~Hpf~~~~~~ 285 (738)
...++.++++|.+||+ +|.+|+ ++.++++||||+..++
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 249 KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 5568899999999999 899995 8999999999986554
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=370.32 Aligned_cols=257 Identities=22% Similarity=0.319 Sum_probs=218.4
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.++++||.|+||.||+|.+..+|..||+|+++.... ........+..|+.+|+.++||||+++++++.. ...++
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~ 77 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL-FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD--DEYLY 77 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--CCEEE
Confidence 479999999999999999999999999999999885432 223456678999999999999999999998754 67899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
+||||+++|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.....
T Consensus 78 lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 78 LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDAS-GHIKLTDFGLSKGIVT- 153 (333)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCC-CCEEEEeCcCCccccc-
Confidence 99999999999999988888999999999999999999999999 9999999999999854 8999999999976544
Q ss_pred ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCC----Ccc--cccCCChH
Q 004672 181 HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK----PEA--LFKVEDPE 253 (738)
Q Consensus 181 ~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~----p~~--l~~~~spe 253 (738)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+.+..+..... |.. .....+++
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~ 232 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQRPVYDDPRFNLSDE 232 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC-CCHHHHHHHHHhccccccCCCCCccccccCHH
Confidence 2344569999999998864 589999999999999999999999986 455666555554321 111 01245889
Q ss_pred HHHHHHHHHh-CcCCCCCHHHHhcCcccCCCCC
Q 004672 254 VRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 285 (738)
Q Consensus 254 l~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~~ 285 (738)
+.+||.+||. +|.+||++.++++||||....+
T Consensus 233 ~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 233 AWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred HHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence 9999999999 7999999999999999986543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=376.50 Aligned_cols=259 Identities=24% Similarity=0.397 Sum_probs=218.0
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.+++.||.|+||+||+|.++.+|..||+|+++.... ........+..|+.+|+.++||||+++++.|.+ ...++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~--~~~~~ 77 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM-LEKEQVGHIRAERDILVEADSLWVVKMFYSFQD--KLNLY 77 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH-HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCeEE
Confidence 479999999999999999999999999999999875432 234456788999999999999999999998755 67899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
+||||++||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..+...
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~-~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKA 154 (363)
T ss_pred EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCC-CCEEEeeccCccccccc
Confidence 99999999999999998889999999999999999999999998 9999999999999854 89999999998654321
Q ss_pred c-------------------------------------cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCC
Q 004672 181 H-------------------------------------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDY 222 (738)
Q Consensus 181 ~-------------------------------------~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~ 222 (738)
. ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 0 123469999999999864 58999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCcccc--cCCChHHHHHHHHHHhCc---CCCCCHHHHhcCcccCCCCCc
Q 004672 223 PYSECTHPAQIYKKVISGKKPEALF--KVEDPEVRQFIEKCLATV---SSRLSARELLTDPFLQIDDYD 286 (738)
Q Consensus 223 Pf~~~~~~~qi~k~i~~g~~p~~l~--~~~spel~~lI~kcL~dP---~~RpSa~ELL~Hpf~~~~~~~ 286 (738)
||.. .+...+++++........++ ...+++++++|.+++.+| ..||++.||++||||+..++.
T Consensus 235 Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~ 302 (363)
T cd05628 235 PFCS-ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWE 302 (363)
T ss_pred CCCC-CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHH
Confidence 9986 45667777777643222222 235789999999977744 457899999999999876654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=370.51 Aligned_cols=250 Identities=23% Similarity=0.378 Sum_probs=214.9
Q ss_pred EEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEecC
Q 004672 27 MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMF 106 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey~ 106 (738)
+.||+|+||+||+|.+..+|..||+|+++... ........++.+|+.+|+.++||||++++++|.. +..+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEV-IIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH-hhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEEEeCC
Confidence 36999999999999999999999999988543 2234556778899999999999999999998754 67899999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc--ccccc
Q 004672 107 TSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAAR 184 (738)
Q Consensus 107 ~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~--~~~~~ 184 (738)
++|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++..... .....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCC-CCEEEeeCCCCcccccCCCcccc
Confidence 99999999998889999999999999999999999999 9999999999999854 8999999999875322 22234
Q ss_pred ccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh
Q 004672 185 CVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 263 (738)
Q Consensus 185 ~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~ 263 (738)
.+||+.|+|||++.+ .|+.++|||||||++|+|+||..||.. .+...++..+..+.. .++...++++++||.+||.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--RFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHcc
Confidence 569999999999874 589999999999999999999999976 455666666665543 2345678999999999999
Q ss_pred -CcCCCC-----CHHHHhcCcccCCCCC
Q 004672 264 -TVSSRL-----SARELLTDPFLQIDDY 285 (738)
Q Consensus 264 -dP~~Rp-----Sa~ELL~Hpf~~~~~~ 285 (738)
+|.+|| ++.++++||||+..++
T Consensus 232 ~dP~~R~~~~~~~~~~ll~h~~f~~~~~ 259 (323)
T cd05571 232 KDPKQRLGGGPEDAKEIMEHRFFASINW 259 (323)
T ss_pred CCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 999999 8999999999987554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=385.25 Aligned_cols=258 Identities=29% Similarity=0.374 Sum_probs=219.9
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCC-CCCcceeeEEEEecCCC
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANR 97 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~ 97 (738)
-.+.|.++++||.|.||.||+|..+.+|..||||+++..- .+-++. -=.+|++.|++|+ |||||++++++.+.. +
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf--~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~-~ 83 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF--YSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDND-R 83 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh--ccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccC-c
Confidence 3568999999999999999999999999999999988542 222332 2357999999998 999999999887643 3
Q ss_pred eEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 98 NINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
.++|||||| ...|.++++.+ +.|++..++.|++||+.||+|+|.+| +.||||||+|||+.++ ..|||+|||+|+.
T Consensus 84 ~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~-~~iKiaDFGLARe 159 (538)
T KOG0661|consen 84 ILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGN-DVIKIADFGLARE 159 (538)
T ss_pred eEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEeccc-ceeEecccccccc
Confidence 999999999 57999998775 45999999999999999999999999 9999999999999865 4899999999998
Q ss_pred hhcc-ccccccCCCCCCCccccc--cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc-CCC----------
Q 004672 177 LRKS-HAARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKK---------- 242 (738)
Q Consensus 177 l~~~-~~~~~vGTp~YmAPEvl~--~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~-g~~---------- 242 (738)
.... ..+.++.|.+|+|||++. +.|+.++||||+|||++|+.+.++.|.+....+||++...- |..
T Consensus 160 v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 160 VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 7654 456778999999999885 46999999999999999999999999999999999876532 211
Q ss_pred ---------C-------cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 243 ---------P-------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 243 ---------p-------~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
| ..+....++++.++|.+||. ||.+||||.++|+||||+...
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 1 11223367899999999999 999999999999999998643
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=376.52 Aligned_cols=258 Identities=21% Similarity=0.348 Sum_probs=215.5
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.++++||.|+||+||+|.++.+|..||+|++..... ...+..+.+.+|+.+|+.++||||++++++|.+ ...+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~ 77 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM-FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--AQYLY 77 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH-HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCeeE
Confidence 478999999999999999999999999999999875432 234556789999999999999999999998855 67899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
+||||+++|+|.+++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..+...
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~-~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCC-CCEEEeecccccccccc
Confidence 99999999999999998889999999999999999999999999 9999999999999854 89999999998532110
Q ss_pred -------------------------------------------------ccccccCCCCCCCcccccc-ccCcccccccc
Q 004672 181 -------------------------------------------------HAARCVGTPEFMAPEVYEE-EYNELVDIYSF 210 (738)
Q Consensus 181 -------------------------------------------------~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSL 210 (738)
.....+||+.|+|||++.+ .|+.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 0012469999999999864 59999999999
Q ss_pred hhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccc--cCCChHHHHHHHHHHhCcCC---CCCHHHHhcCcccCCCCC
Q 004672 211 GMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF--KVEDPEVRQFIEKCLATVSS---RLSARELLTDPFLQIDDY 285 (738)
Q Consensus 211 GviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~--~~~spel~~lI~kcL~dP~~---RpSa~ELL~Hpf~~~~~~ 285 (738)
||++|+|+||..||.. .+....+..+........++ ...++++++||.+||.+|.+ |+++.++|.||||+..++
T Consensus 235 Gvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 235 GAIMFECLIGWPPFCS-ENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred chhhhhhhcCCCCCCC-CCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 9999999999999986 34556666666533222222 24688999999999996655 569999999999986543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=367.97 Aligned_cols=258 Identities=24% Similarity=0.421 Sum_probs=218.0
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCC
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 97 (738)
+..++|.+++.||.|+||+||+|.+..+|..||+|.+... ..+...+++.+|+++|+.++||||+++++++.. ..
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 76 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DG 76 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc---cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CC
Confidence 4568999999999999999999999999999999988753 245566789999999999999999999998865 56
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
.+++||||+.+|+|.+++...+.+++..+..++.|++.||.|||+.+ +|+||||||+|||++.+ +.+||+|||++...
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~ 154 (331)
T cd06649 77 EISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVNSR-GEIKLCDFGVSGQL 154 (331)
T ss_pred EEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEEcCC-CcEEEccCcccccc
Confidence 89999999999999999998888999999999999999999999863 39999999999999855 79999999999876
Q ss_pred hccccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHH--------------------
Q 004672 178 RKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK-------------------- 236 (738)
Q Consensus 178 ~~~~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~-------------------- 236 (738)
.........||+.|+|||++.+ .++.++|||||||++|+|+||+.||... +...+...
T Consensus 155 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 155 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP-DAKELEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred cccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhcccccccccCCccccCccc
Confidence 5554555679999999999874 5899999999999999999999999653 22222211
Q ss_pred --------------------------HHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 237 --------------------------VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 237 --------------------------i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
+.....|......+++++++||.+||. +|.+|||+.+||+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 111222222223467899999999999 99999999999999999754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=371.20 Aligned_cols=258 Identities=24% Similarity=0.372 Sum_probs=219.7
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.+++.||.|+||+||+|.+..+|..||+|+++.... ........+..|+.+|..++||||++++++|.+ +..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~ 77 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM-IKRNQIAHVRAERDILADADSPWIVKLYYSFQD--EEHLY 77 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHH-hhccHHHHHHHHHHHHHhcCCCCccchhhheec--CCeEE
Confidence 479999999999999999999999999999999885432 222455678999999999999999999998754 67899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDAD-GHIKLADFGLCKKMNKA 154 (350)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEeecCCCCccCccc
Confidence 99999999999999998888999999999999999999999998 9999999999999855 89999999999765433
Q ss_pred c-------------------------------cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCC
Q 004672 181 H-------------------------------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT 228 (738)
Q Consensus 181 ~-------------------------------~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~ 228 (738)
. .....||+.|+|||++.+ .++.++|||||||++|+|++|..||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 233469999999999875 58999999999999999999999998744
Q ss_pred CHHHHHHHHHcC--CCCcccccCCChHHHHHHHHHHhCcCCCCC-HHHHhcCcccCCCCC
Q 004672 229 HPAQIYKKVISG--KKPEALFKVEDPEVRQFIEKCLATVSSRLS-ARELLTDPFLQIDDY 285 (738)
Q Consensus 229 ~~~qi~k~i~~g--~~p~~l~~~~spel~~lI~kcL~dP~~RpS-a~ELL~Hpf~~~~~~ 285 (738)
....+..+... ..........++++++||.+||.+|.+|++ +.++|+||||+..++
T Consensus 235 -~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~~~ 293 (350)
T cd05573 235 -LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDW 293 (350)
T ss_pred -HHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCCCH
Confidence 55556666652 211112233689999999999999999999 999999999986554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=385.52 Aligned_cols=254 Identities=28% Similarity=0.424 Sum_probs=226.1
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
..|+....||.|+||.||+|+|..+++.||+|++.+.. ..++.+.+.+|+.+|.+++++||.++|+.|+. +..+|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~---~~deIediqqei~~Ls~~~~~~it~yygsyl~--g~~Lw 87 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE---AEDEIEDIQQEISVLSQCDSPNITEYYGSYLK--GTKLW 87 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh---cchhhHHHHHHHHHHHhcCcchHHhhhhheee--cccHH
Confidence 45777899999999999999999999999999988754 55677889999999999999999999999987 67899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
++||||.||++.+.++....+.+..+..++++++.||.|||.++ .+|||||+.|||+... |.|||+|||++..+...
T Consensus 88 iiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~-g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSES-GDVKLADFGVAGQLTNT 164 (467)
T ss_pred HHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEecc-CcEEEEecceeeeeech
Confidence 99999999999999888877799999999999999999999999 9999999999999866 99999999999877654
Q ss_pred c--cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004672 181 H--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 257 (738)
Q Consensus 181 ~--~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~l 257 (738)
. ..+.+|||.|||||++.+ .|+.++||||||++++||++|.+||..+.....+ .++....|+.+....++.+++|
T Consensus 165 ~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl--flIpk~~PP~L~~~~S~~~kEF 242 (467)
T KOG0201|consen 165 VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL--FLIPKSAPPRLDGDFSPPFKEF 242 (467)
T ss_pred hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE--EeccCCCCCccccccCHHHHHH
Confidence 3 367789999999999986 6999999999999999999999999986653222 2334556666777889999999
Q ss_pred HHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 258 IEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 258 I~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
|+.||+ +|..||||.+||+|+|++...
T Consensus 243 V~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 243 VEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred HHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 999999 899999999999999998743
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=373.71 Aligned_cols=258 Identities=23% Similarity=0.349 Sum_probs=215.9
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
.|.++++||+|+||+||+|.+..++..||+|++.... .......+.+.+|+.+|+.++||||+++++.|.+ +..+++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~-~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~~~~l 78 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKD-VLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYF 78 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHH-hhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CCEEEE
Confidence 5889999999999999999999999999999987543 2234556789999999999999999999998865 678999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc-
Q 004672 102 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS- 180 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~- 180 (738)
||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..+...
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~-g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 79 VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEEeECCCCccccccc
Confidence 9999999999999988888999999999999999999999998 9999999999999854 89999999997532100
Q ss_pred ------------------------------------------------ccccccCCCCCCCcccccc-ccCcccccccch
Q 004672 181 ------------------------------------------------HAARCVGTPEFMAPEVYEE-EYNELVDIYSFG 211 (738)
Q Consensus 181 ------------------------------------------------~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLG 211 (738)
.....+||+.|+|||++.+ .|+.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0123469999999998864 599999999999
Q ss_pred hhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCc--ccccCCChHHHHHHHHHHhCcCCCCC---HHHHhcCcccCCCCCc
Q 004672 212 MCILEMVTFDYPYSECTHPAQIYKKVISGKKPE--ALFKVEDPEVRQFIEKCLATVSSRLS---ARELLTDPFLQIDDYD 286 (738)
Q Consensus 212 viLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~--~l~~~~spel~~lI~kcL~dP~~RpS---a~ELL~Hpf~~~~~~~ 286 (738)
|++|+|++|..||... ++.+....+....... ......+++++++|.+|+.+|.+|++ +.+++.||||+..++.
T Consensus 236 vil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~ 314 (382)
T cd05625 236 VILYEMLVGQPPFLAQ-TPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFS 314 (382)
T ss_pred HHHHHHHhCCCCCCCC-CHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence 9999999999999874 4444445554432221 12245689999999998889999987 9999999999876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=374.62 Aligned_cols=258 Identities=23% Similarity=0.339 Sum_probs=213.9
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
.|.+++.||+|+||+||+|.+..+|..||+|++..... ......+.+.+|+.+|+.++||||++++++|.+ ...+++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~l 78 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDV-LNRNQVAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYF 78 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CCEEEE
Confidence 58899999999999999999999999999999885442 234556789999999999999999999998865 678999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc-
Q 004672 102 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS- 180 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~- 180 (738)
||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |++||+|||++..+...
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~-~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 79 VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCC-CCEEEeeCcCCccccccc
Confidence 9999999999999998889999999999999999999999998 9999999999999854 89999999997532100
Q ss_pred ------------------------------------------------ccccccCCCCCCCcccccc-ccCcccccccch
Q 004672 181 ------------------------------------------------HAARCVGTPEFMAPEVYEE-EYNELVDIYSFG 211 (738)
Q Consensus 181 ------------------------------------------------~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLG 211 (738)
.....+||+.|+|||++.+ .|+.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0123469999999998864 589999999999
Q ss_pred hhhhhhhhcCCCCCCCCCHHHHHHHHHcCCC--CcccccCCChHHHHHHHHHHh---CcCCCCCHHHHhcCcccCCCCCc
Q 004672 212 MCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLA---TVSSRLSARELLTDPFLQIDDYD 286 (738)
Q Consensus 212 viLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~--p~~l~~~~spel~~lI~kcL~---dP~~RpSa~ELL~Hpf~~~~~~~ 286 (738)
|++|+|+||..||.... .......+..... ........++++++||.+++. ++..|+++.+++.||||+..++.
T Consensus 236 ~il~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~ 314 (381)
T cd05626 236 VILFEMLVGQPPFLAPT-PTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFS 314 (381)
T ss_pred hHHHHHHhCCCCCcCCC-HHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChh
Confidence 99999999999998644 3444444443221 111223468999999999765 35569999999999999876554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=374.05 Aligned_cols=259 Identities=22% Similarity=0.332 Sum_probs=215.3
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.++++||+|+||+||+|.+..+|..||+|.+..... ......+.+.+|+.+|+.++||||+++++.|.+ ++.++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~ 77 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADV-LMRNQAAHVKAERDILAEADNEWVVKLYYSFQD--KDNLY 77 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHH-HhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCEEE
Confidence 479999999999999999999999999999999875432 122345678899999999999999999998855 67999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
+||||+++|+|.+++.+.+.+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++..+...
T Consensus 78 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~-~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 78 FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWT 154 (376)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCC-CCEEEEeCCCCcccccc
Confidence 99999999999999998888999999999999999999999998 9999999999999854 89999999997432100
Q ss_pred ---------------------------------------------ccccccCCCCCCCcccccc-ccCcccccccchhhh
Q 004672 181 ---------------------------------------------HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCI 214 (738)
Q Consensus 181 ---------------------------------------------~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviL 214 (738)
.....+||+.|||||++.+ .++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0113469999999999865 589999999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHcCCCC--cccccCCChHHHHHHHHHHhCcCCCC---CHHHHhcCcccCCCCCc
Q 004672 215 LEMVTFDYPYSECTHPAQIYKKVISGKKP--EALFKVEDPEVRQFIEKCLATVSSRL---SARELLTDPFLQIDDYD 286 (738)
Q Consensus 215 yeLlTG~~Pf~~~~~~~qi~k~i~~g~~p--~~l~~~~spel~~lI~kcL~dP~~Rp---Sa~ELL~Hpf~~~~~~~ 286 (738)
|+|++|+.||... ++......+...... .......++++.++|.+|+.+|.+|+ ++.++++||||+..++.
T Consensus 235 yell~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~~~ 310 (376)
T cd05598 235 YEMLVGQPPFLAD-TPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDFA 310 (376)
T ss_pred eehhhCCCCCCCC-CHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCCHH
Confidence 9999999999874 344444444433221 11223568899999999888999999 99999999999875543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=362.15 Aligned_cols=264 Identities=24% Similarity=0.268 Sum_probs=225.3
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCC
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 97 (738)
-.+++|..+++|++|+||.||+|.|+.|++.||+|+++.... ....--.-.+||.+|.+++|||||.+-.+.+...-+
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke--k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE--KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccc--cCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence 356789999999999999999999999999999999997641 122223568999999999999999999998888888
Q ss_pred eEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 98 NINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~~-~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
.+|||||||+ -+|..++.+-+ +|...+++.++.|++.||+|||.+. |+|||||++|+|++ +.|.+||+|||+|+.
T Consensus 151 ~iy~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~-~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 151 KIYIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLS-HKGILKIADFGLARE 226 (419)
T ss_pred eeeeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeec-cCCcEEecccchhhh
Confidence 9999999996 48999887754 8999999999999999999999999 99999999999998 559999999999999
Q ss_pred hhccc--cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc-CCCCcccc----
Q 004672 177 LRKSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKKPEALF---- 247 (738)
Q Consensus 177 l~~~~--~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~-g~~p~~l~---- 247 (738)
+.... .+..+-|.+|+|||++.+ .|+..+|+||+|||+.||+++++.|.+....+|+.+.+.. |...+.++
T Consensus 227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 88763 345568999999999875 4999999999999999999999999998888988765542 22211111
Q ss_pred ----------------------cC--CChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCCCch
Q 004672 248 ----------------------KV--EDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDS 287 (738)
Q Consensus 248 ----------------------~~--~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~~~~ 287 (738)
.. .+....+|+..+|. ||.+|.||.|.|+|.||.......
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~ 371 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPI 371 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCC
Confidence 11 34678899999999 999999999999999998765443
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=370.37 Aligned_cols=259 Identities=24% Similarity=0.421 Sum_probs=218.4
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.+++.||.|+||+||+|.++.+|..||+|.++..+. ...+....+..|+.+|..++||||+++++.|.+ ...++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~ 77 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM-LEKEQVAHIRAERDILVEADGAWVVKMFYSFQD--KRNLY 77 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEE
Confidence 478999999999999999999999999999999875432 234456788999999999999999999998754 67899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
+||||++||+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..+...
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~-~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKA 154 (360)
T ss_pred EEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCC-CCEEEeeccCCcccccc
Confidence 99999999999999998889999999999999999999999998 9999999999999854 89999999998644211
Q ss_pred c-------------------------------------cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCC
Q 004672 181 H-------------------------------------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDY 222 (738)
Q Consensus 181 ~-------------------------------------~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~ 222 (738)
. ....+||+.|+|||++.+ .|+.++|||||||++|+|+||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 0 113469999999999864 59999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCcccc--cCCChHHHHHHHHHHhCcCCCC---CHHHHhcCcccCCCCCc
Q 004672 223 PYSECTHPAQIYKKVISGKKPEALF--KVEDPEVRQFIEKCLATVSSRL---SARELLTDPFLQIDDYD 286 (738)
Q Consensus 223 Pf~~~~~~~qi~k~i~~g~~p~~l~--~~~spel~~lI~kcL~dP~~Rp---Sa~ELL~Hpf~~~~~~~ 286 (738)
||.. .++...+..+........++ ...+++++++|.+++.+|.+|+ ++.+++.||||+..++.
T Consensus 235 Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~ 302 (360)
T cd05627 235 PFCS-ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWG 302 (360)
T ss_pred CCCC-CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCHH
Confidence 9986 45666667766543222121 2368899999999887899888 58999999999876654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=363.28 Aligned_cols=247 Identities=21% Similarity=0.345 Sum_probs=212.9
Q ss_pred EcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEecCCC
Q 004672 29 FLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTS 108 (738)
Q Consensus 29 LG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey~~g 108 (738)
||+|+||+||+|.+..++..||+|+++... .........+..|+.+|+.++||||++++++|.. ...+++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAH-IVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEEcCCCC
Confidence 699999999999999999999999987543 2234556788999999999999999999998754 6789999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc--ccccccc
Q 004672 109 GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAARCV 186 (738)
Q Consensus 109 GSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~--~~~~~~v 186 (738)
|+|.+++.+.+++++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..... ......+
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQ-GHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCC-CcEEEEECcccccCccCCCcccccc
Confidence 999999998889999999999999999999999998 9999999999999854 8999999999875422 2223456
Q ss_pred CCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-C
Q 004672 187 GTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-T 264 (738)
Q Consensus 187 GTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-d 264 (738)
||+.|+|||++.+ .|+.++|||||||++|+|+||..||.. .+..+++..+..+.. .++...++++++||.+||. +
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~d 231 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQEPL--RFPDGFDRDAKDLLIGLLSRD 231 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCC--CCCCcCCHHHHHHHHHHcCCC
Confidence 9999999999875 589999999999999999999999986 456667777766533 3445678999999999999 9
Q ss_pred cCCCC---CHHHHhcCcccCCCC
Q 004672 265 VSSRL---SARELLTDPFLQIDD 284 (738)
Q Consensus 265 P~~Rp---Sa~ELL~Hpf~~~~~ 284 (738)
|.+|| ++.++|.||||....
T Consensus 232 p~~R~~~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 232 PTRRLGYNGAQEIKNHPFFSQLS 254 (312)
T ss_pred HHHcCCCCCHHHHHcCCCcCCCC
Confidence 99997 589999999998654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=387.65 Aligned_cols=261 Identities=24% Similarity=0.425 Sum_probs=232.4
Q ss_pred cCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEec
Q 004672 16 KLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDT 94 (738)
Q Consensus 16 ~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~ 94 (738)
.-+.+++|.+++.||+|+||+|++|..+.+++.+|||.+++.... ..++.+.++.|.+|+... +||.++.+|.+|..
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il-~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT- 440 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDIL-QRDEVESLMCEKRIFELANRHPFLVNLFSCFQT- 440 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeecccee-ccccHHHHHHHHHHHHHhccCCeEeeccccccc-
Confidence 467789999999999999999999999999999999999977644 457789999999999999 59999999999954
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 95 ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 95 ~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
..++|+||||+.||++..+ +..+.|++..++.|+..|+.||.|||++| |||||||.+|||++.. |++||+|||++
T Consensus 441 -~~~l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~e-Gh~kiADFGlc 515 (694)
T KOG0694|consen 441 -KEHLFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTE-GHVKIADFGLC 515 (694)
T ss_pred -CCeEEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEccc-CcEEecccccc
Confidence 7899999999999995543 44478999999999999999999999999 9999999999999965 99999999999
Q ss_pred HHh--hccccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCC
Q 004672 175 AIL--RKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED 251 (738)
Q Consensus 175 ~~l--~~~~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~s 251 (738)
+.. ......+.+|||.|||||++.+ .|+..+|.|||||+|||||+|+.||.+ .+.++++..|...... .+...+
T Consensus 516 Ke~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g-ddEee~FdsI~~d~~~--yP~~ls 592 (694)
T KOG0694|consen 516 KEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG-DDEEEVFDSIVNDEVR--YPRFLS 592 (694)
T ss_pred cccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCCC--CCCccc
Confidence 754 3456778899999999999975 599999999999999999999999997 6788999998865543 345678
Q ss_pred hHHHHHHHHHHh-CcCCCCC-----HHHHhcCcccCCCCCc
Q 004672 252 PEVRQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDDYD 286 (738)
Q Consensus 252 pel~~lI~kcL~-dP~~RpS-----a~ELL~Hpf~~~~~~~ 286 (738)
.+..++++++|. +|.+|+. +.+|..||||+.-++.
T Consensus 593 ~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~ 633 (694)
T KOG0694|consen 593 KEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWD 633 (694)
T ss_pred HHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHH
Confidence 999999999999 9999985 5899999999988765
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=363.90 Aligned_cols=258 Identities=21% Similarity=0.294 Sum_probs=218.8
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.+.+.||+|+||+||+|.++.+|..||+|+++... ....+..+.+..|+.+++.++||||+++++++.+ ...++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--~~~~~ 77 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSV-LLAQETVSFFEEERDILSISNSPWIPQLQYAFQD--KDNLY 77 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCeEE
Confidence 47999999999999999999999999999999988543 2234456788999999999999999999998754 67899
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 101 FVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
+||||+++|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..+..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRT-GHIKLADFGSAARLTA 154 (330)
T ss_pred EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCC-CCEEeccCCCCeECCC
Confidence 999999999999999886 67999999999999999999999998 9999999999999854 8999999999976543
Q ss_pred cc---cccccCCCCCCCccccc-------cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccc--
Q 004672 180 SH---AARCVGTPEFMAPEVYE-------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF-- 247 (738)
Q Consensus 180 ~~---~~~~vGTp~YmAPEvl~-------~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~-- 247 (738)
.. .....||+.|+|||++. ..++.++|||||||++|+|++|..||... +....+..+........++
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~ 233 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG-TSAKTYNNIMNFQRFLKFPED 233 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC-CHHHHHHHHHcCCCccCCCCC
Confidence 32 12346999999999885 34788999999999999999999999864 4555666666544322222
Q ss_pred cCCChHHHHHHHHHHhCcCCCCCHHHHhcCcccCCCCC
Q 004672 248 KVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDY 285 (738)
Q Consensus 248 ~~~spel~~lI~kcL~dP~~RpSa~ELL~Hpf~~~~~~ 285 (738)
...++++++||.+||.+|.+||++.+++.||||+..++
T Consensus 234 ~~~~~~~~~li~~ll~~p~~R~t~~~l~~h~~~~~~~~ 271 (330)
T cd05601 234 PKVSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDW 271 (330)
T ss_pred CCCCHHHHHHHHHHccChhhCCCHHHHhCCCCcCCCCH
Confidence 24688999999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=350.04 Aligned_cols=256 Identities=25% Similarity=0.369 Sum_probs=218.0
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|...++||+|.||.||+|.|..||+.||||+|++.+..+ ...-...+||+.|+.++|+||+.+++.| .....+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd--Gi~~talREIK~Lqel~h~nIi~LiD~F--~~~~~l~ 77 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD--GINRTALREIKLLQELKHPNIIELIDVF--PHKSNLS 77 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc--CccHHHHHHHHHHHHccCcchhhhhhhc--cCCCceE
Confidence 56888999999999999999999999999999999875332 2334689999999999999999999988 4478899
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 101 FVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
+|+||++ .+|...++.. ..++...++.|+.++++||+|||++. |+||||||.|+|++.+ |.+||+|||+|+.+..
T Consensus 78 lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~-g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 78 LVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSD-GQLKIADFGLARFFGS 153 (318)
T ss_pred EEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCC-CcEEeecccchhccCC
Confidence 9999995 6898887664 46999999999999999999999999 9999999999999865 8999999999998875
Q ss_pred ccc--ccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc-CC-CCc---------
Q 004672 180 SHA--ARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GK-KPE--------- 244 (738)
Q Consensus 180 ~~~--~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~-g~-~p~--------- 244 (738)
... .+.+-|.+|+|||++-| .|+..+||||.|||+.||+-|.+-|.+.++.+|+-..+.. |. .+.
T Consensus 154 p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 154 PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 433 33478999999998865 5999999999999999999999999998888888554432 21 111
Q ss_pred --------------ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 245 --------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 245 --------------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
.++...+.++.+|+.+++. +|.+|+||.|+|+|+||+...
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 1233446788999999999 999999999999999997543
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=370.53 Aligned_cols=262 Identities=19% Similarity=0.315 Sum_probs=220.1
Q ss_pred CcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCC
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 96 (738)
.+..++|.+.++||.|+||+||+|.++.+|..||+|+++.... ......+.+..|+.+|+.++||||++++++|.+ .
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~--~ 115 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM-IKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD--D 115 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec--C
Confidence 4567889999999999999999999999999999999875432 222344568899999999999999999998754 6
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
..+++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~-~~~kL~DfG~~~~ 191 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMK 191 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCC-CCEEEEeccceee
Confidence 789999999999999998765 46899999999999999999999998 9999999999999854 8999999999976
Q ss_pred hhccc---cccccCCCCCCCcccccc-----ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCccccc
Q 004672 177 LRKSH---AARCVGTPEFMAPEVYEE-----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFK 248 (738)
Q Consensus 177 l~~~~---~~~~vGTp~YmAPEvl~~-----~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~ 248 (738)
..... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+....+..+..+.....++.
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~ 270 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMDHKNSLTFPD 270 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCCcCCCCC
Confidence 54322 234569999999998853 378899999999999999999999986 455667777776543332322
Q ss_pred --CCChHHHHHHHHHHh-CcCC--CCCHHHHhcCcccCCCCCc
Q 004672 249 --VEDPEVRQFIEKCLA-TVSS--RLSARELLTDPFLQIDDYD 286 (738)
Q Consensus 249 --~~spel~~lI~kcL~-dP~~--RpSa~ELL~Hpf~~~~~~~ 286 (738)
..++++++||.+||. +|.+ |+|+.++++||||+..++.
T Consensus 271 ~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 271 DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 468999999999999 6776 9999999999999876543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=353.35 Aligned_cols=253 Identities=19% Similarity=0.268 Sum_probs=208.3
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.+.+.||.|+||+||+|.++.++..||+|+++... ......+.+.+|+.+++.++||||++++++|.. ...++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 76 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE--ENEEVKETTLRELKMLRTLKQENIVELKEAFRR--RGKLY 76 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccc--ccccchhhHHHHHHHHHhCCCccccchhhhEec--CCEEE
Confidence 47999999999999999999999999999999987543 233455778899999999999999999998754 67899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
+||||+++++|..+......+++..++.++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++......
T Consensus 77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 77 LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHN-DVLKLCDFGFARNLSEG 153 (287)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CcEEEeeccCccccccc
Confidence 99999998888766555567999999999999999999999998 9999999999999854 79999999999776432
Q ss_pred c---cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHH-cCCCCc-----------
Q 004672 181 H---AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI-SGKKPE----------- 244 (738)
Q Consensus 181 ~---~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~-~g~~p~----------- 244 (738)
. .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||........+..... .+..|.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 2 223468999999998864 589999999999999999999999987544443322111 011110
Q ss_pred -----------------ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 245 -----------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 245 -----------------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
......++++++||.+||. +|.+|||+.++|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0112357789999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=363.01 Aligned_cols=250 Identities=22% Similarity=0.366 Sum_probs=213.5
Q ss_pred EEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEecC
Q 004672 27 MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMF 106 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey~ 106 (738)
+.||+|+||+||+|.+..+|..||+|+++... .........+.+|+.+|+.++||||+++++++.. ...+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEV-IIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT--KDRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCEEEEEEeCC
Confidence 36899999999999999999999999987543 2234556788999999999999999999988754 67899999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc--ccccc
Q 004672 107 TSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAAR 184 (738)
Q Consensus 107 ~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~--~~~~~ 184 (738)
++|+|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..... .....
T Consensus 78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCC-CcEEEecCcCCccCCCccccccc
Confidence 99999999988888999999999999999999999998 9999999999999854 8999999999875322 22234
Q ss_pred ccCCCCCCCccccc-cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh
Q 004672 185 CVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 263 (738)
Q Consensus 185 ~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~ 263 (738)
.+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+...+.+.+..+.. .++...++++++||.+||.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~-~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L~ 231 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEDI--KFPRTLSADAKSLLSGLLI 231 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC-CCHHHHHHHhccCCc--cCCCCCCHHHHHHHHHHcC
Confidence 56999999999986 4589999999999999999999999986 345556666554433 2445678999999999999
Q ss_pred -CcCCCC-----CHHHHhcCcccCCCCC
Q 004672 264 -TVSSRL-----SARELLTDPFLQIDDY 285 (738)
Q Consensus 264 -dP~~Rp-----Sa~ELL~Hpf~~~~~~ 285 (738)
+|.+|+ ++.++++||||...++
T Consensus 232 ~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 232 KDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred CCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 999997 8999999999976544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=359.42 Aligned_cols=250 Identities=22% Similarity=0.378 Sum_probs=213.2
Q ss_pred EEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEecC
Q 004672 27 MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMF 106 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey~ 106 (738)
+.||+|+||+||++.+..+|..||+|+++... .........+.+|+.+|+.++||||++++++|.. ...+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEV-IIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH-hhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEEEEeCC
Confidence 36999999999999999999999999988543 2234556778899999999999999999998755 67899999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc--cccc
Q 004672 107 TSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--HAAR 184 (738)
Q Consensus 107 ~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~--~~~~ 184 (738)
++|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++...... ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCC-CCEEecccHHhccccCCCCcccc
Confidence 99999999988888999999999999999999999998 9999999999999854 89999999998753222 2234
Q ss_pred ccCCCCCCCccccc-cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh
Q 004672 185 CVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 263 (738)
Q Consensus 185 ~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~ 263 (738)
..||+.|+|||++. +.++.++|||||||++|+|++|..||.. .+...++..+..+.. .++...+++++++|.+||.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI--RFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHcc
Confidence 46999999999986 4589999999999999999999999976 445556666654433 2345678999999999999
Q ss_pred -CcCCCC-----CHHHHhcCcccCCCCC
Q 004672 264 -TVSSRL-----SARELLTDPFLQIDDY 285 (738)
Q Consensus 264 -dP~~Rp-----Sa~ELL~Hpf~~~~~~ 285 (738)
+|.+|+ ++.++++||||....+
T Consensus 232 ~dP~~R~~~~~~~~~~~l~h~~~~~~~~ 259 (323)
T cd05595 232 KDPKQRLGGGPSDAKEVMEHRFFLSINW 259 (323)
T ss_pred CCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 999998 8999999999986543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=360.21 Aligned_cols=256 Identities=26% Similarity=0.345 Sum_probs=207.4
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCC---Ce
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN---RN 98 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~---~~ 98 (738)
+|.+.++||.|+||.||+|.++.+|..||+|+++... .......++.+|+.+|+.++||||+++++++..... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh--ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence 5889999999999999999999999999999887432 223344678899999999999999999998765322 35
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh
Q 004672 99 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~ 178 (738)
+++||||+ +++|.+++.....+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++....
T Consensus 79 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~-~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 79 IYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANAD-CKLKICDFGLARVAF 154 (338)
T ss_pred EEEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CcEEEccCccccccc
Confidence 89999999 5799999988888999999999999999999999998 9999999999999854 899999999997543
Q ss_pred ccc-----cccccCCCCCCCccccc---cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHH--------------HH
Q 004672 179 KSH-----AARCVGTPEFMAPEVYE---EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY--------------KK 236 (738)
Q Consensus 179 ~~~-----~~~~vGTp~YmAPEvl~---~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~--------------k~ 236 (738)
... ....+||+.|+|||++. ..++.++|||||||++|+|+||+.||.+.....++. ..
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 221 12346999999999875 368999999999999999999999997643322211 11
Q ss_pred HHc-----------CCCCc---ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 237 VIS-----------GKKPE---ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 237 i~~-----------g~~p~---~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
+.. ...+. ......++.+.++|.+||. +|.+|||+.|+|+||||+..
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 100 00111 1123457889999999999 99999999999999999653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=355.06 Aligned_cols=252 Identities=26% Similarity=0.342 Sum_probs=206.3
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCe
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 98 (738)
.+++|.+.++||.|+||+||+|.+..++..||+|+++.... ......+.+|+.+|+.++||||+++++++.. ...
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 77 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKNLKHANIVTLHDIIHT--ERC 77 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc---CCcchhHHHHHHHHHhCCCCCEeeEEEEEcC--CCe
Confidence 46789999999999999999999999999999999875432 2223467899999999999999999998754 568
Q ss_pred EEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 99 INFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~~-~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
+++||||+. |+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++...
T Consensus 78 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~-~~~kl~DfG~~~~~ 153 (288)
T cd07871 78 LTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEK-GELKLADFGLARAK 153 (288)
T ss_pred EEEEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEECcCcceeec
Confidence 999999996 59999887654 5899999999999999999999998 9999999999999854 89999999998654
Q ss_pred hcc--ccccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc--CCCCc-------
Q 004672 178 RKS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GKKPE------- 244 (738)
Q Consensus 178 ~~~--~~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~--g~~p~------- 244 (738)
... ......|++.|+|||++.+ .++.++|||||||++|+|+||+.||......+.+ ..+.. +..+.
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 154 SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL-HLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred cCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCChHHhhccc
Confidence 322 2233468999999998854 5899999999999999999999999875443333 22221 11110
Q ss_pred -------------------ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 245 -------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 245 -------------------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
......++++++||.+||+ +|.+|||+.|+|+||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0112357889999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=371.73 Aligned_cols=263 Identities=22% Similarity=0.398 Sum_probs=221.0
Q ss_pred cCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCC------CHH----HHHHHHHHHHHHHhCCCCCcc
Q 004672 16 KLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQ------SPE----ELERLYCEIHLLKTLKHRNIM 85 (738)
Q Consensus 16 ~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~------s~e----~~e~l~~Ei~iLk~L~HpNIV 85 (738)
....+.+|.+...||+|.||.|-+|.+..+|..||||++....... .+. ..++.++||.+|++|.|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 3455678999999999999999999999999999999988654211 111 236899999999999999999
Q ss_pred eeeEEEEecCCCeEEEEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCC
Q 004672 86 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR-VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 164 (738)
Q Consensus 86 kl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~~-lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g 164 (738)
+++++.-+.....+|||+|||..|.+...- ..+. +++.+++.|++.++.||+|||.+| ||||||||+|+||+.+ |
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~-g 247 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSD-G 247 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCC-C
Confidence 999986666778999999999999886542 2334 999999999999999999999999 9999999999999866 9
Q ss_pred cEEEeccchhHHhhc-------cccccccCCCCCCCccccccc-----cCcccccccchhhhhhhhhcCCCCCCCCCHHH
Q 004672 165 EVKIGDLGLAAILRK-------SHAARCVGTPEFMAPEVYEEE-----YNELVDIYSFGMCILEMVTFDYPYSECTHPAQ 232 (738)
Q Consensus 165 ~VKL~DFGlA~~l~~-------~~~~~~vGTp~YmAPEvl~~~-----ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~q 232 (738)
+|||+|||.+..... ......+|||.|||||...+. .+.+.||||+||+||.|+.|++||.+ ...-.
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-~~~~~ 326 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-DFELE 326 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-chHHH
Confidence 999999999976522 123345799999999988652 45689999999999999999999986 56677
Q ss_pred HHHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 233 IYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 233 i~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
++.+|+.............+.++++|+++|. ||.+|+++.++..|||...+
T Consensus 327 l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 327 LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 8889887654333334467899999999999 99999999999999998755
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=359.71 Aligned_cols=257 Identities=19% Similarity=0.327 Sum_probs=215.3
Q ss_pred CceEEEEEcccCCeEEEEEEEc---CCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecCCC
Q 004672 22 DMEDTMKFLVKELQRHYRAFDE---YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~---~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~ 97 (738)
+|.++++||+|+||+||++.+. .+|..||+|.++...........+.+..|+.+|+.+ +||||++++++|.. ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CC
Confidence 5889999999999999998874 578999999987544333445567889999999999 59999999987744 67
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
.+++||||+.+|+|.+++.+++.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++...
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~-~~~kl~DfG~~~~~ 155 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSE-GHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCC-CCEEEeeCcCCccc
Confidence 89999999999999999988888999999999999999999999998 9999999999999855 79999999999764
Q ss_pred hcc---ccccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCC---CCHHHHHHHHHcCCCCcccccC
Q 004672 178 RKS---HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSEC---THPAQIYKKVISGKKPEALFKV 249 (738)
Q Consensus 178 ~~~---~~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~---~~~~qi~k~i~~g~~p~~l~~~ 249 (738)
... ......||+.|||||++.+ .++.++|||||||++|+|+||..||... .....+...+..... .++..
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~ 233 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP--PFPSF 233 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC--CCCCC
Confidence 322 1224469999999999875 3788999999999999999999999642 234445555554332 23456
Q ss_pred CChHHHHHHHHHHh-CcCCCC-----CHHHHhcCcccCCCCC
Q 004672 250 EDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDY 285 (738)
Q Consensus 250 ~spel~~lI~kcL~-dP~~Rp-----Sa~ELL~Hpf~~~~~~ 285 (738)
.++.++++|.+||. +|.+|| ++.++++||||+..++
T Consensus 234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 275 (332)
T cd05614 234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW 275 (332)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 78999999999999 999999 8899999999986543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=362.01 Aligned_cols=255 Identities=27% Similarity=0.365 Sum_probs=219.2
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEe---cCCCe
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD---TANRN 98 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~---~~~~~ 98 (738)
.|..++.||.|+||.|+.|.++.+|+.||||++. +...+.-..++..+|+++|+.++|+||+.+++.+.. ..-+.
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~--~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKIL--NPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhh--hhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 4445799999999999999999999999999765 345677888999999999999999999999998755 23467
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh
Q 004672 99 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~ 178 (738)
+|+|+|+| +.+|.+.++.++.+++..+..+++||+.||+|+|+.+ |+||||||.|+|++.+ -.+||+|||+|+...
T Consensus 101 vYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~-c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNAD-CDLKICDFGLARYLD 176 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccC-CCEEeccccceeecc
Confidence 99999999 6799999988888999999999999999999999999 9999999999999976 589999999999885
Q ss_pred ----ccccccccCCCCCCCccccc--cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc-------------
Q 004672 179 ----KSHAARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS------------- 239 (738)
Q Consensus 179 ----~~~~~~~vGTp~YmAPEvl~--~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~------------- 239 (738)
....+.++-|.+|.|||++. ..|+.++||||+|||+.||++|++-|.+.....|+..-+..
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 45556778999999999885 46999999999999999999999999887666665321110
Q ss_pred -----------CCCC----cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 240 -----------GKKP----EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 240 -----------g~~p----~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
...| ..+++..+|.+.+|+++||. ||.+|+|++|+|.||||..
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP 315 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence 1111 23345678999999999999 9999999999999999964
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=356.25 Aligned_cols=255 Identities=25% Similarity=0.322 Sum_probs=206.8
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeE
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
.++|.+.++||.|+||+||+|.++.+|..||+|+++..... .....+.+|+.+|+.++||||+++++++.. ...+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE---GTPFTAIREASLLKGLKHANIVLLHDIIHT--KETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc---ccchhHHHHHHHHhhCCCCCcCeEEEEEec--CCeE
Confidence 47899999999999999999999999999999998754321 223457789999999999999999998754 5789
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh
Q 004672 100 NFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~ 178 (738)
++||||+. ++|.+++.++ ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++....
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDT-GELKLADFGLARAKS 154 (303)
T ss_pred EEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEECCCCcceecc
Confidence 99999995 6887777664 56899999999999999999999998 9999999999999854 899999999986543
Q ss_pred cc--ccccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc--CCC----------
Q 004672 179 KS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GKK---------- 242 (738)
Q Consensus 179 ~~--~~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~--g~~---------- 242 (738)
.. ......||+.|+|||++.+ .++.++|||||||++|+|+||..||.+..+.......+.. +..
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 155 VPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred CCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence 22 2233468999999998854 4888999999999999999999999876555444333321 110
Q ss_pred -----Cccc-------------ccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 243 -----PEAL-------------FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 243 -----p~~l-------------~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
+..+ ....++.+++||.+||+ +|.+|||+.|+|.||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 0000 00134678999999999 99999999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=353.08 Aligned_cols=257 Identities=18% Similarity=0.269 Sum_probs=212.0
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
.|+..+.||+|+||+||+|.+..+|..||+|.+...... .......+.+|+.+|+.++|+||++++++|.+ ...+++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~--~~~~~l 77 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKRILEKVNSRFVVSLAYAYET--KDALCL 77 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh-hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc--CCeEEE
Confidence 378899999999999999999999999999998754322 22334567899999999999999999998754 678999
Q ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 102 VTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.....
T Consensus 78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDR-GHIRISDLGLAVQIPE 154 (285)
T ss_pred EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCC-CCEEEeeCCCcEEcCC
Confidence 99999999999887653 36899999999999999999999998 9999999999999854 7999999999976533
Q ss_pred c-ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCH---HHHHHHHHcCCCCcccccCCChHH
Q 004672 180 S-HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHP---AQIYKKVISGKKPEALFKVEDPEV 254 (738)
Q Consensus 180 ~-~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~---~qi~k~i~~g~~p~~l~~~~spel 254 (738)
. ......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||...... ..+...+..+ +..+....++++
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~ 232 (285)
T cd05631 155 GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED--QEEYSEKFSEDA 232 (285)
T ss_pred CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc--cccCCccCCHHH
Confidence 2 2234569999999999864 6999999999999999999999999864322 2233333222 223445678999
Q ss_pred HHHHHHHHh-CcCCCCC-----HHHHhcCcccCCCCCc
Q 004672 255 RQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDDYD 286 (738)
Q Consensus 255 ~~lI~kcL~-dP~~RpS-----a~ELL~Hpf~~~~~~~ 286 (738)
.+||.+||+ +|.+||+ ++++++||||...++.
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05631 233 KSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK 270 (285)
T ss_pred HHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence 999999999 9999997 9999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=360.53 Aligned_cols=250 Identities=23% Similarity=0.374 Sum_probs=212.4
Q ss_pred EEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEecC
Q 004672 27 MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMF 106 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey~ 106 (738)
+.||+|+||+||+|.+..+|..||+|.++... .........+..|+++++.++||||++++++|.. ...+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEV-IVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 36899999999999999999999999988543 2234456778899999999999999999998754 67899999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc--cccc
Q 004672 107 TSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAA 183 (738)
Q Consensus 107 ~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs-~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~--~~~~ 183 (738)
++|+|..++.+.+.+++..++.++.||+.||.|||+ ++ |+||||||+|||++.+ |.+||+|||++..... ....
T Consensus 78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCC-CCEEEecCCCCeecCCCCcccc
Confidence 999999999888889999999999999999999997 67 9999999999999854 8999999999864322 2223
Q ss_pred cccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHH
Q 004672 184 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 262 (738)
Q Consensus 184 ~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL 262 (738)
...||+.|+|||++.+ .++.++|||||||++|+|+||..||.. .+...+...+..+.. .++...++++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~L 231 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--RFPRTLSPEAKSLLSGLL 231 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHh
Confidence 4469999999999864 589999999999999999999999986 445566666654433 234567899999999999
Q ss_pred h-CcCCCC-----CHHHHhcCcccCCCCC
Q 004672 263 A-TVSSRL-----SARELLTDPFLQIDDY 285 (738)
Q Consensus 263 ~-dP~~Rp-----Sa~ELL~Hpf~~~~~~ 285 (738)
. +|.+|+ ++.++|+||||+...+
T Consensus 232 ~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 260 (325)
T cd05594 232 KKDPKQRLGGGPDDAKEIMQHKFFAGIVW 260 (325)
T ss_pred hcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence 9 999997 9999999999986443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=360.27 Aligned_cols=258 Identities=24% Similarity=0.427 Sum_probs=216.2
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCC
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 97 (738)
+..++|.+.++||.|+||+||+|.+..+|..+|+|.++.. ......+.+.+|+++|+.++||||++++++|.. +.
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 76 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DG 76 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc---cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE--CC
Confidence 4568999999999999999999999999999999988753 234556789999999999999999999998866 67
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
.+++||||+.+|+|.+++.+.+.+++..+..++.||+.||.|||+.+ +|+||||||+|||++.+ |.+||+|||++..+
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~ 154 (333)
T cd06650 77 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH-KIMHRDVKPSNILVNSR-GEIKLCDFGVSGQL 154 (333)
T ss_pred EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC-CEEecCCChhhEEEcCC-CCEEEeeCCcchhh
Confidence 89999999999999999998888999999999999999999999752 39999999999999854 79999999999876
Q ss_pred hccccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHH----------------------
Q 004672 178 RKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY---------------------- 234 (738)
Q Consensus 178 ~~~~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~---------------------- 234 (738)
.........|++.|+|||++.+ .++.++|||||||++|+|++|+.||.... ..++.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 155 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD-AKELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred hhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc-hhHHHHHhcCcccCCccccccCcccCC
Confidence 5544445579999999999875 58899999999999999999999997422 22221
Q ss_pred ----------------------HHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 235 ----------------------KKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 235 ----------------------k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
..+.....|.......++++++||.+||. +|.+|||+.|+|.||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 11112222222223457889999999999 99999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=355.99 Aligned_cols=259 Identities=23% Similarity=0.406 Sum_probs=228.3
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCe
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 98 (738)
.-+.|.+-+.||+|+|+.||++.+..||..+|+|.|....+... ..+.+.+|++|-+.|+||||+++.+.. .....
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~--~~e~l~rEarIC~~LqHP~IvrL~~ti--~~~~~ 84 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR--DFQKLEREARICRKLQHPNIVRLHDSI--QEESF 84 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc--cHHHHHHHHHHHHhcCCCcEeehhhhh--cccce
Confidence 34689999999999999999999999999999999887665443 668899999999999999999999976 34678
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCC--CCcEEEeccchhHH
Q 004672 99 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN--QGEVKIGDLGLAAI 176 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~--~g~VKL~DFGlA~~ 176 (738)
.|||+|+|+|++|..-+.+.-.+++..+..+++||+.||.|+|.++ |||||+||+|+++-++ ..-|||+|||+|..
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999999999877777677899999999999999999999999 9999999999999643 23689999999988
Q ss_pred hhcccc-ccccCCCCCCCccccc-cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCC--CcccccCCCh
Q 004672 177 LRKSHA-ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDP 252 (738)
Q Consensus 177 l~~~~~-~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~--p~~l~~~~sp 252 (738)
++.... .-.+|||.|||||++. ..|+..+|||+.|++||-|+.|.+||.+ .+...+|..|..|.. |...+...++
T Consensus 163 l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~-~~~~rlye~I~~g~yd~~~~~w~~is~ 241 (355)
T KOG0033|consen 163 VNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYEQIKAGAYDYPSPEWDTVTP 241 (355)
T ss_pred eCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC-ccHHHHHHHHhccccCCCCcccCcCCH
Confidence 774332 3456999999999997 4699999999999999999999999987 567889999999864 5556788899
Q ss_pred HHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 253 EVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 253 el~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
+++++|.+||. ||++|+|+.|.|+|||++..+
T Consensus 242 ~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 242 EAKSLIRRMLTVNPKKRITADEALKHPWICNRE 274 (355)
T ss_pred HHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence 99999999999 999999999999999998654
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=366.44 Aligned_cols=261 Identities=19% Similarity=0.324 Sum_probs=216.6
Q ss_pred CcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCC
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 96 (738)
.+..++|.+.+.||+|+||+||+|.+..++..||+|.++.... ......+.+.+|+.+++.++||||++++++|.+ .
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~ 115 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM-IKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD--D 115 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--C
Confidence 3455789999999999999999999999999999999875432 223345678899999999999999999998754 6
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
..+++||||+++|+|.+++... .+++..++.++.||+.||.|||+++ |+||||||+|||++. .|.+||+|||++..
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~-~~~~kL~DFG~a~~ 191 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDK-HGHLKLADFGTCMK 191 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECC-CCCEEEEeccccee
Confidence 7899999999999999998654 6899999999999999999999998 999999999999985 48999999999976
Q ss_pred hhccc---cccccCCCCCCCcccccc-----ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccc-
Q 004672 177 LRKSH---AARCVGTPEFMAPEVYEE-----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF- 247 (738)
Q Consensus 177 l~~~~---~~~~vGTp~YmAPEvl~~-----~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~- 247 (738)
..... ....+||+.|||||++.+ .++.++|||||||++|+|+||..||.. .+....+..+........++
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~ 270 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA-DSLVGTYSKIMDHKNSLNFPE 270 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCcccCCCC
Confidence 54322 234569999999999863 278899999999999999999999986 44556667776544322222
Q ss_pred -cCCChHHHHHHHHHHhC-cC--CCCCHHHHhcCcccCCCCC
Q 004672 248 -KVEDPEVRQFIEKCLAT-VS--SRLSARELLTDPFLQIDDY 285 (738)
Q Consensus 248 -~~~spel~~lI~kcL~d-P~--~RpSa~ELL~Hpf~~~~~~ 285 (738)
...++.++++|.+||.+ +. .|+++.++++||||+...+
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 271 DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 24588999999999984 33 4899999999999987543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=358.63 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=213.7
Q ss_pred EEEEcccCCeEEEEEEEc---CCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEE
Q 004672 26 TMKFLVKELQRHYRAFDE---YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 102 (738)
Q Consensus 26 l~kLG~GafgtVYkA~d~---~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV 102 (738)
+++||+|+||+||++.+. .+|..||+|.++.............+..|+.+|+.++||||+++++.|.. ++.+++|
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv 78 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GGKLYLI 78 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CCeEEEE
Confidence 368999999999999874 57899999998865433344455678899999999999999999998755 6789999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc--c
Q 004672 103 TEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--S 180 (738)
Q Consensus 103 ~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~--~ 180 (738)
|||+.+|+|.+++.+.+.+.+..+..++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CCEEEeeCcCCeecccCCC
Confidence 999999999999998888999999999999999999999998 9999999999999855 8999999999864322 2
Q ss_pred ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHH
Q 004672 181 HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 259 (738)
Q Consensus 181 ~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~ 259 (738)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+.......+..+..+ ++...++.+++||.
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~ 232 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILKGKLN--LPPYLTPEARDLLK 232 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHHHHH
Confidence 2233469999999999864 588999999999999999999999986 4455566666666543 34567899999999
Q ss_pred HHHh-CcCCCC-----CHHHHhcCcccCCCCC
Q 004672 260 KCLA-TVSSRL-----SARELLTDPFLQIDDY 285 (738)
Q Consensus 260 kcL~-dP~~Rp-----Sa~ELL~Hpf~~~~~~ 285 (738)
+||. +|.+|| ++.+++.||||....+
T Consensus 233 ~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~ 264 (323)
T cd05584 233 KLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW 264 (323)
T ss_pred HHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 9999 999999 8999999999986543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.77 Aligned_cols=250 Identities=25% Similarity=0.359 Sum_probs=209.5
Q ss_pred EEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHH-HHHhCCCCCcceeeEEEEecCCCeEEEEEec
Q 004672 27 MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIH-LLKTLKHRNIMKFYTSWVDTANRNINFVTEM 105 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~-iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey 105 (738)
+.||+|+||+||+|.+..+|..||+|++........ .....+..|.. +++.++||||++++++|.. ...+++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK-KEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh-hHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEEEEcC
Confidence 369999999999999999999999999875432222 23344555554 5688999999999998755 6789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc--cccc
Q 004672 106 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAA 183 (738)
Q Consensus 106 ~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~--~~~~ 183 (738)
+++|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQ-GHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCC-CcEEEeccCCCcccccCCCccc
Confidence 999999999998889999999999999999999999998 9999999999999854 8999999999865322 2223
Q ss_pred cccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHH
Q 004672 184 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 262 (738)
Q Consensus 184 ~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL 262 (738)
...||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+..+... +....++.+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~l 231 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDTAEMYDNILNKPLR--LKPNISVSARHLLEGLL 231 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHHh
Confidence 4469999999998864 589999999999999999999999986 4667777777765432 34456899999999999
Q ss_pred h-CcCCCCCH----HHHhcCcccCCCCC
Q 004672 263 A-TVSSRLSA----RELLTDPFLQIDDY 285 (738)
Q Consensus 263 ~-dP~~RpSa----~ELL~Hpf~~~~~~ 285 (738)
+ +|.+||++ .+++.||||...++
T Consensus 232 ~~~p~~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 232 QKDRTKRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred hcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 9 99999987 69999999976543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=356.75 Aligned_cols=255 Identities=21% Similarity=0.321 Sum_probs=216.9
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCC-CcceeeEEEEecCCCeEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHR-NIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~Hp-NIVkl~~~fv~~~~~~l~ 100 (738)
+|.+++.||.|+||+||+|.++.++..||+|+++.... ......+.+..|+.++..++|+ +|++++++|.. ...++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~ 77 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI-IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLY 77 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEE
Confidence 58899999999999999999999999999999885432 2334567888999999999765 57888887754 57899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh--
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR-- 178 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~-- 178 (738)
+||||+++|+|.+++.....+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++....
T Consensus 78 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 78 FVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFG 154 (324)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCC-CCEEEeecCcceecCCC
Confidence 99999999999999988888999999999999999999999998 9999999999999854 899999999986432
Q ss_pred ccccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004672 179 KSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 257 (738)
Q Consensus 179 ~~~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~l 257 (738)
.......+||+.|+|||++.+ .++.++|||||||++|+|+||+.||.. .+...++..+..+.. .++...+++++++
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~l 231 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNV--SYPKSLSKEAVSI 231 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHH
Confidence 222334569999999999875 589999999999999999999999986 456677777766543 2345678999999
Q ss_pred HHHHHh-CcCCCCCH-----HHHhcCcccCCCCC
Q 004672 258 IEKCLA-TVSSRLSA-----RELLTDPFLQIDDY 285 (738)
Q Consensus 258 I~kcL~-dP~~RpSa-----~ELL~Hpf~~~~~~ 285 (738)
|.+||. +|.+|+++ .++++||||+..++
T Consensus 232 i~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 232 CKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 999999 99999976 89999999987554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=368.02 Aligned_cols=258 Identities=27% Similarity=0.421 Sum_probs=228.2
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCC-CCCcceeeEEEEecCCCe
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~ 98 (738)
...|.+.+.||.|.||.||++.++.||..+|+|.++..... .....+.+.+|+.+|++|. |||||.+++.|.+ ...
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~-~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~--~~~ 110 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLR-GKEDREDVRREVAILQQLSGHPNIVQLKDAFED--PDS 110 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcc-ccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc--CCe
Confidence 35799999999999999999999999999999999876543 3335678999999999998 9999999998855 669
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCC---CcEEEeccchhH
Q 004672 99 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ---GEVKIGDLGLAA 175 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~---g~VKL~DFGlA~ 175 (738)
+++|||++.||.|++.+.+. .+++..+..+++||+.++.|||+.| |+||||||+|+|+.... +.+|++|||++.
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999999998887 5999999999999999999999998 99999999999997442 479999999998
Q ss_pred Hhhcc-ccccccCCCCCCCccccc-cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCC--CcccccCCC
Q 004672 176 ILRKS-HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVED 251 (738)
Q Consensus 176 ~l~~~-~~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~--p~~l~~~~s 251 (738)
..... .....+|||.|+|||++. ..|+..+||||+|+++|.|++|..||.+ .+.......+..|.. +...+..++
T Consensus 188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~-~~~~~~~~~i~~~~~~f~~~~w~~is 266 (382)
T KOG0032|consen 188 FIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWG-ETEFEIFLAILRGDFDFTSEPWDDIS 266 (382)
T ss_pred EccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcC-CChhHHHHHHHcCCCCCCCCCccccC
Confidence 87763 455668999999999998 6799999999999999999999999987 445566668888765 455677789
Q ss_pred hHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 252 PEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 252 pel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
..+++||.++|. +|.+|+||.++|+|||++...
T Consensus 267 ~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 267 ESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred HHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 999999999999 999999999999999998653
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=358.77 Aligned_cols=250 Identities=21% Similarity=0.366 Sum_probs=213.1
Q ss_pred EEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecCCCeEEEEEec
Q 004672 27 MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEM 105 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~LV~Ey 105 (738)
+.||+|+||+||+|.++.+|..||+|+++.... ......+.+..|+.++..+ +||||++++++|.. ...+++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI-LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH-hhccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcC
Confidence 368999999999999999999999999875432 2234556778899999887 79999999998754 6789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh--ccccc
Q 004672 106 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAA 183 (738)
Q Consensus 106 ~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~--~~~~~ 183 (738)
+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~-~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 78 VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCC-CcEEEeeCCCCeecCcCCCccc
Confidence 999999999998889999999999999999999999998 9999999999999855 899999999986532 12233
Q ss_pred cccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHH
Q 004672 184 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 262 (738)
Q Consensus 184 ~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL 262 (738)
...||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...++..+..+... ++...++++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~L 231 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVV--YPTWLSQDAVDILKAFM 231 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCCC--CCCCCCHHHHHHHHHHc
Confidence 4569999999999874 589999999999999999999999986 5566777777765433 33457899999999999
Q ss_pred h-CcCCCCCH------HHHhcCcccCCCCC
Q 004672 263 A-TVSSRLSA------RELLTDPFLQIDDY 285 (738)
Q Consensus 263 ~-dP~~RpSa------~ELL~Hpf~~~~~~ 285 (738)
. +|.+||++ .++++||||+.-++
T Consensus 232 ~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 232 TKNPTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred ccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 9 99999998 99999999976543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=372.36 Aligned_cols=254 Identities=30% Similarity=0.465 Sum_probs=228.6
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeE
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
.++|..++.+|.|+||.+++..++..+..|++|+|.+.. .+........+|+.++++++|||||.++++|++. +..+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~--~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~-~~~l 79 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEK--LTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED-GQLL 79 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccc--cCchhhHHHHHHHHHHHhccCCCeeeeccchhcC-CceE
Confidence 578999999999999999999999999999999999875 3445556899999999999999999999999763 3459
Q ss_pred EEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 100 NFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~~--~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
+|||+||+||+|.+.+++.+ .|+++.+..|+.||+.|+.|||++. |+|||||+.|||++.+ +.|||+|||+|+.+
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~-~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKD-KKVKLGDFGLAKIL 156 (426)
T ss_pred EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhcccc-Cceeecchhhhhhc
Confidence 99999999999999988765 5999999999999999999999988 9999999999999865 68899999999999
Q ss_pred hcc--ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHH
Q 004672 178 RKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEV 254 (738)
Q Consensus 178 ~~~--~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel 254 (738)
+.. ...+.+|||.||.||++.+ .|+.++||||||||+|||++-+.+|.. .+...+..++..+... .++..++.++
T Consensus 157 ~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-~~m~~Li~ki~~~~~~-Plp~~ys~el 234 (426)
T KOG0589|consen 157 NPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA-SNMSELILKINRGLYS-PLPSMYSSEL 234 (426)
T ss_pred CCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc-cchHHHHHHHhhccCC-CCCccccHHH
Confidence 876 5677789999999999986 599999999999999999999999987 6777787888877733 3567889999
Q ss_pred HHHHHHHHh-CcCCCCCHHHHhcCcccC
Q 004672 255 RQFIEKCLA-TVSSRLSARELLTDPFLQ 281 (738)
Q Consensus 255 ~~lI~kcL~-dP~~RpSa~ELL~Hpf~~ 281 (738)
+.+|+.||. +|..||++.+||.+|.++
T Consensus 235 ~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 235 RSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred HHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 999999999 899999999999999886
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=357.22 Aligned_cols=251 Identities=20% Similarity=0.340 Sum_probs=210.0
Q ss_pred EEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecCCCeEEEEEec
Q 004672 27 MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEM 105 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~LV~Ey 105 (738)
+.||+|+||+||+|.+..+|..||+|.++... .........+..|+.+++.+ +||||++++++|.. ...+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~-~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKEL-VNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeC
Confidence 36899999999999999999999999988543 23345567788999999999 79999999998755 6789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh--ccccc
Q 004672 106 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAA 183 (738)
Q Consensus 106 ~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~--~~~~~ 183 (738)
+++|+|..++.+.+++++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC-CCEEECcCccccccccCCCccc
Confidence 999999999988889999999999999999999999998 9999999999999854 899999999986432 12233
Q ss_pred cccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCC--------CCHHHHHHHHHcCCCCcccccCCChHH
Q 004672 184 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC--------THPAQIYKKVISGKKPEALFKVEDPEV 254 (738)
Q Consensus 184 ~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~--------~~~~qi~k~i~~g~~p~~l~~~~spel 254 (738)
..+||+.|+|||++.+ .++.++|||||||++|+|+||+.||... .....+++.+..+.. .++...++++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~ 232 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI--RIPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC--CCCCCCCHHH
Confidence 4569999999999875 5899999999999999999999999631 122334444544432 2445678899
Q ss_pred HHHHHHHHh-CcCCCCC------HHHHhcCcccCCCCC
Q 004672 255 RQFIEKCLA-TVSSRLS------ARELLTDPFLQIDDY 285 (738)
Q Consensus 255 ~~lI~kcL~-dP~~RpS------a~ELL~Hpf~~~~~~ 285 (738)
.++|.+||+ +|.+|++ +.++++||||..-++
T Consensus 233 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 233 SSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 999999999 9999987 799999999975443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=356.05 Aligned_cols=250 Identities=20% Similarity=0.325 Sum_probs=213.9
Q ss_pred EEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecCCCeEEEEEec
Q 004672 27 MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEM 105 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~LV~Ey 105 (738)
+.||.|+||+||+|.+..+|..||+|+++... ....+..+.+..|+.++..+ +||||++++++|.. ...+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDV-ILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHH-hhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeC
Confidence 36899999999999999999999999988543 22345566788899999876 89999999998855 6789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc--cccc
Q 004672 106 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAA 183 (738)
Q Consensus 106 ~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~--~~~~ 183 (738)
+++|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 78 VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEEeecccceecccCCcccc
Confidence 999999999988889999999999999999999999998 9999999999999855 8999999999865322 2223
Q ss_pred cccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHH
Q 004672 184 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 262 (738)
Q Consensus 184 ~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL 262 (738)
...||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.. .+...++..+..+... .+...+++++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~ll~~~L 231 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA-DNEDDLFESILHDDVL--YPVWLSKEAVSILKAFM 231 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHHh
Confidence 4469999999998875 589999999999999999999999986 4566777777766533 23456899999999999
Q ss_pred h-CcCCCC-------CHHHHhcCcccCCCCC
Q 004672 263 A-TVSSRL-------SARELLTDPFLQIDDY 285 (738)
Q Consensus 263 ~-dP~~Rp-------Sa~ELL~Hpf~~~~~~ 285 (738)
. +|.+|+ ++.++++||||...++
T Consensus 232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~ 262 (321)
T cd05591 232 TKNPNKRLGCVASQGGEDAIKQHPFFKEIDW 262 (321)
T ss_pred ccCHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence 9 999999 9999999999976554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=360.44 Aligned_cols=265 Identities=24% Similarity=0.330 Sum_probs=226.2
Q ss_pred ccCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEec
Q 004672 15 LKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 94 (738)
Q Consensus 15 ~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~ 94 (738)
...+.++.|+++++||.|.-|+||++....++..+|+|++.... ..+...+.|+..|-+||+.++||.++.+|..| +
T Consensus 71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~-l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f--e 147 (459)
T KOG0610|consen 71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKES-LASRKKLKRAQTEREILSLLDHPFLPTLYASF--E 147 (459)
T ss_pred CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHH-HhhhhHHHHHHHHHHHHHhcCCCccchhhhee--e
Confidence 34566678999999999999999999999999999999998665 34567788999999999999999999999988 4
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccc
Q 004672 95 ANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 172 (738)
Q Consensus 95 ~~~~l~LV~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFG 172 (738)
....++++||||+||+|..+++++ +.|++..++.++..++.||+|||..| ||+|||||+||||..+ |+|.|+||.
T Consensus 148 t~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvred-GHIMLsDFD 224 (459)
T KOG0610|consen 148 TDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVRED-GHIMLSDFD 224 (459)
T ss_pred ccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecC-CcEEeeecc
Confidence 478999999999999999999886 56999999999999999999999999 9999999999999854 999999999
Q ss_pred hhHHhh----------------------------------c-c-----------------------ccccccCCCCCCCc
Q 004672 173 LAAILR----------------------------------K-S-----------------------HAARCVGTPEFMAP 194 (738)
Q Consensus 173 lA~~l~----------------------------------~-~-----------------------~~~~~vGTp~YmAP 194 (738)
|+.... . . ...+++||-+|+||
T Consensus 225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP 304 (459)
T KOG0610|consen 225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP 304 (459)
T ss_pred ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence 984320 0 0 01234799999999
Q ss_pred ccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCC--
Q 004672 195 EVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLS-- 270 (738)
Q Consensus 195 Evl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpS-- 270 (738)
|++.+ ..+.++|.|+|||.+|||+.|..||.+.++.+.+...+.+...-.. ....+-.+++||+++|. ||++|+.
T Consensus 305 EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~-~~~vs~~akDLIr~LLvKdP~kRlg~~ 383 (459)
T KOG0610|consen 305 EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPE-EPEVSSAAKDLIRKLLVKDPSKRLGSK 383 (459)
T ss_pred eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCC-CCcchhHHHHHHHHHhccChhhhhccc
Confidence 99986 4899999999999999999999999997776666555443222111 12456899999999999 9999998
Q ss_pred --HHHHhcCcccCCCCCc
Q 004672 271 --ARELLTDPFLQIDDYD 286 (738)
Q Consensus 271 --a~ELL~Hpf~~~~~~~ 286 (738)
|.||.+||||+..+|.
T Consensus 384 rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 384 RGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred cchHHhhcCccccCCChh
Confidence 9999999999988875
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=355.23 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=211.7
Q ss_pred ceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHH---HhCCCCCcceeeEEEEecCCCeE
Q 004672 23 MEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLL---KTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 23 y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iL---k~L~HpNIVkl~~~fv~~~~~~l 99 (738)
|++++.||+|+||+||+|.+..+|..||+|.++.... ......+.+.+|++++ +.++||||++++++|.. +..+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~--~~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI-IARDEVESLMCEKRIFETANSERHPFLVNLFACFQT--EDHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--CCEE
Confidence 6789999999999999999999999999999885432 2234556777787765 45689999999998754 6789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 100 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
++||||+++|+|..++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++.....
T Consensus 78 ~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~-~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 78 CFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMG 153 (324)
T ss_pred EEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCC-CcEEeCcccCCccCCC
Confidence 999999999999988754 57999999999999999999999998 9999999999999855 8999999999864322
Q ss_pred --cccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004672 180 --SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 256 (738)
Q Consensus 180 --~~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~ 256 (738)
......+|++.|||||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+..+... .+...++.+.+
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~ 230 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG-DDEEEVFDSIVNDEVR--YPRFLSREAIS 230 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCCCCCHHHHH
Confidence 22334569999999998865 588999999999999999999999986 4556666666655432 33456899999
Q ss_pred HHHHHHh-CcCCCC-----CHHHHhcCcccCCCC
Q 004672 257 FIEKCLA-TVSSRL-----SARELLTDPFLQIDD 284 (738)
Q Consensus 257 lI~kcL~-dP~~Rp-----Sa~ELL~Hpf~~~~~ 284 (738)
+|.+||. +|.+|| ++.++++||||+...
T Consensus 231 li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred HHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 9999999 999999 799999999997644
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=373.33 Aligned_cols=255 Identities=24% Similarity=0.305 Sum_probs=206.9
Q ss_pred CcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEec--
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT-- 94 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~-- 94 (738)
.....+|.+++.||+|+||+||+|.+..+|..||+|++.... ....+|+.+|+.++||||++++++|...
T Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~ 133 (440)
T PTZ00036 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYTECF 133 (440)
T ss_pred cCcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------chHHHHHHHHHhcCCCCCcceeeeEeeccc
Confidence 345578999999999999999999999999999999875321 2345799999999999999999987542
Q ss_pred ----CCCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcE
Q 004672 95 ----ANRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV 166 (738)
Q Consensus 95 ----~~~~l~LV~Ey~~gGSL~~~l~k----~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~V 166 (738)
....+++||||++ ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+.+.+
T Consensus 134 ~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~v 210 (440)
T PTZ00036 134 KKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTL 210 (440)
T ss_pred ccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCce
Confidence 1235779999996 577776643 457999999999999999999999999 99999999999998665689
Q ss_pred EEeccchhHHhhcc-ccccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc-CCC
Q 004672 167 KIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKK 242 (738)
Q Consensus 167 KL~DFGlA~~l~~~-~~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~-g~~ 242 (738)
||+|||++..+... ......||+.|+|||++.+ .|+.++|||||||++|+|+||.+||.+.....++.+.+.. |..
T Consensus 211 kL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p 290 (440)
T PTZ00036 211 KLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP 290 (440)
T ss_pred eeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99999999876443 2334568999999998754 5899999999999999999999999886665555443321 111
Q ss_pred -----------------C----c----ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 243 -----------------P----E----ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 243 -----------------p----~----~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
| . .++...++++++||.+||. +|.+|||+.|+|.||||..
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 0 0 0122356789999999999 9999999999999999964
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=354.06 Aligned_cols=256 Identities=21% Similarity=0.327 Sum_probs=217.6
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecCCCeEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~ 100 (738)
+|.+++.||+|+||+||+|.+..++..||+|.++... .......+.+..|..++..+ +|++|+++++++.. .+.++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~ 77 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV-VIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLY 77 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEE
Confidence 5889999999999999999999999999999988543 22334456678888888888 68999999988754 67899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc-
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK- 179 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~- 179 (738)
+||||+++|+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.....
T Consensus 78 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~-~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 78 FVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWD 154 (323)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCC-CcEEEccCCCceecCCC
Confidence 99999999999999988889999999999999999999999998 9999999999999855 8999999999864321
Q ss_pred -cccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004672 180 -SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 257 (738)
Q Consensus 180 -~~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~l 257 (738)
.......||+.|+|||++.+ .++.++|||||||++|+|+||..||.. .+...++..+..+... ++...+++++++
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~l 231 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVA--YPKSMSKEAVAI 231 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCCcCCHHHHHH
Confidence 22334569999999998874 589999999999999999999999986 4566777777765432 345678999999
Q ss_pred HHHHHh-CcCCCCC-----HHHHhcCcccCCCCCc
Q 004672 258 IEKCLA-TVSSRLS-----ARELLTDPFLQIDDYD 286 (738)
Q Consensus 258 I~kcL~-dP~~RpS-----a~ELL~Hpf~~~~~~~ 286 (738)
|.+||+ +|.+|++ ..+++.||||+.-++.
T Consensus 232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~ 266 (323)
T cd05616 232 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 266 (323)
T ss_pred HHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 999999 9999998 4899999999876543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=362.12 Aligned_cols=262 Identities=20% Similarity=0.312 Sum_probs=219.3
Q ss_pred cCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC
Q 004672 16 KLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95 (738)
Q Consensus 16 ~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 95 (738)
..+..++|.+.+.||+|+||+||+|.++.++..||+|.+..... ......+.+.+|+.+++.++||||+++++.|..
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-- 114 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-- 114 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--
Confidence 34556899999999999999999999999999999999875432 223345678899999999999999999998754
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
+..+++||||+++|+|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~-~~ikL~DfG~a~ 190 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCM 190 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCC-CCEEEEeCCcee
Confidence 6789999999999999999865 46899999999999999999999999 9999999999999854 899999999997
Q ss_pred Hhhccc---cccccCCCCCCCcccccc-----ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCccc-
Q 004672 176 ILRKSH---AARCVGTPEFMAPEVYEE-----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL- 246 (738)
Q Consensus 176 ~l~~~~---~~~~vGTp~YmAPEvl~~-----~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l- 246 (738)
.+.... ....+||+.|||||++.. .++.++|||||||++|+|++|..||.. .+....+..+........+
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~ 269 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFP 269 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCcccCC
Confidence 654322 234569999999999863 278899999999999999999999986 5666777777765433222
Q ss_pred -ccCCChHHHHHHHHHHhCcC---CCCCHHHHhcCcccCCCCC
Q 004672 247 -FKVEDPEVRQFIEKCLATVS---SRLSARELLTDPFLQIDDY 285 (738)
Q Consensus 247 -~~~~spel~~lI~kcL~dP~---~RpSa~ELL~Hpf~~~~~~ 285 (738)
....+++++++|.+||.+|. .|+++.++++||||+...+
T Consensus 270 ~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 270 DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 23578999999999999543 3789999999999987554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=353.88 Aligned_cols=251 Identities=20% Similarity=0.335 Sum_probs=209.8
Q ss_pred EEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecCCCeEEEEEec
Q 004672 27 MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEM 105 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~LV~Ey 105 (738)
+.||+|+||+||+|.+..++..||+|.++... .......+.+..|+.++..+ +||||++++++|.. ...+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKEL-VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhH-hcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeC
Confidence 36999999999999999999999999988543 23345567788999999887 89999999998765 6789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc--cccc
Q 004672 106 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAA 183 (738)
Q Consensus 106 ~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~--~~~~ 183 (738)
+++|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~-~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCC-CCEEEeeCCccccccCCCCccc
Confidence 999999999988889999999999999999999999998 9999999999999855 8999999999875322 2223
Q ss_pred cccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCC--------CCHHHHHHHHHcCCCCcccccCCChHH
Q 004672 184 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC--------THPAQIYKKVISGKKPEALFKVEDPEV 254 (738)
Q Consensus 184 ~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~--------~~~~qi~k~i~~g~~p~~l~~~~spel 254 (738)
...||+.|+|||++.+ .++.++||||||+++|+|+||..||... .....+++.+..+.. .++...++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~~~~~~ 232 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC--CCCCCCCHHH
Confidence 4569999999999875 5899999999999999999999999521 122334444444332 2445678999
Q ss_pred HHHHHHHHh-CcCCCCC------HHHHhcCcccCCCCC
Q 004672 255 RQFIEKCLA-TVSSRLS------ARELLTDPFLQIDDY 285 (738)
Q Consensus 255 ~~lI~kcL~-dP~~RpS------a~ELL~Hpf~~~~~~ 285 (738)
+++|.+||+ +|.+||+ +.++++||||+..++
T Consensus 233 ~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 233 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred HHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 999999999 9999998 589999999976544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=352.67 Aligned_cols=258 Identities=20% Similarity=0.331 Sum_probs=213.2
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.+++.||+|+||+||++.+..+|..||+|.+...+. ......+.+..|+.+++.++|+||++++++|.. +..++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~ 77 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-LKRAETACFREERDVLVNGDRRWITNLHYAFQD--ENNLY 77 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec--CCeEE
Confidence 479999999999999999999999999999999875332 223455678899999999999999999998754 67899
Q ss_pred EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 101 FVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k-~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
+||||+.+|+|.+++.+ ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..+..
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLA 154 (331)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCC-CCEEEEECCceeecCC
Confidence 99999999999999876 457999999999999999999999999 9999999999999754 8999999999865543
Q ss_pred ccc---ccccCCCCCCCccccc------cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcc---cc
Q 004672 180 SHA---ARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEA---LF 247 (738)
Q Consensus 180 ~~~---~~~vGTp~YmAPEvl~------~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~---l~ 247 (738)
... ....||+.|||||++. +.++.++|||||||++|+|++|+.||.. .+..+.+..+........ ..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~ 233 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKEHFQFPPDV 233 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCcccCCCcc
Confidence 221 2235999999999985 3478899999999999999999999986 445566666655332111 12
Q ss_pred cCCChHHHHHHHHHHhC---cCCCCCHHHHhcCcccCCCCC
Q 004672 248 KVEDPEVRQFIEKCLAT---VSSRLSARELLTDPFLQIDDY 285 (738)
Q Consensus 248 ~~~spel~~lI~kcL~d---P~~RpSa~ELL~Hpf~~~~~~ 285 (738)
...++.+++||.+||.. +..|+++.++|+||||...++
T Consensus 234 ~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 234 TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred CCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 34688999999999973 334889999999999976544
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=353.01 Aligned_cols=250 Identities=22% Similarity=0.385 Sum_probs=210.1
Q ss_pred EEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecCCCeEEEEEec
Q 004672 27 MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEM 105 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~LV~Ey 105 (738)
+.||.|+||+||+|.++.+|..||+|.++..... .....+.+..|+.++..+ +||||++++++|.. ++.+++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-IDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECC
Confidence 4699999999999999999999999998854321 123455677888888765 99999999998855 6799999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh--ccccc
Q 004672 106 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAA 183 (738)
Q Consensus 106 ~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~--~~~~~ 183 (738)
+.+|+|..++....++++..+..++.||+.||+|||+++ |+||||||+|||++.+ |.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 78 LNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRD-GHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC-CCEEeCccCCCeecccCCCcee
Confidence 999999999988888999999999999999999999998 9999999999999855 799999999986422 22234
Q ss_pred cccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHH
Q 004672 184 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 262 (738)
Q Consensus 184 ~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL 262 (738)
...||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+..++.+.+..+.. .++...+++++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l 231 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG-DDEDELFESIRVDTP--HYPRWITKESKDILEKLF 231 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHc
Confidence 4569999999999874 589999999999999999999999986 456666666655432 233457899999999999
Q ss_pred h-CcCCCCCH-HHHhcCcccCCCCC
Q 004672 263 A-TVSSRLSA-RELLTDPFLQIDDY 285 (738)
Q Consensus 263 ~-dP~~RpSa-~ELL~Hpf~~~~~~ 285 (738)
. +|.+|+++ .++++||||+..++
T Consensus 232 ~~dP~~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 232 ERDPTRRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred cCCHHHcCCChHHHHcCCCcCCCCH
Confidence 9 99999998 58999999976543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=343.46 Aligned_cols=253 Identities=26% Similarity=0.351 Sum_probs=201.4
Q ss_pred CCceEEEEEcccCCeEEEEEEEcC-CCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC---CCCCcceeeEEEEe---
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEY-EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL---KHRNIMKFYTSWVD--- 93 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~-tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L---~HpNIVkl~~~fv~--- 93 (738)
++|.+++.||.|+||+||+|.+.. +|..||+|.++..... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC--CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence 478999999999999999999864 5789999998764321 12233456677777766 69999999998753
Q ss_pred cCCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEecc
Q 004672 94 TANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 171 (738)
Q Consensus 94 ~~~~~l~LV~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DF 171 (738)
.....+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+||
T Consensus 79 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~-~~~kl~Df 154 (290)
T cd07862 79 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADF 154 (290)
T ss_pred CCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCC-CCEEEccc
Confidence 23457899999995 6999998764 35899999999999999999999998 9999999999999854 89999999
Q ss_pred chhHHhhccc-cccccCCCCCCCccccc-cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCC-C--Cc--
Q 004672 172 GLAAILRKSH-AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK-K--PE-- 244 (738)
Q Consensus 172 GlA~~l~~~~-~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~-~--p~-- 244 (738)
|++....... .....||+.|+|||++. ..++.++||||||+++|+|++|..||........+ ..+.... . +.
T Consensus 155 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~-~~i~~~~~~~~~~~~ 233 (290)
T cd07862 155 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL-GKILDVIGLPGEEDW 233 (290)
T ss_pred cceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH-HHHHHHhCCCChhhc
Confidence 9997654332 23445899999999886 45899999999999999999999999875444433 3333211 0 00
Q ss_pred --------------------ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 245 --------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 245 --------------------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
.+....++.++++|.+||+ +|.+|||+.++|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 1123457789999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=351.32 Aligned_cols=249 Identities=22% Similarity=0.326 Sum_probs=211.3
Q ss_pred EEEcccCCeEEEEEEEc---CCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEE
Q 004672 27 MKFLVKELQRHYRAFDE---YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 103 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~---~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~ 103 (738)
+.||+|+||+||++.+. .+|..||+|+++.... ......++..|+.+|++++||||++++++|.. ...+++||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCEEEEEE
Confidence 67999999999998873 6789999999885432 22345677889999999999999999998754 67899999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc--c
Q 004672 104 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--H 181 (738)
Q Consensus 104 Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~--~ 181 (738)
||+++|+|.+++.+...+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++...... .
T Consensus 78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 78 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCC-CcEEEeeccCCcccCCCCCc
Confidence 99999999999988888999999999999999999999998 9999999999999855 79999999998765433 2
Q ss_pred cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHH
Q 004672 182 AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 260 (738)
Q Consensus 182 ~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~k 260 (738)
.....||+.|+|||++.+ .++.++||||||+++|+|+||+.||.. .+..+.+..+..+... ++...++.++++|.+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~li~~ 231 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG-KDRKETMTMILKAKLG--MPQFLSPEAQSLLRA 231 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHH
Confidence 234569999999999874 588999999999999999999999986 4556666666655432 345578999999999
Q ss_pred HHh-CcCCCCC-----HHHHhcCcccCCCCC
Q 004672 261 CLA-TVSSRLS-----ARELLTDPFLQIDDY 285 (738)
Q Consensus 261 cL~-dP~~RpS-----a~ELL~Hpf~~~~~~ 285 (738)
||+ +|.+||+ +.+++.||||+..++
T Consensus 232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~ 262 (318)
T cd05582 232 LFKRNPANRLGAGPDGVEEIKRHPFFSTIDW 262 (318)
T ss_pred HhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence 999 9999999 788999999986543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=334.63 Aligned_cols=254 Identities=30% Similarity=0.493 Sum_probs=215.5
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccC-CCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFL-QSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~-~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
+.|.+.+.||.|++|.||+|.+..+|..||+|.+...... ......+.+.+|+.++++++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--DETL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--CCeE
Confidence 5688999999999999999999999999999998755321 123345688999999999999999999998855 5699
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 100 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
++|+||+++++|.+++.+.+.+++..++.++.|++.||.|||+.+ |+||||+|+||+++.+ +.++|+|||++.....
T Consensus 80 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~-~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSA-GNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeecccceeccc
Confidence 999999999999999988888999999999999999999999998 9999999999999854 7999999999865432
Q ss_pred ccc-----ccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChH
Q 004672 180 SHA-----ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 253 (738)
Q Consensus 180 ~~~-----~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spe 253 (738)
... ....|++.|+|||++.+ .++.++||||||+++|+|++|+.||........+. .+........++...+..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIATQPTNPQLPSHVSPD 235 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH-HHhccCCCCCCCccCCHH
Confidence 211 23457889999999875 48899999999999999999999998754444443 344443444455677899
Q ss_pred HHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 254 VRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 254 l~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
+.++|.+||. +|.+|||+.++|+||||
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 236 ARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999999 89999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=351.96 Aligned_cols=250 Identities=22% Similarity=0.384 Sum_probs=210.4
Q ss_pred EEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecCCCeEEEEEec
Q 004672 27 MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEM 105 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~LV~Ey 105 (738)
+.||+|+||+||+|.+..++..||+|+++.... ......+....|..+++.+ +||||++++++|.. ...+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVV-LMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeC
Confidence 369999999999999999999999999885431 1223445677788888865 99999999998765 6789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh--ccccc
Q 004672 106 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAA 183 (738)
Q Consensus 106 ~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~--~~~~~ 183 (738)
+++|+|.+++.....+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.... .....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 78 LNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTD-GHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCC-CCEEEccCCcceECCCCCCcee
Confidence 999999999988888999999999999999999999998 9999999999999855 799999999986432 22233
Q ss_pred cccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHH
Q 004672 184 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 262 (738)
Q Consensus 184 ~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL 262 (738)
...||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+..+... ++...+.++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~l 231 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG-HDEEELFQSIRMDNPC--YPRWLTREAKDILVKLF 231 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCccCCHHHHHHHHHHh
Confidence 4569999999999875 589999999999999999999999986 4566666666554322 33457889999999999
Q ss_pred h-CcCCCCCHH-HHhcCcccCCCCC
Q 004672 263 A-TVSSRLSAR-ELLTDPFLQIDDY 285 (738)
Q Consensus 263 ~-dP~~RpSa~-ELL~Hpf~~~~~~ 285 (738)
. +|.+||++. +++.||||+..++
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 232 VREPERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred ccCHhhcCCChHHHHcCcccCCCCH
Confidence 9 999999997 9999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=352.60 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=207.7
Q ss_pred EEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHH-HHHHHhCCCCCcceeeEEEEecCCCeEEEEEec
Q 004672 27 MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCE-IHLLKTLKHRNIMKFYTSWVDTANRNINFVTEM 105 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~E-i~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey 105 (738)
+.||+|+||+||+|.+..++..||+|++.......... ...+..| ..+++.++||||++++++|.. .+.+++||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~-~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKE-EKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhH-HHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEEEEEeC
Confidence 36999999999999999999999999987543222222 2334444 446788999999999998754 6789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc--cccc
Q 004672 106 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAA 183 (738)
Q Consensus 106 ~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~--~~~~ 183 (738)
+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~-~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC-CCEEEccCCCCcccccCCCCcc
Confidence 999999999988888999999999999999999999998 9999999999999854 8999999999875422 2233
Q ss_pred cccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHH
Q 004672 184 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 262 (738)
Q Consensus 184 ~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL 262 (738)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...++..+..+.. ......++.++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l 231 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPL--QLKPNITNSARHLLEGLL 231 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC-CCHHHHHHHHHhCCc--CCCCCCCHHHHHHHHHHc
Confidence 4569999999998875 588999999999999999999999986 456666676665433 234567899999999999
Q ss_pred h-CcCCCCCHH----HHhcCcccCCCCC
Q 004672 263 A-TVSSRLSAR----ELLTDPFLQIDDY 285 (738)
Q Consensus 263 ~-dP~~RpSa~----ELL~Hpf~~~~~~ 285 (738)
+ +|.+|+++. ++++|+||...++
T Consensus 232 ~~~p~~R~~~~~~~~~i~~~~~~~~~~~ 259 (325)
T cd05602 232 QKDRTKRLGAKDDFMEIKNHIFFSPINW 259 (325)
T ss_pred ccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence 9 999999876 8999999976554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=351.98 Aligned_cols=250 Identities=21% Similarity=0.353 Sum_probs=213.3
Q ss_pred EEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecCCCeEEEEEec
Q 004672 27 MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEM 105 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~LV~Ey 105 (738)
+.||.|+||+||+|.+..++..||+|+++... .........+..|+.+++.+ +||||++++++|.. ...+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDV-ILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH-HhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcC
Confidence 36999999999999999999999999988543 22334566788999999988 79999999998754 6789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh--ccccc
Q 004672 106 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAA 183 (738)
Q Consensus 106 ~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~--~~~~~ 183 (738)
+.+|+|..++.+.+++++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.... .....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 78 VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCC-CcEEecccCCCeecCcCCCccc
Confidence 999999999988889999999999999999999999998 9999999999999855 799999999986422 22223
Q ss_pred cccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHH
Q 004672 184 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 262 (738)
Q Consensus 184 ~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL 262 (738)
..+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+...++..+..+... ++...++++++||.+||
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~-~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~l 231 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG-DDEDELFQSILEDEVR--YPRWLSKEAKSILKSFL 231 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCC--CCCcCCHHHHHHHHHHc
Confidence 4469999999999874 589999999999999999999999976 4566666666655432 34557899999999999
Q ss_pred h-CcCCCCCH-----HHHhcCcccCCCCC
Q 004672 263 A-TVSSRLSA-----RELLTDPFLQIDDY 285 (738)
Q Consensus 263 ~-dP~~RpSa-----~ELL~Hpf~~~~~~ 285 (738)
. +|.+|||+ .+++.||||+..++
T Consensus 232 ~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 232 TKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred cCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 9 99999999 99999999987554
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=351.22 Aligned_cols=250 Identities=22% Similarity=0.391 Sum_probs=209.3
Q ss_pred EEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecCCCeEEEEEec
Q 004672 27 MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEM 105 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~LV~Ey 105 (738)
+.||+|+||+||+|.+..++..||+|.++.... ......+.+..|..++..+ +||||+++++++.. +..+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVV-LEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcC
Confidence 369999999999999999999999999885432 2234455667777777765 89999999998754 6789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc--cccc
Q 004672 106 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAA 183 (738)
Q Consensus 106 ~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~--~~~~ 183 (738)
++||+|..++.....+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..... ....
T Consensus 78 ~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~-~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 78 LNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKD-GHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCC-CCEEEccCcCCeECCCCCCccc
Confidence 999999999988889999999999999999999999998 9999999999999854 8999999999875422 2233
Q ss_pred cccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHH
Q 004672 184 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 262 (738)
Q Consensus 184 ~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL 262 (738)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..+++..+..... .++...++++.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~ll~~~l 231 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILNDRP--HFPRWISKEAKDCLSKLF 231 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHc
Confidence 4569999999999875 589999999999999999999999986 455666666655432 234567889999999999
Q ss_pred h-CcCCCCCH-HHHhcCcccCCCCC
Q 004672 263 A-TVSSRLSA-RELLTDPFLQIDDY 285 (738)
Q Consensus 263 ~-dP~~RpSa-~ELL~Hpf~~~~~~ 285 (738)
. +|.+||++ .+++.||||+..++
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 232 ERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred cCCHHHcCCChHHHHcCcccCCCCH
Confidence 9 99999986 58999999986554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=352.03 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=208.7
Q ss_pred EEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHH-HHHhCCCCCcceeeEEEEecCCCeEEEEEec
Q 004672 27 MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIH-LLKTLKHRNIMKFYTSWVDTANRNINFVTEM 105 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~-iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey 105 (738)
+.||.|+||+||+|.+..+|..||+|++...... .......+..|.. +++.++||||++++++|.. ...+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEEEEEcC
Confidence 3689999999999999999999999998754322 2233445556655 5778999999999998754 6789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc--cccc
Q 004672 106 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAA 183 (738)
Q Consensus 106 ~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~--~~~~ 183 (738)
+.+|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ |.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQ-GHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCC-CCEEEeecCCcccCCCCCCCcc
Confidence 999999999988889999999999999999999999998 9999999999999854 8999999999865322 2233
Q ss_pred cccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHH
Q 004672 184 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 262 (738)
Q Consensus 184 ~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL 262 (738)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+..+... .....+..+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~~ll~~ll 231 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC-RDVAEMYDNILHKPLV--LRPGASLTAWSILEELL 231 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC-CCHHHHHHHHHcCCcc--CCCCCCHHHHHHHHHHh
Confidence 4569999999999875 589999999999999999999999986 4566777777765432 23457889999999999
Q ss_pred h-CcCCCCCH----HHHhcCcccCCCCC
Q 004672 263 A-TVSSRLSA----RELLTDPFLQIDDY 285 (738)
Q Consensus 263 ~-dP~~RpSa----~ELL~Hpf~~~~~~ 285 (738)
. +|.+||++ .++++||||....+
T Consensus 232 ~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 232 EKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred ccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 9 89999876 59999999976443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=350.31 Aligned_cols=250 Identities=24% Similarity=0.327 Sum_probs=208.4
Q ss_pred EEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHH-HHHHhCCCCCcceeeEEEEecCCCeEEEEEec
Q 004672 27 MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEI-HLLKTLKHRNIMKFYTSWVDTANRNINFVTEM 105 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei-~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey 105 (738)
+.||.|+||+||+|.+..+|..||+|.+....... ......+..|+ .+++.++||||++++++|.. .+.+++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK-KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT--AEKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hhHHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCEEEEEEcC
Confidence 36999999999999999999999999987543222 23334555555 46888999999999988754 6789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc--cccc
Q 004672 106 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAA 183 (738)
Q Consensus 106 ~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~--~~~~ 183 (738)
+++|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC-CCEEEccCCCCccCCCCCCccc
Confidence 999999999888888999999999999999999999998 9999999999999854 8999999999875322 2223
Q ss_pred cccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHH
Q 004672 184 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 262 (738)
Q Consensus 184 ~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL 262 (738)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+..+.. .++...+..+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l 231 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILHKPL--QLPGGKTVAACDLLVGLL 231 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHc
Confidence 4469999999999864 589999999999999999999999986 456677777766543 344567889999999999
Q ss_pred h-CcCCCCCH----HHHhcCcccCCCCC
Q 004672 263 A-TVSSRLSA----RELLTDPFLQIDDY 285 (738)
Q Consensus 263 ~-dP~~RpSa----~ELL~Hpf~~~~~~ 285 (738)
+ +|.+|+++ .++++|+||...++
T Consensus 232 ~~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 232 HKDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred cCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 9 99999875 59999999975443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=353.97 Aligned_cols=257 Identities=28% Similarity=0.353 Sum_probs=205.6
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC--
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA-- 95 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~-- 95 (738)
...++|.+++.||.|+||+||+|.+..+|..||+|++.... .......++.+|+.+++.++||||++++++|....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF--QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc--cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence 34689999999999999999999999999999999987432 23445677889999999999999999999875432
Q ss_pred --CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccch
Q 004672 96 --NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 173 (738)
Q Consensus 96 --~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGl 173 (738)
...+++||||+. ++|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+
T Consensus 96 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~-~~~kl~Dfg~ 169 (359)
T cd07876 96 EEFQDVYLVMELMD-ANLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGL 169 (359)
T ss_pred cccceeEEEEeCCC-cCHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEEecCCC
Confidence 235899999996 46666653 35889999999999999999999998 9999999999999855 8999999999
Q ss_pred hHHhhccc-cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc------------
Q 004672 174 AAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS------------ 239 (738)
Q Consensus 174 A~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~------------ 239 (738)
+....... .....||+.|+|||++.+ .++.++|||||||++|+|+||..||.+......+...+..
T Consensus 170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 97653322 234468999999999875 5899999999999999999999999865433322111110
Q ss_pred ---------C--CCC----------------cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 240 ---------G--KKP----------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 240 ---------g--~~p----------------~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
. ..+ .......++++++||.+||. +|.+|||+.|+|.||||..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 0 000 00112246789999999999 9999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=361.76 Aligned_cols=251 Identities=26% Similarity=0.335 Sum_probs=204.1
Q ss_pred ccCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEec
Q 004672 15 LKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 94 (738)
Q Consensus 15 ~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~ 94 (738)
..++...+|.++++||+|+||.||+|.+..++..||+|... .+.+.+|+.+|+.|+||||++++++|..
T Consensus 86 ~~~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----------~~~~~~E~~il~~l~HpnIv~~~~~~~~- 154 (391)
T PHA03212 86 RAGIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----------RGGTATEAHILRAINHPSIIQLKGTFTY- 154 (391)
T ss_pred hcccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----------hhhhHHHHHHHHhCCCCCCCCEeEEEEE-
Confidence 34566678999999999999999999999999999999643 2347889999999999999999998855
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 95 ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 95 ~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
+...++|+|++ +++|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 155 -~~~~~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~-~~vkL~DFG~a 229 (391)
T PHA03212 155 -NKFTCLILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHP-GDVCLGDFGAA 229 (391)
T ss_pred -CCeeEEEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCC-CCEEEEeCCcc
Confidence 67899999999 5799999888888999999999999999999999998 9999999999999854 89999999999
Q ss_pred HHhhc---cccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCC-------CHHHHHHHHHc--CC
Q 004672 175 AILRK---SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT-------HPAQIYKKVIS--GK 241 (738)
Q Consensus 175 ~~l~~---~~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~-------~~~qi~k~i~~--g~ 241 (738)
..... .......||+.|+|||++.+ .|+.++|||||||++|+|+||..||.... ...++ +.+.. |.
T Consensus 230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l-~~i~~~~g~ 308 (391)
T PHA03212 230 CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQI-KLIIRRSGT 308 (391)
T ss_pred cccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHH-HHHHHHhcC
Confidence 65432 22234569999999998864 59999999999999999999998875321 11111 11111 11
Q ss_pred CCccc-------------------------------ccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 242 KPEAL-------------------------------FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 242 ~p~~l-------------------------------~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
.|..+ ....+.++.+||.+||+ +|.+||||.|+|+||||+.
T Consensus 309 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 309 HPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred ChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 11000 01235679999999999 9999999999999999975
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=352.41 Aligned_cols=250 Identities=27% Similarity=0.383 Sum_probs=212.4
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCC---e
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR---N 98 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~---~ 98 (738)
.|...+++|+|+||.||+|....+++.||||++--... --.+|+++|+.++|||||++.-+|...... +
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r--------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR--------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC--------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 37889999999999999999999999999999874432 234699999999999999999888765544 6
Q ss_pred EEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 99 INFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k----~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
.++||||++ .+|.++++. +.+++.-.++-+.+||++||.|||+.| |+||||||.|||+|.+.|.+||+|||.|
T Consensus 97 lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 97 LNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcc
Confidence 778999995 799888774 467999999999999999999999998 9999999999999999999999999999
Q ss_pred HHhhccc-cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc-CCC--------
Q 004672 175 AILRKSH-AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKK-------- 242 (738)
Q Consensus 175 ~~l~~~~-~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~-g~~-------- 242 (738)
+.+.... ..+++.|..|+|||++-+ .|+.+.||||.|||+.||+-|++-|.+.+..+|+...+.- |..
T Consensus 174 K~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 174 KVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 9876543 355678999999998875 5999999999999999999999999997777776443321 111
Q ss_pred ---------C----c----ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 243 ---------P----E----ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 243 ---------p----~----~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
| . -+....++++.+|+.++|. +|.+|.++.|+|.||||..
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde 311 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE 311 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH
Confidence 1 1 1345568999999999999 9999999999999999964
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=354.97 Aligned_cols=254 Identities=27% Similarity=0.410 Sum_probs=208.4
Q ss_pred CcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCC
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 96 (738)
...+++|..+++||.|+||+||+|.+..+|..||+|.+... ........+.+|+.+|+.++|+||++++++|.. .
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 144 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN---HEDTVRRQICREIEILRDVNHPNVVKCHDMFDH--N 144 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC---CcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc--C
Confidence 33467899999999999999999999999999999988643 234556789999999999999999999998744 6
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
..+++||||+.+|+|... ....+..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..
T Consensus 145 ~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-~~~kL~DfG~~~~ 217 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSA-KNVKIADFGVSRI 217 (353)
T ss_pred CeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCC-CCEEEccccccee
Confidence 789999999999999653 34678888999999999999999998 9999999999999854 8999999999976
Q ss_pred hhccc--cccccCCCCCCCcccccc-----c-cCcccccccchhhhhhhhhcCCCCCCCC--CHHHHHHHHHcCCCCccc
Q 004672 177 LRKSH--AARCVGTPEFMAPEVYEE-----E-YNELVDIYSFGMCILEMVTFDYPYSECT--HPAQIYKKVISGKKPEAL 246 (738)
Q Consensus 177 l~~~~--~~~~vGTp~YmAPEvl~~-----~-ys~~sDIWSLGviLyeLlTG~~Pf~~~~--~~~qi~k~i~~g~~p~~l 246 (738)
+.... ....+||+.|+|||++.. . ++.++|||||||++|+|++|+.||.... ....+...+..+..+ ..
T Consensus 218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~ 296 (353)
T PLN00034 218 LAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPP-EA 296 (353)
T ss_pred cccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCC-CC
Confidence 64332 234569999999998742 2 4468999999999999999999997422 222333333333322 33
Q ss_pred ccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 247 FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 247 ~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
....++++++||.+||. +|.+|||+.|+|+||||...
T Consensus 297 ~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 297 PATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred CCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 45678899999999999 99999999999999999754
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=337.11 Aligned_cols=251 Identities=31% Similarity=0.516 Sum_probs=208.4
Q ss_pred ceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEE
Q 004672 23 MEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 102 (738)
Q Consensus 23 y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV 102 (738)
|++++.||+|+||+||++.+..++..||+|.+..... ..........|+.+++.++||||+++++++.. ...+++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v 76 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI--EEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIV 76 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH--HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc--cccccchhhhhhhccccccccccccccccccc--ccccccc
Confidence 7899999999999999999999999999999886531 22223344569999999999999999998866 7789999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh--hcc
Q 004672 103 TEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKS 180 (738)
Q Consensus 103 ~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l--~~~ 180 (738)
|||+.+++|.+++.+.+.+++..+..++.||+.||.+||+++ |+|+||||+||+++ +.+.++|+|||++... ...
T Consensus 77 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~-~~~~~~l~Dfg~~~~~~~~~~ 153 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLD-ENGEVKLIDFGSSVKLSENNE 153 (260)
T ss_dssp EEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEES-TTSEEEESSGTTTEESTSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc-ccccccccccccccccccccc
Confidence 999999999999998889999999999999999999999998 99999999999998 5589999999998753 223
Q ss_pred ccccccCCCCCCCccccc--cccCcccccccchhhhhhhhhcCCCCCCCC--CHHHHHHHHHcCCCCccccc--CCChHH
Q 004672 181 HAARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPYSECT--HPAQIYKKVISGKKPEALFK--VEDPEV 254 (738)
Q Consensus 181 ~~~~~vGTp~YmAPEvl~--~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~--~~~qi~k~i~~g~~p~~l~~--~~spel 254 (738)
......+++.|+|||++. ..++.++||||||+++|+|++|..||.... +.............+..... ...+++
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEEL 233 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHH
Confidence 334556899999999987 568999999999999999999999998752 22223333332222211111 123799
Q ss_pred HHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 255 RQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 255 ~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
+++|.+||. +|.+|||+.++++||||
T Consensus 234 ~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 234 RDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 999999999 99999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=349.10 Aligned_cols=259 Identities=17% Similarity=0.310 Sum_probs=214.0
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.+++.||+|+||+||++.++.++..||+|.+..... ........+..|+.++..++|+||++++++|.. .+.++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--~~~~~ 77 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM-LKRAETACFREERNVLVNGDCQWITTLHYAFQD--ENYLY 77 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH-HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEE
Confidence 579999999999999999999999999999999875331 223445678899999999999999999998754 67899
Q ss_pred EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 101 FVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k-~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
+||||+.||+|.+++.+ ...+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++.....
T Consensus 78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQ 154 (331)
T ss_pred EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCC-CCEEEEeccceeeccC
Confidence 99999999999999987 467999999999999999999999998 9999999999999854 7999999999876543
Q ss_pred ccc---ccccCCCCCCCcccccc------ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcc---cc
Q 004672 180 SHA---ARCVGTPEFMAPEVYEE------EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEA---LF 247 (738)
Q Consensus 180 ~~~---~~~vGTp~YmAPEvl~~------~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~---l~ 247 (738)
... ....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.. .+..+.+..+........ ..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~ 233 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHEERFQFPSHI 233 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC-CCHHHHHHHHHcCCCcccCCCcc
Confidence 322 23469999999998863 588899999999999999999999986 445566666665432111 12
Q ss_pred cCCChHHHHHHHHHHhCcCC---CCCHHHHhcCcccCCCCCc
Q 004672 248 KVEDPEVRQFIEKCLATVSS---RLSARELLTDPFLQIDDYD 286 (738)
Q Consensus 248 ~~~spel~~lI~kcL~dP~~---RpSa~ELL~Hpf~~~~~~~ 286 (738)
...+++++++|.+||..+.+ |++++++++||||+..++.
T Consensus 234 ~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~ 275 (331)
T cd05624 234 TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE 275 (331)
T ss_pred ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence 34578999999999984333 5799999999999865543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=349.29 Aligned_cols=251 Identities=19% Similarity=0.322 Sum_probs=211.0
Q ss_pred EEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecCCCeEEEEEec
Q 004672 27 MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEM 105 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~LV~Ey 105 (738)
+.||+|+||+||+|.+..++..||+|+++... .......+.+..|+.++.++ +||||++++++|.. ...+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKEL-VHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeC
Confidence 36999999999999999999999999988543 23345567889999999998 79999999998755 5789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc--cccc
Q 004672 106 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAA 183 (738)
Q Consensus 106 ~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~--~~~~ 183 (738)
+++|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..... ....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 78 VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCC-CCEEEeccccceeccCCCCcee
Confidence 999999999988889999999999999999999999998 9999999999999855 7999999999864321 2233
Q ss_pred cccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCC------CCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004672 184 RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC------THPAQIYKKVISGKKPEALFKVEDPEVRQ 256 (738)
Q Consensus 184 ~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~------~~~~qi~k~i~~g~~p~~l~~~~spel~~ 256 (738)
..+||+.|+|||++.+ .|+.++||||||+++|+|+||..||... .....++..+..+ +..++...++.+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~ 232 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLSVKASH 232 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCCCHHHHH
Confidence 4569999999998864 5899999999999999999999999532 2334455555443 33355667899999
Q ss_pred HHHHHHh-CcCCCCC------HHHHhcCcccCCCCC
Q 004672 257 FIEKCLA-TVSSRLS------ARELLTDPFLQIDDY 285 (738)
Q Consensus 257 lI~kcL~-dP~~RpS------a~ELL~Hpf~~~~~~ 285 (738)
+|.+||+ +|.+|++ +.+++.||||+..++
T Consensus 233 li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~ 268 (327)
T cd05617 233 VLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW 268 (327)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence 9999999 9999998 579999999987554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=341.59 Aligned_cols=254 Identities=21% Similarity=0.288 Sum_probs=213.3
Q ss_pred ccCcCCCCceEE--EEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEE
Q 004672 15 LKLIPLEDMEDT--MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWV 92 (738)
Q Consensus 15 ~~~I~~~~y~il--~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv 92 (738)
+..|+.+++... ..|++|+++.||+|.. +|..||+|.++... .......+.+.+|+.+|++++||||+++++++.
T Consensus 12 ~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~ 88 (283)
T PHA02988 12 IKCIESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFH-KGHKVLIDITENEIKNLRRIDSNNILKIYGFII 88 (283)
T ss_pred ceecCHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccc-cccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEE
Confidence 334444455444 7899999999999975 79999999987543 233445678899999999999999999999987
Q ss_pred e--cCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeccCCcccEEEeCCCCcEEEe
Q 004672 93 D--TANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR-DPPVIHRDLKCDNIFVNGNQGEVKIG 169 (738)
Q Consensus 93 ~--~~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~-gp~IIHRDLKP~NILl~~~~g~VKL~ 169 (738)
+ .....+++||||+++|+|.+++.+.+.+++.....++.|++.||.|||.. + ++||||||+|||++.+ +.+||+
T Consensus 89 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~-~~~kl~ 165 (283)
T PHA02988 89 DIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTEN-YKLKII 165 (283)
T ss_pred ecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCC-CcEEEc
Confidence 6 44568899999999999999999888899999999999999999999985 6 8899999999999855 899999
Q ss_pred ccchhHHhhccccccccCCCCCCCcccccc---ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCccc
Q 004672 170 DLGLAAILRKSHAARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL 246 (738)
Q Consensus 170 DFGlA~~l~~~~~~~~vGTp~YmAPEvl~~---~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l 246 (738)
|||++..+.... ....|++.|+|||++.+ .|+.++|||||||++|+|+||..||.. .+..+++..+..+.....+
T Consensus 166 dfg~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~ 243 (283)
T PHA02988 166 CHGLEKILSSPP-FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN-LTTKEIYDLIINKNNSLKL 243 (283)
T ss_pred ccchHhhhcccc-ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcCCCCCC
Confidence 999998765432 34468999999999864 689999999999999999999999986 4566777777655444444
Q ss_pred ccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 247 FKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 247 ~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
+...++++++||.+||+ +|.+|||+.+++.
T Consensus 244 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 244 PLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred CCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 44678999999999999 9999999999984
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=347.47 Aligned_cols=255 Identities=20% Similarity=0.319 Sum_probs=215.5
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCC-CCCcceeeEEEEecCCCeEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~l~ 100 (738)
+|...+.||.|+||+||+|.++.+|..||+|+++.... ......+.+..|+.+++.+. |++|++++++|.. ...++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~ 77 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLY 77 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEE
Confidence 47789999999999999999999999999999885432 23345567888999999885 5778888887754 56899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++......
T Consensus 78 lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~-~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 78 FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKEHMVD 154 (323)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEEeccccccccCCC
Confidence 99999999999999988889999999999999999999999998 9999999999999855 89999999998754322
Q ss_pred --ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004672 181 --HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 257 (738)
Q Consensus 181 --~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~l 257 (738)
......||+.|+|||++.+ .++.++|||||||++|+|+||..||.. .+...++..+..+... ++...+++++++
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~l 231 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNVS--YPKSLSKEAVSI 231 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCccCCHHHHHH
Confidence 2234469999999998864 589999999999999999999999986 4566777777765432 345678899999
Q ss_pred HHHHHh-CcCCCCC-----HHHHhcCcccCCCCC
Q 004672 258 IEKCLA-TVSSRLS-----ARELLTDPFLQIDDY 285 (738)
Q Consensus 258 I~kcL~-dP~~RpS-----a~ELL~Hpf~~~~~~ 285 (738)
+.+||. +|.+|++ ..++++||||+..++
T Consensus 232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 232 CKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred HHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 999999 9999997 579999999986554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=347.92 Aligned_cols=258 Identities=19% Similarity=0.322 Sum_probs=213.2
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.+.++||+|+||+||++.++.++..||+|.+..... ........+..|+.++..++|+||+++++.+.+ ...++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~ 77 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-LKRAETACFREERDVLVNGDNQWITTLHYAFQD--ENNLY 77 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH-HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCEEE
Confidence 479999999999999999999999999999999864331 123344568889999999999999999998754 67899
Q ss_pred EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 101 FVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k-~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
+||||+++|+|.+++.+ ...+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..+..
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~-~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMN-GHIRLADFGSCLKLME 154 (332)
T ss_pred EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCC-CCEEEeecchheeccc
Confidence 99999999999999987 467999999999999999999999998 9999999999999844 8999999999865433
Q ss_pred cc---cccccCCCCCCCccccc------cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCccc---c
Q 004672 180 SH---AARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL---F 247 (738)
Q Consensus 180 ~~---~~~~vGTp~YmAPEvl~------~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l---~ 247 (738)
.. ....+||+.|+|||++. +.++.++|||||||++|+|++|+.||.. .+..+.+.++........+ .
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~ 233 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPAQV 233 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCccccCCCcc
Confidence 21 12346999999999885 3588999999999999999999999986 4556666666654322111 2
Q ss_pred cCCChHHHHHHHHHHh-C--cCCCCCHHHHhcCcccCCCCC
Q 004672 248 KVEDPEVRQFIEKCLA-T--VSSRLSARELLTDPFLQIDDY 285 (738)
Q Consensus 248 ~~~spel~~lI~kcL~-d--P~~RpSa~ELL~Hpf~~~~~~ 285 (738)
...++++++||.+||. + +..|+++.++++||||+..++
T Consensus 234 ~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~ 274 (332)
T cd05623 234 TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW 274 (332)
T ss_pred ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence 3468999999999997 3 334789999999999986554
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=340.81 Aligned_cols=257 Identities=20% Similarity=0.303 Sum_probs=211.4
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
.|++.++||+|+||+||++.+..+|..||+|++..... ........+.+|+.+|+.++||||+++++.+.. +..+++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 77 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhh-hhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC--CCeEEE
Confidence 47899999999999999999999999999999875432 222334567889999999999999999998744 568999
Q ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 102 VTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 78 VLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDY-GHIRISDLGLAVEIPE 154 (285)
T ss_pred EEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCC-CCEEEeeCCCceecCC
Confidence 99999999999887653 46999999999999999999999998 9999999999999854 8999999999876543
Q ss_pred cc-cccccCCCCCCCccccc-cccCcccccccchhhhhhhhhcCCCCCCCCCHH---HHHHHHHcCCCCcccccCCChHH
Q 004672 180 SH-AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPA---QIYKKVISGKKPEALFKVEDPEV 254 (738)
Q Consensus 180 ~~-~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~---qi~k~i~~g~~p~~l~~~~spel 254 (738)
.. ....+|++.|+|||++. ..++.++||||||+++|+|++|..||.+..... .+...+..+ +.......++.+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 232 (285)
T cd05605 155 GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED--QEEYSEKFSEAA 232 (285)
T ss_pred CCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc--ccccCcccCHHH
Confidence 22 23346899999999986 458899999999999999999999998643222 222222222 223345578899
Q ss_pred HHHHHHHHh-CcCCCC-----CHHHHhcCcccCCCCCc
Q 004672 255 RQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDYD 286 (738)
Q Consensus 255 ~~lI~kcL~-dP~~Rp-----Sa~ELL~Hpf~~~~~~~ 286 (738)
++||.+||. +|.+|| ++.++++||||...++.
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 233 RSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred HHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence 999999999 999999 99999999999876554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=341.68 Aligned_cols=248 Identities=24% Similarity=0.374 Sum_probs=204.0
Q ss_pred EcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEecCCC
Q 004672 29 FLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTS 108 (738)
Q Consensus 29 LG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey~~g 108 (738)
||.|+||+||++.+..+|..||+|.+..... ......+.+..|+.+|+.++||||++++++|.. ...+++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL-KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHH-hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEEeCCCC
Confidence 6999999999999999999999999875432 223345678899999999999999999987744 6789999999999
Q ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccc--c
Q 004672 109 GTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--A 182 (738)
Q Consensus 109 GSL~~~l~k----~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~--~ 182 (738)
|+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++. .+.+||+|||++..+.... .
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~-~~~~~l~dfg~~~~~~~~~~~~ 154 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDN-DGNVRISDLGLAVELKDGQSKT 154 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECC-CCCEEEeeCccceecCCCCccc
Confidence 999988743 346999999999999999999999998 999999999999985 4899999999997654322 2
Q ss_pred ccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCC---HHHHHHHHHcCCCCcccccCCChHHHHHH
Q 004672 183 ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTH---PAQIYKKVISGKKPEALFKVEDPEVRQFI 258 (738)
Q Consensus 183 ~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~---~~qi~k~i~~g~~p~~l~~~~spel~~lI 258 (738)
....||+.|+|||++.+ .++.++||||||+++|+|++|+.||..... ...+...+..+ +...+...++.+++++
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li 232 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASKSFC 232 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHHHHH
Confidence 23469999999999874 588999999999999999999999975332 22233333322 2234456789999999
Q ss_pred HHHHh-CcCCCC-----CHHHHhcCcccCCCC
Q 004672 259 EKCLA-TVSSRL-----SARELLTDPFLQIDD 284 (738)
Q Consensus 259 ~kcL~-dP~~Rp-----Sa~ELL~Hpf~~~~~ 284 (738)
.+||+ +|.+|| +++++++||||+.-.
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence 99999 999999 889999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=349.63 Aligned_cols=248 Identities=25% Similarity=0.345 Sum_probs=208.0
Q ss_pred EcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC---CCCCcceeeEEEEecCCCeEEEEEec
Q 004672 29 FLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL---KHRNIMKFYTSWVDTANRNINFVTEM 105 (738)
Q Consensus 29 LG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L---~HpNIVkl~~~fv~~~~~~l~LV~Ey 105 (738)
||+|+||+||+|.++.+|..||+|++...... ..........|..++..+ +||||++++++|.. ...+++||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV-AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHh-hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcC
Confidence 69999999999999999999999998754322 223344566677777766 79999999998754 6789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc--cccc
Q 004672 106 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAA 183 (738)
Q Consensus 106 ~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~--~~~~ 183 (738)
+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..... ....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 78 MSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDAT-GHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred CCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC-CCEEEecCCcCcCCCCCCCCcc
Confidence 999999999988889999999999999999999999998 9999999999999854 7999999999865322 2233
Q ss_pred cccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHH
Q 004672 184 RCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKC 261 (738)
Q Consensus 184 ~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kc 261 (738)
..+||+.|+|||++.+ .++.++|||||||++|+|+||..||.. .+..++++.+..+..... ....++++++||.+|
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~-~~~~~~~~~~li~~~ 232 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA-EDTQQMYRNIAFGKVRFP-KNVLSDEGRQFVKGL 232 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC-CCHHHHHHHHHcCCCCCC-CccCCHHHHHHHHHH
Confidence 4569999999998864 488999999999999999999999976 556777777776654321 234688999999999
Q ss_pred Hh-CcCCCC----CHHHHhcCcccCCCC
Q 004672 262 LA-TVSSRL----SARELLTDPFLQIDD 284 (738)
Q Consensus 262 L~-dP~~Rp----Sa~ELL~Hpf~~~~~ 284 (738)
|. +|.+|| ++.++++||||+..+
T Consensus 233 L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 233 LNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred cCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 99 999998 799999999997654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=336.73 Aligned_cols=265 Identities=22% Similarity=0.352 Sum_probs=235.4
Q ss_pred CCCcccccCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceee
Q 004672 9 QIPPSLLKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY 88 (738)
Q Consensus 9 ~vp~~l~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~ 88 (738)
+..........+++|.+++.||.|-||.||+|+.+.++-.||+|++-+... ......+++.+|++|-..|+||||+++|
T Consensus 10 ~~~~~~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi-~~~~v~~qlrREiEIqs~L~hpnilrlY 88 (281)
T KOG0580|consen 10 PFGSRATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQI-LKTQVEHQLRREIEIQSHLRHPNILRLY 88 (281)
T ss_pred CcccccccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHH-HHhcchhhhhheeEeecccCCccHHhhh
Confidence 334555677889999999999999999999999999999999999876653 2334457899999999999999999999
Q ss_pred EEEEecCCCeEEEEEecCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcE
Q 004672 89 TSWVDTANRNINFVTEMFTSGTLRQYRL--KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV 166 (738)
Q Consensus 89 ~~fv~~~~~~l~LV~Ey~~gGSL~~~l~--k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~V 166 (738)
++|.+ ...+|+++||.+.|+|...+. ...++++.....+++|++.||.|+|.++ +|||||||+|+|+..+ |.+
T Consensus 89 ~~fhd--~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~-~~l 163 (281)
T KOG0580|consen 89 GYFHD--SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSA-GEL 163 (281)
T ss_pred hheec--cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCC-CCe
Confidence 99977 678999999999999999998 5678999999999999999999999999 9999999999999855 899
Q ss_pred EEeccchhHHhhccccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcc
Q 004672 167 KIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEA 245 (738)
Q Consensus 167 KL~DFGlA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~ 245 (738)
||+|||.+..-..+...+.+||..|.+||+..+ .++..+|+|++|++.||++.|.+||.... ..+.|++|..-...
T Consensus 164 kiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~~~-- 240 (281)
T KOG0580|consen 164 KIADFGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVDLK-- 240 (281)
T ss_pred eccCCCceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHcccc--
Confidence 999999998776677778899999999999986 49999999999999999999999998754 78888888764432
Q ss_pred cccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 246 LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 246 l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
++...+.+++++|.+||. +|.+|.+..|++.|||+..
T Consensus 241 ~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 241 FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 236678999999999999 8999999999999999853
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=341.40 Aligned_cols=253 Identities=26% Similarity=0.426 Sum_probs=212.6
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.+.++||.|+||.||+|.+..+|..||+|.++.. .......++.+|+++|+.++||||++++++|.. +..++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE---IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--DGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCEEE
Confidence 4789999999999999999999999999999988743 234566789999999999999999999998865 67899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs-~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
+||||+++++|.+++.+.+++++..+..++.||+.||.|||+ .+ ++||||||+|||++.+ +.+||+|||++.....
T Consensus 76 lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLID 152 (308)
T ss_pred EEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecC-CcEEEccCCCcccccc
Confidence 999999999999999988889999999999999999999998 46 9999999999999854 7999999999876655
Q ss_pred cccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHH---------------------
Q 004672 180 SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV--------------------- 237 (738)
Q Consensus 180 ~~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i--------------------- 237 (738)
.......|++.|+|||++.+ .++.++||||||+++|+|+||..||.... .......+
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 153 SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-AKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc-hhhHHHhhcCccccccccCCcccccCCCC
Confidence 44455679999999998864 48889999999999999999999996422 22222211
Q ss_pred ---------------HcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 238 ---------------ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 238 ---------------~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
.....|.......++++++||.+||. +|.+||++.+++.||||..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 11111211122367889999999999 9999999999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=330.82 Aligned_cols=257 Identities=30% Similarity=0.475 Sum_probs=216.0
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEecccc-CCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDF-LQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~-~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
.+|.+.+.||.|+||+||+|.+..+|..||+|++..... .......+.+.+|+.+++.++||||++++++|.+.....+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 578999999999999999999999999999999875432 2234557789999999999999999999998866556688
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 100 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
+++|||+++++|.+++.+...+++..+..++.|++.||.|||+++ |+|+||||+||+++.+ +.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSV-GNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCC-CCEEECcCcccccccc
Confidence 999999999999999988888999999999999999999999998 9999999999999854 8999999999875532
Q ss_pred c-----ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChH
Q 004672 180 S-----HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 253 (738)
Q Consensus 180 ~-----~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spe 253 (738)
. ......|+..|+|||++.+ .++.++||||||+++|+|++|..||........+.+ +.........+...+..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 237 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK-IATQPTNPVLPPHVSDH 237 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH-HhcCCCCCCCchhhCHH
Confidence 1 1223458899999998864 588999999999999999999999987544444433 33332223344556788
Q ss_pred HHHHHHHHHhCcCCCCCHHHHhcCcccC
Q 004672 254 VRQFIEKCLATVSSRLSARELLTDPFLQ 281 (738)
Q Consensus 254 l~~lI~kcL~dP~~RpSa~ELL~Hpf~~ 281 (738)
+.++|.+|+.+|.+||++.+++.|||+.
T Consensus 238 ~~~~i~~~l~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 238 CRDFLKRIFVEAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHHhcChhhCCCHHHHhcCcccC
Confidence 9999999999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=337.14 Aligned_cols=252 Identities=29% Similarity=0.383 Sum_probs=200.8
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC---CCCCcceeeEEEEec---C
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL---KHRNIMKFYTSWVDT---A 95 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L---~HpNIVkl~~~fv~~---~ 95 (738)
+|.+++.||.|+||+||+|.+..+|..||+|.++...... .....+.+|+.+++.+ +||||++++++|... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~ 78 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED--GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR 78 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC--CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence 5889999999999999999999999999999988643111 1123455677777665 799999999987542 2
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccch
Q 004672 96 NRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 173 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGl 173 (738)
...+++||||+. ++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 79 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~-~~~kl~dfg~ 154 (288)
T cd07863 79 ETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSG-GQVKLADFGL 154 (288)
T ss_pred CceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEECccCc
Confidence 356899999996 5899888764 34899999999999999999999998 9999999999999854 8999999999
Q ss_pred hHHhhcccc-ccccCCCCCCCccccc-cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc--CCC-----C-
Q 004672 174 AAILRKSHA-ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GKK-----P- 243 (738)
Q Consensus 174 A~~l~~~~~-~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~--g~~-----p- 243 (738)
+........ ....||+.|+|||++. ..++.++|||||||++|+|++|.+||........+ .++.. +.. +
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 155 ARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL-GKIFDLIGLPPEDDWPR 233 (288)
T ss_pred cccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHH-HHHHHHhCCCChhhCcc
Confidence 977654322 3446899999999886 45899999999999999999999999765444333 22221 100 0
Q ss_pred -----------------cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 244 -----------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 244 -----------------~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
.......+..++++|.+||+ +|.+|||+.++|.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 01123456788999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=349.01 Aligned_cols=251 Identities=22% Similarity=0.323 Sum_probs=206.2
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEE-----cCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEE
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFD-----EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSW 91 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d-----~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~f 91 (738)
++.++|.+.++||.|+||+||+|.+ ..++..||+|+++.. ......+.+.+|+.+|+.+ +||||++++++|
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG---ATASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc---cchHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 5667999999999999999999975 345678999987632 2344567899999999999 899999999987
Q ss_pred EecCCCeEEEEEecCCCCCHHHHHHhc-----------------------------------------------------
Q 004672 92 VDTANRNINFVTEMFTSGTLRQYRLKH----------------------------------------------------- 118 (738)
Q Consensus 92 v~~~~~~l~LV~Ey~~gGSL~~~l~k~----------------------------------------------------- 118 (738)
.. .+..+++||||+++|+|.+++...
T Consensus 81 ~~-~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 81 TK-PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred cC-CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 54 345789999999999999998753
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccc----cccc
Q 004672 119 ---------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARC 185 (738)
Q Consensus 119 ---------~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~----~~~~ 185 (738)
.++++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++....... ....
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~ 236 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGSA 236 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCC-CcEEEeecccccccccCcchhcccCC
Confidence 23778889999999999999999998 9999999999999854 799999999997653321 1223
Q ss_pred cCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh
Q 004672 186 VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 263 (738)
Q Consensus 186 vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~ 263 (738)
.+++.|+|||++. ..|+.++||||||+++|+|++ |..||........+...+..+..+. .+...++.++++|.+||.
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~ 315 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR-APENATPEIYRIMLACWQ 315 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcc
Confidence 4668899999886 458999999999999999997 9999987555555555555554432 345678899999999999
Q ss_pred -CcCCCCCHHHHhc
Q 004672 264 -TVSSRLSARELLT 276 (738)
Q Consensus 264 -dP~~RpSa~ELL~ 276 (738)
+|.+|||+.+|++
T Consensus 316 ~dp~~RPs~~el~~ 329 (338)
T cd05102 316 GDPKERPTFSALVE 329 (338)
T ss_pred CChhhCcCHHHHHH
Confidence 9999999999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=350.70 Aligned_cols=252 Identities=23% Similarity=0.402 Sum_probs=226.7
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
-.|.+.++||.|.||+|-+|.+...|+.||||.|+... ..++..+-.+.+||+||..|+||||+++|.+| ++...+.
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdk-IkdeqDlvhIRREIeIMSsLNHPhII~IyEVF--ENkdKIv 129 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDK-IKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF--ENKDKIV 129 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhh-cccHHHHHHHHHHHHHHhhcCCCceeehhhhh--cCCceEE
Confidence 35889999999999999999999999999999998655 56778888999999999999999999999987 5578999
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
|||||..+|.|.+|+...+.+++..++.+++||+.|+.|||.++ ++|||||.+|||++.| +.+||+||||+..+...
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N-~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQN-NNIKIADFGLSNLYADK 206 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCC-CCeeeeccchhhhhccc
Confidence 99999999999999999999999999999999999999999999 9999999999999976 79999999999887654
Q ss_pred -ccccccCCCCCCCccccccc--cCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004672 181 -HAARCVGTPEFMAPEVYEEE--YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 257 (738)
Q Consensus 181 -~~~~~vGTp~YmAPEvl~~~--ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~l 257 (738)
...+++|+|.|.+||+.++. -++.+|.||||++||.|+.|..||.+ .+-..+.+.|..|.+-+ +..+..+.-|
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-~Dhk~lvrQIs~GaYrE---P~~PSdA~gL 282 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-RDHKRLVRQISRGAYRE---PETPSDASGL 282 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-chHHHHHHHhhcccccC---CCCCchHHHH
Confidence 46788999999999999875 36789999999999999999999998 45667778888887643 2235578899
Q ss_pred HHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 258 IEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 258 I~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
|..||. +|.+|.|+.++-.|=|+.-
T Consensus 283 IRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 283 IRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred HHHHHhcCcccchhHHHHhhhheeec
Confidence 999999 9999999999999999853
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=335.16 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=212.3
Q ss_pred cCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC
Q 004672 16 KLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95 (738)
Q Consensus 16 ~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 95 (738)
.....++|.+.++||.|+||.||+|.+..++..||+|.++... ......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-- 77 (267)
T cd06645 4 RRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-- 77 (267)
T ss_pred ccCcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--
Confidence 3445678999999999999999999999999999999987542 2344568899999999999999999998765
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
...+++||||+++++|.+++...+.+++..++.++.||+.||.|||+++ |+|+||||+||+++.+ +.+||+|||++.
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~-~~~~l~dfg~~~ 154 (267)
T cd06645 78 RDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDN-GHVKLADFGVSA 154 (267)
T ss_pred CCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEECcceeee
Confidence 6789999999999999999988889999999999999999999999998 9999999999999854 799999999986
Q ss_pred Hhhccc--cccccCCCCCCCccccc----cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccc--
Q 004672 176 ILRKSH--AARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF-- 247 (738)
Q Consensus 176 ~l~~~~--~~~~vGTp~YmAPEvl~----~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~-- 247 (738)
...... .....|++.|+|||++. +.++.++|||||||++|+|++|..||........+.........+..+.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06645 155 QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDK 234 (267)
T ss_pred EccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCccccc
Confidence 554322 23346899999999873 3588999999999999999999999976444443333222222222221
Q ss_pred cCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcc
Q 004672 248 KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 279 (738)
Q Consensus 248 ~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf 279 (738)
...+..+++||.+||. +|.+||++.+|+.|||
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 235 MKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 2356789999999999 8999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=346.39 Aligned_cols=259 Identities=28% Similarity=0.357 Sum_probs=217.3
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCC-cceeeEEEEecC---
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN-IMKFYTSWVDTA--- 95 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpN-IVkl~~~fv~~~--- 95 (738)
...|..+++||+|+||+||+|.++.+|..||+|++++.... +..-....+|+.+|+.|+|+| |+.+++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~ 87 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHR 87 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccc
Confidence 56788889999999999999999999999999999976421 223346789999999999999 999999876533
Q ss_pred -CCeEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEec
Q 004672 96 -NRNINFVTEMFTSGTLRQYRLKHR----RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 170 (738)
Q Consensus 96 -~~~l~LV~Ey~~gGSL~~~l~k~~----~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~D 170 (738)
...+++|+||+ .-+|..|+.... .++...++.+++||+.||+|||+++ |+||||||+||||+. .|.+||+|
T Consensus 88 ~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~-~G~lKlaD 163 (323)
T KOG0594|consen 88 GIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISS-SGVLKLAD 163 (323)
T ss_pred ccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECC-CCcEeeec
Confidence 23899999999 679999998865 5888999999999999999999999 999999999999996 59999999
Q ss_pred cchhHHhhcc--ccccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc-CCCCc-
Q 004672 171 LGLAAILRKS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKKPE- 244 (738)
Q Consensus 171 FGlA~~l~~~--~~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~-g~~p~- 244 (738)
||+|+...-+ ...+.++|.+|+|||++.+ .|+..+||||+|||++||++++..|.+....+++.+.... |...+
T Consensus 164 FGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 164 FGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred cchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence 9999976632 3466789999999999875 4999999999999999999999999998887777654432 21110
Q ss_pred cc-------------------------ccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 245 AL-------------------------FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 245 ~l-------------------------~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
.| .+..++...+++.+||+ +|.+|.||+.+|.||||....
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 00 11223689999999999 999999999999999997654
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=326.51 Aligned_cols=252 Identities=30% Similarity=0.472 Sum_probs=218.8
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
+|.+.+.||.|+||+||+|.+..+|..||+|.++... ......+++..|+.+|+.++||||+++++++....+..+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN--MTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEeccc--CCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEE
Confidence 5889999999999999999999999999999887543 24566788999999999999999999999887766778999
Q ss_pred EEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH-----hCCCCceeccCCcccEEEeCCCCcEEEeccc
Q 004672 102 VTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLH-----SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 172 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~----~~lse~~i~~i~~QIl~aL~yLH-----s~gp~IIHRDLKP~NILl~~~~g~VKL~DFG 172 (738)
+|||+++++|.+++... .++++..++.++.||+.||.||| +.+ |+|+||||+||+++.+ +.+||+|||
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~-~~~kl~d~g 155 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDAN-NNVKLGDFG 155 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecC-CCEEEeccc
Confidence 99999999999998763 57999999999999999999999 777 9999999999999854 899999999
Q ss_pred hhHHhhccc--cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccC
Q 004672 173 LAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKV 249 (738)
Q Consensus 173 lA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~ 249 (738)
++....... .....|++.|+|||++.+ .++.++||||||+++|+|++|..||... +...+...+..+..+ .+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~ 233 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR-NQLQLASKIKEGKFR-RIPYR 233 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc-CHHHHHHHHhcCCCC-CCccc
Confidence 998765433 234468999999998864 4888999999999999999999999864 466666777666544 34456
Q ss_pred CChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 250 EDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 250 ~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
.++.+.+++.+||. +|.+||++.++|+|||+
T Consensus 234 ~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 234 YSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 78899999999999 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=331.57 Aligned_cols=255 Identities=31% Similarity=0.498 Sum_probs=214.1
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEecccc-CCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDF-LQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~-~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
+|...+.||+|+||.||+|.+..+|..||+|++..... ....+..+.+.+|+.+++.++||||+++++++.......++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 68899999999999999999999999999999876542 22345567899999999999999999999987765567899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
+++||+++++|.+++.....+++..++.++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++..+...
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~-~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSA-GNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC-CCEEEccCCCccccccc
Confidence 99999999999999988888999999999999999999999998 9999999999999854 78999999998755321
Q ss_pred -----ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHH
Q 004672 181 -----HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEV 254 (738)
Q Consensus 181 -----~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel 254 (738)
......++..|+|||.+.+ .++.++||||||+++|+|++|+.||........+......+. ...++...++.+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT-NPQLPSHISEHA 238 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCC-CCCCchhcCHHH
Confidence 1122358899999998864 488899999999999999999999987655555544333332 333445678899
Q ss_pred HHHHHHHHh-CcCCCCCHHHHhcCcccC
Q 004672 255 RQFIEKCLA-TVSSRLSARELLTDPFLQ 281 (738)
Q Consensus 255 ~~lI~kcL~-dP~~RpSa~ELL~Hpf~~ 281 (738)
+++| .||. +|.+||+++|+++||||+
T Consensus 239 ~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 239 RDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 9999 5665 999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=326.46 Aligned_cols=250 Identities=30% Similarity=0.486 Sum_probs=215.9
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
+|.+.+.||+|++|.||+|.+..+|..|++|.+..... .....+.+.+|+.+++.++||||+++++++.. .+.+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 76 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM--NRREREEAIDEARVLAKLDSSYIIRYYESFLD--KGKLNI 76 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC--CHHHHHHHHHHHHHHHhcCCCCeehheeeecc--CCEEEE
Confidence 58899999999999999999999999999999876532 34566789999999999999999999998765 578999
Q ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 102 VTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+||+++.+ +.++|+|||++..+..
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~-~~~~l~df~~~~~~~~ 153 (256)
T cd08529 77 VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAY-DNVKIGDLGVAKLLSD 153 (256)
T ss_pred EEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCC-CCEEEcccccceeccC
Confidence 99999999999998775 56899999999999999999999998 9999999999999855 7999999999876543
Q ss_pred cc--cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004672 180 SH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 256 (738)
Q Consensus 180 ~~--~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~ 256 (738)
.. .....|++.|+|||++.+ .++.++||||||+++++|++|..||... +...+...+..+..+. +...+++.+++
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (256)
T cd08529 154 NTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN-NQGALILKIIRGVFPP-VSQMYSQQLAQ 231 (256)
T ss_pred ccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCCC-CccccCHHHHH
Confidence 32 123358899999998864 4889999999999999999999999764 4566666677666554 33467899999
Q ss_pred HHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 257 FIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 257 lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
+|.+||+ +|.+||++.+++.|||+
T Consensus 232 ~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 232 LIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHccCCcccCcCHHHHhhCCCC
Confidence 9999999 89999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.82 Aligned_cols=255 Identities=26% Similarity=0.443 Sum_probs=220.1
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.+.+.||.|++|+||+|.+..++..||+|++..... ......+.+.+|+++|++++||||+++++++.. ...++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 77 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI-VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--DSNLY 77 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCeEE
Confidence 478999999999999999999999999999999875432 233456789999999999999999999998755 67899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
+||||+++++|.+++.+.+.+++..+..++.||+.||.|||+++ |+|+||+|.|||++.+ |.+||+|||++......
T Consensus 78 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSD-GYIKITDFGFAKRVKGR 154 (290)
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCC-CCEEEeeCCCccccCCC
Confidence 99999999999999998889999999999999999999999998 9999999999999855 89999999999776544
Q ss_pred ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHH
Q 004672 181 HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 259 (738)
Q Consensus 181 ~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~ 259 (738)
.....|++.|+|||.+.+ .++.++||||||+++|+|++|..||... .....++.+..+..+ ++...++.++++|.
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~--~~~~~~~~l~~li~ 230 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD-NPIQIYEKILEGKVR--FPSFFSPDAKDLIR 230 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCcc--CCccCCHHHHHHHH
Confidence 334468999999998764 5788999999999999999999999864 455666666655433 34456899999999
Q ss_pred HHHh-CcCCCC-----CHHHHhcCcccCCCCC
Q 004672 260 KCLA-TVSSRL-----SARELLTDPFLQIDDY 285 (738)
Q Consensus 260 kcL~-dP~~Rp-----Sa~ELL~Hpf~~~~~~ 285 (738)
+||. +|.+|+ +++|+++||||+..++
T Consensus 231 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 262 (290)
T cd05580 231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDW 262 (290)
T ss_pred HHccCCHHHccCcccCCHHHHHcCcccccCCH
Confidence 9999 999999 9999999999976543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=342.09 Aligned_cols=254 Identities=26% Similarity=0.352 Sum_probs=206.3
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCe
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 98 (738)
..++|.+.++||.|+||+||+|.++.++..||+|+++..... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 78 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIVHT--DKS 78 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC---CcchhHHHHHHHHHhCCCCCcceEEEEEee--CCe
Confidence 357899999999999999999999999999999998865321 223457789999999999999999998755 678
Q ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 99 INFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++...
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~ 154 (309)
T cd07872 79 LTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINER-GELKLADFGLARAK 154 (309)
T ss_pred EEEEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEECccccceec
Confidence 999999996 5888887665 45899999999999999999999998 9999999999999854 79999999998754
Q ss_pred hccc--cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc--CCC---------
Q 004672 178 RKSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GKK--------- 242 (738)
Q Consensus 178 ~~~~--~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~--g~~--------- 242 (738)
.... .....+|+.|+|||++.+ .++.++||||||+++|+|+||+.||......+.+ ..+.. +..
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 155 SVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDEL-HLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred CCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCCHHHHhhhc
Confidence 3322 223458999999998854 5889999999999999999999999865433322 22211 000
Q ss_pred ----------Cc-------ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 243 ----------PE-------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 243 ----------p~-------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
|. ......+++++++|.+||. +|.+|||+.|+|.||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 00 0112357889999999999 9999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=334.30 Aligned_cols=252 Identities=25% Similarity=0.432 Sum_probs=211.5
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.+.++||.|+||+||+|.+..++..||+|.+... ...+....+.+|+.+|++++||||+++++++.. .+..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD---ITVELQKQIMSELEILYKCDSPYIIGFYGAFFV--ENRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecC---CChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--CCEEE
Confidence 4678899999999999999999999999999988743 234556779999999999999999999998866 57889
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
+||||+++++|..+ ..+++..+..++.||+.||.|||+++ |+|+||||+|||++.+ +.+||+|||++......
T Consensus 76 lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~-~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 76 ICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTR-GQVKLCDFGVSTQLVNS 148 (279)
T ss_pred EEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCC-CCEEEeeCCcceecccc
Confidence 99999999999765 35789999999999999999999998 9999999999999854 89999999999766555
Q ss_pred ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCC------HHHHHHHHHcCCCCcccccCCChH
Q 004672 181 HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTH------PAQIYKKVISGKKPEALFKVEDPE 253 (738)
Q Consensus 181 ~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~------~~qi~k~i~~g~~p~~l~~~~spe 253 (738)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||..... .......+.....+.......+++
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEK 228 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHH
Confidence 4555679999999998864 588999999999999999999999964221 223333333333333333456889
Q ss_pred HHHHHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 254 VRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 254 l~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
+++||.+||. +|.+||++.++++||||+..+
T Consensus 229 ~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 229 FVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred HHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 9999999999 999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=363.57 Aligned_cols=253 Identities=21% Similarity=0.262 Sum_probs=200.6
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCC------CcceeeEEEEe
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHR------NIMKFYTSWVD 93 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~Hp------NIVkl~~~fv~ 93 (738)
.++|.++++||+|+||+||+|.+..++..||||+++.. ......+..|+.+++.++|. +|++++++|..
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 46899999999999999999999999999999998632 12234456688888777554 58888888754
Q ss_pred cCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCcccEEEeCCC---------
Q 004672 94 TANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQ--------- 163 (738)
Q Consensus 94 ~~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs-~gp~IIHRDLKP~NILl~~~~--------- 163 (738)
....+++|||++ |++|.+++.+++.+++..++.++.||+.||.|||+ .+ ||||||||+|||++.+.
T Consensus 203 -~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 203 -ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred -CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCccccccccc
Confidence 345789999998 88999999888899999999999999999999998 47 99999999999997542
Q ss_pred ------CcEEEeccchhHHhhccccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHH
Q 004672 164 ------GEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 236 (738)
Q Consensus 164 ------g~VKL~DFGlA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~ 236 (738)
+.+||+|||++..... .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||....+.+.+...
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERH-SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred ccCCCCceEEECCCCccccCcc-ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 1499999998754322 2344579999999999875 5999999999999999999999999875544333211
Q ss_pred H-HcCCCCccc--------------------------------------ccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 237 V-ISGKKPEAL--------------------------------------FKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 237 i-~~g~~p~~l--------------------------------------~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
. ..|..|..+ ....++.+.+||.+||. ||.+|||+.|+|+
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 1 112221110 01124668899999999 9999999999999
Q ss_pred CcccCC
Q 004672 277 DPFLQI 282 (738)
Q Consensus 277 Hpf~~~ 282 (738)
||||..
T Consensus 438 Hp~~~~ 443 (467)
T PTZ00284 438 HPYVLK 443 (467)
T ss_pred Cccccc
Confidence 999975
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=367.99 Aligned_cols=261 Identities=26% Similarity=0.453 Sum_probs=224.4
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
+-|.++..||-|+||+||+|..+.++-..|-|.|. ..+.+.++.+.-||.||..++||+||++|+.|+. .+.+|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe----tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~--enkLw 105 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE----TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYF--ENKLW 105 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhc----ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhc--cCceE
Confidence 45788999999999999999999999999989877 4567889999999999999999999999998876 56899
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 101 FVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
|+.|||.||-....+..- +.+++.++..+++|++.||.|||+++ |||||||..|||++-+ |.|+|+|||.+.....
T Consensus 106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~Tld-GdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLD-GDIRLADFGVSAKNKS 182 (1187)
T ss_pred EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEec-CcEeeecccccccchh
Confidence 999999999999887764 56999999999999999999999999 9999999999999855 8999999999976543
Q ss_pred --cccccccCCCCCCCccccc------cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcc-cccCC
Q 004672 180 --SHAARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEA-LFKVE 250 (738)
Q Consensus 180 --~~~~~~vGTp~YmAPEvl~------~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~-l~~~~ 250 (738)
....+++|||+|||||+.. ..|+.++||||||++|.||..+++|.++. ++-.+.-+|.....|.- -+...
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-npMRVllKiaKSePPTLlqPS~W 261 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPTLLQPSHW 261 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-chHHHHHHHhhcCCCcccCcchh
Confidence 2346788999999999874 35999999999999999999999999984 45555555555544432 24556
Q ss_pred ChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCCCchhhhh
Q 004672 251 DPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDSDLRM 291 (738)
Q Consensus 251 spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~~~~~~~~ 291 (738)
+..+++|+.+||. +|..||++++||+|||++..+....++.
T Consensus 262 s~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK~ire 303 (1187)
T KOG0579|consen 262 SRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNKMIRE 303 (1187)
T ss_pred hhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcchHHHH
Confidence 7899999999999 8999999999999999996665544443
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=348.99 Aligned_cols=256 Identities=27% Similarity=0.355 Sum_probs=205.5
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC---
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA--- 95 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~--- 95 (738)
..++|.+++.||+|+||+||+|.+..++..||+|++.... .......++.+|+.+|+.++||||++++++|....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc--cChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 4579999999999999999999999999999999887432 33455678889999999999999999999875432
Q ss_pred -CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 96 -NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 96 -~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
...+++||||+. ++|.+++.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 93 ~~~~~~lv~e~~~-~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~-~~~kl~Dfg~~ 166 (355)
T cd07874 93 EFQDVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA 166 (355)
T ss_pred ccceeEEEhhhhc-ccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCC-CCEEEeeCccc
Confidence 246899999996 567776543 5889999999999999999999998 9999999999999854 89999999999
Q ss_pred HHhhccc-cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc-C-C---------
Q 004672 175 AILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-G-K--------- 241 (738)
Q Consensus 175 ~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~-g-~--------- 241 (738)
....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...+.. + .
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred ccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 7654432 234569999999998875 5899999999999999999999999864433222211110 0 0
Q ss_pred ---------C--------Cc-----------ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 242 ---------K--------PE-----------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 242 ---------~--------p~-----------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
. +. ......+.++++||.+||. +|.+|||+.|+|+||||..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 0 00 0112235678999999999 9999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=363.53 Aligned_cols=252 Identities=24% Similarity=0.360 Sum_probs=215.3
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCC-CeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCe
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYE-GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~t-G~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 98 (738)
...|.+.+.||.|++|.||+|.+..+ +..||+|.+... .......+..|+.+|+.++||||++++++|.. ...
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~ 139 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAYARSELHCLAACDHFGIVKHFDDFKS--DDK 139 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE--CCE
Confidence 44599999999999999999999888 788999876532 34555678899999999999999999998865 678
Q ss_pred EEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 99 INFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k----~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
++|||||+++|+|.+++.. ..++++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~-~~~kL~DFgla 216 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPT-GIIKLGDFGFS 216 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCC-CcEEEEeCcCc
Confidence 9999999999999988754 346899999999999999999999998 9999999999999854 89999999999
Q ss_pred HHhhccc----cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccC
Q 004672 175 AILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKV 249 (738)
Q Consensus 175 ~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~ 249 (738)
..+.... ....+||+.|+|||++.+ .++.++|||||||++|+|+||..||.. .+...++..+..+..+. ++..
T Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~-~~~~~~~~~~~~~~~~~-~~~~ 294 (478)
T PTZ00267 217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG-PSQREIMQQVLYGKYDP-FPCP 294 (478)
T ss_pred eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCC-CCcc
Confidence 7654332 234469999999999864 599999999999999999999999986 45566667776665542 3345
Q ss_pred CChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 250 EDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 250 ~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
.++++++||.+||. +|.+||++.++|.|+|++.
T Consensus 295 ~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 295 VSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 68899999999999 9999999999999999964
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=329.87 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=213.5
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCC--CHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQ--SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~--s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
+|...+.||.|++|.||+|.+..+|..||+|.+....... .....+.+.+|+.+|+.++||||+++++++.+ ...+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE--DSHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc--CCeE
Confidence 4778899999999999999999999999999987543221 23356789999999999999999999998754 6789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 100 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
++|+||+.+++|.+++.+.+++++..++.|+.||+.||.|||+++ ++|+||+|+||+++.+...+||+|||++..+..
T Consensus 79 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 999999999999999988888999999999999999999999998 999999999999986645799999999876643
Q ss_pred cc------cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCC--HHHHHHHHHcCCCCcccccCC
Q 004672 180 SH------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTH--PAQIYKKVISGKKPEALFKVE 250 (738)
Q Consensus 180 ~~------~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~--~~qi~k~i~~g~~p~~l~~~~ 250 (738)
.. .....|+..|+|||++.+ .++.++||||||+++|+|++|..||..... .......+.....+...+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL 236 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhh
Confidence 21 122358899999998864 588999999999999999999999964332 222222333333334455567
Q ss_pred ChHHHHHHHHHHh-CcCCCCCHHHHhcCcccC
Q 004672 251 DPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 281 (738)
Q Consensus 251 spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~ 281 (738)
++++++++.+||. +|.+||++.++++||||+
T Consensus 237 ~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 237 SPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 8999999999999 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=352.27 Aligned_cols=255 Identities=26% Similarity=0.361 Sum_probs=208.1
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC---CCe
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA---NRN 98 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~---~~~ 98 (738)
+|.+.++||.|+||+||+|.+..+|..||+|++... .......+++.+|+.+|+.++||||+++++++.... ...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV--FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccc--ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence 477899999999999999999999999999987632 223445678999999999999999999999875432 127
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh
Q 004672 99 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~ 178 (738)
+++||||+. ++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++....
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~-~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 79 IYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSN-CVLKICDFGLARVEE 154 (372)
T ss_pred EEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCC-CCEEeccccceeecc
Confidence 899999995 689998888888999999999999999999999998 9999999999999854 899999999997543
Q ss_pred ccc---cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc--------------
Q 004672 179 KSH---AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-------------- 239 (738)
Q Consensus 179 ~~~---~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~-------------- 239 (738)
... .....+++.|+|||++.+ .|+.++|||||||++|+|++|+.||....... ....+..
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHHHhh
Confidence 221 233468999999998865 48899999999999999999999998644333 2222221
Q ss_pred ----------CCCCc------ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 240 ----------GKKPE------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 240 ----------g~~p~------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
...+. .+....++++.+||.+||. +|.+|||+.|+|.||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 11111 1123357889999999999 99999999999999999764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=381.72 Aligned_cols=264 Identities=24% Similarity=0.399 Sum_probs=224.2
Q ss_pred cCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC
Q 004672 16 KLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95 (738)
Q Consensus 16 ~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 95 (738)
..+.+++|.++++||.|+||+||+|.+..++..||+|.+.... ........+..|+.+|+.|+|||||+++++|+...
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~--l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRG--LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccc--cCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 4556789999999999999999999999999999999988653 23455678999999999999999999999998877
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceeccCCcccEEEeCC----
Q 004672 96 NRNINFVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSRD-----PPVIHRDLKCDNIFVNGN---- 162 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~l~k~----~~lse~~i~~i~~QIl~aL~yLHs~g-----p~IIHRDLKP~NILl~~~---- 162 (738)
...+||||||+.+|+|.+++... ..+++..++.|+.||+.||.|||+.+ .+||||||||+||||+..
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 78899999999999999998763 56999999999999999999999854 249999999999999632
Q ss_pred ------------CCcEEEeccchhHHhhccc-cccccCCCCCCCccccc---cccCcccccccchhhhhhhhhcCCCCCC
Q 004672 163 ------------QGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYE---EEYNELVDIYSFGMCILEMVTFDYPYSE 226 (738)
Q Consensus 163 ------------~g~VKL~DFGlA~~l~~~~-~~~~vGTp~YmAPEvl~---~~ys~~sDIWSLGviLyeLlTG~~Pf~~ 226 (738)
.+.+||+|||++..+.... ....+||+.|+|||++. ..++.++||||||||||+|+||..||..
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 2358999999997664332 23456999999999885 3488999999999999999999999987
Q ss_pred CCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 227 CTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 227 ~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
.....++...+..+... .....++++.+||..||. +|.+||++.++|.||||+..
T Consensus 246 ~~~~~qli~~lk~~p~l--pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 246 ANNFSQLISELKRGPDL--PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCcHHHHHHHHhcCCCC--CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 77777777666554322 234568899999999999 99999999999999999643
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=341.78 Aligned_cols=246 Identities=26% Similarity=0.341 Sum_probs=193.7
Q ss_pred EEEEcccCCeEEEEEEEc--CCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEE
Q 004672 26 TMKFLVKELQRHYRAFDE--YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 103 (738)
Q Consensus 26 l~kLG~GafgtVYkA~d~--~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~ 103 (738)
.++||+|+||+||+|.++ .++..||+|+++... ....+.+|+.+|+.++||||++++++|.......++++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG------ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC------CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence 568999999999999965 477899999886432 123467899999999999999999998777677899999
Q ss_pred ecCCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEe---CCCCcEEEecc
Q 004672 104 EMFTSGTLRQYRLKH---------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN---GNQGEVKIGDL 171 (738)
Q Consensus 104 Ey~~gGSL~~~l~k~---------~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~---~~~g~VKL~DF 171 (738)
||+ +++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+. ...+.+||+||
T Consensus 80 e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 80 DYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 998 56888887543 24899999999999999999999998 99999999999994 23478999999
Q ss_pred chhHHhhccc-----cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCC---------HHHHHH
Q 004672 172 GLAAILRKSH-----AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTH---------PAQIYK 235 (738)
Q Consensus 172 GlA~~l~~~~-----~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~---------~~qi~k 235 (738)
|++....... .....||+.|+|||++.+ .|+.++|||||||++|+|++|++||..... ..++.+
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence 9997664321 234568999999998864 489999999999999999999999964221 111111
Q ss_pred HHHc-CCC-----------Cc-----------------------ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcc
Q 004672 236 KVIS-GKK-----------PE-----------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 279 (738)
Q Consensus 236 ~i~~-g~~-----------p~-----------------------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf 279 (738)
.+.. |.. +. ......+.++.+||.+||. ||.+|||++|+|+|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07868 237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 316 (317)
T ss_pred HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 1110 000 00 0011235678999999999 9999999999999999
Q ss_pred c
Q 004672 280 L 280 (738)
Q Consensus 280 ~ 280 (738)
|
T Consensus 317 f 317 (317)
T cd07868 317 F 317 (317)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=365.05 Aligned_cols=260 Identities=23% Similarity=0.336 Sum_probs=221.5
Q ss_pred cCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC
Q 004672 16 KLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95 (738)
Q Consensus 16 ~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 95 (738)
.....++|.+.+.||+|+||+||+|.+..+|..||+|.+.... .+.....++.+|+.+|..++|+||++++..|....
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~--~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG--MSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEeccc--CCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 3445579999999999999999999999999999999987653 24566778999999999999999999988765432
Q ss_pred C------CeEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCc
Q 004672 96 N------RNINFVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 165 (738)
Q Consensus 96 ~------~~l~LV~Ey~~gGSL~~~l~k~----~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~ 165 (738)
. ..+++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~-~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSN-GL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCC-CC
Confidence 2 1478999999999999998653 46899999999999999999999998 9999999999999855 79
Q ss_pred EEEeccchhHHhhcc----ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcC
Q 004672 166 VKIGDLGLAAILRKS----HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 240 (738)
Q Consensus 166 VKL~DFGlA~~l~~~----~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g 240 (738)
+||+|||+++.+... ......||+.|+|||++.+ .|+.++||||||+++|+|++|+.||.. .+...++..+..+
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~-~~~~~~~~~~~~~ 260 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKTLAG 260 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcC
Confidence 999999999765432 2234569999999999875 599999999999999999999999986 4566677777766
Q ss_pred CCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 241 KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 241 ~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
..+. ++...+++++++|.+||. +|.+||++.++|+|||++.
T Consensus 261 ~~~~-~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 261 RYDP-LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 5543 445678999999999999 9999999999999999864
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=338.71 Aligned_cols=256 Identities=23% Similarity=0.381 Sum_probs=222.6
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEecccc----CCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEec
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDF----LQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDT 94 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~----~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~ 94 (738)
+..|.-.+.||.|..++|-++.++.+|.++|+|++....- ....+.++.-.+|+.||+++ .||+|+++.++| +
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--e 93 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--E 93 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec--c
Confidence 4578888999999999999999999999999999887542 22344566778999999999 799999999987 4
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 95 ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 95 ~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
.+..+++|+|+|+.|.|++|+...-.++++..+.+++|++.|++|||.++ |+||||||+|||++.| -+|||+|||+|
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn-~~i~isDFGFa 170 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDN-MNIKISDFGFA 170 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccc-cceEEecccee
Confidence 47788999999999999999999888999999999999999999999999 9999999999999966 68999999999
Q ss_pred HHhhccc-cccccCCCCCCCccccc-------cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC--c
Q 004672 175 AILRKSH-AARCVGTPEFMAPEVYE-------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP--E 244 (738)
Q Consensus 175 ~~l~~~~-~~~~vGTp~YmAPEvl~-------~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p--~ 244 (738)
+.+.... ....+|||+|+|||.+. ..|+..+|+|++|+|+|.|+.|.+||.. ...--+.+.|.+|+.. .
T Consensus 171 ~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH-RkQmlMLR~ImeGkyqF~s 249 (411)
T KOG0599|consen 171 CQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH-RKQMLMLRMIMEGKYQFRS 249 (411)
T ss_pred eccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH-HHHHHHHHHHHhcccccCC
Confidence 9887654 45668999999999885 3589999999999999999999999975 2223345778888864 2
Q ss_pred ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccC
Q 004672 245 ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 281 (738)
Q Consensus 245 ~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~ 281 (738)
.-|..++.+++++|.+||+ ||.+|.|++|+|.||||.
T Consensus 250 peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 250 PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 3356778899999999999 999999999999999994
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=348.59 Aligned_cols=254 Identities=28% Similarity=0.366 Sum_probs=205.8
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEec----
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT---- 94 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~---- 94 (738)
-.++|.+++.||.|+||.||+|.+..++..||+|++.... ......+.+.+|+.+++.++||||++++++|...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc--cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 3578999999999999999999999999999999887432 2344567788999999999999999999987542
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 95 ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 95 ~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
....+++||||+. ++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 100 ~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~DfG~a 173 (364)
T cd07875 100 EFQDVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA 173 (364)
T ss_pred ccCeEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCC-CcEEEEeCCCc
Confidence 2246899999995 577777643 5889999999999999999999998 9999999999999855 89999999999
Q ss_pred HHhhccc-cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcC--C---------
Q 004672 175 AILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG--K--------- 241 (738)
Q Consensus 175 ~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g--~--------- 241 (738)
....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||....... .+..+... .
T Consensus 174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 174 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred cccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHhh
Confidence 7664432 234569999999998865 58999999999999999999999998754333 33333221 0
Q ss_pred ----------CCc-------------------ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccC
Q 004672 242 ----------KPE-------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 281 (738)
Q Consensus 242 ----------~p~-------------------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~ 281 (738)
.|. ......+..+++||.+||. +|.+|||+.++|.||||.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~ 322 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 000 0011234678999999999 999999999999999995
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=328.25 Aligned_cols=253 Identities=29% Similarity=0.402 Sum_probs=211.3
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEecccc--CCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDF--LQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~--~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
+|.+.+.||.|+||+||+|.+ .+|..+|+|+++.... ........++.+|+.+|+.++|+||+++++++.+ ...+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--DNTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec--CCeE
Confidence 478899999999999999987 5899999999886432 2234455789999999999999999999998755 5799
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 100 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
++|+||+++++|.+++.+...+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.+ +.++|+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 78 SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAW 154 (265)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCC-CeEEeccchhhHhhhh
Confidence 999999999999999988888999999999999999999999998 9999999999999854 8999999999976532
Q ss_pred c--------ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCC
Q 004672 180 S--------HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE 250 (738)
Q Consensus 180 ~--------~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~ 250 (738)
. ......|++.|+|||++.+ .++.++||||||+++|+|++|..||.....................+...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSF 234 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCC
Confidence 1 1123458999999999874 488999999999999999999999986554444433222212222345567
Q ss_pred ChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 251 DPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 251 spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
+.++.+||.+||. +|.+||++.++|.||||
T Consensus 235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 8999999999999 99999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=331.02 Aligned_cols=254 Identities=26% Similarity=0.450 Sum_probs=217.9
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|...+.||.|++|.||+|.+..++..||+|.+.... ..+..+.+.+|+.+++.++||||+++++.+.. ...++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFYGAFYN--NGDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc---ChHHHHHHHHHHHHHHHCCCCchhhhheeeec--CCEEE
Confidence 46788899999999999999999999999999887542 23556788999999999999999999998766 57899
Q ss_pred EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh
Q 004672 101 FVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs-~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~ 178 (738)
+++||+.+++|.+++... ..+++..+..++.||+.||.|||+ .+ ++|+||||+||+++. .+.++|+|||.+....
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~-~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNS-RGQIKLCDFGVSGQLV 152 (265)
T ss_pred EEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECC-CCCEEEeecccchhhH
Confidence 999999999999999876 789999999999999999999999 87 999999999999985 5899999999997765
Q ss_pred ccccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCC----CCHHHHHHHHHcCCCCcccccCCChH
Q 004672 179 KSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC----THPAQIYKKVISGKKPEALFKVEDPE 253 (738)
Q Consensus 179 ~~~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~----~~~~qi~k~i~~g~~p~~l~~~~spe 253 (738)
........+++.|+|||.+.+ .++.++||||||+++|+|++|..||... .......+.+..+..+.......+++
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (265)
T cd06605 153 NSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPD 232 (265)
T ss_pred HHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence 544334668999999998864 5889999999999999999999999754 23444555555555544333337899
Q ss_pred HHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 254 VRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 254 l~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
+++||.+||. +|.+|||+.+++.||||+.
T Consensus 233 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 233 FQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 9999999999 9999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=324.04 Aligned_cols=251 Identities=27% Similarity=0.460 Sum_probs=213.0
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
+|.+.+.||.|++|.||++.++.++..||+|++.... ......+.+.+|+.+++.++|+||+++++.|.. ....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~l 77 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN--ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG-EDGLLYI 77 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh--cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC-CCCEEEE
Confidence 5889999999999999999999999999999987543 234456778999999999999999999987643 3457899
Q ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 102 VTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
+|||+++++|.+++... ..+++.+++.++.|++.||.|||+++ |+||||||+||+++. .+.++|+|||++.....
T Consensus 78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~-~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTR-TNIIKVGDLGIARVLEN 154 (257)
T ss_pred EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEec-CCcEEEecccceEEecc
Confidence 99999999999998763 45899999999999999999999998 999999999999985 48999999999876533
Q ss_pred c--ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004672 180 S--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 256 (738)
Q Consensus 180 ~--~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~ 256 (738)
. ......|++.|+|||++.+ .++.++||||||+++|+|++|+.||... +.......+..+..+. .....++++.+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 232 (257)
T cd08223 155 QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-DMNSLVYRIIEGKLPP-MPKDYSPELGE 232 (257)
T ss_pred cCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhcCCCC-CccccCHHHHH
Confidence 2 2233458999999998864 4888999999999999999999999864 4455555566665543 34567899999
Q ss_pred HHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 257 FIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 257 lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
||.+||+ +|.+||++.++++||||
T Consensus 233 li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 233 LIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=331.01 Aligned_cols=255 Identities=27% Similarity=0.423 Sum_probs=209.6
Q ss_pred cCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC
Q 004672 16 KLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95 (738)
Q Consensus 16 ~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 95 (738)
.....++|.+.++||.|+||.||+|.+..+|..||+|++.... ......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-- 77 (267)
T cd06646 4 RRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP----GDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-- 77 (267)
T ss_pred ccCchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc----cchHHHHHHHHHHHHhcCCCCeeeeeEEEEe--
Confidence 3455678999999999999999999999999999999887432 2334568899999999999999999998865
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
...+++||||+++++|.+++.+...+++..+..++.|++.||.|||+++ |+||||||+||+++.+ +.+||+|||++.
T Consensus 78 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~-~~~~l~dfg~~~ 154 (267)
T cd06646 78 REKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDN-GDVKLADFGVAA 154 (267)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCC-CCEEECcCccce
Confidence 5789999999999999999888888999999999999999999999998 9999999999999754 789999999997
Q ss_pred Hhhccc--cccccCCCCCCCccccc----cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCccc--c
Q 004672 176 ILRKSH--AARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL--F 247 (738)
Q Consensus 176 ~l~~~~--~~~~vGTp~YmAPEvl~----~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l--~ 247 (738)
...... .....|++.|+|||.+. ..++.++||||||+++|+|++|..||..................+..+ .
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06646 155 KITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDK 234 (267)
T ss_pred eecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccc
Confidence 654322 22345889999999873 347889999999999999999999997543322222111111122211 1
Q ss_pred cCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcc
Q 004672 248 KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 279 (738)
Q Consensus 248 ~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf 279 (738)
...++.+++||.+||. +|.+|||+.++|+|+|
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 235 TKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 2357899999999999 9999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=333.27 Aligned_cols=256 Identities=30% Similarity=0.501 Sum_probs=216.7
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCe
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 98 (738)
+.++|.++++||.|++|+||+|.+..++..||+|.++.. .....+.+..|+.+++.++||||+++++++.. +..
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 76 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLYEAYFY--ENK 76 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEec--CCe
Confidence 356799999999999999999999999999999998743 45566789999999999999999999998764 678
Q ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 99 INFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
+++||||+++++|.+++.+. +.+++..++.++.|++.||.|||+++ |+|+||||+||+++.+ +.++|+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~-~~~~l~d~g~~~~~ 153 (280)
T cd06611 77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLD-GDVKLADFGVSAKN 153 (280)
T ss_pred EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCC-CCEEEccCccchhh
Confidence 99999999999999998764 56999999999999999999999998 9999999999999854 89999999998765
Q ss_pred hccc--cccccCCCCCCCccccc------cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCc-cccc
Q 004672 178 RKSH--AARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE-ALFK 248 (738)
Q Consensus 178 ~~~~--~~~~vGTp~YmAPEvl~------~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~-~l~~ 248 (738)
.... .....|++.|+|||++. ..++.++||||||+++|+|++|..||... ........+..+..|. ....
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (280)
T cd06611 154 KSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLDQPS 232 (280)
T ss_pred cccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC-CHHHHHHHHhcCCCCCcCCcc
Confidence 4322 23345899999999874 23778999999999999999999999864 4445555565554432 2234
Q ss_pred CCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 249 VEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 249 ~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
..+.++.++|.+||. +|.+||++.++|+||||....
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 233 KWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence 567899999999999 999999999999999997643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=363.81 Aligned_cols=252 Identities=31% Similarity=0.471 Sum_probs=218.1
Q ss_pred EEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEe
Q 004672 25 DTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTE 104 (738)
Q Consensus 25 il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~E 104 (738)
.--.||+|.||+||.|+|..|...+|||.|... ..+..+-+..||.+-++|+|.|||++++++ ..++.+-|.||
T Consensus 579 ervVLGKGTYG~VYA~RD~~tqvrIaIKEIpek----dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~--senGf~kIFME 652 (1226)
T KOG4279|consen 579 ERVVLGKGTYGTVYAARDMDTQVRIAIKEIPEK----DSREVQPLHEEIALHSTLRHKNIVRYLGSV--SENGFFKIFME 652 (1226)
T ss_pred ceEEeecCceeEEEeeccccceeEEEeeecccc----cchhhccHHHHHHHHHHHhhHhHHHHhhcc--CCCCeEEEEee
Confidence 345799999999999999999999999988733 345667899999999999999999999986 45779999999
Q ss_pred cCCCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc--
Q 004672 105 MFTSGTLRQYRLKH-RRV--NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK-- 179 (738)
Q Consensus 105 y~~gGSL~~~l~k~-~~l--se~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~-- 179 (738)
-++||+|..++... +++ ++.++..+.+||++||.|||.+. |||||||-+|+||+.-.|.+||+|||-++.+..
T Consensus 653 qVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin 730 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN 730 (1226)
T ss_pred cCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCC
Confidence 99999999998765 567 89999999999999999999998 999999999999998889999999999987753
Q ss_pred cccccccCCCCCCCcccccc---ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004672 180 SHAARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 256 (738)
Q Consensus 180 ~~~~~~vGTp~YmAPEvl~~---~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~ 256 (738)
+...++.||..|||||++.. .|+.++|||||||++.||.||++||.+..++...+-++---+.-+.++...+.+++.
T Consensus 731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~ 810 (1226)
T KOG4279|consen 731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKN 810 (1226)
T ss_pred ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHH
Confidence 34566679999999999974 499999999999999999999999998777665444332222333455667889999
Q ss_pred HHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 257 FIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 257 lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
||.+|.. +|.+||+|.+||.+||++..+
T Consensus 811 FilrcFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 811 FILRCFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred HHHHHcCCCcccCccHHHhccCcccccCC
Confidence 9999999 999999999999999998663
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=348.46 Aligned_cols=253 Identities=27% Similarity=0.429 Sum_probs=218.3
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
-|.++.+||+|+||.||+|+++.+|..||||++.+. ..++.+.+||.+|.+++.|++|++|++|+. +..+|+
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK--~sDLWI 105 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD------TDLQEIIKEISIMQQCKSKYVVKYYGSYFK--HSDLWI 105 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc------chHHHHHHHHHHHHHcCCchhhhhhhhhcc--CCceEe
Confidence 378899999999999999999999999999998854 457889999999999999999999999876 567999
Q ss_pred EEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 102 VTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k-~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
|||||..|+..+.+.- ++.+++..+..+++.-++||.|||... -||||||..|||++.+ |..||+|||.|..+...
T Consensus 106 VMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~-G~AKLADFGVAGQLTDT 182 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTD-GIAKLADFGVAGQLTDT 182 (502)
T ss_pred ehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEccc-chhhhhhccccchhhhh
Confidence 9999999999998754 567999999999999999999999987 8999999999999855 89999999999888765
Q ss_pred c--cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCccc--ccCCChHHH
Q 004672 181 H--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL--FKVEDPEVR 255 (738)
Q Consensus 181 ~--~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l--~~~~spel~ 255 (738)
. ..+.+|||.|||||++.+ .|+.++||||||++..||.-|++||.+......|+. +-.+.|..+ +...+.++-
T Consensus 183 MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM--IPT~PPPTF~KPE~WS~~F~ 260 (502)
T KOG0574|consen 183 MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM--IPTKPPPTFKKPEEWSSEFN 260 (502)
T ss_pred HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe--ccCCCCCCCCChHhhhhHHH
Confidence 4 356679999999999985 699999999999999999999999998654443332 122333333 233477899
Q ss_pred HHHHHHHh-CcCCCCCHHHHhcCcccCCCCCch
Q 004672 256 QFIEKCLA-TVSSRLSARELLTDPFLQIDDYDS 287 (738)
Q Consensus 256 ~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~~~~ 287 (738)
+||++||. +|.+|-||.+|++|||++......
T Consensus 261 DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~ 293 (502)
T KOG0574|consen 261 DFIRSCLIKKPEERKTALRLCEHTFIKNAPGCD 293 (502)
T ss_pred HHHHHHhcCCHHHHHHHHHHhhhhhhcCCCccc
Confidence 99999999 899999999999999998765443
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=335.52 Aligned_cols=255 Identities=26% Similarity=0.354 Sum_probs=207.8
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCe
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 98 (738)
.+++|.++++||.|+||.||+|.+..++..||+|.++..... .....+.+|+.+++.|+||||+++++++.. ...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~ 78 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE---GAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKS 78 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc---CchhHHHHHHHHHHhcCCCCcceEEEEEec--CCe
Confidence 468899999999999999999999999999999998865322 223467789999999999999999998754 678
Q ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 99 INFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.+ +.+||+|||++...
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~ 154 (301)
T cd07873 79 LTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINER-GELKLADFGLARAK 154 (301)
T ss_pred EEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCC-CcEEECcCcchhcc
Confidence 999999996 6898887764 56899999999999999999999998 9999999999999854 79999999999764
Q ss_pred hccc--cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc--CC----------
Q 004672 178 RKSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GK---------- 241 (738)
Q Consensus 178 ~~~~--~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~--g~---------- 241 (738)
.... .....+++.|+|||++.+ .++.++||||||+++|+|+||+.||.......++ ..+.. +.
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL-HFIFRILGTPTEETWPGIL 233 (301)
T ss_pred CCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHcCCCChhhchhhh
Confidence 3322 223357899999998864 4788999999999999999999999875433332 22211 00
Q ss_pred ---------CCc-------ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 242 ---------KPE-------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 242 ---------~p~-------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
.|. ......++.+++||.+||. +|.+|||+.|+|.||||+.-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 000 1112457889999999999 99999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=323.75 Aligned_cols=252 Identities=30% Similarity=0.462 Sum_probs=212.4
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCe
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 98 (738)
+.++|.+.+.||.|++|.||+|.+..++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~ 74 (262)
T cd06613 1 PQEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVAYFGSYLR--RDK 74 (262)
T ss_pred CccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc----hhhHHHHHHHHHHHHhCCCCChhceEEEEEe--CCE
Confidence 3578999999999999999999999999999999988543 2356789999999999999999999998765 678
Q ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 99 INFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
++++|||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+|+||+|+||+++. ++.+||+|||++...
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~ 151 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTE-DGDVKLADFGVSAQL 151 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECC-CCCEEECccccchhh
Confidence 99999999999999998876 78999999999999999999999998 999999999999984 489999999999766
Q ss_pred hccc--cccccCCCCCCCcccccc----ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcc--cccC
Q 004672 178 RKSH--AARCVGTPEFMAPEVYEE----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEA--LFKV 249 (738)
Q Consensus 178 ~~~~--~~~~vGTp~YmAPEvl~~----~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~--l~~~ 249 (738)
.... .....++..|+|||.+.. .++.++||||||+++|+|+||..||........+......+..+.. ....
T Consensus 152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (262)
T cd06613 152 TATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEK 231 (262)
T ss_pred hhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhh
Confidence 5432 234468899999998753 5888999999999999999999999875544444333222222211 1223
Q ss_pred CChHHHHHHHHHHh-CcCCCCCHHHHhcCcc
Q 004672 250 EDPEVRQFIEKCLA-TVSSRLSARELLTDPF 279 (738)
Q Consensus 250 ~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf 279 (738)
.+.++++||.+||. +|..|||+.+++.|+|
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 232 WSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 46789999999999 8999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=334.49 Aligned_cols=257 Identities=19% Similarity=0.302 Sum_probs=209.9
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
.|+..+.||.|+||+||+|.+..++..||+|.+..... ........+..|+.+|+.++|+||+++++.+.. ...+++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~l 77 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGESMALNEKQILEKVNSRFVVSLAYAYET--KDALCL 77 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhc-cchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CCEEEE
Confidence 36788999999999999999999999999998875432 223344567889999999999999999998754 578999
Q ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 102 VTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
||||+++|+|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.+ +.++|+|||++.....
T Consensus 78 v~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDH-GHIRISDLGLAVHVPE 154 (285)
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCC-CCEEEeeccceeecCC
Confidence 99999999999988654 35899999999999999999999998 9999999999999854 7899999999865433
Q ss_pred cc-cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHH--HHHHHHHcCCCCcccccCCChHHH
Q 004672 180 SH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPA--QIYKKVISGKKPEALFKVEDPEVR 255 (738)
Q Consensus 180 ~~-~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~--qi~k~i~~g~~p~~l~~~~spel~ 255 (738)
.. .....|++.|+|||++.+ .++.++||||||+++|+|++|..||....... .....+... .+.......+++++
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 233 (285)
T cd05630 155 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VQEEYSEKFSPDAR 233 (285)
T ss_pred CccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-hhhhcCccCCHHHH
Confidence 22 233469999999999864 58999999999999999999999997643211 112222111 12234456788999
Q ss_pred HHHHHHHh-CcCCCCC-----HHHHhcCcccCCCCC
Q 004672 256 QFIEKCLA-TVSSRLS-----ARELLTDPFLQIDDY 285 (738)
Q Consensus 256 ~lI~kcL~-dP~~RpS-----a~ELL~Hpf~~~~~~ 285 (738)
+||.+||+ +|.+||| +.|+++||||+..++
T Consensus 234 ~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05630 234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF 269 (285)
T ss_pred HHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence 99999999 9999999 999999999976443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=346.29 Aligned_cols=253 Identities=27% Similarity=0.394 Sum_probs=205.8
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC----C
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA----N 96 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~----~ 96 (738)
++|.+++.||.|+||+||+|.+..++..||+|++.... ......+.+.+|+.+|+.++||||++++++|.... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF--QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh--hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 68999999999999999999999999999999887432 22334567889999999999999999999875322 2
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
..++++++++ +++|.+++. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~ 167 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNED-CELRILDFGLARQ 167 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCC-CCEEEcCCcccee
Confidence 4578999998 889988764 467999999999999999999999998 9999999999999854 8999999999976
Q ss_pred hhccccccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc--CCCCc--------
Q 004672 177 LRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GKKPE-------- 244 (738)
Q Consensus 177 l~~~~~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~--g~~p~-------- 244 (738)
.... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||........ ...+.. +..+.
T Consensus 168 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 168 ADDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ-LKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred cCCC-cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHhcch
Confidence 5443 334569999999999865 588999999999999999999999976433322 222211 11100
Q ss_pred -------------------ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 245 -------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 245 -------------------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
......++.+.+||.+||. +|.+|||+.|+|.||||..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 0112346778999999999 9999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=334.51 Aligned_cols=256 Identities=31% Similarity=0.467 Sum_probs=215.3
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCe
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 98 (738)
+..+|.+++.||.|++|+||+|.+..+|..||+|.+.... ....+.+.+|+.+++.+.||||+++++.|.. +..
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~--~~~ 91 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLV--GDE 91 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC----cchHHHHHHHHHHHHhCCCCCEeeEEEEEEe--CCE
Confidence 3468999999999999999999999999999999987543 2234678999999999999999999998865 568
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh
Q 004672 99 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~ 178 (738)
.++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||++....
T Consensus 92 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~-~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 92 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGM-DGSVKLTDFGFCAQIT 167 (296)
T ss_pred EEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcC-CCCEEECccccchhcc
Confidence 9999999999999999764 46899999999999999999999998 999999999999974 4799999999987654
Q ss_pred ccc--cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHH
Q 004672 179 KSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVR 255 (738)
Q Consensus 179 ~~~--~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~ 255 (738)
... .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||........++.....+..+.......++.+.
T Consensus 168 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 247 (296)
T cd06654 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247 (296)
T ss_pred ccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHH
Confidence 322 223468999999998865 48899999999999999999999998654444444433334333333455678999
Q ss_pred HHHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 256 QFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 256 ~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
++|.+||. +|.+||++.+++.||||....
T Consensus 248 ~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 248 DFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred HHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 99999999 999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=326.86 Aligned_cols=255 Identities=31% Similarity=0.436 Sum_probs=209.8
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCC
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 97 (738)
+..+.......||+|+||+||+|.+..++..||+|.+... .....+.+.+|+.+++.++|+||+++++++.. +.
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 78 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER----DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE--NG 78 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC----CHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc--CC
Confidence 3455666678999999999999999999999999987743 34556789999999999999999999998754 67
Q ss_pred eEEEEEecCCCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 98 NINFVTEMFTSGTLRQYRLKH-RRV--NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~-~~l--se~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
.+++|+||+++++|.+++... ..+ ++..+..++.||+.||.|||+++ |+||||||.||+++...+.++|+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 79 FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 899999999999999998764 445 88899999999999999999998 9999999999999865679999999998
Q ss_pred HHhhccc--cccccCCCCCCCcccccc---ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccC
Q 004672 175 AILRKSH--AARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKV 249 (738)
Q Consensus 175 ~~l~~~~--~~~~vGTp~YmAPEvl~~---~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~ 249 (738)
....... .....|++.|+|||++.. .++.++||||||+++|+|++|..||.....................++..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd06624 157 KRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPES 236 (268)
T ss_pred eecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcc
Confidence 7654322 223358999999998853 37889999999999999999999998654433332222211222234556
Q ss_pred CChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 250 EDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 250 ~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
.++++++|+.+||. +|.+|||+.+++.||||
T Consensus 237 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 237 LSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred cCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 78899999999999 89999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=330.63 Aligned_cols=251 Identities=27% Similarity=0.377 Sum_probs=205.5
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
+|.+++.||.|++|+||+|.+..+|..||+|.++.... .....+.+.+|+.+++.++||||+++++++.. +..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 76 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ESRLYL 76 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc--cCCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CCeEEE
Confidence 58899999999999999999999999999999876432 22334578889999999999999999998865 678999
Q ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh
Q 004672 102 VTEMFTSGTLRQYRLKH---RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~---~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~ 178 (738)
||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++. +|.+||+|||++....
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 77 IFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDN-KGVIKLADFGLARAFG 152 (285)
T ss_pred EEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcC-CCcEEECcccceeecC
Confidence 999996 6898887653 46899999999999999999999998 999999999999985 4899999999987553
Q ss_pred ccc--cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC-----------
Q 004672 179 KSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP----------- 243 (738)
Q Consensus 179 ~~~--~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p----------- 243 (738)
... .....+++.|+|||++.+ .++.++||||||+++|+|+||..||.+......+.........+
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence 321 223357899999998864 47889999999999999999999998755444443322111000
Q ss_pred ---------------cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 244 ---------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 244 ---------------~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
.......+++++++|.+||. +|.+|||+.+|+.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 01123467899999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=329.52 Aligned_cols=252 Identities=27% Similarity=0.426 Sum_probs=208.3
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecC---
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTA--- 95 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~--- 95 (738)
.+.|.+.+.||.|+||+||+|.+..+++.||+|.+.... .....+..|+.+++.+ +||||++++++|....
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 356888999999999999999999999999999987432 2235688999999999 7999999999987542
Q ss_pred -CCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccc
Q 004672 96 -NRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 172 (738)
Q Consensus 96 -~~~l~LV~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFG 172 (738)
...+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~-~~~~l~Dfg 156 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLVDFG 156 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCC-CCEEEccCC
Confidence 24689999999999999998764 35899999999999999999999998 9999999999999855 799999999
Q ss_pred hhHHhhcc--ccccccCCCCCCCccccc------cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCc
Q 004672 173 LAAILRKS--HAARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE 244 (738)
Q Consensus 173 lA~~l~~~--~~~~~vGTp~YmAPEvl~------~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~ 244 (738)
++...... ......|++.|+|||++. ..|+.++|||||||++|+|++|..||......... ..+.....+.
T Consensus 157 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-~~~~~~~~~~ 235 (272)
T cd06637 157 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-FLIPRNPAPR 235 (272)
T ss_pred CceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-HHHhcCCCCC
Confidence 98765332 223346899999999884 24888999999999999999999999764433333 2333333333
Q ss_pred ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 245 ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 245 ~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
......+.++++||.+||. +|.+|||+.++++||||
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 236 LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 3334567899999999999 99999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=331.03 Aligned_cols=258 Identities=29% Similarity=0.456 Sum_probs=215.7
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCe
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 98 (738)
+.+.|+++++||.|+||.||+|.+..+|..||+|.+.. ......+.+.+|+.+++.++||||+++++++.. ...
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 83 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET----KSEEELEDYMVEIEILATCNHPYIVKLLGAFYW--DGK 83 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEecc----CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe--CCe
Confidence 34679999999999999999999999999999999874 345667889999999999999999999998765 568
Q ss_pred EEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 99 INFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k-~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
+++||||+++++|..++.+ ...+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++...
T Consensus 84 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~ 160 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLD-GDIKLADFGVSAKN 160 (292)
T ss_pred EEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCC-CCEEEccCccceec
Confidence 9999999999999988755 456899999999999999999999998 9999999999999854 79999999988654
Q ss_pred hccc--cccccCCCCCCCccccc------cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCc-cccc
Q 004672 178 RKSH--AARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE-ALFK 248 (738)
Q Consensus 178 ~~~~--~~~~vGTp~YmAPEvl~------~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~-~l~~ 248 (738)
.... .....+++.|+|||++. ..++.++|||||||++|+|++|..||.... ....+.++..+..|. ....
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~ 239 (292)
T cd06644 161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLSQPS 239 (292)
T ss_pred cccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc-HHHHHHHHhcCCCccCCCCc
Confidence 3221 23345889999999874 237889999999999999999999997643 445555555444432 2234
Q ss_pred CCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCCCc
Q 004672 249 VEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYD 286 (738)
Q Consensus 249 ~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~~~ 286 (738)
..+.++.++|.+||. +|.+||++.++++||||..-...
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 278 (292)
T cd06644 240 KWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN 278 (292)
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 567899999999999 99999999999999999765443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=329.61 Aligned_cols=254 Identities=29% Similarity=0.505 Sum_probs=212.0
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
-|.+.++||.|+||+||+|.+..++..+++|.+.. ......+.+.+|+.+++.++||||++++++|.. ....++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~~ 79 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDT----KSEEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWI 79 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCC----CCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCEEEE
Confidence 36788999999999999999999999999998763 234567788999999999999999999998865 578999
Q ss_pred EEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 102 VTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k-~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
|+||+.+++|..++.+ ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++......
T Consensus 80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~ 156 (282)
T cd06643 80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRT 156 (282)
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccC-CCEEEcccccccccccc
Confidence 9999999999988765 456999999999999999999999998 9999999999999854 79999999998654332
Q ss_pred --ccccccCCCCCCCccccc------cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCc-ccccCCC
Q 004672 181 --HAARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE-ALFKVED 251 (738)
Q Consensus 181 --~~~~~vGTp~YmAPEvl~------~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~-~l~~~~s 251 (738)
......|++.|+|||++. ..++.++|||||||++|+|++|..||.... ..+....+..+..+. ..+...+
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd06643 157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRWS 235 (282)
T ss_pred ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-HHHHHHHHhhcCCCCCCCccccC
Confidence 123345899999999873 247889999999999999999999998644 444444444443322 2234567
Q ss_pred hHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCCC
Q 004672 252 PEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 285 (738)
Q Consensus 252 pel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~~ 285 (738)
.++++||.+||+ +|.+||++.++++||||+....
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 270 (282)
T cd06643 236 SEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270 (282)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence 899999999999 9999999999999999986543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=325.83 Aligned_cols=252 Identities=32% Similarity=0.475 Sum_probs=211.8
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCC-----HHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCC
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQS-----PEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s-----~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 96 (738)
.|.+...||.|++|.||+|.+..++..||+|.+........ ....+.+.+|+.+++.++||||+++++++.. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--A 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--C
Confidence 36788999999999999999999999999998876543222 2344678999999999999999999998765 5
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
...++||||+++++|.+++...+.+++..+..++.|++.||.|||+++ ++||||+|+||+++.+ +.+||+|||++..
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~-~~~~l~dfg~~~~ 155 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNK-GGIKISDFGISKK 155 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCC-CCEEecccCCCcc
Confidence 688999999999999999998888999999999999999999999998 9999999999999854 7999999999876
Q ss_pred hhccc--------cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccc
Q 004672 177 LRKSH--------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF 247 (738)
Q Consensus 177 l~~~~--------~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~ 247 (738)
..... .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||........+ ..+..+..+ .+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~-~~~ 233 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI-FKIGENASP-EIP 233 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH-HHHhccCCC-cCC
Confidence 64211 112348899999998864 5888999999999999999999999876544433 333333333 334
Q ss_pred cCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 248 KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 248 ~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
...+..++++|.+||+ +|.+||++.++++||||
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 5568899999999999 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=333.16 Aligned_cols=251 Identities=27% Similarity=0.369 Sum_probs=204.0
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
+|.+.+.||.|++|+||+|.+..+|..||+|.++.... .......+.+|+.+++.++||||+++++++.+ ...+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~~~~l 76 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLYDVLHS--DKKLTL 76 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc--cccCccchhHHHHHHHhcCCCCeeeHHHHhcc--CCceEE
Confidence 48899999999999999999999999999999876432 22233567889999999999999999998855 568999
Q ss_pred EEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 102 VTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k-~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
|+||+. ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++......
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 77 VFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKN-GELKLADFGLARAFGIP 152 (284)
T ss_pred EEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCC-CcEEECccchhhccCCC
Confidence 999996 688887765 467999999999999999999999998 9999999999999855 79999999999765432
Q ss_pred c--cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCC--------------
Q 004672 181 H--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK-------------- 242 (738)
Q Consensus 181 ~--~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~-------------- 242 (738)
. .....+++.|+|||++.+ .++.++||||||+++|+|+||..||....+....++.+.....
T Consensus 153 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 153 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 2 223457899999998864 3789999999999999999999986544444444333321100
Q ss_pred -----C--------cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 243 -----P--------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 243 -----p--------~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
+ .......++++++||.+||. +|.+|||+.++|+||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 01112357899999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=324.23 Aligned_cols=256 Identities=27% Similarity=0.458 Sum_probs=218.0
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEecccc-CCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDF-LQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~-~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
.+|.+.+.||.|+||.||+|.+..+|..||+|.+..... .........+.+|+.+++.++||||+++++++.+.....+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 478999999999999999999999999999998865321 2234566789999999999999999999998876656789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 100 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
++++||+++++|.+++...+.+++..++.++.||+.||.|||+++ ++|+||||+||+++.+ +.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSA-GNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC-CCEEECcccccccccc
Confidence 999999999999999988788999999999999999999999998 9999999999999854 7899999999976532
Q ss_pred c-----ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChH
Q 004672 180 S-----HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 253 (738)
Q Consensus 180 ~-----~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spe 253 (738)
. ......|++.|+|||.+.+ .++.++||||||+++|+|++|..||........+. .+.....+..++...+++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~p~~~~~~ 237 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF-KIATQPTKPMLPDGVSDA 237 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHH-HHHcCCCCCCCCcccCHH
Confidence 1 1123458999999998865 48889999999999999999999998765555544 344344444556677899
Q ss_pred HHHHHHHHHhCcCCCCCHHHHhcCccc
Q 004672 254 VRQFIEKCLATVSSRLSARELLTDPFL 280 (738)
Q Consensus 254 l~~lI~kcL~dP~~RpSa~ELL~Hpf~ 280 (738)
+.++|.+||++|..||++.++|.|||.
T Consensus 238 ~~~~i~~~l~~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 238 CRDFLKQIFVEEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHhcCcccCccHHHHhcCCCC
Confidence 999999999988999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=340.15 Aligned_cols=250 Identities=22% Similarity=0.345 Sum_probs=202.4
Q ss_pred EEEEEccc--CCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEE
Q 004672 25 DTMKFLVK--ELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 102 (738)
Q Consensus 25 il~kLG~G--afgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV 102 (738)
++.+||+| +|++||++.+..+|..||+|+++... ......+.+.+|+.+++.++||||++++++|.. ++..++|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv 77 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEA--CTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNELWVV 77 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhh--ccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCEEEEE
Confidence 46789999 78999999999999999999987543 123456678899999999999999999998866 5789999
Q ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 103 TEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 103 ~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
|||+++|+|.+++..+ ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.++++||+.+......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~-~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLSGLRSNLSMINH 154 (327)
T ss_pred EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecC-CcEEEcccchhhccccc
Confidence 9999999999998764 45899999999999999999999998 9999999999999855 79999999876443211
Q ss_pred ---------ccccccCCCCCCCcccccc---ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCc----
Q 004672 181 ---------HAARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE---- 244 (738)
Q Consensus 181 ---------~~~~~vGTp~YmAPEvl~~---~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~---- 244 (738)
......++..|+|||++.+ .|+.++|||||||++|+|++|..||....... .......+..|.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 233 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKLNGTVPCLLDT 233 (327)
T ss_pred cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH-HHHHHhcCCccccccc
Confidence 1122346788999999864 48999999999999999999999998644333 222222222210
Q ss_pred ----------------------------------------ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 245 ----------------------------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 245 ----------------------------------------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
......++.+++||.+||+ +|.+|||+.+||+||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 0112346789999999999 9999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=322.37 Aligned_cols=251 Identities=30% Similarity=0.466 Sum_probs=211.6
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.+.+.||.|++|+||+|....+|..+|+|++..... ....+.+.+|+.+|+.++|+||+++++.+.. ...++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC---QTSVDELRKEVQAMSQCNHPNVVKYYTSFVV--GDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc---chHHHHHHHHHHHHHhcCCCCEEEEEEEEee--CCEEE
Confidence 479999999999999999999999999999998764332 2356789999999999999999999998755 67899
Q ss_pred EEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 101 FVTEMFTSGTLRQYRLKH---RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~---~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
+|||++++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||+|+||+++.+ +.++|+|||++..+
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~-~~~~l~df~~~~~~ 152 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGED-GSVKIADFGVSASL 152 (267)
T ss_pred EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCC-CCEEEcccchHHHh
Confidence 999999999999998764 45899999999999999999999998 9999999999999865 78999999999876
Q ss_pred hcccc------ccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCccc---
Q 004672 178 RKSHA------ARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL--- 246 (738)
Q Consensus 178 ~~~~~------~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l--- 246 (738)
..... ....|++.|+|||++.. .++.++|+||||+++|+|++|+.||..... ...+..+..+..+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd06610 153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP-MKVLMLTLQNDPPSLETGA 231 (267)
T ss_pred ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh-hhhHHHHhcCCCCCcCCcc
Confidence 54321 23358999999998864 488899999999999999999999987544 3444444444332111
Q ss_pred -ccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 247 -FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 247 -~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
....++.+++||.+||. +|.+||++.+|+.||||
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 232 DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 12457889999999999 99999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=324.88 Aligned_cols=250 Identities=24% Similarity=0.395 Sum_probs=213.7
Q ss_pred EcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEecCCC
Q 004672 29 FLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTS 108 (738)
Q Consensus 29 LG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey~~g 108 (738)
||.|++|+||+|.+..++..||+|.+.... .......+.+.+|+.+++.++||||+++++.+.+ +..+++||||+++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRH-IVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhc-chhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc--CCccEEEEecCCC
Confidence 689999999999999999999999987543 2233456789999999999999999999998754 6789999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccc-cccccC
Q 004672 109 GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-AARCVG 187 (738)
Q Consensus 109 GSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~-~~~~vG 187 (738)
++|.+++.+...+++..+..++.||+.||.|||+++ ++|+||+|+||+++.+ +.++|+|||++....... .....|
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~-~~~~l~df~~~~~~~~~~~~~~~~~ 154 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQKTWTFCG 154 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCC-CCEEEeeCCcccccCcccccccccC
Confidence 999999988888999999999999999999999998 9999999999999854 899999999998765432 223468
Q ss_pred CCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCC-CHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-C
Q 004672 188 TPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT-HPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-T 264 (738)
Q Consensus 188 Tp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~-~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-d 264 (738)
++.|+|||.+.. .++.++|+||||+++|+|++|..||.... ++..++..+..+......+...++++++||.+||. +
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCC
Confidence 999999998764 58899999999999999999999997644 35666677765444444444558899999999999 9
Q ss_pred cCCCCC-----HHHHhcCcccCCCC
Q 004672 265 VSSRLS-----ARELLTDPFLQIDD 284 (738)
Q Consensus 265 P~~RpS-----a~ELL~Hpf~~~~~ 284 (738)
|.+||+ ++|+++||||+..+
T Consensus 235 p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred hhhCcCCcccCHHHHhcChhhhCCC
Confidence 999999 99999999997543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=324.86 Aligned_cols=253 Identities=27% Similarity=0.430 Sum_probs=209.7
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecC--
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTA-- 95 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~-- 95 (738)
+.++|.+.+.||.|++|+||+|.++.++..|++|.+.... ...+.+.+|+.+++++ +|+||++++++|....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 3588999999999999999999999999999999887432 2346789999999999 7999999999987643
Q ss_pred --CCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEe
Q 004672 96 --NRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIG 169 (738)
Q Consensus 96 --~~~l~LV~Ey~~gGSL~~~l~k----~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~ 169 (738)
...+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.+ +.+||+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~-~~~~l~ 155 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKN-AEVKLV 155 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccC-CeEEEC
Confidence 4578999999999999998765 357999999999999999999999998 9999999999999855 799999
Q ss_pred ccchhHHhhcc--ccccccCCCCCCCcccccc------ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCC
Q 004672 170 DLGLAAILRKS--HAARCVGTPEFMAPEVYEE------EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 241 (738)
Q Consensus 170 DFGlA~~l~~~--~~~~~vGTp~YmAPEvl~~------~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~ 241 (738)
|||++...... ......|++.|+|||++.. .++.++||||||+++|+|++|..||........+ ..+..+.
T Consensus 156 d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~ 234 (275)
T cd06608 156 DFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL-FKIPRNP 234 (275)
T ss_pred CCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH-HHhhccC
Confidence 99998654332 2233458999999998742 3778999999999999999999999864433333 3444443
Q ss_pred CCccc-ccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 242 KPEAL-FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 242 ~p~~l-~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
.+... ....+.++++||.+||. +|.+|||+.++++|||+
T Consensus 235 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 235 PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 33222 12357789999999999 99999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=327.46 Aligned_cols=255 Identities=27% Similarity=0.437 Sum_probs=217.0
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.+.+.||.|++|.||+|.+..+|..||+|.+.... .......+.+|+.+++.++||||+++++++.+ ...++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--GSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE--CCeEE
Confidence 46888999999999999999999999999999987542 34455678899999999999999999998866 57899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
+|+||+.+++|.+++... ++++..++.++.||+.||.|||+++ ++|+||+|+||+++.+ +.++|+|||++..+...
T Consensus 76 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEE-GDVKLADFGVSGQLTST 151 (274)
T ss_pred EEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEEcccccceeeccc
Confidence 999999999999998765 8999999999999999999999998 9999999999999854 89999999999776543
Q ss_pred --ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004672 181 --HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 257 (738)
Q Consensus 181 --~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~l 257 (738)
......|++.|+|||.+.+ .++.++||||||+++|+|+||..||... ++......+..+..+.......++.+.++
T Consensus 152 ~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (274)
T cd06609 152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL-HPMRVLFLIPKNNPPSLEGNKFSKPFKDF 230 (274)
T ss_pred ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC-chHHHHHHhhhcCCCCCcccccCHHHHHH
Confidence 2234468899999998864 5899999999999999999999999764 34455555555544433322378899999
Q ss_pred HHHHHh-CcCCCCCHHHHhcCcccCCCCC
Q 004672 258 IEKCLA-TVSSRLSARELLTDPFLQIDDY 285 (738)
Q Consensus 258 I~kcL~-dP~~RpSa~ELL~Hpf~~~~~~ 285 (738)
|.+||. +|.+|||+.++++||||+....
T Consensus 231 l~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 231 VSLCLNKDPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred HHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence 999999 9999999999999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=327.21 Aligned_cols=255 Identities=26% Similarity=0.433 Sum_probs=207.0
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHH-HHhCCCCCcceeeEEEEecCCCeE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHL-LKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~i-Lk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
++|.+++.||+|+||.||+|.++.+|..||+|+++... .... ..++..|+.+ ++.++||||+++++++.. +..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV--NSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFR--EGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCC--CcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEec--CCcE
Confidence 47899999999999999999999999999999987542 1222 3345556664 677799999999998754 5679
Q ss_pred EEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 100 NFVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSR-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~----~~lse~~i~~i~~QIl~aL~yLHs~-gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
+++|||++ |+|.+++... ..+++..++.++.||+.||.|||++ + ++||||||+||+++.+ +.+||+|||++
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~-~~~kl~dfg~~ 151 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRN-GQVKLCDFGIS 151 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCC-CCEEEeecccc
Confidence 99999995 7888876542 4689999999999999999999997 7 9999999999999855 79999999999
Q ss_pred HHhhcccc-ccccCCCCCCCcccccc-----ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCccccc
Q 004672 175 AILRKSHA-ARCVGTPEFMAPEVYEE-----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFK 248 (738)
Q Consensus 175 ~~l~~~~~-~~~vGTp~YmAPEvl~~-----~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~ 248 (738)
..+..... ....|+..|+|||++.+ .++.++|+||||+++|+|++|..||.......+....+..+..+.....
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd06617 152 GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAE 231 (283)
T ss_pred cccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCcc
Confidence 76644332 22458999999998753 4788999999999999999999999754444344444455544433334
Q ss_pred CCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 249 VEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 249 ~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
.++.++++||.+||. +|.+||++.+++.||||+...
T Consensus 232 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 232 KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 568899999999999 999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=356.87 Aligned_cols=253 Identities=26% Similarity=0.410 Sum_probs=220.8
Q ss_pred ceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEE
Q 004672 23 MEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 102 (738)
Q Consensus 23 y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV 102 (738)
|..++.||+|+||.||-|.|..+.+.||||++.... .++.+..+.+..|++.|.+|+|||+|.+.++|+. ..+.|+|
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySG-KQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr--e~TaWLV 104 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR--EHTAWLV 104 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccc-cccHHHHHHHHHHHHHHHhccCCCcccccceeec--cchHHHH
Confidence 778899999999999999999999999999988554 6777888999999999999999999999999977 4578999
Q ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccc
Q 004672 103 TEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 181 (738)
Q Consensus 103 ~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~ 181 (738)
|||| -|+..+++.-+ +++.+..+..|+.+.+.||+|||+++ .||||||..|||++. .|.|||+|||.|.+...
T Consensus 105 MEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse-~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 105 MEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSE-PGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecC-CCeeeeccccchhhcCc--
Confidence 9999 57888887665 56999999999999999999999999 999999999999984 48999999999987644
Q ss_pred cccccCCCCCCCccccc----cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004672 182 AARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 257 (738)
Q Consensus 182 ~~~~vGTp~YmAPEvl~----~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~l 257 (738)
..+++|||.||||||+. |.|+-++||||||++-.||.-.++|+.+++-...+|. |.....|.-.....+..+++|
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH-IAQNesPtLqs~eWS~~F~~F 257 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-IAQNESPTLQSNEWSDYFRNF 257 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH-HHhcCCCCCCCchhHHHHHHH
Confidence 46789999999999874 6799999999999999999999999987655555554 444555544445567899999
Q ss_pred HHHHHh-CcCCCCCHHHHhcCcccCCCCC
Q 004672 258 IEKCLA-TVSSRLSARELLTDPFLQIDDY 285 (738)
Q Consensus 258 I~kcL~-dP~~RpSa~ELL~Hpf~~~~~~ 285 (738)
|+.||+ -|.+|||.++||+|+|..-+..
T Consensus 258 vd~CLqKipqeRptse~ll~H~fv~R~Rp 286 (948)
T KOG0577|consen 258 VDSCLQKIPQERPTSEELLKHRFVLRERP 286 (948)
T ss_pred HHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence 999999 6999999999999999976543
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=331.44 Aligned_cols=249 Identities=20% Similarity=0.327 Sum_probs=202.7
Q ss_pred EcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEecCCC
Q 004672 29 FLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTS 108 (738)
Q Consensus 29 LG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey~~g 108 (738)
||.|+||+||++.++.+|..||+|.+...... .......+..|+.+|+.++||||++++++|.. +..+++||||+.|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLK-KKSGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhh-cchhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEEecCCC
Confidence 69999999999999999999999998753321 12223456679999999999999999997744 6789999999999
Q ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcccc-ccc
Q 004672 109 GTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-ARC 185 (738)
Q Consensus 109 GSL~~~l~k~~--~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~~-~~~ 185 (738)
|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.++|+|||++........ ...
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~-~~~~l~Dfg~~~~~~~~~~~~~~ 154 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQ-GNCRLSDLGLAVELKDGKTITQR 154 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCC-CCEEEeeceeeeecCCCceeecc
Confidence 99998876543 5889999999999999999999998 9999999999999854 7999999999876544322 234
Q ss_pred cCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCC---CHHHHHHHHHcCCCCcccccCCChHHHHHHHHH
Q 004672 186 VGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT---HPAQIYKKVISGKKPEALFKVEDPEVRQFIEKC 261 (738)
Q Consensus 186 vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~---~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kc 261 (738)
.|++.|+|||++.+ .++.++|||||||++|+|++|..||.... +..++......+..+. .....+++++++|.+|
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~ 233 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICRLF 233 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHHHHHHHHH
Confidence 58999999998864 58999999999999999999999997532 2234444444333322 2245789999999999
Q ss_pred Hh-CcCCCCCH----HHHhcCcccCCCC
Q 004672 262 LA-TVSSRLSA----RELLTDPFLQIDD 284 (738)
Q Consensus 262 L~-dP~~RpSa----~ELL~Hpf~~~~~ 284 (738)
|+ +|.+||++ .++++||||+.-+
T Consensus 234 L~~~P~~R~~~~~~~~~~~~h~~f~~~~ 261 (277)
T cd05607 234 LAKKPEDRLGSREKNDDPRKHEFFKTIN 261 (277)
T ss_pred hccCHhhCCCCccchhhhhcChhhcCCC
Confidence 99 99999999 6788999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=330.68 Aligned_cols=253 Identities=25% Similarity=0.469 Sum_probs=213.3
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.+++.||.|+||+||+|.+..+|..||+|.++.. ........+.+|+.+|++++||||+++++.+.. .+.++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE---LDESKFNQIIMELDILHKAVSPYIVDFYGAFFI--EGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc---cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--CCeEE
Confidence 4788999999999999999999999999999988743 234556789999999999999999999998755 67899
Q ss_pred EEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 101 FVTEMFTSGTLRQYRLKH---RRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~---~~lse~~i~~i~~QIl~aL~yLHs-~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
+||||+++++|..++... ..+++..+..++.||+.||.|||+ .+ |+||||||+||+++. .+.+||+|||++..
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~-~~~~~l~dfg~~~~ 152 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNG-NGQVKLCDFGVSGN 152 (286)
T ss_pred EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECC-CCCEEEeecCCccc
Confidence 999999999999988763 379999999999999999999997 46 999999999999986 58999999999977
Q ss_pred hhccccccccCCCCCCCcccccc-------ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHH---HHHHcCCCCccc
Q 004672 177 LRKSHAARCVGTPEFMAPEVYEE-------EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY---KKVISGKKPEAL 246 (738)
Q Consensus 177 l~~~~~~~~vGTp~YmAPEvl~~-------~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~---k~i~~g~~p~~l 246 (738)
+.........|++.|+|||.+.+ .++.++|||||||++|+|++|..||.... ....+ ..+..+..+ .+
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~-~~ 230 (286)
T cd06622 153 LVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-YANIFAQLSAIVDGDPP-TL 230 (286)
T ss_pred ccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-hhhHHHHHHHHhhcCCC-CC
Confidence 65554555568999999998753 25789999999999999999999997533 22222 233344333 34
Q ss_pred ccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 247 FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 247 ~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
+...++++++||.+||. +|.+||++.+++.||||...
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 231 PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred CcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 45578999999999999 89999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=350.55 Aligned_cols=254 Identities=23% Similarity=0.371 Sum_probs=222.6
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
-|.+.+.||.|-|+.|-+|.+..||..||||+|..... ..-....+.+|++.|+.++|||||++|++ ......+||
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl--D~~st~hlfqEVRCMKLVQHpNiVRLYEV--iDTQTKlyL 94 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL--DTLSTGHLFQEVRCMKLVQHPNIVRLYEV--IDTQTKLYL 94 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc--chhhhhHHHHHHHHHHHhcCcCeeeeeeh--hcccceEEE
Confidence 37778899999999999999999999999999987653 23445689999999999999999999995 345678999
Q ss_pred EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 102 VTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~~-~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
|+|+=.+|+|++|+.++. .+.+..+++|+.||+.|+.|||+.. +|||||||+|+.+..+.|-|||+|||++..+...
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999999998874 5999999999999999999999998 9999999999999889999999999999776554
Q ss_pred -ccccccCCCCCCCccccccc-cC-cccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004672 181 -HAARCVGTPEFMAPEVYEEE-YN-ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 257 (738)
Q Consensus 181 -~~~~~vGTp~YmAPEvl~~~-ys-~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~l 257 (738)
...+.+|+..|-|||++.+. |+ +++||||||+|||.|++|++||.+.++ .+...+|+..++. .+...+.++++|
T Consensus 173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND-SETLTmImDCKYt--vPshvS~eCrdL 249 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND-SETLTMIMDCKYT--VPSHVSKECRDL 249 (864)
T ss_pred chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc-hhhhhhhhccccc--CchhhhHHHHHH
Confidence 56788999999999988764 65 579999999999999999999998554 4445666655543 456778999999
Q ss_pred HHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 258 IEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 258 I~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
|..||. +|.+|.|.+++..++|++..+
T Consensus 250 I~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 250 IQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred HHHHHhcCchhhccHHHHhccccccCCC
Confidence 999999 999999999999999998765
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=357.37 Aligned_cols=251 Identities=24% Similarity=0.379 Sum_probs=214.1
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCC-C-----CCcceeeEEEEecC
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-H-----RNIMKFYTSWVDTA 95 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~-H-----pNIVkl~~~fv~~~ 95 (738)
+|.+++.||+|+||.|.+|.|..|++.||||+++. .+....+...|+.+|..|+ | -|||+++++|+.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-----~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f-- 259 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-----KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF-- 259 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeecc-----ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--
Confidence 68999999999999999999999999999999983 4567778899999999996 4 489999999966
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEe-CCCCcEEEeccc
Q 004672 96 NRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN-GNQGEVKIGDLG 172 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~l~k~~--~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~-~~~g~VKL~DFG 172 (738)
.++++||+|++ +-+|.++++.++ .|++..++.+++||+.||.+||+.+ |||+||||+||||. .+...|||+|||
T Consensus 260 r~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 260 RNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred ccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEecc
Confidence 78999999999 789999998874 5899999999999999999999999 99999999999995 334579999999
Q ss_pred hhHHhhccccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc-CCCCc------
Q 004672 173 LAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKKPE------ 244 (738)
Q Consensus 173 lA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~-g~~p~------ 244 (738)
.|+....... +++-+..|+|||++.+ .|+.+.||||||||+.||++|.+.|.+.+..+|+...+.. |..|.
T Consensus 337 SSc~~~q~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 337 SSCFESQRVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cccccCCcce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 9998777665 7788999999998875 6999999999999999999999999987777776543311 11110
Q ss_pred --------------------c---------------------------------cccCCChHHHHHHHHHHh-CcCCCCC
Q 004672 245 --------------------A---------------------------------LFKVEDPEVRQFIEKCLA-TVSSRLS 270 (738)
Q Consensus 245 --------------------~---------------------------------l~~~~spel~~lI~kcL~-dP~~RpS 270 (738)
. +.......+.+||.+||. ||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 0 000123468999999999 9999999
Q ss_pred HHHHhcCcccCCC
Q 004672 271 ARELLTDPFLQID 283 (738)
Q Consensus 271 a~ELL~Hpf~~~~ 283 (738)
+.++|+||||...
T Consensus 496 p~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 496 PAQALNHPFLTGT 508 (586)
T ss_pred HHHHhcCcccccc
Confidence 9999999999743
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=333.38 Aligned_cols=258 Identities=21% Similarity=0.333 Sum_probs=214.5
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.+.+.||.|++|+||+|.+..+|..||+|.+..... ......+.+..|+.+|+.++||||+++++.+.. ...++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 77 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM-IKRNKVKRVLTEQEILATLDHPFLPTLYASFQT--ETYLC 77 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEecccc-chHHHHHHHHHHHHHHHhCCCCCchhheeeeec--CCEEE
Confidence 478999999999999999999999999999999886542 223456789999999999999999999998744 67899
Q ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh
Q 004672 101 FVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~ 178 (738)
+||||+.+++|.+++.+. ..+++..++.++.||+.||.|||+.+ ++|+||||+||+++.+ |.++|+|||++....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~ 154 (316)
T cd05574 78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHES-GHIMLSDFDLSKQSD 154 (316)
T ss_pred EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCC-CCEEEeecchhhccc
Confidence 999999999999998764 56999999999999999999999998 9999999999999855 899999999986543
Q ss_pred ccc-------------------------------cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCC
Q 004672 179 KSH-------------------------------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSE 226 (738)
Q Consensus 179 ~~~-------------------------------~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~ 226 (738)
... ....+||..|+|||++.+ .++.++||||||+++|+|++|..||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 211 112358899999998864 488899999999999999999999987
Q ss_pred CCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCC----HHHHhcCcccCCCCC
Q 004672 227 CTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLS----ARELLTDPFLQIDDY 285 (738)
Q Consensus 227 ~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpS----a~ELL~Hpf~~~~~~ 285 (738)
...... +..+.....+.......++.++++|.+||. +|.+||| +.++|.||||+..++
T Consensus 235 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~ 297 (316)
T cd05574 235 SNRDET-FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNW 297 (316)
T ss_pred CchHHH-HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCCh
Confidence 544433 444443332222222368999999999999 9999999 999999999986543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=319.60 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=213.8
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
+|...+.||.|++|.||+|.+..++..+|+|.+..... +......+.+|+.+|+.++||||+++++.+.. ...+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 76 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM--TKDERLAAQNECQVLKLLSHPNIIEYYENFLE--DKALMI 76 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHhhCCCCchhheeeeEec--CCEEEE
Confidence 58899999999999999999999999999999875432 34556789999999999999999999998754 678999
Q ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 102 VTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
||||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+|+||+|+||+++.+.+.+||+|||++.....
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 77 VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred EEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 99999999999998764 34899999999999999999999998 999999999999986666789999999976654
Q ss_pred ccc-ccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004672 180 SHA-ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 257 (738)
Q Consensus 180 ~~~-~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~l 257 (738)
... ....|++.|+|||.+.+ .++.++||||||+++|+|++|..||.... .......+..+..+ .+....+++++++
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~l~~l 232 (256)
T cd08220 155 KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN-LPALVLKIMSGTFA-PISDRYSPDLRQL 232 (256)
T ss_pred CccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc-hHHHHHHHHhcCCC-CCCCCcCHHHHHH
Confidence 322 23458999999999874 47889999999999999999999998754 34455555544433 2344578899999
Q ss_pred HHHHHh-CcCCCCCHHHHhcCccc
Q 004672 258 IEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 258 I~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
|.+||. +|.+|||+.++|.||||
T Consensus 233 i~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 233 ILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHccCChhhCCCHHHHhhCCCC
Confidence 999999 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=327.08 Aligned_cols=253 Identities=26% Similarity=0.383 Sum_probs=209.1
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.+...||.|++|.||+|.+..+|..||+|++..... .....+.+.+|+.+++.++||||++++++|.. ...++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 76 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLKHPNLVNLIEVFRR--KRKLH 76 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc--CccccHHHHHHHHHHHhCCCCCEeeeeeEEee--CCEEE
Confidence 478999999999999999999999999999998875431 22234567899999999999999999998865 67899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
+||||+++++|..++.....+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++......
T Consensus 77 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 77 LVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQ-GQIKLCDFGFARILTGP 153 (286)
T ss_pred EEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCC-CcEEECccccceecCCC
Confidence 99999999999888777778999999999999999999999998 9999999999999855 79999999999766443
Q ss_pred c--cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc-CC--------------
Q 004672 181 H--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GK-------------- 241 (738)
Q Consensus 181 ~--~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~-g~-------------- 241 (738)
. .....++..|+|||++.+ .++.++||||||+++|+|++|..||.+..+.+.++..... +.
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 2 223458899999998764 4789999999999999999999999876655544332211 00
Q ss_pred -----CCc--------ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 242 -----KPE--------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 242 -----~p~--------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
.|. ......++.+.+||.+||. +|.+||++.++|.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 0112457889999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=321.72 Aligned_cols=254 Identities=29% Similarity=0.465 Sum_probs=219.6
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.+.+.||.|++|.||+|.+..+|..||+|++.... .....+.+.+|+.+++.++|+||+++++++.. ...++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG---DEEFRKQLLRELKTLRSCESPYVVKCYGAFYK--EGEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCc---chHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc--CCeEE
Confidence 46889999999999999999999999999999887543 22556789999999999999999999998755 57899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs-~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
+||||+++++|.+++.....+++..++.++.||+.||.|||+ .+ ++||||+|+||+++.+ +.++|+|||++.....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~-~~~~l~df~~~~~~~~ 152 (264)
T cd06623 76 IVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSK-GEVKIADFGISKVLEN 152 (264)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCC-CCEEEccCccceeccc
Confidence 999999999999999888889999999999999999999999 88 9999999999999854 8999999999977654
Q ss_pred cccc--cccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCC--CHHHHHHHHHcCCCCcccccCCChHH
Q 004672 180 SHAA--RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT--HPAQIYKKVISGKKPEALFKVEDPEV 254 (738)
Q Consensus 180 ~~~~--~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~--~~~qi~k~i~~g~~p~~l~~~~spel 254 (738)
.... ...++..|+|||.+.. .++.++||||||+++|+|+||..||.... ...++.+.+.....+.......+..+
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (264)
T cd06623 153 TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEF 232 (264)
T ss_pred CCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence 3322 3458899999998864 48889999999999999999999998764 55666666665554433323278899
Q ss_pred HHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 255 RQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 255 ~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
.++|.+||. +|.+||++.+++.||||+.
T Consensus 233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 233 RDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 999999999 8999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=316.88 Aligned_cols=254 Identities=35% Similarity=0.527 Sum_probs=220.2
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
+|.+.+.||.|++|.||+|.+..+|..|++|++..... .....+.+.+|+.++++++||||+++++.+.......+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD--SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEE
Confidence 47889999999999999999999999999999876542 2566789999999999999999999999876643378999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccc
Q 004672 102 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 181 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~ 181 (738)
++||+.+++|.+++.+...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCC-CCEEEcccccEEeccccc
Confidence 9999999999999988889999999999999999999999998 9999999999999864 799999999997765543
Q ss_pred ----cccccCCCCCCCccccccc-cCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004672 182 ----AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 256 (738)
Q Consensus 182 ----~~~~vGTp~YmAPEvl~~~-ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~ 256 (738)
.....++..|+|||.+.+. ++.++||||||+++|+|++|..||....+.......+..+.....++...++.+++
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKD 235 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHH
Confidence 3344689999999988754 88999999999999999999999987655555555555444444455666899999
Q ss_pred HHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 257 FIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 257 lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
||.+||. +|.+||++.+++.||||
T Consensus 236 ~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 236 FLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHhCcCChhhCCCHHHHhhCCCC
Confidence 9999999 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=330.15 Aligned_cols=258 Identities=22% Similarity=0.390 Sum_probs=215.8
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCC
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 97 (738)
+..++|+++++||+|+||+||+|.+..+|..||+|.+.... .....+.+.+|+++++.++||||+++++++.. ..
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~ 76 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---KSSVRKQILRELQIMHECRSPYIVSFYGAFLN--EN 76 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---cchHHHHHHHHHHHHHHcCCCCcceEeeeEec--CC
Confidence 45678999999999999999999999999999999877432 34456789999999999999999999998865 57
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs-~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
.+++||||+++++|.+++.+.+.+++..+..++.+++.||.|||+ ++ ++||||||+||+++. .+.++|+|||++..
T Consensus 77 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~-~~~~~l~d~gl~~~ 153 (284)
T cd06620 77 NICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNS-RGQIKLCDFGVSGE 153 (284)
T ss_pred EEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECC-CCcEEEccCCcccc
Confidence 899999999999999999888889999999999999999999997 46 999999999999984 48999999999876
Q ss_pred hhccccccccCCCCCCCccccc-cccCcccccccchhhhhhhhhcCCCCCCCCCH----------HHHHHHHHcCCCCcc
Q 004672 177 LRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHP----------AQIYKKVISGKKPEA 245 (738)
Q Consensus 177 l~~~~~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~----------~qi~k~i~~g~~p~~ 245 (738)
..........|+..|+|||++. +.++.++||||||+++|+|+||..||...... ..+...+.....+..
T Consensus 154 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd06620 154 LINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL 233 (284)
T ss_pred hhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCC
Confidence 5444444557999999999875 56889999999999999999999999754321 122333333333322
Q ss_pred cccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 246 LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 246 l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
.....++++.+||.+||+ +|.+|||+.|+++|+||...
T Consensus 234 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 234 PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 222367889999999999 99999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=319.60 Aligned_cols=253 Identities=32% Similarity=0.461 Sum_probs=213.7
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEecccc-CCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDF-LQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~-~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
+|...+.||.|++|+||+|.+..++..|++|.+..... ....+..+.+.+|+.+|+.++||||+++++++.. ...++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE--EDNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec--CCeEE
Confidence 46778999999999999999998999999999876542 2234566789999999999999999999997744 67899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
+++||+++++|.+++.+...+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.+ +.+||+|||++......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~-~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 79 IFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTN-GVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEccCccceecccc
Confidence 99999999999999988888999999999999999999999998 9999999999999854 79999999998765443
Q ss_pred c-cccccCCCCCCCcccccc-c-cCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004672 181 H-AARCVGTPEFMAPEVYEE-E-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 257 (738)
Q Consensus 181 ~-~~~~vGTp~YmAPEvl~~-~-ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~l 257 (738)
. .....|++.|+|||.+.. . ++.++|+||||+++|+|++|..||........+.+ +.........+...++.+++|
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l 234 (258)
T cd06632 156 SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK-IGRSKELPPIPDHLSDEAKDF 234 (258)
T ss_pred ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH-HHhcccCCCcCCCcCHHHHHH
Confidence 3 234558999999998753 3 78999999999999999999999987554444433 333222233445678999999
Q ss_pred HHHHHh-CcCCCCCHHHHhcCccc
Q 004672 258 IEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 258 I~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
+.+||. +|.+||++.++|.|||+
T Consensus 235 i~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 235 ILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHhhcCcccCcCHHHHhcCCCC
Confidence 999999 99999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=326.99 Aligned_cols=253 Identities=28% Similarity=0.442 Sum_probs=211.2
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEec---
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDT--- 94 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~--- 94 (738)
+.+.|.+.+.||.|+||+||+|.+..++..||+|.+... ......+..|+.+++.+ +||||++++++|+..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 457899999999999999999999999999999987643 23446788999999999 799999999988643
Q ss_pred -CCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEecc
Q 004672 95 -ANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 171 (738)
Q Consensus 95 -~~~~l~LV~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DF 171 (738)
....++++|||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+|+||||+||+++. .+.++|+||
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~-~~~~~l~df 165 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTE-NAEVKLVDF 165 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECC-CCCEEEeeC
Confidence 246889999999999999998764 35889999999999999999999998 999999999999985 479999999
Q ss_pred chhHHhhcc--ccccccCCCCCCCccccc------cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 004672 172 GLAAILRKS--HAARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 243 (738)
Q Consensus 172 GlA~~l~~~--~~~~~vGTp~YmAPEvl~------~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p 243 (738)
|++...... ......|++.|+|||++. ..++.++||||||+++|+|++|..||........+. .+.....+
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-~~~~~~~~ 244 (282)
T cd06636 166 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPPP 244 (282)
T ss_pred cchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-hHhhCCCC
Confidence 998765432 223456899999999874 348889999999999999999999998755444433 23333333
Q ss_pred cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 244 EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 244 ~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
.......++++.+||.+||. +|.+||++.|||+||||
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 33344578899999999999 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=329.48 Aligned_cols=256 Identities=23% Similarity=0.435 Sum_probs=221.7
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecCCCe
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~ 98 (738)
+.++..+..||+|+.|+|+++....+|..+|||++... .+.++.+++...+.++... ++|+||+.|++|+. +..
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt---~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~--n~d 165 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT---GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT--NTD 165 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc---CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee--Cch
Confidence 45677788999999999999999999999999998754 5778899999999977766 59999999999987 567
Q ss_pred EEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 99 INFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k-~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
+++.||.| +..+..++++ .++++|..+-.+...+++||.||-.+. +|||||+||+|||++ ..|.|||||||++..+
T Consensus 166 V~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlD-e~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 166 VFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLD-ERGNIKLCDFGISGRL 242 (391)
T ss_pred HHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEc-cCCCEEeeccccccee
Confidence 88999999 5566666555 467999999999999999999998874 599999999999998 5599999999999888
Q ss_pred hcccccc-ccCCCCCCCccccc----cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccc--cCC
Q 004672 178 RKSHAAR-CVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF--KVE 250 (738)
Q Consensus 178 ~~~~~~~-~vGTp~YmAPEvl~----~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~--~~~ 250 (738)
-.+...+ ..|-+.|||||.+. .+|+.++||||||++++||.||++||.+|....++..+|.....| .++ ...
T Consensus 243 vdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP-~L~~~~gF 321 (391)
T KOG0983|consen 243 VDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPP-LLPGHMGF 321 (391)
T ss_pred ecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCC-CCCcccCc
Confidence 7766543 45999999999986 359999999999999999999999999999888888888885444 332 237
Q ss_pred ChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 251 DPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 251 spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
++.+++|++.||. |+.+||...+||+|||+...+
T Consensus 322 Sp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 322 SPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred CHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 9999999999999 999999999999999997654
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=319.35 Aligned_cols=250 Identities=27% Similarity=0.445 Sum_probs=216.5
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
.|+.++.||.|+||.||.+.+..+|..|++|.+.... .+.....++.+|+.+|++++|+||++++++|.+ ...+++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~ 76 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR--LSEKERRDALNEIVILSLLQHPNIIAYYNHFMD--DNTLLI 76 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecc--cchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CCeEEE
Confidence 4889999999999999999999999999999987654 234556788999999999999999999999865 678999
Q ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 102 VTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
+|||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.+ +.+||+|||++.....
T Consensus 77 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~-~~~kl~d~~~~~~~~~ 153 (256)
T cd08221 77 EMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKA-GLIKLGDFGISKILGS 153 (256)
T ss_pred EEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCC-CCEEECcCcceEEccc
Confidence 99999999999998775 46899999999999999999999998 9999999999999854 7999999999876543
Q ss_pred cc--cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004672 180 SH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 256 (738)
Q Consensus 180 ~~--~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~ 256 (738)
.. .....|++.|+|||++.+ .++.++||||||+++|+|++|..||.. .+..+....+..+..+.. ....+.++.+
T Consensus 154 ~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 231 (256)
T cd08221 154 EYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQGNYTPV-VSVYSSELIS 231 (256)
T ss_pred ccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCC-ccccCHHHHH
Confidence 32 234468999999998864 488899999999999999999999976 455666667777665542 3566889999
Q ss_pred HHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 257 FIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 257 lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
+|.+||. +|.+||++.++|+|||+
T Consensus 232 ~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 232 LVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHcccCcccCCCHHHHhhCcCC
Confidence 9999999 89999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=324.23 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=213.7
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
+|.+.+.||.|+||.||+|.+..+|..||+|.+.... .......+.+.+|++++++++||||+++++.|. .+..+++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~l 77 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQK-CVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ--DEENMYL 77 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhh-hcchhHHHHHHHHHHHHHhCCCCChHHHHHhhc--CCCeEEE
Confidence 4889999999999999999999999999999987543 233356678999999999999999999999774 3678999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc-
Q 004672 102 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS- 180 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~- 180 (738)
|+||+.+++|.+++.+...+++..+..|+.||+.||.|||+++ ++|+||+|+||+++.+ +.++|+|||++......
T Consensus 78 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 78 VVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQ-GHVHITDFNIATKVTPDT 154 (258)
T ss_pred EEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCC-CCEEEeecccccccCCCc
Confidence 9999999999999988778999999999999999999999998 9999999999999854 89999999999766543
Q ss_pred ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCC--HHHHHHHHHcCCCCcccccCCChHHHHH
Q 004672 181 HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTH--PAQIYKKVISGKKPEALFKVEDPEVRQF 257 (738)
Q Consensus 181 ~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~--~~qi~k~i~~g~~p~~l~~~~spel~~l 257 (738)
......|+..|+|||++.. .++.++|+||||+++|+|++|..||..... ...+...... .....+...++.+.++
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 232 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDA 232 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHH
Confidence 2233458899999998864 478999999999999999999999986543 4444333332 2223344567899999
Q ss_pred HHHHHh-CcCCCCCH--HHHhcCccc
Q 004672 258 IEKCLA-TVSSRLSA--RELLTDPFL 280 (738)
Q Consensus 258 I~kcL~-dP~~RpSa--~ELL~Hpf~ 280 (738)
|.+||. +|.+||++ .|+++||||
T Consensus 233 i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 233 INKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHccCChhHcCCccHHHHhcCCCC
Confidence 999999 99999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=331.15 Aligned_cols=254 Identities=31% Similarity=0.487 Sum_probs=212.9
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeE
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
...|.+++.||.|++|+||+|.+..+|..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 91 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK----QPKKELIINEILVMKELKNPNIVNFLDSFLV--GDEL 91 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc----CchHHHHHHHHHHHHhcCCCceeeeeeeEec--CceE
Confidence 456999999999999999999999999999999987532 2335678999999999999999999998755 6789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 100 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
++|+||+.+++|..++.. ..+++..+..++.|++.||.|||+++ ++||||||+||+++. .+.+||+|||++.....
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~-~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGM-DGSVKLTDFGFCAQITP 167 (296)
T ss_pred EEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECC-CCCEEEccCccchhccc
Confidence 999999999999998765 46899999999999999999999998 999999999999985 48999999999876543
Q ss_pred cc--cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004672 180 SH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 256 (738)
Q Consensus 180 ~~--~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~ 256 (738)
.. .....|++.|+|||.+.+ .++.++||||||+++|+|++|..||........+......+..+...+...++.+++
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (296)
T cd06655 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRD 247 (296)
T ss_pred ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHH
Confidence 32 223458999999998864 488999999999999999999999987544444333222232232334556889999
Q ss_pred HHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 257 FIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 257 lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
||.+||. +|.+||++.+++.||||+..
T Consensus 248 li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 248 FLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred HHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 9999999 99999999999999999743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=327.00 Aligned_cols=258 Identities=25% Similarity=0.434 Sum_probs=214.3
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|...++||.|++|.||+|.+..++..||+|.+.... ......++.+|+++|+.++||||++++++|.+.....++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC---chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence 46889999999999999999999999999999887542 234567899999999999999999999998777677899
Q ss_pred EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 101 FVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k----~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.+ +.++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~-~~~~l~dfg~~~~ 154 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRK-GQVKLCDFGVSGE 154 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecC-CeEEEeecccccc
Confidence 99999999999988654 345899999999999999999999998 9999999999999854 7899999999876
Q ss_pred hhccccccccCCCCCCCccccc-cccCcccccccchhhhhhhhhcCCCCCCC----CCHHHHHHHHHcCCCCcc---cc-
Q 004672 177 LRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSEC----THPAQIYKKVISGKKPEA---LF- 247 (738)
Q Consensus 177 l~~~~~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~~----~~~~qi~k~i~~g~~p~~---l~- 247 (738)
..........++..|+|||.+. ..++.++||||||+++|+|++|..||... ....++...+.....+.. ..
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd06621 155 LVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234 (287)
T ss_pred ccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCC
Confidence 5544434456889999999886 45899999999999999999999999764 233444444444322211 11
Q ss_pred -cCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 248 -KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 248 -~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
...++.+++||.+||. +|.+|||+.|+++||||+...
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 1235789999999999 999999999999999996543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=333.63 Aligned_cols=255 Identities=31% Similarity=0.466 Sum_probs=213.2
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeE
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
..+|.++++||.|++|+||+|.+..+|..||+|.+.... ....+.+.+|+.+++.++||||++++++|.. ...+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~ 91 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLV--GDEL 91 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc----cchHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEE
Confidence 368999999999999999999999999999999987543 2334678999999999999999999998855 6789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 100 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
++||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.++|+|||++.....
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~-~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGM-DGSVKLTDFGFCAQITP 167 (297)
T ss_pred EEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECC-CCCEEECcCccceEccC
Confidence 999999999999999765 56899999999999999999999998 999999999999984 48999999999876543
Q ss_pred cc--cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004672 180 SH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 256 (738)
Q Consensus 180 ~~--~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~ 256 (738)
.. .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||........++.....+..+...+...++.+++
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T cd06656 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRD 247 (297)
T ss_pred CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHH
Confidence 22 223458999999998864 488999999999999999999999976444343333222233333344556788999
Q ss_pred HHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 257 FIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 257 lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
||.+||. +|.+||++.++|+||||+...
T Consensus 248 li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 248 FLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred HHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 9999999 999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.68 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=208.1
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
+|.+.+.||.|++|.||+|.+..+|..||+|++..... .....+.+.+|+.+++.++||||+++++++.. ...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~ 76 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL--EGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVL 76 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc--cchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEE
Confidence 58899999999999999999999999999999886542 23445678999999999999999999998865 678999
Q ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 102 VTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
||||+ +++|.+++... +.+++..++.++.||+.||.|||+++ ++|+||||+||+++.+ +.++|+|||++......
T Consensus 77 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~-~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 77 VMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISAD-GVLKIADFGLARLFSEE 152 (286)
T ss_pred Eeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCC-CcEEEeeeeecccccCC
Confidence 99999 99999998653 56999999999999999999999998 9999999999999864 79999999999876543
Q ss_pred c---cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC------------
Q 004672 181 H---AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP------------ 243 (738)
Q Consensus 181 ~---~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p------------ 243 (738)
. .....|++.|+|||++.+ .++.++||||||+++|+|+||.+||....+...+...+..-..|
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 2 234468999999998753 37899999999999999999988887654443332222111000
Q ss_pred ---------------cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccC
Q 004672 244 ---------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 281 (738)
Q Consensus 244 ---------------~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~ 281 (738)
.......+.++.++|.+||. +|.+|||++++|.||||.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 01122446889999999999 999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=328.72 Aligned_cols=257 Identities=20% Similarity=0.301 Sum_probs=210.7
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
.|+..+.||.|+||+||+|.+..+|..||+|.+..... ........+.+|+.+|+.++|+||+.+++.+.. +..+++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~l 77 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI-KKRKGESMALNEKQILEKVNSQFVVNLAYAYET--KDALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh-hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CCEEEE
Confidence 37788999999999999999999999999999875432 222334567889999999999999999987754 678999
Q ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 102 VTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
||||+.+++|..++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.+ +.+||+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~-~~~kl~Dfg~~~~~~~ 154 (285)
T cd05632 78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDY-GHIRISDLGLAVKIPE 154 (285)
T ss_pred EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCC-CCEEEecCCcceecCC
Confidence 99999999999887653 36999999999999999999999998 9999999999999855 7999999999865432
Q ss_pred c-ccccccCCCCCCCccccc-cccCcccccccchhhhhhhhhcCCCCCCCCCHH---HHHHHHHcCCCCcccccCCChHH
Q 004672 180 S-HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPA---QIYKKVISGKKPEALFKVEDPEV 254 (738)
Q Consensus 180 ~-~~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~---qi~k~i~~g~~p~~l~~~~spel 254 (738)
. ......|++.|+|||++. ..++.++||||||+++|+|++|..||....... .+...+..+. ..+....++++
T Consensus 155 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 232 (285)
T cd05632 155 GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE--EVYSAKFSEEA 232 (285)
T ss_pred CCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc--cccCccCCHHH
Confidence 2 223446899999999886 458999999999999999999999998643322 2222222222 22344567899
Q ss_pred HHHHHHHHh-CcCCCCC-----HHHHhcCcccCCCCCc
Q 004672 255 RQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDDYD 286 (738)
Q Consensus 255 ~~lI~kcL~-dP~~RpS-----a~ELL~Hpf~~~~~~~ 286 (738)
.+|+.+||+ +|.+||+ +.+++.|+||+..+.+
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 233 KSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred HHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 999999999 9999999 8999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=329.84 Aligned_cols=260 Identities=22% Similarity=0.350 Sum_probs=217.2
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.+++.||.|+||.||+|.+..++..||+|.+.... .......+.+.+|+.+++.++||||+++++.+.. +..++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~ 77 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQN-LILRNQIQQVFVERDILTFAENPFVVSMFCSFET--KRHLC 77 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhh-hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--CCEEE
Confidence 47899999999999999999999999999999887543 2223456788899999999999999999998744 67899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
+||||++|++|.+++...+.+++..+..++.|++.||.|||+++ ++||||||+||+++. .|.+||+|||++......
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~-~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 78 MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITS-MGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECC-CCCEEEeeCCCccccCcC
Confidence 99999999999999988888999999999999999999999998 999999999999984 489999999988632100
Q ss_pred -----------------ccccccCCCCCCCccccc-cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCC
Q 004672 181 -----------------HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK 242 (738)
Q Consensus 181 -----------------~~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~ 242 (738)
......|++.|+|||.+. ..++.++||||||+++|+|++|..||.+. ...++...+..+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~-~~~~~~~~~~~~~~ 233 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-TPEELFGQVISDDI 233 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhccc
Confidence 011234788999999875 45899999999999999999999999863 55666666665543
Q ss_pred Cc-ccccCCChHHHHHHHHHHh-CcCCCCC---HHHHhcCcccCCCCCch
Q 004672 243 PE-ALFKVEDPEVRQFIEKCLA-TVSSRLS---ARELLTDPFLQIDDYDS 287 (738)
Q Consensus 243 p~-~l~~~~spel~~lI~kcL~-dP~~RpS---a~ELL~Hpf~~~~~~~~ 287 (738)
+. ......+++++++|.+||+ +|.+||+ +.++|.||||...++..
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 234 EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 21 1122568889999999999 9999998 89999999998766553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=321.01 Aligned_cols=249 Identities=31% Similarity=0.469 Sum_probs=208.8
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeE
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
-++|.+.++||.|++|.||+|.+..++..||+|.++... ..+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~ 73 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQEIIKEISILKQCDSPYIVKYYGSYFK--NTDL 73 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCcE
Confidence 468999999999999999999999999999999887432 26789999999999999999999998865 5789
Q ss_pred EEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh
Q 004672 100 NFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k-~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~ 178 (738)
++++||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.+ +.+||+|||++....
T Consensus 74 ~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~-~~~~l~dfg~~~~~~ 150 (256)
T cd06612 74 WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEE-GQAKLADFGVSGQLT 150 (256)
T ss_pred EEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCC-CcEEEcccccchhcc
Confidence 999999999999999876 456899999999999999999999998 9999999999999854 799999999998765
Q ss_pred ccc--cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC-cccccCCChHH
Q 004672 179 KSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP-EALFKVEDPEV 254 (738)
Q Consensus 179 ~~~--~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p-~~l~~~~spel 254 (738)
... .....|+..|+|||++.+ .++.++||||||+++|+|++|..||......... ..+.....+ .......+.++
T Consensus 151 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 229 (256)
T cd06612 151 DTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-FMIPNKPPPTLSDPEKWSPEF 229 (256)
T ss_pred cCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-hhhccCCCCCCCchhhcCHHH
Confidence 433 223458899999998864 5889999999999999999999999864433322 222221111 11223457889
Q ss_pred HHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 255 RQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 255 ~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
.+||.+||+ +|.+|||+.++|.||||
T Consensus 230 ~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 230 NDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 999999999 99999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=326.42 Aligned_cols=253 Identities=26% Similarity=0.419 Sum_probs=207.1
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEec---
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDT--- 94 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~--- 94 (738)
..++|.+++.||.|+||+||+|.++.+|..||+|.++... .....+..|+.+++.+ +||||+++++++...
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 4578999999999999999999999999999999865321 2235678899999999 799999999987542
Q ss_pred CCCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEec
Q 004672 95 ANRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 170 (738)
Q Consensus 95 ~~~~l~LV~Ey~~gGSL~~~l~k----~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~D 170 (738)
.+..+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+||+++.+ +.+||+|
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~-~~~kl~d 167 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTE-GGVKLVD 167 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCC-CCEEEcc
Confidence 34679999999999999998753 346889999999999999999999998 9999999999999855 7899999
Q ss_pred cchhHHhhccc--cccccCCCCCCCccccc------cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCC
Q 004672 171 LGLAAILRKSH--AARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK 242 (738)
Q Consensus 171 FGlA~~l~~~~--~~~~vGTp~YmAPEvl~------~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~ 242 (738)
||++..+.... .....|++.|+|||++. ..++.++|||||||++|+|++|+.||........+. .+..+..
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~-~~~~~~~ 246 (286)
T cd06638 168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF-KIPRNPP 246 (286)
T ss_pred CCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh-hccccCC
Confidence 99987654321 23346999999999874 347889999999999999999999998754444433 2222222
Q ss_pred C-cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 243 P-EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 243 p-~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
+ .......+..++++|.+||+ +|.+|||+.|+|+|+||
T Consensus 247 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 247 PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 2 22234457789999999999 99999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=332.14 Aligned_cols=247 Identities=26% Similarity=0.350 Sum_probs=192.5
Q ss_pred EEEEEcccCCeEEEEEEEcC--CCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEE
Q 004672 25 DTMKFLVKELQRHYRAFDEY--EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 102 (738)
Q Consensus 25 il~kLG~GafgtVYkA~d~~--tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV 102 (738)
...+||+|+||+||+|.+.. ++..||+|.++... ....+.+|+.+|+.++||||++++++|....+..+++|
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCC------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence 34689999999999999653 67899999876432 12357789999999999999999999887777889999
Q ss_pred EecCCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEe---CCCCcEEEec
Q 004672 103 TEMFTSGTLRQYRLKH---------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN---GNQGEVKIGD 170 (738)
Q Consensus 103 ~Ey~~gGSL~~~l~k~---------~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~---~~~g~VKL~D 170 (738)
|||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+. ...+.+||+|
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 79 FDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred EeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 99985 6888876532 24889999999999999999999998 99999999999994 2347899999
Q ss_pred cchhHHhhccc-----cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCC---------HHHHH
Q 004672 171 LGLAAILRKSH-----AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTH---------PAQIY 234 (738)
Q Consensus 171 FGlA~~l~~~~-----~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~---------~~qi~ 234 (738)
||++....... .....||+.|+|||++.+ .++.++|||||||++|+|+||..||..... ..++.
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 235 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLD 235 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHH
Confidence 99997664322 223468999999998864 488999999999999999999999964221 11111
Q ss_pred HHHHc-CCC--------------C--------------------cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCc
Q 004672 235 KKVIS-GKK--------------P--------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDP 278 (738)
Q Consensus 235 k~i~~-g~~--------------p--------------------~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hp 278 (738)
+.+.. |.. + .......+..++++|.+||. ||.+|||+.|+|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp 315 (317)
T cd07867 236 RIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDP 315 (317)
T ss_pred HHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCC
Confidence 11100 000 0 00011235678899999999 999999999999999
Q ss_pred cc
Q 004672 279 FL 280 (738)
Q Consensus 279 f~ 280 (738)
||
T Consensus 316 ~f 317 (317)
T cd07867 316 YF 317 (317)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=328.28 Aligned_cols=250 Identities=23% Similarity=0.319 Sum_probs=200.6
Q ss_pred EEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHH---HHhCCCCCcceeeEEEEecCCCeEEEEEe
Q 004672 28 KFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHL---LKTLKHRNIMKFYTSWVDTANRNINFVTE 104 (738)
Q Consensus 28 kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~i---Lk~L~HpNIVkl~~~fv~~~~~~l~LV~E 104 (738)
.||+|+||.||+|.+..+|..||+|.+........ ........|..+ +...+||||+.+++++.. .+.+++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc-hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEe
Confidence 48999999999999999999999998875432211 222233444443 344589999999998754 568999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcccccc
Q 004672 105 MFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR 184 (738)
Q Consensus 105 y~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~~~~ 184 (738)
|+++|+|.+++..++.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.++|+|||++..........
T Consensus 78 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~ 154 (279)
T cd05633 78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDFSKKKPHA 154 (279)
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCC-CCEEEccCCcceeccccCccC
Confidence 9999999999988888999999999999999999999998 9999999999999855 799999999987654443444
Q ss_pred ccCCCCCCCccccc--cccCcccccccchhhhhhhhhcCCCCCCCCC--HHHHHHHHHcCCCCcccccCCChHHHHHHHH
Q 004672 185 CVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPYSECTH--PAQIYKKVISGKKPEALFKVEDPEVRQFIEK 260 (738)
Q Consensus 185 ~vGTp~YmAPEvl~--~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~--~~qi~k~i~~g~~p~~l~~~~spel~~lI~k 260 (738)
..|++.|+|||.+. ..++.++||||||+++|+|++|..||..... ...+.... ...+..++...+++++++|.+
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~ 232 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTVNVELPDSFSPELKSLLEG 232 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh--hcCCcCCccccCHHHHHHHHH
Confidence 56999999999885 3488999999999999999999999975332 22222221 122333455678999999999
Q ss_pred HHh-CcCCCC-----CHHHHhcCcccCCCCC
Q 004672 261 CLA-TVSSRL-----SARELLTDPFLQIDDY 285 (738)
Q Consensus 261 cL~-dP~~Rp-----Sa~ELL~Hpf~~~~~~ 285 (738)
||. +|.+|+ |+.++++||||+.-++
T Consensus 233 ~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 233 LLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred HhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence 999 999999 6999999999987553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=324.94 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=208.3
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecC---
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTA--- 95 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~--- 95 (738)
.++|.+.+.||.|+||.||+|.++.+|..+|+|.+.... ...+.+.+|+.+++++ +||||++++++|....
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 578999999999999999999999999999999876321 2345678899999999 8999999999886532
Q ss_pred CCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEecc
Q 004672 96 NRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 171 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~l~k----~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DF 171 (738)
...+++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.+ +.+||+||
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~-~~~kl~df 172 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTE-GGVKLVDF 172 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCC-CCEEEeec
Confidence 3578999999999999998753 357899999999999999999999998 9999999999999854 78999999
Q ss_pred chhHHhhccc--cccccCCCCCCCcccccc------ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 004672 172 GLAAILRKSH--AARCVGTPEFMAPEVYEE------EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 243 (738)
Q Consensus 172 GlA~~l~~~~--~~~~vGTp~YmAPEvl~~------~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p 243 (738)
|++....... .....|++.|+|||++.. .++.++||||||+++|+|++|+.||........+ ..+..+..+
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~-~~~~~~~~~ 251 (291)
T cd06639 173 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL-FKIPRNPPP 251 (291)
T ss_pred ccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH-HHHhcCCCC
Confidence 9987654322 223458999999998753 2688999999999999999999999875443333 334333332
Q ss_pred c-ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccC
Q 004672 244 E-ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 281 (738)
Q Consensus 244 ~-~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~ 281 (738)
. .........++++|.+||+ +|.+||++.++|.||||+
T Consensus 252 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 252 TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 1 1123456789999999999 999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=330.91 Aligned_cols=259 Identities=24% Similarity=0.268 Sum_probs=210.2
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCe
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 98 (738)
..++|.+.+.||.|+||.||+|.+..+|..||+|.++..... ......+.+|+.+|++++|+||+++++++.+.....
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER--DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS 82 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC--CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence 578999999999999999999999999999999998865321 122234667999999999999999999987765678
Q ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 99 INFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+.+ ++||||||+||+++.+ +.+||+|||++...
T Consensus 83 ~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~kL~dfg~~~~~ 158 (309)
T cd07845 83 IFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDK-GCLKIADFGLARTY 158 (309)
T ss_pred EEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEECccceeeec
Confidence 999999996 5888887763 66999999999999999999999999 9999999999999854 79999999999766
Q ss_pred hcc--ccccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcC--CCCcc------
Q 004672 178 RKS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG--KKPEA------ 245 (738)
Q Consensus 178 ~~~--~~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g--~~p~~------ 245 (738)
... ......+++.|+|||++.+ .++.++||||||+++|+|++|..||..... ...+..+... ..+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE-IEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCChhhchhhh
Confidence 532 1222346888999998854 488999999999999999999999987544 3333333321 00000
Q ss_pred --------------------cccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 246 --------------------LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 246 --------------------l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
.....++++.+||.+||. +|.+|||+.++|.||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 012247889999999999 999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=326.06 Aligned_cols=251 Identities=27% Similarity=0.396 Sum_probs=206.1
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
+|++++.||.|++|.||+|.++.+|..||||+++... ......+.+.+|+.++++++||||+++++++.+ ...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 76 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYL 76 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccc--cccccchHHHHHHHHHHhcCCCCCcchhhhccc--CCcEEE
Confidence 4889999999999999999999999999999887543 222344578899999999999999999998754 678999
Q ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 102 VTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
||||+. ++|..++... ..+++..++.++.||+.||.|||+++ ++||||+|+||+++.+ +.+||+|||++.....
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~-~~~~l~dfg~~~~~~~ 152 (284)
T cd07860 77 VFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFGV 152 (284)
T ss_pred Eeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEEeeccchhhccc
Confidence 999995 6899887653 46899999999999999999999998 9999999999999855 7999999999876543
Q ss_pred cc--cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCc-----------
Q 004672 180 SH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE----------- 244 (738)
Q Consensus 180 ~~--~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~----------- 244 (738)
.. .....+++.|+|||++.+ .++.++||||||+++|+|+||+.||........+.+.+.....+.
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 153 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred CccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence 22 223357889999998864 268899999999999999999999987555444444332211110
Q ss_pred ---------------ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 245 ---------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 245 ---------------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
......+++++++|.+||. +|.+|||+.++|+||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 1123457889999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=317.54 Aligned_cols=250 Identities=26% Similarity=0.473 Sum_probs=214.1
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
+|+++++||.|+||+||++.+..+|..||+|.+..... .......+.+|+.++++++||||+++++++.. ....++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 76 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMKHPNIVQYQESFEE--NGNLYI 76 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--CCeEEE
Confidence 58899999999999999999999999999999886432 33455688999999999999999999998744 678999
Q ss_pred EEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 102 VTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~~--~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
||||+.+++|.+++.... .+++..+..|+.|++.||.|||+++ ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~-~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 77 VMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNS 153 (256)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC-CCEEEeeccceeecCc
Confidence 999999999999987643 5899999999999999999999998 9999999999999854 7999999999976543
Q ss_pred cc--cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004672 180 SH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 256 (738)
Q Consensus 180 ~~--~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~ 256 (738)
.. .....|++.|+|||++.+ .++.++|+||||+++|+|++|..||.. .+...+...+..+..+. .....++++.+
T Consensus 154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (256)
T cd08218 154 TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA-GNMKNLVLKIIRGSYPP-VSSHYSYDLRN 231 (256)
T ss_pred chhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC-CCHHHHHHHHhcCCCCC-CcccCCHHHHH
Confidence 22 223458899999998864 578899999999999999999999986 45556666666666553 23456889999
Q ss_pred HHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 257 FIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 257 lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
+|.+||+ +|.+||++.++|.||||
T Consensus 232 li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 232 LVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHhhCChhhCcCHHHHhhCcCC
Confidence 9999999 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=353.88 Aligned_cols=245 Identities=28% Similarity=0.388 Sum_probs=207.5
Q ss_pred ccCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEec
Q 004672 15 LKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 94 (738)
Q Consensus 15 ~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~ 94 (738)
+=+|+++.+..++-||+|+-|.||+|. ..++.||||+|+ +.-..+|+-|++|+||||+.|.++| .
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Gr--l~netVAVKKV~-----------elkETdIKHLRkLkH~NII~FkGVC--t 182 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGR--LHNETVAVKKVR-----------ELKETDIKHLRKLKHPNIITFKGVC--T 182 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeee--ccCceehhHHHh-----------hhhhhhHHHHHhccCcceeeEeeee--c
Confidence 446888999999999999999999995 678999999876 2234588999999999999999966 5
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 95 ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 95 ~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
....++||||||..|-|...++..+.++...+..|..+|+.|+.|||.+. |||||||.-||||..+ ..|||+|||-+
T Consensus 183 qsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~-d~VKIsDFGTS 259 (904)
T KOG4721|consen 183 QSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYD-DVVKISDFGTS 259 (904)
T ss_pred CCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeecc-ceEEeccccch
Confidence 57899999999999999999999999999999999999999999999999 9999999999999876 48999999999
Q ss_pred HHhhcc-ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCCh
Q 004672 175 AILRKS-HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 252 (738)
Q Consensus 175 ~~l~~~-~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~sp 252 (738)
+.+... ...++.||..|||||++.. ..++++|||||||+|||||||+.||.+....+.| --|-........+...+.
T Consensus 260 ~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII-wGVGsNsL~LpvPstcP~ 338 (904)
T KOG4721|consen 260 KELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII-WGVGSNSLHLPVPSTCPD 338 (904)
T ss_pred HhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE-EeccCCcccccCcccCch
Confidence 877654 3456789999999999975 5899999999999999999999999864332222 111111122223445567
Q ss_pred HHHHHHHHHHh-CcCCCCCHHHHhcCc
Q 004672 253 EVRQFIEKCLA-TVSSRLSARELLTDP 278 (738)
Q Consensus 253 el~~lI~kcL~-dP~~RpSa~ELL~Hp 278 (738)
.++-||+.||+ +|..|||+.++|.|-
T Consensus 339 GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 339 GFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred HHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 89999999999 999999999999984
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=316.65 Aligned_cols=251 Identities=32% Similarity=0.533 Sum_probs=213.4
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
+|.+.+.||.|++|.||+|.+..++..||+|.++.... .....+.+..|+.+++.++|+||+++++++.. ...+++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l 76 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN--DPKTIKEIADEMKVLELLKHPNLVKYYGVEVH--REKVYI 76 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc--chHHHHHHHHHHHHHHhCCCCChhheeeeEec--CCEEEE
Confidence 48899999999999999999999999999999886542 25677899999999999999999999997643 678999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccc
Q 004672 102 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 181 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~ 181 (738)
|+||+++++|.+++.....+++..+..++.|++.||.|||+++ |+|+||+|+||+++. .+.+||+|||++.......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~-~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 77 FMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDH-NGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred EEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECC-CCCEEEcccccccccCCCC
Confidence 9999999999999988878999999999999999999999998 999999999999985 5899999999997764322
Q ss_pred c------ccccCCCCCCCcccccc-c---cCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCccccc--C
Q 004672 182 A------ARCVGTPEFMAPEVYEE-E---YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFK--V 249 (738)
Q Consensus 182 ~------~~~vGTp~YmAPEvl~~-~---ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~--~ 249 (738)
. ....+++.|+|||++.+ . ++.++||||||+++|+|++|..||....+...+...+..+..+. ++. .
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~ 232 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPP-IPDSLQ 232 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCC-CCcccc
Confidence 1 12357899999998864 2 78899999999999999999999976555555444444443332 222 3
Q ss_pred CChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 250 EDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 250 ~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
.++.+.+||.+||+ +|.+||++.+++.|||+
T Consensus 233 ~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 233 LSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 48899999999999 89999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=319.50 Aligned_cols=252 Identities=28% Similarity=0.433 Sum_probs=212.2
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeE
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
.++|.+.+.||.|+||.||+|.+..+|..||+|.++.... ........+.+|+.+|+.++||||+++++++.. .+.+
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 77 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--DNEL 77 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--CCeE
Confidence 3689999999999999999999999999999998875442 345566788999999999999999999998865 5688
Q ss_pred EEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 100 NFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k----~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
++|+||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ ++|+||||+||+++.+ +.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~-~~~~l~d~g~~~ 154 (267)
T cd08228 78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCC-CCEEECccccce
Confidence 999999999999988753 245899999999999999999999998 9999999999999854 799999999987
Q ss_pred Hhhccc--cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCC-CCHHHHHHHHHcCCCCcccccCCC
Q 004672 176 ILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC-THPAQIYKKVISGKKPEALFKVED 251 (738)
Q Consensus 176 ~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~-~~~~qi~k~i~~g~~p~~l~~~~s 251 (738)
...... .....|++.|+|||.+.+ .++.++||||||+++|+|++|..||... .+...+...+..+..|.......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08228 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYS 234 (267)
T ss_pred eccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcC
Confidence 654322 123458899999998864 5888999999999999999999999643 344556666666555554445667
Q ss_pred hHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 252 PEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 252 pel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
..++++|.+||. +|.+||++.++++.
T Consensus 235 ~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 235 EKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 889999999999 99999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.53 Aligned_cols=255 Identities=24% Similarity=0.389 Sum_probs=207.2
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCC-CCCcceeeEEEEecCCC
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANR 97 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~ 97 (738)
..++|.....||.|+||+||++.+..+|..||+|++.... .......+.+|+.++.++. ||||+++++++.. ..
T Consensus 2 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~ 76 (288)
T cd06616 2 TAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV---DEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EG 76 (288)
T ss_pred cHHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhcc---ChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CC
Confidence 3467778899999999999999999999999999987543 2245668899999999995 9999999998755 56
Q ss_pred eEEEEEecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeccCCcccEEEeCCCCcEEEecc
Q 004672 98 NINFVTEMFTSGTLRQYRL-----KHRRVNIRAVKHWCRQILSGLLYLHSR-DPPVIHRDLKCDNIFVNGNQGEVKIGDL 171 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~-----k~~~lse~~i~~i~~QIl~aL~yLHs~-gp~IIHRDLKP~NILl~~~~g~VKL~DF 171 (738)
..+++|||+. ++|.++.. ....+++..+..++.|++.||+|||+. + |+||||||+||+++.+ +.+||+||
T Consensus 77 ~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~-~~~kl~df 152 (288)
T cd06616 77 DCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRN-GNIKLCDF 152 (288)
T ss_pred cEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccC-CcEEEeec
Confidence 7889999985 56655422 236799999999999999999999975 6 9999999999999854 79999999
Q ss_pred chhHHhhcccc-ccccCCCCCCCcccccc----ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCccc
Q 004672 172 GLAAILRKSHA-ARCVGTPEFMAPEVYEE----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL 246 (738)
Q Consensus 172 GlA~~l~~~~~-~~~vGTp~YmAPEvl~~----~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l 246 (738)
|++..+..... ....|++.|+|||++.. .++.++||||||+++|+|++|+.||.......+....+..+..|...
T Consensus 153 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd06616 153 GISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILS 232 (288)
T ss_pred chhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCC
Confidence 99976654332 33458999999999864 48899999999999999999999998655433333444444443322
Q ss_pred c---cCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 247 F---KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 247 ~---~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
. ...++++.+||.+||+ +|.+|||+.++++||||+.
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 2 2368899999999999 9999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=343.15 Aligned_cols=253 Identities=22% Similarity=0.280 Sum_probs=202.5
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEc--CCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDE--YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~--~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 95 (738)
+...+|.++++||.|+||+||+|... .++..||+|.+... ....+|+.+|+.|+||||++++++|..
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------~~~~~E~~il~~l~h~~iv~~~~~~~~-- 157 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------KTPGREIDILKTISHRAIINLIHAYRW-- 157 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---------ccHHHHHHHHHhcCCCCccceeeeEee--
Confidence 34457999999999999999999754 45788999976532 135679999999999999999998754
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
...+++|||++ +++|.+++.....+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.
T Consensus 158 ~~~~~lv~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~-~~~~l~DfG~a~ 233 (392)
T PHA03207 158 KSTVCMVMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEP-ENAVLGDFGAAC 233 (392)
T ss_pred CCEEEEEehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCC-CCEEEccCcccc
Confidence 56899999999 4789999877788999999999999999999999998 9999999999999854 899999999997
Q ss_pred Hhhccc----cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCH--HHHHHHHHc--CCCCc--
Q 004672 176 ILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHP--AQIYKKVIS--GKKPE-- 244 (738)
Q Consensus 176 ~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~--~qi~k~i~~--g~~p~-- 244 (738)
.+.... .....||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.... ...+..+.. +..|.
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence 654322 123469999999999874 5899999999999999999999999654321 111111111 00000
Q ss_pred -----------------------cc-----ccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCCC
Q 004672 245 -----------------------AL-----FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 285 (738)
Q Consensus 245 -----------------------~l-----~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~~ 285 (738)
.+ ....+.++++||.+||. +|.+|||+.|+|.||||+..+.
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 00 01345688999999999 9999999999999999976543
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=339.16 Aligned_cols=248 Identities=27% Similarity=0.322 Sum_probs=195.9
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCe
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 98 (738)
...+|.+++.||.|+||+||+|.+..++..||+|..... ....|+.+|+.++||||++++++|.. ...
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 131 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVS--GAI 131 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEe--CCe
Confidence 345799999999999999999999999999999964321 23569999999999999999998865 568
Q ss_pred EEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 99 INFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k-~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
.++||||+ .++|.+++.. ...+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++...
T Consensus 132 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~ 207 (357)
T PHA03209 132 TCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDV-DQVCIGDLGAAQFP 207 (357)
T ss_pred eEEEEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEEecCcccccc
Confidence 89999999 4688888765 467999999999999999999999998 9999999999999855 79999999999754
Q ss_pred hcc-ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCC----------HHHHHHHHHc-CCCCc
Q 004672 178 RKS-HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTH----------PAQIYKKVIS-GKKPE 244 (738)
Q Consensus 178 ~~~-~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~----------~~qi~k~i~~-g~~p~ 244 (738)
... ......||+.|+|||++.+ .|+.++|||||||++|+|+++..|+..... ...+.+.+.. +..|.
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 287 (357)
T PHA03209 208 VVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287 (357)
T ss_pred ccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence 322 2234469999999999864 599999999999999999986555422111 1112221111 11121
Q ss_pred ccc------------------------------cCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 245 ALF------------------------------KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 245 ~l~------------------------------~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
.+. ...+.++.+||.+||+ +|.+|||+.|+|+||||+.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 111 1235677889999999 9999999999999999963
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=323.74 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=202.0
Q ss_pred EEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHH---HHHHHhCCCCCcceeeEEEEecCCCeEEEEEe
Q 004672 28 KFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCE---IHLLKTLKHRNIMKFYTSWVDTANRNINFVTE 104 (738)
Q Consensus 28 kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~E---i~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~E 104 (738)
.||+|+||.||+|.+..+|+.||+|.+........ ........| +.+++...||||++++++|.. ...+++|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccc-hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEe
Confidence 37999999999999999999999999875432211 111223333 344555689999999987754 578999999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcccccc
Q 004672 105 MFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR 184 (738)
Q Consensus 105 y~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~~~~ 184 (738)
|+.||+|.+++.+.+.+++..++.|+.|++.||.|||+.+ |+||||||+||+++.+ +.+||+|||++..+.......
T Consensus 78 ~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~-~~~kl~dfg~~~~~~~~~~~~ 154 (278)
T cd05606 78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDFSKKKPHA 154 (278)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCC-CCEEEccCcCccccCccCCcC
Confidence 9999999999988888999999999999999999999998 9999999999999855 799999999987665444445
Q ss_pred ccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCC--CHHHHHHHHHcCCCCcccccCCChHHHHHHHH
Q 004672 185 CVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECT--HPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 260 (738)
Q Consensus 185 ~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~--~~~qi~k~i~~g~~p~~l~~~~spel~~lI~k 260 (738)
..|++.|+|||++.+ .++.++||||+|+++|+|++|..||.... ....+...... .+..++...++++.++|.+
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~ 232 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPELRSLLEG 232 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc--cCCCCCCcCCHHHHHHHHH
Confidence 579999999999863 48999999999999999999999997642 22233222222 2223445568999999999
Q ss_pred HHh-CcCCCC-----CHHHHhcCcccCCCCC
Q 004672 261 CLA-TVSSRL-----SARELLTDPFLQIDDY 285 (738)
Q Consensus 261 cL~-dP~~Rp-----Sa~ELL~Hpf~~~~~~ 285 (738)
||. +|.+|| ++.++++||||+...+
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~ 263 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW 263 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHhCccccCCCc
Confidence 999 899999 9999999999986554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=324.06 Aligned_cols=250 Identities=21% Similarity=0.302 Sum_probs=210.8
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCCC-----eEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEE
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEG-----IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWV 92 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG-----~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv 92 (738)
++.++|.+++.||+|+||.||+|.+...+ ..||+|.++.. ......+.+.+|+.+|+.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~---~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~ 78 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN---AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT 78 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC---CCHHHHHHHHHHHHHHHhcCCcccceEEEEEc
Confidence 56678999999999999999999987655 78999987633 24556678999999999999999999999875
Q ss_pred ecCCCeEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCccc
Q 004672 93 DTANRNINFVTEMFTSGTLRQYRLKH----------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156 (738)
Q Consensus 93 ~~~~~~l~LV~Ey~~gGSL~~~l~k~----------------~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~N 156 (738)
. ...++++|||+++|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+|
T Consensus 79 ~--~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~N 154 (283)
T cd05048 79 K--EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARN 154 (283)
T ss_pred C--CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccce
Confidence 4 56789999999999999998775 45788999999999999999999998 9999999999
Q ss_pred EEEeCCCCcEEEeccchhHHhhccc----cccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCH
Q 004672 157 IFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHP 230 (738)
Q Consensus 157 ILl~~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~ 230 (738)
|+++.+ +.+||+|||++....... .....+++.|+|||.+. +.++.++|||||||++|+|++ |..||.+ ...
T Consensus 155 il~~~~-~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~-~~~ 232 (283)
T cd05048 155 CLVGEG-LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG-FSN 232 (283)
T ss_pred EEEcCC-CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC-CCH
Confidence 999854 799999999987543221 22335688999999875 568999999999999999998 9999987 455
Q ss_pred HHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 231 AQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 231 ~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
.++...+..+..+. .+...++++.+++.+||+ +|.+||++.+++++
T Consensus 233 ~~~~~~i~~~~~~~-~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 233 QEVIEMIRSRQLLP-CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHHHHcCCcCC-CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 66777777666543 345678999999999999 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=342.05 Aligned_cols=261 Identities=21% Similarity=0.296 Sum_probs=212.6
Q ss_pred CCCCcccccCcCCCCceEEEEEcccCCeEEEEEEE-----cCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CC
Q 004672 8 NQIPPSLLKLIPLEDMEDTMKFLVKELQRHYRAFD-----EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KH 81 (738)
Q Consensus 8 ~~vp~~l~~~I~~~~y~il~kLG~GafgtVYkA~d-----~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~H 81 (738)
..+|....-.++.++|.+.++||.|+||+||+|.+ ..++..||+|+++... .....+.+.+|+.+|+.+ +|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~il~~l~~H 98 (375)
T cd05104 22 TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNH 98 (375)
T ss_pred CCCCCccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc---CcHHHHHHHHHHHHHHHhcCC
Confidence 34455555567778999999999999999999974 4567799999886432 234557889999999999 89
Q ss_pred CCcceeeEEEEecCCCeEEEEEecCCCCCHHHHHHhcC------------------------------------------
Q 004672 82 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR------------------------------------------ 119 (738)
Q Consensus 82 pNIVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~------------------------------------------ 119 (738)
|||++++++|.. ....++||||+++|+|.+++...+
T Consensus 99 pnIv~l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (375)
T cd05104 99 INIVNLLGACTV--GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVS 176 (375)
T ss_pred cceeeeeeeecc--CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcc
Confidence 999999998755 667899999999999999986532
Q ss_pred ---------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcE
Q 004672 120 ---------------------------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV 166 (738)
Q Consensus 120 ---------------------------------~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~V 166 (738)
.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~-~~~ 253 (375)
T cd05104 177 YVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHG-RIT 253 (375)
T ss_pred cccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECC-CcE
Confidence 3678889999999999999999998 9999999999999854 789
Q ss_pred EEeccchhHHhhccccc----cccCCCCCCCcccccc-ccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcC
Q 004672 167 KIGDLGLAAILRKSHAA----RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISG 240 (738)
Q Consensus 167 KL~DFGlA~~l~~~~~~----~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g 240 (738)
||+|||++......... ...+++.|+|||++.+ .++.++||||||+++|+|++ |..||........+++.+..+
T Consensus 254 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~ 333 (375)
T cd05104 254 KICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG 333 (375)
T ss_pred EEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC
Confidence 99999999765432211 1234567999998864 58999999999999999998 899998766666666666666
Q ss_pred CCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 241 KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 241 ~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
..+. .+...+.++++||.+||+ +|.+|||+.+++..
T Consensus 334 ~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 334 YRML-SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred ccCC-CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 5433 234567899999999999 99999999999854
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=323.59 Aligned_cols=256 Identities=25% Similarity=0.322 Sum_probs=204.6
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecCC---
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTAN--- 96 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~--- 96 (738)
++|.+.+.||.|+||+||+|.+..+|..||+|+++... ........+.+|+.+++.+ +||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 78 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM--DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK 78 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc--cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence 47899999999999999999999999999999877542 1222345688899999999 56999999998755322
Q ss_pred CeEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEecc
Q 004672 97 RNINFVTEMFTSGTLRQYRLKH-----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 171 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k~-----~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DF 171 (738)
..+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+.+.+||+||
T Consensus 79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeec
Confidence 248999999975 898887653 35799999999999999999999998 9999999999999974689999999
Q ss_pred chhHHhhccc--cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC----
Q 004672 172 GLAAILRKSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP---- 243 (738)
Q Consensus 172 GlA~~l~~~~--~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p---- 243 (738)
|++..+.... .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||........+.+....-..|
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 9987543321 223357889999998753 47899999999999999999999998765555443322110000
Q ss_pred ---------------------cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccC
Q 004672 244 ---------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 281 (738)
Q Consensus 244 ---------------------~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~ 281 (738)
.......++++.+||.+||. +|.+||++.|+|.||||+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 01113467889999999999 999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=318.43 Aligned_cols=249 Identities=22% Similarity=0.375 Sum_probs=204.1
Q ss_pred EEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHH-HHhCCCCCcceeeEEEEecCCCeEEEEEec
Q 004672 27 MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHL-LKTLKHRNIMKFYTSWVDTANRNINFVTEM 105 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~i-Lk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey 105 (738)
+.||.|++|.||+|.+..+|..||+|.++...... ......+..|..+ ...++||||++++++|.. +..+++||||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA-KNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH-HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEec
Confidence 56899999999999999999999999887543221 2223344555554 445599999999998754 6789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccccccc
Q 004672 106 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC 185 (738)
Q Consensus 106 ~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~~~~~ 185 (738)
+.+++|.+++...+.+++..+..++.||+.||.|||+.+ ++||||+|.||+++.+ +.+||+|||++..... ....
T Consensus 79 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~--~~~~ 153 (260)
T cd05611 79 LNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQT-GHLKLTDFGLSRNGLE--NKKF 153 (260)
T ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CcEEEeecccceeccc--cccC
Confidence 999999999988888999999999999999999999998 9999999999999854 7999999999865433 2334
Q ss_pred cCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCC--CcccccCCChHHHHHHHHHH
Q 004672 186 VGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCL 262 (738)
Q Consensus 186 vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~--p~~l~~~~spel~~lI~kcL 262 (738)
.|++.|+|||.+.+ .++.++||||||+++|+|+||..||.. .+..+++..+..+.. +.......++++.++|.+||
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 232 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA-ETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHc
Confidence 58999999998865 478999999999999999999999976 445666666555432 33344457899999999999
Q ss_pred h-CcCCCCC---HHHHhcCcccCCCC
Q 004672 263 A-TVSSRLS---ARELLTDPFLQIDD 284 (738)
Q Consensus 263 ~-dP~~RpS---a~ELL~Hpf~~~~~ 284 (738)
+ +|.+||+ +.|+|.||||+.-+
T Consensus 233 ~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 233 CMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred cCCHHHccCCCcHHHHHcChHhhcCC
Confidence 9 9999995 57999999996543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=353.26 Aligned_cols=249 Identities=27% Similarity=0.409 Sum_probs=214.1
Q ss_pred cCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC
Q 004672 16 KLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95 (738)
Q Consensus 16 ~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 95 (738)
=+|+.++..+...||.|+||+||+|++-. .||||.++... -++++++.|++|+.+|++-+|.||+-|.+++..
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~--pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~-- 459 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDD--PTPEQLQAFKNEVAVLKKTRHENILLFMGACMN-- 459 (678)
T ss_pred cccCHHHhhccceeccccccceeeccccc---ceEEEEEecCC--CCHHHHHHHHHHHHHHhhcchhhheeeehhhcC--
Confidence 35677888999999999999999998754 39999999765 356799999999999999999999999998743
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 96 NRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
..+.||+-+|+|.+|..++.-. .+|.+.+.+.|++||+.|+.|||.++ |||||||..|||+..+ ++|||+||||+
T Consensus 460 -p~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~-~kVkIgDFGLa 535 (678)
T KOG0193|consen 460 -PPLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHED-LKVKIGDFGLA 535 (678)
T ss_pred -CceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccC-CcEEEecccce
Confidence 3459999999999999997654 46999999999999999999999999 9999999999999854 89999999999
Q ss_pred HHhhc----cccccccCCCCCCCccccc----cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCC---C
Q 004672 175 AILRK----SHAARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK---P 243 (738)
Q Consensus 175 ~~l~~----~~~~~~vGTp~YmAPEvl~----~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~---p 243 (738)
..... ......-|...|||||++. ..|++.+||||||+|+|||+||..||. ..+.++|+-.+-+|.. +
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~ 614 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDL 614 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccc
Confidence 65432 2233445888999999986 359999999999999999999999999 6899999888888843 3
Q ss_pred cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 244 EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 244 ~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
.......++++++|+..||. ++.+||...+||.
T Consensus 615 s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 615 SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 33344445699999999999 9999999999985
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=324.57 Aligned_cols=256 Identities=26% Similarity=0.355 Sum_probs=209.0
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCC-CHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQ-SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~-s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
+|.+.+.||.|++|.||+|.+..+|..||||+++...... .......+..|+.+++.++|+||+++++++.+ ...++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEE
Confidence 4788999999999999999999999999999998654321 12344567889999999999999999998865 67899
Q ss_pred EEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 101 FVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~-~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
+||||+ +|+|.+++.... .+++..++.++.||+.||.|||+++ |+|+||||+||+++.+ |.+||+|||++.....
T Consensus 79 lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 79 LVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASD-GVLKLADFGLARSFGS 154 (298)
T ss_pred EEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCC-CCEEEccceeeeeccC
Confidence 999999 999999988766 7999999999999999999999998 9999999999999855 8999999999976644
Q ss_pred cc--cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CC-----------
Q 004672 180 SH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK-KP----------- 243 (738)
Q Consensus 180 ~~--~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~-~p----------- 243 (738)
.. .....+++.|+|||.+.+ .++.++||||||+++|+|++|.+||........ +.++.... .|
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ-LGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH-HHHHHHHcCCCchhhhhhcccc
Confidence 32 223357889999998753 478899999999999999999888876444333 23332110 00
Q ss_pred --------------cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 244 --------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 244 --------------~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
.......+..+.+||.+||. +|.+|||+.|+|.||||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 01123346789999999999 999999999999999998644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=319.58 Aligned_cols=254 Identities=29% Similarity=0.431 Sum_probs=209.3
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCC------CHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQ------SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~------s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 95 (738)
+|.+.+.||.|++|.||+|.+..+|..||+|.++...... .....+.+..|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 4788899999999999999999999999999987542111 12234678899999999999999999997744
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
...+++||||+.+++|.+++.+...+++..++.++.||+.||.|||+++ ++||||+|+||+++.+ +.++|+|||++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~-~~~~l~d~~~~~ 156 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDAD-GICKISDFGISK 156 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCC-CeEEEeeccccc
Confidence 6789999999999999999988888999999999999999999999998 9999999999999854 899999999987
Q ss_pred Hhhcc----ccccccCCCCCCCcccccc---ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcC---CCCcc
Q 004672 176 ILRKS----HAARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG---KKPEA 245 (738)
Q Consensus 176 ~l~~~----~~~~~vGTp~YmAPEvl~~---~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g---~~p~~ 245 (738)
..... ......|+..|+|||++.. .++.++|+||||+++|+|++|..||........+.+..... ..+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPD 236 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcc
Confidence 54322 1223358899999998863 37889999999999999999999997644443333322221 12233
Q ss_pred cccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 246 LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 246 l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
.....+.+++++|.+||. +|.+||++.++|+||||
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 237 VSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 334567899999999999 99999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=316.08 Aligned_cols=247 Identities=27% Similarity=0.414 Sum_probs=209.6
Q ss_pred EcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEecCCC
Q 004672 29 FLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTS 108 (738)
Q Consensus 29 LG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey~~g 108 (738)
||.|+||.||++.+..+|..||+|.+.... .......+.+.+|+.+++.++||||+++++.+.. +..++++|||+.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD-MIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchh-hhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCC
Confidence 689999999999999999999999887543 2234567789999999999999999999987643 6789999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc--------
Q 004672 109 GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-------- 180 (738)
Q Consensus 109 GSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~-------- 180 (738)
++|.+++.+.+.+++..+..++.||+.||.|||.++ ++|+||+|+||+++.+ +.++|+|||++......
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCC-CCEEEEecccchhcccCcccccccc
Confidence 999999988888999999999999999999999998 9999999999999855 79999999998765332
Q ss_pred --ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004672 181 --HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 257 (738)
Q Consensus 181 --~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~l 257 (738)
......+++.|+|||.+.. .++.++||||||+++|+|++|..||.. .....++..+..+..+.......++.+.+|
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVEVSDEAIDL 233 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCcCCCccccCCHHHHHH
Confidence 1223458899999998764 488899999999999999999999976 456666666666554322222248899999
Q ss_pred HHHHHh-CcCCCCCH---HHHhcCcccCC
Q 004672 258 IEKCLA-TVSSRLSA---RELLTDPFLQI 282 (738)
Q Consensus 258 I~kcL~-dP~~RpSa---~ELL~Hpf~~~ 282 (738)
|.+||+ +|.+|||+ .++|+||||+.
T Consensus 234 i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 234 ISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred HHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 999999 99999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=327.81 Aligned_cols=254 Identities=29% Similarity=0.493 Sum_probs=211.0
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeE
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
.+.|....+||.|+||.||++.+..++..||+|.+... .....+.+.+|+.+++.++||||+++++.+.. +...
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~ 94 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLV--GDEL 94 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheec--CCeE
Confidence 35566678899999999999999999999999988642 34556779999999999999999999998755 6789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 100 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
++||||+++++|.+++.. +++++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.++|+|||++.....
T Consensus 95 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~-~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 95 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSD-GRIKLSDFGFCAQVSK 170 (292)
T ss_pred EEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCC-CCEEEccCcchhhccc
Confidence 999999999999998754 56899999999999999999999998 9999999999999855 7999999999876543
Q ss_pred cc--cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCc-ccccCCChHHH
Q 004672 180 SH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE-ALFKVEDPEVR 255 (738)
Q Consensus 180 ~~--~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~-~l~~~~spel~ 255 (738)
.. .....|++.|+|||.+.+ .++.++||||||+++|+|++|..||... .....+..+.....+. ......+..++
T Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (292)
T cd06658 171 EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE-PPLQAMRRIRDNLPPRVKDSHKVSSVLR 249 (292)
T ss_pred ccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCccccccccCHHHH
Confidence 22 233458999999998864 5889999999999999999999999863 3444444444332221 11234678899
Q ss_pred HHHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 256 QFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 256 ~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
+||.+||. +|.+|||+.++|.||||+...
T Consensus 250 ~li~~~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 250 GFLDLMLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred HHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence 99999999 999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=320.95 Aligned_cols=253 Identities=24% Similarity=0.355 Sum_probs=209.5
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.+.++||.|++|.||+|.+..++..||+|.++... ......+.+.+|+++|+.++|+||++++++|.. +..++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 76 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE--DDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLY 76 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc--ccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEE
Confidence 46899999999999999999999999999999887543 233456789999999999999999999998865 67899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
+||||+.++.|..+..+...+++..+..++.||+.||.|||.++ ++|+||+|+||+++. .+.+||+|||++......
T Consensus 77 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~-~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 77 LVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSE-SGVLKLCDFGFARALRAR 153 (288)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECC-CCCEEEEeeecccccCCC
Confidence 99999998777777666677999999999999999999999998 999999999999985 489999999998776543
Q ss_pred c---cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc-CCCC-----------
Q 004672 181 H---AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKKP----------- 243 (738)
Q Consensus 181 ~---~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~-g~~p----------- 243 (738)
. .....+++.|+|||++.+ .++.++||||||+++|+|++|..||......+.+...... +..+
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 2 234468899999998863 5788999999999999999999999875554444332110 0000
Q ss_pred --------c---------ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 244 --------E---------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 244 --------~---------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
. ......++++++||.+||. +|.+|||+.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 1122347889999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=319.26 Aligned_cols=249 Identities=17% Similarity=0.235 Sum_probs=206.1
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEc---CCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEec
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDE---YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 94 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~---~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~ 94 (738)
+...+|.+.+.||+|+||.||+|.++ ..+..||+|.++.. .+......+.+|+.+|+.++||||+++++++..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 77 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG---CSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR- 77 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC---CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-
Confidence 45678999999999999999999875 45678999987743 234555678999999999999999999998754
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccch
Q 004672 95 ANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 173 (738)
Q Consensus 95 ~~~~l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGl 173 (738)
+..+++||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+++ ++||||||+|||++.+ +.+|++|||.
T Consensus 78 -~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~-~~~~l~dfg~ 153 (266)
T cd05064 78 -GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSD-LVCKISGFRR 153 (266)
T ss_pred -CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCC-CcEEECCCcc
Confidence 67899999999999999998775 46899999999999999999999998 9999999999999855 7999999998
Q ss_pred hHHhhcccc---ccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCccccc
Q 004672 174 AAILRKSHA---ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFK 248 (738)
Q Consensus 174 A~~l~~~~~---~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~ 248 (738)
+........ ....+++.|+|||++. +.++.++|||||||++|+|++ |..||... ....+.+.+..+..+. .+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~ 231 (266)
T cd05064 154 LQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM-SGQDVIKAVEDGFRLP-APR 231 (266)
T ss_pred cccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCCC-CCC
Confidence 755422211 1123567899999876 568999999999999999775 99999874 4455666666664433 345
Q ss_pred CCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 249 VEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 249 ~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
..+..+.+++.+||+ +|.+||++.+|++
T Consensus 232 ~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 232 NCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 678899999999999 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=348.56 Aligned_cols=248 Identities=25% Similarity=0.307 Sum_probs=200.8
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCe
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 98 (738)
....|.+...||.|+||.||+|.+..++..||+|.... ..+.+|+++|++|+|+|||++++++.. +..
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~~--~~~ 234 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRVV--GGL 234 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEEE--CCE
Confidence 34579999999999999999999999999999996331 235689999999999999999998755 578
Q ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 99 INFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
.++|||++ .++|..++... +.+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++...
T Consensus 235 ~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~-~~vkL~DFGla~~~ 310 (461)
T PHA03211 235 TCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGP-EDICLGDFGAACFA 310 (461)
T ss_pred EEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCC-CCEEEcccCCceec
Confidence 89999999 57888887764 46999999999999999999999998 9999999999999855 78999999999765
Q ss_pred hcccc----ccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCC-------CCHHHHHHHHHcCCCC--
Q 004672 178 RKSHA----ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC-------THPAQIYKKVISGKKP-- 243 (738)
Q Consensus 178 ~~~~~----~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~-------~~~~qi~k~i~~g~~p-- 243 (738)
..... ....||+.|+|||++.+ .++.++|||||||++|||++|..|+... ....++.+.+..+...
T Consensus 311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 43221 23459999999999875 5899999999999999999987654321 1234444444432211
Q ss_pred ---c-------------------------cc--ccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 244 ---E-------------------------AL--FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 244 ---~-------------------------~l--~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
. .+ ....++++++||.+||+ ||.+|||+.|||+||||+.
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0 00 01245689999999999 9999999999999999963
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=314.15 Aligned_cols=251 Identities=29% Similarity=0.456 Sum_probs=211.6
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
+|.+.+.||.|+||.||+|.++.+|..||+|.+..... .....+.+.+|+.+++.++|+||+++++.+.. ...+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~~~~~l 76 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM--PVKEKEASKKEVILLAKMKHPNIVTFFASFQE--NGRLFI 76 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc--cchhhHHHHHHHHHHHhCCCCChhhhhheecc--CCeEEE
Confidence 48899999999999999999999999999999876532 22345678899999999999999999998744 678999
Q ss_pred EEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 102 VTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~~--~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
|+||+++++|.+++.... .+++..++.|+.||+.||.|||+++ ++|+||||+||+++.+...+||+|||.+.....
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 77 VMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 999999999999987654 4799999999999999999999998 999999999999986645679999999977654
Q ss_pred cc--cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004672 180 SH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 256 (738)
Q Consensus 180 ~~--~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~ 256 (738)
.. .....|++.|+|||++.. .++.++|+||||+++++|++|..||... +..+....+..+..+. .....+.++++
T Consensus 155 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 232 (257)
T cd08225 155 SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQGYFAP-ISPNFSRDLRS 232 (257)
T ss_pred CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHhcccCCC-CCCCCCHHHHH
Confidence 32 223458999999998864 5889999999999999999999999764 4444445555444332 23456789999
Q ss_pred HHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 257 FIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 257 lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
+|.+||. +|.+|||+.++++||||
T Consensus 233 ~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 233 LISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHhccChhhCcCHHHHhhCCCC
Confidence 9999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=381.56 Aligned_cols=253 Identities=28% Similarity=0.438 Sum_probs=225.5
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
++....+||.|.||.||-|.+..||+..|+|.+++.+.. ......+.+|..+|..|+|||+|++|+ ++.+....+|
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyG--VEvHRekv~I 1311 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYG--VEVHREKVYI 1311 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCc--eeecHHHHHH
Confidence 456688999999999999999999999999999987643 455678999999999999999999999 5555778999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccc
Q 004672 102 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 181 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~ 181 (738)
.||||.+|+|.+.+...+-.++...+.+..|++.||.|||++| ||||||||+|||++.+ |.+|++|||.|..+....
T Consensus 1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~-g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFN-GLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecC-CcEEeecccceeEecCch
Confidence 9999999999999877777888889999999999999999999 9999999999999966 799999999997765442
Q ss_pred ------cccccCCCCCCCcccccc----ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCC
Q 004672 182 ------AARCVGTPEFMAPEVYEE----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED 251 (738)
Q Consensus 182 ------~~~~vGTp~YmAPEvl~~----~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~s 251 (738)
.....|||-|||||++.+ ....++|||||||+++||+||+.||.+..+.-+|+-+|-.|..|..... .+
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~-ls 1467 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPER-LS 1467 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchh-hh
Confidence 234469999999999974 3567899999999999999999999999999999999999999875544 89
Q ss_pred hHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 252 PEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 252 pel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
++.++||++||. ||++|.++.|||.|.|-+.
T Consensus 1468 ~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1468 SEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred HhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 999999999999 9999999999999999754
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=324.17 Aligned_cols=254 Identities=25% Similarity=0.299 Sum_probs=207.9
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeE
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
+++|.+.+.||.|++|.||+|.+..+|..||+|+++..... ......+.+|+.+|++++||||+++++++.......+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 46899999999999999999999999999999999865422 2333467789999999999999999999877655899
Q ss_pred EEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh
Q 004672 100 NFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~~-~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~ 178 (738)
++||||+. ++|.+++.... .+++..++.++.||+.||.|||+++ |+|+||||+||+++.+ +.+||+|||++....
T Consensus 82 ~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~-~~~~l~d~g~~~~~~ 157 (293)
T cd07843 82 YMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNR-GILKICDFGLAREYG 157 (293)
T ss_pred EEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCC-CcEEEeecCceeecc
Confidence 99999996 59999887654 5999999999999999999999998 9999999999999855 899999999987665
Q ss_pred ccc--cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCC-C-----------
Q 004672 179 KSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK-K----------- 242 (738)
Q Consensus 179 ~~~--~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~-~----------- 242 (738)
... .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||........+ .++.... .
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL-NKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCchHHHHHhhc
Confidence 431 223457899999998864 3688999999999999999999999865443332 2221100 0
Q ss_pred -----------------CcccccC-CChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 243 -----------------PEALFKV-EDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 243 -----------------p~~l~~~-~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
...+... .++.++++|.+||+ +|.+|||+.|+|.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0011111 47889999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=321.71 Aligned_cols=253 Identities=26% Similarity=0.353 Sum_probs=202.9
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCe
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 98 (738)
..++|.+.+.||.|++|+||+|.++.+|..||+|.+...... .....+.+|+.+++.++||||+++++++.. +..
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~ 77 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE---GAPFTAIREASLLKDLKHANIVTLHDIIHT--KKT 77 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc---CCchhHHHHHHHHhhCCCcceeeEEEEEec--CCe
Confidence 357899999999999999999999999999999998754311 122346789999999999999999998754 678
Q ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 99 INFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
.++||||+. ++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++...
T Consensus 78 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~ 153 (291)
T cd07844 78 LTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISER-GELKLADFGLARAK 153 (291)
T ss_pred EEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCC-CCEEECcccccccc
Confidence 999999996 5999988765 46899999999999999999999998 9999999999999855 79999999998654
Q ss_pred hccc--cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcC--C-C--------
Q 004672 178 RKSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG--K-K-------- 242 (738)
Q Consensus 178 ~~~~--~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g--~-~-------- 242 (738)
.... .....+++.|+|||++.+ .++.++||||||+++|+|++|..||..........+.+... . .
T Consensus 154 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 154 SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred CCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence 3221 122347889999998854 48889999999999999999999997655333332222110 0 0
Q ss_pred --------------Ccc---cccCCC--hHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 243 --------------PEA---LFKVED--PEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 243 --------------p~~---l~~~~s--pel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
+.. .....+ +++.++|.+||. +|.+|||+.++|.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 001223 788999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=311.90 Aligned_cols=247 Identities=28% Similarity=0.409 Sum_probs=210.4
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
+|.+.++||.|+||.||++.+..++..||+|.++... .....+.+..|+.+++.++||||++++++|.. ...+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA--DGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEE
Confidence 5889999999999999999999999999999987543 34456788999999999999999999998855 678999
Q ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 102 VTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
+|||+++|+|.+++... ..+++..++.|+.||+.||.|||+++ |+|+||||+||+++.+ +.++|+|||++.....
T Consensus 76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTS 152 (255)
T ss_pred EEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCC-CcEEEcccCcceeecc
Confidence 99999999999987653 45899999999999999999999998 9999999999999854 7999999999876543
Q ss_pred cc--cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004672 180 SH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 256 (738)
Q Consensus 180 ~~--~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~ 256 (738)
.. .....|++.|+|||++.+ .++.++||||||+++|+|++|..||.. .+.......+..+..+. .....+..+++
T Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 230 (255)
T cd08219 153 PGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA-NSWKNLILKVCQGSYKP-LPSHYSYELRS 230 (255)
T ss_pred cccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC-CCHHHHHHHHhcCCCCC-CCcccCHHHHH
Confidence 22 233468999999999874 488999999999999999999999986 45555566666655432 34456789999
Q ss_pred HHHHHHh-CcCCCCCHHHHhcCc
Q 004672 257 FIEKCLA-TVSSRLSARELLTDP 278 (738)
Q Consensus 257 lI~kcL~-dP~~RpSa~ELL~Hp 278 (738)
||.+||+ +|.+||++.+++.--
T Consensus 231 li~~~l~~~P~~Rp~~~~il~~~ 253 (255)
T cd08219 231 LIKQMFKRNPRSRPSATTILSRG 253 (255)
T ss_pred HHHHHHhCCcccCCCHHHHhhcc
Confidence 9999999 999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=324.79 Aligned_cols=258 Identities=26% Similarity=0.384 Sum_probs=213.1
Q ss_pred CcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCC
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 96 (738)
..+...|.+.+.||.|+||+||+|.+..+|..||+|++.... ....+..+.+.+|+.+++.++||||++++++|.. .
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~--~ 87 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG-KQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR--E 87 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccc-cCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe--C
Confidence 344467999999999999999999999999999999887543 2344556789999999999999999999998865 5
Q ss_pred CeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 97 RNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k-~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
...++||||+. |+|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||+|+||+++.+ +.+||+|||++.
T Consensus 88 ~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~-~~~kL~dfg~~~ 163 (307)
T cd06607 88 HTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEP-GTVKLADFGSAS 163 (307)
T ss_pred CeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCC-CCEEEeecCcce
Confidence 67899999996 677777654 456999999999999999999999998 9999999999999854 899999999986
Q ss_pred HhhccccccccCCCCCCCccccc----cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCC
Q 004672 176 ILRKSHAARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED 251 (738)
Q Consensus 176 ~l~~~~~~~~vGTp~YmAPEvl~----~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~s 251 (738)
..... ....|++.|+|||++. +.++.++||||||+++|+|+||..||....... ....+..+..+.......+
T Consensus 164 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 240 (307)
T cd06607 164 LVSPA--NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNDSPTLSSNDWS 240 (307)
T ss_pred ecCCC--CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-HHHHHhcCCCCCCCchhhC
Confidence 54322 3446889999999873 458899999999999999999999997644333 3333444444433334467
Q ss_pred hHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 252 PEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 252 pel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
..++++|.+||. +|.+||++.+++.||||....
T Consensus 241 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 241 DYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 889999999999 999999999999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=318.53 Aligned_cols=249 Identities=27% Similarity=0.397 Sum_probs=204.3
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
+|.++++||.|++|+||+|.+..+|..||+|++++... ....+.+.+|+.+++.++||||++++++|.. ...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHENIVRLHDVIHT--ENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc---ccchHHHHHHHHHHHhhcCCCEeeeeeeEee--CCcEEE
Confidence 58899999999999999999999999999999886532 2234567789999999999999999998866 567899
Q ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh
Q 004672 102 VTEMFTSGTLRQYRLKH---RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~---~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~ 178 (738)
||||+. ++|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++.+ +.++|+|||++....
T Consensus 76 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~-~~~~l~d~g~~~~~~ 151 (284)
T cd07836 76 VFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKR-GELKLADFGLARAFG 151 (284)
T ss_pred EEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCC-CcEEEeecchhhhhc
Confidence 999997 5898887664 35899999999999999999999998 9999999999999854 899999999997654
Q ss_pred ccc--cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcC-CCC----------
Q 004672 179 KSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG-KKP---------- 243 (738)
Q Consensus 179 ~~~--~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g-~~p---------- 243 (738)
... .....+++.|+|||++.+ .++.++||||||+++|+|++|..||......+.. ..+... ..|
T Consensus 152 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 152 IPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQL-LKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred CCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHHHhCCCChhhHHHHhc
Confidence 322 123457899999998754 4788999999999999999999999875544433 222211 000
Q ss_pred ----------------cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 244 ----------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 244 ----------------~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
..+....++.++++|.+||+ +|.+||++.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00112357889999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=321.68 Aligned_cols=257 Identities=25% Similarity=0.336 Sum_probs=208.1
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeE
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
+++|.+.+.||.|++|+||+|.++.+|..||+|.+..... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 76 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKRL 76 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchHHHHHHHHHHHhccCCCEeeEEEEEec--CCeE
Confidence 3689999999999999999999999999999998875432 22344578899999999999999999998865 6789
Q ss_pred EEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 100 NFVTEMFTSGTLRQYRLKHRR--VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~~~--lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
++||||+. ++|.+++..... +++..++.++.||+.||.|||+++ ++||||+|+||+++..++.+||+|||++...
T Consensus 77 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred EEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 99999995 688888766443 588899999999999999999998 9999999999999866568999999999755
Q ss_pred hccc--cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc-CCCCc--------
Q 004672 178 RKSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKKPE-------- 244 (738)
Q Consensus 178 ~~~~--~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~-g~~p~-------- 244 (738)
.... .....+++.|+|||++.+ .++.++||||||+++|+|+||..||........+.+.+.. +..+.
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 3321 233457899999998864 4788999999999999999999999875554444433211 11100
Q ss_pred -----------------ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 245 -----------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 245 -----------------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
......+++++++|.+||+ +|.+||++.++|.||||..-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0123457889999999999 89999999999999999643
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=309.18 Aligned_cols=250 Identities=29% Similarity=0.504 Sum_probs=215.7
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
+|.+.+.||.|++|.||++.+..++..||+|++.... ...+..+.+.+|+++++.++|||++++++.+.. ...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~~~~l 76 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN--MSEKEREDALNEVKILKKLNHPNIIKYYESFEE--KGKLCI 76 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeeccc--CChHHHHHHHHHHHHHHhcCCCChhheEEEEec--CCEEEE
Confidence 5889999999999999999999999999999987543 234566789999999999999999999998865 478999
Q ss_pred EEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 102 VTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~----~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
|+||+++++|.+++... ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++.+ +.++|+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~-~~~~l~d~~~~~~~ 153 (258)
T cd08215 77 VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSN-GLVKLGDFGISKVL 153 (258)
T ss_pred EEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCC-CcEEECCccceeec
Confidence 99999999999998774 67999999999999999999999998 9999999999999854 79999999999765
Q ss_pred hccc--cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHH
Q 004672 178 RKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEV 254 (738)
Q Consensus 178 ~~~~--~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel 254 (738)
.... .....|++.|+|||.+.. .++.++|+||||+++++|++|..||... +...+......+..+ .+....+..+
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~ 231 (258)
T cd08215 154 SSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE-NLLELALKILKGQYP-PIPSQYSSEL 231 (258)
T ss_pred ccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC-cHHHHHHHHhcCCCC-CCCCCCCHHH
Confidence 4432 233468999999998764 5888999999999999999999999764 456666666655433 3445678899
Q ss_pred HHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 255 RQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 255 ~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
.+++.+||. +|.+||++.++|.||||
T Consensus 232 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 232 RNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=321.05 Aligned_cols=252 Identities=25% Similarity=0.367 Sum_probs=201.7
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeE
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
..+|.+++.||.|+||+||+|.+..+|..||+|.++.... ......+.+|+.+|+.++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~ 78 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE---EGVPFTAIREASLLKGLKHANIVLLHDIIHT--KETL 78 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc---CCCcHHHHHHHHHHHhcCCCCEeEEEEEEec--CCeE
Confidence 3689999999999999999999999999999999875432 1223356789999999999999999998754 6789
Q ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh
Q 004672 100 NFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~ 178 (738)
++||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.+ +.+||+|||++....
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 79 TFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYL-GELKLADFGLARAKS 154 (291)
T ss_pred EEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCC-CcEEEeccccccccC
Confidence 99999995 6777776553 56888999999999999999999998 9999999999999854 899999999987543
Q ss_pred ccc--cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc--CCC----------
Q 004672 179 KSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GKK---------- 242 (738)
Q Consensus 179 ~~~--~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~--g~~---------- 242 (738)
... .....+++.|+|||.+.+ .++.++||||||+++|+|+||..||.......+....+.. |..
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 221 223357899999998864 4788999999999999999999999765544333333211 100
Q ss_pred -------------Cccc---c--cCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 243 -------------PEAL---F--KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 243 -------------p~~l---~--~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
+..+ . ...++.+.+++.+||. +|.+|||+.++|.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0000 0 1125789999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=325.50 Aligned_cols=258 Identities=32% Similarity=0.472 Sum_probs=213.0
Q ss_pred CcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCC
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 96 (738)
+...++|.+++.||.|+||+||++.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. .
T Consensus 15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~ 88 (293)
T cd06647 15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKHPNIVNYLDSYLV--G 88 (293)
T ss_pred cCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHHHHHHHHHHHHhhcCCCCeeehhheeee--C
Confidence 444678999999999999999999999999999999886432 2335678999999999999999999998865 5
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
...++|+||+++++|.+++.+ ..+++..+..++.|++.||.|||+++ ++||||||+||+++.+ +.+||+|||++..
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~-~~~kL~dfg~~~~ 164 (293)
T cd06647 89 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQ 164 (293)
T ss_pred CcEEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCC-CCEEEccCcceec
Confidence 688999999999999999765 45889999999999999999999998 9999999999999854 7999999998865
Q ss_pred hhccc--cccccCCCCCCCccccc-cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChH
Q 004672 177 LRKSH--AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 253 (738)
Q Consensus 177 l~~~~--~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spe 253 (738)
..... .....|++.|+|||.+. +.++.++||||||+++|+|++|+.||.......++......+..+.......++.
T Consensus 165 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (293)
T cd06647 165 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 244 (293)
T ss_pred ccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHH
Confidence 54322 22335889999999876 4588999999999999999999999986544443332222222222223345788
Q ss_pred HHHHHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 254 VRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 254 l~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
++++|.+||. +|.+||++.+++.|+||+...
T Consensus 245 l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 245 FRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 9999999999 899999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=323.41 Aligned_cols=249 Identities=22% Similarity=0.290 Sum_probs=198.4
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcC----------------CCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCC
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEY----------------EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 81 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~----------------tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~H 81 (738)
++.++|.+.++||+|+||.||+|.+.. ++..||+|.++.. ........+.+|+.+|++++|
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h 78 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD---ANKNARNDFLKEVKILSRLKD 78 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC---CCHHHHHHHHHHHHHHhhcCC
Confidence 456789999999999999999998532 4557999987643 234556789999999999999
Q ss_pred CCcceeeEEEEecCCCeEEEEEecCCCCCHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHh
Q 004672 82 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-------------------RVNIRAVKHWCRQILSGLLYLHS 142 (738)
Q Consensus 82 pNIVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~-------------------~lse~~i~~i~~QIl~aL~yLHs 142 (738)
|||+++++++.+ ...+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+
T Consensus 79 ~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 156 (304)
T cd05096 79 PNIIRLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156 (304)
T ss_pred CCeeEEEEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 999999998865 567899999999999999986532 36778899999999999999999
Q ss_pred CCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccc----cccccCCCCCCCccccc-cccCcccccccchhhhhhh
Q 004672 143 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEM 217 (738)
Q Consensus 143 ~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeL 217 (738)
++ |+||||||+|||++.+ +.+||+|||++..+.... .....+++.|||||++. +.++.++||||||+++|+|
T Consensus 157 ~~--ivH~dlkp~Nill~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 233 (304)
T cd05096 157 LN--FVHRDLATRNCLVGEN-LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233 (304)
T ss_pred CC--ccccCcchhheEEcCC-ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHH
Confidence 98 9999999999999854 799999999997653321 12334678999999875 5699999999999999999
Q ss_pred hh--cCCCCCCCCCHHHHHHHHHc----CC--CCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHh
Q 004672 218 VT--FDYPYSECTHPAQIYKKVIS----GK--KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELL 275 (738)
Q Consensus 218 lT--G~~Pf~~~~~~~qi~k~i~~----g~--~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL 275 (738)
++ +..||..... .++...+.. .. .....+...++.+.+||.+||. +|.+|||+.+|.
T Consensus 234 ~~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 234 LMLCKEQPYGELTD-EQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred HHccCCCCCCcCCH-HHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 86 5678876543 333332221 11 1111223457889999999999 999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=368.60 Aligned_cols=261 Identities=22% Similarity=0.337 Sum_probs=229.5
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCe
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 98 (738)
..++|.+++.||.|+||.|.++.++.|+..||+|++...+... ......|..|-.+|..-+.+=|++++-.|.+ .++
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK-r~~tA~F~EERDimv~~ns~Wiv~LhyAFQD--~~~ 149 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK-RAETACFREERDIMVFGNSEWIVQLHYAFQD--ERY 149 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh-chhHHHHHHHhHHHHcCCcHHHHHHHHHhcC--ccc
Confidence 4578999999999999999999999999999999988654322 2334678899999999999999999888866 789
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh
Q 004672 99 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~ 178 (738)
+|+|||||+||+|-.++.++.++++..++.|+..|+.||.-||+.| +|||||||+|||++. .|+|||+|||.+..+.
T Consensus 150 LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~-~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDK-SGHIKLADFGSCLKMD 226 (1317)
T ss_pred eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecc-cCcEeeccchhHHhcC
Confidence 9999999999999999999999999999999999999999999999 999999999999985 4999999999998876
Q ss_pred ccc---cccccCCCCCCCccccc------cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccc--
Q 004672 179 KSH---AARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF-- 247 (738)
Q Consensus 179 ~~~---~~~~vGTp~YmAPEvl~------~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~-- 247 (738)
... ....+|||-|++||++. +.|+..+|.||+||++|||+.|..||.. ......|.+|+..+..-.++
T Consensus 227 ~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~l~FP~~ 305 (1317)
T KOG0612|consen 227 ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKESLSFPDE 305 (1317)
T ss_pred CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhhcCCCcc
Confidence 432 24457999999999984 4699999999999999999999999986 56778899998765433333
Q ss_pred cCCChHHHHHHHHHHhCcCCCCC---HHHHhcCcccCCCCCc
Q 004672 248 KVEDPEVRQFIEKCLATVSSRLS---ARELLTDPFLQIDDYD 286 (738)
Q Consensus 248 ~~~spel~~lI~kcL~dP~~RpS---a~ELL~Hpf~~~~~~~ 286 (738)
...++++++||.+.|.+|..|.. +.++..||||...+|.
T Consensus 306 ~~VSeeakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W~ 347 (1317)
T KOG0612|consen 306 TDVSEEAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDWD 347 (1317)
T ss_pred cccCHHHHHHHHHHhcChhhhcccccHHHHHhCccccCCChh
Confidence 34799999999999999999998 9999999999999884
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.63 Aligned_cols=255 Identities=23% Similarity=0.320 Sum_probs=202.0
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC---
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA--- 95 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~--- 95 (738)
.+++|.+.++||.|+||+||+|.+..+|..||+|.+..... .......+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKATPY 87 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC--cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence 45689999999999999999999999999999999875432 2223345678999999999999999999875532
Q ss_pred ---CCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEecc
Q 004672 96 ---NRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 171 (738)
Q Consensus 96 ---~~~l~LV~Ey~~gGSL~~~l~k~~-~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DF 171 (738)
...+++||||+. ++|.+++.+.. .+++..++.++.||+.||.|||+++ ++|+||||+||+++.+ +.+||+||
T Consensus 88 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~df 163 (310)
T cd07865 88 NRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKD-GILKLADF 163 (310)
T ss_pred cCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCC-CcEEECcC
Confidence 246799999995 58888776643 6899999999999999999999998 9999999999999854 79999999
Q ss_pred chhHHhhcccc------ccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHH--cCC
Q 004672 172 GLAAILRKSHA------ARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI--SGK 241 (738)
Q Consensus 172 GlA~~l~~~~~------~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~--~g~ 241 (738)
|++..+..... ....++..|+|||.+.+ .++.++||||||+++|+|+||..||...... .....+. .|.
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-~~~~~~~~~~~~ 242 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-HQLTLISQLCGS 242 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCC
Confidence 99976543221 22357889999998764 3788999999999999999999999764332 2211111 111
Q ss_pred CCccc----------------------------ccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 242 KPEAL----------------------------FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 242 ~p~~l----------------------------~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
.|... ....++.+++||.+||. +|.+|||++++|.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 11110 11235678899999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=345.11 Aligned_cols=247 Identities=25% Similarity=0.378 Sum_probs=207.4
Q ss_pred ccCcCCCCceEEEEEcccCCeEEEEEEEcCCCe-EEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEe
Q 004672 15 LKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGI-EVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD 93 (738)
Q Consensus 15 ~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~-~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~ 93 (738)
.-+|..+.+..++.||+|-||.||.|.. .|. .||+|.++... .+ .+.+.+|+++|++|+|+|||++|+++..
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~--~~~~~vavk~ik~~~--m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~ 272 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKW--NGSTKVAVKTIKEGS--MS---PEAFLREAQIMKKLRHEKLVKLYGVCTK 272 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEE--cCCCcccceEEeccc--cC---hhHHHHHHHHHHhCcccCeEEEEEEEec
Confidence 4456666788899999999999999964 555 89999988542 12 2457799999999999999999997644
Q ss_pred cCCCeEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEecc
Q 004672 94 TANRNINFVTEMFTSGTLRQYRLK--HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 171 (738)
Q Consensus 94 ~~~~~l~LV~Ey~~gGSL~~~l~k--~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DF 171 (738)
...++||||||+.|+|.+|++. ...+...+++.++.||++|++||++++ +|||||-..||||+.+ +.+||+||
T Consensus 273 --~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~-~~vKIsDF 347 (468)
T KOG0197|consen 273 --QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDED-LVVKISDF 347 (468)
T ss_pred --CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccC-ceEEEccc
Confidence 5589999999999999999987 467999999999999999999999999 9999999999999855 79999999
Q ss_pred chhHHhhccccccccC---CCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCccc
Q 004672 172 GLAAILRKSHAARCVG---TPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEAL 246 (738)
Q Consensus 172 GlA~~l~~~~~~~~vG---Tp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l 246 (738)
|||+...+.......| ...|.|||.+. +.++.++||||||++|+||+| |+.||.+.+ ..++.+.+.+|..-..
T Consensus 348 GLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-n~ev~~~le~GyRlp~- 425 (468)
T KOG0197|consen 348 GLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-NEEVLELLERGYRLPR- 425 (468)
T ss_pred ccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-HHHHHHHHhccCcCCC-
Confidence 9999655443322222 35799999886 679999999999999999998 889998854 5667788888876443
Q ss_pred ccCCChHHHHHHHHHHh-CcCCCCCHHHHh
Q 004672 247 FKVEDPEVRQFIEKCLA-TVSSRLSARELL 275 (738)
Q Consensus 247 ~~~~spel~~lI~kcL~-dP~~RpSa~ELL 275 (738)
+...++++-+++..||. +|.+|||...|.
T Consensus 426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 426 PEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 34578999999999999 999999998654
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.53 Aligned_cols=250 Identities=28% Similarity=0.465 Sum_probs=211.3
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.+.+.||.|++|.||+|.+..+|..||+|.++.... ......+++.+|+.++++++|+||++++++|.. .+..+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--~~~~~ 78 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM-MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--NNELN 78 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc-cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEE
Confidence 689999999999999999999999999999999886542 334556789999999999999999999998865 57889
Q ss_pred EEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 101 FVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~----~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
+||||+++|+|..++... ..+++..++.|+.||+.||.|||+.+ |+||||+|+||+++.+ +.++|+|||++..
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~-~~~~l~d~~~~~~ 155 (267)
T cd08224 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITAT-GVVKLGDLGLGRF 155 (267)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCC-CcEEEeccceeee
Confidence 999999999999998642 45899999999999999999999998 9999999999999855 7999999999875
Q ss_pred hhccc--cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCC-CCHHHHHHHHHcCCCCcccccCCCh
Q 004672 177 LRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC-THPAQIYKKVISGKKPEALFKVEDP 252 (738)
Q Consensus 177 l~~~~--~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~-~~~~qi~k~i~~g~~p~~l~~~~sp 252 (738)
+.... .....|++.|+|||.+.+ .++.++||||||+++|+|++|..||... .+...+...+..+..+.......+.
T Consensus 156 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08224 156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSE 235 (267)
T ss_pred ccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCH
Confidence 54322 223458999999998764 5889999999999999999999999643 3444556666666655444446778
Q ss_pred HHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 253 EVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 253 el~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
.++++|.+||. +|.+|||+.+|+.
T Consensus 236 ~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 236 ELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99999999999 8999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=306.11 Aligned_cols=248 Identities=33% Similarity=0.538 Sum_probs=209.5
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
+|...+.||.|++|.||++.+..+|..|++|++..... .....+.+|+.+++.++||||+++++++.. ....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 74 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLK--KDELWI 74 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEE
Confidence 58889999999999999999999999999999875432 456789999999999999999999998755 578899
Q ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 102 VTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
++||+.+++|.+++... +.+++..+..++.|++.||.|||.++ ++||||+|+||+++. .+.++|+|||.+......
T Consensus 75 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 75 VMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTS-DGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred EEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEcc-CCeEEEeecccccccccc
Confidence 99999999999998876 57999999999999999999999988 999999999999985 489999999999776554
Q ss_pred c-cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccc-cCCChHHHHH
Q 004672 181 H-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF-KVEDPEVRQF 257 (738)
Q Consensus 181 ~-~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~-~~~spel~~l 257 (738)
. .....|+..|+|||.+.+ .++.++||||||+++|+|++|..||........+.. ......+.... ..++..+.++
T Consensus 152 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 230 (253)
T cd05122 152 KARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK-IATNGPPGLRNPEKWSDEFKDF 230 (253)
T ss_pred ccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH-HHhcCCCCcCcccccCHHHHHH
Confidence 3 334568999999998864 478899999999999999999999987544443333 22222222222 2237889999
Q ss_pred HHHHHh-CcCCCCCHHHHhcCcc
Q 004672 258 IEKCLA-TVSSRLSARELLTDPF 279 (738)
Q Consensus 258 I~kcL~-dP~~RpSa~ELL~Hpf 279 (738)
|.+||+ +|.+|||+.++|+|||
T Consensus 231 i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 231 LKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHccCChhhCCCHHHHhcCCC
Confidence 999999 9999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.85 Aligned_cols=249 Identities=22% Similarity=0.297 Sum_probs=200.3
Q ss_pred ceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCC-CCCcceeeEEEEecCCCeEEE
Q 004672 23 MEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 23 y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~l~L 101 (738)
|.++++||.|+||.||+|.+..++..||+|+++... ..... ....+|+.++.++. ||||+++++++.+...+.+++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~--~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF--KSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhcc--CCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence 678999999999999999999999999999877432 12222 23457899999994 999999999987755578999
Q ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 102 VTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
||||+. |+|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+||+++. +.+||+|||++..+...
T Consensus 78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 78 VFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD--DILKLADFGSCRGIYSK 152 (282)
T ss_pred EEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC--CCeEEEecccccccccC
Confidence 999996 5787777654 56899999999999999999999998 999999999999985 89999999999766443
Q ss_pred cc-ccccCCCCCCCccccc--cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc--CCCCc-----------
Q 004672 181 HA-ARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GKKPE----------- 244 (738)
Q Consensus 181 ~~-~~~vGTp~YmAPEvl~--~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~--g~~p~----------- 244 (738)
.. ....+++.|+|||++. +.++.++|||||||++|+|++|..||..... ...+..+.. +..+.
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE-LDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH-HHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 22 3345899999999764 3478899999999999999999999986433 222222221 11100
Q ss_pred --------------ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 245 --------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 245 --------------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
.+....+.+++++|.+||. +|.+||++.++|.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0112457899999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=318.46 Aligned_cols=249 Identities=22% Similarity=0.344 Sum_probs=205.1
Q ss_pred EcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEecCCC
Q 004672 29 FLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTS 108 (738)
Q Consensus 29 LG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey~~g 108 (738)
||.|+||+||+|.+..+|..||+|.+..... ........+..|+.+|+.++||||++++++|.. .+.+++||||+++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRL-KKRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhh-hhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEecCCC
Confidence 6899999999999999999999999875432 222345567889999999999999999998744 6789999999999
Q ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccc-cccc
Q 004672 109 GTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-AARC 185 (738)
Q Consensus 109 GSL~~~l~k~~--~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~-~~~~ 185 (738)
++|.+++.+.. .+++..+..++.|++.||.|||+++ ++||||+|+||+++.+ +.+||+|||++....... ....
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~ 154 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDH-GNVRISDLGLAVELKGGKKIKGR 154 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEEccCcchhhhccCCccccc
Confidence 99999987765 7999999999999999999999998 9999999999999854 799999999997664322 2334
Q ss_pred cCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCC---HHHHHHHHHcCCCCcccccCCChHHHHHHHHH
Q 004672 186 VGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTH---PAQIYKKVISGKKPEALFKVEDPEVRQFIEKC 261 (738)
Q Consensus 186 vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~---~~qi~k~i~~g~~p~~l~~~~spel~~lI~kc 261 (738)
.++..|+|||++.+ .++.++||||||+++|+|++|+.||..... ...+...+.. .+...+...++.++++|.+|
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~ 232 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLCEAL 232 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccCCHHHHHHHHHH
Confidence 58899999998764 588899999999999999999999975432 2233322221 23334456789999999999
Q ss_pred Hh-CcCCCC-----CHHHHhcCcccCCCCC
Q 004672 262 LA-TVSSRL-----SARELLTDPFLQIDDY 285 (738)
Q Consensus 262 L~-dP~~Rp-----Sa~ELL~Hpf~~~~~~ 285 (738)
|+ +|.+|| ++.+|+.||||..-++
T Consensus 233 l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 233 LQKDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred ccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence 99 999999 8999999999975543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=320.26 Aligned_cols=253 Identities=25% Similarity=0.355 Sum_probs=206.9
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.+.++||.|+||.||+|.+..+|..||+|++.... ......+.+.+|+.+|+.++||||++++++|.. ...++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 76 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESE--DDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR--KKRLY 76 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhcc--CcchhhHHHHHHHHHHHhcCCcchhhHHHhccc--CCeEE
Confidence 47899999999999999999999999999999876433 222445678899999999999999999998744 67899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
+||||+.+++|..+......+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.+ +.++|+|||++..+...
T Consensus 77 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~-~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 77 LVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFARTLAAP 153 (286)
T ss_pred EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCC-CcEEEEeeeeeeeccCC
Confidence 99999999999988776667999999999999999999999998 9999999999999854 79999999998765432
Q ss_pred c--cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc-CC--------------
Q 004672 181 H--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GK-------------- 241 (738)
Q Consensus 181 ~--~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~-g~-------------- 241 (738)
. .....+++.|+|||++.+ .++.++||||||+++|+|++|..||........+.+.... +.
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 2 223458899999998864 4788999999999999999999999764443333221110 00
Q ss_pred -----CCc--------ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 242 -----KPE--------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 242 -----~p~--------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
.|. ......+..+++|+.+||. +|.+||++.++|.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000 0123457789999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=309.53 Aligned_cols=250 Identities=29% Similarity=0.448 Sum_probs=216.1
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
+|.+.++||.|++|.||++.+..+|..+|+|.+..... .......+.+|+.+++.++||||+++++++.. ....++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~ 76 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM--SQKEREDAVNEIRILASVNHPNIISYKEAFLD--GNKLCI 76 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc--cHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--CCEEEE
Confidence 48899999999999999999999999999999875432 34556788899999999999999999998865 578999
Q ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 102 VTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k----~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
||||+++++|.+++.+ ...+++..+..++.|++.||.|||+++ ++|+||+|.||+++. .+.+||+|||++...
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~-~~~~kl~d~g~~~~~ 153 (256)
T cd08530 77 VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVA-NDLVKIGDLGISKVL 153 (256)
T ss_pred EehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEec-CCcEEEeeccchhhh
Confidence 9999999999999866 356899999999999999999999998 999999999999986 479999999999877
Q ss_pred hccccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004672 178 RKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 256 (738)
Q Consensus 178 ~~~~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~ 256 (738)
.........|++.|+|||.+.+ .++.++|+||||+++|+|++|..||... +...+...+..+..+. .....+.++++
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (256)
T cd08530 154 KKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR-SMQDLRYKVQRGKYPP-IPPIYSQDLQN 231 (256)
T ss_pred ccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCCCC-CchhhCHHHHH
Confidence 6654444568999999998864 4888999999999999999999999864 4555666666665553 33467889999
Q ss_pred HHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 257 FIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 257 lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
+|.+||. +|.+||++.++|.||++
T Consensus 232 li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 232 FIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999 99999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=318.73 Aligned_cols=253 Identities=30% Similarity=0.448 Sum_probs=209.7
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCC---CCCcceeeEEEEecCCCe
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK---HRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~---HpNIVkl~~~fv~~~~~~ 98 (738)
.|.+.++||.|+||.||+|.+..+|..||+|.++... .....+.+.+|+.+++.++ ||||++++++|.. +..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCE
Confidence 4778899999999999999999999999999887432 3345667889999999996 9999999998765 678
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh
Q 004672 99 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~ 178 (738)
+++||||+.+++|.+++.. +.+++..+..++.||+.||.|||+.+ |+|+||+|+||+++. .+.++|+|||++....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~-~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTN-TGNVKLCDFGVAALLN 152 (277)
T ss_pred EEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcC-CCCEEEccCCceeecC
Confidence 9999999999999999765 47999999999999999999999998 999999999999985 5899999999987654
Q ss_pred ccc--cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHH
Q 004672 179 KSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEV 254 (738)
Q Consensus 179 ~~~--~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel 254 (738)
... .....|++.|+|||.+.+ .++.++||||||+++|+|++|..||..... ......+.....+.......++++
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 231 (277)
T cd06917 153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-FRAMMLIPKSKPPRLEDNGYSKLL 231 (277)
T ss_pred CCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-hhhhhccccCCCCCCCcccCCHHH
Confidence 432 233468999999998864 378899999999999999999999986433 222222222222222222367899
Q ss_pred HHHHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 255 RQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 255 ~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
.+|+.+||. +|.+||++.+++.|+||+...
T Consensus 232 ~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 232 REFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 999999999 899999999999999997644
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=318.01 Aligned_cols=252 Identities=31% Similarity=0.521 Sum_probs=212.3
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
..|....+||.|++|.||+|.+..++..|++|++... .....+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~~~~~ 92 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR----KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV--GDELW 92 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc----chhHHHHHHHHHHHHHHcCCCChheEEEEEEc--CCeEE
Confidence 3566678999999999999999999999999988643 23445678999999999999999999998765 67889
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
+|+||+++++|.+++.. .++++..+..++.||+.||.|||+++ |+||||+|+||+++.+ +.++|+|||++......
T Consensus 93 ~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 93 VVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKE 168 (285)
T ss_pred EEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCC-CcEEEcccccchhhccC
Confidence 99999999999999877 67999999999999999999999998 9999999999999854 89999999988765432
Q ss_pred c--cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCccc-ccCCChHHHH
Q 004672 181 H--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL-FKVEDPEVRQ 256 (738)
Q Consensus 181 ~--~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l-~~~~spel~~ 256 (738)
. .....|++.|+|||.+.+ .++.++||||||+++|+|++|..||.. .++...+..+..+..+... ....++.+.+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 247 (285)
T cd06648 169 VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLKNLHKVSPRLRS 247 (285)
T ss_pred CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHhcCCCCCcccccCCHHHHH
Confidence 2 223458999999998864 588999999999999999999999976 4455555666655333211 2236789999
Q ss_pred HHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 257 FIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 257 lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
||.+||. +|.+||++.+++.||||+..
T Consensus 248 li~~~l~~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 248 FLDRMLVRDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred HHHHHcccChhhCcCHHHHccCcccccC
Confidence 9999999 89999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=315.11 Aligned_cols=251 Identities=30% Similarity=0.482 Sum_probs=211.0
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeE
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
+++|.+.+.||.|++|.||+|.+..+|..||+|.+...+. ......+.+.+|+.+++.++||||++++++|.. ++.+
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~ 77 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNEL 77 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-hhHHHHHHHHHHHHHHHHccCCchhhhhheeEe--CCeE
Confidence 3678899999999999999999999999999998875542 234456788999999999999999999998865 5689
Q ss_pred EEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 100 NFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k----~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
+++|||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.+ +.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~-~~~~l~dfg~~~ 154 (267)
T cd08229 78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CCEEECcchhhh
Confidence 999999999999998764 346899999999999999999999998 9999999999999855 799999999987
Q ss_pred Hhhccc--cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCC-CHHHHHHHHHcCCCCcccccCCC
Q 004672 176 ILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT-HPAQIYKKVISGKKPEALFKVED 251 (738)
Q Consensus 176 ~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~-~~~qi~k~i~~g~~p~~l~~~~s 251 (738)
...... .....|++.|+|||.+.+ .++.++||||||+++|+|++|..||.... ....+.+.+.....+.......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08229 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 234 (267)
T ss_pred ccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCccccc
Confidence 664332 123458999999998864 58889999999999999999999996533 33455556655555544445678
Q ss_pred hHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 252 PEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 252 pel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
++++++|.+||. +|.+|||+.++++
T Consensus 235 ~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 235 EELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 899999999999 9999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=337.74 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=205.1
Q ss_pred CcCCCCceEEEEEcccCCeEEEEEEEcCCC-----eEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEE
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEG-----IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTS 90 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG-----~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~ 90 (738)
.++.++|.+.+.||.|+||.||+|.+..+| ..||+|.++... ..+..+.+.+|+.+|+.+ +||||++++++
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 466778999999999999999999865444 579999887432 345567899999999999 89999999998
Q ss_pred EEecCCCeEEEEEecCCCCCHHHHHHhc----------------------------------------------------
Q 004672 91 WVDTANRNINFVTEMFTSGTLRQYRLKH---------------------------------------------------- 118 (738)
Q Consensus 91 fv~~~~~~l~LV~Ey~~gGSL~~~l~k~---------------------------------------------------- 118 (738)
|.. ...+++||||+.+|+|.+++.+.
T Consensus 111 ~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 111 CTH--GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred ecC--CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 755 56899999999999999998643
Q ss_pred ------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 119 ------------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 119 ------------------~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
.++++..+..++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||++..+...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~-~~~~kL~DfGla~~~~~~ 265 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTD-GRVAKICDFGLARDIMND 265 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeC-CCeEEEeeceeeeeccCC
Confidence 24788889999999999999999998 999999999999984 479999999999765432
Q ss_pred ccc----cccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHH
Q 004672 181 HAA----RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEV 254 (738)
Q Consensus 181 ~~~----~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel 254 (738)
... ...+++.|||||++. ..|+.++|||||||++|+|++ |..||........++..+..+..+ ..+...++++
T Consensus 266 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l 344 (374)
T cd05106 266 SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM-SRPDFAPPEI 344 (374)
T ss_pred cceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc-cCCCCCCHHH
Confidence 211 223556899999876 469999999999999999997 999998755544455544444332 2334568999
Q ss_pred HHHHHHHHh-CcCCCCCHHHHhc
Q 004672 255 RQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 255 ~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
+++|.+||+ +|.+|||+.++++
T Consensus 345 ~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 345 YSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=330.86 Aligned_cols=253 Identities=28% Similarity=0.386 Sum_probs=204.3
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC----
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA---- 95 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~---- 95 (738)
.++|.+++.||+|+||+||+|.+..+|..||+|.+.... ......+.+.+|+.+++.++||||++++++|....
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF--QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc--cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 478999999999999999999999999999999876332 23445567889999999999999999999875432
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
...+++||||+. ++|.+++... +++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++.
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~ 166 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLAR 166 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC-CCEEEccCccce
Confidence 235799999995 6888887654 899999999999999999999998 9999999999999855 799999999997
Q ss_pred Hhhcccc-ccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc--CCCC--------
Q 004672 176 ILRKSHA-ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GKKP-------- 243 (738)
Q Consensus 176 ~l~~~~~-~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~--g~~p-------- 243 (738)
....... ....+++.|+|||++.+ .++.++|||||||++|+|++|+.||........ +..+.. +..+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 167 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ-WNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred eCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHhh
Confidence 6544322 23458899999998864 589999999999999999999999976443222 222211 1000
Q ss_pred -----------------------ccc--------ccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccC
Q 004672 244 -----------------------EAL--------FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 281 (738)
Q Consensus 244 -----------------------~~l--------~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~ 281 (738)
... ....++.+++||.+||. +|.+|||+.|+|.||||+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 000 11345678999999999 999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=318.11 Aligned_cols=250 Identities=26% Similarity=0.368 Sum_probs=204.7
Q ss_pred ceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEE
Q 004672 23 MEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 102 (738)
Q Consensus 23 y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV 102 (738)
|.+.++||.|++|+||+|.++.+|..||+|++..... .......+.+|+.+++.++||||+++++++.+ ....+++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~--~~~~~iv 76 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELNHPNIVRLLDVVHS--ENKLYLV 76 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc--cccchhHHHHHHHHHHhcCCCCccCHhheecc--CCeEEEE
Confidence 5778999999999999999999999999999876532 22334568889999999999999999998754 6789999
Q ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 103 TEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 103 ~Ey~~gGSL~~~l~k~~--~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
|||+ +++|.+++.... .+++..++.++.||+.||.|||+++ ++||||+|+||+++. ++.++|+|||++......
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~ 152 (283)
T cd07835 77 FEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDR-EGALKLADFGLARAFGVP 152 (283)
T ss_pred Eecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcC-CCcEEEeecccccccCCC
Confidence 9999 479999988766 7999999999999999999999998 999999999999986 589999999998754322
Q ss_pred c--cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC-------------
Q 004672 181 H--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP------------- 243 (738)
Q Consensus 181 ~--~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p------------- 243 (738)
. .....+++.|+|||++.+ .++.++||||||+++|+|++|+.||.......++.+.+.....|
T Consensus 153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 153 VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 1 223357899999998754 37889999999999999999999998654444433322211100
Q ss_pred -------------cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 244 -------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 244 -------------~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
.......++.+.++|.+||+ +|.+|||+.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 11123456889999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=317.55 Aligned_cols=249 Identities=21% Similarity=0.317 Sum_probs=208.3
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEc-----CCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEE
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDE-----YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWV 92 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~-----~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv 92 (738)
+..++|.+.+.||.|+||.||+|.+. .++..||+|.++.. ...+..+.+.+|+++|+.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 78 (280)
T cd05049 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET---ASNDARKDFEREAELLTNFQHENIVKFYGVCT 78 (280)
T ss_pred CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc---CCHHHHHHHHHHHHHHHhcCCCCchheeeEEe
Confidence 45678999999999999999999874 34688999987643 23345678999999999999999999999876
Q ss_pred ecCCCeEEEEEecCCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEE
Q 004672 93 DTANRNINFVTEMFTSGTLRQYRLKHR--------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 158 (738)
Q Consensus 93 ~~~~~~l~LV~Ey~~gGSL~~~l~k~~--------------~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NIL 158 (738)
. ....++||||+++|+|.+++...+ .+++..+..++.||+.||.|||+++ ++||||||+||+
T Consensus 79 ~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nil 154 (280)
T cd05049 79 E--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCL 154 (280)
T ss_pred c--CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEE
Confidence 5 578999999999999999987642 4788999999999999999999998 999999999999
Q ss_pred EeCCCCcEEEeccchhHHhhccc----cccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHH
Q 004672 159 VNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQ 232 (738)
Q Consensus 159 l~~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~q 232 (738)
++.+ +.+||+|||++....... .....+++.|+|||++. +.++.++||||||+++|+|++ |..||... +...
T Consensus 155 i~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~-~~~~ 232 (280)
T cd05049 155 VGYD-LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL-SNEE 232 (280)
T ss_pred EcCC-CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC-CHHH
Confidence 9855 899999999987543221 12334678999999886 458999999999999999998 99999864 4556
Q ss_pred HHHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 233 IYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 233 i~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
+...+..+..+. .....+..+++++.+||. +|.+||++.|+++
T Consensus 233 ~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 233 VIECITQGRLLQ-RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHHHcCCcCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 667777665543 234678899999999999 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=306.23 Aligned_cols=250 Identities=32% Similarity=0.498 Sum_probs=214.0
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
+|.+.++||.|++|.||+|.+..++..||+|.+..... .....+.+.+|+++++.++||||+++++++.. ...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~ 76 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVKYIGSIET--SDSLYI 76 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc--CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEEEE
Confidence 58899999999999999999999999999999886542 24567889999999999999999999998755 578999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccc
Q 004672 102 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 181 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~ 181 (738)
+|||+++++|.+++.....+++..+..++.|++.||.|||+++ |+||||+|+||+++. .+.++|+|||++.......
T Consensus 77 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 77 ILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTK-DGVVKLADFGVATKLNDVS 153 (254)
T ss_pred EEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECC-CCCEEEeccccceecCCCc
Confidence 9999999999999988888999999999999999999999998 999999999999985 4899999999997665433
Q ss_pred c--ccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHH
Q 004672 182 A--ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 258 (738)
Q Consensus 182 ~--~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI 258 (738)
. ....+++.|+|||.+.+ .++.++||||||+++|+|++|..||..........+ ......+ .+....++.++++|
T Consensus 154 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~i 231 (254)
T cd06627 154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR-IVQDDHP-PLPEGISPELKDFL 231 (254)
T ss_pred ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH-HhccCCC-CCCCCCCHHHHHHH
Confidence 2 23458999999998764 478899999999999999999999986543333333 3333333 34456688999999
Q ss_pred HHHHh-CcCCCCCHHHHhcCccc
Q 004672 259 EKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 259 ~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
.+||. +|.+||++.+++.||||
T Consensus 232 ~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 232 MQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHhCChhhCcCHHHHhcCCCC
Confidence 99999 99999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=324.37 Aligned_cols=251 Identities=22% Similarity=0.388 Sum_probs=206.7
Q ss_pred cCcCCCCceEEEEEcccCCeEEEEEEEcCCCeE----EEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEE
Q 004672 16 KLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIE----VAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSW 91 (738)
Q Consensus 16 ~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~----VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~f 91 (738)
+.+...+|++.+.||+|+||+||+|.+..+|.. ||+|.++.. ......+++..|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~ 78 (316)
T cd05108 2 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGIC 78 (316)
T ss_pred cccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 456778999999999999999999998766654 898887632 3445667899999999999999999999987
Q ss_pred EecCCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEec
Q 004672 92 VDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 170 (738)
Q Consensus 92 v~~~~~~l~LV~Ey~~gGSL~~~l~k~~-~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~D 170 (738)
.. ...++|+||+.+|+|.+++..+. .++...+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|
T Consensus 79 ~~---~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~-~~~kl~D 152 (316)
T cd05108 79 LT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTP-QHVKITD 152 (316)
T ss_pred cC---CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCC-CcEEEcc
Confidence 54 35679999999999999988754 6899999999999999999999998 9999999999999854 7899999
Q ss_pred cchhHHhhcccc----ccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCc
Q 004672 171 LGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPE 244 (738)
Q Consensus 171 FGlA~~l~~~~~----~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~ 244 (738)
||++........ ....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+ ....++...+..+..+.
T Consensus 153 fG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~ 231 (316)
T cd05108 153 FGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLP 231 (316)
T ss_pred ccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhCCCCCC
Confidence 999987653221 1122466899999886 458999999999999999998 9999976 34555555554444332
Q ss_pred ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 245 ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 245 ~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
.....+..+.+++.+||. +|.+||++.+++.+
T Consensus 232 -~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 232 -QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred -CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 234567899999999999 99999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.04 Aligned_cols=254 Identities=26% Similarity=0.444 Sum_probs=213.5
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
..|..+++||.|+||.||+|.+..++..||+|.++... .....+.+.+|+.+++.+.||||+++++++.+ +..++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--GTKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEE
Confidence 35778899999999999999999999999999887532 34566889999999999999999999998866 67899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
+||||+.+|+|.+++.. .++++..+..++.|++.||.|||+++ ++|+||+|+||+++.+ +.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 79 IIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDT 154 (277)
T ss_pred EEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCC-CCEEEcccccceeccCC
Confidence 99999999999998765 56899999999999999999999998 9999999999999854 79999999999665432
Q ss_pred c--cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004672 181 H--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 257 (738)
Q Consensus 181 ~--~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~l 257 (738)
. .....++..|+|||++.+ .++.++|+||||+++|+|+||..||.... +......+..+. +.......+..+.++
T Consensus 155 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~l 232 (277)
T cd06640 155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH-PMRVLFLIPKNN-PPTLTGEFSKPFKEF 232 (277)
T ss_pred ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC-hHhHhhhhhcCC-CCCCchhhhHHHHHH
Confidence 2 223358889999998864 58899999999999999999999998744 344333333333 333445567889999
Q ss_pred HHHHHh-CcCCCCCHHHHhcCcccCCCCC
Q 004672 258 IEKCLA-TVSSRLSARELLTDPFLQIDDY 285 (738)
Q Consensus 258 I~kcL~-dP~~RpSa~ELL~Hpf~~~~~~ 285 (738)
|.+||. +|.+||++.+++.||||.....
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 233 IDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred HHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 999999 8999999999999999976544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=316.34 Aligned_cols=256 Identities=35% Similarity=0.536 Sum_probs=214.9
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCe
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 98 (738)
..+.|.....||.|++|.||+|.+..++..||+|+++.... ..+.+.+|+.+|+.++|+||+++++++.. ...
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~ 89 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLV--GDE 89 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEE--CCE
Confidence 34668889999999999999999998999999999885432 45678899999999999999999998876 578
Q ss_pred EEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 99 INFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~~-~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
.++|+||+.+++|.+++.... .++...+..++.||+.||.|||+.+ |+|+||+|+||+++.+ +.++|+|||++...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~ 166 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKD-GSVKLADFGFAAQL 166 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCC-CCEEECccchhhhh
Confidence 999999999999999998876 8999999999999999999999998 9999999999999854 79999999998765
Q ss_pred hccc--cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCc-ccccCCChH
Q 004672 178 RKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE-ALFKVEDPE 253 (738)
Q Consensus 178 ~~~~--~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~-~l~~~~spe 253 (738)
.... .....+++.|+|||++.+ .++.++||||||+++|+|++|..||.... +......+.....+. ......+..
T Consensus 167 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (286)
T cd06614 167 TKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP-PLRALFLITTKGIPPLKNPEKWSPE 245 (286)
T ss_pred ccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCCCcchhhCCHH
Confidence 4322 123358899999998764 48899999999999999999999998643 333334443333222 222336789
Q ss_pred HHHHHHHHHh-CcCCCCCHHHHhcCcccCCCCC
Q 004672 254 VRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 285 (738)
Q Consensus 254 l~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~~ 285 (738)
+++||.+||+ +|.+||++.++|.|+||+....
T Consensus 246 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 278 (286)
T cd06614 246 FKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP 278 (286)
T ss_pred HHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence 9999999999 8999999999999999987443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=356.91 Aligned_cols=251 Identities=22% Similarity=0.352 Sum_probs=210.7
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCC-CCCcceeeEEE-Eec---
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSW-VDT--- 94 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~-HpNIVkl~~~f-v~~--- 94 (738)
--.+++.+.|.+|+|+.||+|.+...|.+||+|++-. .++..+..+.+||.+|+.|+ |+|||.|+++. ...
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~----~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV----NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec----CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 3457889999999999999999999889999998663 36788899999999999995 99999999943 221
Q ss_pred C-CCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEecc
Q 004672 95 A-NRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 171 (738)
Q Consensus 95 ~-~~~l~LV~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DF 171 (738)
. ...++|+||||.||.|-+++.+. .+|++..+++|++++++|+.+||...|||||||||-+||||+.+ |+.|||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~-g~~KLCDF 190 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSAD-GNYKLCDF 190 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCC-CCEEeCcc
Confidence 1 24688999999999999998853 56999999999999999999999999999999999999999855 89999999
Q ss_pred chhHHhhccc-c----------ccccCCCCCCCccccc----cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHH
Q 004672 172 GLAAILRKSH-A----------ARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 236 (738)
Q Consensus 172 GlA~~l~~~~-~----------~~~vGTp~YmAPEvl~----~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~ 236 (738)
|.|....... . -...-||.|+|||++. ...++|+|||+|||+||-|+....||.+... -.
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-----la 265 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-----LA 265 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----ee
Confidence 9996432221 0 0113799999999875 3589999999999999999999999986432 24
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 237 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 237 i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
|+.|.+.......++..+++||..||+ +|.+||++.+++.+-|.
T Consensus 266 Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 266 ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 566766555556788999999999999 99999999999977553
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.18 Aligned_cols=253 Identities=31% Similarity=0.504 Sum_probs=210.0
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
..|....+||.|+||.||+|.+..+|..||+|.+.... ....+.+.+|+.+++.++||||++++++|.. +..++
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~ 94 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQHQNVVEMYKSYLV--GEELW 94 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc----cchHHHHHHHHHHHHhCCCCchhhhhhheee--CCeEE
Confidence 45666778999999999999999999999999987533 2234678899999999999999999998765 67899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
+|+||+++++|..++.. ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++......
T Consensus 95 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~-~~~kL~dfg~~~~~~~~ 170 (297)
T cd06659 95 VLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKD 170 (297)
T ss_pred EEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccC-CcEEEeechhHhhcccc
Confidence 99999999999997654 67899999999999999999999998 9999999999999854 89999999999765433
Q ss_pred c--cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC-cccccCCChHHHH
Q 004672 181 H--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP-EALFKVEDPEVRQ 256 (738)
Q Consensus 181 ~--~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p-~~l~~~~spel~~ 256 (738)
. .....|++.|+|||++.+ .++.++||||||+++|+|++|+.||... ........+.....+ .......++.+.+
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 249 (297)
T cd06659 171 VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD-SPVQAMKRLRDSPPPKLKNAHKISPVLRD 249 (297)
T ss_pred cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhccCCCCccccCCCCHHHHH
Confidence 2 233468999999998864 5889999999999999999999999764 344444444433222 1223346788999
Q ss_pred HHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 257 FIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 257 lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
||.+||+ +|.+||++.+++.||||....
T Consensus 250 ~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 250 FLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred HHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 9999999 999999999999999997554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=321.35 Aligned_cols=255 Identities=29% Similarity=0.385 Sum_probs=201.7
Q ss_pred CceEEEEEcccCCeEEEEEEEcC--CCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEY--EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~--tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
+|.+.++||.|++|.||+|.+.. +|..||+|.+..... ......+.+.+|+.+++.++||||+++++++.+.....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence 48899999999999999999998 899999999885321 122334567889999999999999999999887655789
Q ss_pred EEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeC---CCCcEEEecc
Q 004672 100 NFVTEMFTSGTLRQYRLKH-----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG---NQGEVKIGDL 171 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~-----~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~---~~g~VKL~DF 171 (738)
++||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++. ..+.+||+||
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 80 YLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999996 5777766543 26899999999999999999999998 999999999999985 1479999999
Q ss_pred chhHHhhcccc-----ccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHH--------HHHHH
Q 004672 172 GLAAILRKSHA-----ARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPA--------QIYKK 236 (738)
Q Consensus 172 GlA~~l~~~~~-----~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~--------qi~k~ 236 (738)
|++........ ....+++.|+|||++.+ .++.++||||||+++|+|++|..||....... .....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99976543221 23357899999998764 48899999999999999999999997533211 00011
Q ss_pred HHc----------------------------CCCC-ccc------ccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 237 VIS----------------------------GKKP-EAL------FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 237 i~~----------------------------g~~p-~~l------~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
+.. ...+ ..+ ....++++.++|.+||. +|.+|||+.|++.||||
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 100 0000 000 01456789999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=317.75 Aligned_cols=248 Identities=24% Similarity=0.352 Sum_probs=207.8
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEE-----cCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEE
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFD-----EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWV 92 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d-----~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv 92 (738)
|...+|.+.+.||.|+||+||++.+ ..++..||+|.+.. ......+.+.+|+.+|++++||||+++++++.
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD----ASDNARKDFHREAELLTNLQHEHIVKFYGVCV 77 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCC----cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 4567899999999999999999986 34567799998763 23456678999999999999999999999875
Q ss_pred ecCCCeEEEEEecCCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEE
Q 004672 93 DTANRNINFVTEMFTSGTLRQYRLKHR-------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 159 (738)
Q Consensus 93 ~~~~~~l~LV~Ey~~gGSL~~~l~k~~-------------~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl 159 (738)
. ...+++||||+++++|.+++..++ .+++..++.++.||+.||+|||+++ ++||||||+||++
T Consensus 78 ~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili 153 (288)
T cd05093 78 E--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLV 153 (288)
T ss_pred c--CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEE
Confidence 4 678999999999999999987654 4899999999999999999999998 9999999999999
Q ss_pred eCCCCcEEEeccchhHHhhccc----cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhh-cCCCCCCCCCHHHH
Q 004672 160 NGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQI 233 (738)
Q Consensus 160 ~~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi 233 (738)
+.+ +.+||+|||++....... .....+++.|+|||++.+ .++.++||||||+++|+|+| |..||... ....+
T Consensus 154 ~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~-~~~~~ 231 (288)
T cd05093 154 GEN-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL-SNNEV 231 (288)
T ss_pred ccC-CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHH
Confidence 854 899999999997553321 123345788999998874 58999999999999999998 89999764 45566
Q ss_pred HHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 234 YKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 234 ~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
...+..+..+. .....++++.+|+.+||+ +|.+|||+.+++.
T Consensus 232 ~~~i~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 232 IECITQGRVLQ-RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHHHcCCcCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 67777776543 334578899999999999 9999999999953
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.57 Aligned_cols=251 Identities=27% Similarity=0.426 Sum_probs=212.9
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCC-CCCcceeeEEEEecCCCeE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~l 99 (738)
++|.+.+.||.|++|.||+|.+..+|..||+|.+.... .......+.+..|+.+++++. ||||+++++++.. ...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~ 77 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQ-LIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENL 77 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHh-ccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceE
Confidence 47899999999999999999999999999999887543 223444578899999999998 9999999997744 6789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 100 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
++||||+.+++|.+++.+.+.+++..++.|+.||+.||.|||+++ ++|+||+|+||+++. +|.++|+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~-~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 78 YFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDK-DMHIKITDFGTAKVLDP 154 (280)
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECC-CCCEEecCCccccccCC
Confidence 999999999999999998889999999999999999999999998 999999999999975 48999999999976543
Q ss_pred ccc----------------------ccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHH
Q 004672 180 SHA----------------------ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 236 (738)
Q Consensus 180 ~~~----------------------~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~ 236 (738)
... ....|++.|+|||++.. .++.++||||||+++++|++|..||.... ....+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~ 233 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-EYLTFQK 233 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHH
Confidence 221 22357899999998764 58889999999999999999999998644 4444555
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCH----HHHhcCccc
Q 004672 237 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSA----RELLTDPFL 280 (738)
Q Consensus 237 i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa----~ELL~Hpf~ 280 (738)
+..... .++...++.+.+||.+||. +|.+||++ .++|+||||
T Consensus 234 ~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILKLEY--SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHhcCC--CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 543332 2334558899999999999 89999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=315.76 Aligned_cols=243 Identities=21% Similarity=0.340 Sum_probs=197.4
Q ss_pred CCceEEEEE--cccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecCCC
Q 004672 21 EDMEDTMKF--LVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 21 ~~y~il~kL--G~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~ 97 (738)
++|.+.+.+ |.|+||.||++.++.+|..+|+|.+....... .|+.....+ +||||++++++|.. .+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---------~e~~~~~~~~~h~~iv~~~~~~~~--~~ 82 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---------IEPMVHQLMKDNPNFIKLYYSVTT--LK 82 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---------hhHHHHHHhhcCCCEEEEEEEEec--CC
Confidence 456666665 99999999999999999999999987543211 122222222 79999999998865 56
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
.+++||||+++|+|.+++.....+++..++.++.||+.||.|||+.+ ++||||||+||+++.+.+.++|+|||++...
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 89999999999999999988889999999999999999999999998 9999999999999866448999999998765
Q ss_pred hccccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCH----HHHHHHHHcCCCCcccccCCCh
Q 004672 178 RKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHP----AQIYKKVISGKKPEALFKVEDP 252 (738)
Q Consensus 178 ~~~~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~----~qi~k~i~~g~~p~~l~~~~sp 252 (738)
... ....|++.|+|||++.+ .++.++||||||+++|+|++|..||...... ..+.... ..+.......++
T Consensus 161 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 235 (267)
T PHA03390 161 GTP--SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---QKKLPFIKNVSK 235 (267)
T ss_pred CCC--ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---cccCCcccccCH
Confidence 432 23458999999999864 5889999999999999999999999753322 1122211 223334457899
Q ss_pred HHHHHHHHHHh-CcCCCCC-HHHHhcCcccC
Q 004672 253 EVRQFIEKCLA-TVSSRLS-ARELLTDPFLQ 281 (738)
Q Consensus 253 el~~lI~kcL~-dP~~RpS-a~ELL~Hpf~~ 281 (738)
.+++||.+||+ +|.+||+ +.++|+||||+
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 236 NANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 99999999999 9999996 59999999996
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=312.02 Aligned_cols=247 Identities=24% Similarity=0.334 Sum_probs=208.0
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCC
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 97 (738)
+...+|.+.++||.|++|+||+|.+..++..||+|.++.. ....+.+.+|+.+|+.++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 75 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EP 75 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-----chHHHHHHHHHHHHHhCCCCChhheEEEEcC--CC
Confidence 4567899999999999999999999999999999987632 2335678899999999999999999998744 56
Q ss_pred eEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 98 NINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
.+++||||+++++|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+||+++. ++.+||+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~-~~~~kl~df~~~~ 152 (263)
T cd05052 76 PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGE-NHLVKVADFGLSR 152 (263)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcC-CCcEEeCCCcccc
Confidence 889999999999999998764 35899999999999999999999998 999999999999974 4899999999997
Q ss_pred Hhhcccccc---ccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCC
Q 004672 176 ILRKSHAAR---CVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVE 250 (738)
Q Consensus 176 ~l~~~~~~~---~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~ 250 (738)
......... ..+++.|+|||.+. ..++.++||||||+++|+|++ |..||.. .+...++..+..+..+. .....
T Consensus 153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~ 230 (263)
T cd05052 153 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKGYRME-RPEGC 230 (263)
T ss_pred ccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCCC-CCCCC
Confidence 665432211 12456899999876 458899999999999999998 9999976 45666777776654443 34567
Q ss_pred ChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 251 DPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 251 spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
++++.++|.+||. +|.+|||+.++++
T Consensus 231 ~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 231 PPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 8999999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=328.23 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=205.1
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC-----
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA----- 95 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~----- 95 (738)
.+|.+.+.||.|+||+||+|.++.+|..||+|++...+. ...+.+.+|+.+|+.++||||+++++++....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 689999999999999999999999999999999875542 44567889999999999999999998764432
Q ss_pred -------CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEE
Q 004672 96 -------NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 168 (738)
Q Consensus 96 -------~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL 168 (738)
...+++||||+. ++|.+++.. .++++..++.++.||+.||.|||+++ |+||||||+||+++..++.+||
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEEE
Confidence 135799999996 699888754 56999999999999999999999998 9999999999999866678999
Q ss_pred eccchhHHhhccc-----cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCC
Q 004672 169 GDLGLAAILRKSH-----AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 241 (738)
Q Consensus 169 ~DFGlA~~l~~~~-----~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~ 241 (738)
+|||++..+.... .....|+..|+|||++.+ .++.++|||||||++|+|++|+.||......... ..+....
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~-~~~~~~~ 235 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM-QLILESV 235 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhc
Confidence 9999997653321 122357889999997643 4888999999999999999999999765433332 2222110
Q ss_pred ------------------------CC----cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 242 ------------------------KP----EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 242 ------------------------~p----~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
.+ .......+.++++||.+||+ +|.+|||+.++|.||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 00 01123467889999999999 9999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=315.04 Aligned_cols=250 Identities=21% Similarity=0.309 Sum_probs=207.0
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEc----CCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEe
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDE----YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD 93 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~----~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~ 93 (738)
+++++|++.+.||+|+||+||+|... .++..||+|.++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 78 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI---NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ 78 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC---CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec
Confidence 56789999999999999999999853 45678999988742 234556788999999999999999999998754
Q ss_pred cCCCeEEEEEecCCCCCHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCccc
Q 004672 94 TANRNINFVTEMFTSGTLRQYRLKH-----------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156 (738)
Q Consensus 94 ~~~~~l~LV~Ey~~gGSL~~~l~k~-----------------~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~N 156 (738)
....++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 79 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~n 154 (283)
T cd05090 79 --EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARN 154 (283)
T ss_pred --CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccce
Confidence 56789999999999999998643 23788899999999999999999998 9999999999
Q ss_pred EEEeCCCCcEEEeccchhHHhhccc----cccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCH
Q 004672 157 IFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHP 230 (738)
Q Consensus 157 ILl~~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~ 230 (738)
||++.+ +.+||+|||++....... .....++..|+|||++. +.++.++||||||+++|+|++ |..||.+. ..
T Consensus 155 ili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~-~~ 232 (283)
T cd05090 155 ILIGEQ-LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF-SN 232 (283)
T ss_pred EEEcCC-CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-CH
Confidence 999854 789999999997653321 22334667899999886 458999999999999999998 99999763 45
Q ss_pred HHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 231 AQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 231 ~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
..+...+..+..+. .+...++.+++++.+||+ +|.+||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 233 QEVIEMVRKRQLLP-CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 56666666555432 445678999999999999 99999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=319.33 Aligned_cols=254 Identities=26% Similarity=0.343 Sum_probs=202.0
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC----
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA---- 95 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~---- 95 (738)
+++|.+.++||.|++|.||+|.+..+|..||+|++...... ......+.+|+++|+.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC--CCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 68999999999999999999999999999999998754321 122345678999999999999999999876533
Q ss_pred --CCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccc
Q 004672 96 --NRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 172 (738)
Q Consensus 96 --~~~l~LV~Ey~~gGSL~~~l~k-~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFG 172 (738)
...+++||||+. ++|..++.. ...+++..++.++.||+.||.|||+++ |+|+||||+||+++.+ +.+||+|||
T Consensus 85 ~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg 160 (311)
T cd07866 85 RKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQ-GILKIADFG 160 (311)
T ss_pred ccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEECcCc
Confidence 236899999996 467766654 457999999999999999999999998 9999999999999855 899999999
Q ss_pred hhHHhhcccc-------------ccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHH
Q 004672 173 LAAILRKSHA-------------ARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 237 (738)
Q Consensus 173 lA~~l~~~~~-------------~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i 237 (738)
++........ ....|++.|+|||++.+ .++.++||||||+++|+|++|..||........ ...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~-~~~~ 239 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ-LHLI 239 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence 9976543211 12347889999998753 488999999999999999999999986444332 2222
Q ss_pred Hc--CC-CCc-------------------------ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 238 IS--GK-KPE-------------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 238 ~~--g~-~p~-------------------------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
.. +. .+. .......+.+.+||.+||. +|.+|||+.++|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 21 10 000 0012334788999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=314.41 Aligned_cols=251 Identities=28% Similarity=0.447 Sum_probs=211.5
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
-|.++++||.|+||.||+|.+..++..||+|.+.... .....+.+.+|+.+++.++||||++++++|.. +..+++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe--CCeEEE
Confidence 4778899999999999999999999999999876432 33456789999999999999999999998865 678999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccc
Q 004672 102 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 181 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~ 181 (738)
||||+.+++|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||+|.||+++.+ +.++|+|||++..+....
T Consensus 80 v~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~-~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 80 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCC-CCEEEeecccceecccch
Confidence 9999999999998765 56899999999999999999999998 9999999999999854 899999999986554321
Q ss_pred --cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHH
Q 004672 182 --AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 258 (738)
Q Consensus 182 --~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI 258 (738)
.....|+..|+|||.+.. .++.++|+||||+++|+|++|..||... +.......+..+.. ..+....+.++.++|
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i 233 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL-HPMKVLFLIPKNNP-PTLEGNYSKPLKEFV 233 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc-chHHHHHHHhcCCC-CCCCcccCHHHHHHH
Confidence 123458899999998864 5788999999999999999999999863 44444444444433 334456788999999
Q ss_pred HHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 259 EKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 259 ~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
.+||. +|.+||++.++++||||...
T Consensus 234 ~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 234 EACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHHccCChhhCcCHHHHHhCHHHhhh
Confidence 99999 99999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=312.42 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=205.6
Q ss_pred ceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEE
Q 004672 23 MEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 102 (738)
Q Consensus 23 y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV 102 (738)
|.+++.||.|++|.||+|.+..+|..||+|.+.... ........+.+|+.+++.++||||+++++++.......+++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence 678999999999999999999999999999988653 233445678899999999999999999998765434789999
Q ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccc
Q 004672 103 TEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 181 (738)
Q Consensus 103 ~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~ 181 (738)
|||++ ++|..++... ..+++..++.++.||+.||+|||+.+ ++|+||+|+||+++.+ +.+||+|||++.......
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~-~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 79 FEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINND-GVLKLADFGLARPYTKRN 154 (287)
T ss_pred ecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCC-CCEEEccccceeeccCCC
Confidence 99996 5899888765 57999999999999999999999998 9999999999999854 899999999997665442
Q ss_pred ---cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCC--C-Cc---------
Q 004672 182 ---AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK--K-PE--------- 244 (738)
Q Consensus 182 ---~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~--~-p~--------- 244 (738)
.....++..|+|||.+.+ .++.++||||||+++|+|+||+.||........ ...+.... . +.
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ-LEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchhhccccccch
Confidence 223357889999997754 478999999999999999999999987554333 23332210 0 00
Q ss_pred -----------------ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 245 -----------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 245 -----------------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
.+....++.+.++|.+||. +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0111237889999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=320.09 Aligned_cols=251 Identities=27% Similarity=0.437 Sum_probs=209.4
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
+.|..++.||.|+||.||+|.+..+|..||+|.++... .....+.+.+|+.+++.++||||++++++|.. +..++
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 78 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYITRYYGSYLK--GTKLW 78 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHHHHHHHHHHHHcCCCCccHhhhccccc--CCceE
Confidence 34677788999999999999999999999999877432 34556789999999999999999999998755 67899
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
+||||+++++|.+++.. ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++. ++.++|+|||++..+...
T Consensus 79 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~-~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 79 IIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSE-QGDVKLADFGVAGQLTDT 154 (277)
T ss_pred EEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeC-CCCEEEccccccccccCc
Confidence 99999999999998754 56899999999999999999999998 999999999999985 489999999998765432
Q ss_pred c--cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004672 181 H--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 257 (738)
Q Consensus 181 ~--~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~l 257 (738)
. .....|+..|+|||.+.+ .++.++||||||+++|+|+||..||.... +......+..+.. ..+....+.++.++
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~l 232 (277)
T cd06642 155 QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH-PMRVLFLIPKNSP-PTLEGQYSKPFKEF 232 (277)
T ss_pred chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc-hhhHHhhhhcCCC-CCCCcccCHHHHHH
Confidence 2 123358899999998865 58889999999999999999999997633 3333333333332 23344567889999
Q ss_pred HHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 258 IEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 258 I~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
|.+||. +|.+||++.+++.||||..
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 233 VEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred HHHHccCCcccCcCHHHHHHhHHHHH
Confidence 999999 9999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=326.80 Aligned_cols=255 Identities=24% Similarity=0.330 Sum_probs=206.8
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCC---C
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN---R 97 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~---~ 97 (738)
.+|.+.+.||.|+||+||+|.+..+|..||||+++... .......++.+|+.+|+.++||||+++++++..... .
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF--DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc--cccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 57999999999999999999999999999999887432 223345677889999999999999999997754322 3
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
.+++|+||+ +++|.+++...+++++..++.++.||+.||.|||+++ ++||||||+||+++.+ +.+||+|||++...
T Consensus 83 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~ 158 (337)
T cd07858 83 DVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNAN-CDLKICDFGLARTT 158 (337)
T ss_pred cEEEEEeCC-CCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC-CCEEECcCcccccc
Confidence 589999999 4799999988888999999999999999999999998 9999999999999855 79999999999765
Q ss_pred hcc--ccccccCCCCCCCccccc--cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc--CC----------
Q 004672 178 RKS--HAARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GK---------- 241 (738)
Q Consensus 178 ~~~--~~~~~vGTp~YmAPEvl~--~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~--g~---------- 241 (738)
... ......++..|+|||++. ..++.++||||||+++|+|++|..||.+... ...+..+.. |.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCChHHhhhcC
Confidence 432 223446889999999875 3588999999999999999999999975322 111111110 00
Q ss_pred -------------C--C--cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 242 -------------K--P--EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 242 -------------~--p--~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
. + .......+++++++|.+||+ +|.+|||+.++|+||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 0 0 11123567889999999999 9999999999999999963
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=325.78 Aligned_cols=263 Identities=23% Similarity=0.378 Sum_probs=231.0
Q ss_pred ccCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEec
Q 004672 15 LKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 94 (738)
Q Consensus 15 ~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~ 94 (738)
...++.++|..++.||.|.||+|-++..+.+|+.+|+|+++..- ....++...-..|-++|+..+||.+..+.-+|.
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKev-iiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ-- 238 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEV-IIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ-- 238 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhh-eeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc--
Confidence 45678899999999999999999999999999999999988554 445667778889999999999999998877774
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 95 ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 95 ~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
.+..+++||||..||.|+-.+.+.+.+++...+.+...|+.||.|||+++ ||+||||.+|+|++. +|+|||+|||++
T Consensus 239 t~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDk-DGHIKitDFGLC 315 (516)
T KOG0690|consen 239 TQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDK-DGHIKITDFGLC 315 (516)
T ss_pred cCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheecc-CCceEeeecccc
Confidence 47899999999999999999999899999999999999999999999999 999999999999984 599999999999
Q ss_pred HHh--hccccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCC
Q 004672 175 AIL--RKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED 251 (738)
Q Consensus 175 ~~l--~~~~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~s 251 (738)
+.- ......+.+|||.|+|||++.. .|+.++|.|.+|+++|||++|+.||... +-+.++.-|..+.. .++...+
T Consensus 316 KE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~-dh~kLFeLIl~ed~--kFPr~ls 392 (516)
T KOG0690|consen 316 KEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK-DHEKLFELILMEDL--KFPRTLS 392 (516)
T ss_pred hhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc-chhHHHHHHHhhhc--cCCccCC
Confidence 743 2345677899999999999985 5999999999999999999999999874 45666676665433 2456789
Q ss_pred hHHHHHHHHHHh-CcCCCC-----CHHHHhcCcccCCCCCc
Q 004672 252 PEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDYD 286 (738)
Q Consensus 252 pel~~lI~kcL~-dP~~Rp-----Sa~ELL~Hpf~~~~~~~ 286 (738)
++++.++..+|. +|.+|+ .|.|+.+|+||...++.
T Consensus 393 ~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~ 433 (516)
T KOG0690|consen 393 PEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE 433 (516)
T ss_pred HHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence 999999999999 999997 48999999999987765
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=342.47 Aligned_cols=257 Identities=24% Similarity=0.378 Sum_probs=226.0
Q ss_pred CcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCC
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 96 (738)
......|.+..+||.|.|++|.+|.+..||.+||||.+.... .+...++.+.+|+++|+.|+|||||++|.+. ...
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~--ln~~~~~k~~rev~imk~l~HPnIvkl~~v~--~t~ 127 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQ--LNPSKRQKLGREVDIMKSLNHPNIVKLFSVI--ETE 127 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcc--cChHHHHHHHHHHHHHHhcCCcceeeeeeee--eec
Confidence 445667999999999999999999999999999999888654 3445566799999999999999999999965 447
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
..+|+||||+.+|.+++|+.+++++.+..++.++.|++.|++|||+++ |+|||||.+|||++.+ -.+||+|||++..
T Consensus 128 ~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~-mnikIaDfgfS~~ 204 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDEN-MNIKIADFGFSTF 204 (596)
T ss_pred ceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccc-cceeeecccccee
Confidence 899999999999999999999999999999999999999999999999 9999999999999976 4699999999988
Q ss_pred hhcc-ccccccCCCCCCCccccccc--cCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChH
Q 004672 177 LRKS-HAARCVGTPEFMAPEVYEEE--YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 253 (738)
Q Consensus 177 l~~~-~~~~~vGTp~YmAPEvl~~~--ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spe 253 (738)
+... ...+.+|+|.|.|||++.+. -.+.+|+||+|+++|-|+.|..||.+ .+...+..+++.|+.-. +...+-+
T Consensus 205 ~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG-~~lk~Lr~rvl~gk~rI--p~~ms~d 281 (596)
T KOG0586|consen 205 FDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG-QNLKELRPRVLRGKYRI--PFYMSCD 281 (596)
T ss_pred ecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC-cccccccchheeeeecc--cceeech
Confidence 7654 45678899999999999864 46789999999999999999999987 45556666677776543 3446789
Q ss_pred HHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 254 VRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 254 l~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
+.++|+++|. +|.+|++.+++.+|.|....
T Consensus 282 ce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 282 CEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred hHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 9999999999 99999999999999998654
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=325.29 Aligned_cols=253 Identities=26% Similarity=0.415 Sum_probs=202.5
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC---CC
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA---NR 97 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~---~~ 97 (738)
++|.+.++||.|+||+||+|.+..+|..||+|+++... ......++.+|+.+|+.++||||+++++++.... ..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE---HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 68999999999999999999999999999999886422 2344567889999999999999999998765432 24
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
.+++|+||+. ++|..++. .+++++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++...
T Consensus 82 ~~~lv~e~~~-~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~ 156 (336)
T cd07849 82 DVYIVQELME-TDLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTN-CDLKICDFGLARIA 156 (336)
T ss_pred eEEEEehhcc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCC-CCEEECcccceeec
Confidence 6899999995 58888764 457999999999999999999999998 9999999999999854 89999999998765
Q ss_pred hccc-----cccccCCCCCCCccccc--cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc--CC-------
Q 004672 178 RKSH-----AARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GK------- 241 (738)
Q Consensus 178 ~~~~-----~~~~vGTp~YmAPEvl~--~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~--g~------- 241 (738)
.... .....|++.|+|||++. ..++.++||||||+++|+|++|+.||.+......+ ..+.. +.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL-NLILGVLGTPSQEDLN 235 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHcCCCCHHHHH
Confidence 3321 12346899999999864 35889999999999999999999999764322211 11110 00
Q ss_pred -------------CC-------cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 242 -------------KP-------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 242 -------------~p-------~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
.+ .......++++.+||.+||+ +|.+|||+.+++.||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~ 297 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ 297 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccc
Confidence 00 00112357889999999999 9999999999999999974
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=328.36 Aligned_cols=252 Identities=22% Similarity=0.321 Sum_probs=205.3
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEc-----CCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEE
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDE-----YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSW 91 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~-----~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~f 91 (738)
++.++|.+.+.||.|+||.||+|.+. .+++.||+|+++.. ......+.+..|+.+++++ +||||+++++++
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG---ATASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCC---CCHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 45678999999999999999999754 35689999987632 2334557788999999999 899999999987
Q ss_pred EecCCCeEEEEEecCCCCCHHHHHHhc-----------------------------------------------------
Q 004672 92 VDTANRNINFVTEMFTSGTLRQYRLKH----------------------------------------------------- 118 (738)
Q Consensus 92 v~~~~~~l~LV~Ey~~gGSL~~~l~k~----------------------------------------------------- 118 (738)
... ...++++|||+++|+|.+++...
T Consensus 81 ~~~-~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 81 TKP-GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred ecC-CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 543 56789999999999999998642
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccc----ccccc
Q 004672 119 --------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCV 186 (738)
Q Consensus 119 --------~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~----~~~~v 186 (738)
..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..+.... .....
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~-~~vkL~DfG~a~~~~~~~~~~~~~~~~ 236 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDAR 236 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCC-CcEEEeccccchhcccCcchhhccCCC
Confidence 25788999999999999999999998 9999999999999854 799999999998754321 12234
Q ss_pred CCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-
Q 004672 187 GTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA- 263 (738)
Q Consensus 187 GTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~- 263 (738)
++..|+|||++. ..++.++|||||||++|+|++ |..||.+......+...+..+..+ ......++++.+++.+||+
T Consensus 237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~ 315 (337)
T cd05054 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-RAPEYATPEIYSIMLDCWHN 315 (337)
T ss_pred CCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC-CCCccCCHHHHHHHHHHccC
Confidence 677899999876 459999999999999999998 999998644444444444444433 2345567899999999999
Q ss_pred CcCCCCCHHHHhcC
Q 004672 264 TVSSRLSARELLTD 277 (738)
Q Consensus 264 dP~~RpSa~ELL~H 277 (738)
+|.+||++.++++|
T Consensus 316 ~p~~RPs~~ell~~ 329 (337)
T cd05054 316 NPEDRPTFSELVEI 329 (337)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=314.13 Aligned_cols=243 Identities=28% Similarity=0.450 Sum_probs=200.2
Q ss_pred eEEEEEcccCCeEEEEEEEc----CCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeE
Q 004672 24 EDTMKFLVKELQRHYRAFDE----YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 24 ~il~kLG~GafgtVYkA~d~----~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
.+.+.||.|+||.||+|... ..+..|+||.++. ....+..+.+.+|+++|++++||||+++++++.. ...+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~---~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~--~~~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP---SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE--NEPL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST---TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES--SSSE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc---ccccccceeeeecccccccccccccccccccccc--cccc
Confidence 46889999999999999987 4578899998853 2355668899999999999999999999999873 5569
Q ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 100 NFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
++||||+++|+|.+++... ..+++..+..|+.||+.||.|||+++ ++|++|++.|||++.+ +.+||+|||++...
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~-~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSN-GQVKLSDFGLSRPI 153 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETT-TEEEEESTTTGEET
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccc-cccccccccccccc
Confidence 9999999999999999987 67999999999999999999999998 9999999999999965 79999999999766
Q ss_pred hcc----ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCC
Q 004672 178 RKS----HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVED 251 (738)
Q Consensus 178 ~~~----~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~s 251 (738)
... ......+...|+|||.+.. .++.++||||||+++|||+| |+.||... +..++...+..+..+. .....+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~ 231 (259)
T PF07714_consen 154 SEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKLKQGQRLP-IPDNCP 231 (259)
T ss_dssp TTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHHHTTEETT-SBTTSB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccce-eccchh
Confidence 321 1122346779999999864 58999999999999999999 78999875 6777777777666543 345568
Q ss_pred hHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 252 PEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 252 pel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
..+.++|..||. +|.+|||+.+|++
T Consensus 232 ~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 232 KDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 899999999999 8999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=314.62 Aligned_cols=257 Identities=20% Similarity=0.302 Sum_probs=208.2
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcC-----CCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEE
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEY-----EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWV 92 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~-----tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv 92 (738)
+..++|.+.++||.|+||.||+|.++. .+..||+|.++.. ........+.+|+.+++.++||||+++++++.
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES---ASLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc---CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 445789999999999999999997652 3568999986632 23344557889999999999999999999875
Q ss_pred ecCCCeEEEEEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCC
Q 004672 93 DTANRNINFVTEMFTSGTLRQYRLKHR----------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 162 (738)
Q Consensus 93 ~~~~~~l~LV~Ey~~gGSL~~~l~k~~----------~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~ 162 (738)
. +...++||||+.+|+|.+++.+.+ .++...+..++.||+.||.|||+++ |+||||||+||+++.+
T Consensus 80 ~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~ 155 (288)
T cd05061 80 K--GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHD 155 (288)
T ss_pred C--CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCC
Confidence 4 567899999999999999987532 3466788999999999999999998 9999999999999854
Q ss_pred CCcEEEeccchhHHhhcccc----ccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHH
Q 004672 163 QGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKK 236 (738)
Q Consensus 163 ~g~VKL~DFGlA~~l~~~~~----~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~ 236 (738)
+.+||+|||++........ ....++..|+|||.+. +.++.++||||||+++|+|++ |..||.. ....++.+.
T Consensus 156 -~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~-~~~~~~~~~ 233 (288)
T cd05061 156 -FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-LSNEQVLKF 233 (288)
T ss_pred -CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHH
Confidence 7999999999875433211 1223567899999886 468999999999999999998 7889976 455666676
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc------CcccCCCC
Q 004672 237 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT------DPFLQIDD 284 (738)
Q Consensus 237 i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~------Hpf~~~~~ 284 (738)
+..+..+. .....++.+++++.+||+ +|.+|||+.++++ ||||+..+
T Consensus 234 ~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 234 VMDGGYLD-QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred HHcCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 66665443 233457899999999999 9999999999986 89887543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=313.82 Aligned_cols=252 Identities=19% Similarity=0.303 Sum_probs=206.5
Q ss_pred CcCCCCceEEEEEcccCCeEEEEEEEcC-----CCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEE
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEY-----EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSW 91 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~-----tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~f 91 (738)
.+..++|.+.+.||.|++|.||+|.+.. ++..||+|.+... ........+..|+.+++.++|+||+++++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (277)
T cd05036 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES---CSEQDESDFLMEALIMSKFNHQNIVRLIGVS 78 (277)
T ss_pred CCCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3456789999999999999999999987 7889999977632 2334456789999999999999999999987
Q ss_pred EecCCCeEEEEEecCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCC--
Q 004672 92 VDTANRNINFVTEMFTSGTLRQYRLKHR-------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN-- 162 (738)
Q Consensus 92 v~~~~~~l~LV~Ey~~gGSL~~~l~k~~-------~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~-- 162 (738)
.+ ....++||||+.+++|.+++...+ .+++..+..++.||+.||.|||+++ ++||||||+||+++.+
T Consensus 79 ~~--~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~ 154 (277)
T cd05036 79 FE--RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGP 154 (277)
T ss_pred cc--CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCC
Confidence 55 567789999999999999987754 4899999999999999999999998 9999999999999744
Q ss_pred CCcEEEeccchhHHhhcccc----ccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHH
Q 004672 163 QGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKK 236 (738)
Q Consensus 163 ~g~VKL~DFGlA~~l~~~~~----~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~ 236 (738)
...+||+|||++........ ....+++.|+|||++. ..++.++|||||||++|+|++ |..||.... ...+...
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~-~~~~~~~ 233 (277)
T cd05036 155 GRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT-NQEVMEF 233 (277)
T ss_pred CcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHH
Confidence 23689999999976533211 1122356899999886 459999999999999999997 999998744 4455565
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 237 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 237 i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
+..+..+ ..+...++.+.+|+.+||+ +|.+|||+.++|+|
T Consensus 234 ~~~~~~~-~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 234 VTGGGRL-DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HHcCCcC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 5554333 2345568899999999999 89999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=314.72 Aligned_cols=257 Identities=21% Similarity=0.337 Sum_probs=212.7
Q ss_pred CceEEEEEcccCCeEEEEEEEc---CCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecCCC
Q 004672 22 DMEDTMKFLVKELQRHYRAFDE---YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~---~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~ 97 (738)
.|.+.+.||.|+||.||+|.+. .+|..||+|.++...........+++..|+.+|+.+ +|+||+++++.|.. +.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CC
Confidence 4788999999999999999885 489999999987544333344567789999999999 69999999987744 67
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
.+++||||+++++|.+++.....+++..+..++.||+.||.|||+.+ ++||||+|+|||++.+ +.+||+|||++...
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~ 155 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSN-GHVVLTDFGLSKEF 155 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCC-CCEEEeeCccceec
Confidence 89999999999999999988888999999999999999999999998 9999999999999854 89999999998765
Q ss_pred hccc---cccccCCCCCCCcccccc---ccCcccccccchhhhhhhhhcCCCCCCCC---CHHHHHHHHHcCCCCccccc
Q 004672 178 RKSH---AARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECT---HPAQIYKKVISGKKPEALFK 248 (738)
Q Consensus 178 ~~~~---~~~~vGTp~YmAPEvl~~---~ys~~sDIWSLGviLyeLlTG~~Pf~~~~---~~~qi~k~i~~g~~p~~l~~ 248 (738)
.... .....|++.|+|||.+.. .++.++||||||+++|+|+||..||.... ....+...+..+..+ ++.
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~ 233 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQ 233 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCC--CCc
Confidence 4322 123458999999998863 47789999999999999999999996422 223344444433332 345
Q ss_pred CCChHHHHHHHHHHh-CcCCCC-----CHHHHhcCcccCCCCC
Q 004672 249 VEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDY 285 (738)
Q Consensus 249 ~~spel~~lI~kcL~-dP~~Rp-----Sa~ELL~Hpf~~~~~~ 285 (738)
..++.+.+++.+||. +|.+|| ++.+++.||||+.-.+
T Consensus 234 ~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 578899999999999 899997 8999999999987654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=309.43 Aligned_cols=246 Identities=22% Similarity=0.379 Sum_probs=204.3
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCC
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 97 (738)
|..++|+++++||+|++|+||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+.. ..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 74 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYAVVTK--EE 74 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CC
Confidence 56789999999999999999999974 56789999876322 235688999999999999999999997644 67
Q ss_pred eEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 98 NINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
..+++|||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++ ++||||||+||+++. .+.+||+|||++.
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~-~~~~~l~dfg~~~ 151 (261)
T cd05072 75 PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSE-SLMCKIADFGLAR 151 (261)
T ss_pred CcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecC-CCcEEECCCccce
Confidence 789999999999999998764 46889999999999999999999998 999999999999985 4899999999997
Q ss_pred Hhhcccc---ccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCC
Q 004672 176 ILRKSHA---ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVE 250 (738)
Q Consensus 176 ~l~~~~~---~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~ 250 (738)
....... ....++..|+|||.+. +.++.++||||||+++|+|+| |..||.. .....+...+..+..+. .....
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~ 229 (261)
T cd05072 152 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG-MSNSDVMSALQRGYRMP-RMENC 229 (261)
T ss_pred ecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCC
Confidence 6543221 1223567899999886 458889999999999999998 9999986 34555666666554332 33456
Q ss_pred ChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 251 DPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 251 spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
+.++.++|.+||. +|.+||++.++++
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 230 PDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 7899999999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=310.61 Aligned_cols=249 Identities=21% Similarity=0.346 Sum_probs=206.8
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCC-----CeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEE
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYE-----GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWV 92 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~t-----G~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv 92 (738)
+..++|.+.+.||.|+||.||+|.++.. +..||+|.+... ........+.+|+.+|+.++||||+++++++.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN---ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc---cCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 5567899999999999999999998754 489999987532 23455567889999999999999999999875
Q ss_pred ecCCCeEEEEEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCC
Q 004672 93 DTANRNINFVTEMFTSGTLRQYRLKHR----------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 162 (738)
Q Consensus 93 ~~~~~~l~LV~Ey~~gGSL~~~l~k~~----------~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~ 162 (738)
. ...+++||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 80 ~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~ 155 (277)
T cd05032 80 T--GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAED 155 (277)
T ss_pred C--CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCC
Confidence 4 578999999999999999986532 3678899999999999999999998 9999999999999855
Q ss_pred CCcEEEeccchhHHhhccc----cccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHH
Q 004672 163 QGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKK 236 (738)
Q Consensus 163 ~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~ 236 (738)
+.+||+|||++..+.... .....++..|+|||.+. +.++.++||||||+++|+|+| |..||.. .+...+.+.
T Consensus 156 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~ 233 (277)
T cd05032 156 -LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG-LSNEEVLKF 233 (277)
T ss_pred -CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc-CCHHHHHHH
Confidence 899999999997654332 12334678999999876 468999999999999999998 9999976 456666666
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 237 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 237 i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
+..+..+. .+...++++.++|.+||+ +|.+|||+.+++.
T Consensus 234 ~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 234 VIDGGHLD-LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HhcCCCCC-CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 66554332 334458899999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=306.27 Aligned_cols=241 Identities=23% Similarity=0.333 Sum_probs=206.6
Q ss_pred EEEcccCCeEEEEEEEcCC---CeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEE
Q 004672 27 MKFLVKELQRHYRAFDEYE---GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 103 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~t---G~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~ 103 (738)
+.||.|+||.||+|.+... +..||+|.++... .....+.+.+|+.+++.++|+||+++++++.. ...+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA---SEEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeecccc---chhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEE
Confidence 3689999999999999866 9999999887543 22256789999999999999999999998755 77899999
Q ss_pred ecCCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 104 EMFTSGTLRQYRLKH---------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 104 Ey~~gGSL~~~l~k~---------~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||.+
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~-~~~~l~dfg~~ 152 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGED-LVVKISDFGLS 152 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCC-CcEEEcccccc
Confidence 999999999999886 67999999999999999999999998 9999999999999865 89999999999
Q ss_pred HHhhccc----cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCccccc
Q 004672 175 AILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFK 248 (738)
Q Consensus 175 ~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~ 248 (738)
....... .....+++.|+|||.+.. .++.++||||||+++|+|++ |..||... ...++...+..+..+. ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~ 230 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRKGYRLP-KPE 230 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCCC-CCc
Confidence 8765432 233457899999998864 68999999999999999999 69999874 5667777777654432 344
Q ss_pred CCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 249 VEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 249 ~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
..++++.+++.+||. +|.+|||+.+++++
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 231 YCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred cCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 568999999999999 89999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=313.07 Aligned_cols=249 Identities=20% Similarity=0.321 Sum_probs=203.2
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEc-----CCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEe
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDE-----YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD 93 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~-----~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~ 93 (738)
..++|++.+.||.|+||+||+|.+. .++..||+|.++.. ........+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~- 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS- 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc-
Confidence 4578999999999999999999875 34678999987532 23345567899999999999999999999874
Q ss_pred cCCCeEEEEEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCC
Q 004672 94 TANRNINFVTEMFTSGTLRQYRLKHR----------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 163 (738)
Q Consensus 94 ~~~~~l~LV~Ey~~gGSL~~~l~k~~----------~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~ 163 (738)
.+...++||||+++|+|.+++.+.+ .++...+..++.|++.||.|||+.+ ++||||||+||+++.+
T Consensus 80 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~- 155 (277)
T cd05062 80 -QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED- 155 (277)
T ss_pred -CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCC-
Confidence 3668999999999999999987632 2577889999999999999999998 9999999999999855
Q ss_pred CcEEEeccchhHHhhcccc----ccccCCCCCCCcccccc-ccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHH
Q 004672 164 GEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 237 (738)
Q Consensus 164 g~VKL~DFGlA~~l~~~~~----~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i 237 (738)
+.+||+|||++........ ....+++.|||||++.+ .++.++||||||+++|+|++ |..||.+. +.....+.+
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~-~~~~~~~~~ 234 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM-SNEQVLRFV 234 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHH
Confidence 7999999999875533211 12245788999999864 58999999999999999999 78899764 455666666
Q ss_pred HcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 238 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 238 ~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
..+..+. .....++.++++|.+||+ +|.+|||+.|++++
T Consensus 235 ~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 235 MEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HcCCcCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5554432 334567889999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=315.15 Aligned_cols=258 Identities=25% Similarity=0.434 Sum_probs=210.8
Q ss_pred CcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecC
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTA 95 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~ 95 (738)
.+..++|.+.+.||.|++|+||+|.+..+|..||+|+++... .......+..|+.++..+ .||||+++++++..
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-- 85 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-- 85 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC---ChHHHHHHHHHHHHHHhccCCCchHhhheeeec--
Confidence 456789999999999999999999999999999999987543 233455677788777676 59999999998865
Q ss_pred CCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCcccEEEeCCCCcEEEeccch
Q 004672 96 NRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 173 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~l~k-~~~lse~~i~~i~~QIl~aL~yLHs-~gp~IIHRDLKP~NILl~~~~g~VKL~DFGl 173 (738)
...+++||||+ +++|.+++.. ...+++..+..++.||+.||.|||+ ++ |+||||+|+||+++. ++.+||+|||+
T Consensus 86 ~~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~-~~~~kL~dfg~ 161 (296)
T cd06618 86 DSDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDA-SGNVKLCDFGI 161 (296)
T ss_pred CCeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcC-CCCEEECcccc
Confidence 66899999998 4578777665 4578999999999999999999997 46 999999999999984 48999999999
Q ss_pred hHHhhcccc-ccccCCCCCCCcccccc-----ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCccc-
Q 004672 174 AAILRKSHA-ARCVGTPEFMAPEVYEE-----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL- 246 (738)
Q Consensus 174 A~~l~~~~~-~~~vGTp~YmAPEvl~~-----~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l- 246 (738)
+..+..... ....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.......+.+..+..+..+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06618 162 SGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPP 241 (296)
T ss_pred chhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCC
Confidence 976543322 23347889999998863 37889999999999999999999997654445555666555433221
Q ss_pred ccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 247 FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 247 ~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
....+.++++||.+||. +|.+||++.+++.||||+..
T Consensus 242 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 242 NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 22467899999999999 99999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=326.21 Aligned_cols=257 Identities=25% Similarity=0.362 Sum_probs=208.7
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEec--CCCe
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT--ANRN 98 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~--~~~~ 98 (738)
++|.+.+.||.|++|.||+|.++.+|..||+|++.... ......+.+.+|+.+|+.++||||++++++|... ....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF--DVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc--ccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 68999999999999999999999999999999887432 2234456788999999999999999999876532 3457
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh
Q 004672 99 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~ 178 (738)
+++||||+. |+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++....
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~-~~~kl~dfg~~~~~~ 158 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNED-CELRIGDFGMARGLS 158 (334)
T ss_pred EEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CcEEecccccceeec
Confidence 899999995 699999888788999999999999999999999998 9999999999999854 899999999986553
Q ss_pred ccc------cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHH-cCCCC------
Q 004672 179 KSH------AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI-SGKKP------ 243 (738)
Q Consensus 179 ~~~------~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~-~g~~p------ 243 (738)
... .....|+..|+|||.+.+ .++.++||||||+++|+|++|..||.......++..... .|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 321 123468999999998753 488999999999999999999999976443332211111 01110
Q ss_pred ---------------------cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 244 ---------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 244 ---------------------~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
.......++++++||.+||+ +|.+||++.++|.||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 01123457899999999999 99999999999999999643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=318.28 Aligned_cols=253 Identities=23% Similarity=0.315 Sum_probs=204.9
Q ss_pred cCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEE--EEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEE
Q 004672 16 KLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEV--AWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWV 92 (738)
Q Consensus 16 ~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~V--AIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv 92 (738)
+.+.+++|.+.+.||.|+||+||+|.+..+|..+ |+|.++. .........+.+|+.+|.++ +||||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~---~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~ 78 (303)
T cd05088 2 PVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE---YASKDDHRDFAGELEVLCKLGHHPNIINLLGACE 78 (303)
T ss_pred CccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc---cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC
Confidence 4567889999999999999999999998888654 6665442 22445667889999999999 8999999999874
Q ss_pred ecCCCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCccc
Q 004672 93 DTANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156 (738)
Q Consensus 93 ~~~~~~l~LV~Ey~~gGSL~~~l~k~~----------------~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~N 156 (738)
. .+.+++||||+++|+|.+++.+.+ .+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 79 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~N 154 (303)
T cd05088 79 H--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARN 154 (303)
T ss_pred C--CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchhe
Confidence 4 678999999999999999987543 4789999999999999999999998 9999999999
Q ss_pred EEEeCCCCcEEEeccchhHHhhcccc-ccccCCCCCCCcccccc-ccCcccccccchhhhhhhhh-cCCCCCCCCCHHHH
Q 004672 157 IFVNGNQGEVKIGDLGLAAILRKSHA-ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQI 233 (738)
Q Consensus 157 ILl~~~~g~VKL~DFGlA~~l~~~~~-~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi 233 (738)
||++.+ +.+||+|||++........ ....+++.|+|||.+.+ .++.++||||||+++|+|+| |..||.. .+..++
T Consensus 155 ili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~ 232 (303)
T cd05088 155 ILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAEL 232 (303)
T ss_pred EEecCC-CcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc-CChHHH
Confidence 999854 7999999999853321111 11224567999998864 48899999999999999998 9999975 344556
Q ss_pred HHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCc
Q 004672 234 YKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDP 278 (738)
Q Consensus 234 ~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hp 278 (738)
++.+..+..+. .....++++.++|.+||+ +|.+||++.++|.+.
T Consensus 233 ~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l 277 (303)
T cd05088 233 YEKLPQGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277 (303)
T ss_pred HHHHhcCCcCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 66665443332 233467899999999999 999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=313.58 Aligned_cols=253 Identities=23% Similarity=0.330 Sum_probs=208.9
Q ss_pred ccCcCCCCceEEEEEcccCCeEEEEEEEcCCC-----eEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceee
Q 004672 15 LKLIPLEDMEDTMKFLVKELQRHYRAFDEYEG-----IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFY 88 (738)
Q Consensus 15 ~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG-----~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~ 88 (738)
.-.+..++|.+.+.||+|+||.||+|.+...+ ..+|+|.++.. ........+.+|+.+++.+ +||||++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 82 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNIINLL 82 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC---CCHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 34556678999999999999999999986443 78999987632 2345567799999999999 899999999
Q ss_pred EEEEecCCCeEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccC
Q 004672 89 TSWVDTANRNINFVTEMFTSGTLRQYRLKH----------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL 152 (738)
Q Consensus 89 ~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~----------------~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDL 152 (738)
+++.. +..++++|||+++|+|..++... +.+++..++.++.||+.||.|||+++ |+||||
T Consensus 83 ~~~~~--~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dl 158 (293)
T cd05053 83 GVCTQ--EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDL 158 (293)
T ss_pred EEEcC--CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--cccccc
Confidence 98744 66899999999999999998653 35889999999999999999999998 999999
Q ss_pred CcccEEEeCCCCcEEEeccchhHHhhcccc----ccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCC
Q 004672 153 KCDNIFVNGNQGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSE 226 (738)
Q Consensus 153 KP~NILl~~~~g~VKL~DFGlA~~l~~~~~----~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~ 226 (738)
||+|||++. ++.+||+|||++..+..... ....+++.|+|||++. ..++.++|||||||++|+|++ |..||..
T Consensus 159 kp~Nil~~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 237 (293)
T cd05053 159 AARNVLVTE-DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237 (293)
T ss_pred ceeeEEEcC-CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence 999999985 48999999999976543221 1122457899999876 458999999999999999997 9999986
Q ss_pred CCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 227 CTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 227 ~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
.+..++++.+..+..+. .+...+..+.+|+.+||. +|.+|||+.+++++
T Consensus 238 -~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 238 -IPVEELFKLLKEGYRME-KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred -CCHHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 45566777777665543 334567899999999999 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.15 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=210.3
Q ss_pred ceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEE
Q 004672 23 MEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 102 (738)
Q Consensus 23 y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV 102 (738)
|...++||.|+||+||+|.+..+|..||+|++.... .......+.+.+|+.+++.++||||+++++++.+ ....++|
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 99 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSG-KQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK--EHTAWLV 99 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccc-cCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEEE
Confidence 666788999999999999999999999999987543 2344556788999999999999999999998866 5789999
Q ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccc
Q 004672 103 TEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 181 (738)
Q Consensus 103 ~Ey~~gGSL~~~l~k-~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~ 181 (738)
|||+. |+|.+++.. ...+++..+..++.||+.||.|||+++ |+|+||+|+||+++.+ +.+||+|||++.... .
T Consensus 100 ~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~-~~~kL~dfg~~~~~~--~ 173 (313)
T cd06633 100 MEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEP-GQVKLADFGSASKSS--P 173 (313)
T ss_pred EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCC-CCEEEeecCCCcccC--C
Confidence 99995 677777655 456899999999999999999999998 9999999999999854 799999999985432 2
Q ss_pred cccccCCCCCCCccccc----cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004672 182 AARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 257 (738)
Q Consensus 182 ~~~~vGTp~YmAPEvl~----~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~l 257 (738)
.....|++.|+|||++. +.++.++||||||+++|+|++|..||........+. .+..+..|.......+..+++|
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l 252 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNDSPTLQSNEWTDSFRGF 252 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhcCCCCCCccccCHHHHHH
Confidence 23456899999999873 458889999999999999999999998754444443 3444444444444567789999
Q ss_pred HHHHHh-CcCCCCCHHHHhcCcccCCCCC
Q 004672 258 IEKCLA-TVSSRLSARELLTDPFLQIDDY 285 (738)
Q Consensus 258 I~kcL~-dP~~RpSa~ELL~Hpf~~~~~~ 285 (738)
|.+||+ +|.+||++.+++.||||+....
T Consensus 253 i~~~l~~~P~~Rp~~~~~l~~~~~~~~~~ 281 (313)
T cd06633 253 VDYCLQKIPQERPASAELLRHDFVRRDRP 281 (313)
T ss_pred HHHHccCChhhCcCHHHHhcCcccCCCch
Confidence 999999 8999999999999999987553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=309.87 Aligned_cols=248 Identities=21% Similarity=0.293 Sum_probs=203.4
Q ss_pred ceEEEEEcccCCeEEEEEEEcCCCe--EEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC----C
Q 004672 23 MEDTMKFLVKELQRHYRAFDEYEGI--EVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA----N 96 (738)
Q Consensus 23 y~il~kLG~GafgtVYkA~d~~tG~--~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~----~ 96 (738)
+.+.++||.|+||.||+|.+..++. .||+|.++... .+....+.+.+|+.+|+.++||||+++++++.... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI--CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence 3567899999999999999887775 69999877542 34566788999999999999999999999765422 2
Q ss_pred CeEEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEec
Q 004672 97 RNINFVTEMFTSGTLRQYRLKH------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 170 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k~------~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~D 170 (738)
...+++|||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~D 155 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNEN-MNVCVAD 155 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCC-CCEEECC
Confidence 3578999999999999987532 34889999999999999999999998 9999999999999854 7999999
Q ss_pred cchhHHhhcccc----ccccCCCCCCCcccccc-ccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCc
Q 004672 171 LGLAAILRKSHA----ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPE 244 (738)
Q Consensus 171 FGlA~~l~~~~~----~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~ 244 (738)
||++........ ....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||.. ....+++..+..+..+.
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~ 234 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG-VENSEIYDYLRQGNRLK 234 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCCC
Confidence 999987643221 12236778999998864 58999999999999999999 8899976 45567777777765543
Q ss_pred ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 245 ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 245 ~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
. ....+..++++|.+||. +|.+|||+.+|+++
T Consensus 235 ~-~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 235 Q-PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred C-CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 2 33567889999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=317.28 Aligned_cols=258 Identities=22% Similarity=0.322 Sum_probs=211.5
Q ss_pred CCcccccCcCCCCceEEEEEcccCCeEEEEEEE-----cCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCC
Q 004672 10 IPPSLLKLIPLEDMEDTMKFLVKELQRHYRAFD-----EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRN 83 (738)
Q Consensus 10 vp~~l~~~I~~~~y~il~kLG~GafgtVYkA~d-----~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpN 83 (738)
+|......+..++|.+.+.||.|+||.||+|.+ ..++..||+|.++... .....+.+.+|+.+++++ +|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~ 100 (302)
T cd05055 24 LPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA---HSSEREALMSELKIMSHLGNHEN 100 (302)
T ss_pred ccccccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC---ChHHHHHHHHHHHHHHhccCCCC
Confidence 355455567778899999999999999999986 3456789999876432 345567899999999999 8999
Q ss_pred cceeeEEEEecCCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeC
Q 004672 84 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 161 (738)
Q Consensus 84 IVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~--~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~ 161 (738)
|+++++++.. .+.+++||||+.+|+|.+++.... .+++.++..++.||+.||.|||+++ |+|+||||+|||++.
T Consensus 101 iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~ 176 (302)
T cd05055 101 IVNLLGACTI--GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTH 176 (302)
T ss_pred cceEEEEEec--CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcC
Confidence 9999998755 567999999999999999987643 3899999999999999999999998 999999999999985
Q ss_pred CCCcEEEeccchhHHhhcccc----ccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHH
Q 004672 162 NQGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYK 235 (738)
Q Consensus 162 ~~g~VKL~DFGlA~~l~~~~~----~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k 235 (738)
+ +.+||+|||++..+..... ....+++.|+|||.+. ..++.++||||||+++|+|++ |..||........+.+
T Consensus 177 ~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~ 255 (302)
T cd05055 177 G-KIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK 255 (302)
T ss_pred C-CeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH
Confidence 4 7899999999976543211 1223678899999876 458999999999999999998 9999987655555555
Q ss_pred HHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 236 KVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 236 ~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
.+..+..+ ......++++++|+.+||. +|.+|||+.+++.
T Consensus 256 ~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 256 LIKEGYRM-AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHcCCcC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 55555433 2334568899999999999 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=314.27 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=205.8
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEc-----CCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEE
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDE-----YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWV 92 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~-----~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv 92 (738)
++..+|.+...||.|+||.||+|.+. .++..+++|.++. ......+.+.+|+.++++++||||+++++++.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD----PTLAARKDFQREAELLTNLQHEHIVKFYGVCG 77 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC----ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc
Confidence 45678999999999999999999853 3566799888763 23445567899999999999999999999875
Q ss_pred ecCCCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCccc
Q 004672 93 DTANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156 (738)
Q Consensus 93 ~~~~~~l~LV~Ey~~gGSL~~~l~k~~----------------~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~N 156 (738)
. ...+++||||+++++|.+++..+. .+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 78 ~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~N 153 (291)
T cd05094 78 D--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRN 153 (291)
T ss_pred c--CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcce
Confidence 4 668999999999999999987643 3789999999999999999999998 9999999999
Q ss_pred EEEeCCCCcEEEeccchhHHhhccc----cccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCH
Q 004672 157 IFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHP 230 (738)
Q Consensus 157 ILl~~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~ 230 (738)
||++.+ +.++|+|||++....... .....+++.|+|||++. ..++.++||||||+++|+|+| |..||... +.
T Consensus 154 il~~~~-~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~-~~ 231 (291)
T cd05094 154 CLVGAN-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL-SN 231 (291)
T ss_pred EEEccC-CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CH
Confidence 999855 799999999997654321 22344688999999876 458899999999999999999 99999764 44
Q ss_pred HHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 231 AQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 231 ~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
......+..+..+. .....+..+.+++.+||+ +|.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 232 TEVIECITQGRVLE-RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHHHHhCCCCCC-CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 55666666665543 344567899999999999 9999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.63 Aligned_cols=249 Identities=21% Similarity=0.302 Sum_probs=206.3
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCC---CeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYE---GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~t---G~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 95 (738)
..++|++.+.||.|+||+||+|.++.+ ...||+|.++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 76 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG---SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-- 76 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC---CChHHHHHHHHHHHHHHhCCCCCcceEeEEEec--
Confidence 356899999999999999999998754 458999987643 234556778999999999999999999998744
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 96 NRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
+..+++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+|+||||+|||++.+ +.++|+|||++
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~-~~~~l~dfg~~ 153 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSN-LVCKVSDFGLS 153 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC-CCEEECccchh
Confidence 67899999999999999998775 46899999999999999999999998 9999999999999855 79999999999
Q ss_pred HHhhccc--c--ccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCccccc
Q 004672 175 AILRKSH--A--ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFK 248 (738)
Q Consensus 175 ~~l~~~~--~--~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~ 248 (738)
....... . ....+++.|+|||.+. ..++.++||||||+++|+|++ |..||.... ...+...+..+..+. ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~~-~~~ 231 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS-NQDVIKAVEDGYRLP-PPM 231 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHHcCCCCC-CCC
Confidence 8764211 1 1123467899999886 458999999999999999998 999997644 455666666554332 234
Q ss_pred CCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 249 VEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 249 ~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
..++.+.+++.+||+ +|.+||++.+++++
T Consensus 232 ~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 232 DCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 568899999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=311.64 Aligned_cols=250 Identities=21% Similarity=0.357 Sum_probs=206.6
Q ss_pred cCcCCCCceEEEEEcccCCeEEEEEEEcCCCe----EEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEE
Q 004672 16 KLIPLEDMEDTMKFLVKELQRHYRAFDEYEGI----EVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSW 91 (738)
Q Consensus 16 ~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~----~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~f 91 (738)
+.+..++|.+.++||.|+||+||+|.+..+|. .||+|.++.. ........+.+|+.+++.++||||+++++++
T Consensus 2 ~~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 78 (279)
T cd05109 2 RILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN---TSPKANKEILDEAYVMAGVGSPYVCRLLGIC 78 (279)
T ss_pred cccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC---CCHHHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 34667899999999999999999999877776 4898887643 2445567899999999999999999999987
Q ss_pred EecCCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEec
Q 004672 92 VDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 170 (738)
Q Consensus 92 v~~~~~~l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~D 170 (738)
.. ...++++||+++|+|.+++..+ +.+++..+..++.||+.||.|||+++ |+||||||+|||++. .+.+||+|
T Consensus 79 ~~---~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~-~~~~kL~d 152 (279)
T cd05109 79 LT---STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKS-PNHVKITD 152 (279)
T ss_pred cC---CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcC-CCcEEECC
Confidence 53 3578999999999999998774 56999999999999999999999998 999999999999974 47899999
Q ss_pred cchhHHhhccccc----cccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCc
Q 004672 171 LGLAAILRKSHAA----RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPE 244 (738)
Q Consensus 171 FGlA~~l~~~~~~----~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~ 244 (738)
||++......... ...+++.|+|||.+. ..++.++||||||+++|||++ |..||.. .....+...+..+..+.
T Consensus 153 fG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~ 231 (279)
T cd05109 153 FGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG-IPAREIPDLLEKGERLP 231 (279)
T ss_pred CCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcCC
Confidence 9999766432211 122467899999875 458999999999999999998 8999975 34555656565554433
Q ss_pred ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 245 ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 245 ~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
.....++++.++|.+||. +|..||++.+++.
T Consensus 232 -~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 232 -QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred -CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 345578899999999999 9999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=322.00 Aligned_cols=257 Identities=26% Similarity=0.357 Sum_probs=205.2
Q ss_pred CCceE-EEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCH----------HHHHHHHHHHHHHHhCCCCCcceeeE
Q 004672 21 EDMED-TMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSP----------EELERLYCEIHLLKTLKHRNIMKFYT 89 (738)
Q Consensus 21 ~~y~i-l~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~----------e~~e~l~~Ei~iLk~L~HpNIVkl~~ 89 (738)
++|.. .+.||.|+||+||+|.+..+|..||+|+++........ .....+.+|+.+|+.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 57799999999999999999999999998765322100 01125789999999999999999999
Q ss_pred EEEecCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEe
Q 004672 90 SWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIG 169 (738)
Q Consensus 90 ~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~ 169 (738)
+|.. ...+++||||+. |+|.+++.....+++..+..++.||+.||.|||+++ |+|+||+|+||+++.+ +.+||+
T Consensus 88 ~~~~--~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~-~~~kl~ 161 (335)
T PTZ00024 88 VYVE--GDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSK-GICKIA 161 (335)
T ss_pred EEec--CCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCC-CCEEEC
Confidence 8755 578999999996 699999988888999999999999999999999998 9999999999999854 799999
Q ss_pred ccchhHHhhc----------------cccccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHH
Q 004672 170 DLGLAAILRK----------------SHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPA 231 (738)
Q Consensus 170 DFGlA~~l~~----------------~~~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~ 231 (738)
|||++..... .......+++.|+|||.+.+ .++.++||||||+++|+|+||..||.......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999976541 11122346889999998864 37889999999999999999999998754443
Q ss_pred HHHHHHHc--CCCCc------------------------ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 232 QIYKKVIS--GKKPE------------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 232 qi~k~i~~--g~~p~------------------------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
.+ ..+.. +..+. ......+.++.++|.+||. +|.+|||+.++|.||||+...
T Consensus 242 ~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 242 QL-GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred HH-HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 33 33221 10000 0112346789999999999 999999999999999998654
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=306.60 Aligned_cols=240 Identities=20% Similarity=0.314 Sum_probs=197.6
Q ss_pred EEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEecC
Q 004672 27 MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMF 106 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey~ 106 (738)
+.||+|+||+||+|.+..+|..||+|.+... ...+....+.+|+.+|+.++||||+++++++.. ...+++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET---LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEEEeec
Confidence 3689999999999999999999999986522 235566789999999999999999999998754 66899999999
Q ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccccccc
Q 004672 107 TSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC 185 (738)
Q Consensus 107 ~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~~~~~ 185 (738)
.+++|.+++.+. ..+++..++.++.|++.||.|||+++ |+||||||+|||++.+ +.+||+|||++...........
T Consensus 76 ~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 76 QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEK-NVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred cCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCC-CcEEECccccCccccccccccc
Confidence 999999998764 46899999999999999999999998 9999999999999854 7999999999875443211111
Q ss_pred ----cCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHH
Q 004672 186 ----VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 259 (738)
Q Consensus 186 ----vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~ 259 (738)
.++..|+|||.+. +.++.++||||||+++|+|++ |..||... ........+..+..+ ......+..+.+|+.
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 230 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL-SNQQTREAIEQGVRL-PCPELCPDAVYRLME 230 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc-CHHHHHHHHHcCCCC-CCcccCCHHHHHHHH
Confidence 1245799999886 458899999999999999998 88899753 344455555544333 334566889999999
Q ss_pred HHHh-CcCCCCCHHHHhc
Q 004672 260 KCLA-TVSSRLSARELLT 276 (738)
Q Consensus 260 kcL~-dP~~RpSa~ELL~ 276 (738)
+||+ +|.+|||+.++++
T Consensus 231 ~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 231 RCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 9999 9999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=307.53 Aligned_cols=239 Identities=20% Similarity=0.307 Sum_probs=201.2
Q ss_pred EEcccCCeEEEEEEE--cCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEec
Q 004672 28 KFLVKELQRHYRAFD--EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEM 105 (738)
Q Consensus 28 kLG~GafgtVYkA~d--~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey 105 (738)
+||+|+||+||+|.+ +.++..||+|.++... ......+.+..|+.+|+.++||||+++++++. ...+++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVRMIGICE---AESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC--CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc---CCCcEEEEec
Confidence 589999999999964 5678999999876442 34556778999999999999999999999753 3567899999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcccc---
Q 004672 106 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA--- 182 (738)
Q Consensus 106 ~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~~--- 182 (738)
+++|+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||.||+++.+ +.+||+|||++..+.....
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~-~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 77 AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCC-CeEEECCCccccccCCCCCeee
Confidence 999999999988888999999999999999999999998 9999999999999854 7999999999976643321
Q ss_pred --ccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHH
Q 004672 183 --ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 258 (738)
Q Consensus 183 --~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI 258 (738)
....+++.|+|||.+. ..++.++||||||+++|+|++ |..||.. .+...+...+..+..+. .+...++++.++|
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~l~~li 231 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG-MKGNEVTQMIESGERME-CPQRCPPEMYDLM 231 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHCCCCCC-CCCCCCHHHHHHH
Confidence 1223457999999886 458889999999999999998 9999976 45566777777766543 4456789999999
Q ss_pred HHHHh-CcCCCCCHHHHhc
Q 004672 259 EKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 259 ~kcL~-dP~~RpSa~ELL~ 276 (738)
.+||+ +|.+||++.+|..
T Consensus 232 ~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 232 KLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHhccCchhCcCHHHHHH
Confidence 99999 9999999998854
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=306.93 Aligned_cols=245 Identities=20% Similarity=0.322 Sum_probs=202.6
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCe
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 98 (738)
..++|.+.+.||+|+||.||+|..+ .+..+|+|.++... ...+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 73 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA-----MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ--QKP 73 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC-----ccHHHHHHHHHHHHHCCCCCceeEEEEEcc--CCC
Confidence 4568999999999999999999875 45689999876332 123468889999999999999999998744 668
Q ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 99 INFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
+++||||+++|+|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.+ +.+||+|||++...
T Consensus 74 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~-~~~kl~d~g~~~~~ 150 (256)
T cd05114 74 LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSST-GVVKVSDFGMTRYV 150 (256)
T ss_pred EEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCC-CeEEECCCCCcccc
Confidence 99999999999999998754 46899999999999999999999998 9999999999999854 79999999998765
Q ss_pred hccccc---cccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCCh
Q 004672 178 RKSHAA---RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 252 (738)
Q Consensus 178 ~~~~~~---~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~sp 252 (738)
...... ...++..|+|||++. ..++.++||||||+++|+|++ |+.||.. .+..++...+..+..+. .+...++
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~ 228 (256)
T cd05114 151 LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK-KSNYEVVEMISRGFRLY-RPKLASM 228 (256)
T ss_pred CCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCCC-CCCCCCH
Confidence 332211 122456899999886 458899999999999999999 8999976 44556667777765443 2345678
Q ss_pred HHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 253 EVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 253 el~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
.+.+++.+||. +|.+||++.+++.
T Consensus 229 ~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 229 TVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 89999999999 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=307.99 Aligned_cols=248 Identities=19% Similarity=0.288 Sum_probs=203.5
Q ss_pred ceEEEEEcccCCeEEEEEEEcC---CCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCC---
Q 004672 23 MEDTMKFLVKELQRHYRAFDEY---EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN--- 96 (738)
Q Consensus 23 y~il~kLG~GafgtVYkA~d~~---tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~--- 96 (738)
|.+.+.||+|+||+||+|.+.. ++..||+|.++... ......+.+.+|+.+|+.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI--HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 5678999999999999999765 34889999987532 234566789999999999999999999997654322
Q ss_pred -CeEEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEe
Q 004672 97 -RNINFVTEMFTSGTLRQYRLKH------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIG 169 (738)
Q Consensus 97 -~~l~LV~Ey~~gGSL~~~l~k~------~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~ 169 (738)
...++++||+++|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLRED-MTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCC-CeEEEC
Confidence 3479999999999999997543 35899999999999999999999998 9999999999999854 799999
Q ss_pred ccchhHHhhcccc----ccccCCCCCCCcccccc-ccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCC
Q 004672 170 DLGLAAILRKSHA----ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKP 243 (738)
Q Consensus 170 DFGlA~~l~~~~~----~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p 243 (738)
|||++........ ....++..|+|||.+.. .++.++||||||+++|+|++ |..||.+. ...++++.+..+..+
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~ 234 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV-ENHEIYDYLRHGNRL 234 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC
Confidence 9999876543221 11225678999998864 58999999999999999999 88999764 455666777666544
Q ss_pred cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 244 EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 244 ~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
. .+...++++.+++.+||+ +|.+|||+.+++++
T Consensus 235 ~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 K-QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred C-CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3 345678899999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=332.15 Aligned_cols=260 Identities=23% Similarity=0.295 Sum_probs=210.5
Q ss_pred CCCCcccccCcCCCCceEEEEEcccCCeEEEEEEEcC-----CCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCC-C
Q 004672 8 NQIPPSLLKLIPLEDMEDTMKFLVKELQRHYRAFDEY-----EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-H 81 (738)
Q Consensus 8 ~~vp~~l~~~I~~~~y~il~kLG~GafgtVYkA~d~~-----tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~-H 81 (738)
-.+|...--.++.++|.++++||.|+||+||+|.+.. ++..||+|+++.. ......+.+.+|+++|+.+. |
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~~Ei~~l~~l~~H 100 (400)
T cd05105 24 MQLPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT---ARSSEKQALMSELKIMTHLGPH 100 (400)
T ss_pred ccCCCCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC---CChHHHHHHHHHHHHHHhcCCC
Confidence 3344444456677899999999999999999998743 3457999988643 23445678999999999996 9
Q ss_pred CCcceeeEEEEecCCCeEEEEEecCCCCCHHHHHHhc-------------------------------------------
Q 004672 82 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH------------------------------------------- 118 (738)
Q Consensus 82 pNIVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~------------------------------------------- 118 (738)
|||++++++|.. ...+++||||+++|+|.+++.+.
T Consensus 101 pnIv~l~~~~~~--~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (400)
T cd05105 101 LNIVNLLGACTK--SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYM 178 (400)
T ss_pred CCeeeEEEEEcc--CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccc
Confidence 999999998854 57899999999999999987653
Q ss_pred -----------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 004672 119 -----------------------------------------------------RRVNIRAVKHWCRQILSGLLYLHSRDP 145 (738)
Q Consensus 119 -----------------------------------------------------~~lse~~i~~i~~QIl~aL~yLHs~gp 145 (738)
+.+++..+..++.||+.||.|||+++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~- 257 (400)
T cd05105 179 DMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN- 257 (400)
T ss_pred ccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 23677888999999999999999998
Q ss_pred CceeccCCcccEEEeCCCCcEEEeccchhHHhhccc----cccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-
Q 004672 146 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT- 219 (738)
Q Consensus 146 ~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT- 219 (738)
|+||||||+|||++.+ +.+||+|||++....... .....+++.|+|||++. ..++.++||||||+++|+|++
T Consensus 258 -ivH~dikp~Nill~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~ 335 (400)
T cd05105 258 -CVHRDLAARNVLLAQG-KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSL 335 (400)
T ss_pred -eeCCCCChHhEEEeCC-CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHC
Confidence 9999999999999854 789999999997653321 12234678899999886 458999999999999999997
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 220 FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 220 G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
|..||........++..+..+..+. .....++++++++.+||+ +|.+||++.+|.+
T Consensus 336 g~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 336 GGTPYPGMIVDSTFYNKIKSGYRMA-KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred CCCCCcccchhHHHHHHHhcCCCCC-CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 9999987655556666666664432 334567899999999999 9999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=323.50 Aligned_cols=256 Identities=26% Similarity=0.327 Sum_probs=209.0
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecCCCe
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~ 98 (738)
.++|.+.+.||.|+||.||+|.+..+|..||+|++... .........+.+|+.+++++ +||||++++++|.......
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA--FRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccc--cCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 46899999999999999999999999999999987532 12334456788899999999 9999999999886655668
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh
Q 004672 99 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~ 178 (738)
+++||||+. ++|..++... .+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~-~~~kl~d~g~~~~~~ 158 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSD-CRVKLADFGLARSLS 158 (337)
T ss_pred EEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CcEEEeeccchhccc
Confidence 999999996 6999988765 7899999999999999999999998 9999999999999855 899999999997654
Q ss_pred ccc-------cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCC-------
Q 004672 179 KSH-------AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK------- 242 (738)
Q Consensus 179 ~~~-------~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~------- 242 (738)
... .....|++.|+|||++.+ .++.++||||||+++|+|+||+.||....+...+.+.+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 321 223458999999998753 4788999999999999999999999765544433222111110
Q ss_pred ---------------------CcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 243 ---------------------PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 243 ---------------------p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
+.......+.+++++|.+||+ +|.+|||+.++|.||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~ 300 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence 111223357889999999999 9999999999999999965
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=335.78 Aligned_cols=257 Identities=23% Similarity=0.343 Sum_probs=207.9
Q ss_pred CcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecC
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTA 95 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~ 95 (738)
.|.-..|.++++||+|+.+.||++.... ...||+|++.+. ..+...+.-+.+||.+|.+| .|.+||++|+|-+.
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~--~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-- 431 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLL--EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-- 431 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHh--hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--
Confidence 4555689999999999999999998644 455666665543 35677889999999999999 68999999997544
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 96 NRNINFVTEMFTSGTLRQYRLKHRRV-NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~l~k~~~l-se~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
.+.+||||||= .-+|..++++.... +.-.++.+..||+.|+.++|.+| |||.||||.|+|+- . |.+||+|||.|
T Consensus 432 d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV-k-G~LKLIDFGIA 506 (677)
T KOG0596|consen 432 DGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV-K-GRLKLIDFGIA 506 (677)
T ss_pred CceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE-e-eeEEeeeechh
Confidence 78999999995 56999999887653 33589999999999999999999 99999999999986 3 89999999999
Q ss_pred HHhhcccc----ccccCCCCCCCcccccc------------ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHH
Q 004672 175 AILRKSHA----ARCVGTPEFMAPEVYEE------------EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 238 (738)
Q Consensus 175 ~~l~~~~~----~~~vGTp~YmAPEvl~~------------~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~ 238 (738)
..+..... .+.+||+.||+||.+.. +.+.++||||||||||+|+.|+.||....+...-+..|+
T Consensus 507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~ 586 (677)
T KOG0596|consen 507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAIT 586 (677)
T ss_pred cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhc
Confidence 88876532 45579999999998741 266789999999999999999999987554444444444
Q ss_pred cCCCCcccccCCCh-HHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 239 SGKKPEALFKVEDP-EVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 239 ~g~~p~~l~~~~sp-el~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
.-.....++....+ ++.++++.||. ||.+|||+.+||.|||++.-
T Consensus 587 ~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 587 DPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred CCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 33222233333333 39999999999 99999999999999999863
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=308.48 Aligned_cols=247 Identities=22% Similarity=0.359 Sum_probs=203.9
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCC
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 97 (738)
|..++|.+++.||+|+||+||+|... .+..||+|.++.... ..+.+.+|+.++++++||||+++++++.. ..
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 72 (256)
T cd05113 1 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMKLSHEKLVQLYGVCTK--QR 72 (256)
T ss_pred CChHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc-----cHHHHHHHHHHHhcCCCCCeeeEEEEEcc--CC
Confidence 34678999999999999999999764 345699998774321 13568899999999999999999998744 56
Q ss_pred eEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 98 NINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
.+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ ++|+||||.||+++.+ +.+||+|||++..
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~-~~~kl~d~g~~~~ 149 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQ-GCVKVSDFGLSRY 149 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCC-CCEEECCCcccee
Confidence 789999999999999998774 46899999999999999999999998 9999999999999854 7999999999875
Q ss_pred hhccccccc---cCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCC
Q 004672 177 LRKSHAARC---VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVED 251 (738)
Q Consensus 177 l~~~~~~~~---vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~s 251 (738)
......... .++..|+|||.+. ..++.++||||||+++|+|+| |..||... +...+...+..+..+. .....+
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~ 227 (256)
T cd05113 150 VLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF-NNSETVEKVSQGLRLY-RPHLAS 227 (256)
T ss_pred cCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHhcCCCCC-CCCCCC
Confidence 543322222 2456799999986 468999999999999999998 99999864 4455666676665443 234568
Q ss_pred hHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 252 PEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 252 pel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
+.+++++.+||. +|.+||++.+|+.+
T Consensus 228 ~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 228 EKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 899999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=320.56 Aligned_cols=250 Identities=24% Similarity=0.375 Sum_probs=215.6
Q ss_pred EEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecCCCeEEEEEec
Q 004672 27 MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEM 105 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~LV~Ey 105 (738)
+.||+|+|+.|--+....||.+||||+|... ..-.+.++.+|++++.++ .|+||++++++|.+ ...+|+|||.
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq----~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd--d~~FYLVfEK 157 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ----PGHSRSRVFREVETFYQCQGHKNILQLIEFFED--DTRFYLVFEK 157 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC----CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc--cceEEEEEec
Confidence 5799999999999999999999999998854 334568999999999999 69999999998855 6789999999
Q ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCC--CcEEEeccchhHHhh-----
Q 004672 106 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ--GEVKIGDLGLAAILR----- 178 (738)
Q Consensus 106 ~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~--g~VKL~DFGlA~~l~----- 178 (738)
|.||.|...+++++.|++..+..+.+.|+.||.|||.+| |.||||||+|||-...+ .-|||+||.|...+.
T Consensus 158 m~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 158 MRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred ccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 999999999999999999999999999999999999999 99999999999985321 248999998875432
Q ss_pred ----ccccccccCCCCCCCccccc---c---ccCcccccccchhhhhhhhhcCCCCCCC-----C---------CHHHHH
Q 004672 179 ----KSHAARCVGTPEFMAPEVYE---E---EYNELVDIYSFGMCILEMVTFDYPYSEC-----T---------HPAQIY 234 (738)
Q Consensus 179 ----~~~~~~~vGTp~YmAPEvl~---~---~ys~~sDIWSLGviLyeLlTG~~Pf~~~-----~---------~~~qi~ 234 (738)
.+...+.+|+.+|||||+.. + .|+.++|.||||||+|-|+.|.+||.+. . -...++
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 12334567999999999764 2 4999999999999999999999999642 1 134578
Q ss_pred HHHHcCCC--CcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 235 KKVISGKK--PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 235 k~i~~g~~--p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
..|..|++ |..-|...+.+.+++|..+|. ++..|.++.++|+|||++.-.
T Consensus 316 esIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 316 ESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred HHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 88888874 666677889999999999999 999999999999999997543
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.39 Aligned_cols=250 Identities=22% Similarity=0.266 Sum_probs=204.1
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCCC----------------eEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCC
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEG----------------IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 81 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG----------------~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~H 81 (738)
+..++|.+++.||+|+||.||+|.+..++ ..||+|.+... ......+.+.+|+.+|+.++|
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~~e~~~l~~l~~ 78 (296)
T cd05051 2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD---ASDNAREDFLKEVKILSRLSD 78 (296)
T ss_pred CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCc---cCHHHHHHHHHHHHHHHhcCC
Confidence 45678999999999999999999887644 56899987643 234667889999999999999
Q ss_pred CCcceeeEEEEecCCCeEEEEEecCCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCceec
Q 004672 82 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-----------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 150 (738)
Q Consensus 82 pNIVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~-----------~lse~~i~~i~~QIl~aL~yLHs~gp~IIHR 150 (738)
|||++++++|.. +..++++|||+.+++|.+++.+.. .+++..++.++.|++.||.|||+++ |+||
T Consensus 79 ~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~ 154 (296)
T cd05051 79 PNIARLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHR 154 (296)
T ss_pred CCEeEEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccc
Confidence 999999998755 578999999999999999988765 6899999999999999999999998 9999
Q ss_pred cCCcccEEEeCCCCcEEEeccchhHHhhccc----cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhh--cCCC
Q 004672 151 DLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT--FDYP 223 (738)
Q Consensus 151 DLKP~NILl~~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlT--G~~P 223 (738)
||||+||+++.+ +.++|+|||++....... .....+++.|+|||++.+ .++.++||||||+++|+|++ +..|
T Consensus 155 dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 233 (296)
T cd05051 155 DLATRNCLVGKN-YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP 233 (296)
T ss_pred ccchhceeecCC-CceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCC
Confidence 999999999855 899999999987653321 223346789999998764 69999999999999999998 7788
Q ss_pred CCCCCCHHHHHHHHHcC----C--CCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 224 YSECTHPAQIYKKVISG----K--KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 224 f~~~~~~~qi~k~i~~g----~--~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
|.... ..+++..+... . .........+.++.++|.+||+ +|.+|||+.+|+.
T Consensus 234 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 234 YEHLT-DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CCCcC-hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 87644 34444444332 1 1111223456899999999999 9999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.71 Aligned_cols=258 Identities=25% Similarity=0.377 Sum_probs=213.3
Q ss_pred CcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCC
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 96 (738)
..+...|...+.||.|++|+||+|.++.++..||+|.+.... ........++.+|+.+++.++|+||+++++++.. .
T Consensus 11 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 87 (308)
T cd06634 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--E 87 (308)
T ss_pred CCcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccc-ccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc--C
Confidence 334556888999999999999999999999999999987533 2234556678899999999999999999998865 5
Q ss_pred CeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 97 RNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k-~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
...++||||+. |+|.+++.. ...+++..+..++.|++.||.|||+++ ++||||+|+||+++.+ +.+||+|||++.
T Consensus 88 ~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~ 163 (308)
T cd06634 88 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFGSAS 163 (308)
T ss_pred CeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCC-CcEEECCcccce
Confidence 68899999996 688777654 456899999999999999999999998 9999999999999854 899999999986
Q ss_pred HhhccccccccCCCCCCCccccc----cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCC
Q 004672 176 ILRKSHAARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED 251 (738)
Q Consensus 176 ~l~~~~~~~~vGTp~YmAPEvl~----~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~s 251 (738)
..... ....|++.|+|||.+. +.++.++||||||+++|+|++|..||........+ ..+..+..|.......+
T Consensus 164 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 240 (308)
T cd06634 164 IMAPA--NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQNESPALQSGHWS 240 (308)
T ss_pred eecCc--ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH-HHHhhcCCCCcCccccc
Confidence 55432 3345899999999874 45888999999999999999999999764433333 34444555544445678
Q ss_pred hHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 252 PEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 252 pel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
..+++||.+||. +|.+||++.+++.|||+....
T Consensus 241 ~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~ 274 (308)
T cd06634 241 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (308)
T ss_pred HHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence 899999999999 899999999999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=330.59 Aligned_cols=259 Identities=26% Similarity=0.410 Sum_probs=221.5
Q ss_pred EEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEec
Q 004672 26 TMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEM 105 (738)
Q Consensus 26 l~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey 105 (738)
-+.||+|-||+||-|.+..+|+.||||.|....+....+ .++.+|+.||..+.||.||.+.-.| +..+.+++|||.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe--sqlR~EVaILq~l~HPGiV~le~M~--ET~ervFVVMEK 644 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE--SQLRNEVAILQNLHHPGIVNLECMF--ETPERVFVVMEK 644 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchH--HHHHHHHHHHHhcCCCCeeEEEEee--cCCceEEEEehh
Confidence 378999999999999999999999999999877654433 7899999999999999999997655 557899999999
Q ss_pred CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCC--CcEEEeccchhHHhhcc-
Q 004672 106 FTSGTLRQYRLK--HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ--GEVKIGDLGLAAILRKS- 180 (738)
Q Consensus 106 ~~gGSL~~~l~k--~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~--g~VKL~DFGlA~~l~~~- 180 (738)
+. |++.+.+.. .+++++..-+.++.||+.||.|||-++ |+|.||||+|||+.... .++||||||+|+++...
T Consensus 645 l~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 645 LH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred hc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 95 565555543 468999999999999999999999999 99999999999997543 47999999999998765
Q ss_pred ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc--CCCCcccccCCChHHHHH
Q 004672 181 HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GKKPEALFKVEDPEVRQF 257 (738)
Q Consensus 181 ~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~--g~~p~~l~~~~spel~~l 257 (738)
...+.+|||.|+|||++.. .|+..-|+||.|+|+|--+.|..||++.. +|...|.. -.+|...|+..++++.+|
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE---dIndQIQNAaFMyPp~PW~eis~~Aidl 798 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE---DINDQIQNAAFMYPPNPWSEISPEAIDL 798 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc---chhHHhhccccccCCCchhhcCHHHHHH
Confidence 4567789999999999975 59999999999999999999999998743 34444444 346777788899999999
Q ss_pred HHHHHh-CcCCCCCHHHHhcCcccCCCCCchhhhhhhc
Q 004672 258 IEKCLA-TVSSRLSARELLTDPFLQIDDYDSDLRMIQY 294 (738)
Q Consensus 258 I~kcL~-dP~~RpSa~ELL~Hpf~~~~~~~~~~~~~~~ 294 (738)
|..+|+ +-.+|.|....|.|||++....-.++|.+..
T Consensus 799 In~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE~ 836 (888)
T KOG4236|consen 799 INNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELEV 836 (888)
T ss_pred HHHHHHHHHHHhcchHhhccchhhhcchHHHHHHHHHH
Confidence 999999 8999999999999999998766566666543
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=313.59 Aligned_cols=257 Identities=25% Similarity=0.353 Sum_probs=205.7
Q ss_pred CcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC-
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA- 95 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~- 95 (738)
+...++|.+.+.||.|+||+||+|.++.+|..||+|.++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE--KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQD 80 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc--ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence 3456789999999999999999999999999999999886532 1223356778999999999999999999876532
Q ss_pred -------CCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEE
Q 004672 96 -------NRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVK 167 (738)
Q Consensus 96 -------~~~l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VK 167 (738)
...+++|+||+++ +|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~-~~~k 156 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNK-GQIK 156 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CcEE
Confidence 3479999999975 777776654 46999999999999999999999998 9999999999999854 7999
Q ss_pred EeccchhHHhhcccc---ccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc---
Q 004672 168 IGDLGLAAILRKSHA---ARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--- 239 (738)
Q Consensus 168 L~DFGlA~~l~~~~~---~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~--- 239 (738)
|+|||++........ ....+++.|+|||++.+ .++.++||||||+++|+|++|++||........+ ..+..
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~-~~~~~~~~ 235 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL-ELISRLCG 235 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhC
Confidence 999999976643321 12246789999998864 4788999999999999999999999764433322 22222
Q ss_pred CCCCcc-------------------------cccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 240 GKKPEA-------------------------LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 240 g~~p~~-------------------------l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
+..+.. .....++.++++|.+||. +|.+||++.++|.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 211111 112357899999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=305.34 Aligned_cols=246 Identities=22% Similarity=0.345 Sum_probs=203.3
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCC
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 97 (738)
+..++|.+.+.||.|++|.||+|.+. ++..||+|.++.... ..+.+.+|+.++++++||||+++++++.. .+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 74 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM-----DPKDFLAEAQIMKKLRHPKLIQLYAVCTL--EE 74 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc-----cHHHHHHHHHHHHHCCCCCccceeEEEec--CC
Confidence 45678999999999999999999975 557899998874331 23568889999999999999999997644 66
Q ss_pred eEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 98 NINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~~--~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
.+++||||+.+++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.+ +.+||+|||++.
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~~l~dfg~~~ 151 (261)
T cd05068 75 PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGEN-NICKVADFGLAR 151 (261)
T ss_pred CeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCC-CCEEECCcceEE
Confidence 7899999999999999987654 6999999999999999999999998 9999999999999855 799999999997
Q ss_pred HhhccccccccC---CCCCCCcccccc-ccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCC
Q 004672 176 ILRKSHAARCVG---TPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVE 250 (738)
Q Consensus 176 ~l~~~~~~~~vG---Tp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~ 250 (738)
...........| +..|+|||++.+ .++.++||||||+++|+|+| |+.||.+. +...+...+..+..+ ......
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~ 229 (261)
T cd05068 152 VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM-TNAEVLQQVDQGYRM-PCPPGC 229 (261)
T ss_pred EccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcC
Confidence 665332222223 357999998764 58899999999999999999 99999864 455566666554332 233456
Q ss_pred ChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 251 DPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 251 spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
+..+.+++.+||+ +|.+||++.+|+.
T Consensus 230 ~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 230 PKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 7899999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=303.75 Aligned_cols=244 Identities=20% Similarity=0.317 Sum_probs=206.5
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCC
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 97 (738)
+..++|.+.+.||.|++|.||+|.. .|..||+|.++... ...+++.+|+.+++.++|+||+++++++.. ..
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 73 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDS-----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GN 73 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccch-----hHHHHHHHHHHHHHhcCCcceeeeEEEEcC--CC
Confidence 3567899999999999999999976 48999999887432 256789999999999999999999998754 67
Q ss_pred eEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 98 NINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~~--~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+||+++.+ +.+||+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~-~~~~l~d~g~~~ 150 (256)
T cd05039 74 PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSED-LVAKVSDFGLAK 150 (256)
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCC-CCEEEccccccc
Confidence 8899999999999999987765 6999999999999999999999998 9999999999999854 799999999997
Q ss_pred HhhccccccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChH
Q 004672 176 ILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 253 (738)
Q Consensus 176 ~l~~~~~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spe 253 (738)
....... ...++..|+|||.+. +.++.++||||||+++|+|++ |..||.. .+...+...+..+..+ ......++.
T Consensus 151 ~~~~~~~-~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 227 (256)
T cd05039 151 EASQGQD-SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPHVEKGYRM-EAPEGCPPE 227 (256)
T ss_pred ccccccc-cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCC-CCccCCCHH
Confidence 7643322 233566899999876 468889999999999999997 9999976 4566666666655443 234556899
Q ss_pred HHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 254 VRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 254 l~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
+.++|.+||. +|.+||++.++++
T Consensus 228 ~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 228 VYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHHHhccChhhCcCHHHHHH
Confidence 9999999999 9999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=320.61 Aligned_cols=255 Identities=27% Similarity=0.376 Sum_probs=207.2
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCC---
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN--- 96 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~--- 96 (738)
.++|.+++.||.|+||+||+|.+..+|..||+|++... .......+.+.+|+.+|+.++||||+++++++.....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRP--FQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccc--ccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 46799999999999999999999999999999987643 2334455678899999999999999999998754321
Q ss_pred -CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 97 -RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 97 -~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
..+++||||+ +++|..++.. ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++.
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~-~~~kl~dfg~~~ 166 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNED-CELKILDFGLAR 166 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeeccccc
Confidence 2568999999 7899988654 67999999999999999999999998 9999999999999854 899999999987
Q ss_pred HhhccccccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcC-CCC---------
Q 004672 176 ILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG-KKP--------- 243 (738)
Q Consensus 176 ~l~~~~~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g-~~p--------- 243 (738)
..... .....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||..........+..... ..+
T Consensus 167 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 167 QTDSE-MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred ccccC-ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 65432 233458899999998864 48889999999999999999999998754433322211110 000
Q ss_pred ------------------cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 244 ------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 244 ------------------~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
..+....++.+.++|.+||. +|.+|||+.+++.||||+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~ 303 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhh
Confidence 01123467889999999999 9999999999999999974
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=312.83 Aligned_cols=248 Identities=23% Similarity=0.328 Sum_probs=202.8
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCe--EEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecCC
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGI--EVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~--~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~ 96 (738)
.++|.+.+.||.|+||.||+|.++.+|. .+++|.++.. ......+.+.+|+.++.++ +||||+++++++.. .
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~ 75 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF---ASENDHRDFAGELEVLCKLGHHPNIINLLGACEN--R 75 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc---CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--C
Confidence 3689999999999999999999987775 4688876632 2344567899999999999 79999999998754 5
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEe
Q 004672 97 RNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 160 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k~~----------------~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~ 160 (738)
..+++||||+++|+|.+++.+.+ .+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~ 153 (297)
T cd05089 76 GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVG 153 (297)
T ss_pred CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEEC
Confidence 67999999999999999987643 4788999999999999999999998 99999999999998
Q ss_pred CCCCcEEEeccchhHHhhcccccc-ccCCCCCCCcccccc-ccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHH
Q 004672 161 GNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 237 (738)
Q Consensus 161 ~~~g~VKL~DFGlA~~l~~~~~~~-~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i 237 (738)
.+ +.+||+|||++.......... ...+..|+|||++.. .++.++||||||+++|+|++ |..||.. .....+...+
T Consensus 154 ~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~-~~~~~~~~~~ 231 (297)
T cd05089 154 EN-LASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG-MTCAELYEKL 231 (297)
T ss_pred CC-CeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHH
Confidence 54 799999999986432221111 123457999998864 58999999999999999997 9999976 4556666666
Q ss_pred HcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 238 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 238 ~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
..+..+. .+...++.+++||.+||. +|.+||++.++++.
T Consensus 232 ~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 232 PQGYRME-KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred hcCCCCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6654432 334578899999999999 89999999999755
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=320.68 Aligned_cols=254 Identities=29% Similarity=0.385 Sum_probs=210.2
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC---CCe
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA---NRN 98 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~---~~~ 98 (738)
+|.+.+.||.|++|+||+|.+..+|..||+|++.... ......+.+.+|+.+++.++||||+++++++.... ...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc--ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence 4889999999999999999999999999999887432 23455678999999999999999999999876532 247
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh
Q 004672 99 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~ 178 (738)
+++||||+. ++|.+++.+...+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.++|+|||++....
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~-~~~~L~dfg~~~~~~ 154 (330)
T cd07834 79 VYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSN-CDLKICDFGLARGVD 154 (330)
T ss_pred eEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEcccCceEeec
Confidence 899999996 689999888788999999999999999999999998 9999999999999866 899999999998765
Q ss_pred ccc-----cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc--CCCCc-----
Q 004672 179 KSH-----AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GKKPE----- 244 (738)
Q Consensus 179 ~~~-----~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~--g~~p~----- 244 (738)
... .....+++.|+|||++.+ .++.++||||||+++|+|++|..||..... ...++.+.. +..+.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY-IDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH-HHHHHHHHHhcCCCChhHhhh
Confidence 432 234458999999998864 488899999999999999999999987543 333344332 11110
Q ss_pred ----------------------ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 245 ----------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 245 ----------------------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
......++++.+||.+||. +|.+||++.++|.||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 0112357889999999999 9999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=304.62 Aligned_cols=244 Identities=20% Similarity=0.312 Sum_probs=203.9
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCC
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 97 (738)
+..++|.+.+.||+|+||.||+|.. .|..||+|.++.. ...+.+.+|+.+++.++|+||+++++++.. .+.
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 73 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKG 73 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEc-CCC
Confidence 4567899999999999999999965 5889999987632 234578999999999999999999997654 345
Q ss_pred eEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 98 NINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~~--~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
.+++||||+++++|.+++.+.+ .+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~-~~~kl~dfg~~~ 150 (256)
T cd05082 74 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSED-NVAKVSDFGLTK 150 (256)
T ss_pred ceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCC-CcEEecCCccce
Confidence 7899999999999999987654 3889999999999999999999998 9999999999999854 899999999987
Q ss_pred HhhccccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChH
Q 004672 176 ILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 253 (738)
Q Consensus 176 ~l~~~~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spe 253 (738)
...... ....++..|+|||++.+ .++.++||||||+++|+|++ |+.||.. .+..++...+..+..+ ......++.
T Consensus 151 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 227 (256)
T cd05082 151 EASSTQ-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKM-DAPDGCPPV 227 (256)
T ss_pred eccccC-CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCCCCHH
Confidence 543322 22335678999998864 58899999999999999997 9999975 4566666666665443 344567899
Q ss_pred HHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 254 VRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 254 l~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
++++|.+||. +|.+|||+.++++
T Consensus 228 ~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 228 VYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=315.07 Aligned_cols=258 Identities=26% Similarity=0.373 Sum_probs=213.2
Q ss_pred CcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCC
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 96 (738)
..+...|...+.||.|+||+||+|.+..+|..||+|.+.... ....+....+.+|+.+|+.++||||+++++++.. .
T Consensus 21 ~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~ 97 (317)
T cd06635 21 EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG-KQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR--E 97 (317)
T ss_pred CCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCC-CCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--C
Confidence 334456889999999999999999999999999999987543 2344566789999999999999999999998765 5
Q ss_pred CeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 97 RNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k-~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
...++||||+. |+|.+++.. ..++++..+..++.||+.||.|||+++ |+||||+|+||+++. .+.+||+|||++.
T Consensus 98 ~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~-~~~~kl~dfg~~~ 173 (317)
T cd06635 98 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTE-PGQVKLADFGSAS 173 (317)
T ss_pred CeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECC-CCCEEEecCCCcc
Confidence 67899999996 577777654 456899999999999999999999998 999999999999985 4899999999986
Q ss_pred HhhccccccccCCCCCCCccccc----cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCC
Q 004672 176 ILRKSHAARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED 251 (738)
Q Consensus 176 ~l~~~~~~~~vGTp~YmAPEvl~----~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~s 251 (738)
.... .....|++.|+|||.+. +.++.++||||||+++|+|++|..||...... .....+..+..+.......+
T Consensus 174 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 250 (317)
T cd06635 174 IASP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESPTLQSNEWS 250 (317)
T ss_pred ccCC--cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhccCCCCCCcccc
Confidence 5432 23345899999999873 45889999999999999999999999765433 33344444444433344567
Q ss_pred hHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 252 PEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 252 pel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
+.++++|.+||+ +|.+||++.++++|+|+....
T Consensus 251 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 251 DYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 889999999999 899999999999999996554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=310.22 Aligned_cols=249 Identities=20% Similarity=0.334 Sum_probs=203.1
Q ss_pred CcCCCCceEEEEEcccCCeEEEEEEEcCCCeE----EEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEE
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEGIE----VAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWV 92 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~----VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv 92 (738)
.+..++|++++.||.|+||+||+|....+|.. |++|.+.. .........+..|+.+++.++||||+++++++.
T Consensus 3 ~~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~ 79 (279)
T cd05111 3 ILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD---RSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP 79 (279)
T ss_pred cCCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccc---ccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC
Confidence 45668999999999999999999999877764 66666542 223345577888999999999999999999763
Q ss_pred ecCCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEecc
Q 004672 93 DTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 171 (738)
Q Consensus 93 ~~~~~~l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DF 171 (738)
....++++||+++|+|.+++... +.+++..+..|+.||+.||.|||+++ ++||||||+||+++.+ +.+||+||
T Consensus 80 ---~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~-~~~kl~Df 153 (279)
T cd05111 80 ---GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSD-SIVQIADF 153 (279)
T ss_pred ---CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCC-CcEEEcCC
Confidence 34578899999999999998764 56899999999999999999999998 9999999999999854 79999999
Q ss_pred chhHHhhccc----cccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcc
Q 004672 172 GLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEA 245 (738)
Q Consensus 172 GlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~ 245 (738)
|++....... .....++..|+|||.+. +.++.++||||||+++|||++ |..||.+. ....+...+..+..+.
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~- 231 (279)
T cd05111 154 GVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM-RPHEVPDLLEKGERLA- 231 (279)
T ss_pred ccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHCCCcCC-
Confidence 9997653321 12234677899999886 569999999999999999998 99999864 4455555555555443
Q ss_pred cccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 246 LFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 246 l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
.....+..+.+++.+||. +|.+|||+.|+++
T Consensus 232 ~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 232 QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 234457789999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=320.35 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=198.4
Q ss_pred EEEccc--CCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEe
Q 004672 27 MKFLVK--ELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTE 104 (738)
Q Consensus 27 ~kLG~G--afgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~E 104 (738)
..||.| +|++||+|.+..+|..||+|.+.... ...+..+.+.+|+.+++.++||||++++++|.. +..+++|+|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~~v~e 79 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLEN--CTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWLWVISP 79 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCceEEEEe
Confidence 356666 99999999999999999999887543 234556889999999999999999999998865 678999999
Q ss_pred cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcccc
Q 004672 105 MFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 182 (738)
Q Consensus 105 y~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~~ 182 (738)
|+.+++|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.++++||+.+........
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~-~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCC-CcEEEechHHHhhhhccCc
Confidence 99999999998774 35899999999999999999999998 9999999999999854 7999999987654322110
Q ss_pred ---------ccccCCCCCCCcccccc---ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC-------
Q 004672 183 ---------ARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP------- 243 (738)
Q Consensus 183 ---------~~~vGTp~YmAPEvl~~---~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p------- 243 (738)
....++..|+|||++.+ .++.++||||||+++|+|++|..||........+...+. +...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 235 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLK-GPPYSPLDITT 235 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhc-CCCCCCccccc
Confidence 01124567999999864 378999999999999999999999987554444333221 1100
Q ss_pred --------------------------------------cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 244 --------------------------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 244 --------------------------------------~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
.......++.+++||.+||. +|.+|||+.++|+||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 00112245789999999999 9999999999999999953
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=307.10 Aligned_cols=246 Identities=21% Similarity=0.337 Sum_probs=202.8
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCe
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 98 (738)
...+|++.+.||.|+||.||+|.+. ++..+|+|.+..... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~ 73 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-----SEDDFIEEAKVMMKLSHPNLVQLYGVCTK--QRP 73 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEEEEEEEEcC--CCc
Confidence 4567889999999999999999875 567899998763221 12457889999999999999999997644 568
Q ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 99 INFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
+++||||+++++|.+++..+ ..+++..+..++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++...
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~-~~~kl~dfg~~~~~ 150 (256)
T cd05059 74 IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGED-NVVKVSDFGLARYV 150 (256)
T ss_pred eEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCC-CcEEECCcccceec
Confidence 89999999999999998764 46899999999999999999999998 9999999999999854 89999999998765
Q ss_pred hcccccccc---CCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCCh
Q 004672 178 RKSHAARCV---GTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 252 (738)
Q Consensus 178 ~~~~~~~~v---GTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~sp 252 (738)
......... ++..|+|||.+. ..++.++||||||+++|+|+| |..||... ....+...+..+..+. .+...++
T Consensus 151 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 228 (256)
T cd05059 151 LDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF-SNSEVVESVSAGYRLY-RPKLAPT 228 (256)
T ss_pred ccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHcCCcCC-CCCCCCH
Confidence 433222222 335799999886 468999999999999999999 89999764 4556666666654332 3456789
Q ss_pred HHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 253 EVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 253 el~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
++.+++.+||. +|.+|||+.++++.
T Consensus 229 ~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 229 EVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 99999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=308.06 Aligned_cols=249 Identities=26% Similarity=0.376 Sum_probs=198.8
Q ss_pred CCCceEEEEEcccCCeEEEEEE----EcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC
Q 004672 20 LEDMEDTMKFLVKELQRHYRAF----DEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~----d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 95 (738)
-.+|++++.||+|+||+||+|. +..++..||+|.++.. .....+.+.+|+++|+.++||||+++++++....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 3578999999999999999987 5568999999987732 4556678999999999999999999999876655
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 96 NRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
...+++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~-~~~~l~dfg~~ 155 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESE-NRVKIGDFGLT 155 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCC-CeEEECCCccc
Confidence 66899999999999999998765 45899999999999999999999998 9999999999999854 79999999999
Q ss_pred HHhhccccc-----cccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCH---------------HHH
Q 004672 175 AILRKSHAA-----RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHP---------------AQI 233 (738)
Q Consensus 175 ~~l~~~~~~-----~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~---------------~qi 233 (738)
......... ...++..|+|||++.+ .++.++||||||+++|+|++|..|+...... ..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 866432211 1123456999998864 5889999999999999999987776431100 011
Q ss_pred HHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 234 YKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 234 ~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
...+..+..+ ......+.++.+||.+||. +|.+|||+.++++
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 236 IELLKNNGRL-PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHhcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1112222211 1234457899999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=353.66 Aligned_cols=252 Identities=26% Similarity=0.360 Sum_probs=202.9
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeE
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
+++|.++++||.|+||+||+|.+..+|..||+|+++.. ....+...+++.+|+.+++.++||||+++++++.+ ++..
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~-l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--~~~l 77 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIRED-LSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD--GDPV 77 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcc-cccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--CCEE
Confidence 46899999999999999999999999999999998743 23445567789999999999999999999998754 6789
Q ss_pred EEEEecCCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEE
Q 004672 100 NFVTEMFTSGTLRQYRLKH-----------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 168 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~-----------~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL 168 (738)
++||||++||+|.+++... ..++...+..++.||+.||.|||+++ |+||||||+||+++.+ |.+||
T Consensus 78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~d-g~vKL 154 (932)
T PRK13184 78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLF-GEVVI 154 (932)
T ss_pred EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCC-CCEEE
Confidence 9999999999999998642 23566788999999999999999998 9999999999999854 89999
Q ss_pred eccchhHHhhcc--------------------ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCC
Q 004672 169 GDLGLAAILRKS--------------------HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC 227 (738)
Q Consensus 169 ~DFGlA~~l~~~--------------------~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~ 227 (738)
+|||++...... .....+||+.|||||++.+ .++.++|||||||++|+|+||..||...
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 999999765210 0112469999999998864 5899999999999999999999999764
Q ss_pred CCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 228 THPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 228 ~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
......+................++.+.+++.+||. +|.+|++..+.|.+
T Consensus 235 ~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 235 KGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred chhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 333222222221111111224567899999999999 99999887766654
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=310.07 Aligned_cols=257 Identities=23% Similarity=0.347 Sum_probs=210.6
Q ss_pred CceEEEEEcccCCeEEEEEEEc---CCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecCCC
Q 004672 22 DMEDTMKFLVKELQRHYRAFDE---YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~---~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~ 97 (738)
+|.+.+.||.|++|+||+|.+. .++..||+|.++...........+++..|+.++.++ +||||+++++.|.. +.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CC
Confidence 4789999999999999999864 467899999987544333344567889999999999 69999999987743 67
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
.+++||||+.+|+|.+++.....+++..++.++.|++.||.|||+.+ ++||||||.||+++.+ +.++|+|||++...
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~-~~~~l~dfg~~~~~ 155 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSE-GHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEEEECcccccc
Confidence 89999999999999999888788999999999999999999999998 9999999999999855 79999999998765
Q ss_pred hcccc---ccccCCCCCCCccccccc---cCcccccccchhhhhhhhhcCCCCCCCC---CHHHHHHHHHcCCCCccccc
Q 004672 178 RKSHA---ARCVGTPEFMAPEVYEEE---YNELVDIYSFGMCILEMVTFDYPYSECT---HPAQIYKKVISGKKPEALFK 248 (738)
Q Consensus 178 ~~~~~---~~~vGTp~YmAPEvl~~~---ys~~sDIWSLGviLyeLlTG~~Pf~~~~---~~~qi~k~i~~g~~p~~l~~ 248 (738)
..... ....|++.|+|||.+.+. ++.++||||||+++|+|++|..||.... ....+.+.+.....+ .+.
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~ 233 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP--FPK 233 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCC--CCc
Confidence 43321 223589999999988643 6889999999999999999999996422 233444444444332 334
Q ss_pred CCChHHHHHHHHHHh-CcCCCCC---HHHHhcCcccCCCCC
Q 004672 249 VEDPEVRQFIEKCLA-TVSSRLS---ARELLTDPFLQIDDY 285 (738)
Q Consensus 249 ~~spel~~lI~kcL~-dP~~RpS---a~ELL~Hpf~~~~~~ 285 (738)
..++.++++|.+||+ +|++||| +.++|+||||+.-.+
T Consensus 234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 568899999999999 9999998 578899999976543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=307.49 Aligned_cols=246 Identities=21% Similarity=0.347 Sum_probs=206.0
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCe
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 98 (738)
+..+|.++++||.|+||+||+|.+.. +..+|+|.++.. .......+..|+.+|+.++||||+++++++.. ...
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~ 76 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD----DLLKQQDFQKEVQALKRLRHKHLISLFAVCSV--GEP 76 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc----chhhHHHHHHHHHHHhcCCCcchhheeeeEec--CCC
Confidence 44679999999999999999999987 899999987743 23345678999999999999999999997744 668
Q ss_pred EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 99 INFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
+++||||+++|+|.+++.+. ..+++..+..|+.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~-~~~kl~d~g~~~~ 153 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGED-LVCKVADFGLARL 153 (261)
T ss_pred eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCC-ceEEEccccchhh
Confidence 99999999999999998763 46899999999999999999999998 9999999999999854 7999999999976
Q ss_pred hhcccc--ccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCCh
Q 004672 177 LRKSHA--ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 252 (738)
Q Consensus 177 l~~~~~--~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~sp 252 (738)
...... ....+++.|+|||++. ..++.++||||||+++|+|++ |..||... +..+++..+..+..+. .....++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 231 (261)
T cd05148 154 IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM-NNHEVYDQITAGYRMP-CPAKCPQ 231 (261)
T ss_pred cCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC-CHHHHHHHHHhCCcCC-CCCCCCH
Confidence 643321 1223567899999886 458889999999999999998 89999763 4555666666554332 3456788
Q ss_pred HHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 253 EVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 253 el~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
.+.++|.+||+ +|.+|||+.+|++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 232 EIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.20 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=205.5
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEE-----cCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEE
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFD-----EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSW 91 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d-----~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~f 91 (738)
++.++|++.+.||.|+||+||+|.+ ..+++.||+|+++... .......+.+|+.+|..+ +||||+++++++
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 4567899999999999999999984 3568899999987432 234456788999999999 789999999987
Q ss_pred EecCCCeEEEEEecCCCCCHHHHHHhc-----------------------------------------------------
Q 004672 92 VDTANRNINFVTEMFTSGTLRQYRLKH----------------------------------------------------- 118 (738)
Q Consensus 92 v~~~~~~l~LV~Ey~~gGSL~~~l~k~----------------------------------------------------- 118 (738)
... +..+++||||+++|+|.+++...
T Consensus 81 ~~~-~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 81 TKP-GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred ecC-CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 543 45789999999999999998653
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcccc--
Q 004672 119 --------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-- 182 (738)
Q Consensus 119 --------------~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~~-- 182 (738)
..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~ 236 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYV 236 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCC-CcEEEEecccccccccCcchh
Confidence 23677888999999999999999998 9999999999999854 7999999999976532211
Q ss_pred --ccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHH
Q 004672 183 --ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 258 (738)
Q Consensus 183 --~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI 258 (738)
....+++.|+|||++. ..++.++||||||+++|+|++ |..||........+...+..+..+. .+...++++.+++
T Consensus 237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 315 (343)
T cd05103 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR-APDYTTPEMYQTM 315 (343)
T ss_pred hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCC-CCCCCCHHHHHHH
Confidence 1223567899999875 458999999999999999997 9999987655555655555554432 2345678999999
Q ss_pred HHHHh-CcCCCCCHHHHhcC
Q 004672 259 EKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 259 ~kcL~-dP~~RpSa~ELL~H 277 (738)
..||. +|.+|||+.+|++|
T Consensus 316 ~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 316 LDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHccCChhhCcCHHHHHHH
Confidence 99999 99999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=317.27 Aligned_cols=254 Identities=20% Similarity=0.302 Sum_probs=213.1
Q ss_pred CCCceEE-EEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEec--C
Q 004672 20 LEDMEDT-MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDT--A 95 (738)
Q Consensus 20 ~~~y~il-~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~--~ 95 (738)
.++|++. ++||.|-.|.|-.++++.||+.+|+|++. .+ ....+|+++--.. .|||||.++++|... .
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DS----PKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 3556554 67999999999999999999999999754 22 3467788766555 799999999987432 3
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCC--CcEEEecc
Q 004672 96 NRNINFVTEMFTSGTLRQYRLKHRR--VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ--GEVKIGDL 171 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~l~k~~~--lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~--g~VKL~DF 171 (738)
...+.+|||.|+||.|+..++.++. |+++.+..|++||..|+.|||+.+ |.||||||+|+|...+. -.+||+||
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEeccc
Confidence 4578999999999999999988765 999999999999999999999999 99999999999997442 36899999
Q ss_pred chhHHhhc-cccccccCCCCCCCccccc-cccCcccccccchhhhhhhhhcCCCCCCCCC---HHHHHHHHHcCC--CCc
Q 004672 172 GLAAILRK-SHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTH---PAQIYKKVISGK--KPE 244 (738)
Q Consensus 172 GlA~~l~~-~~~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~---~~qi~k~i~~g~--~p~ 244 (738)
|+|+.... ....+.+-||.|.|||++. ++|+..+|+||+|+++|-|++|.+||..... .-.+..+|..|. .|.
T Consensus 209 GFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~ 288 (400)
T KOG0604|consen 209 GFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE 288 (400)
T ss_pred ccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence 99987663 3456667899999999997 5699999999999999999999999975332 223456777776 366
Q ss_pred ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 245 ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 245 ~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
.-|...+...+++|+++|. +|.+|+|+.+++.|||+....
T Consensus 289 pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 289 PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 6667789999999999999 999999999999999997543
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=309.85 Aligned_cols=248 Identities=24% Similarity=0.379 Sum_probs=204.8
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEE-----cCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEE
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFD-----EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWV 92 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d-----~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv 92 (738)
|...+|...++||+|+||+||++.. ..++..+|+|.++. ......+.+.+|+.+++.++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE----ASESARQDFQREAELLTVLQHQHIVRFYGVCT 77 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc----CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe
Confidence 4457889999999999999999964 34677899998663 34566778999999999999999999999875
Q ss_pred ecCCCeEEEEEecCCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccE
Q 004672 93 DTANRNINFVTEMFTSGTLRQYRLKHR---------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157 (738)
Q Consensus 93 ~~~~~~l~LV~Ey~~gGSL~~~l~k~~---------------~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NI 157 (738)
. ...++++|||+.+|+|.+++..++ .+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 78 ~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~ni 153 (280)
T cd05092 78 E--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNC 153 (280)
T ss_pred c--CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhE
Confidence 5 567899999999999999987653 4889999999999999999999998 99999999999
Q ss_pred EEeCCCCcEEEeccchhHHhhccc----cccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHH
Q 004672 158 FVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPA 231 (738)
Q Consensus 158 Ll~~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~ 231 (738)
|++. ++.+||+|||++....... .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.... ..
T Consensus 154 l~~~-~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~ 231 (280)
T cd05092 154 LVGQ-GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS-NT 231 (280)
T ss_pred EEcC-CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC-HH
Confidence 9985 4799999999986543221 12223578899999876 458999999999999999998 899997644 44
Q ss_pred HHHHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 232 QIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 232 qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
.....+..+..+. .....++.+.+||.+||. +|.+||++.+|+.
T Consensus 232 ~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 232 EAIECITQGRELE-RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHHHHcCccCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 4555566554443 334668899999999999 9999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=301.44 Aligned_cols=243 Identities=27% Similarity=0.425 Sum_probs=208.8
Q ss_pred EcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEecCCC
Q 004672 29 FLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTS 108 (738)
Q Consensus 29 LG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey~~g 108 (738)
||.|+||.||++.+..+|..||+|.+.... .......+.+..|+.+++.++||||+++++.+. .+..+++||||+.+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKK-IIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ--TEEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhh-hcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee--cCCeeEEEEecCCC
Confidence 689999999999999999999999987554 233446778999999999999999999998764 47789999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc--cccccc
Q 004672 109 GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--HAARCV 186 (738)
Q Consensus 109 GSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~--~~~~~v 186 (738)
++|.+++.....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.+ +.++|+|||++...... ......
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCC-CcEEEeecCcceecccCCCcccCCc
Confidence 999999988888999999999999999999999998 9999999999999854 79999999999765443 233445
Q ss_pred CCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-C
Q 004672 187 GTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-T 264 (738)
Q Consensus 187 GTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-d 264 (738)
++..|+|||...+ .++.++|+||||+++|+|++|..||.. .....++..+..+..+ ++...+..+.+||.+||. +
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~--~~~~~~~~l~~~i~~~l~~~ 231 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKILKDPLR--FPEFLSPEARDLISGLLQKD 231 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCCCC--CCCCCCHHHHHHHHHHhcCC
Confidence 8899999998864 478899999999999999999999975 3446666666654332 444558899999999999 9
Q ss_pred cCCCCCH---HHHhcCccc
Q 004672 265 VSSRLSA---RELLTDPFL 280 (738)
Q Consensus 265 P~~RpSa---~ELL~Hpf~ 280 (738)
|.+||++ .+++.||||
T Consensus 232 p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 232 PTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HhhCCCcccHHHHHhCCCC
Confidence 9999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.87 Aligned_cols=251 Identities=29% Similarity=0.484 Sum_probs=206.6
Q ss_pred ceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEE
Q 004672 23 MEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 102 (738)
Q Consensus 23 y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV 102 (738)
|....+||.|+||.||+|.+..+|..||+|++... .......+.+|+.+++.++|+||+++++.|.. +...++|
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 95 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVV 95 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc----chhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEEE
Confidence 33446799999999999999999999999987632 23456779999999999999999999998865 6789999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccc-
Q 004672 103 TEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH- 181 (738)
Q Consensus 103 ~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~- 181 (738)
|||+++++|.+++. ..++++..+..++.|++.||+|||+++ ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 96 ~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~-~~~~l~dfg~~~~~~~~~~ 171 (292)
T cd06657 96 MEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVP 171 (292)
T ss_pred EecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEEcccccceecccccc
Confidence 99999999999864 457899999999999999999999998 9999999999999855 799999999886554322
Q ss_pred -cccccCCCCCCCccccc-cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCc-ccccCCChHHHHHH
Q 004672 182 -AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE-ALFKVEDPEVRQFI 258 (738)
Q Consensus 182 -~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~-~l~~~~spel~~lI 258 (738)
.....|++.|+|||.+. ..++.++|+||||+++|+|++|..||... ........+..+..+. ......++.+.++|
T Consensus 172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 250 (292)
T cd06657 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-PPLKAMKMIRDNLPPKLKNLHKVSPSLKGFL 250 (292)
T ss_pred cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhhCCcccCCcccCCHHHHHHH
Confidence 22345899999999876 45889999999999999999999999863 3333333333332221 12234688999999
Q ss_pred HHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 259 EKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 259 ~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
.+||. +|.+||++.++|.||||....
T Consensus 251 ~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 251 DRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred HHHHhCCcccCcCHHHHhcChHHhccC
Confidence 99999 999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=303.71 Aligned_cols=239 Identities=21% Similarity=0.321 Sum_probs=198.4
Q ss_pred EEEcccCCeEEEEEEEcCCC---eEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEE
Q 004672 27 MKFLVKELQRHYRAFDEYEG---IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 103 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG---~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~ 103 (738)
++||.|+||.||+|....++ ..||+|.+..... ....+.+..|+.+|+.++||||+++++++. ...+++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI---AAGKKEFLREASVMAQLDHPCIVRLIGVCK---GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEc---CCceEEEE
Confidence 46999999999999876655 7999998774432 145568999999999999999999999753 34689999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccccc
Q 004672 104 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 183 (738)
Q Consensus 104 Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~~~ 183 (738)
||+.+|+|.+++.+...+++..+..|+.|++.||.|||..+ ++||||||+|||++.+ +.+||+|||++.........
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~-~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 75 ELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred EeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCC-CcEEeccccccceeecCCcc
Confidence 99999999999998888999999999999999999999998 9999999999999854 79999999999765432211
Q ss_pred -----cccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004672 184 -----RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 256 (738)
Q Consensus 184 -----~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~ 256 (738)
...++..|+|||.+. ..++.++||||||+++|+|++ |..||... +..++.+.+..+... ..+...++.+++
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 229 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-KGAEVIAMLESGERL-PRPEECPQEIYS 229 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHHcCCcC-CCCCCCCHHHHH
Confidence 111346799999886 458999999999999999998 99999874 445666666655433 344567889999
Q ss_pred HHHHHHh-CcCCCCCHHHHhc
Q 004672 257 FIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 257 lI~kcL~-dP~~RpSa~ELL~ 276 (738)
+|.+||. +|.+||++.+|++
T Consensus 230 li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 230 IMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 9999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=303.19 Aligned_cols=240 Identities=24% Similarity=0.339 Sum_probs=198.5
Q ss_pred EEEcccCCeEEEEEEEcC-CC--eEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEE
Q 004672 27 MKFLVKELQRHYRAFDEY-EG--IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 103 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~-tG--~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~ 103 (738)
++||.|++|+||+|.+.. .+ ..||+|.++..... ...+.+.+|+.+|++++||||+++++++.+ ..+++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEE
Confidence 368999999999999865 33 36999988754321 667899999999999999999999998765 6889999
Q ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccc
Q 004672 104 EMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 181 (738)
Q Consensus 104 Ey~~gGSL~~~l~k~~--~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~ 181 (738)
||+++|+|.+++.... .+++..+..++.||+.||.|||+++ ++|+||||+||+++.+ +.+||+|||++..+....
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~-~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASD-DKVKIGDFGLMRALPQNE 151 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecC-CEEEeccccccccccccc
Confidence 9999999999987764 6899999999999999999999998 9999999999999866 899999999997764421
Q ss_pred -----cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHH
Q 004672 182 -----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEV 254 (738)
Q Consensus 182 -----~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel 254 (738)
.....++..|+|||.+.. .++.++||||||+++|+|++ |..||... +..++.+.+.............+..+
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
T cd05040 152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKIDKEGERLERPEACPQDI 230 (257)
T ss_pred cceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHhcCCcCCCCccCCHHH
Confidence 112347789999998864 68999999999999999999 99999764 44555555553222222334567899
Q ss_pred HHHHHHHHh-CcCCCCCHHHHhc
Q 004672 255 RQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 255 ~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
.+++.+||. +|.+|||+.+++.
T Consensus 231 ~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 231 YNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHHCCCCcccCCCHHHHHH
Confidence 999999999 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=308.87 Aligned_cols=258 Identities=19% Similarity=0.203 Sum_probs=209.6
Q ss_pred ccCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEec
Q 004672 15 LKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 94 (738)
Q Consensus 15 ~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~ 94 (738)
..-|--++|++.+.||+|+|+.||++....++..||+|+|... +.+..+...+|+..-++++||||++++++.+..
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~----~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~ 90 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH----SQEDIEEALREIDNHRKFNSPNVLRLVDHQLRE 90 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc----chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence 3445567899999999999999999999999999999999854 467788999999999999999999999877543
Q ss_pred ---CCCeEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEE
Q 004672 95 ---ANRNINFVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVK 167 (738)
Q Consensus 95 ---~~~~l~LV~Ey~~gGSL~~~l~k~----~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VK 167 (738)
.....|+++.|+..|||.+.+... ..+++.+++.|+.+|++||++||+..||++||||||.|||+.+ .+.++
T Consensus 91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~-~~~~v 169 (302)
T KOG2345|consen 91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD-SGLPV 169 (302)
T ss_pred hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC-CCceE
Confidence 235799999999999999997653 3699999999999999999999999999999999999999985 58999
Q ss_pred EeccchhHHhhcccc-----------ccccCCCCCCCcccccc----ccCcccccccchhhhhhhhhcCCCCCCCC-CHH
Q 004672 168 IGDLGLAAILRKSHA-----------ARCVGTPEFMAPEVYEE----EYNELVDIYSFGMCILEMVTFDYPYSECT-HPA 231 (738)
Q Consensus 168 L~DFGlA~~l~~~~~-----------~~~vGTp~YmAPEvl~~----~ys~~sDIWSLGviLyeLlTG~~Pf~~~~-~~~ 231 (738)
|.|||.+....-... .....|..|+|||++.- ..++++|||||||+||.|+.|..||...- .-.
T Consensus 170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg 249 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG 249 (302)
T ss_pred EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC
Confidence 999999876532111 12247899999999863 37899999999999999999999996310 000
Q ss_pred HHHHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 232 QIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 232 qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
.+.-.+.++.........++..+.++|+.||+ ||.+||++.+|+.+
T Consensus 250 SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 250 SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 01112223332222233478899999999999 99999999999864
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=313.72 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=206.8
Q ss_pred cCcCCCCceEEEEEcccCCeEEEEEEEcC-------CCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCccee
Q 004672 16 KLIPLEDMEDTMKFLVKELQRHYRAFDEY-------EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKF 87 (738)
Q Consensus 16 ~~I~~~~y~il~kLG~GafgtVYkA~d~~-------tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl 87 (738)
-.+..++|.+.+.||+|+||+||+|.+.. ++..||+|.++.. ........+..|+.+++.+ +||||+++
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC---CChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 35556899999999999999999998743 3357999987632 2345567889999999999 89999999
Q ss_pred eEEEEecCCCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecc
Q 004672 88 YTSWVDTANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 151 (738)
Q Consensus 88 ~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~----------------~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRD 151 (738)
++++.. ...+++||||+.+|+|.+++..++ .+++..++.++.||+.||.|||+++ ++|||
T Consensus 90 ~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~d 165 (307)
T cd05098 90 LGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRD 165 (307)
T ss_pred EEEEec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--ccccc
Confidence 998754 568999999999999999997642 3788999999999999999999998 99999
Q ss_pred CCcccEEEeCCCCcEEEeccchhHHhhccc----cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhh-cCCCCC
Q 004672 152 LKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYS 225 (738)
Q Consensus 152 LKP~NILl~~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlT-G~~Pf~ 225 (738)
|||+||+++.+ +.+||+|||++....... .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.
T Consensus 166 lkp~Nill~~~-~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~ 244 (307)
T cd05098 166 LAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 244 (307)
T ss_pred ccHHheEEcCC-CcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999855 799999999987553211 111224578999998864 58999999999999999998 888997
Q ss_pred CCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 226 ECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 226 ~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
. .+..++.+.+..+..+. .+...+++++++|.+||. +|.+|||+.+++++
T Consensus 245 ~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 245 G-VPVEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred c-CCHHHHHHHHHcCCCCC-CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 5 56677777776665432 344568899999999999 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.53 Aligned_cols=255 Identities=28% Similarity=0.413 Sum_probs=208.2
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCC---
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN--- 96 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~--- 96 (738)
.++|.+...||.|++|+||+|.+..++..||+|++... .......+.+.+|+.+++.++||||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP--FQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccc--cchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 46899999999999999999999999999999987643 1233455678899999999999999999987654221
Q ss_pred -CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 97 -RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 97 -~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
..+++|+||+ +++|.+++.. .++++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++.
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~-~~~kL~dfg~~~ 166 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNED-CELKILDFGLAR 166 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CCEEEccccccc
Confidence 3589999999 7899998765 57999999999999999999999998 9999999999999854 899999999997
Q ss_pred HhhccccccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCC--CCc-------
Q 004672 176 ILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK--KPE------- 244 (738)
Q Consensus 176 ~l~~~~~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~--~p~------- 244 (738)
..... .....+++.|+|||++.+ .++.++||||||+++|+|+||+.||...... ..+..+.... .+.
T Consensus 167 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 167 HTDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred ccccc-ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCHHHHhhcc
Confidence 65433 334468999999998754 5788999999999999999999999864433 3333333211 110
Q ss_pred --------------------ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 245 --------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 245 --------------------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
......++.+.+||.+||+ +|.+|||+.+||.||||+.-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~ 304 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence 1122358899999999999 99999999999999999753
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=314.49 Aligned_cols=248 Identities=27% Similarity=0.395 Sum_probs=198.6
Q ss_pred EEccc--CCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEec
Q 004672 28 KFLVK--ELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEM 105 (738)
Q Consensus 28 kLG~G--afgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey 105 (738)
+||+| +++.||.+.+..+|..||+|+++... ......+++..|+.+|+.++||||++++++|.. ....+++|||
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~--~~~~~~~~e~ 80 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS--CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYVVSPL 80 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccc--cchhHHHHHHHHHHHHHhcCCcchhhhhheeec--CCeEEEEEec
Confidence 34444 55677777778899999999988642 244567889999999999999999999998865 5788999999
Q ss_pred CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccc--
Q 004672 106 FTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-- 181 (738)
Q Consensus 106 ~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~-- 181 (738)
+++|+|.+++... ..+++..+..+++||+.||.|||+++ |+||||||+||+++.+ |.+||+|||.+..+....
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~-~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecC-CceEEecCccceeecccccc
Confidence 9999999998764 45899999999999999999999998 9999999999999854 899999999886443211
Q ss_pred -------cccccCCCCCCCcccccc---ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCc-------
Q 004672 182 -------AARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE------- 244 (738)
Q Consensus 182 -------~~~~vGTp~YmAPEvl~~---~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~------- 244 (738)
.....++..|+|||++.. .|+.++||||||+++|+|++|..||........+..++. +..+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~ 236 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR-GTVPCLLDKSTY 236 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-ccCccccccCch
Confidence 122347789999999864 488999999999999999999999987554444433332 11110
Q ss_pred -------------------------ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 245 -------------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 245 -------------------------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
......++++.+||.+||. +|.+|||+.++|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 0011224678899999999 99999999999999999743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.45 Aligned_cols=250 Identities=27% Similarity=0.387 Sum_probs=205.8
Q ss_pred ceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEE
Q 004672 23 MEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 102 (738)
Q Consensus 23 y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV 102 (738)
|.+.+.||.|++|.||+|.+..+|..+++|+++.... .+.....+..|+.+|+.++|+||+++++++.. +..+++|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v 76 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE--SEGIPKTALREIKLLKELNHPNIIKLLDVFRH--KGDLYLV 76 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCcchHHHhhcc--CCCEEEE
Confidence 5678999999999999999999999999999875432 22445688899999999999999999998754 5789999
Q ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccc
Q 004672 103 TEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 181 (738)
Q Consensus 103 ~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~ 181 (738)
+||+. ++|.+++... ..+++..+..++.||+.||.|||+++ |+|+||||+||+++.+ +.+||+|||.+.......
T Consensus 77 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~-~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 77 FEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTE-GVLKLADFGLARSFGSPV 152 (283)
T ss_pred EeccC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCC-CcEEEeeeeeeEecCCCc
Confidence 99996 5888877664 57999999999999999999999998 9999999999999854 799999999987665432
Q ss_pred --cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC--c-----------
Q 004672 182 --AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP--E----------- 244 (738)
Q Consensus 182 --~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p--~----------- 244 (738)
.....++..|+|||.+.+ .++.++||||||+++|+|+||+.||......+++.+.......+ .
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence 223458889999998764 58889999999999999999999998765555443332221111 0
Q ss_pred --------------ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 245 --------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 245 --------------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
......+.++++||.+||. +|.+||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 1122357889999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=307.47 Aligned_cols=246 Identities=24% Similarity=0.362 Sum_probs=196.2
Q ss_pred ceEEEEEcccCCeEEEEEE----EcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCe
Q 004672 23 MEDTMKFLVKELQRHYRAF----DEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 23 y~il~kLG~GafgtVYkA~----d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 98 (738)
|.+++.||.|+||+||++. ...++..||+|.++... .....+.+.+|+.+|+.++||||+++++++.......
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 3889999999999998764 34578899999887432 2345567889999999999999999999877665668
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh
Q 004672 99 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~ 178 (738)
+++||||+++|+|.+++... .+++..++.++.|++.||.|||+++ |+||||||+|||++.+ +.+||+|||++....
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~ 158 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDND-RLVKIGDFGLAKAVP 158 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCC-CcEEEeecccccccC
Confidence 99999999999999998764 5999999999999999999999998 9999999999999855 799999999997654
Q ss_pred cccc-----ccccCCCCCCCccccc-cccCcccccccchhhhhhhhhcCCCCCCCCCHH--------------HHHHHHH
Q 004672 179 KSHA-----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPA--------------QIYKKVI 238 (738)
Q Consensus 179 ~~~~-----~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~--------------qi~k~i~ 238 (738)
.... ....++..|+|||.+. ..++.++||||||+++|+|+||..||....... .+...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 3221 1223566799999886 458999999999999999999999986432110 0111111
Q ss_pred cCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 239 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 239 ~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
.+..+ ......++++++++.+||. +|++|||+.+++.
T Consensus 239 ~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RGMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cCCCC-CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11111 1234457899999999999 9999999999984
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=306.52 Aligned_cols=249 Identities=28% Similarity=0.373 Sum_probs=203.9
Q ss_pred ceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCC-CCCcceeeEEEEecCCCeEEE
Q 004672 23 MEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 23 y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~l~L 101 (738)
|.+.+.||.|++|+||+|.+..++..||+|++..... . .......+|+..++.++ ||||+++++++.+ +...++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--S-WEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--c-hhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEE
Confidence 6788999999999999999999999999998764321 1 22234567999999998 9999999998755 678999
Q ss_pred EEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 102 VTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~~--~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
||||+ +|+|.+++.... .+++..++.++.|++.+|.|||+++ ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~-~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGP-EVVKIADFGLAREIRS 151 (283)
T ss_pred EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCC-CCEEEeecccceeccC
Confidence 99999 889999887765 7899999999999999999999998 9999999999999854 8999999999976654
Q ss_pred cc-cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC-------------
Q 004672 180 SH-AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP------------- 243 (738)
Q Consensus 180 ~~-~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p------------- 243 (738)
.. .....++..|+|||++.. .++.++||||||+++++|++|+.||........+++.......|
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 32 234468999999998853 47899999999999999999999998765555544332211111
Q ss_pred --------------cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 244 --------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 244 --------------~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
.......++.+++||.+||+ +|.+|||+.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 01112236789999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=309.66 Aligned_cols=250 Identities=18% Similarity=0.230 Sum_probs=206.3
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcC-----CCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEE
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEY-----EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWV 92 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~-----tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv 92 (738)
+...+|.+.++||.|+||+||+|.+.. .+..||+|.++.. ......+.+..|+.+++.++||||+++++++.
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~ 78 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK---AEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT 78 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCC---CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 556778899999999999999998754 3578999987743 23445678999999999999999999999875
Q ss_pred ecCCCeEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCccc
Q 004672 93 DTANRNINFVTEMFTSGTLRQYRLKH----------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156 (738)
Q Consensus 93 ~~~~~~l~LV~Ey~~gGSL~~~l~k~----------------~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~N 156 (738)
. ...+++++||+.+++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 79 ~--~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~N 154 (283)
T cd05091 79 K--EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRN 154 (283)
T ss_pred C--CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhh
Confidence 4 56789999999999999998532 24788899999999999999999998 9999999999
Q ss_pred EEEeCCCCcEEEeccchhHHhhccc----cccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCH
Q 004672 157 IFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHP 230 (738)
Q Consensus 157 ILl~~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~ 230 (738)
|+++.+ +.+||+|||++....... .....+++.|+|||.+. +.++.++||||||+++|+|+| |..||.+ ...
T Consensus 155 il~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~ 232 (283)
T cd05091 155 VLVFDK-LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSN 232 (283)
T ss_pred eEecCC-CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC-CCH
Confidence 999854 789999999987653322 12334678999999875 568999999999999999998 8889876 455
Q ss_pred HHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 231 AQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 231 ~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
.++...+..+..+. .....+..+.+++.+||+ +|.+||++.+++..
T Consensus 233 ~~~~~~i~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 233 QDVIEMIRNRQVLP-CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 66777777665432 334567889999999999 89999999999853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=305.68 Aligned_cols=251 Identities=19% Similarity=0.309 Sum_probs=206.9
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCC-----CeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEE
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYE-----GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWV 92 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~t-----G~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv 92 (738)
+..++|.++..||.|+||+||+|..+.+ ...|++|.+... ......+.+.+|+++|++++||||+++++++.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 78 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT---KDENLQSEFRRELDMFRKLSHKNVVRLLGLCR 78 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc---cchHHHHHHHHHHHHHHhcCCcceeeeEEEEC
Confidence 4557899999999999999999997643 467888876532 23346678999999999999999999999774
Q ss_pred ecCCCeEEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCC
Q 004672 93 DTANRNINFVTEMFTSGTLRQYRLKHR---------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 163 (738)
Q Consensus 93 ~~~~~~l~LV~Ey~~gGSL~~~l~k~~---------~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~ 163 (738)
+ ....++||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.+
T Consensus 79 ~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~- 153 (275)
T cd05046 79 E--AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQ- 153 (275)
T ss_pred C--CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCC-
Confidence 4 568899999999999999998766 6899999999999999999999998 9999999999999854
Q ss_pred CcEEEeccchhHHhhccc---cccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHH
Q 004672 164 GEVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVI 238 (738)
Q Consensus 164 g~VKL~DFGlA~~l~~~~---~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~ 238 (738)
+.++|+|||++....... .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||... ....+...+.
T Consensus 154 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~-~~~~~~~~~~ 232 (275)
T cd05046 154 REVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL-SDEEVLNRLQ 232 (275)
T ss_pred CcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc-chHHHHHHHH
Confidence 799999999986543221 12234677899999875 458889999999999999998 88899764 3455666666
Q ss_pred cCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 239 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 239 ~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
.+..+.......+..+.+++.+||+ +|.+||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 233 AGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred cCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 5655444445678899999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=317.98 Aligned_cols=253 Identities=29% Similarity=0.408 Sum_probs=204.4
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC----C
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA----N 96 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~----~ 96 (738)
++|.+++.||+|+||.||+|.+..+|..||+|+++... ......+.+.+|+.++++++||||+++++++.... .
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 78999999999999999999999999999999887432 23344567889999999999999999999875421 2
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
..++++++++ +++|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+||+++.+ |.+||+|||++..
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~-~~~kl~dfg~~~~ 169 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLARH 169 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCC-CCEEEeccccccc
Confidence 4578888887 8899887654 46999999999999999999999998 9999999999999854 7999999999876
Q ss_pred hhccccccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc--CCC----------
Q 004672 177 LRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GKK---------- 242 (738)
Q Consensus 177 l~~~~~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~--g~~---------- 242 (738)
.... .....|++.|+|||++.+ .++.++||||||+++|+|++|+.||....... ....+.. +..
T Consensus 170 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 170 TDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred cccc-ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHhhccc
Confidence 5332 234468999999998754 48889999999999999999999997643322 2222211 100
Q ss_pred -------------C----cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 243 -------------P----EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 243 -------------p----~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
| .......++++++||.+||. +|.+||++.++|.||||+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305 (345)
T ss_pred HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence 0 01112357889999999999 9999999999999999974
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=311.53 Aligned_cols=250 Identities=23% Similarity=0.358 Sum_probs=204.5
Q ss_pred CcCCCCceEEEEEcccCCeEEEEEEEc-------CCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceee
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDE-------YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFY 88 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~-------~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~ 88 (738)
.++.++|.+.++||+|+||.||+|.+. ..+..||+|.++.. ........+..|+.+++.+ +||||++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN---ATDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC---CChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 445678999999999999999999863 23567999987632 2345567889999999999 699999999
Q ss_pred EEEEecCCCeEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccC
Q 004672 89 TSWVDTANRNINFVTEMFTSGTLRQYRLKH----------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL 152 (738)
Q Consensus 89 ~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~----------------~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDL 152 (738)
+++.. ...+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||
T Consensus 85 ~~~~~--~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dl 160 (314)
T cd05099 85 GVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDL 160 (314)
T ss_pred EEEcc--CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccc
Confidence 98754 56799999999999999998764 24888999999999999999999998 999999
Q ss_pred CcccEEEeCCCCcEEEeccchhHHhhccc----cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhh-cCCCCCC
Q 004672 153 KCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSE 226 (738)
Q Consensus 153 KP~NILl~~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlT-G~~Pf~~ 226 (738)
||+|||++.+ +.+||+|||++....... .....+++.|||||++.+ .++.++||||||+++|+|++ |..||..
T Consensus 161 kp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 239 (314)
T cd05099 161 AARNVLVTED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239 (314)
T ss_pred cceeEEEcCC-CcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence 9999999854 799999999997654321 111224568999998764 58999999999999999999 8899976
Q ss_pred CCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 227 CTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 227 ~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
.+...++..+..+..+. .....+.+++++|.+||. +|.+|||+.+++.
T Consensus 240 -~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 240 -IPVEELFKLLREGHRMD-KPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred -CCHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 45666777776654432 234557789999999999 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=304.44 Aligned_cols=250 Identities=23% Similarity=0.269 Sum_probs=208.2
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcC----CCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEe
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEY----EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD 93 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~----tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~ 93 (738)
+..++|.+.+.||+|+||+||+|.+.. ++..|++|.++. .......+.+.+|+.+|+.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~---~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 79 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD---HASEIQVTLLLQESCLLYGLSHQNILPILHVCIE 79 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC---CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 556789999999999999999999876 368899998652 2345667889999999999999999999998654
Q ss_pred cCCCeEEEEEecCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCc
Q 004672 94 TANRNINFVTEMFTSGTLRQYRLKH--------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 165 (738)
Q Consensus 94 ~~~~~l~LV~Ey~~gGSL~~~l~k~--------~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~ 165 (738)
. +...++++||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++.+ +.
T Consensus 80 ~-~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~-~~ 155 (280)
T cd05043 80 D-GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEE-LQ 155 (280)
T ss_pred C-CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCC-Cc
Confidence 3 56789999999999999998764 35889999999999999999999998 9999999999999854 79
Q ss_pred EEEeccchhHHhhcccc----ccccCCCCCCCcccccc-ccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHc
Q 004672 166 VKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVIS 239 (738)
Q Consensus 166 VKL~DFGlA~~l~~~~~----~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~ 239 (738)
+||+|||+++.+..... ....++..|+|||++.+ .++.++||||||+++|+|++ |+.||.. .++..+...+..
T Consensus 156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~ 234 (280)
T cd05043 156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE-IDPFEMAAYLKD 234 (280)
T ss_pred EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc-CCHHHHHHHHHc
Confidence 99999999976533211 12235678999998864 58999999999999999999 9999986 456667666666
Q ss_pred CCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 240 GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 240 g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
+..+. .....++++.+++.+||. +|++|||+.+++.
T Consensus 235 ~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 235 GYRLA-QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCCC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 54433 234467899999999999 9999999999984
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=307.22 Aligned_cols=249 Identities=20% Similarity=0.260 Sum_probs=205.0
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcC-----CCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEE
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEY-----EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWV 92 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~-----tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv 92 (738)
+..++|.+...||.|+||.||+|.+.. ++..||+|++... ........+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~ 78 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQADFQREAALMAEFDHPNIVKLLGVCA 78 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC---cCHHHHHHHHHHHHHHHhcCCCchheEEEEEc
Confidence 456789999999999999999998753 6789999987632 23455677999999999999999999999775
Q ss_pred ecCCCeEEEEEecCCCCCHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceec
Q 004672 93 DTANRNINFVTEMFTSGTLRQYRLKHR----------------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 150 (738)
Q Consensus 93 ~~~~~~l~LV~Ey~~gGSL~~~l~k~~----------------------~lse~~i~~i~~QIl~aL~yLHs~gp~IIHR 150 (738)
. ...+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+++ ++||
T Consensus 79 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~ 154 (288)
T cd05050 79 V--GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHR 154 (288)
T ss_pred C--CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecc
Confidence 4 567899999999999999987532 3678889999999999999999998 9999
Q ss_pred cCCcccEEEeCCCCcEEEeccchhHHhhccc----cccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCC
Q 004672 151 DLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPY 224 (738)
Q Consensus 151 DLKP~NILl~~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf 224 (738)
||||+||+++.+ +.++|+|||++....... .....+++.|+|||++. ..++.++|||||||++|+|++ |..||
T Consensus 155 dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~ 233 (288)
T cd05050 155 DLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233 (288)
T ss_pred cccHhheEecCC-CceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 999999999854 899999999987543221 11223567899999876 568999999999999999997 88898
Q ss_pred CCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 225 SECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 225 ~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
.+ .+..++...+..+..+. .....++++.+||.+||+ +|.+|||+.|+++
T Consensus 234 ~~-~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 234 YG-MAHEEVIYYVRDGNVLS-CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CC-CCHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 76 34566666676665442 234567899999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=304.04 Aligned_cols=245 Identities=22% Similarity=0.315 Sum_probs=200.6
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCC
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 97 (738)
|..++|.+.++||+|+||+||+|.+..++ .||+|.++.... ..+++.+|+.+++.++||||+++++.+. ..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~ 73 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVS---EE 73 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCcceEEEEEC---CC
Confidence 55678999999999999999999987654 599998874321 1246889999999999999999998752 34
Q ss_pred eEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 98 NINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
..++||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.+ +.+||+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~-~~~~L~dfg~~~ 150 (262)
T cd05071 74 PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLAR 150 (262)
T ss_pred CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCC-CcEEeccCCcee
Confidence 578999999999999998764 35899999999999999999999998 9999999999999854 799999999997
Q ss_pred Hhhccccc---cccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCC
Q 004672 176 ILRKSHAA---RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVE 250 (738)
Q Consensus 176 ~l~~~~~~---~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~ 250 (738)
.+...... ...++..|+|||++. ..++.++||||||+++|+|+| |..||... ....++..+..+..+. .....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~ 228 (262)
T cd05071 151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMP-CPPEC 228 (262)
T ss_pred eccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-ChHHHHHHHhcCCCCC-Ccccc
Confidence 65433221 223567899999875 468999999999999999999 88899764 4455566665544322 23456
Q ss_pred ChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 251 DPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 251 spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
++.+.++|.+||+ +|.+||++.+++.
T Consensus 229 ~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 229 PESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 7899999999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=344.47 Aligned_cols=150 Identities=22% Similarity=0.307 Sum_probs=136.7
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeE
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
+++|.++++||.|+||+||+|.+..+|..||+|+++.... ......+.+..|+.+++.++||||++++.++.. ...+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~ 79 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM-INKNMVHQVQAERDALALSKSPFIVHLYYSLQS--ANNV 79 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc-cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--CCEE
Confidence 6789999999999999999999999999999999885542 345666889999999999999999999987754 6789
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 100 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
+|||||+.+++|.+++...+.+++..++.|+.||+.||.|||.++ |+||||||+|||++.+ +.+||+|||++.
T Consensus 80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~-g~vkL~DFGls~ 152 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNE-GHIKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCC-CCEEEEeCCCCc
Confidence 999999999999999988888999999999999999999999998 9999999999999854 899999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=330.13 Aligned_cols=249 Identities=21% Similarity=0.326 Sum_probs=209.7
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCe---E-EEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCC
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGI---E-VAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~---~-VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 96 (738)
++..+.++||+|+||.||+|.-+..+. . ||+|..+.. .....+.+..+.+|+++|++|+|||||+|||+.+. .
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~-~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~--~ 233 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGS-SELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL--E 233 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccc-ccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC--C
Confidence 556667999999999999999876533 3 899988752 23567889999999999999999999999996654 6
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 97 RNINFVTEMFTSGTLRQYRLKHRR-VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k~~~-lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
..+++|||+|.||+|.+|+++.+. ++..+...++.+.+.||+|||+++ +|||||-..|+|++.+ +.+||+|||++.
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~-~~vKISDFGLs~ 310 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKK-GVVKISDFGLSR 310 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCC-CeEEeCcccccc
Confidence 789999999999999999999874 999999999999999999999999 9999999999999854 578999999987
Q ss_pred Hhhccccc--cccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCC
Q 004672 176 ILRKSHAA--RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVED 251 (738)
Q Consensus 176 ~l~~~~~~--~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~s 251 (738)
........ ...-...|+|||.+. +.|++++|||||||++||+++ |..||.+ ....++..+|.....+...+...+
T Consensus 311 ~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g-~~~~~v~~kI~~~~~r~~~~~~~p 389 (474)
T KOG0194|consen 311 AGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG-MKNYEVKAKIVKNGYRMPIPSKTP 389 (474)
T ss_pred CCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC-CCHHHHHHHHHhcCccCCCCCCCH
Confidence 65422111 112346899999997 469999999999999999998 8889998 456677788856555555556778
Q ss_pred hHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 252 PEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 252 pel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
+++..++++|+. +|.+||++.++.+
T Consensus 390 ~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 390 KELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHHHHhccCChhhccCHHHHHH
Confidence 889999999999 9999999998864
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=302.86 Aligned_cols=251 Identities=28% Similarity=0.356 Sum_probs=200.1
Q ss_pred ceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC---CCCCcceeeEEEEecCC---
Q 004672 23 MEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL---KHRNIMKFYTSWVDTAN--- 96 (738)
Q Consensus 23 y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L---~HpNIVkl~~~fv~~~~--- 96 (738)
|.+.+.||.|+||.||+|.+..+|..||+|.++.... .......+.+|+.+++.+ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc--cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 6789999999999999999998999999999885432 222334566788877766 69999999999876322
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 97 RNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k~~--~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
..++++|||+. ++|.+++.... .+++..++.++.||+.||.|||+++ ++|+||+|+||+++.+ +.+||+|||++
T Consensus 79 ~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~-~~~~l~dfg~~ 154 (287)
T cd07838 79 LKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSD-GQVKIADFGLA 154 (287)
T ss_pred ceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccC-CCEEEeccCcc
Confidence 24899999996 58999887643 5899999999999999999999998 9999999999999866 89999999998
Q ss_pred HHhhccc-cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcC-CCC--------
Q 004672 175 AILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG-KKP-------- 243 (738)
Q Consensus 175 ~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g-~~p-------- 243 (738)
....... .....+++.|+|||++.+ .++.++||||||+++|+|++|..||......+.+ .++... ..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 155 RIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL-DKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred eeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH-HHHHHHcCCCChHhcCCC
Confidence 7664332 223357889999998864 5888999999999999999999999875444333 333221 000
Q ss_pred ----------------cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 244 ----------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 244 ----------------~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
.......++.+.++|.+||+ +|.+||++.++|.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00111235778999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=326.78 Aligned_cols=261 Identities=23% Similarity=0.336 Sum_probs=212.8
Q ss_pred CCCCcccccCcCCCCceEEEEEcccCCeEEEEEEEc-----CCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCC-C
Q 004672 8 NQIPPSLLKLIPLEDMEDTMKFLVKELQRHYRAFDE-----YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-H 81 (738)
Q Consensus 8 ~~vp~~l~~~I~~~~y~il~kLG~GafgtVYkA~d~-----~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~-H 81 (738)
-.++...--.++.++|.+.++||+|+||.||+|.+. .++..||+|+++... .....+.+.+|+.+|..+. |
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~~H 100 (401)
T cd05107 24 MQLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQALMSELKIMSHLGPH 100 (401)
T ss_pred CCCCCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHHHHHHHHHHHHhcCCC
Confidence 344555556778889999999999999999999853 456789999987432 2344567899999999997 9
Q ss_pred CCcceeeEEEEecCCCeEEEEEecCCCCCHHHHHHhcC------------------------------------------
Q 004672 82 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR------------------------------------------ 119 (738)
Q Consensus 82 pNIVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~------------------------------------------ 119 (738)
|||++++++|.. ...+++||||+.+|+|.+++.+.+
T Consensus 101 ~niv~~~~~~~~--~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (401)
T cd05107 101 LNIVNLLGACTK--GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGY 178 (401)
T ss_pred CCeEEEEEEEcc--CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccc
Confidence 999999998855 568999999999999999986532
Q ss_pred --------------------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhC
Q 004672 120 --------------------------------------------------------RVNIRAVKHWCRQILSGLLYLHSR 143 (738)
Q Consensus 120 --------------------------------------------------------~lse~~i~~i~~QIl~aL~yLHs~ 143 (738)
.+++..+..++.||+.||.|||+.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~ 258 (401)
T cd05107 179 MDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK 258 (401)
T ss_pred cccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 256677889999999999999998
Q ss_pred CCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccc----cccccCCCCCCCcccccc-ccCcccccccchhhhhhhh
Q 004672 144 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMV 218 (738)
Q Consensus 144 gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLl 218 (738)
+ |+||||||+|||++. .+.+||+|||++....... .....+++.|||||.+.+ .++.++||||||+++|||+
T Consensus 259 ~--ivHrdlkp~NiLl~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l 335 (401)
T cd05107 259 N--CVHRDLAARNVLICE-GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIF 335 (401)
T ss_pred C--cCcccCCcceEEEeC-CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHH
Confidence 8 999999999999985 4799999999997643221 122347789999998864 5889999999999999999
Q ss_pred h-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 219 T-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 219 T-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
+ |..||......+.+...+..+..+. .+...+.++.+++.+||. +|.+||++.+|+..
T Consensus 336 ~~g~~P~~~~~~~~~~~~~~~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 336 TLGGTPYPELPMNEQFYNAIKRGYRMA-KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HcCCCCCCCCCchHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8 8999987666666666666664433 344568899999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=317.38 Aligned_cols=253 Identities=28% Similarity=0.372 Sum_probs=202.9
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC----C
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA----N 96 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~----~ 96 (738)
++|.+...||.|+||+||+|.+..+|..||+|+++... ........+.+|+.+++.++||||++++++|.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF--QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc--ccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 68999999999999999999999999999999887432 22334467889999999999999999999875432 2
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
..+++|+||+. .+|..++ ...+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++..
T Consensus 93 ~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~-~~~kL~dfg~~~~ 166 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNED-CELKILDFGLARH 166 (342)
T ss_pred ceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEeeCCCCcC
Confidence 35799999995 5787764 346899999999999999999999998 9999999999999855 8999999999865
Q ss_pred hhccccccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCC-C-----------
Q 004672 177 LRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK-K----------- 242 (738)
Q Consensus 177 l~~~~~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~-~----------- 242 (738)
.... .....+++.|+|||++.+ .++.++||||||+++|+|++|+.||....... .+..+.... .
T Consensus 167 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 167 ADAE-MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CCCC-CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHHhcc
Confidence 4322 223457899999998864 48899999999999999999999998643332 233222210 0
Q ss_pred ----------C----c---ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 243 ----------P----E---ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 243 ----------p----~---~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
+ . ......++.+.+||.+||+ +|.+||++.++|.||||+.-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0 0 0112457789999999999 99999999999999999653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=300.26 Aligned_cols=245 Identities=24% Similarity=0.346 Sum_probs=202.6
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCC
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 97 (738)
+..++|.+.++||.|++|+||+|.+. .+..||+|.+.... ...+.+.+|+.+++.++||||+++++++.. ..
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 74 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-----MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE--EE 74 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc-----cCHHHHHHHHHHHhhCCCCCEeeeeeeeec--CC
Confidence 56789999999999999999999975 56789999877432 223568999999999999999999997643 56
Q ss_pred eEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 98 NINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~~--~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
.+++||||+++++|.+++.... .+++..+..|+.||+.||.|||+++ ++|+||||+||+++.+ +.+||+|||++.
T Consensus 75 ~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~-~~~~l~d~g~~~ 151 (261)
T cd05034 75 PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGEN-LVCKIADFGLAR 151 (261)
T ss_pred ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCC-CCEEECccccce
Confidence 7999999999999999987653 6899999999999999999999998 9999999999999855 899999999987
Q ss_pred Hhhcccc---ccccCCCCCCCcccccc-ccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCC
Q 004672 176 ILRKSHA---ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVE 250 (738)
Q Consensus 176 ~l~~~~~---~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~ 250 (738)
....... ....++..|+|||.+.+ .++.++||||||+++|+|+| |+.||.+. +.......+..+..+. .....
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~ 229 (261)
T cd05034 152 LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM-TNREVLEQVERGYRMP-RPPNC 229 (261)
T ss_pred eccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCC-CCCCC
Confidence 6543211 11224578999998874 58899999999999999998 99999864 4455566666553322 22344
Q ss_pred ChHHHHHHHHHHh-CcCCCCCHHHHh
Q 004672 251 DPEVRQFIEKCLA-TVSSRLSARELL 275 (738)
Q Consensus 251 spel~~lI~kcL~-dP~~RpSa~ELL 275 (738)
+.++++++.+||. +|.+||++.+++
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rp~~~~l~ 255 (261)
T cd05034 230 PEELYDLMLQCWDKDPEERPTFEYLQ 255 (261)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHH
Confidence 7899999999999 899999999986
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=303.16 Aligned_cols=250 Identities=22% Similarity=0.382 Sum_probs=207.4
Q ss_pred cCcCCCCceEEEEEcccCCeEEEEEEEcCCCe----EEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEE
Q 004672 16 KLIPLEDMEDTMKFLVKELQRHYRAFDEYEGI----EVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSW 91 (738)
Q Consensus 16 ~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~----~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~f 91 (738)
+.+...+|.+++.||+|+||+||+|.+..+|. .||+|.++... .......+.+|+.+|+.++||||+++++++
T Consensus 2 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 78 (279)
T cd05057 2 RILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMASVDHPHVVRLLGIC 78 (279)
T ss_pred cccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 35566889999999999999999999877765 58888765332 355667899999999999999999999987
Q ss_pred EecCCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEec
Q 004672 92 VDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 170 (738)
Q Consensus 92 v~~~~~~l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~D 170 (738)
.. ...++||||+++|+|.+++... ..+++..+..|+.||+.||+|||+++ |+||||||+||+++.+ +.+||+|
T Consensus 79 ~~---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~-~~~kL~d 152 (279)
T cd05057 79 LS---SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTP-QHVKITD 152 (279)
T ss_pred ec---CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCC-CeEEECC
Confidence 64 5789999999999999998775 46999999999999999999999998 9999999999999854 7999999
Q ss_pred cchhHHhhccccc----cccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCc
Q 004672 171 LGLAAILRKSHAA----RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPE 244 (738)
Q Consensus 171 FGlA~~l~~~~~~----~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~ 244 (738)
||++......... ...++..|+|||.+. ..++.++||||||+++|+|++ |..||... ...++...+..+...
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~- 230 (279)
T cd05057 153 FGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKGERL- 230 (279)
T ss_pred CcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhCCCCC-
Confidence 9999765432211 112356899999876 568899999999999999998 99999864 566677777665433
Q ss_pred ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 245 ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 245 ~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
..+...+..+.+++.+||. +|..||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 231 PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 2334567899999999999 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=305.96 Aligned_cols=250 Identities=24% Similarity=0.379 Sum_probs=200.3
Q ss_pred CCceEEEEEcccCCeEEEEEEE----cCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCC
Q 004672 21 EDMEDTMKFLVKELQRHYRAFD----EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d----~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 96 (738)
.-|.++++||+|+||.||+|.. ..++..||+|.++.. ......+.+.+|+.+|+.++||||+++++++.....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE---SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc---ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 3478899999999999999974 467889999987643 234556789999999999999999999998876555
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 97 RNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k~~-~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
..+++||||++|++|.+++.+.. .+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||++.
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~-~~~~l~dfg~~~ 157 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESE-HQVKIGDFGLTK 157 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCC-CCEEECCCcccc
Confidence 78899999999999999987653 5899999999999999999999998 9999999999999854 799999999997
Q ss_pred Hhhccc-----cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCC--------------CCHHHHHH
Q 004672 176 ILRKSH-----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC--------------THPAQIYK 235 (738)
Q Consensus 176 ~l~~~~-----~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~--------------~~~~qi~k 235 (738)
.+.... .....++..|+|||++.+ .++.++||||||+++|+|+|+..|+... .......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 654322 123346778999998764 5889999999999999999987665321 11122222
Q ss_pred HHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 236 KVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 236 ~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
.+..+.... .....++.+.+||.+||+ +|.+|||+.++++.
T Consensus 238 ~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 238 VLEEGKRLP-RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHcCccCC-CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 223333222 234568899999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=302.31 Aligned_cols=244 Identities=23% Similarity=0.340 Sum_probs=200.5
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCC
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 97 (738)
+..++|.++++||.|++|+||+|.+. .+..||+|.++.... . .+.+.+|+.+|++++||||+++++++. ..
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~---~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~ 73 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM--S---PESFLEEAQIMKKLRHDKLVQLYAVVS---EE 73 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC--C---HHHHHHHHHHHHhcCCCceEEEEeEEC---CC
Confidence 45678999999999999999999875 667799998874332 1 246889999999999999999998752 34
Q ss_pred eEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 98 NINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
.++++|||+.+++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.+ +.++|+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~-~~~~l~dfg~~~ 150 (260)
T cd05070 74 PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDG-LVCKIADFGLAR 150 (260)
T ss_pred CcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCC-ceEEeCCceeee
Confidence 578999999999999998764 45899999999999999999999998 9999999999999854 799999999997
Q ss_pred Hhhccccc---cccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCC
Q 004672 176 ILRKSHAA---RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVE 250 (738)
Q Consensus 176 ~l~~~~~~---~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~ 250 (738)
.+...... ...++..|+|||++. ..++.++||||||+++|+|++ |..||... +...+...+..+..+ ......
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~ 228 (260)
T cd05070 151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-NNREVLEQVERGYRM-PCPQDC 228 (260)
T ss_pred eccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcC
Confidence 65432211 123556899999876 458899999999999999999 89999864 444555666554333 234566
Q ss_pred ChHHHHHHHHHHh-CcCCCCCHHHHh
Q 004672 251 DPEVRQFIEKCLA-TVSSRLSARELL 275 (738)
Q Consensus 251 spel~~lI~kcL~-dP~~RpSa~ELL 275 (738)
+..+++|+.+||. +|.+|||+.+++
T Consensus 229 ~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 229 PISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred CHHHHHHHHHHcccCcccCcCHHHHH
Confidence 8899999999999 899999999986
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=301.68 Aligned_cols=248 Identities=19% Similarity=0.299 Sum_probs=203.6
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCe---EEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGI---EVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~---~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 95 (738)
...+|++.+.||.|+||+||+|.++.+|. .||+|.++.. ......+.+..|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-- 76 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-- 76 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC--
Confidence 35679999999999999999999987765 6999987643 245667889999999999999999999998744
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 96 NRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
+..+++||||+.+|+|.+++... +.+++..++.++.|++.||.|||+++ ++|+||||+||+++.+ +.+||+|||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~-~~~kl~dfg~~ 153 (269)
T cd05065 77 SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSN-LVCKVSDFGLS 153 (269)
T ss_pred CCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCC-CcEEECCCccc
Confidence 66789999999999999998764 56899999999999999999999998 9999999999999855 79999999998
Q ss_pred HHhhccccc----ccc---CCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcc
Q 004672 175 AILRKSHAA----RCV---GTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEA 245 (738)
Q Consensus 175 ~~l~~~~~~----~~v---GTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~ 245 (738)
......... ... .+..|+|||.+. ..++.++||||||+++|||++ |..||... ....+...+...... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~-~~~~~~~~i~~~~~~-~ 231 (269)
T cd05065 154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-SNQDVINAIEQDYRL-P 231 (269)
T ss_pred cccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCcC-C
Confidence 765432211 111 235799999886 468999999999999999886 99999763 445566666544322 2
Q ss_pred cccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 246 LFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 246 l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
.....++.+.+++.+||. +|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 232 PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 234567889999999999 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=354.96 Aligned_cols=253 Identities=30% Similarity=0.516 Sum_probs=215.1
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC-----
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA----- 95 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~----- 95 (738)
.+|..+..||+||||.||+++++.+|..||||+|.+.- +.....++.+|+.+|.+|+|||||++|..|++..
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 46788999999999999999999999999999988653 5667788999999999999999999999986410
Q ss_pred --------------------------------------------------------------------------------
Q 004672 96 -------------------------------------------------------------------------------- 95 (738)
Q Consensus 96 -------------------------------------------------------------------------------- 95 (738)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CeEEEEEecCCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHh
Q 004672 96 ------------------------N--------RNINFVTEMFTSGTLRQYRLKHRRV-NIRAVKHWCRQILSGLLYLHS 142 (738)
Q Consensus 96 ------------------------~--------~~l~LV~Ey~~gGSL~~~l~k~~~l-se~~i~~i~~QIl~aL~yLHs 142 (738)
. ..+||=||||+..+|++++..+... ....+++++++|++||.|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0 3478889999988888887766544 467889999999999999999
Q ss_pred CCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh--------------------ccccccccCCCCCCCcccccc---
Q 004672 143 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--------------------KSHAARCVGTPEFMAPEVYEE--- 199 (738)
Q Consensus 143 ~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~--------------------~~~~~~~vGTp~YmAPEvl~~--- 199 (738)
.| ||||||||.|||++.. +.|||+|||+|+... ....+..+||..|+|||++.+
T Consensus 716 ~g--iIHRDLKP~NIFLd~~-~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 QG--IIHRDLKPRNIFLDSR-NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred Cc--eeeccCCcceeEEcCC-CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 99 9999999999999955 799999999998721 012345579999999999963
Q ss_pred -ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcc--cccCCChHHHHHHHHHHh-CcCCCCCHHHHh
Q 004672 200 -EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEA--LFKVEDPEVRQFIEKCLA-TVSSRLSARELL 275 (738)
Q Consensus 200 -~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~--l~~~~spel~~lI~kcL~-dP~~RpSa~ELL 275 (738)
.|+.|+|+||||||++||+. ||........+...+..|..|.. ++...-+.-+.+|..+|+ ||++||||.|||
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence 59999999999999999984 79877777888888888887765 344456788999999999 999999999999
Q ss_pred cCcccCC
Q 004672 276 TDPFLQI 282 (738)
Q Consensus 276 ~Hpf~~~ 282 (738)
++.||..
T Consensus 870 ~s~llpp 876 (1351)
T KOG1035|consen 870 NSELLPP 876 (1351)
T ss_pred hccCCCc
Confidence 9999974
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=303.33 Aligned_cols=241 Identities=21% Similarity=0.266 Sum_probs=189.8
Q ss_pred EEcccCCeEEEEEEEc--CCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEec
Q 004672 28 KFLVKELQRHYRAFDE--YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEM 105 (738)
Q Consensus 28 kLG~GafgtVYkA~d~--~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey 105 (738)
.||+|+||.||+|... .++..+|+|.++... .......+.+|+.+++.++||||+++++++.+ ...+++||||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~ 76 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA---SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE--VTPYLLVMEF 76 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCCcEEEEEC
Confidence 5899999999999854 456789999876432 23344578889999999999999999998754 5678999999
Q ss_pred CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 106 FTSGTLRQYRLKHR-----RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 106 ~~gGSL~~~l~k~~-----~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
+++|+|.+++...+ ..++..++.++.|++.||.|||+++ ++||||||+||+++.+ +.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTAD-LTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCC-CcEEECCccccccccCc
Confidence 99999999987542 3567788899999999999999998 9999999999999854 79999999998654322
Q ss_pred c----cccccCCCCCCCcccccc--------ccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCC---Cc
Q 004672 181 H----AARCVGTPEFMAPEVYEE--------EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKK---PE 244 (738)
Q Consensus 181 ~----~~~~vGTp~YmAPEvl~~--------~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~---p~ 244 (738)
. .....|++.|+|||++.+ .++.++||||||+++|+|++ |..||....+.......+..... ..
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC
Confidence 1 112347788999998853 35789999999999999996 99999875544433333322221 11
Q ss_pred ccccCCChHHHHHHHHHHhCcCCCCCHHHHhc
Q 004672 245 ALFKVEDPEVRQFIEKCLATVSSRLSARELLT 276 (738)
Q Consensus 245 ~l~~~~spel~~lI~kcL~dP~~RpSa~ELL~ 276 (738)
.+....++.+.+++..|+.+|.+|||+.+|+.
T Consensus 234 ~~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~ 265 (269)
T cd05087 234 RLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHL 265 (269)
T ss_pred ccCCCCChHHHHHHHHHhcCcccCCCHHHHHH
Confidence 22234577899999999989999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=313.58 Aligned_cols=254 Identities=26% Similarity=0.353 Sum_probs=203.3
Q ss_pred CceEEEEEcccCCeEEEEEEEcCC--CeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEec--CC
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYE--GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDT--AN 96 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~t--G~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~--~~ 96 (738)
+|.+.+.||.|+||.||++.+..+ +..||+|.+.... ......+.+.+|+.+++.+ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 78 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF--SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF 78 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc--ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence 478999999999999999999988 9999999876432 2233456788999999999 699999999875432 23
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
..+++++||+. ++|.+++.....+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..
T Consensus 79 ~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~-~~~kl~Dfg~a~~ 154 (332)
T cd07857 79 NELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNAD-CELKICDFGLARG 154 (332)
T ss_pred CcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCC-CCEEeCcCCCcee
Confidence 46788999984 799999988888999999999999999999999998 9999999999999854 7999999999976
Q ss_pred hhccc------cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc--C------
Q 004672 177 LRKSH------AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--G------ 240 (738)
Q Consensus 177 l~~~~------~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~--g------ 240 (738)
+.... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||....... ....+.. |
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPDEET 233 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCCHHH
Confidence 54221 223468999999998754 58899999999999999999999997643222 2111111 0
Q ss_pred -----------------CCC----cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 241 -----------------KKP----EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 241 -----------------~~p----~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
..+ .......++.+++||.+||+ +|.+|||+.+++.||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~ 297 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI 297 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhh
Confidence 000 11123357899999999999 9999999999999999953
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=313.56 Aligned_cols=276 Identities=27% Similarity=0.387 Sum_probs=214.6
Q ss_pred ccccCCCCcccccCcCCCCceEEEEEcccCCeEEEEEEEcCCCe----EEEEEEEeccccCCCHHHHHHHHHHHHHHHhC
Q 004672 4 QAQKNQIPPSLLKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGI----EVAWNQVKLYDFLQSPEELERLYCEIHLLKTL 79 (738)
Q Consensus 4 ~~q~~~vp~~l~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~----~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L 79 (738)
...+.....+..+--....|..+.+||+|.||.||+|..+.+.. .+|+|+++-... ....-....+|+.+++.|
T Consensus 7 ~~~~~~~~ser~rve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd--~tGiS~SAcREiaL~REl 84 (438)
T KOG0666|consen 7 YDFKSKLASERERVEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD--GTGISMSACREIALLREL 84 (438)
T ss_pred ccchhhhhhhhhhHHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC--CCCcCHHHHHHHHHHHHh
Confidence 33344444444433445689999999999999999997766543 789999885531 112234678999999999
Q ss_pred CCCCcceeeEEEEecCCCeEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCc
Q 004672 80 KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 154 (738)
Q Consensus 80 ~HpNIVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~-----~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP 154 (738)
+||||+.+..+|+.. ...+++++||.+. +|++.++-+ +.++...++.++.||+.|+.|||++. |+||||||
T Consensus 85 ~h~nvi~Lv~Vfl~~-d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKP 160 (438)
T KOG0666|consen 85 KHPNVISLVKVFLSH-DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKP 160 (438)
T ss_pred cCCcchhHHHHHhcc-CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCc
Confidence 999999999988765 7899999999975 898888665 34899999999999999999999999 99999999
Q ss_pred ccEEEeCC---CCcEEEeccchhHHhhcccc-----ccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCC
Q 004672 155 DNIFVNGN---QGEVKIGDLGLAAILRKSHA-----ARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPY 224 (738)
Q Consensus 155 ~NILl~~~---~g~VKL~DFGlA~~l~~~~~-----~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf 224 (738)
.||||.++ .|.|||+|||+++.+..... ...+-|.+|+|||++.+ .|+.+.|||++|||+.||+|.++.|
T Consensus 161 aNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF 240 (438)
T KOG0666|consen 161 ANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLF 240 (438)
T ss_pred ceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccc
Confidence 99999754 48999999999999877543 33457999999999875 4999999999999999999998887
Q ss_pred CCC------CCH---HHHHHHHHc--CC-----------CCcc----------------------cccCCChHHHHHHHH
Q 004672 225 SEC------THP---AQIYKKVIS--GK-----------KPEA----------------------LFKVEDPEVRQFIEK 260 (738)
Q Consensus 225 ~~~------~~~---~qi~k~i~~--g~-----------~p~~----------------------l~~~~spel~~lI~k 260 (738)
.+. .++ +|+ .+|.. |. .|+- ..+..++...+++.+
T Consensus 241 ~g~E~k~~~~~Pfq~dQl-~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~k 319 (438)
T KOG0666|consen 241 KGREEKIKTKNPFQHDQL-DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQK 319 (438)
T ss_pred cchhhhcccCCCchHHHH-HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHH
Confidence 531 111 122 11111 11 1110 012346778999999
Q ss_pred HHh-CcCCCCCHHHHhcCcccCCCCCc
Q 004672 261 CLA-TVSSRLSARELLTDPFLQIDDYD 286 (738)
Q Consensus 261 cL~-dP~~RpSa~ELL~Hpf~~~~~~~ 286 (738)
+|+ ||.+|+|++++|+|+||..++..
T Consensus 320 lL~yDP~kRIta~qAleh~yF~~d~lp 346 (438)
T KOG0666|consen 320 LLTYDPIKRITAEQALEHPYFTEDPLP 346 (438)
T ss_pred HhccCchhhccHHHHhcccccccCCCC
Confidence 999 99999999999999999987543
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=306.40 Aligned_cols=245 Identities=23% Similarity=0.344 Sum_probs=200.4
Q ss_pred CceEEEEEcccCCeEEEEEEEcC-----CCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCC
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEY-----EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~-----tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 96 (738)
+|.+.+.||+|+||+||+|.+.. ....+|+|.+... ......+++.+|+.+|+.++||||+++++.+.. .
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN---ASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ--D 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC---CCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec--C
Confidence 47788999999999999998753 2357888876632 234456789999999999999999999998754 5
Q ss_pred CeEEEEEecCCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccC
Q 004672 97 RNINFVTEMFTSGTLRQYRLKH------------------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL 152 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k~------------------------~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDL 152 (738)
...++++||+.+|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~di 153 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDL 153 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhh
Confidence 6789999999999999998653 24788999999999999999999998 999999
Q ss_pred CcccEEEeCCCCcEEEeccchhHHhhccc----cccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCC
Q 004672 153 KCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSE 226 (738)
Q Consensus 153 KP~NILl~~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~ 226 (738)
||+|||++.+ +.+||+|||++....... .....++..|+|||.+. ..++.++||||||+++|+|+| |..||.+
T Consensus 154 kp~nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 154 AARNVLVAEG-RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hhheEEEcCC-CcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 9999999854 799999999997553221 11223567899999875 458999999999999999999 9999976
Q ss_pred CCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 227 CTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 227 ~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
..+..+...+..+..+. .....+.++++|+..||+ +|.+||++.++++
T Consensus 233 -~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 233 -IAPERLFNLLKTGYRME-RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred -CCHHHHHHHHhCCCCCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 45667776666554433 234567899999999999 9999999999974
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=302.66 Aligned_cols=251 Identities=27% Similarity=0.417 Sum_probs=206.5
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccC-CCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFL-QSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~-~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
+|.+.++||.|+||+||++.+..++..+++|.++..... .......++..|+.+++.++||||+++++++.+ ...++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE--RDAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc--CCceE
Confidence 488899999999999999999888877777766543321 122334567789999999999999999998754 56789
Q ss_pred EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 101 FVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k----~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++. +.+||+|||++..
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~--~~~~l~d~g~~~~ 154 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN--NLLKIGDFGVSRL 154 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec--CCEeecccCceee
Confidence 99999999999988764 356999999999999999999999998 999999999999973 5799999999876
Q ss_pred hhccc--cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChH
Q 004672 177 LRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 253 (738)
Q Consensus 177 l~~~~--~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spe 253 (738)
..... .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||... ........+..+..|. .....+++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (260)
T cd08222 155 LMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ-NFLSVVLRIVEGPTPS-LPETYSRQ 232 (260)
T ss_pred cCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHHcCCCCC-CcchhcHH
Confidence 53321 223458899999998764 4888999999999999999999999753 4445555565555443 34567889
Q ss_pred HHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 254 VRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 254 l~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
+.++|.+||. +|.+||++.+++.||||
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 233 LNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=308.14 Aligned_cols=251 Identities=24% Similarity=0.358 Sum_probs=206.5
Q ss_pred CcCCCCceEEEEEcccCCeEEEEEEEc-------CCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceee
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDE-------YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFY 88 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~-------~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~ 88 (738)
.+..++|.+...||.|+||.||+|.+. .++..||+|.++.. ........+.+|+.+++.+ +||||++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc---cchHHHHHHHHHHHHHHhhccCCCchhee
Confidence 466789999999999999999999752 24568999987632 2345567899999999999 899999999
Q ss_pred EEEEecCCCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccC
Q 004672 89 TSWVDTANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL 152 (738)
Q Consensus 89 ~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~----------------~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDL 152 (738)
+++.. ...+++||||+.+|+|.+++.+.. .++...+..++.||+.||.|||+++ |+||||
T Consensus 88 ~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dl 163 (304)
T cd05101 88 GACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDL 163 (304)
T ss_pred EEEec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeeccc
Confidence 98754 568899999999999999987642 4778889999999999999999998 999999
Q ss_pred CcccEEEeCCCCcEEEeccchhHHhhccc----cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhh-cCCCCCC
Q 004672 153 KCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSE 226 (738)
Q Consensus 153 KP~NILl~~~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlT-G~~Pf~~ 226 (738)
||+||+++.+ +.+||+|||++....... .....+++.|+|||++.+ .|+.++||||||+++|+|++ |..||..
T Consensus 164 kp~Nili~~~-~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 242 (304)
T cd05101 164 AARNVLVTEN-NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242 (304)
T ss_pred ccceEEEcCC-CcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 9999999854 799999999997654321 112235678999998864 58999999999999999998 7888876
Q ss_pred CCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 227 CTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 227 ~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
.+..++.+.+..+..+. .....+.++++||.+||. +|.+|||+.++++.
T Consensus 243 -~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 243 -IPVEELFKLLKEGHRMD-KPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred -CCHHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 45677777776655432 334567899999999999 89999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=331.92 Aligned_cols=264 Identities=20% Similarity=0.358 Sum_probs=237.2
Q ss_pred cCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC
Q 004672 16 KLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95 (738)
Q Consensus 16 ~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 95 (738)
..+.+.++.++..||-|+||.|=++.-+.....+|+|.++..+... ..+.+.+..|-+||..++.|.||++|..|-+
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd-tkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd-- 491 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD-TKQQEHVFSERNIMMECRSDFIVRLYRTFRD-- 491 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccc-hhHHHHHHhHHHHHHhcCchHHHHHHHHhcc--
Confidence 4566788899999999999999988776666668999888776443 4566889999999999999999999998854
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
.+++|++||-|-||.|+..+...+.|++.+.+.++..+++|++|||++| ||+|||||+|.+++ +.|-+||.|||+|+
T Consensus 492 ~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd-~~Gy~KLVDFGFAK 568 (732)
T KOG0614|consen 492 SKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLD-NRGYLKLVDFGFAK 568 (732)
T ss_pred chhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeec-cCCceEEeehhhHH
Confidence 7899999999999999999999999999999999999999999999999 99999999999998 45999999999999
Q ss_pred Hhhcc-ccccccCCCCCCCccccc-cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChH
Q 004672 176 ILRKS-HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 253 (738)
Q Consensus 176 ~l~~~-~~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spe 253 (738)
.+... ...+++|||+|.|||++. ...+.++|.||||+++|||+||.+||++ .++-..|..|..|.....+++..+..
T Consensus 569 ki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~-~dpmktYn~ILkGid~i~~Pr~I~k~ 647 (732)
T KOG0614|consen 569 KIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG-VDPMKTYNLILKGIDKIEFPRRITKT 647 (732)
T ss_pred HhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC-CchHHHHHHHHhhhhhhhcccccchh
Confidence 88765 456789999999999765 5689999999999999999999999997 78889999999999988888999999
Q ss_pred HHHHHHHHHh-CcCCCCC-----HHHHhcCcccCCCCCc
Q 004672 254 VRQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDDYD 286 (738)
Q Consensus 254 l~~lI~kcL~-dP~~RpS-----a~ELL~Hpf~~~~~~~ 286 (738)
..++|+++.. +|.+|+. +.++-+|.||..-++.
T Consensus 648 a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe 686 (732)
T KOG0614|consen 648 ATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE 686 (732)
T ss_pred HHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence 9999999887 8999986 8999999999876664
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=296.68 Aligned_cols=243 Identities=25% Similarity=0.366 Sum_probs=205.4
Q ss_pred eEEEEEcccCCeEEEEEEEcCCC----eEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeE
Q 004672 24 EDTMKFLVKELQRHYRAFDEYEG----IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 24 ~il~kLG~GafgtVYkA~d~~tG----~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
.+.+.||.|+||.||+|.+..++ ..||+|.++.. ...+..+.+..|+.+|+.++|+||+++++++.. ....
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED---ADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE--EEPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC---CChHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CCee
Confidence 56789999999999999998876 99999988643 223366789999999999999999999998755 5789
Q ss_pred EEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 100 NFVTEMFTSGTLRQYRLKHRR--VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~~~--lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
+++|||+++++|.+++..... +++..+..++.||+.||.|||+++ ++|+||||+||+++.+ +.++|+|||++...
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~-~~~~l~dfg~~~~~ 153 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGEN-LVVKISDFGLSRDL 153 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccC-CeEEEcccCCceec
Confidence 999999999999999877654 999999999999999999999998 9999999999999854 79999999999766
Q ss_pred hccccc---cccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCCh
Q 004672 178 RKSHAA---RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 252 (738)
Q Consensus 178 ~~~~~~---~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~sp 252 (738)
...... ...+++.|+|||.+. ..++.++||||||+++|+|++ |..||.. .+...++..+..+..+. .....+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLEYLKKGYRLP-KPENCPP 231 (258)
T ss_pred ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCH
Confidence 543111 123678999999885 458999999999999999998 7888876 55666677777665543 3345788
Q ss_pred HHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 253 EVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 253 el~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
++.+++.+||. +|.+|||+.++++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHh
Confidence 99999999999 9999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.07 Aligned_cols=248 Identities=21% Similarity=0.320 Sum_probs=204.2
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCC---eEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEG---IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG---~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 95 (738)
..++|.+.+.||.|+||.||+|.+..++ ..||+|.++.. ......+.+.+|+.+|+.++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 76 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG---YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-- 76 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCC---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--
Confidence 3568899999999999999999987554 37999887632 234556789999999999999999999998754
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 96 NRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
++.+++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+++ ++||||||+|||++.+ +.++|+|||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~-~~~~l~dfg~~ 153 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSN-LVCKVSDFGLS 153 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCC-CeEEeCCCCcc
Confidence 67899999999999999998775 46899999999999999999999998 9999999999999854 79999999999
Q ss_pred HHhhccccc-----cccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccc
Q 004672 175 AILRKSHAA-----RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALF 247 (738)
Q Consensus 175 ~~l~~~~~~-----~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~ 247 (738)
..+...... ...++..|+|||.+. +.++.++||||||+++|++++ |..||.... ..++...+..+..+. ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~-~~~~~~~~~~~~~~~-~~ 231 (267)
T cd05066 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS-NQDVIKAIEEGYRLP-AP 231 (267)
T ss_pred cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC-HHHHHHHHhCCCcCC-CC
Confidence 766432211 112356899999887 468999999999999999886 999998643 455666666654332 23
Q ss_pred cCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 248 KVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 248 ~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
...++.+++++.+||+ +|.+||++.+++.
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 232 MDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 4567899999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=302.59 Aligned_cols=241 Identities=21% Similarity=0.291 Sum_probs=189.7
Q ss_pred EEcccCCeEEEEEEEcC--CCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEec
Q 004672 28 KFLVKELQRHYRAFDEY--EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEM 105 (738)
Q Consensus 28 kLG~GafgtVYkA~d~~--tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey 105 (738)
.||.|+||+||+|.... ....+|+|.+... ........+.+|+.+++.++||||+++++++.. ...+++||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~--~~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS---ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE--SIPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc---CChHHHHHHHHHHHHHHhCCCCCcceEEEEECC--CCceEEEEEe
Confidence 68999999999996532 4456787776532 234455678899999999999999999998754 5789999999
Q ss_pred CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 106 FTSGTLRQYRLKHR-----RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 106 ~~gGSL~~~l~k~~-----~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
+++|+|.+++...+ ..++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTAD-LSVKIGDYGLALEQYPE 153 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCC-CcEEEeccccccccccc
Confidence 99999999987753 2467888999999999999999998 9999999999999855 79999999998643221
Q ss_pred c----cccccCCCCCCCccccc--------cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCC---c
Q 004672 181 H----AARCVGTPEFMAPEVYE--------EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKP---E 244 (738)
Q Consensus 181 ~----~~~~vGTp~YmAPEvl~--------~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p---~ 244 (738)
. .....+++.|+|||++. ..++.++||||||+++|+|++ |..||....+...+...+..+..+ .
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP 233 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC
Confidence 1 12223567899999874 246789999999999999999 788998755554444444433221 2
Q ss_pred ccccCCChHHHHHHHHHHhCcCCCCCHHHHhc
Q 004672 245 ALFKVEDPEVRQFIEKCLATVSSRLSARELLT 276 (738)
Q Consensus 245 ~l~~~~spel~~lI~kcL~dP~~RpSa~ELL~ 276 (738)
.+....++.+.+++..|+.+|.+|||+.+|+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~ 265 (269)
T cd05042 234 QLDLKYSDRWYEVMQFCWLDPETRPTAEEVHE 265 (269)
T ss_pred cccccCCHHHHHHHHHHhcCcccccCHHHHHH
Confidence 23345678899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=300.44 Aligned_cols=245 Identities=22% Similarity=0.356 Sum_probs=201.8
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCC
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 97 (738)
|.-++|.++++||.|+||+||+|.++ ++..||+|.+.... ...+.+.+|+.+|+.++||||+++++++. ..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~ 73 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS-----MSPEAFLAEANLMKQLQHPRLVRLYAVVT---QE 73 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC-----CcHHHHHHHHHHHHhcCCcCeeeEEEEEc---cC
Confidence 55678999999999999999999864 67889999876432 12356889999999999999999998752 35
Q ss_pred eEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 98 NINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
.++++|||+.+++|.+++.+. ..+++..+..++.|++.||+|||+++ ++||||||+||+++.+ +.++|+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~-~~~~l~dfg~~~ 150 (260)
T cd05067 74 PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSET-LCCKIADFGLAR 150 (260)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCC-CCEEEccCccee
Confidence 689999999999999998764 35899999999999999999999998 9999999999999854 799999999997
Q ss_pred Hhhcccc---ccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCC
Q 004672 176 ILRKSHA---ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVE 250 (738)
Q Consensus 176 ~l~~~~~---~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~ 250 (738)
....... ....++..|+|||++. ..++.++||||||+++|+|++ |+.||.+.. ...+...+..+..+ ......
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~ 228 (260)
T cd05067 151 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT-NPEVIQNLERGYRM-PRPDNC 228 (260)
T ss_pred ecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC-hHHHHHHHHcCCCC-CCCCCC
Confidence 6542211 1223567899999886 458889999999999999999 999998744 44555555555433 233456
Q ss_pred ChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 251 DPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 251 spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
+.+++++|.+||. +|.+||++.+++.
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 229 PEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 7899999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=301.31 Aligned_cols=249 Identities=23% Similarity=0.377 Sum_probs=203.6
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCC---CeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEec
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYE---GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 94 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~t---G~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~ 94 (738)
+..++|.+.++||.|+||.||+|.+... ...||+|.+... ...+..+.+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~- 78 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC---TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE- 78 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc---CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-
Confidence 4567799999999999999999987644 456888876532 235567789999999999999999999998643
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccch
Q 004672 95 ANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 173 (738)
Q Consensus 95 ~~~~l~LV~Ey~~gGSL~~~l~k~~-~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGl 173 (738)
...++||||+++|+|.+++.+.. .+++..+..++.||+.||.|||+++ ++||||||+||+++.+ +.+||+|||+
T Consensus 79 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~-~~~~l~d~g~ 153 (270)
T cd05056 79 --NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSP-DCVKLGDFGL 153 (270)
T ss_pred --CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecC-CCeEEccCce
Confidence 45789999999999999987754 5899999999999999999999998 9999999999999855 7999999999
Q ss_pred hHHhhcccc---ccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCccccc
Q 004672 174 AAILRKSHA---ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFK 248 (738)
Q Consensus 174 A~~l~~~~~---~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~ 248 (738)
+........ ....+++.|+|||.+. ..++.++||||||+++|+|++ |..||..... ......+..+..+. .+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~~~~~~~~~~~~-~~~ 231 (270)
T cd05056 154 SRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-NDVIGRIENGERLP-MPP 231 (270)
T ss_pred eeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCcCC-CCC
Confidence 876543321 1112456899999876 458899999999999999986 9999987554 34445565555442 345
Q ss_pred CCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 249 VEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 249 ~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
..++.+.++|.+|+. +|.+|||+.+++..
T Consensus 232 ~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 232 NCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 568899999999999 99999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=300.55 Aligned_cols=245 Identities=22% Similarity=0.317 Sum_probs=199.3
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCC
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 97 (738)
++.+.|.+..+||.|++|+||+|.+..+ ..||+|.+.... ...+.+.+|+.+++.++||||+++++++. ..
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~ 73 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-----MMPEAFLQEAQIMKKLRHDKLVPLYAVVS---EE 73 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-----ccHHHHHHHHHHHHhCCCCCeeeEEEEEc---CC
Confidence 4557799999999999999999988655 469999766332 12356889999999999999999998752 34
Q ss_pred eEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 98 NINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~~--~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
..+++|||+.+|+|.+++.... .+++..+..++.||+.||.|||+.+ |+|+||||+||+++.+ +.++|+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~-~~~~l~dfg~~~ 150 (260)
T cd05069 74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDN-LVCKIADFGLAR 150 (260)
T ss_pred CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCC-CeEEECCCccce
Confidence 6789999999999999987643 4889999999999999999999998 9999999999999854 799999999997
Q ss_pred Hhhcccc---ccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCC
Q 004672 176 ILRKSHA---ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVE 250 (738)
Q Consensus 176 ~l~~~~~---~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~ 250 (738)
....... ....++..|+|||... ..++.++||||||+++|+|+| |..||.+.. .......+..+..+ ......
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~ 228 (260)
T cd05069 151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV-NREVLEQVERGYRM-PCPQGC 228 (260)
T ss_pred EccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCC-CCCccc
Confidence 6543221 1223567899999876 458899999999999999999 899998743 44555555554333 233456
Q ss_pred ChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 251 DPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 251 spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
+..++++|.+||. +|.+||+++++++
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 229 PESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 7899999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=307.82 Aligned_cols=250 Identities=22% Similarity=0.312 Sum_probs=199.0
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCC--------------CeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCC
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYE--------------GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN 83 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~t--------------G~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpN 83 (738)
++..+|.+.++||+|+||.||++.+..+ ...||+|.++.. ......+.+.+|+++|++++|||
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~ei~~l~~l~h~~ 78 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD---VTKTARNDFLKEIKIMSRLKNPN 78 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC---CCHHHHHHHHHHHHHHHhCCCCC
Confidence 5667999999999999999999987543 235899987632 24556678999999999999999
Q ss_pred cceeeEEEEecCCCeEEEEEecCCCCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceecc
Q 004672 84 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 151 (738)
Q Consensus 84 IVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~------------~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRD 151 (738)
|+++++++.. ...+++||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ ++|||
T Consensus 79 i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~d 154 (295)
T cd05097 79 IIRLLGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRD 154 (295)
T ss_pred cCeEEEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccc
Confidence 9999998754 678899999999999999986532 3688899999999999999999998 99999
Q ss_pred CCcccEEEeCCCCcEEEeccchhHHhhcccc----ccccCCCCCCCccccc-cccCcccccccchhhhhhhhh--cCCCC
Q 004672 152 LKCDNIFVNGNQGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT--FDYPY 224 (738)
Q Consensus 152 LKP~NILl~~~~g~VKL~DFGlA~~l~~~~~----~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT--G~~Pf 224 (738)
|||+||+++.+ +.+||+|||++........ ....+++.|+|||++. +.++.++||||||+++|+|++ |..||
T Consensus 155 lkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~ 233 (295)
T cd05097 155 LATRNCLVGNH-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY 233 (295)
T ss_pred cChhhEEEcCC-CcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 99999999854 7899999999976533221 2223567899999875 568999999999999999988 67788
Q ss_pred CCCCCHHHHHHHHHc-----CC-CCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 225 SECTHPAQIYKKVIS-----GK-KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 225 ~~~~~~~qi~k~i~~-----g~-~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
.... ..++...+.. +. .........++.+++||.+||. +|.+|||+.++++
T Consensus 234 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 234 SLLS-DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cccC-hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 7643 3333333221 11 1112234567899999999999 9999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=300.05 Aligned_cols=238 Identities=18% Similarity=0.312 Sum_probs=196.0
Q ss_pred EEcccCCeEEEEEEEc--CCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEec
Q 004672 28 KFLVKELQRHYRAFDE--YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEM 105 (738)
Q Consensus 28 kLG~GafgtVYkA~d~--~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey 105 (738)
.||+|+||.||+|.+. .++..||+|++... ......+.+.+|+.+|++++||||+++++++. ...+++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~---~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~---~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE---NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE---AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc---cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc---CCCeEEEEEe
Confidence 3899999999999775 45678999987643 23455678999999999999999999999763 3478999999
Q ss_pred CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcccc--
Q 004672 106 FTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-- 182 (738)
Q Consensus 106 ~~gGSL~~~l~k-~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~~-- 182 (738)
+++|+|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.+ +.+||+|||++..+.....
T Consensus 76 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 76 ASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQ-HYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCC-CcEEeccCCccccccCCccce
Confidence 999999999875 456999999999999999999999998 9999999999999854 7999999999975543211
Q ss_pred ---ccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 004672 183 ---ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 257 (738)
Q Consensus 183 ---~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~l 257 (738)
....+++.|+|||.+. +.++.++||||||+++|+|++ |..||... ....+...+..+..+. .....++++.++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~l~~l 230 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM-KGPEVMSFIEQGKRLD-CPAECPPEMYAL 230 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCCC-CCCCCCHHHHHH
Confidence 1112357899999876 468899999999999999996 99999874 4455666666665443 445668999999
Q ss_pred HHHHHh-CcCCCCCHHHHhc
Q 004672 258 IEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 258 I~kcL~-dP~~RpSa~ELL~ 276 (738)
|.+||. +|.+||++.++++
T Consensus 231 i~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 231 MKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=299.93 Aligned_cols=249 Identities=21% Similarity=0.328 Sum_probs=204.5
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCCCe---EEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEec
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGI---EVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 94 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~---~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~ 94 (738)
|..++|...+.||+|+||.||+|.++.++. .+|+|.++.. ......+.+..|+.+++.++||||+++++++..
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 77 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG---YTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK- 77 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc---CCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc-
Confidence 455788999999999999999999876665 6888877632 234556789999999999999999999998744
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccch
Q 004672 95 ANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 173 (738)
Q Consensus 95 ~~~~l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGl 173 (738)
...+++||||+++++|.+++..+ ..+++..+..++.|++.||.|||+.+ ++||||||+||+++. ++.+||+|||+
T Consensus 78 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~-~~~~kl~dfg~ 153 (268)
T cd05063 78 -FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNS-NLECKVSDFGL 153 (268)
T ss_pred -CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcC-CCcEEECCCcc
Confidence 56789999999999999998764 56899999999999999999999998 999999999999985 47999999999
Q ss_pred hHHhhcccccc-----ccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCccc
Q 004672 174 AAILRKSHAAR-----CVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEAL 246 (738)
Q Consensus 174 A~~l~~~~~~~-----~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l 246 (738)
+.......... ...++.|+|||++. ..++.++||||||+++|+|++ |..||... +...+.+.+..+.... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~-~~~~~~~~i~~~~~~~-~ 231 (268)
T cd05063 154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM-SNHEVMKAINDGFRLP-A 231 (268)
T ss_pred ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC-CHHHHHHHHhcCCCCC-C
Confidence 87554322111 11345799999886 458999999999999999997 99999764 4456666666553322 2
Q ss_pred ccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 247 FKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 247 ~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
....+..+.+++.+||. +|.+||++.++++
T Consensus 232 ~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 232 PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 33567899999999999 9999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.41 Aligned_cols=265 Identities=23% Similarity=0.361 Sum_probs=224.1
Q ss_pred CcccccCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHh-CCCCCcceeeE
Q 004672 11 PPSLLKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKT-LKHRNIMKFYT 89 (738)
Q Consensus 11 p~~l~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~-L~HpNIVkl~~ 89 (738)
+++.+-.+..+++..+..||.|+||+|++..++.+|+.+|||+|+... ...+.+++..|..+..+ =+.||||+||+
T Consensus 54 ~~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n---~~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 54 DDAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN---IEKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred CcccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc---chHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 345566777788899999999999999999999999999999998543 35677889999985554 48999999999
Q ss_pred EEEecCCCeEEEEEecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCC
Q 004672 90 SWVDTANRNINFVTEMFTSGTLRQYRL-----KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 164 (738)
Q Consensus 90 ~fv~~~~~~l~LV~Ey~~gGSL~~~l~-----k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g 164 (738)
..+. .+.-||.||+| ..||..+.+ +..+++|..+-.+....+.||.||-..- .|||||+||+|||++.. |
T Consensus 131 a~F~--EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILldr~-G 205 (361)
T KOG1006|consen 131 ALFS--EGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILLDRH-G 205 (361)
T ss_pred hhhc--CCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEEecC-C
Confidence 8765 45689999999 678776643 2457999999999999999999998752 49999999999999955 8
Q ss_pred cEEEeccchhHHhhcccccc-ccCCCCCCCccccc---cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcC
Q 004672 165 EVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYE---EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 240 (738)
Q Consensus 165 ~VKL~DFGlA~~l~~~~~~~-~vGTp~YmAPEvl~---~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g 240 (738)
.|||||||.+..+..+...+ -.|-..|||||.+. ..|+.++||||||++|||+.||.+||.+..+.-+....+..|
T Consensus 206 ~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~g 285 (361)
T KOG1006|consen 206 DVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIG 285 (361)
T ss_pred CEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcC
Confidence 99999999999887776544 36999999999986 349999999999999999999999999877666666778888
Q ss_pred CCCccccc----CCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 241 KKPEALFK----VEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 241 ~~p~~l~~----~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
..|.-... .++..++.||..||. +.+.||...+|+++||++..
T Consensus 286 dpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 286 DPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred CCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 88764432 358899999999999 89999999999999999753
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=335.35 Aligned_cols=259 Identities=24% Similarity=0.342 Sum_probs=191.5
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCC-eEEEEEEEe-------------ccccCCCHHHHHHHHHHHHHHHhCCCCCcc
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEG-IEVAWNQVK-------------LYDFLQSPEELERLYCEIHLLKTLKHRNIM 85 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG-~~VAIK~vk-------------i~~~~~s~e~~e~l~~Ei~iLk~L~HpNIV 85 (738)
.++|.++++||+|+||+||++...... ..+++|.+. .............+.+|+.+|+.|+||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998764332 222222110 001112334556789999999999999999
Q ss_pred eeeEEEEecCCCeEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEe
Q 004672 86 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 160 (738)
Q Consensus 86 kl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~-----~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~ 160 (738)
++++++.. ....++|++++ +++|..++... .......++.|+.||+.||.|||+++ |+||||||+|||++
T Consensus 227 ~l~~~~~~--~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~ 301 (501)
T PHA03210 227 KIEEILRS--EANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLN 301 (501)
T ss_pred cEeEEEEE--CCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC
Confidence 99998755 56789999999 56787776543 23456778899999999999999998 99999999999998
Q ss_pred CCCCcEEEeccchhHHhhccc---cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCC-CCCCC-CH-HHH
Q 004672 161 GNQGEVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYP-YSECT-HP-AQI 233 (738)
Q Consensus 161 ~~~g~VKL~DFGlA~~l~~~~---~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~P-f~~~~-~~-~qi 233 (738)
.+ |.+||+|||++..+.... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..+ |.... ++ .++
T Consensus 302 ~~-~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CD-GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CC-CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 54 899999999997664332 223569999999999874 599999999999999999998864 43221 22 233
Q ss_pred HHHHHcCC-----CCc-------------------cc-----ccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 234 YKKVISGK-----KPE-------------------AL-----FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 234 ~k~i~~g~-----~p~-------------------~l-----~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
.+.+.... .|. .+ ....+..+.++|.+||+ ||.+|||+.|+|.||||...
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 32222100 010 00 01235677888999999 99999999999999999764
Q ss_pred C
Q 004672 284 D 284 (738)
Q Consensus 284 ~ 284 (738)
.
T Consensus 461 ~ 461 (501)
T PHA03210 461 E 461 (501)
T ss_pred C
Confidence 3
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=303.57 Aligned_cols=249 Identities=31% Similarity=0.413 Sum_probs=204.0
Q ss_pred ceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEE
Q 004672 23 MEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 102 (738)
Q Consensus 23 y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV 102 (738)
|+....||.|.+|.||+|.+..+|..||+|.+.... ......+.+..|+.+++.++|+||+++++++.+ ...+++|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v 76 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN--EEEGIPSTALREISLLKELKHPNIVKLLDVIHT--ERKLYLV 76 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc--ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc--CCceEEE
Confidence 567889999999999999999999999999988653 223345678889999999999999999998755 5789999
Q ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccc
Q 004672 103 TEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 181 (738)
Q Consensus 103 ~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~ 181 (738)
|||+. ++|.+++.+. ..+++..++.++.|++.||.|||+++ |+||||+|+||+++.+ +.+||+|||++.......
T Consensus 77 ~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~-~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 77 FEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRD-GVLKLADFGLARAFGIPL 152 (282)
T ss_pred ecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCC-CCEEEecCCcccccCCCc
Confidence 99996 6999999886 57999999999999999999999998 9999999999999854 899999999997664432
Q ss_pred --cccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc------------------
Q 004672 182 --AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS------------------ 239 (738)
Q Consensus 182 --~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~------------------ 239 (738)
.....++..|+|||.+.+ .++.++||||||+++|+|++|..||........+. ++..
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 153 RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLF-KIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH-HHHHHhCCCcHHHHHhhccccc
Confidence 223346788999998753 58889999999999999999999997654433322 2211
Q ss_pred --CCCCc-------ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 240 --GKKPE-------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 240 --g~~p~-------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
...+. ......++.+.++|.+||. +|.+||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 00000 1112346789999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.65 Aligned_cols=255 Identities=31% Similarity=0.428 Sum_probs=204.6
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeE
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
.++|.+++.||.|+||.||+|.+..+|..||+|++.... ......+.+..|+.+++.++||||++++++|... ....
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~ 85 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF--STPVLAKRTYRELKLLKHLRHENIISLSDIFISP-LEDI 85 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc--cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-CCcE
Confidence 467999999999999999999999999999999876432 2233456788999999999999999999987543 4578
Q ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 100 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
++|+||+ +++|..++.. .++++..+..++.||+.||.|||+++ |+||||+|.||+++. .+.+||+|||++.....
T Consensus 86 ~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~-~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINE-NCDLKICDFGLARIQDP 160 (328)
T ss_pred EEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECC-CCCEEeCccccccccCC
Confidence 8999998 6789888654 56889999999999999999999998 999999999999985 48999999999875433
Q ss_pred cccccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHH--------------HHHHHHcC---
Q 004672 180 SHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ--------------IYKKVISG--- 240 (738)
Q Consensus 180 ~~~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~q--------------i~k~i~~g--- 240 (738)
. .....+++.|+|||.+.+ .++.++||||||+++|+|+||..||........ +...+..+
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 161 Q-MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred C-cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 2 233468899999998754 589999999999999999999999976432111 11111000
Q ss_pred ----------CCC-cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 241 ----------KKP-EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 241 ----------~~p-~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
..| .......++.++++|.+||+ +|.+||++.++|.||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 000 11123457899999999999 99999999999999999643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=295.46 Aligned_cols=239 Identities=24% Similarity=0.349 Sum_probs=196.7
Q ss_pred EEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEecC
Q 004672 27 MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMF 106 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey~ 106 (738)
++||.|++|.||+|.+.. |..||+|.++... ..+..+.+.+|+.+++.++||||+++++++.. ....++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTL---PPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCCeEEEEEcC
Confidence 368999999999999987 9999999877543 22456789999999999999999999998754 56889999999
Q ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcccc---
Q 004672 107 TSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA--- 182 (738)
Q Consensus 107 ~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~~--- 182 (738)
.+++|.+++.+. ..+++..+..++.+++.||.|||+++ ++||||||+||+++.+ +.+||+|||++........
T Consensus 75 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~ 151 (251)
T cd05041 75 PGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGEN-NVLKISDFGMSREEEGGIYTVS 151 (251)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCC-CcEEEeeccccccccCCcceec
Confidence 999999998663 56899999999999999999999998 9999999999999854 7999999999976542111
Q ss_pred -ccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHH
Q 004672 183 -ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 259 (738)
Q Consensus 183 -~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~ 259 (738)
....++..|+|||.+. +.++.++||||||+++|+|+| |..||... ........+..+..+ ..+...+.++.+++.
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 229 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM-SNQQTRERIESGYRM-PAPQLCPEEIYRLML 229 (251)
T ss_pred cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC-CHHHHHHHHhcCCCC-CCCccCCHHHHHHHH
Confidence 1122356799999876 458999999999999999999 88899764 344455555444322 234456789999999
Q ss_pred HHHh-CcCCCCCHHHHhc
Q 004672 260 KCLA-TVSSRLSARELLT 276 (738)
Q Consensus 260 kcL~-dP~~RpSa~ELL~ 276 (738)
+||. +|.+|||+.|+|+
T Consensus 230 ~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 230 QCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHhccChhhCcCHHHHHH
Confidence 9999 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=296.23 Aligned_cols=246 Identities=21% Similarity=0.349 Sum_probs=202.5
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCe
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 98 (738)
...+|.+.+.||.|+||.||+|.+. .+..+|+|.++.... . ...+.+|+++++.++||||+++++++.. ...
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~--~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~ 73 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM--S---EEDFIEEAQVMMKLSHPKLVQLYGVCTE--RSP 73 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC--C---HHHHHHHHHHHHhCCCCCeeeEEEEEcc--CCc
Confidence 4578999999999999999999875 577899998764321 1 2468889999999999999999998744 568
Q ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 99 INFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
+++||||+++++|.+++... ..+++..++.++.|++.||+|||+++ ++||||||+||+++.+ +.+||+|||++...
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~ 150 (256)
T cd05112 74 ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGEN-QVVKVSDFGMTRFV 150 (256)
T ss_pred eEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCC-CeEEECCCcceeec
Confidence 89999999999999998764 46899999999999999999999998 9999999999999844 79999999998654
Q ss_pred hccccc---cccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCCh
Q 004672 178 RKSHAA---RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 252 (738)
Q Consensus 178 ~~~~~~---~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~sp 252 (738)
...... ...++..|+|||.+. +.++.++||||||+++|+|++ |..||.. .....+...+..+..+. .....+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~ 228 (256)
T cd05112 151 LDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN-RSNSEVVETINAGFRLY-KPRLASQ 228 (256)
T ss_pred ccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHhCCCCCC-CCCCCCH
Confidence 332221 112456899999886 468899999999999999998 9999976 44566666666554432 2345688
Q ss_pred HHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 253 EVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 253 el~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
.+.+|+.+||+ +|.+|||+.++++.
T Consensus 229 ~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 229 SVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHHh
Confidence 99999999999 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=297.34 Aligned_cols=233 Identities=20% Similarity=0.305 Sum_probs=188.9
Q ss_pred EEEcccCCeEEEEEEEcCCC----------eEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCC
Q 004672 27 MKFLVKELQRHYRAFDEYEG----------IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG----------~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 96 (738)
+.||+|+||.||+|.+..++ ..|++|.+.... .....+.+|+.+|+.++||||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RDSLAFFETASLMSQLSHKHLVKLYGVCVR--- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hhHHHHHHHHHHHHcCCCcchhheeeEEec---
Confidence 36899999999999998777 457777655322 115788999999999999999999998765
Q ss_pred CeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCC-------cEEE
Q 004672 97 RNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG-------EVKI 168 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k~~-~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g-------~VKL 168 (738)
...++||||+.+|+|.+++.+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.. + .+||
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~-~~~~~~~~~~kl 149 (259)
T cd05037 73 DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARY-GLNEGYVPFIKL 149 (259)
T ss_pred CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecC-ccccCCceeEEe
Confidence 45789999999999999998766 7999999999999999999999998 9999999999999854 4 6999
Q ss_pred eccchhHHhhccccccccCCCCCCCcccccc---ccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCc
Q 004672 169 GDLGLAAILRKSHAARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPE 244 (738)
Q Consensus 169 ~DFGlA~~l~~~~~~~~vGTp~YmAPEvl~~---~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~ 244 (738)
+|||++..... .....++..|+|||++.+ .++.++||||||+++|+|++ |..||.... ............
T Consensus 150 ~Dfg~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~~~~~--- 223 (259)
T cd05037 150 SDPGIPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQDQH--- 223 (259)
T ss_pred CCCCccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHHhcCC---
Confidence 99999976543 223457889999999864 48899999999999999999 588887654 222222222111
Q ss_pred ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 245 ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 245 ~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
.........+.++|.+||. +|.+|||+.++++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 224 RLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1122234789999999999 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=295.94 Aligned_cols=246 Identities=22% Similarity=0.349 Sum_probs=201.7
Q ss_pred CcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCC
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 96 (738)
+++.++|.+.++||+|+||.||+|.+. .+..+|+|.++.. ....+.+.+|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--- 72 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK--- 72 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC-----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---
Confidence 356789999999999999999999864 5567999977632 2345678999999999999999999998644
Q ss_pred CeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 97 RNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
...+++|||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++ ++||||||+||+++.. +.+||+|||++
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~-~~~~l~d~~~~ 149 (260)
T cd05073 73 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSAS-LVCKIADFGLA 149 (260)
T ss_pred CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCC-CcEEECCCcce
Confidence 5689999999999999998764 35788899999999999999999998 9999999999999854 89999999998
Q ss_pred HHhhcccc---ccccCCCCCCCcccccc-ccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccC
Q 004672 175 AILRKSHA---ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKV 249 (738)
Q Consensus 175 ~~l~~~~~---~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~ 249 (738)
........ ....++..|+|||++.. .++.++||||||+++|+|+| |..||... +...+...+..+... .....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~ 227 (260)
T cd05073 150 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERGYRM-PRPEN 227 (260)
T ss_pred eeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhCCCCC-CCccc
Confidence 76543221 11235678999998864 58889999999999999999 99999864 344555555555433 23356
Q ss_pred CChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 250 EDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 250 ~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
.+.++.+++.+||. +|.+||++.+++.
T Consensus 228 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 228 CPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 77899999999999 9999999998863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=303.95 Aligned_cols=250 Identities=21% Similarity=0.308 Sum_probs=197.0
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcC----------------CCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCC
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEY----------------EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH 81 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~----------------tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~H 81 (738)
++.++|++.++||+|+||+||++.+.. ++..||+|.++.. ......+.+.+|+.+|+.++|
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~~E~~~l~~l~~ 78 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED---ANKNARNDFLKEIKIMSRLKD 78 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc---CCHHHHHHHHHHHHHHHhCCC
Confidence 355789999999999999999986542 3557899987633 234556789999999999999
Q ss_pred CCcceeeEEEEecCCCeEEEEEecCCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCceec
Q 004672 82 RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-----------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 150 (738)
Q Consensus 82 pNIVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~-----------~lse~~i~~i~~QIl~aL~yLHs~gp~IIHR 150 (738)
+||+++++++.. ...+++||||+.+|+|.+++.+.. .+++..+..++.||+.||.|||+++ |+||
T Consensus 79 ~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~ 154 (296)
T cd05095 79 PNIIRLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHR 154 (296)
T ss_pred CCcceEEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecc
Confidence 999999998755 567899999999999999987643 3677889999999999999999998 9999
Q ss_pred cCCcccEEEeCCCCcEEEeccchhHHhhcccc----ccccCCCCCCCccccc-cccCcccccccchhhhhhhhh--cCCC
Q 004672 151 DLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT--FDYP 223 (738)
Q Consensus 151 DLKP~NILl~~~~g~VKL~DFGlA~~l~~~~~----~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT--G~~P 223 (738)
||||+|||++. .+.++|+|||++..+..... ....+++.|+|||+.. +.++.++|||||||++|+|+| |..|
T Consensus 155 dlkp~Nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p 233 (296)
T cd05095 155 DLATRNCLVGK-NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233 (296)
T ss_pred cCChheEEEcC-CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCC
Confidence 99999999985 47999999999976533221 1223467899999754 569999999999999999998 7789
Q ss_pred CCCCCCHHHHHHHHHc----CCC--CcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 224 YSECTHPAQIYKKVIS----GKK--PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 224 f~~~~~~~qi~k~i~~----g~~--p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
|.... ..++...... ... ........++.+++|+..||+ +|.+||++.++++
T Consensus 234 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 234 YSQLS-DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ccccC-hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 97643 3333332211 100 111123456899999999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=296.91 Aligned_cols=242 Identities=21% Similarity=0.343 Sum_probs=201.1
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCC
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 97 (738)
++.++|.+.+.||.|+||.||++. .++..||+|.++.. ...+.+.+|+.+|+.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~ 71 (254)
T cd05083 3 LNLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD------VTAQAFLEETAVMTKLHHKNLVRLLGVILH---N 71 (254)
T ss_pred ccHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCc------chHHHHHHHHHHHHhCCCCCcCeEEEEEcC---C
Confidence 356789999999999999999985 58899999987632 224578899999999999999999998753 3
Q ss_pred eEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 98 NINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~~--~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
..++||||+.+++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++.+ +.+||+|||++.
T Consensus 72 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~-~~~kl~Dfg~~~ 148 (254)
T cd05083 72 GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSED-GVAKVSDFGLAR 148 (254)
T ss_pred CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCC-CcEEECCCccce
Confidence 4789999999999999987653 4899999999999999999999998 9999999999999855 799999999986
Q ss_pred HhhccccccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChH
Q 004672 176 ILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 253 (738)
Q Consensus 176 ~l~~~~~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spe 253 (738)
..... ......+..|+|||.+. +.++.++||||||+++|+|++ |..||... +...+...+..+..+. .....++.
T Consensus 149 ~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 225 (254)
T cd05083 149 VGSMG-VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM-SLKEVKECVEKGYRME-PPEGCPAD 225 (254)
T ss_pred ecccc-CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC-CHHHHHHHHhCCCCCC-CCCcCCHH
Confidence 54322 12223567899999876 468899999999999999997 99999864 4555666666665443 33556889
Q ss_pred HHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 254 VRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 254 l~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
+++++.+||+ +|..||++.+++.
T Consensus 226 ~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 226 VYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=310.46 Aligned_cols=251 Identities=23% Similarity=0.344 Sum_probs=204.5
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcC-------CCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeE
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEY-------EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYT 89 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~-------tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~ 89 (738)
+...+|.+++.||+|+||.||+|.+.. ++..||+|.++.. ......+.+.+|+.+++++ +||||+++++
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD---ATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc---cCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 344579999999999999999998643 2347899976632 2345567899999999999 8999999999
Q ss_pred EEEecCCCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCC
Q 004672 90 SWVDTANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 153 (738)
Q Consensus 90 ~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~----------------~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLK 153 (738)
++.. ...+++++||+++|+|.+++.+.. .++...+..++.||+.||.|||+++ |+|||||
T Consensus 86 ~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlk 161 (334)
T cd05100 86 ACTQ--DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLA 161 (334)
T ss_pred EEcc--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccc
Confidence 8754 568999999999999999987632 3778889999999999999999998 9999999
Q ss_pred cccEEEeCCCCcEEEeccchhHHhhcccc----ccccCCCCCCCcccccc-ccCcccccccchhhhhhhhh-cCCCCCCC
Q 004672 154 CDNIFVNGNQGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSEC 227 (738)
Q Consensus 154 P~NILl~~~~g~VKL~DFGlA~~l~~~~~----~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlT-G~~Pf~~~ 227 (738)
|+|||++.+ +.+||+|||++........ ....++..|+|||++.+ .++.++||||||+++|+|++ |..||..
T Consensus 162 p~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~- 239 (334)
T cd05100 162 ARNVLVTED-NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG- 239 (334)
T ss_pred cceEEEcCC-CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC-
Confidence 999999855 7999999999875543211 11224568999998864 58899999999999999998 8899976
Q ss_pred CCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCc
Q 004672 228 THPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDP 278 (738)
Q Consensus 228 ~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hp 278 (738)
.+...+++.+..+..+. .....+.++.++|.+||. +|.+||++.+++.+-
T Consensus 240 ~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 240 IPVEELFKLLKEGHRMD-KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred CCHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 45666777776655433 234567899999999999 999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=318.04 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=192.9
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
++|.....||+|+||+||+|.-. .|..||||++..... . . ...|.+|+.+|.+++|||+|++++||.+... ..+
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~--~-~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~~ 148 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSG--Q-G-EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HRL 148 (361)
T ss_pred hCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCC--c-c-hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eEE
Confidence 46777789999999999999864 559999997664321 1 1 3349999999999999999999999977432 689
Q ss_pred EEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC-CCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 101 FVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRD-PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~--~lse~~i~~i~~QIl~aL~yLHs~g-p~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
||+|||+.|+|.+++.... .+++....+|+.+++.||+|||... |+|||||||+.|||+|.+ ...||+|||+|...
T Consensus 149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~-~~aKlsDFGLa~~~ 227 (361)
T KOG1187|consen 149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED-FNAKLSDFGLAKLG 227 (361)
T ss_pred EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC-CCEEccCccCcccC
Confidence 9999999999999987765 8999999999999999999999964 589999999999999955 79999999999665
Q ss_pred hc-ccc-ccc-cCCCCCCCccccc-cccCcccccccchhhhhhhhhcCCCCCCCC-----CHHHH-HHHHHcCCCCc---
Q 004672 178 RK-SHA-ARC-VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECT-----HPAQI-YKKVISGKKPE--- 244 (738)
Q Consensus 178 ~~-~~~-~~~-vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~-----~~~qi-~k~i~~g~~p~--- 244 (738)
.. ... ... .||..|+|||.+. +..+.++||||||++|+||+||+.|..... +.... ...+..+....
T Consensus 228 ~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD 307 (361)
T KOG1187|consen 228 PEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVD 307 (361)
T ss_pred CccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeC
Confidence 43 222 122 7999999999886 679999999999999999999998876422 11121 12222232211
Q ss_pred -ccc-cCCC--hH---HHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 245 -ALF-KVED--PE---VRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 245 -~l~-~~~s--pe---l~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
.+. ..++ .+ +..+...|++ +|.+||+..++++
T Consensus 308 ~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 308 PRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 111 2222 23 4456668999 8999999999743
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=301.74 Aligned_cols=237 Identities=18% Similarity=0.274 Sum_probs=188.8
Q ss_pred EEEcccCCeEEEEEEEcCCCe-------EEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeE
Q 004672 27 MKFLVKELQRHYRAFDEYEGI-------EVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG~-------~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
+.||.|+||+||+|.+..++. .||+|.+.. ......+.+..|+.+|+.++||||+++++++.. +...
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~ 74 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK----SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC--GDES 74 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcc----hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe--CCCc
Confidence 368999999999999866554 388777652 223455788999999999999999999998866 4678
Q ss_pred EEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCC-------cEEEecc
Q 004672 100 NFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG-------EVKIGDL 171 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~~-~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g-------~VKL~DF 171 (738)
++||||+.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+||+++.+.. .++++||
T Consensus 75 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccc
Confidence 99999999999999987754 5899999999999999999999998 999999999999975532 2799999
Q ss_pred chhHHhhccccccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcC-CCCCCCCCHHHHHHHHHcCCCCccccc
Q 004672 172 GLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFD-YPYSECTHPAQIYKKVISGKKPEALFK 248 (738)
Q Consensus 172 GlA~~l~~~~~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~-~Pf~~~~~~~qi~k~i~~g~~p~~l~~ 248 (738)
|++...... ....+++.|+|||++.+ .++.++||||||+++|+|++|. .||.... ...... +.... ..++.
T Consensus 153 g~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~-~~~~~~-~~~~~--~~~~~ 226 (258)
T cd05078 153 GISITVLPK--EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD-SQKKLQ-FYEDR--HQLPA 226 (258)
T ss_pred ccccccCCc--hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc-HHHHHH-HHHcc--ccCCC
Confidence 998654322 23458899999999874 4789999999999999999984 6665433 322222 22111 12333
Q ss_pred CCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 249 VEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 249 ~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
..++++.++|.+||+ +|.+|||+.++++.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 227 PKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 456889999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=299.72 Aligned_cols=240 Identities=19% Similarity=0.272 Sum_probs=187.7
Q ss_pred EEcccCCeEEEEEEEcCC--CeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEec
Q 004672 28 KFLVKELQRHYRAFDEYE--GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEM 105 (738)
Q Consensus 28 kLG~GafgtVYkA~d~~t--G~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey 105 (738)
.||+|+||+||+|..... ...+++|.++.. ......+.+.+|+.+++.++||||+++++.+.. ...+++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN---ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC---CChHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccEEEEec
Confidence 689999999999975433 234556655432 334556789999999999999999999998765 5678999999
Q ss_pred CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc-
Q 004672 106 FTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS- 180 (738)
Q Consensus 106 ~~gGSL~~~l~k~----~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~- 180 (738)
+++|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~-~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSD-LTVKVGDYGIGPSRYKED 153 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCC-ccEEecccccccccCcch
Confidence 9999999998764 34677788999999999999999998 9999999999999855 79999999997542211
Q ss_pred ---ccccccCCCCCCCcccccc--------ccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCC----c
Q 004672 181 ---HAARCVGTPEFMAPEVYEE--------EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKP----E 244 (738)
Q Consensus 181 ---~~~~~vGTp~YmAPEvl~~--------~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p----~ 244 (738)
......+++.|+|||++.. .++.++||||||+++|+|++ |..||..... ..++..+..+... .
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~ 232 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNHVIKDQQVKLFKP 232 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhhcccccCCC
Confidence 1123457899999998742 35778999999999999997 5778876444 4444444433221 2
Q ss_pred ccccCCChHHHHHHHHHHhCcCCCCCHHHHhc
Q 004672 245 ALFKVEDPEVRQFIEKCLATVSSRLSARELLT 276 (738)
Q Consensus 245 ~l~~~~spel~~lI~kcL~dP~~RpSa~ELL~ 276 (738)
.+...+++.+.+++..|+.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~ 264 (268)
T cd05086 233 QLELPYSERWYEVLQFCWLSPEKRATAEEVHR 264 (268)
T ss_pred ccCCCCcHHHHHHHHHHhhCcccCCCHHHHHH
Confidence 23345688899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=297.98 Aligned_cols=227 Identities=18% Similarity=0.228 Sum_probs=187.9
Q ss_pred cCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEecCCCCCH
Q 004672 32 KELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTL 111 (738)
Q Consensus 32 GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey~~gGSL 111 (738)
|.+++||++.++.+|..||+|+++... ....|...+....||||+++++++.. ...+++||||+++|+|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EYSRERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---------hhhhHHHHHHhcCCCceeehhhheec--CCeEEEEEecCCCCCH
Confidence 899999999999999999999987532 13345556666789999999998754 6789999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccccccccCCCCC
Q 004672 112 RQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF 191 (738)
Q Consensus 112 ~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~~~~~vGTp~Y 191 (738)
.+++.+...+++..+..++.|++.||.|||+++ |+||||||+||+++.+ +.++|+|||++....... ....++..|
T Consensus 73 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~~l~df~~~~~~~~~~-~~~~~~~~y 148 (237)
T cd05576 73 WSHISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDR-GHIQLTYFSRWSEVEDSC-DGEAVENMY 148 (237)
T ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCC-CCEEEecccchhcccccc-ccCCcCccc
Confidence 999988888999999999999999999999998 9999999999999855 789999999886654332 233467889
Q ss_pred CCccccc-cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCC
Q 004672 192 MAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRL 269 (738)
Q Consensus 192 mAPEvl~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~Rp 269 (738)
+|||.+. +.++.++||||+|+++|+|++|..|+..... .+ .......++...++.++++|.+||+ +|.+|+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~--~~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~ 221 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPS--GI-----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERL 221 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCch--hc-----ccccccCCcccCCHHHHHHHHHHccCCHHHhc
Confidence 9999886 4588999999999999999999998864221 11 1111112344568899999999999 999999
Q ss_pred CH-----HHHhcCccc
Q 004672 270 SA-----RELLTDPFL 280 (738)
Q Consensus 270 Sa-----~ELL~Hpf~ 280 (738)
++ .++++||||
T Consensus 222 ~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 222 GAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCCccchHHHHcCCCC
Confidence 86 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=294.89 Aligned_cols=242 Identities=19% Similarity=0.291 Sum_probs=194.5
Q ss_pred EEEcccCCeEEEEEEEcC---CCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEE
Q 004672 27 MKFLVKELQRHYRAFDEY---EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 103 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~---tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~ 103 (738)
+.||+|+||+||+|.+.. .+..||+|.+.. .......+.+.+|+.+++.++||||+++++++... ++..++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR---ITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCc---cCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEE
Confidence 368999999999998754 346799997652 22345667899999999999999999999976533 45678999
Q ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccc-
Q 004672 104 EMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH- 181 (738)
Q Consensus 104 Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~- 181 (738)
||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++.......
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~-~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDES-FTVKVADFGLARDIYDKEY 153 (262)
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCC-CcEEECCccccccccCCcc
Confidence 999999999998764 45678888999999999999999998 9999999999999854 799999999997553211
Q ss_pred -----cccccCCCCCCCccccc-cccCcccccccchhhhhhhhhc-CCCCCCCCCHHHHHHHHHcCCCCcccccCCChHH
Q 004672 182 -----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPEALFKVEDPEV 254 (738)
Q Consensus 182 -----~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlTG-~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel 254 (738)
.....+++.|+|||.+. ..++.++||||||+++|+|++| .+||.. .+...+...+..+..+. .....++.+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VDSFDITVYLLQGRRLL-QPEYCPDPL 231 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCHHH
Confidence 11223677899999875 5688999999999999999995 556654 45566666666665443 234457889
Q ss_pred HHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 255 RQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 255 ~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
.+++.+||. +|.+||++.++++.
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999 99999999999853
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=297.53 Aligned_cols=250 Identities=20% Similarity=0.363 Sum_probs=205.9
Q ss_pred CceEEEEEcccCCeEEEEEEEcC-CCeEEEEEEEecccc------CCCHHHHHHHHHHHHHHHh-CCCCCcceeeEEEEe
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEY-EGIEVAWNQVKLYDF------LQSPEELERLYCEIHLLKT-LKHRNIMKFYTSWVD 93 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~-tG~~VAIK~vki~~~------~~s~e~~e~l~~Ei~iLk~-L~HpNIVkl~~~fv~ 93 (738)
+|.+.+.||.|+||.||+|.++. ++..+|+|.+..... ........++..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999988 788999999875431 1234556778889998876 699999999998754
Q ss_pred cCCCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCcccEEEeCCCCcEEE
Q 004672 94 TANRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQGEVKI 168 (738)
Q Consensus 94 ~~~~~l~LV~Ey~~gGSL~~~l~k----~~~lse~~i~~i~~QIl~aL~yLHs-~gp~IIHRDLKP~NILl~~~~g~VKL 168 (738)
+..+++||||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.+ +.+||
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~-~~~~l 155 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGED-DKVTI 155 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCC-CcEEE
Confidence 6789999999999999998743 3468999999999999999999996 55 9999999999999854 79999
Q ss_pred eccchhHHhhcc-ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCccc
Q 004672 169 GDLGLAAILRKS-HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL 246 (738)
Q Consensus 169 ~DFGlA~~l~~~-~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l 246 (738)
+|||++...... ......|+..|+|||.+.+ .++.++||||||+++|+|++|+.||.. .+.......+..+..+...
T Consensus 156 ~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd08528 156 TDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLP 234 (269)
T ss_pred ecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc-cCHHHHHHHHhhccCCcCC
Confidence 999999765543 2234458999999998864 488999999999999999999999975 4445555566555544333
Q ss_pred ccCCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 247 FKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 247 ~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
....++.+.++|.+||+ +|.+||++.|+..+
T Consensus 235 ~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 235 EGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 34568999999999999 99999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=298.24 Aligned_cols=239 Identities=24% Similarity=0.334 Sum_probs=193.6
Q ss_pred EEcccCCeEEEEEEEcCCCe--EEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecCCCeEEEEEe
Q 004672 28 KFLVKELQRHYRAFDEYEGI--EVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTE 104 (738)
Q Consensus 28 kLG~GafgtVYkA~d~~tG~--~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~LV~E 104 (738)
.||.|+||.||+|.+..+|. .+|+|.++. .......+.+.+|+.++.++ +||||+++++++.. ...+++|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e 76 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKE---YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIE 76 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccc---cCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEE
Confidence 58999999999999988876 467777652 22345567899999999999 89999999998754 567899999
Q ss_pred cCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEE
Q 004672 105 MFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 168 (738)
Q Consensus 105 y~~gGSL~~~l~k~~----------------~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL 168 (738)
|+++|+|.+++...+ .+++..+..++.|++.||+|||+++ ++||||||+||+++.+ +.+||
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~-~~~kl 153 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN-YVAKI 153 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCC-CeEEE
Confidence 999999999987643 4789999999999999999999998 9999999999999855 79999
Q ss_pred eccchhHHhhcccc-ccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcc
Q 004672 169 GDLGLAAILRKSHA-ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEA 245 (738)
Q Consensus 169 ~DFGlA~~l~~~~~-~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~ 245 (738)
+|||++........ .....++.|+|||++. ..++.++||||||+++|+|++ |..||.. .+....+..+..+..+.
T Consensus 154 ~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~-~~~~~~~~~~~~~~~~~- 231 (270)
T cd05047 154 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRLE- 231 (270)
T ss_pred CCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc-cCHHHHHHHHhCCCCCC-
Confidence 99999853221111 1122456799999886 458899999999999999997 9999976 34555666665554332
Q ss_pred cccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 246 LFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 246 l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
.....+.++.+++.+||. +|.+|||+.+++.
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 232 KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 334467899999999999 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=304.66 Aligned_cols=251 Identities=23% Similarity=0.400 Sum_probs=203.6
Q ss_pred cCcCCCCceEEEEEcccCCeEEEEEEEcCCCe----EEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEE
Q 004672 16 KLIPLEDMEDTMKFLVKELQRHYRAFDEYEGI----EVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSW 91 (738)
Q Consensus 16 ~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~----~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~f 91 (738)
+.+...+|+..+.||+|+||.||+|.+..+|. .||+|.+... ........+.+|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~ 78 (303)
T cd05110 2 RILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET---TGPKANVEFMDEALIMASMDHPHLVRLLGVC 78 (303)
T ss_pred cccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 34667889999999999999999999988876 4677776532 2344455789999999999999999999987
Q ss_pred EecCCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEec
Q 004672 92 VDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 170 (738)
Q Consensus 92 v~~~~~~l~LV~Ey~~gGSL~~~l~k~~-~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~D 170 (738)
.. ...++++||+++|+|.+++..+. .+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|
T Consensus 79 ~~---~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~-~~~kL~D 152 (303)
T cd05110 79 LS---PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSP-NHVKITD 152 (303)
T ss_pred cC---CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCC-CceEEcc
Confidence 54 34678999999999999987754 5899999999999999999999998 9999999999999744 7899999
Q ss_pred cchhHHhhcccc----ccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCc
Q 004672 171 LGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPE 244 (738)
Q Consensus 171 FGlA~~l~~~~~----~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~ 244 (738)
||++........ ....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+. ....+...+..+..+.
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~ 231 (303)
T cd05110 153 FGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLP 231 (303)
T ss_pred ccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHCCCCCC
Confidence 999986543221 1223567899999886 458899999999999999997 89999763 3444444444444332
Q ss_pred ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 245 ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 245 ~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
.....+..+++++.+||. +|.+||++.+++..
T Consensus 232 -~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 232 -QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 234567899999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.24 Aligned_cols=261 Identities=25% Similarity=0.359 Sum_probs=215.2
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEecccc---CCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCC
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDF---LQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~---~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 97 (738)
+.|-.++.||.|+|+.||+|||....+.||+|+-.+... .......+...+|.+|-+.|+||.||++|++|.- +..
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl-Dtd 541 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL-DTD 541 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee-ccc
Confidence 568889999999999999999999999999997665431 1122344678899999999999999999999854 356
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCC--CCcEEEeccchhH
Q 004672 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN--QGEVKIGDLGLAA 175 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~--~g~VKL~DFGlA~ 175 (738)
.++-|+|||+|.+|.-|++.++.++++.++.|+.||+.||.||....|||||-||||.|||+-.. .|.|||+||||++
T Consensus 542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 89999999999999999999999999999999999999999999999999999999999999522 3689999999999
Q ss_pred Hhhcccc---------ccccCCCCCCCccccc-c----ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHH--HHHc
Q 004672 176 ILRKSHA---------ARCVGTPEFMAPEVYE-E----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK--KVIS 239 (738)
Q Consensus 176 ~l~~~~~---------~~~vGTp~YmAPEvl~-~----~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k--~i~~ 239 (738)
++..... ....||.+|++||.+. + +.+.++||||+|+|+|..+.|+.||........|.. .|+.
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk 701 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK 701 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc
Confidence 9865432 2335899999999774 2 478899999999999999999999976444444432 2222
Q ss_pred CC-CCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 240 GK-KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 240 g~-~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
.. ..-...++.+++++.||++||+ .-.+|....+|-.||+|..
T Consensus 702 AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 702 ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 11 1111235678999999999999 7899999999999999953
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=285.23 Aligned_cols=253 Identities=25% Similarity=0.350 Sum_probs=208.3
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
.+|...++||+|.||+||+|....+++.||+|.+++.+. .+.......+||-+|+.|+|.|||++++.. ...+.+-
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd--degvpssalreicllkelkhknivrl~dvl--hsdkklt 77 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVL--HSDKKLT 77 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC--CCCCcHHHHHHHHHHHHhhhcceeehhhhh--ccCceeE
Confidence 467778999999999999999999999999999998752 223345688999999999999999999954 4577899
Q ss_pred EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 101 FVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k-~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
+|+||| ..+|..|... ++.++.+.++.++.|++.||.|+|+++ +.||||||.|+||+.| |.+||+|||+++.++-
T Consensus 78 lvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~n-gelkladfglarafgi 153 (292)
T KOG0662|consen 78 LVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRN-GELKLADFGLARAFGI 153 (292)
T ss_pred EeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccC-CcEEecccchhhhcCC
Confidence 999999 6789888776 467999999999999999999999999 9999999999999966 8999999999998775
Q ss_pred ccc--ccccCCCCCCCccccccc--cCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHc-CCCCccc-------
Q 004672 180 SHA--ARCVGTPEFMAPEVYEEE--YNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVIS-GKKPEAL------- 246 (738)
Q Consensus 180 ~~~--~~~vGTp~YmAPEvl~~~--ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~-g~~p~~l------- 246 (738)
+.. ...+-|.+|.+|.++-+. |+...|+||.|||+.|+.. |.+.|.+..-.+|+.+.... |...+..
T Consensus 154 pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 542 233579999999998754 9999999999999999996 66668775555555443321 2211110
Q ss_pred ------------------ccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccC
Q 004672 247 ------------------FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 281 (738)
Q Consensus 247 ------------------~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~ 281 (738)
.+......++++.++|. +|..|++|++.|+||||.
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~ 287 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFS 287 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccc
Confidence 11123457899999999 999999999999999995
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=291.79 Aligned_cols=239 Identities=21% Similarity=0.302 Sum_probs=195.8
Q ss_pred EEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEecCC
Q 004672 28 KFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFT 107 (738)
Q Consensus 28 kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey~~ 107 (738)
+||.|+||.||+|... ++..||+|.++.. ........+.+|+.+++.++||||+++++++.. ....++||||++
T Consensus 2 ~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~ 75 (250)
T cd05085 2 LLGKGNFGEVFKGTLK-DKTPVAVKTCKED---LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ--RQPIYIVMELVP 75 (250)
T ss_pred ccCCCCCceEEEEEec-CCcEEEEEecCCc---CCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec--CCccEEEEECCC
Confidence 6899999999999864 6889999986632 234445678999999999999999999998754 567899999999
Q ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcccc---c
Q 004672 108 SGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA---A 183 (738)
Q Consensus 108 gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~~---~ 183 (738)
+++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++. ++.+||+|||++........ .
T Consensus 76 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~-~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 76 GGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGE-NNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcC-CCeEEECCCccceeccccccccCC
Confidence 99999998764 45899999999999999999999998 999999999999985 47999999999865433221 1
Q ss_pred cccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHH
Q 004672 184 RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKC 261 (738)
Q Consensus 184 ~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kc 261 (738)
...+++.|+|||++. +.++.++||||||+++|+|++ |..||... +.......+..+..+ ......++.+.+++.+|
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~ 230 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM-TNQQAREQVEKGYRM-SCPQKCPDDVYKVMQRC 230 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHH
Confidence 123456799999886 458899999999999999998 99999875 445555556555433 23345678999999999
Q ss_pred Hh-CcCCCCCHHHHhcC
Q 004672 262 LA-TVSSRLSARELLTD 277 (738)
Q Consensus 262 L~-dP~~RpSa~ELL~H 277 (738)
|+ +|.+||++.++++.
T Consensus 231 l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 231 WDYKPENRPKFSELQKE 247 (250)
T ss_pred cccCcccCCCHHHHHHH
Confidence 99 99999999999753
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=297.60 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=201.1
Q ss_pred CCCceEEEEEcccCCeEEEEEEEc----CCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDE----YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~----~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 95 (738)
.++|.+.+.||.|+||+||+|... .++..||+|.++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~ 79 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE---EQHRSDFEREIEILRTLDHENIVKYKGVCEKPG 79 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc---hHHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence 457888999999999999999864 3588999998874431 145678999999999999999999999876655
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 96 NRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~l~k~~-~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
....++||||+++++|.+++.+.. .+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.++|+|||++
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~ 156 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESE-DLVKISDFGLA 156 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCC-CCEEEcccccc
Confidence 678999999999999999987765 6999999999999999999999998 9999999999999855 89999999999
Q ss_pred HHhhccccc-----cccCCCCCCCccccc-cccCcccccccchhhhhhhhhcCCCCCCCCCH--------------HHHH
Q 004672 175 AILRKSHAA-----RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHP--------------AQIY 234 (738)
Q Consensus 175 ~~l~~~~~~-----~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~--------------~qi~ 234 (738)
......... ...++..|+|||.+. ..++.++||||||+++|+|+||..|+...... ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 876532211 123456799999876 45888999999999999999999998643211 1122
Q ss_pred HHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 235 KKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 235 k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
..+..+.. .......+.++.+++.+||. +|.+|||+.|++.
T Consensus 237 ~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 237 ELLKEGER-LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHcCCc-CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 22222222 12233456789999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=321.37 Aligned_cols=262 Identities=22% Similarity=0.340 Sum_probs=218.6
Q ss_pred cCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC
Q 004672 16 KLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95 (738)
Q Consensus 16 ~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 95 (738)
..++...|+.-+.||.|+||.||.+....||+.||.|.+...... ......-...|..||.+++.+.||.+--.| ++
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiK-kr~ge~maLnEk~iL~kV~s~FiVslaYAf--eT 256 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIK-KRKGETMALNEKQILEKVSSPFIVSLAYAF--ET 256 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHH-HhhhhHHhhHHHHHHHHhccCcEEEEeeee--cC
Confidence 345667788999999999999999999999999999987654321 122223567899999999999999986555 55
Q ss_pred CCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccch
Q 004672 96 NRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 173 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~l~k~~--~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGl 173 (738)
.+.+++|+..|+||+|.-.|...+ .|+++.+..++.+|+.||++||..+ ||+|||||+|||+| +.|+|+|+|+||
T Consensus 257 kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLD-d~GhvRISDLGL 333 (591)
T KOG0986|consen 257 KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLD-DHGHVRISDLGL 333 (591)
T ss_pred CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeec-cCCCeEeeccce
Confidence 789999999999999988887765 7999999999999999999999998 99999999999998 559999999999
Q ss_pred hHHhhcccccc-ccCCCCCCCccccc-cccCcccccccchhhhhhhhhcCCCCCCCC---CHHHHHHHHHcCCCCccccc
Q 004672 174 AAILRKSHAAR-CVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECT---HPAQIYKKVISGKKPEALFK 248 (738)
Q Consensus 174 A~~l~~~~~~~-~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~---~~~qi~k~i~~g~~p~~l~~ 248 (738)
|..+....... .+||.+|||||++. +.|+...|.|||||++|+|+.|+.||.... ..+++-+.+. ..+..++.
T Consensus 334 Avei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~--~~~~ey~~ 411 (591)
T KOG0986|consen 334 AVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL--EDPEEYSD 411 (591)
T ss_pred EEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh--cchhhccc
Confidence 98887665433 38999999999997 459999999999999999999999996422 2223333333 34555667
Q ss_pred CCChHHHHHHHHHHh-CcCCCC-----CHHHHhcCcccCCCCC
Q 004672 249 VEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDY 285 (738)
Q Consensus 249 ~~spel~~lI~kcL~-dP~~Rp-----Sa~ELL~Hpf~~~~~~ 285 (738)
..+++++++.+.+|. +|++|+ .+.++..||||+.-++
T Consensus 412 kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 412 KFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW 454 (591)
T ss_pred ccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence 789999999999999 999987 5779999999987655
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=323.39 Aligned_cols=260 Identities=23% Similarity=0.336 Sum_probs=218.8
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
-|..++.||-|+||.|.++....|...||+|.++..+.. ...+...++.|-.||..-+.+=||++|-+|.+ +.++||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl-~rnQvaHVKAERDILAEADn~WVVrLyySFQD--kdnLYF 706 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVL-MRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYF 706 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHH-hhhhhhhhhhhhhhHhhcCCcceEEEEEEecc--CCceEE
Confidence 477889999999999999999999999999998877743 34566788999999999999999999999966 789999
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc-
Q 004672 102 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS- 180 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~- 180 (738)
||+|++||++-.+|.+-+-|.|..++.++..+..|+++.|..| +|||||||+||||+.+ |+|||+||||+.-++..
T Consensus 707 VMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrd-GHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred EEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccC-Cceeeeeccccccceecc
Confidence 9999999999999999999999999999999999999999999 9999999999999955 99999999999654200
Q ss_pred -------------------------------------------ccccccCCCCCCCccccc-cccCcccccccchhhhhh
Q 004672 181 -------------------------------------------HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILE 216 (738)
Q Consensus 181 -------------------------------------------~~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLye 216 (738)
.....+||+.|+|||++. ..|+..+|.||.|+||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 011346999999999986 569999999999999999
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHcCC-CCcccccCCChHHHHHHHHHHhCcCCCCC---HHHHhcCcccCCCCCch
Q 004672 217 MVTFDYPYSECTHPAQIYKKVISGK-KPEALFKVEDPEVRQFIEKCLATVSSRLS---ARELLTDPFLQIDDYDS 287 (738)
Q Consensus 217 LlTG~~Pf~~~~~~~qi~k~i~~g~-~p~~l~~~~spel~~lI~kcL~dP~~RpS---a~ELL~Hpf~~~~~~~~ 287 (738)
|+.|++||...+..+..++.+-... .-.......++++.++|.++...+..|+. +.++..||||+.-++..
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHh
Confidence 9999999987554443333222111 11222345789999999999998888874 77899999999888764
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=336.75 Aligned_cols=254 Identities=22% Similarity=0.295 Sum_probs=215.6
Q ss_pred CcccccCcCCCCceEEEEEcccCCeEEEEEEEc-----CCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcc
Q 004672 11 PPSLLKLIPLEDMEDTMKFLVKELQRHYRAFDE-----YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIM 85 (738)
Q Consensus 11 p~~l~~~I~~~~y~il~kLG~GafgtVYkA~d~-----~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIV 85 (738)
+.....+|+..+....+.||+|+||+||+|... .....||||.++- ..+.+..+.|.+|+.+|..|+|||||
T Consensus 476 ~~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd---~a~~~~~~dF~REaeLla~l~H~nIV 552 (774)
T KOG1026|consen 476 PDLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKD---KAENQARQDFRREAELLAELQHPNIV 552 (774)
T ss_pred CccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcc---cccHHHHHHHHHHHHHHHhccCCCeE
Confidence 455677889999999999999999999999754 3456899998773 23455788999999999999999999
Q ss_pred eeeEEEEecCCCeEEEEEecCCCCCHHHHHHhcC----------C----CCHHHHHHHHHHHHHHHHHHHhCCCCceecc
Q 004672 86 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR----------R----VNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 151 (738)
Q Consensus 86 kl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~----------~----lse~~i~~i~~QIl~aL~yLHs~gp~IIHRD 151 (738)
+|++.+. .++.+++|+|||..|+|.+++..+. . ++..+.+.|+.||+.|+.||-++. +||||
T Consensus 553 rLlGVC~--~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRD 628 (774)
T KOG1026|consen 553 RLLGVCR--EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRD 628 (774)
T ss_pred EEEEEEc--cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccc
Confidence 9999774 4889999999999999999987642 2 788999999999999999999998 99999
Q ss_pred CCcccEEEeCCCCcEEEeccchhHHhhccccccc----cCCCCCCCcccc-ccccCcccccccchhhhhhhhh-cCCCCC
Q 004672 152 LKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC----VGTPEFMAPEVY-EEEYNELVDIYSFGMCILEMVT-FDYPYS 225 (738)
Q Consensus 152 LKP~NILl~~~~g~VKL~DFGlA~~l~~~~~~~~----vGTp~YmAPEvl-~~~ys~~sDIWSLGviLyeLlT-G~~Pf~ 225 (738)
|-..|+||..+ -.|||+||||++..-....... .-...|||||.+ .++|+.++|||||||+|||+++ |..||.
T Consensus 629 LATRNCLVge~-l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~ 707 (774)
T KOG1026|consen 629 LATRNCLVGEN-LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYY 707 (774)
T ss_pred hhhhhceeccc-eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccc
Confidence 99999999755 6899999999986543322222 234699999955 5889999999999999999997 899999
Q ss_pred CCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHH
Q 004672 226 ECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSAREL 274 (738)
Q Consensus 226 ~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~EL 274 (738)
+.+| +++++.|..|.. -.-+...+.++..|+..||+ .|++||++.||
T Consensus 708 glSn-~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 708 GLSN-QEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred ccch-HHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 8665 556678888887 34456778999999999999 89999999997
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.74 Aligned_cols=263 Identities=21% Similarity=0.345 Sum_probs=228.9
Q ss_pred cCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEec
Q 004672 16 KLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDT 94 (738)
Q Consensus 16 ~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~ 94 (738)
.-|...+|..+..||.|+||+|.+|..+.|.+.+|||+++..- ....+..+--..|.++|... +-|.+++++..|..
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDV-iiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT- 421 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDV-IIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT- 421 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccce-eeecCcccceehhhhheecCCCCchHHHHHHHhhh-
Confidence 3567788999999999999999999999999999999888543 33445667778888999888 67889999887744
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 95 ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 95 ~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
-+.+|+||||+.||+|--.+++.+++.+..+..++..|+-||-|||++| ||+||||.+|||++++ |+|||+|||++
T Consensus 422 -mDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~e-GHiKi~DFGmc 497 (683)
T KOG0696|consen 422 -MDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMC 497 (683)
T ss_pred -hhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccC-CceEeeecccc
Confidence 5789999999999999999999999999999999999999999999999 9999999999999966 89999999999
Q ss_pred HH--hhccccccccCCCCCCCccccc-cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCC
Q 004672 175 AI--LRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED 251 (738)
Q Consensus 175 ~~--l~~~~~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~s 251 (738)
+. .......+.+|||.|+|||++. ..|+..+|.||||++||||+.|++||.+ .+.++++..|...+. .+++..+
T Consensus 498 KEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG-eDE~elF~aI~ehnv--syPKslS 574 (683)
T KOG0696|consen 498 KENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQAIMEHNV--SYPKSLS 574 (683)
T ss_pred cccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHccC--cCccccc
Confidence 64 3344567789999999999876 6799999999999999999999999987 677888888886553 2456779
Q ss_pred hHHHHHHHHHHh-CcCCCCC-----HHHHhcCcccCCCCCch
Q 004672 252 PEVRQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDDYDS 287 (738)
Q Consensus 252 pel~~lI~kcL~-dP~~RpS-----a~ELL~Hpf~~~~~~~~ 287 (738)
.++.++.+..|. .|.+|+. -.++-.||||+.-++..
T Consensus 575 kEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek 616 (683)
T KOG0696|consen 575 KEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEK 616 (683)
T ss_pred HHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHH
Confidence 999999999999 8999975 46899999999887753
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=295.50 Aligned_cols=248 Identities=21% Similarity=0.286 Sum_probs=200.3
Q ss_pred ceEEEEEcccCCeEEEEEEEc---CCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCC--
Q 004672 23 MEDTMKFLVKELQRHYRAFDE---YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR-- 97 (738)
Q Consensus 23 y~il~kLG~GafgtVYkA~d~---~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~-- 97 (738)
|.+.+.||+|+||+||+|.+. .+|..||+|+++... ......+++.+|+++|+.++||||+++++++......
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI--FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc--CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 567889999999999999865 468999999886432 3445567899999999999999999999987653222
Q ss_pred --eEEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEe
Q 004672 98 --NINFVTEMFTSGTLRQYRLKH------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIG 169 (738)
Q Consensus 98 --~l~LV~Ey~~gGSL~~~l~k~------~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~ 169 (738)
..+++++|+.+|+|.+++... ..++...++.++.||+.||+|||+++ |+||||||+||+++.+ +.+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~-~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNEN-MTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCC-CCEEEC
Confidence 347899999999999887532 14788999999999999999999998 9999999999999854 789999
Q ss_pred ccchhHHhhccc----cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCC
Q 004672 170 DLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKP 243 (738)
Q Consensus 170 DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p 243 (738)
|||++....... .....+++.|++||.+.. .++.++||||||+++|+|++ |..||.. .+...++..+..+..+
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~ 234 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG-VENSEIYNYLIKGNRL 234 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC-CCHHHHHHHHHcCCcC
Confidence 999987654321 122235678999998864 48889999999999999999 8899976 4556666666665443
Q ss_pred cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 244 EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 244 ~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
. .....++.+.+++.+||+ +|.+|||+.+++..
T Consensus 235 ~-~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 235 K-QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred C-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2 234567899999999999 89999999999853
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=299.38 Aligned_cols=236 Identities=20% Similarity=0.236 Sum_probs=186.5
Q ss_pred EEcccCCeEEEEEEEcCC------------------------CeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCC
Q 004672 28 KFLVKELQRHYRAFDEYE------------------------GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN 83 (738)
Q Consensus 28 kLG~GafgtVYkA~d~~t------------------------G~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpN 83 (738)
+||+|+||.||+|....+ ...||+|.+... ..+....+.+|+.+++.++|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS----HRDIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH----HHHHHHHHHHHHHHHhcCCCCC
Confidence 689999999999985322 245888876532 2344567889999999999999
Q ss_pred cceeeEEEEecCCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCC
Q 004672 84 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 162 (738)
Q Consensus 84 IVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k-~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~ 162 (738)
|+++++++.. ....++||||+++|+|..++.+ .+++++..+..++.||+.||.|||+++ |+||||||+|||++..
T Consensus 78 iv~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~ 153 (274)
T cd05076 78 LAFVHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARL 153 (274)
T ss_pred eeeEEEEEEe--CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEecc
Confidence 9999998765 5678999999999999999866 457899999999999999999999998 9999999999999743
Q ss_pred ------CCcEEEeccchhHHhhccccccccCCCCCCCcccccc--ccCcccccccchhhhhhhh-hcCCCCCCCCCHHHH
Q 004672 163 ------QGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMV-TFDYPYSECTHPAQI 233 (738)
Q Consensus 163 ------~g~VKL~DFGlA~~l~~~~~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLl-TG~~Pf~~~~~~~qi 233 (738)
.+.+|++|||++...... ....+++.|+|||.+.+ .++.++||||||+++|+|+ +|..||..... ...
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~ 230 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP-SEK 230 (274)
T ss_pred CcccCccceeeecCCccccccccc--cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh-HHH
Confidence 124899999987543221 23357889999998864 4899999999999999985 79999976433 332
Q ss_pred HHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 234 YKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 234 ~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
...+.... ..+....+.+.++|.+||+ +|.+|||+.++|++
T Consensus 231 ~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 231 ERFYEKKH---RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHhcc---CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22222111 1223346789999999999 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=299.06 Aligned_cols=255 Identities=18% Similarity=0.176 Sum_probs=191.3
Q ss_pred ccCcCCCCceEEEEEcccCCeEEEEEEEcCC---CeEEEEEEEeccccCCCHHH-------HHHHHHHHHHHHhCCCCCc
Q 004672 15 LKLIPLEDMEDTMKFLVKELQRHYRAFDEYE---GIEVAWNQVKLYDFLQSPEE-------LERLYCEIHLLKTLKHRNI 84 (738)
Q Consensus 15 ~~~I~~~~y~il~kLG~GafgtVYkA~d~~t---G~~VAIK~vki~~~~~s~e~-------~e~l~~Ei~iLk~L~HpNI 84 (738)
+..+.-.+|.+.++||+|+||+||+|.+..+ +..+|+|...+.......+. ......+...+..+.|+||
T Consensus 6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i 85 (294)
T PHA02882 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI 85 (294)
T ss_pred eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence 4455567899999999999999999998877 66778776443321110010 0122334455667799999
Q ss_pred ceeeEEEEecCC--CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCC
Q 004672 85 MKFYTSWVDTAN--RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 162 (738)
Q Consensus 85 Vkl~~~fv~~~~--~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~ 162 (738)
+++++.+..... ...+++++++ ..++.+++......++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGN 162 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC
Confidence 999987654322 2457788887 4577777776666789999999999999999999998 9999999999999854
Q ss_pred CCcEEEeccchhHHhhcc---------ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHH
Q 004672 163 QGEVKIGDLGLAAILRKS---------HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ 232 (738)
Q Consensus 163 ~g~VKL~DFGlA~~l~~~---------~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~q 232 (738)
+.++|+|||+|..+... ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||........
T Consensus 163 -~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 163 -NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred -CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 78999999999765321 1122359999999998875 589999999999999999999999987533322
Q ss_pred H--------HHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 233 I--------YKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 233 i--------~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
+ .+.+..+.. .....++++.+++..|+. +|.+||+..+|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 242 LIHAAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2 223333322 123447889999999999 9999999999874
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=296.84 Aligned_cols=236 Identities=19% Similarity=0.326 Sum_probs=186.9
Q ss_pred EEEcccCCeEEEEEEEcC------------CCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEec
Q 004672 27 MKFLVKELQRHYRAFDEY------------EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 94 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~------------tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~ 94 (738)
+.||+|+||.||+|.... ....||+|.+... .......+..|+.+|+.++||||+++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~- 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS----HRDISLAFFETASMMRQVSHKHIVLLYGVCVR- 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 368999999999998532 2346888875532 23455678899999999999999999998765
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCC-------cE
Q 004672 95 ANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG-------EV 166 (738)
Q Consensus 95 ~~~~l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g-------~V 166 (738)
+...++||||+++|+|..++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ + .+
T Consensus 76 -~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~-~~~~~~~~~~ 151 (262)
T cd05077 76 -DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLARE-GIDGECGPFI 151 (262)
T ss_pred -CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecC-CccCCCCcee
Confidence 56778999999999999988764 56999999999999999999999998 9999999999999743 3 38
Q ss_pred EEeccchhHHhhccccccccCCCCCCCccccc--cccCcccccccchhhhhhhh-hcCCCCCCCCCHHHHHHHHHcCCCC
Q 004672 167 KIGDLGLAAILRKSHAARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMV-TFDYPYSECTHPAQIYKKVISGKKP 243 (738)
Q Consensus 167 KL~DFGlA~~l~~~~~~~~vGTp~YmAPEvl~--~~ys~~sDIWSLGviLyeLl-TG~~Pf~~~~~~~qi~k~i~~g~~p 243 (738)
|++|||++...... ....++..|+|||.+. ..++.++|||||||++|+|+ +|..||.... ..+. .....+..+
T Consensus 152 ~l~d~g~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-~~~~-~~~~~~~~~ 227 (262)
T cd05077 152 KLSDPGIPITVLSR--QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT-LAEK-ERFYEGQCM 227 (262)
T ss_pred EeCCCCCCccccCc--ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc-hhHH-HHHHhcCcc
Confidence 99999998654322 2345889999999885 45889999999999999998 5888987532 2222 222222222
Q ss_pred cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 244 EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 244 ~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
.....++++++||.+||+ +|.+||++.+||.+
T Consensus 228 --~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 228 --LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred --CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 223346789999999999 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=293.81 Aligned_cols=239 Identities=24% Similarity=0.367 Sum_probs=194.6
Q ss_pred EEcccCCeEEEEEEEcCCC------eEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 28 KFLVKELQRHYRAFDEYEG------IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 28 kLG~GafgtVYkA~d~~tG------~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
.||.|+||.||+|.++..+ ..||+|.+... ........+.+|+.+|+.++||||+++++++.. ....++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 76 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG---ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL--NEPQYI 76 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcc---cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC--CCCeEE
Confidence 6899999999999986544 78999987532 223456678999999999999999999998754 567999
Q ss_pred EEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCC-----cEEEe
Q 004672 102 VTEMFTSGTLRQYRLKH-------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG-----EVKIG 169 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~-------~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g-----~VKL~ 169 (738)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.+ + .++|+
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~~~~~~~l~ 153 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEK-GYDADRVVKIG 153 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecC-CCCCCcceEEC
Confidence 99999999999998653 24788999999999999999999998 9999999999999854 4 79999
Q ss_pred ccchhHHhhcccc----ccccCCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCC
Q 004672 170 DLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKP 243 (738)
Q Consensus 170 DFGlA~~l~~~~~----~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p 243 (738)
|||++........ ....++..|+|||++. +.++.++||||||+++|+|+| |..||... +.......+..+..+
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~-~~~~~~~~~~~~~~~ 232 (269)
T cd05044 154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL-NNQEVLQHVTAGGRL 232 (269)
T ss_pred CcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc-CHHHHHHHHhcCCcc
Confidence 9999976543211 1224578899999886 458999999999999999998 99999864 344555555554433
Q ss_pred cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 244 EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 244 ~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
. .....++.+.++|.+||. +|.+||++.++++
T Consensus 233 ~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 233 Q-KPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred C-CcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2 334567899999999999 8999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=324.70 Aligned_cols=244 Identities=23% Similarity=0.319 Sum_probs=211.4
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecCCC
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~ 97 (738)
..++|.+...+|.|+|+.|-.+.+..++...++|++.... ....+|+.++... +||||+++++.+ ..+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~--------~~~~~e~~~~~~~~~h~niv~~~~v~--~~~~ 389 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA--------DDNQDEIPISLLVRDHPNIVKSHDVY--EDGK 389 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc--------cccccccchhhhhcCCCcceeeccee--cCCc
Confidence 4678989999999999999999999999999999987542 1245577666555 899999999976 4478
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
.+|+|||++.|+-|.+-+.+.+.+. ..+..|+++|+.|+.|||++| +|||||||+|||+.++.|+++|+|||.++..
T Consensus 390 ~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred eeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 9999999999999988877766665 788899999999999999998 9999999999999656689999999999887
Q ss_pred hccccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 004672 178 RKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 256 (738)
Q Consensus 178 ~~~~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~ 256 (738)
... ..+.+-|..|.|||++.. .|++++||||||++||+|++|..||....+..+++.++..|... ...|.++++
T Consensus 467 ~~~-~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s----~~vS~~AKd 541 (612)
T KOG0603|consen 467 ERS-CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS----ECVSDEAKD 541 (612)
T ss_pred chh-hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc----cccCHHHHH
Confidence 766 334456889999999974 59999999999999999999999998766666788877766544 567999999
Q ss_pred HHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 257 FIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 257 lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
||.+||+ +|.+||++.+++.||||
T Consensus 542 Ll~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 542 LLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHhccCChhhCcChhhhccCcch
Confidence 9999999 99999999999999999
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=323.21 Aligned_cols=255 Identities=26% Similarity=0.407 Sum_probs=215.9
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEec---C
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDT---A 95 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~---~ 95 (738)
.+.+.+.+.||.|.+|.||++.+..+|..+|+|+..... +.-+.+..|..+|+.+ .|||++.+|++|... .
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 467899999999999999999999999999999765332 3335688899999999 799999999998653 3
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccch
Q 004672 96 NRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 173 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGl 173 (738)
++.+|||||||.|||.-++++.. .++.|..+..|++.++.||.+||.+. +||||||-.|||++.+ |.|||.|||+
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e-~~VKLvDFGv 169 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTEN-AEVKLVDFGV 169 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEecc-CcEEEeeeee
Confidence 56899999999999999998764 57999999999999999999999998 9999999999999966 8999999999
Q ss_pred hHHhhcc--ccccccCCCCCCCccccc------cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcc
Q 004672 174 AAILRKS--HAARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEA 245 (738)
Q Consensus 174 A~~l~~~--~~~~~vGTp~YmAPEvl~------~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~ 245 (738)
+..+... ...+++|||.|||||++. ..|+..+|+||||++..||.-|.+|+.+......++. |-....|..
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~-IpRNPPPkL 248 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-IPRNPPPKL 248 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc-CCCCCCccc
Confidence 9887654 346778999999999985 2488899999999999999999999987554444433 333333322
Q ss_pred c-ccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 246 L-FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 246 l-~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
. +...+.++.+||..||. +-.+||+..++|+|||++..
T Consensus 249 krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 249 KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 2 45567899999999999 89999999999999999843
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=332.35 Aligned_cols=252 Identities=21% Similarity=0.306 Sum_probs=208.9
Q ss_pred ccCcCCCCceEEEEEcccCCeEEEEEEEcCCC-----eEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeE
Q 004672 15 LKLIPLEDMEDTMKFLVKELQRHYRAFDEYEG-----IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYT 89 (738)
Q Consensus 15 ~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG-----~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~ 89 (738)
++.+..........||+|+||.||.|.-.... ..||+|.++. ..+.++...|.+|..+|+.++|||||++++
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~---~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liG 762 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR---LSSEQEVSDFLKEALLMSKFDHPNIVSLIG 762 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc---cCCHHHHHHHHHHHHHHhcCCCcceeeEEE
Confidence 55677888899999999999999999875432 3488887664 346778889999999999999999999999
Q ss_pred EEEecCCCeEEEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCC
Q 004672 90 SWVDTANRNINFVTEMFTSGTLRQYRLKH-------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 162 (738)
Q Consensus 90 ~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~-------~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~ 162 (738)
++++ ....+|++|||+||+|..|+.+. ..+++..+..++.+|++|+.||++++ +|||||.+.|+|++..
T Consensus 763 v~l~--~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~ 838 (1025)
T KOG1095|consen 763 VCLD--SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDER 838 (1025)
T ss_pred eecC--CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeeccc
Confidence 8877 66789999999999999999886 24899999999999999999999998 9999999999999966
Q ss_pred CCcEEEeccchhHHhhcccccccc----CCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHH
Q 004672 163 QGEVKIGDLGLAAILRKSHAARCV----GTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKK 236 (738)
Q Consensus 163 ~g~VKL~DFGlA~~l~~~~~~~~v----GTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~ 236 (738)
..|||+|||+|+.+-.....+.- -...|||||.+. +.++.++|||||||++||++| |..||.+..+.+-+...
T Consensus 839 -r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~ 917 (1025)
T KOG1095|consen 839 -RVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV 917 (1025)
T ss_pred -CcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH
Confidence 79999999999955433222221 235899999887 679999999999999999998 88899986554444334
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 237 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 237 i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
...|..+ .+...+..+.+++..||+ +|.+||+...|++
T Consensus 918 ~~ggRL~--~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 918 LEGGRLD--PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred HhCCccC--CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 4445333 234456678899999999 9999999999998
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=278.09 Aligned_cols=240 Identities=36% Similarity=0.552 Sum_probs=205.9
Q ss_pred CCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEecCCCCCHH
Q 004672 33 ELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLR 112 (738)
Q Consensus 33 afgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey~~gGSL~ 112 (738)
+||.||+|.+..+|..+|+|++...... ...+.+.+|+++++.++|+||+++++++.. ....++++||+.+++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK---KKRERILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc---cHHHHHHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCCCCCHH
Confidence 5899999999999999999988754321 116789999999999999999999998765 57899999999999999
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc-ccccccCCCCC
Q 004672 113 QYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-HAARCVGTPEF 191 (738)
Q Consensus 113 ~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~-~~~~~vGTp~Y 191 (738)
.++.....+++..+..++.+++.+|.|||+.+ ++|+||+|.||+++.+ +.++|+|||++...... ......+++.|
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 152 (244)
T smart00220 76 DLLKKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDED-GHVKLADFGLARQLDPGGLLTTFVGTPEY 152 (244)
T ss_pred HHHHhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCC-CcEEEccccceeeeccccccccccCCcCC
Confidence 99888777999999999999999999999998 9999999999999865 89999999999776543 33445689999
Q ss_pred CCccccc-cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccC-CChHHHHHHHHHHh-CcCCC
Q 004672 192 MAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKV-EDPEVRQFIEKCLA-TVSSR 268 (738)
Q Consensus 192 mAPEvl~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~-~spel~~lI~kcL~-dP~~R 268 (738)
++||.+. ..++.++||||||+++++|++|..||....+...+...+..+..+...... .+.++.+++.+||. +|.+|
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 232 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR 232 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence 9999886 568889999999999999999999998756677777766665554332222 67899999999999 99999
Q ss_pred CCHHHHhcCccc
Q 004672 269 LSARELLTDPFL 280 (738)
Q Consensus 269 pSa~ELL~Hpf~ 280 (738)
|++.++++||||
T Consensus 233 p~~~~~~~~~~~ 244 (244)
T smart00220 233 LTAEEALQHPFF 244 (244)
T ss_pred cCHHHHhhCCCC
Confidence 999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=323.59 Aligned_cols=259 Identities=20% Similarity=0.244 Sum_probs=183.6
Q ss_pred ccCcCCCCceEEEEEcccCCeEEEEEEEcCC----CeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEE
Q 004672 15 LKLIPLEDMEDTMKFLVKELQRHYRAFDEYE----GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTS 90 (738)
Q Consensus 15 ~~~I~~~~y~il~kLG~GafgtVYkA~d~~t----G~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~ 90 (738)
...+..++|.+.++||+|+||+||+|.+..+ +..||+|++.... ..+....+ .++...+.++..++..
T Consensus 126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e~~~~e--~l~~~~~~~~~~~~~~ 197 (566)
T PLN03225 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVEIWMNE--RVRRACPNSCADFVYG 197 (566)
T ss_pred CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hhHHHHHH--HHHhhchhhHHHHHHh
Confidence 4456778999999999999999999999998 9999999876321 11111111 1222233333333322
Q ss_pred EEe----cCCCeEEEEEecCCCCCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCC
Q 004672 91 WVD----TANRNINFVTEMFTSGTLRQYRLKHRR--------------------VNIRAVKHWCRQILSGLLYLHSRDPP 146 (738)
Q Consensus 91 fv~----~~~~~l~LV~Ey~~gGSL~~~l~k~~~--------------------lse~~i~~i~~QIl~aL~yLHs~gp~ 146 (738)
|.. .....+++|+||+.+++|.+++..... .....+..++.||+.||.|||+++
T Consensus 198 ~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g-- 275 (566)
T PLN03225 198 FLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG-- 275 (566)
T ss_pred hhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--
Confidence 211 345689999999999999999865421 123457789999999999999998
Q ss_pred ceeccCCcccEEEeCCCCcEEEeccchhHHhhcc---ccccccCCCCCCCcccccc-----------------------c
Q 004672 147 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS---HAARCVGTPEFMAPEVYEE-----------------------E 200 (738)
Q Consensus 147 IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~---~~~~~vGTp~YmAPEvl~~-----------------------~ 200 (738)
|+||||||+|||++.+.+.+||+|||+|..+... ......||+.|||||.+.. .
T Consensus 276 IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~ 355 (566)
T PLN03225 276 IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 355 (566)
T ss_pred EEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhcccc
Confidence 9999999999999866679999999999765432 2345579999999996531 2
Q ss_pred cCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC-------------cc------cccCCChHHHHHHHHH
Q 004672 201 YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP-------------EA------LFKVEDPEVRQFIEKC 261 (738)
Q Consensus 201 ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p-------------~~------l~~~~spel~~lI~kc 261 (738)
++.++|||||||++|||+++..|+.. ...++.+.+...... .. .....+....+||.+|
T Consensus 356 ~~~k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m 433 (566)
T PLN03225 356 LPDRFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSM 433 (566)
T ss_pred CCCCcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHH
Confidence 34567999999999999997776542 233333222221110 00 0111233456899999
Q ss_pred Hh-CcCCCCCHHHHhcCcccCCCCC
Q 004672 262 LA-TVSSRLSARELLTDPFLQIDDY 285 (738)
Q Consensus 262 L~-dP~~RpSa~ELL~Hpf~~~~~~ 285 (738)
|+ ||.+|||+.++|+||||+....
T Consensus 434 L~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 434 MRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred ccCCcccCCCHHHHhCCcCcCCCCc
Confidence 99 9999999999999999986543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=299.78 Aligned_cols=254 Identities=20% Similarity=0.304 Sum_probs=205.8
Q ss_pred CcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCC--CC----cceeeEE
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH--RN----IMKFYTS 90 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~H--pN----IVkl~~~ 90 (738)
.+....|.++.++|+|.||.|-.+.|..++..||+|+++.. ....+...-|+++|.++.+ |+ +|++.++
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 34467899999999999999999999999999999988743 3566778889999999932 22 5666665
Q ss_pred EEecCCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCC------
Q 004672 91 WVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN------ 162 (738)
Q Consensus 91 fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~--~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~------ 162 (738)
| .-.+.++||+|.+ |-|+++++..+. +++...++.+++||+.+++|||+.+ ++|.||||+|||+...
T Consensus 160 F--dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 160 F--DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred h--hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEe
Confidence 5 3367999999999 779999998864 6999999999999999999999999 9999999999998321
Q ss_pred -------------CCcEEEeccchhHHhhccccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCC
Q 004672 163 -------------QGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT 228 (738)
Q Consensus 163 -------------~g~VKL~DFGlA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~ 228 (738)
...|+|+|||.|......+ ...+.|..|+|||++.+ .++.++||||+||||+|+.||...|....
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccCc-ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 1358999999998766554 55679999999998876 79999999999999999999999998766
Q ss_pred CHHHH--HHHHHcCCCCccc-----------------c----------------------cC---CChHHHHHHHHHHh-
Q 004672 229 HPAQI--YKKVISGKKPEAL-----------------F----------------------KV---EDPEVRQFIEKCLA- 263 (738)
Q Consensus 229 ~~~qi--~k~i~~g~~p~~l-----------------~----------------------~~---~spel~~lI~kcL~- 263 (738)
+.+.+ +.+|. |..|... . .. ...++.+||++||.
T Consensus 314 n~EHLaMMerIl-Gp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 314 NLEHLAMMERIL-GPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred cHHHHHHHHHhh-CCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 66654 22222 2322110 0 00 12358899999999
Q ss_pred CcCCCCCHHHHhcCcccCC
Q 004672 264 TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 264 dP~~RpSa~ELL~Hpf~~~ 282 (738)
||.+|+|+.|+|.||||+.
T Consensus 393 DP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 393 DPARRITLREALSHPFFAR 411 (415)
T ss_pred CccccccHHHHhcCHHhhc
Confidence 9999999999999999964
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=319.06 Aligned_cols=205 Identities=28% Similarity=0.374 Sum_probs=174.9
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC----C
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA----N 96 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~----~ 96 (738)
.-+..-+.||.||||.||+|.++.||+.||||.++... +....+++-+|+++|++|+|||||+++++=.... .
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES---SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc---ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence 34566788999999999999999999999999988654 4556789999999999999999999998532222 3
Q ss_pred CeEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeC-CCCc--EEEec
Q 004672 97 RNINFVTEMFTSGTLRQYRLKH---RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG-NQGE--VKIGD 170 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k~---~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~-~~g~--VKL~D 170 (738)
+...+|||||.||||+.++.+- ..+++.+++.++..+..||.|||.+| |+||||||.||++.. .+|+ -||+|
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeec
Confidence 4568999999999999998763 46999999999999999999999999 999999999999852 2243 59999
Q ss_pred cchhHHhhccc-cccccCCCCCCCccccc--cccCcccccccchhhhhhhhhcCCCCCCCCCH
Q 004672 171 LGLAAILRKSH-AARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPYSECTHP 230 (738)
Q Consensus 171 FGlA~~l~~~~-~~~~vGTp~YmAPEvl~--~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~ 230 (738)
||.|+.+.+.. ..+.+||+.|.+||++. +.|+..+|.|||||++|+++||..||--...+
T Consensus 168 fG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 168 FGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 99999887654 45667999999999998 56999999999999999999999999644433
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=281.68 Aligned_cols=252 Identities=20% Similarity=0.338 Sum_probs=213.5
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCC-CCCcceeeEEEEecCCC
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANR 97 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~ 97 (738)
.+++|.+++++|+|-++.||.|+...+.+.++||.++ +-..+.+.+|+.||..|. ||||+++++...+....
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK-------PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk 108 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK-------PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK 108 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeec-------hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence 4678999999999999999999999999999999877 345678999999999995 99999999998888888
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
...+|+||+...+...+. ..++...++.++.++++||.|||+.| |+|||+||.|++|+.....++|+|||+|.+.
T Consensus 109 tpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred CchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhc
Confidence 999999999888777653 45888899999999999999999999 9999999999999987778999999999998
Q ss_pred hcccccc-ccCCCCCCCccccc--cccCcccccccchhhhhhhhhcCCCC-CCCCCHHHHHHHHHc-C------------
Q 004672 178 RKSHAAR-CVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPY-SECTHPAQIYKKVIS-G------------ 240 (738)
Q Consensus 178 ~~~~~~~-~vGTp~YmAPEvl~--~~ys~~sDIWSLGviLyeLlTG~~Pf-~~~~~~~qi~k~i~~-g------------ 240 (738)
....... .+.+..|--||++. ..|+..-|+|||||++..|+..+-|| .+..|.+|+.+...- |
T Consensus 184 Hp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 184 HPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred CCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 7665433 35778899999986 46999999999999999999988886 566778887543210 0
Q ss_pred ------------CC---------CcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 241 ------------KK---------PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 241 ------------~~---------p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
.. +.......+|++.+|++++|. |-.+|+||.|++.||||..
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 00 011122347999999999999 9999999999999999953
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=292.82 Aligned_cols=261 Identities=23% Similarity=0.326 Sum_probs=208.3
Q ss_pred CCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEe------
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD------ 93 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~------ 93 (738)
.+.|..+.+||+|.||.||+|..+.+|+.||+|++-... .....-....+|+++|..|+|+|++.+++.+-.
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen--eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN--EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc--cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 467888999999999999999999999999999765432 112233467899999999999999988876522
Q ss_pred cCCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccc
Q 004672 94 TANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 172 (738)
Q Consensus 94 ~~~~~l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFG 172 (738)
.....+|+|+.+|+ -+|.-++... .+++...++.++++++.||.|+|.+. |+|||+|++|+||+.+ |.+||+|||
T Consensus 94 r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~d-gilklADFG 169 (376)
T KOG0669|consen 94 RDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKD-GILKLADFG 169 (376)
T ss_pred cccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCC-ceEEeeccc
Confidence 12346999999996 4888877655 57999999999999999999999999 9999999999999855 899999999
Q ss_pred hhHHhhcccc------ccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHH--HHHcCCC
Q 004672 173 LAAILRKSHA------ARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK--KVISGKK 242 (738)
Q Consensus 173 lA~~l~~~~~------~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k--~i~~g~~ 242 (738)
+++.+..+.. +..+-|.+|++||.+.+ .|+++.|||+.|||+.+|.|+.+-+.+.++..++.- .+.....
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 9977654322 23345999999998865 599999999999999999999999988665555421 1111111
Q ss_pred Cccc------------------------------ccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCCCc
Q 004672 243 PEAL------------------------------FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYD 286 (738)
Q Consensus 243 p~~l------------------------------~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~~~ 286 (738)
++.| +-+.+++..++++++|. ||.+|+.+.++|+|.||..+...
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 1111 11235689999999999 99999999999999999887654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=302.84 Aligned_cols=258 Identities=22% Similarity=0.302 Sum_probs=216.9
Q ss_pred ccCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCC------CCcceee
Q 004672 15 LKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH------RNIMKFY 88 (738)
Q Consensus 15 ~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~H------pNIVkl~ 88 (738)
+.++.=..|.+....|.|-|++|.+|.|...|..||||+|.. ++...+.-..|++||++|+. -++++|+
T Consensus 426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-----NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-----NEVMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec-----chHHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 344444679999999999999999999999999999999883 45666778899999999952 4788999
Q ss_pred EEEEecCCCeEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCc
Q 004672 89 TSWVDTANRNINFVTEMFTSGTLRQYRLKHRR---VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 165 (738)
Q Consensus 89 ~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~~---lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~ 165 (738)
..|. ..+++|||+|-+ ...|++.+++.++ |..++++.|+.|++.||..|-..| |+|.||||+||||+.....
T Consensus 501 r~F~--hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 501 RHFK--HKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHhh--hcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcce
Confidence 8874 478999999998 7899999998764 889999999999999999999998 9999999999999988788
Q ss_pred EEEeccchhHHhhccccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHH-HHHHcCCCC
Q 004672 166 VKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY-KKVISGKKP 243 (738)
Q Consensus 166 VKL~DFGlA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~-k~i~~g~~p 243 (738)
+||||||.|........+.+.-+..|.|||++.+ .|+...|+||+||+||||.||+..|++.+|..-+. -.-..|+.|
T Consensus 576 LKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred eeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 9999999999988888888888889999998876 59999999999999999999999999876655431 111234433
Q ss_pred cccc---------------------------------cC----------------C-------ChHHHHHHHHHHh-CcC
Q 004672 244 EALF---------------------------------KV----------------E-------DPEVRQFIEKCLA-TVS 266 (738)
Q Consensus 244 ~~l~---------------------------------~~----------------~-------spel~~lI~kcL~-dP~ 266 (738)
..+. .. + -..+++|+++||. ||.
T Consensus 656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~ 735 (752)
T KOG0670|consen 656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE 735 (752)
T ss_pred HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence 2100 00 0 1358899999999 999
Q ss_pred CCCCHHHHhcCcccCC
Q 004672 267 SRLSARELLTDPFLQI 282 (738)
Q Consensus 267 ~RpSa~ELL~Hpf~~~ 282 (738)
+|.|+.++|+||||+.
T Consensus 736 KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 736 KRITVNQALKHPFITE 751 (752)
T ss_pred hcCCHHHHhcCCcccC
Confidence 9999999999999974
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=286.01 Aligned_cols=264 Identities=19% Similarity=0.321 Sum_probs=223.5
Q ss_pred ccCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEe
Q 004672 15 LKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVD 93 (738)
Q Consensus 15 ~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~ 93 (738)
...+..++|.++..||+|+|++|.++..+.|.+.||+|+++..- ....+..+-...|..+..+- +||.+|-++.+|..
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel-~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKEL-VNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHh-cCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 34566789999999999999999999999999999999988654 34456677788899999888 89999999988754
Q ss_pred cCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccch
Q 004672 94 TANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 173 (738)
Q Consensus 94 ~~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGl 173 (738)
...+++|.||++||+|--.++++++++++.++.+...|+.||.|||+.| ||+||||.+|+|++.. |++||+|+|+
T Consensus 323 --esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldae-ghikltdygm 397 (593)
T KOG0695|consen 323 --ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAE-GHIKLTDYGM 397 (593)
T ss_pred --cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccC-Cceeecccch
Confidence 5689999999999999888899999999999999999999999999999 9999999999999966 8999999999
Q ss_pred hHHhh--ccccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCC-------CCCCHHHHHHHHHcCCCC
Q 004672 174 AAILR--KSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYS-------ECTHPAQIYKKVISGKKP 243 (738)
Q Consensus 174 A~~l~--~~~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~-------~~~~~~qi~k~i~~g~~p 243 (738)
++.-- .....+.+|||.|+|||++.+ .|...+|.|+||++++||+.|+.||. +.++.+.++..|....
T Consensus 398 cke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq-- 475 (593)
T KOG0695|consen 398 CKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ-- 475 (593)
T ss_pred hhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc--
Confidence 97532 334567789999999999986 59999999999999999999999994 2334455666665433
Q ss_pred cccccCCChHHHHHHHHHHh-CcCCCC------CHHHHhcCcccCCCCCc
Q 004672 244 EALFKVEDPEVRQFIEKCLA-TVSSRL------SARELLTDPFLQIDDYD 286 (738)
Q Consensus 244 ~~l~~~~spel~~lI~kcL~-dP~~Rp------Sa~ELL~Hpf~~~~~~~ 286 (738)
..++...+-.+..+++..|+ ||.+|+ ...++..|+||+.-++.
T Consensus 476 iriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd 525 (593)
T KOG0695|consen 476 IRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWD 525 (593)
T ss_pred ccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHH
Confidence 23445556677889999999 899986 47899999999977664
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-31 Score=301.44 Aligned_cols=263 Identities=19% Similarity=0.237 Sum_probs=190.5
Q ss_pred CcCCCCceEEEEEcccCCeEEEEEEEc----------------CCCeEEEEEEEeccccCCCH----------HHHHHHH
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDE----------------YEGIEVAWNQVKLYDFLQSP----------EELERLY 70 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~----------------~tG~~VAIK~vki~~~~~s~----------e~~e~l~ 70 (738)
.+..++|.+.++||+|+||+||+|.+. ..++.||||+++........ ...+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 356789999999999999999999752 34568999998753211000 0112344
Q ss_pred HHHHHHHhCCCCCc-----ceeeEEEEec------CCCeEEEEEecCCCCCHHHHHHhc---------------------
Q 004672 71 CEIHLLKTLKHRNI-----MKFYTSWVDT------ANRNINFVTEMFTSGTLRQYRLKH--------------------- 118 (738)
Q Consensus 71 ~Ei~iLk~L~HpNI-----Vkl~~~fv~~------~~~~l~LV~Ey~~gGSL~~~l~k~--------------------- 118 (738)
.|+.++.+++|.++ ++++++|... .....++||||+++|+|.+++...
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 57788888877654 6677766432 235689999999999999987642
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcccc-c--cccCCCCCC
Q 004672 119 ---RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-A--RCVGTPEFM 192 (738)
Q Consensus 119 ---~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~~-~--~~vGTp~Ym 192 (738)
..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..+..... . ...+|+.|+
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~ 377 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVD-GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS 377 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCC-CcEEEEeCcCccccccCCccCccccCCCccee
Confidence 12456778999999999999999998 9999999999999855 7999999999976543221 1 123589999
Q ss_pred Cccccccc---------------------cC--cccccccchhhhhhhhhcCC-CCCCCC----------CHHHHHHHHH
Q 004672 193 APEVYEEE---------------------YN--ELVDIYSFGMCILEMVTFDY-PYSECT----------HPAQIYKKVI 238 (738)
Q Consensus 193 APEvl~~~---------------------ys--~~sDIWSLGviLyeLlTG~~-Pf~~~~----------~~~qi~k~i~ 238 (738)
|||++... |+ .+.||||+||++|+|++|.. ||.... +....++.+.
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~ 457 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK 457 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence 99987421 12 24799999999999999986 775321 1111122222
Q ss_pred cCCCCcccccCCChHHHHHHHHHHh-Cc---CCCCCHHHHhcCcccCC
Q 004672 239 SGKKPEALFKVEDPEVRQFIEKCLA-TV---SSRLSARELLTDPFLQI 282 (738)
Q Consensus 239 ~g~~p~~l~~~~spel~~lI~kcL~-dP---~~RpSa~ELL~Hpf~~~ 282 (738)
.+...-......++..++|+.++|. +| .+|+|+.|+|+||||..
T Consensus 458 ~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 458 GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 2232223345568899999999998 54 68999999999999953
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-33 Score=308.69 Aligned_cols=257 Identities=28% Similarity=0.449 Sum_probs=224.6
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCC
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 97 (738)
=+.++|..+.++|.|.||.||+|+|+.+|+..|+|.|++.. .+...-+.+||-+++..+|||||.+++.+.. ..
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep----~dd~~~iqqei~~~~dc~h~nivay~gsylr--~d 85 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP----GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR--RD 85 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccC----CccccccccceeeeecCCCcChHHHHhhhhh--hc
Confidence 56789999999999999999999999999999999999764 2445668889999999999999999999865 56
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh
Q 004672 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l 177 (738)
.+|++||||.||+|.+.-.-.+++++.++...++..+.||+|||+.+ -+|||||-.||+++ +.|.||++|||.+..+
T Consensus 86 klwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanillt-d~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 86 KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLT-DEGDVKLADFGVSAQI 162 (829)
T ss_pred CcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeec-ccCceeecccCchhhh
Confidence 89999999999999998777789999999999999999999999998 99999999999998 4589999999999887
Q ss_pred hcc--ccccccCCCCCCCccccc----cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccc--cC
Q 004672 178 RKS--HAARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF--KV 249 (738)
Q Consensus 178 ~~~--~~~~~vGTp~YmAPEvl~----~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~--~~ 249 (738)
... +.+.++|||.|||||+.. +.|+.++|||++|++..|+--.++|.........++-.-.++..|..+. ..
T Consensus 163 tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~k 242 (829)
T KOG0576|consen 163 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTK 242 (829)
T ss_pred hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCcc
Confidence 654 346678999999999863 6799999999999999999988998776555555555556677776553 23
Q ss_pred CChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 250 EDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 250 ~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
.++.+-+|++.+|. +|++||+++-+|.|||....
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 56789999999999 89999999999999998754
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=267.27 Aligned_cols=219 Identities=24% Similarity=0.402 Sum_probs=188.3
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecCC
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~ 96 (738)
++-+++.-+..||.|++|.|-+.++..+|...|+|.++..- +.+..+++.+|+.+..+. .+|.+|.||+.+.+ .
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv---n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r--e 117 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV---NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR--E 117 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc---ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc--c
Confidence 44455666788999999999999999999999999988542 346678889999876665 89999999998766 4
Q ss_pred CeEEEEEecCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccc
Q 004672 97 RNINFVTEMFTSGTLRQYR----LKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 172 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l----~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFG 172 (738)
..+|+.||.| ..||..+. ++.+.++|..+-+++..++.||.|||++= .+||||+||.|||++.+ |+||+||||
T Consensus 118 gdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn~~-GqVKiCDFG 194 (282)
T KOG0984|consen 118 GDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILINYD-GQVKICDFG 194 (282)
T ss_pred ccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEccC-CcEEEcccc
Confidence 6799999999 67887773 44577999999999999999999999982 59999999999999965 899999999
Q ss_pred hhHHhhcccccc-ccCCCCCCCcccccc-----ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCc
Q 004672 173 LAAILRKSHAAR-CVGTPEFMAPEVYEE-----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE 244 (738)
Q Consensus 173 lA~~l~~~~~~~-~vGTp~YmAPEvl~~-----~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~ 244 (738)
.+..+.++...+ ..|-..|||||.+.. .|+.++||||||++++||.++++||....++.+..+.+.....|.
T Consensus 195 IsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~ 272 (282)
T KOG0984|consen 195 ISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQ 272 (282)
T ss_pred cceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCC
Confidence 999888877666 468999999998862 599999999999999999999999998888888888888766554
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=294.71 Aligned_cols=255 Identities=23% Similarity=0.314 Sum_probs=206.6
Q ss_pred cccccCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEE
Q 004672 12 PSLLKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSW 91 (738)
Q Consensus 12 ~~l~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~f 91 (738)
...+.+++.+.+.++++||+|-||.|-++.-. .+..||+|.++-. ........|.+||++|.+|+||||+.++++|
T Consensus 529 ~~al~EfPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~---a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC 604 (807)
T KOG1094|consen 529 GPALVEFPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPD---ATKNARNDFLKEIKILSRLKHPNIVELLGVC 604 (807)
T ss_pred CcchhhcchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcc---cchhHHHHHHHHHHHHhccCCCCeeEEEeee
Confidence 34577888899999999999999999999753 3699999987743 3445568899999999999999999999988
Q ss_pred EecCCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEe
Q 004672 92 VDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIG 169 (738)
Q Consensus 92 v~~~~~~l~LV~Ey~~gGSL~~~l~k~~--~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~ 169 (738)
+. ++.+++|||||+.|+|.+|+.++. .+.-+....++.||+.|++||.+.+ +|||||.+.|+|++++ +++||+
T Consensus 605 ~~--DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e-~~iKia 679 (807)
T KOG1094|consen 605 VQ--DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGE-FTIKIA 679 (807)
T ss_pred ec--CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCc-ccEEec
Confidence 65 788999999999999999999983 3355566779999999999999999 9999999999999977 799999
Q ss_pred ccchhHHhhccccccc----cCCCCCCCccc-cccccCcccccccchhhhhhhhh--cCCCCCCCCCHHHHHHHHH---c
Q 004672 170 DLGLAAILRKSHAARC----VGTPEFMAPEV-YEEEYNELVDIYSFGMCILEMVT--FDYPYSECTHPAQIYKKVI---S 239 (738)
Q Consensus 170 DFGlA~~l~~~~~~~~----vGTp~YmAPEv-l~~~ys~~sDIWSLGviLyeLlT--G~~Pf~~~~~~~qi~k~i~---~ 239 (738)
|||+++.+-....... +-...|||||. +.++++.++|+|+||+++||+++ .+.||+..++ +++.+..- .
T Consensus 680 dfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-e~vven~~~~~~ 758 (807)
T KOG1094|consen 680 DFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-EQVVENAGEFFR 758 (807)
T ss_pred CcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-HHHHHhhhhhcC
Confidence 9999986644333322 34579999995 46899999999999999999775 6789987544 44443322 1
Q ss_pred CCCCc---ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 240 GKKPE---ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 240 g~~p~---~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
+..+. ..+...+..+.+++..|+. +-.+|||.++|-.
T Consensus 759 ~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 759 DQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred CCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 21111 2234556788999999999 8999999999843
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=302.91 Aligned_cols=255 Identities=21% Similarity=0.337 Sum_probs=216.9
Q ss_pred ccccCcCCCCceEEEEEcccCCeEEEEEEEcCCC---eEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeE
Q 004672 13 SLLKLIPLEDMEDTMKFLVKELQRHYRAFDEYEG---IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYT 89 (738)
Q Consensus 13 ~l~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG---~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~ 89 (738)
+.-++|......+.+.||.|.||.||+|..+..| ..||||.+|.. -.+.++..|..|+.||-+++||||+++.+
T Consensus 621 eFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G---ytekqrrdFL~EAsIMGQFdHPNIIrLEG 697 (996)
T KOG0196|consen 621 EFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG---YTEKQRRDFLSEASIMGQFDHPNIIRLEG 697 (996)
T ss_pred HhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC---ccHHHHhhhhhhhhhcccCCCCcEEEEEE
Confidence 3456788888999999999999999999998777 47999998854 35677889999999999999999999999
Q ss_pred EEEecCCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEE
Q 004672 90 SWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 168 (738)
Q Consensus 90 ~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL 168 (738)
+ .+..+.+.||+|||+.|+|+.++.++ +.|+.-++.-+++.|+.|+.||-..+ +|||||-..||||+.| -..|+
T Consensus 698 V--VTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsn-LvCKV 772 (996)
T KOG0196|consen 698 V--VTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSN-LVCKV 772 (996)
T ss_pred E--EecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccc-eEEEe
Confidence 5 35578999999999999999998876 56999999999999999999999999 9999999999999977 58899
Q ss_pred eccchhHHhhccccc--cccC---CCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCC
Q 004672 169 GDLGLAAILRKSHAA--RCVG---TPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGK 241 (738)
Q Consensus 169 ~DFGlA~~l~~~~~~--~~vG---Tp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~ 241 (738)
+||||++.+.+.... +..| ...|.|||.+. .+++.++||||||++|||.++ |+.||.+.+|. ++++.|..|.
T Consensus 773 sDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ-dVIkaIe~gy 851 (996)
T KOG0196|consen 773 SDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVIKAIEQGY 851 (996)
T ss_pred ccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH-HHHHHHHhcc
Confidence 999999988654422 2222 35899999876 679999999999999999775 99999987664 5567888876
Q ss_pred CCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 242 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 242 ~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
..+.. -..+..+-+|+..||+ +-..||...+|+.+
T Consensus 852 RLPpP-mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 852 RLPPP-MDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred CCCCC-CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 54322 3457789999999999 89999999999853
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=296.01 Aligned_cols=244 Identities=24% Similarity=0.403 Sum_probs=202.7
Q ss_pred CceEEEEEcccCCeEEEEEEEcC----CCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCC
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEY----EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~----tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 97 (738)
.....+.||.|-||.||+|.-.. ....||||.-+.. ..++..+.|..|..+|+.++|||||++++++.+ .
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d---~t~d~tekflqEa~iMrnfdHphIikLIGv~~e---~ 463 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD---CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE---Q 463 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC---CChhhHHHHHHHHHHHHhCCCcchhheeeeeec---c
Confidence 34455789999999999998543 2346888876642 356668899999999999999999999998765 5
Q ss_pred eEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 98 NINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~~-~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
..|||||+++.|.|+.|++.++ .++...+..++.||..||+|||+.+ +|||||-..||||.+. ..|||+|||+++.
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp-~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSP-QCVKLADFGLSRY 540 (974)
T ss_pred ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCc-ceeeecccchhhh
Confidence 7899999999999999998875 5999999999999999999999999 9999999999999876 4899999999998
Q ss_pred hhcccccc-cc--CCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCC
Q 004672 177 LRKSHAAR-CV--GTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVED 251 (738)
Q Consensus 177 l~~~~~~~-~v--GTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~s 251 (738)
+....... .. -..-|||||-++ .+++.++|||-||+|+||++. |..||.+-.|.+.| -.+..|..++ .+...+
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-~~iEnGeRlP-~P~nCP 618 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-GHIENGERLP-CPPNCP 618 (974)
T ss_pred ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-EEecCCCCCC-CCCCCC
Confidence 87643221 12 346899999887 679999999999999999886 88899886655443 4556666554 345678
Q ss_pred hHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 252 PEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 252 pel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
|.+..++.+||. +|.+||...+|..
T Consensus 619 p~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 619 PALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred hHHHHHHHHHhccCcccCCcHHHHHH
Confidence 999999999999 9999999988753
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-32 Score=280.79 Aligned_cols=252 Identities=28% Similarity=0.385 Sum_probs=210.2
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC----C
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA----N 96 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~----~ 96 (738)
..|.-+..+|.|+- .|..|+|..++..||+|++... ..+.....+.++|..++..++|+||++++.+|.-.. -
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p--f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP--FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCc--cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 56888899999999 8999999999999999987755 344566789999999999999999999999874321 2
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
..+|+||||| ..+|.+.+. -.++-+.++.++.|++.|+.|||+.+ |+||||||+||++..+ ..+||.|||+|..
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~-~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSD-CTLKILDFGLART 167 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecch-hheeeccchhhcc
Confidence 3689999999 679988876 56888999999999999999999999 9999999999999855 7999999999987
Q ss_pred hhcc-ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc-CC------------
Q 004672 177 LRKS-HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GK------------ 241 (738)
Q Consensus 177 l~~~-~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~-g~------------ 241 (738)
.... ..+.++.|..|.|||++-+ .|.+.+||||+||++.||++|...|.+....+|..+.+.. |.
T Consensus 168 e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 168 EDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred cCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 7666 4566789999999998864 4999999999999999999999999886666666544422 11
Q ss_pred -------------------CCcccc-------cCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccC
Q 004672 242 -------------------KPEALF-------KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 281 (738)
Q Consensus 242 -------------------~p~~l~-------~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~ 281 (738)
.|...+ +.....+++++.+||. +|.+|.|+.++|+|||++
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 111111 1223468999999999 999999999999999997
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=289.31 Aligned_cols=282 Identities=23% Similarity=0.329 Sum_probs=225.9
Q ss_pred CcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCC
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 96 (738)
++...++...++||-|-||.||.|..+.-.-.||||.++- ..-..+.|..|+.+|+.++|||+|+++++| +..
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-----DtMeveEFLkEAAvMKeikHpNLVqLLGVC--T~E 335 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVC--THE 335 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-----cchhHHHHHHHHHHHHhhcCccHHHHhhhh--ccC
Confidence 4455677788999999999999999999999999998772 234568899999999999999999999976 556
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 97 RNINFVTEMFTSGTLRQYRLKHRR--VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k~~~--lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
..+|||+|||..|.|.+|+....+ ++.-.++.++.||..|++||..++ +|||||-..|.||..+ ..||++||||+
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEn-hiVKvADFGLs 412 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HIVKVADFGLS 412 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhcccccc-ceEEeeccchh
Confidence 789999999999999999988654 777888999999999999999999 9999999999999765 58999999999
Q ss_pred HHhhccccccccC---CCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccC
Q 004672 175 AILRKSHAARCVG---TPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKV 249 (738)
Q Consensus 175 ~~l~~~~~~~~vG---Tp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~ 249 (738)
+.+.....+...| ...|.|||-+. ..++.++|||+||++|||+.| |-.||.+ .+..++|..+..|..-.. +..
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-idlSqVY~LLEkgyRM~~-PeG 490 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYGLLEKGYRMDG-PEG 490 (1157)
T ss_pred hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHHhccccccC-CCC
Confidence 9987765444334 46899999775 679999999999999999998 7779997 578888888777765432 356
Q ss_pred CChHHHHHHHHHHh-CcCCCCCHHHHhc---CcccCCCCCchhhhhhhccCcccccchhhhhhhh
Q 004672 250 EDPEVRQFIEKCLA-TVSSRLSARELLT---DPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLY 310 (738)
Q Consensus 250 ~spel~~lI~kcL~-dP~~RpSa~ELL~---Hpf~~~~~~~~~~~~~~~~~~~~~i~p~l~~~~~ 310 (738)
.+|.+..|+..||+ .|++||+.+|+-+ .-|-...-.+...+.+..+.....+.|+++.++.
T Consensus 491 CPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSisdEV~keLgk~~~~~sv~~l~~lp~l 555 (1157)
T KOG4278|consen 491 CPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSISDEVQKELGKNNDKKSVVPLPRLPIL 555 (1157)
T ss_pred CCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccccHHHHHHHhhcccccccccccccccC
Confidence 68899999999999 9999999998732 1221111112223334444455555566655444
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=301.98 Aligned_cols=237 Identities=27% Similarity=0.375 Sum_probs=189.0
Q ss_pred EEEcccCCeE-EEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecCCCeEEEEEe
Q 004672 27 MKFLVKELQR-HYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTE 104 (738)
Q Consensus 27 ~kLG~Gafgt-VYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~LV~E 104 (738)
+.+|.|+-|+ ||+|+ +.|++||||++- .+......+||..|+.- +|||||++|+ .+.+...+||+.|
T Consensus 515 eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll-------~e~~~~A~rEi~lL~eSD~H~NviRyyc--~E~d~qF~YIalE 583 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGV--YEGREVAVKRLL-------EEFFDFAQREIQLLQESDEHPNVIRYYC--SEQDRQFLYIALE 583 (903)
T ss_pred HHcccCCCCcEEEEEe--eCCceehHHHHh-------hHhHHHHHHHHHHHHhccCCCceEEEEe--eccCCceEEEEeh
Confidence 4578999987 79995 689999999765 34556789999999999 7999999987 5666889999999
Q ss_pred cCCCCCHHHHHHhc-CCCCH---HHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCC----CCcEEEeccchhHH
Q 004672 105 MFTSGTLRQYRLKH-RRVNI---RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN----QGEVKIGDLGLAAI 176 (738)
Q Consensus 105 y~~gGSL~~~l~k~-~~lse---~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~----~g~VKL~DFGlA~~ 176 (738)
+| .-+|.+++... ..+.. -..+..+.|++.||++||+.+ ||||||||.||||... ..+++|+|||+++.
T Consensus 584 LC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 584 LC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred Hh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 99 57999998874 21111 345778999999999999998 9999999999999852 24689999999998
Q ss_pred hhccc-----cccccCCCCCCCccccccc-cCcccccccchhhhhhhhhc-CCCCCCCCCHHHHHHHHHcCCCCc-cccc
Q 004672 177 LRKSH-----AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPE-ALFK 248 (738)
Q Consensus 177 l~~~~-----~~~~vGTp~YmAPEvl~~~-ys~~sDIWSLGviLyeLlTG-~~Pf~~~~~~~qi~k~i~~g~~p~-~l~~ 248 (738)
+.... .....||-+|+|||++.+. -+.++|||||||++|+.++| ..||... -+....|..|.... .+..
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~---~~R~~NIl~~~~~L~~L~~ 737 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS---LERQANILTGNYTLVHLEP 737 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch---HHhhhhhhcCccceeeecc
Confidence 76432 2344599999999999754 56689999999999999987 8899752 22223455565432 2222
Q ss_pred CCChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 249 VEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 249 ~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
..+.++++||.+||. +|..||+|.++|.||||
T Consensus 738 ~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlF 770 (903)
T KOG1027|consen 738 LPDCEAKDLISRMLNPDPQLRPSATDVLNHPLF 770 (903)
T ss_pred CchHHHHHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence 223389999999999 99999999999999999
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=294.74 Aligned_cols=258 Identities=22% Similarity=0.312 Sum_probs=215.7
Q ss_pred ccccCcCCCCceEEEEEcccCCeEEEEEEEcCC---CeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeE
Q 004672 13 SLLKLIPLEDMEDTMKFLVKELQRHYRAFDEYE---GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYT 89 (738)
Q Consensus 13 ~l~~~I~~~~y~il~kLG~GafgtVYkA~d~~t---G~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~ 89 (738)
.+.-.|+.+++.+.++||+|+||.|++|..+.- -..||||.++..... ..+..|.+|+.+|.+|+|||++++|+
T Consensus 102 ~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~---~~mddflrEas~M~~L~H~hliRLyG 178 (1039)
T KOG0199|consen 102 DLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN---AIMDDFLREASHMLKLQHPHLIRLYG 178 (1039)
T ss_pred CcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc---hhHHHHHHHHHHHHhccCcceeEEee
Confidence 345667888899999999999999999987643 357999998854432 26789999999999999999999999
Q ss_pred EEEecCCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEE
Q 004672 90 SWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVK 167 (738)
Q Consensus 90 ~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VK 167 (738)
+..+ ..+.||||+++.|+|.+.+.+. ..|....+..|+.||+.|+.||.+++ +|||||-..|||+-.. ..||
T Consensus 179 vVl~---qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasp-rtVK 252 (1039)
T KOG0199|consen 179 VVLD---QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASP-RTVK 252 (1039)
T ss_pred eecc---chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheeccc-ceee
Confidence 8654 5788999999999999998873 35888899999999999999999999 9999999999999754 5899
Q ss_pred EeccchhHHhhcccccccc-----CCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcC
Q 004672 168 IGDLGLAAILRKSHAARCV-----GTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISG 240 (738)
Q Consensus 168 L~DFGlA~~l~~~~~~~~v-----GTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g 240 (738)
|+||||.+-+......... -...|+|||.++ .+++.++|||+|||++|||+| |+.||.++ +..+|.+.|..|
T Consensus 253 I~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~-~g~qIL~~iD~~ 331 (1039)
T KOG0199|consen 253 ICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC-RGIQILKNIDAG 331 (1039)
T ss_pred eecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC-CHHHHHHhcccc
Confidence 9999999887654322221 345899999887 679999999999999999998 78999985 567888888766
Q ss_pred CCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccC
Q 004672 241 KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 281 (738)
Q Consensus 241 ~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~ 281 (738)
..... ++..+..+.++++.||. +|.+|||+..|..+-+++
T Consensus 332 erLpR-Pk~csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 332 ERLPR-PKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred ccCCC-CCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 54332 34567889999999999 899999999998666654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=317.42 Aligned_cols=239 Identities=21% Similarity=0.314 Sum_probs=180.6
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
.+.....||+|+||+||+|.+..+|..||+|+++.... ....|+++|++++|||||++++++.. ....++
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~l~~l~HpnIv~~~~~~~~--~~~~~l 760 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--------IPSSEIADMGKLQHPNIVKLIGLCRS--EKGAYL 760 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--------ccHHHHHHHhhCCCCCcceEEEEEEc--CCCCEE
Confidence 45667899999999999999999999999998763321 12346889999999999999998865 567899
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 102 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~-gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
||||+++|+|.+++. .+++..+..++.||+.||+|||.. .++|+||||||+||+++.+ +..++. ||.......
T Consensus 761 v~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~-~~~~~~-~~~~~~~~~- 834 (968)
T PLN00113 761 IHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK-DEPHLR-LSLPGLLCT- 834 (968)
T ss_pred EEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC-CceEEE-ecccccccc-
Confidence 999999999999985 388999999999999999999954 2349999999999999855 566654 555433221
Q ss_pred ccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCC----CHHHHHHHHHcCC------CCcc----
Q 004672 181 HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT----HPAQIYKKVISGK------KPEA---- 245 (738)
Q Consensus 181 ~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~----~~~qi~k~i~~g~------~p~~---- 245 (738)
.....||+.|||||++.+ .|+.++|||||||++|||+||+.||.... ......+...... .|..
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence 123368999999998874 59999999999999999999999985321 1111111111110 0100
Q ss_pred -cccCCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 246 -LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 246 -l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
.......++.+++.+||+ +|.+|||+.|+++.
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 000112356788999999 99999999999854
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=295.19 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=210.7
Q ss_pred ccCcCCCCceEEEEEcccCCeEEEEEEEcC-------CCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcce
Q 004672 15 LKLIPLEDMEDTMKFLVKELQRHYRAFDEY-------EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMK 86 (738)
Q Consensus 15 ~~~I~~~~y~il~kLG~GafgtVYkA~d~~-------tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVk 86 (738)
.-+++.+++.+.+.||+|+||.|++|.-.. ....||||.++... ...+.+.+..|+.+|+.+ +|+||+.
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~---~~~~~~~~~~El~~m~~~g~H~niv~ 366 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA---SSSEKKDLMSELNVLKELGKHPNIVN 366 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc---CcHHHHHHHHHHHHHHHhcCCcchhh
Confidence 344555666778899999999999997541 25689999877432 336778999999999999 7999999
Q ss_pred eeEEEEecCCCeEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceec
Q 004672 87 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 150 (738)
Q Consensus 87 l~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~----------------~lse~~i~~i~~QIl~aL~yLHs~gp~IIHR 150 (738)
+++.+.. ...+++|+||+..|+|.+|+...+ .++...+..++.||+.|++||++.. +|||
T Consensus 367 llG~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHR 442 (609)
T KOG0200|consen 367 LLGACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHR 442 (609)
T ss_pred heeeecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccch
Confidence 9998755 788999999999999999988766 3889999999999999999999998 9999
Q ss_pred cCCcccEEEeCCCCcEEEeccchhHHhhcccccc---ccCC--CCCCCcccccc-ccCcccccccchhhhhhhhh-cCCC
Q 004672 151 DLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR---CVGT--PEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYP 223 (738)
Q Consensus 151 DLKP~NILl~~~~g~VKL~DFGlA~~l~~~~~~~---~vGT--p~YmAPEvl~~-~ys~~sDIWSLGviLyeLlT-G~~P 223 (738)
||-..|||+..+ ..+||+|||+|+......... ..|+ ..|||||.+.. .|+.++||||||++||||+| |..|
T Consensus 443 DLAaRNVLi~~~-~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~P 521 (609)
T KOG0200|consen 443 DLAARNVLITKN-KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTP 521 (609)
T ss_pred hhhhhhEEecCC-CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCC
Confidence 999999999865 689999999998654332222 2232 35999998875 69999999999999999998 7899
Q ss_pred CCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 224 YSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 224 f~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
|.+......+++.+..|...... ...++++.+++..||+ +|.+||+..++..
T Consensus 522 Yp~~~~~~~l~~~l~~G~r~~~P-~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 522 YPGIPPTEELLEFLKEGNRMEQP-EHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CCCCCcHHHHHHHHhcCCCCCCC-CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 99866677788888889876543 4458999999999999 9999999999863
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=274.32 Aligned_cols=132 Identities=25% Similarity=0.363 Sum_probs=116.4
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCC-----C---CCcceeeEEEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-----H---RNIMKFYTSWV 92 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~-----H---pNIVkl~~~fv 92 (738)
..|-+.++||.|-|+|||+|.|+.+.+.||+|+++- .....+....||++|+++. | ..||++++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-----AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-----AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-----hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 679999999999999999999999999999999882 3355678899999999992 3 46999999985
Q ss_pred e--cCCCeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEE
Q 004672 93 D--TANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 159 (738)
Q Consensus 93 ~--~~~~~l~LV~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl 159 (738)
- .++.+++||+|++ |..|..+|++. +.++...++.|++|||.||.|||..- +|||.||||+|||+
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLL 221 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeee
Confidence 4 3566999999999 88999998875 56999999999999999999999973 69999999999998
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-30 Score=276.58 Aligned_cols=247 Identities=26% Similarity=0.391 Sum_probs=193.0
Q ss_pred ccCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC--CCCCcceeeEEEE
Q 004672 15 LKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL--KHRNIMKFYTSWV 92 (738)
Q Consensus 15 ~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L--~HpNIVkl~~~fv 92 (738)
.+......+.+++.||+|.||.||+| ..+++.||||++. .+..+.+..|-.|.+.. +|+||++|++.
T Consensus 204 spl~~l~pl~l~eli~~Grfg~V~Ka--qL~~~~VAVKifp-------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~-- 272 (534)
T KOG3653|consen 204 SPLLELDPLQLLELIGRGRFGCVWKA--QLDNRLVAVKIFP-------EQEKQSFQNEKNIYSLPGMKHENILQFIGA-- 272 (534)
T ss_pred cccccCCchhhHHHhhcCccceeehh--hccCceeEEEecC-------HHHHHHHHhHHHHHhccCccchhHHHhhch--
Confidence 34444667888999999999999999 4677999999876 35567888888887765 89999999884
Q ss_pred ecCC----CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCceeccCCcccEEEeC
Q 004672 93 DTAN----RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR-------DPPVIHRDLKCDNIFVNG 161 (738)
Q Consensus 93 ~~~~----~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~-------gp~IIHRDLKP~NILl~~ 161 (738)
+... ..++||++|.+.|+|-+|++.+ .+++....+++..|+.||+|||+- .|+|+|||||..||||.
T Consensus 273 ekr~t~~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK- 350 (534)
T KOG3653|consen 273 EKRGTADRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK- 350 (534)
T ss_pred hccCCccccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc-
Confidence 3323 3799999999999999998775 589999999999999999999973 37899999999999997
Q ss_pred CCCcEEEeccchhHHhhccc----cccccCCCCCCCccccccccCc-------ccccccchhhhhhhhhcC---------
Q 004672 162 NQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEEEYNE-------LVDIYSFGMCILEMVTFD--------- 221 (738)
Q Consensus 162 ~~g~VKL~DFGlA~~l~~~~----~~~~vGTp~YmAPEvl~~~ys~-------~sDIWSLGviLyeLlTG~--------- 221 (738)
++++..|+|||||..+.... ....+||..|||||++.+..+. +.||||+|.+||||++..
T Consensus 351 ~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp 430 (534)
T KOG3653|consen 351 NDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVP 430 (534)
T ss_pred cCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCC
Confidence 55899999999998775432 3345799999999999875433 489999999999999842
Q ss_pred ---CCCC----CCCCHHHHHHHHHcCCC----CcccccC-CChHHHHHHHHHHh-CcCCCCCHHHH
Q 004672 222 ---YPYS----ECTHPAQIYKKVISGKK----PEALFKV-EDPEVRQFIEKCLA-TVSSRLSAREL 274 (738)
Q Consensus 222 ---~Pf~----~~~~~~qi~k~i~~g~~----p~~l~~~-~spel~~lI~kcL~-dP~~RpSa~EL 274 (738)
.||. .....+++...+++.+. |..+... .-.-+++.++.||. |+..|+||.=+
T Consensus 431 ~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 431 EYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred cccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 2332 12344555555554432 2333222 23468899999999 99999998744
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=272.41 Aligned_cols=244 Identities=28% Similarity=0.434 Sum_probs=186.8
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC--CCCCcceeeEEEEecCC--
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL--KHRNIMKFYTSWVDTAN-- 96 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L--~HpNIVkl~~~fv~~~~-- 96 (738)
.+..+.+.||+|.||.||+| .+.|+.||||++.-.+ -..+.+|.+|.... +|+||+.|++.=....+
T Consensus 211 rqI~L~e~IGkGRyGEVwrG--~wrGe~VAVKiF~srd-------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRG--RWRGEDVAVKIFSSRD-------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred heeEEEEEecCccccceeec--cccCCceEEEEecccc-------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 46789999999999999999 6899999999876322 24688888888775 99999999874221111
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------CCCCceeccCCcccEEEeCCCCcEEEec
Q 004672 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS------RDPPVIHRDLKCDNIFVNGNQGEVKIGD 170 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs------~gp~IIHRDLKP~NILl~~~~g~VKL~D 170 (738)
..+|||++|.+.|||++|+.+ ..++.....+++..++.||+|||. ..|.|.|||||..||||..+ |..-|+|
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn-~~C~IAD 359 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIAD 359 (513)
T ss_pred EEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC-CcEEEee
Confidence 269999999999999999988 679999999999999999999995 23789999999999999855 8999999
Q ss_pred cchhHHhhcc------ccccccCCCCCCCccccccccC-------cccccccchhhhhhhhhc----------CCCCCCC
Q 004672 171 LGLAAILRKS------HAARCVGTPEFMAPEVYEEEYN-------ELVDIYSFGMCILEMVTF----------DYPYSEC 227 (738)
Q Consensus 171 FGlA~~l~~~------~~~~~vGTp~YmAPEvl~~~ys-------~~sDIWSLGviLyeLlTG----------~~Pf~~~ 227 (738)
+|||-..... .....+||..|||||++.+..+ ..+||||||.++||++.. ++||.+.
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 9999665433 2245579999999999976432 358999999999998862 5788643
Q ss_pred ----CCHHHHHHHHHcCC-CCccccc-CCCh---HHHHHHHHHHh-CcCCCCCHHHHh
Q 004672 228 ----THPAQIYKKVISGK-KPEALFK-VEDP---EVRQFIEKCLA-TVSSRLSARELL 275 (738)
Q Consensus 228 ----~~~~qi~k~i~~g~-~p~~l~~-~~sp---el~~lI~kcL~-dP~~RpSa~ELL 275 (738)
...+++.+.+-..+ .|..... ..++ .+..+++.||. +|.-|.||--+.
T Consensus 440 Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 440 VPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred CCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 33444443332221 2211111 1233 35677899999 999999987654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=273.42 Aligned_cols=249 Identities=24% Similarity=0.390 Sum_probs=200.9
Q ss_pred CCceEEEEEcccCCeEEEEEEEcC---CCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecCC
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEY---EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~---tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~ 96 (738)
..|..+++||+|.|++||+|++.. +...||+|.+.... ...++..|+++|..+ .+.||+++.+.+ ..+
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts------~p~ri~~El~~L~~~gG~~ni~~~~~~~--rnn 107 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS------SPSRILNELEMLYRLGGSDNIIKLNGCF--RNN 107 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc------CchHHHHHHHHHHHhccchhhhcchhhh--ccC
Confidence 568999999999999999999987 78999999887543 235799999999999 689999999976 457
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
+...+|+||++..+..++... ++...++.+++.++.||.++|.+| ||||||||.|+|.+...+.-.|.|||+|..
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred CeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHHH
Confidence 899999999999999888644 678999999999999999999999 999999999999998888999999999972
Q ss_pred hhc--------c--------------------------------------ccccccCCCCCCCccccc--cccCcccccc
Q 004672 177 LRK--------S--------------------------------------HAARCVGTPEFMAPEVYE--EEYNELVDIY 208 (738)
Q Consensus 177 l~~--------~--------------------------------------~~~~~vGTp~YmAPEvl~--~~ys~~sDIW 208 (738)
... . ......|||+|.|||++. +..++++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 210 0 001225999999999986 4578899999
Q ss_pred cchhhhhhhhhcCCCCCCCCCHHHHHHHH--------------HcCC---------------------------------
Q 004672 209 SFGMCILEMVTFDYPYSECTHPAQIYKKV--------------ISGK--------------------------------- 241 (738)
Q Consensus 209 SLGviLyeLlTG~~Pf~~~~~~~qi~k~i--------------~~g~--------------------------------- 241 (738)
|.|+|++-++++.+||-...+.......+ ..|.
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 99999999999999995433222211111 0111
Q ss_pred --CCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 242 --KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 242 --~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
.+.......+..+.+|+++||. +|.+|.||+++|+||||..
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 0011122334578999999999 9999999999999999973
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-30 Score=282.59 Aligned_cols=206 Identities=26% Similarity=0.367 Sum_probs=182.0
Q ss_pred cCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHH----HHHHHHHHHHHHHhCC---CCCcceee
Q 004672 16 KLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPE----ELERLYCEIHLLKTLK---HRNIMKFY 88 (738)
Q Consensus 16 ~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e----~~e~l~~Ei~iLk~L~---HpNIVkl~ 88 (738)
..-.+.+|..++.+|+||||.|++|.++.+..+|+||.|.+........ .+-.+-.||+||..|+ |+||++++
T Consensus 556 ~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlL 635 (772)
T KOG1152|consen 556 EYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLL 635 (772)
T ss_pred eecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhh
Confidence 3345667999999999999999999999999999999988765332222 2345678999999997 99999999
Q ss_pred EEEEecCCCeEEEEEecCC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEE
Q 004672 89 TSWVDTANRNINFVTEMFT-SGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVK 167 (738)
Q Consensus 89 ~~fv~~~~~~l~LV~Ey~~-gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VK 167 (738)
++|.+ ++++||+||-.. |-+|++++..+++++|..++.|++|++.|+++||+.| |||||||-+|++++++ |-+|
T Consensus 636 dfFEd--dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~-g~~k 710 (772)
T KOG1152|consen 636 DFFED--DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSN-GFVK 710 (772)
T ss_pred heeec--CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecC-CeEE
Confidence 99844 889999999864 4589999999999999999999999999999999999 9999999999999977 8999
Q ss_pred EeccchhHHhhccccccccCCCCCCCccccccc-c-CcccccccchhhhhhhhhcCCCCCC
Q 004672 168 IGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE-Y-NELVDIYSFGMCILEMVTFDYPYSE 226 (738)
Q Consensus 168 L~DFGlA~~l~~~~~~~~vGTp~YmAPEvl~~~-y-s~~sDIWSLGviLyeLlTG~~Pf~~ 226 (738)
|+|||.|...........+||..|.|||++.+. | +..-|||++|++||.++..+.||.+
T Consensus 711 lidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 711 LIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred EeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999999998888888888999999999999864 4 5678999999999999999999974
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-31 Score=268.50 Aligned_cols=253 Identities=25% Similarity=0.390 Sum_probs=203.3
Q ss_pred eEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCC---CeEE
Q 004672 24 EDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN---RNIN 100 (738)
Q Consensus 24 ~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~---~~l~ 100 (738)
.--+.||.|+||.||...|..+|+.||+|++. ...++-...+++.+|+++|..++|.|++..++...-..- ..+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~p--nvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMP--NVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcc--hHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 34467999999999999999999999999755 345556667899999999999999999998886432221 2578
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
+|+|+| ..+|...+..-..++...++-+++||+.||+|||+.+ |.||||||.|+|+++| -.+||+|||+++.....
T Consensus 134 V~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSN-CvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 134 VLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSN-CILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccC-ceEEecccccccccchh
Confidence 899999 4689998888889999999999999999999999999 9999999999999977 47899999999876543
Q ss_pred ---ccccccCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHH-----------------
Q 004672 181 ---HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI----------------- 238 (738)
Q Consensus 181 ---~~~~~vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~----------------- 238 (738)
..+..+-|..|+|||++.+ .|+.++||||.|||+.||+..+..|.......++ ..|.
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL-~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQL-QMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHH-HHHHHHhCCCcHHHHHHHhhh
Confidence 3345567899999999975 5999999999999999999988899875555544 2221
Q ss_pred -------cCCCCcccc---cCCC-----hHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 239 -------SGKKPEALF---KVED-----PEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 239 -------~g~~p~~l~---~~~s-----pel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
.+.++..+. ...+ -+...++.++|. +|.+|.+..+.+.|+++...
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 122332222 2222 356777888888 89999999999999998543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-28 Score=235.34 Aligned_cols=209 Identities=36% Similarity=0.559 Sum_probs=183.2
Q ss_pred EcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEecCCC
Q 004672 29 FLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTS 108 (738)
Q Consensus 29 LG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey~~g 108 (738)
||.|++|.||++.+..+|..+++|.+...... ...+.+.+|+.+++.+.|++|+++++++.. ....++++|++.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS---SLLEELLREIEILKKLNHPNIVKLYGVFED--ENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccch---hHHHHHHHHHHHHHhcCCCCeeeEeeeeec--CCeEEEEEecCCC
Confidence 68999999999999888999999988754321 145789999999999999999999998754 5789999999999
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccc--cccc
Q 004672 109 GTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--AARC 185 (738)
Q Consensus 109 GSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~--~~~~ 185 (738)
++|.+++... ..++...+..++.+++.+|.+||+.+ ++|+||+|.||+++...+.++|+|||.+....... ....
T Consensus 76 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (215)
T cd00180 76 GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI 153 (215)
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence 9999998876 57899999999999999999999998 99999999999998624799999999997665543 3344
Q ss_pred cCCCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh
Q 004672 186 VGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 263 (738)
Q Consensus 186 vGTp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~ 263 (738)
.+...|++||.+.. .++.+.|+|++|+++++| ..+.+++.+|+.
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~~~l~ 199 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------PELKDLIRKMLQ 199 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------HHHHHHHHHHhh
Confidence 58899999999875 688899999999999999 577899999999
Q ss_pred -CcCCCCCHHHHhcCc
Q 004672 264 -TVSSRLSARELLTDP 278 (738)
Q Consensus 264 -dP~~RpSa~ELL~Hp 278 (738)
+|.+||++.++++|+
T Consensus 200 ~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 200 KDPEKRPSAKEILEHL 215 (215)
T ss_pred CCcccCcCHHHHhhCC
Confidence 999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=279.35 Aligned_cols=243 Identities=26% Similarity=0.409 Sum_probs=202.4
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCe----EEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCC
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGI----EVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~----~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 97 (738)
+.+..++||.|+||+||+|.....|+ +||||++.- ...++.-+.+..|+-+|.+|+|||++++++++...
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~---~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s--- 770 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE---FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS--- 770 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeec---cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc---
Confidence 45677899999999999999877765 678886553 23455667899999999999999999999987553
Q ss_pred eEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 98 NINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~~-~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
.+.||++|+++|+|.+|++.++ .+..+..+.|+.||++||.|||.+. ++||||-..|+||..- .+|||.|||+++.
T Consensus 771 ~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP-~hvkitdfgla~l 847 (1177)
T KOG1025|consen 771 TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSP-NHVKITDFGLAKL 847 (1177)
T ss_pred hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCC-CeEEEEecchhhc
Confidence 4889999999999999988875 6999999999999999999999998 9999999999999854 6999999999988
Q ss_pred hhcccccccc----CCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCC
Q 004672 177 LRKSHAARCV----GTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVE 250 (738)
Q Consensus 177 l~~~~~~~~v----GTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~ 250 (738)
+......... -.+.|||-|.+. ..|+.++|||||||++||++| |..||.+ ...++|-+.+..|.. ..-+..-
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g-i~~~eI~dlle~geR-LsqPpiC 925 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG-IPAEEIPDLLEKGER-LSQPPIC 925 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC-CCHHHhhHHHhcccc-CCCCCCc
Confidence 7654322211 245778888765 569999999999999999998 7889987 456777777777766 3345667
Q ss_pred ChHHHHHHHHHHh-CcCCCCCHHHHh
Q 004672 251 DPEVRQFIEKCLA-TVSSRLSARELL 275 (738)
Q Consensus 251 spel~~lI~kcL~-dP~~RpSa~ELL 275 (738)
+.++..++.+||. |+..||+++++.
T Consensus 926 tiDVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 926 TIDVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred cHHHHHHHHHHhccCcccCccHHHHH
Confidence 8899999999999 999999999875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=236.95 Aligned_cols=212 Identities=33% Similarity=0.446 Sum_probs=182.8
Q ss_pred ceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEE
Q 004672 23 MEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 102 (738)
Q Consensus 23 y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV 102 (738)
|.+.+.||.|++++||++.+..++..+|+|.+...... ...+.+.+|+..++.++|+||+++++++.. ....+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFED--PEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeec--CCceEEE
Confidence 56789999999999999999988999999998754321 356789999999999999999999998754 5688999
Q ss_pred EecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc-
Q 004672 103 TEMFTSGTLRQYRLKHRR-VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS- 180 (738)
Q Consensus 103 ~Ey~~gGSL~~~l~k~~~-lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~- 180 (738)
+|++.+++|.+++..... +++..+..++.+++.+|.+||+++ ++|+||+|.||+++.+ +.++|+|||++......
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMD-GLVKLADFGLARFIHRDL 152 (225)
T ss_pred EeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeeCceeeEecCcc
Confidence 999999999999988777 899999999999999999999998 9999999999999865 79999999998776543
Q ss_pred --ccccccCCCCCCCcccc-c-cccCcccccccchhhhhhhhhcCCCCCC-CCCHHHHHHHHHcCCC
Q 004672 181 --HAARCVGTPEFMAPEVY-E-EEYNELVDIYSFGMCILEMVTFDYPYSE-CTHPAQIYKKVISGKK 242 (738)
Q Consensus 181 --~~~~~vGTp~YmAPEvl-~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~-~~~~~qi~k~i~~g~~ 242 (738)
......++..|++||.+ . ..++.++|||+||+++++|++|+.||.. ..+...+.+.+..|..
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence 22344588899999987 3 3477799999999999999999999976 5666677787777664
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=242.07 Aligned_cols=266 Identities=22% Similarity=0.295 Sum_probs=208.3
Q ss_pred cccCCCCcccccCcCCC-CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCC
Q 004672 5 AQKNQIPPSLLKLIPLE-DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHR 82 (738)
Q Consensus 5 ~q~~~vp~~l~~~I~~~-~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~Hp 82 (738)
||-.-+|..-++.+++. .|.+.+.||+|.||.+-++.|..+...+++|.+... ......|.+|.+.--.| .|.
T Consensus 7 g~ih~I~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-----~tt~~dF~rEfhY~~~Ls~H~ 81 (378)
T KOG1345|consen 7 GQIHLIPMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-----QTTQADFVREFHYSFFLSPHQ 81 (378)
T ss_pred CcccccccccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-----hhhHHHHHHHhccceeeccch
Confidence 45566777777777765 699999999999999999999999999999987643 24556799999887777 689
Q ss_pred CcceeeEEEEecCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEe-C
Q 004672 83 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN-G 161 (738)
Q Consensus 83 NIVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~-~ 161 (738)
||+.-|+.-+.+ .+.+++++||++.|+|..-+.. ..+.+...+.++.|++.||.|+|+++ +||||||.+||||- .
T Consensus 82 hIi~tY~vaFqt-~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~ 157 (378)
T KOG1345|consen 82 HIIDTYEVAFQT-SDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDA 157 (378)
T ss_pred hhhHHHHHHhhc-CceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecC
Confidence 999988764443 5589999999999999887544 45899999999999999999999999 99999999999984 4
Q ss_pred CCCcEEEeccchhHHhhccccccccCCCCCCCccccc----c--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHH--
Q 004672 162 NQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE----E--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQI-- 233 (738)
Q Consensus 162 ~~g~VKL~DFGlA~~l~~~~~~~~vGTp~YmAPEvl~----~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi-- 233 (738)
+.-+|||||||+....+..... .--+..|.+||+.. + ..++..|||.||+++|.++||..||....-.++-
T Consensus 158 df~rvKlcDFG~t~k~g~tV~~-~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~ 236 (378)
T KOG1345|consen 158 DFYRVKLCDFGLTRKVGTTVKY-LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYW 236 (378)
T ss_pred CccEEEeeecccccccCceehh-hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHH
Confidence 5568999999998665433221 12456899999774 2 2677899999999999999999999754333322
Q ss_pred -HHHHHcCCCC--cccccCCChHHHHHHHHHHh-CcCCC---CCHHHHhcCccc
Q 004672 234 -YKKVISGKKP--EALFKVEDPEVRQFIEKCLA-TVSSR---LSARELLTDPFL 280 (738)
Q Consensus 234 -~k~i~~g~~p--~~l~~~~spel~~lI~kcL~-dP~~R---pSa~ELL~Hpf~ 280 (738)
+.+...+..| +..++..++.+..+.++-|. ++.+| -+++...+..|.
T Consensus 237 ~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 237 EWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred HHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 3344445444 23456678899999999999 78888 456666666664
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-27 Score=281.55 Aligned_cols=199 Identities=19% Similarity=0.204 Sum_probs=149.7
Q ss_pred HhCCC-CCcceeeEEEEe-----cCCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCcee
Q 004672 77 KTLKH-RNIMKFYTSWVD-----TANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIH 149 (738)
Q Consensus 77 k~L~H-pNIVkl~~~fv~-----~~~~~l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIH 149 (738)
+.+.| +||++++++|-. .....+++++||+ +++|.+++... ..+++..++.+++||+.||.|||+++ |+|
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvH 103 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVV 103 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence 45556 688888887611 1134688889988 67999999763 45999999999999999999999998 999
Q ss_pred ccCCcccEEEeC------------------CCCcEEEeccchhHHhhcc------------------ccccccCCCCCCC
Q 004672 150 RDLKCDNIFVNG------------------NQGEVKIGDLGLAAILRKS------------------HAARCVGTPEFMA 193 (738)
Q Consensus 150 RDLKP~NILl~~------------------~~g~VKL~DFGlA~~l~~~------------------~~~~~vGTp~YmA 193 (738)
|||||+||||+. ..+.+||+|||+++..... .....+||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999952 2346777788877532110 0011358999999
Q ss_pred ccccc-cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCH
Q 004672 194 PEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSA 271 (738)
Q Consensus 194 PEvl~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa 271 (738)
||++. ..|+.++|||||||+||||++|..|+... ...+..+.....|... ....+....++.+||. +|.+||++
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~ 259 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK---SRTMSSLRHRVLPPQI-LLNWPKEASFCLWLLHPEPSCRPSM 259 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH---HHHHHHHHHhhcChhh-hhcCHHHHHHHHHhCCCChhhCcCh
Confidence 99876 46999999999999999999998887542 2222333333333222 1235677899999999 99999999
Q ss_pred HHHhcCcccCC
Q 004672 272 RELLTDPFLQI 282 (738)
Q Consensus 272 ~ELL~Hpf~~~ 282 (738)
.|+|+||||..
T Consensus 260 ~eil~h~~~~~ 270 (793)
T PLN00181 260 SELLQSEFINE 270 (793)
T ss_pred HHHhhchhhhh
Confidence 99999999965
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.7e-26 Score=221.06 Aligned_cols=159 Identities=26% Similarity=0.389 Sum_probs=128.7
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccccccccC
Q 004672 109 GTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG 187 (738)
Q Consensus 109 GSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~~~~~vG 187 (738)
|+|.+++..+ +.+++..++.|+.||+.||.|||+++ ||+|||++.+ +.+|+ ||++...... ...|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~-~~~~~--fG~~~~~~~~---~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWD-GLLKL--DGSVAFKTPE---QSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCc-cceee--ccceEeeccc---cCCC
Confidence 7899999874 46999999999999999999999985 9999999855 78998 9998765432 2368
Q ss_pred CCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCccc-----ccCCCh--HHHHHHH
Q 004672 188 TPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL-----FKVEDP--EVRQFIE 259 (738)
Q Consensus 188 Tp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l-----~~~~sp--el~~lI~ 259 (738)
|+.|||||++.+ .|+.++|||||||++|+|+||+.||.........+..+..+..+... ....+. +++++|.
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 146 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR 146 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence 999999999864 59999999999999999999999997655555555555544333211 111222 6999999
Q ss_pred HHHh-CcCCCCCHHHHhcCcccC
Q 004672 260 KCLA-TVSSRLSARELLTDPFLQ 281 (738)
Q Consensus 260 kcL~-dP~~RpSa~ELL~Hpf~~ 281 (738)
+||. +|.+||++.+++.|+|+.
T Consensus 147 ~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 147 VCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHhcccccccCHHHHHHHHHHH
Confidence 9999 999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-23 Score=211.62 Aligned_cols=253 Identities=30% Similarity=0.371 Sum_probs=206.1
Q ss_pred ceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCC-CcceeeEEEEecCCCeEEE
Q 004672 23 MEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHR-NIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 23 y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~Hp-NIVkl~~~fv~~~~~~l~L 101 (738)
|.+...||.|+|+.||++.+. ..+++|.+..... ........+.+|+.++..+.|+ +|+++++.+.. ....++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLE-SKSKEVERFLREIQILASLNHPPNIVKLYDFFQD--EGSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhc-cchhHHHHHHHHHHHHHHccCCcceeeEEEEEec--CCEEEE
Confidence 788999999999999999987 7889998775542 2224577899999999999988 79999998733 556899
Q ss_pred EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh
Q 004672 102 VTEMFTSGTLRQYRLKHR---RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~~---~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~ 178 (738)
+++++.+++|.+++.... .+.......++.|++.+|.|+|..+ ++|||+||+||+++.....++++|||++....
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 999999999998777664 7999999999999999999999999 99999999999998663379999999997554
Q ss_pred ccc--------cccccCCCCCCCcccccc----ccCcccccccchhhhhhhhhcCCCCCCCCC---HHHHHHHHHcCCCC
Q 004672 179 KSH--------AARCVGTPEFMAPEVYEE----EYNELVDIYSFGMCILEMVTFDYPYSECTH---PAQIYKKVISGKKP 243 (738)
Q Consensus 179 ~~~--------~~~~vGTp~YmAPEvl~~----~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~---~~qi~k~i~~g~~p 243 (738)
... .....||+.|+|||.+.+ .+....|+||+|++++++++|..||..... ..+....+.....+
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 332 345579999999998875 688899999999999999999999876553 45666655554433
Q ss_pred -cccccCC------ChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 244 -EALFKVE------DPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 244 -~~l~~~~------spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
....... ...+.+++..++. +|..|.+..+...++|....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 1111111 1578999999999 89999999999999776543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=222.75 Aligned_cols=246 Identities=22% Similarity=0.263 Sum_probs=202.4
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCC-----eEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecC
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEG-----IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG-----~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 95 (738)
.+++....+-+|.||.||.|+..... +.|.+|.++- ..++-+...+..|.-+|..+.|||+..+.++.++.
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~---~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~- 359 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ---HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED- 359 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh---cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec-
Confidence 34666778889999999999765332 3566666552 34666778999999999999999999999987664
Q ss_pred CCeEEEEEecCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEE
Q 004672 96 NRNINFVTEMFTSGTLRQYRLKH--------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVK 167 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~l~k~--------~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VK 167 (738)
....+.++.++.-|.|..++... +.++..++..++.|++.|++|||+++ |||.||-..|.+|+ +.-+||
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvId-d~LqVk 436 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVID-DQLQVK 436 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceeh-hheeEE
Confidence 45678889999999999998843 24777888999999999999999999 99999999999998 557999
Q ss_pred EeccchhHHhhcccccccc-----CCCCCCCccccc-cccCcccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcC
Q 004672 168 IGDLGLAAILRKSHAARCV-----GTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISG 240 (738)
Q Consensus 168 L~DFGlA~~l~~~~~~~~v-----GTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g 240 (738)
|+|=.+++.+..... ++. ....||+||.+. ..|+.++||||||++||||+| |+.||.+ .+|.+++..+..|
T Consensus 437 ltDsaLSRDLFP~DY-hcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae-IDPfEm~~ylkdG 514 (563)
T KOG1024|consen 437 LTDSALSRDLFPGDY-HCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE-IDPFEMEHYLKDG 514 (563)
T ss_pred eccchhccccCcccc-cccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc-cCHHHHHHHHhcc
Confidence 999999987654322 223 346899999886 569999999999999999998 8999987 6788898888888
Q ss_pred CCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 241 KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 241 ~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
..-.. +...+.++..++..||. .|.+||+.+++..
T Consensus 515 yRlaQ-P~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 515 YRLAQ-PFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ceecC-CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 76543 34567899999999999 9999999999863
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.5e-24 Score=247.28 Aligned_cols=254 Identities=22% Similarity=0.306 Sum_probs=197.3
Q ss_pred eEEEEEcccCCeEEEEEEEcCCCeEEEEEEEecc--ccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 24 EDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLY--DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 24 ~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~--~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
.....+|.|++|.|+.+.........++|.++.. ...........+..|+-+-..|.||||+..+..+.+ .....-
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~--~~~~~~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE--IDGILQ 398 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh--cccchh
Confidence 5678899999999988888777777777765532 112222233347788888888999999877665433 333444
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccc
Q 004672 102 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 181 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~ 181 (738)
+||||++ +|+.++....+++...+-.+++|++.||.|||+.| |.|||||++|+++..+ |.+||+|||.+..+....
T Consensus 399 ~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~-g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTEN-GILKIIDFGAASVFRYPW 474 (601)
T ss_pred hhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecC-CceEEeecCcceeeccCc
Confidence 4999999 99999888878999999999999999999999999 9999999999999855 799999999997765432
Q ss_pred c------ccccCCCCCCCcccccc-ccCcc-cccccchhhhhhhhhcCCCCCCCCCHHHHH-HHHHcC-----CCCcccc
Q 004672 182 A------ARCVGTPEFMAPEVYEE-EYNEL-VDIYSFGMCILEMVTFDYPYSECTHPAQIY-KKVISG-----KKPEALF 247 (738)
Q Consensus 182 ~------~~~vGTp~YmAPEvl~~-~ys~~-sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~-k~i~~g-----~~p~~l~ 247 (738)
. ...+|+..|+|||++.+ .|++. +||||.|++++.|++|+.||......++.+ .....+ .-|..+.
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL 554 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence 2 33469999999999975 57774 899999999999999999997544333321 111111 1233445
Q ss_pred cCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 248 KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 248 ~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
...+.+.+.+|.++|+ +|.+|.|+.+||+++||+.-
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 5567789999999999 99999999999999999754
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=221.38 Aligned_cols=176 Identities=18% Similarity=0.150 Sum_probs=135.0
Q ss_pred CcCCCCceEEEEEcccCCeEEEEEEEcC-CCeEEEEEEEecccc-CCCHHHHHHHHHHHHHHHhCCCCCcce-eeEEEEe
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEY-EGIEVAWNQVKLYDF-LQSPEELERLYCEIHLLKTLKHRNIMK-FYTSWVD 93 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~-tG~~VAIK~vki~~~-~~s~e~~e~l~~Ei~iLk~L~HpNIVk-l~~~fv~ 93 (738)
....++|.+.+.||+|+||+||+|.+.. +|..||||++..... .......+.+.+|+++|+.|+|+||+. +++.
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 3445789999999999999999999876 788889997652210 113345678999999999999999985 4431
Q ss_pred cCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccC-CcccEEEeCCCCcEEEeccc
Q 004672 94 TANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL-KCDNIFVNGNQGEVKIGDLG 172 (738)
Q Consensus 94 ~~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDL-KP~NILl~~~~g~VKL~DFG 172 (738)
...++||||++|++|... .. .. ...++.|++.||.|||++| |+|||| ||+|||++.+ +.+||+|||
T Consensus 91 ---~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~-~~ikLiDFG 157 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPD-GEAAVIDFQ 157 (365)
T ss_pred ---CCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCC-CCEEEEECc
Confidence 357999999999999732 11 11 2568899999999999998 999999 9999999744 789999999
Q ss_pred hhHHhhccc----------cccccCCCCCCCccccccc-------cCcccccc
Q 004672 173 LAAILRKSH----------AARCVGTPEFMAPEVYEEE-------YNELVDIY 208 (738)
Q Consensus 173 lA~~l~~~~----------~~~~vGTp~YmAPEvl~~~-------ys~~sDIW 208 (738)
+|..+.... ....++++.|+|||.+..+ .+...|-|
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 998654321 1344688999999998632 34456766
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-21 Score=207.84 Aligned_cols=246 Identities=20% Similarity=0.158 Sum_probs=182.8
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCC-eEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCC----CCcceeeEEEEecCC
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEG-IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH----RNIMKFYTSWVDTAN 96 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG-~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~H----pNIVkl~~~fv~~~~ 96 (738)
.|.+.++||+|+||.||++.+..++ ..+|+|.......... ..+..|+.+|..+.. +++..+++... ...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC----ccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCC
Confidence 8999999999999999999998875 7889887664421111 158889999999963 68888888653 346
Q ss_pred CeEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCC----CcEEEec
Q 004672 97 RNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ----GEVKIGD 170 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~----g~VKL~D 170 (738)
..-++||+++ |.+|.+++... +.++..++..++.|++.+|++||+.| ++||||||+|+++.... -.+.|.|
T Consensus 94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEe
Confidence 6889999998 89999988665 57999999999999999999999999 99999999999997442 3699999
Q ss_pred cchhH--Hhhccc----------cccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCCCCHHHH--HH
Q 004672 171 LGLAA--ILRKSH----------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQI--YK 235 (738)
Q Consensus 171 FGlA~--~l~~~~----------~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi--~k 235 (738)
||+++ .+.... .....||..|+++.+..+ ..+.+.|+||++.++.+|+.|..||......... ++
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 99998 321111 122349999999998875 5889999999999999999999999765433222 12
Q ss_pred HHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHh
Q 004672 236 KVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELL 275 (738)
Q Consensus 236 ~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL 275 (738)
...............+.++..+...+-. +...+|....+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~ 291 (322)
T KOG1164|consen 251 KDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLA 291 (322)
T ss_pred HHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHH
Confidence 2211111111222234556666665555 566666655544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.9e-22 Score=200.27 Aligned_cols=247 Identities=22% Similarity=0.244 Sum_probs=196.8
Q ss_pred ccccCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCC-CCcceeeEEE
Q 004672 13 SLLKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH-RNIMKFYTSW 91 (738)
Q Consensus 13 ~l~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~H-pNIVkl~~~f 91 (738)
.+...|...+|+++++||+|+||.+|.|.....|++||||.-+. . ...-++..|.++.+.|++ ..|..+..++
T Consensus 7 s~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~-~-----a~hpqL~yEskvY~iL~~g~GiP~i~~y~ 80 (341)
T KOG1163|consen 7 SLEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS-K-----AKHPQLLYESKVYRILQGGVGIPHIRHYG 80 (341)
T ss_pred chhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecc-c-----CCCcchhHHHHHHHHhccCCCCchhhhhc
Confidence 45667788999999999999999999999999999999996331 1 122358889999999965 5666665433
Q ss_pred EecCCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEe--CCCCcEEE
Q 004672 92 VDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN--GNQGEVKI 168 (738)
Q Consensus 92 v~~~~~~l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~--~~~g~VKL 168 (738)
....+-.+||++. |-||.++..-. +++++++++-++-|++.-++|+|.++ +|||||||+|+|.. .....+.|
T Consensus 81 --~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~L 155 (341)
T KOG1163|consen 81 --TEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYL 155 (341)
T ss_pred --cccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEE
Confidence 4467889999998 88999987764 67999999999999999999999999 99999999999984 23357999
Q ss_pred eccchhHHhhcccc---------ccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCCC--CCHHHHHHH
Q 004672 169 GDLGLAAILRKSHA---------ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC--THPAQIYKK 236 (738)
Q Consensus 169 ~DFGlA~~l~~~~~---------~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~~--~~~~qi~k~ 236 (738)
+|||+|+.+.+... ....||..|.+-....+ ..+.+.|+-|+|.+|.++..|..||.+. .+..|-|++
T Consensus 156 IDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk 235 (341)
T KOG1163|consen 156 IDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK 235 (341)
T ss_pred EeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH
Confidence 99999988754322 23358999988776543 4677899999999999999999999874 455677777
Q ss_pred HHcCC---CCcccccCCChHHHHHHHHHHh-CcCCCCC
Q 004672 237 VISGK---KPEALFKVEDPEVRQFIEKCLA-TVSSRLS 270 (738)
Q Consensus 237 i~~g~---~p~~l~~~~spel~~lI~kcL~-dP~~RpS 270 (738)
|...+ .++.+.+..+.++.-.+..|-. --.+-|.
T Consensus 236 I~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 236 ISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred HHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 77644 3455667788899999999987 4444444
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.3e-21 Score=199.66 Aligned_cols=234 Identities=19% Similarity=0.238 Sum_probs=184.4
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecCCC
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~ 97 (738)
-.-.|+++++||+|+||.++.|....+++.||||.-... ...-++..|.+..+.| ..++|..+|- +...+.
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk------S~APQLrdEYr~YKlL~g~~GIP~vYY--FGqeG~ 97 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK------SEAPQLRDEYRTYKLLGGTEGIPQVYY--FGQEGK 97 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecccc------CCcchHHHHHHHHHHHcCCCCCCceee--eccccc
Confidence 335799999999999999999999999999999842211 2234688899999999 5789999874 455577
Q ss_pred eEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeC----CCCcEEEeccc
Q 004672 98 NINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG----NQGEVKIGDLG 172 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~----~~g~VKL~DFG 172 (738)
+-.||+|++ |-||.++..-. ++|+.+++..++.|++.-++|+|+++ +|+|||||+|+||.. +...|.|+|||
T Consensus 98 ~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG 174 (449)
T KOG1165|consen 98 YNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFG 174 (449)
T ss_pred hhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEecc
Confidence 788999998 88999987765 56999999999999999999999999 999999999999952 33468999999
Q ss_pred hhHHhhcccc---------ccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCCCCCC--CCCHHHHHHHHHcC
Q 004672 173 LAAILRKSHA---------ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSE--CTHPAQIYKKVISG 240 (738)
Q Consensus 173 lA~~l~~~~~---------~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~Pf~~--~~~~~qi~k~i~~g 240 (738)
+|+.+.++.. ++..||..||+-....+ +-+.+.|.-|||-++++.|.|..||.+ ..+..+-|.+|-..
T Consensus 175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred chhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 9998876533 23359999999987655 478889999999999999999999976 35667777777544
Q ss_pred CCC---cccccCCChHHHHHHHHHHh
Q 004672 241 KKP---EALFKVEDPEVRQFIEKCLA 263 (738)
Q Consensus 241 ~~p---~~l~~~~spel~~lI~kcL~ 263 (738)
+.. ..+....+.++...++..-.
T Consensus 255 Kr~T~i~~Lc~g~P~efa~Yl~yvR~ 280 (449)
T KOG1165|consen 255 KRSTPIEVLCEGFPEEFATYLRYVRR 280 (449)
T ss_pred cccCCHHHHHhcCHHHHHHHHHHHHh
Confidence 332 22333344455555554443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-21 Score=220.39 Aligned_cols=241 Identities=19% Similarity=0.263 Sum_probs=200.8
Q ss_pred EcccCCeEEEEEE---EcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCC-CCCcceeeEEEEecCCCeEEEEEe
Q 004672 29 FLVKELQRHYRAF---DEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANRNINFVTE 104 (738)
Q Consensus 29 LG~GafgtVYkA~---d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~l~LV~E 104 (738)
+|.|+||.|+++. -...|..+|+|..+.......... .-..|-.++...+ ||.++++...|.. ....+++++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f~v~lhyafqt--~~kl~l~ld 77 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPFLVKLHYAFQT--DGKLYLILD 77 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc--ccccHHHHHhhccCCCceeeeeeeecc--ccchhHhhh
Confidence 6899999998654 235677889888776553333222 6677889999996 9999999887744 678899999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcccccc
Q 004672 105 MFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR 184 (738)
Q Consensus 105 y~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~~~~ 184 (738)
+..||.|...+.+...+.+...+.+...++.+++++|..+ |+|||+|++||+++.+ |++++.|||+++..-.....
T Consensus 78 ~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~-Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLE-GHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred hcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeeccc-CccccCCchhhhHhHhhhhc-
Confidence 9999999999888888999999999999999999999999 9999999999999966 89999999999877655444
Q ss_pred ccCCCCCCCccccccccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-
Q 004672 185 CVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA- 263 (738)
Q Consensus 185 ~vGTp~YmAPEvl~~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~- 263 (738)
+||..|||||+.. .....+|.||||+++++|+||..||.. ++.+.|.....+ .+...++.+++++..++.
T Consensus 154 -cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~~~--~p~~l~~~a~~~~~~l~~r 224 (612)
T KOG0603|consen 154 -CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAELE--MPRELSAEARSLFRQLFKR 224 (612)
T ss_pred -ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhccC--CchhhhHHHHHHHHHHHhh
Confidence 8999999999998 667899999999999999999999986 555555543333 345567899999999999
Q ss_pred CcCCCCC-----HHHHhcCcccCCCCCc
Q 004672 264 TVSSRLS-----ARELLTDPFLQIDDYD 286 (738)
Q Consensus 264 dP~~RpS-----a~ELL~Hpf~~~~~~~ 286 (738)
+|..|.- +.|+++|+||+.-++.
T Consensus 225 ~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 225 NPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred CHHHHhccCcchhHHHhccchheeeeHh
Confidence 8998875 5799999999877654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.9e-21 Score=222.56 Aligned_cols=223 Identities=28% Similarity=0.409 Sum_probs=173.2
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEE
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 100 (738)
.+|..++.|..|+||.||...|+.+...+|+| +.... -||+ ||..+-+ +.+
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~---------------lilR-----nilt~a~--------npf 133 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN---------------LILR-----NILTFAG--------NPF 133 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccc---------------hhhh-----ccccccC--------Ccc
Confidence 57999999999999999999999999999984 33111 1111 1333221 222
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~ 180 (738)
.| |+....++.-+.++... +.+++|||+.+ |+|||+||+|.+|+.- |++|++|||+++.....
T Consensus 134 vv------gDc~tllk~~g~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT~m-GhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 134 VV------GDCATLLKNIGPLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLITSM-GHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ee------chhhhhcccCCCCcchh--------hHHhHhhccCC--eecCCCCCCcceeeec-ccccccchhhhhhhhhh
Confidence 23 67777666655555443 78999999998 9999999999999854 89999999999764221
Q ss_pred -----------------ccccccCCCCCCCccccc-cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHc--C
Q 004672 181 -----------------HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--G 240 (738)
Q Consensus 181 -----------------~~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~--g 240 (738)
..+..+|||.|+|||++. ..|+..+|.|++|+|+|+.+.|.+||.+ .++++++..++. .
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG-dtpeelfg~visd~i 275 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDI 275 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC-CCHHHHHhhhhhhhc
Confidence 113447999999999875 6799999999999999999999999987 567888887775 3
Q ss_pred CCCcccccCCChHHHHHHHHHHh-CcCCCC---CHHHHhcCcccCCCCCchhhhh
Q 004672 241 KKPEALFKVEDPEVRQFIEKCLA-TVSSRL---SARELLTDPFLQIDDYDSDLRM 291 (738)
Q Consensus 241 ~~p~~l~~~~spel~~lI~kcL~-dP~~Rp---Sa~ELL~Hpf~~~~~~~~~~~~ 291 (738)
..|+. ...+.++++++|+++|. +|..|. .+.++.+|+||+.-++...+|.
T Consensus 276 ~wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRq 329 (1205)
T KOG0606|consen 276 EWPEE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQ 329 (1205)
T ss_pred ccccc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhh
Confidence 34554 45668999999999999 898884 6889999999999888755443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.4e-20 Score=183.65 Aligned_cols=143 Identities=17% Similarity=0.103 Sum_probs=112.5
Q ss_pred EEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHH----------------------HHHHHHHHHHHHHhCCCCC
Q 004672 26 TMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPE----------------------ELERLYCEIHLLKTLKHRN 83 (738)
Q Consensus 26 l~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e----------------------~~e~l~~Ei~iLk~L~HpN 83 (738)
...||.|++|.||+|.+. +|+.||+|.++......... .......|+++|..|.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357999999999999997 99999999998642110000 0123456999999998888
Q ss_pred cceeeEEEEecCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceeccCCcccEEEeCC
Q 004672 84 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYL-HSRDPPVIHRDLKCDNIFVNGN 162 (738)
Q Consensus 84 IVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yL-Hs~gp~IIHRDLKP~NILl~~~ 162 (738)
|...+.+.. . ..+|||||++|++|...+.....+++..+..++.||+.+|.|| |+.| |+||||||+|||++ +
T Consensus 81 v~~p~~~~~---~-~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~ 153 (190)
T cd05147 81 IPCPEPILL---K-SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCCcEEEe---c-CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-C
Confidence 754443211 1 2379999999988876655567899999999999999999999 7888 99999999999998 3
Q ss_pred CCcEEEeccchhHHh
Q 004672 163 QGEVKIGDLGLAAIL 177 (738)
Q Consensus 163 ~g~VKL~DFGlA~~l 177 (738)
+.++|+|||+|...
T Consensus 154 -~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 -GKLYIIDVSQSVEH 167 (190)
T ss_pred -CcEEEEEccccccC
Confidence 68999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.6e-20 Score=188.54 Aligned_cols=182 Identities=12% Similarity=0.070 Sum_probs=140.0
Q ss_pred ccccCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHH------HHHHHHHHHhCCCCCcce
Q 004672 13 SLLKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELER------LYCEIHLLKTLKHRNIMK 86 (738)
Q Consensus 13 ~l~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~------l~~Ei~iLk~L~HpNIVk 86 (738)
.+...+-..+|+.++.||.|+||.||++.+ ++..+|+|++... ....+...++ +.+|++.+.+|.||+|..
T Consensus 23 ~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~-~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~ 99 (232)
T PRK10359 23 EIFDDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPK-VKRTERFLKSFVKGDYYENLIVQTDRVRSEGLAS 99 (232)
T ss_pred HHHHHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechh-cCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCc
Confidence 445566678999999999999999999644 5778999988633 2344455455 589999999999999999
Q ss_pred eeEEEEecC------CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEe
Q 004672 87 FYTSWVDTA------NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 160 (738)
Q Consensus 87 l~~~fv~~~------~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~ 160 (738)
+.+++.... ....+++|||++|.+|.++. .+++ ....+|+.+|..||..| ++|||+||+||+++
T Consensus 100 ~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~ 169 (232)
T PRK10359 100 LNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVS 169 (232)
T ss_pred ceEeeeecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEe
Confidence 999876543 23578999999999998873 2333 34569999999999999 99999999999998
Q ss_pred CCCCcEEEeccchhHHhhccccccccCCCCCCCccccccccCcccccccchhhhhhhh
Q 004672 161 GNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMV 218 (738)
Q Consensus 161 ~~~g~VKL~DFGlA~~l~~~~~~~~vGTp~YmAPEvl~~~ys~~sDIWSLGviLyeLl 218 (738)
.+ | ++|+|||............. =++...|+.++||||||+++..+.
T Consensus 170 ~~-g-i~liDfg~~~~~~e~~a~d~---------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KN-G-LRIIDLSGKRCTAQRKAKDR---------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-C-EEEEECCCcccccchhhHHH---------HHHHhHhcccccccceeEeehHHH
Confidence 54 6 99999998755422211100 023345788999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-19 Score=179.33 Aligned_cols=144 Identities=19% Similarity=0.138 Sum_probs=114.2
Q ss_pred EEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccC--------------------CCH--HHHHHHHHHHHHHHhCCCCC
Q 004672 26 TMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFL--------------------QSP--EELERLYCEIHLLKTLKHRN 83 (738)
Q Consensus 26 l~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~--------------------~s~--e~~e~l~~Ei~iLk~L~HpN 83 (738)
...||+|++|.||+|.+. +|..||+|.++..... ... .....+..|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 9999999998864210 000 11234578999999999999
Q ss_pred cceeeEEEEecCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCcccEEEeCC
Q 004672 84 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGN 162 (738)
Q Consensus 84 IVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs-~gp~IIHRDLKP~NILl~~~ 162 (738)
|.....++.. ..+|||||++|+++........+++...+..++.|++.+|.+||. .| |+||||||+|||++
T Consensus 81 i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-- 152 (190)
T cd05145 81 VPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-- 152 (190)
T ss_pred CCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE--
Confidence 8655443322 237999999988665443445678889999999999999999999 88 99999999999998
Q ss_pred CCcEEEeccchhHHhh
Q 004672 163 QGEVKIGDLGLAAILR 178 (738)
Q Consensus 163 ~g~VKL~DFGlA~~l~ 178 (738)
.+.++|+|||++..+.
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 4799999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.4e-19 Score=193.75 Aligned_cols=268 Identities=22% Similarity=0.291 Sum_probs=187.8
Q ss_pred cCCCCcccccCcCCCCceEEEEEcccCCeEEEEEEEcCCC-----------------------------------eEEEE
Q 004672 7 KNQIPPSLLKLIPLEDMEDTMKFLVKELQRHYRAFDEYEG-----------------------------------IEVAW 51 (738)
Q Consensus 7 ~~~vp~~l~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG-----------------------------------~~VAI 51 (738)
..+++..+...+++++|.++..||+|....||.|.-...| -+.||
T Consensus 143 hDei~~r~dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAi 222 (598)
T KOG4158|consen 143 HDEIPNRIDSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAI 222 (598)
T ss_pred CCcCcchhhcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHH
Confidence 4567888899999999999999999999999998765321 13455
Q ss_pred EEEeccccC-CCHHHHHHHHHHHH------H--------HHh-------C-CCCCcceeeEEEEec--------------
Q 004672 52 NQVKLYDFL-QSPEELERLYCEIH------L--------LKT-------L-KHRNIMKFYTSWVDT-------------- 94 (738)
Q Consensus 52 K~vki~~~~-~s~e~~e~l~~Ei~------i--------Lk~-------L-~HpNIVkl~~~fv~~-------------- 94 (738)
|.+-..+.. .+...+....+|.- + .+. | +|||||++++.|.++
T Consensus 223 KmMfN~~~~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPda 302 (598)
T KOG4158|consen 223 KMMFNFEHDSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDA 302 (598)
T ss_pred HHhcccccCCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCccc
Confidence 543333322 22223344444421 1 111 2 599999999988652
Q ss_pred -----------CCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCC
Q 004672 95 -----------ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 163 (738)
Q Consensus 95 -----------~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~ 163 (738)
.+.++|+||.-. .-+|++|+-.+ ..+.....-++.|+++|+.|||.+| |.|||+|.+|||+.-++
T Consensus 303 lp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hg--vAhRDlKSDNiL~Eldd 378 (598)
T KOG4158|consen 303 LPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHG--VAHRDLKSDNILLELDD 378 (598)
T ss_pred ccceecccccCCCceEEEehhcc-hhhHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHcc--chhhcccccceEEEecC
Confidence 356899999988 46999998764 4667788889999999999999999 99999999999995322
Q ss_pred ---CcEEEeccchhHHhhc-----cccc---cccCCCCCCCcccccccc-------CcccccccchhhhhhhhhcCCCCC
Q 004672 164 ---GEVKIGDLGLAAILRK-----SHAA---RCVGTPEFMAPEVYEEEY-------NELVDIYSFGMCILEMVTFDYPYS 225 (738)
Q Consensus 164 ---g~VKL~DFGlA~~l~~-----~~~~---~~vGTp~YmAPEvl~~~y-------s~~sDIWSLGviLyeLlTG~~Pf~ 225 (738)
..+.|+|||.+-.-.. +... ..-|...-||||+..... -.++|.|+.|.+.||+++...||.
T Consensus 379 D~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY 458 (598)
T KOG4158|consen 379 DEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFY 458 (598)
T ss_pred CCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCccc
Confidence 2578999997632111 1111 113778899999986322 247999999999999999999997
Q ss_pred CCCCHHHH-HHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCH---HHHhcCccc
Q 004672 226 ECTHPAQI-YKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSA---RELLTDPFL 280 (738)
Q Consensus 226 ~~~~~~qi-~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa---~ELL~Hpf~ 280 (738)
... ...+ .+.......| .++...+|.++++|..+|+ +|++|+|+ +.+|.-..+
T Consensus 459 ~rG-em~L~~r~Yqe~qLP-alp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw 516 (598)
T KOG4158|consen 459 KRG-EMLLDTRTYQESQLP-ALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLW 516 (598)
T ss_pred ccc-hheechhhhhhhhCC-CCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHh
Confidence 621 1111 1112223333 4556778999999999999 99999984 455543333
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.9e-19 Score=186.12 Aligned_cols=234 Identities=16% Similarity=0.126 Sum_probs=154.0
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCC----------CCcceeeEEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH----------RNIMKFYTSW 91 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~H----------pNIVkl~~~f 91 (738)
.+.....||.|+++.||.+.|..||+++|+|++.... .......+.+.+|.-....+.+ -.++.-++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 4678899999999999999999999999999988776 4455567888888766555432 1222222221
Q ss_pred Ee---------cCC-C-----eEEEEEecCCCCCHHHHHHh---cCC----CCHHHHHHHHHHHHHHHHHHHhCCCCcee
Q 004672 92 VD---------TAN-R-----NINFVTEMFTSGTLRQYRLK---HRR----VNIRAVKHWCRQILSGLLYLHSRDPPVIH 149 (738)
Q Consensus 92 v~---------~~~-~-----~l~LV~Ey~~gGSL~~~l~k---~~~----lse~~i~~i~~QIl~aL~yLHs~gp~IIH 149 (738)
.. ..+ . +.+++|.-+ .++|.+++.- ... +...+...+..|+++.+++||..| ++|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVH 168 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVH 168 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEe
Confidence 11 111 1 346788887 6788887432 222 233444566689999999999999 999
Q ss_pred ccCCcccEEEeCCCCcEEEeccchhHHhhccccccccCCCCCCCcccccc---------ccCcccccccchhhhhhhhhc
Q 004672 150 RDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE---------EYNELVDIYSFGMCILEMVTF 220 (738)
Q Consensus 150 RDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~~~~~vGTp~YmAPEvl~~---------~ys~~sDIWSLGviLyeLlTG 220 (738)
+||+|+|+|++.+ |.++|+||+.....+..... ...+..|.+||+... .++.+.|.|+||+++|.|.+|
T Consensus 169 gdi~~~nfll~~~-G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 169 GDIKPENFLLDQD-GGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp ST-SGGGEEE-TT-S-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cccceeeEEEcCC-CCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999999965 99999999877655543332 345688999997643 378899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCC
Q 004672 221 DYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSR 268 (738)
Q Consensus 221 ~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~R 268 (738)
..||......... .. .-......+..++.+|..+|+ +|.+|
T Consensus 247 ~lPf~~~~~~~~~-~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADP-EW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTS-GG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccc-cc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999753211100 00 011122557789999999999 88887
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-19 Score=212.93 Aligned_cols=249 Identities=20% Similarity=0.217 Sum_probs=186.6
Q ss_pred ccCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEec
Q 004672 15 LKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 94 (738)
Q Consensus 15 ~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~ 94 (738)
..++.. ++...+-||.+.|=+|.+|.| ..|. |+||++-..+...+-+...+...|++ .+.+++||.+.|.-. ..
T Consensus 18 fsd~~~-e~~~~~~LGstRFlKv~r~k~-~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~--~~ 91 (1431)
T KOG1240|consen 18 FSDLSV-ECHYVENLGSTRFLKVARAKD-REGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKV--LV 91 (1431)
T ss_pred hhcCcc-ceeeecccCchhhhhhhhccC-CCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHH--HH
Confidence 344443 788899999999999999987 4566 88998877765555555566666777 777799999998653 34
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 95 ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 95 ~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
..+..|||-+|+ .-+|.+.+..+.-+..-..++|+.||+.||.-+|..| |.|+|||.+||||+. .+-+.|+||..-
T Consensus 92 t~kAAylvRqyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTS-WNW~~LtDFAsF 167 (1431)
T KOG1240|consen 92 TDKAAYLVRQYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITS-WNWLYLTDFASF 167 (1431)
T ss_pred hhHHHHHHHHHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEee-echhhhhccccc
Confidence 567889999999 4589998888777888899999999999999999999 999999999999983 467999999654
Q ss_pred HHh--hcccc-------ccccCCCCCCCcccccc------------ccCcccccccchhhhhhhhh-cCCCCCCCCCHHH
Q 004672 175 AIL--RKSHA-------ARCVGTPEFMAPEVYEE------------EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQ 232 (738)
Q Consensus 175 ~~l--~~~~~-------~~~vGTp~YmAPEvl~~------------~ys~~sDIWSLGviLyeLlT-G~~Pf~~~~~~~q 232 (738)
+.. ..... .+...-.+|+|||.+.. ..+++.||||+||+++||++ |.+||. ..|
T Consensus 168 KPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQ 243 (1431)
T KOG1240|consen 168 KPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQ 243 (1431)
T ss_pred CCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHH
Confidence 321 11111 11123458999998742 14678999999999999998 577774 244
Q ss_pred HHHHHHcCC-CCc-ccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 233 IYKKVISGK-KPE-ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 233 i~k~i~~g~-~p~-~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
+..--..+. .++ -+....++.++.+|..|++ +|++|.||++.|+-
T Consensus 244 L~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 244 LLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 433221111 111 1234457789999999999 99999999999976
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.8e-19 Score=183.70 Aligned_cols=248 Identities=15% Similarity=0.262 Sum_probs=194.9
Q ss_pred ccCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEec
Q 004672 15 LKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 94 (738)
Q Consensus 15 ~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~ 94 (738)
-.+|...++.++.+|.+.-.|..|+|. +.|..++.|++++.+. +...-..|..|.-.|+-+.||||+.+++.+ .
T Consensus 184 ~~gid~~~lnl~tkl~e~hsgelwrgr--wqgndivakil~vr~~--t~risrdfneefp~lrifshpnilpvlgac--n 257 (448)
T KOG0195|consen 184 YTGIDVSSLNLITKLAESHSGELWRGR--WQGNDIVAKILNVREV--TARISRDFNEEFPALRIFSHPNILPVLGAC--N 257 (448)
T ss_pred ccCcchhhhhhhhhhccCCCccccccc--ccCcchhhhhhhhhhc--chhhcchhhhhCcceeeecCCchhhhhhhc--c
Confidence 456777788888999999999999994 6777888888776653 233345688899999999999999999976 4
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEE--ec
Q 004672 95 ANRNINFVTEMFTSGTLRQYRLKHRR--VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI--GD 170 (738)
Q Consensus 95 ~~~~l~LV~Ey~~gGSL~~~l~k~~~--lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL--~D 170 (738)
...++.+|..||+.|+|...+..... ++..++.+++..|+.|++|||+..|-|.---|....++|+.+ -+.+| +|
T Consensus 258 sppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmided-ltarismad 336 (448)
T KOG0195|consen 258 SPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDED-LTARISMAD 336 (448)
T ss_pred CCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecch-hhhheeccc
Confidence 46789999999999999999887654 677899999999999999999998655555688888898744 34333 34
Q ss_pred cchhHHhhccccccccCCCCCCCccccccc----cCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCccc
Q 004672 171 LGLAAILRKSHAARCVGTPEFMAPEVYEEE----YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL 246 (738)
Q Consensus 171 FGlA~~l~~~~~~~~vGTp~YmAPEvl~~~----ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l 246 (738)
--++.. ..-..-.|.||+||.+..+ --.++|+|||++++|||.|.+.||.+..+.+--++....|..+. +
T Consensus 337 ~kfsfq-----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~-i 410 (448)
T KOG0195|consen 337 TKFSFQ-----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVH-I 410 (448)
T ss_pred ceeeee-----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccccc-C
Confidence 322211 1111247899999998743 23479999999999999999999998877777777777776654 4
Q ss_pred ccCCChHHHHHHHHHHh-CcCCCCCHHHHh
Q 004672 247 FKVEDPEVRQFIEKCLA-TVSSRLSARELL 275 (738)
Q Consensus 247 ~~~~spel~~lI~kcL~-dP~~RpSa~ELL 275 (738)
++..++.+..++.-|++ ||.+||....++
T Consensus 411 ppgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 411 PPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred CCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 56778999999999999 999999876553
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.8e-18 Score=173.18 Aligned_cols=140 Identities=15% Similarity=0.140 Sum_probs=109.2
Q ss_pred ceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-----CCCCcceeeEEEEecCC-
Q 004672 23 MEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-----KHRNIMKFYTSWVDTAN- 96 (738)
Q Consensus 23 y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-----~HpNIVkl~~~fv~~~~- 96 (738)
+.-...||+|+++.||. +..++.. +||++.... ....+.+.+|+.+++.| +||||+++|+++....+
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~----~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~ 76 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG----DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT 76 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccc----cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC
Confidence 34567899999999995 6667666 688877533 12346799999999999 67999999998765432
Q ss_pred Ce-EEEEEec--CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCCCceeccCCcccEEEeCC---CCcEEEe
Q 004672 97 RN-INFVTEM--FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGL-LYLHSRDPPVIHRDLKCDNIFVNGN---QGEVKIG 169 (738)
Q Consensus 97 ~~-l~LV~Ey--~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL-~yLHs~gp~IIHRDLKP~NILl~~~---~g~VKL~ 169 (738)
.. +.+|+|| +.+|+|.+++.+. .+++. ..++.|++.++ +|||+++ |+||||||+|||++.. .+.++|+
T Consensus 77 g~v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 77 GYVYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred eEEEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEE
Confidence 34 4478999 5579999999664 56666 46688888888 8999999 9999999999999742 2479999
Q ss_pred ccchh
Q 004672 170 DLGLA 174 (738)
Q Consensus 170 DFGlA 174 (738)
||+.+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95433
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.7e-20 Score=191.86 Aligned_cols=242 Identities=35% Similarity=0.593 Sum_probs=176.1
Q ss_pred EEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEec---CCCeEEEEEecCCCCCHH
Q 004672 36 RHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT---ANRNINFVTEMFTSGTLR 112 (738)
Q Consensus 36 tVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~---~~~~l~LV~Ey~~gGSL~ 112 (738)
.||++.|...|.+|.|+.|+......-...-+....-..-|-++.|.|||+++.+|-+. ......|++|||..|+|.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 47999999999999999887654333222223333445667778899999999999653 234688999999999999
Q ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHh------hcccc
Q 004672 113 QYRLKH----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL------RKSHA 182 (738)
Q Consensus 113 ~~l~k~----~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l------~~~~~ 182 (738)
+++++- ..+..+.+++|+-||+.||.|||+..|||+|+++.++-|++..+ |-|||+--...... .....
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~n-gLIkig~~ap~s~h~s~~~~~~~Ek 239 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHN-GLIKIGSVAPDSTHPSVNSTREAEK 239 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCC-ceEEecccCccccchhhhhhhHhhh
Confidence 998764 45899999999999999999999999999999999999999855 78887643222111 01111
Q ss_pred ccccCCCCCCCccccc-cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHH
Q 004672 183 ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKC 261 (738)
Q Consensus 183 ~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kc 261 (738)
....|-++|.|||.=. ...+.++|||+||++.++|..|+.--.+.......-..+.. .......+--+.+|.+|
T Consensus 240 ~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~-----~i~~len~lqr~~i~kc 314 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIAN-----VIIGLENGLQRGSITKC 314 (458)
T ss_pred hccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhh-----heeeccCccccCcCccc
Confidence 2223678999998643 34667899999999999999988764332211111111111 11122334457899999
Q ss_pred Hh-CcCCCCCHHHHhcCcccCCC
Q 004672 262 LA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 262 L~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
|+ .|..||+++++|.||.+-..
T Consensus 315 l~~eP~~rp~ar~llfHpllfeV 337 (458)
T KOG1266|consen 315 LEGEPNGRPDARLLLFHPLLFEV 337 (458)
T ss_pred ccCCCCCCcchhhhhcCceeeec
Confidence 99 89999999999999998544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.4e-18 Score=171.63 Aligned_cols=185 Identities=14% Similarity=0.046 Sum_probs=138.3
Q ss_pred eEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCC-CCCcceeeEEEEecCCCeEEEE
Q 004672 24 EDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANRNINFV 102 (738)
Q Consensus 24 ~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~l~LV 102 (738)
.+...|++|+||+||.+.. .+..++.+.+.....-...-....+.+|+++|++|. |++|++++++ ...+++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lv 76 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLD 76 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEE
Confidence 4678999999999997754 677887666553332111222336889999999994 5889999884 246899
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccC-CcccEEEeCCCCcEEEeccchhHHhhccc
Q 004672 103 TEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL-KCDNIFVNGNQGEVKIGDLGLAAILRKSH 181 (738)
Q Consensus 103 ~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDL-KP~NILl~~~~g~VKL~DFGlA~~l~~~~ 181 (738)
|||+.|.+|.+.+.. ....++.|++.+|.++|.+| |+|||| ||+|||++.+ |.++|+|||++.......
T Consensus 77 meyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~-g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 77 RSYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQED-GSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred EeeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCC-CCEEEEECCCceecCCcc
Confidence 999999999754321 12457889999999999999 999999 7999999854 799999999997443221
Q ss_pred c--------------c-cccCCCCCCCccccc--cccC-cccccccchhhhhhhhhcCCCCCC
Q 004672 182 A--------------A-RCVGTPEFMAPEVYE--EEYN-ELVDIYSFGMCILEMVTFDYPYSE 226 (738)
Q Consensus 182 ~--------------~-~~vGTp~YmAPEvl~--~~ys-~~sDIWSLGviLyeLlTG~~Pf~~ 226 (738)
. + -...++.|++|+... ...+ ...+.++.|.-+|.++|+..|+.+
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 0 012688899998543 3334 567888999999999999998764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.5e-17 Score=170.30 Aligned_cols=148 Identities=21% Similarity=0.106 Sum_probs=116.5
Q ss_pred CceEEEEEcccCCeEEEEEE-EcCCCeEEEEEEEeccccCC------------------CHH--HHHHHHHHHHHHHhCC
Q 004672 22 DMEDTMKFLVKELQRHYRAF-DEYEGIEVAWNQVKLYDFLQ------------------SPE--ELERLYCEIHLLKTLK 80 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~-d~~tG~~VAIK~vki~~~~~------------------s~e--~~e~l~~Ei~iLk~L~ 80 (738)
.|.+.+.||.|++|.||+|. +..+|..||+|+++...... .+. ....+..|+.+++.+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47889999999999999999 77899999999988543110 011 1235678999999997
Q ss_pred CCC--cceeeEEEEecCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEE
Q 004672 81 HRN--IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 158 (738)
Q Consensus 81 HpN--IVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NIL 158 (738)
+.. +.++++. ...++||||+.|++|..+......+....+..++.||+.+|.+||.+| +|+||||||+||+
T Consensus 109 ~~~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEE
Confidence 533 3444442 124799999999898776555556777788899999999999999986 5999999999999
Q ss_pred EeCCCCcEEEeccchhHHhh
Q 004672 159 VNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 159 l~~~~g~VKL~DFGlA~~l~ 178 (738)
++ .+.++|+|||.+....
T Consensus 182 i~--~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 182 VH--DGKVVIIDVSQSVELD 199 (237)
T ss_pred EE--CCCEEEEEChhhhccC
Confidence 98 4789999999986543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.3e-18 Score=187.65 Aligned_cols=205 Identities=26% Similarity=0.425 Sum_probs=153.1
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeE-------EEEec---CCCeEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHH
Q 004672 66 LERLYCEIHLLKTLKHRNIMKFYT-------SWVDT---ANRNINFVTEMFTSGTLRQYRLKHR---RVNIRAVKHWCRQ 132 (738)
Q Consensus 66 ~e~l~~Ei~iLk~L~HpNIVkl~~-------~fv~~---~~~~l~LV~Ey~~gGSL~~~l~k~~---~lse~~i~~i~~Q 132 (738)
.....+++-.+....|.+..-+.+ .+... ...++||.|++|...+|.+|+...+ ..+...++.|+.|
T Consensus 288 ~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q 367 (516)
T KOG1033|consen 288 CKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQ 367 (516)
T ss_pred hhhhhhhhhheeccccCCcccccCCCCchhhhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHh
Confidence 344555666666664444333322 11111 1236899999999999999997653 3677889999999
Q ss_pred HHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhccc--------cccccCCCCCCCcccccc-ccCc
Q 004672 133 ILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--------AARCVGTPEFMAPEVYEE-EYNE 203 (738)
Q Consensus 133 Il~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~--------~~~~vGTp~YmAPEvl~~-~ys~ 203 (738)
+..|++| ++ .+|||+||.||++..+ ..+||+|||+........ ....+||..||+||.+.+ .|+.
T Consensus 368 ~~~~~~y---k~--~ihrdlkp~nif~~~d-~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~ 441 (516)
T KOG1033|consen 368 IAPAVEY---KG--LIHRDLKPSNIFFSDD-DQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSE 441 (516)
T ss_pred hccchhh---cc--chhhhccccccccccc-hhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhh
Confidence 9999999 76 9999999999999744 689999999997654432 234569999999999985 6999
Q ss_pred ccccccchhhhhhhhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccC
Q 004672 204 LVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 281 (738)
Q Consensus 204 ~sDIWSLGviLyeLlT-G~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~ 281 (738)
++||||||++|+||++ ...++.. ...+..+..|..|+.+.. ..|+-..|+.++|. .|.+||++.+.-.|+|++
T Consensus 442 kvdIyaLGlil~EL~~~f~T~~er----~~t~~d~r~g~ip~~~~~-d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 442 KVDIYALGLILAELLIQFSTQFER----IATLTDIRDGIIPPEFLQ-DYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred hcchhhHHHHHHHHHHHhccHHHH----HHhhhhhhcCCCChHHhh-cCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 9999999999999997 4444433 233455667777754433 35667799999999 899999988888888763
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.6e-16 Score=157.53 Aligned_cols=138 Identities=20% Similarity=0.169 Sum_probs=112.0
Q ss_pred EEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCC----HHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEE
Q 004672 27 MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQS----PEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 102 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s----~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV 102 (738)
+.||+|++|.||+|.. .|..|++|+......... .....++.+|+.++..+.|++|+....++.+ ....+++
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD--PENFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe--CCCCEEE
Confidence 5789999999999976 788899997553221111 1123578899999999999998776666554 4567899
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 103 TEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 103 ~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
|||++|++|.+++..... ....++.+++.+|.+||+.+ ++|+|++|.|||++ .+.++|+|||.+..
T Consensus 78 ~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~--~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS--GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE--CCCEEEEECCcccC
Confidence 999999999999866432 78899999999999999998 99999999999998 37899999998754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.1e-18 Score=197.63 Aligned_cols=257 Identities=23% Similarity=0.299 Sum_probs=206.8
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEc-CCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCC-CCCcceeeEEEEecCC
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDE-YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTAN 96 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~-~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~ 96 (738)
+...|.+...||+|+|+.|-++... .+...+|.|.+.... .+....++...|..+-+.+. |+|++.+++.. ...
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~--~~~ 93 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS--SSP 93 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCcc--CCC
Confidence 4677889999999999999887763 334556666655443 45666778888999999996 99999999965 457
Q ss_pred CeEEEEEecCCCCCHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCCCceeccCCcccEEEeCCCC-cEEEeccc
Q 004672 97 RNINFVTEMFTSGTLRQYR-LKHR-RVNIRAVKHWCRQILSGLLYLH-SRDPPVIHRDLKCDNIFVNGNQG-EVKIGDLG 172 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l-~k~~-~lse~~i~~i~~QIl~aL~yLH-s~gp~IIHRDLKP~NILl~~~~g-~VKL~DFG 172 (738)
...+++++|..|+++...+ .... ..+...+..++.|+..+|.|+| ..+ +.||||||+|.+++.. + .+++.|||
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s-~~~l~~~df~ 170 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDES-GSALKIADFG 170 (601)
T ss_pred cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccC-CCcccCCCch
Confidence 7889999999999999987 5444 6778889999999999999999 877 9999999999999855 6 89999999
Q ss_pred hhHHhhc-cc----cccccC-CCCCCCcccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCC--
Q 004672 173 LAAILRK-SH----AARCVG-TPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK-- 242 (738)
Q Consensus 173 lA~~l~~-~~----~~~~vG-Tp~YmAPEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~-- 242 (738)
+|..+.. .. ....+| ++.|+|||.+.+ ...+..|+||.|+++.-|++|..||.........+..+.....
T Consensus 171 ~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 250 (601)
T KOG0590|consen 171 LATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRF 250 (601)
T ss_pred hhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccccc
Confidence 9988765 22 223358 999999999876 4677899999999999999999999764444433333333221
Q ss_pred CcccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCC
Q 004672 243 PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 243 p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~ 282 (738)
-...+...+....+++.+++. +|..|.+.+++..+||+..
T Consensus 251 ~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 251 TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 234456678889999999997 8999999999999999975
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-15 Score=152.68 Aligned_cols=134 Identities=19% Similarity=0.180 Sum_probs=105.8
Q ss_pred EEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCC----HHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEE
Q 004672 28 KFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQS----PEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVT 103 (738)
Q Consensus 28 kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s----~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~ 103 (738)
.||+|++|+||+|. .+|..|++|+......... .....++.+|+.+++.+.|+++....-++.. ....++||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD--PDNKTIVM 76 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE--CCCCEEEE
Confidence 37999999999997 5788999998553221111 1234678899999999998876544444443 34568999
Q ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 104 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 104 Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
||++|++|.+++..... .++.+++.+|.+||+.+ ++|+|++|.||+++ .+.++++|||++..
T Consensus 77 e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~--~~~~~liDfg~a~~ 138 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR--DDKLYLIDFGLGKY 138 (199)
T ss_pred EEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE--CCcEEEEECCCCcC
Confidence 99999999998755321 78999999999999998 99999999999998 47999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.5e-16 Score=188.16 Aligned_cols=196 Identities=20% Similarity=0.191 Sum_probs=152.6
Q ss_pred cCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCC---CCCcceeeEEEE
Q 004672 16 KLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK---HRNIMKFYTSWV 92 (738)
Q Consensus 16 ~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~---HpNIVkl~~~fv 92 (738)
-.+....|.|-+.||.|+||+||+|.+.. |+.||+|+=+-.. .. .++=-.+++.+|+ -+.|+.+...++
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~----~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPN----PW---EFYICLQVMERLKPQMLPSIMHISSAHV 764 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCC----ce---eeeehHHHHHhhchhhhcchHHHHHHHc
Confidence 34455679999999999999999999876 9999999644322 11 1222334444444 234555554444
Q ss_pred ecCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeC------CCCcE
Q 004672 93 DTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG------NQGEV 166 (738)
Q Consensus 93 ~~~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~------~~g~V 166 (738)
. .+.-++|+||.+.|||.++++..+.+++..+..+..||+..+++||..+ |||+||||+|.||.. +.--+
T Consensus 765 ~--~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 765 F--QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred c--CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccce
Confidence 3 4556889999999999999998889999999999999999999999999 999999999999942 22358
Q ss_pred EEeccchhHHhh---cc-ccccccCCCCCCCccccccc-cCcccccccchhhhhhhhhcCCC
Q 004672 167 KIGDLGLAAILR---KS-HAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP 223 (738)
Q Consensus 167 KL~DFGlA~~l~---~~-~~~~~vGTp~YmAPEvl~~~-ys~~sDIWSLGviLyeLlTG~~P 223 (738)
+|+|||.+..+. +. .....++|-.|--+|+..++ ++..+|-|.|+.+++-||.|++-
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 999999996543 12 23344588899999999875 89999999999999999998763
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1e-15 Score=153.91 Aligned_cols=141 Identities=20% Similarity=0.094 Sum_probs=109.4
Q ss_pred ceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCC-----C-------------HHHHHHHHHHHHHHHhCCCCC-
Q 004672 23 MEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQ-----S-------------PEELERLYCEIHLLKTLKHRN- 83 (738)
Q Consensus 23 y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~-----s-------------~e~~e~l~~Ei~iLk~L~HpN- 83 (738)
|.+.+.||.|+||.||+|... +|..||||.+....... . .........|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 778899999999999999874 89999999877532100 0 011224678999999998874
Q ss_pred -cceeeEEEEecCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCC
Q 004672 84 -IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 162 (738)
Q Consensus 84 -IVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~ 162 (738)
++..++ ....++||||++|++|..+... .....++.+|+.++.++|..+ |+||||||+||+++.
T Consensus 96 ~v~~~~~------~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~- 160 (198)
T cd05144 96 PVPKPID------WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDD- 160 (198)
T ss_pred CCCceee------cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcC-
Confidence 444443 2345899999999999775321 346778999999999999998 999999999999985
Q ss_pred CCcEEEeccchhHHhhc
Q 004672 163 QGEVKIGDLGLAAILRK 179 (738)
Q Consensus 163 ~g~VKL~DFGlA~~l~~ 179 (738)
++.++|+|||++.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 47999999999965443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.62 E-value=3e-15 Score=173.01 Aligned_cols=138 Identities=16% Similarity=0.110 Sum_probs=108.5
Q ss_pred ceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccC----CCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCe
Q 004672 23 MEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFL----QSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 23 y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~----~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 98 (738)
|...++||+|+||+||+|... +..+++|+....... ......+++.+|+++|+.++|++|+..+.++.. ...
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~ 410 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--PEE 410 (535)
T ss_pred cCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--CCC
Confidence 355789999999999999754 444555543221111 112234678999999999999999887766554 345
Q ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 99 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
.++||||++|++|.+++. ....++.+++.+|.|||+.+ ++||||||+|||++ .+.++|+|||++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl~--~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIVR--DDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEEE--CCcEEEEeCccccc
Confidence 689999999999999875 35778999999999999998 99999999999994 36899999999865
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.7e-15 Score=170.64 Aligned_cols=197 Identities=25% Similarity=0.384 Sum_probs=153.5
Q ss_pred HHhCCCCCcceeeEEEEecCCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCc
Q 004672 76 LKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 154 (738)
Q Consensus 76 Lk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP 154 (738)
|+.+.|.|+.+|++.+++. ..+++|.+||.-|+|.+.+... ..++......+++.|+.||.|||..- --.|+.++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP-IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc-ceeeeeecc
Confidence 4678999999999988774 7899999999999999998873 46888888899999999999999874 239999999
Q ss_pred ccEEEeCCCCcEEEeccchhHHhhc----cccccccCCCCCCCccccccc--------cCcccccccchhhhhhhhhcCC
Q 004672 155 DNIFVNGNQGEVKIGDLGLAAILRK----SHAARCVGTPEFMAPEVYEEE--------YNELVDIYSFGMCILEMVTFDY 222 (738)
Q Consensus 155 ~NILl~~~~g~VKL~DFGlA~~l~~----~~~~~~vGTp~YmAPEvl~~~--------ys~~sDIWSLGviLyeLlTG~~ 222 (738)
.|.+++.. -.+||+|||+...... .......-...|.|||++... .+.+.||||||++++|+++..-
T Consensus 78 ~nClvd~~-w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 78 SNCLVDSR-WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred ccceeeee-EEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999966 5899999999877642 001111134579999998752 4667999999999999999999
Q ss_pred CCCCC---CCHHHHHHHHHc-CCC---Cccccc-CCChHHHHHHHHHHh-CcCCCCCHHHHhc
Q 004672 223 PYSEC---THPAQIYKKVIS-GKK---PEALFK-VEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 223 Pf~~~---~~~~qi~k~i~~-g~~---p~~l~~-~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
||... ..++++...+.. +.. |.-... ...+++..++..||. +|.+||++..+-.
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 99752 233456666665 332 221111 234579999999999 8999999987743
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.3e-14 Score=143.49 Aligned_cols=141 Identities=23% Similarity=0.144 Sum_probs=100.0
Q ss_pred EEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHH---------------------HHHHHHHHHHHhCCCCC-
Q 004672 26 TMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEEL---------------------ERLYCEIHLLKTLKHRN- 83 (738)
Q Consensus 26 l~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~---------------------e~l~~Ei~iLk~L~HpN- 83 (738)
.+.||+|+||+||+|.+. +|..||+|+++...... .... .....|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSF-KKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccch-hhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 467999999999999986 89999999887532111 1111 11246777777775443
Q ss_pred -cceeeEEEEecCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCcccEEEeC
Q 004672 84 -IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNG 161 (738)
Q Consensus 84 -IVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs-~gp~IIHRDLKP~NILl~~ 161 (738)
+.+.+.. ...++||||++++.+........... ..+..++.+++.++.++|. .+ |+||||||+||+++
T Consensus 80 ~~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~- 149 (187)
T cd05119 80 PVPKPIDL------NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD- 149 (187)
T ss_pred CCCceEec------CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-
Confidence 4555542 23589999999854321111111111 6678999999999999999 87 99999999999998
Q ss_pred CCCcEEEeccchhHHhhc
Q 004672 162 NQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 162 ~~g~VKL~DFGlA~~l~~ 179 (738)
++.++|+|||.+.....
T Consensus 150 -~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -CCcEEEEECcccccccC
Confidence 47999999999965433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.3e-13 Score=143.84 Aligned_cols=141 Identities=16% Similarity=0.161 Sum_probs=106.9
Q ss_pred EEEEc-ccCCeEEEEEEEcCCCeEEEEEEEecccc---------CCCHHHHHHHHHHHHHHHhCCCCCc--ceeeEEEEe
Q 004672 26 TMKFL-VKELQRHYRAFDEYEGIEVAWNQVKLYDF---------LQSPEELERLYCEIHLLKTLKHRNI--MKFYTSWVD 93 (738)
Q Consensus 26 l~kLG-~GafgtVYkA~d~~tG~~VAIK~vki~~~---------~~s~e~~e~l~~Ei~iLk~L~HpNI--Vkl~~~fv~ 93 (738)
...|| .|+.|+||.+.. .|..+++|.+..... .-+.....++.+|+.++..|.|++| ++.+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 35677 889999998865 488999998864221 1112345678999999999998885 667765433
Q ss_pred cCCC--eEEEEEecCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEec
Q 004672 94 TANR--NINFVTEMFTS-GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 170 (738)
Q Consensus 94 ~~~~--~l~LV~Ey~~g-GSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~D 170 (738)
.... ..++|||+++| .+|.+++.. ..+++.. +.||+.+|.+||.+| |+||||||.|||++.+ +.++|+|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~-~~v~LID 185 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLDPD-GKFWLID 185 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEcCC-CCEEEEE
Confidence 2222 23599999997 699988755 4566543 578999999999999 9999999999999855 6899999
Q ss_pred cchhHH
Q 004672 171 LGLAAI 176 (738)
Q Consensus 171 FGlA~~ 176 (738)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998854
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.2e-13 Score=126.83 Aligned_cols=134 Identities=17% Similarity=0.053 Sum_probs=109.1
Q ss_pred EEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCC--CCcceeeEEEEecCCCeEEEE
Q 004672 25 DTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH--RNIMKFYTSWVDTANRNINFV 102 (738)
Q Consensus 25 il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~H--pNIVkl~~~fv~~~~~~l~LV 102 (738)
+++.||.|.++.||++.+.. ..+++|.+..... ...+..|+.+++.+.| ..+++++.++. ..+..+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~--~~~~~~~v 71 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGE--SDGWSYLL 71 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcC--CCCccEEE
Confidence 56889999999999998743 7899998763321 4578899999999976 58889887653 34678999
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-CCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 103 TEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD-PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 103 ~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~g-p~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
|||+.++.+..+ +......++.+++.+|.+||... .+++|+|++|+||+++. .+.++++|||.+..
T Consensus 72 ~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~-~~~~~l~Df~~~~~ 138 (155)
T cd05120 72 MEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD-GKILGIIDWEYAGY 138 (155)
T ss_pred EEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC-CcEEEEEecccccC
Confidence 999998888754 55667788999999999999852 24999999999999985 47899999998853
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.8e-14 Score=159.30 Aligned_cols=252 Identities=20% Similarity=0.207 Sum_probs=199.9
Q ss_pred ceEEEEEcc--cCCeEEEEEEE--cCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEecCCC
Q 004672 23 MEDTMKFLV--KELQRHYRAFD--EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 23 y~il~kLG~--GafgtVYkA~d--~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~ 97 (738)
+-+...+|. |.+|.||.+.. ..++..+|+|.-++. ...+....+-++|+...+.+ .|+|.++.+..|.+ .+
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p--~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~--~~ 191 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP--FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG--SG 191 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCC--CCCccccccccchhhcccccCccccccccCccccc--CC
Confidence 556788999 99999999999 889999999974432 22233344566777777777 69999999988754 67
Q ss_pred eEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHH----HHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccc
Q 004672 98 NINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILS----GLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 172 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~~-~lse~~i~~i~~QIl~----aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFG 172 (738)
..++-+|++ +.+|..+...-. -++...++..+.+... ||.++|+.+ ++|-|+||+||++..+....+++|||
T Consensus 192 ~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 192 ILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred cceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCcc
Confidence 888899998 688888876644 4888999999999999 999999998 99999999999998775688999999
Q ss_pred hhHHhhcccc-------ccccCCCCCCCccccccccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcc
Q 004672 173 LAAILRKSHA-------ARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEA 245 (738)
Q Consensus 173 lA~~l~~~~~-------~~~vGTp~YmAPEvl~~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~ 245 (738)
+...+..... ....|...|++||+..+-++...|||++|.++.+..++..++....+. -+..+..+..|..
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--~W~~~r~~~ip~e 346 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS--SWSQLRQGYIPLE 346 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC--CccccccccCchh
Confidence 9987765432 122478899999999999999999999999999999887766432111 1222334446666
Q ss_pred cccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 246 LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 246 l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
+....+..++..+..++. ++..|++++.++.|+++...
T Consensus 347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 347 FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred hhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 666667788888888998 89999999999999999743
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=7.4e-14 Score=164.74 Aligned_cols=264 Identities=20% Similarity=0.302 Sum_probs=208.7
Q ss_pred CcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCC
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 96 (738)
...++.+.+.+.+.+|+++.++.+.-..+|...++|...+...... ...+.+..+-.++-...+|.++...-.| ...
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~-~~~~s~r~~s~~~i~p~~P~v~~~~~s~--~~r 876 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT-NDYESIRSKSNILITPRSPAVVRSFPSF--PCR 876 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhcc-ccccccCCccCccccCCCCceecccCCC--CCC
Confidence 4677889999999999999999998888887777776554432221 2234455555555556678888766554 345
Q ss_pred CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 97 ~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
...+++++|..+++|...+..-+..+....+.+...+..+++|||+.. +.|||++|.|+++..+ |+.+++|||....
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~-gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYD-GHRPLTDFGTLSK 953 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch--hhcccccccchhhccc-CCcccCccccccc
Confidence 688999999999999999888888888889999999999999999987 9999999999999754 8999999984322
Q ss_pred hh------------------------------c---cccccccCCCCCCCcccccc-ccCcccccccchhhhhhhhhcCC
Q 004672 177 LR------------------------------K---SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDY 222 (738)
Q Consensus 177 l~------------------------------~---~~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviLyeLlTG~~ 222 (738)
.. . .......||+.|.+||.+.+ .....+|.|++|+++++.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 10 0 00123358999999998765 47788999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCccc-ccCCChHHHHHHHHHHh-CcCCCCCHH---HHhcCcccCCCCCch
Q 004672 223 PYSECTHPAQIYKKVISGKKPEAL-FKVEDPEVRQFIEKCLA-TVSSRLSAR---ELLTDPFLQIDDYDS 287 (738)
Q Consensus 223 Pf~~~~~~~qi~k~i~~g~~p~~l-~~~~spel~~lI~kcL~-dP~~RpSa~---ELL~Hpf~~~~~~~~ 287 (738)
||.. ..+.+++..+..+..|... ....++++++++...|. +|.+|..+. ++-.|+||+..++..
T Consensus 1034 p~na-~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1034 PFNA-ETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred CCCC-cchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc
Confidence 9986 6788888888877665333 34468899999999999 899999888 999999999877653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.17 E-value=1e-10 Score=113.40 Aligned_cols=129 Identities=19% Similarity=0.074 Sum_probs=95.0
Q ss_pred EEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCc-ceeeEEEEecCCCeEEEEEe
Q 004672 26 TMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNI-MKFYTSWVDTANRNINFVTE 104 (738)
Q Consensus 26 l~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNI-Vkl~~~fv~~~~~~l~LV~E 104 (738)
++.|+.|.++.||++.. .|..|++|...... .....+..|+.+++.+.+.++ .+++.. +. ...++|||
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~--~~~~lv~e 71 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGT-----ELLINRENEAENSKLAAEAGIGPKLYYF--DP--ETGVLITE 71 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCc-----ccccCHHHHHHHHHHHHHhCCCCceEEE--eC--CCCeEEEE
Confidence 57789999999999975 48889999754221 112346789999999965554 455543 22 23478999
Q ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC---CceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 105 MFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP---PVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 105 y~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp---~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
|++|.++... . .....++.+++.+|..||..+. .++|+|++|.||+++ + +.++++|||.+.
T Consensus 72 ~i~G~~l~~~----~----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~-~~~~liDf~~a~ 135 (170)
T cd05151 72 FIEGSELLTE----D----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D-GRLWLIDWEYAG 135 (170)
T ss_pred ecCCCccccc----c----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C-CeEEEEeccccc
Confidence 9999888653 1 1123457899999999999861 259999999999998 3 589999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.1e-11 Score=140.32 Aligned_cols=147 Identities=18% Similarity=0.164 Sum_probs=94.6
Q ss_pred CCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEecccc--------------------------CCC----HHHHHHHH
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDF--------------------------LQS----PEELERLY 70 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~--------------------------~~s----~e~~e~l~ 70 (738)
.+|.. +.||+|++|.||+|..+.+|+.||||+.+..-. ..- .+..+.+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45655 799999999999999988899999998863210 000 02223344
Q ss_pred HHHHH------HHhC----CCCCcceeeEEEEecCCCeEEEEEecCCCCCHHHH--HHhcC----CCCHHHHHHHHHHHH
Q 004672 71 CEIHL------LKTL----KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY--RLKHR----RVNIRAVKHWCRQIL 134 (738)
Q Consensus 71 ~Ei~i------Lk~L----~HpNIVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~--l~k~~----~lse~~i~~i~~QIl 134 (738)
+|+.. +.++ .+.+.+.+-..+.+- ....+|||||+.|+.|.++ +...+ .+.+..+..++.|++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 44443 3333 133222222222111 2345799999999999875 23322 244555556666665
Q ss_pred HHHHHHHhCCCCceeccCCcccEEEeCCC---CcEEEeccchhHHhh
Q 004672 135 SGLLYLHSRDPPVIHRDLKCDNIFVNGNQ---GEVKIGDLGLAAILR 178 (738)
Q Consensus 135 ~aL~yLHs~gp~IIHRDLKP~NILl~~~~---g~VKL~DFGlA~~l~ 178 (738)
..| ++|+|+||.||+++.+. ++++++|||++..+.
T Consensus 278 -------~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 -------RDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -------hCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 366 99999999999998552 389999999986654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.1e-10 Score=132.17 Aligned_cols=144 Identities=19% Similarity=0.119 Sum_probs=95.0
Q ss_pred EEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCH------------------------------HHHH------HH
Q 004672 26 TMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSP------------------------------EELE------RL 69 (738)
Q Consensus 26 l~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~------------------------------e~~e------~l 69 (738)
.+.||.|++|.||+|.. .+|+.||||+.+..-...-. +... .+
T Consensus 122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 36799999999999986 48999999986532100000 0000 23
Q ss_pred HHHHHHHHhC----C-CCCcceeeEEEEecCCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHh
Q 004672 70 YCEIHLLKTL----K-HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILS-GLLYLHS 142 (738)
Q Consensus 70 ~~Ei~iLk~L----~-HpNIVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~-aL~yLHs 142 (738)
..|...+.++ + +++| .+-..+.+- ....++||||++|++|.++.... ..++ ...++.+++. .+..+|.
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 201 RREAANASELGENFKNDPGV-YVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCE-EeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHh
Confidence 4455555555 2 3332 222222111 23468999999999998876432 1222 3445666655 4678899
Q ss_pred CCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh
Q 004672 143 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 143 ~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~ 178 (738)
.| ++|+|+||.||+++.+ |.++|+|||++..+.
T Consensus 276 ~g--~~H~D~hPgNilv~~~-g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DG--FFHADLHPGNIFVLKD-GKIIALDFGIVGRLS 308 (437)
T ss_pred CC--ceeCCCCcccEEECCC-CcEEEEeCCCeeECC
Confidence 88 9999999999999754 899999999986554
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.9e-11 Score=135.92 Aligned_cols=252 Identities=18% Similarity=0.120 Sum_probs=183.6
Q ss_pred cCcCCCCceEEEEEcccCCeEEEEEEEc-CCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEEEe
Q 004672 16 KLIPLEDMEDTMKFLVKELQRHYRAFDE-YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVD 93 (738)
Q Consensus 16 ~~I~~~~y~il~kLG~GafgtVYkA~d~-~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~ 93 (738)
......++..+..||.|.|+.|+...-. ..+..|++|.+...- ........-..|+.+...+ .|.+++.++..|..
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~ 337 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ 337 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCccc
Confidence 4455678899999999999999876644 677889988766332 2223334456677888777 69999999998865
Q ss_pred cCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccch
Q 004672 94 TANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 173 (738)
Q Consensus 94 ~~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGl 173 (738)
.+..++=.|||.++++...+.....+++...+.+..|++.++.++|+.. ++|+|+||.||++..+++.-+++|||.
T Consensus 338 --~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 338 --LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred --cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhcccccc
Confidence 5667789999999998877655566888899999999999999999998 999999999999985546789999998
Q ss_pred hHHhhccccccccCCCCCC-Ccccccc--ccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCC
Q 004672 174 AAILRKSHAARCVGTPEFM-APEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE 250 (738)
Q Consensus 174 A~~l~~~~~~~~vGTp~Ym-APEvl~~--~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~ 250 (738)
...+.-.. ....+.-.++ .+|++.+ .+..+.|++|||..+.+.+++..--.... ....+.+|..|... ..
T Consensus 414 ~t~~~~~~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~~p~~~--~~ 486 (524)
T KOG0601|consen 414 WTRLAFSS-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSGDTPNLP--GL 486 (524)
T ss_pred ccccceec-ccccccccccccchhhccccccccccccccccccccccccCcccCcccc----cceeeecccccCCC--ch
Confidence 86422111 1112334444 3555543 47789999999999999998765322211 12334555555322 22
Q ss_pred ChHHHHHHHHHHh-CcCCCCCHHHHhcCccc
Q 004672 251 DPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 251 spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~ 280 (738)
..++..+.+.++. ++..|+++.++..|.=|
T Consensus 487 ~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 487 KLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred HHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 2566777777777 88999999999888765
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.11 E-value=7.2e-10 Score=112.48 Aligned_cols=141 Identities=18% Similarity=0.107 Sum_probs=102.6
Q ss_pred EEEcccCCeEEEEEEEcC------CCeEEEEEEEeccc--cCC-------C---------HHHHHHHH----HHHHHHHh
Q 004672 27 MKFLVKELQRHYRAFDEY------EGIEVAWNQVKLYD--FLQ-------S---------PEELERLY----CEIHLLKT 78 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~------tG~~VAIK~vki~~--~~~-------s---------~e~~e~l~----~Ei~iLk~ 78 (738)
..||.|-=+.||.|.... .+..+|+|..+... +.. . ..-.+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998654 35899999888532 100 0 11122333 89999999
Q ss_pred CC--CCCcceeeEEEEecCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceeccCCcc
Q 004672 79 LK--HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYL-HSRDPPVIHRDLKCD 155 (738)
Q Consensus 79 L~--HpNIVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yL-Hs~gp~IIHRDLKP~ 155 (738)
|. .-++.+.+++ ..-+|||||+.++.+..-..+...++...+..+..+++.+|..| |..+ |+|+||++.
T Consensus 83 l~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHH
Confidence 94 3567777763 24578999997654432223333466677788899999999999 8888 999999999
Q ss_pred cEEEeCCCCcEEEeccchhHHh
Q 004672 156 NIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 156 NILl~~~~g~VKL~DFGlA~~l 177 (738)
|||+.. |.+.|+|||.+...
T Consensus 155 NIL~~~--~~v~iIDF~qav~~ 174 (197)
T cd05146 155 NMLWHD--GKVWFIDVSQSVEP 174 (197)
T ss_pred HEEEEC--CcEEEEECCCceeC
Confidence 999973 68999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.8e-10 Score=128.49 Aligned_cols=168 Identities=24% Similarity=0.250 Sum_probs=125.6
Q ss_pred EEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEecCCCCCHHHHHHhc
Q 004672 39 RAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH 118 (738)
Q Consensus 39 kA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~ 118 (738)
.|..+.+|.+|.|...+... .+..+...+-++.|+.|+||||++|++.+.. .+.+|+|||-+. -|..++++.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~----~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~--~~~~ylvTErV~--Pl~~~lk~l 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSN----GEVTELAKRAVKRLKTLRHPNILSYLDTTEE--EGTLYLVTERVR--PLETVLKEL 101 (690)
T ss_pred ccceeccCCceEEEEEeCCC----chhhHHHHHHHHHhhhccCchhhhhhhhhcc--cCceEEEeeccc--cHHHHHHHh
Confidence 46667889999998887543 2455678888999999999999999998754 569999999984 566666654
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcccc--ccccCCCCCCCccc
Q 004672 119 RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA--ARCVGTPEFMAPEV 196 (738)
Q Consensus 119 ~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~~--~~~vGTp~YmAPEv 196 (738)
. ...+..-+.||+.||.|||..+ .++|++|.-+.|+|+.. |..||++|.++........ ....---.|..|+.
T Consensus 102 ~---~~~v~~Gl~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn~~-GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 102 G---KEEVCLGLFQILAALSFLNDDC-NLVHGNVCKDSVFVNES-GEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEE 176 (690)
T ss_pred H---HHHHHHHHHHHHHHHHHHhccC-CeeeccEeeeeEEEcCC-CcEEEeeeEEEeccccCCcccccchhhhcccChhh
Confidence 3 6667778999999999998653 49999999999999855 8999999998854432211 11111223445544
Q ss_pred cccccCcccccccchhhhhhhhhc
Q 004672 197 YEEEYNELVDIYSFGMCILEMVTF 220 (738)
Q Consensus 197 l~~~ys~~sDIWSLGviLyeLlTG 220 (738)
+... .-..|.|-||+++++++.|
T Consensus 177 ~~~s-~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDPS-EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCcc-ccchhhhhHHHHHHHHhCc
Confidence 4211 1246999999999999998
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.7e-08 Score=113.02 Aligned_cols=214 Identities=17% Similarity=0.245 Sum_probs=156.1
Q ss_pred CCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEec--CCCeEEEEEecCCC-C
Q 004672 33 ELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT--ANRNINFVTEMFTS-G 109 (738)
Q Consensus 33 afgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~--~~~~l~LV~Ey~~g-G 109 (738)
-..+.|+++...+|..|++|++.... .++.. ....-+++++++.|+|||+|.++|... ....++||++|.++ +
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r-~~~~n---k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDR-DQSTN---KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred ccceeEeeeeccCCceeeeeeecccc-ccCcc---cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 34688999999999999999984322 22221 234457899999999999999988632 34589999999875 5
Q ss_pred CHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 110 TLRQYRLK---------------HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 110 SL~~~l~k---------------~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
+|.++.-. ..+.++..++.++.||..||.++|+.| +.-+-|.|.+||++++ -+|+|...|..
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~-~RIriS~C~i~ 440 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGK-MRIRISGCGIM 440 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCc-ceEEEecccce
Confidence 77776322 124788999999999999999999999 8889999999999977 38899888877
Q ss_pred HHhhccccccccCCCCCCCccccccccCcccccccchhhhhhhhhcCCCCCCCCCHHHH-HHHHHcCCCCcccccCCChH
Q 004672 175 AILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQI-YKKVISGKKPEALFKVEDPE 253 (738)
Q Consensus 175 ~~l~~~~~~~~vGTp~YmAPEvl~~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi-~k~i~~g~~p~~l~~~~spe 253 (738)
..+..... +.+.+ -.+-|.=.||.+++.|.||..--.......+. .+. +...++.+
T Consensus 441 Dvl~~d~~------------~~le~--~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~---------I~~~yS~D 497 (655)
T KOG3741|consen 441 DVLQEDPT------------EPLES--QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR---------ITTTYSTD 497 (655)
T ss_pred eeecCCCC------------cchhH--HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH---------hhhhhhHH
Confidence 65544321 11111 13457778999999999986542221222222 222 23567889
Q ss_pred HHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 254 VRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 254 l~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
++++|+.+.. .+.+ .++.++|-+
T Consensus 498 ~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 498 LRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHHhcCccc-ccHHHHHHH
Confidence 9999999998 5665 788888876
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.91 E-value=5.8e-09 Score=104.89 Aligned_cols=146 Identities=18% Similarity=0.205 Sum_probs=106.3
Q ss_pred EEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCC--CCcceeeEEEEecC-CCeEEEE
Q 004672 26 TMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH--RNIMKFYTSWVDTA-NRNINFV 102 (738)
Q Consensus 26 l~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~H--pNIVkl~~~fv~~~-~~~l~LV 102 (738)
.+.|+.|.++.||++... .|..+++|........ .....+..|+.+++.+.+ .++.+++.+..... .+..++|
T Consensus 3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v 78 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYV 78 (223)
T ss_pred ceecCCCccceEEEEEec-CCcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEE
Confidence 467899999999999764 3688999976533211 124568899999999965 34567776432211 1356899
Q ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 004672 103 TEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD-------------------------------------- 144 (738)
Q Consensus 103 ~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~g-------------------------------------- 144 (738)
|||++|.+|.+.+.. ..+++.....++.+++.+|..||+..
T Consensus 79 ~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 79 MERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred EEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 999999988775432 45677777888888888888888521
Q ss_pred ----------------CCceeccCCcccEEEeCC-CCcEEEeccchhHH
Q 004672 145 ----------------PPVIHRDLKCDNIFVNGN-QGEVKIGDLGLAAI 176 (738)
Q Consensus 145 ----------------p~IIHRDLKP~NILl~~~-~g~VKL~DFGlA~~ 176 (738)
..++|+|++|.||+++.+ .+.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246999999999999863 35689999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.6e-08 Score=99.26 Aligned_cols=145 Identities=19% Similarity=0.233 Sum_probs=108.7
Q ss_pred EEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccc-----cCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeE
Q 004672 25 DTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYD-----FLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 25 il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~-----~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 99 (738)
.+..|.+||-+.|+++. ..|+...||. +... .....-..++..+|+++|.++.--.|.--.-+|++.. .-
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~-Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~--~~ 85 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKE-RFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY--GG 85 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEee-cccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC--CC
Confidence 57889999999999995 6888888874 2222 1122334578899999999996555543333556643 44
Q ss_pred EEEEecCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcE--EEeccchh
Q 004672 100 NFVTEMFTS-GTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV--KIGDLGLA 174 (738)
Q Consensus 100 ~LV~Ey~~g-GSL~~~l~k~~--~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~V--KL~DFGlA 174 (738)
.|+|||+.| .++.+++...- .........++++|-..+.-||.++ |||+||..+||++.++.+.+ .++|||++
T Consensus 86 ~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 86 QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecch
Confidence 679999966 48899987752 3344444788999999999999999 99999999999998766555 89999998
Q ss_pred HH
Q 004672 175 AI 176 (738)
Q Consensus 175 ~~ 176 (738)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 54
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.4e-08 Score=98.69 Aligned_cols=134 Identities=19% Similarity=0.208 Sum_probs=98.0
Q ss_pred EEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHH-----HHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEE
Q 004672 27 MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPE-----ELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e-----~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~L 101 (738)
..++.|+-+.+|.+ .+-|..+.+|. ++.+.-..++ -.++..+|+++|.++.--.|..-+=++++ ...-.|
T Consensus 2 ~~i~~GAEa~i~~~--~~~g~~av~K~-Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~~~~~I 76 (204)
T COG3642 2 DLIKQGAEAIIYLT--DFLGLPAVVKE-RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--PDNGLI 76 (204)
T ss_pred chhhCCcceeEEee--eccCcceEEEe-ecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--CCCCEE
Confidence 35788999999988 34566666663 4443222233 23577889999999965444333323355 445678
Q ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 102 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
+|||++|-.|.+++... ...+++.+=.-+.-||..| |+|+||.++||++.+. .+.++||||+..
T Consensus 77 ~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~--~i~~IDfGLg~~ 140 (204)
T COG3642 77 VMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGG--RIYFIDFGLGEF 140 (204)
T ss_pred EEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCC--cEEEEECCcccc
Confidence 99999999999998775 2456677777788899999 9999999999999743 599999999864
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.2e-06 Score=93.23 Aligned_cols=136 Identities=16% Similarity=0.128 Sum_probs=96.0
Q ss_pred CeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHH----------HHHHHHHHHHhCCCCCc--ceeeEEEEecC---CCe
Q 004672 34 LQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELE----------RLYCEIHLLKTLKHRNI--MKFYTSWVDTA---NRN 98 (738)
Q Consensus 34 fgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e----------~l~~Ei~iLk~L~HpNI--Vkl~~~fv~~~---~~~ 98 (738)
...|++. ...|..|.||+...... .+..+ .+.+|...+..|..-+| ++...+..... ...
T Consensus 35 ~rrvvr~--~~~g~~~~vKr~~~~~~---~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~ 109 (268)
T PRK15123 35 GRRTLRF--ELAGKSYFLKWHRGTGW---GEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRT 109 (268)
T ss_pred CceEEEE--EECCEEEEEEEecCCcH---HHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccce
Confidence 3345554 45788899997642221 11111 37789998888844343 33343333221 235
Q ss_pred EEEEEecCCCC-CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeC------CCCcEEEe
Q 004672 99 INFVTEMFTSG-TLRQYRLK--HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG------NQGEVKIG 169 (738)
Q Consensus 99 l~LV~Ey~~gG-SL~~~l~k--~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~------~~g~VKL~ 169 (738)
-+||||++++. +|.+++.. ....+......++.+++..+.-||..| |+|+|+++.|||++. +.+.+.|+
T Consensus 110 s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LI 187 (268)
T PRK15123 110 SFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVI 187 (268)
T ss_pred eEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEE
Confidence 68999999876 89999764 345667778899999999999999999 999999999999974 24689999
Q ss_pred ccchhHH
Q 004672 170 DLGLAAI 176 (738)
Q Consensus 170 DFGlA~~ 176 (738)
||+.+..
T Consensus 188 Dl~r~~~ 194 (268)
T PRK15123 188 DLHRAQI 194 (268)
T ss_pred ECCcccc
Confidence 9998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.8e-07 Score=93.08 Aligned_cols=129 Identities=26% Similarity=0.205 Sum_probs=83.8
Q ss_pred EEEEEEEcCCCeEEEEEEEeccc--------------c--------CCCHHHHHHHHHHHHHHHhCCCC--CcceeeEEE
Q 004672 36 RHYRAFDEYEGIEVAWNQVKLYD--------------F--------LQSPEELERLYCEIHLLKTLKHR--NIMKFYTSW 91 (738)
Q Consensus 36 tVYkA~d~~tG~~VAIK~vki~~--------------~--------~~s~e~~e~l~~Ei~iLk~L~Hp--NIVkl~~~f 91 (738)
.||.|.. ..|..+|+|..+... . ....-......+|.+.|..+..- ++.+.+++
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 4899986 678899999888632 0 01112346788999999999765 56777753
Q ss_pred EecCCCeEEEEEecCC--CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCCCceeccCCcccEEEeCCCCcEEE
Q 004672 92 VDTANRNINFVTEMFT--SGTLRQYRLKHRRVNIRAVKHWCRQILSGLLY-LHSRDPPVIHRDLKCDNIFVNGNQGEVKI 168 (738)
Q Consensus 92 v~~~~~~l~LV~Ey~~--gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~y-LHs~gp~IIHRDLKP~NILl~~~~g~VKL 168 (738)
. .-.|||||++ |..+..+... .++......++.+++..+.. +|..| |+|+||.+.|||++.+ .+.|
T Consensus 79 -~----~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~--~~~i 147 (188)
T PF01163_consen 79 -N----RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG--KVYI 147 (188)
T ss_dssp -E----TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT--CEEE
T ss_pred -e----CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc--eEEE
Confidence 2 2268999998 6555543222 12244567778888886555 57888 9999999999999844 8999
Q ss_pred eccchhHHh
Q 004672 169 GDLGLAAIL 177 (738)
Q Consensus 169 ~DFGlA~~l 177 (738)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.3e-07 Score=109.37 Aligned_cols=147 Identities=20% Similarity=0.235 Sum_probs=106.8
Q ss_pred HHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhhcccc-----------ccccCCCCCCCcccccc-cc
Q 004672 134 LSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-----------ARCVGTPEFMAPEVYEE-EY 201 (738)
Q Consensus 134 l~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~~-----------~~~vGTp~YmAPEvl~~-~y 201 (738)
+.||.|+|.. +.+||+.|.|++|.++.+ |.+||+.|+++........ .-......|.|||++.+ .-
T Consensus 109 ~dgl~flh~s-Ak~VH~ni~p~~i~~na~-~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~ 186 (700)
T KOG2137|consen 109 ADGLAFLHRS-AKVVHGNIQPEAIVVNAN-GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN 186 (700)
T ss_pred cchhhhhccC-cceeecccchhheeeccC-cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence 3899999998 479999999999999966 8999999999866544211 11125678999998875 46
Q ss_pred Ccccccccchhhhhhhh-hcCCCCCCCCCHHHHHHHHH-cCCCC-cccccCCChHHHHHHHHHHh-CcCCCCCHHHHhcC
Q 004672 202 NELVDIYSFGMCILEMV-TFDYPYSECTHPAQIYKKVI-SGKKP-EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 202 s~~sDIWSLGviLyeLl-TG~~Pf~~~~~~~qi~k~i~-~g~~p-~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
+.++|+||+|+++|.+. .|+.-+..... ...+.... .+... .......++++++=+.++|. ++..||++.+++..
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAANGG-LLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhccCC-cchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence 78899999999999999 45555543222 22222111 11111 11224567899999999999 99999999999999
Q ss_pred cccCCC
Q 004672 278 PFLQID 283 (738)
Q Consensus 278 pf~~~~ 283 (738)
|||...
T Consensus 266 ~ff~D~ 271 (700)
T KOG2137|consen 266 PFFSDP 271 (700)
T ss_pred cccCCc
Confidence 999643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.35 E-value=3.9e-06 Score=85.58 Aligned_cols=109 Identities=17% Similarity=0.163 Sum_probs=84.5
Q ss_pred HHHHHHHHHHHHhCCCCC--cceeeEEEEecCC--CeEEEEEecCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 004672 66 LERLYCEIHLLKTLKHRN--IMKFYTSWVDTAN--RNINFVTEMFTSG-TLRQYRLKHRRVNIRAVKHWCRQILSGLLYL 140 (738)
Q Consensus 66 ~e~l~~Ei~iLk~L~HpN--IVkl~~~fv~~~~--~~l~LV~Ey~~gG-SL~~~l~k~~~lse~~i~~i~~QIl~aL~yL 140 (738)
..+..+|...+..|..-. +++.+++.....+ ...++|||++++. +|.+++......+......++.+++..+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 347888998888885433 3444544333221 3468999999874 8999988755577888899999999999999
Q ss_pred HhCCCCceeccCCcccEEEeCCC--CcEEEeccchhHH
Q 004672 141 HSRDPPVIHRDLKCDNIFVNGNQ--GEVKIGDLGLAAI 176 (738)
Q Consensus 141 Hs~gp~IIHRDLKP~NILl~~~~--g~VKL~DFGlA~~ 176 (738)
|..| |+|+|+++.|||++.+. ..+.++||+.+..
T Consensus 135 H~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999 99999999999998653 2689999997754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=8.3e-08 Score=109.77 Aligned_cols=238 Identities=20% Similarity=0.205 Sum_probs=165.5
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCC-cceeeEEEEecCCCeEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN-IMKFYTSWVDTANRNIN 100 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpN-IVkl~~~fv~~~~~~l~ 100 (738)
-+...+-+++|+++++||+++..+...+ .+.|... ....-++++|.+++||| .+..++.+ ....+.+
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---------l~~rl~~eLLdK~n~P~~~v~~~~d~--~~E~~~~ 310 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---------LSRRLAIELLDKVNNPNPVVRYLEDY--DGEDYLW 310 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---------hhhHHHHHHHHHccCCCCcccccccC--Ccccccc
Confidence 3555677899999999999887776655 5544421 34566889999999999 56655543 3456889
Q ss_pred EEEecCCCC-CHHHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchhHHhh
Q 004672 101 FVTEMFTSG-TLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 101 LV~Ey~~gG-SL~~~-l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~ 178 (738)
++++++.++ +-... -...-.+...+...+++.-+++|++||+.. -+||| ||+... +.+|.+||+....+.
T Consensus 311 i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~--~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 311 IPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE--EEVKLLDFAVPPQLT 382 (829)
T ss_pred hhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc--cccccccccCCcccC
Confidence 999999877 22111 111122444566677778888999999974 58998 888763 589999999987776
Q ss_pred ccc-cccccCCCCCCCccccc-cccCcccccccchhhhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccc----cCCCh
Q 004672 179 KSH-AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF----KVEDP 252 (738)
Q Consensus 179 ~~~-~~~~vGTp~YmAPEvl~-~~ys~~sDIWSLGviLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~----~~~sp 252 (738)
... ..+..+++.++|||+.. +.+....|+|++|.-..+|.-|.+|-.. .+... ...|.-|.... ...++
T Consensus 383 ~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~---~~~g~~p~s~~L~~~~aw~~ 457 (829)
T KOG0576|consen 383 RTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVL---PMIGNGPNSPMLTDKSAWSP 457 (829)
T ss_pred cccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC--Ccccc---CCCCCCCCccccchhhhcCc
Confidence 543 34556999999999765 5699999999999988888888777653 11111 11122221110 00111
Q ss_pred -HHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 253 -EVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 253 -el~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
.-+++...|+. .|..|+.+..++.|.+|..-.
T Consensus 458 ~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp 491 (829)
T KOG0576|consen 458 VFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP 491 (829)
T ss_pred ccccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence 22358889999 799999999999999996543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.27 E-value=5.6e-06 Score=91.26 Aligned_cols=234 Identities=16% Similarity=0.206 Sum_probs=149.2
Q ss_pred eEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhC-CCCCcceeeEEE-----Eec-CC
Q 004672 24 EDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSW-----VDT-AN 96 (738)
Q Consensus 24 ~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~f-----v~~-~~ 96 (738)
.....||.|+-+-+|-. ..-+..|| |++..... ....+ -+..|... .||-+-.-+ .| ... ..
T Consensus 14 ~~gr~LgqGgea~ly~l--~e~~d~VA-KIYh~Ppp----a~~aq---k~a~la~~p~~p~~~~rv-aWPqa~L~G~~~~ 82 (637)
T COG4248 14 PPGRPLGQGGEADLYTL--GEVRDQVA-KIYHAPPP----AAQAQ---KVAELAATPDAPLLNYRV-AWPQATLHGGRRG 82 (637)
T ss_pred CCCccccCCccceeeec--chhhchhh-eeecCCCc----hHHHH---HHHHhccCCCCcchhhhh-cccHHHhhCCCcc
Confidence 34677899999988854 23334455 44432221 11111 12233333 666543311 12 111 23
Q ss_pred CeEEEEEecCCCCC-HHHH------HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEe
Q 004672 97 RNINFVTEMFTSGT-LRQY------RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIG 169 (738)
Q Consensus 97 ~~l~LV~Ey~~gGS-L~~~------l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~ 169 (738)
..+.|+|..+.|.. +..+ ++......+..+.+.++.|+.+.+-||.+| .+-+|+.++|+||+ +.+.|.|.
T Consensus 83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVs-d~~~V~LV 159 (637)
T COG4248 83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVS-DDSKVVLV 159 (637)
T ss_pred ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeee-cCceEEEE
Confidence 34888999987753 2222 122245788899999999999999999999 99999999999997 55899998
Q ss_pred ccchhHHhhcc-ccccccCCCCCCCccccc-c-----ccCcccccccchhhhhhhhhc-CCCCCCCC------CHHHHHH
Q 004672 170 DLGLAAILRKS-HAARCVGTPEFMAPEVYE-E-----EYNELVDIYSFGMCILEMVTF-DYPYSECT------HPAQIYK 235 (738)
Q Consensus 170 DFGlA~~l~~~-~~~~~vGTp~YmAPEvl~-~-----~ys~~sDIWSLGviLyeLlTG-~~Pf~~~~------~~~qi~k 235 (738)
|=..-.+-... ...-.+|.++|.+||.-. + .-+...|.|.||+++++++.| ..||++.. ++-+ .
T Consensus 160 dsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E--~ 237 (637)
T COG4248 160 DSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--T 237 (637)
T ss_pred cccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch--h
Confidence 75433222222 222336999999999754 1 356789999999999999987 89997531 2211 1
Q ss_pred HHHcC-----------CCC--ccc-ccCCChHHHHHHHHHHhC---cCCCCCHHH
Q 004672 236 KVISG-----------KKP--EAL-FKVEDPEVRQFIEKCLAT---VSSRLSARE 273 (738)
Q Consensus 236 ~i~~g-----------~~p--~~l-~~~~spel~~lI~kcL~d---P~~RpSa~E 273 (738)
.|..| ..| ..+ +...+|.+..+..+|..+ +.-|||++-
T Consensus 238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 22222 222 111 345678999999999984 558999874
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=4.5e-06 Score=88.10 Aligned_cols=137 Identities=22% Similarity=0.171 Sum_probs=99.7
Q ss_pred ceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccc-----------c-----CCC--HHHHHHHHHHHHHHHhCCCC--
Q 004672 23 MEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYD-----------F-----LQS--PEELERLYCEIHLLKTLKHR-- 82 (738)
Q Consensus 23 y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~-----------~-----~~s--~e~~e~l~~Ei~iLk~L~Hp-- 82 (738)
+.++.+||.|--+.||.|.+. .|.++|+|.=+... . ..+ .-.+....+|..+|..|.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 356789999999999999974 89999999544321 0 001 12345678899999999654
Q ss_pred CcceeeEEEEecCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCC
Q 004672 83 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 162 (738)
Q Consensus 83 NIVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~ 162 (738)
.|.+.+++ +.-.+||||++|-.|.... ++.+....++..|+.-+.-+-..| |||+|+.+=||+++.+
T Consensus 172 ~VP~P~~~------nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~d 238 (304)
T COG0478 172 KVPKPIAW------NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTED 238 (304)
T ss_pred CCCCcccc------ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEecC
Confidence 78887762 4567899999997776543 234445555666666555555666 9999999999999855
Q ss_pred CCcEEEeccchh
Q 004672 163 QGEVKIGDLGLA 174 (738)
Q Consensus 163 ~g~VKL~DFGlA 174 (738)
|.+.++||--+
T Consensus 239 -g~~~vIDwPQ~ 249 (304)
T COG0478 239 -GDIVVIDWPQA 249 (304)
T ss_pred -CCEEEEeCccc
Confidence 89999999544
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.18 E-value=3.6e-06 Score=102.06 Aligned_cols=205 Identities=24% Similarity=0.362 Sum_probs=146.8
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeEEEEecCCC--eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 004672 64 EELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR--NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLH 141 (738)
Q Consensus 64 e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~--~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLH 141 (738)
..+.....|+..+..+.|+|++.++.+-+..... ...+..+++++.++...+..-..++...++.+..++++||.|+|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence 4556667778888888999999999876554322 23456889999999999888899999999999999999999999
Q ss_pred hCCCCceeccCCcc---cEEEeCCCCcEEEe--ccchhHHhhcccc-ccccCCCCCCCccccccc---cCcccccccchh
Q 004672 142 SRDPPVIHRDLKCD---NIFVNGNQGEVKIG--DLGLAAILRKSHA-ARCVGTPEFMAPEVYEEE---YNELVDIYSFGM 212 (738)
Q Consensus 142 s~gp~IIHRDLKP~---NILl~~~~g~VKL~--DFGlA~~l~~~~~-~~~vGTp~YmAPEvl~~~---ys~~sDIWSLGv 212 (738)
+.. ..|.-|... +--+++. +.+.++ ||+.+..+..... ....-+..+.+||.+... .....|+|.+|.
T Consensus 304 ~~~--l~~v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 304 SLS--LEHVVLSASSSKESTVDGE-GVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred Hhc--cceeEEecccccccccCcc-ceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 986 555555444 2233333 456666 8887766544322 233456678888887654 233469999999
Q ss_pred hhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCC-hHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCCC
Q 004672 213 CILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED-PEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 213 iLyeLlTG~~Pf~~~~~~~qi~k~i~~g~~p~~l~~~~s-pel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~~ 284 (738)
.+..+..|..+-.....+.. +..... .+..+++.+|+. ++++|+++.++|.|+|++...
T Consensus 381 l~~~~~~~~~i~~~~~~~~~-------------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSAVPVS-------------LLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred HHhhhhhcCcccccccchhh-------------hhccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence 99999887665432111111 111111 267899999998 899999999999999997654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.07 E-value=0.00012 Score=73.74 Aligned_cols=142 Identities=20% Similarity=0.191 Sum_probs=83.1
Q ss_pred EEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCC--CcceeeEEEEe-cCCCeEEEE
Q 004672 26 TMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHR--NIMKFYTSWVD-TANRNINFV 102 (738)
Q Consensus 26 l~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~Hp--NIVkl~~~fv~-~~~~~l~LV 102 (738)
++.|+.|..+.||+..... ..+++|... .......+..|..+++.|... .+.+++..... ......+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~------~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYR------PPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEES------SHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeC------CCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEE
Confidence 5789999999999998754 488888744 124567788999999998433 35566653322 223457999
Q ss_pred EecCCCCCHHH----------------HHH---hc----CCCCHH------H---HHHH------------HHHHHH-HH
Q 004672 103 TEMFTSGTLRQ----------------YRL---KH----RRVNIR------A---VKHW------------CRQILS-GL 137 (738)
Q Consensus 103 ~Ey~~gGSL~~----------------~l~---k~----~~lse~------~---i~~i------------~~QIl~-aL 137 (738)
|++++|..+.. .+. .. ..+... . ...+ ...+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 99999988887 111 11 000000 0 0000 011111 23
Q ss_pred HHHHh-----CCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 138 LYLHS-----RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 138 ~yLHs-----~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
..++. ....++|+|+.|.|||++..++.+.|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 33332 223599999999999999444677899998763
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.06 E-value=6.6e-05 Score=77.23 Aligned_cols=141 Identities=13% Similarity=0.096 Sum_probs=98.3
Q ss_pred cccCCeEEEEEEEcCCCeEEEEEEEecc--ccCCCHHHHHHHHHHHHHHHhCCCCC--cceeeEEEEe--cCCCeEEEEE
Q 004672 30 LVKELQRHYRAFDEYEGIEVAWNQVKLY--DFLQSPEELERLYCEIHLLKTLKHRN--IMKFYTSWVD--TANRNINFVT 103 (738)
Q Consensus 30 G~GafgtVYkA~d~~tG~~VAIK~vki~--~~~~s~e~~e~l~~Ei~iLk~L~HpN--IVkl~~~fv~--~~~~~l~LV~ 103 (738)
+.|+.+-|+... ..|..+-+|+-... ....-+--...+.+|+..|..|..-+ +.+....-.. .....-+||+
T Consensus 27 ~rgG~SgV~r~~--~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVE--RNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEE--eCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 458888888863 45557888875411 10000223467999999999994322 3443311111 1223568899
Q ss_pred ecCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCc--EEEeccchhH
Q 004672 104 EMFTS-GTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE--VKIGDLGLAA 175 (738)
Q Consensus 104 Ey~~g-GSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~--VKL~DFGlA~ 175 (738)
|-+.| -+|.+++... .+.+......++.+++..|.-||..| +.|+|+-+.|||++.. |. |+++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~-g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTE-GKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCC-CCeeEEEEEhhccc
Confidence 97643 5899887663 34677778899999999999999999 9999999999999744 45 9999998664
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00015 Score=75.39 Aligned_cols=135 Identities=10% Similarity=0.094 Sum_probs=79.9
Q ss_pred EEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCc--ceeeEEEEecCCCeEEEEEe
Q 004672 27 MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNI--MKFYTSWVDTANRNINFVTE 104 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNI--Vkl~~~fv~~~~~~l~LV~E 104 (738)
..||.|..+.||+. .|..+++|..... . ....+.+|.++|+.+..-.+ .+.+.+. ...+...+|||
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~---~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~--~~~~~~glv~e 74 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPG---F---DKETIKREFDASRKVFSLGIPTPHPFDLV--EDGGRLGLIYE 74 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCC---C---CHHHHHHHHHHHHHHHHcCCCCCceEEEE--ecCCeeeeeee
Confidence 67899999999984 2556777765421 1 22457889999999964444 5666543 34566788999
Q ss_pred cCCCCC-HHHH--------------HHh-----cC----CCCHHH-HHHHHHH----------HHH-HHHHHH--hCCCC
Q 004672 105 MFTSGT-LRQY--------------RLK-----HR----RVNIRA-VKHWCRQ----------ILS-GLLYLH--SRDPP 146 (738)
Q Consensus 105 y~~gGS-L~~~--------------l~k-----~~----~lse~~-i~~i~~Q----------Il~-aL~yLH--s~gp~ 146 (738)
+++|.+ +... +.+ |. ...... ...+..+ +.. ...+|. ...+.
T Consensus 75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 998863 2111 111 10 111111 1111100 111 112222 22345
Q ss_pred ceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 147 VIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 147 IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
++|+|+.|.||+++.+ + +.|+||+.+.
T Consensus 155 ~~HgD~~~~Nii~~~~-~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITSGK-G-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEcCC-C-cEEEechhcC
Confidence 7899999999999854 5 9999999874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00016 Score=74.89 Aligned_cols=147 Identities=12% Similarity=0.074 Sum_probs=92.0
Q ss_pred cccCcCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHH------HHHHHHHHHhC---CCCCc
Q 004672 14 LLKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELER------LYCEIHLLKTL---KHRNI 84 (738)
Q Consensus 14 l~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~------l~~Ei~iLk~L---~HpNI 84 (738)
+...+--.+|...+.+.......|.+. ...|..+.+|..+-.. ......... ..+++..+..+ .--.+
T Consensus 24 l~~~i~~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~-~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~ 100 (229)
T PF06176_consen 24 LGEKILDNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREEN-RRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEP 100 (229)
T ss_pred HHHHHHhCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhh-hhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccc
Confidence 344555677888888888776666544 6788999999766432 111111111 12333333333 22333
Q ss_pred ceeeEEEEec---CCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeC
Q 004672 85 MKFYTSWVDT---ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 161 (738)
Q Consensus 85 Vkl~~~fv~~---~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~ 161 (738)
..++-.-... -....+++|||++|..|.++.. +++ .+...|..++.-||..| ++|+|..|.|++++.
T Consensus 101 ~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 101 ADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSN 170 (229)
T ss_pred ccceeeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEEC
Confidence 3333221111 1235678999999998877522 332 24456777899999999 999999999999984
Q ss_pred CCCcEEEeccchhH
Q 004672 162 NQGEVKIGDLGLAA 175 (738)
Q Consensus 162 ~~g~VKL~DFGlA~ 175 (738)
+.++++||+..+
T Consensus 171 --~~i~iID~~~k~ 182 (229)
T PF06176_consen 171 --NGIRIIDTQGKR 182 (229)
T ss_pred --CcEEEEECcccc
Confidence 369999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12202 OSR1_C: Oxidative-stress-responsive kinase 1 C terminal; InterPro: IPR024678 Oxidative-stress-responsive kinase 1 (OSR1) is involved in the signalling cascade which activates Na/K/2Cl co-transporter during osmotic stress | Back alignment and domain information |
|---|
Probab=97.77 E-value=3.6e-05 Score=57.07 Aligned_cols=32 Identities=47% Similarity=0.593 Sum_probs=26.8
Q ss_pred eEEEEEEecCCC------CccceeeeeecCCCCHHHHH
Q 004672 375 IFLRLRIADKEG------RIRNIYFPFDIQTDTALSVA 406 (738)
Q Consensus 375 i~L~Lri~d~~g------~~r~i~F~Fd~~~Dta~svA 406 (738)
|.|+||+.|+.+ ...+|.|.|+++.|+|..||
T Consensus 1 i~l~Lrv~d~kK~~~k~ken~aI~F~F~~~~D~~e~VA 38 (38)
T PF12202_consen 1 INLRLRVRDPKKRKGKHKENEAIEFEFDLGKDTAEEVA 38 (38)
T ss_dssp EEEEEEEC-TTSSSSS--TCEEEEEEEETTT--HHHHH
T ss_pred CcEEEEEeccccccCccccCccEEEEEecCCCcccccC
Confidence 679999999987 77899999999999999998
|
This entry represents the CCT domain found in OSR1, STE20/SPS1-related kinase and in WNK activators []. This domain is found in eukaryotes, and is approximately 40 amino acids in length. There is a single completely conserved residue F that may be functionally important. ; PDB: 2V3S_A 2LRU_A. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.0001 Score=85.12 Aligned_cols=144 Identities=15% Similarity=0.113 Sum_probs=88.1
Q ss_pred EEEcccCCeEEEEEEEcCCCeEEEEEEEecccc--------------------------CCCH----HHHHH------HH
Q 004672 27 MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDF--------------------------LQSP----EELER------LY 70 (738)
Q Consensus 27 ~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~--------------------------~~s~----e~~e~------l~ 70 (738)
..|+.++-|.||+|.-. +|+.||||+.+..-. ..-. +..++ +.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 67889999999999875 599999997652100 0000 01122 23
Q ss_pred HHHHHHHhC-----CCCCcceeeEEEEecCCCeEEEEEecCCCCCHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 004672 71 CEIHLLKTL-----KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYR--LKHRRVNIRAVKHWCRQILSGLLYLHSR 143 (738)
Q Consensus 71 ~Ei~iLk~L-----~HpNIVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l--~k~~~lse~~i~~i~~QIl~aL~yLHs~ 143 (738)
+|...+.++ +.++|.--.=+|-- ...-+|+|||+.|-.+.+.. .. ..++.+.+.....++.- ..+-..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~--t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~--~q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEY--TTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFL--RQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhc--cCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHH--HHHHhc
Confidence 344444444 23443211112211 23457999999999888873 33 44664444433333322 222224
Q ss_pred CCCceeccCCcccEEEeCCCCcEEEeccchhHHhhc
Q 004672 144 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 144 gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~ 179 (738)
| ++|.|.+|.||+++.+ |++.+.|||+...+..
T Consensus 285 g--ffHaDpHpGNi~v~~~-g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 G--FFHADPHPGNILVRSD-GRIVLLDFGIVGRLDP 317 (517)
T ss_pred C--ccccCCCccceEEecC-CcEEEEcCcceecCCH
Confidence 5 9999999999999966 8999999999866543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00051 Score=71.22 Aligned_cols=78 Identities=9% Similarity=-0.087 Sum_probs=51.9
Q ss_pred EEEEcccCC-eEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCC-CCCcceeeEEEEecCCCeEEEEE
Q 004672 26 TMKFLVKEL-QRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANRNINFVT 103 (738)
Q Consensus 26 l~kLG~Gaf-gtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~l~LV~ 103 (738)
...|..|.. ..||+... .+..+.+|...-.. ...+.+|+++++.|. +--+.+++.+.. ..+..++||
T Consensus 3 ~~~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~--~~~~~~lv~ 71 (244)
T cd05150 3 WERVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYGS--DDGRAWLLT 71 (244)
T ss_pred ceecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEEe--cCCccEEEE
Confidence 345666766 78999964 34677777644211 235778999999983 444567776543 235678999
Q ss_pred ecCCCCCHHHH
Q 004672 104 EMFTSGTLRQY 114 (738)
Q Consensus 104 Ey~~gGSL~~~ 114 (738)
|+++|.+|...
T Consensus 72 e~i~G~~l~~~ 82 (244)
T cd05150 72 SAVPGVPAAAL 82 (244)
T ss_pred EeeCCccHhHh
Confidence 99999877643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00061 Score=71.53 Aligned_cols=142 Identities=20% Similarity=0.125 Sum_probs=95.3
Q ss_pred EEEEcccCCeEEEEEEEcCCCeEEEEEEEecccc------------------CCCHHHH--HHHHHHHHHHHhCC--CCC
Q 004672 26 TMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDF------------------LQSPEEL--ERLYCEIHLLKTLK--HRN 83 (738)
Q Consensus 26 l~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~------------------~~s~e~~--e~l~~Ei~iLk~L~--HpN 83 (738)
...|+.|--+.||+|.. ..+..||+|+++.... ..+...+ .=..+|+.-|+++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34667778889999975 6789999999886421 0011111 12356888888883 455
Q ss_pred cceeeEEEEecCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCcccEEEeCC
Q 004672 84 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGN 162 (738)
Q Consensus 84 IVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs-~gp~IIHRDLKP~NILl~~~ 162 (738)
+.+-+.++ .-.|||||+....+.-=+.+.-.+....+..+..+++..+.-|-. .+ +||+||+.=|||+. +
T Consensus 132 vP~Pi~~~------~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 132 VPEPIAFR------NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH-D 202 (268)
T ss_pred CCCceeec------CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE-C
Confidence 56666642 347899999543110000111123344678888899999888877 55 99999999999997 3
Q ss_pred CCcEEEeccchhHHhh
Q 004672 163 QGEVKIGDLGLAAILR 178 (738)
Q Consensus 163 ~g~VKL~DFGlA~~l~ 178 (738)
|.+.|+|||-|....
T Consensus 203 -~~p~iID~~QaV~~~ 217 (268)
T COG1718 203 -GEPYIIDVSQAVTID 217 (268)
T ss_pred -CeEEEEECccccccC
Confidence 689999999886554
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00092 Score=81.91 Aligned_cols=150 Identities=17% Similarity=0.256 Sum_probs=91.9
Q ss_pred EEEEEcccCCeEEEEEEEcCCC--eEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCC-CCCc--ceeeEEEEec-CCCe
Q 004672 25 DTMKFLVKELQRHYRAFDEYEG--IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNI--MKFYTSWVDT-ANRN 98 (738)
Q Consensus 25 il~kLG~GafgtVYkA~d~~tG--~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~-HpNI--Vkl~~~fv~~-~~~~ 98 (738)
.+..|+.|.+..+|+......+ ..+++|+....... .....+.+|+++|+.|. |++| .+++.++.+. ..+.
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~---~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~ 118 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL---QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT 118 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC---ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence 4788999999999998654332 46777754322211 12346889999999995 6765 6766654332 1245
Q ss_pred EEEEEecCCCCCHHH--------------------HHHh-cC----C-----------CCHHHHHHHHHH----------
Q 004672 99 INFVTEMFTSGTLRQ--------------------YRLK-HR----R-----------VNIRAVKHWCRQ---------- 132 (738)
Q Consensus 99 l~LV~Ey~~gGSL~~--------------------~l~k-~~----~-----------lse~~i~~i~~Q---------- 132 (738)
.|+||||++|..+.+ .+.. |. . ....++..|..+
T Consensus 119 ~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~ 198 (822)
T PLN02876 119 AFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKP 198 (822)
T ss_pred ceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCC
Confidence 789999998764321 1110 00 0 112234443332
Q ss_pred -----HHHHHHHHHhCCC---------CceeccCCcccEEEeCCCCc-EEEeccchhHHh
Q 004672 133 -----ILSGLLYLHSRDP---------PVIHRDLKCDNIFVNGNQGE-VKIGDLGLAAIL 177 (738)
Q Consensus 133 -----Il~aL~yLHs~gp---------~IIHRDLKP~NILl~~~~g~-VKL~DFGlA~~l 177 (738)
+...+.+|..+-| .++|+|+++.|||++.+.+. +-|.||+++..-
T Consensus 199 ~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 199 PRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred CCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 2233566754332 39999999999999854344 479999988653
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0051 Score=63.07 Aligned_cols=131 Identities=18% Similarity=0.215 Sum_probs=93.7
Q ss_pred CCceEEEEEcccCC-eEEEEEEEcCCCeEEEEEEEeccccCCC----------H-------HHHHHHHHHHHHHHhC---
Q 004672 21 EDMEDTMKFLVKEL-QRHYRAFDEYEGIEVAWNQVKLYDFLQS----------P-------EELERLYCEIHLLKTL--- 79 (738)
Q Consensus 21 ~~y~il~kLG~Gaf-gtVYkA~d~~tG~~VAIK~vki~~~~~s----------~-------e~~e~l~~Ei~iLk~L--- 79 (738)
+++..++.||.|.- |.||++. ..|..+|+|.++....... . -...-|..|.+...+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68899999999999 9999994 6888999998443221111 0 2234678888877776
Q ss_pred CCCCc--ceeeEEEEecC----------------CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 004672 80 KHRNI--MKFYTSWVDTA----------------NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLH 141 (738)
Q Consensus 80 ~HpNI--Vkl~~~fv~~~----------------~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLH 141 (738)
.+.++ |++++++.-.. .....||-||..... .+.... +.+|+.-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHH
Confidence 45566 99999874331 123567888876544 233333 467778888999
Q ss_pred hCCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 142 SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 142 s~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
..| |+-+|+++.|.. + -||+|||.+
T Consensus 182 k~g--I~~~Dv~~~ny~-~-----G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLG--IVPRDVKPRNYR-G-----GKLVDFSSS 206 (207)
T ss_pred HCC--eeeccCcccccc-C-----CEEEecccC
Confidence 998 999999999987 2 289999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.001 Score=68.93 Aligned_cols=76 Identities=9% Similarity=-0.102 Sum_probs=44.5
Q ss_pred EEEEcccCCe-EEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCC---CcceeeEEEEecC-CCeEE
Q 004672 26 TMKFLVKELQ-RHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHR---NIMKFYTSWVDTA-NRNIN 100 (738)
Q Consensus 26 l~kLG~Gafg-tVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~Hp---NIVkl~~~fv~~~-~~~l~ 100 (738)
++.|+.|+.. .||+. +..+++|... . ......+..|.++|..|... -+.+++....... ....+
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~---~---~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~ 70 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPS---A---AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPW 70 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCC---c---cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcce
Confidence 3567766665 58976 2346666432 1 11245789999999988532 3445444221111 12457
Q ss_pred EEEecCCCCCHH
Q 004672 101 FVTEMFTSGTLR 112 (738)
Q Consensus 101 LV~Ey~~gGSL~ 112 (738)
++|++++|.++.
T Consensus 71 ~l~~~i~G~~l~ 82 (235)
T cd05155 71 SVYRWLEGETAT 82 (235)
T ss_pred EEEEeecCCCCC
Confidence 899999987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.001 Score=77.11 Aligned_cols=143 Identities=17% Similarity=0.125 Sum_probs=89.1
Q ss_pred EEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCC----------------------------CHHHHHHHHHH-----
Q 004672 26 TMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQ----------------------------SPEELERLYCE----- 72 (738)
Q Consensus 26 l~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~----------------------------s~e~~e~l~~E----- 72 (738)
-+.|+..+.|.||+|.-+. |+.||||+-+. .... -.+..+.+..|
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P-~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~ 243 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHP-GLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTK 243 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCc-ChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHH
Confidence 3679999999999999765 99999995431 1100 01112233333
Q ss_pred -HH----HHHhCCCCC------cceeeEEEEecCCCeEEEEEecCCCCCHHHH--HHhcCCCCHHHHHHHHHHHHHHHHH
Q 004672 73 -IH----LLKTLKHRN------IMKFYTSWVDTANRNINFVTEMFTSGTLRQY--RLKHRRVNIRAVKHWCRQILSGLLY 139 (738)
Q Consensus 73 -i~----iLk~L~HpN------IVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~--l~k~~~lse~~i~~i~~QIl~aL~y 139 (738)
.+ ..+.+.|-+ |.++|-.+ ...-+|+||||.|..+.+. +.++ .++...+..-+.+... ..
T Consensus 244 EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~--~q 316 (538)
T KOG1235|consen 244 EAKNAERFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYL--EQ 316 (538)
T ss_pred HHHhHHHHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHH--HH
Confidence 22 223334545 55655432 2356899999999876554 3433 3555544443333322 22
Q ss_pred HHhCCCCceeccCCcccEEEeC---CCCcEEEeccchhHHhhc
Q 004672 140 LHSRDPPVIHRDLKCDNIFVNG---NQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 140 LHs~gp~IIHRDLKP~NILl~~---~~g~VKL~DFGlA~~l~~ 179 (738)
|-..| ++|.|=.|.||+++. .++.+.+.|||+...+..
T Consensus 317 If~~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 317 IFKTG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHhcC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 23345 999999999999984 357899999999976644
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0014 Score=65.65 Aligned_cols=131 Identities=19% Similarity=0.204 Sum_probs=90.0
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcc-eeeEEEEecCCCeEE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIM-KFYTSWVDTANRNIN 100 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIV-kl~~~fv~~~~~~l~ 100 (738)
.....+.|++|.+|.||++ .+.|..+|+|.-+ .+ ..+..+..|+++|..+.--++. ++|. ++ ..+
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~--~~~~~~~a~Kvrr-~d-----s~r~~l~kEakiLeil~g~~~~p~vy~--yg----~~~ 88 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLG--EWRGGEVALKVRR-RD-----SPRRNLEKEAKILEILAGEGVTPEVYF--YG----EDF 88 (201)
T ss_pred hhhhhhhhhcccccEEEEe--eccCceEEEEEec-CC-----cchhhHHHHHHHHHHhhhcCCCceEEE--ec----hhh
Confidence 3456678999999999999 4678899998533 22 3356799999999999887774 5554 22 335
Q ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCC-cc-cEEEeCCCCcEEEeccchhHHh
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK-CD-NIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLK-P~-NILl~~~~g~VKL~DFGlA~~l 177 (738)
+.|||..|-.|.+.-... +.+. +..+++.-.-|-..| |-|..|. |. ||++. + +.+.|+||..|+..
T Consensus 89 i~me~i~G~~L~~~~~~~---~rk~----l~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~-~-~~~~iIDFd~At~k 156 (201)
T COG2112 89 IRMEYIDGRPLGKLEIGG---DRKH----LLRVLEKAYKLDRLG--IEHGELSRPWKNVLVN-D-RDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhhcCcchhhhhhcc---cHHH----HHHHHHHHHHHHHhc--cchhhhcCCceeEEec-C-CcEEEEEccchhhc
Confidence 669999988887763321 2222 334455544455556 8888884 44 55554 3 58999999998744
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.003 Score=64.93 Aligned_cols=75 Identities=16% Similarity=0.115 Sum_probs=47.7
Q ss_pred EEEEcccCCeEEEEEEEcC-CCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCC-CcceeeEEEEecCCCeEEEEE
Q 004672 26 TMKFLVKELQRHYRAFDEY-EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHR-NIMKFYTSWVDTANRNINFVT 103 (738)
Q Consensus 26 l~kLG~GafgtVYkA~d~~-tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~Hp-NIVkl~~~fv~~~~~~l~LV~ 103 (738)
++.|..|-...+|+..... .+..|++|...... ...-...+|+.+++.+... -.++++..+ . + .+||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-----~~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~-~---~~l~ 71 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-----ELIIDRERELRIHKLLSKHGLAPKLYATF--Q-N---GLIY 71 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-----cceecHHHHHHHHHHHHhCCCCCeEEEEe--C-C---cEEE
Confidence 5678888899999986433 35678888654211 1111234789999998433 345555432 1 1 3799
Q ss_pred ecCCCCCH
Q 004672 104 EMFTSGTL 111 (738)
Q Consensus 104 Ey~~gGSL 111 (738)
||++|-++
T Consensus 72 e~i~G~~l 79 (235)
T cd05157 72 EFIPGRTL 79 (235)
T ss_pred EeeCCCcC
Confidence 99998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.13 E-value=4.8e-05 Score=94.23 Aligned_cols=160 Identities=15% Similarity=0.070 Sum_probs=122.0
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHH
Q 004672 65 ELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYL 140 (738)
Q Consensus 65 ~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~----~~lse~~i~~i~~QIl~aL~yL 140 (738)
..+-+..|...++...|+++...+.-.........|..++|+.+|.+++.+.+. ..+....+.....+.+.+..-+
T Consensus 1272 lkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ 1351 (2724)
T KOG1826|consen 1272 LKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVI 1351 (2724)
T ss_pred HHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchh
Confidence 345556666777788999998877654455566789999999999999998775 3455555555555557777776
Q ss_pred HhCC---CCceeccCCcccEEEeCCCCcEEEeccchhHHhhcc--ccccccCCCCCCCcccccc-ccCcccccccchhhh
Q 004672 141 HSRD---PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCI 214 (738)
Q Consensus 141 Hs~g---p~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~--~~~~~vGTp~YmAPEvl~~-~ys~~sDIWSLGviL 214 (738)
|+.. .-.+|++||+-|.+|..++ .||++++|+.++.... .....+++|.|++|++... +++.++|+|..|+-+
T Consensus 1352 ls~tnlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1352 LSLTNLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSL 1430 (2724)
T ss_pred hhcccCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHH
Confidence 6542 2469999999999999885 7999999999844332 2345568889999998875 588889999999999
Q ss_pred hhhhhcCCCCC
Q 004672 215 LEMVTFDYPYS 225 (738)
Q Consensus 215 yeLlTG~~Pf~ 225 (738)
|....|..+|-
T Consensus 1431 y~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1431 YLRSDGNAYFI 1441 (2724)
T ss_pred HHHhcccHHHH
Confidence 99988887774
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0016 Score=65.97 Aligned_cols=102 Identities=23% Similarity=0.130 Sum_probs=79.1
Q ss_pred HHHHHHHHhCCC-CCcceeeEEEEecCCCeEEEEEecCCCCCHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 004672 70 YCEIHLLKTLKH-RNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY---RLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 145 (738)
Q Consensus 70 ~~Ei~iLk~L~H-pNIVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~---l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp 145 (738)
..|.-+|+.|.+ +++++++|+| + -++|+||...+++... +...-..++....+++.+++..+.+|+..-.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G--~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----G--RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----C--CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 458889999976 6999999977 2 2669999987766421 1122346889999999999999999987421
Q ss_pred -CceeccCCcccEEEeCCCCcEEEeccchhHHhh
Q 004672 146 -PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 146 -~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~l~ 178 (738)
.+.-.|++++|+-++. +|++|++|...+....
T Consensus 81 ~~~~lcDv~~~nfgv~~-~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVND-DGRLKLIDLDDVFVED 113 (188)
T ss_pred CcEEEeecchHHeEEeC-CCcEEEEechhcchhH
Confidence 4888999999999984 4899999998876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0063 Score=65.77 Aligned_cols=82 Identities=9% Similarity=0.001 Sum_probs=56.1
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCC---CCcceeeEEEEec-CCC
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH---RNIMKFYTSWVDT-ANR 97 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~H---pNIVkl~~~fv~~-~~~ 97 (738)
...-.+.||.|..+.||+..+ ..| .+.+|..+. . .....+..|...|+.|.- -.+.++++++... ..+
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~----~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g 86 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYD-SQG-NPMPLMARS----F--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPG 86 (297)
T ss_pred hhheeeecCCccceeEEEEEc-CCC-CEEEEEecc----c--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCC
Confidence 455678899999999999853 233 466665431 1 012468899999999843 3677888765332 235
Q ss_pred eEEEEEecCCCCCH
Q 004672 98 NINFVTEMFTSGTL 111 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL 111 (738)
..++|||+++|+++
T Consensus 87 ~~~LVmE~i~G~~~ 100 (297)
T PRK10593 87 PDVLLLERLRGVSV 100 (297)
T ss_pred CeEEEEeccCCEec
Confidence 68999999998765
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.014 Score=65.78 Aligned_cols=83 Identities=23% Similarity=0.149 Sum_probs=58.1
Q ss_pred eEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccC--C-CHHHHHHHHHHHHHHHhC-C--CCCcceeeEEEEecCCC
Q 004672 24 EDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFL--Q-SPEELERLYCEIHLLKTL-K--HRNIMKFYTSWVDTANR 97 (738)
Q Consensus 24 ~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~--~-s~e~~e~l~~Ei~iLk~L-~--HpNIVkl~~~fv~~~~~ 97 (738)
...+.||.|.+..||++.+...++.|+||+....... . .+-..++...|...|+.+ . -..++++|.+ + ..
T Consensus 29 ~~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D--~~ 104 (401)
T PRK09550 29 LTAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--D--EE 104 (401)
T ss_pred ceeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--C--CC
Confidence 3467899999999999998644468999985422111 1 133457888899999987 2 2467788763 3 34
Q ss_pred eEEEEEecCCCCC
Q 004672 98 NINFVTEMFTSGT 110 (738)
Q Consensus 98 ~l~LV~Ey~~gGS 110 (738)
..++||||+++..
T Consensus 105 ~~~lVME~L~~~~ 117 (401)
T PRK09550 105 LAVTVMEDLSDHK 117 (401)
T ss_pred CCEEEEecCCCcc
Confidence 5689999998754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.015 Score=59.59 Aligned_cols=135 Identities=17% Similarity=0.210 Sum_probs=87.4
Q ss_pred EEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccC------------CCHHHHHHHHHHHHHHHhCC------CCCcce
Q 004672 25 DTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFL------------QSPEELERLYCEIHLLKTLK------HRNIMK 86 (738)
Q Consensus 25 il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~------------~s~e~~e~l~~Ei~iLk~L~------HpNIVk 86 (738)
....||.|+.-.||.- .......||++...... ..........+|+.-...+. +..|.+
T Consensus 5 ~~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 3567999999999965 34445677876644300 00112345566666555555 788999
Q ss_pred eeEEEEecCCCeEEEEEecCCC------CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEe
Q 004672 87 FYTSWVDTANRNINFVTEMFTS------GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 160 (738)
Q Consensus 87 l~~~fv~~~~~~l~LV~Ey~~g------GSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~ 160 (738)
+|++. +++..+.+|+|.+.. -||.+++.. +.++. .+...+.++ ..||-.++ |+.+||+|.||++.
T Consensus 82 ~~G~v--eT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~L~~f---~~~l~~~~--Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 82 FYGFV--ETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQALDEF---KRYLLDHH--IVIRDLNPHNIVVQ 152 (199)
T ss_pred EeEEE--ecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHHHHHH---HHHHHHcC--CeecCCCcccEEEE
Confidence 99964 345667888887643 368998744 45666 444444444 45667777 99999999999996
Q ss_pred CCC-C--cEEEecc
Q 004672 161 GNQ-G--EVKIGDL 171 (738)
Q Consensus 161 ~~~-g--~VKL~DF 171 (738)
... | .+.|+|-
T Consensus 153 ~~~~~~~~lvlIDG 166 (199)
T PF10707_consen 153 RRDSGEFRLVLIDG 166 (199)
T ss_pred ecCCCceEEEEEeC
Confidence 332 2 4666663
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.0087 Score=64.13 Aligned_cols=76 Identities=22% Similarity=0.136 Sum_probs=48.8
Q ss_pred EEEEcccCCeEEEEEEEcC------CCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCc-ceeeEEEEecCCCe
Q 004672 26 TMKFLVKELQRHYRAFDEY------EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNI-MKFYTSWVDTANRN 98 (738)
Q Consensus 26 l~kLG~GafgtVYkA~d~~------tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNI-Vkl~~~fv~~~~~~ 98 (738)
++.|..|-...+|+..... ++..+++|...... .......+|+.+++.+....+ .+++.++ . +
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~--~-~-- 72 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-----ELLIDRERELVVFARLSERNLGPKLYGIF--P-N-- 72 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-----cceechHHHHHHHHHHHhCCCCCceEEEe--C-C--
Confidence 5677788888999886533 25788888754321 122346788888988843333 4555543 2 1
Q ss_pred EEEEEecCCCCCHH
Q 004672 99 INFVTEMFTSGTLR 112 (738)
Q Consensus 99 l~LV~Ey~~gGSL~ 112 (738)
.+|+||++|.++.
T Consensus 73 -~~v~e~i~G~~l~ 85 (302)
T cd05156 73 -GRIEEFIPSRTLT 85 (302)
T ss_pred -CchhheeCCCcCC
Confidence 3589999887654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.0058 Score=63.99 Aligned_cols=134 Identities=18% Similarity=0.179 Sum_probs=75.7
Q ss_pred EEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCc-ceeeEEEEecCCCeEEEEEecC
Q 004672 28 KFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNI-MKFYTSWVDTANRNINFVTEMF 106 (738)
Q Consensus 28 kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNI-Vkl~~~fv~~~~~~l~LV~Ey~ 106 (738)
.+..|-...+|+.. ..|..+++|...... ....-...+|..+|+.+....+ .+++.. +. -++||||+
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~----~~~~~~r~~E~~~l~~l~~~g~~P~~i~~--~~----~~~v~e~i 70 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVC----KALGVDRQREYQILQALSALGLAPKPILV--NE----HWLLVEWL 70 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccc----ccccCcHHHHHHHHHHHHhcCCCCceEEE--eC----CEEEEEec
Confidence 45678888999885 457788887543211 1100124678899999954333 344432 22 26899999
Q ss_pred CCCCHHHH--------------HHh-c------CCCCHH-HHHHHHHHH---------HHHHHHHHhC------CCCcee
Q 004672 107 TSGTLRQY--------------RLK-H------RRVNIR-AVKHWCRQI---------LSGLLYLHSR------DPPVIH 149 (738)
Q Consensus 107 ~gGSL~~~--------------l~k-~------~~lse~-~i~~i~~QI---------l~aL~yLHs~------gp~IIH 149 (738)
+|..+..- +.+ | .+++.. .+..+..++ ...+..+-.. .+.++|
T Consensus 71 ~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H 150 (256)
T TIGR02721 71 EGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLH 150 (256)
T ss_pred cCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeec
Confidence 98765321 111 1 012211 122222222 1112222211 124899
Q ss_pred ccCCcccEEEeCCCCcEEEeccchhH
Q 004672 150 RDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 150 RDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
+|+.|.||+++++ + +.|+||+.+.
T Consensus 151 ~Dl~~~Nil~~~~-~-~~lIDwE~a~ 174 (256)
T TIGR02721 151 MDVHAYNLVVTPQ-G-LKLIDWEYAS 174 (256)
T ss_pred CCCCcCcEEEeCC-C-CEEEeccccC
Confidence 9999999999854 4 8999999874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.0048 Score=70.44 Aligned_cols=163 Identities=18% Similarity=0.190 Sum_probs=103.2
Q ss_pred HHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 004672 68 RLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPV 147 (738)
Q Consensus 68 ~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~I 147 (738)
++....++++.+.|+|...++++ .........+|+|++ +.+|.+++..+. +-..... .++ +
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~-~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~--~ 88 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDF-SRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHG--V 88 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEee-ecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------ccc--c
Confidence 46667799999999999999875 334445688999999 689999877654 2211111 122 3
Q ss_pred eeccCCcccEEEeCCCCcEEEeccchhHHhhccccccccCCCCCCCccccccccCcccccccchhhhhhhhhcCCCCCCC
Q 004672 148 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSEC 227 (738)
Q Consensus 148 IHRDLKP~NILl~~~~g~VKL~DFGlA~~l~~~~~~~~vGTp~YmAPEvl~~~ys~~sDIWSLGviLyeLlTG~~Pf~~~ 227 (738)
.|- +.++++| .++ ... ....| +++||||+|.++.++.-|...+...
T Consensus 89 ~~~-------------~~~~~td-~~~---t~~--~~~~~---------------pKsdVwsl~~i~~el~L~~~l~~~~ 134 (725)
T KOG1093|consen 89 LHL-------------NIIYITD-HFL---TKY--PSPIG---------------PKSDVWSLGFIILELYLGISLEAEL 134 (725)
T ss_pred cee-------------hhhhccc-ccc---ccC--CCCCC---------------cchhhhhHHHHHHHHHHhhHHHHHH
Confidence 221 2344444 111 000 11111 4999999999999999988777654
Q ss_pred CCHHHHHHHHHcCCCCccc---------ccCCChHHHHHHHHHHh-CcCCCCCHHHHhcCcccCCC
Q 004672 228 THPAQIYKKVISGKKPEAL---------FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 228 ~~~~qi~k~i~~g~~p~~l---------~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf~~~~ 283 (738)
.+.+++..-..-+..+... ....+..+.++.++|+. .|+.||...++.+++-|...
T Consensus 135 ~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 135 TESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 4444332222222222211 12235667888999999 89999999999999988643
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.028 Score=62.06 Aligned_cols=144 Identities=15% Similarity=0.172 Sum_probs=83.9
Q ss_pred CCceEEEEEcccCCeEEEEEEEcC----CCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCc-ceeeEEEEecC
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEY----EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNI-MKFYTSWVDTA 95 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~----tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNI-Vkl~~~fv~~~ 95 (738)
.+...+..|..|-.-.+|++.... ++..|++|..... ......+ ..|+.+++.+..-++ .++++.+ .
T Consensus 36 ~~~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~----t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~--~- 107 (344)
T PLN02236 36 DEALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEG----VELFFDR-DDEIRTFECMSRHGQGPRLLGRF--P- 107 (344)
T ss_pred cCcEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCC----CCeeech-HHHHHHHHHHHHcCCCCceEEEE--C-
Confidence 344456677779999999986432 3467888865422 2222233 679999999954444 4566644 2
Q ss_pred CCeEEEEEecCCCCCHHHH--------------HHh-cC------C-C-CHHHHHHHHHHHH-----------------H
Q 004672 96 NRNINFVTEMFTSGTLRQY--------------RLK-HR------R-V-NIRAVKHWCRQIL-----------------S 135 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~~--------------l~k-~~------~-l-se~~i~~i~~QIl-----------------~ 135 (738)
+ ..|++|+++-+|... +.+ |. + . ....+..|+.++. .
T Consensus 108 ~---g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~ 184 (344)
T PLN02236 108 N---GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLED 184 (344)
T ss_pred C---ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHH
Confidence 1 158999987665321 111 10 0 1 1233334432221 1
Q ss_pred HHHH----HHhC--CCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 136 GLLY----LHSR--DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 136 aL~y----LHs~--gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
.+.. +... ...++|+|+++.|||++...+.+.|+||..+.
T Consensus 185 ~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 185 EINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1111 2211 12489999999999998555689999998874
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.031 Score=62.13 Aligned_cols=87 Identities=15% Similarity=0.066 Sum_probs=58.5
Q ss_pred EEcccCCeEEEEEEEcCCCeEEEEEEEecccc---CCCHHHHHHHHHHHHHHHhCC--CC-CcceeeEEEEecCCCeEEE
Q 004672 28 KFLVKELQRHYRAFDEYEGIEVAWNQVKLYDF---LQSPEELERLYCEIHLLKTLK--HR-NIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 28 kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~---~~s~e~~e~l~~Ei~iLk~L~--Hp-NIVkl~~~fv~~~~~~l~L 101 (738)
.||-|-...||++.+...+..|+||+-...-. ...+-..+|..-|...|+.+. -| .++++|. ++ .....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D--~e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FD--TEMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Ec--ccccee
Confidence 47889999999999854447899998553321 123455677888999998873 24 5667765 34 445678
Q ss_pred EEecCCCC-CHHHHHHhc
Q 004672 102 VTEMFTSG-TLRQYRLKH 118 (738)
Q Consensus 102 V~Ey~~gG-SL~~~l~k~ 118 (738)
|||+++.. .|+..+.++
T Consensus 78 vMEdL~~~~ilR~~Li~g 95 (370)
T TIGR01767 78 VMEDLSHHKIARKGLIEG 95 (370)
T ss_pred hHhhCccchHHHHHHHcC
Confidence 99999653 355555443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.058 Score=57.48 Aligned_cols=144 Identities=15% Similarity=0.126 Sum_probs=82.8
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCC--cceeeEE----EEecC
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN--IMKFYTS----WVDTA 95 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpN--IVkl~~~----fv~~~ 95 (738)
+..-++.|..|....+|+... .+..+++|.... .+ .+.+..|+.++..|.+.+ +.+++.. ++...
T Consensus 15 ~~~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~----~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~ 85 (296)
T cd05153 15 ELLSFEGISAGIENTNYFVTT--DSGRYVLTLFEK----VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSEL 85 (296)
T ss_pred chhheecccCccccceEEEEe--CCCcEEEEEcCC----CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeee
Confidence 444577888898899998753 344688886542 11 345777888888884332 4454431 11122
Q ss_pred CCeEEEEEecCCCCCHHH-----H------HHh-c---CCCCH--------HHHH------------HHHHHHHHHHHHH
Q 004672 96 NRNINFVTEMFTSGTLRQ-----Y------RLK-H---RRVNI--------RAVK------------HWCRQILSGLLYL 140 (738)
Q Consensus 96 ~~~l~LV~Ey~~gGSL~~-----~------l~k-~---~~lse--------~~i~------------~i~~QIl~aL~yL 140 (738)
++..++|+++++|..+.. + +.+ | ..+.. .-.. .....+..++.++
T Consensus 86 ~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 165 (296)
T cd05153 86 AGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQ 165 (296)
T ss_pred CCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHH
Confidence 345689999999866421 1 000 0 00000 0000 0111123344444
Q ss_pred Hh-----CCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 141 HS-----RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 141 Hs-----~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
.. ....++|+|+.|.||+++.+ +.+.|+||+.+.
T Consensus 166 ~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~iIDfe~a~ 204 (296)
T cd05153 166 DAFDPSDLPRGVIHADLFRDNVLFDGD-ELSGVIDFYFAC 204 (296)
T ss_pred HhhhhhcCCCcCCccCcCcccEEEeCC-ceEEEeehhhhc
Confidence 43 11249999999999999854 456899998874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.1 Score=56.35 Aligned_cols=79 Identities=9% Similarity=0.008 Sum_probs=45.2
Q ss_pred ceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCC--cceeeEE----EEecCC
Q 004672 23 MEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN--IMKFYTS----WVDTAN 96 (738)
Q Consensus 23 y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpN--IVkl~~~----fv~~~~ 96 (738)
...++.|+.|...++|+... .+| .+++|++. . ... +.+..|+.++..|...+ +.+.+.. ++....
T Consensus 24 ~~~~~~l~~G~~n~~y~v~t-~~g-~~vLK~~~-~---~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~ 94 (319)
T PRK05231 24 LLSLKGIAEGIENSNFFLTT-TQG-EYVLTLFE-R---LTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELA 94 (319)
T ss_pred hhccchhccccccceEEEEe-CCC-cEEEEEec-c---CCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeC
Confidence 34456777888889998864 334 67888654 1 122 23445666666663222 3333321 111224
Q ss_pred CeEEEEEecCCCCC
Q 004672 97 RNINFVTEMFTSGT 110 (738)
Q Consensus 97 ~~l~LV~Ey~~gGS 110 (738)
+..+++++|++|..
T Consensus 95 g~~~~l~~~l~G~~ 108 (319)
T PRK05231 95 GKPAAIVTFLEGKW 108 (319)
T ss_pred CEEEEEEEecCCCC
Confidence 56789999998874
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.032 Score=60.19 Aligned_cols=148 Identities=19% Similarity=0.146 Sum_probs=81.7
Q ss_pred CCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCC--cceeeEE----EE
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN--IMKFYTS----WV 92 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpN--IVkl~~~----fv 92 (738)
.++....+..++.|....+|+... .+| .+++|..... .+. +.+..|+.++..|.... +.+++.. ++
T Consensus 20 ~~~~~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~---~~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~ 91 (307)
T TIGR00938 20 DLGELLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKR---VKA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQL 91 (307)
T ss_pred CCCCceeccccCCccccceEEEEe-CCC-cEEEEEecCC---CCH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCee
Confidence 444455577788888889998753 344 5777865421 122 23556777777773222 3444331 11
Q ss_pred ecCCCeEEEEEecCCCCCHH-----HH------HHh-c---CCC--------CHHHHH---------------HHHHHHH
Q 004672 93 DTANRNINFVTEMFTSGTLR-----QY------RLK-H---RRV--------NIRAVK---------------HWCRQIL 134 (738)
Q Consensus 93 ~~~~~~l~LV~Ey~~gGSL~-----~~------l~k-~---~~l--------se~~i~---------------~i~~QIl 134 (738)
....+..+++++|++|..+. ++ +.+ | ..+ ...... .....+.
T Consensus 92 ~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~ 171 (307)
T TIGR00938 92 STLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELD 171 (307)
T ss_pred hhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHH
Confidence 11235678999999885431 11 100 0 001 001000 0011223
Q ss_pred HHHHHHHh-----CCCCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 135 SGLLYLHS-----RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 135 ~aL~yLHs-----~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
..+.++.. ...+++|+|+.+.||+++.+ +.+.|+||+.+.
T Consensus 172 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~~ 216 (307)
T TIGR00938 172 KELDYLDKFWPRDLPRGVIHADLFPDNVLFDGD-SVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHhhhhhcCCCccCCCCCCcCcEEEECC-ceEEEeeccccc
Confidence 34555532 12359999999999999865 556899998763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.055 Score=57.97 Aligned_cols=30 Identities=20% Similarity=0.352 Sum_probs=24.7
Q ss_pred CceeccCCcccEEEeCCCCc-EEEeccchhHH
Q 004672 146 PVIHRDLKCDNIFVNGNQGE-VKIGDLGLAAI 176 (738)
Q Consensus 146 ~IIHRDLKP~NILl~~~~g~-VKL~DFGlA~~ 176 (738)
.++|+|++|.|||++.+ +. +-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~-~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDED-ARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCC-CCEEEEECcHhccc
Confidence 48999999999999854 44 56999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.075 Score=58.27 Aligned_cols=149 Identities=14% Similarity=0.148 Sum_probs=85.5
Q ss_pred CceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCC--cceeeEEEEecCCCeE
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN--IMKFYTSWVDTANRNI 99 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpN--IVkl~~~fv~~~~~~l 99 (738)
...++..+..|..-.+|...+. ++.+++.. ..............+|..+|+.+.--- +...++.+.+......
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR~---P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~p 100 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGDT--GQKYVLRK---PPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTP 100 (321)
T ss_pred CCceeeeccCCcccceEEEecC--CceEEEec---CCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCc
Confidence 4456666666666566666543 77788661 211223345567778888888884322 2334444333222467
Q ss_pred EEEEecCCCCCH---------H-HHHH--------h-cC-------------CCCHHHHHHHHHHH--------------
Q 004672 100 NFVTEMFTSGTL---------R-QYRL--------K-HR-------------RVNIRAVKHWCRQI-------------- 133 (738)
Q Consensus 100 ~LV~Ey~~gGSL---------~-~~l~--------k-~~-------------~lse~~i~~i~~QI-------------- 133 (738)
+.||+|++|..+ . .+.. . |. .....++..|..+.
T Consensus 101 f~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 101 FYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred eEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 999999988322 2 2211 1 00 01112222332222
Q ss_pred HHHHHHHHhCC------CCceeccCCcccEEEeCCCCcEEEeccchhHH
Q 004672 134 LSGLLYLHSRD------PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 134 l~aL~yLHs~g------p~IIHRDLKP~NILl~~~~g~VKL~DFGlA~~ 176 (738)
..-..||+.+. +.++|+|+.+.||++++. +-+-+.||+++..
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~-~~~gVlDwe~~~l 228 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPG-RPTGVLDWELATL 228 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCC-CeeEEEecccccc
Confidence 22345665544 359999999999999866 4589999999864
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.065 Score=60.36 Aligned_cols=90 Identities=20% Similarity=0.140 Sum_probs=62.1
Q ss_pred EEEEEcccCCeEEEEEEEcCCCeEEEEEEEecccc--CCCHHHHHHHHHHHHHHHhCC--CC-CcceeeEEEEecCCCeE
Q 004672 25 DTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDF--LQSPEELERLYCEIHLLKTLK--HR-NIMKFYTSWVDTANRNI 99 (738)
Q Consensus 25 il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~--~~s~e~~e~l~~Ei~iLk~L~--Hp-NIVkl~~~fv~~~~~~l 99 (738)
.++.||-|-...||++.+...+..|+||+-...-. ...+-..+|..-|...|+.+. -| .++++|. ++ ....
T Consensus 33 ~~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D--~e~~ 108 (409)
T PRK12396 33 QCKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FD--SVMN 108 (409)
T ss_pred eeeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--EC--cHHh
Confidence 47889999999999999854467899998543211 123455678888999999873 34 5667765 34 4566
Q ss_pred EEEEecCCCC-CHHHHHHhc
Q 004672 100 NFVTEMFTSG-TLRQYRLKH 118 (738)
Q Consensus 100 ~LV~Ey~~gG-SL~~~l~k~ 118 (738)
.+|||+++.. .|++.+.++
T Consensus 109 ~~vMEdL~~~~ilR~~Li~G 128 (409)
T PRK12396 109 CCVMEDLSDHTILRTALINH 128 (409)
T ss_pred hHHHHhCcccHHHHHHHHcC
Confidence 7899999653 355555443
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.097 Score=58.19 Aligned_cols=141 Identities=18% Similarity=0.170 Sum_probs=95.0
Q ss_pred EEcccCCeEEEEEEEcCCCeEEEEEEEeccc--------------------cCCCHHHHHHH--HHHHHHHHhCCCCCcc
Q 004672 28 KFLVKELQRHYRAFDEYEGIEVAWNQVKLYD--------------------FLQSPEELERL--YCEIHLLKTLKHRNIM 85 (738)
Q Consensus 28 kLG~GafgtVYkA~d~~tG~~VAIK~vki~~--------------------~~~s~e~~e~l--~~Ei~iLk~L~HpNIV 85 (738)
-|..|--+.||.|.. ..|..+|||+++..- ...++..+-.. ..|++-|++|+...|.
T Consensus 151 CiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 151 CISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred ccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 356677888999974 689999999887421 11233333333 4578889998766654
Q ss_pred eeeEEEEecCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCc
Q 004672 86 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 165 (738)
Q Consensus 86 kl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~ 165 (738)
----..+ +.-+|||+++....--.=+.+.-.++...+..+-.|++.-+.-|-... ++||.||.==|+|+. .|.
T Consensus 230 ~PePIlL----k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c-~LVHADLSEfN~Lyh--dG~ 302 (520)
T KOG2270|consen 230 CPEPILL----KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC-RLVHADLSEFNLLYH--DGK 302 (520)
T ss_pred CCCceee----ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh-ceeccchhhhhheEE--CCE
Confidence 3222212 245789999943221111223345777788888888888888776542 499999999999996 379
Q ss_pred EEEeccchhHH
Q 004672 166 VKIGDLGLAAI 176 (738)
Q Consensus 166 VKL~DFGlA~~ 176 (738)
+.|+|.+-+..
T Consensus 303 lyiIDVSQSVE 313 (520)
T KOG2270|consen 303 LYIIDVSQSVE 313 (520)
T ss_pred EEEEEcccccc
Confidence 99999987643
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.016 Score=63.30 Aligned_cols=135 Identities=19% Similarity=0.107 Sum_probs=93.0
Q ss_pred ceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccc-----cCC-----------CHHH--HHHHHHHHHHHHhCC-CC-
Q 004672 23 MEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYD-----FLQ-----------SPEE--LERLYCEIHLLKTLK-HR- 82 (738)
Q Consensus 23 y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~-----~~~-----------s~e~--~e~l~~Ei~iLk~L~-Hp- 82 (738)
+.+++.||-|--+.||.+-+ ..|.+.++|.-++.. ... +--. +-...+|...|+.|. |-
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 56788999999999999987 578889888544432 000 1111 123567899999993 33
Q ss_pred CcceeeEEEEecCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCC
Q 004672 83 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 162 (738)
Q Consensus 83 NIVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~ 162 (738)
-|.+.++ .+.-++|||++.|-.|.+... ..+.. .+...+..-+.-|-.+| +||+|+.-=||+|..
T Consensus 173 pVPkpiD------~~RH~Vvmelv~g~Pl~~v~~---v~d~~---~ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~d- 237 (465)
T KOG2268|consen 173 PVPKPID------HNRHCVVMELVDGYPLRQVRH---VEDPP---TLYDDLMGLIVRLANHG--LIHGDFNEFNIMVKD- 237 (465)
T ss_pred CCCCccc------ccceeeHHHhhcccceeeeee---cCChH---HHHHHHHHHHHHHHHcC--ceecccchheeEEec-
Confidence 3445554 345688999999988876521 12333 33445555566677888 999999999999984
Q ss_pred CCcEEEeccch
Q 004672 163 QGEVKIGDLGL 173 (738)
Q Consensus 163 ~g~VKL~DFGl 173 (738)
++.++++||--
T Consensus 238 d~~i~vIDFPQ 248 (465)
T KOG2268|consen 238 DDKIVVIDFPQ 248 (465)
T ss_pred CCCEEEeechH
Confidence 47899999953
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.13 Score=56.44 Aligned_cols=149 Identities=13% Similarity=0.132 Sum_probs=82.9
Q ss_pred ccCcCCCCceEEEEEcccCCeEEEEEEEcCC---CeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCc-ceeeEE
Q 004672 15 LKLIPLEDMEDTMKFLVKELQRHYRAFDEYE---GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNI-MKFYTS 90 (738)
Q Consensus 15 ~~~I~~~~y~il~kLG~GafgtVYkA~d~~t---G~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNI-Vkl~~~ 90 (738)
+..+.-+++ .++.|..|-.-.+|+...... +..|+++..... ... .-.-.+|+.+++.+..-++ .+++.+
T Consensus 9 w~~~~~~~i-~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~----t~~-~IdR~~E~~il~~l~~~gl~P~~l~~ 82 (330)
T PLN02421 9 WSDLDDSDF-SVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPN----TDY-VIDRERELQAIKYLSAAGFGAKLLGV 82 (330)
T ss_pred cccCCcCce-EEEEeCCcccceEEEEEecCCCCCCceEEEEEecCC----cCe-EechHHHHHHHHHHHhcCCCCceeEE
Confidence 444443444 455666688888998864332 337887765421 111 1123578899999965555 455654
Q ss_pred EEecCCCeEEEEEecCCCCCHHHH--------------HHh-cC-C------CC-HHHHHHHHHHH--------------
Q 004672 91 WVDTANRNINFVTEMFTSGTLRQY--------------RLK-HR-R------VN-IRAVKHWCRQI-------------- 133 (738)
Q Consensus 91 fv~~~~~~l~LV~Ey~~gGSL~~~--------------l~k-~~-~------ls-e~~i~~i~~QI-------------- 133 (738)
+ . ++ +|.+|++|-+|..- +.+ |. . .+ ...+..|..++
T Consensus 83 ~--~-~G---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~ 156 (330)
T PLN02421 83 F--G-NG---MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKY 156 (330)
T ss_pred e--C-Cc---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhh
Confidence 3 2 22 58999987665220 111 10 1 11 12233332222
Q ss_pred -----------HHHHHHHH-hCC--CCceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 134 -----------LSGLLYLH-SRD--PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 134 -----------l~aL~yLH-s~g--p~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
+..+..+. ..+ .-+.|.|+.+.|||++.+.+.++++||..|.
T Consensus 157 ~~~~~~~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 157 ETISFEELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred cccCHHHHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 11122221 111 1379999999999997555789999999874
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.27 Score=55.77 Aligned_cols=85 Identities=15% Similarity=0.024 Sum_probs=57.1
Q ss_pred EEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCC---HHHHHHHHHHHHHHHhCC---CCCcceeeEEEEecCCCe
Q 004672 25 DTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQS---PEELERLYCEIHLLKTLK---HRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 25 il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s---~e~~e~l~~Ei~iLk~L~---HpNIVkl~~~fv~~~~~~ 98 (738)
..+.||.|....||+..+ .+..|+||+-...-...+ +-...+...|...|+.+. -..+.++|.+. . ..
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d--e--d~ 109 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD--R--TM 109 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC--C--CC
Confidence 578899999999999876 345688997552221111 124566777788887773 24788888743 2 45
Q ss_pred EEEEEecCCC--CCHHHHH
Q 004672 99 INFVTEMFTS--GTLRQYR 115 (738)
Q Consensus 99 l~LV~Ey~~g--GSL~~~l 115 (738)
-+++||++++ ..+++.+
T Consensus 110 ~vlvME~L~~~~~ilr~~L 128 (418)
T PLN02756 110 ALIGMRYLEPPHIILRKGL 128 (418)
T ss_pred CEEEEeecCCcceehhhhh
Confidence 6789999977 3455554
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.60 E-value=0.021 Score=66.21 Aligned_cols=67 Identities=25% Similarity=0.409 Sum_probs=55.8
Q ss_pred ceEEEEEEecCCC----CccceeeeeecCCCCHHHHHHHHHhcCCCChhhHHHHHHHHHHHHHhhCCCccC
Q 004672 374 GIFLRLRIADKEG----RIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKR 440 (738)
Q Consensus 374 ~i~L~Lri~d~~g----~~r~i~F~Fd~~~Dta~svA~EMV~~l~i~~~dv~~IA~~Id~~i~~l~p~w~~ 440 (738)
++.|++|..|..+ ..+.|.|.|+++.|++.+||+|||++..+++.|-..+|+++.+.+.++--.-..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~n~i~~~~~~~~D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~~ 388 (632)
T KOG0584|consen 318 ALSLSLRDEDGKKNKRPKANAIQFDYNLNTDESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRND 388 (632)
T ss_pred cccccccccchhhcCCcccccccceeecCCCchhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhhc
Confidence 4456677776652 335899999999999999999999999999999999999999999888654433
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.46 E-value=0.45 Score=53.55 Aligned_cols=91 Identities=12% Similarity=-0.046 Sum_probs=50.5
Q ss_pred ccCcCCCCceEEEEEcccCCeEEEEEEEcCC-CeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCc-ceeeEEEE
Q 004672 15 LKLIPLEDMEDTMKFLVKELQRHYRAFDEYE-GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNI-MKFYTSWV 92 (738)
Q Consensus 15 ~~~I~~~~y~il~kLG~GafgtVYkA~d~~t-G~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNI-Vkl~~~fv 92 (738)
++.++.+.+ .++.|..|-...+|++..... +..+.+|.|-+.......+..-.-.+|+++++.|...++ .++++.|.
T Consensus 45 w~~~~~~~i-~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~ 123 (383)
T PTZ00384 45 WNNVNPEFI-EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG 123 (383)
T ss_pred cccCCcccE-EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC
Confidence 444443334 556777799999999964332 222222221111111111111123568999999965555 56666541
Q ss_pred ecCCCeEEEEEecCCCCCHH
Q 004672 93 DTANRNINFVTEMFTSGTLR 112 (738)
Q Consensus 93 ~~~~~~l~LV~Ey~~gGSL~ 112 (738)
-++|+||++|-+|.
T Consensus 124 ------~g~l~efIeGr~l~ 137 (383)
T PTZ00384 124 ------DFTIQEWVEGNTMG 137 (383)
T ss_pred ------CEEEEEEeccccCC
Confidence 26899999987653
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=92.56 E-value=1.2 Score=48.19 Aligned_cols=29 Identities=10% Similarity=0.126 Sum_probs=25.2
Q ss_pred CceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 146 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 146 ~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
+++|+|+.++|||++++ +.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~-~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDET-RGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCC-CCEEEEEhhhcc
Confidence 59999999999999855 679999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=91.51 E-value=0.73 Score=48.29 Aligned_cols=86 Identities=16% Similarity=0.234 Sum_probs=60.8
Q ss_pred HHHHHHHHHHhCCCCCcceeeEEEEecCCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 004672 68 RLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPV 147 (738)
Q Consensus 68 ~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~I 147 (738)
.++.+.+++.++. .|+++.. ..+-.+.+|.|+|-.-.. .. ..++..=+.+|.-.|+.+++.
T Consensus 104 ~y~nky~v~Armh--GilrL~N----Dn~~~yGvIlE~Cy~~~i---------~~----~N~i~agi~~L~~fH~~~~~~ 164 (308)
T PF07387_consen 104 LYFNKYRVFARMH--GILRLKN----DNNYKYGVILERCYKIKI---------NF----SNFITAGIKDLMDFHSENQHC 164 (308)
T ss_pred hhhhhhhHHHHhh--heeEeec----CCCceeEEEEeeccCccc---------ch----hHHHHHhHHHHHHhhccCCCe
Confidence 4577888888885 5777764 345678899999832111 11 111222256788889776789
Q ss_pred eeccCCcccEEEeCCCCcEEEeccch
Q 004672 148 IHRDLKCDNIFVNGNQGEVKIGDLGL 173 (738)
Q Consensus 148 IHRDLKP~NILl~~~~g~VKL~DFGl 173 (738)
+|+|-.|+||+-+.. |.+||.|-+.
T Consensus 165 lHGD~np~NiM~D~~-G~lKlVDP~~ 189 (308)
T PF07387_consen 165 LHGDCNPDNIMCDKF-GYLKLVDPVC 189 (308)
T ss_pred ecCCCChhheeecCC-CCEEecChhh
Confidence 999999999999855 8999999763
|
The function of this family is unknown. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=90.84 E-value=1.1 Score=48.41 Aligned_cols=76 Identities=13% Similarity=0.033 Sum_probs=45.1
Q ss_pred ceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCC---CCCcceeeEEEEecCCCeE
Q 004672 23 MEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK---HRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 23 y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~---HpNIVkl~~~fv~~~~~~l 99 (738)
......++.|....+|+.. .++..+.+|.-. . .....+..|..-|+.|. --.+++.+.+... ...-
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-~------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~--~~~~ 87 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNS-E------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY--DDDA 87 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEE-G------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE---SSCC
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecC-h------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee--cCCc
Confidence 4567889999999999985 678889988755 1 12245788888888883 3456677775433 3445
Q ss_pred EEEEecCCCC
Q 004672 100 NFVTEMFTSG 109 (738)
Q Consensus 100 ~LV~Ey~~gG 109 (738)
+|||||++.+
T Consensus 88 fLlle~l~~~ 97 (288)
T PF03881_consen 88 FLLLEFLEMG 97 (288)
T ss_dssp EEEEE-----
T ss_pred eEEEEeecCC
Confidence 8999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=90.79 E-value=0.48 Score=52.84 Aligned_cols=73 Identities=19% Similarity=0.237 Sum_probs=56.9
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 95 ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 95 ~~~~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
...+.|++|++. |+.|.-. +--..+++..++++.+..|.-+..+ -+.=||++..+||||+ + |.|.|+||-++
T Consensus 297 e~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId-~-GnvtLIDfkls 368 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID-E-GNVTLIDFKLS 368 (488)
T ss_pred CceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee-c-CceEEEEeeee
Confidence 356788899986 6666432 2234577888888888877777666 3689999999999998 4 89999999998
Q ss_pred H
Q 004672 175 A 175 (738)
Q Consensus 175 ~ 175 (738)
+
T Consensus 369 R 369 (488)
T COG5072 369 R 369 (488)
T ss_pred e
Confidence 7
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.70 E-value=1.7 Score=49.88 Aligned_cols=85 Identities=12% Similarity=0.096 Sum_probs=53.1
Q ss_pred ccCcCCCCceEEEEEcccCCeEEEEEEEcC--------CCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCc-c
Q 004672 15 LKLIPLEDMEDTMKFLVKELQRHYRAFDEY--------EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNI-M 85 (738)
Q Consensus 15 ~~~I~~~~y~il~kLG~GafgtVYkA~d~~--------tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNI-V 85 (738)
+..++.+++ .++.|..|-.-.+|++.... ++..|.++..-. ...... .-..|..+++.+..-+| .
T Consensus 100 W~~~~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~----~te~lI-dR~~E~~v~~~ls~~gi~P 173 (442)
T PTZ00296 100 WRRFTEDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGK----DVDELY-NPISEFEVYKTMSKYRIAP 173 (442)
T ss_pred cccCCcccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCC----Ccccee-CHHHHHHHHHHHHHCCCCC
Confidence 345555566 78888889889999987542 256788765432 111222 33568888888865555 3
Q ss_pred eeeEEEEecCCCeEEEEEecCCCCCH
Q 004672 86 KFYTSWVDTANRNINFVTEMFTSGTL 111 (738)
Q Consensus 86 kl~~~fv~~~~~~l~LV~Ey~~gGSL 111 (738)
++++.| . -+.|.||++|-+|
T Consensus 174 ~l~~~f--~----gg~I~efi~g~~l 193 (442)
T PTZ00296 174 QLLNTF--S----GGRIEEWLYGDPL 193 (442)
T ss_pred ceEEEe--C----CCEEEEeeCCccC
Confidence 566644 1 2458999988643
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=84.34 E-value=1.8 Score=46.27 Aligned_cols=28 Identities=25% Similarity=0.381 Sum_probs=24.1
Q ss_pred CCceeccCCcccEEEeCCCCcEEEeccchh
Q 004672 145 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 145 p~IIHRDLKP~NILl~~~~g~VKL~DFGlA 174 (738)
.+++|+|+.+.||+++. +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~--~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD--NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC--CcEEEEECccc
Confidence 35999999999999985 46899999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=84.24 E-value=3.3 Score=47.04 Aligned_cols=64 Identities=16% Similarity=0.178 Sum_probs=45.4
Q ss_pred eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceeccCCcccEEEeCCCC
Q 004672 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYL-HSRDPPVIHRDLKCDNIFVNGNQG 164 (738)
Q Consensus 98 ~l~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yL-Hs~gp~IIHRDLKP~NILl~~~~g 164 (738)
...++-+|..|-++..+++. +..+++..+.++.-...||--+ --.+ ++|.|+.|.||++..+.+
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlirf~~t 383 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIRFNKT 383 (565)
T ss_pred cceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEEecCC
Confidence 34677788888899888654 4456666777776666665433 3335 999999999999975544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=83.05 E-value=0.32 Score=55.91 Aligned_cols=74 Identities=16% Similarity=0.273 Sum_probs=62.8
Q ss_pred cCCCCceEEEEEcccCCeEEEEEEEcCCCeEEEEEEEeccccCCCHHHHHHHHHHHHHHHhCCCCCcceeeEEEEec
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 94 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~vki~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~ 94 (738)
....++.....+|.|+||+|+.+..+..+-.+|||.|.+.. ......+..+|..-+..+.|++|++++..|...
T Consensus 46 r~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn---~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~ 119 (516)
T KOG1033|consen 46 REANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKN---REESRSRVLREVSSLAEFEHPGIKRYFHAWYER 119 (516)
T ss_pred hhhccccccccccccCccccCCccccccchhhHHHHhcccc---hhhhhhhhhccccchhhhcccchhhheeceecC
Confidence 34567888899999999999999988888899999988754 445667899999999999999999999888653
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=82.97 E-value=0.84 Score=46.34 Aligned_cols=30 Identities=40% Similarity=0.586 Sum_probs=20.1
Q ss_pred CceeccCCcccEEEeCCCCcEEEeccchhH
Q 004672 146 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 146 ~IIHRDLKP~NILl~~~~g~VKL~DFGlA~ 175 (738)
.+.|.|+.|.|||++...+.++|+||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 489999999999994455899999999884
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 738 | ||||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-65 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-23 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-21 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-21 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-21 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-20 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-20 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-20 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-20 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-20 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-20 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-20 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-20 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-20 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-19 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-18 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-18 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-18 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-18 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-18 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-17 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-17 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-17 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-17 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-17 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-17 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-17 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-17 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-17 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-17 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-17 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-17 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-17 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-17 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-17 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-17 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-17 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-17 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-17 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-17 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-16 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-16 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-16 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-16 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-16 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-16 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-16 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-16 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-16 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-16 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-16 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-16 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-16 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-16 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-16 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-16 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-16 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-16 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-16 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-16 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-16 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-16 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-16 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-16 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-16 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-16 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-16 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-16 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-16 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-16 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-16 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-16 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-14 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-13 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-13 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-12 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-12 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-11 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-11 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-11 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-11 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-08 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-08 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-08 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 8e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-07 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-07 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-06 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-06 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-06 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-06 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-06 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-06 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 5e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 5e-06 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-05 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-05 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-05 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-05 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-05 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-05 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-05 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-05 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-05 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-05 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-05 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-04 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-04 |
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 390 bits (1004), Expect = e-131
Identities = 123/249 (49%), Positives = 166/249 (66%), Gaps = 5/249 (2%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA-- 95
Y+ D +EVAW +++ + E +R E +LK L+H NI++FY SW T
Sbjct: 43 YKGLDTETTVEVAWCELQDRK--LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100
Query: 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
+ I VTE+ TSGTL+ Y + + + I+ ++ WCRQIL GL +LH+R PP+IHRDLKCD
Sbjct: 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD 160
Query: 156 NIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCIL 215
NIF+ G G VKIGDLGLA + R S A +GTPEFMAPE+YEE+Y+E VD+Y+FGMC+L
Sbjct: 161 NIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCML 220
Query: 216 EMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSAREL 274
EM T +YPYSEC + AQIY++V SG KP + KV PEV++ IE C+ R S ++L
Sbjct: 221 EMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 280
Query: 275 LTDPFLQID 283
L F Q +
Sbjct: 281 LNHAFFQEE 289
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 5e-55
Identities = 76/257 (29%), Positives = 116/257 (45%), Gaps = 25/257 (9%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y D + +A ++ + + L+ EI L K LKH+NI+++ S+ +
Sbjct: 39 YAGRDLSNQVRIAIKEIPE----RDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI 94
Query: 98 NINFVTEMFTSGTLRQ-YRLKHRRVNIR--AVKHWCRQILSGLLYLHSRDPPVIHRDLKC 154
I E G+L R K + + + +QIL GL YLH ++HRD+K
Sbjct: 95 KI--FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKG 150
Query: 155 DNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYEEE---YNELVDIYS 209
DN+ +N G +KI D G + L + GT ++MAPE+ ++ Y + DI+S
Sbjct: 151 DNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWS 210
Query: 210 FGMCILEMVTFDYPYSECTHPAQIYKKVISGKK----PEALFKVEDPEVRQFIEKCLAT- 264
G I+EM T P+ E P KV K PE++ E + FI KC
Sbjct: 211 LGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESM----SAEAKAFILKCFEPD 266
Query: 265 VSSRLSARELLTDPFLQ 281
R A +LL D FL+
Sbjct: 267 PDKRACANDLLVDEFLK 283
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 4e-53
Identities = 74/256 (28%), Positives = 115/256 (44%), Gaps = 18/256 (7%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+ + +G + W ++ + E + L E++LL+ LKH NI+++Y +D N
Sbjct: 23 QKIRRKSDGKILVWKELDYGS--MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 80
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIR----AVKHWCRQILSGLLYLHSRDPP---VIHR 150
+ V E G L K + V Q+ L H R V+HR
Sbjct: 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR 140
Query: 151 DLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSHAARCVGTPEFMAPEVYEEE-YNELVDI 207
DLK N+F++G VK+GD GLA IL S A VGTP +M+PE YNE DI
Sbjct: 141 DLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDI 199
Query: 208 YSFGMCIL-EMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-V 265
+S G C+L E+ P++ + ++ K+ G K + E+ + I + L
Sbjct: 200 WSLG-CLLYELCALMPPFTAFSQK-ELAGKIREG-KFRRIPYRYSDELNEIITRMLNLKD 256
Query: 266 SSRLSARELLTDPFLQ 281
R S E+L +P +
Sbjct: 257 YHRPSVEEILENPLIL 272
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 1e-51
Identities = 56/249 (22%), Positives = 101/249 (40%), Gaps = 18/249 (7%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTAN 96
++ + +G A + + P++ R E+ + + +H ++ +W +
Sbjct: 74 FKVRSKEDGRLYAVKRSMSPF--RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--G 129
Query: 97 RNINFVTEMFTSGTLRQYRLKHRRVNI--RAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 154
+ TE +L Q + ++ V + R L L +LHS+ ++H D+K
Sbjct: 130 GILYLQTE-LCGPSL-QQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKP 185
Query: 155 DNIFVNGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEEYNELVDIYSFGMC 213
NIF+ G K+GD GL L + A G P +MAPE+ + Y D++S G+
Sbjct: 186 ANIFLGPR-GRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLT 244
Query: 214 ILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSAR 272
ILE+ Q+ + + + L E+R + L R +A
Sbjct: 245 ILEVACNMELPHGGEGWQQLRQGYLPPEFTAGL----SSELRSVLVMMLEPDPKLRATAE 300
Query: 273 ELLTDPFLQ 281
LL P L+
Sbjct: 301 ALLALPVLR 309
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-51
Identities = 61/250 (24%), Positives = 113/250 (45%), Gaps = 15/250 (6%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+G + ++ + S +E E E+ +L +KH NI+++ S+ + N
Sbjct: 41 ILVKSTEDGRQYVIKEINISR--MSSKEREESRREVAVLANMKHPNIVQYRESFEE--NG 96
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNI--RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
++ V + G L + + V + W QI L ++H R ++HRD+K
Sbjct: 97 SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQ 154
Query: 156 NIFVNGNQGEVKIGDLGLAAILR--KSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGM 212
NIF+ + G V++GD G+A +L A C+GTP +++PE+ E + YN DI++ G
Sbjct: 155 NIFLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGC 213
Query: 213 CILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATV-SSRLSA 271
+ E+ T + + E + K+ISG + ++R + + R S
Sbjct: 214 VLYELCTLKHAF-EAGSMKNLVLKIISG-SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSV 271
Query: 272 RELLTDPFLQ 281
+L F+
Sbjct: 272 NSILEKGFIA 281
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-51
Identities = 76/253 (30%), Positives = 119/253 (47%), Gaps = 15/253 (5%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
YRA +G+ VA +V+++D L + EI LLK L H N++K+Y S+++ +
Sbjct: 49 YRAACLLDGVPVALKKVQIFD-LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DN 105
Query: 98 NINFVTEMFTSGTLRQY--RLKHRRVNI--RAVKHWCRQILSGLLYLHSRDPPVIHRDLK 153
+N V E+ +G L + K ++ I R V + Q+ S L ++HSR V+HRD+K
Sbjct: 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIK 163
Query: 154 CDNIFVNGNQGEVKIGDLGLAAILR--KSHAARCVGTPEFMAPEVYEEE-YNELVDIYSF 210
N+F+ G VK+GDLGL + A VGTP +M+PE E YN DI+S
Sbjct: 164 PANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSL 222
Query: 211 GMCILEMVTFDYPY-SECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATV-SSR 268
G + EM P+ + + + KK+ P E+RQ + C+ R
Sbjct: 223 GCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 282
Query: 269 LSARELLTDPFLQ 281
+
Sbjct: 283 PDVTYVYDVAKRM 295
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-50
Identities = 59/263 (22%), Positives = 107/263 (40%), Gaps = 37/263 (14%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD---- 93
++A +G +VK E+ E+ L L H NI+ + W
Sbjct: 28 FKAKHRIDGKTYVIKRVKY--------NNEKAEREVKALAKLDHVNIVHYNGCWDGFDYD 79
Query: 94 ----------TANRNINFVTEMFTSGTLRQY--RLKHRRVNIRAVKHWCRQILSGLLYLH 141
+ + + E GTL Q+ + + +++ QI G+ Y+H
Sbjct: 80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH 139
Query: 142 SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK-SHAARCVGTPEFMAPEVYEEE 200
S+ +I+RDLK NIF+ +VKIGD GL L+ R GT +M+PE +
Sbjct: 140 SKK--LINRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ 196
Query: 201 -YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 259
Y + VD+Y+ G+ + E++ E ++ + + G + D + + ++
Sbjct: 197 DYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRDGIISDIF----DKKEKTLLQ 249
Query: 260 KCLATV-SSRLSARELLTDPFLQ 281
K L+ R + E+L +
Sbjct: 250 KLLSKKPEDRPNTSEILRTLTVW 272
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-49
Identities = 72/286 (25%), Positives = 121/286 (42%), Gaps = 44/286 (15%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+A + + A +++ + E+L + E+ LL +L H+ ++++Y +W++ N
Sbjct: 23 VKARNALDSRYYAIKKIRH-----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNF 77
Query: 98 NIN-----------FVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 145
E +GTL ++ RQIL L Y+HS+
Sbjct: 78 VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG- 136
Query: 146 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR----------------CVGTP 189
+IHRDLK NIF++ + VKIGD GLA + +S +GT
Sbjct: 137 -IIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTA 194
Query: 190 EFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEA 245
++A EV + YNE +D+YS G+ EM+ YP+S I KK+ S P
Sbjct: 195 MYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILKKLRSVSIEFPPD 251
Query: 246 LFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLR 290
+ ++ I + + R AR LL +L + D ++
Sbjct: 252 FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIK 297
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 4e-49
Identities = 57/274 (20%), Positives = 109/274 (39%), Gaps = 41/274 (14%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+ A ++ + A +++L + E++ E+ L L+H I++++ +W++
Sbjct: 22 FEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78
Query: 98 NINF----------VTEMFTSGTLRQYRLKHRRVN----IRAVKHWCRQILSGLLYLHSR 143
++ L+ + + R H QI + +LHS+
Sbjct: 79 EKLQPSSPKVYLYIQMQLCRKENLKDW-MNGRCTIEERERSVCLHIFLQIAEAVEFLHSK 137
Query: 144 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA--------------RCVGTP 189
++HRDLK NIF + VK+GD GL + + VGT
Sbjct: 138 G--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTK 194
Query: 190 EFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFK 248
+M+PE Y+ VDI+S G+ + E++ YP+S + V + K P LF
Sbjct: 195 LYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQMERVRTLTDVRNLKFPP-LFT 250
Query: 249 VEDPEVRQFIEKCLATV-SSRLSARELLTDPFLQ 281
+ P ++ L+ R A ++ + +
Sbjct: 251 QKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 5e-48
Identities = 60/258 (23%), Positives = 101/258 (39%), Gaps = 26/258 (10%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+R D+ G + A +V+L F E+ L I+ Y + +
Sbjct: 75 HRMKDKQTGFQCAVKKVRLEVFRVE---------ELVACAGLSSPRIVPLYGAVREGPWV 125
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
NI E+ G+L Q + + ++ Q L GL YLH+R ++H D+K DN+
Sbjct: 126 NI--FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNV 181
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARC-------VGTPEFMAPEVYEEE-YNELVDIYS 209
++ + + D G A L+ + GT MAPEV + + VDI+S
Sbjct: 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWS 241
Query: 210 FGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED--PEVRQFIEKCLAT-VS 266
+L M+ +P+++ K I+ + P P Q I++ L
Sbjct: 242 SCCMMLHMLNGCHPWTQYFRGPLCLK--IASEPPPIREIPPSCAPLTAQAIQEGLRKEPV 299
Query: 267 SRLSARELLTDPFLQIDD 284
R SA EL + +
Sbjct: 300 HRASAMELRRKVGKALQE 317
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-46
Identities = 74/238 (31%), Positives = 116/238 (48%), Gaps = 24/238 (10%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQ-SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96
+RA E+ G +VA VK+ E + E+ ++K L+H NI+ F + N
Sbjct: 54 HRA--EWHGSDVA---VKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108
Query: 97 RNINFVTEMFTSGTLRQY---RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 153
+I VTE + G+L + +++ R + G+ YLH+R+PP++HR+LK
Sbjct: 109 LSI--VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLK 166
Query: 154 CDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYE-EEYNELVDIYSF 210
N+ V+ VK+ D GL+ + + + GTPE+MAPEV E NE D+YSF
Sbjct: 167 SPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSF 225
Query: 211 GMCILEMVTFDYPYSECTHPAQIYKKVISGKK----PEALFKVEDPEVRQFIEKCLAT 264
G+ + E+ T P+ +PAQ+ V K P L +P+V IE C
Sbjct: 226 GVILWELATLQQPWGNL-NPAQVVAAVGFKCKRLEIPRNL----NPQVAAIIEGCWTN 278
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 4e-46
Identities = 64/230 (27%), Positives = 105/230 (45%), Gaps = 20/230 (8%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+A ++ +VA +K ++S E + E+ L + H NI+K Y + ++
Sbjct: 25 CKA--KWRAKDVA---IKQ---IESESERKAFIVELRQLSRVNHPNIVKLYGACLN---- 72
Query: 98 NINFVTEMFTSGTLRQYRLKHRR---VNIRAVKHWCRQILSGLLYLHSRDP-PVIHRDLK 153
+ V E G+L WC Q G+ YLHS P +IHRDLK
Sbjct: 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK 132
Query: 154 CDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGM 212
N+ + +KI D G A + ++H G+ +MAPEV+E Y+E D++S+G+
Sbjct: 133 PPNLLLVAGGTVLKICDFGTACDI-QTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGI 191
Query: 213 CILEMVTFDYPYSECTHPAQ-IYKKVISGKKPEALFKVEDPEVRQFIEKC 261
+ E++T P+ E PA I V +G +P L K + + +C
Sbjct: 192 ILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP-LIKNLPKPIESLMTRC 240
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 8e-45
Identities = 60/233 (25%), Positives = 96/233 (41%), Gaps = 15/233 (6%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
YRA + G EVA + + +E + E L LKH NI+ + N
Sbjct: 24 YRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP-PVIHRDLKCDN 156
+ V E G L + L +R+ + +W QI G+ YLH P+IHRDLK N
Sbjct: 82 CL--VMEFARGGPLNRV-LSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSN 138
Query: 157 IFVNGNQGE-------VKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIY 208
I + +KI D GLA ++ G +MAPEV +++ D++
Sbjct: 139 ILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVW 198
Query: 209 SFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKC 261
S+G+ + E++T + P+ A Y ++ + +E C
Sbjct: 199 SYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC-PEPFAKLMEDC 250
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-44
Identities = 48/270 (17%), Positives = 103/270 (38%), Gaps = 39/270 (14%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTAN 96
++ +G A + K L + + E++ L +H ++++++++W + +
Sbjct: 28 FKCVKRLDGCIYAIKRSKK--PLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE--D 83
Query: 97 RNINFVTEMFTSGTLRQYRLKHRRVNIR----AVKHWCRQILSGLLYLHSRDPPVIHRDL 152
++ E G+L ++ R+ +K Q+ GL Y+HS ++H D+
Sbjct: 84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDI 141
Query: 153 KCDNIFVNGN------------------QGEVKIGDLGLAAILRKSHAARCVGTPEFMAP 194
K NIF++ + KIGDLG + G F+A
Sbjct: 142 KPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV--EEGDSRFLAN 199
Query: 195 EVYEEE--YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 252
EV +E + DI++ + ++ + + ++ G+ P + +V
Sbjct: 200 EVLQENYTHLPKADIFALALTVVCAAGAEPLPRN----GDQWHEIRQGRLPR-IPQVLSQ 254
Query: 253 EVRQFIEKCLATV-SSRLSARELLTDPFLQ 281
E + ++ + R SA L+ L
Sbjct: 255 EFTELLKVMIHPDPERRPSAMALVKHSVLL 284
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 5e-44
Identities = 56/243 (23%), Positives = 94/243 (38%), Gaps = 31/243 (12%)
Query: 38 YRAFDEYEGIEVAWNQVKLY------DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSW 91
++ + VA +K + E+ + E+ ++ L H NI+K Y
Sbjct: 36 HKGRLVKDKSVVA---IKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL- 91
Query: 92 VDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 150
+ V E G L K + I G+ Y+ +++PP++HR
Sbjct: 92 ---MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHR 148
Query: 151 DLKCDNIFVNGNQGE----VKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE---YNE 203
DL+ NIF+ K+ D GL+ S + +G ++MAPE E Y E
Sbjct: 149 DLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-VSGLLGNFQWMAPETIGAEEESYTE 207
Query: 204 LVDIYSFGMCILEMVTFDYPYSECTH-PAQIYKKVISGKK----PEALFKVEDPEVRQFI 258
D YSF M + ++T + P+ E ++ + + PE P +R I
Sbjct: 208 KADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDC----PPRLRNVI 263
Query: 259 EKC 261
E C
Sbjct: 264 ELC 266
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-43
Identities = 52/266 (19%), Positives = 104/266 (39%), Gaps = 31/266 (11%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH--RNIMKFYTSWVDTA 95
++ +E + A V L + + L+ EI L L+ I++ Y +
Sbjct: 26 FQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-- 80
Query: 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
++ I V E + L + K + ++ K + + +L + +H ++H DLK
Sbjct: 81 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPA 137
Query: 156 NI-FVNGNQGEVKIGDLGLAAILR----KSHAARCVGTPEFMAPEV------------YE 198
N V+G +K+ D G+A ++ VGT +M PE +
Sbjct: 138 NFLIVDGM---LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSK 194
Query: 199 EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 258
+ + D++S G + M P+ + + +I + + +++ +
Sbjct: 195 SKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVL 254
Query: 259 EKCLAT-VSSRLSARELLTDPFLQID 283
+ CL R+S ELL P++QI
Sbjct: 255 KCCLKRDPKQRISIPELLAHPYVQIQ 280
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 8e-43
Identities = 54/267 (20%), Positives = 105/267 (39%), Gaps = 33/267 (12%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH--RNIMKFYTSWVDTA 95
++ +E + A V L + + L+ EI L L+ I++ Y +
Sbjct: 73 FQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-- 127
Query: 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
++ I V E + L + K + ++ K + + +L + +H ++H DLK
Sbjct: 128 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPA 184
Query: 156 NI-FVNGNQGEVKIGDLGLAAILR----KSHAARCVGTPEFMAPEVYEEE---------- 200
N V+G +K+ D G+A ++ VG +M PE ++
Sbjct: 185 NFLIVDGM---LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSK 241
Query: 201 --YNELVDIYSFGMCIL-EMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 257
+ D++S G CIL M P+ + + +I + + +++
Sbjct: 242 SKISPKSDVWSLG-CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDV 300
Query: 258 IEKCLAT-VSSRLSARELLTDPFLQID 283
++ CL R+S ELL P++QI
Sbjct: 301 LKCCLKRDPKQRISIPELLAHPYVQIQ 327
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 9e-43
Identities = 55/272 (20%), Positives = 109/272 (40%), Gaps = 33/272 (12%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN--IMKFYTSWVDTA 95
++ +E + A V L + + L+ EI L L+ + I++ Y +
Sbjct: 45 FQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-- 99
Query: 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
++ I V E + L + K + ++ K + + +L + +H ++H DLK
Sbjct: 100 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPA 156
Query: 156 NI-FVNGNQGEVKIGDLGLAAILRK----SHAARCVGTPEFMAPEVYEEE---------- 200
N V+G +K+ D G+A ++ VGT +M PE ++
Sbjct: 157 NFLIVDGM---LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSK 213
Query: 201 --YNELVDIYSFGMCIL-EMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 257
+ D++S G CIL M P+ + + +I + + +++
Sbjct: 214 SKISPKSDVWSLG-CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDV 272
Query: 258 IEKCLAT-VSSRLSARELLTDPFLQIDDYDSD 288
++ CL R+S ELL P++QI + +
Sbjct: 273 LKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-42
Identities = 35/231 (15%), Positives = 90/231 (38%), Gaps = 17/231 (7%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYC-EIHLLKTLKHRNIMKFYTSWVDTAN 96
++ ++G ++ VK+ R + E L+ H N++ +
Sbjct: 27 WKG--RWQGNDIV---VKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81
Query: 97 RNINFVTEMFTSGTLRQY--RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 154
+ +T G+L + V+ + + G+ +LH+ +P + L
Sbjct: 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNS 141
Query: 155 DNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE----YNELVDIYSF 210
++ ++ + +I + + + P ++APE +++ D++SF
Sbjct: 142 RSVMIDED-MTARISMADVKFSFQSPGR---MYAPAWVAPEALQKKPEDTNRRSADMWSF 197
Query: 211 GMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKC 261
+ + E+VT + P+++ ++ K + G +P + P V + ++ C
Sbjct: 198 AVLLWELVTREVPFADLSNMEIGMKVALEGLRPT-IPPGISPHVSKLMKIC 247
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-42
Identities = 52/243 (21%), Positives = 104/243 (42%), Gaps = 32/243 (13%)
Query: 44 YEGI---EVAWNQVKLYDFLQ-SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99
Y G EVA ++L D + + ++L+ E+ + +H N++ F + + + I
Sbjct: 50 YHGRWHGEVA---IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106
Query: 100 NFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 158
+T + TL R +++ + ++I+ G+ YLH++ ++H+DLK N+F
Sbjct: 107 --ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK--GILHKDLKSKNVF 162
Query: 159 VNGNQGEVKIGDLGLAAILRKSHAAR-------CVGTPEFMAPEV----------YEEEY 201
+ G+V I D GL +I A R G +APE+ + +
Sbjct: 163 YD--NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPF 220
Query: 202 NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKC 261
++ D+++ G E+ ++P+ I ++ +G KP E+ + C
Sbjct: 221 SKHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFC 279
Query: 262 LAT 264
A
Sbjct: 280 WAF 282
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-42
Identities = 62/304 (20%), Positives = 116/304 (38%), Gaps = 46/304 (15%)
Query: 15 LKLIPLEDMEDTMKFLVKELQ-----------RHYRAF-------DEYEGIEVAWNQVKL 56
+K I L + E + +++E++ R++ A+ + E E+
Sbjct: 36 IKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDEST 95
Query: 57 YDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-- 114
L SP ++ +I + +N + I ++ L+ +
Sbjct: 96 DWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYI--QMQLCRKENLKDWMN 153
Query: 115 -RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 173
R H QI + +LHS+ ++HRDLK NIF + VK+GD GL
Sbjct: 154 RRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGL 210
Query: 174 AAIL--------------RKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMV 218
+ + VGT +M+PE Y+ VDI+S G+ + E++
Sbjct: 211 VTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270
Query: 219 TFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATV-SSRLSARELLTD 277
Y +S +I V + K P LF + P+ ++ L+ + R A +++ +
Sbjct: 271 ---YSFSTQMERVRIITDVRNLKFPL-LFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326
Query: 278 PFLQ 281
+
Sbjct: 327 AIFE 330
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-42
Identities = 76/251 (30%), Positives = 123/251 (49%), Gaps = 21/251 (8%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
++ D VA +K+ D ++ +E+E + EI +L + K+Y S++ +
Sbjct: 39 FKGIDNRTQKVVA---IKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DT 93
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
+ + E G+ L+ ++ + R+IL GL YLHS IHRD+K N+
Sbjct: 94 KLWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANV 150
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPEVYEE-EYNELVDIYSFGMCI 214
++ GEVK+ D G+A L + R VGTP +MAPEV ++ Y+ DI+S G+
Sbjct: 151 LLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITA 209
Query: 215 LEMVTFDYPYSECTHPAQIYKKV---ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLS 270
+E+ + P+SE HP KV I P L +++F+E CL S R +
Sbjct: 210 IELARGEPPHSE-LHPM----KVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPT 264
Query: 271 ARELLTDPFLQ 281
A+ELL F+
Sbjct: 265 AKELLKHKFIL 275
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 8e-42
Identities = 65/234 (27%), Positives = 113/234 (48%), Gaps = 25/234 (10%)
Query: 44 YEGI---EVAWNQVKLYDFLQ-SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99
Y+G +VA VK+ + +P++L+ E+ +L+ +H NI+ F + I
Sbjct: 41 YKGKWHGDVA---VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYSTAPQLAI 96
Query: 100 NFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 158
VT+ +L + + ++ + RQ G+ YLH++ +IHRDLK +NIF
Sbjct: 97 --VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK--SIIHRDLKSNNIF 152
Query: 159 VNGNQGEVKIGDLGLAAILRKSHAARC----VGTPEFMAPEVYEEE----YNELVDIYSF 210
++ + VKIGD GLA + + G+ +MAPEV + Y+ D+Y+F
Sbjct: 153 LHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAF 211
Query: 211 GMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE---DPEVRQFIEKC 261
G+ + E++T PYS + QI + V G L KV +++ + +C
Sbjct: 212 GIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAEC 265
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 84/260 (32%), Positives = 120/260 (46%), Gaps = 38/260 (14%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTS------- 90
Y A D G EVA ++ + LQ + E + EI +++ K+ NI+ + S
Sbjct: 37 YTAMDVATGQEVA---IRQMN-LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92
Query: 91 WVDTANRNINFVTEMFTSGTLRQYRLKHRRVN---IRAVKHWCRQILSGLLYLHSRDPPV 147
WV V E G+L + ++ I AV CR+ L L +LHS V
Sbjct: 93 WV---------VMEYLAGGSLTDV-VTETCMDEGQIAAV---CRECLQALEFLHSNQ--V 137
Query: 148 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPEV-YEEEYNEL 204
IHRD+K DNI + G VK+ D G A + + R VGTP +MAPEV + Y
Sbjct: 138 IHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 205 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED--PEVRQFIEKCL 262
VDI+S G+ +EM+ + PY +P + I+ L E R F+ +CL
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLN-ENPLRALYL-IATNGTPELQNPEKLSAIFRDFLNRCL 254
Query: 263 A-TVSSRLSARELLTDPFLQ 281
V R SA+ELL FL+
Sbjct: 255 EMDVEKRGSAKELLQHQFLK 274
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 7e-41
Identities = 84/260 (32%), Positives = 124/260 (47%), Gaps = 38/260 (14%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTS------- 90
A +++ G +VA VK+ D L+ + E L+ E+ +++ +H N+++ Y S
Sbjct: 62 CLAREKHSGRQVA---VKMMD-LRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117
Query: 91 WVDTANRNINFVTEMFTSGTLRQYRLKHRRVN---IRAVKHWCRQILSGLLYLHSRDPPV 147
WV + E G L + R+N I V C +L L YLH++ V
Sbjct: 118 WV---------LMEFLQGGALTDI-VSQVRLNEEQIATV---CEAVLQALAYLHAQG--V 162
Query: 148 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPEV-YEEEYNEL 204
IHRD+K D+I + G VK+ D G A + K R VGTP +MAPEV Y
Sbjct: 163 IHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATE 221
Query: 205 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED--PEVRQFIEKCL 262
VDI+S G+ ++EMV + PY P Q K+ + P L P +R F+E+ L
Sbjct: 222 VDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKR-LRDSPPPKLKNSHKVSPVLRDFLERML 279
Query: 263 A-TVSSRLSARELLTDPFLQ 281
R +A+ELL PFL
Sbjct: 280 VRDPQERATAQELLDHPFLL 299
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 77/260 (29%), Positives = 126/260 (48%), Gaps = 31/260 (11%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y+A ++ G A K+ + +S EELE EI +L T H I+K ++ +
Sbjct: 36 YKAKNKETGALAA---AKVIE-TKSEEELEDYIVEIEILATCDHPYIVKLLGAYY--HDG 89
Query: 98 NINFVTEMFTSGTLRQYRLKHRRV----NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 153
+ + E G + L+ R I+ V CRQ+L L +LHS+ +IHRDLK
Sbjct: 90 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVV---CRQMLEALNFLHSKR--IIHRDLK 144
Query: 154 CDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPEV------YEEEYNELV 205
N+ + +G++++ D G++A K+ R +GTP +MAPEV + Y+
Sbjct: 145 AGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKA 203
Query: 206 DIYSFGMCILEMVTFDYPYSECTHPAQ-IYKKVISGKKPEALFKVED--PEVRQFIEKCL 262
DI+S G+ ++EM + P+ E +P + + K I+ P L E R F++ L
Sbjct: 204 DIWSLGITLIEMAQIEPPHHE-LNPMRVLLK--IAKSDPPTLLTPSKWSVEFRDFLKIAL 260
Query: 263 A-TVSSRLSARELLTDPFLQ 281
+R SA +LL PF+
Sbjct: 261 DKNPETRPSAAQLLEHPFVS 280
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-40
Identities = 67/279 (24%), Positives = 112/279 (40%), Gaps = 50/279 (17%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+ ++ G +VA VK+ F + E EI+ ++H NI+ F + +
Sbjct: 54 WMG--KWRGEKVA---VKV--FFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106
Query: 98 NINF--VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD------PPVIH 149
+T+ +G+L Y LK ++ +++ +SGL +LH+ P + H
Sbjct: 107 WTQLYLITDYHENGSLYDY-LKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAH 165
Query: 150 RDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC------VGTPEFMAPEVYEE---- 199
RDLK NI V N G I DLGLA VGT +M PEV +E
Sbjct: 166 RDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNR 224
Query: 200 ---EYNELVDIYSFGMCILEMVT----------FDYPYSECTHP----AQIYKKVISGKK 242
+ + D+YSFG+ + E+ + PY + + + V K
Sbjct: 225 NHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKL 284
Query: 243 ----PEALFKVE-DPEVRQFIEKCLATV-SSRLSARELL 275
P E ++ + + +C A +SRL+A +
Sbjct: 285 RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 4e-40
Identities = 75/275 (27%), Positives = 112/275 (40%), Gaps = 45/275 (16%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
A+ + +VA +K + + ++ L EI + H NI+ +YTS+V
Sbjct: 32 QAAYCAPKKEKVA---IKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV--KD 86
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHW---------CRQILSGLLYLHSRDPPVI 148
+ V ++ + G++ +KH R++L GL YLH I
Sbjct: 87 ELWLVMKLLSGGSVLDI-IKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QI 143
Query: 149 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC-------VGTPEFMAPEVYEE-- 199
HRD+K NI + G V+I D G++A L VGTP +MAPEV E+
Sbjct: 144 HRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR 202
Query: 200 EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV---ISGKKPEALFKVED----- 251
Y+ DI+SFG+ +E+ T PY + P KV P +L
Sbjct: 203 GYDFKADIWSFGITAIELATGAAPYHK-YPPM----KVLMLTLQNDPPSLETGVQDKEML 257
Query: 252 ----PEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 281
R+ I CL R +A ELL F Q
Sbjct: 258 KKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 45/265 (16%), Positives = 82/265 (30%), Gaps = 33/265 (12%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD--TA 95
++G A ++ ++ E E + + H NI++ + A
Sbjct: 46 DLVEGLHDGHFYALKRI----LCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101
Query: 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRA-----VKHWCRQILSGLLYLHSRDPPVIHR 150
+ F GTL ++ + + I GL +H+ HR
Sbjct: 102 KHEAWLLLPFFKRGTLWNE-IERLKDKGNFLTEDQILWLLLGICRGLEAIHA--KGYAHR 158
Query: 151 DLKCDNIFVNGNQGEVKIGDLGLAAILRKS-----------HAARCVGTPEFMAPEVYEE 199
DLK NI + G+ + DLG A T + APE++
Sbjct: 159 DLKPTNILLGDE-GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSV 217
Query: 200 E----YNELVDIYSFGMCIL-EMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEV 254
+ +E D++S G C+L M+ + PY + + +
Sbjct: 218 QSHCVIDERTDVWSLG-CVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSAL 276
Query: 255 RQFIEKCLAT-VSSRLSARELLTDP 278
Q + + R LL+
Sbjct: 277 WQLLNSMMTVDPHQRPHIPLLLSQL 301
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-39
Identities = 76/255 (29%), Positives = 125/255 (49%), Gaps = 28/255 (10%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y+A + G VA +K +E+ + EI +++ +++K+Y S+ N
Sbjct: 46 YKAIHKETGQIVA---IKQVPVESDLQEIIK---EISIMQQCDSPHVVKYYGSYF--KNT 97
Query: 98 NINFVTEMFTSGTLRQ-YRLKHRRVN---IRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 153
++ V E +G++ RL+++ + I + + L GL YLH IHRD+K
Sbjct: 98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATI---LQSTLKGLEYLHFMR--KIHRDIK 152
Query: 154 CDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPEV-YEEEYNELVDIYSF 210
NI +N +G K+ D G+A L + A R +GTP +MAPEV E YN + DI+S
Sbjct: 153 AGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSL 211
Query: 211 GMCILEMVTFDYPYSECTHPAQ-IYKKVISGKKPEALFKVED--PEVRQFIEKCLA-TVS 266
G+ +EM PY++ HP + I+ I P K E F+++CL +
Sbjct: 212 GITAIEMAEGKPPYAD-IHPMRAIFM--IPTNPPPTFRKPELWSDNFTDFVKQCLVKSPE 268
Query: 267 SRLSARELLTDPFLQ 281
R +A +LL PF++
Sbjct: 269 QRATATQLLQHPFVR 283
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-39
Identities = 69/279 (24%), Positives = 104/279 (37%), Gaps = 50/279 (17%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+R ++ G EVA VK+ F E EI+ L+H NI+ F +
Sbjct: 59 WRG--KWRGEEVA---VKI--FSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111
Query: 98 NINF--VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD------PPVIH 149
V++ G+L Y L V + + SGL +LH P + H
Sbjct: 112 WTQLWLVSDYHEHGSLFDY-LNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 170
Query: 150 RDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC------VGTPEFMAPEVYEE---- 199
RDLK NI V N G I DLGLA + VGT +MAPEV ++
Sbjct: 171 RDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 229
Query: 200 ---EYNELVDIYSFGMCILEMVT----------FDYPYSECTHP----AQIYKKVISGKK 242
E + DIY+ G+ E+ + PY + ++ K V K
Sbjct: 230 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL 289
Query: 243 ----PEALFKVE-DPEVRQFIEKCLATV-SSRLSARELL 275
P E + + + +C ++RL+A +
Sbjct: 290 RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-39
Identities = 70/279 (25%), Positives = 118/279 (42%), Gaps = 50/279 (17%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+R ++G VA VK+ F E+ E++ L+H NI+ F S + + +
Sbjct: 25 WRG--SWQGENVA---VKI--FSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHS 77
Query: 98 NINF--VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR------DPPVIH 149
+ +T G+L Y L+ ++ + I SGL +LH P + H
Sbjct: 78 STQLWLITHYHEMGSLYDY-LQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAH 136
Query: 150 RDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC------VGTPEFMAPEVYEE---- 199
RDLK NI V N G+ I DLGLA + +S VGT +MAPEV +E
Sbjct: 137 RDLKSKNILVKKN-GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 195
Query: 200 ---EYNELVDIYSFGMCILEMVT----------FDYPYSECT--HPA--QIYKKVISGKK 242
+ + VDI++FG+ + E+ + P+ + P+ + K V ++
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ 255
Query: 243 ----PEALFKVE-DPEVRQFIEKCLATV-SSRLSARELL 275
P F + + +++C S+RL+A +
Sbjct: 256 RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 69/263 (26%), Positives = 116/263 (44%), Gaps = 24/263 (9%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y A D VA ++ QS E+ + + E+ L+ L+H N +++ ++
Sbjct: 71 YFARDVRNSEVVAIKKMSY-SGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EH 127
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVN---IRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 154
V E + + + I AV L GL YLHS + +IHRD+K
Sbjct: 128 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLHSHN--MIHRDVKA 182
Query: 155 DNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEV----YEEEYNELVDIYSF 210
NI ++ G VK+GD G A+I+ +++ VGTP +MAPEV E +Y+ VD++S
Sbjct: 183 GNILLS-EPGLVKLGDFGSASIMAPANSF--VGTPYWMAPEVILAMDEGQYDGKVDVWSL 239
Query: 211 GMCILEMVTFDYPYSECTHPAQ-IYKKVISGKKPEALFKVE-DPEVRQFIEKCLA-TVSS 267
G+ +E+ P + +Y I+ + AL R F++ CL
Sbjct: 240 GITCIELAERKPPLFN-MNAMSALYH--IAQNESPALQSGHWSEYFRNFVDSCLQKIPQD 296
Query: 268 RLSARELLTDPFLQIDDYDSDLR 290
R ++ LL F+ + + +
Sbjct: 297 RPTSEVLLKHRFVLRERPPTVIM 319
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-38
Identities = 72/266 (27%), Positives = 121/266 (45%), Gaps = 37/266 (13%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTAN 96
Y+ G A + + + +E E + EI++LK HRNI +Y +++
Sbjct: 41 YKGRHVKTGQLAAIKVMDV-----TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95
Query: 97 RNIN----FVTEMFTSGTLR--QYRLKHRRVN---IRAVKHWCRQILSGLLYLHSRDPPV 147
++ V E +G++ K + I + CR+IL GL +LH V
Sbjct: 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI---CREILRGLSHLHQHK--V 150
Query: 148 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEV------YEE 199
IHRD+K N+ + EVK+ D G++A L ++ R +GTP +MAPEV +
Sbjct: 151 IHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDA 209
Query: 200 EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ-IYKKVISGKKPEALFKVED--PEVRQ 256
Y+ D++S G+ +EM P + HP + ++ I L K + + +
Sbjct: 210 TYDFKSDLWSLGITAIEMAEGAPPLCD-MHPMRALFL--IPRNPAPRL-KSKKWSKKFQS 265
Query: 257 FIEKCLA-TVSSRLSARELLTDPFLQ 281
FIE CL S R + +L+ PF++
Sbjct: 266 FIESCLVKNHSQRPATEQLMKHPFIR 291
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 63/255 (24%), Positives = 107/255 (41%), Gaps = 18/255 (7%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIH-LLKTLKHRNIMKFYTSWVDTAN 96
+ G +A VK + +E +RL ++ ++T+ + FY +
Sbjct: 24 EKMRHVPSGQIMA---VKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR--E 78
Query: 97 RNINFVTE-MFTSGT--LRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 153
++ E M TS +Q K + + + I+ L +LHS+ VIHRD+K
Sbjct: 79 GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS-VIHRDVK 137
Query: 154 CDNIFVNGNQGEVKIGDLGLAAILRKSHAARC-VGTPEFMAPEV-----YEEEYNELVDI 207
N+ +N G+VK+ D G++ L A G +MAPE ++ Y+ DI
Sbjct: 138 PSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDI 196
Query: 208 YSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVS 266
+S G+ ++E+ +PY P Q K+V+ P+ E F +CL
Sbjct: 197 WSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSK 256
Query: 267 SRLSARELLTDPFLQ 281
R + EL+ PF
Sbjct: 257 ERPTYPELMQHPFFT 271
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 55/254 (21%), Positives = 113/254 (44%), Gaps = 17/254 (6%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIH-LLKTLKHRNIMKFYTSWVDTAN 96
++ G +A VK + EE +R+ ++ +LK+ I++ + +++ N
Sbjct: 42 WKMRFRKTGHVIA---VKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT--N 96
Query: 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
++ E+ + + + + R + I+ L YL + VIHRD+K N
Sbjct: 97 TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG-VIHRDVKPSN 155
Query: 157 IFVNGNQGEVKIGDLGLAAILRKSHAARC-VGTPEFMAPEV------YEEEYNELVDIYS 209
I ++ +G++K+ D G++ L A G +MAPE + +Y+ D++S
Sbjct: 156 ILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWS 214
Query: 210 FGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE-DPEVRQFIEKCLA-TVSS 267
G+ ++E+ T +PY C ++ KV+ + P + + + F++ CL
Sbjct: 215 LGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRK 274
Query: 268 RLSARELLTDPFLQ 281
R +LL F++
Sbjct: 275 RPKYNKLLEHSFIK 288
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-37
Identities = 60/277 (21%), Positives = 106/277 (38%), Gaps = 30/277 (10%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+R + G A +K+++ + ++ E +LK L H+NI+K + +T R
Sbjct: 26 FRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNI---RAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 154
+ + E G+L + R ++ G+ +L ++HR++K
Sbjct: 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKP 140
Query: 155 DNIFVNGNQGE---VKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYE---------EEY 201
NI + K+ D G A L GT E++ P++YE ++Y
Sbjct: 141 GNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY 200
Query: 202 NELVDIYSFGMCIL-EMVT----FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 256
VD++S G T F P+ ++ K+I+GK A+ V+ E
Sbjct: 201 GATVDLWSIG-VTFYHAATGSLPF-RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGP 258
Query: 257 FIEKCLATVSSRLS--ARELLTDPFLQIDDYDSDLRM 291
VS LS + LLT I + D +
Sbjct: 259 IDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW 295
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 69/257 (26%), Positives = 120/257 (46%), Gaps = 27/257 (10%)
Query: 38 YRAFDEYEGIEVAWNQVKLYD--FLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95
+ D A K+ L P + E++ EI + ++L H++++ F+ + D
Sbjct: 32 FEISDADTKEVFA---GKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-- 86
Query: 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
N + V E+ +L + + + + +++ RQI+ G YLH VIHRDLK
Sbjct: 87 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLG 144
Query: 156 NIFVNGNQGEVKIGDLGLAAILRKSHAAR---CVGTPEFMAPEVYEEE-YNELVDIYSFG 211
N+F+N + EVKIGD GLA + + C GTP ++APEV ++ ++ VD++S G
Sbjct: 145 NLFLNED-LEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHSFEVDVWSIG 202
Query: 212 MCIL-EMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED---PEVRQFIEKCLATV-S 266
CI+ ++ P+ Y ++ + + + P I+K L T +
Sbjct: 203 -CIMYTLLVGKPPFETSCLKE-TYLRIKKNE-----YSIPKHINPVAASLIQKMLQTDPT 255
Query: 267 SRLSARELLTDPFLQID 283
+R + ELL D F
Sbjct: 256 ARPTINELLNDEFFTSG 272
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 69/257 (26%), Positives = 120/257 (46%), Gaps = 27/257 (10%)
Query: 38 YRAFDEYEGIEVAWNQVKLYD--FLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95
+ D A K+ L P + E++ EI + ++L H++++ F+ + D
Sbjct: 58 FEISDADTKEVFA---GKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-- 112
Query: 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
N + V E+ +L + + + + +++ RQI+ G YLH VIHRDLK
Sbjct: 113 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLG 170
Query: 156 NIFVNGNQGEVKIGDLGLAAILRKSHAAR---CVGTPEFMAPEVYEEE-YNELVDIYSFG 211
N+F+N + EVKIGD GLA + + C GTP ++APEV ++ ++ VD++S G
Sbjct: 171 NLFLNED-LEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHSFEVDVWSIG 228
Query: 212 MCIL-EMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED---PEVRQFIEKCLATV-S 266
CI+ ++ P+ Y ++ + + + P I+K L T +
Sbjct: 229 -CIMYTLLVGKPPFETSCLKE-TYLRIKKNE-----YSIPKHINPVAASLIQKMLQTDPT 281
Query: 267 SRLSARELLTDPFLQID 283
+R + ELL D F
Sbjct: 282 ARPTINELLNDEFFTSG 298
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-36
Identities = 56/308 (18%), Positives = 106/308 (34%), Gaps = 77/308 (25%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDF-LQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96
A + G V V+ + S E + L E+H+ K H NI+ + +++ A+
Sbjct: 44 NLARYKPTGEYVT---VRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI--AD 98
Query: 97 RNINFVTEMFTSGTLRQYRLKHRRVN------IRAVKHWCRQILSGLLYLHSRDPPVIHR 150
+ VT G+ + + ++ I + + +L L Y+H +HR
Sbjct: 99 NELWVVTSFMAYGSAKDL-ICTHFMDGMNELAIAYI---LQGVLKALDYIHHMG--YVHR 152
Query: 151 DLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR---------CVGTPEFMAPEVYEE-- 199
+K +I ++ + G+V + L + + V +++PEV ++
Sbjct: 153 SVKASHILISVD-GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNL 211
Query: 200 -EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED------- 251
Y+ DIYS G+ E+ P+ + Q+ + ++G P L
Sbjct: 212 QGYDAKSDIYSVGITACELANGHVPFKD-MPATQMLLEKLNGTVPCLLDTSTIPAEELTM 270
Query: 252 -------------------------------------PEVRQFIEKCLA-TVSSRLSARE 273
P F+E+CL +R SA
Sbjct: 271 SPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST 330
Query: 274 LLTDPFLQ 281
LL F +
Sbjct: 331 LLNHSFFK 338
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-36
Identities = 59/272 (21%), Positives = 110/272 (40%), Gaps = 23/272 (8%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIH-LLKTLKHRNIMKFYTSWVDTAN 96
+ + G +A VK +E ++L ++ ++++ I++FY +
Sbjct: 39 NKMVHKPSGQIMA---VKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR--E 93
Query: 97 RNINFVTE-MFTS---GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL 152
+ E M TS Y + + + + L +L + +IHRD+
Sbjct: 94 GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDI 152
Query: 153 KCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEV-----YEEEYNELVD 206
K NI ++ G +K+ D G++ L S A G +MAPE + Y+ D
Sbjct: 153 KPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSD 211
Query: 207 IYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED---PEVRQFIEKCLA 263
++S G+ + E+ T +PY + +V+ G P+ E P F+ CL
Sbjct: 212 VWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLT 271
Query: 264 -TVSSRLSARELLTDPFLQIDDYDSDLRMIQY 294
S R +ELL PF+ + + + + + Y
Sbjct: 272 KDESKRPKYKELLKHPFILMYE-ERAVEVACY 302
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 60/277 (21%), Positives = 106/277 (38%), Gaps = 30/277 (10%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+R + G A +K+++ + ++ E +LK L H+NI+K + +T R
Sbjct: 26 FRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNI---RAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 154
+ + E G+L + R ++ G+ +L ++HR++K
Sbjct: 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKP 140
Query: 155 DNIFVNGNQGE---VKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYE---------EEY 201
NI + K+ D G A L GT E++ P++YE ++Y
Sbjct: 141 GNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY 200
Query: 202 NELVDIYSFGMCIL-EMVT----FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 256
VD++S G T F P+ ++ K+I+GK A+ V+ E
Sbjct: 201 GATVDLWSIG-VTFYHAATGSLPF-RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGP 258
Query: 257 FIEKCLATVSSRLS--ARELLTDPFLQIDDYDSDLRM 291
VS LS + LLT I + D +
Sbjct: 259 IDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW 295
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 54/271 (19%), Positives = 98/271 (36%), Gaps = 40/271 (14%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTAN 96
Y A D G E A ++ E+ + E+ +K L H NI++F ++
Sbjct: 45 YEAQDVGSGREYALKRL----LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100
Query: 97 RNIN-----FVTEMFTSGTLRQYRLKHR---RVNIRAVKHWCRQILSGLLYLHSRDPPVI 148
+ + G L ++ K ++ V Q + ++H + PP+I
Sbjct: 101 ESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPII 160
Query: 149 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--------------HAARCVGTPEFMAP 194
HRDLK +N+ ++ G +K+ D G A + TP + P
Sbjct: 161 HRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTP 219
Query: 195 EVYE----EEYNELVDIYSFGMCIL-EMVTFDYPYSECTHPAQIYKKVISGKKPEALFKV 249
E+ + E DI++ G CIL + +P+ + ++++GK
Sbjct: 220 EIIDLYSNFPIGEKQDIWALG-CILYLLCFRQHPFED-----GAKLRIVNGKYSIPPHDT 273
Query: 250 EDPEVRQFIEKCLAT-VSSRLSARELLTDPF 279
+ I L RLS E++
Sbjct: 274 QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-34
Identities = 64/287 (22%), Positives = 114/287 (39%), Gaps = 50/287 (17%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
++ + G+ +A KL P ++ E+ +L I+ FY ++ +
Sbjct: 50 FKVSHKPSGLVMA---RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DG 104
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
I+ E G+L Q K R+ + + ++ GL YL + ++HRD+K NI
Sbjct: 105 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNI 163
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILE 216
VN ++GE+K+ D G++ L S A VGT +M+PE + Y+ DI+S G+ ++E
Sbjct: 164 LVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 222
Query: 217 MVTFDYPYSECTHPAQIYKKVISGK-------------------------KPEALFKVED 251
M YP + P A+F++ D
Sbjct: 223 MAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLD 282
Query: 252 ----------------PEVRQFIEKCLATVSS-RLSARELLTDPFLQ 281
E + F+ KCL + R ++L+ F++
Sbjct: 283 YIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 329
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 67/280 (23%), Positives = 115/280 (41%), Gaps = 48/280 (17%)
Query: 44 YEGIEVAWNQ----VKLYDFLQSPEELERLYC-EIHLLKTLKHRNIMKFYTSWVDTANRN 98
+ + + + + ++ EE +R + E+ +++ L+H N++KF V ++
Sbjct: 27 IKVT---HRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG--VLYKDKR 81
Query: 99 INFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
+NF+TE GTLR + + + + I SG+ YLHS + +IHRDL N
Sbjct: 82 LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNC 139
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAAR----------------CVGTPEFMAPEVYE-EE 200
V N V + D GLA ++ VG P +MAPE+
Sbjct: 140 LVREN-KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS 198
Query: 201 YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--------PEALFKV--- 249
Y+E VD++SFG+ + E++ + + + G P + F +
Sbjct: 199 YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVR 258
Query: 250 ---EDPEVR---QFIEKCLATVSSRLSARELLTDPFLQID 283
DPE R +E L T+ L+ L Q+D
Sbjct: 259 CCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLD 298
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 9e-34
Identities = 37/276 (13%), Positives = 81/276 (29%), Gaps = 35/276 (12%)
Query: 27 MKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK 86
+ + A + + + ++ + + R L+K + + +++
Sbjct: 103 VHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIR 162
Query: 87 FYTSWVDTANRNINFVTEMFTS------GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYL 140
D + F+ S L + H+ + A Q++ L L
Sbjct: 163 VRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 222
Query: 141 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE 200
H ++H L+ +I ++ G V + +R + F PE+
Sbjct: 223 HHYG--LVHTYLRPVDIVLDQR-GGVFLTGFEHL--VRDGARVVSSVSRGFEPPELEARR 277
Query: 201 ------------YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEAL 246
D ++ G+ I + D P ++ + + K P
Sbjct: 278 ATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK-DAALGGSEWIFRSCKNIP--- 333
Query: 247 FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 281
VR +E L RL + + P +
Sbjct: 334 -----QPVRALLEGFLRYPKEDRLLPLQAMETPEYE 364
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 70/255 (27%), Positives = 122/255 (47%), Gaps = 26/255 (10%)
Query: 38 YRAFDEYEGIEVAWNQVKLYD--FLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95
YRA + G+EVA +K+ D + ++R+ E+ + LKH +I++ Y + D
Sbjct: 28 YRAESIHTGLEVA---IKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-- 82
Query: 96 NRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 154
+ + V EM +G + +Y + + + + +H+ QI++G+LYLHS ++HRDL
Sbjct: 83 SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTL 140
Query: 155 DNIFVNGNQGEVKIGDLGLAAILRKSHAAR---CVGTPEFMAPEVYE-EEYNELVDIYSF 210
N+ + N +KI D GLA L+ H C GTP +++PE+ + D++S
Sbjct: 141 SNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIATRSAHGLESDVWSL 198
Query: 211 GMCIL-EMVTFDYPYSECTHPAQIYKKVISG--KKPEALFKVEDPEVRQFIEKCLATV-S 266
G C+ ++ P+ T KV+ + P L E + I + L +
Sbjct: 199 G-CMFYTLLIGRPPFDTDTVKN-TLNKVVLADYEMPSFL----SIEAKDLIHQLLRRNPA 252
Query: 267 SRLSARELLTDPFLQ 281
RLS +L PF+
Sbjct: 253 DRLSLSSVLDHPFMS 267
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 51/216 (23%), Positives = 92/216 (42%), Gaps = 29/216 (13%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
++A + VA VK++ +Q + + Y E++ L +KH NI++F + +
Sbjct: 41 WKA--QLLNEYVA---VKIFP-IQDKQSWQNEY-EVYSLPGMKHENILQFIGAEKRGTSV 93
Query: 98 NINF--VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS--------RDPPV 147
+++ +T G+L + LK V+ + H + GL YLH P +
Sbjct: 94 DVDLWLITAFHEKGSLSDF-LKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAI 152
Query: 148 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC----VGTPEFMAPEV------Y 197
HRD+K N+ + N I D GLA +A VGT +MAPEV +
Sbjct: 153 SHRDIKSKNVLLKNN-LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINF 211
Query: 198 EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQI 233
+ + +D+Y+ G+ + E+ + +
Sbjct: 212 QRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 9e-33
Identities = 56/219 (25%), Positives = 101/219 (46%), Gaps = 14/219 (6%)
Query: 67 ERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAV 126
+L E+ + L+H NI++ Y + D + + E GT+ + K + + +
Sbjct: 54 HQLRREVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRT 111
Query: 127 KHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCV 186
+ ++ + L Y HS+ VIHRD+K +N+ + G+ GE+KI D G + S
Sbjct: 112 ATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTDLC 168
Query: 187 GTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG--KKP 243
GT +++ PE+ E ++E VD++S G+ E + P E + YK++ P
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV-GKPPFEANTYQETYKRISRVEFTFP 227
Query: 244 EALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 281
+ + R I + L S R RE+L P++
Sbjct: 228 DFV----TEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-32
Identities = 68/255 (26%), Positives = 100/255 (39%), Gaps = 17/255 (6%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY----TSWVD 93
R + G +VA +K SP+ ER EI ++K L H N++
Sbjct: 31 LRWIHQDTGEQVA---IKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87
Query: 94 TANRNINFVTEMFTSGTLRQYRLKHRRVNI---RAVKHWCRQILSGLLYLHSRDPPVIHR 150
N E G LR+Y + ++ I S L YLH +IHR
Sbjct: 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHR 145
Query: 151 DLKCDNI--FVNGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYE-EEYNELVD 206
DLK +NI + KI DLG A L + VGT +++APE+ E ++Y VD
Sbjct: 146 DLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVD 205
Query: 207 IYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVS 266
+SFG E +T P+ P Q + K + K E + +D L T +
Sbjct: 206 YWSFGTLAFECITGFRPFLPNWQPVQWHGK-VREKSNEHIVVYDDLTGAVKFSSVLPTPN 264
Query: 267 SRLSARELLTDPFLQ 281
+ +LQ
Sbjct: 265 HLSGILAGKLERWLQ 279
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-32
Identities = 67/235 (28%), Positives = 111/235 (47%), Gaps = 11/235 (4%)
Query: 60 LQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR 119
++ + E L E+ LLK L H NIMK Y + D V E++T G L + +
Sbjct: 64 VKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED--KGYFYLVGEVYTGGELFDEIISRK 121
Query: 120 RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAIL 177
R + RQ+LSG+ Y+H ++HRDLK +N+ + ++ ++I D GL+
Sbjct: 122 RFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179
Query: 178 RKSHAAR-CVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 236
S + +GT ++APEV Y+E D++S G+ + +++ P++ I KK
Sbjct: 180 EASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANE-YDILKK 238
Query: 237 VISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSD 288
V GK +K + I K L S R+SAR+ L ++Q +
Sbjct: 239 VEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQI 293
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 58/269 (21%), Positives = 117/269 (43%), Gaps = 14/269 (5%)
Query: 22 DMEDTMKFLVKELQRH--YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL 79
+ D + +K L + R + +Q +E++Y EI +LK L
Sbjct: 34 NENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93
Query: 80 KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLY 139
H N++K D ++ V E+ G + + + ++ + + + ++ G+ Y
Sbjct: 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV-PTLKPLSEDQARFYFQDLIKGIEY 152
Query: 140 LHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA--ARCVGTPEFMAPEV- 196
LH + +IHRD+K N+ V + G +KI D G++ + S A + VGTP FMAPE
Sbjct: 153 LHYQK--IIHRDIKPSNLLVGED-GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESL 209
Query: 197 --YEEEYN-ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 253
+ ++ + +D+++ G+ + V P+ + ++ K+ S +
Sbjct: 210 SETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC-LHSKIKSQALEFPDQPDIAED 268
Query: 254 VRQFIEKCLAT-VSSRLSARELLTDPFLQ 281
++ I + L SR+ E+ P++
Sbjct: 269 LKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-31
Identities = 43/287 (14%), Positives = 80/287 (27%), Gaps = 51/287 (17%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDF--LQSPEELERLYCEIHLLKTLKHRN------------ 83
+ D + A +K++ S ELERL+ L +
Sbjct: 79 FLVRDVERLEDFA---LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLL 135
Query: 84 ------------IMKFYTSWVDTANRNINFVTEMFTS------GTLRQYRLKHRRVNIRA 125
+ D A N + + TL + I A
Sbjct: 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILA 195
Query: 126 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC 185
+ Q++ L S+ ++H DN+F+ + G + +GD+ +
Sbjct: 196 LHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPD-GRLMLGDVSALW--KVGTRGPA 250
Query: 186 VGTPEFMAPEVY----EEEYNELVDIYSFGMCILEMVTFDYPYSECT-HPAQIYKKVISG 240
P AP + + ++ + G+ I + P+ T +K+
Sbjct: 251 SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLR 310
Query: 241 --KKPEALFKVED---PEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 281
F V+ I + L RL E + P
Sbjct: 311 VPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 61/237 (25%), Positives = 110/237 (46%), Gaps = 15/237 (6%)
Query: 64 EELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI 123
E+++R EI ++K+L H NI++ Y ++ D N +I V E+ T G L + + R
Sbjct: 48 EDVDRFKQEIEIMKSLDHPNIIRLYETFED--NTDIYLVMELCTGGELFERVVHKRVFRE 105
Query: 124 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSH 181
+ +LS + Y H + V HRDLK +N F+ + +K+ D GLAA +
Sbjct: 106 SDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163
Query: 182 AAR-CVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKVI 238
R VGTP +++P+V E Y D +S G ++ ++ YP + +++ K+
Sbjct: 164 MMRTKVGTPYYVSPQVLEGLYGPECDEWSAG-VMMYVLLCGYPPFSAP--TDSEVMLKIR 220
Query: 239 SGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMI 292
G PE + P+ I + L R+++ + L + + S ++
Sbjct: 221 EGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNLL 277
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-31
Identities = 65/226 (28%), Positives = 111/226 (49%), Gaps = 11/226 (4%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV 121
S +L E+ +LK L H NIMK Y + D RN V E + G L + +
Sbjct: 76 STSSNSKLLEEVAVLKLLDHPNIMKLYDFFED--KRNYYLVMECYKGGELFDEIIHRMKF 133
Query: 122 NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRK 179
N +Q+LSG+ YLH + ++HRDLK +N+ + + +KI D GL+A+
Sbjct: 134 NEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191
Query: 180 SHAAR-CVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 238
+ +GT ++APEV ++Y+E D++S G+ + ++ P+ T +I +KV
Sbjct: 192 QKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTD-QEILRKVE 250
Query: 239 SGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 281
GK +K + I++ L R+SA++ L P+++
Sbjct: 251 KGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIK 296
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 56/226 (24%), Positives = 104/226 (46%), Gaps = 14/226 (6%)
Query: 60 LQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR 119
L+ +L EI + L+H NI++ Y + D + I + E G L + KH
Sbjct: 52 LEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD--RKRIYLMLEFAPRGELYKELQKHG 109
Query: 120 RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179
R + + + ++ L Y H R VIHRD+K +N+ + G +GE+KI D G +
Sbjct: 110 RFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLM-GYKGELKIADFGWSVHAPS 166
Query: 180 SHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 238
GT +++ PE+ E + ++E VD++ G+ E + P+ +H +++++
Sbjct: 167 LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-THRRIV 225
Query: 239 SG--KKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 281
+ K P L + I K L RL + ++ P+++
Sbjct: 226 NVDLKFPPFL----SDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-31
Identities = 70/283 (24%), Positives = 117/283 (41%), Gaps = 41/283 (14%)
Query: 38 YRAFDEYEGIEVAWNQVK-------LYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTS 90
AF+ +VA ++ + + + EI +LK L H I+K
Sbjct: 152 KLAFERKTCKKVA---IRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 208
Query: 91 WVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 150
+ + V E+ G L + ++R+ K + Q+L + YLH +IHR
Sbjct: 209 FDA---EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHR 263
Query: 151 DLKCDNIFV--NGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEE----YNE 203
DLK +N+ + +KI D G + IL ++ R GTP ++APEV YN
Sbjct: 264 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNR 323
Query: 204 LVDIYSFGMCILEMVTFDY-------PYSECTHPAQIYKKVISGK---KPEALFKVEDPE 253
VD +S G IL + P+SE + ++ SGK PE +V + +
Sbjct: 324 AVDCWSLG-VIL------FICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE-K 375
Query: 254 VRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMIQYQ 295
++K L +R + E L P+LQ +D + + +
Sbjct: 376 ALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSE 418
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 71/283 (25%), Positives = 120/283 (42%), Gaps = 41/283 (14%)
Query: 38 YRAFDEYEGIEVAWNQVK-------LYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTS 90
AF+ +VA +K + + + EI +LK L H I+K
Sbjct: 27 KLAFERKTCKKVA---IKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 83
Query: 91 WVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 150
+ + V E+ G L + ++R+ K + Q+L + YLH +IHR
Sbjct: 84 FDA---EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHR 138
Query: 151 DLKCDNIFVNGNQGE--VKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEE----YNE 203
DLK +N+ ++ + + +KI D G + IL ++ R GTP ++APEV YN
Sbjct: 139 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNR 198
Query: 204 LVDIYSFGMCILEMVTFDY-------PYSECTHPAQIYKKVISGK---KPEALFKVEDPE 253
VD +S G IL + P+SE + ++ SGK PE +V + +
Sbjct: 199 AVDCWSLG-VIL------FICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE-K 250
Query: 254 VRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMIQYQ 295
++K L +R + E L P+LQ +D + + +
Sbjct: 251 ALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSE 293
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 53/210 (25%), Positives = 86/210 (40%), Gaps = 37/210 (17%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWV-DTAN 96
Y+ + VA VK++ F + + I+ + ++H NI +F TA+
Sbjct: 30 YKG--SLDERPVA---VKVFSF-ANRQNFINE-KNIYRVPLMEHDNIARFIVGDERVTAD 82
Query: 97 RNINF--VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-------RDPPV 147
+ + V E + +G+L +Y L + + + GL YLH+ P +
Sbjct: 83 GRMEYLLVMEYYPNGSLXKY-LSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAI 141
Query: 148 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC----------VGTPEFMAPEVY 197
HRDL N+ V + G I D GL+ L + R VGT +MAPEV
Sbjct: 142 SHRDLNSRNVLVKND-GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVL 200
Query: 198 E--------EEYNELVDIYSFGMCILEMVT 219
E E + VD+Y+ G+ E+
Sbjct: 201 EGAVNLRDXESALKQVDMYALGLIYWEIFM 230
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-30
Identities = 68/282 (24%), Positives = 111/282 (39%), Gaps = 35/282 (12%)
Query: 42 DEYEGIEVAWNQVK--LYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRN 98
++ +VA VK L + +R E+ LL+ +H N+++++ + D +
Sbjct: 44 GMFDNRDVA---VKRILPECF---SFADR---EVQLLRESDEHPNVIRYFCTEKD--RQF 92
Query: 99 INFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
E + TL++Y K +Q SGL +LHS + ++HRDLK NI
Sbjct: 93 QYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNI 149
Query: 158 FVNGNQGE----VKIGDLGLAAILRK-----SHAARCVGTPEFMAPEVYEEE----YNEL 204
++ I D GL L S + GT ++APE+ E+
Sbjct: 150 LISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYT 209
Query: 205 VDIYSFGMCILEMVTFDY-PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 263
VDI+S G +++ P+ + K ED R+ IEK +A
Sbjct: 210 VDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIA 269
Query: 264 T-VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPL 304
R SA+ +L PF + L+ Q +D E L
Sbjct: 270 MDPQKRPSAKHVLKHPFFW--SLEKQLQFFQDVSDRIEKESL 309
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 43/256 (16%), Positives = 94/256 (36%), Gaps = 33/256 (12%)
Query: 60 LQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR 119
+ + + E+ ++ +K+ + + + + E + ++ ++
Sbjct: 81 ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFF 138
Query: 120 RVNIRAV--------KHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 171
++ K + +L+ Y+H+ + HRD+K NI ++ N G VK+ D
Sbjct: 139 VLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-ICHRDVKPSNILMDKN-GRVKLSDF 196
Query: 172 GLAAILRKSHAARCVGTPEFMAPEVYEEE---YNELVDIYSFGMCILEMVTFDYPYSECT 228
G + + GT EFM PE + E VDI+S G+C+ M P+S
Sbjct: 197 GESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256
Query: 229 HPAQIYKKVISGK-----------------KPEALFKVEDPEVRQFIEKCLAT-VSSRLS 270
+++ + + K E F++ L + R++
Sbjct: 257 SLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT 316
Query: 271 ARELLTDPFLQIDDYD 286
+ + L +L + +
Sbjct: 317 SEDALKHEWLADTNIE 332
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-30
Identities = 71/238 (29%), Positives = 117/238 (49%), Gaps = 15/238 (6%)
Query: 52 NQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTL 111
D + E +Y EI LLK+L H NI+K + + D + VTE + G L
Sbjct: 76 KGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED--KKYFYLVTEFYEGGEL 133
Query: 112 RQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQG-EVKIG 169
+ + + + + +QILSG+ YLH + ++HRD+K +NI N N +KI
Sbjct: 134 FEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIV 191
Query: 170 DLGLAAILRKSHAAR-CVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYP--YSE 226
D GL++ K + R +GT ++APEV +++YNE D++S G I+ ++ YP +
Sbjct: 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCG-VIMYILLCGYPPFGGQ 250
Query: 227 CTHPAQIYKKVISGK--KPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 281
+ I KKV GK +K E ++ I+ L + R +A E L +++
Sbjct: 251 --NDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK 306
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-30
Identities = 61/226 (26%), Positives = 113/226 (50%), Gaps = 11/226 (4%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV 121
++ + E+ LLK L H NIMK + D + + V E++T G L +K +R
Sbjct: 61 KNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYIVGELYTGGELFDEIIKRKRF 118
Query: 122 NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRK 179
+ +Q+ SG+ Y+H + ++HRDLK +NI + + ++KI D GL+ ++
Sbjct: 119 SEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 180 SHAAR-CVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 238
+ + +GT ++APEV Y+E D++S G+ + +++ P+ I K+V
Sbjct: 177 NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNE-YDILKRVE 235
Query: 239 SGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 281
+GK ++ + + I K L S R++A + L P++Q
Sbjct: 236 TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 59/252 (23%), Positives = 124/252 (49%), Gaps = 20/252 (7%)
Query: 46 GIEVAWNQVKLYDFLQ-SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTE 104
G EVA +K+ D Q +P L++L+ E+ ++K L H NI+K + V + + + E
Sbjct: 40 GREVA---IKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE--VIETEKTLYLIME 94
Query: 105 MFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 164
+ G + Y + H R+ + + RQI+S + Y H + ++HRDLK +N+ ++ +
Sbjct: 95 YASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDAD-M 151
Query: 165 EVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYE-EEYN-ELVDIYSFGMCILEMVTFD 221
+KI D G + G P + APE+++ ++Y+ VD++S G+ + +V+
Sbjct: 152 NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211
Query: 222 YPYSECTHPAQIYKKVISGK--KPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDP 278
P+ ++ ++V+ GK P + + +++ L R + +++ D
Sbjct: 212 LPFDGQNLK-ELRERVLRGKYRIPFYM----STDCENLLKRFLVLNPIKRGTLEQIMKDR 266
Query: 279 FLQIDDYDSDLR 290
++ + +L+
Sbjct: 267 WINAGHEEDELK 278
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 60/245 (24%), Positives = 110/245 (44%), Gaps = 15/245 (6%)
Query: 46 GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEM 105
VA VK+ D ++ + E + EI + K L H N++KFY N E
Sbjct: 32 EEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-REGNI-QYLFLEY 86
Query: 106 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 165
+ G L + + + Q+++G++YLH + HRD+K +N+ ++
Sbjct: 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DN 143
Query: 166 VKIGDLGLAAILRKSHAAR----CVGTPEFMAPEVYE-EEYN-ELVDIYSFGMCILEMVT 219
+KI D GLA + R ++ R GT ++APE+ + E++ E VD++S G+ + M+
Sbjct: 144 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203
Query: 220 FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDP 278
+ P+ + + Q Y K +K D + K L S+R++ ++ D
Sbjct: 204 GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263
Query: 279 FLQID 283
+
Sbjct: 264 WYNKP 268
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 65/233 (27%), Positives = 115/233 (49%), Gaps = 25/233 (10%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV 121
++ + E+ LLK L H NIMK + D + + V E++T G L +K +R
Sbjct: 61 KNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYIVGELYTGGELFDEIIKRKRF 118
Query: 122 NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE--VKIGDLGLAAILRK 179
+ +Q+ SG+ Y+H + ++HRDLK +NI + + + +KI D GL+ ++
Sbjct: 119 SEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 180 SHAAR-CVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKK 236
+ + +GT ++APEV Y+E D++S G IL ++ P Y + + I K+
Sbjct: 177 NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAG-VILYILLSGTPPFYGK--NEYDILKR 233
Query: 237 VISGKKPEALFKVEDP-------EVRQFIEKCLAT-VSSRLSARELLTDPFLQ 281
V +GK + + P + + I K L S R++A + L P++Q
Sbjct: 234 VETGK-----YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 59/257 (22%), Positives = 114/257 (44%), Gaps = 25/257 (9%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+ + G+E +K + +S +E++ EI +LK+L H NI+K + + D
Sbjct: 39 HLVEERSSGLERV---IKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED--YH 93
Query: 98 NINFVTEMFTSGTL----RQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 153
N+ V E G L + + + ++ V +Q+++ L Y HS+ V+H+DLK
Sbjct: 94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLK 151
Query: 154 CDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEEYNELVDIYSF 210
+NI F + + +KI D GLA + + + GT +MAPEV++ + DI+S
Sbjct: 152 PENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSA 211
Query: 211 GMCILEMVTFDYP--YSECTHPAQIYKKVISGK---KPEALFKVEDPEVRQFIEKCLAT- 264
G ++ + ++ +K + E + P+ +++ L
Sbjct: 212 G-VVMYFLLTGCLPFTGT--SLEEVQQKATYKEPNYAVE--CRPLTPQAVDLLKQMLTKD 266
Query: 265 VSSRLSARELLTDPFLQ 281
R SA ++L + +
Sbjct: 267 PERRPSAAQVLHHEWFK 283
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (298), Expect = 7e-29
Identities = 37/271 (13%), Positives = 80/271 (29%), Gaps = 30/271 (11%)
Query: 31 VKELQRHYRA-FDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYT 89
V R + + ++ +++L +++ ++ + I +K K
Sbjct: 108 VHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIR 167
Query: 90 SWVDTANRNIN--FVTEMFTSG-------TLRQYRLKHRRVNIRAVKHWCRQILSGLLYL 140
+D + + F L + H+ + A Q++ L L
Sbjct: 168 VRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 227
Query: 141 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC---VGTPEFMAPEVY 197
H ++H L+ +I ++ G V + S + PE A +
Sbjct: 228 HHYG--LVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERML 284
Query: 198 ------EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED 251
D ++ G+ I + D P ++ + + K
Sbjct: 285 PFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD-DAALGGSEWIFRSCKNIP------ 337
Query: 252 PEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 281
VR +E L RL + + P +
Sbjct: 338 QPVRALLEGFLRYPKEDRLLPLQAMETPEYE 368
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 54/238 (22%), Positives = 97/238 (40%), Gaps = 27/238 (11%)
Query: 64 EELERLYCEIHLLKTL----KHRNIMKFYTSWVDTANRNINFVTEMFTSGT-LRQYRLKH 118
+ E+ LL + H +++ W +T V E L Y +
Sbjct: 76 SDSVTCPLEVALLWKVGAGGGHPGVIRLLD-WFET-QEGFMLVLERPLPAQDLFDYITEK 133
Query: 119 RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178
+ + + Q+++ + + HSR V+HRD+K +NI ++ +G K+ D G A+L
Sbjct: 134 GPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLH 191
Query: 179 KSHAARCVGTPEFMAPEVYE-EEYN-ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 236
GT + PE +Y+ ++S G+ + +MV D P+ ++
Sbjct: 192 DEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER-------DQE 244
Query: 237 VISGKKPEALFKVED---PEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLR 290
++ + P+ I +CLA SSR S E+L DP++Q D L
Sbjct: 245 ILEAE-----LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLN 297
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 66/303 (21%), Positives = 123/303 (40%), Gaps = 19/303 (6%)
Query: 46 GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEM 105
VA VK+ D ++ + E + EI + K L H N++KFY N E
Sbjct: 32 EEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-REGNI-QYLFLEY 86
Query: 106 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 165
+ G L + + + Q+++G++YLH + HRD+K +N+ ++
Sbjct: 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DN 143
Query: 166 VKIGDLGLAAILRKSHAAR----CVGTPEFMAPEVYE-EEYN-ELVDIYSFGMCILEMVT 219
+KI D GLA + R ++ R GT ++APE+ + E++ E VD++S G+ + M+
Sbjct: 144 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203
Query: 220 FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDP 278
+ P+ + + Q Y K +K D + K L S+R++ ++ D
Sbjct: 204 GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263
Query: 279 FLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCGHYIGYDTENGLDYH 338
+ R E + + + ++ G+ E +H
Sbjct: 264 WYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGWSKE----HH 319
Query: 339 PHE 341
H
Sbjct: 320 HHH 322
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 59/237 (24%), Positives = 111/237 (46%), Gaps = 26/237 (10%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV 121
S + ++L E + + L+H NI++ + S + V ++ T G L + +
Sbjct: 45 SARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYLVFDLVTGGELFEDIVAREFY 102
Query: 122 NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRK 179
+ H +QIL + Y HS ++HR+LK +N+ + +G VK+ D GLA +
Sbjct: 103 SEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160
Query: 180 SHAAR-CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDY-------PYSECTHP 230
S A GTP +++PEV +++ Y++ VDI++ G IL Y P+ +
Sbjct: 161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG-VIL------YILLVGYPPFWDEDQH 213
Query: 231 AQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDD 284
++Y ++ +G P + PE + I+ L R++A + L P++ +
Sbjct: 214 -RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 49/230 (21%), Positives = 95/230 (41%), Gaps = 25/230 (10%)
Query: 61 QSPEELERLYCEIHLLKTLKHR--NIMKFYTSWVDTANRNINFVTEMFT-SGTLRQYRLK 117
R+ E+ LLK + +++ W + + + E L + +
Sbjct: 85 GELPNGTRVPMEVVLLKKVSSGFSGVIRLLD-WFER-PDSFVLILERPEPVQDLFDFITE 142
Query: 118 HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177
+ + + Q+L + + H+ V+HRD+K +NI ++ N+GE+K+ D G A+L
Sbjct: 143 RGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL 200
Query: 178 RKSHAARCVGTPEFMAPEVYE-EEYN-ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 235
+ + GT + PE Y+ ++S G+ + +MV D P+ +
Sbjct: 201 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------DE 253
Query: 236 KVISGKKPEALFKVED---PEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 281
++I G+ E + I CLA S R + E+ P++Q
Sbjct: 254 EIIRGQ-----VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 63/231 (27%), Positives = 107/231 (46%), Gaps = 18/231 (7%)
Query: 60 LQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR 119
++S + + ++ EI LK +H +I+K Y V + + V E + G L Y KH
Sbjct: 49 IRSLDVVGKIKREIQNLKLFRHPHIIKLYQ--VISTPTDFFMVMEYVSGGELFDYICKHG 106
Query: 120 RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179
RV + +QILS + Y H V+HRDLK +N+ ++ + KI D GL+ ++
Sbjct: 107 RVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSD 163
Query: 180 SHAAR--CVGTPEFMAPEVYE-EEYN-ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 235
R C G+P + APEV Y VDI+S G+ + ++ P+ + P ++K
Sbjct: 164 GEFLRTSC-GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-LFK 221
Query: 236 KVISGK--KPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQID 283
K+ G PE L + V + L R + +++ + + D
Sbjct: 222 KIRGGVFYIPEYL----NRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 54/241 (22%), Positives = 95/241 (39%), Gaps = 18/241 (7%)
Query: 61 QSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR 120
P + + EI ++ L H ++ + ++ D + + E + G L R+
Sbjct: 87 PYPLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVLILEFLSGGELFD-RIAAED 143
Query: 121 VNI--RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAIL 177
+ V ++ RQ GL ++H ++H D+K +NI VKI D GLA L
Sbjct: 144 YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKL 201
Query: 178 RKSHAAR-CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQI 233
+ T EF APE+ + E D+++ G + ++ E +
Sbjct: 202 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIG-VLGYVLLSGLSPFAGE--DDLET 258
Query: 234 YKKVISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLR 290
+ V E F PE + FI+ L RL+ + L P+L+ D + R
Sbjct: 259 LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 318
Query: 291 M 291
+
Sbjct: 319 I 319
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 59/241 (24%), Positives = 112/241 (46%), Gaps = 26/241 (10%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV 121
S + ++L E + + L+H NI++ + S + V ++ T G L + +
Sbjct: 68 SARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYLVFDLVTGGELFEDIVAREFY 125
Query: 122 NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRK 179
+ H +QIL + Y HS ++HR+LK +N+ + +G VK+ D GLA +
Sbjct: 126 SEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183
Query: 180 SHAAR-CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDY-------PYSECTHP 230
S A GTP +++PEV +++ Y++ VDI++ G IL Y P+ +
Sbjct: 184 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG-VIL------YILLVGYPPFWDEDQH 236
Query: 231 AQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDS 287
++Y ++ +G P + PE + I+ L R++A + L P++ + +
Sbjct: 237 -RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA 295
Query: 288 D 288
Sbjct: 296 S 296
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-26
Identities = 60/300 (20%), Positives = 102/300 (34%), Gaps = 52/300 (17%)
Query: 42 DEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANRNIN 100
++G VA VK + + EI LL H N++++Y S +R +
Sbjct: 35 GSFQGRPVA---VKRML----IDFCDIALMEIKLLTESDDHPNVIRYYCSETT--DRFLY 85
Query: 101 FVTEMFTSGTL-------RQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 153
E + L + RQI SG+ +LHS +IHRDLK
Sbjct: 86 IALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLK 142
Query: 154 CDNIFVN------------GNQGEVKIGDLGLAAILR------KSHAARCVGTPEFMAPE 195
NI V+ + I D GL L +++ GT + APE
Sbjct: 143 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPE 202
Query: 196 V--------YEEEYNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKVISGKKPEA 245
+ + +DI+S G +++ + + + I + + S + +
Sbjct: 203 LLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKC 262
Query: 246 LFKVE-DPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISP 303
L E I + + R +A ++L P L + +D EI
Sbjct: 263 LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW--PKSKKLEFLLKVSDRLEIEN 320
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 56/271 (20%), Positives = 115/271 (42%), Gaps = 18/271 (6%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV 121
+ + EI +L +HRNI+ + S+ + + E + + + R+
Sbjct: 41 KGTDQVLVKKEISILNIARHRNILHLHESFES--MEELVMIFEFISGLDIFE-RINTSAF 97
Query: 122 NI--RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILR 178
+ R + + Q+ L +LHS + + H D++ +NI + +KI + G A L+
Sbjct: 98 ELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155
Query: 179 KSHAARC-VGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIY 234
R PE+ APEV++ + + D++S G ++ ++ +E QI
Sbjct: 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLG-TLVYVLLSGINPFLAE--TNQQII 212
Query: 235 KKVISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRM 291
+ +++ + E FK E F+++ L SR++A E L P+L+ ++
Sbjct: 213 ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKV 272
Query: 292 IQYQTDYDEISPLLRQSLYGIYHSNSSSNNG 322
I+ L+++ L + + S G
Sbjct: 273 IRTLKHRRYYHTLIKKDLNMVVSAARISCGG 303
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-26
Identities = 61/331 (18%), Positives = 116/331 (35%), Gaps = 39/331 (11%)
Query: 61 QSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR 120
+ E + EI + L+H ++ + ++ D + + + E + G L + ++
Sbjct: 193 PHESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVMIYEFMSGGELFE-KVADEH 249
Query: 121 VNI--RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAIL 177
+ + RQ+ GL ++H + +H DLK +NI F E+K+ D GL A L
Sbjct: 250 NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307
Query: 178 RKSHAAR-CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQI 233
+ + GT EF APEV E + D++S G + ++ E + +
Sbjct: 308 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVG-VLSYILLSGLSPFGGE--NDDET 364
Query: 234 YKKVISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLR 290
+ V S ++ F + + FI K L ++R++ + L P+L +
Sbjct: 365 LRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 424
Query: 291 MI--------------QYQTDYDEISPLLRQSLYGIYHSNSSSNNGCGHYIGYDTENGLD 336
I +Y + + PL R S Y +
Sbjct: 425 QIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYSI------RDAFWDR 478
Query: 337 YHPHEFQESEIDLFTCQEDEHLTNFDISIKG 367
+ E + F +
Sbjct: 479 SEAQPRFIVKPYGTEVGEGQSAN-FYCRVIA 508
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 66/303 (21%), Positives = 107/303 (35%), Gaps = 69/303 (22%)
Query: 38 YRAFDEYEGIEVAWNQVKLYD----FLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD 93
A + A +K+ + +P+++ER+ E+ L+K L H NI + Y + D
Sbjct: 43 RVAIENQTRAIRA---IKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99
Query: 94 TANRNINFVTEMFTSGTLRQYRLKHRRVNI------------------------------ 123
+ I V E+ G L +
Sbjct: 100 --EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGF 157
Query: 124 ----------RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQGEVKIGDLG 172
+ + + RQI S L YLH++ + HRD+K +N F E+K+ D G
Sbjct: 158 RESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFG 215
Query: 173 LAAILRKSHAARC------VGTPEFMAPEV---YEEEYNELVDIYSFGMCILEMVTFDYP 223
L+ K + GTP F+APEV E Y D +S G +L ++
Sbjct: 216 LSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG-VLLHLLLMGAV 274
Query: 224 --YSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDP 278
+ A +V++ K + V P R + L V R A L P
Sbjct: 275 PFPGV--NDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHP 332
Query: 279 FLQ 281
++
Sbjct: 333 WIS 335
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 63/240 (26%), Positives = 110/240 (45%), Gaps = 18/240 (7%)
Query: 61 QSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR 120
+ ++ E + EI ++ L H N+++ Y ++ +I V E G L R+
Sbjct: 125 RGMKDKEEVKNEISVMNQLDHANLIQLYDAFES--KNDIVLVMEYVDGGELFD-RIIDES 181
Query: 121 VNI--RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAIL 177
N+ + +QI G+ ++H ++H DLK +NI VN + ++KI D GLA
Sbjct: 182 YNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239
Query: 178 RKSHAARC-VGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQI 233
+ + GTPEF+APEV + + D++S G+ I M+ + + A+
Sbjct: 240 KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGV-IAYMLLSGLSPFLGD--NDAET 296
Query: 234 YKKVISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLR 290
+++ + + F+ E ++FI K L S R+SA E L P+L S L
Sbjct: 297 LNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLS 356
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 56/261 (21%), Positives = 107/261 (40%), Gaps = 27/261 (10%)
Query: 38 YRAFDEYEGIEVAWNQVKLYD---FLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 94
D A VK+ + P + EI LL+ L+H+N+++ +
Sbjct: 22 KEVLDSETLCRRA---VKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE 78
Query: 95 ANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 153
+ + V E G + +R + + Q++ GL YLHS+ ++H+D+K
Sbjct: 79 EKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIK 136
Query: 154 CDNIFVNGNQGEVKIGDLGLAAILRKSHAAR-----CVGTPEFMAPEVY--EEEYN-ELV 205
N+ + G +KI LG+A L A G+P F PE+ + ++ V
Sbjct: 137 PGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQ-GSPAFQPPEIANGLDTFSGFKV 194
Query: 206 DIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK--KPEALFKVEDPEVRQFIEKCLA 263
DI+S G+ + + T YP+ E + ++++ + G P P + ++ L
Sbjct: 195 DIWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKGSYAIPGDC----GPPLSDLLKGMLE 249
Query: 264 T-VSSRLSARELLTDPFLQID 283
+ R S R++ + +
Sbjct: 250 YEPAKRFSIRQIRQHSWFRKK 270
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 64/231 (27%), Positives = 114/231 (49%), Gaps = 19/231 (8%)
Query: 60 LQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR 119
L+ + R+ EI LK L+H +I+K Y T +I V E + G L Y ++ +
Sbjct: 47 LKKSDMHMRVEREISYLKLLRHPHIIKLYDVI-TT-PTDIVMVIE-YAGGELFDYIVEKK 103
Query: 120 RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179
R+ + + +QI+ + Y H ++HRDLK +N+ ++ N VKI D GL+ I+
Sbjct: 104 RMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDN-LNVKIADFGLSNIMTD 160
Query: 180 SHAAR--CVGTPEFMAPEVYE-EEYN-ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 235
+ + C G+P + APEV + Y VD++S G+ + M+ P+ + P ++K
Sbjct: 161 GNFLKTSC-GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-NLFK 218
Query: 236 KVISGK--KPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQID 283
KV S P+ L P + I + + R++ +E+ DP+ ++
Sbjct: 219 KVNSCVYVMPDFL----SPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 62/241 (25%), Positives = 103/241 (42%), Gaps = 25/241 (10%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV 121
S E+L+R E + LKH +I++ ++ + + V E L +K
Sbjct: 69 STEDLKR---EASICHMLKHPHIVELLETYSS--DGMLYMVFEFMDGADLCFEIVKRADA 123
Query: 122 NI----RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVN-GNQGEVKIGDLGLAA 175
H+ RQIL L Y H + +IHRD+K + + N VK+G G+A
Sbjct: 124 GFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181
Query: 176 ILRKSHAA--RCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHP 230
L +S VGTP FMAPEV + E Y + VD++ G IL ++ Y
Sbjct: 182 QLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCG-VILFILLSGCLPFYGT---K 237
Query: 231 AQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDS 287
++++ +I GK + + + + L + R++ E L P+L+ D +
Sbjct: 238 ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYA 297
Query: 288 D 288
Sbjct: 298 Y 298
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 53/239 (22%), Positives = 100/239 (41%), Gaps = 17/239 (7%)
Query: 61 QSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR 120
+ E + E+ +L+ + H N++ + + + ++ + E+ + G L + +
Sbjct: 54 RRGVSREEIEREVSILRQVLHHNVITLHDVYEN--RTDVVLILELVSGGELFDFLAQKES 111
Query: 121 VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV---NGNQGEVKIGDLGLAAIL 177
++ + +QIL G+ YLH++ + H DLK +NI + N +K+ D GLA +
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 178 RKSHAAR-CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQI 233
+ GTPEF+APE+ E D++S G I ++ + +
Sbjct: 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQET 226
Query: 234 YKKVISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDL 289
+ S E F + FI K L RL+ +E L P++ D +
Sbjct: 227 LANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAM 285
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 64/256 (25%), Positives = 116/256 (45%), Gaps = 17/256 (6%)
Query: 60 LQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR 119
++S + + ++ EI LK +H +I+K Y V + +I V E + G L Y K+
Sbjct: 54 IRSLDVVGKIRREIQNLKLFRHPHIIKLYQ--VISTPSDIFMVMEYVSGGELFDYICKNG 111
Query: 120 RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179
R++ + + +QILSG+ Y H V+HRDLK +N+ ++ + KI D GL+ ++
Sbjct: 112 RLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSD 168
Query: 180 SHAAR-CVGTPEFMAPEVYE-EEYN-ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 236
R G+P + APEV Y VDI+S G+ + ++ P+ + P ++KK
Sbjct: 169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-LFKK 227
Query: 237 VISGK--KPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMIQ 293
+ G P+ L +P V ++ L R + +++ + + D L
Sbjct: 228 ICDGIFYTPQYL----NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ-DLPKYLFPED 282
Query: 294 YQTDYDEISPLLRQSL 309
I + +
Sbjct: 283 PSYSSTMIDDEALKEV 298
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 54/231 (23%), Positives = 96/231 (41%), Gaps = 29/231 (12%)
Query: 67 ERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAV 126
+ + EI +L L H NI+K + I+ V E+ T G L ++ + R
Sbjct: 93 KIVRTEIGVLLRLSHPNIIKLKEIFET--PTEISLVLELVTGGELFDRIVEKGYYSERDA 150
Query: 127 KHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAR 184
+QIL + YLH ++HRDLK +N+ + +KI D GL+ I+ +
Sbjct: 151 ADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208
Query: 185 -CVGTPEFMAPEVYEEE-YNELVDIYSFG--MCILEMVTFDYP--YSECTHPAQIYKKVI 238
GTP + APE+ Y VD++S G IL + Y E ++++++
Sbjct: 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYIL---LCGFEPFYDE-RGDQFMFRRIL 264
Query: 239 SGKKPEALFKVEDP-------EVRQFIEKCLAT-VSSRLSARELLTDPFLQ 281
+ + + P + + K + RL+ + L P++
Sbjct: 265 NCE-----YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 54/244 (22%), Positives = 103/244 (42%), Gaps = 18/244 (7%)
Query: 61 QSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR 120
+ E + E+ +LK ++H N++ + + + ++ + E+ G L + +
Sbjct: 53 RRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KTDVILILELVAGGELFDFLAEKES 110
Query: 121 VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV---NGNQGEVKIGDLGLAAIL 177
+ + +QIL+G+ YLHS + H DLK +NI + N + +KI D GLA +
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168
Query: 178 RKSHAAR-CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQI 233
+ + GTPEF+APE+ E D++S G I ++ + +
Sbjct: 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQET 225
Query: 234 YKKVISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDL- 289
V + + F + FI + L R++ ++ L P+++ D L
Sbjct: 226 LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALS 285
Query: 290 RMIQ 293
R
Sbjct: 286 RKAS 289
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 56/228 (24%), Positives = 107/228 (46%), Gaps = 25/228 (10%)
Query: 67 ERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAV 126
L EI +LK +KH NI+ ++ + V ++ + G L L+ +
Sbjct: 51 SSLENEIAVLKKIKHENIVTLE-DIYESTT-HYYLVMQLVSGGELFDRILERGVYTEKDA 108
Query: 127 KHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAR 184
+Q+LS + YLH ++HRDLK +N+ ++ + ++ I D GL+ + + +
Sbjct: 109 SLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST 166
Query: 185 CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKVISGK 241
GTP ++APEV ++ Y++ VD +S G I ++ YP Y E +++++K+ G
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIG-VITYILLCGYPPFYEE--TESKLFEKIKEGY 223
Query: 242 KPEALFKVEDP-------EVRQFIEKCLAT-VSSRLSARELLTDPFLQ 281
++ E P + FI L + R + + L+ P++
Sbjct: 224 -----YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 62/292 (21%), Positives = 117/292 (40%), Gaps = 26/292 (8%)
Query: 56 LYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGT-LRQY 114
L D +L ++ EI +L ++H NI+K + V E SG L +
Sbjct: 63 LEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLD--IFENQGFFQLVMEKHGSGLDLFAF 120
Query: 115 RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174
+H R++ + RQ++S + YL +D +IHRD+K +NI + + +K+ D G A
Sbjct: 121 IDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAED-FTIKLIDFGSA 177
Query: 175 AILRKSHA-ARCVGTPEFMAPEVYE-EEYN-ELVDIYSFGMCILEMVTFDYPYSECTHPA 231
A L + GT E+ APEV Y ++++S G+ + +V + P+ E
Sbjct: 178 AYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE----- 232
Query: 232 QIYKKVISGK--KPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSD 288
++ + P + E+ + L R + +L+TDP++ +
Sbjct: 233 --LEETVEAAIHPPYLV----SKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ-PVNLA 285
Query: 289 LRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCGHYIGYDTENGLDYHPH 340
+ ++ + + + S S+ G +H H
Sbjct: 286 DYTWEEVFRVNKPESGVLSAASLEMGNRSLSD--VAQAQELCGGEGHHHHHH 335
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 56/236 (23%), Positives = 102/236 (43%), Gaps = 20/236 (8%)
Query: 64 EELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI 123
EE+ER E+ +L+ + H NI+ + + + ++ + E+ + G L + + ++
Sbjct: 60 EEIER---EVSILRQVLHPNIITLHDVYEN--RTDVVLILELVSGGELFDFLAQKESLSE 114
Query: 124 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV---NGNQGEVKIGDLGLAAILRKS 180
+ +QIL G+ YLH++ + H DLK +NI + N +K+ D GLA +
Sbjct: 115 EEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 181 HAAR-CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKK 236
+ GTPEF+APE+ E D++S G I ++ + +
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLAN 229
Query: 237 VISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDL 289
+ + E F + FI K L RL+ +E L P++ D +
Sbjct: 230 ITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAM 285
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 39/241 (16%), Positives = 80/241 (33%), Gaps = 34/241 (14%)
Query: 61 QSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR 120
+P E + LK MKFY++ + V E+++ GTL ++
Sbjct: 106 ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF--QNGSVLVGELYSYGTLLNAINLYKN 163
Query: 121 VNIRA-----VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG----------NQGE 165
+ V + ++L + +H + +IH D+K DN +
Sbjct: 164 TPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAG 221
Query: 166 VKIGDLGLAAILRKSHA-----ARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVT 219
+ + DLG + ++ A+C T F E+ + +N +D + + M+
Sbjct: 222 LALIDLGQSIDMKLFPKGTIFTAKC-ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280
Query: 220 FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL-ATVSSRLSARELLTDP 278
Y + + + ++ +F L L + +LL
Sbjct: 281 GTYMKVKNEGGECKPEGLFRRLPHLDMWN-------EFFHVMLNIPDCHHLPSLDLLRQK 333
Query: 279 F 279
Sbjct: 334 L 334
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 57/280 (20%), Positives = 106/280 (37%), Gaps = 47/280 (16%)
Query: 38 YRAFDEYEGIEVA-----WNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSW 91
R + E A + + E E E+ +L+ + H NI++ ++
Sbjct: 34 RRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93
Query: 92 VDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 151
N V ++ G L Y + ++ + + R +L + LH + ++HRD
Sbjct: 94 ET--NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRD 149
Query: 152 LKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEV-------YEEEYNE 203
LK +NI ++ + +K+ D G + L R GTP ++APE+ Y +
Sbjct: 150 LKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGK 208
Query: 204 LVDIYSFGMCILEMVTFDY-------PYSECTHPAQIYKKVISGKKPEALFKVEDP---- 252
VD++S G I+ Y P+ + + ++SG ++ P
Sbjct: 209 EVDMWSTG-VIM------YTLLAGSPPFWHRKQM-LMLRMIMSGN-----YQFGSPEWDD 255
Query: 253 ---EVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSD 288
V+ + + L R +A E L PF Q +
Sbjct: 256 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 72/328 (21%), Positives = 115/328 (35%), Gaps = 77/328 (23%)
Query: 38 YRA--FDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95
Y+A D + + A Q++ S EI LL+ LKH N++ ++ A
Sbjct: 38 YKAKRKDGKDDKDYALKQIEGTGISMSA------CREIALLRELKHPNVISLQKVFLSHA 91
Query: 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRA---------VKHWCRQILSGLLYLHSRDPP 146
+R + + + + L HR VK QIL G+ YLH+
Sbjct: 92 DRKVWLLFD-YAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-- 148
Query: 147 VIHRDLKCDNIFVNG---NQGEVKIGDLGLA----AILRK-SHAARCVGTPEFMAPEVY- 197
V+HRDLK NI V G +G VKI D+G A + L+ + V T + APE+
Sbjct: 149 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL 208
Query: 198 -EEEYNELVDIYSFGMCIL-EMVT----F------------------------------- 220
Y + +DI++ G CI E++T F
Sbjct: 209 GARHYTKAIDIWAIG-CIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADK 267
Query: 221 ---------DYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATV-SSRLS 270
++ Y K E D + ++K L R++
Sbjct: 268 DWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT 327
Query: 271 ARELLTDPFLQIDDYDSDLRMIQYQTDY 298
+ + + DP+ D + Q Y
Sbjct: 328 SEQAMQDPYFLEDPLPTSDVFAGCQIPY 355
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 52/169 (30%), Positives = 83/169 (49%), Gaps = 33/169 (19%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA--VKHW 129
EI LLK LKH+NI++ + V +++ + V E F L++Y ++ VK +
Sbjct: 51 EICLLKELKHKNIVRLHD--VLHSDKKLTLVFE-FCDQDLKKY-FDSCNGDLDPEIVKSF 106
Query: 130 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG-- 187
Q+L GL + HSR+ V+HRDLK N+ +N GE+K+ + GL AR G
Sbjct: 107 LFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGL---------ARAFGIP 154
Query: 188 ----TPEFM-----APEVY--EEEYNELVDIYSFGMCIL-EMVTFDYPY 224
+ E + P+V + Y+ +D++S G CI E+ P
Sbjct: 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAG-CIFAELANAGRPL 202
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 59/247 (23%), Positives = 110/247 (44%), Gaps = 37/247 (14%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV 121
S + ++L E + + LKH NI++ + S + + + ++ T G L + +
Sbjct: 50 SARDHQKLEREARICRLLKHPNIVRLHDSISE--EGHHYLIFDLVTGGELFEDIVAREYY 107
Query: 122 NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRK 179
+ H +QIL +L+ H V+HR+LK +N+ + +G VK+ D GLA +
Sbjct: 108 SEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165
Query: 180 SHAA--RCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDY-------PYSECTH 229
A GTP +++PEV ++ Y + VD+++ G IL Y P+ +
Sbjct: 166 EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACG-VIL------YILLVGYPPFWDEDQ 218
Query: 230 PAQIYKKVISGKKPEALFKVEDP-------EVRQFIEKCLAT-VSSRLSARELLTDPFLQ 281
++Y+++ +G + P E + I K L S R++A E L P++
Sbjct: 219 -HRLYQQIKAGA-----YDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWIS 272
Query: 282 IDDYDSD 288
+
Sbjct: 273 HRSTVAS 279
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 65/254 (25%), Positives = 117/254 (46%), Gaps = 19/254 (7%)
Query: 67 ERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAV 126
E + EI ++L+H NI++F V ++ + E + G L + R +
Sbjct: 61 ENVQREIINHRSLRHPNIVRFKE--VILTPTHLAIIMEYASGGELYERICNAGRFSEDEA 118
Query: 127 KHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ-GEVKIGDLGLAAILRKSHAAR- 184
+ + +Q+LSG+ Y HS + HRDLK +N ++G+ +KI D G + +
Sbjct: 119 RFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 176
Query: 185 CVGTPEFMAPEVYE-EEYN-ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK----VI 238
VGTP ++APEV +EY+ ++ D++S G+ + M+ YP+ E + Y+K ++
Sbjct: 177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKTIQRIL 235
Query: 239 SGK--KPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMIQYQ 295
S K P+ + PE I + ++R+S E+ T + + +DL
Sbjct: 236 SVKYSIPDDIRI--SPECCHLISRIFVADPATRISIPEIKTHSWFLK-NLPADLMNESNT 292
Query: 296 TDYDEISPLLRQSL 309
+ QSL
Sbjct: 293 GSQFQEPEQPMQSL 306
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 49/238 (20%), Positives = 100/238 (42%), Gaps = 17/238 (7%)
Query: 61 QSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR 120
+ E + E+++L+ ++H NI+ + + + ++ + E+ + G L + +
Sbjct: 47 RRGVSREEIEREVNILREIRHPNIITLHDIFEN--KTDVVLILELVSGGELFDFLAEKES 104
Query: 121 VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV---NGNQGEVKIGDLGLAAIL 177
+ + +QIL G+ YLHS+ + H DLK +NI + N +K+ D G+A +
Sbjct: 105 LTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162
Query: 178 RKSHAAR-CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQI 233
+ + GTPEF+APE+ E D++S G I ++ E +
Sbjct: 163 EAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGE--TKQET 219
Query: 234 YKKVISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSD 288
+ + E F + FI + L R++ + L +++ +
Sbjct: 220 LTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 61/286 (21%), Positives = 108/286 (37%), Gaps = 57/286 (19%)
Query: 38 YRAFDEYEGIEVAWNQVKLYD--FLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDT 94
+ E A VK+ + + R E+ +L + HRN+++ + +
Sbjct: 30 QTCINLITSQEYA---VKIIEKQPGHIRSRVFR---EVEMLYQCQGHRNVLELIEFFEE- 82
Query: 95 ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 154
V E G++ + K R N + + S L +LH++ + HRDLK
Sbjct: 83 -EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKP 139
Query: 155 DNI-FVNGNQG-EVKIGDLGLAAILRKSHAARC---------VGTPEFMAPEV------Y 197
+NI + NQ VKI D L + ++ + G+ E+MAPEV
Sbjct: 140 ENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEE 199
Query: 198 EEEYNELVDIYSFG--MCIL------------EMVTFDYPYSECTHPAQIYKKVISGKKP 243
Y++ D++S G + IL +D + +++ + GK
Sbjct: 200 ASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK-- 257
Query: 244 EALFKVEDP-------EVRQFIEKCLAT-VSSRLSARELLTDPFLQ 281
++ D + I K L RLSA ++L P++Q
Sbjct: 258 ---YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 61/244 (25%), Positives = 98/244 (40%), Gaps = 31/244 (12%)
Query: 66 LERLYCEIHLLKTLK-HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIR 124
EI LK + H NI+K + + D + V E+ G L + K + +
Sbjct: 49 EANTQKEITALKLCEGHPNIVKLHEVFHD--QLHTFLVMELLNGGELFERIKKKKHFSET 106
Query: 125 AVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHA 182
+ R+++S + ++H V+HRDLK +N+ F + N E+KI D G A + +
Sbjct: 107 EASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164
Query: 183 A--RCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSE-----CTHPAQ 232
T + APE+ + Y+E D++S G IL + S CT +
Sbjct: 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLG-VILYTMLSGQVPFQSHDRSLTCTSAVE 223
Query: 233 IYKKVISGKKPEALFKVEDP-------EVRQFIEKCLAT-VSSRLSARELLTDPFLQIDD 284
I KK+ G F E E + I+ L + RL L + +LQ
Sbjct: 224 IMKKIKKGD-----FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278
Query: 285 YDSD 288
S
Sbjct: 279 QLSS 282
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 52/164 (31%), Positives = 79/164 (48%), Gaps = 33/164 (20%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA--VKHW 129
EI LLK L H NI+ V + R + V E F L++ L + ++ +K +
Sbjct: 69 EISLLKELHHPNIVSLID--VIHSERCLTLVFE-FMEKDLKKV-LDENKTGLQDSQIKIY 124
Query: 130 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG-- 187
Q+L G+ + H ++HRDLK N+ +N + G +K+ D GL AR G
Sbjct: 125 LYQLLRGVAHCHQHR--ILHRDLKPQNLLIN-SDGALKLADFGL---------ARAFGIP 172
Query: 188 ----TPEFM-----APEVY--EEEYNELVDIYSFGMCIL-EMVT 219
T E + AP+V ++Y+ VDI+S G CI EM+T
Sbjct: 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIG-CIFAEMIT 215
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 67/232 (28%), Positives = 105/232 (45%), Gaps = 24/232 (10%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQ--SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95
Y + G VA VK LQ + E L EI +LK+L+H NI+K+
Sbjct: 31 YDPLQDNTGEVVA---VKK---LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84
Query: 96 NRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 154
RN+ + E G+LR Y KH+ R++ + + QI G+ YL ++ IHRDL
Sbjct: 85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLAT 142
Query: 155 DNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP-EF----MAPEV-YEEEYNELVDIY 208
NI V N+ VKIGD GL +L + V P E APE E +++ D++
Sbjct: 143 RNILV-ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVW 201
Query: 209 SFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 260
SFG+ + E+ T Y E + + G + ++ + + ++
Sbjct: 202 SFGVVLYELFT----YIEKSKSPPAEFMRMIGNDKQG--QMIVFHLIELLKN 247
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 45/237 (18%), Positives = 93/237 (39%), Gaps = 28/237 (11%)
Query: 72 EIHLLKTL-KHRNIMKFYTSWVDTANRNINF--VTEMFTSGTL--RQYRLKHRRVNIRAV 126
E+ +I+ + + + + E G L R + R
Sbjct: 71 EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREA 130
Query: 127 KHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAR 184
R I + + +LHS + + HRD+K +N+ + + + +K+ D G A ++
Sbjct: 131 AEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT 188
Query: 185 CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTH--PAQIYKKVIS 239
TP ++APEV E Y++ D++S G I+ ++ +P YS + +++
Sbjct: 189 PCYTPYYVAPEVLGPEKYDKSCDMWSLG-VIMYILLCGFPPFYSNTGQAISPGMKRRIRL 247
Query: 240 GKKPEALFKVEDP-------EVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSD 288
G+ + +P + +Q I L T + RL+ + + P++
Sbjct: 248 GQ-----YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ 299
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 61/231 (26%), Positives = 96/231 (41%), Gaps = 27/231 (11%)
Query: 75 LLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQIL 134
LL+ +H NI+ + D + + VTE+ G L L+ + + R I
Sbjct: 69 LLRYGQHPNIITLKDVYDD--GKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTIT 126
Query: 135 SGLLYLHSRDPPVIHRDLKCDNIFV---NGNQGEVKIGDLGLAAILRKSHAAR--CVGTP 189
+ YLH++ V+HRDLK NI +GN ++I D G A LR + T
Sbjct: 127 KTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTA 184
Query: 190 EFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECT-HPAQIYKKVISGKKPEA 245
F+APEV E + Y+ DI+S G +L + Y + P +I ++ SGK
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLG-VLLYTMLTGYTPFANGPDDTPEEILARIGSGK---- 239
Query: 246 LFKVEDP-------EVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSD 288
F + + + K L RL+A +L P++ D
Sbjct: 240 -FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQ 289
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 52/242 (21%), Positives = 104/242 (42%), Gaps = 42/242 (17%)
Query: 64 EELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVN 122
E E E H+L+ + H +I+ S+ + + V ++ G L Y + ++
Sbjct: 141 EVREATRRETHILRQVAGHPHIITLIDSYES--SSFMFLVFDLMRKGELFDYLTEKVALS 198
Query: 123 IRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 182
+ + R +L + +LH+ + ++HRDLK +NI ++ N ++++ D G + L
Sbjct: 199 EKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDN-MQIRLSDFGFSCHLEPGEK 255
Query: 183 AR-CVGTPEFMAPEV-------YEEEYNELVDIYSFGMCILEMVTFDY-------PYSEC 227
R GTP ++APE+ Y + VD+++ G IL + P+
Sbjct: 256 LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG-VIL------FTLLAGSPPFWHR 308
Query: 228 THPAQIYKKVISGKKPEALFKVEDP-------EVRQFIEKCLAT-VSSRLSARELLTDPF 279
+ + ++ G+ ++ P V+ I + L +RL+A + L PF
Sbjct: 309 RQI-LMLRMIMEGQ-----YQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPF 362
Query: 280 LQ 281
+
Sbjct: 363 FE 364
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 49/243 (20%), Positives = 94/243 (38%), Gaps = 29/243 (11%)
Query: 67 ERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINF--VTEMFTSGTL--RQYRLKHRRV 121
+ E+ L + +I++ + + V E G L R +
Sbjct: 99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 158
Query: 122 NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRK 179
R + I + YLHS + + HRD+K +N+ + + +K+ D G A
Sbjct: 159 TEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
Query: 180 SHAAR-CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQ--I 233
++ TP ++APEV E Y++ D++S G I+ ++ YP YS +
Sbjct: 217 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGM 275
Query: 234 YKKVISGKKPEALFKVEDP-------EVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDY 285
++ G+ ++ +P EV+ I L T + R++ E + P++
Sbjct: 276 KTRIRMGQ-----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330
Query: 286 DSD 288
Sbjct: 331 VPQ 333
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 68/232 (29%), Positives = 104/232 (44%), Gaps = 24/232 (10%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQ--SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95
Y + G VA VK LQ + E L EI +LK+L+H NI+K+
Sbjct: 62 YDPLQDNTGEVVA---VKK---LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115
Query: 96 NRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 154
RN+ + E G+LR Y KH+ R++ + + QI G+ YL ++ IHRDL
Sbjct: 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLAT 173
Query: 155 DNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP-EF----MAPEV-YEEEYNELVDIY 208
NI V N+ VKIGD GL +L + V P E APE E +++ D++
Sbjct: 174 RNILV-ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVW 232
Query: 209 SFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 260
SFG+ + E+ T Y E + + G + V + + ++
Sbjct: 233 SFGVVLYELFT----YIEKSKSPPAEFMRMIGNDKQGQMIVF--HLIELLKN 278
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 56/164 (34%), Positives = 80/164 (48%), Gaps = 33/164 (20%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA--VKHW 129
EI +LK LKH NI+K Y V + + V E L++ L + + K +
Sbjct: 50 EISILKELKHSNIVKLYD--VIHTKKRLVLVFE-HLDQDLKKL-LDVCEGGLESVTAKSF 105
Query: 130 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG-- 187
Q+L+G+ Y H R V+HRDLK N+ +N +GE+KI D GL AR G
Sbjct: 106 LLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGL---------ARAFGIP 153
Query: 188 ----TPEFM-----APEVY--EEEYNELVDIYSFGMCIL-EMVT 219
T E + AP+V ++Y+ +DI+S G CI EMV
Sbjct: 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVG-CIFAEMVN 196
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 51/166 (30%), Positives = 82/166 (49%), Gaps = 33/166 (19%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCR 131
E+ LLK L+HRNI++ + V N ++ + E + L++Y K+ V++R +K +
Sbjct: 83 EVSLLKELQHRNIIELKS--VIHHNHRLHLIFE-YAENDLKKYMDKNPDVSMRVIKSFLY 139
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVN----GNQGEVKIGDLGLAAILRKSHAARCVG 187
Q+++G+ + HSR +HRDLK N+ ++ +KIGD GL AR G
Sbjct: 140 QLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGL---------ARAFG 188
Query: 188 ------TPEFM-----APEVY--EEEYNELVDIYSFGMCIL-EMVT 219
T E + PE+ Y+ VDI+S CI EM+
Sbjct: 189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIA-CIWAEMLM 233
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 54/226 (23%), Positives = 101/226 (44%), Gaps = 25/226 (11%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRL-KHRRVNIRAVKHWC 130
E+ +++ L+H ++ + S+ D ++ V ++ G LR Y L ++ VK +
Sbjct: 65 ELQIMQGLEHPFLVNLWYSFQD--EEDMFMVVDLLLGGDLR-YHLQQNVHFKEETVKLFI 121
Query: 131 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGT 188
+++ L YL ++ +IHRD+K DNI ++ G V I D +AA+L + GT
Sbjct: 122 CELVMALDYLQNQR--IIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQITTMA-GT 177
Query: 189 PEFMAPEVYEEE----YNELVDIYSFGMCILEMVTFDYPYSECTH--PAQIYKKVISGKK 242
+MAPE++ Y+ VD +S G+ E++ PY + +I +
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV 237
Query: 243 --PEALFKVEDPEVRQFIEKCL-ATVSSRL-SARELLTDPFLQ-ID 283
P A E+ ++K L R ++ P++ I+
Sbjct: 238 TYPSAW----SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 58/189 (30%), Positives = 90/189 (47%), Gaps = 13/189 (6%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y ++ G VA VK P+ EI +L+TL H +I+K+ D
Sbjct: 52 YDPTNDGTGEMVA---VKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
++ V E G+LR Y L + + + + +QI G+ YLH++ IHRDL N+
Sbjct: 109 SLQLVMEYVPLGSLRDY-LPRHSIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNV 165
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGT----PEF-MAPE-VYEEEYNELVDIYSFG 211
+ N VKIGD GLA + + H V P F APE + E ++ D++SFG
Sbjct: 166 LL-DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFG 224
Query: 212 MCILEMVTF 220
+ + E++T
Sbjct: 225 VTLYELLTH 233
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 6e-23
Identities = 56/169 (33%), Positives = 82/169 (48%), Gaps = 38/169 (22%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA------ 125
EI L+K LKH NI++ Y V + V E F L++Y + R V
Sbjct: 53 EISLMKELKHENIVRLYD--VIHTENKLTLVFE-FMDNDLKKY-MDSRTVGNTPRGLELN 108
Query: 126 -VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR 184
VK++ Q+L GL + H ++HRDLK N+ +N +G++K+GD GL AR
Sbjct: 109 LVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLIN-KRGQLKLGDFGL---------AR 156
Query: 185 CVG------TPEFM-----APEVY--EEEYNELVDIYSFGMCIL-EMVT 219
G + E + AP+V Y+ +DI+S G CIL EM+T
Sbjct: 157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCG-CILAEMIT 204
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 27/233 (11%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQ--SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95
Y + G VA VK LQ P++ EI +LK L I+K+
Sbjct: 44 YDPLGDNTGALVA---VKQ---LQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97
Query: 96 NRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 154
+++ V E SG LR + +HR R++ + + QI G+ YL SR +HRDL
Sbjct: 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAA 155
Query: 155 DNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP-EF----MAPE-VYEEEYNELVDIY 208
NI V ++ VKI D GLA +L V P + APE + + ++ D++
Sbjct: 156 RNILV-ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVW 214
Query: 209 SFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 260
SFG+ + E+ T+ D S P+ + +++ ++ + + +E+
Sbjct: 215 SFGVVLYELFTYCDKSCS----PSAEFLRMMGCERDV----PALSRLLELLEE 259
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 56/269 (20%), Positives = 97/269 (36%), Gaps = 70/269 (26%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI--RAVKHW 129
EI +LK LKH N++ V R ++ V E + T+ L + + VK
Sbjct: 52 EIRMLKQLKHPNLVNLLE--VFRRKRRLHLVFE-YCDHTVLHE-LDRYQRGVPEHLVKSI 107
Query: 130 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP 189
Q L + + H + IHRD+K +NI + +K+ D G AR + P
Sbjct: 108 TWQTLQAVNFCHKHN--CIHRDVKPENILIT-KHSVIKLCDFGF---------ARLLTGP 155
Query: 190 -EFM----------APEVY--EEEYNELVDIYSFGMCIL-EMVTFDYPY----SECTHPA 231
++ +PE+ + +Y VD+++ G C+ E+++ P S+
Sbjct: 156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIG-CVFAELLSGV-PLWPGKSD---VD 210
Query: 232 QIYK----------------------KVISGKKP------EALFKVEDPEVRQFIEKCLA 263
Q+Y + P E F ++ CL
Sbjct: 211 QLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLH 270
Query: 264 TV-SSRLSARELLTDPFLQIDDYDSDLRM 291
+ RL+ +LL P+ + DL
Sbjct: 271 MDPTERLTCEQLLHHPYFENIREIEDLAK 299
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 54/262 (20%), Positives = 95/262 (36%), Gaps = 69/262 (26%)
Query: 72 EIHLLKTLKHRNIMK----FYTSWVDTANRNINFVTEMFTSGTL----RQYRLKHRRVNI 123
E+ +++ L H NI++ FY+S +N V + + T+ R Y + + +
Sbjct: 97 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD-YVPETVYRVARHYSRAKQTLPV 155
Query: 124 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 183
VK + Q+ L Y+HS + HRD+K N+ ++ + +K+ D G A L +
Sbjct: 156 IYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--- 210
Query: 184 RCVGTPEFM----------APEVY--EEEYNELVDIYSFGMCIL-EMVT----FDYPYSE 226
E APE+ +Y +D++S G C+L E++ F P
Sbjct: 211 ------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG-CVLAELLLGQPIF--PGDS 261
Query: 227 CTHPAQIYK----------KVISGKKPEA----------------LFKVEDPEVRQFIEK 260
Q+ + + I P PE +
Sbjct: 262 GVD--QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 319
Query: 261 CLA-TVSSRLSARELLTDPFLQ 281
L T ++RL+ E F
Sbjct: 320 LLEYTPTARLTPLEACAHSFFD 341
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 51/244 (20%), Positives = 94/244 (38%), Gaps = 21/244 (8%)
Query: 62 SPEELERLYCEIHLLKTLKHR-NIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR 120
+ + EI +L+ K ++ + + + I + E G +
Sbjct: 68 GQDCRAEILHEIAVLELAKSCPRVINLHEVYEN--TSEIILILEYAAGGEI-FSLCLPEL 124
Query: 121 VNI---RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQ-GEVKIGDLGLAA 175
+ V +QIL G+ YLH + ++H DLK NI + G++KI D G++
Sbjct: 125 AEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182
Query: 176 ILRKSHAAR-CVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYP--YSECTHPA 231
+ + R +GTPE++APE+ + D+++ G+ I M+ E
Sbjct: 183 KIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGI-IAYMLLTHTSPFVGE--DNQ 239
Query: 232 QIYKKVISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSD 288
+ Y + E F FI+ L R +A L+ +LQ D+++
Sbjct: 240 ETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299
Query: 289 LRMI 292
Sbjct: 300 FHPE 303
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-22
Identities = 61/266 (22%), Positives = 104/266 (39%), Gaps = 71/266 (26%)
Query: 72 EIHLLKTLKHRNIMK----FYTSWVDTANRNINFVTEMFTSGTL----RQYRLKHRRVNI 123
E+ +++ +KH N++ FY++ +N V E + T+ R Y + + +
Sbjct: 82 ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE-YVPETVYRASRHYAKLKQTMPM 140
Query: 124 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 183
+K + Q+L L Y+HS + HRD+K N+ ++ G +K+ D G A IL
Sbjct: 141 LLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG--- 195
Query: 184 RCVGTPEFM----------APEVY--EEEYNELVDIYSFGMCIL-EMVT----FDYPYSE 226
E APE+ Y +DI+S G C++ E++ F P
Sbjct: 196 ------EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTG-CVMAELMQGQPLF--PGES 246
Query: 227 CTHPAQIYK----------KVISGKKP---------------EALFKVE-DPEVRQFIEK 260
Q+ + + I P +F+ P+ I +
Sbjct: 247 GID--QLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISR 304
Query: 261 CLA-TVSSRLSARELLTDPFLQIDDY 285
L T S+RL+A E L PF D+
Sbjct: 305 LLEYTPSARLTAIEALCHPFF--DEL 328
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 50/164 (30%), Positives = 76/164 (46%), Gaps = 33/164 (20%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA--VKHW 129
E+ LLK LKH NI+ + + +++ V E + L+QY L I VK +
Sbjct: 50 EVSLLKDLKHANIVTLHD--IIHTEKSLTLVFE-YLDKDLKQY-LDDCGNIINMHNVKLF 105
Query: 130 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG-- 187
Q+L GL Y H + V+HRDLK N+ +N +GE+K+ D GL AR
Sbjct: 106 LFQLLRGLAYCHRQK--VLHRDLKPQNLLIN-ERGELKLADFGL---------ARAKSIP 153
Query: 188 ----TPEFM-----APEVY--EEEYNELVDIYSFGMCIL-EMVT 219
E + P++ +Y+ +D++ G CI EM T
Sbjct: 154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVG-CIFYEMAT 196
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 62/266 (23%), Positives = 103/266 (38%), Gaps = 68/266 (25%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWC 130
EI LLK L+H N++ V + V E F T+ L ++ + V+ +
Sbjct: 74 EIKLLKQLRHENLVNLLE--VCKKKKRWYLVFE-FVDHTILDDLELFPNGLDYQVVQKYL 130
Query: 131 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPE 190
QI++G+ + HS + +IHRD+K +NI V+ G VK+ D G AR + P
Sbjct: 131 FQIINGIGFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGF---------ARTLAAPG 178
Query: 191 FM-----------APEVY--EEEYNELVDIYSFGMCIL-EMVTFDYPY----SECTHPAQ 232
+ APE+ + +Y + VD+++ G C++ EM + P S+ Q
Sbjct: 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIG-CLVTEMFMGE-PLFPGDSD---IDQ 233
Query: 233 IYK----------------------------KVISGKKPEALFKVEDPEVRQFIEKCLAT 264
+Y ++ + E + V +KCL
Sbjct: 234 LYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHI 293
Query: 265 V-SSRLSARELLTDPFLQIDDYDSDL 289
R ELL F Q+D +
Sbjct: 294 DPDKRPFCAELLHHDFFQMDGFAERF 319
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 47/246 (19%), Positives = 89/246 (36%), Gaps = 26/246 (10%)
Query: 38 YRAFDEY-EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYT--SWVDT 94
Y A D G V +K E E L + H +I++ + D
Sbjct: 97 YLALDRNVNGRPVV---LKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR 153
Query: 95 ANRNINF-VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 153
+ + V E +L++ + +++ + + +IL L YLHS +++ DLK
Sbjct: 154 HGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPALSYLHSI--GLVYNDLK 209
Query: 154 CDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMC 213
+NI + Q +K+ DLG + R + GTP F APE+ DIY+ G
Sbjct: 210 PENIMLTEEQ--LKLIDLGAVS--RINSFGYLYGTPGFQAPEIVRTGPTVATDIYTVGRT 265
Query: 214 ILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSR--LSA 271
+ + + + + + K + + + + + +A
Sbjct: 266 LAALTLDLPTRNG-RYVDGLPEDDPVLKTY--------DSYGRLLRRAIDPDPRQRFTTA 316
Query: 272 RELLTD 277
E+
Sbjct: 317 EEMSAQ 322
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 65 ELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIR 124
++ + E ++ L H +K Y ++ D + + F +G L +Y K +
Sbjct: 73 KVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDET 130
Query: 125 AVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK-SHAA 183
+ + +I+S L YLH + +IHRDLK +NI +N ++I D G A +L S A
Sbjct: 131 CTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQA 187
Query: 184 RC---VGTPEFMAPEV-YEEEYNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKV 237
R VGT ++++PE+ E+ + D+++ G I ++V P + + I++K+
Sbjct: 188 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPFRAG--NEYLIFQKI 244
Query: 238 ISGKK--PEALFKVEDPEVRQFIEKCL 262
I + PE P+ R +EK L
Sbjct: 245 IKLEYDFPEKF----FPKARDLVEKLL 267
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 64/253 (25%), Positives = 108/253 (42%), Gaps = 24/253 (9%)
Query: 38 YRAFDEYEGIEVAWNQVKL--YDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT- 94
Y A D I+VA +K + E L+R E+H L H+NI+ D
Sbjct: 28 YLAEDTILNIKVA---IKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI----DVD 80
Query: 95 ANRNINF-VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 153
+ + V E TL +Y H +++ ++ QIL G+ + H ++HRD+K
Sbjct: 81 EEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIK 138
Query: 154 CDNIFVNGNQGEVKIGDLGLAAILRKS---HAARCVGTPEFMAPE-VYEEEYNELVDIYS 209
NI + + +KI D G+A L ++ +GT ++ +PE E +E DIYS
Sbjct: 139 PQNILI-DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYS 197
Query: 210 FGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED---PEVRQFIEKCLA-TV 265
G+ + EM+ + P++ T I K I P V + I +
Sbjct: 198 IGIVLYEMLVGEPPFNGET-AVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDK 256
Query: 266 SSR-LSARELLTD 277
++R + +E+ D
Sbjct: 257 ANRYKTIQEMKDD 269
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 3e-22
Identities = 46/164 (28%), Positives = 72/164 (43%), Gaps = 33/164 (20%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA--VKHW 129
EI LL+ L H NI+ NI+ V + F L +K + + +K +
Sbjct: 62 EIKLLQELSHPNIIGLLD--AFGHKSNISLVFD-FMETDLEVI-IKDNSLVLTPSHIKAY 117
Query: 130 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG-- 187
L GL YLH ++HRDLK +N+ ++ G +K+ D GL A+ G
Sbjct: 118 MLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGL---------AKSFGSP 165
Query: 188 ----TPEFM-----APEVY--EEEYNELVDIYSFGMCIL-EMVT 219
T + + APE+ Y VD+++ G CIL E++
Sbjct: 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVG-CILAELLL 208
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-22
Identities = 53/241 (21%), Positives = 100/241 (41%), Gaps = 22/241 (9%)
Query: 64 EELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI 123
+ + E ++ +++ + ++ D +R + V E G L + + V
Sbjct: 111 SDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRYLYMVMEYMPGGDLVNL-MSNYDVPE 167
Query: 124 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 183
+ + + +++ L +HS IHRD+K DN+ ++ G +K+ D G + K
Sbjct: 168 KWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMV 224
Query: 184 RC---VGTPEFMAPEV-----YEEEYNELVDIYSFGMCILEMVTFDYP-YSECTHPAQIY 234
RC VGTP++++PEV + Y D +S G+ + EM+ D P Y++ Y
Sbjct: 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--SLVGTY 282
Query: 235 KKVISGKKPEALFKVED--PEVRQFIEKCLATVSSRL---SARELLTDPFLQIDDYDSDL 289
K+++ K D E + I L RL E+ F + D + +
Sbjct: 283 SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWET 342
Query: 290 R 290
Sbjct: 343 L 343
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 55/190 (28%), Positives = 92/190 (48%), Gaps = 13/190 (6%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y + G +VA VK + L EI +L+ L H NI+K+ +
Sbjct: 42 YDPEGDNTGEQVA---VKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98
Query: 98 NINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
I + E SG+L++Y K++ ++N++ + QI G+ YL SR +HRDL N
Sbjct: 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARN 156
Query: 157 IFVNGNQGEVKIGDLGLAAILRKSHAARCVGT----PEF-MAPE-VYEEEYNELVDIYSF 210
+ V ++ +VKIGD GL + V P F APE + + ++ D++SF
Sbjct: 157 VLV-ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSF 215
Query: 211 GMCILEMVTF 220
G+ + E++T+
Sbjct: 216 GVTLHELLTY 225
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 48/168 (28%), Positives = 70/168 (41%), Gaps = 34/168 (20%)
Query: 72 EIHLLKTLK---HRNIMKFY---TSWVDTANRNINFVTEMFTSGTLRQY--RLKHRRVNI 123
E+ LL+ L+ H N+++ + + V E LR Y + +
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPA 119
Query: 124 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 183
+K RQ L GL +LH+ ++HRDLK +NI V + G VK+ D GL A
Sbjct: 120 ETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGL---------A 167
Query: 184 RCVGTPEFM----------APEV-YEEEYNELVDIYSFGMCIL-EMVT 219
R + APEV + Y VD++S G CI EM
Sbjct: 168 RIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVG-CIFAEMFR 214
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 48/168 (28%), Positives = 71/168 (42%), Gaps = 34/168 (20%)
Query: 72 EIHLLKTLK---HRNIMKFY---TSWVDTANRNINFVTEMFTSGTLRQY--RLKHRRVNI 123
E+ +L+ L+ H N+++ + T + V E L Y ++ V
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPT 119
Query: 124 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 183
+K Q+L GL +LHS V+HRDLK NI V + G++K+ D GL A
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGL---------A 167
Query: 184 RCVGTPEFM----------APEV-YEEEYNELVDIYSFGMCIL-EMVT 219
R + APEV + Y VD++S G CI EM
Sbjct: 168 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVG-CIFAEMFR 214
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 4e-21
Identities = 55/238 (23%), Positives = 92/238 (38%), Gaps = 29/238 (12%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+ + VA VK P+ + E +LK H NI++ V T +
Sbjct: 131 FSGRLRADNTLVA---VKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG--VCTQKQ 185
Query: 98 NINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
I V E+ G + R + R+ ++ + +G+ YL S+ IHRDL N
Sbjct: 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK--CCIHRDLAARN 243
Query: 157 IFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPEVYEE-EYNELVDIYSFG 211
V +KI D G++ A G + APE Y+ D++SFG
Sbjct: 244 CLVTEK-NVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFG 302
Query: 212 MCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 255
+ + E + PY ++ Q + V G + P+A+F++ +P R
Sbjct: 303 ILLWETFSLGASPYPNLSN-QQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQR 359
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 5e-21
Identities = 41/179 (22%), Positives = 82/179 (45%), Gaps = 24/179 (13%)
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC---VGT 188
+++ + +H +HRD+K DNI ++ G +++ D G L + + VGT
Sbjct: 183 EMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGT 239
Query: 189 PEFMAPEVYEEE------YNELVDIYSFGMCILEMVTFDYP-YSECTHPAQIYKKVISGK 241
P++++PE+ + Y D +S G+C+ EM+ + P Y+E + Y K+++ K
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHK 297
Query: 242 K----PEALFKVEDPEVRQFIEKCLATVSSRL---SARELLTDPFLQIDDYDSDLRMIQ 293
+ P + V + I + + + RL + PF D+D ++R +
Sbjct: 298 ERFQFPTQVTDV-SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWD-NIRNCE 354
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 6e-21
Identities = 76/295 (25%), Positives = 122/295 (41%), Gaps = 67/295 (22%)
Query: 40 AFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99
A + G VA +K + P R EI +LK KH NI+ + + +
Sbjct: 30 ATHKPTGEIVA---IKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN--IQRPDSFE 84
Query: 100 NF-----VTE-MFT--SGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 151
NF + E M T + L + +++ Q L + LH + VIHRD
Sbjct: 85 NFNEVYIIQELMQTDLHRVISTQMLSDDHI-----QYFIYQTLRAVKVLHGSN--VIHRD 137
Query: 152 LKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPE--FM----------APEV--Y 197
LK N+ +N N ++K+ D GLA I+ +S A T + M APEV
Sbjct: 138 LKPSNLLINSN-CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT 196
Query: 198 EEEYNELVDIYSFGMCIL-EMVT----F---DY-------------PYSE------CTHP 230
+Y+ +D++S G CIL E+ F DY P+S+ +
Sbjct: 197 SAKYSRAMDVWSCG-CILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPR 255
Query: 231 AQIYKKVISGKKP---EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 281
A+ Y K + E +F +P+ +++ L + R++A+E L P+LQ
Sbjct: 256 AREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 65 ELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIR 124
++E E +L+ + ++K S+ D N N+ V E G + + + R +
Sbjct: 84 QIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 125 AVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR 184
+ + QI+ YLHS D +I+RDLK +N+ ++ QG +++ D G A ++
Sbjct: 142 HARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTWTL 198
Query: 185 CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKVISGK 241
C GTPE +APE+ + YN+ VD ++ G+ I EM YP +++ P QIY+K++SGK
Sbjct: 199 C-GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFAD--QPIQIYEKIVSGK 254
Query: 242 K--PEALFKVEDPEVRQFIEKCL-ATVSSRL 269
P +++ + L ++ R
Sbjct: 255 VRFPSHF----SSDLKDLLRNLLQVDLTKRF 281
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 49/180 (27%), Positives = 82/180 (45%), Gaps = 24/180 (13%)
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC---VGT 188
+I+ + +H +HRD+K DNI ++ G +++ D G LR R VGT
Sbjct: 170 EIVMAIDSVHRLG--YVHRDIKPDNILLD-RCGHIRLADFGSCLKLRADGTVRSLVAVGT 226
Query: 189 PEFMAPEV--------YEEEYNELVDIYSFGMCILEMVTFDYP-YSECTHPAQIYKKVIS 239
P++++PE+ Y D ++ G+ EM P Y++ A+ Y K++
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD--STAETYGKIVH 284
Query: 240 GKKPEALFKVED---PEVRQFIEKCLATVSSRL---SARELLTDPFLQIDDYDSDLRMIQ 293
K+ +L V++ E R FI++ L +RL A + T PF D+D LR
Sbjct: 285 YKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWD-GLRDSV 343
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 69/293 (23%), Positives = 114/293 (38%), Gaps = 63/293 (21%)
Query: 40 AFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY-------TSWV 92
A D VA +K P+ ++ EI +++ L H NI+K + +
Sbjct: 30 AVDNDCDKRVA---IKKIVL-TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85
Query: 93 DTANRNINF-----VTE-MFT--SGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 144
D V E M T + L Q L + + Q+L GL Y+HS +
Sbjct: 86 DDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHA-----RLFMYQLLRGLKYIHSAN 140
Query: 145 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC-----VGTPEFMAPEV--Y 197
V+HRDLK N+F+N +KIGD GLA I+ ++ + + T + +P +
Sbjct: 141 --VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS 198
Query: 198 EEEYNELVDIYSFGMCIL-EMVT----F---DY-------------PYSE----CTHPAQ 232
Y + +D+++ G CI EM+T F + E
Sbjct: 199 PNNYTKAIDMWAAG-CIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIP 257
Query: 233 IYKKVISGKKP---EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 281
+Y + + L E F+E+ L + RL+A E L+ P++
Sbjct: 258 VYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS 310
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 86/287 (29%), Positives = 123/287 (42%), Gaps = 60/287 (20%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
A D+ G +VA KL QS +R Y E+ LLK ++H N++ V T
Sbjct: 41 CSAIDKRSGEKVAIK--KLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLD--VFTPAS 96
Query: 98 NIN------FVTE-MFT--SGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVI 148
++ V M T + + ++ ++ Q+L GL Y+HS V+
Sbjct: 97 SLRNFYDFYLVMPFMQTDLQKIMGL-KFSEEKI-----QYLVYQMLKGLKYIHSAG--VV 148
Query: 149 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPEV--YEEEYNEL 204
HRDLK N+ VN + E+KI D GLA R + A V T + APEV YN+
Sbjct: 149 HRDLKPGNLAVNED-CELKILDFGLA---RHADAEMTGYVVTRWYRAPEVILSWMHYNQT 204
Query: 205 VDIYSFGMCIL-EMVT----F---DY-------------PYSE-----CTHPAQIYKKVI 238
VDI+S G CI+ EM+T F DY P +E A+ Y + +
Sbjct: 205 VDIWSVG-CIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSL 263
Query: 239 SGKKP---EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 281
LF P+ +EK L V RL+A + LT PF +
Sbjct: 264 PQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 52/238 (21%), Positives = 101/238 (42%), Gaps = 30/238 (12%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+ E I VA +K SP+ + + E +++ ++ + ++ + + +
Sbjct: 36 WIPEGEKVKIPVA---IKELREATSPKANKEILDEAYVMASVDNPHVCRLLG--ICLTST 90
Query: 98 NINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
+ +T++ G L Y +H+ + + + +WC QI G+ YL R ++HRDL N
Sbjct: 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARN 147
Query: 157 IFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFG 211
+ V Q VKI D GLA +L + MA E + Y D++S+G
Sbjct: 148 VLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 206
Query: 212 MCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 255
+ + E++TF PY ++I + G++ ++ + D + R
Sbjct: 207 VTVWELMTFGSKPYDGIP-ASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSR 263
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 2e-20
Identities = 53/193 (27%), Positives = 92/193 (47%), Gaps = 23/193 (11%)
Query: 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 160
F+ ++ G L + +H + ++ + +I+ GL ++H+R V++RDLK NI ++
Sbjct: 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD 326
Query: 161 GNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEV--YEEEYNELVDIYSFGMCILEMV 218
G V+I DLGLA K VGT +MAPEV Y+ D +S G + +++
Sbjct: 327 -EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
Query: 219 T----FDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLA-TVSSRL-- 269
F ++ H +I + ++ P++ PE+R +E L V+ RL
Sbjct: 386 RGHSPFRQHKTKDKH--EIDRMTLTMAVELPDSF----SPELRSLLEGLLQRDVNRRLGC 439
Query: 270 ---SARELLTDPF 279
A+E+ PF
Sbjct: 440 LGRGAQEVKESPF 452
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 23/165 (13%)
Query: 72 EIHLLKTLKHRNIMKFY------TSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA 125
EI +L+ LKH N++ S + +I V + F L L + V
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFD-FCEHDLAGL-LSNVLVKFTL 123
Query: 126 --VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKS 180
+K + +L+GL Y+H ++HRD+K N+ + G +K+ D GLA ++ + S
Sbjct: 124 SEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNS 180
Query: 181 HAAR---CVGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EMVT 219
R V T + PE+ E +Y +D++ G CI+ EM T
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG-CIMAEMWT 224
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 72/289 (24%), Positives = 112/289 (38%), Gaps = 59/289 (20%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
A+D + VA +K + +R EI +L +H NI+ + A
Sbjct: 44 CSAYDNLNKVRVA---IKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND--IIRAPT 98
Query: 98 NINF-----VTE-MFT--SGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIH 149
V + M T L+ L + + ++ QIL GL Y+HS + V+H
Sbjct: 99 IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-----CYFLYQILRGLKYIHSAN--VLH 151
Query: 150 RDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC-----VGTPEFMAPEV--YEEEYN 202
RDLK N+ +N ++KI D GLA + H V T + APE+ + Y
Sbjct: 152 RDLKPSNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 203 ELVDIYSFGMCIL-EMVT----F---DY-------------PYSE-----CTHPAQIYKK 236
+ +DI+S G CIL EM++ F Y P E A+ Y
Sbjct: 211 KSIDIWSVG-CILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 269
Query: 237 VISGKKP---EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 281
+ K LF D + ++K L R+ + L P+L+
Sbjct: 270 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 82/283 (28%), Positives = 123/283 (43%), Gaps = 51/283 (18%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
A D G +VA KLY QS +R Y E+ LLK ++H N++ V T +
Sbjct: 42 CSAVDGRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD--VFTPDE 97
Query: 98 NIN------FVTE-MFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 150
++ V M T L + +KH ++ ++ Q+L GL Y+H+ +IHR
Sbjct: 98 TLDDFTDFYLVMPFMGTD--LGKL-MKHEKLGEDRIQFLVYQMLKGLRYIHAAG--IIHR 152
Query: 151 DLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEV--YEEEYNELVDIY 208
DLK N+ VN + E+KI D GLA S V T + APEV Y + VDI+
Sbjct: 153 DLKPGNLAVNED-CELKILDFGLARQA-DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIW 210
Query: 209 SFGMCIL-EMVT----F---DY-------------PYSE-----CTHPAQIYKKVISGKK 242
S G CI+ EM+T F D+ P +E + A+ Y K + +
Sbjct: 211 SVG-CIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELE 269
Query: 243 P---EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 281
++ P +EK L R++A E L P+ +
Sbjct: 270 KKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 65/284 (22%), Positives = 103/284 (36%), Gaps = 65/284 (22%)
Query: 47 IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY---TSWVDTANRNINFVT 103
+ + + + L +R+ EI LL H NI+ + + A + VT
Sbjct: 54 VFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVT 113
Query: 104 E-MFTSGTLRQYRLKHRRVNIRA--VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 160
E M T L Q + +R+ I ++++ IL GL LH V+HRDL NI +
Sbjct: 114 ELMRTD--LAQV-IHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLA 168
Query: 161 GNQGEVKIGDLGLAAILRKSHAARCVGTPEFM----------APEV--YEEEYNELVDIY 208
N ++ I D L AR APE+ + + +LVD++
Sbjct: 169 DN-NDITICDFNL---------AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMW 218
Query: 209 SFGMCIL-EMVT----F---DY-------------PYSE-----CTHPAQIYKKVISGKK 242
S G C++ EM F + P E + A+ Y +
Sbjct: 219 SAG-CVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNV 277
Query: 243 P----EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 281
P A+ DP I K L R+S + L P+ +
Sbjct: 278 PARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFE 321
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-20
Identities = 84/285 (29%), Positives = 124/285 (43%), Gaps = 55/285 (19%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
AFD G+ VA KL QS +R Y E+ LLK +KH N++ V T R
Sbjct: 46 CAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD--VFTPAR 101
Query: 98 NIN------FVTE-MFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 150
++ VT M L +K +++ V+ QIL GL Y+HS D +IHR
Sbjct: 102 SLEEFNDVYLVTHLMGAD--LNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHR 156
Query: 151 DLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPEV--YEEEYNELVD 206
DLK N+ VN + E+KI D GLA R + V T + APE+ YN+ VD
Sbjct: 157 DLKPSNLAVNED-CELKILDFGLA---RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVD 212
Query: 207 IYSFGMCIL-EMVT----F---DY-------------PYSE-----CTHPAQIYKKVISG 240
I+S G CI+ E++T F D+ P +E + A+ Y + ++
Sbjct: 213 IWSVG-CIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 271
Query: 241 KKP---EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 281
+F +P +EK L R++A + L +
Sbjct: 272 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 25/256 (9%)
Query: 38 YRAFDEYEGIEVAWNQVKL--YDFLQSPEELERLYCEIHLLKTLKHRNIMKFY-TSWVDT 94
+ A D + +VA VK+ D + P R E L H I+ Y T +T
Sbjct: 29 HLARDLRDHRDVA---VKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85
Query: 95 ANRNINF-VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 153
+ + V E TLR + + L + H +IHRD+K
Sbjct: 86 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVK 143
Query: 154 CDNIFVNGNQGEVKIGDLGLAAILRKS-----HAARCVGTPEFMAPE-VYEEEYNELVDI 207
NI + VK+ D G+A + S A +GT ++++PE + + D+
Sbjct: 144 PANIMI-SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDV 202
Query: 208 YSFGMCILEMVTFDYPYSECTHPAQI-YKKVISGKKPEALFKVED---PEVRQFIEKCLA 263
YS G + E++T + P++ + P + Y+ V + P + ++ + K LA
Sbjct: 203 YSLGCVLYEVLTGEPPFTGDS-PVSVAYQHV--REDPIPPSARHEGLSADLDAVVLKALA 259
Query: 264 -TVSSR-LSARELLTD 277
+R +A E+ D
Sbjct: 260 KNPENRYQTAAEMRAD 275
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 54/263 (20%), Positives = 101/263 (38%), Gaps = 53/263 (20%)
Query: 63 PEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV 121
P + +++ EI +L+ L+ NI+ D +R V E + +Q ++ +
Sbjct: 71 PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTL 127
Query: 122 NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 181
++ + +IL L Y HS ++HRD+K N+ ++ ++++ D GLA H
Sbjct: 128 TDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLA---EFYH 182
Query: 182 AARC----VGTPEFMAPE--VYEEEYNELVDIYSFGMCIL-EMVT--------------- 219
+ V + F PE V + Y+ +D++S G C+L M+
Sbjct: 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLG-CMLASMIFRKEPFFHGHDNYDQL 241
Query: 220 ------------FDYPYSECTHPAQIYKKVISGKK--------PEALFKVEDPEVRQFIE 259
+DY + ++ + PE F++
Sbjct: 242 VRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLD 301
Query: 260 KCLA-TVSSRLSARELLTDPFLQ 281
K L SRL+ARE + P+
Sbjct: 302 KLLRYDHQSRLTAREAMEHPYFY 324
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 63/203 (31%), Positives = 87/203 (42%), Gaps = 44/203 (21%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
A+D VA KL Q+ +R Y E+ L+K + H+NI+ V T +
Sbjct: 42 CAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN--VFTPQK 97
Query: 98 NIN------FVTE-MFT--SGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVI 148
++ V E M ++ L H R + + Q+L G+ +LHS +I
Sbjct: 98 SLEEFQDVYIVMELMDANLCQVIQM-ELDHER-----MSYLLYQMLCGIKHLHSAG--II 149
Query: 149 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFM----------APEV-Y 197
HRDLK NI V + +KI D GL AR GT M APEV
Sbjct: 150 HRDLKPSNIVVKSD-CTLKILDFGL---------ARTAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 198 EEEYNELVDIYSFGMCIL-EMVT 219
Y E VDI+S G CI+ EM+
Sbjct: 200 GMGYKENVDIWSVG-CIMGEMIK 221
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 2e-19
Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 27/215 (12%)
Query: 65 ELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIR 124
++E E +L + H I++ + ++ D + I + + G L K +R
Sbjct: 49 QVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIFMIMDYIEGGELFSLLRKSQRFPNP 106
Query: 125 AVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR 184
K + ++ L YLHS+D +I+RDLK +NI ++ G +KI D G A K
Sbjct: 107 VAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFA----KYVPDV 159
Query: 185 ----CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKV 237
C GTP+++APEV + YN+ +D +SFG+ I EM+ Y Y + + Y+K+
Sbjct: 160 TYTLC-GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA-GYTPFYDS--NTMKTYEKI 215
Query: 238 ISGKK--PEALFKVEDPEVRQFIEKCL-ATVSSRL 269
++ + P + +V+ + + + +S RL
Sbjct: 216 LNAELRFPPFF----NEDVKDLLSRLITRDLSQRL 246
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 2e-19
Identities = 59/241 (24%), Positives = 100/241 (41%), Gaps = 29/241 (12%)
Query: 58 DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTL----RQ 113
L+ + + E +L + R I+ ++ +T + V + G +
Sbjct: 221 KRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-ETKTD-LCLVMTIMNGGDIRYHIYN 278
Query: 114 YRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 173
+ + QI+SGL +LH R+ +I+RDLK +N+ ++ + G V+I DLGL
Sbjct: 279 VDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDLGL 335
Query: 174 A--AILRKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVT----FDYPYSE 226
A ++ GTP FMAPE+ E Y+ VD ++ G+ + EM+ F E
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF-RARGE 394
Query: 227 CTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDP 278
++ ++V+ P+ P + F E L RL S L T P
Sbjct: 395 KVENKELKQRVLEQAVTYPDKF----SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHP 450
Query: 279 F 279
Sbjct: 451 L 451
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 56/268 (20%), Positives = 108/268 (40%), Gaps = 43/268 (16%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV 121
S E E ++K ++++ V + + + E+ T G L+ Y R
Sbjct: 68 SMRERIEFLNEASVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPA 125
Query: 122 NIRAVK----------HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 171
+I G+ YL++ +HRDL N V + VKIGD
Sbjct: 126 MANNPVLAPPSLSKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDF-TVKIGDF 182
Query: 172 GLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYS 225
G+ + ++ R G M+PE + + + D++SFG+ + E+ T + PY
Sbjct: 183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 242
Query: 226 ECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR-QFIEKCLATVSSRLSA 271
++ Q+ + V+ G P+ LF++ +P++R F+E + S +
Sbjct: 243 GLSN-EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLE-----IISSI-- 294
Query: 272 RELLTDPFLQIDDYDSDLRMIQYQTDYD 299
+E + F ++ Y S+ + + D
Sbjct: 295 KEEMEPGFREVSFYYSEENKLPEPEELD 322
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 3e-19
Identities = 61/201 (30%), Positives = 86/201 (42%), Gaps = 40/201 (19%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
A+D VA KL Q+ +R Y E+ L+K + H+NI+ V T +
Sbjct: 79 CAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN--VFTPQK 134
Query: 98 NIN------FVTE-MFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 150
+ V E M + ++ ++ + + Q+L G+ +LHS +IHR
Sbjct: 135 TLEEFQDVYLVMELMDAN----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG--IIHR 188
Query: 151 DLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFM----------APEV-YEE 199
DLK NI V + +KI D GL AR GT M APEV
Sbjct: 189 DLKPSNIVVKSD-CTLKILDFGL---------ARTAGTSFMMTPYVVTRYYRAPEVILGM 238
Query: 200 EYNELVDIYSFGMCIL-EMVT 219
Y E VDI+S G CI+ EMV
Sbjct: 239 GYKENVDIWSVG-CIMGEMVR 258
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 3e-19
Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 65 ELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIR 124
E+E E ++K +KH N+++ V T +TE T G L Y + R +
Sbjct: 259 EVEEFLKEAAVMKEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVS 316
Query: 125 AVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL----- 177
AV + QI S + YL ++ IHR+L N V N VK+ D GL+ ++
Sbjct: 317 AVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGEN-HLVKVADFGLSRLMTGDTY 373
Query: 178 RKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYK 235
A+ ++ APE ++ D+++FG+ + E+ T+ PY +Q+Y+
Sbjct: 374 TAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYE 430
Query: 236 KVISGKK-------PEALFKV------EDPEVR 255
+ + PE ++++ +P R
Sbjct: 431 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 463
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 6e-19
Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 37/218 (16%)
Query: 58 DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RL 116
+F Q E + L H ++KFY V + I VTE ++G L Y R
Sbjct: 49 EFFQ----------EAQTMMKLSHPKLVKFYG--VCSKEYPIYIVTEYISNGCLLNYLRS 96
Query: 117 KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176
+ + + C + G+ +L S IHRDL N V+ + VK+ D G+
Sbjct: 97 HGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRD-LCVKVSDFGMTRY 153
Query: 177 LRKSHAARCVGTPEF----MAPEV-YEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHP 230
+ VGT +F APEV + +Y+ D+++FG+ + E+ + PY T+
Sbjct: 154 VLDDQYVSSVGT-KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN- 211
Query: 231 AQIYKKVISGKK-------PEALFKV------EDPEVR 255
+++ KV G + + ++++ E PE R
Sbjct: 212 SEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKR 249
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 7e-19
Identities = 52/219 (23%), Positives = 89/219 (40%), Gaps = 39/219 (17%)
Query: 58 DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK 117
DF++ E ++ L H +++ Y V I VTE G L Y L+
Sbjct: 49 DFIE----------EAEVMMKLSHPKLVQLYG--VCLEQAPICLVTEFMEHGCLSDY-LR 95
Query: 118 HRRVNIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175
+R A C + G+ YL VIHRDL N V G +K+ D G+
Sbjct: 96 TQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLV-GENQVIKVSDFGMTR 152
Query: 176 ILRKSHAARCVGTPEF----MAPEV-YEEEYNELVDIYSFGMCILEMVTF-DYPYSECTH 229
+ GT +F +PEV Y+ D++SFG+ + E+ + PY ++
Sbjct: 153 FVLDDQYTSSTGT-KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 211
Query: 230 PAQIYKKVISGKK-------PEALFKV------EDPEVR 255
+++ + + +G + ++++ E PE R
Sbjct: 212 -SEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDR 249
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 1e-18
Identities = 54/236 (22%), Positives = 99/236 (41%), Gaps = 22/236 (9%)
Query: 58 DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQ--YR 115
++ + E +L+ + R ++ ++ +T + + V + G L+ Y
Sbjct: 220 KRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-ETKDA-LCLVLTLMNGGDLKFHIYH 277
Query: 116 LKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175
+ + +I GL LH +++RDLK +NI ++ + G ++I DLGLA
Sbjct: 278 MGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLD-DHGHIRISDLGLAV 334
Query: 176 ILRKSHAAR-CVGTPEFMAPEVY-EEEYNELVDIYSFGMCILEMVT----FDYPYSECTH 229
+ + + VGT +MAPEV E Y D ++ G + EM+ F +
Sbjct: 335 HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF-QQRKKKIK 393
Query: 230 PAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPF 279
++ + V + PE + P+ R + L + RL SARE+ P
Sbjct: 394 REEVERLVK--EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 56/296 (18%), Positives = 110/296 (37%), Gaps = 49/296 (16%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+ E I VA +K SP+ + + E +++ ++ + ++ + + +
Sbjct: 36 WIPEGEKVKIPVA---IKELREATSPKANKEILDEAYVMASVDNPHVCRLLG--ICLTST 90
Query: 98 NINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
+ +T++ G L Y +H+ + + + +WC QI G+ YL R ++HRDL N
Sbjct: 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARN 147
Query: 157 IFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFG 211
+ V Q VKI D GLA +L + MA E + Y D++S+G
Sbjct: 148 VLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 206
Query: 212 MCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR-- 255
+ + E++TF PY ++I + G++ ++ + D + R
Sbjct: 207 VTVWELMTFGSKPYDGIP-ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPK 265
Query: 256 -----QFIEKCLA------------TVSSRLSARELLTDPFLQIDDYDSDLRMIQY 294
K + + +D D + +Y
Sbjct: 266 FRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEY 321
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 64/300 (21%), Positives = 101/300 (33%), Gaps = 70/300 (23%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
++ G+ VA +V +Q P R + L L H NI++ + + R
Sbjct: 40 QLGKEKSTGMSVAIKKV-----IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94
Query: 98 N-----INFVTEMFTSGTL----RQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVI 148
+ +N V E + TL R Y + +K + Q++ + LH V
Sbjct: 95 DRRDIYLNVVME-YVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVC 153
Query: 149 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFM----------APEVY- 197
HRD+K N+ VN G +K+ D G A+ + E APE+
Sbjct: 154 HRDIKPHNVLVNEADGTLKLCDFGS---------AKKLSPSEPNVAYICSRYYRAPELIF 204
Query: 198 -EEEYNELVDIYSFGMCIL-EMVT----F---DY-------------PYSE---CTHP-- 230
+ Y VDI+S G CI EM+ F + P E +P
Sbjct: 205 GNQHYTTAVDIWSVG-CIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSH 263
Query: 231 AQIYKKVISGKKPEALFKVE----DPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 285
+ G +F E + L R+ E L P+ D+
Sbjct: 264 TDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF--DEL 321
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 51/218 (23%), Positives = 92/218 (42%), Gaps = 37/218 (16%)
Query: 58 DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RL 116
+F++ E ++ L H +++ Y V T R I +TE +G L Y R
Sbjct: 65 EFIE----------EAKVMMNLSHEKLVQLYG--VCTKQRPIFIITEYMANGCLLNYLRE 112
Query: 117 KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176
R + + C+ + + YL S+ +HRDL N VN G VK+ D GL+
Sbjct: 113 MRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQ-GVVKVSDFGLSRY 169
Query: 177 LRKSHAARCVGTPEF----MAPEV-YEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHP 230
+ VG+ +F PEV +++ DI++FG+ + E+ + PY T+
Sbjct: 170 VLDDEYTSSVGS-KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN- 227
Query: 231 AQIYKKVISGKK-------PEALFKV------EDPEVR 255
++ + + G + E ++ + E + R
Sbjct: 228 SETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADER 265
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 40/218 (18%), Positives = 75/218 (34%), Gaps = 35/218 (16%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-R 120
E + ++ L H++++ Y V V E G+L Y K++
Sbjct: 52 HRNYSESFFEAASMMSKLSHKHLVLNYG--VCVCGDENILVQEFVKFGSLDTYLKKNKNC 109
Query: 121 VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN-------GNQGEVKIGDLGL 173
+NI +Q+ + + +L +IH ++ NI + GN +K+ D G+
Sbjct: 110 INILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI 167
Query: 174 AAILRKSHAARCVGTPEF-------MAPEV--YEEEYNELVDIYSFGMCILEMVTF-DYP 223
+ V + + PE + N D +SFG + E+ + D P
Sbjct: 168 ---------SITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
Query: 224 YSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKC 261
S + + L + E+ I C
Sbjct: 219 LSALDS-QRKLQFYEDR---HQLPAPKAAELANLINNC 252
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 45/238 (18%), Positives = 99/238 (41%), Gaps = 30/238 (12%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+ E I V +K+ + + + + + + +L H +I++ + +
Sbjct: 34 WIPEGESIKIPVC---IKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLG--LCPGSS 88
Query: 98 NINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
+ VT+ G+L + +HR + + + +W QI G+ YL ++HR+L N
Sbjct: 89 -LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARN 145
Query: 157 IFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPEV-YEEEYNELVDIYSFG 211
+ + +V++ D G+A +L + MA E + +Y D++S+G
Sbjct: 146 VLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYG 204
Query: 212 MCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 255
+ + E++TF PY+ A++ + G++ ++ V D +R
Sbjct: 205 VTVWELMTFGAEPYAGLR-LAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIR 261
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 6e-18
Identities = 50/230 (21%), Positives = 94/230 (40%), Gaps = 31/230 (13%)
Query: 47 IEVAWNQVK-LYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEM 105
VA VK L + P + L E ++++ L + I++ + A V EM
Sbjct: 45 KTVA---VKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG--ICEAES-WMLVMEM 98
Query: 106 FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 165
G L +Y ++R V + + Q+ G+ YL + +HRDL N+ + Q
Sbjct: 99 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLL-VTQHY 155
Query: 166 VKIGDLGLA-AILRKSHAARCVGTPEF----MAPEV-YEEEYNELVDIYSFGMCILEMVT 219
KI D GL+ A+ + + ++ APE +++ D++SFG+ + E +
Sbjct: 156 AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
Query: 220 F-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 255
+ PY ++ + G++ P ++ + D E R
Sbjct: 216 YGQKPYRGMKGS-EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENR 264
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 6e-18
Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 38/217 (17%)
Query: 65 ELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIR 124
E+E E ++K +KH N+++ V T +TE T G L Y + R +
Sbjct: 52 EVEEFLKEAAVMKEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVS 109
Query: 125 AVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL----- 177
AV + QI S + YL ++ IHRDL N V N VK+ D GL+ ++
Sbjct: 110 AVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTY 166
Query: 178 RKSHAARCVGTPEF----MAPEV-YEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPA 231
A+ F APE +++ D+++FG+ + E+ T+ PY +
Sbjct: 167 TAHAGAK------FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-S 219
Query: 232 QIYKKVISGKK-------PEALFKV------EDPEVR 255
Q+Y+ + + PE ++++ +P R
Sbjct: 220 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 256
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 8e-18
Identities = 60/234 (25%), Positives = 109/234 (46%), Gaps = 23/234 (9%)
Query: 58 DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK 117
+ + + +E+ E +L+ +H + ++ T +R + FV E G L + +
Sbjct: 41 EVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-QTHDR-LCFVMEYANGGELFFHLSR 98
Query: 118 HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AI 176
R + + +I+S L YLHSRD V++RD+K +N+ ++ G +KI D GL
Sbjct: 99 ERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDK-DGHIKITDFGLCKEG 155
Query: 177 LRKSHAAR--CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQI 233
+ + C GTPE++APEV E+ Y VD + G+ + EM+ P+ H ++
Sbjct: 156 ISDGATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERL 213
Query: 234 YKKVISGKK--PEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPF 279
++ ++ + P L PE + + L RL A+E++ F
Sbjct: 214 FELILMEEIRFPRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 8e-18
Identities = 44/236 (18%), Positives = 87/236 (36%), Gaps = 46/236 (19%)
Query: 72 EIHLLKTL-KHRNIMKFYTSWVDT--ANRNINFVTEMFTSGTL--RQYRLKHRRVNIRAV 126
E+ L + +I++ + + + + V E G L R + R
Sbjct: 60 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 119
Query: 127 KHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAR 184
+ I + YLHS + + HRD+K +N+ + + +K+ D G A
Sbjct: 120 SEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA---------- 167
Query: 185 CVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYP--YSECTHPAQ--IYKKVISG 240
E E+Y++ D++S G I+ ++ YP YS + ++ G
Sbjct: 168 ---------KETTGEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 217
Query: 241 KKPEALFKVEDP-------EVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSD 288
+ ++ +P EV+ I L T + R++ E + P++
Sbjct: 218 Q-----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 268
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 59/257 (22%), Positives = 103/257 (40%), Gaps = 51/257 (19%)
Query: 40 AFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTANRN 98
+ D G VA K++D Q+ + +R + EI +L L H NI+ +R+
Sbjct: 28 SIDRRTGEVVAVK--KIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85
Query: 99 INFVTE-MFT--SGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
+ V + M T +R L+ ++ Q++ + YLHS ++HRD+K
Sbjct: 86 VYLVFDYMETDLHAVIRANILEPVHK-----QYVVYQLIKVIKYLHSGG--LLHRDMKPS 138
Query: 156 NIFVNGNQGEVKIGDLGLA-------------AILRKSHAARCVGTPEFM---------- 192
NI +N VK+ D GL+ + + +
Sbjct: 139 NILLNAE-CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYR 197
Query: 193 APEV--YEEEYNELVDIYSFGMCIL-EMVT----FDYPYSECTHPAQIYK--KVISGKKP 243
APE+ +Y + +D++S G CIL E++ F P S + Q+ + VI
Sbjct: 198 APEILLGSTKYTKGIDMWSLG-CILGEILCGKPIF--PGSSTMN--QLERIIGVIDFPSN 252
Query: 244 EALFKVEDPEVRQFIEK 260
E + ++ P + IE
Sbjct: 253 EDVESIQSPFAKTMIES 269
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 20/143 (13%)
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC---VGT 188
+I+ L +LH +I+RD+K +NI ++ + G V + D GL+ R GT
Sbjct: 167 EIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGT 223
Query: 189 PEFMAPEVYEEE---YNELVDIYSFGMCILEMVT----FDYPYSECTHPAQIYKKVISGK 241
E+MAP++ +++ VD +S G+ + E++T F E A+I ++++ +
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF-TVDGEKNSQAEISRRILKSE 282
Query: 242 K--PEALFKVEDPEVRQFIEKCL 262
P+ + + I++ L
Sbjct: 283 PPYPQEM----SALAKDLIQRLL 301
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 2e-17
Identities = 52/212 (24%), Positives = 90/212 (42%), Gaps = 27/212 (12%)
Query: 64 EELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI 123
E E ++K L+H +++ Y V + I VTE + G+L + +
Sbjct: 304 MSPEAFLQEAQVMKKLRHEKLVQLYA--VVS-EEPIYIVTEYMSKGSLLDFLKGETGKYL 360
Query: 124 RAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 181
R + QI SG+ Y+ + +HRDL+ NI V N K+ D GLA ++ +
Sbjct: 361 RLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLIEDNE 417
Query: 182 AARCVGTP---EFMAPEVYEE-EYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKK 236
G ++ APE + D++SFG+ + E+ T PY + ++ +
Sbjct: 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQ 476
Query: 237 VISGKK-------PEALFKV------EDPEVR 255
V G + PE+L + ++PE R
Sbjct: 477 VERGYRMPCPPECPESLHDLMCQCWRKEPEER 508
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 56/265 (21%), Positives = 101/265 (38%), Gaps = 40/265 (15%)
Query: 47 IEVAWNQVK-LYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY----TSWVDTANRNINF 101
++VA VK L + + ++E E +K H ++ K S
Sbjct: 52 VKVA---VKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMV 108
Query: 102 VTEMFTSGTLRQYRLKHR------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
+ G L + L R + ++ + + I G+ YL SR+ IHRDL
Sbjct: 109 ILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAAR 166
Query: 156 NIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSF 210
N + + V + D GL+ + R + +A E + + Y D+++F
Sbjct: 167 NCMLAED-MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAF 225
Query: 211 GMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR- 255
G+ + E++T PY+ + A+IY +I G + E ++ + DP+ R
Sbjct: 226 GVTMWEIMTRGQTPYAGIEN-AEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRP 284
Query: 256 --QFIEKCLATVSSRLSARELLTDP 278
+ L + LS DP
Sbjct: 285 SFTCLRMELENILGHLSVLSTSQDP 309
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-17
Identities = 52/212 (24%), Positives = 90/212 (42%), Gaps = 27/212 (12%)
Query: 64 EELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI 123
E E ++K L+H +++ Y V + I VTE + G+L + +
Sbjct: 221 MSPEAFLQEAQVMKKLRHEKLVQLYA--VVSEEP-IYIVTEYMSKGSLLDFLKGETGKYL 277
Query: 124 RAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 181
R + QI SG+ Y+ + +HRDL+ NI V N K+ D GLA ++ +
Sbjct: 278 RLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLIEDNE 334
Query: 182 AARCVGTP---EFMAPEVYEE-EYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKK 236
G ++ APE + D++SFG+ + E+ T PY + ++ +
Sbjct: 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQ 393
Query: 237 VISGKK-------PEALFKV------EDPEVR 255
V G + PE+L + ++PE R
Sbjct: 394 VERGYRMPCPPECPESLHDLMCQCWRKEPEER 425
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 47/214 (21%), Positives = 82/214 (38%), Gaps = 43/214 (20%)
Query: 39 RAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98
A+D+ VA K+ + + +R+ EI +L LK I++ Y + +
Sbjct: 44 LAYDKNTEKNVAIK--KVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD--LIIPDDL 99
Query: 99 INF-----VTE-MFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL 152
+ F V E + L++ + +K +L G ++H +IHRDL
Sbjct: 100 LKFDELYIVLEIADSD--LKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDL 155
Query: 153 KCDNIFVNGNQGEVKIGDLGLA--------------AILRKSHAARCVGTPEFM------ 192
K N +N + VK+ D GLA + + +
Sbjct: 156 KPANCLLNQD-CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVT 214
Query: 193 ----APEV--YEEEYNELVDIYSFGMCIL-EMVT 219
APE+ +E Y + +DI+S G CI E++
Sbjct: 215 RWYRAPELILLQENYTKSIDIWSTG-CIFAELLN 247
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 58 DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK 117
+ + + +E+ E +L+ +H + S+ T +R + FV E G L + +
Sbjct: 184 EVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-QTHDR-LCFVMEYANGGELFFHLSR 241
Query: 118 HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--A 175
R + + + +I+S L YLHS V++RDLK +N+ ++ G +KI D GL
Sbjct: 242 ERVFSEDRARFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLDK-DGHIKITDFGLCKEG 299
Query: 176 ILRKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 234
I + GTPE++APEV E+ Y VD + G+ + EM+ P+ H +++
Sbjct: 300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLF 358
Query: 235 KKVISGKK--PEALFKVEDPEVRQFIEKCL 262
+ ++ + P L PE + + L
Sbjct: 359 ELILMEEIRFPRTL----GPEAKSLLSGLL 384
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 6e-17
Identities = 48/213 (22%), Positives = 94/213 (44%), Gaps = 26/213 (12%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-R 120
S E+ E ++ H +I+K V T N + + E+ T G LR + +
Sbjct: 56 SDSVREKFLQEALTMRQFDHPHIVKLIG--VITENP-VWIIMELCTLGELRSFLQVRKYS 112
Query: 121 VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180
+++ ++ + Q+ + L YL S+ +HRD+ N+ V + VK+GD GL+ + S
Sbjct: 113 LDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV-SSNDCVKLGDFGLSRYMEDS 169
Query: 181 HAARCVGT--P-EFMAPEVYEE-EYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYK 235
+ P ++MAPE + D++ FG+C+ E++ P+ + +
Sbjct: 170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIG 228
Query: 236 KVISGKK-------PEALFKV------EDPEVR 255
++ +G++ P L+ + DP R
Sbjct: 229 RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRR 261
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 6e-17
Identities = 39/136 (28%), Positives = 67/136 (49%), Gaps = 13/136 (9%)
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTP 189
++ L +LHS +I+RDLK +NI ++ +G +K+ D GL+ +I + A GT
Sbjct: 134 ELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 190 EFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEAL 246
E+MAPEV + + D +SFG+ + EM+T P+ + ++ K P+ L
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-KETMTMILKAKLGMPQFL 249
Query: 247 FKVEDPEVRQFIEKCL 262
PE + +
Sbjct: 250 ----SPEAQSLLRMLF 261
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 6e-17
Identities = 54/276 (19%), Positives = 106/276 (38%), Gaps = 48/276 (17%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-R 120
+ ++ E ++ H NI++ V T ++ + VTE +G+L + KH +
Sbjct: 86 TEKQRRDFLGEASIMGQFDHPNIIRLEG--VVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 143
Query: 121 VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRK 179
+ + R I SG+ YL +HRDL NI +N N K+ D GL +
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSN-LVCKVSDFGLGRVLEDD 200
Query: 180 SHAARCVGTPEF----MAPEVYEE-EYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQI 233
AA + +PE ++ D++S+G+ + E++++ + PY E ++ +
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDV 259
Query: 234 YKKVISGKK-------PEALFKV--------------------------EDPEVRQFIEK 260
K V G + P AL+++ +P + I
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITS 319
Query: 261 CLATVSSRLSARELLTDPFLQ-IDDYDSDLRMIQYQ 295
A S+ L + + + D+ + + +
Sbjct: 320 AAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCK 355
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 48/216 (22%), Positives = 86/216 (39%), Gaps = 29/216 (13%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV 121
+ + E ++ H NI++ V T R VTE +G+L + L+
Sbjct: 90 TERQRRDFLSEASIMGQFDHPNIIRLEG--VVTRGRLAMIVTEYMENGSLDTF-LRTHDG 146
Query: 122 NIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILR 178
++ R + +G+ YL +HRDL N+ V+ N K+ D GL+ +
Sbjct: 147 QFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSN-LVCKVSDFGLSRVLED 203
Query: 179 KSHAARCVGTPEF----MAPEV-YEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQ 232
AA + APE ++ D++SFG+ + E++ + + PY T+
Sbjct: 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-RD 262
Query: 233 IYKKVISGKK-------PEALFKV------EDPEVR 255
+ V G + P AL ++ +D R
Sbjct: 263 VISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQR 298
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 7e-17
Identities = 51/235 (21%), Positives = 98/235 (41%), Gaps = 39/235 (16%)
Query: 43 EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR-NINF 101
+Y G +VA VK +++ + E ++ L+H N+++ V + +
Sbjct: 41 DYRGNKVA---VKC---IKNDATAQAFLAEASVMTQLRHSNLVQLLG--VIVEEKGGLYI 92
Query: 102 VTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 159
VTE G+L Y R + + + + YL + +HRDL N+ V
Sbjct: 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLV 150
Query: 160 NGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPEV-YEEEYNELVDIYSFGMCI 214
+ + K+ D GL +++ + + G + APE E++++ D++SFG+ +
Sbjct: 151 SED-NVAKVSDFGLT---KEASSTQDTG--KLPVKWTAPEALREKKFSTKSDVWSFGILL 204
Query: 215 LEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 255
E+ +F PY + +V G K P A+++V D +R
Sbjct: 205 WEIYSFGRVPYPRIPL-KDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMR 258
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 39/137 (28%), Positives = 68/137 (49%), Gaps = 15/137 (10%)
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRKSHAAR--CVGT 188
+I S L YLHS + +++RDLK +NI ++ +QG + + D GL + + C GT
Sbjct: 147 EIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNSTTSTFC-GT 202
Query: 189 PEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEA 245
PE++APEV ++ Y+ VD + G + EM+ P+ A++Y +++
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-AEMYDNILNKPLQLKPN 261
Query: 246 LFKVEDPEVRQFIEKCL 262
+ R +E L
Sbjct: 262 I----TNSARHLLEGLL 274
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 1e-16
Identities = 48/220 (21%), Positives = 81/220 (36%), Gaps = 48/220 (21%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
A+D+ E VA K+ + + +R+ EI +L L H +++K +
Sbjct: 70 CEAYDKLEKRVVAIK--KILRVFEDLIDCKRILREIAILNRLNHDHVVKVLD--IVIPKD 125
Query: 98 NINF-----VTE-MFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 151
F V E + ++ + +K +L G+ Y+HS ++HRD
Sbjct: 126 VEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRD 181
Query: 152 LKCDNIFVNGNQGEVKIGDLGLA-------------------AILRKSHAARCVGTPEFM 192
LK N VN + VK+ D GLA + +
Sbjct: 182 LKPANCLVNQD-CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQL 240
Query: 193 ----------APEV--YEEEYNELVDIYSFGMCIL-EMVT 219
APE+ +E Y E +D++S G CI E++
Sbjct: 241 TGHVVTRWYRAPELILLQENYTEAIDVWSIG-CIFAELLN 279
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 1e-16
Identities = 45/217 (20%), Positives = 85/217 (39%), Gaps = 36/217 (16%)
Query: 58 DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RL 116
F+ E ++K L H +I+K + + E++ G L Y
Sbjct: 59 KFMS----------EAVIMKNLDHPHIVKLIG--IIEEEP-TWIIMELYPYGELGHYLER 105
Query: 117 KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176
+ + + + QI + YL S + +HRD+ NI V + VK+GD GL+
Sbjct: 106 NKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILV-ASPECVKLGDFGLSRY 162
Query: 177 LRKSHAARCVGT--P-EFMAPEVYE-EEYNELVDIYSFGMCILEMVTF-DYPYSECTHPA 231
+ + T P ++M+PE + D++ F +C+ E+++F P+ +
Sbjct: 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-K 221
Query: 232 QIYKKVISGKK-------PEALFKV------EDPEVR 255
+ + G + P L+ + DP R
Sbjct: 222 DVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDR 258
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 43/136 (31%), Positives = 68/136 (50%), Gaps = 13/136 (9%)
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTP 189
+I L +LH + +I+RDLK +NI +N +QG VK+ D GL +I + GT
Sbjct: 129 EISMALGHLHQKG--IIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTI 185
Query: 190 EFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEAL 246
E+MAPE+ +N VD +S G + +M+T P++ + K++ K P L
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-KKTIDKILKCKLNLPPYL 244
Query: 247 FKVEDPEVRQFIEKCL 262
E R ++K L
Sbjct: 245 ----TQEARDLLKKLL 256
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 44/218 (20%), Positives = 84/218 (38%), Gaps = 31/218 (14%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF-VTEMFTSGTLRQYRLKHRR 120
E+ + E ++K H N++ + + V G LR + +++
Sbjct: 66 DIGEVSQFLTEGIIMKDFSHPNVLSLLG--ICLRSEGSPLVVLPYMKHGDLRNF-IRNET 122
Query: 121 VNIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178
N + Q+ G+ YL S+ +HRDL N ++ VK+ D GLA +
Sbjct: 123 HNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEK-FTVKVADFGLARDMY 179
Query: 179 KSHAARCVGTPEF------MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHP 230
MA E + +++ D++SFG+ + E++T PY +
Sbjct: 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-T 238
Query: 231 AQIYKKVISGKK-------PEALFKV------EDPEVR 255
I ++ G++ P+ L++V E+R
Sbjct: 239 FDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMR 276
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 44/218 (20%), Positives = 86/218 (39%), Gaps = 31/218 (14%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF-VTEMFTSGTLRQYRLKHRR 120
+++E E L++ L H N++ + + + G L Q+ ++ +
Sbjct: 62 EMQQVEAFLREGLLMRGLNHPNVLALIG--IMLPPEGLPHVLLPYMCHGDLLQF-IRSPQ 118
Query: 121 VNIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178
N + Q+ G+ YL + +HRDL N ++ + VK+ D GLA +
Sbjct: 119 RNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDES-FTVKVADFGLARDIL 175
Query: 179 KSH--AARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHP 230
+ + A E + + D++SFG+ + E++T PY P
Sbjct: 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-P 234
Query: 231 AQIYKKVISGKK-------PEALFKV------EDPEVR 255
+ + G++ P++L++V DP VR
Sbjct: 235 FDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVR 272
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 29/212 (13%)
Query: 65 ELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIR 124
+ E +L+K L+H+ +++ Y V T I +TE +G+L + + +
Sbjct: 51 SPDAFLAEANLMKQLQHQRLVRLYA--VVT-QEPIYIITEYMENGSLVDFLKTPSGIKLT 107
Query: 125 AVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 182
K QI G+ ++ R+ IHRDL+ NI V+ KI D GLA ++ +
Sbjct: 108 INKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEY 164
Query: 183 ARCVGTPEF----MAPEVYEE-EYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKK 236
G +F APE + D++SFG+ + E+VT PY T+P ++ +
Sbjct: 165 TAREGA-KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQN 222
Query: 237 VISGKK-------PEALFKV------EDPEVR 255
+ G + PE L+++ E PE R
Sbjct: 223 LERGYRMVRPDNCPEELYQLMRLCWKERPEDR 254
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 29/212 (13%)
Query: 65 ELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIR 124
+E E +++KTL+H ++K + V T I +TE G+L +
Sbjct: 226 SVEAFLAEANVMKTLQHDKLVKLHA--VVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQP 282
Query: 125 AVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 182
K + QI G+ ++ R+ IHRDL+ NI V+ + KI D GLA ++ +
Sbjct: 283 LPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSAS-LVCKIADFGLARVIEDNEY 339
Query: 183 ARCVGTPEF----MAPEVYEE-EYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKK 236
G +F APE + D++SFG+ ++E+VT+ PY ++P ++ +
Sbjct: 340 TAREGA-KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRA 397
Query: 237 VISGKK-------PEALFKV------EDPEVR 255
+ G + PE L+ + PE R
Sbjct: 398 LERGYRMPRPENCPEELYNIMMRCWKNRPEER 429
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 15/155 (9%)
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTP 189
+I+ GL +LHS+ +++RDLK DNI ++ G +KI D G+ +L + GTP
Sbjct: 126 EIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTP 182
Query: 190 EFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEAL 246
+++APE+ + YN VD +SFG+ + EM+ P+ +++ + P L
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-EELFHSIRMDNPFYPRWL 241
Query: 247 FKVEDPEVRQFIEKCLA-TVSSRL-SARELLTDPF 279
+ E + + K RL ++ P
Sbjct: 242 ----EKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 272
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 48/223 (21%), Positives = 84/223 (37%), Gaps = 35/223 (15%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV 121
S ++ E ++ H+NI++ V + + E+ G L+ + + R
Sbjct: 73 SEQDELDFLMEALIISKFNHQNIVRCIG--VSLQSLPRFILMELMAGGDLKSFLRETRPR 130
Query: 122 NIRAVK-------HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE---VKIGDL 171
+ H R I G YL IHRD+ N + G KIGD
Sbjct: 131 PSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLT-CPGPGRVAKIGDF 187
Query: 172 GLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYS 225
G+A + ++ R G M PE E + D +SFG+ + E+ + PY
Sbjct: 188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 247
Query: 226 ECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 255
++ ++ + V SG + P ++++ PE R
Sbjct: 248 SKSN-QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 289
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 53/230 (23%), Positives = 95/230 (41%), Gaps = 43/230 (18%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV 121
+ + E LL L+H +I+KFY V + V E G L ++ L+
Sbjct: 57 TLAARKDFQREAELLTNLQHEHIVKFYG--VCGDGDPLIMVFEYMKHGDLNKF-LRAHGP 113
Query: 122 NIRAVK-----------------HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 164
+ + H QI SG++YL S+ +HRDL N V N
Sbjct: 114 DAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANL- 170
Query: 165 EVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVT 219
VKIGD G++ + + R G M PE + ++ D++SFG+ + E+ T
Sbjct: 171 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
Query: 220 FDY-PYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 255
+ P+ + ++ ++ + + G+ P+ ++ V +P+ R
Sbjct: 231 YGKQPWFQLSN-TEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQR 279
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 34/136 (25%), Positives = 69/136 (50%), Gaps = 13/136 (9%)
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTP 189
+I+S L++LH + +I+RDLK DN+ ++ +G K+ D G+ I A GTP
Sbjct: 132 EIISALMFLHDKG--IIYRDLKLDNVLLDH-EGHCKLADFGMCKEGICNGVTTATFCGTP 188
Query: 190 EFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEAL 246
+++APE+ +E Y VD ++ G+ + EM+ P+ +++ +++ + P L
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAILNDEVVYPTWL 247
Query: 247 FKVEDPEVRQFIEKCL 262
+ ++ +
Sbjct: 248 ----HEDATGILKSFM 259
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 5e-16
Identities = 47/277 (16%), Positives = 87/277 (31%), Gaps = 60/277 (21%)
Query: 52 NQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN-----INFVTE-M 105
N +KL D+ + + E + +N + E +
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 106 FT--SGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 163
L+ + R + + + + Q+ + ++HS + HRD+K N+ VN
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKD 178
Query: 164 GEVKIGDLGLAAILRKSHAARCVGTPEFM----------APEVY--EEEYNELVDIYSFG 211
+K+ D G A L S E APE+ EY +D++S G
Sbjct: 179 NTLKLCDFGSAKKLIPS---------EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229
Query: 212 MCIL-EMVT----F---DY-------------PYSE-----CTHPAQIYKKVISGKKPEA 245
C+ E++ F P E H ++ + K
Sbjct: 230 -CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRK 288
Query: 246 LF-KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280
+ + +E+ L R++ E + PF
Sbjct: 289 ILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 48/228 (21%), Positives = 89/228 (39%), Gaps = 40/228 (17%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV 121
S + E LL L+H++I++F+ V T R + V E G L ++ H
Sbjct: 83 SESARQDFQREAELLTMLQHQHIVRFFG--VCTEGRPLLMVFEYMRHGDLNRFLRSHGPD 140
Query: 122 NIRAVK---------------HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV 166
Q+ +G++YL +HRDL N V V
Sbjct: 141 AKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGL-VV 197
Query: 167 KIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF- 220
KIGD G++ + + R G M PE + ++ D++SFG+ + E+ T+
Sbjct: 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYG 257
Query: 221 DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 255
P+ + ++ + + G++ P ++ + +P+ R
Sbjct: 258 KQPWYQLSN-TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQR 304
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 6e-16
Identities = 50/255 (19%), Positives = 83/255 (32%), Gaps = 30/255 (11%)
Query: 38 YRAFDEYEGIEVAWNQVKL--YDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95
Y A D VA +KL P R+ E L+ +++ +
Sbjct: 51 YEAEDTVRERIVA---LKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107
Query: 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
+ + L + + RQI S L H+ HRD+K +
Sbjct: 108 QLYV--DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPE 163
Query: 156 NIFVNGNQGEVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYE-EEYNELVDIYSFG 211
NI V+ + + D G+A+ VGT +MAPE + DIY+
Sbjct: 164 NILVSAD-DFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALT 222
Query: 212 MCIL-EMVTFDYPYSECTHPAQIYKKV------ISGKKPEALFKVEDPEVRQFIEKCLA- 263
C+L E +T PY + + + S +P I + +A
Sbjct: 223 -CVLYECLTGSPPYQGDQ-LSVMGAHINQAIPRPSTVRPGI-----PVAFDAVIARGMAK 275
Query: 264 TVSSR-LSARELLTD 277
R ++ +L
Sbjct: 276 NPEDRYVTCGDLSAA 290
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 56/260 (21%), Positives = 111/260 (42%), Gaps = 51/260 (19%)
Query: 58 DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK 117
DFL E ++ H NI++ V + + + +TE +G L ++ L+
Sbjct: 92 DFLG----------EAGIMGQFSHHNIIRLEG--VISKYKPMMIITEYMENGALDKF-LR 138
Query: 118 HRRVNIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175
+ ++ R I +G+ YL + + +HRDL NI VN N K+ D GL+
Sbjct: 139 EKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSN-LVCKVSDFGLSR 195
Query: 176 IL-------RKSHAARCVGTP-EFMAPEVYEE-EYNELVDIYSFGMCILEMVTF-DYPYS 225
+L + + P + APE ++ D++SFG+ + E++T+ + PY
Sbjct: 196 VLEDDPEATYTTSGGKI---PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 252
Query: 226 ECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR-QFIEKCLATVSSRLSA 271
E ++ ++ K + G + P A++++ ++ R +F + + S L
Sbjct: 253 ELSN-HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFAD-----IVSILDK 306
Query: 272 RELLTDPFLQIDDYDSDLRM 291
D + D+D + +
Sbjct: 307 LIRAPDSLKTLADFDPRVSI 326
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 6e-16
Identities = 48/213 (22%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-R 120
S E+ E ++ H +I+K V T N + + E+ T G LR + +
Sbjct: 431 SDSVREKFLQEALTMRQFDHPHIVKLIG--VITEN-PVWIIMELCTLGELRSFLQVRKFS 487
Query: 121 VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180
+++ ++ + Q+ + L YL S+ +HRD+ N+ V + VK+GD GL+ + S
Sbjct: 488 LDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV-SSNDCVKLGDFGLSRYMEDS 544
Query: 181 HAARCVGT--P-EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYK 235
+ P ++MAPE + + D++ FG+C+ E++ P+ + +
Sbjct: 545 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIG 603
Query: 236 KVISGKK-------PEALFKV------EDPEVR 255
++ +G++ P L+ + DP R
Sbjct: 604 RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRR 636
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 8e-16
Identities = 31/108 (28%), Positives = 53/108 (49%), Gaps = 6/108 (5%)
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTP 189
+I L YLH R +I+RDLK DN+ ++ +G +K+ D G+ + + GTP
Sbjct: 118 EISLALNYLHERG--IIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRPGDTTSTFCGTP 174
Query: 190 EFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 236
++APE+ E Y VD ++ G+ + EM+ P+ +
Sbjct: 175 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 9e-16
Identities = 38/159 (23%), Positives = 75/159 (47%), Gaps = 19/159 (11%)
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTP 189
+I GL +L S+ +I+RDLK DN+ ++ ++G +KI D G+ I GTP
Sbjct: 129 EIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKTFCGTP 185
Query: 190 EFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEAL 246
+++APE+ + Y + VD ++FG+ + EM+ P+ ++++ ++ P+++
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSIMEHNVAYPKSM 244
Query: 247 FKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPF 279
E + + RL R++ F
Sbjct: 245 ----SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 279
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 9e-16
Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 20/203 (9%)
Query: 45 EGIEVAWNQVKLY--DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 102
+ + VA VK D L PE ++ E++ + +L HRN+++ Y V + V
Sbjct: 45 KTVSVA---VKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG--VVLTPP-MKMV 98
Query: 103 TEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 161
TE+ G+L KH+ + + + Q+ G+ YL S+ IHRDL N+ +
Sbjct: 99 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLAT 156
Query: 162 NQGEVKIGDLGLA-AILRKSHAARCVGTPEF----MAPEV-YEEEYNELVDIYSFGMCIL 215
VKIGD GL A+ + + APE ++ D + FG+ +
Sbjct: 157 RD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLW 215
Query: 216 EMVTF-DYPYSECTHPAQIYKKV 237
EM T+ P+ +QI K+
Sbjct: 216 EMFTYGQEPWIGLN-GSQILHKI 237
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 80.0 bits (197), Expect = 9e-16
Identities = 55/249 (22%), Positives = 107/249 (42%), Gaps = 38/249 (15%)
Query: 47 IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMF 106
I+VA +K+ + E + E ++ L + I++ V A + V EM
Sbjct: 364 IDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG--VCQAEA-LMLVMEMA 417
Query: 107 TSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 165
G L ++ + R + + V Q+ G+ YL ++ +HR+L N+ + N+
Sbjct: 418 GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLL-VNRHY 474
Query: 166 VKIGDLGLAAILRKSHA---ARCVGT-P-EFMAPE-VYEEEYNELVDIYSFGMCILEMVT 219
KI D GL+ L + AR G P ++ APE + +++ D++S+G+ + E ++
Sbjct: 475 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
Query: 220 F-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR-------QFI 258
+ PY + P ++ + GK+ P L+ + E R Q +
Sbjct: 535 YGQKPYKKMKGP-EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 593
Query: 259 EKCLATVSS 267
C +++S
Sbjct: 594 RACYYSLAS 602
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 46/221 (20%), Positives = 79/221 (35%), Gaps = 45/221 (20%)
Query: 58 DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR-NINFVTEMFTSGTLRQYRL 116
FL E ++ L+H N+++ V + + VTE G+L Y
Sbjct: 232 AFLA----------EASVMTQLRHSNLVQLLG--VIVEEKGGLYIVTEYMAKGSLVDYLR 279
Query: 117 KHRRVNIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174
R + + + + YL + +HRDL N+ V+ + K+ D GL
Sbjct: 280 SRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLT 336
Query: 175 -AILRKSHAARCVGTPEF----MAPEVYEE-EYNELVDIYSFGMCILEMVTF-DYPYSEC 227
+ APE E +++ D++SFG+ + E+ +F PY
Sbjct: 337 KEASSTQDTGK------LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 390
Query: 228 THPAQIYKKVISGKK-------PEALFKV------EDPEVR 255
+ +V G K P A++ V D R
Sbjct: 391 PL-KDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATR 430
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 48/223 (21%), Positives = 84/223 (37%), Gaps = 35/223 (15%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV 121
S ++ E ++ H+NI++ V + + E+ G L+ + + R
Sbjct: 114 SEQDELDFLMEALIISKFNHQNIVRCIG--VSLQSLPRFILLELMAGGDLKSFLRETRPR 171
Query: 122 NIRAVK-------HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE---VKIGDL 171
+ H R I G YL IHRD+ N + G KIGD
Sbjct: 172 PSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLT-CPGPGRVAKIGDF 228
Query: 172 GLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYS 225
G+A + ++ R G M PE E + D +SFG+ + E+ + PY
Sbjct: 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 288
Query: 226 ECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 255
++ ++ + V SG + P ++++ PE R
Sbjct: 289 SKSN-QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 330
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 43/223 (19%), Positives = 80/223 (35%), Gaps = 34/223 (15%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFY---TSWVDTANRNINFVTEMFTSGTLRQYRLKH 118
S E+E E +K H N+++ + G L Y L +
Sbjct: 76 SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTY-LLY 134
Query: 119 RRVNIRAVK-------HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 171
R+ + I G+ YL +R+ +HRDL N + + V + D
Sbjct: 135 SRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDD-MTVCVADF 191
Query: 172 GLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYS 225
GL+ + R + +A E + + Y D+++FG+ + E+ T PY
Sbjct: 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYP 251
Query: 226 ECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 255
++Y ++ G + + L+++ DP R
Sbjct: 252 GVQ-NHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDR 293
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 44/225 (19%), Positives = 86/225 (38%), Gaps = 50/225 (22%)
Query: 58 DFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQY-RL 116
+ ++ E ++ L + I++ V A + V EM G L ++
Sbjct: 56 EMMR----------EAQIMHQLDNPYIVRLIG--VCQAEA-LMLVMEMAGGGPLHKFLVG 102
Query: 117 KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176
K + + V Q+ G+ YL ++ +HRDL N+ + N+ KI D GL+
Sbjct: 103 KREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLL-VNRHYAKISDFGLSKA 159
Query: 177 L-------RKSHAARCVGTPEF----MAPEVYE-EEYNELVDIYSFGMCILEMVTF-DYP 223
L A + + APE +++ D++S+G+ + E +++ P
Sbjct: 160 LGADDSYYTARSAGK------WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
Query: 224 YSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 255
Y + ++ + GK+ P L+ + E R
Sbjct: 214 YKKMKG-PEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDR 257
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 51/212 (24%), Positives = 81/212 (38%), Gaps = 35/212 (16%)
Query: 62 SPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR 120
E E L E+ +L L H NI+ T +TE G L + L+ +R
Sbjct: 66 HLTEREALMSELKVLSYLGNHMNIVNLLG--ACTIGGPTLVITEYCCYGDLLNF-LRRKR 122
Query: 121 VNIRAVK-------------------HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 161
+ K + Q+ G+ +L S++ IHRDL NI +
Sbjct: 123 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILL-T 179
Query: 162 NQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILE 216
+ KI D GLA ++ G MAPE ++ Y D++S+G+ + E
Sbjct: 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE 239
Query: 217 MVTF-DYPYSECTHPAQIYKKVISGK---KPE 244
+ + PY ++ YK + G PE
Sbjct: 240 LFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPE 271
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 2e-15
Identities = 38/144 (26%), Positives = 70/144 (48%), Gaps = 7/144 (4%)
Query: 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 160
FV E G L + + R + +I GL +L S+ +I+RDLK DN+ ++
Sbjct: 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD 476
Query: 161 GNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEM 217
+G +KI D G+ I GTP+++APE+ + Y + VD ++FG+ + EM
Sbjct: 477 S-EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 535
Query: 218 VTFDYPYSECTHPAQIYKKVISGK 241
+ P+ ++++ ++
Sbjct: 536 LAGQAPFEGEDED-ELFQSIMEHN 558
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 44/202 (21%), Positives = 82/202 (40%), Gaps = 30/202 (14%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV 121
E E L L+H N++ V T ++ ++ + + G L ++ L R
Sbjct: 52 EGPLREEFRHEAMLRARLQHPNVVCLLG--VVTKDQPLSMIFSYCSHGDLHEF-LVMRSP 108
Query: 122 NIRAVK-----------------HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 164
+ H QI +G+ YL S V+H+DL N+ V
Sbjct: 109 HSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDK-L 165
Query: 165 EVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVT 219
VKI DLGL + + + +G MAPE + +++ DI+S+G+ + E+ +
Sbjct: 166 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
Query: 220 FDY-PYSECTHPAQIYKKVISG 240
+ PY ++ + + + +
Sbjct: 226 YGLQPYCGYSN-QDVVEMIRNR 246
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 31/108 (28%), Positives = 53/108 (49%), Gaps = 6/108 (5%)
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTP 189
+I L YLH R +I+RDLK DN+ ++ +G +K+ D G+ + + GTP
Sbjct: 161 EISLALNYLHERG--IIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRPGDTTSTFCGTP 217
Query: 190 EFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 236
++APE+ E Y VD ++ G+ + EM+ P+ +
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 265
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 48/210 (22%), Positives = 81/210 (38%), Gaps = 32/210 (15%)
Query: 62 SPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR 120
+ E L E+ +L + H N++ + + + E G L Y L+ +R
Sbjct: 70 THSEHRALMSELKILIHIGHHLNVVNLLGA-CTKPGGPLMVIVEFCKFGNLSTY-LRSKR 127
Query: 121 VNIRAVK-----------------HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 163
K + Q+ G+ +L SR IHRDL NI ++
Sbjct: 128 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK- 184
Query: 164 GEVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMV 218
VKI D GLA + K G MAPE +++ Y D++SFG+ + E+
Sbjct: 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244
Query: 219 TF-DYPYSECTHPAQIYKKVISG---KKPE 244
+ PY + +++ G + P+
Sbjct: 245 SLGASPYPGVKIDEEFCRRLKEGTRMRAPD 274
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} Length = 98 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 6e-15
Identities = 23/98 (23%), Positives = 42/98 (42%), Gaps = 14/98 (14%)
Query: 349 LFTCQEDEHLTNFDISIKGKRRED---DGIFLRLRIAD---KEGRIRN---IYFPFDIQT 399
QE+ + ++ +D I L LRI D +G+ ++ I F FD++
Sbjct: 2 AMDPQEE-----TGVRVELAEEDDGEKIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLER 56
Query: 400 DTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPE 437
D VA EMV + + D +A+ I ++ + +
Sbjct: 57 DVPEDVAQEMVESGYVCEGDHKTMAKAIKDRVSLIKRK 94
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 43/218 (19%), Positives = 85/218 (38%), Gaps = 31/218 (14%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF-VTEMFTSGTLRQYRLKHRR 120
E+ + E ++K H N++ + + V G LR + +++
Sbjct: 130 DIGEVSQFLTEGIIMKDFSHPNVLSLLG--ICLRSEGSPLVVLPYMKHGDLRNF-IRNET 186
Query: 121 VNIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178
N + Q+ G+ +L S+ +HRDL N ++ VK+ D GLA +
Sbjct: 187 HNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEK-FTVKVADFGLARDMY 243
Query: 179 KSHAARCVGTPE------FMAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHP 230
+MA E + +++ D++SFG+ + E++T PY +
Sbjct: 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-T 302
Query: 231 AQIYKKVISGKK-------PEALFKV------EDPEVR 255
I ++ G++ P+ L++V E+R
Sbjct: 303 FDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMR 340
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 50/209 (23%), Positives = 84/209 (40%), Gaps = 32/209 (15%)
Query: 62 SPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR 120
+ ++L L E+ ++K + KH+NI+ T + + + E + G LR+Y R
Sbjct: 80 TEKDLSDLVSEMEMMKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRP 137
Query: 121 VNIRAVK----------------HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 164
+ Q+ G+ YL S+ IHRDL N+ V
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLV-TENN 194
Query: 165 EVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVT 219
+KI D GLA + + MAPE +++ Y D++SFG+ + E+ T
Sbjct: 195 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
Query: 220 F-DYPYSECTHPAQIYKKVISGK---KPE 244
PY +++K + G KP
Sbjct: 255 LGGSPYPGIPV-EELFKLLKEGHRMDKPA 282
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 49/216 (22%), Positives = 90/216 (41%), Gaps = 39/216 (18%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV 121
SP EL L E ++LK + H +++K Y + + + + E G+LR + + R+V
Sbjct: 66 SPSELRDLLSEFNVLKQVNHPHVIKLYG--ACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
Query: 122 NIRAVK------------------------HWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
+ + QI G+ YL ++HRDL NI
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNI 181
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGM 212
V ++KI D GL+ + + + MA E +++ Y D++SFG+
Sbjct: 182 LVAEG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240
Query: 213 CILEMVTF-DYPYSECTHPAQIYKKVISG---KKPE 244
+ E+VT PY +++ + +G ++P+
Sbjct: 241 LLWEIVTLGGNPYPGIPP-ERLFNLLKTGHRMERPD 275
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 62/278 (22%), Positives = 100/278 (35%), Gaps = 72/278 (25%)
Query: 72 EIHLLKTLK-----------HRNIMKFYTSWVDTANRNIN---FVTEMFTSGTLRQY--R 115
EI LL+ + +I+K + N V E+ L +
Sbjct: 65 EIKLLQRVNDADNTKEDSMGANHILKLL-DHFNHKGPNGVHVVMVFEV-LGENLLALIKK 122
Query: 116 LKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV-----NGNQGEVKIGD 170
+HR + + VK +Q+L GL Y+H R +IH D+K +N+ + N ++KI D
Sbjct: 123 YEHRGIPLIYVKQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIAD 181
Query: 171 LGLAAILRKSHAARCVGTPEFMAPEV-YEEEYNELVDIYSFGMCILEMVT----FD---- 221
LG A + H + T E+ +PEV + DI+S I E++T F+
Sbjct: 182 LGNACWYDE-HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 240
Query: 222 -YPYSECTHPAQI--------------------------YKKVISGKKPEAL-------F 247
+ H AQI + IS K L +
Sbjct: 241 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKY 300
Query: 248 KVEDPEVRQF---IEKCLA-TVSSRLSARELLTDPFLQ 281
K E ++ + L R A L+ P+L+
Sbjct: 301 KFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 338
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 49/209 (23%), Positives = 75/209 (35%), Gaps = 35/209 (16%)
Query: 62 SPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR 120
S ++ E+ +L L H NI+ + E G L + K R
Sbjct: 65 SKDDHRDFAGELEVLCKLGHHPNIINLLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRV 122
Query: 121 VNIRAVK----------------HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 164
+ H+ + G+ YL + IHRDL NI V N
Sbjct: 123 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY- 179
Query: 165 EVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVT 219
KI D GL+ R MA E + Y D++S+G+ + E+V+
Sbjct: 180 VAKIADFGLS---RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
Query: 220 F-DYPYSECTHPAQIYKKVISG---KKPE 244
PY T A++Y+K+ G +KP
Sbjct: 237 LGGTPYCGMTC-AELYEKLPQGYRLEKPL 264
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 4e-14
Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 16/94 (17%)
Query: 136 GLLYLHSR-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSHAA-RCVGTPEF 191
GL YLH DP +IHRD+K NI ++ E +GD GLA ++ + +H GT
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 201
Query: 192 MAPEVYEEEY------NELVDIYSFGMCILEMVT 219
+AP EY +E D++ +G+ +LE++T
Sbjct: 202 IAP-----EYLSTGKSSEKTDVFGYGVMLLELIT 230
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 5e-14
Identities = 34/88 (38%), Positives = 48/88 (54%), Gaps = 7/88 (7%)
Query: 136 GLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL---RKSH-AARCVGTPEF 191
G+ +LH + IHRD+K NI ++ KI D GLA ++ +R VGT +
Sbjct: 145 GINFLH--ENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTAY 201
Query: 192 MAPEVYEEEYNELVDIYSFGMCILEMVT 219
MAPE E DIYSFG+ +LE++T
Sbjct: 202 MAPEALRGEITPKSDIYSFGVVLLEIIT 229
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 8e-14
Identities = 44/216 (20%), Positives = 77/216 (35%), Gaps = 39/216 (18%)
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV 121
S + E L+ + NI+K V + + + E G L ++
Sbjct: 90 SADMQADFQREAALMAEFDNPNIVKLLG--VCAVGKPMCLLFEYMAYGDLNEFLRSMSPH 147
Query: 122 NIRAVK------------------------HWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
+ ++ RQ+ +G+ YL R +HRDL N
Sbjct: 148 TVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNC 205
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGM 212
V N VKI D GL+ + + + G M PE ++ Y D++++G+
Sbjct: 206 LVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 264
Query: 213 CILEMVTF-DYPYSECTHPAQIYKKVISG---KKPE 244
+ E+ ++ PY H ++ V G PE
Sbjct: 265 VLWEIFSYGLQPYYGMAH-EEVIYYVRDGNILACPE 299
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 8e-14
Identities = 50/209 (23%), Positives = 84/209 (40%), Gaps = 32/209 (15%)
Query: 62 SPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR 120
+ ++L L E+ ++K + KH+NI+ T + + + E + G LR+Y R
Sbjct: 126 TEKDLSDLVSEMEMMKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRP 183
Query: 121 VNIRAVK----------------HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 164
+ Q+ G+ YL S+ IHRDL N+ V
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLV-TENN 240
Query: 165 EVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVT 219
+KI D GLA + + MAPE +++ Y D++SFG+ + E+ T
Sbjct: 241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
Query: 220 F-DYPYSECTHPAQIYKKVISGK---KPE 244
PY +++K + G KP
Sbjct: 301 LGGSPYPGIPV-EELFKLLKEGHRMDKPA 328
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 8e-14
Identities = 57/265 (21%), Positives = 102/265 (38%), Gaps = 45/265 (16%)
Query: 62 SPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR 120
+ ++L L E+ ++K + KH+NI+ T + + + E + G LR+Y R
Sbjct: 114 TEKDLSDLISEMEMMKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLQARRP 171
Query: 121 VNIRAVK----------------HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 164
+ Q+ G+ YL S+ IHRDL N+ V +
Sbjct: 172 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN- 228
Query: 165 EVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVT 219
+KI D GLA + + MAPE +++ Y D++SFG+ + E+ T
Sbjct: 229 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
Query: 220 F-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR---QFIEKCL 262
PY +++K + G + L+ + P R + + + L
Sbjct: 289 LGGSPYPGVPV-EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347
Query: 263 ATVSSRLSARELLTDPFLQIDDYDS 287
+ + S +E+ DYD
Sbjct: 348 DRIVALTSNQEMGYYHHHHHHDYDI 372
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 9e-14
Identities = 49/208 (23%), Positives = 84/208 (40%), Gaps = 31/208 (14%)
Query: 62 SPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR 120
+E E L E+ ++ L +H NI+ T + +TE G L + L+ +
Sbjct: 89 HADEKEALMSELKIMSHLGQHENIVNLLG--ACTHGGPVLVITEYCCYGDLLNF-LRRKS 145
Query: 121 VNIRAVK---------------HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 165
+ H+ Q+ G+ +L S++ IHRD+ N+ + N
Sbjct: 146 RVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLL-TNGHV 202
Query: 166 VKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF 220
KIGD GLA + G MAPE +++ Y D++S+G+ + E+ +
Sbjct: 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 262
Query: 221 -DYPYSECTHPAQIYKKVISGK---KPE 244
PY ++ YK V G +P
Sbjct: 263 GLNPYPGILVNSKFYKLVKDGYQMAQPA 290
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 56/259 (21%), Positives = 89/259 (34%), Gaps = 57/259 (22%)
Query: 62 SPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR 120
E E L E+ ++ L H NI+ T + I + E G L Y L+ +R
Sbjct: 88 DSSEREALMSELKMMTQLGSHENIVNLLG--ACTLSGPIYLIFEYCCYGDLLNY-LRSKR 144
Query: 121 VNIRAVK------------------------HWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
+ + Q+ G+ +L + +HRDL N
Sbjct: 145 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARN 202
Query: 157 IFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFG 211
+ V VKI D GLA + G MAPE ++E Y D++S+G
Sbjct: 203 VLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG 261
Query: 212 MCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR-- 255
+ + E+ + PY A YK + +G K E ++ + D R
Sbjct: 262 ILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS 321
Query: 256 -----QFIEKCLATVSSRL 269
F+ LA +
Sbjct: 322 FPNLTSFLGCQLADAEEAM 340
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 71.4 bits (174), Expect = 8e-13
Identities = 86/635 (13%), Positives = 171/635 (26%), Gaps = 170/635 (26%)
Query: 27 MKFLVKELQRHYR------------AFDEYEGIEVAWNQV----KLYDFLQSPEELERLY 70
M F E Q Y+ FD + ++ + ++ + S + +
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFDCKD-VQDMPKSILSKEEIDHIIMSKDAVSGTL 65
Query: 71 CEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMF------TSGTLRQYRLKHRRV--- 121
L + + + KF + N F+ S R Y + R+
Sbjct: 66 RLFWTLLSKQEEMVQKFV---EEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND 122
Query: 122 -------NI-RAVKHWCRQILSGLLYLHSRDPPVIH---------------RDLKCDNIF 158
N+ R + ++ LL L +I K
Sbjct: 123 NQVFAKYNVSRLQPYL--KLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKM 180
Query: 159 VNG----NQGEVKIGDLGLAAILRKSHAARCVGT--PEFMA--PEVYEEEYNELVDI--- 207
N + L + + + T + + EL +
Sbjct: 181 DFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKS 240
Query: 208 --YSFGMCILEMV-------TFDYPYSEC-----THPAQI-------YKKVISGKKPEAL 246
Y + +L V F+ C T Q+ IS
Sbjct: 241 KPYENCLLVLLNVQNAKAWNAFNL---SCKILLTTRFKQVTDFLSAATTTHISLDHHSMT 297
Query: 247 FKVEDPEVRQFIEKCLATVSSRLSARELLTDPFL--QIDDYDSD-LRMIQY--QTDYDEI 301
EV+ + K L L L T+P I + D L + D++
Sbjct: 298 L--TPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKL 355
Query: 302 SPLLRQSLYGIYHSNSSSNNGCGHYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHLTNF 361
+ ++ SL N L+ P E+++ L H+
Sbjct: 356 TTIIESSL-----------------------NVLE--PAEYRKMFDRLSVFPPSAHIPTI 390
Query: 362 DISI---KGKRREDDGI---FLRLRIADKEGRIRNIYFPFDIQTDTALSVATEMVSELDI 415
+S+ + + + + + +K+ + I P I + + + E I
Sbjct: 391 LLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIP-SIYLELKVKLENEYALHRSI 449
Query: 416 TDQDVTKIAEIIDSEIASLVPEWKRG---------MAMEESPHRSSF------------- 453
D I + DS+ L+P + + E P R +
Sbjct: 450 VDHY--NIPKTFDSD--DLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQ 505
Query: 454 --CHNCASNGCLPDYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEITYQV-DGAEQCAPE 510
H+ + IL+ LQ L+ K ++E + + D +
Sbjct: 506 KIRHDS-TAWNASGSILNT------LQQLKFYKPYICDNDPKYERLVNAILDFLPKI--- 555
Query: 511 GADQAASPQSAVVHYADIWAQHEGQVLSSQGSRDI 545
+ S + ++ A E + + + + +
Sbjct: 556 EENLICSKYTDLLRIA---LMAEDEAIFEEAHKQV 587
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.2 bits (150), Expect = 5e-10
Identities = 79/570 (13%), Positives = 151/570 (26%), Gaps = 176/570 (30%)
Query: 192 MAPEVYEEE--YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKV 249
M E E + Y +++ ++ + ++ +C + K ++S ++ + +
Sbjct: 7 MDFETGEHQYQYKDILSVF------EDAFVDNF---DCKDVQDMPKSILSKEEIDHIIMS 57
Query: 250 EDPE-----------------VRQFIEKCLAT----VSSRLSARELLTDPFLQIDDYDSD 288
+D V++F+E+ L + S + + P + Y
Sbjct: 58 KDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQR--QPSMMTRMYIEQ 115
Query: 289 LRMIQYQTDYDEISPL----------LRQSLYGIYHSNSSSNN-------GCG-HYIGYD 330
+ D + LRQ+L + + N G G ++ D
Sbjct: 116 RDRL--YNDNQVFAKYNVSRLQPYLKLRQALLEL----RPAKNVLIDGVLGSGKTWVALD 169
Query: 331 TENGLDYHPHEFQESEI---DLFTCQED----EHLTNF--DISIKGKRREDDGIFLRLRI 381
Y + +I +L C E L I R D ++LRI
Sbjct: 170 VCL--SYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI 227
Query: 382 ADKEGRIRNIYF---------------------PFDIQ------------TDTALSVATE 408
+ +R + F++ TD LS AT
Sbjct: 228 HSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTD-FLSAATT 286
Query: 409 MVSELDITDQDVTK------IAEIIDSEIASLVPEWKRGMAMEESP-HRSSFCHNCASNG 461
LD +T + + +D L E + +P S +
Sbjct: 287 THISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPRE-----VLTTNPRRLSIIAESIRDGL 341
Query: 462 CLPDYILSDGSGAKN------LQVL------QCSKDGCAAIHGRFEE---ITYQV----- 501
D L VL + ++ F I +
Sbjct: 342 ATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDR--LSV---FPPSAHIPTILLSLIW 396
Query: 502 -DGAEQCAPEGADQAASPQSAVVHYADIWAQHEGQVLSSQGS-RDIHCDEEHKTLNQSSY 559
D + ++ S V E Q S S I+ + + K N+ Y
Sbjct: 397 FDVIKSDVMVVVNKLHK-YSLV----------EKQPKESTISIPSIYLELKVKLENE--Y 443
Query: 560 GAEEKIINMDSQSKCHERNCFSMNSAMDY-----------GLLDDYENEIRQ---ELRWL 605
I++ + K + + Y + R + R+L
Sbjct: 444 ALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFL 503
Query: 606 KAKYQIQLRELRDQQLGVKYKSSSLTLITD 635
+ K +R S L +
Sbjct: 504 EQK-------IRHDSTAWNASGSILNTLQQ 526
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 2e-04
Identities = 40/241 (16%), Positives = 69/241 (28%), Gaps = 71/241 (29%)
Query: 2 VFQAQKNQIPPSLLKLI----PLEDMEDTMKFLVKE--LQRHYRAFDEYEGIEVAWNQVK 55
VF + IP LL LI D+ + L K +++ E +
Sbjct: 380 VFPPSAH-IPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQP---KES--------TIS 427
Query: 56 LYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYR 115
+ L ++ L HR+I+ Y N F ++ L QY
Sbjct: 428 IPSIYL------ELKVKLENEYAL-HRSIVDHY-------NIPKTFDSDDLIPPYLDQYF 473
Query: 116 LKH-----------------RRV--NIRAVKHWCRQ--ILSGLLYLHSRDPPVIHRDLKC 154
H R V + R + Q + S + LK
Sbjct: 474 YSHIGHHLKNIEHPERMTLFRMVFLDFR----FLEQKIRHDSTAWNASGSILNTLQQLKF 529
Query: 155 --DNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPE-------FMAPE--VYEEEYNE 203
I N + E + + L K + + MA + ++EE + +
Sbjct: 530 YKPYICDNDPKYERLVNAIL--DFLPK-IEENLICSKYTDLLRIALMAEDEAIFEEAHKQ 586
Query: 204 L 204
+
Sbjct: 587 V 587
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 8e-13
Identities = 39/159 (24%), Positives = 71/159 (44%), Gaps = 18/159 (11%)
Query: 72 EIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHW-- 129
EI L +H +++ + + + + +G L+++ L + W
Sbjct: 85 EIETLSFCRHPHLVSLIGFCDERNEMIL--IYKYMENGNLKRH-L-YGSDLPTMSMSWEQ 140
Query: 130 ----CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHA 182
C GL YLH+ +IHRD+K NI ++ N KI D G++ L ++H
Sbjct: 141 RLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENF-VPKITDFGISKKGTELDQTHL 197
Query: 183 A-RCVGTPEFMAPEVYEEEY-NELVDIYSFGMCILEMVT 219
+ GT ++ PE + + E D+YSFG+ + E++
Sbjct: 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 35/125 (28%), Positives = 57/125 (45%), Gaps = 12/125 (9%)
Query: 129 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT 188
+ Q+ G+ +L SR IHRDL NI ++ VKI D GLA + K G
Sbjct: 198 YSFQVAKGMEFLASR--KCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGD 254
Query: 189 PEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISG-- 240
MAPE +++ Y D++SFG+ + E+ + PY + +++ G
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 314
Query: 241 -KKPE 244
+ P+
Sbjct: 315 MRAPD 319
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 55/263 (20%), Positives = 84/263 (31%), Gaps = 97/263 (36%)
Query: 113 QYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV------------- 159
+ ++ + + VK +Q+L GL YLH+ +IH D+K +NI +
Sbjct: 135 IIKSNYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLAAE 193
Query: 160 -----------------------------------NGNQGEVKIGDLGLAAILRKSHAAR 184
N + +VKI DLG A + K
Sbjct: 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-TE 252
Query: 185 CVGTPEFMAPEVY-EEEYNELVDIYSFGMCILEMVTFDYP---------YSECTHPAQIY 234
+ T ++ + EV YN DI+S E+ T DY + H A I
Sbjct: 253 DIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALII 312
Query: 235 K--------------------------KVISGKKPEALFKV----------EDPEVRQFI 258
+ K I+ KP LF+V E F+
Sbjct: 313 ELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFL 372
Query: 259 EKCLATV-SSRLSARELLTDPFL 280
L + R +A E L P+L
Sbjct: 373 LPMLELIPEKRATAAECLRHPWL 395
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 7e-12
Identities = 26/232 (11%), Positives = 64/232 (27%), Gaps = 40/232 (17%)
Query: 38 YRAFDEYEGIEVAWNQVKL--YDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95
++A D +VA + + + L+ L + + + V T
Sbjct: 48 WQALDTALDRQVA---LTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL-DVVHTR 103
Query: 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
+ V E G+L++ + + + + + H V
Sbjct: 104 AGGL-VVAEWIRGGSLQE--VADTSPSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPS 158
Query: 156 NIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCIL 215
+ V+ + G+V + P+ DI G +
Sbjct: 159 RVRVSID-GDVVLAYPATMP----------DANPQ--------------DDIRGIGASLY 193
Query: 216 EMVTFDYPYSECTHPAQIYK--KVISGKKPEALFKVED--PEVRQFIEKCLA 263
++ +P E + + + +G+ E D ++ + +
Sbjct: 194 ALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQ 245
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 34/112 (30%), Positives = 58/112 (51%), Gaps = 7/112 (6%)
Query: 111 LRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQGEVKIG 169
LR R V++ + + +Q+ + LL+L + + +IH DLK +NI N + +KI
Sbjct: 146 LRNT--NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV 203
Query: 170 DLGLAAILRKSHAARCVGTPEFMAPEV-YEEEYNELVDIYSFGMCIL-EMVT 219
D G + L + + + + +PEV Y+ +D++S G CIL EM T
Sbjct: 204 DFGSSCQLGQRIYQ-YIQSRFYRSPEVLLGMPYDLAIDMWSLG-CILVEMHT 253
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 65/321 (20%), Positives = 110/321 (34%), Gaps = 98/321 (30%)
Query: 38 YRAFDEYEGIEVAW----NQVKLYDFLQSPEE---LERL--------YCEIHLLKTLKHR 82
+A+D VA N+ + + Q+ EE LE L IH+L+ R
Sbjct: 114 VKAYDHKVHQHVALKMVRNEKRFHR--QAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171
Query: 83 NIMKFYTSWVDTANRNINFVTEMFTSGTLRQY--RLKHRRVNIRAVKHWCRQILSGLLYL 140
N +I E+ S L + + K + ++ V+ + IL L L
Sbjct: 172 N--------------HICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 141 HSRDPPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVY-E 198
H +IH DLK +NI + +K+ D G + + + + + APEV
Sbjct: 217 HKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV-YTYIQSRFYRAPEVILG 273
Query: 199 EEYNELVDIYSFGMCIL-EMVT-------------------------------------- 219
Y +D++S G CIL E++T
Sbjct: 274 ARYGMPIDMWSLG-CILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNF 332
Query: 220 FD---YPYSECTHPAQIYKKVISGKKP---------------EALFKVEDPEVRQFIEKC 261
YP V++G + AL +DP F+++C
Sbjct: 333 VSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQC 392
Query: 262 LA-TVSSRLSARELLTDPFLQ 281
L + R++ + L P+L+
Sbjct: 393 LEWDPAVRMTPGQALRHPWLR 413
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 43/233 (18%), Positives = 72/233 (30%), Gaps = 80/233 (34%)
Query: 117 KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG------------ 164
+ ++ QI + +LHS + H DLK +NI +
Sbjct: 111 GFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDE 168
Query: 165 ------EVKIGDLGLAAILRKSHAA-------RCVGTPEFMAPEV-YEEEYNELVDIYSF 210
++K+ D G A + H+ R APEV +++ D++S
Sbjct: 169 RTLINPDIKVVDFGSATYDDEHHSTLVSTRHYR--------APEVILALGWSQPCDVWSI 220
Query: 211 GMCIL-EMVT-------------------------------------FDYPYSECTHPAQ 232
G CIL E F + + +
Sbjct: 221 G-CILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSS 279
Query: 233 IYKKVISGKKP-EALFKVEDPEVRQ---FIEKCLA-TVSSRLSARELLTDPFL 280
+ V KP + +D E + I+K L + R++ RE L PF
Sbjct: 280 AGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 35/183 (19%), Positives = 64/183 (34%), Gaps = 37/183 (20%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y AF + + A + VK+ +E L+ E+ + + ++ +K +
Sbjct: 54 YLAFPTNKPEKDARHVVKV-----EYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYL 108
Query: 98 NI----------------NF-VTEMFTSGT-LRQYRLKHRRVNIRAVKHWCRQILSGLLY 139
I F V E G L++ ++ V ++L L Y
Sbjct: 109 GIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEY 166
Query: 140 LHSRDPPVIHRDLKCDNIFVN-GNQGEVKIGDLGLAAILR--KSHAARC-------VGTP 189
+H + +H D+K N+ + N +V + D GL+ +H GT
Sbjct: 167 IHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTI 224
Query: 190 EFM 192
EF
Sbjct: 225 EFT 227
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 7e-07
Identities = 49/310 (15%), Positives = 94/310 (30%), Gaps = 42/310 (13%)
Query: 2 VFQAQKNQIPPSLLKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQ 61
VFQ + P +K+I +E + + I ++ L +
Sbjct: 36 VFQTIADHTP-VAIKIIAIEGPDL------VNGSHQKTFEEILPEIIISKELSLLSGEVC 88
Query: 62 SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT-----------ANRNINFVTEMFTSGT 110
+ E +H ++ ++K + + T + + V E G
Sbjct: 89 NRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGI 148
Query: 111 LRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN---------- 160
+++ + ++ K Q+ + L + HRDL N+ +
Sbjct: 149 D-LEQMRTKLSSLATAKSILHQLTASLAVAEAS-LRFEHRDLHWGNVLLKKTSLKKLHYT 206
Query: 161 GNQGEVKIGDLGLAAIL------RKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCI 214
N I GL + R V M +++ + + DIY
Sbjct: 207 LNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKE 266
Query: 215 LEMVTFDY-PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRL---S 270
+Y PYS + K++ + K P ++Q K + L S
Sbjct: 267 NNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT--KCNTPAMKQIKRKIQEFHRTMLNFSS 324
Query: 271 ARELLTDPFL 280
A +LL L
Sbjct: 325 ATDLLCQHSL 334
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 52/298 (17%), Positives = 89/298 (29%), Gaps = 106/298 (35%)
Query: 72 EIHLLKTLKHR-----NIMKFYTSWVDTANRN-INFVTEMFTSGTLRQYRLKH---RRVN 122
E +LK +++ NI+K++ + + + E +L + + +
Sbjct: 81 EADILKKIQNDDINNNNIVKYH-GKFM--YYDHMCLIFEPL-GPSLYEI-ITRNNYNGFH 135
Query: 123 IRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG------------------ 164
I +K +C +IL L YL + H DLK +NI ++
Sbjct: 136 IEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193
Query: 165 ------EVKIGDLGLAAILRKSHAA-------RCVGTPEFMAPEV-YEEEYNELVDIYSF 210
+K+ D G A H + R APEV ++ D++SF
Sbjct: 194 YRTKSTGIKLIDFGCATFKSDYHGSIINTRQYR--------APEVILNLGWDVSSDMWSF 245
Query: 211 GMCIL-EMVT---------------------------------------------FDYPY 224
G C+L E+ T +
Sbjct: 246 G-CVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAW 304
Query: 225 SECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATV-SSRLSARELLTDPFLQ 281
E K V + ++ F+ L + R S ELL FL+
Sbjct: 305 PENASSINSIKHVKKCLPLYKI--IKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 37/234 (15%), Positives = 66/234 (28%), Gaps = 80/234 (34%)
Query: 117 KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG------------ 164
+ + V+H Q+ L +LH + H DLK +NI ++
Sbjct: 116 NFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEE 173
Query: 165 ------EVKIGDLGLAAILRKSHAA-------RCVGTPEFMAPEV-YEEEYNELVDIYSF 210
+++ D G A + H R PEV E + + D++S
Sbjct: 174 KSVKNTSIRVADFGSATFDHEHHTTIVATRHYR--------PPEVILELGWAQPCDVWSI 225
Query: 211 GMCIL-EMVT--------------------------------------FDYPYSECTHPA 231
G CIL E + + +
Sbjct: 226 G-CILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSS 284
Query: 232 QIYKKVISGKKPEALFKVEDPEVRQ---FIEKCLA-TVSSRLSARELLTDPFLQ 281
+ K ++ + E Q + + L + R++ E L PF
Sbjct: 285 DGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFA 338
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 36/155 (23%), Positives = 64/155 (41%), Gaps = 26/155 (16%)
Query: 54 VKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTS-WVDTANRNINF-VTEMFTSGTL 111
+K Y PE++++ + LK+ + K++ S D ++ F + + F S
Sbjct: 84 LKFYQRAAKPEQIQKW----IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQ 139
Query: 112 RQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN-GNQGEVKIGD 170
+ Y +R + + V +IL L Y+H + +H D+K N+ +N N +V + D
Sbjct: 140 KIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVD 197
Query: 171 LGLAAILR-------------KSHAARCVGTPEFM 192
GLA + H GT EF
Sbjct: 198 YGLAYRYCPEGVHKAYAADPKRCH----DGTIEFT 228
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 17/71 (23%), Positives = 31/71 (43%), Gaps = 12/71 (16%)
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVN-GNQGEVKIGDLGLAAILRKSH--------- 181
++L L +LH + +H ++ +NIFV+ +Q +V + G A S
Sbjct: 167 RLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGS 224
Query: 182 AARCVGTPEFM 192
+ G EF+
Sbjct: 225 RSPHEGDLEFI 235
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 9e-05
Identities = 23/90 (25%), Positives = 40/90 (44%), Gaps = 13/90 (14%)
Query: 114 YRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV--NGNQGEVKIGDL 171
+ R+ +++ V Q++S + Y+HS++ IHRD+K DN + V I D
Sbjct: 95 FNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDF 152
Query: 172 GLAAILRKSHAARCV---------GTPEFM 192
GLA R + + + GT +
Sbjct: 153 GLAKKYRDARTHQHIPYRENKNLTGTARYA 182
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 738 | ||||
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-66 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-49 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-48 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-48 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-48 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-47 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-47 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-42 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-41 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-39 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-38 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-37 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-37 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-37 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-36 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-36 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-36 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-36 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-36 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-35 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-35 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-35 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-33 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-33 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-33 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-33 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-33 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-33 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-31 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-31 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-31 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-31 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-31 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-30 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-30 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-30 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-30 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-29 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-29 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-19 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-10 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 2e-66
Identities = 125/247 (50%), Positives = 165/247 (66%), Gaps = 5/247 (2%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA-- 95
Y+ D +EVAW +L D + E +R E +LK L+H NI++FY SW T
Sbjct: 26 YKGLDTETTVEVAW--CELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 83
Query: 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
+ I VTE+ TSGTL+ Y + + + I+ ++ WCRQIL GL +LH+R PP+IHRDLKCD
Sbjct: 84 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD 143
Query: 156 NIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCIL 215
NIF+ G G VKIGDLGLA + R S A +GTPEFMAPE+YEE+Y+E VD+Y+FGMC+L
Sbjct: 144 NIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCML 203
Query: 216 EMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSAREL 274
EM T +YPYSEC + AQIY++V SG KP + KV PEV++ IE C+ R S ++L
Sbjct: 204 EMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
Query: 275 LTDPFLQ 281
L F Q
Sbjct: 264 LNHAFFQ 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 3e-50
Identities = 72/254 (28%), Positives = 114/254 (44%), Gaps = 16/254 (6%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+ + +G + W ++ + E + L E++LL+ LKH NI+++Y +D N
Sbjct: 21 QKIRRKSDGKILVWKELDYGS--MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 78
Query: 98 NINFVTEMFTSGTLRQYRLKHRR----VNIRAVKHWCRQILSGLLYLHSR---DPPVIHR 150
+ V E G L K + ++ V Q+ L H R V+HR
Sbjct: 79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR 138
Query: 151 DLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVYE-EEYNELVDI 207
DLK N+F++G VK+GD GLA IL S A VGTP +M+PE YNE DI
Sbjct: 139 DLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDI 197
Query: 208 YSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VS 266
+S G + E+ P+ ++ K+ GK ++ E+ + I + L
Sbjct: 198 WSLGCLLYELCALMPPF-TAFSQKELAGKIREGKFRRIPYRY-SDELNEIITRMLNLKDY 255
Query: 267 SRLSARELLTDPFL 280
R S E+L +P +
Sbjct: 256 HRPSVEEILENPLI 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (439), Expect = 4e-49
Identities = 64/249 (25%), Positives = 107/249 (42%), Gaps = 14/249 (5%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y A D VA ++ QS E+ + + E+ L+ L+H N +++ ++
Sbjct: 32 YFARDVRNSEVVAIKKMSY-SGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EH 88
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
V E + + + + L GL YLHS +IHRD+K NI
Sbjct: 89 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH--NMIHRDVKAGNI 146
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVY----EEEYNELVDIYSFGMC 213
++ G VK+GD G A+I+ ++ VGTP +MAPEV E +Y+ VD++S G+
Sbjct: 147 LLSEP-GLVKLGDFGSASIMAPAN--SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 203
Query: 214 ILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSAR 272
+E+ P + +Y + + P R F++ CL R ++
Sbjct: 204 CIELAERKPPLFNMNAMSALY-HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSE 262
Query: 273 ELLTDPFLQ 281
LL F+
Sbjct: 263 VLLKHRFVL 271
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 2e-48
Identities = 73/257 (28%), Positives = 124/257 (48%), Gaps = 21/257 (8%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y+A ++ + A K+ D +S EELE EI +L + H NI+K ++
Sbjct: 29 YKAQNKETSVLAA---AKVID-TKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY--EN 82
Query: 98 NINFVTEMFTSGTLRQYRLKHRR-VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
N+ + E G + L+ R + ++ C+Q L L YLH +IHRDLK N
Sbjct: 83 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGN 140
Query: 157 IFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVY------EEEYNELVDIY 208
I + G++K+ D G++A ++ R +GTP +MAPEV + Y+ D++
Sbjct: 141 ILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVW 199
Query: 209 SFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE-DPEVRQFIEKCLAT-VS 266
S G+ ++EM + P+ E P ++ K+ + P + F++KCL V
Sbjct: 200 SLGITLIEMAEIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVD 258
Query: 267 SRLSARELLTDPFLQID 283
+R + +LL PF+ +D
Sbjct: 259 ARWTTSQLLQHPFVTVD 275
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 6e-48
Identities = 58/246 (23%), Positives = 107/246 (43%), Gaps = 11/246 (4%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y A ++ +A + L+ +L E+ + L+H NI++ Y + D
Sbjct: 23 YLAREKQSKFILALKVLFK-AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--AT 79
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
+ + E GT+ + K + + + + ++ + L Y HS+ VIHRD+K +N+
Sbjct: 80 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK--RVIHRDIKPENL 137
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILE 216
+ GE+KI D G + S GT +++ PE+ E ++E VD++S G+ E
Sbjct: 138 LLGSA-GELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYE 196
Query: 217 MVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELL 275
+ P+ E + YK++ + R I + L S R RE+L
Sbjct: 197 FLVGKPPF-EANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
Query: 276 TDPFLQ 281
P++
Sbjct: 254 EHPWIT 259
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 8e-48
Identities = 58/251 (23%), Positives = 108/251 (43%), Gaps = 15/251 (5%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
A + VA VK+ D ++ + E + EI + K L H N++KFY
Sbjct: 22 QLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--GHRREGN 76
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
E + G L + + + Q+++G++YLH + HRD+K +N+
Sbjct: 77 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENL 134
Query: 158 FVNGNQGEVKIGDLGLAAIL----RKSHAARCVGTPEFMAPEVYEEE--YNELVDIYSFG 211
++ +KI D GLA + R+ + GT ++APE+ + + E VD++S G
Sbjct: 135 LLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCG 193
Query: 212 MCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLS 270
+ + M+ + P+ + + Q Y K +K D + K L S+R++
Sbjct: 194 IVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 253
Query: 271 ARELLTDPFLQ 281
++ D +
Sbjct: 254 IPDIKKDRWYN 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 1e-47
Identities = 81/257 (31%), Positives = 121/257 (47%), Gaps = 14/257 (5%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y A D G EVA Q+ L Q + E + EI +++ K+ NI+ + S++
Sbjct: 37 YTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYLDSYLV--GD 90
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
+ V E G+L + ++ + CR+ L L +LHS VIHRD+K DNI
Sbjct: 91 ELWVVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQALEFLHSN--QVIHRDIKSDNI 147
Query: 158 FVNGNQGEVKIGDLGLAAIL--RKSHAARCVGTPEFMAPE-VYEEEYNELVDIYSFGMCI 214
+ + G VK+ D G A + +S + VGTP +MAPE V + Y VDI+S G+
Sbjct: 148 LLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 206
Query: 215 LEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARE 273
+EM+ + PY +Y +G + R F+ +CL V R SA+E
Sbjct: 207 IEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKE 266
Query: 274 LLTDPFLQIDDYDSDLR 290
LL FL+I S L
Sbjct: 267 LLQHQFLKIAKPLSSLT 283
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-47
Identities = 64/296 (21%), Positives = 115/296 (38%), Gaps = 51/296 (17%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
++ + G+ +A KL P ++ E+ +L I+ FY ++ +
Sbjct: 23 FKVSHKPSGLVMA---RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DG 77
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
I+ E G+L Q K R+ + + ++ GL YL + ++HRD+K NI
Sbjct: 78 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNI 136
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILE 216
VN GE+K+ D G++ L S A VGT +M+PE + Y+ DI+S G+ ++E
Sbjct: 137 LVNSR-GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 195
Query: 217 MVTFDYPYSECTH-----------------------------------------PAQIYK 235
M YP ++
Sbjct: 196 MAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLD 255
Query: 236 KVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ-IDDYDSDL 289
+++ P+ V E + F+ KCL + R ++L+ F++ D + D
Sbjct: 256 YIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDF 311
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 8e-44
Identities = 63/241 (26%), Positives = 112/241 (46%), Gaps = 21/241 (8%)
Query: 48 EVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFT 107
+VA + + +P++L+ E+ +L+ +H NI+ F + VT+
Sbjct: 32 DVAVKMLNVTA--PTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP---QLAIVTQWCE 86
Query: 108 SGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV 166
+L + + + + + RQ G+ YLH++ +IHRDLK +NIF++ + V
Sbjct: 87 GSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK--SIIHRDLKSNNIFLHED-LTV 143
Query: 167 KIGDLGLAAILRK----SHAARCVGTPEFMAPEVYEEE----YNELVDIYSFGMCILEMV 218
KIGD GLA + + + G+ +MAPEV + Y+ D+Y+FG+ + E++
Sbjct: 144 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203
Query: 219 TFDYPYSECTHPAQIYKKVISGKKPEALFKVED---PEVRQFIEKCLAT-VSSRLSAREL 274
T PYS + QI V G L KV +++ + +CL R ++
Sbjct: 204 TGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQI 263
Query: 275 L 275
L
Sbjct: 264 L 264
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 155 bits (393), Expect = 2e-42
Identities = 57/277 (20%), Positives = 112/277 (40%), Gaps = 16/277 (5%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+R ++ G + P + + EI ++ L H ++ + ++ D
Sbjct: 46 HRCVEKATGRVFVAKFINT----PYPLDKYTVKNEISIMNQLHHPKLINLHDAFED--KY 99
Query: 98 NINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
+ + E + G L +++ V ++ RQ GL ++H ++H D+K +N
Sbjct: 100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPEN 157
Query: 157 IFVNGNQ-GEVKIGDLGLAAILRKSHAARC-VGTPEFMAPEVYE-EEYNELVDIYSFGMC 213
I + VKI D GLA L + T EF APE+ + E D+++ G+
Sbjct: 158 IMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVL 217
Query: 214 ILEMVTFDYPYSECTHPAQIYK-KVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSA 271
+++ P++ + K + E F PE + FI+ L RL+
Sbjct: 218 GYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTV 277
Query: 272 RELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQS 308
+ L P+L+ S+L + Y++I +++
Sbjct: 278 HDALEHPWLK--GDHSNLTSRIPSSRYNKIRQKIKEK 312
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 152 bits (384), Expect = 3e-41
Identities = 56/261 (21%), Positives = 108/261 (41%), Gaps = 14/261 (5%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+R + G A V + E + EI + L+H ++ + ++ D +
Sbjct: 43 HRVTERATGNNFAAKFVMT----PHESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DN 96
Query: 98 NINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
+ + E + G L + +H +++ + RQ+ GL ++H + +H DLK +N
Sbjct: 97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPEN 154
Query: 157 IFVNGNQ-GEVKIGDLGLAAILRKSHAARC-VGTPEFMAPEVYE-EEYNELVDIYSFGMC 213
I + E+K+ D GL A L + + GT EF APEV E + D++S G+
Sbjct: 155 IMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 214
Query: 214 ILEMVTFDYPYSECTHPAQIYK-KVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSA 271
+++ P+ + K ++ F + + FI K L ++R++
Sbjct: 215 SYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTI 274
Query: 272 RELLTDPFLQIDDYDSDLRMI 292
+ L P+L + I
Sbjct: 275 HQALEHPWLTPGNAPGRDSQI 295
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 6e-41
Identities = 61/252 (24%), Positives = 114/252 (45%), Gaps = 19/252 (7%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
A + E A ++ + ++ + E ++ L H +K Y ++ D +
Sbjct: 25 VLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DE 81
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
+ F +G L +Y K + + + +I+S L YLH +IHRDLK +NI
Sbjct: 82 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENI 139
Query: 158 FVNGNQGEVKIGDLGLAAIL----RKSHAARCVGTPEFMAPEVY-EEEYNELVDIYSFGM 212
+N + ++I D G A +L +++ A VGT ++++PE+ E+ + D+++ G
Sbjct: 140 LLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGC 198
Query: 213 CILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRL 269
I ++V P+ I++K+I + PE F P+ R +EK L + RL
Sbjct: 199 IIYQLVAGLPPFRAGN-EYLIFQKIIKLEYDFPEKFF----PKARDLVEKLLVLDATKRL 253
Query: 270 SARELLTDPFLQ 281
E+ L+
Sbjct: 254 GCEEMEGYGPLK 265
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (378), Expect = 7e-41
Identities = 50/254 (19%), Positives = 103/254 (40%), Gaps = 15/254 (5%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
A D+ VA +K + + EI +L +KH NI+ +
Sbjct: 26 ILAEDKRTQKLVA---IKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES--GG 80
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
++ + ++ + G L ++ R Q+L + YLH ++HRDLK +N+
Sbjct: 81 HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD--LGIVHRDLKPENL 138
Query: 158 FVN--GNQGEVKIGDLGLAAILRKSHAARC-VGTPEFMAPEVYE-EEYNELVDIYSFGMC 213
++ I D GL+ + GTP ++APEV + Y++ VD +S G+
Sbjct: 139 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 198
Query: 214 ILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLS 270
++ P+ + + A+++++++ + + + FI + R +
Sbjct: 199 AYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFT 257
Query: 271 ARELLTDPFLQIDD 284
+ L P++ D
Sbjct: 258 CEQALQHPWIAGDT 271
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 3e-40
Identities = 60/292 (20%), Positives = 119/292 (40%), Gaps = 17/292 (5%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+R + VK+ + + EI +L +HRNI+ + S+
Sbjct: 22 HRCVETSSKKTYMAKFVKV-----KGTDQVLVKKEISILNIARHRNILHLHESFES--ME 74
Query: 98 NINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
+ + E + + + +N R + + Q+ L +LHS + H D++ +N
Sbjct: 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH--NIGHFDIRPEN 132
Query: 157 IFV-NGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEE-YNELVDIYSFGMC 213
I +KI + G A L+ R PE+ APEV++ + + D++S G
Sbjct: 133 IIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTL 192
Query: 214 ILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLS 270
+ +++ P+ T QI + +++ + E FK E F+++ L SR++
Sbjct: 193 VYVLLSGINPFLAET-NQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT 251
Query: 271 ARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNG 322
A E L P+L+ ++I+ L+++ L + + S G
Sbjct: 252 ASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARISCGG 303
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 144 bits (365), Expect = 2e-39
Identities = 55/261 (21%), Positives = 107/261 (40%), Gaps = 23/261 (8%)
Query: 38 YRAFDEYEGIEVAWNQVKL-----YDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSW 91
R + E A + + + + E E E+ +L+ + H NI++ ++
Sbjct: 20 RRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 79
Query: 92 VDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 151
N V ++ G L Y + ++ + + R +L + LH + ++HRD
Sbjct: 80 ET--NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRD 135
Query: 152 LKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEE-------YNE 203
LK +NI ++ + +K+ D G + L R GTP ++APE+ E Y +
Sbjct: 136 LKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGK 194
Query: 204 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKC 261
VD++S G+ + ++ P+ + + ++SG + V+ + +
Sbjct: 195 EVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRF 253
Query: 262 LAT-VSSRLSARELLTDPFLQ 281
L R +A E L PF Q
Sbjct: 254 LVVQPQKRYTAEEALAHPFFQ 274
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 8e-39
Identities = 56/262 (21%), Positives = 113/262 (43%), Gaps = 15/262 (5%)
Query: 38 YRAFDEYEGIEVAWNQVK--LYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95
+ ++ G++ A +K + E + E+ +LK ++H N++ + + +
Sbjct: 27 KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-- 84
Query: 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
++ + E+ G L + + + + +QIL+G+ YLHS + H DLK +
Sbjct: 85 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL--QIAHFDLKPE 142
Query: 156 NIFV---NGNQGEVKIGDLGLAAILRKSHAARC-VGTPEFMAPEVYE-EEYNELVDIYSF 210
NI + N + +KI D GLA + + + GTPEF+APE+ E D++S
Sbjct: 143 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI 202
Query: 211 GMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLAT-VSS 267
G+ +++ P+ + V + + F + FI + L
Sbjct: 203 GVITYILLSGASPF-LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKK 261
Query: 268 RLSARELLTDPFLQIDDYDSDL 289
R++ ++ L P+++ D L
Sbjct: 262 RMTIQDSLQHPWIKPKDTQQAL 283
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-38
Identities = 50/242 (20%), Positives = 96/242 (39%), Gaps = 18/242 (7%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+Y G +VA VK +++ + E ++ L+H N+++ V+
Sbjct: 24 MLG--DYRGNKVA---VKC---IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 75
Query: 98 NINFVTEMFTSGTLRQYRLKHRR--VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
+ VTE G+L Y R + + + + + YL +HRDL
Sbjct: 76 -LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--NFVHRDLAAR 132
Query: 156 NIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVY-EEEYNELVDIYSFGMCI 214
N+ V+ + K+ D GL + ++ APE E++++ D++SFG+ +
Sbjct: 133 NVLVSED-NVAKVSDFGLTKEASSTQDTGK-LPVKWTAPEALREKKFSTKSDVWSFGILL 190
Query: 215 LEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARE 273
E+ +F + +V G K +A P V + ++ C + R S +
Sbjct: 191 WEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC-PPAVYEVMKNCWHLDAAMRPSFLQ 249
Query: 274 LL 275
L
Sbjct: 250 LR 251
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (356), Expect = 5e-38
Identities = 43/248 (17%), Positives = 89/248 (35%), Gaps = 16/248 (6%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+ G + +K + ++ E ++ H N++ V T +
Sbjct: 43 CSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE--GVVTKST 100
Query: 98 NINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
+ +TE +G+L + R + + + R I +G+ YL D +HRDL N
Sbjct: 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARN 158
Query: 157 IFVNGNQGEVKIGDLGLAAILRKS-------HAARCVGTPEFMAPEVYE-EEYNELVDIY 208
I VN N K+ D GL+ L A + APE + ++ D++
Sbjct: 159 ILVNSN-LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVW 217
Query: 209 SFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSS 267
S+G+ + E++++ + + + + Q + C +
Sbjct: 218 SYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC-PSALHQLMLDCWQKDRNH 276
Query: 268 RLSARELL 275
R +++
Sbjct: 277 RPKFGQIV 284
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-37
Identities = 51/251 (20%), Positives = 102/251 (40%), Gaps = 19/251 (7%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDF--LQSPEELERLYCEIHLLKTLK--HRNIMKFYTSWVD 93
Y + + VA V+ R+ E+ LLK + +++ W +
Sbjct: 21 YSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL-DWFE 79
Query: 94 TANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 153
+ + + L + + + + + Q+L + + H+ V+HRD+K
Sbjct: 80 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC--GVLHRDIK 137
Query: 154 CDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE--YNELVDIYSFG 211
+NI ++ N+GE+K+ D G A+L+ + GT + PE + ++S G
Sbjct: 138 DENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG 197
Query: 212 MCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLS 270
+ + +MV D P+ H +I + + ++ E + I CLA S R +
Sbjct: 198 ILLYDMVCGDIPFE---HDEEIIRGQVFFRQR------VSSECQHLIRWCLALRPSDRPT 248
Query: 271 ARELLTDPFLQ 281
E+ P++Q
Sbjct: 249 FEEIQNHPWMQ 259
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 4e-37
Identities = 49/258 (18%), Positives = 97/258 (37%), Gaps = 23/258 (8%)
Query: 38 YRAF--DEYEGIEVAWNQVK-LYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 94
+ + + VA VK L + P + L E ++++ L + I++
Sbjct: 24 KKGYYQMKKVVKTVA---VKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-- 78
Query: 95 ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 154
+ V EM G L +Y ++R V + + Q+ G+ YL +HRDL
Sbjct: 79 -AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES--NFVHRDLAA 135
Query: 155 DNIFVNGNQGEVKIGDLGLAAILRKSHAA-----RCVGTPEFMAPEVYE-EEYNELVDIY 208
N+ + Q KI D GL+ LR ++ APE +++ D++
Sbjct: 136 RNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVW 194
Query: 209 SFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSS 267
SFG+ + E ++ +++ + G++ E+ + C V +
Sbjct: 195 SFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC-PREMYDLMNLCWTYDVEN 253
Query: 268 RLSAREL---LTDPFLQI 282
R + L + + +
Sbjct: 254 RPGFAAVELRLRNYYYDV 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 139 bits (350), Expect = 5e-37
Identities = 57/260 (21%), Positives = 117/260 (45%), Gaps = 17/260 (6%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+ + G A +K + + +++E E +L + H I++ + ++ D +
Sbjct: 21 HLIRSRHNGRYYAMKVLKK-EIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQ 77
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
I + + G L K +R K + ++ L YLHS +I+RDLK +NI
Sbjct: 78 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENI 135
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILE 216
++ N G +KI D G A + C GTP+++APEV + YN+ +D +SFG+ I E
Sbjct: 136 LLDKN-GHIKITDFGFAKYVPDVTYTLC-GTPDYIAPEVVSTKPYNKSIDWWSFGILIYE 193
Query: 217 MVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT------VSSRLS 270
M+ P+ + + Y+K+++ + + +V+ + + + + +
Sbjct: 194 MLAGYTPFYDSN-TMKTYEKILNAELR--FPPFFNEDVKDLLSRLITRDLSQRLGNLQNG 250
Query: 271 ARELLTDPFLQIDDYDSDLR 290
++ P+ + ++ L
Sbjct: 251 TEDVKNHPWFKEVVWEKLLS 270
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-36
Identities = 57/248 (22%), Positives = 108/248 (43%), Gaps = 15/248 (6%)
Query: 38 YRAFDEYEGIEVAWNQ-VKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96
Y+ EG +V +K SP+ + + E +++ ++ + ++ + +
Sbjct: 26 YKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--- 82
Query: 97 RNINFVTEMFTSGTLRQYRLKHRR-VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
+ +T++ G L Y +H+ + + + +WC QI G+ YL R ++HRDL
Sbjct: 83 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--RLVHRDLAAR 140
Query: 156 NIFVNGNQGEVKIGDLGLAAILRKS----HAARCVGTPEFMAPEVYE-EEYNELVDIYSF 210
N+ V VKI D GLA +L HA ++MA E Y D++S+
Sbjct: 141 NVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 199
Query: 211 GMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRL 269
G+ + E++TF + ++I + G++ + +V + KC SR
Sbjct: 200 GVTVWELMTFGSKPYDGIPASEISSILEKGERLP-QPPICTIDVYMIMVKCWMIDADSRP 258
Query: 270 SARELLTD 277
REL+ +
Sbjct: 259 KFRELIIE 266
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 2e-36
Identities = 48/244 (19%), Positives = 93/244 (38%), Gaps = 18/244 (7%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+ + +VA +K + E E ++ L H +++ Y ++
Sbjct: 22 HLGYWL-NKDKVA---IKTIR--EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE--QA 73
Query: 98 NINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
I V E G L Y R + C + G+ YL + VIHRDL N
Sbjct: 74 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARN 131
Query: 157 IFVNGNQGEVKIGDLGLAAIL---RKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGM 212
V N +K+ D G+ + + + + ++ +PEV+ Y+ D++SFG+
Sbjct: 132 CLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGV 190
Query: 213 CILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSA 271
+ E+ + E +++ + + +G + ++ V Q + C R +
Sbjct: 191 LMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-KPRLASTHVYQIMNHCWKERPEDRPAF 249
Query: 272 RELL 275
LL
Sbjct: 250 SRLL 253
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 3e-36
Identities = 54/262 (20%), Positives = 111/262 (42%), Gaps = 18/262 (6%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
++ G A ++ + + + +E+ E +L+ +H + ++ +
Sbjct: 22 ILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HD 78
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
+ FV E G L + + R + + +I+S L YLH V++RD+K +N+
Sbjct: 79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENL 136
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPEVYE-EEYNELVDIYSFGMCI 214
++ + G +KI D GL A GTPE++APEV E +Y VD + G+ +
Sbjct: 137 MLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 195
Query: 215 LEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLS--- 270
EM+ P+ ++++ ++ + + PE + + L RL
Sbjct: 196 YEMMCGRLPF-YNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGP 252
Query: 271 --ARELLTDPFLQIDDYDSDLR 290
A+E++ F ++ ++
Sbjct: 253 SDAKEVMEHRFFLSINWQDVVQ 274
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 137 bits (345), Expect = 6e-36
Identities = 60/263 (22%), Positives = 108/263 (41%), Gaps = 15/263 (5%)
Query: 38 YRAFDEYEGIEVAWNQV--KLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95
Y G A + K Q + L+ T I+ ++
Sbjct: 21 YGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-- 78
Query: 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
++F+ ++ G L + +H + ++ + +I+ GL ++H+R V++RDLK
Sbjct: 79 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPA 136
Query: 156 NIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE--YNELVDIYSFGMC 213
NI ++ G V+I DLGLA K VGT +MAPEV ++ Y+ D +S G
Sbjct: 137 NILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCM 195
Query: 214 ILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLS-- 270
+ +++ P+ + + ++ L PE+R +E L V+ RL
Sbjct: 196 LFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCL 255
Query: 271 ---ARELLTDPFLQIDDYDSDLR 290
A+E+ PF + D+
Sbjct: 256 GRGAQEVKESPFFRSLDWQMVFL 278
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 134 bits (339), Expect = 6e-36
Identities = 52/255 (20%), Positives = 95/255 (37%), Gaps = 14/255 (5%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD--TA 95
+ A D +VA ++ D + P R E L H I+ Y + A
Sbjct: 24 HLARDLRLHRDVAVKVLRA-DLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 82
Query: 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
V E TLR + + L + H +IHRD+K
Sbjct: 83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN--GIIHRDVKPA 140
Query: 156 NIFVNGNQGEVKIGDLGLAAILRKSH-----AARCVGTPEFMAPEVYE-EEYNELVDIYS 209
NI ++ VK+ D G+A + S A +GT ++++PE + + D+YS
Sbjct: 141 NIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 199
Query: 210 FGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE-DPEVRQFIEKCLAT-VSS 267
G + E++T + P++ + + Y+ V P + ++ + K LA +
Sbjct: 200 LGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPEN 259
Query: 268 RLSARELLTDPFLQI 282
R + +++
Sbjct: 260 RYQTAAEMRADLVRV 274
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 6e-36
Identities = 57/275 (20%), Positives = 105/275 (38%), Gaps = 36/275 (13%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEEL-ERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96
Y+A D+ VA ++KL ++ + + EI LL+ L H NI+ ++
Sbjct: 15 YKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--K 72
Query: 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
NI+ V + + + + +K + L GL YLH ++HRDLK +N
Sbjct: 73 SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH--WILHRDLKPNN 130
Query: 157 IFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVY--EEEYNELVDIYSFGM 212
+ ++ N G +K+ D GLA + A V T + APE+ Y VD+++ G
Sbjct: 131 LLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGC 189
Query: 213 CILEMVTFDYPYSECTHPAQIYK-------------------------KVISGKKPEALF 247
+ E++ + Q+ + K G +F
Sbjct: 190 ILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIF 249
Query: 248 KVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 281
++ I+ +R++A + L +
Sbjct: 250 SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 8e-36
Identities = 55/239 (23%), Positives = 100/239 (41%), Gaps = 15/239 (6%)
Query: 45 EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTE 104
+ + VA +K D L PE ++ E++ + +L HRN+++ Y + + VTE
Sbjct: 35 KTVSVAVKCLKP-DVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---PPMKMVTE 90
Query: 105 MFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 163
+ G+L KH+ + + + Q+ G+ YL S+ IHRDL N+ +
Sbjct: 91 LAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK--RFIHRDLAARNLLLATR- 147
Query: 164 GEVKIGDLGLAAILRKSH-----AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEM 217
VKIGD GL L ++ + APE + ++ D + FG+ + EM
Sbjct: 148 DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 207
Query: 218 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELL 275
T+ + +QI K+ + + ++ + +C A R + L
Sbjct: 208 FTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 9e-36
Identities = 51/249 (20%), Positives = 101/249 (40%), Gaps = 19/249 (7%)
Query: 38 YRAFD---EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 94
++ E + VA +K S E+ E ++ H +I+K +
Sbjct: 24 HQGIYMSPENPALAVA---IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE- 79
Query: 95 ANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 153
+ + E+ T G LR + +++ ++ + Q+ + L YL S+ +HRD+
Sbjct: 80 --NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--RFVHRDIA 135
Query: 154 CDNIFVNGNQGEVKIGDLGLAAILRKS---HAARCVGTPEFMAPEVYEEE-YNELVDIYS 209
N+ V+ VK+GD GL+ + S A++ ++MAPE + D++
Sbjct: 136 ARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 194
Query: 210 FGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSR 268
FG+C+ E++ + + ++ +G++ P + + KC A S R
Sbjct: 195 FGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC-PPTLYSLMTKCWAYDPSRR 253
Query: 269 LSARELLTD 277
EL
Sbjct: 254 PRFTELKAQ 262
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 9e-36
Identities = 44/258 (17%), Positives = 95/258 (36%), Gaps = 23/258 (8%)
Query: 38 YRAFDEY--EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95
+ + I+VA +K+ + E + E ++ L + I++
Sbjct: 26 RQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-- 80
Query: 96 NRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 154
+ V EM G L ++ + R + + V Q+ G+ YL + +HRDL
Sbjct: 81 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--NFVHRDLAA 137
Query: 155 DNIFVNGNQGEVKIGDLGLAAILRKSHAAR-----CVGTPEFMAPEVYE-EEYNELVDIY 208
N+ + KI D GL+ L + ++ APE +++ D++
Sbjct: 138 RNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 196
Query: 209 SFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSS 267
S+G+ + E +++ + ++ + GK+ E + PE+ + C
Sbjct: 197 SYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC-PPELYALMSDCWIYKWED 255
Query: 268 RLSAREL---LTDPFLQI 282
R + + + +
Sbjct: 256 RPDFLTVEQRMRACYYSL 273
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 7e-35
Identities = 56/259 (21%), Positives = 112/259 (43%), Gaps = 15/259 (5%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLL-KTLKHRNIMKFYTSWVDTAN 96
+ A + A +K D + +++E E +L +H + + ++
Sbjct: 19 FLAEFKKTNQFFAIKALKK-DVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--K 75
Query: 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
N+ FV E G L + + ++ + +I+ GL +LHS+ +++RDLK DN
Sbjct: 76 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDN 133
Query: 157 IFVNGNQGEVKIGDLGLAAILRKSHAA--RCVGTPEFMAPEVYE-EEYNELVDIYSFGMC 213
I ++ + G +KI D G+ A GTP+++APE+ ++YN VD +SFG+
Sbjct: 134 ILLDKD-GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVL 192
Query: 214 ILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSAR 272
+ EM+ P+ +++ + + + E + + K RL R
Sbjct: 193 LYEMLIGQSPF-HGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVKLFVREPEKRLGVR 249
Query: 273 -ELLTDPFLQIDDYDSDLR 290
++ P + +++ R
Sbjct: 250 GDIRQHPLFREINWEELER 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 8e-35
Identities = 48/246 (19%), Positives = 93/246 (37%), Gaps = 18/246 (7%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+VA +K+ + + E ++ L H +++ Y R
Sbjct: 21 KYGKWR-GQYDVA---IKMIK--EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK--QR 72
Query: 98 NINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
I +TE +G L Y R R + + C+ + + YL S+ +HRDL N
Sbjct: 73 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK--QFLHRDLAARN 130
Query: 157 IFVNGNQGEVKIGDLGLAAILRKS---HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGM 212
VN G VK+ D GL+ + + + PEV +++ DI++FG+
Sbjct: 131 CLVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGV 189
Query: 213 CILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSA 271
+ E+ + E ++ + + G + + +V + C R +
Sbjct: 190 LMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-RPHLASEKVYTIMYSCWHEKADERPTF 248
Query: 272 RELLTD 277
+ LL++
Sbjct: 249 KILLSN 254
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 9e-35
Identities = 48/245 (19%), Positives = 93/245 (37%), Gaps = 20/245 (8%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+ + +VA +K Q + E +L+K L+H+ +++ Y
Sbjct: 30 WMGYYN-GHTKVAVKSLK-----QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---E 80
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNI--RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
I +TE +G+L + + + + QI G+ ++ R IHRDL+
Sbjct: 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--NYIHRDLRAA 138
Query: 156 NIFVNGNQGEVKIGDLGLAAILRKSHAARC---VGTPEFMAP-EVYEEEYNELVDIYSFG 211
NI V+ + KI D GLA ++ + ++ AP + + D++SFG
Sbjct: 139 NILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 197
Query: 212 MCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLS 270
+ + E+VT ++ + + G + E+ Q + C R +
Sbjct: 198 ILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC-PEELYQLMRLCWKERPEDRPT 256
Query: 271 ARELL 275
L
Sbjct: 257 FDYLR 261
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-34
Identities = 46/250 (18%), Positives = 93/250 (37%), Gaps = 20/250 (8%)
Query: 38 YRAFD---EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 94
Y + + I A VK + + E+ + E ++K H N++ + +
Sbjct: 44 YHGTLLDNDGKKIHCA---VKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 100
Query: 95 ANRNINFVTEMFTSGTLRQYRLKHRR-VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 153
+ V G LR + ++ + + Q+ G+ +L +HRDL
Sbjct: 101 -EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLA 157
Query: 154 CDNIFVNGNQGEVKIGDLGLAAILRKSHAA------RCVGTPEFMAPEVYE-EEYNELVD 206
N ++ VK+ D GLA + ++MA E + +++ D
Sbjct: 158 ARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSD 216
Query: 207 IYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-V 265
++SFG+ + E++T P + I ++ G++ + + + KC
Sbjct: 217 VWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC-PDPLYEVMLKCWHPKA 275
Query: 266 SSRLSARELL 275
R S EL+
Sbjct: 276 EMRPSFSELV 285
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 7e-34
Identities = 65/299 (21%), Positives = 110/299 (36%), Gaps = 43/299 (14%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD-TAN 96
A+D + VA +K + +R EI +L +H NI+ T
Sbjct: 25 CSAYDNVNKVRVA---IKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81
Query: 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
+ + G LK + ++ + ++ QIL GL Y+HS V+HRDLK N
Sbjct: 82 QMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA--NVLHRDLKPSN 139
Query: 157 IFVNGNQGEVKIGDLGLAAILRKSHAARC-----VGTPEFMAPEVYEEE--YNELVDIYS 209
+ +N ++KI D GLA + H V T + APE+ Y + +DI+S
Sbjct: 140 LLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 198
Query: 210 FGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP-------------------------- 243
G + EM++ + + Q+ + P
Sbjct: 199 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 258
Query: 244 --EALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYD 299
LF D + ++K L R+ + L P+L+ SD + + +D
Sbjct: 259 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD 317
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-33
Identities = 59/297 (19%), Positives = 107/297 (36%), Gaps = 49/297 (16%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA-- 95
++A G +VA +V + + + EI +L+ LKH N++ A
Sbjct: 27 FKARHRKTGQKVALKKVLMEN--EKEGFPITALREIKILQLLKHENVVNLIEICRTKASP 84
Query: 96 ----NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 151
+I V + + + +K + +L+GL Y+H ++HRD
Sbjct: 85 YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR--NKILHRD 142
Query: 152 LKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC------VGTPEFMAPEVY--EEEYNE 203
+K N+ + + G +K+ D GLA + ++ V T + PE+ E +Y
Sbjct: 143 MKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGP 201
Query: 204 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYK-KVISGKKPEALFK-------------- 248
+D++ G + EM T T Q+ + G ++
Sbjct: 202 PIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELV 261
Query: 249 --------------VEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLR 290
V DP I+K L + R+ + + L F D SDL+
Sbjct: 262 KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLK 318
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 1e-33
Identities = 50/246 (20%), Positives = 90/246 (36%), Gaps = 22/246 (8%)
Query: 38 YRAFDEYEGIEVAWNQVK-LYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96
+ VA +K L SPE + E ++K L+H +++ Y
Sbjct: 34 WMGTWN-GTTRVA---IKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAVVS---E 83
Query: 97 RNINFVTEMFTSGTLRQYRLKHRR--VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 154
I VTE + G+L + + + + QI SG+ Y+ +HRDL+
Sbjct: 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--NYVHRDLRA 141
Query: 155 DNIFVNGNQGEVKIGDLGLAAILRKSHAAR---CVGTPEFMAPEVYE-EEYNELVDIYSF 210
NI V N K+ D GLA ++ + ++ APE + D++SF
Sbjct: 142 ANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 200
Query: 211 GMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRL 269
G+ + E+ T ++ +V G + + + + +C R
Sbjct: 201 GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC-PESLHDLMCQCWRKEPEERP 259
Query: 270 SARELL 275
+ L
Sbjct: 260 TFEYLQ 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 2e-33
Identities = 47/257 (18%), Positives = 100/257 (38%), Gaps = 19/257 (7%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+ + + VA +K + ++ E ++ H NI++ +
Sbjct: 28 LKTSSGKKEVPVA---IKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK--YK 82
Query: 98 NINFVTEMFTSGTLRQYRLKHRRV-NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
+ +TE +G L ++ + ++ + R I +G+ YL + +HRDL N
Sbjct: 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARN 140
Query: 157 IFVNGNQGEVKIGDLGLAAILRKSHAAR-----CVGTPEFMAPE-VYEEEYNELVDIYSF 210
I VN N K+ D GL+ +L A + APE + ++ D++SF
Sbjct: 141 ILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSF 199
Query: 211 GMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRL 269
G+ + E++T+ ++ K + G + + Q + +C + R
Sbjct: 200 GIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC-PSAIYQLMMQCWQQERARRP 258
Query: 270 SARELLT--DPFLQIDD 284
++++ D ++ D
Sbjct: 259 KFADIVSILDKLIRAPD 275
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-33
Identities = 50/259 (19%), Positives = 103/259 (39%), Gaps = 26/259 (10%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIH-LLKTLKHRNIMKFYTSWVD--T 94
+ F++ + A +K+ LQ + R E+ + + +I++ + +
Sbjct: 29 LQIFNKRTQEKFA---LKM---LQDCPKARR---EVELHWRASQCPHIVRIVDVYENLYA 79
Query: 95 ANRNINFVTEMFTSGTLRQY--RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL 152
+ + V E G L + R + I + YLHS + + HRD+
Sbjct: 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDV 137
Query: 153 KCDNIFVN--GNQGEVKIGDLGLAAILRKSHAARCV-GTPEFMAPEVYE-EEYNELVDIY 208
K +N+ +K+ D G A ++ TP ++APEV E+Y++ D++
Sbjct: 138 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 197
Query: 209 SFGMCILEMVTFDYPYSECTHPA---QIYKKVISGKK--PEALFKVEDPEVRQFIEKCLA 263
S G+ + ++ P+ A + ++ G+ P + EV+ I L
Sbjct: 198 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 257
Query: 264 T-VSSRLSARELLTDPFLQ 281
T + R++ E + P++
Sbjct: 258 TEPTQRMTITEFMNHPWIM 276
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 3e-33
Identities = 60/271 (22%), Positives = 96/271 (35%), Gaps = 40/271 (14%)
Query: 36 RHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDT 94
Y I+VA VK+ E E L E+ ++ L H NI+ +
Sbjct: 57 TAYGISKTGVSIQVA---VKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL- 112
Query: 95 ANRNINFVTEMFTSGTLRQYRLKHRR-----------------------VNIRAVKHWCR 131
+ I + E G L Y R + + +
Sbjct: 113 -SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 171
Query: 132 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK----SHAARCVG 187
Q+ G+ +L + +HRDL N+ V VKI D GLA +
Sbjct: 172 QVAKGMEFLEFK--SCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARL 228
Query: 188 TPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDY-PYSECTHPAQIYKKVISGKKPEA 245
++MAPE ++E Y D++S+G+ + E+ + PY A YK + +G K +
Sbjct: 229 PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ 288
Query: 246 LFKVEDPEVRQFIEKCLAT-VSSRLSARELL 275
F E+ ++ C A R S L
Sbjct: 289 PFYA-TEEIYIIMQSCWAFDSRKRPSFPNLT 318
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (324), Expect = 3e-33
Identities = 58/260 (22%), Positives = 112/260 (43%), Gaps = 17/260 (6%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+ G A + + +++E E +L+ + ++K S+ D N
Sbjct: 58 MLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NS 114
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
N+ V E G + + + R + + + QI+ YLHS D +I+RDLK +N+
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENL 172
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVY-EEEYNELVDIYSFGMCILE 216
++ G +++ D G A ++ C GTPE +APE+ + YN+ VD ++ G+ I E
Sbjct: 173 LIDQQ-GYIQVTDFGFAKRVKGRTWTLC-GTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 217 MVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT------VSSRLS 270
M P+ P QIY+K++SGK +++ + L + +
Sbjct: 231 MAAGYPPF-FADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNG 287
Query: 271 ARELLTDPFLQIDDYDSDLR 290
++ + D+ + +
Sbjct: 288 VNDIKNHKWFATTDWIAIYQ 307
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 4e-33
Identities = 55/289 (19%), Positives = 101/289 (34%), Gaps = 37/289 (12%)
Query: 12 PSLLKLIPLEDMEDTMKFLVKELQRH-----YRAFDEYEGIEVAWNQVKLYDFLQSPEEL 66
P++ ++ D++ + +A + +G+ + +K S ++
Sbjct: 1 PTIYPVLDWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDA-AIKRMKEYASKDDH 54
Query: 67 ERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH------- 118
E+ +L L H NI+ + E G L + K
Sbjct: 55 RDFAGELEVLCKLGHHPNIINLL--GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDP 112
Query: 119 ---------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIG 169
++ + + H+ + G+ YL IHRDL NI V N KI
Sbjct: 113 AFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENY-VAKIA 169
Query: 170 DLGLAAILRKSHAARC-VGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDYPYSEC 227
D GL+ +MA E + Y D++S+G+ + E+V+
Sbjct: 170 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 229
Query: 228 THPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELL 275
A++Y+K+ G + E D EV + +C R S ++L
Sbjct: 230 MTCAELYEKLPQGYRLEKPLNC-DDEVYDLMRQCWREKPYERPSFAQIL 277
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (319), Expect = 4e-33
Identities = 53/245 (21%), Positives = 98/245 (40%), Gaps = 18/245 (7%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y + + VA +K + E+E E ++K +KH N+++
Sbjct: 34 YEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EP 86
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNI--RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
+TE T G L Y + R + + + QI S + YL + IHRDL
Sbjct: 87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK--NFIHRDLAAR 144
Query: 156 NIFVNGNQGEVKIGDLGLAAILRKSHA---ARCVGTPEFMAP-EVYEEEYNELVDIYSFG 211
N V N VK+ D GL+ ++ A ++ AP + +++ D+++FG
Sbjct: 145 NCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 203
Query: 212 MCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLS 270
+ + E+ T+ +Q+Y+ + + E + +V + + C S R S
Sbjct: 204 VLLWEIATYGMSPYPGIDLSQVYELLEKDYRME-RPEGCPEKVYELMRACWQWNPSDRPS 262
Query: 271 ARELL 275
E+
Sbjct: 263 FAEIH 267
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-32
Identities = 54/281 (19%), Positives = 101/281 (35%), Gaps = 47/281 (16%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMK----FYTSWVD 93
Y+A G VA +V Q R E+ +++ L H NI++ FY+S
Sbjct: 37 YQAKLCDSGELVAIKKVL-----QDKRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEK 88
Query: 94 TANRNINFVTEMFTSG---TLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 150
+N V + R Y + + + VK + Q+ L Y+HS + HR
Sbjct: 89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF--GICHR 146
Query: 151 DLKCDNIFVNGNQGEVKIGDLGLAAILRK-SHAARCVGTPEFMAPEVY--EEEYNELVDI 207
D+K N+ ++ + +K+ D G A L + + + + APE+ +Y +D+
Sbjct: 147 DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDV 206
Query: 208 YSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP------------------------ 243
+S G + E++ + + Q+ + + P
Sbjct: 207 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 266
Query: 244 --EALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 281
+ PE + L ++RL+ E F
Sbjct: 267 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 1e-31
Identities = 66/276 (23%), Positives = 106/276 (38%), Gaps = 39/276 (14%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y+A ++ G VA +++L ++ EI LLK L H NI+K
Sbjct: 19 YKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--EN 74
Query: 98 NINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
+ V E + + + +K + Q+L GL + HS V+HRDLK N
Sbjct: 75 KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--RVLHRDLKPQN 132
Query: 157 IFVNGNQGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVY--EEEYNELVDIYSFGM 212
+ +N G +K+ D GLA V T + APE+ + Y+ VDI+S G
Sbjct: 133 LLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC 191
Query: 213 CILEMVTFDYPYSECTHPAQIYKKVISGKKP--------------------------EAL 246
EMVT + + Q+++ + P +
Sbjct: 192 IFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKV 251
Query: 247 FKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 281
D + R + + L + R+SA+ L PF Q
Sbjct: 252 VPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (307), Expect = 2e-31
Identities = 56/282 (19%), Positives = 102/282 (36%), Gaps = 33/282 (11%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y D G EVA +KL + +L+ E + K ++ + W
Sbjct: 24 YLGTDIAAGEEVA---IKL---ECVKTKHPQLHIESKIYKMMQGGVGIPTI-RWCGAEGD 76
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
V E+ + R+ +++ V Q++S + Y+HS++ IHRD+K DN
Sbjct: 77 YNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNF 134
Query: 158 FV--NGNQGEVKIGDLGLAAILRKSHAARC---------VGTPEFMAPEVYE-EEYNELV 205
+ V I D GLA R + + GT + + + E +
Sbjct: 135 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRD 194
Query: 206 DIYSFGMCILEMVT--FDYPYSECTHPAQIYKKVISGK---KPEALFKVEDPEVRQFIEK 260
D+ S G ++ + + Q Y+++ K E L K E ++
Sbjct: 195 DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNF 254
Query: 261 CLA-TVSSRLSA---RELLTDPFLQI---DDYDSDLRMIQYQ 295
C + + R+L + F + DY D M+++
Sbjct: 255 CRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFG 296
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 122 bits (306), Expect = 2e-31
Identities = 64/275 (23%), Positives = 104/275 (37%), Gaps = 39/275 (14%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
Y+A + Y G A +++L + EI +LK LKH NI+K Y +
Sbjct: 19 YKAQNNY-GETFALKKIRLEK--EDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KK 73
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
+ V E + + + K + Q+L+G+ Y H R V+HRDLK N+
Sbjct: 74 RLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR--RVLHRDLKPQNL 131
Query: 158 FVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPEVYEEE--YNELVDIYSFGMC 213
+N GE+KI D GLA + T + AP+V Y+ +DI+S G
Sbjct: 132 LINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCI 190
Query: 214 ILEMVTFDYPYSECTHPAQIYK--------------------------KVISGKKPEALF 247
EMV + + Q+ + V E+
Sbjct: 191 FAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL 250
Query: 248 KVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 281
K D + K L + R++A++ L + +
Sbjct: 251 KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-31
Identities = 75/304 (24%), Positives = 120/304 (39%), Gaps = 40/304 (13%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
A D G +VA ++ QS +R Y E+ LLK ++H N++ +
Sbjct: 35 CSAVDGRTGAKVAIKKLYR--PFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 92
Query: 98 NI--NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
+ +F M GT +KH ++ ++ Q+L GL Y+H+ HRDLK
Sbjct: 93 DDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII--HRDLKPG 150
Query: 156 NIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMC 213
N+ VN + E+KI D GLA S V T + APEV Y + VDI+S G
Sbjct: 151 NLAVNED-CELKILDFGLARQAD-SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCI 208
Query: 214 ILEMVTFDYPYSECTHPAQIYKKV----------------------------ISGKKPEA 245
+ EM+T + H Q+ + + + K +
Sbjct: 209 MAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS 268
Query: 246 LFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMIQ-YQTDYDEISP 303
+ P +EK L R++A E L P+ + D +Q Y +D++
Sbjct: 269 ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDR 328
Query: 304 LLRQ 307
L +
Sbjct: 329 TLDE 332
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 3e-31
Identities = 49/265 (18%), Positives = 91/265 (34%), Gaps = 33/265 (12%)
Query: 36 RHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDT 94
Y + VA VK+ E E L E+ +L L H NI+ +
Sbjct: 43 TAYGLIKSDAAMTVA---VKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI- 98
Query: 95 ANRNINFVTEMFTSGTLRQYRLKHR------------------RVNIRAVKHWCRQILSG 136
+TE G L + + R +++ + + Q+ G
Sbjct: 99 -GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKG 157
Query: 137 LLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFM 192
+ +L S++ IHRDL NI + KI D GLA ++ ++M
Sbjct: 158 MAFLASKN--CIHRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWM 214
Query: 193 APEVYEEEY-NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED 251
APE D++S+G+ + E+ + + K+I +
Sbjct: 215 APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAP 274
Query: 252 PEVRQFIEKCLAT-VSSRLSARELL 275
E+ ++ C R + ++++
Sbjct: 275 AEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 122 bits (306), Expect = 5e-31
Identities = 54/284 (19%), Positives = 105/284 (36%), Gaps = 52/284 (18%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKFYTSWVDTAN 96
+ A + +V +K P + +++ EI +L+ L+ NI+ D +
Sbjct: 52 FEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRGGPNIITLADIVKDPVS 104
Query: 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 156
R V E + +Q ++ + ++ + +IL L Y HS ++HRD+K N
Sbjct: 105 RTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSM--GIMHRDVKPHN 159
Query: 157 IFVNGNQGEVKIGDLGLAAILR-KSHAARCVGTPEFMAPEVYEEE--YNELVDIYSFGMC 213
+ ++ ++++ D GLA V + F PE+ + Y+ +D++S G
Sbjct: 160 VMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCM 219
Query: 214 ILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF-------------------------- 247
+ M+ P+ ++ E L+
Sbjct: 220 LASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRW 279
Query: 248 ---------KVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 281
+ PE F++K L SRL+ARE + P+
Sbjct: 280 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 120 bits (302), Expect = 8e-31
Identities = 53/307 (17%), Positives = 99/307 (32%), Gaps = 55/307 (17%)
Query: 10 IPPSLLKL-IPLEDMEDTMKFLVKEL----------QRHYRAFDEYEGIEVAWNQVKLYD 58
+ P LL L P ++E V+++ R VA VK+
Sbjct: 1 LNPKLLSLEYPRNNIE-----YVRDIGEGAFGRVFQARAPGLLPYEPFTMVA---VKMLK 52
Query: 59 FLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH 118
S + E L+ + NI+K + + + E G L ++
Sbjct: 53 EEASADMQADFQREAALMAEFDNPNIVKLLGVCAV--GKPMCLLFEYMAYGDLNEFLRSM 110
Query: 119 RRVNIRAVKH------------------------WCRQILSGLLYLHSRDPPVIHRDLKC 154
+ ++ H RQ+ +G+ YL +HRDL
Sbjct: 111 SPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLAT 168
Query: 155 DNIFVNGNQGEVKIGDLGLAAILRKS----HAARCVGTPEFMAPE-VYEEEYNELVDIYS 209
N V N VKI D GL+ + + +M PE ++ Y D+++
Sbjct: 169 RNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWA 227
Query: 210 FGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSR 268
+G+ + E+ ++ ++ V G + E+ + C + + R
Sbjct: 228 YGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILA-CPENCPLELYNLMRLCWSKLPADR 286
Query: 269 LSARELL 275
S +
Sbjct: 287 PSFCSIH 293
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 2e-30
Identities = 67/279 (24%), Positives = 108/279 (38%), Gaps = 50/279 (17%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+R ++ G EVA VK++ + EI+ L+H NI+ F +
Sbjct: 20 WRG--KWRGEEVA---VKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNKDNGT 72
Query: 98 --NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS------RDPPVIH 149
+ V++ G+L Y L V + + SGL +LH P + H
Sbjct: 73 WTQLWLVSDYHEHGSLFDY-LNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 131
Query: 150 RDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH------AARCVGTPEFMAPEVYEE---- 199
RDLK NI V N G I DLGLA + VGT +MAPEV ++
Sbjct: 132 RDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 190
Query: 200 ---EYNELVDIYSFGMCILEMVT----------FDYPYSECTHPA----QIYKKVISGK- 241
E + DIY+ G+ E+ + PY + ++ K V K
Sbjct: 191 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL 250
Query: 242 KPEALFKVEDPE----VRQFIEKCLAT-VSSRLSARELL 275
+P + + E + + + +C ++RL+A +
Sbjct: 251 RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 2e-30
Identities = 67/277 (24%), Positives = 107/277 (38%), Gaps = 36/277 (12%)
Query: 38 YRAFD-EYEGIEVAWNQVKLYDFLQS-PEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95
++A D + G VA +V++ + P R + L+T +H N+++ + +
Sbjct: 24 FKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83
Query: 96 NRN---INFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 151
+ V E ++ V +K Q+L GL +LHS V+HRD
Sbjct: 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRD 141
Query: 152 LKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA-RCVGTPEFMAPEV-YEEEYNELVDIYS 209
LK NI V + G++K+ D GLA I A V T + APEV + Y VD++S
Sbjct: 142 LKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWS 200
Query: 210 FGMCILEMVTFDYPYSECTHPAQIYK------------------------KVISGKKPEA 245
G EM + + Q+ K S + E
Sbjct: 201 VGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEK 260
Query: 246 LFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 281
D + + KCL + R+SA L+ P+ Q
Sbjct: 261 FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-30
Identities = 61/276 (22%), Positives = 104/276 (37%), Gaps = 39/276 (14%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
++A + VA +V+L D EI LLK LKH+NI++ + ++
Sbjct: 19 FKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DK 74
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
+ V E + + + ++ VK + Q+L GL + HSR V+HRDLK N+
Sbjct: 75 KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR--NVLHRDLKPQNL 132
Query: 158 FVNGNQGEVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMC 213
+N N GE+K+ + GLA + V T + P+V + Y+ +D++S G
Sbjct: 133 LINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI 191
Query: 214 ILEMVTFDYPYSECTHPAQIYKKVISG---------------------------KKPEAL 246
E+ P K++ +
Sbjct: 192 FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNV 251
Query: 247 FKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 281
+ R ++ L R+SA E L P+
Sbjct: 252 VPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 3e-30
Identities = 55/264 (20%), Positives = 109/264 (41%), Gaps = 21/264 (7%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+ G A +K +Q + E E +L+ ++ + T
Sbjct: 44 RKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-ET 102
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
++ + + G L + + R V+ + +I+ L +LH +I+RD+K +NI
Sbjct: 103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL--GIIYRDIKLENI 160
Query: 158 FVNGNQGEVKIGDLGLAAIL---RKSHAARCVGTPEFMAPEVY---EEEYNELVDIYSFG 211
++ N G V + D GL+ A GT E+MAP++ + +++ VD +S G
Sbjct: 161 LLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLG 219
Query: 212 MCILEMVTFDYPY---SECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSS 267
+ + E++T P+ E A+I ++++ + P + + I++ L
Sbjct: 220 VLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALAKDLIQRLLMKDPKK 277
Query: 268 RLS-----ARELLTDPFLQIDDYD 286
RL A E+ F Q ++D
Sbjct: 278 RLGCGPRDADEIKEHLFFQKINWD 301
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 7e-30
Identities = 47/256 (18%), Positives = 94/256 (36%), Gaps = 25/256 (9%)
Query: 36 RHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95
+ VA +K + S E E ++K ++++ V +
Sbjct: 40 VAKGVVKDEPETRVA---IKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL--GVVSQ 94
Query: 96 NRNINFVTEMFTSGTLRQYRLKHRRV----------NIRAVKHWCRQILSGLLYLHSRDP 145
+ + E+ T G L+ Y R ++ + +I G+ YL++
Sbjct: 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-- 152
Query: 146 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC----VGTPEFMAPEVYE-EE 200
+HRDL N V + VKIGD G+ + ++ R + +M+PE +
Sbjct: 153 KFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV 211
Query: 201 YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 260
+ D++SFG+ + E+ T + Q+ + V+ G + + + +
Sbjct: 212 FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC-PDMLFELMRM 270
Query: 261 CLAT-VSSRLSARELL 275
C R S E++
Sbjct: 271 CWQYNPKMRPSFLEII 286
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 116 bits (292), Expect = 2e-29
Identities = 35/245 (14%), Positives = 81/245 (33%), Gaps = 28/245 (11%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+ + +VA +K +L E K L + +
Sbjct: 22 FEGTNLLNNQQVA---IKFEPRRSDAPQLRD---EYRTYKLLAGCTGIPNVYYFGQEGLH 75
Query: 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 157
N+ V ++ L R+ +++ V +Q+L+ + +H + +++RD+K DN
Sbjct: 76 NV-LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNF 132
Query: 158 FVN----GNQGEVKIGDLGLAAILRKSHAARC---------VGTPEFMAPEVYE-EEYNE 203
+ N + + D G+ R + GT +M+ + E +
Sbjct: 133 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSR 192
Query: 204 LVDIYSFGMCILEMVT--FDYPYSECTHPAQIYKKVISGKKP---EALFKVEDPEVRQFI 258
D+ + G + + + + Q Y+++ K+ L E +++
Sbjct: 193 RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYM 252
Query: 259 EKCLA 263
Sbjct: 253 HYARN 257
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 3e-29
Identities = 55/255 (21%), Positives = 105/255 (41%), Gaps = 32/255 (12%)
Query: 46 GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANRNINFVTE 104
+VA VK+ + ++L L E+ ++K + KH+NI+ + + + + E
Sbjct: 45 VTKVA---VKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVE 99
Query: 105 MFTSGTLRQY----------------RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVI 148
+ G LR+Y +++ + + Q+ G+ YL S+ I
Sbjct: 100 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK--KCI 157
Query: 149 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR----CVGTPEFMAPEVYEEE-YNE 203
HRDL N+ V + +KI D GLA + + ++MAPE + Y
Sbjct: 158 HRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH 216
Query: 204 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 263
D++SFG+ + E+ T +++K + G + + E+ + C
Sbjct: 217 QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNC-TNELYMMMRDCWH 275
Query: 264 TV-SSRLSARELLTD 277
V S R + ++L+ D
Sbjct: 276 AVPSQRPTFKQLVED 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 3e-28
Identities = 53/263 (20%), Positives = 92/263 (34%), Gaps = 30/263 (11%)
Query: 36 RHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95
+ VA VK+ + E L E+ +L + H +
Sbjct: 33 DAFGIDKTATCRTVA---VKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89
Query: 96 NRNINFVTEMFTSGTLRQYRLKHRR----------------VNIRAVKHWCRQILSGLLY 139
+ + E G L Y R + + + + Q+ G+ +
Sbjct: 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 149
Query: 140 LHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS----HAARCVGTPEFMA-P 194
L SR IHRDL NI ++ VKI D GLA + K ++MA
Sbjct: 150 LASR--KCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 206
Query: 195 EVYEEEYNELVDIYSFGMCILEMVTFDY-PYSECTHPAQIYKKVISGKKPEALFKVEDPE 253
+++ Y D++SFG+ + E+ + PY + +++ G + PE
Sbjct: 207 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR-APDYTTPE 265
Query: 254 VRQFIEKCLAT-VSSRLSARELL 275
+ Q + C S R + EL+
Sbjct: 266 MYQTMLDCWHGEPSQRPTFSELV 288
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 3e-27
Identities = 68/277 (24%), Positives = 105/277 (37%), Gaps = 39/277 (14%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD--TA 95
AFD G+ VA ++ QS +R Y E+ LLK +KH N++ + +
Sbjct: 35 CAAFDTKTGLRVAVKKLSRP--FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 92
Query: 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 155
+ G +K +++ V+ QIL GL Y+HS D +IHRDLK
Sbjct: 93 EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPS 150
Query: 156 NIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMC 213
N+ VN E+KI D GLA T + APE+ YN+ VDI+S G
Sbjct: 151 NLAVN-EDCELKILDFGLARHTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCI 208
Query: 214 ILEMVTFDYPYSECTHPAQIYK----------------------------KVISGKKPEA 245
+ E++T + H Q+ +
Sbjct: 209 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN 268
Query: 246 LFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 281
+F +P +EK L R++A + L +
Sbjct: 269 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 6e-24
Identities = 64/300 (21%), Positives = 110/300 (36%), Gaps = 54/300 (18%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA-- 95
A+D VA ++ Q+ +R Y E+ L+K + H+NI+ +
Sbjct: 34 CAAYDAVLDRNVAIKKLSRP--FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 91
Query: 96 --NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 153
+++ V E+ + + ++ + + Q+L G+ +LHS IHRDLK
Sbjct: 92 EEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGI--IHRDLK 146
Query: 154 CDNIFVNGNQGEVKIGDLGLAAILRKSHAARC-VGTPEFMAPE-VYEEEYNELVDIYSFG 211
NI V + +KI D GLA S V T + APE + Y E VDI+S G
Sbjct: 147 PSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 205
Query: 212 MCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF------------------------ 247
+ EMV + + Q K + P F
Sbjct: 206 CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFP 265
Query: 248 ---------------KVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRM 291
K++ + R + K L + R+S + L P++ + +++
Sbjct: 266 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEA 325
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 87.4 bits (215), Expect = 4e-19
Identities = 62/319 (19%), Positives = 108/319 (33%), Gaps = 71/319 (22%)
Query: 38 YRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97
+ A D VA V+ E EI LL+ + + K + + +
Sbjct: 30 WLAKDMVNNTHVAMKIVR-----GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 84
Query: 98 NINFVTEMFTSGTLRQY--------------RLKHRRVNIRAVKHWCRQILSGLLYLHSR 143
++ +G + +HR + + VK +Q+L GL Y+H R
Sbjct: 85 LLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR 144
Query: 144 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA----AILRKSHAARCVGTPEFMAPEVYE- 198
+IH D+K +N+ + + + +A A H + T E+ +PEV
Sbjct: 145 -CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLG 203
Query: 199 EEYNELVDIYSFGMCILEMVTFDYPYS---------ECTHPAQIYK-------------- 235
+ DI+S I E++T D+ + + H AQI +
Sbjct: 204 APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGK 263
Query: 236 ------------KVISGKKPEALFKV----------EDPEVRQFIEKCLAT-VSSRLSAR 272
+ IS K L V E E+ F+ L R A
Sbjct: 264 YTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323
Query: 273 ELLTDPFLQIDDYDSDLRM 291
L+ P+L+ ++R+
Sbjct: 324 GLVNHPWLKDTLGMEEIRV 342
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 57.9 bits (139), Expect = 3e-10
Identities = 33/199 (16%), Positives = 65/199 (32%), Gaps = 35/199 (17%)
Query: 24 EDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRN 83
E + +VK + + +F + + D S + E L+ L+
Sbjct: 22 EKFGECVVKFHKVGHTSFKK------VKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA 75
Query: 84 IMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR 143
+ K Y N + E+ + L + R+++ IL + + R
Sbjct: 76 VPKVYA-----WEGNA-VLMELIDAKELYRVRVENPD-------EVLDMILEEVAKFYHR 122
Query: 144 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEV------Y 197
++H DL N+ V+ + I D + + + E + +V +
Sbjct: 123 --GIVHGDLSQYNVLVSEEG--IWIIDFPQSVEVGEEGW------REILERDVRNIITYF 172
Query: 198 EEEYNELVDIYSFGMCILE 216
Y DI S IL+
Sbjct: 173 SRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 738 | |||
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.49 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.49 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.89 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.32 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.89 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.62 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=424.27 Aligned_cols=257 Identities=48% Similarity=0.885 Sum_probs=235.8
Q ss_pred CEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC--CCCEEE
Q ss_conf 008999810297479999995799199999975156679988999999999999937999843045797845--898599
Q 004672 23 MEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT--ANRNIN 100 (738)
Q Consensus 23 y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~--~~~~i~ 100 (738)
|++.++||+|+||+||+|.+..++..||+|.+.... ......+++.+|+++|++++|||||+++++|... ....++
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHH--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEE
T ss_conf 885169700828499999999999599999985122--798999999999999985799985069999840334588899
Q ss_pred EEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHHHHHHCC
Q ss_conf 99923799999999996699999999999999999999988199990304687551798089992999415326875202
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~~~~~~ 180 (738)
+||||+++|+|.+++.+.+.+++..++.|++||+.||.|||+++++|+||||||+|||++...+.+||+|||+|......
T Consensus 89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEECCCCCEEEEECCCCEECCCC
T ss_conf 99957898948999751355469999999999999999999789979968767435116679998898005765423687
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 45533699887893210124683100002102266555258999999998999999991999963446899589999999
Q 004672 181 HAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 260 (738)
Q Consensus 181 ~~~~~~GTp~YmAPEvl~~~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~p~~l~~~~spel~~lI~k 260 (738)
.....+||+.|||||++.+.|+.++|||||||++|+|++|+.||.+..+..++++.+..+..|..+....++++++||.+
T Consensus 169 ~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~ 248 (270)
T d1t4ha_ 169 FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 248 (270)
T ss_dssp SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHH
T ss_pred CCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHH
T ss_conf 66775538130089884789998671100799999998788999876559999999973899865675578999999999
Q ss_pred HHH-CCCCCCCHHHHHCCCCCC
Q ss_conf 972-727998999895294568
Q 004672 261 CLA-TVSSRLSARELLTDPFLQ 281 (738)
Q Consensus 261 cL~-dP~~RpSa~ELL~Hpfl~ 281 (738)
||. +|.+|||+.|+|+||||+
T Consensus 249 ~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 249 CIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HSCSSGGGSCCHHHHHTSGGGC
T ss_pred HCCCCHHHCCCHHHHHCCCCCC
T ss_conf 7637975892999996775409
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=412.51 Aligned_cols=259 Identities=24% Similarity=0.414 Sum_probs=221.6
Q ss_pred CCCCCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC
Q ss_conf 76789900899981029747999999579919999997515667998899999999999993799984304579784589
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 96 (738)
++..++|.++++||+|+||+||+|.+..+|..||+|.++... .+...+++.+|+.+|+.++|||||+++++|.+ .
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~ 76 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--D 76 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC---CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC--S
T ss_pred CCCCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH---CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--C
T ss_conf 787568889789712778099999998999699999987540---97899999999999986799999949999998--9
Q ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEECCCCCCCEEEECCCCCEEEECCCHHH
Q ss_conf 8599999237999999999966999999999999999999999881-999903046875517980899929994153268
Q 004672 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 97 ~~i~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs-~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~ 175 (738)
..+++||||++||+|.+++.+.+.+++..++.++.||+.||.|||+ ++ |+||||||+|||++.+ |.+||+|||+|.
T Consensus 77 ~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~-~~vkl~DFGla~ 153 (322)
T d1s9ja_ 77 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSG 153 (322)
T ss_dssp SEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTT-CCEEECCCCCCH
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEECCC-CCEEEEECCCCC
T ss_conf 9999999767998689987424999999999999999999999998599--9714457799468789-989995487762
Q ss_pred HHHCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH-H--------------------
Q ss_conf 752024553369988789321012-468310000210226655525899999999899-9--------------------
Q 004672 176 ILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ-I-------------------- 233 (738)
Q Consensus 176 ~~~~~~~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~-i-------------------- 233 (738)
........+.+||+.|||||++.+ .|+.++||||+||++|+|++|+.||........ .
T Consensus 154 ~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 154 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp HHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred CCCCCCCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC
T ss_conf 56788621113771411946875899894888998999999999888998998878999999887517754577421233
Q ss_pred --------------------HHHHHCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCC
Q ss_conf --------------------999991999963446899589999999972-72799899989529456877
Q 004672 234 --------------------YKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 234 --------------------~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpfl~~~ 283 (738)
...+.....|.......++++++||.+||. +|.+||||.|+|+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCC
T ss_conf 32211112223541347788766502687667644489999999999868994679089999609864769
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=410.24 Aligned_cols=255 Identities=31% Similarity=0.454 Sum_probs=222.7
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEE
Q ss_conf 89900899981029747999999579919999997515667998899999999999993799984304579784589859
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~i 99 (738)
.++|.++++||+|+||+||+|.+..+|..||+|+++..... ..+.+.+|+.+|+.++|||||+++++|.+ ...+
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~ 92 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLV--GDEL 92 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS----CHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEE
T ss_pred CCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCH----HHHHHHHHHHHHHHCCCCCEEEEEEEEEE--CCEE
T ss_conf 10538878981285829999999899989999998430172----79999999999986799988058577988--9998
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHHHHHHC
Q ss_conf 99992379999999999669999999999999999999998819999030468755179808999299941532687520
Q 004672 100 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~~~~~ 179 (738)
|+||||++||+|.+++.+ +.+++..++.|++||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+|..+..
T Consensus 93 ~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~-~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 93 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITP 168 (293)
T ss_dssp EEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECCS
T ss_pred EEEEEECCCCCHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHEEECCC-CCEEECCCHHHEEECC
T ss_conf 999970379808988641-59999999999999999999999879--7226776888688789-9686425156413213
Q ss_pred C--CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHH
Q ss_conf 2--4553369988789321012-468310000210226655525899999999899999999199996344689958999
Q 004672 180 S--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 256 (738)
Q Consensus 180 ~--~~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~p~~l~~~~spel~~ 256 (738)
. .....+||+.|||||++.+ .|+.++||||||+++|+|+||+.||.+......++..+..+..+...+...++++++
T Consensus 169 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 248 (293)
T d1yhwa1 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248 (293)
T ss_dssp TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHH
T ss_pred CCCCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHH
T ss_conf 66644444447773682664479988012031372999998048899899799999999985799988885537999999
Q ss_pred HHHHHHH-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf 9999972-727998999895294568777
Q 004672 257 FIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 257 lI~kcL~-dP~~RpSa~ELL~Hpfl~~~~ 284 (738)
||.+||. +|.+|||+.|+|+||||+...
T Consensus 249 li~~~L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 249 FLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 99998669966890999996499657788
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=411.14 Aligned_cols=255 Identities=23% Similarity=0.344 Sum_probs=223.3
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEE
Q ss_conf 89900899981029747999999579919999997515667998899999999999993799984304579784589859
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~i 99 (738)
.++|++++.||+|+||+||+|.+..+|..||+|+++... ..+..+++.+|+.+|+.++||||++++++|.+ ...+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~--~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEE--TTEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHH---CCHHHHHHHHHHHHHHHCCCCCEEEEEEEECC--CCEE
T ss_conf 746089989721748099999999999799999984566---41279999999999985799888469654046--7436
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHHHHHHC
Q ss_conf 99992379999999999669999999999999999999998819999030468755179808999299941532687520
Q 004672 100 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~~~~~ 179 (738)
|+||||+++|+|.+++.+.+.+++..++.+++||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|.....
T Consensus 79 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~-~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRY 155 (271)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTTCEECEE
T ss_pred EEEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHEEECCC-CCEEECCCHHHEEECC
T ss_conf 798864589808999753799999999999999999999999759--8357546899788789-9879832314224046
Q ss_pred C----CCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHH
Q ss_conf 2----4553369988789321012-4-68310000210226655525899999999899999999199996344689958
Q 004672 180 S----HAARCVGTPEFMAPEVYEE-E-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 253 (738)
Q Consensus 180 ~----~~~~~~GTp~YmAPEvl~~-~-ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~p~~l~~~~spe 253 (738)
. .....+||+.|||||++.+ . ++.++||||+|+++|+|+||+.||....+....+............+...+++
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 235 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 235 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHH
T ss_pred CCCCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHH
T ss_conf 88653111325574742872861899999710161737999999829978888985999999986388878864469999
Q ss_pred HHHHHHHHHH-CCCCCCCHHHHHCCCCCCC
Q ss_conf 9999999972-7279989998952945687
Q 004672 254 VRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 254 l~~lI~kcL~-dP~~RpSa~ELL~Hpfl~~ 282 (738)
+++||.+||. +|.+|||+.|+|+||||+.
T Consensus 236 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 236 PLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 999999976799668909999961984585
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=402.37 Aligned_cols=269 Identities=22% Similarity=0.311 Sum_probs=229.1
Q ss_pred CCCCCCCCCCCCCCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEE
Q ss_conf 78995434676789900899981029747999999579919999997515667998899999999999993799984304
Q 004672 8 NQIPPSLLKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKF 87 (738)
Q Consensus 8 ~~~~~~~~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl 87 (738)
.|.|..+...--+++|.+++.||+|+||+||+|.+..+|..||+|++... .....+.+.+|+.+|+.|+|||||++
T Consensus 13 ~p~p~~l~~~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~~ 88 (350)
T d1koaa2 13 YPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNL 88 (350)
T ss_dssp CCCCCCCBCSCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC----SHHHHHHHHHHHHHHHHTCCTTBCCE
T ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC----CHHHHHHHHHHHHHHHHCCCCCCCCE
T ss_conf 89987689887865758988984076819999998899989999998452----43169999999999986799799929
Q ss_pred EEEEEECCCCEEEEEEECCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEEC-CCCC
Q ss_conf 579784589859999923799999999996-69999999999999999999998819999030468755179808-9992
Q 004672 88 YTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG-NQGE 165 (738)
Q Consensus 88 ~~~fv~~~~~~i~LV~Ey~~gGSL~~~l~k-~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~-~~g~ 165 (738)
+++|.+ ...+++||||++||+|.+++.+ .+++++..++.|++||+.||.|||+++ |+||||||+|||++. ..+.
T Consensus 89 ~~~~~~--~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~ 164 (350)
T d1koaa2 89 HDAFED--DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNE 164 (350)
T ss_dssp EEEEEE--TTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCC
T ss_pred EEEEEE--CCEEEEEEECCCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--CEEEEECHHHEEECCCCCCE
T ss_conf 999998--99999999857998899999762378999999999999999999997569--76000154673641688986
Q ss_pred EEEECCCHHHHHHCCC-CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC-
Q ss_conf 9994153268752024-553369988789321012-4683100002102266555258999999998999999991999-
Q 004672 166 VKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK- 242 (738)
Q Consensus 166 VKL~DFGlA~~~~~~~-~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~- 242 (738)
+||+|||+|..+.... .....||+.|||||++.+ .|+.++|||||||++|+|+||..||.+ .+..+++..+..+..
T Consensus 165 vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~ 243 (350)
T d1koaa2 165 LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWN 243 (350)
T ss_dssp EEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCC
T ss_pred EEEEECCHHEECCCCCCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHHCCCC
T ss_conf 999545210442565432000686242188997589987267655465999999859899899-7999999999847889
Q ss_pred -CCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCCC
Q ss_conf -963446899589999999972-7279989998952945687777
Q 004672 243 -PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 285 (738)
Q Consensus 243 -p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpfl~~~~~ 285 (738)
+.......++++++||.+||. +|.+|||+.|+|+||||+....
T Consensus 244 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 244 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCC
T ss_conf 894223589999999999975689667908999862913288988
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=404.83 Aligned_cols=254 Identities=25% Similarity=0.384 Sum_probs=223.9
Q ss_pred CCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEE
Q ss_conf 90089998102974799999957991999999751566799889999999999999379998430457978458985999
Q 004672 22 DMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 22 ~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~i~L 101 (738)
.|+.+++||+|+||+||+|.+..+|..||+|+++... .......+.+.+|+.+|+.|+|||||+++++|.+ ...+|+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~i 92 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWL 92 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCS-SCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE--CCEEEE
T ss_conf 5676279701888099999998999399999984444-3588999999999999997789998238999998--998899
Q ss_pred EEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHHHHHHCCC
Q ss_conf 99237999999999966999999999999999999999881999903046875517980899929994153268752024
Q 004672 102 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH 181 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~~~~~~~ 181 (738)
||||+.+|+|..++...+++++..++.+++||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|......
T Consensus 93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~-~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETT-TEEEECCCTTCBSSSSB-
T ss_pred EEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCCCEEEECCC-CCEEEEECCCCCCCCCC-
T ss_conf 9980699945789973799999999999999999999998689--7666788421798799-97898443653346778-
Q ss_pred CCCCCCCCCCCCCCCCC----CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHHH
Q ss_conf 55336998878932101----24683100002102266555258999999998999999991999963446899589999
Q 004672 182 AARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 257 (738)
Q Consensus 182 ~~~~~GTp~YmAPEvl~----~~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~p~~l~~~~spel~~l 257 (738)
....||+.|||||++. +.|+.++|||||||++|+|++|..||.+. +..+....+..+..|.......++++++|
T Consensus 169 -~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~s~~~~~l 246 (309)
T d1u5ra_ 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSGHWSEYFRNF 246 (309)
T ss_dssp -CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSCTTSCHHHHHH
T ss_pred -CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHHCCCCCCCCCCCCHHHHHH
T ss_conf -7313476636889983467888672145455899999998788999997-99999999982899988878889999999
Q ss_pred HHHHHH-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf 999972-727998999895294568777
Q 004672 258 IEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 258 I~kcL~-dP~~RpSa~ELL~Hpfl~~~~ 284 (738)
|.+||. +|.+|||+.|+|+||||....
T Consensus 247 i~~~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 247 VDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp HHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHCCCCHHHCCCHHHHHHCHHHCCCC
T ss_conf 9997737965791899997199753789
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=408.20 Aligned_cols=256 Identities=23% Similarity=0.361 Sum_probs=227.0
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCC
Q ss_conf 67899008999810297479999995799199999975156679988999999999999937999843045797845898
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 97 (738)
..+++|.+++.||+|+||+||+|.++.+|..||+|.+...... .....+++.+|+.+|+.++||||++++++|.+ ..
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~ 79 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--AT 79 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SS
T ss_pred CCHHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCC-CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE--CC
T ss_conf 6153769988985177858999999899949999998168856-76899999999999985688888859999998--99
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHHHHH
Q ss_conf 59999923799999999996699999999999999999999988199990304687551798089992999415326875
Q 004672 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 98 ~i~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~~~ 177 (738)
.+++||||+++|+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|...
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~-~~~kl~DFG~a~~~ 156 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSA-GELKIADFGWSVHA 156 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCCSCSCC
T ss_pred EEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEEEECCCCCEECCC-CCEEECCCCEEEEC
T ss_conf 98999850479858988750489999999999999999999999889--4652202344146689-98711555633544
Q ss_pred HCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHH
Q ss_conf 20245533699887893210124-68310000210226655525899999999899999999199996344689958999
Q 004672 178 RKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 256 (738)
Q Consensus 178 ~~~~~~~~~GTp~YmAPEvl~~~-ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~p~~l~~~~spel~~ 256 (738)
.........||+.|||||++.+. |+.++|||||||++|+|++|+.||.+ .+..+++..+..+..+ ++...++++++
T Consensus 157 ~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~ 233 (263)
T d2j4za1 157 PSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEFT--FPDFVTEGARD 233 (263)
T ss_dssp CCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCCC--CCTTSCHHHHH
T ss_pred CCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHCCCCC--CCCCCCHHHHH
T ss_conf 88852355788763499997589989314404675999998329999888-9999999999718999--98668999999
Q ss_pred HHHHHHH-CCCCCCCHHHHHCCCCCCC
Q ss_conf 9999972-7279989998952945687
Q 004672 257 FIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 257 lI~kcL~-dP~~RpSa~ELL~Hpfl~~ 282 (738)
||.+||. +|.+|||+.|+|+||||+.
T Consensus 234 li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 234 LISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf 999976479768909999971907078
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=402.97 Aligned_cols=257 Identities=29% Similarity=0.452 Sum_probs=227.1
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCE
Q ss_conf 78990089998102974799999957991999999751566799889999999999999379998430457978458985
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 98 (738)
+.++|.+++.||+|+||+||+|.++.+|..||+|.++... .++...+.+.+|+++|+.++||||++++++|.+.....
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 79 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS--MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 79 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTT--SCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----C
T ss_pred CCHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCE
T ss_conf 7333799679830889199999999999799999987465--79799999999999999778999824899999178998
Q ss_pred EEEEEECCCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCEECCCCCCCEEEECCCCCEEEECC
Q ss_conf 9999923799999999996----699999999999999999999988199---990304687551798089992999415
Q 004672 99 INFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRD---PPVIHRDLKCDNIFVNGNQGEVKIGDL 171 (738)
Q Consensus 99 i~LV~Ey~~gGSL~~~l~k----~~~lse~~i~~i~~QIl~aL~yLHs~g---p~IIHrDIKp~NILI~~~~g~VKL~DF 171 (738)
+|+||||+++|+|.+++.+ .+.+++..++.|+.||+.||.|||+++ .+|+||||||+|||++.+ +.+||+||
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~-~~vkl~DF 158 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDF 158 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT-SCEEECCH
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCC-CCEEEEEC
T ss_conf 99999568999389999851545789999999999999999999999716778878858676542574788-85798001
Q ss_pred CHHHHHHCCC--CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 3268752024--553369988789321012-4683100002102266555258999999998999999991999963446
Q 004672 172 GLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFK 248 (738)
Q Consensus 172 GlA~~~~~~~--~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~p~~l~~ 248 (738)
|+|..+.... .....||+.|||||++.+ .|+.++||||||+++|+|+||+.||.+ .+..+++..+..+..+. ++.
T Consensus 159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~-~~~~~~~~~i~~~~~~~-~~~ 236 (269)
T d2java1 159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFRR-IPY 236 (269)
T ss_dssp HHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCC-CCT
T ss_pred CCEEECCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCCCC-CCC
T ss_conf 0003224577755667788232799998399999389887527899998018899899-89999999997189988-974
Q ss_pred CCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCC
Q ss_conf 899589999999972-72799899989529456
Q 004672 249 VEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 280 (738)
Q Consensus 249 ~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpfl 280 (738)
..++++++||.+||. +|.+|||+.|+|+|||+
T Consensus 237 ~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 237 RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHHCCCC
T ss_conf 359999999999767995579189999729819
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=403.50 Aligned_cols=260 Identities=22% Similarity=0.386 Sum_probs=229.3
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCC
Q ss_conf 67899008999810297479999995799199999975156679988999999999999937999843045797845898
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 97 (738)
|++++|.+++.||+|+||+||+|.++.+|..||+|+++..... .....+++.+|+.+|+.++||||++++++|.+ ..
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~ 78 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HD 78 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SS
T ss_pred CCHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC--CC
T ss_conf 8447428988983176849999999899989999998156544-97999999999999986799988778764035--64
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHHHHH
Q ss_conf 59999923799999999996699999999999999999999988199990304687551798089992999415326875
Q 004672 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 98 ~i~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~~~ 177 (738)
.+|+||||++||+|.+++.+.+.+++..++.+++||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+|+..
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~-g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEG 155 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCS
T ss_pred CCCCCEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHEEECCC-CCEEEEECCCCCCC
T ss_conf 21110003579860555532567759999999999965211343159--6224647778476589-98888205652003
Q ss_pred HC--CCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 20--24553369988789321012-4683100002102266555258999999998999999991999963446899589
Q 004672 178 RK--SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEV 254 (738)
Q Consensus 178 ~~--~~~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~p~~l~~~~spel 254 (738)
.. ......+||+.|||||++.+ .|+.++||||+||++|+|++|++||.+ .+..++++.+..+..+ ++...++++
T Consensus 156 ~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~ 232 (337)
T d1o6la_ 156 ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEIR--FPRTLSPEA 232 (337)
T ss_dssp CCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHH
T ss_pred CCCCCCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCCC--CCCCCCHHH
T ss_conf 5678620551008899666650489888333102230678899878999999-6999999998528998--986689999
Q ss_pred HHHHHHHHH-CCCCCCC-----HHHHHCCCCCCCCCCC
Q ss_conf 999999972-7279989-----9989529456877774
Q 004672 255 RQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDDYD 286 (738)
Q Consensus 255 ~~lI~kcL~-dP~~RpS-----a~ELL~Hpfl~~~~~~ 286 (738)
++||.+||+ +|.+|++ +.++++||||+..++.
T Consensus 233 ~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~ 270 (337)
T d1o6la_ 233 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp HHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred HHHHHHHCCCCCHHHCCCCCCCHHHHHCCCCCCCCCHH
T ss_conf 99998666389344225652349999729150369999
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=401.56 Aligned_cols=267 Identities=20% Similarity=0.301 Sum_probs=227.7
Q ss_pred CCCCCCCCCCCCCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEE
Q ss_conf 89954346767899008999810297479999995799199999975156679988999999999999937999843045
Q 004672 9 QIPPSLLKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFY 88 (738)
Q Consensus 9 ~~~~~~~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~ 88 (738)
|.|.....+--.++|++++.||+|+||+||+|.+..+|..||+|+++.. .....+.+.+|+.+|+.|+|||||+++
T Consensus 17 p~p~~~~~~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~~~~Ei~il~~l~HpnIv~~~ 92 (352)
T d1koba_ 17 PQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLHHPKLINLH 92 (352)
T ss_dssp CCCCCCBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCSTTBCCEE
T ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC----CHHHHHHHHHHHHHHHHCCCCCCCCEE
T ss_conf 9986578998540359989993177829999999899979999998872----646799999999999867997989199
Q ss_pred EEEEECCCCEEEEEEECCCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEEC-CCCCE
Q ss_conf 7978458985999992379999999999669-999999999999999999998819999030468755179808-99929
Q 004672 89 TSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG-NQGEV 166 (738)
Q Consensus 89 ~~fv~~~~~~i~LV~Ey~~gGSL~~~l~k~~-~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~-~~g~V 166 (738)
++|.+ ...+|+||||++||+|.+++.+.+ ++++..++.|++||+.||.|||+++ |+||||||+|||++. ..+.+
T Consensus 93 ~~~~~--~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~v 168 (352)
T d1koba_ 93 DAFED--KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSV 168 (352)
T ss_dssp EEEEC--SSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCE
T ss_pred EEEEE--CCEEEEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCCCCCCCCCCCCCEE
T ss_conf 99998--99999999828998088889863899899999999999999999999779--265131445531134678848
Q ss_pred EEECCCHHHHHHCCC-CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--
Q ss_conf 994153268752024-553369988789321012-4683100002102266555258999999998999999991999--
Q 004672 167 KIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK-- 242 (738)
Q Consensus 167 KL~DFGlA~~~~~~~-~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~-- 242 (738)
||+|||+|..+.... .....||+.|||||++.+ .|+.++|||||||++|+|+||..||.+ .+...++..+..+..
T Consensus 169 kL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~ 247 (352)
T d1koba_ 169 KIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEF 247 (352)
T ss_dssp EECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCC
T ss_pred EEEECCCCEECCCCCCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHHCCCCC
T ss_conf 99525630343788720100476453489997479989763338989999999968899899-79999999998478898
Q ss_pred CCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf 963446899589999999972-727998999895294568777
Q 004672 243 PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 243 p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpfl~~~~ 284 (738)
+...+...++++++||.+||. +|.+|||+.|+|+||||+...
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 9300247999999999997569966891899996097348882
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=401.31 Aligned_cols=262 Identities=23% Similarity=0.332 Sum_probs=221.3
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCC--CCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC
Q ss_conf 678990089998102974799999957991999999751566--799889999999999999379998430457978458
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDF--LQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA 95 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~--~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 95 (738)
+++++|.+++.||+|+||+||+|.+..+|..||+|++..... ........+...++.+++.++|||||+++++|..
T Consensus 1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~-- 78 (364)
T d1omwa3 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-- 78 (364)
T ss_dssp CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--
T ss_pred CCHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE--
T ss_conf 977768510188428890999999999997999999845875426679999999999999850899858899999998--
Q ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHHH
Q ss_conf 98599999237999999999966999999999999999999999881999903046875517980899929994153268
Q 004672 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 96 ~~~i~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~ 175 (738)
...+|+||||++||+|.+++.++..+++..++.|++||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+|.
T Consensus 79 ~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~-g~iKl~DFGla~ 155 (364)
T d1omwa3 79 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLAC 155 (364)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-SCEEECCCTTCE
T ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCEEEECCC-CCEEEEEECEEE
T ss_conf 9988999991489838999873255327899999999999999999779--6220444221678588-967982201023
Q ss_pred HHHCCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCHHHHHHHHHCCCCCCCCCC--HHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 75202455336998878932101-2-468310000210226655525899999999--8999999991999963446899
Q 004672 176 ILRKSHAARCVGTPEFMAPEVYE-E-EYNELVDIYSFGMCILEMVTFDYPYSECTH--PAQIYKKVISGKKPEALFKVED 251 (738)
Q Consensus 176 ~~~~~~~~~~~GTp~YmAPEvl~-~-~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~--~~~i~k~i~~g~~p~~l~~~~s 251 (738)
.+.........||+.|||||++. + .|+.++|||||||++|+|+||+.||..... ...+...+ ...+..++...+
T Consensus 156 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~s 233 (364)
T d1omwa3 156 DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFS 233 (364)
T ss_dssp ECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS--SSCCCCCCSSSC
T ss_pred ECCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHC--CCCCCCCCCCCC
T ss_conf 337886433113455421687603899984410467789999998599988889989999999860--468887887789
Q ss_pred HHHHHHHHHHHH-CCCCCCC-----HHHHHCCCCCCCCCCC
Q ss_conf 589999999972-7279989-----9989529456877774
Q 004672 252 PEVRQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDDYD 286 (738)
Q Consensus 252 pel~~lI~kcL~-dP~~RpS-----a~ELL~Hpfl~~~~~~ 286 (738)
+++++||.+||. +|.+||| |.|+|+||||+..++.
T Consensus 234 ~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~ 274 (364)
T d1omwa3 234 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 274 (364)
T ss_dssp HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred HHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCCCCCCCCCHH
T ss_conf 99999999985669888088743579999749102378987
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=402.49 Aligned_cols=256 Identities=28% Similarity=0.485 Sum_probs=220.0
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEE
Q ss_conf 89900899981029747999999579919999997515667998899999999999993799984304579784589859
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~i 99 (738)
.+.|++++.||+|+||+||+|.+..+|..||+|+++.. +....+.+.+|+.+|+.++|||||+++++|.+ ...+
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~ 84 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNL 84 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE--TTEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCC----CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE--CCEE
T ss_conf 03759847993077819999999999939999998728----99999999999999986799998849889800--9958
Q ss_pred EEEEECCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHHHHHH
Q ss_conf 999923799999999996-6999999999999999999999881999903046875517980899929994153268752
Q 004672 100 NFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k-~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~~~~ 178 (738)
++||||+++|+|.+++.+ .+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+|....
T Consensus 85 ~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~-~~~Kl~DFG~a~~~~ 161 (288)
T d2jfla1 85 WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLD-GDIKLADFGVSAKNT 161 (288)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECH
T ss_pred EEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEEECCHHHEEECCC-CCEEEEECHHHHCCC
T ss_conf 9999627998188999862899999999999999999999999889--8871407003148789-998997161230357
Q ss_pred CC--CCCCCCCCCCCCCCCCCC------CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC-CCCCCC
Q ss_conf 02--455336998878932101------246831000021022665552589999999989999999919999-634468
Q 004672 179 KS--HAARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP-EALFKV 249 (738)
Q Consensus 179 ~~--~~~~~~GTp~YmAPEvl~------~~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~p-~~l~~~ 249 (738)
.. ......||+.|||||++. ..|+.++|||||||++|+|+||+.||.+. +..+++..+..+..+ ...+..
T Consensus 162 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~ 240 (288)
T d2jfla1 162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIAKSEPPTLAQPSR 240 (288)
T ss_dssp HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS-CGGGHHHHHHHSCCCCCSSGGG
T ss_pred CCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHCCCCCCCCCCCC
T ss_conf 786410010256264799998320257888880665787899999982088999998-9999999997079987776566
Q ss_pred CCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCCC
Q ss_conf 99589999999972-7279989998952945687777
Q 004672 250 EDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 285 (738)
Q Consensus 250 ~spel~~lI~kcL~-dP~~RpSa~ELL~Hpfl~~~~~ 285 (738)
.++++++||.+||+ +|.+|||+.|+|+||||+.+..
T Consensus 241 ~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~~ 277 (288)
T d2jfla1 241 WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 277 (288)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCCC
T ss_pred CCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCC
T ss_conf 9999999999976699668919999962923188989
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=398.00 Aligned_cols=256 Identities=19% Similarity=0.326 Sum_probs=224.4
Q ss_pred CCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEE
Q ss_conf 99008999810297479999995799199999975156679988999999999999937999843045797845898599
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~i~ 100 (738)
+.|.+++.||+|+||+||+|.++.+|..||+|.+...... ...+.+.+|+.+|+.++||||++++++|.+ ...+|
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~ 83 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE---GKEGSMENEIAVLHKIKHPNIVALDDIYES--GGHLY 83 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHH---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--CCEEE
T ss_conf 6669988994065839999999999989999998157731---289999999999986799899919899998--99888
Q ss_pred EEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEEC--CCCCEEEECCCHHHHHH
Q ss_conf 9992379999999999669999999999999999999998819999030468755179808--99929994153268752
Q 004672 101 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG--NQGEVKIGDLGLAAILR 178 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~--~~g~VKL~DFGlA~~~~ 178 (738)
+||||++||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||+.. +++.+||+|||+|....
T Consensus 84 lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCE--EEEEEECCCCEEECCCCCCCEEEEECCCEEEECC
T ss_conf 98852689848886530367887899999999999987524130--5568704630011046888249983154358725
Q ss_pred CCC-CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC--CCCCCCCCHHH
Q ss_conf 024-553369988789321012-46831000021022665552589999999989999999919999--63446899589
Q 004672 179 KSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP--EALFKVEDPEV 254 (738)
Q Consensus 179 ~~~-~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~p--~~l~~~~spel 254 (738)
... ....+||+.|||||++.+ .|+.++|||||||++|+|++|..||.+ .+...++..+..+..+ .......++++
T Consensus 162 ~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 240 (307)
T d1a06a_ 162 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSA 240 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred CCCEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCCCCCCCCCCCCCHHH
T ss_conf 89704400328422591887379998078734515999999859799999-89999999986168777876666789999
Q ss_pred HHHHHHHHH-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf 999999972-727998999895294568777
Q 004672 255 RQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 255 ~~lI~kcL~-dP~~RpSa~ELL~Hpfl~~~~ 284 (738)
++||.+||. +|.+|||+.|+|+||||+...
T Consensus 241 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 271 (307)
T d1a06a_ 241 KDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271 (307)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred HHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 9999997608975791899986298447997
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=401.73 Aligned_cols=261 Identities=24% Similarity=0.361 Sum_probs=226.8
Q ss_pred CCCCCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC
Q ss_conf 76789900899981029747999999579919999997515667998899999999999993799984304579784589
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 96 (738)
.+..++|.+++.||+|+||+||+|.++.+|..||+|.++..... .....+.+.+|+.+|+.++||||++++++|.+ .
T Consensus 4 ~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~ 80 (288)
T d1uu3a_ 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--D 80 (288)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC--S
T ss_pred CCCCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE--C
T ss_conf 98998778988985087909999999899979999998657755-77789999999999987688886179999998--9
Q ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHHHH
Q ss_conf 85999992379999999999669999999999999999999998819999030468755179808999299941532687
Q 004672 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 97 ~~i~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~~ 176 (738)
..+|+||||++||+|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+|||++.+ |.+||+|||+|..
T Consensus 81 ~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~-~~vkl~DFG~a~~ 157 (288)
T d1uu3a_ 81 EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNED-MHIQITDFGTAKV 157 (288)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEE
T ss_pred CEEEEEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCC--EECCCCCCCCCCCCCC-CEEEECCCCCCEE
T ss_conf 988999970489877776531599999999999999999997621650--8847677412366888-5388603210242
Q ss_pred HHCC----CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 5202----4553369988789321012-4683100002102266555258999999998999999991999963446899
Q 004672 177 LRKS----HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED 251 (738)
Q Consensus 177 ~~~~----~~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~p~~l~~~~s 251 (738)
+... .....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+...++..+..+... ++...+
T Consensus 158 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s 234 (288)
T d1uu3a_ 158 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLEYD--FPEKFF 234 (288)
T ss_dssp CC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCCC--CCTTCC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCCC--CCCCCC
T ss_conf 2567764333555677552584400268989666230456999998038899899-5999999999718999--985479
Q ss_pred HHHHHHHHHHHH-CCCCCCCHHH------HHCCCCCCCCCCC
Q ss_conf 589999999972-7279989998------9529456877774
Q 004672 252 PEVRQFIEKCLA-TVSSRLSARE------LLTDPFLQIDDYD 286 (738)
Q Consensus 252 pel~~lI~kcL~-dP~~RpSa~E------LL~Hpfl~~~~~~ 286 (738)
+++++||.+||. +|.+|||+.| +++||||+.-++.
T Consensus 235 ~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~ 276 (288)
T d1uu3a_ 235 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 276 (288)
T ss_dssp HHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred HHHHHHHHHHCCCCHHHCCCHHHHCCCHHHHCCCCCCCCCHH
T ss_conf 999999999855797689197897377898769764789988
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=398.13 Aligned_cols=260 Identities=23% Similarity=0.380 Sum_probs=227.5
Q ss_pred CCCCCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC
Q ss_conf 76789900899981029747999999579919999997515667998899999999999993799984304579784589
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 96 (738)
...+++|.+++.||+|+||+||+|.++.+|..||+|++...... .....+++.+|+.+|+.++||||++++++|.. .
T Consensus 37 ~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~ 113 (350)
T d1rdqe_ 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--N 113 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--S
T ss_pred CCCCCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCC-CHHHHHHHHHHHHHHHHCCCCCEEECCCCCCC--C
T ss_conf 88723708988961176808999999899989999998267745-88999999999999997487727403444432--2
Q ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHHHH
Q ss_conf 85999992379999999999669999999999999999999998819999030468755179808999299941532687
Q 004672 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 97 ~~i~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~~ 176 (738)
..+++||||+.+|+|..++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+|..
T Consensus 114 ~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~-g~ikL~DFG~a~~ 190 (350)
T d1rdqe_ 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKR 190 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEE
T ss_pred CCCCCCCCCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHCCCCCC-CCEEEEECEEEEE
T ss_conf 222322223346622666751589899999999999999899998599--8617679999360778-9788610103332
Q ss_pred HHCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHH
Q ss_conf 52024553369988789321012-46831000021022665552589999999989999999919999634468995899
Q 004672 177 LRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVR 255 (738)
Q Consensus 177 ~~~~~~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~p~~l~~~~spel~ 255 (738)
+... .....||+.|||||++.+ .|+.++|||||||++|+|+||..||.+ .+...++..+..+..+ .+...++++.
T Consensus 191 ~~~~-~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~ 266 (350)
T d1rdqe_ 191 VKGR-TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKVR--FPSHFSSDLK 266 (350)
T ss_dssp CSSC-BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTCCHHHH
T ss_pred CCCC-CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCCC--CCCCCCHHHH
T ss_conf 2566-6433676356788997179988533114500789999758899899-5999999998617988--9766899999
Q ss_pred HHHHHHHH-CCCCCC-----CHHHHHCCCCCCCCCCC
Q ss_conf 99999972-727998-----99989529456877774
Q 004672 256 QFIEKCLA-TVSSRL-----SARELLTDPFLQIDDYD 286 (738)
Q Consensus 256 ~lI~kcL~-dP~~Rp-----Sa~ELL~Hpfl~~~~~~ 286 (738)
+||.+||. +|.+|+ |+.++|+||||+..++.
T Consensus 267 ~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~ 303 (350)
T d1rdqe_ 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred HHHHHHHHHCHHHCCCCCCCCHHHHHCCCCCCCCCHH
T ss_conf 9999983409986065534549999719051589989
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=396.26 Aligned_cols=258 Identities=24% Similarity=0.412 Sum_probs=227.1
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCE
Q ss_conf 78990089998102974799999957991999999751566799889999999999999379998430457978458985
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 98 (738)
.+++|++++.||+|+||+||+|.++.+|..||+|+++..... .....+++.+|+.+|+.++||||++++++|.+ ...
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~ 78 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQ 78 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSE
T ss_pred CHHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCC-CHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEE--CCE
T ss_conf 654708888972076808999999899979999998457754-88999999999999986369675330356852--880
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHHHHHH
Q ss_conf 99999237999999999966999999999999999999999881999903046875517980899929994153268752
Q 004672 99 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 99 i~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~~~~ 178 (738)
+|+||||+.||+|..++.....+++..++.+++||+.||.|||+++ |+||||||+|||++.+ |.+||+|||+|....
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~-g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN-GHIKITDFGFAKYVP 155 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTT-SCEEECCCSSCEECS
T ss_pred EEEEEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCC--EECCCCCCHHEEECCC-CCEEEECCCCCEEEC
T ss_conf 0567650378632234322221110079999999987655412476--7705568105038689-988983175216712
Q ss_pred CCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHHH
Q ss_conf 024553369988789321012-4683100002102266555258999999998999999991999963446899589999
Q 004672 179 KSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 257 (738)
Q Consensus 179 ~~~~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~p~~l~~~~spel~~l 257 (738)
.. ....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++..+..+..+ ++...+++++++
T Consensus 156 ~~-~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~l 231 (316)
T d1fota_ 156 DV-TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAELR--FPPFFNEDVKDL 231 (316)
T ss_dssp SC-BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHH
T ss_pred CC-CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCCC--CCCCCCHHHHHH
T ss_conf 45-6434576343599998389998043046533368999759899999-6999999999708988--997789999999
Q ss_pred HHHHHH-CCCCCC-----CHHHHHCCCCCCCCCCC
Q ss_conf 999972-727998-----99989529456877774
Q 004672 258 IEKCLA-TVSSRL-----SARELLTDPFLQIDDYD 286 (738)
Q Consensus 258 I~kcL~-dP~~Rp-----Sa~ELL~Hpfl~~~~~~ 286 (738)
|.+||. +|.+|+ |+.++|+||||+..++.
T Consensus 232 i~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~ 266 (316)
T d1fota_ 232 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 266 (316)
T ss_dssp HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred HHHHHHHCHHHCCCCCHHHHHHHHCCCCCCCCCHH
T ss_conf 99995449976664310219999819351467989
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=392.46 Aligned_cols=260 Identities=20% Similarity=0.342 Sum_probs=226.0
Q ss_pred CCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCC--CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCE
Q ss_conf 99008999810297479999995799199999975156679--9889999999999999379998430457978458985
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQ--SPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~--s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 98 (738)
+.|.+++.||+|+||+||+|.++.+|..||+|+++...... .....+.+.+|+.+|+.|+|||||+++++|.+ ...
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~ 87 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KTD 87 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--CCE
T ss_conf 677982798117895999999999998999999875663213406899999999999986799899938899997--998
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCC---CCEEEECCCHHH
Q ss_conf 99999237999999999966999999999999999999999881999903046875517980899---929994153268
Q 004672 99 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ---GEVKIGDLGLAA 175 (738)
Q Consensus 99 i~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~---g~VKL~DFGlA~ 175 (738)
+++||||+++|+|.+++...+.+++..++.+++||+.||.|||+++ |+||||||+|||++.+. ..+||+|||+|.
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEECCCCCCCCCHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCCCEEEEECCCCCCCCEEECCHHHHH
T ss_conf 9999986778643100103564215578999999999987666254--22113330127982589866646964334421
Q ss_pred HHHCC-CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--CCCCCCCCC
Q ss_conf 75202-4553369988789321012-4683100002102266555258999999998999999991999--963446899
Q 004672 176 ILRKS-HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVED 251 (738)
Q Consensus 176 ~~~~~-~~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~--p~~l~~~~s 251 (738)
..... ......||+.|+|||++.+ .|+.++||||+|+++|+|+||+.||.+ .+..+++..+..+.. +...+...+
T Consensus 166 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (293)
T d1jksa_ 166 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTS 244 (293)
T ss_dssp ECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred HCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHHCCCCCCCHHCCCCC
T ss_conf 05777631224777743099998189999766522140999999708899889-99999999998168888701047889
Q ss_pred HHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCCC
Q ss_conf 589999999972-7279989998952945687777
Q 004672 252 PEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 285 (738)
Q Consensus 252 pel~~lI~kcL~-dP~~RpSa~ELL~Hpfl~~~~~ 285 (738)
+++++||.+||. +|.+|||+.|+|+||||+..+.
T Consensus 245 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred HHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCH
T ss_conf 99999999986389668919999961904188870
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=388.21 Aligned_cols=254 Identities=22% Similarity=0.306 Sum_probs=221.9
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEE
Q ss_conf 89900899981029747999999579919999997515667998899999999999993799984304579784589859
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~i 99 (738)
+++|.+++.||+|+||+||+|.++.+|..||+|.++... .....+.+|+.+|+.++||||++++++|.+ ...+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~ 76 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFES--MEEL 76 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-----CCHHHHHHHHHHHHHCCCCCCCEEEEEEEE--CCEE
T ss_conf 010588789831778399999998999699999975786-----659999999999985799798909899988--9988
Q ss_pred EEEEECCCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECC-CCCEEEECCCHHHHH
Q ss_conf 99992379999999999669-9999999999999999999988199990304687551798089-992999415326875
Q 004672 100 NFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN-QGEVKIGDLGLAAIL 177 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~~-~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~-~g~VKL~DFGlA~~~ 177 (738)
|+||||++||+|.+++...+ .+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ ...+||+|||++...
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEECCCCCEEEEECCCCHHHCC
T ss_conf 9999538998088998753899999999999999999999998769--97513554443443788518997644111003
Q ss_pred HCCC-CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--CCCCCCCCCHH
Q ss_conf 2024-553369988789321012-4683100002102266555258999999998999999991999--96344689958
Q 004672 178 RKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPE 253 (738)
Q Consensus 178 ~~~~-~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~--p~~l~~~~spe 253 (738)
.... .....||+.|+|||++.+ .|+.++||||+||++|+|++|..||.. .+...++..+..+.. +...+...+++
T Consensus 155 ~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T d1tkia_ 155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred CCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCC-CCHHHHHHHHHHCCCCCCHHHCCCCCHH
T ss_conf 467753212233222340210487778401130279999999828999999-8999999999838999880223678999
Q ss_pred HHHHHHHHHH-CCCCCCCHHHHHCCCCCCCC
Q ss_conf 9999999972-72799899989529456877
Q 004672 254 VRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 254 l~~lI~kcL~-dP~~RpSa~ELL~Hpfl~~~ 283 (738)
+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 234 ~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 9999999866996689099999639965667
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=386.88 Aligned_cols=257 Identities=22% Similarity=0.381 Sum_probs=221.6
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHH-HCCCCCCCEEEEEEEECCCCE
Q ss_conf 8990089998102974799999957991999999751566799889999999999999-379998430457978458985
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLK-TLKHRNIMKFYTSWVDTANRN 98 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk-~L~HpNIVkl~~~fv~~~~~~ 98 (738)
+++|.+++.||+|+||+||+|.++.+|..||+|+++...... ....+.+..|+.++. .++||||++++++|.+ +..
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~--~~~ 77 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KEN 77 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSE
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCC-HHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC--CCC
T ss_conf 997188658940878289999999999899999980555338-48999999999999984799968789889704--983
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHHHHHH
Q ss_conf 99999237999999999966999999999999999999999881999903046875517980899929994153268752
Q 004672 99 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 178 (738)
Q Consensus 99 i~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~~~~ 178 (738)
+|+||||+++|+|.+++....++++..++.++.||+.||.|||+++ |+||||||+|||++.+ |.+||+|||++....
T Consensus 78 ~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~-~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 78 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKD-GHIKIADFGMCKENM 154 (320)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCCC
T ss_pred EEEEEEECCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCCCCEEECCC-CCEECCCCCHHHHCC
T ss_conf 1677750379808998640478999999999999999999998689--3403476540444489-963015553023235
Q ss_pred CC--CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHH
Q ss_conf 02--4553369988789321012-46831000021022665552589999999989999999919999634468995899
Q 004672 179 KS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVR 255 (738)
Q Consensus 179 ~~--~~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~p~~l~~~~spel~ 255 (738)
.. ......||+.|+|||++.+ .|+.++||||+||++|+|+||+.||.+ .+..+++..+..+..+ ++...+++++
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~ 231 (320)
T d1xjda_ 155 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNPF--YPRWLEKEAK 231 (320)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHH
T ss_pred CCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHCCCCC--CCCCCCHHHH
T ss_conf 665334545787776899998279988323201122789898738899999-8999999999718998--9756799999
Q ss_pred HHHHHHHH-CCCCCCCHH-HHHCCCCCCCCCC
Q ss_conf 99999972-727998999-8952945687777
Q 004672 256 QFIEKCLA-TVSSRLSAR-ELLTDPFLQIDDY 285 (738)
Q Consensus 256 ~lI~kcL~-dP~~RpSa~-ELL~Hpfl~~~~~ 285 (738)
+||.+||. +|.+||++. ++++||||+.-++
T Consensus 232 dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 232 DLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp HHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred HHHHHHCCCCCCCCCCHHHHHHHCCHHCCCCH
T ss_conf 99999654489878388999980901315899
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=380.09 Aligned_cols=257 Identities=22% Similarity=0.347 Sum_probs=224.0
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCC-----HHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEE
Q ss_conf 8990089998102974799999957991999999751566799-----889999999999999379-9984304579784
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQS-----PEELERLYCEIHLLKTLK-HRNIMKFYTSWVD 93 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s-----~e~~e~l~~Ei~iLk~L~-HpNIVkl~~~fv~ 93 (738)
.++|.+.+.||+|+||+||+|.+..+|..||+|+++....... ....+++.+|+.+|+.|+ ||||++++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCCCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCH
Q ss_conf 58985999992379999999999669999999999999999999998819999030468755179808999299941532
Q 004672 94 TANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 173 (738)
Q Consensus 94 ~~~~~i~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGl 173 (738)
+..+|+||||+++|+|.+++..++++++..++.|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 82 --~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~-~~~kl~DFG~ 156 (277)
T d1phka_ 82 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDD-MNIKLTDFGF 156 (277)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTT
T ss_pred --CCCEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCEEEECCC-CCEEECCCHH
T ss_conf --7605999976898668999986599999999999999999999998759--9432346254898689-9838712403
Q ss_pred HHHHHCCC-CCCCCCCCCCCCCCCCCC-------CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--C
Q ss_conf 68752024-553369988789321012-------4683100002102266555258999999998999999991999--9
Q 004672 174 AAILRKSH-AARCVGTPEFMAPEVYEE-------EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--P 243 (738)
Q Consensus 174 A~~~~~~~-~~~~~GTp~YmAPEvl~~-------~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~--p 243 (738)
+..+.... .....||+.|+|||++.+ .|+.++||||+|+++|+|+||+.||.+ .+...+...+..+.. +
T Consensus 157 a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~-~~~~~~~~~i~~~~~~~~ 235 (277)
T d1phka_ 157 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFG 235 (277)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCC
T ss_pred EEECCCCCCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCC-CCHHHHHHHHHHCCCCCC
T ss_conf 1672688721345246788898886053445678899233185656023103228889889-999999999981898889
Q ss_pred CCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCC
Q ss_conf 63446899589999999972-7279989998952945687
Q 004672 244 EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 244 ~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpfl~~ 282 (738)
.......++++++||.+||+ +|.+|||+.|+|+||||+.
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHH
T ss_conf 8543468999999999976589668919999973978797
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=381.62 Aligned_cols=256 Identities=22% Similarity=0.284 Sum_probs=210.6
Q ss_pred EEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCC-HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEEE
Q ss_conf 089998102974799999957991999999751566799-8899999999999993799984304579784589859999
Q 004672 24 EDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQS-PEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINFV 102 (738)
Q Consensus 24 ~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s-~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~i~LV 102 (738)
+.+++||+|+||+||+|.+..+|..||+|+++....... ....+++.+|+.+|+.++|||||+++++|.. ...+++|
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~--~~~~~iv 78 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSNISLV 78 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTCCEEE
T ss_pred CCCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC--CCCEEEH
T ss_conf 95638512728299999999999699999984202124567999999999999986799998689854225--8740220
Q ss_pred EECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHHHHHHCCC-
Q ss_conf 9237999999999966999999999999999999999881999903046875517980899929994153268752024-
Q 004672 103 TEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH- 181 (738)
Q Consensus 103 ~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~~~~~~~- 181 (738)
|||+.++++..+......+++..++.|++||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|.......
T Consensus 79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~-~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECCCGGGSTTTSCCC
T ss_pred HHHHCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCC--EECCCCCCCEEEECCC-CCCCCCCCCCCCCCCCCCC
T ss_conf 455345077655412667789999999999999998863163--5503577625885377-8411465761000578755
Q ss_pred -CCCCCCCCCCCCCCCCCC--CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-CCCC--------------
Q ss_conf -553369988789321012--4683100002102266555258999999998999999991-9999--------------
Q 004672 182 -AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKKP-------------- 243 (738)
Q Consensus 182 -~~~~~GTp~YmAPEvl~~--~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~-g~~p-------------- 243 (738)
....+||+.|+|||++.. .|+.++||||+||++|+|+||.+||.+..+.+++.+.... +..+
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHCCCHHH
T ss_conf 43302047333639997267788805643630428999985969999999999999999851899725452100021344
Q ss_pred ----------CCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf ----------63446899589999999972-727998999895294568777
Q 004672 244 ----------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 244 ----------~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpfl~~~~ 284 (738)
.......++++++||.+||. +|.+||||.|+|+||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred HHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 3034789886785656899999999997638945690899996799657899
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=379.59 Aligned_cols=258 Identities=19% Similarity=0.283 Sum_probs=210.4
Q ss_pred CCCCCCCCEEEE-EECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEE
Q ss_conf 676789900899-9810297479999995799199999975156679988999999999999937-99984304579784
Q 004672 16 KLIPLEDMEDTM-KFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVD 93 (738)
Q Consensus 16 ~~I~~~~y~il~-kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~ 93 (738)
...-.++|.++. .||+|+||+||+|.+..+|..||+|+++.. ..+.+|+.++.++ +|||||+++++|.+
T Consensus 6 ~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp CSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CCCCCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC---------HHHHHHHHHHHHHCCCCCCCEEEEEEEE
T ss_conf 9970148798107965454869999998899989999998974---------7799999999986699997829899950
Q ss_pred --CCCCEEEEEEECCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEEC--CCCCEE
Q ss_conf --5898599999237999999999966--9999999999999999999998819999030468755179808--999299
Q 004672 94 --TANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG--NQGEVK 167 (738)
Q Consensus 94 --~~~~~i~LV~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~--~~g~VK 167 (738)
.....+|+|||||+||+|.+++.+. .++++..++.|++||+.||.|||+++ |+||||||+|||++. +.+.+|
T Consensus 77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~K 154 (335)
T d2ozaa1 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILK 154 (335)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEE
T ss_pred CCCCCCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 3468978999997789984999998627877579999999999999999999769--86444100220113555566311
Q ss_pred EECCCHHHHHHCC-CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH---HHHHHHCCC-
Q ss_conf 9415326875202-4553369988789321012-468310000210226655525899999999899---999999199-
Q 004672 168 IGDLGLAAILRKS-HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ---IYKKVISGK- 241 (738)
Q Consensus 168 L~DFGlA~~~~~~-~~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~---i~k~i~~g~- 241 (738)
|+|||+|...... ......||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+...... +...+..+.
T Consensus 155 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~ 234 (335)
T d2ozaa1 155 LTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234 (335)
T ss_dssp ECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS
T ss_pred CCCCCEEEECCCCCCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHCCCC
T ss_conf 35455123336888643226775637927774898888888876451677886588998898877889999999853888
Q ss_pred -CCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf -9963446899589999999972-727998999895294568777
Q 004672 242 -KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 242 -~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpfl~~~~ 284 (738)
.|...+...++++++||.+||. +|.+|||+.|+|+||||+...
T Consensus 235 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHCCC
T ss_conf 889854346999999999997569965790999997098761788
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.88 Aligned_cols=256 Identities=27% Similarity=0.395 Sum_probs=211.6
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEE
Q ss_conf 89900899981029747999999579919999997515667998899999999999993799984304579784589859
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~i 99 (738)
.++|+++++||+|+||+||+|.+..+|..||+|+++... ......+++.+|+++|++++|||||+++++|.+ ...+
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--~~~~ 76 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKL 76 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEE
T ss_pred CCCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHH--CCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCC--CCCE
T ss_conf 999776517723768099999999999799999980222--575899999999999986799838874453322--4320
Q ss_pred EEEEECCCCCCHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHHHHH
Q ss_conf 999923799999999996--699999999999999999999988199990304687551798089992999415326875
Q 004672 100 NFVTEMFTSGTLRQYRLK--HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k--~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~~~ 177 (738)
++||||+.+ .+..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|...
T Consensus 77 ~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~-~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 77 YLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAF 152 (298)
T ss_dssp EEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECSTTHHHHH
T ss_pred EEEEEECCC-CHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCC--EECCCCCCHHEEECCC-CCCEECCCCCCEEC
T ss_conf 378862377-4455544202568888999999999999999865288--9921357114011346-76210357861343
Q ss_pred HCCC--CCCCCCCCCCCCCCCCCC--CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-CCCCC--------
Q ss_conf 2024--553369988789321012--4683100002102266555258999999998999999991-99996--------
Q 004672 178 RKSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKKPE-------- 244 (738)
Q Consensus 178 ~~~~--~~~~~GTp~YmAPEvl~~--~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~-g~~p~-------- 244 (738)
.... .....||+.|+|||++.. .++.++||||+|+++|+|++|+.||.+......+++.... +....
T Consensus 153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CCCCCCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCC
T ss_conf 68864100103652154112213665777422103333134279668799898899999999998328983331444222
Q ss_pred -----------------CCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCC
Q ss_conf -----------------3446899589999999972-72799899989529456877
Q 004672 245 -----------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 245 -----------------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpfl~~~ 283 (738)
......++++++||.+||. +|.+|||+.|+|+||||+.-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 421243454322220444166789999999999763995579189999678701469
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.65 Aligned_cols=251 Identities=20% Similarity=0.293 Sum_probs=213.8
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCC--HHHHHHHHHHHHHHHHCC--CCCCCEEEEEEEECC
Q ss_conf 8990089998102974799999957991999999751566799--889999999999999379--998430457978458
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQS--PEELERLYCEIHLLKTLK--HRNIMKFYTSWVDTA 95 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s--~e~~e~l~~Ei~iLk~L~--HpNIVkl~~~fv~~~ 95 (738)
.++|.+.+.||+|+||+||+|.+..+|..||+|+++....... .....++.+|+.+|+.++ ||||++++++|.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-- 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEE--
T ss_conf 883799679840878399999999999799999985688443345567999999999999743589881279999830--
Q ss_pred CCEEEEEEECCCC-CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHH
Q ss_conf 9859999923799-999999996699999999999999999999988199990304687551798089992999415326
Q 004672 96 NRNINFVTEMFTS-GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 96 ~~~i~LV~Ey~~g-GSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA 174 (738)
...+++||||+.+ +++.+++.+...+++..++.|++||+.||.|||+++ |+||||||+|||++.+.+.+||+|||+|
T Consensus 81 ~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 81 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEEECCCCEEEECCCCCC
T ss_conf 99689999833686228999861589999999999999999999998779--7556676111477447884897754653
Q ss_pred HHHHCCCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCH
Q ss_conf 8752024553369988789321012-4-6831000021022665552589999999989999999919999634468995
Q 004672 175 AILRKSHAARCVGTPEFMAPEVYEE-E-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 252 (738)
Q Consensus 175 ~~~~~~~~~~~~GTp~YmAPEvl~~-~-ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~p~~l~~~~sp 252 (738)
............||+.|+|||++.+ . ++.++||||+||++|+|+||+.||... . .+..+.. .+....++
T Consensus 159 ~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~----~i~~~~~--~~~~~~s~ 229 (273)
T d1xwsa_ 159 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---E----EIIRGQV--FFRQRVSS 229 (273)
T ss_dssp EECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---H----HHHHCCC--CCSSCCCH
T ss_pred EECCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCC---H----HHHHCCC--CCCCCCCH
T ss_conf 5324445566565877479999848997886533255403453675688998873---6----7761544--77877999
Q ss_pred HHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCC
Q ss_conf 89999999972-72799899989529456877
Q 004672 253 EVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 253 el~~lI~kcL~-dP~~RpSa~ELL~Hpfl~~~ 283 (738)
++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 230 ~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 230 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 99999999760897589399998539866788
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.31 Aligned_cols=253 Identities=24% Similarity=0.299 Sum_probs=214.4
Q ss_pred CCCCCCCEEEEEECCCCCEEEEEEEECCCC-----EEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEE
Q ss_conf 767899008999810297479999995799-----199999975156679988999999999999937-99984304579
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEG-----IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTS 90 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG-----~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~ 90 (738)
+|+.++|.+++.||+|+||+||+|.+..++ ..||+|.+.... .......+.+|+.+|+++ +|||||+++++
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCC---CHHHHHHHHHHHHHHHHHCCCCCEEEEEEE
T ss_conf 57789939701983078819999998578855420499999966335---878999999999999971589968687788
Q ss_pred EEECCCCEEEEEEECCCCCCHHHHHHHCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCCC
Q ss_conf 78458985999992379999999999669-----------------------9999999999999999999988199990
Q 004672 91 WVDTANRNINFVTEMFTSGTLRQYRLKHR-----------------------RVNIRAVKHWCRQILSGLLYLHSRDPPV 147 (738)
Q Consensus 91 fv~~~~~~i~LV~Ey~~gGSL~~~l~k~~-----------------------~lse~~i~~i~~QIl~aL~yLHs~gp~I 147 (738)
|.+ ...+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||+++ |
T Consensus 110 ~~~--~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--I 185 (325)
T d1rjba_ 110 CTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--C 185 (325)
T ss_dssp ECS--SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred EEE--CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--E
T ss_conf 862--995899997279995999998625777510221000012220012577899999999999999999997399--0
Q ss_pred EECCCCCCCEEEECCCCCEEEECCCHHHHHHCCCC----CCCCCCCCCCCCCCCC-CCCCCCCCCCCCHHHHHHHHH-CC
Q ss_conf 30468755179808999299941532687520245----5336998878932101-246831000021022665552-58
Q 004672 148 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FD 221 (738)
Q Consensus 148 IHrDIKp~NILI~~~~g~VKL~DFGlA~~~~~~~~----~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyeLlT-G~ 221 (738)
+||||||+|||++.+ +.+||+|||+|+....... ....||+.|||||++. +.|+.++|||||||++|||+| |.
T Consensus 186 iHRDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~ 264 (325)
T d1rjba_ 186 VHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264 (325)
T ss_dssp EETTCSGGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred EECCCCHHCCCCCCC-CEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCC
T ss_conf 505270321443459-8289851422220457786156234357876578388727999963303000399999983899
Q ss_pred CCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCC
Q ss_conf 999999998999999991999963446899589999999972-727998999895294
Q 004672 222 YPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDP 278 (738)
Q Consensus 222 ~Pf~~~~~~~~i~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hp 278 (738)
.||.+......+.+.+..+..+. .+...++++++||.+||+ +|.+|||+.||++|.
T Consensus 265 ~Pf~~~~~~~~~~~~~~~~~~~~-~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 321 (325)
T d1rjba_ 265 NPYPGIPVDANFYKLIQNGFKMD-QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321 (325)
T ss_dssp CSSTTCCCSHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHCCCCCC-CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf 99999898999999985699899-8876789999999997588966893999999997
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=371.41 Aligned_cols=249 Identities=22% Similarity=0.298 Sum_probs=216.9
Q ss_pred CCCCCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC
Q ss_conf 76789900899981029747999999579919999997515667998899999999999993799984304579784589
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 96 (738)
+|+.++|.+.++||+|+||+||+|.+..+|..||+|+++... ...+++.+|+.+|+.++|||||+++++|.+ .
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~ 85 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--E 85 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred EECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC-----CHHHHHHHHHHHHHHCCCCCEECCCCCEEE--C
T ss_conf 745799398659820888089999999999699999977761-----039999999999986799988267752745--7
Q ss_pred CEEEEEEECCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHH
Q ss_conf 8599999237999999999966--99999999999999999999988199990304687551798089992999415326
Q 004672 97 RNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 97 ~~i~LV~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA 174 (738)
..+++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~-~~~Kl~DFG~a 162 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADFGLS 162 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCCCT
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCEEEECCC-CCEEECCCCCE
T ss_conf 85478763146760677753035541579999999999999788898789--3057604576899899-92898324454
Q ss_pred HHHHCCCCC---CCCCCCCCCCCCCCC-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 875202455---336998878932101-2468310000210226655525899999999899999999199996344689
Q 004672 175 AILRKSHAA---RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE 250 (738)
Q Consensus 175 ~~~~~~~~~---~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~p~~l~~~~ 250 (738)
......... ...|++.|+|||++. +.|+.++||||||+++|+|++|..||....+..+++..+..+..+. .+...
T Consensus 163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~ 241 (287)
T d1opja_ 163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME-RPEGC 241 (287)
T ss_dssp TTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC-CCTTC
T ss_pred EECCCCCCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC-CCCCC
T ss_conf 65378872210355665466692787279998104302178999999867998877425999999985588888-87433
Q ss_pred CHHHHHHHHHHHH-CCCCCCCHHHHHC
Q ss_conf 9589999999972-7279989998952
Q 004672 251 DPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 251 spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
++++++||.+||. +|.+|||+.++++
T Consensus 242 ~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 242 PEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 099999999975779768939999999
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=365.60 Aligned_cols=253 Identities=18% Similarity=0.279 Sum_probs=215.3
Q ss_pred CCCCCCCCCEEEEEECCCCCEEEEEEEECCCCE---EEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEE
Q ss_conf 467678990089998102974799999957991---99999975156679988999999999999937999843045797
Q 004672 15 LKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGI---EVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSW 91 (738)
Q Consensus 15 ~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~---~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~f 91 (738)
...+..++|++.+.||+|+||+||+|.+..+|. .||+|.+.. ..+....+.+.+|+.+|++|+|||||++++++
T Consensus 20 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~ 96 (299)
T d1jpaa_ 20 AKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS---GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV 96 (299)
T ss_dssp SCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCS---SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CHHHCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECC---CCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEE
T ss_conf 622080042785698027882999999957997889999999784---45989999999999999857998886189999
Q ss_pred EECCCCEEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEEC
Q ss_conf 845898599999237999999999966-9999999999999999999998819999030468755179808999299941
Q 004672 92 VDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 170 (738)
Q Consensus 92 v~~~~~~i~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~D 170 (738)
.. ...+++||||+++|+|.+++... +.+++..+..|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|
T Consensus 97 ~~--~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~-~~~Kl~D 171 (299)
T d1jpaa_ 97 TK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSN-LVCKVSD 171 (299)
T ss_dssp CS--SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECC
T ss_pred EE--CCEEEEEEEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCEEEECCC-CCEEECC
T ss_conf 62--88779999722798530021045679999999999999999889885279--8357615044898899-9199888
Q ss_pred CCHHHHHHCCCC-------CCCCCCCCCCCCCCCC-CCCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 532687520245-------5336998878932101-246831000021022665552-5899999999899999999199
Q 004672 171 LGLAAILRKSHA-------ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGK 241 (738)
Q Consensus 171 FGlA~~~~~~~~-------~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyeLlT-G~~Pf~~~~~~~~i~k~i~~g~ 241 (738)
||+|+.+..... ....||+.|||||++. +.|+.++||||||+++|||+| |+.||.+ ....++...+..+.
T Consensus 172 FGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~-~~~~~~~~~i~~~~ 250 (299)
T d1jpaa_ 172 FGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MTNQDVINAIEQDY 250 (299)
T ss_dssp C-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTC
T ss_pred CCCCEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCC-CCHHHHHHHHHCCC
T ss_conf 44315756777765365025666883003878883699786121445357899998679999999-99999999997378
Q ss_pred CCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 9963446899589999999972-72799899989529
Q 004672 242 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 242 ~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
.+. .+...++++.+++.+||. +|.+|||+.+++++
T Consensus 251 ~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 251 RLP-PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CCC-CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CCC-CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 899-974226999999999758797689299999999
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=366.22 Aligned_cols=255 Identities=25% Similarity=0.359 Sum_probs=213.1
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEE
Q ss_conf 89900899981029747999999579919999997515667998899999999999993799984304579784589859
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~i 99 (738)
.++|.++++||+|+||+||+|.+. +|..||+|+++.... .....+++.+|+.+|+.++||||++++++|.. ...+
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~ 75 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRL 75 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCE
T ss_pred CCCCEECCEEECCCCCEEEEEEEC-CCCEEEEEEEEHHHC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC--CCCE
T ss_conf 999634318722778189999968-999999999812326--85899999999999986799868766012046--7731
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHHHHHHC
Q ss_conf 99992379999999999669999999999999999999998819999030468755179808999299941532687520
Q 004672 100 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~~~~~ 179 (738)
++++|++.++.+..+....+.+++..++.+++||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.....
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~-~~~kl~DfG~a~~~~~ 152 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINRE-GELKIADFGLARAFGI 152 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC
T ss_pred EEEEEEEHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHCCCC--EEECCCCCCEEEECCC-CCEEECCCCCCEECCC
T ss_conf 589974004567899860477514456899999999999860574--8826787750568689-9787323664301146
Q ss_pred CC--CCCCCCCCCCCCCCCCCC--CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-CCCC-----------
Q ss_conf 24--553369988789321012--4683100002102266555258999999998999999991-9999-----------
Q 004672 180 SH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKKP----------- 243 (738)
Q Consensus 180 ~~--~~~~~GTp~YmAPEvl~~--~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~-g~~p----------- 243 (738)
.. .....|++.|+|||++.+ .++.++||||+|+++|+|++|+.||.+....+++.+.... +..+
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred CCCCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 76541010243110137887178888841002111758999977979989889899999999863899711042123332
Q ss_pred --------------CCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCC
Q ss_conf --------------63446899589999999972-7279989998952945687
Q 004672 244 --------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 244 --------------~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpfl~~ 282 (738)
.......++.+++||.+||+ +|.+|||+.|+|+||||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf 214333335676466651258999999999986689668909999856922074
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=362.66 Aligned_cols=254 Identities=21% Similarity=0.319 Sum_probs=211.7
Q ss_pred CCCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEECCCC
Q ss_conf 7899008999810297479999995799199999975156679988999999999999937-999843045797845898
Q 004672 19 PLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 19 ~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~ 97 (738)
..++|+++++||.|+||+||+|.+..+|..||+|+++... .+++.+|+.+|+.+ .||||++++++|......
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~ 105 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVSR 105 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-------HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCC
T ss_conf 9867189789831748199999988999799999988899-------999999999998515799876799999816877
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHHHHH
Q ss_conf 59999923799999999996699999999999999999999988199990304687551798089992999415326875
Q 004672 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 98 ~i~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~~~ 177 (738)
.+++||||+.+++|..+ .+.+++..++.+++||+.||.|||+++ |+||||||+|||++.+.+.+||+|||+|...
T Consensus 106 ~~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 106 TPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp SEEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred CEEEEEEECCCCCHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEECCCCCEEEECCCCCCEEC
T ss_conf 12688863179858997---468999999999999999998876433--4434564412377489983664156542664
Q ss_pred HCC-CCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHC--C-----------C
Q ss_conf 202-4553369988789321012--4683100002102266555258999999998999999991--9-----------9
Q 004672 178 RKS-HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--G-----------K 241 (738)
Q Consensus 178 ~~~-~~~~~~GTp~YmAPEvl~~--~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~--g-----------~ 241 (738)
... .....+||+.|+|||++.+ .|+.++||||+|+++|+|++|..||....+.......+.. | .
T Consensus 181 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 181 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp CTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHCC
T ss_conf 68874443224864247610268888884523233545558760488999887601899999999878841555554225
Q ss_pred ----------------------CCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf ----------------------9963446899589999999972-727998999895294568777
Q 004672 242 ----------------------KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 242 ----------------------~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpfl~~~~ 284 (738)
.+.......++++++||.+||. +|.+||||.|+|+||||+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred CCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCC
T ss_conf 444743000003334331121155211244899999999998669956890899996493558879
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.60 Aligned_cols=252 Identities=21% Similarity=0.274 Sum_probs=205.1
Q ss_pred CCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC----CC
Q ss_conf 99008999810297479999995799199999975156679988999999999999937999843045797845----89
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT----AN 96 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~----~~ 96 (738)
-+|..+++||+|+||+||+|.+..+|..||+|+++.... ...+|+.+|+.|+||||++++++|... ..
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH--------HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCC
T ss_conf 776751698217683999999999997999999881606--------899999999866898987387899744765773
Q ss_pred CEEEEEEECCCCCCHHHH---HHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCH
Q ss_conf 859999923799999999---99669999999999999999999998819999030468755179808999299941532
Q 004672 97 RNINFVTEMFTSGTLRQY---RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 173 (738)
Q Consensus 97 ~~i~LV~Ey~~gGSL~~~---l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGl 173 (738)
.++++||||+++|.+..+ ......+++..++.|++||+.||.|||+++ |+||||||+|||++.+...+||+|||+
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCEEEEECCCCCEEEECCCC
T ss_conf 189999841688607888863103689999999999999999999998668--764578860378735897116733660
Q ss_pred HHHHHCC-CCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-CCC-------
Q ss_conf 6875202-455336998878932101--24683100002102266555258999999998999999991-999-------
Q 004672 174 AAILRKS-HAARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKK------- 242 (738)
Q Consensus 174 A~~~~~~-~~~~~~GTp~YmAPEvl~--~~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~-g~~------- 242 (738)
+...... .....+|++.|+|||++. ..|+.++||||+||++|+|++|+.||......+++...+.. |..
T Consensus 170 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred HHHCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHHH
T ss_conf 54404776532002555556827764046888210002465277855028799898799999999999748981776543
Q ss_pred ----------C--------CCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCC
Q ss_conf ----------9--------63446899589999999972-7279989998952945687
Q 004672 243 ----------P--------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 243 ----------p--------~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpfl~~ 282 (738)
+ .......++++.+||.+||. +|.+||||.|+|+||||+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred HCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 06210110355445674444315689999999999976589557929999966984524
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.60 Aligned_cols=256 Identities=27% Similarity=0.374 Sum_probs=213.6
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC----
Q ss_conf 8990089998102974799999957991999999751566799889999999999999379998430457978458----
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA---- 95 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~---- 95 (738)
.+.|+++++||+|+||+||+|.+..+|..||+|+++.. ..+....+++.+|+.+|+.++|||||+++++|....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~--~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP--FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSST--TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH--HCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCC
T ss_conf 77189988980177819999999999989999998522--2596999999999999986689875479998635765555
Q ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHHH
Q ss_conf 98599999237999999999966999999999999999999999881999903046875517980899929994153268
Q 004672 96 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 96 ~~~i~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~ 175 (738)
...+++||||+ +++|..+.. +.++++..++.+++||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|.
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~-~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNED-CELKILDFGLAR 169 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCE
T ss_pred CCEEEEEEECC-CCCHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCHHHCCCC-CCCCCCCCCCEE
T ss_conf 41599998405-521899987-402269999999999999999987378--7645668511112100-122113431022
Q ss_pred HHHCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-CCCC---------
Q ss_conf 752024553369988789321012--4683100002102266555258999999998999999991-9999---------
Q 004672 176 ILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKKP--------- 243 (738)
Q Consensus 176 ~~~~~~~~~~~GTp~YmAPEvl~~--~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~-g~~p--------- 243 (738)
..... .....||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+......+...... +..+
T Consensus 170 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 170 QADSE-MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp ECCSS-CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred CCCCC-CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHHHHHCC
T ss_conf 06876-31024553335889981787899650103003899999978699888976899999985037884888865300
Q ss_pred ------------------CCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCC
Q ss_conf ------------------63446899589999999972-72799899989529456877
Q 004672 244 ------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 244 ------------------~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpfl~~~ 283 (738)
.......++++++||.+||. +|.+||||.|+|+||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 03443311578666556677556899999999999772995579299999639623758
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.80 Aligned_cols=251 Identities=25% Similarity=0.375 Sum_probs=214.8
Q ss_pred CCCCCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC
Q ss_conf 76789900899981029747999999579919999997515667998899999999999993799984304579784589
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 96 (738)
+|+.++|.+.+.||+|+||+||+|.. +..||+|+++... .+....+.+.+|+.+|++++|||||++++++. .
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~---~ 75 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTA--PTPQQLQAFKNEVGVLRKTRHVNILLFMGYST---A 75 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSS--CCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC---S
T ss_pred CCCCCCEEEEEEEEECCCCEEEEEEE---CCEEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE---C
T ss_conf 31545189988983078858999999---9989999997346--99899999999999998479987864567971---5
Q ss_pred CEEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHHH
Q ss_conf 8599999237999999999966-999999999999999999999881999903046875517980899929994153268
Q 004672 97 RNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 97 ~~i~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~ 175 (738)
..+++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|.
T Consensus 76 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~-~~~Kl~DFGla~ 152 (276)
T d1uwha_ 76 PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHED-LTVKIGDFGLAT 152 (276)
T ss_dssp SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT-SSEEECCCCCSC
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCC--EECCCCCHHHEEECCC-CCEEECCCCCEE
T ss_conf 5899999658998889998523578999999999999999988875099--9516147899798189-978875002213
Q ss_pred HHHCC----CCCCCCCCCCCCCCCCCC----CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCC--
Q ss_conf 75202----455336998878932101----24683100002102266555258999999998999999991999963--
Q 004672 176 ILRKS----HAARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEA-- 245 (738)
Q Consensus 176 ~~~~~----~~~~~~GTp~YmAPEvl~----~~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~p~~-- 245 (738)
..... ......||+.|||||++. +.|+.++||||||+++|||+||+.||.+..+..++...+..+..+..
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~ 232 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS 232 (276)
T ss_dssp C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGG
T ss_pred ECCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCH
T ss_conf 33556776312566557431799999505689999531516359999999978899899896999999996588898600
Q ss_pred -CCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCC
Q ss_conf -446899589999999972-727998999895294
Q 004672 246 -LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDP 278 (738)
Q Consensus 246 -l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hp 278 (738)
.....++++.+||.+||. +|.+|||+.+++++.
T Consensus 233 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~L 267 (276)
T d1uwha_ 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267 (276)
T ss_dssp GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf 03655549999999997588976892999999999
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=363.61 Aligned_cols=258 Identities=20% Similarity=0.243 Sum_probs=216.4
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC--C
Q ss_conf 89900899981029747999999579919999997515667998899999999999993799984304579784589--8
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN--R 97 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~--~ 97 (738)
.++|.+.+.||+|+||+||+|.+..+|..||+|.++... ....+..+++.+|+.+|+.++||||+++++++..... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL-ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-TTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHH-CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCC
T ss_conf 620698689960899299999999999899999985566-4698999999999999985699988731143543268876
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHHHHH
Q ss_conf 59999923799999999996699999999999999999999988199990304687551798089992999415326875
Q 004672 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 98 ~i~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~~~ 177 (738)
.+|+||||++||+|.+++...+.+++..++.+++||+.||.|||+++ |+||||||+|||++.+ +.++++|||.+...
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~-~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISAT-NAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETT-SCEEECCCTTCEEC
T ss_pred EEEEEEECCCCCEEHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCCCCCCC-CCCEEEHHHHHHHH
T ss_conf 69999977889871011203589999999999999999999998579--5276346755665754-32010034443221
Q ss_pred HCC-----CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC-CCCCCCC
Q ss_conf 202-----4553369988789321012-46831000021022665552589999999989999999919999-6344689
Q 004672 178 RKS-----HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP-EALFKVE 250 (738)
Q Consensus 178 ~~~-----~~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~p-~~l~~~~ 250 (738)
... .....+||+.|||||++.+ .|+.++||||||+++|+|+||..||.+....+.+.+.+..+..+ .......
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCHHCCCC
T ss_conf 23544333346425762436999983999996632026528999997697998996999999999846999971003478
Q ss_pred CHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCC
Q ss_conf 9589999999972-727998999895294568
Q 004672 251 DPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 281 (738)
Q Consensus 251 spel~~lI~kcL~-dP~~RpSa~ELL~Hpfl~ 281 (738)
++++.+||.+||. +|.+||+..+.|.|+|++
T Consensus 242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHH
T ss_conf 99999999998667976777399999999999
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.74 Aligned_cols=258 Identities=26% Similarity=0.335 Sum_probs=205.2
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCC-CEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHC---CCCCCCEEEEEEEEC-
Q ss_conf 89900899981029747999999579-9199999975156679988999999999999937---999843045797845-
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYE-GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL---KHRNIMKFYTSWVDT- 94 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~t-G~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L---~HpNIVkl~~~fv~~- 94 (738)
.++|+++++||+|+||+||+|.+..+ +..||+|+++...... .....+.+|+.+|+.| +||||++++++|...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCC--HHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCC
T ss_conf 5897988899215586999999988899899999980232451--67999999999999874258988023663221466
Q ss_pred --CCCEEEEEEECCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECC
Q ss_conf --89859999923799999999996-699999999999999999999988199990304687551798089992999415
Q 004672 95 --ANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 171 (738)
Q Consensus 95 --~~~~i~LV~Ey~~gGSL~~~l~k-~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DF 171 (738)
....+++++|++.++.+...... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.+ +.+||+||
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~-~~~kl~df 160 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADF 160 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECSC
T ss_pred CCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCCCEEEECCC-CCEEECCH
T ss_conf 66674699999740587144444303789998999999999999999997588--9835798627898589-97542100
Q ss_pred CHHHHHHCC-CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHC--CCC-----
Q ss_conf 326875202-455336998878932101-24683100002102266555258999999998999999991--999-----
Q 004672 172 GLAAILRKS-HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GKK----- 242 (738)
Q Consensus 172 GlA~~~~~~-~~~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~--g~~----- 242 (738)
|++...... ......||+.|+|||++. ..|+.++||||+||++|+|+||..||.+....+.+ ..+.. +..
T Consensus 161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 161 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL-GKILDVIGLPGEEDW 239 (305)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCCCCGGGS
T ss_pred HHHHHHCCCCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHH-HHHHHHHCCCCHHCC
T ss_conf 0101100234577765485114831001798881110003289999998787998998989999-999984079961105
Q ss_pred ------------------CCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCC
Q ss_conf ------------------963446899589999999972-72799899989529456877
Q 004672 243 ------------------PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 243 ------------------p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpfl~~~ 283 (738)
...+....++.+++||.+||. +|.+||||.|+|+||||+.-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 321111033302234564544044589999999999874896679189999669634075
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.71 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=208.6
Q ss_pred CCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC---C
Q ss_conf 9900899981029747999999579919999997515667998899999999999993799984304579784589---8
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN---R 97 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~---~ 97 (738)
++|+++++||+|+||+||+|.+..+|..||+|+++... .....+++.+|+.+|+.|+||||+++++++..... .
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHC---CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCC
T ss_conf 98599789940648099999999999499999980310---958999999999999976898988588899505645541
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHHHHH
Q ss_conf 59999923799999999996699999999999999999999988199990304687551798089992999415326875
Q 004672 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 98 ~i~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~~~ 177 (738)
.++++ +++.+|+|.+++.. +++++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|...
T Consensus 85 ~~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~-~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 85 DVYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTT-CDLKICDFGLARVA 159 (345)
T ss_dssp CEEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEEC
T ss_pred EEEEE-EEECCCCHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCEEEECCC-CCEEECCCCCEEEC
T ss_conf 49999-96259865664405-89999999999999999999999789--8677787643788799-97787545705650
Q ss_pred HCCC-----CCCCCCCCCCCCCCCCCC--CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC-------
Q ss_conf 2024-----553369988789321012--46831000021022665552589999999989999999919999-------
Q 004672 178 RKSH-----AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP------- 243 (738)
Q Consensus 178 ~~~~-----~~~~~GTp~YmAPEvl~~--~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~p------- 243 (738)
.... ....+||+.|+|||++.. .|+.++||||+|+++|+|++|..||............+.....+
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf 47776410101102652000387860478887410100467013377669799788888999998765206997566423
Q ss_pred ---------------------CCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCC
Q ss_conf ---------------------63446899589999999972-727998999895294568777
Q 004672 244 ---------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 284 (738)
Q Consensus 244 ---------------------~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpfl~~~~ 284 (738)
.......++++++||.+||. +|.+||||.|+|+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 433222202446775577877783789999999999997648956790899986198655588
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.09 Aligned_cols=260 Identities=22% Similarity=0.314 Sum_probs=211.2
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC----
Q ss_conf 8990089998102974799999957991999999751566799889999999999999379998430457978458----
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTA---- 95 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~---- 95 (738)
+++|.++++||+|+||+||+|.+..+|..||+|++..... ......++.+|+.+|+.++||||+++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C--TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC--CHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCC
T ss_conf 2798899997227482999999989997999999842224--63789999999999998359996606765402465444
Q ss_pred --CCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCH
Q ss_conf --985999992379999999999669999999999999999999998819999030468755179808999299941532
Q 004672 96 --NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 173 (738)
Q Consensus 96 --~~~i~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGl 173 (738)
...+++||||+.++.+..+......+++..++.+++|++.||.|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~-~~~kl~dfg~ 163 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLKLADFGL 163 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCCTT
T ss_pred CCCCEEEEEEECCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCC--EEECCCCCHHEEECCC-CCEEEEECCE
T ss_conf 457638999853578741012220344330899999999999998852299--8856767222036689-9687631350
Q ss_pred HHHHHCC------CCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHC--CCCC
Q ss_conf 6875202------4553369988789321012--4683100002102266555258999999998999999991--9999
Q 004672 174 AAILRKS------HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GKKP 243 (738)
Q Consensus 174 A~~~~~~------~~~~~~GTp~YmAPEvl~~--~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~--g~~p 243 (738)
+...... .....+||+.|+|||++.+ .|+.++||||+|+++|+|++|+.||.+.. .......+.. +..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~-~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-EQHQLALISQLCGSIT 242 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCC
T ss_pred EEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCC-HHHHHHHHHHHCCCCC
T ss_conf 022355444321135660249787428997079998917870067864661744879989989-9999999998418998
Q ss_pred CCCC----------------------------CCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCCCC
Q ss_conf 6344----------------------------6899589999999972-7279989998952945687777
Q 004672 244 EALF----------------------------KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 285 (738)
Q Consensus 244 ~~l~----------------------------~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpfl~~~~~ 285 (738)
.... ...++++++||.+||. +|.+|+||.|+|+||||+.+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~ 313 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 313 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSC
T ss_pred HHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 25534432034443320133445550334044459989999999987389658909999974950156999
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.82 Aligned_cols=251 Identities=19% Similarity=0.288 Sum_probs=210.8
Q ss_pred CCCEEE-EEECCCCCEEEEEEEEC--CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCC
Q ss_conf 990089-99810297479999995--799199999975156679988999999999999937999843045797845898
Q 004672 21 EDMEDT-MKFLVKELQRHYRAFDE--YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 21 ~~y~il-~kLG~GafgtVYkA~d~--~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 97 (738)
..+.+. ++||+|+||+||+|... .++..||+|+++... .++...+++.+|+.+|++++|||||+++++|.. .
T Consensus 6 ~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~ 80 (277)
T d1xbba_ 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEA---E 80 (277)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---S
T ss_pred HHCEECCCCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHH--CCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC---C
T ss_conf 53700187834587829999998169738599999988010--898999999999999986799898527777505---9
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHHHHH
Q ss_conf 59999923799999999996699999999999999999999988199990304687551798089992999415326875
Q 004672 98 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 177 (738)
Q Consensus 98 ~i~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~~~ 177 (738)
.+++||||+++|+|.+++.+.+.+++..+..|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..+
T Consensus 81 ~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~-~~~kl~DFGla~~~ 157 (277)
T d1xbba_ 81 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKAL 157 (277)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCCTTCEEC
T ss_pred CEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCHHHCCCCC-CCCCCCCHHHHHHC
T ss_conf 77999974788968999752257899999999999999976687479--5567776113102356-75123413453313
Q ss_pred HCCC-----CCCCCCCCCCCCCCCCC-CCCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 2024-----55336998878932101-246831000021022665552-5899999999899999999199996344689
Q 004672 178 RKSH-----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVE 250 (738)
Q Consensus 178 ~~~~-----~~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyeLlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~l~~~~ 250 (738)
.... .....||+.|||||++. +.|+.++||||||+++|||+| |+.||.+ .+..++...+..+..+. .+...
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~~-~p~~~ 235 (277)
T d1xbba_ 158 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERMG-CPAGC 235 (277)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCCC-CCTTC
T ss_pred CCCCCCCCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCC-CCHHHHHHHHHCCCCCC-CCCCC
T ss_conf 43234432244567784203916653799984344303403132896589999999-89999999998289999-98656
Q ss_pred CHHHHHHHHHHHH-CCCCCCCHHHH---HCCCCCC
Q ss_conf 9589999999972-72799899989---5294568
Q 004672 251 DPEVRQFIEKCLA-TVSSRLSAREL---LTDPFLQ 281 (738)
Q Consensus 251 spel~~lI~kcL~-dP~~RpSa~EL---L~Hpfl~ 281 (738)
++++.+||.+||. +|.+|||+.++ |+|+|+.
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHHH
T ss_conf 79999999997588976890989999985288750
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.75 Aligned_cols=248 Identities=19% Similarity=0.290 Sum_probs=212.2
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCC
Q ss_conf 67899008999810297479999995799199999975156679988999999999999937999843045797845898
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 97 (738)
|..++|.+++.||+|+||+||+|.+. ++..||+|+++... ...+.+.+|+.+++.++||||++++++|.. ..
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~ 73 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE--QA 73 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SS
T ss_pred CCHHHCEEEEEEEECCCEEEEEEEEC-CCCEEEEEEECCCC-----CCHHHHHHHHHHHHHCCCCCCCCCCCEECC--CC
T ss_conf 89699588889820888299999988-99999999987886-----768999999999996689975653524315--99
Q ss_pred EEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHHHH
Q ss_conf 599999237999999999966-9999999999999999999998819999030468755179808999299941532687
Q 004672 98 NINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 98 ~i~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~~ 176 (738)
.+++||||+++|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~-~~~Kl~DFGla~~ 150 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN-QVIKVSDFGMTRF 150 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGG-GCEEECSCC----
T ss_pred CEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCC--EEECCCCHHHEEECCC-CCEEECCCCHHEE
T ss_conf 337999836999189975201347889999999999999877653164--3104431532666688-7768655321002
Q ss_pred HHCCCC---CCCCCCCCCCCCCCCC-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCH
Q ss_conf 520245---5336998878932101-246831000021022665552589999999989999999919999634468995
Q 004672 177 LRKSHA---ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 252 (738)
Q Consensus 177 ~~~~~~---~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~p~~l~~~~sp 252 (738)
...... ....||+.|+|||++. +.|+.++||||||+++|||+|+..|+....+..++...+..+..+. .+...++
T Consensus 151 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-~p~~~~~ 229 (263)
T d1sm2a_ 151 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-KPRLAST 229 (263)
T ss_dssp --------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC-CCTTSCH
T ss_pred CCCCCCEEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC-CCCCCCH
T ss_conf 368873350430017666785786079998403321059999999878988877899999999998068889-9543679
Q ss_pred HHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 89999999972-72799899989529
Q 004672 253 EVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 253 el~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
++.+||.+||. +|.+|||+.++++|
T Consensus 230 ~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 230 HVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 99999999765797689199999999
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.60 Aligned_cols=252 Identities=21% Similarity=0.337 Sum_probs=214.0
Q ss_pred CCCCCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC
Q ss_conf 76789900899981029747999999579919999997515667998899999999999993799984304579784589
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 96 (738)
+|+.++|++.++||+|+||+||+|.+. ++..||+|+++... ...+.+.+|+.+|++++|||||++++++. .
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~---~ 79 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVT---Q 79 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEEC---S
T ss_pred ECCHHHEEEEEEEECCCCCEEEEEEEC-CCCEEEEEEECCCC-----CCHHHHHHHHHHHHHCCCCCEEEEEEEEC---C
T ss_conf 038899388679810798289999999-99999999986476-----88899999999998679998857873104---5
Q ss_pred CEEEEEEECCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHH
Q ss_conf 8599999237999999999966--99999999999999999999988199990304687551798089992999415326
Q 004672 97 RNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 97 ~~i~LV~Ey~~gGSL~~~l~k~--~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA 174 (738)
..+++||||+++|+|.+++... .++++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~-~~~Kl~DFGla 156 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDT-LSCKIADFGLA 156 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTC
T ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHEEEECC-CCEEECCCCCE
T ss_conf 97699999578982888875147898878899999999999999997489--5467564225156202-44042341014
Q ss_pred HHHHCCC---CCCCCCCCCCCCCCCCC-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 8752024---55336998878932101-2468310000210226655525899999999899999999199996344689
Q 004672 175 AILRKSH---AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE 250 (738)
Q Consensus 175 ~~~~~~~---~~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~p~~l~~~~ 250 (738)
....... .....||+.|||||++. +.|+.++||||||+++|||+||..|+....+..++...+..+..+.. +...
T Consensus 157 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~-p~~~ 235 (272)
T d1qpca_ 157 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-PDNC 235 (272)
T ss_dssp EECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC-CTTC
T ss_pred EECCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCC-CCCC
T ss_conf 773588644203567744445828983799982456452579999999689888888899999999970688889-6557
Q ss_pred CHHHHHHHHHHHH-CCCCCCCHHHHHC--CCCCC
Q ss_conf 9589999999972-7279989998952--94568
Q 004672 251 DPEVRQFIEKCLA-TVSSRLSARELLT--DPFLQ 281 (738)
Q Consensus 251 spel~~lI~kcL~-dP~~RpSa~ELL~--Hpfl~ 281 (738)
++++.+||.+||. +|.+|||+.++++ |+||.
T Consensus 236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 1999999999758897689399999998611321
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.24 Aligned_cols=256 Identities=25% Similarity=0.346 Sum_probs=218.8
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEE
Q ss_conf 89900899981029747999999579919999997515667998899999999999993799984304579784589859
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNI 99 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~i 99 (738)
.++|+++++||+|+||+||+|.+..+|..||+|+++... ......+++.+|+.+|+.++||||++++++|.. ...+
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~ 76 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKL 76 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC--SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHH--CCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCC--CCCE
T ss_conf 999786269712868199999999999699999980321--786899999999999985675788821354444--4311
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHHHHHHC
Q ss_conf 99992379999999999669999999999999999999998819999030468755179808999299941532687520
Q 004672 100 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 179 (738)
Q Consensus 100 ~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~~~~~ 179 (738)
++|++++.+++|..++...+.+++..++.++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||.+.....
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~-~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRN-GELKLANFGLARAFGI 153 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECCS
T ss_pred EEEEEECCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC--EEEECCCCCCCCCCCC-CCEEEEECCHHHCCCC
T ss_conf 588630233222112123565403678999999999987743399--8600146761211337-8266520460110468
Q ss_pred CC--CCCCCCCCCCCCCCCCCC--CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHC--CCC-----------
Q ss_conf 24--553369988789321012--4683100002102266555258999999998999999991--999-----------
Q 004672 180 SH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GKK----------- 242 (738)
Q Consensus 180 ~~--~~~~~GTp~YmAPEvl~~--~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~--g~~----------- 242 (738)
.. .....+++.|+|||++.. .++.++||||+||++|+|++|..||....+..+....+.. +..
T Consensus 154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred CCCCCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHC
T ss_conf 87510010344310146675069888804440265418899851899998899999999999861189973551344322
Q ss_pred --------------CCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCC
Q ss_conf --------------963446899589999999972-7279989998952945687
Q 004672 243 --------------PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 282 (738)
Q Consensus 243 --------------p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpfl~~ 282 (738)
........++.+++||.+||. +|.+||||.|+|+||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 2113344454431043306568999999999986499668909999964953407
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.47 Aligned_cols=255 Identities=23% Similarity=0.378 Sum_probs=215.0
Q ss_pred CCCCCCCCCCEEEEEECCCCCEEEEEEEECCCCE----EEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEE
Q ss_conf 3467678990089998102974799999957991----999999751566799889999999999999379998430457
Q 004672 14 LLKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGI----EVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYT 89 (738)
Q Consensus 14 ~~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~----~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~ 89 (738)
+++.++..+|++++.||+|+||+||+|.+..+|. .||+|+++.. .+.+..+.+.+|+.+|+.++|||||++++
T Consensus 2 ~~~~~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~g 78 (317)
T d1xkka_ 2 LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLG 78 (317)
T ss_dssp CSEECCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCCCCCHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCC---CCHHHHHHHHHHHHHHHHCCCCCEEEEEE
T ss_conf 624388899978319820899299999995899889899999996513---49799999999999998679988815899
Q ss_pred EEEECCCCEEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEE
Q ss_conf 97845898599999237999999999966-99999999999999999999988199990304687551798089992999
Q 004672 90 SWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 168 (738)
Q Consensus 90 ~fv~~~~~~i~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL 168 (738)
+|.+ ...++++|++.+|+|.+++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ +.+||
T Consensus 79 ~~~~---~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~-~~~kl 152 (317)
T d1xkka_ 79 ICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP-QHVKI 152 (317)
T ss_dssp EEES---SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET-TEEEE
T ss_pred EEEC---CCEEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCHHHCCEECCC-CCEEE
T ss_conf 9961---9836999842687401011133457999999999999999999998769--5047621203116799-87586
Q ss_pred ECCCHHHHHHCCCC----CCCCCCCCCCCCCCCC-CCCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 41532687520245----5336998878932101-246831000021022665552-58999999998999999991999
Q 004672 169 GDLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKK 242 (738)
Q Consensus 169 ~DFGlA~~~~~~~~----~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyeLlT-G~~Pf~~~~~~~~i~k~i~~g~~ 242 (738)
+|||+|........ ....||+.|||||++. +.|+.++||||||+++|||+| |..||.+ .+..++...+..+..
T Consensus 153 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~-~~~~~~~~~i~~~~~ 231 (317)
T d1xkka_ 153 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGER 231 (317)
T ss_dssp CCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCGGGHHHHHHHTCC
T ss_pred ECCCCCEECCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHCCCC
T ss_conf 0255222335444532236510586446708874699983565440799999999779999999-998999999975998
Q ss_pred CCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCC
Q ss_conf 963446899589999999972-7279989998952945
Q 004672 243 PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 279 (738)
Q Consensus 243 p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpf 279 (738)
+. .+...++++.++|.+||. +|.+|||+.+++.|..
T Consensus 232 ~~-~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~ 268 (317)
T d1xkka_ 232 LP-QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268 (317)
T ss_dssp CC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CC-CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 99-98556899999999847899346919999999999
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.09 Aligned_cols=264 Identities=21% Similarity=0.332 Sum_probs=220.2
Q ss_pred CCCCCCCCEEEEEECCCCCEEEEEEEE---CCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCC-CCCCEEEEEE
Q ss_conf 676789900899981029747999999---579919999997515667998899999999999993799-9843045797
Q 004672 16 KLIPLEDMEDTMKFLVKELQRHYRAFD---EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH-RNIMKFYTSW 91 (738)
Q Consensus 16 ~~I~~~~y~il~kLG~GafgtVYkA~d---~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~H-pNIVkl~~~f 91 (738)
..+.+++|.++++||+|+||+||+|.+ ..+|..||+|.++...........+++.+|+.+|++++| |||+++++.+
T Consensus 19 ~~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~ 98 (322)
T d1vzoa_ 19 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 98 (322)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred CCCCHHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE
T ss_conf 53451025999898328783999999876588794899999836772101689999999999998646798399962000
Q ss_pred EECCCCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECC
Q ss_conf 84589859999923799999999996699999999999999999999988199990304687551798089992999415
Q 004672 92 VDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 171 (738)
Q Consensus 92 v~~~~~~i~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DF 171 (738)
.+ ...+++++||+.+|+|.+++...+.+++..++.+++||+.||.|||+++ |+||||||+|||++.+ |.+||+||
T Consensus 99 ~~--~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~-~~vkL~DF 173 (322)
T d1vzoa_ 99 QT--ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSN-GHVVLTDF 173 (322)
T ss_dssp EE--TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEESCS
T ss_pred CC--CCCEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHCCC--EEECCCCCCCEEECCC-CCEEEEEC
T ss_conf 24--8730012312341179999873045437888888999999998851499--8965477320124699-98887413
Q ss_pred CHHHHHHCC---CCCCCCCCCCCCCCCCCCC---CCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCHHHHHHHHHCCCC
Q ss_conf 326875202---4553369988789321012---4683100002102266555258999999---998999999991999
Q 004672 172 GLAAILRKS---HAARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSEC---THPAQIYKKVISGKK 242 (738)
Q Consensus 172 GlA~~~~~~---~~~~~~GTp~YmAPEvl~~---~ys~~sDIWSLGiiLyeLlTG~~Pf~~~---~~~~~i~k~i~~g~~ 242 (738)
|++..+... ......|++.|+|||.+.+ .++.++|||||||++|+|+||..||... .....+.+.......
T Consensus 174 G~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~ 253 (322)
T d1vzoa_ 174 GLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 253 (322)
T ss_dssp SEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC
T ss_pred CCHHHHCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCC
T ss_conf 20222034444322122233333106876057768871325177779999997689998888777799999983356899
Q ss_pred CCCCCCCCCHHHHHHHHHHHH-CCCCCC-----CHHHHHCCCCCCCCCCC
Q ss_conf 963446899589999999972-727998-----99989529456877774
Q 004672 243 PEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDYD 286 (738)
Q Consensus 243 p~~l~~~~spel~~lI~kcL~-dP~~Rp-----Sa~ELL~Hpfl~~~~~~ 286 (738)
+ ++...++++++||.+||. +|.+|+ +|.|+|+||||+..++.
T Consensus 254 ~--~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~ 301 (322)
T d1vzoa_ 254 P--YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 301 (322)
T ss_dssp C--CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred C--CCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHHCCCCHH
T ss_conf 8--86547999999999974458988199974509999749723489988
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.29 Aligned_cols=252 Identities=18% Similarity=0.310 Sum_probs=212.9
Q ss_pred CCCCCCEEEE-EECCCCCEEEEEEEECC--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC
Q ss_conf 6789900899-98102974799999957--99199999975156679988999999999999937999843045797845
Q 004672 18 IPLEDMEDTM-KFLVKELQRHYRAFDEY--EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT 94 (738)
Q Consensus 18 I~~~~y~il~-kLG~GafgtVYkA~d~~--tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~ 94 (738)
+..++|.+.. +||+|+||+||+|.+.. ++..||+|+++.. ......+++.+|+.+|++++|||||++++++..
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~- 80 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 80 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred ECCCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHH---CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-
T ss_conf 5444718878487306080999999960897689999998820---397899999999999986799888068656036-
Q ss_pred CCCEEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCH
Q ss_conf 898599999237999999999966-9999999999999999999998819999030468755179808999299941532
Q 004672 95 ANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 173 (738)
Q Consensus 95 ~~~~i~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGl 173 (738)
..+++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 81 --~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~-~~~Kl~DFGl 155 (285)
T d1u59a_ 81 --EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNR-HYAKISDFGL 155 (285)
T ss_dssp --SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEET-TEEEECCCTT
T ss_pred --CEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEECCC-CCEEECCCHH
T ss_conf --8079999807899689975212569999999999999999878998688--1057676466045468-8542033134
Q ss_pred HHHHHCCC-----CCCCCCCCCCCCCCCCC-CCCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCC
Q ss_conf 68752024-----55336998878932101-246831000021022665552-589999999989999999919999634
Q 004672 174 AAILRKSH-----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEAL 246 (738)
Q Consensus 174 A~~~~~~~-----~~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyeLlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~l 246 (738)
|..+.... .....||+.|||||++. +.|+.++||||||+++|||+| |+.||.+.. ..++...+..|..+. .
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~-~~~~~~~i~~~~~~~-~ 233 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRME-C 233 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-THHHHHHHHTTCCCC-C
T ss_pred HHCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCC-HHHHHHHHHCCCCCC-C
T ss_conf 21155434321135621137433586887279999541232201789999938999999979-999999998189999-9
Q ss_pred CCCCCHHHHHHHHHHHH-CCCCCCCHHHH---HCCCCC
Q ss_conf 46899589999999972-72799899989---529456
Q 004672 247 FKVEDPEVRQFIEKCLA-TVSSRLSAREL---LTDPFL 280 (738)
Q Consensus 247 ~~~~spel~~lI~kcL~-dP~~RpSa~EL---L~Hpfl 280 (738)
+...++++.++|.+||. +|.+|||+.++ |+|+|+
T Consensus 234 p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 97678999999999757797689099999999999999
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.95 Aligned_cols=252 Identities=19% Similarity=0.284 Sum_probs=216.3
Q ss_pred CCCCCCCCEEEEEECCCCCEEEEEEEECCCC----EEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEE
Q ss_conf 6767899008999810297479999995799----199999975156679988999999999999937999843045797
Q 004672 16 KLIPLEDMEDTMKFLVKELQRHYRAFDEYEG----IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSW 91 (738)
Q Consensus 16 ~~I~~~~y~il~kLG~GafgtVYkA~d~~tG----~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~f 91 (738)
.+|..+.|.+.+.||+|+||+||+|....++ ..||+|+++.. ........+.+|+.+|+.++|||||++++++
T Consensus 2 ~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~ 78 (283)
T d1mqba_ 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 78 (283)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCCCHHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCC---CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEE
T ss_conf 8578899686159811779099999996899878799999998844---5968999999999999856898783236778
Q ss_pred EECCCCEEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEEC
Q ss_conf 845898599999237999999999966-9999999999999999999998819999030468755179808999299941
Q 004672 92 VDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 170 (738)
Q Consensus 92 v~~~~~~i~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~D 170 (738)
.. ...+++||||+.+|+|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|
T Consensus 79 ~~--~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~-~~~Kl~D 153 (283)
T d1mqba_ 79 SK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSN-LVCKVSD 153 (283)
T ss_dssp CS--SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECC
T ss_pred EC--CCCEEEEEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCC--CCCCCCCCCEEEECCC-CEEEECC
T ss_conf 33--88038999721357402221023454208999999999998541212123--4257656442788899-8499845
Q ss_pred CCHHHHHHCCCC-----CCCCCCCCCCCCCCCC-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 532687520245-----5336998878932101-2468310000210226655525899999999899999999199996
Q 004672 171 LGLAAILRKSHA-----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE 244 (738)
Q Consensus 171 FGlA~~~~~~~~-----~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~p~ 244 (738)
||+|+.+..... ....||+.|||||++. +.|+.++||||||+++|||+++..|+....+..+++..+..+..+.
T Consensus 154 FGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~ 233 (283)
T d1mqba_ 154 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP 233 (283)
T ss_dssp CCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred CCHHHCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC
T ss_conf 51030035787652674267777343488887049999735563448989999967988655689999999986357899
Q ss_pred CCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHC
Q ss_conf 3446899589999999972-7279989998952
Q 004672 245 ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 245 ~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
. +...++++.++|.+||. +|.+|||+.++++
T Consensus 234 ~-~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 234 T-PMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp C-CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred C-CHHHHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 8-5045799999999977679768939999999
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.67 Aligned_cols=254 Identities=27% Similarity=0.361 Sum_probs=208.5
Q ss_pred CCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC----CC
Q ss_conf 99008999810297479999995799199999975156679988999999999999937999843045797845----89
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT----AN 96 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~----~~ 96 (738)
++|+++++||+|+||+||+|.|+.+|..||+|+++... .+....+++.+|+.+|+.++||||++++++|... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCC
T ss_conf 77599889621758599999999999899999988233--6979999999999999864898764899897025643457
Q ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHHHH
Q ss_conf 85999992379999999999669999999999999999999998819999030468755179808999299941532687
Q 004672 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 97 ~~i~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~~ 176 (738)
..+|+||||+.++.+ +.+ ...+++..++.+++||+.||.|||++| |+||||||+|||++.+ +.+|++|||++..
T Consensus 95 ~~~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~-~~~kl~df~~~~~ 168 (355)
T d2b1pa1 95 QDVYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLART 168 (355)
T ss_dssp CEEEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCCCC---
T ss_pred CEEEEEEECCCHHHH-HHH--HCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCCCCCCC-CCEEEECHHHHHC
T ss_conf 626999841446778-765--038999999999999999998865221--1245677632113654-4313201023211
Q ss_pred HHCCCC-CCCCCCCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHC---CCCC--------
Q ss_conf 520245-53369988789321012-4683100002102266555258999999998999999991---9999--------
Q 004672 177 LRKSHA-ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS---GKKP-------- 243 (738)
Q Consensus 177 ~~~~~~-~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~---g~~p-------- 243 (738)
...... ....||+.|+|||++.+ .|+.++||||+||++|+|++|++||.+...... ..++.. +..+
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHTTSCH
T ss_pred CCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHH-HHHHHHHCCCCCHHHHHHHHH
T ss_conf 4666553322146555581331477778774333566257898659899888977889-999997205898799987656
Q ss_pred ----------------------CCC-------CCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCC
Q ss_conf ----------------------634-------46899589999999972-72799899989529456877
Q 004672 244 ----------------------EAL-------FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 244 ----------------------~~l-------~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpfl~~~ 283 (738)
... ....++++++||.+||. +|.+||||.|+|+||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf 6777764175435666421264333543210133379999999999876994579089999669420878
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.87 Aligned_cols=256 Identities=28% Similarity=0.385 Sum_probs=210.1
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC---CC
Q ss_conf 899008999810297479999995799199999975156679988999999999999937999843045797845---89
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDT---AN 96 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~---~~ 96 (738)
.++|+++++||+|+||+||+|.+..+|..||+|+++.. ..+....+++.+|+.+|+.|+||||++++++|... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP--FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCT--TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCH--HCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCC
T ss_conf 98718888983178839999999999979999998820--0286899999999999986689874259999963464566
Q ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHHHH
Q ss_conf 85999992379999999999669999999999999999999998819999030468755179808999299941532687
Q 004672 97 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 97 ~~i~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~~ 176 (738)
...+++++++.+|+|.+++. .+++++..++.+++||+.||.|||+++ |+||||||+|||++.+ |.+|++|||++..
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~-~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLARH 170 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECCC----C
T ss_pred CCEEEEEEEECCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCCCCCCC-CCCCCCCCCHHCC
T ss_conf 86499999625886232002-245309999999999999999997388--7651667763345543-2200132100012
Q ss_pred HHCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHC--CCCCC--------
Q ss_conf 52024553369988789321012--4683100002102266555258999999998999999991--99996--------
Q 004672 177 LRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GKKPE-------- 244 (738)
Q Consensus 177 ~~~~~~~~~~GTp~YmAPEvl~~--~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~--g~~p~-------- 244 (738)
.... .....|++.|+|||++.+ .++.++||||+|+++|+|++|..||.+... ......+.. +..+.
T Consensus 171 ~~~~-~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 171 TDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp CTGG-GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred CCCC-CCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHCCCCCHHHHHHCCC
T ss_conf 5754-44434543555835533775678551243205899999768899788988-999999997307997577320010
Q ss_pred -------------------CCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCCCCCCCC
Q ss_conf -------------------3446899589999999972-72799899989529456877
Q 004672 245 -------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 283 (738)
Q Consensus 245 -------------------~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~Hpfl~~~ 283 (738)
......++++++||.+||. +|.+||||.|+|+||||+.-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 24454443035578755566267899999999999775883459389998559954879
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.54 Aligned_cols=256 Identities=23% Similarity=0.341 Sum_probs=218.4
Q ss_pred CCCCCCCCCCCCEEEEEECCCCCEEEEEEEECCCCEE--EEEEEEECCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEE
Q ss_conf 5434676789900899981029747999999579919--9999975156679988999999999999937-999843045
Q 004672 12 PSLLKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIE--VAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFY 88 (738)
Q Consensus 12 ~~~~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~--VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~ 88 (738)
|+.-+-|+.++|++.+.||+|+||+||+|.++.+|.. ||+|+++.. ...+..+.+.+|+.+|+.+ +||||++++
T Consensus 1 ~~~~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~~HpnIv~~~ 77 (309)
T d1fvra_ 1 PTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLL 77 (309)
T ss_dssp CCCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEE
T ss_pred CCCCCCCCHHHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCC---CCHHHHHHHHHHHHHHHHCCCCCCEEEEE
T ss_conf 998996687996887798207882899999989996999999997823---38579999999999998622899883678
Q ss_pred EEEEECCCCEEEEEEECCCCCCHHHHHHHC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCC
Q ss_conf 797845898599999237999999999966----------------9999999999999999999998819999030468
Q 004672 89 TSWVDTANRNINFVTEMFTSGTLRQYRLKH----------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL 152 (738)
Q Consensus 89 ~~fv~~~~~~i~LV~Ey~~gGSL~~~l~k~----------------~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDI 152 (738)
++|.. ...+++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||
T Consensus 78 ~~~~~--~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDl 153 (309)
T d1fvra_ 78 GACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDL 153 (309)
T ss_dssp EEEEE--TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCC
T ss_pred EEEEC--CCEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC--CCCCCC
T ss_conf 88841--87369999802898699998640355555123101234578999999999999999987663089--545550
Q ss_pred CCCCEEEECCCCCEEEECCCHHHHHHCCCCC-CCCCCCCCCCCCCCC-CCCCCCCCCCCCHHHHHHHHHCCC-CCCCCCC
Q ss_conf 7551798089992999415326875202455-336998878932101-246831000021022665552589-9999999
Q 004672 153 KCDNIFVNGNQGEVKIGDLGLAAILRKSHAA-RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDY-PYSECTH 229 (738)
Q Consensus 153 Kp~NILI~~~~g~VKL~DFGlA~~~~~~~~~-~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyeLlTG~~-Pf~~~~~ 229 (738)
||+|||++.+ +.+||+|||++......... ...||+.|+|||.+. +.|+.++||||||+++|||++|.. ||. ..+
T Consensus 154 kp~NIL~~~~-~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~-~~~ 231 (309)
T d1fvra_ 154 AARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMT 231 (309)
T ss_dssp SGGGEEECGG-GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT-TCC
T ss_pred CCCEEEECCC-CCEEECCCCCCCCCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCC-CCC
T ss_conf 5204898688-76387434432244422345530137755553875269999622153138899999836899999-999
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 8999999991999963446899589999999972-72799899989529
Q 004672 230 PAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 230 ~~~i~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
..+++..+..+..+.. +...++++++||.+||. +|.+|||+.+++++
T Consensus 232 ~~~~~~~i~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 232 CAELYEKLPQGYRLEK-PLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HHHHHHHGGGTCCCCC-CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHCCCCCC-CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9999999982688888-76678999999999767896689499999999
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.71 Aligned_cols=253 Identities=23% Similarity=0.316 Sum_probs=213.3
Q ss_pred CCCCCCCEEEEEECCCCCEEEEEEEECC-----CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEE
Q ss_conf 7678990089998102974799999957-----99199999975156679988999999999999937-99984304579
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEY-----EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFYTS 90 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~-----tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~~~ 90 (738)
+|+.++|.++++||+|+||+||+|.+.. +++.||+|+++.. ......+.+..|..++.++ +|+||+.+++.
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCC---CCCHHHHHHHHHHHHHHHHCCCCEEEEEEEE
T ss_conf 6167997984498416783999999867775557839999998600---1717899999999998861499849974115
Q ss_pred EEECCCCEEEEEEECCCCCCHHHHHHHCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCC
Q ss_conf 78458985999992379999999999669----------------99999999999999999999881999903046875
Q 004672 91 WVDTANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 154 (738)
Q Consensus 91 fv~~~~~~i~LV~Ey~~gGSL~~~l~k~~----------------~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp 154 (738)
+.. .+..+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||
T Consensus 86 ~~~-~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp 162 (299)
T d1ywna1 86 CTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAA 162 (299)
T ss_dssp ECS-TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred ECC-CCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCC
T ss_conf 404-797579999845899299999853666665322202332146899999999999999999887379--71786773
Q ss_pred CCEEEECCCCCEEEECCCHHHHHHCCC----CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHHC-CCCCCCCC
Q ss_conf 517980899929994153268752024----553369988789321012-468310000210226655525-89999999
Q 004672 155 DNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTF-DYPYSECT 228 (738)
Q Consensus 155 ~NILI~~~~g~VKL~DFGlA~~~~~~~----~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyeLlTG-~~Pf~~~~ 228 (738)
+|||++.+ +.+||+|||+|+...... .....||+.|||||++.+ .|+.++||||||+++|||+|+ ..||....
T Consensus 163 ~NILl~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 163 RNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGEEECGG-GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCEEECCC-CCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCC
T ss_conf 10657799-82898457520011356652224751667210203686468899663221367899999868899998999
Q ss_pred CHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 98999999991999963446899589999999972-72799899989529
Q 004672 229 HPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 229 ~~~~i~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
....+...+..+..+. .+...+++++++|.+||. +|.+|||+.|+++|
T Consensus 242 ~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 242 IDEEFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp CSHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHCCCCCC-CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 8999999996389888-886578999999999767796679199999999
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.81 Aligned_cols=250 Identities=22% Similarity=0.345 Sum_probs=213.8
Q ss_pred CCCCCCCEEEEEECCCCCEEEEEEEECCC---CEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf 76789900899981029747999999579---919999997515667998899999999999993799984304579784
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYE---GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVD 93 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~t---G~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~ 93 (738)
+|+.++|.+++.||+|+||+||+|.+..+ +..||+|.++. .......+.+.+|+.+|+.++||||+++++++.
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~---~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN---CTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT---TTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred CCCHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECC---CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-
T ss_conf 7688996987799307882999999936996449999999365---668799999999999998689999856988995-
Q ss_pred CCCCEEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCC
Q ss_conf 5898599999237999999999966-999999999999999999999881999903046875517980899929994153
Q 004672 94 TANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 172 (738)
Q Consensus 94 ~~~~~i~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFG 172 (738)
...+++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+ +.+||+|||
T Consensus 79 --~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~-~~~Kl~DfG 153 (273)
T d1mp8a_ 79 --ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-DCVKLGDFG 153 (273)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECC--
T ss_pred --CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHCCCC--EECCCCCHHHEEECCC-CCEEECCCH
T ss_conf --37479999840698077654224789999999999999987752302267--4414102655320678-967876503
Q ss_pred HHHHHHCCC---CCCCCCCCCCCCCCCCC-CCCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCC
Q ss_conf 268752024---55336998878932101-246831000021022665552-5899999999899999999199996344
Q 004672 173 LAAILRKSH---AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALF 247 (738)
Q Consensus 173 lA~~~~~~~---~~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyeLlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~l~ 247 (738)
+|....... .....||+.|+|||++. +.|+.++||||||+++|||+| |.+||.+ .+..+++..+..+..+. .+
T Consensus 154 ~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~-~~~~~~~~~i~~~~~~~-~~ 231 (273)
T d1mp8a_ 154 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERLP-MP 231 (273)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCCC-CC
T ss_pred HHEECCCCCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCC-CCHHHHHHHHHCCCCCC-CC
T ss_conf 42133677623305400583103266751699887452444247899998269999888-99999999998189998-98
Q ss_pred CCCCHHHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 6899589999999972-72799899989529
Q 004672 248 KVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 248 ~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
...++++.+||.+||. +|.+|||+.++++|
T Consensus 232 ~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 232 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 7779999999999768797689299999999
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=347.73 Aligned_cols=250 Identities=20% Similarity=0.259 Sum_probs=214.8
Q ss_pred CCCCCCCEEEEEECCCCCEEEEEEEEC-----CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEE
Q ss_conf 767899008999810297479999995-----799199999975156679988999999999999937999843045797
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDE-----YEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSW 91 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~-----~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~f 91 (738)
+++.++|.+++.||+|+||+||+|... .++..||+|+++.. ...+..+++.+|+.+|+.++||||++++++|
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHH---CCHHHHHHHHHHHHHHHHCCCCCCCCCEEEE
T ss_conf 3898893886798207883999999888765778829999998821---0857999999999999966899765524666
Q ss_pred EECCCCEEEEEEECCCCCCHHHHHHHCC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCCC
Q ss_conf 8458985999992379999999999669------------------------9999999999999999999988199990
Q 004672 92 VDTANRNINFVTEMFTSGTLRQYRLKHR------------------------RVNIRAVKHWCRQILSGLLYLHSRDPPV 147 (738)
Q Consensus 92 v~~~~~~i~LV~Ey~~gGSL~~~l~k~~------------------------~lse~~i~~i~~QIl~aL~yLHs~gp~I 147 (738)
.. ...++++|||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |
T Consensus 86 ~~--~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--i 161 (301)
T d1lufa_ 86 AV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--F 161 (301)
T ss_dssp CS--SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--C
T ss_pred CC--CCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC--E
T ss_conf 05--9803899981589929999985275542100001110012103467889899999999999999855413578--6
Q ss_pred EECCCCCCCEEEECCCCCEEEECCCHHHHHHCCC----CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHHCC-
Q ss_conf 3046875517980899929994153268752024----553369988789321012-4683100002102266555258-
Q 004672 148 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFD- 221 (738)
Q Consensus 148 IHrDIKp~NILI~~~~g~VKL~DFGlA~~~~~~~----~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyeLlTG~- 221 (738)
+||||||+|||++.+ +.+||+|||+|....... .....|++.|+|||++.+ .|+.++||||||+++|||++|.
T Consensus 162 vHrDlKp~NILld~~-~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 162 VHRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CCSCCSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred EEEEECCCCEEECCC-CCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCC
T ss_conf 854884011689899-9289833144211367764111577776767679899726889805630252362999980689
Q ss_pred CCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHC
Q ss_conf 999999998999999991999963446899589999999972-7279989998952
Q 004672 222 YPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 222 ~Pf~~~~~~~~i~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
+||.+ .+..++...+..+..+. .+...++++.++|.+||. +|.+|||+.|+++
T Consensus 241 ~p~~~-~~~~e~~~~v~~~~~~~-~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 241 QPYYG-MAHEEVIYYVRDGNILA-CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp CTTTT-SCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCC-CCHHHHHHHHHCCCCCC-CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 99999-89999999997399788-87325299999999974889657939999999
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.45 Aligned_cols=253 Identities=21% Similarity=0.279 Sum_probs=215.1
Q ss_pred CCCCCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC
Q ss_conf 76789900899981029747999999579919999997515667998899999999999993799984304579784589
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 96 (738)
+|+.++|++.+.||+|+||+||+|.+.. +..||+|+++... .. .+.+.+|+.+|++++|||||+++++|. .
T Consensus 13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~--~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~---~ 83 (285)
T d1fmka3 13 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT--MS---PEAFLQEAQVMKKLRHEKLVQLYAVVS---E 83 (285)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS--SC---HHHHHHHHHHHHHCCCTTBCCEEEEEC---S
T ss_pred ECCHHHEEEEEEEEECCCEEEEEEEECC-CCEEEEEEECCCC--CC---HHHHHHHHHHHHHCCCCCEEEEEEEEE---C
T ss_conf 7477997984699307980999999999-9999999988044--88---899999999998666678868999982---3
Q ss_pred CEEEEEEECCCCCCHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHH
Q ss_conf 859999923799999999996--699999999999999999999988199990304687551798089992999415326
Q 004672 97 RNINFVTEMFTSGTLRQYRLK--HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 97 ~~i~LV~Ey~~gGSL~~~l~k--~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA 174 (738)
..+++||||+++|+|..++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~-~~~kl~DfGla 160 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLA 160 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCCTT
T ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHH--EECCCCCCEEEEECCC-CCEEECCCCHH
T ss_conf 97599999447994354200003553059999999999999999875411--4335312307999899-92998442555
Q ss_pred HHHHCCC---CCCCCCCCCCCCCCCCC-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 8752024---55336998878932101-2468310000210226655525899999999899999999199996344689
Q 004672 175 AILRKSH---AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE 250 (738)
Q Consensus 175 ~~~~~~~---~~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~p~~l~~~~ 250 (738)
....... .....||+.|+|||++. +.++.++||||||+++|||+||..||.......++...+..+..+. .....
T Consensus 161 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~ 239 (285)
T d1fmka3 161 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPEC 239 (285)
T ss_dssp C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTS
T ss_pred HHCCCCCCEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC-CCCCC
T ss_conf 42568873352454556654580898379989177413235899999868999998888999999998268999-98323
Q ss_pred CHHHHHHHHHHHH-CCCCCCCHHHHHC--CCCCCC
Q ss_conf 9589999999972-7279989998952--945687
Q 004672 251 DPEVRQFIEKCLA-TVSSRLSARELLT--DPFLQI 282 (738)
Q Consensus 251 spel~~lI~kcL~-dP~~RpSa~ELL~--Hpfl~~ 282 (738)
++++++||.+||. +|.+||++.+++. ++||..
T Consensus 240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf 79999999997566975891999999987666238
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.71 Aligned_cols=247 Identities=21% Similarity=0.334 Sum_probs=212.9
Q ss_pred CCCCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCC
Q ss_conf 67899008999810297479999995799199999975156679988999999999999937999843045797845898
Q 004672 18 IPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANR 97 (738)
Q Consensus 18 I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 97 (738)
+..++|+++++||+|+||+||+|.. .++..||+|+++.... . .+.+.+|+.+++.++||||++++++|.+ ..
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~--~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~--~~ 72 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM--S---EDEFIEEAKVMMNLSHEKLVQLYGVCTK--QR 72 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSS--C---HHHHHHHHHHHHTCCCTTBCCEEEEECC--SS
T ss_pred CCHHHCEEEEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCC--C---HHHHHHHHHHHHHCCCCCEEEEEEEEEE--CC
T ss_conf 9969979968982078839999998-8998999999874757--7---8999999999996689860158899850--78
Q ss_pred EEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHHHH
Q ss_conf 599999237999999999966-9999999999999999999998819999030468755179808999299941532687
Q 004672 98 NINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 176 (738)
Q Consensus 98 ~i~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~~ 176 (738)
.+++||||+++|+|..++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~-~~~kl~DfG~a~~ 149 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQ-GVVKVSDFGLSRY 149 (258)
T ss_dssp SEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTT-CCEEECCCSSCCB
T ss_pred CEEEEEECCCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCEEEEECCC-CCEEECCCHHHEE
T ss_conf 169999704899388864102467768999999999999999875468--4346654135887699-8479886144202
Q ss_pred HHCCCC---CCCCCCCCCCCCCCCC-CCCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 520245---5336998878932101-246831000021022665552-58999999998999999991999963446899
Q 004672 177 LRKSHA---ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVED 251 (738)
Q Consensus 177 ~~~~~~---~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyeLlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~l~~~~s 251 (738)
...... ....||+.|+|||++. ..|+.++||||||+++|||+| |+.||... +..++...+..+..+. .+...+
T Consensus 150 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~-~~~~~~~~i~~~~~~~-~p~~~~ 227 (258)
T d1k2pa_ 150 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-TNSETAEHIAQGLRLY-RPHLAS 227 (258)
T ss_dssp CSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CHHHHHHHHHTTCCCC-CCTTCC
T ss_pred CCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCC-CHHHHHHHHHHCCCCC-CCCCCC
T ss_conf 35787225246578877578078637998852103364324673975599998899-9999999998079789-965465
Q ss_pred HHHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 589999999972-72799899989529
Q 004672 252 PEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 252 pel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
+++.+||.+||+ +|.+|||+.++|+|
T Consensus 228 ~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 228 EKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 999999999766897689399999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.29 Aligned_cols=250 Identities=23% Similarity=0.353 Sum_probs=215.3
Q ss_pred CCCCCCCEEEEEECCCCCEEEEEEEECCCC-------EEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEE
Q ss_conf 767899008999810297479999995799-------199999975156679988999999999999937-999843045
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEG-------IEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMKFY 88 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG-------~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVkl~ 88 (738)
.|+.++|.+++.||+|+||.||+|.+..++ ..||+|+++.. ........+.+|...+.++ +|||||+++
T Consensus 9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCC---CCHHHHHHHHHHHHHHHHHCCCCEEEECC
T ss_conf 225899697009851678289999985787555667549999998811---28688999999999999813999697346
Q ss_pred EEEEECCCCEEEEEEECCCCCCHHHHHHHCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCC
Q ss_conf 7978458985999992379999999999669----------------999999999999999999998819999030468
Q 004672 89 TSWVDTANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL 152 (738)
Q Consensus 89 ~~fv~~~~~~i~LV~Ey~~gGSL~~~l~k~~----------------~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDI 152 (738)
++|.+ ...+++||||+++|+|.+++...+ .+++..++.|+.||+.||.|||+++ |+||||
T Consensus 86 ~~~~~--~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDi 161 (299)
T d1fgka_ 86 GACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDL 161 (299)
T ss_dssp EEECS--SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred CCCCC--CCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEEEE
T ss_conf 52201--88689999736999099999860677643222334574346799999999999999998766379--786302
Q ss_pred CCCCEEEECCCCCEEEECCCHHHHHHCCC----CCCCCCCCCCCCCCCCC-CCCCCCCCCCCCHHHHHHHHH-CCCCCCC
Q ss_conf 75517980899929994153268752024----55336998878932101-246831000021022665552-5899999
Q 004672 153 KCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSE 226 (738)
Q Consensus 153 Kp~NILI~~~~g~VKL~DFGlA~~~~~~~----~~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyeLlT-G~~Pf~~ 226 (738)
||+|||++.+ +.+||+|||++....... .....|++.|+|||++. +.|+.++||||||+++|+|++ |..||.+
T Consensus 162 Kp~NiLl~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~ 240 (299)
T d1fgka_ 162 AARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240 (299)
T ss_dssp SGGGEEECTT-CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCCCEEECCC-CCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 2102245478-976762211101135555543146678884663266751798882555477588888740179898999
Q ss_pred CCCHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHC
Q ss_conf 9998999999991999963446899589999999972-7279989998952
Q 004672 227 CTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 227 ~~~~~~i~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
.+..+++..+..+..+. .+...++++.+||.+||+ +|.+|||+.|+|+
T Consensus 241 -~~~~~~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 241 -VPVEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp -CCHHHHHHHHHTTCCCC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCHHHHHHHHHCCCCCC-CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf -99999999997288889-87435299999999976679767939999999
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.26 Aligned_cols=261 Identities=21% Similarity=0.299 Sum_probs=218.2
Q ss_pred CCCCCCCCCCCCCCCCCEEEEEECCCCCEEEEEEEE-----CCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHC-C
Q ss_conf 578995434676789900899981029747999999-----5799199999975156679988999999999999937-9
Q 004672 7 KNQIPPSLLKLIPLEDMEDTMKFLVKELQRHYRAFD-----EYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-K 80 (738)
Q Consensus 7 ~~~~~~~~~~~I~~~~y~il~kLG~GafgtVYkA~d-----~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L-~ 80 (738)
+..+|....=+|+.++|.+.++||+|+||.||+|.. ..++..||+|+++.. ........+.+|+.+++.+ +
T Consensus 9 ~~~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~~E~~~~~~l~~ 85 (311)
T d1t46a_ 9 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS---AHLTEREALMSELKVLSYLGN 85 (311)
T ss_dssp TTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCCCCCCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCC---CCHHHHHHHHHHHHHHHHCCC
T ss_conf 54489840263778996985498206882999999806644778869999998742---487799999999999876269
Q ss_pred CCCCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHCC------------------CCCHHHHHHHHHHHHHHHHHHHH
Q ss_conf 998430457978458985999992379999999999669------------------99999999999999999999881
Q 004672 81 HRNIMKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR------------------RVNIRAVKHWCRQILSGLLYLHS 142 (738)
Q Consensus 81 HpNIVkl~~~fv~~~~~~i~LV~Ey~~gGSL~~~l~k~~------------------~lse~~i~~i~~QIl~aL~yLHs 142 (738)
|||||++++++.. ...+++||||+++|+|.+++.+.. .+++..+..++.||+.||.|||+
T Consensus 86 HpnIv~~~g~~~~--~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~ 163 (311)
T d1t46a_ 86 HMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS 163 (311)
T ss_dssp CTTBCCEEEEECS--SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCEEEEEEEEEE--CCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_conf 9988789989831--99789999737998799999853566544444533222334588999999999999999998875
Q ss_pred CCCCCEECCCCCCCEEEECCCCCEEEECCCHHHHHHCCC----CCCCCCCCCCCCCCCCC-CCCCCCCCCCCCHHHHHHH
Q ss_conf 999903046875517980899929994153268752024----55336998878932101-2468310000210226655
Q 004672 143 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEM 217 (738)
Q Consensus 143 ~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~~~~~~~----~~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyeL 217 (738)
++ ++||||||+|||++.+ +.+||+|||++....... .....||+.|+|||++. +.++.++||||||+++|+|
T Consensus 164 ~~--ivHrDLKp~NIl~~~~-~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~el 240 (311)
T d1t46a_ 164 KN--CIHRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240 (311)
T ss_dssp TT--CCCSCCSGGGEEEETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CC--EEECCCCCCCCCCCCC-CCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHH
T ss_conf 79--2666241021000025-75210234010233678861586201359687677886179999740010258999999
Q ss_pred HH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHC
Q ss_conf 52-58999999998999999991999963446899589999999972-7279989998952
Q 004672 218 VT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 218 lT-G~~Pf~~~~~~~~i~k~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
+| |.+||........+.+.+..+..+. .+...++++.+||.+||. +|.+|||+.++|+
T Consensus 241 lt~g~p~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 241 FSLGSSPYPGMPVDSKFYKMIKEGFRML-SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HTTTCCSSTTCCSSHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHCCCCCCCCCCHHHHHHHHHHCCCCCC-CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 8589988778998999999986689889-85436599999999975779657929999999
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.74 Aligned_cols=245 Identities=18% Similarity=0.255 Sum_probs=209.1
Q ss_pred EEEEECCCCCEEEEEEEECCC---CEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEEE
Q ss_conf 899981029747999999579---91999999751566799889999999999999379998430457978458985999
Q 004672 25 DTMKFLVKELQRHYRAFDEYE---GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNINF 101 (738)
Q Consensus 25 il~kLG~GafgtVYkA~d~~t---G~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~i~L 101 (738)
+.++||+|+||+||+|.+..+ ...||||+++. ..+....+++.+|+.+|++++||||+++++++... ...+++
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~---~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~l 106 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR---ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLV 106 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEE
T ss_pred CCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECC---CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CCCEEE
T ss_conf 66698136880999999977998799999999884---36978999999999999867899986786789806-994389
Q ss_pred EEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHHHHHHCC
Q ss_conf 99237999999999966-99999999999999999999988199990304687551798089992999415326875202
Q 004672 102 VTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS 180 (738)
Q Consensus 102 V~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA~~~~~~ 180 (738)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.+ +.+||+|||++......
T Consensus 107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~-~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEK-FTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-CCEEECSSGGGCCTTTT
T ss_pred EEEEEECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCC--CCCCCCCHHHEEECCC-CCEEEECCCCHHHCCCC
T ss_conf 99874067414421013454048999999999887652003367--6257766875767799-98899106523225566
Q ss_pred C------CCCCCCCCCCCCCCCCC-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHH
Q ss_conf 4------55336998878932101-2468310000210226655525899999999899999999199996344689958
Q 004672 181 H------AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE 253 (738)
Q Consensus 181 ~------~~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k~i~~g~~p~~l~~~~spe 253 (738)
. .....||+.|+|||++. +.|+.++||||||+++|||+||..||....+..++...+..|..+. .+...+++
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~-~p~~~~~~ 262 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-QPEYCPDP 262 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC-CCTTCCHH
T ss_pred CCCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC-CCCCCCHH
T ss_conf 55531002565556455676887437999745746619999999978999988899999999998089889-96447599
Q ss_pred HHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 9999999972-72799899989529
Q 004672 254 VRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 254 l~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
+.+||.+||. +|.+||++.|+++|
T Consensus 263 l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 263 LYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9999999768897689399999999
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.84 Aligned_cols=253 Identities=24% Similarity=0.320 Sum_probs=210.3
Q ss_pred CCCCCCCCEEEEEECCCCCEEEEEEEECC-C--CEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE
Q ss_conf 67678990089998102974799999957-9--91999999751566799889999999999999379998430457978
Q 004672 16 KLIPLEDMEDTMKFLVKELQRHYRAFDEY-E--GIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWV 92 (738)
Q Consensus 16 ~~I~~~~y~il~kLG~GafgtVYkA~d~~-t--G~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv 92 (738)
..|..++|++.+.||+|+||+||+|.... + +..||+|+++... ....+..+++.+|+.+|+.++||||+++++++.
T Consensus 3 ~~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~-~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 3 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV-LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred EEECHHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHH-CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE
T ss_conf 4886489199789803888399999998899907999999998355-579899999999999998689999878987774
Q ss_pred ECCCCEEEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECC
Q ss_conf 45898599999237999999999966-99999999999999999999988199990304687551798089992999415
Q 004672 93 DTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 171 (738)
Q Consensus 93 ~~~~~~i~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DF 171 (738)
+ ..+++||||+++|+|.+++..+ +.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+||
T Consensus 82 ~---~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~-~~vkl~Df 155 (273)
T d1u46a_ 82 T---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATR-DLVKIGDF 155 (273)
T ss_dssp S---SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET-TEEEECCC
T ss_pred E---CCHHEEEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEEEECHHHHCCCCC-CCEEECCC
T ss_conf 0---1001146542386125444212689999999999999999998752178--7520566888156556-54332561
Q ss_pred CHHHHHHCCC-----CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 3268752024-----553369988789321012-46831000021022665552-5899999999899999999199996
Q 004672 172 GLAAILRKSH-----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPE 244 (738)
Q Consensus 172 GlA~~~~~~~-----~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyeLlT-G~~Pf~~~~~~~~i~k~i~~g~~p~ 244 (738)
|++....... .....|++.|+|||++.+ .|+.++||||||+++|||+| |..||.+ .+..++...+.......
T Consensus 156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~-~~~~~~~~~i~~~~~~~ 234 (273)
T d1u46a_ 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERL 234 (273)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCC
T ss_pred HHHHHCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHHCCCCC
T ss_conf 15553035887526547632573107999983799994215661489999999689999999-69999999998479999
Q ss_pred CCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHC
Q ss_conf 3446899589999999972-7279989998952
Q 004672 245 ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 276 (738)
Q Consensus 245 ~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~ 276 (738)
..+...+++++++|.+||. +|.+|||+.++++
T Consensus 235 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 235 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 985445399999999976889667929999999
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.59 Aligned_cols=251 Identities=19% Similarity=0.309 Sum_probs=214.3
Q ss_pred CCCCCCCEEEEEECCCCCEEEEEEEECC-----CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEE
Q ss_conf 7678990089998102974799999957-----99199999975156679988999999999999937999843045797
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEY-----EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSW 91 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~-----tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~f 91 (738)
+|+.++|.+.++||+|+||+||+|.+.. ++..||+|+++.. ........+.+|+.++++++||||+++++.|
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~---~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT---SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred EECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCC---CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEE
T ss_conf 4268991883598207881899999878644778968999998701---2868999999999999976999884125478
Q ss_pred EECCCCEEEEEEECCCCCCHHHHHHHC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEEC
Q ss_conf 845898599999237999999999966----------9999999999999999999998819999030468755179808
Q 004672 92 VDTANRNINFVTEMFTSGTLRQYRLKH----------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 161 (738)
Q Consensus 92 v~~~~~~i~LV~Ey~~gGSL~~~l~k~----------~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~ 161 (738)
.. ...+++||||+.+|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.
T Consensus 93 ~~--~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~ 168 (308)
T d1p4oa_ 93 SQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAE 168 (308)
T ss_dssp CS--SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECT
T ss_pred EC--CCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECEECCCCEEECC
T ss_conf 42--88106777604899889998750332113444688799999999999999999876479--654328677540359
Q ss_pred CCCCEEEECCCHHHHHHCCC----CCCCCCCCCCCCCCCCC-CCCCCCCCCCCCHHHHHHHHHCC-CCCCCCCCHHHHHH
Q ss_conf 99929994153268752024----55336998878932101-24683100002102266555258-99999999899999
Q 004672 162 NQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFD-YPYSECTHPAQIYK 235 (738)
Q Consensus 162 ~~g~VKL~DFGlA~~~~~~~----~~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyeLlTG~-~Pf~~~~~~~~i~k 235 (738)
+ +.+||+|||+|....... .....||+.|+|||.+. +.|+.++||||||+++|||+||. .||.+ .+..+++.
T Consensus 169 ~-~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-~~~~~~~~ 246 (308)
T d1p4oa_ 169 D-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLR 246 (308)
T ss_dssp T-CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHH
T ss_pred C-CEEEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC-CCHHHHHH
T ss_conf 9-649994245420235776303134023163237888873699883334443789999999689999999-89999999
Q ss_pred HHHCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 9991999963446899589999999972-72799899989529
Q 004672 236 KVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 236 ~i~~g~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
.+..+..+.. +...++.+.++|.+||+ +|.+|||+.+++++
T Consensus 247 ~i~~~~~~~~-p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~ 288 (308)
T d1p4oa_ 247 FVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288 (308)
T ss_dssp HHHTTCCCCC-CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHCCCCCC-CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9980888888-63353999999999757796589399999999
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.39 Aligned_cols=246 Identities=20% Similarity=0.311 Sum_probs=212.4
Q ss_pred CCCCCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC
Q ss_conf 76789900899981029747999999579919999997515667998899999999999993799984304579784589
Q 004672 17 LIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN 96 (738)
Q Consensus 17 ~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 96 (738)
+|+.++|++++.||+|+||.||+|.. +|..||+|+++.. ...+.+.+|+.+|++++||||++++++|.+. .
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~ 73 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-K 73 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CCCHHHEEEEEEEECCCCEEEEEEEE--CCEEEEEEEECCH------HHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-C
T ss_conf 55789948857982079808999999--9909999998857------7799999999999867898985498788723-8
Q ss_pred CEEEEEEECCCCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEEECCCHH
Q ss_conf 85999992379999999999669--9999999999999999999988199990304687551798089992999415326
Q 004672 97 RNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 174 (738)
Q Consensus 97 ~~i~LV~Ey~~gGSL~~~l~k~~--~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL~DFGlA 174 (738)
..+++||||+++|+|.+++.+.+ .+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~-~~~kl~dfg~s 150 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLT 150 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-SCEEECCCCC-
T ss_pred CCEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCC--EECCCCCHHHHEECCC-CCEEECCCCCC
T ss_conf 92899996369998999987457888899999999999985232113376--5536665676014689-97763245600
Q ss_pred HHHHCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCH
Q ss_conf 875202455336998878932101-246831000021022665552-589999999989999999919999634468995
Q 004672 175 AILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 252 (738)
Q Consensus 175 ~~~~~~~~~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyeLlT-G~~Pf~~~~~~~~i~k~i~~g~~p~~l~~~~sp 252 (738)
...... .....+++.|+|||++. +.|+.++||||||+++|||+| |++||.. .+..++...+..+..+.. +...++
T Consensus 151 ~~~~~~-~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~-~~~~~~~~~i~~~~~~~~-~~~~~~ 227 (262)
T d1byga_ 151 KEASST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKMDA-PDGCPP 227 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTTCCCCC-CTTCCH
T ss_pred EECCCC-CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHCCCCCCC-CCCCCH
T ss_conf 344787-76556664677817872798885887775799999999789999999-999999999980899999-765799
Q ss_pred HHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf 89999999972-72799899989529
Q 004672 253 EVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 253 el~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
++++||.+||. +|.+|||+.+++++
T Consensus 228 ~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 228 AVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 99999999756697689399999999
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=324.44 Aligned_cols=250 Identities=20% Similarity=0.201 Sum_probs=197.2
Q ss_pred CCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCEEE
Q ss_conf 99008999810297479999995799199999975156679988999999999999937999843045797845898599
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTANRNIN 100 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~i~ 100 (738)
++|++++.||+|+||+||+|.+..+|..||+|.+...... +++..|+.+++.++|++++..+..+.. .....+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~i~~~l~~~~~i~~~~~~~~-~~~~~~ 79 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNV 79 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS------CCHHHHHHHHHHSTTSTTCCCEEEEEE-ETTEEE
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC------HHHHHHHHHHHHCCCCCCCCEEEEEEE-CCCEEE
T ss_conf 8899968985078809999999889989999997210058------889999999997038996017999995-198778
Q ss_pred EEEECCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEEC--CCCCEEEECCCHHHHH
Q ss_conf 99923799999999996-69999999999999999999998819999030468755179808--9992999415326875
Q 004672 101 FVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG--NQGEVKIGDLGLAAIL 177 (738)
Q Consensus 101 LV~Ey~~gGSL~~~l~k-~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~--~~g~VKL~DFGlA~~~ 177 (738)
+||||+ +++|...+.. .+.+++..+..++.|++.||.|||+++ |+||||||+|||++. ....+||+|||+|..+
T Consensus 80 ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 80 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEEEC-CCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCHHHCCCCCCCCCCEEEEECCCCCEEC
T ss_conf 999873-87133324430688768999999999999999999799--442667876606433577761565046751342
Q ss_pred HCCC---------CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHH--HHHC---CCC
Q ss_conf 2024---------553369988789321012-468310000210226655525899999999899999--9991---999
Q 004672 178 RKSH---------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK--KVIS---GKK 242 (738)
Q Consensus 178 ~~~~---------~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~~~i~k--~i~~---g~~ 242 (738)
.... .....||+.|||||++.+ .|+.++||||||+++|+|+||..||........... .... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred CCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCC
T ss_conf 55445541000135776787353299999189989832188617789999849876655305779999998523567898
Q ss_pred CCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHH---HHCCCCC
Q ss_conf 963446899589999999972-7279989998---9529456
Q 004672 243 PEALFKVEDPEVRQFIEKCLA-TVSSRLSARE---LLTDPFL 280 (738)
Q Consensus 243 p~~l~~~~spel~~lI~kcL~-dP~~RpSa~E---LL~Hpfl 280 (738)
+..+....++++.+||.+||. +|.+||++.+ +|+|+|.
T Consensus 237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 357534788999999999843995579199999999999999
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=322.55 Aligned_cols=248 Identities=25% Similarity=0.298 Sum_probs=190.9
Q ss_pred CCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCC--CE
Q ss_conf 9900899981029747999999579919999997515667998899999999999993799984304579784589--85
Q 004672 21 EDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNIMKFYTSWVDTAN--RN 98 (738)
Q Consensus 21 ~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~--~~ 98 (738)
.+|.+.+.||+|+||+||+|. .+|..||+|+++... ........|+..++.++||||+++++++..... ..
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~--~~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEE--ETTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CEEEEEEEEEECCCEEEEEEE--ECCEEEEEEEECCCC-----HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEE
T ss_conf 689998898207881999999--999899999987200-----4679999999999627998683268899837986048
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC------CCCCEECCCCCCCEEEECCCCCEEEECCC
Q ss_conf 999992379999999999669999999999999999999998819------99903046875517980899929994153
Q 004672 99 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR------DPPVIHRDLKCDNIFVNGNQGEVKIGDLG 172 (738)
Q Consensus 99 i~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~------gp~IIHrDIKp~NILI~~~~g~VKL~DFG 172 (738)
+++||||+++|+|.+++.+. .+++..+..++.|++.||.|||+. .++|+||||||+|||++.+ +.+||+|||
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~-~~~Kl~DFG 153 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLG 153 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT-SCEEECCCT
T ss_pred EEEEEECCCCCCHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCC-CCEEEEECC
T ss_conf 99999646698989998658-9998999999999999999988766520468986615317313578688-776887638
Q ss_pred HHHHHHCCC------CCCCCCCCCCCCCCCCCC-------CCCCCCCCCCCHHHHHHHHHCCCCCCCC------------
Q ss_conf 268752024------553369988789321012-------4683100002102266555258999999------------
Q 004672 173 LAAILRKSH------AARCVGTPEFMAPEVYEE-------EYNELVDIYSFGMCILEMVTFDYPYSEC------------ 227 (738)
Q Consensus 173 lA~~~~~~~------~~~~~GTp~YmAPEvl~~-------~ys~~sDIWSLGiiLyeLlTG~~Pf~~~------------ 227 (738)
++....... .....||+.|||||++.+ .++.++||||||+++|||+||..||...
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCC
T ss_conf 66234677762001355250354767822105654546777675012201599999996289988766311241012255
Q ss_pred --CCHHHHHHHHHCCCCCCCCCCC-----CCHHHHHHHHHHHH-CCCCCCCHHHHHCC
Q ss_conf --9989999999919999634468-----99589999999972-72799899989529
Q 004672 228 --THPAQIYKKVISGKKPEALFKV-----EDPEVRQFIEKCLA-TVSSRLSARELLTD 277 (738)
Q Consensus 228 --~~~~~i~k~i~~g~~p~~l~~~-----~spel~~lI~kcL~-dP~~RpSa~ELL~H 277 (738)
.....+...+..+...+.++.. ....+.+++.+||+ +|.+|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 6430999999875024688877655776899999999999760698589599999999
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=311.36 Aligned_cols=245 Identities=15% Similarity=0.159 Sum_probs=200.7
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCC-CCCCEEEEEEEECCCCE
Q ss_conf 89900899981029747999999579919999997515667998899999999999993799-98430457978458985
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH-RNIMKFYTSWVDTANRN 98 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~H-pNIVkl~~~fv~~~~~~ 98 (738)
.++|.++++||+|+||+||+|.+..+|..||+|.+..... ...+.+|+++++.|.| +||+.+++++.. +..
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~ 75 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLH 75 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC------CHHHHHHHHHHHHHCCCCCCCEEEEEEEC--CCC
T ss_conf 9806997998417882999999988997999999750258------29999999999996489998779999601--881
Q ss_pred EEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEEC----CCCCEEEECCCH
Q ss_conf 99999237999999999966-9999999999999999999998819999030468755179808----999299941532
Q 004672 99 INFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG----NQGEVKIGDLGL 173 (738)
Q Consensus 99 i~LV~Ey~~gGSL~~~l~k~-~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~----~~g~VKL~DFGl 173 (738)
.++||||+ +++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++. ..+.+||+|||+
T Consensus 76 ~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 76 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred CEEEEEEC-CCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHCC--CEECCCCCCCEEECCCCCCCCCCEEECCCCE
T ss_conf 17999964-88879999752031106899999999999999999779--6626677131523475434479568723660
Q ss_pred HHHHHCC---------CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHHCCCCCCCCC--CHHHHHHHHHCC-
Q ss_conf 6875202---------4553369988789321012-46831000021022665552589999999--989999999919-
Q 004672 174 AAILRKS---------HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT--HPAQIYKKVISG- 240 (738)
Q Consensus 174 A~~~~~~---------~~~~~~GTp~YmAPEvl~~-~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~--~~~~i~k~i~~g- 240 (738)
|...... .....+||+.|||||++.+ .|+.++||||||+++|+|+||..||.+.. .....+..+...
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~ 232 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 232 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred EEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCC
T ss_conf 57714676654111024676277510267989648888869998983199999986987678853021999999997056
Q ss_pred --CCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHHHH
Q ss_conf --99963446899589999999972-727998999895
Q 004672 241 --KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELL 275 (738)
Q Consensus 241 --~~p~~l~~~~spel~~lI~kcL~-dP~~RpSa~ELL 275 (738)
..+..+....++++.+++..|+. +|.+||++..+.
T Consensus 233 ~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 233 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred CCCCHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHH
T ss_conf 79995896579989999999998439930085999999
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=312.11 Aligned_cols=256 Identities=25% Similarity=0.312 Sum_probs=197.3
Q ss_pred CCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCC-----------CCCCCEEE
Q ss_conf 8990089998102974799999957991999999751566799889999999999999379-----------99843045
Q 004672 20 LEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-----------HRNIMKFY 88 (738)
Q Consensus 20 ~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~-----------HpNIVkl~ 88 (738)
-++|.++++||+|+||+||+|.+..+|..||+|+++.. ....+.+.+|+.+|+.++ |+||++++
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~ 86 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECC-----CCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEE
T ss_conf 78579989975077818999999999979999998343-----1336899999999998401455555422767647899
Q ss_pred EEEEECCCCEEEEEEECCCCCC-HHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEECCCCCCCEEEECCCC
Q ss_conf 7978458985999992379999-9999996--6999999999999999999999881-9999030468755179808999
Q 004672 89 TSWVDTANRNINFVTEMFTSGT-LRQYRLK--HRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQG 164 (738)
Q Consensus 89 ~~fv~~~~~~i~LV~Ey~~gGS-L~~~l~k--~~~lse~~i~~i~~QIl~aL~yLHs-~gp~IIHrDIKp~NILI~~~~g 164 (738)
+++........+++++++..+. ...+... ...+++..++.+++||+.||.|||+ .+ |+||||||+|||++.+..
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~ 164 (362)
T d1q8ya_ 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDS 164 (362)
T ss_dssp EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEET
T ss_pred EEEEECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHEEEECCCC
T ss_conf 876312565202343200035420000012234678689999999999999888764058--646567705705630576
Q ss_pred -----CEEEECCCHHHHHHCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH------HH
Q ss_conf -----2999415326875202455336998878932101-24683100002102266555258999999998------99
Q 004672 165 -----EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHP------AQ 232 (738)
Q Consensus 165 -----~VKL~DFGlA~~~~~~~~~~~~GTp~YmAPEvl~-~~ys~~sDIWSLGiiLyeLlTG~~Pf~~~~~~------~~ 232 (738)
.++++|||.+...... ....+||+.|+|||++. ..|+.++||||+|+++++|++|+.||...... ..
T Consensus 165 ~~~~~~~kl~dfg~s~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 165 PENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp TTTEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred CCCCCEEEEEECCCCCCCCCC-CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHH
T ss_conf 564430567531442123445-4223665210571321466777643201237899999878899898755432102689
Q ss_pred HHHHH-HCCCCCC--------------------------------------CCCCCCCHHHHHHHHHHHH-CCCCCCCHH
Q ss_conf 99999-9199996--------------------------------------3446899589999999972-727998999
Q 004672 233 IYKKV-ISGKKPE--------------------------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSAR 272 (738)
Q Consensus 233 i~k~i-~~g~~p~--------------------------------------~l~~~~spel~~lI~kcL~-dP~~RpSa~ 272 (738)
+...+ ..|..|. ......++++++||.+||. +|.+||||.
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH
T ss_conf 99999983799878862453220001320122024323577644421000156743589999999998779945790899
Q ss_pred HHHCCCCCCCC
Q ss_conf 89529456877
Q 004672 273 ELLTDPFLQID 283 (738)
Q Consensus 273 ELL~Hpfl~~~ 283 (738)
|+|+||||+..
T Consensus 324 e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 324 GLVNHPWLKDT 334 (362)
T ss_dssp HHHTCGGGTTC
T ss_pred HHHCCCCCCCC
T ss_conf 99669340789
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=2.2e-25 Score=170.61 Aligned_cols=173 Identities=15% Similarity=0.089 Sum_probs=123.4
Q ss_pred CEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCC----C----------CHHHHHHHHHHHHHHHHCCCCCCCEEE
Q ss_conf 00899981029747999999579919999997515667----9----------988999999999999937999843045
Q 004672 23 MEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFL----Q----------SPEELERLYCEIHLLKTLKHRNIMKFY 88 (738)
Q Consensus 23 y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~----~----------s~e~~e~l~~Ei~iLk~L~HpNIVkl~ 88 (738)
+.+.++||+|+||+||+|.+ .+|..||+|.++..... . ..........|...+..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred CHHCCEEEECCCEEEEEEEC-CCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEE
T ss_conf 02277802485659999997-99999999998604434666556563000888999999778999999981699914499
Q ss_pred EEEEECCCCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCEEEECCCCCEEE
Q ss_conf 79784589859999923799999999996699999999999999999999988199990304687551798089992999
Q 004672 89 TSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 168 (738)
Q Consensus 89 ~~fv~~~~~~i~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~gp~IIHrDIKp~NILI~~~~g~VKL 168 (738)
+. . .. +++|||++++.+.. ++...+..++.|++.+|.|||+++ |+||||||+|||++ + +.++|
T Consensus 81 ~~--~--~~--~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~-~-~~~~l 143 (191)
T d1zara2 81 AW--E--GN--AVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-E-EGIWI 143 (191)
T ss_dssp EE--E--TT--EEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-T-TEEEE
T ss_pred EE--C--CC--EEEEEEECCCCCCC-------HHHHHHHHHHHHHHHHHHHHHHCC--EEECCCCHHHEEEE-C-CCEEE
T ss_conf 86--2--88--89999504565420-------015789999999999999982688--89836890361142-8-98999
Q ss_pred ECCCHHHHHHCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCHHHH
Q ss_conf 4153268752024553369-988789321012468310000210226
Q 004672 169 GDLGLAAILRKSHAARCVG-TPEFMAPEVYEEEYNELVDIYSFGMCI 214 (738)
Q Consensus 169 ~DFGlA~~~~~~~~~~~~G-Tp~YmAPEvl~~~ys~~sDIWSLGiiL 214 (738)
+|||+|.....+....... ... .-.+.+...|+..+|+||+.--+
T Consensus 144 iDFG~a~~~~~~~~~~~l~rd~~-~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWREILERDVR-NIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHHHHHHHHHH-HHHHHHHHHHCCCCCHHHHHHHH
T ss_pred EECCCCCCCCCCCCHHHHHHHHH-HHHHHHCCCCCCCCCHHHHHHHH
T ss_conf 87788430899870999987799-99999757899844689999987
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.49 E-value=8e-07 Score=57.05 Aligned_cols=83 Identities=16% Similarity=0.142 Sum_probs=55.0
Q ss_pred EEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCC---CCHHHHHHHHHHHHHHHHC-CC--CCCCEEEEEEEECCCCE
Q ss_conf 899981029747999999579919999997515667---9988999999999999937-99--98430457978458985
Q 004672 25 DTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFL---QSPEELERLYCEIHLLKTL-KH--RNIMKFYTSWVDTANRN 98 (738)
Q Consensus 25 il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~---~s~e~~e~l~~Ei~iLk~L-~H--pNIVkl~~~fv~~~~~~ 98 (738)
..+.||.|....||+..+...+..|.+|+....-.. ..+-...+...|...|+.+ .+ ..+++++. .+. ..
T Consensus 30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~--~~ 105 (392)
T d2pula1 30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDT--EM 105 (392)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EET--TT
T ss_pred EEEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEE--ECC--CC
T ss_conf 69980798527689999579984899961771303467778887789999999999865057988552899--859--88
Q ss_pred EEEEEECCCCCCH
Q ss_conf 9999923799999
Q 004672 99 INFVTEMFTSGTL 111 (738)
Q Consensus 99 i~LV~Ey~~gGSL 111 (738)
.++|||++.+..+
T Consensus 106 ~~lvmE~L~~~~~ 118 (392)
T d2pula1 106 AVTVMEDLSHLKI 118 (392)
T ss_dssp TEEEECCCTTSEE
T ss_pred CEEEEECCCCCCC
T ss_conf 7798713577653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.49 E-value=3.9e-07 Score=58.98 Aligned_cols=151 Identities=17% Similarity=0.051 Sum_probs=92.7
Q ss_pred CCCCCCCCCCCCCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCC-CCCCCEE
Q ss_conf 899543467678990089998102974799999957991999999751566799889999999999999379-9984304
Q 004672 9 QIPPSLLKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLK-HRNIMKF 87 (738)
Q Consensus 9 ~~~~~~~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~-HpNIVkl 87 (738)
.+.+++... ++.|+.++..+.++...||+.. ..+..+.+|........ ....+.+|..++..|. +--+.++
T Consensus 4 ~~~~~l~~~--~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~----~~~~~~~E~~~l~~l~~~vpvP~v 75 (263)
T d1j7la_ 4 RISPELKKL--IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG----TTYDVEREKDMMLWLEGKLPVPKV 75 (263)
T ss_dssp SSCHHHHHH--HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT----STTCHHHHHHHHHHHTTTSCCCCE
T ss_pred CCCHHHHHH--HHCEEEEECCCCCCCCCEEEEE--ECCCEEEEEECCCCCCC----CHHHHHHHHHHHHHHHCCCCCCCE
T ss_conf 557999975--1352799767899877189999--08986999984887653----255699999999987606998728
Q ss_pred EEEEEECCCCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC-----------------------
Q ss_conf 579784589859999923799999999996699999999999999999999988199-----------------------
Q 004672 88 YTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD----------------------- 144 (738)
Q Consensus 88 ~~~fv~~~~~~i~LV~Ey~~gGSL~~~l~k~~~lse~~i~~i~~QIl~aL~yLHs~g----------------------- 144 (738)
+.+. ...+..++||++.+|.++...... ......++.++...|..||+..
T Consensus 76 l~~~--~~~~~~~lv~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (263)
T d1j7la_ 76 LHFE--RHDGWSNLLMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNN 148 (263)
T ss_dssp EEEE--EETTEEEEEEECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHT
T ss_pred EEEE--ECCCCEEEEEEECCCCCCCCCCCC-----CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHH
T ss_conf 9997--508964999986043343543344-----026999999899999998556842143576446565557789987
Q ss_pred ----------------------------------CCCEECCCCCCCEEEECCCCCEEEECCCHHH
Q ss_conf ----------------------------------9903046875517980899929994153268
Q 004672 145 ----------------------------------PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 145 ----------------------------------p~IIHrDIKp~NILI~~~~g~VKL~DFGlA~ 175 (738)
+.++|+|+.+.|||++.+ +.+-|+||+.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDwe~a~ 212 (263)
T d1j7la_ 149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSG 212 (263)
T ss_dssp TCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCE
T ss_pred HHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCC-CEEEEEECHHCC
T ss_conf 7655554303323200579999999984498678178986004764236499-659996023144
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.89 E-value=6.3e-05 Score=45.45 Aligned_cols=138 Identities=14% Similarity=-0.035 Sum_probs=76.8
Q ss_pred EEECCCCC-EEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCC--CCCCEEEEEEEECCCCEEEEEE
Q ss_conf 99810297-47999999579919999997515667998899999999999993799--9843045797845898599999
Q 004672 27 MKFLVKEL-QRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH--RNIMKFYTSWVDTANRNINFVT 103 (738)
Q Consensus 27 ~kLG~Gaf-gtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~H--pNIVkl~~~fv~~~~~~i~LV~ 103 (738)
..+..|.. ..||+... ..+..+.+|...... ...+..|...|+.|.. -.+.+++... ......++||
T Consensus 16 ~~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~-------~~~l~~E~~~l~~L~~~gvpvP~v~~~~--~~~~~~~~v~ 85 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVV--TEAGRDWLLL 85 (255)
T ss_dssp EECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEE--ECSSCEEEEE
T ss_pred EECCCCCCCCEEEEEEE-CCCCEEEEEECCCCC-------HHHHHHHHHHHHHHHHCCCCCCCEEEEC--CCCCCEEEEE
T ss_conf 87678654775899993-898789999589667-------7689999999999986599988613222--4566159998
Q ss_pred ECCCCCCHHHH--------------HHH-CC------CC--CHHHHHHHHH--------------------HHHHHHHHH
Q ss_conf 23799999999--------------996-69------99--9999999999--------------------999999998
Q 004672 104 EMFTSGTLRQY--------------RLK-HR------RV--NIRAVKHWCR--------------------QILSGLLYL 140 (738)
Q Consensus 104 Ey~~gGSL~~~--------------l~k-~~------~l--se~~i~~i~~--------------------QIl~aL~yL 140 (738)
++++|.++... +.+ |. .+ .......... .....+..+
T Consensus 86 ~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 165 (255)
T d1nd4a_ 86 GEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 165 (255)
T ss_dssp ECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred EEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHH
T ss_conf 74413554322126899999999999987368854488755412468899999987541101134011213799999999
Q ss_pred HHCC-----CCCEECCCCCCCEEEECCCCCEEEECCCHHH
Q ss_conf 8199-----9903046875517980899929994153268
Q 004672 141 HSRD-----PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 141 Hs~g-----p~IIHrDIKp~NILI~~~~g~VKL~DFGlA~ 175 (738)
.... +.++|+|+.+.|||++.+ +.+-|+||+.+.
T Consensus 166 ~~~~~~~~~~~liHgD~~~~Nvl~~~~-~~~~iID~~~~~ 204 (255)
T d1nd4a_ 166 KARMPDGEDLVVTHGDACLPNIMVENG-RFSGFIDCGRLG 204 (255)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETT-EEEEECCCTTCE
T ss_pred HHHCCCCCCCEEEECCCCCCCEEEECC-CEEEEEECHHCC
T ss_conf 871876579567867888763577379-658999853326
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.32 E-value=0.0012 Score=37.69 Aligned_cols=84 Identities=17% Similarity=0.099 Sum_probs=52.4
Q ss_pred CCCCCCCCCEEEEEECCCCCEEEEEEEECC-------CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCE
Q ss_conf 467678990089998102974799999957-------99199999975156679988999999999999937-9998430
Q 004672 15 LKLIPLEDMEDTMKFLVKELQRHYRAFDEY-------EGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTL-KHRNIMK 86 (738)
Q Consensus 15 ~~~I~~~~y~il~kLG~GafgtVYkA~d~~-------tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L-~HpNIVk 86 (738)
|..++.+++ .+..|+.|-.-.+|++.... ....|.++..- . ... .....+|..+++.+ .+.-..+
T Consensus 37 W~~~~~~~l-~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~--~~~---~idr~~E~~i~~~ls~~gl~Pk 109 (395)
T d1nw1a_ 37 WKTVPLEHL-RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N--PET---ESHLVAESVIFTLLSERHLGPK 109 (395)
T ss_dssp HHHCCGGGE-EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S--CCC---HHHHHHHHHHHHHHHHTTSSSC
T ss_pred CCCCCCCCE-EEEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-C--CCH---HHHHHHHHHHHHHHHHCCCCCE
T ss_conf 268993016-99991785334348999688775445789817999659-9--611---6589999999999975799980
Q ss_pred EEEEEEECCCCEEEEEEECCCCCCH
Q ss_conf 4579784589859999923799999
Q 004672 87 FYTSWVDTANRNINFVTEMFTSGTL 111 (738)
Q Consensus 87 l~~~fv~~~~~~i~LV~Ey~~gGSL 111 (738)
+++.+ . + ++|+||++|.+|
T Consensus 110 ll~~~--~--~--g~I~efi~g~~l 128 (395)
T d1nw1a_ 110 LYGIF--S--G--GRLEEYIPSRPL 128 (395)
T ss_dssp EEEEE--T--T--EEEECCCCEEEC
T ss_pred EEEEC--C--C--CEEEEEECCCCC
T ss_conf 89981--8--9--569997345548
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.89 E-value=0.0025 Score=35.66 Aligned_cols=135 Identities=13% Similarity=0.065 Sum_probs=70.9
Q ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCCCCC-----CEEEEEEEECCCCEEEEEEECC
Q ss_conf 29747999999579919999997515667998899999999999993799984-----3045797845898599999237
Q 004672 32 KELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKHRNI-----MKFYTSWVDTANRNINFVTEMF 106 (738)
Q Consensus 32 GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~HpNI-----Vkl~~~fv~~~~~~i~LV~Ey~ 106 (738)
+.--.||++.. .+|..|++|..+... .+ .+.+..|...|..|....| +..-+-.........+.++++.
T Consensus 33 s~EN~vy~v~~-~dg~~~VlK~~rp~~--~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~ 106 (325)
T d1zyla1 33 SYENRVYQFQD-EDRRRFVVKFYRPER--WT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 106 (325)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECTTT--SC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred CCCCEEEEEEC-CCCCEEEEEEECCCC--CC---HHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEEC
T ss_conf 61202699983-899979999847877--88---9999999999999985599878752068980566534799998652
Q ss_pred CCCC-----HHHHHH---------H----C-----CCCCH-------------------H---HHHHHHHHHHHHHHHHH
Q ss_conf 9999-----999999---------6----6-----99999-------------------9---99999999999999988
Q 004672 107 TSGT-----LRQYRL---------K----H-----RRVNI-------------------R---AVKHWCRQILSGLLYLH 141 (738)
Q Consensus 107 ~gGS-----L~~~l~---------k----~-----~~lse-------------------~---~i~~i~~QIl~aL~yLH 141 (738)
.|.. ...+.. . . ..++. . .....+..++..+.-+-
T Consensus 107 ~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~ 186 (325)
T d1zyla1 107 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 186 (325)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHC
T ss_conf 77688999999999989999998863035786556778978876656899987476998898999999999999999845
Q ss_pred -HCC-CCCEECCCCCCCEEEECCCCCEEEECCCHHH
Q ss_conf -199-9903046875517980899929994153268
Q 004672 142 -SRD-PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 142 -s~g-p~IIHrDIKp~NILI~~~~g~VKL~DFGlA~ 175 (738)
... .++||+|+.+.|||++ + + ..++||+-+.
T Consensus 187 ~~~~p~~liHgDlh~~NvL~~-~-~-~~~IDFdd~~ 219 (325)
T d1zyla1 187 REDFTVLRLHGDCHAGNILWR-D-G-PMFVDLDDAR 219 (325)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-S-EEECCCTTCC
T ss_pred CCCCCCEEECCCCCCCCEEEE-C-C-CEEEECHHCC
T ss_conf 456871202478880428783-8-9-3588652014
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.62 E-value=0.0033 Score=34.91 Aligned_cols=152 Identities=14% Similarity=0.087 Sum_probs=78.0
Q ss_pred CCCCCCCCCEEEEEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHHHHCCC-----CCCCEE-E
Q ss_conf 4676789900899981029747999999579919999997515667998899999999999993799-----984304-5
Q 004672 15 LKLIPLEDMEDTMKFLVKELQRHYRAFDEYEGIEVAWNQVKLYDFLQSPEELERLYCEIHLLKTLKH-----RNIMKF-Y 88 (738)
Q Consensus 15 ~~~I~~~~y~il~kLG~GafgtVYkA~d~~tG~~VAIK~ikl~~~~~s~e~~e~l~~Ei~iLk~L~H-----pNIVkl-~ 88 (738)
+..+.++++.-.+.|..|.--+.|+... .+| .+++|.+... .+ .+.+..|+.+|..|.. |..+.. -
T Consensus 12 l~~Y~lg~~~~~~~i~~G~~N~ny~v~t-~~g-~yVLri~~~~---~~---~~~l~~~~~~l~~L~~~g~pvp~pi~~~~ 83 (316)
T d2ppqa1 12 LTQYDVGSLTSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKR---VE---KNDLPFFLGLMQHLAAKGLSCPLPLPRKD 83 (316)
T ss_dssp HTTBCCCCEEEEEEECC---EEEEEEEE-SSC-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCCBCCBTT
T ss_pred HHHCCCCCCEEEECCCCCCCCCEEEEEE-CCC-CEEEEECCCC---CC---HHHHHHHHHHHHHHHHCCCCCCCCCEECC
T ss_conf 9867999856852378885267389997-897-2899980789---99---88999999998754302555455641048
Q ss_pred EEEEECCCCEEEEEEECCCCCCH-----HHHH---------HHC-C--------CC------------------CHHHHH
Q ss_conf 79784589859999923799999-----9999---------966-9--------99------------------999999
Q 004672 89 TSWVDTANRNINFVTEMFTSGTL-----RQYR---------LKH-R--------RV------------------NIRAVK 127 (738)
Q Consensus 89 ~~fv~~~~~~i~LV~Ey~~gGSL-----~~~l---------~k~-~--------~l------------------se~~i~ 127 (738)
+.++.........++.+..+... .... ... . .. ......
T Consensus 84 g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (316)
T d2ppqa1 84 GELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLR 163 (316)
T ss_dssp CCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHH
T ss_pred CCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHH
T ss_conf 97621341255024531146553332046788888998764544432024531011101200245677776531141279
Q ss_pred HHHHHHHHHHHHHHHCC-C-CCEECCCCCCCEEEECCCCCEEEECCCHHH
Q ss_conf 99999999999988199-9-903046875517980899929994153268
Q 004672 128 HWCRQILSGLLYLHSRD-P-PVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 175 (738)
Q Consensus 128 ~i~~QIl~aL~yLHs~g-p-~IIHrDIKp~NILI~~~~g~VKL~DFGlA~ 175 (738)
..+..+...+.-....+ | ++||+|+.++||+++++ ...-++||+.+.
T Consensus 164 ~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~-~v~gvIDF~~~~ 212 (316)
T d2ppqa1 164 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGD-ELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETT-EEEEECCCTTCE
T ss_pred HHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCC-CCEEEECCCCCC
T ss_conf 9999998764204855454503337863656402045-412674222123
|